DeSCID main publications
(click to expand or collapse)
Main publications
Buetti N, Ruckly S, de Montmollin E, Reignier J, Terzi N, Cohen Y, Shiami S, Dupuis C, Timsit JF
COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network.
Intensive Care Medicine 2021, 47, 180-187.
Ghosn J, Piroth L, Epaulard O, Le Turnier P, Mentré F, Bachelet D, Laouénan C, FCcsaig
Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1041.e1-1041.e4.
Charpentier C, Storto A, Soulié C, Ferré VM, Wirden M, Joly V, Lambert-Niclot S, Palich R, Morand-Joubert L, Landman R, Lacombe K, Katlama C, Ghosn J, Marcelin AG, Calvez V, Descamps D
Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients.
The Journal of Antimicrobial Chemotherapy 2021, 76, 2983-2987.
Bouzid D, Casalino E, Mullaert J, Laurent O, Duval X, Lescure FX, Peiffer Smadja N, Tubiana S, Armand Lefèvre L, Descamps D, Fidouh N, Choquet C, Lucet JC, Visseaux B
Added value of rapid respiratory syndromic testing at point of care versus central laboratory testing: a controlled clinical trial.
The Journal of Antimicrobial Chemotherapy 2021, 76, iii20-iii27.
Lescure FX, Bouadma L, Nguyen D, Parisey M, Wicky PH, Behillil S, Gaymard A, Bouscambert-Duchamp M, Donati F, Le Hingrat Q, Enouf V, Houhou-Fidouh N, Valette M, Mailles A, Lucet JC, Mentre F, Duval X, Descamps D, Malvy D, Timsit JF, Lina B, van-der-Werf S, Yazdanpanah Y
Clinical and virological data of the first cases of COVID-19 in Europe: a case series.
The Lancet. Infectious Diseases 2020, 20, 697-706.
Charpentier C, Peytavin G, Raffi F, Burdet C, Landman R, Lê MP, Katlama C, Collin G, Benalycherif A, Cabie A, Mentré F, Yazdanpanah Y, Descamps D, Joly V
Pharmacovirological analyses of blood and male genital compartment in patients receiving dolutegravir + lamivudine dual therapy as a switch strategy (ANRS 167 LAMIDOL trial).
The Journal of Antimicrobial Chemotherapy 2020, 75, 1611-1617.
Buetti N, Ruckly S, Lucet JC, Perozziello A, Mimoz O, Souweine B, Timsit JF
The Insertion Site Should Be Considered for the Empirical Therapy of Short-Term Central Venous and Arterial Catheter-Related Infections.
Critical Care Medicine 2020, 48, 739-744.
Le Hingrat Q, Visseaux B, Bertine M, Chauveau L, Schwartz O, Collin F, Damond F, Matheron S, Descamps D, Charpentier C
Genetic Variability of Long Terminal Repeat Region between HIV-2 Groups Impacts Transcriptional Activity.
Journal of Virology 2020, 94,
Castry M, Cousien A, Supervie V, Velter A, Ghosn J, Paltiel AD, Yazdanpanah Y, Deuffic-Burban S
Impact of test-and-treat and risk reduction strategies on HCV transmission among MSM living with HIV in France: a modelling approach.
Gut 2020
Kardaś-Słoma L, Yazdanpanah Y, Perozziello A, Zahar JR, Lescure FX, Cousien A, Lucet JC
Hand hygiene improvement or antibiotic restriction to control the household transmission of extended-spectrum β-lactamase-producing Escherichia coli: a mathematical modelling study.
Antimicrobial Resistance and Infection Control 2020, 9, 139.
Ferré V, Ekouevi D, Gbeasor-Komlanvi F, Collin G, Le Hingrat Q, Tchounga B, Salou M, Descamps D, Charpentier C, Dagnra A
Prevalence of human papillomavirus, human immunodeficiency virus and other sexually transmitted infections among female sex workers in Togo: a national cross-sectional survey.
Clinical Microbiology and Infection 2019, 25, 1560.e1-1560.e7.
Perozziello A, Lescure FX, Truel A, Routelous C, Vaillant L, Yazdanpanah Y, Lucet JC, Csg
Prescribers' experience and opinions on antimicrobial stewardship programmes in hospitals: a French nationwide survey.
The Journal of Antimicrobial Chemotherapy 2019, 74, 2451-2458.
Ibn Saied W, Mourvillier B, Cohen Y, Ruckly S, Reignier J, Marcotte G, Siami S, Bouadma L, Darmon M, de Montmollin E, Argaud L, Kallel H, Garrouste-Orgeas M, Soufir L, Schwebel C, Souweine B, Glodgran-Toledano D, Papazian L, Timsit JF
A Comparison of the Mortality Risk Associated With Ventilator-Acquired Bacterial Pneumonia and Nonventilator ICU-Acquired Bacterial Pneumonia*:.
Critical Care Medicine 2019, 47, 345-352.
Deuffic-Burban S, Huneau A, Verleene A, Brouard C, Pillonel J, Le Strat Y, Cossais S, Roudot-Thoraval F, Canva V, Mathurin P, Dhumeaux D, Yazdanpanah Y
Assessing the cost-effectiveness of hepatitis C screening strategies in France.
Journal of Hepatology 2018, 69, 785-792.
Matheron S, Descamps D, Gallien S, Besseghir A, Sellier P, Blum L, Mortier E, Charpentier C, Tubiana R, Damond F, Peytavin G, Ponscarme D, Collin F, Brun-Vezinet F, Chene G, France REcherche Nord&Sud Sida-Hiv Hépatites (ANRS) 159 HIV-2 Trial Study Group
First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2).
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018, 67, 1161-1167.
COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network.
Intensive Care Medicine 2021, 47, 180-187.
Ghosn J, Piroth L, Epaulard O, Le Turnier P, Mentré F, Bachelet D, Laouénan C, FCcsaig
Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1041.e1-1041.e4.
Charpentier C, Storto A, Soulié C, Ferré VM, Wirden M, Joly V, Lambert-Niclot S, Palich R, Morand-Joubert L, Landman R, Lacombe K, Katlama C, Ghosn J, Marcelin AG, Calvez V, Descamps D
Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients.
The Journal of Antimicrobial Chemotherapy 2021, 76, 2983-2987.
Bouzid D, Casalino E, Mullaert J, Laurent O, Duval X, Lescure FX, Peiffer Smadja N, Tubiana S, Armand Lefèvre L, Descamps D, Fidouh N, Choquet C, Lucet JC, Visseaux B
Added value of rapid respiratory syndromic testing at point of care versus central laboratory testing: a controlled clinical trial.
The Journal of Antimicrobial Chemotherapy 2021, 76, iii20-iii27.
Lescure FX, Bouadma L, Nguyen D, Parisey M, Wicky PH, Behillil S, Gaymard A, Bouscambert-Duchamp M, Donati F, Le Hingrat Q, Enouf V, Houhou-Fidouh N, Valette M, Mailles A, Lucet JC, Mentre F, Duval X, Descamps D, Malvy D, Timsit JF, Lina B, van-der-Werf S, Yazdanpanah Y
Clinical and virological data of the first cases of COVID-19 in Europe: a case series.
The Lancet. Infectious Diseases 2020, 20, 697-706.
Charpentier C, Peytavin G, Raffi F, Burdet C, Landman R, Lê MP, Katlama C, Collin G, Benalycherif A, Cabie A, Mentré F, Yazdanpanah Y, Descamps D, Joly V
Pharmacovirological analyses of blood and male genital compartment in patients receiving dolutegravir + lamivudine dual therapy as a switch strategy (ANRS 167 LAMIDOL trial).
The Journal of Antimicrobial Chemotherapy 2020, 75, 1611-1617.
Buetti N, Ruckly S, Lucet JC, Perozziello A, Mimoz O, Souweine B, Timsit JF
The Insertion Site Should Be Considered for the Empirical Therapy of Short-Term Central Venous and Arterial Catheter-Related Infections.
Critical Care Medicine 2020, 48, 739-744.
Le Hingrat Q, Visseaux B, Bertine M, Chauveau L, Schwartz O, Collin F, Damond F, Matheron S, Descamps D, Charpentier C
Genetic Variability of Long Terminal Repeat Region between HIV-2 Groups Impacts Transcriptional Activity.
Journal of Virology 2020, 94,
Castry M, Cousien A, Supervie V, Velter A, Ghosn J, Paltiel AD, Yazdanpanah Y, Deuffic-Burban S
Impact of test-and-treat and risk reduction strategies on HCV transmission among MSM living with HIV in France: a modelling approach.
Gut 2020
Kardaś-Słoma L, Yazdanpanah Y, Perozziello A, Zahar JR, Lescure FX, Cousien A, Lucet JC
Hand hygiene improvement or antibiotic restriction to control the household transmission of extended-spectrum β-lactamase-producing Escherichia coli: a mathematical modelling study.
Antimicrobial Resistance and Infection Control 2020, 9, 139.
Ferré V, Ekouevi D, Gbeasor-Komlanvi F, Collin G, Le Hingrat Q, Tchounga B, Salou M, Descamps D, Charpentier C, Dagnra A
Prevalence of human papillomavirus, human immunodeficiency virus and other sexually transmitted infections among female sex workers in Togo: a national cross-sectional survey.
Clinical Microbiology and Infection 2019, 25, 1560.e1-1560.e7.
Perozziello A, Lescure FX, Truel A, Routelous C, Vaillant L, Yazdanpanah Y, Lucet JC, Csg
Prescribers' experience and opinions on antimicrobial stewardship programmes in hospitals: a French nationwide survey.
The Journal of Antimicrobial Chemotherapy 2019, 74, 2451-2458.
Ibn Saied W, Mourvillier B, Cohen Y, Ruckly S, Reignier J, Marcotte G, Siami S, Bouadma L, Darmon M, de Montmollin E, Argaud L, Kallel H, Garrouste-Orgeas M, Soufir L, Schwebel C, Souweine B, Glodgran-Toledano D, Papazian L, Timsit JF
A Comparison of the Mortality Risk Associated With Ventilator-Acquired Bacterial Pneumonia and Nonventilator ICU-Acquired Bacterial Pneumonia*:.
Critical Care Medicine 2019, 47, 345-352.
Deuffic-Burban S, Huneau A, Verleene A, Brouard C, Pillonel J, Le Strat Y, Cossais S, Roudot-Thoraval F, Canva V, Mathurin P, Dhumeaux D, Yazdanpanah Y
Assessing the cost-effectiveness of hepatitis C screening strategies in France.
Journal of Hepatology 2018, 69, 785-792.
Matheron S, Descamps D, Gallien S, Besseghir A, Sellier P, Blum L, Mortier E, Charpentier C, Tubiana R, Damond F, Peytavin G, Ponscarme D, Collin F, Brun-Vezinet F, Chene G, France REcherche Nord&Sud Sida-Hiv Hépatites (ANRS) 159 HIV-2 Trial Study Group
First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2).
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018, 67, 1161-1167.
IAME SARS COV 2 / COVID 19 list of publications
(click to expand or collapse)
2024
Lingas G, Planas D, Péré H, Porrot F, Guivel-Benhassine F, Staropoli I, Duffy D, Chapuis N, Gobeaux C, Veyer D, Delaugerre C, Le Goff J, Getten P, Hadjadj J, Bellino A, Parfait B, Treluyer JM, Schwartz O, Guedj J, Kernéis S, Terrier B
Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection: A Modeling Analysis.
Clinical Pharmacology and Therapeutics 2024, 115, 86-94.
Battaglini D, White NM, Premraj L, Wanjiru Citarella B, Merson L, Robba C, Thomson D, Cho SM, ISARIC Clinical Characterization Group
Long-term neurological symptoms after acute COVID-19 illness requiring hospitalization in adult patients: insights from the ISARIC-COVID-19 follow-up study.
Journal of Neurology 2024, 271, 79-86.
Bichali S, Ouldali N, Godart F, Maboudou P, Houeijeh A, Leteurtre S
NT-proBNP course during MIS-C post-COVID-19: an observational study.
European Journal of Pediatrics 2024
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X, CORIMUNO-19 Collaborative Group, DisCoVeRy Study Group, ACTT-2 Study Group, ACTT-3 Study Group
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
EClinicalMedicine 2024, 69, 102472.
Hites M, Lapique EL, Massonnaud CR, Belhadi D, Jamard S, Goehringer F, Danion F, Reignier J, de Castro N, Garot D, Lacombe K, Tolsma V, Faure E, Malvy D, Staub T, Courjon J, Cazenave-Roblot F, Dyrhol Riise AM, Leturnier P, Martin-Blondel G, Roger C, Akinosoglou K, Moing VL, Piroth L, Sellier P, Lescure X, Trøseid M, Clevenbergh P, Dalgard O, Gallien S, Gousseff M, Loubet P, Vardon-Bounes F, Visée C, Belkhir L, Botelho-Nevers É, Cabié A, Kotanidou A, Lanternier F, Rouveix-Nordon E, Silva S, Thiery G, Poignard P, Carcelain G, Diallo A, Mercier N, Terzic V, Bouscambert-Duchamp M, Gaymard A, Trabaud MA, Destras G, Josset L, Billard N, Han THL, Guedj J, Couffin-Cadiergues S, Dechanet A, Delmas C, Esperou H, Fougerou-Leurent C, Mestre SL, Métois A, Noret M, Bally I, Dergan-Dylon S, Tubiana S, Kalif O, Bergaud N, Leveau B, Eustace J, Greil R, Hajdu E, Halanova M, Paiva JA, Piekarska A, Rodriguez Baño J, Tonby K, Trojánek M, Tsiodras S, Unal S, Burdet C, Costagliola D, Yazdanpanah Y, Peiffer-Smadja N, Mentré F, Ader F, DisCoVeRy study group
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial.
The Journal of Infection 2024, 88, 106120.
Fafi I, Assad Z, Lenglart L, Valtuille Z, Ouldali N
Evolution of respiratory syncytial virus burden in young children following the COVID-19 pandemic: influence of concomitant changes in testing practices.
The Lancet. Infectious Diseases 2024, 24, e216-e217.
Charmasson A, Ecollan M, Jaury P, Partouche H, Frachon A, Pinot J
Perceived impact of discussions with a healthcare professional on patients' decision regarding COVID-19 vaccine.
Human Vaccines & Immunotherapeutics 2024, 20, 2307735.
Bastard P, Gervais A, Taniguchi M, Saare L, Särekannu K, Le Voyer T, Philippot Q, Rosain J, Bizien L, Asano T, Garcia-Prat M, Parra-Martínez A, Migaud M, Tsumura M, Conti F, Belot A, Rivière JG, Morio T, Tanaka J, Javouhey E, Haerynck F, Duvlis S, Ozcelik T, Keles S, Tandjaoui-Lambiotte Y, Escoda S, Husain M, Pan-Hammarström Q, Hammarström L, Ahlijah G, Abi Haidar A, Soudee C, Arseguel V, Abolhassani H, Sahanic S, Tancevski I, Nukui Y, Hayakawa S, Chrousos GP, Michos A, Tatsi EB, Filippatos F, Rodriguez-Palmero A, Troya J, Tipu I, Meyts I, Roussel L, Ostrowski SR, Schidlowski L, Prando C, Condino-Neto A, Cheikh N, Bousfiha AA, El Bakkouri J, COVID Clinicians, GEN-COVID Study Group, COVID Human Genetic Effort, Peterson P, Pujol A, Lévy R, Quartier P, Vinh DC, Boisson B, Béziat V, Zhang SY, Borghesi A, Pession A, Andreakos E, Marr N, Mentis AFA, Mogensen TH, Rodríguez-Gallego C, Soler-Palacin P, Colobran R, Tillmann V, Neven B, Trouillet-Assant S, Brodin P, Abel L, Jouanguy E, Zhang Q, Martinón-Torres F, Salas A, Gómez-Carballa A, Gonzalez-Granado LI, Kisand K, Okada S, Puel A, Cobat A, Casanova JL
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children.
The Journal of Experimental Medicine 2024, 221, e20231353.
Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection: A Modeling Analysis.
Clinical Pharmacology and Therapeutics 2024, 115, 86-94.
Battaglini D, White NM, Premraj L, Wanjiru Citarella B, Merson L, Robba C, Thomson D, Cho SM, ISARIC Clinical Characterization Group
Long-term neurological symptoms after acute COVID-19 illness requiring hospitalization in adult patients: insights from the ISARIC-COVID-19 follow-up study.
Journal of Neurology 2024, 271, 79-86.
Bichali S, Ouldali N, Godart F, Maboudou P, Houeijeh A, Leteurtre S
NT-proBNP course during MIS-C post-COVID-19: an observational study.
European Journal of Pediatrics 2024
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X, CORIMUNO-19 Collaborative Group, DisCoVeRy Study Group, ACTT-2 Study Group, ACTT-3 Study Group
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
EClinicalMedicine 2024, 69, 102472.
Hites M, Lapique EL, Massonnaud CR, Belhadi D, Jamard S, Goehringer F, Danion F, Reignier J, de Castro N, Garot D, Lacombe K, Tolsma V, Faure E, Malvy D, Staub T, Courjon J, Cazenave-Roblot F, Dyrhol Riise AM, Leturnier P, Martin-Blondel G, Roger C, Akinosoglou K, Moing VL, Piroth L, Sellier P, Lescure X, Trøseid M, Clevenbergh P, Dalgard O, Gallien S, Gousseff M, Loubet P, Vardon-Bounes F, Visée C, Belkhir L, Botelho-Nevers É, Cabié A, Kotanidou A, Lanternier F, Rouveix-Nordon E, Silva S, Thiery G, Poignard P, Carcelain G, Diallo A, Mercier N, Terzic V, Bouscambert-Duchamp M, Gaymard A, Trabaud MA, Destras G, Josset L, Billard N, Han THL, Guedj J, Couffin-Cadiergues S, Dechanet A, Delmas C, Esperou H, Fougerou-Leurent C, Mestre SL, Métois A, Noret M, Bally I, Dergan-Dylon S, Tubiana S, Kalif O, Bergaud N, Leveau B, Eustace J, Greil R, Hajdu E, Halanova M, Paiva JA, Piekarska A, Rodriguez Baño J, Tonby K, Trojánek M, Tsiodras S, Unal S, Burdet C, Costagliola D, Yazdanpanah Y, Peiffer-Smadja N, Mentré F, Ader F, DisCoVeRy study group
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial.
The Journal of Infection 2024, 88, 106120.
Fafi I, Assad Z, Lenglart L, Valtuille Z, Ouldali N
Evolution of respiratory syncytial virus burden in young children following the COVID-19 pandemic: influence of concomitant changes in testing practices.
The Lancet. Infectious Diseases 2024, 24, e216-e217.
Charmasson A, Ecollan M, Jaury P, Partouche H, Frachon A, Pinot J
Perceived impact of discussions with a healthcare professional on patients' decision regarding COVID-19 vaccine.
Human Vaccines & Immunotherapeutics 2024, 20, 2307735.
Bastard P, Gervais A, Taniguchi M, Saare L, Särekannu K, Le Voyer T, Philippot Q, Rosain J, Bizien L, Asano T, Garcia-Prat M, Parra-Martínez A, Migaud M, Tsumura M, Conti F, Belot A, Rivière JG, Morio T, Tanaka J, Javouhey E, Haerynck F, Duvlis S, Ozcelik T, Keles S, Tandjaoui-Lambiotte Y, Escoda S, Husain M, Pan-Hammarström Q, Hammarström L, Ahlijah G, Abi Haidar A, Soudee C, Arseguel V, Abolhassani H, Sahanic S, Tancevski I, Nukui Y, Hayakawa S, Chrousos GP, Michos A, Tatsi EB, Filippatos F, Rodriguez-Palmero A, Troya J, Tipu I, Meyts I, Roussel L, Ostrowski SR, Schidlowski L, Prando C, Condino-Neto A, Cheikh N, Bousfiha AA, El Bakkouri J, COVID Clinicians, GEN-COVID Study Group, COVID Human Genetic Effort, Peterson P, Pujol A, Lévy R, Quartier P, Vinh DC, Boisson B, Béziat V, Zhang SY, Borghesi A, Pession A, Andreakos E, Marr N, Mentis AFA, Mogensen TH, Rodríguez-Gallego C, Soler-Palacin P, Colobran R, Tillmann V, Neven B, Trouillet-Assant S, Brodin P, Abel L, Jouanguy E, Zhang Q, Martinón-Torres F, Salas A, Gómez-Carballa A, Gonzalez-Granado LI, Kisand K, Okada S, Puel A, Cobat A, Casanova JL
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children.
The Journal of Experimental Medicine 2024, 221, e20231353.
2023
Labbé V, Contou D, Heming N, Megarbane B, Razazi K, Boissier F, Ait-Oufella H, Turpin M, Carreira S, Robert A, Monchi M, Souweine B, Preau S, Doyen D, Vivier E, Zucman N, Dres M, Fejjal M, Noel-Savina E, Bachir M, Jaffal K, Timsit JF, Picos SA, Mariotte E, Martis N, Juguet W, Melica G, Rondeau P, Audureau E, Mekontso Dessap A, ANTICOVID Investigators
Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical Trial.
JAMA internal medicine 2023, 183, 520-531.
Camirand-Lemyre F, Merson L, Tirupakuzhi Vijayaraghavan BK, Burrell AJC, Citarella BW, Domingue MP, Lévesque S, Usuf E, Wils EJ, Ohshimo S, Martin-Loeches I, Sandulescu O, Laake JH, Lamontagne F, ISARIC Clinical Characterisation Group
Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19.
JAMA network open 2023, 6, e2346502.
Sorin B, Gaigne L, Garzaro M, Moulis G, Mageau A, Lopez C, Roy-Peaud F, Jeandel PY, Crickx E, Dossier A, Gobert D, Hadjadj J, Puyade M, Languille L, Rasmussen C, Terrier B, Ebbo M, Bonnotte B, Audia S, Galicier L, Michel M, Mahevas M, Viallard JF, Godeau B, CERECAI (Centre de Référence des Cytopénies Auto-Immunes de L'adulte)
Severe SARS-CoV-2 infection in rituximab-treated patients with autoimmune cytopenia: A multicenter observational study.
American Journal of Hematology 2023, 98, E259-E262.
Gault N, Bachelet D, Laouénan C, Borie R, Cracowski C, Poissy J, Faure K, Lainé F, Lefèvre B, Isnard M, Patrier J, Launay O, Costagliola D, Ghosn J, Bouadma L, French COVID Cohort Study Group and The French COVID Investigators Study Group
Impact of corticosteroids use on midterm sequelae in survivors of COVID-19 admitted to hospital: A prospective cohort study.
Journal of Medical Virology 2023, 95, e28819.
Chenane HR, Lingas G, Menidjel R, Laouenan C, Tubiana S, Descamps D, Le Hingrat Q, Abel L, Guedj J, Malhotra S, Kumar-Singh S, Visseaux B, Ghosn J, Charpentier C, Lebourgeois S, French COVID Cohort Study Group
High sera levels of SARS-CoV-2 N antigen are associated with death in hospitalized COVID-19 patients.
Journal of Medical Virology 2023, 95, e29247.
Mercier N, Belhadi D, DeChanet A, Delmas C, Saillard J, Dumousseaux M, Le Mestre S, Fougerou-Leurent C, Ferrane A, Burdet C, Espérou H, Ader F, Hites M, Peiffer-Smadja N, Poissy J, Andrejak C, Paiva JA, Tacconelli E, Staub T, Greil R, Costagliola D, Mentre F, Yazdanpanah Y, Diallo A, DisCoVeRy Safety Working group
Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial.
Pharmacology Research & Perspectives 2023, 11, e01072.
Néant N, Lingas G, Gaymard A, Belhadi D, Hites M, Staub T, Greil R, Paiva JA, Poissy J, Peiffer-Smadja N, Costagliola D, Yazdanpanah Y, Bouscambert-Duchamp M, Gagneux-Brunon A, Ader F, Mentré F, Wallet F, Burdet C, Guedj J, DisCoVeRy study group
Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients.
CPT: pharmacometrics & systems pharmacology 2023, 12, 2027-2037.
Hocini H, Wiedemann A, Blengio F, Lefebvre C, Cervantes-Gonzalez M, Foucat E, Tisserand P, Surenaud M, Coléon S, Prague M, Guillaumat L, Krief C, Fenwick C, Laouénan C, Bouadma L, Ghosn J, Pantaleo G, Thiébaut R, French COVID cohort study group, Lévy Y
Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19.
Journal of Clinical Immunology 2023, 43, 882-893.
Beaumont AL, Rozencwajg S, Peiffer-Smadja N, Montravers P
COVID-19: Brief overview of therapeutic strategies.
Anaesthesia, Critical Care & Pain Medicine 2023, 42, 101181.
Amarsy R, Fournier S, Trystram D, Monteil C, Raynaud X, Jarlier V, Robert J
Decrease of hospital- and community-acquired bloodstream infections due to Streptococcus pneumoniae and Streptococcus pyogenes during the first year of the COVID-19 pandemic: A time-series analysis in Paris region..
American journal of infection control 2023, 51, 475-477.
Lefebvre T, Boutten A, Raulet-Bussian C, Raynor A, Manceau H, Puy H, Moulouel B, Schmitt C, Timsit JF, Lefort A, Weiss E, Lescure FX, Ricard JD, Sonneville R, Peoc'h K
Evaluation of iron metabolism in hospitalized COVID-19 patients.
Clinica Chimica Acta; International Journal of Clinical Chemistry 2023, 548, 117509.
Fougerou-Leurent C, Delmas C, Saillard J, Dumousseaux M, Ferrane A, Mercier N, Terzic V, Le Mestre S, Dechanet A, Belhadi D, Metois A, Burdet C, Mentré F, Noret M, Diallo A, Petrov-Sanchez V, Couffin-Cadiergues S, Hites M, Ader F, Esperou H
Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20-15 DisCoVeRy study.
Contemporary Clinical Trials 2023, 131, 107267.
Ghosn J, Bachelet D, Livrozet M, Cervantes-Gonzalez M, Poissy J, Goehringer F, Gandonniere CS, Maillet M, Bani-Sadr F, Martin-Blondel G, Tattevin P, Launay O, Surgers L, Dudoignon E, Liegeon G, Zucman D, Joseph C, Senneville E, Yelnik C, Roger PM, Faure K, Gousseff M, Cabié A, Duval X, Chirouze C, Laouénan C, French COVID cohort Study Group and the French COVID cohort Investigators Group
Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 254.e7-254.e13.
Alidjinou EK, Demaret J, Corroyer-Simovic B, Vuotto F, Miczek S, Labreuche J, Goffard A, Trauet J, Lupau D, Dendooven A, Huvent-Grelle D, Podvin J, Dreuil D, Faure K, Deplanque D, Bocket L, Duhamel A, Sobaszek A, Hober D, Hisbergues M, Puisieux F, Autran B, Yazdanpanah Y, Labalette M, Lefèvre G
Serum neutralization of SARS coronavirus 2 Omicron sublineages BA.1 and BA.2 and cellular immune responses 3 months after booster vaccination.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 258.e1-258.e4.
Martin-Blondel G, Marcelin AG, Soulié C, Kaisaridi S, Lusivika-Nzinga C, Zafilaza K, Dorival C, Nailler L, Boston A, Ronchetti AM, Melenotte C, Cabié A, Choquet C, Trinh-Duc A, Lacombe K, Gaube G, Coustillères F, Pourcher V, Martellosio JP, Peiffer-Smadja N, Chauveau M, Housset P, Piroth L, Devaux M, Pialoux G, Martin A, Dubee V, Frey J, Le Bot A, Cazanave C, Petua P, Liblau R, Carrat F, Yordanov Y
Time to negative PCR conversion amongst high-risk patients with mild-to-moderate Omicron BA.1 and BA.2 COVID-19 treated with sotrovimab or nirmatrelvir.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 543.e5-543.e9.
Bouzid D, Kapfer T, Marot S, Ing V, Ferré VM, Chauvin A, Le Goff J, Ellouze S, Salmona M, Hermand C, Bourg A, Schnuriger A, Fémy F, Van Tinh MN, Brichler S, Veyer D, Le Borgne P, Fafi-Kremer S, L'Honneur AS, Augustin C, Simon T, Cachanado M, IMProving Emergency Care (IMPEC) FHU authors group, Freund Y
Outcomes of Omicron sub-lineages BA.1.1 and BA.2 infection compared with the sub-lineage BA.1 infection in emergency departments' patients.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 551-553.
Farfour E, Clichet V, Péan de Ponfilly G, Carbonnelle E, Vasse M
Impact of COVID-19 pandemic on blood culture practices and bacteremia epidemiology..
Diagnostic microbiology and infectious disease 2023, 107, 116002.
Gentilotti E, Górska A, Tami A, Gusinow R, Mirandola M, Rodríguez Baño J, Palacios Baena ZR, Rossi E, Hasenauer J, Lopes-Rafegas I, Righi E, Caroccia N, Cataudella S, Pasquini Z, Osmo T, Del Piccolo L, Savoldi A, Kumar-Singh S, Mazzaferri F, Caponcello MG, de Boer G, Hara GL, ORCHESTRA Study Group, De Nardo P, Malhotra S, Canziani LM, Ghosn J, Florence AM, Lafhej N, van der Gun BTF, Giannella M, Laouénan C, Tacconelli E
Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort.
EClinicalMedicine 2023, 62, 102107.
Wainstein M, Spyrison N, Dai D, Ghadimi M, Chávez-Iñiguez JS, Rizo-Topete L, Citarella BW, Merson L, Pole JD, Claure-Del Granado R, Johnson DW, Shrapnel S, ISARIC Characterization Group
Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19.
Kidney International Reports 2023
Hazan F, Verdonk C, Coutance G, Ferré VM, Marot S, Melo VDD, Legeai C, Lebreton G, Para M, Varnous S, Dorent R
Severity of SARS-CoV-2 Omicron variant infection in heart transplant recipients.
The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation 2023, 42, 558-561.
Tandjaoui-Lambiotte Y, Lomont A, Moenne-Locoz P, Seytre D, Zahar JR
Spread of viruses, which measures are the most apt to control COVID-19?.
Infectious Diseases Now 2023, 53, 104637.
Mageau A, Tchen J, Ferré VM, Nicaise-Roland P, Descamps D, Delory N, François C, Mendes C, Papo T, Goulenok T, Charles N, Sacré K
Impact of BNT162b2 mRNA anti-SARS-CoV-2 vaccine on interferon-alpha production by plasmacytoid dendritic cells and autoreactive T cells in patients with systemic lupus erythematosus: The COVALUS project.
Journal of Autoimmunity 2023, 134, 102987.
Hassold N, Brichler S, Gater Y, Leclerc D, Gordien E, Bouchaud O, Carbonnelle E, Mechai F, Cordel H, Delagreverie H
Mixed outcomes following a third SARS-CoV-2 vaccine dose in previously unresponsive people with HIV.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2023, 158, 105347.
Brebant D, Couffignal C, Manchon P, Duquesne S, Picone O, Vauloup-Fellous C
Transplacental transfer of anti-SARS-CoV-2 neutralizing antibodies in comparison to other pathogens total antibodies.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2023, 165, 105495.
Farfour E, Lebourgeois S, Chenane HR, Charpentier C, Pascreau T, Jolly E, Descamps D, Vasse M, Visseaux B
SARS-CoV-2 viability and viral RNA persistence on microbiological agar plates.
The Journal of Hospital Infection 2023, 132, 140-142.
de Lamballerie X, Martin-Blondel G, Dupont A, Izopet J, Mentré F, Kamar N, Autran B, Paintaud G, Caillard S, le Bourgeois A, Richez C, Couzi L, Xhaard A, Marjanovic Z, Avouac J, Jacquet C, Anglicheau D, Cheminant M, Yazdanpanah Y, Guyen SN, Terrier B, Gottenberg JE, Besson C, Letrou S, Kali S, Angoulvant D, Sanchez VP, Tardivon C, Blancho G, Lévy V
Low serum neutralization of Omicron variants a month after AZD7442 prophylaxis initiation.
The Journal of Infection 2023, 86, 66-117.
Touret F, Martin-Blondel G, de Lamballerie X, Dupont A, Izopet J, Mentré F, Kamar N, Autran B, Paintaud G, Caillard S, Richez C, Couzi L, Xhaard A, Marjanovic Z, Avouac J, Jacquet C, Anglicheau D, Cheminant M, Yazdanpanah Y, N'Guyen S, Terrier B, Gottenberg JE, Besson C, Letrou S, Kali S, Angoulvant D, Barthélémy K, Priet S, Nurtop E, Sanchez VP, Tardivon C, Blancho G, Le Bourgeois A, Lévy V
Low to undetectable Omicron BQ.1.1 neutralization by patient's sera a month after initiation of AZD7442 600 mg.
The Journal of Infection 2023, 86, e126-e129.
Picone O, Vivanti AJ, Sibiude J, Cordier AG, Alessandrini V, Kayem G, Borie C, Luton D, Manchon P, Couffignal C, Vauloup Fellous C, COVIPREG study group
SARS-COV-2 excretion and maternal-fetal transmission: Virological data of French prospective multi-center cohort study COVIPREG during the first wave.
Journal of Gynecology Obstetrics and Human Reproduction 2023, 52, 102547.
Poisson M, Sibiude J, Mosnino E, Koual M, Landraud L, Fidouh N, Mandelbrot L, Vauloup-Fellous C, Luton D, Benachi A, Vivanti AJ, Picone O
Impact of variants of SARS-CoV-2 on obstetrical and neonatal outcomes.
Journal of Gynecology Obstetrics and Human Reproduction 2023, 52, 102566.
Vivanti AJ, Vauloup-Fellous C, Khalil A, Badr DA, Raimondi F, Salome S, Prasad S, Portella G, Fiorenza M, Jani JC, Landraud L, Picone O, Pezza L, Bourgeois-Nicolaos N, Cordier AG, Vedovelli L, De Luca D
Nasopharyngeal SARS-CoV-2 load and perinatal outcomes after maternal infection diagnosed close to delivery.
Journal of Gynecology Obstetrics and Human Reproduction 2023, 52, 102569.
Lafay C, Assad Z, Ouldali N, Quoc EB, Clement A, Durand C, Fares S, Faye A, Eveillard LA, Kaguelidou F, Titah C, Valtuille Z, Vinit C, Meinzer U, Dumaine C
Increased Incidence of Pediatric Uveitis Associated with the COVID-19 Pandemic Occurring Before COVID-19 Vaccine Implementation: A Time-Series Analysis.
The Journal of Pediatrics 2023, 263, 113682.
Egloff C, Roques P, Picone O
Impact of COVID-19 on pregnant women's health: Consequences in obstetrics two years after the pandemic.
Journal of Reproductive Immunology 2023, 158, 103981.
Brault A, Tran-Kiem C, Couteaux C, Olié V, Paireau J, Yazdanpanah Y, Ghosn J, Martin-Blondel G, Bosetti P, Cauchemez S
Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna.
The Lancet Regional Health. Western Pacific 2023, 30, 100634.
Ardellier FD, Baloglu S, Sokolska M, Noblet V, Lersy F, Collange O, Ferré JC, Maamar A, Carsin-Nicol B, Helms J, Schenck M, Khalil A, Gaudemer A, Caillard S, Pottecher J, Lefèbvre N, Zorn PE, Matthieu M, Brisset JC, Boulay C, Mutschler V, Hansmann Y, Mertes PM, Schneider F, Fafi-Kremer S, Ohana M, Meziani F, Meyer N, Yousry T, Anheim M, Cotton F, Jäger HR, Kremer S, SFNR-COVID group
Cerebral perfusion using ASL in patients with COVID-19 and neurological manifestations: A retrospective multicenter observational study.
Journal of Neuroradiology = Journal De Neuroradiologie 2023, S0150-9861(23)00006-8.
Griffee MJ, Bozza PT, Reyes LF, Eddington DP, Rosenberger D, Merson L, Citarella BW, Fanning JP, Alexander PMA, Fraser J, Dalton H, Cho SM, ISARIC Clinical Characterisation Group
Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry.
Research and Practice in Thrombosis and Haemostasis 2023, 7, 102142.
Coppée R, Chenane HR, Bridier-Nahmias A, Tcherakian C, Catherinot E, Collin G, Lebourgeois S, Visseaux B, Descamps D, Vasse M, Farfour E
Temporal dynamics of RSV shedding and genetic diversity in adults during the COVID-19 pandemic in a French hospital, early 2021.
Virus Research 2023, 323, 198950.
Lefrançois T, Malvy D, Atlani-Duault L, Benamouzig D, Druais PL, Yazdanpanah Y, Delfraissy JF, Lina B
After 2 years of the COVID-19 pandemic, translating One Health into action is urgent.
Lancet (London, England) 2023, 401, 789-794.
Amstutz A, Speich B, Mentré F, Rueegg CS, Belhadi D, Assoumou L, Burdet C, Murthy S, Dodd LE, Wang Y, Tikkinen KAO, Ader F, Hites M, Bouscambert M, Trabaud MA, Fralick M, Lee TC, Pinto R, Barratt-Due A, Lund-Johansen F, Müller F, Nevalainen OPO, Cao B, Bonnett T, Griessbach A, Taji Heravi A, Schönenberger C, Janiaud P, Werlen L, Aghlmandi S, Schandelmaier S, Yazdanpanah Y, Costagliola D, Olsen IC, Briel M
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials.
The Lancet. Respiratory Medicine 2023, 11, 453-464.
COVID-19 Host Genetics Initiative
A second update on mapping the human genetic architecture of COVID-19.
Nature 2023, 621, E7-E26.
Mirouse A, Friol A, Moreau AS, Jung B, Jullien E, Bureau C, Djibré M, de Prost N, Zafrani L, Argaud L, Reuter D, Calvet L, de Montmollin E, Benghanem S, Pichereau C, Pham T, Cacoub P, Biard L, Saadoun D
Severe SARS-Cov2 pneumonia in vaccinated patients: a multicenter cohort study.
Scientific Reports 2023, 13, 1902.
Chabrol F, Traverson L, Hou R, Chotard L, Lucet JC, Peiffer-Smadja N, Bendjelloul G, Lescure FX, Yazdanpanah Y, Zinszer K, Ridde V
Adaptation and Response of a Major Parisian Referral Hospital to the COVID-19 Surge: A Qualitative Study.
Health Systems and Reform 2023, 9, 2165429.
Dagenais C, Kielende M, Coulibaly A, Gautier L, David PM, Peiffer-Smadja N, Honda A, de Araújo Oliveira SR, Traverson L, Zinszer K, Ridde V
Lessons Learned from Field Experiences on Hospitals' Resilience to the COVID-19 Pandemic: A Systematic Approach.
Health Systems and Reform 2023, 9, 2231644.
Cho SM, White N, Premraj L, Battaglini D, Fanning J, Suen J, Bassi GL, Fraser J, Robba C, Griffee M, Singh B, Citarella BW, Merson L, Solomon T, Thomson D, ISARIC Clinical Characterisation Group
Neurological manifestations of COVID-19 in adults and children.
Brain: A Journal of Neurology 2023, 146, 1648-1661.
Kartsonaki C, Baillie JK, Barrio NG, Baruch J, Beane A, Blumberg L, Bozza F, Broadley T, Burrell A, Carson G, Citarella BW, Dagens A, Dankwa EA, Donnelly CA, Dunning J, Elotmani L, Escher M, Farshait N, Goffard JC, Gonçalves BP, Hall M, Hashmi M, Sim Lim Heng B, Ho A, Jassat W, Pedrera Jiménez M, Laouenan C, Lissauer S, Martin-Loeches I, Mentré F, Merson L, Morton B, Munblit D, Nekliudov NA, Nichol AD, Singh Oinam BC, Ong D, Panda PK, Petrovic M, Pritchard MG, Ramakrishnan N, Ramos GV, Roger C, Sandulescu O, Semple MG, Sharma P, Sigfrid L, Somers EC, Streinu-Cercel A, Taccone F, Vecham PK, Kumar Tirupakuzhi Vijayaraghavan B, Wei J, Wils EJ, Ci Wong X, Horby P, Rojek A, Olliaro PL, ISARIC Clinical Characterisation Group
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19.
International Journal of Epidemiology 2023, 52, 355-376.
Leducq V, Zafilaza K, Fauchois A, Ghidaoui E, Sayon S, Dorival C, Meledje ML, Lusivika-Nzinga C, Yordanov Y, Martin-Blondel G, Carrat F, Marcelin AG, Soulie C, COCOPREV Study Group
Spike protein genetic evolution in patients at high-risk of severe COVID-19 treated by monoclonal antibodies.
The Journal of Infectious Diseases 2023, jiad523.
Sonneville R, Dangayach NS, Newcombe V
Neurological complications of critically ill COVID-19 patients.
Current Opinion in Critical Care 2023, 29, 61-67.
Cancella de Abreu M, Peyrony O, Hermand C, Bompard R, Bouzid D, Eyer X
Time to result advantage of point-of-care SARS-CoV-2 PCR testing to confirm COVID-19 in emergency department: a retrospective multicenter study.
European Journal of Emergency Medicine: Official Journal of the European Society for Emergency Medicine 2023, 30, 132-134.
Ghazali DA, Choquet C, Bouzid D, Peyrony O, Fontaine JP, Sonja C, Javaud N, Plaisance P, Revue E, Chauvin A, Casalino E
The Response of Emergency Departments (EDs) to the COVID-19 Pandemic: The Experience of 5 EDs in a Paris-Based Academic Hospital Trust.
Quality Management in Health Care 2023, 32, 46-52.
Lee D, Le Pen J, Yatim A, Dong B, Aquino Y, Ogishi M, Pescarmona R, Talouarn E, Rinchai D, Zhang P, Perret M, Liu Z, Jordan I, Elmas Bozdemir S, Bayhan GI, Beaufils C, Bizien L, Bisiaux A, Lei W, Hasan M, Chen J, Gaughan C, Asthana A, Libri V, Luna JM, Jaffré F, Hoffmann HH, Michailidis E, Moreews M, Seeleuthner Y, Bilguvar K, Mane S, Flores C, Zhang Y, Arias AA, Bailey R, Schlüter A, Milisavljevic B, Bigio B, Le Voyer T, Materna M, Gervais A, Moncada-Velez M, Pala F, Lazarov T, Levy R, Neehus AL, Rosain J, Peel J, Chan YH, Morin MP, Pino-Ramirez RM, Belkaya S, Lorenzo L, Anton J, Delafontaine S, Toubiana J, Bajolle F, Fumadó V, DeDiego ML, Fidouh N, Rozenberg F, Pérez-Tur J, Chen S, Evans T, Geissmann F, Lebon P, Weiss SR, Bonnet D, Duval X, CoV-Contact Cohort§, COVID Human Genetic Effort¶, Pan-Hammarström Q, Planas AM, Meyts I, Haerynck F, Pujol A, Sancho-Shimizu V, Dalgard CL, Bustamante J, Puel A, Boisson-Dupuis S, Boisson B, Maniatis T, Zhang Q, Bastard P, Notarangelo L, Béziat V, Perez de Diego R, Rodriguez-Gallego C, Su HC, Lifton RP, Jouanguy E, Cobat A, Alsina L, Keles S, Haddad E, Abel L, Belot A, Quintana-Murci L, Rice CM, Silverman RH, Zhang SY, Casanova JL
Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children.
Science (New York, N.Y.) 2023, 379, eabo3627.
Bastard P, Vazquez SE, Liu J, Laurie MT, Wang CY, Gervais A, Le Voyer T, Bizien L, Zamecnik C, Philippot Q, Rosain J, Catherinot E, Willmore A, Mitchell AM, Bair R, Garçon P, Kenney H, Fekkar A, Salagianni M, Poulakou G, Siouti E, Sahanic S, Tancevski I, Weiss G, Nagl L, Manry J, Duvlis S, Arroyo-Sánchez D, Paz Artal E, Rubio L, Perani C, Bezzi M, Sottini A, Quaresima V, Roussel L, Vinh DC, Reyes LF, Garzaro M, Hatipoglu N, Boutboul D, Tandjaoui-Lambiotte Y, Borghesi A, Aliberti A, Cassaniti I, Venet F, Monneret G, Halwani R, Sharif-Askari NS, Danielson J, Burrel S, Morbieu C, Stepanovskyy Y, Bondarenko A, Volokha A, Boyarchuk O, Gagro A, Neuville M, Neven B, Keles S, Hernu R, Bal A, Novelli A, Novelli G, Saker K, Ailioaie O, Antolí A, Jeziorski E, Rocamora-Blanch G, Teixeira C, Delaunay C, Lhuillier M, Le Turnier P, Zhang Y, Mahevas M, Pan-Hammarström Q, Abolhassani H, Bompoil T, Dorgham K, COVID HGE Consortium, French COVID Study Group, COMET Consortium, Gorochov G, Laouenan C, Rodríguez-Gallego C, Ng LFP, Renia L, Pujol A, Belot A, Raffi F, Allende LM, Martinez-Picado J, Ozcelik T, Imberti L, Notarangelo LD, Troya J, Solanich X, Zhang SY, Puel A, Wilson MR, Trouillet-Assant S, Abel L, Jouanguy E, Ye CJ, Cobat A, Thompson LM, Andreakos E, Zhang Q, Anderson MS, Casanova JL, DeRisi JL
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs.
Science Immunology 2023, 8, eabp8966.
Chommeloux J, Valentin S, Winiszewski H, Adda M, Pineton de Chambrun M, Moyon Q, Mathian A, Capellier G, Guervilly C, Levy B, Jaquet P, Sonneville R, Voiriot G, Demoule A, Boussouar S, Painvin B, Lebreton G, Combes A, Schmidt M
One-Year Mental and Physical Health Assessment in Survivors after Extracorporeal Membrane Oxygenation for COVID-19-related Acute Respiratory Distress Syndrome.
American Journal of Respiratory and Critical Care Medicine 2023, 207, 150-159.
Penaud V, Duburcq T, Bureau C, Salmon Gandonnière C, Arrestier R, Henri S, Dres M, Jacquier S, Prost ND, Giraud R, Ricard JD, Roux D, Uhel F, Legouis D, Verney C
Kidney Increase Natriuresis but Not Glomerular Filtration Under Veno-venous ECMO, a Retrospective Study.
Journal of Intensive Care Medicine 2023, 8850666231195755.
Pichon M, Cremniter J, Burucoa C
French national epidemiology of bacterial superinfections in ventilator-associated pneumonia in patients infected with COVID-19: the COVAP study..
Annals of clinical microbiology and antimicrobials 2023, 22, 50.
Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M, Ünal S, Schlegel M, Ader F, Lacombe K, Amdal CD, Rodrigues S, Tonby K, Gaudet A, Heggelund L, Mootien J, Johannessen A, Møller JH, Pollan BD, Tveita AA, Kildal AB, Richard JC, Dalgard O, Simensen VC, Baldé A, de Gastines L, Del Álamo M, Aydin B, Lund-Johansen F, Trabaud MA, Diallo A, Halvorsen B, Røttingen JA, Tacconelli E, Yazdanpanah Y, Olsen IC, Costagliola D, EU SolidAct study group
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
Critical Care (London, England) 2023, 27, 9.
Giabicani M, Le Terrier C, Poncet A, Guidet B, Rigaud JP, Quenot JP, Mamzer MF, Pugin J, Weiss E, Bourcier S
Limitation of life-sustaining therapies in critically ill patients with COVID-19: a descriptive epidemiological investigation from the COVID-ICU study..
Critical care (London, England) 2023, 27, 103.
Walter T, Ricard JD
Extended prone positioning for intubated ARDS: a review..
Critical care (London, England) 2023, 27, 264.
Matuozzo D, Talouarn E, Marchal A, Zhang P, Manry J, Seeleuthner Y, Zhang Y, Bolze A, Chaldebas M, Milisavljevic B, Gervais A, Bastard P, Asano T, Bizien L, Barzaghi F, Abolhassani H, Abou Tayoun A, Aiuti A, Alavi Darazam I, Allende LM, Alonso-Arias R, Arias AA, Aytekin G, Bergman P, Bondesan S, Bryceson YT, Bustos IG, Cabrera-Marante O, Carcel S, Carrera P, Casari G, Chaïbi K, Colobran R, Condino-Neto A, Covill LE, Delmonte OM, El Zein L, Flores C, Gregersen PK, Gut M, Haerynck F, Halwani R, Hancerli S, Hammarström L, Hatipoğlu N, Karbuz A, Keles S, Kyheng C, Leon-Lopez R, Franco JL, Mansouri D, Martinez-Picado J, Metin Akcan O, Migeotte I, Morange PE, Morelle G, Martin-Nalda A, Novelli G, Novelli A, Ozcelik T, Palabiyik F, Pan-Hammarström Q, de Diego RP, Planas-Serra L, Pleguezuelo DE, Prando C, Pujol A, Reyes LF, Rivière JG, Rodriguez-Gallego C, Rojas J, Rovere-Querini P, Schlüter A, Shahrooei M, Sobh A, Soler-Palacin P, Tandjaoui-Lambiotte Y, Tipu I, Tresoldi C, Troya J, van de Beek D, Zatz M, Zawadzki P, Al-Muhsen SZ, Alosaimi MF, Alsohime FM, Baris-Feldman H, Butte MJ, Constantinescu SN, Cooper MA, Dalgard CL, Fellay J, Heath JR, Lau YL, Lifton RP, Maniatis T, Mogensen TH, von Bernuth H, Lermine A, Vidaud M, Boland A, Deleuze JF, Nussbaum R, Kahn-Kirby A, Mentre F, Tubiana S, Gorochov G, Tubach F, Hausfater P, COVID Human Genetic Effort, COVIDeF Study Group, French COVID Cohort Study Group, CoV-Contact Cohort, COVID-STORM Clinicians, COVID Clinicians, Orchestra Working Group, Amsterdam UMC Covid-19 Biobank, NIAID-USUHS COVID Study Group, Meyts I, Zhang SY, Puel A, Notarangelo LD, Boisson-Dupuis S, Su HC, Boisson B, Jouanguy E, Casanova JL, Zhang Q, Abel L, Cobat A
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
Genome Medicine 2023, 15, 22.
Mekontso Dessap A, Papazian L, Schaller M, Nseir S, Megarbane B, Haudebourg L, Timsit JF, Teboul JL, Kuteifan K, Gainnier M, Slama M, Houeto P, Lecourt L, Mercat A, Vieillard-Baron A
Inhaled nitric oxide in patients with acute respiratory distress syndrome caused by COVID-19: treatment modalities, clinical response, and outcomes.
Annals of Intensive Care 2023, 13, 57.
Chevret S, Bouadma L, Dupuis C, Burdet C, Timsit JF, COVIDICUS RCT group
Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial.
Annals of Intensive Care 2023, 13, 75.
de Prost N, Audureau E, Préau S, Favory R, Guigon A, Bay P, Heming N, Gault E, Pham T, Chaghouri A, Voiriot G, Morand-Joubert L, Jochmans S, Pitsch A, Meireles S, Contou D, Henry A, Joseph A, Chaix ML, Uhel F, Descamps D, Emery M, Garcia-Sanchez C, Luyt CE, Marot S, Pène F, Lhonneur AS, Gaudry S, Brichler S, Picard L, Mekontso Dessap A, Rodriguez C, Pawlotsky JM, Fourati S, SEVARVIR investigators
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron variants BA.2, BA.5 and BQ.1.1 in critically ill patients with COVID-19: a prospective, multicenter cohort study.
Intensive Care Medicine Experimental 2023, 11, 48.
Marc A, Marlin R, Donati F, Prague M, Kerioui M, Hérate C, Alexandre M, Dereuddre-Bosquet N, Bertrand J, Contreras V, Behillil S, Maisonnasse P, Van Der Werf S, Le Grand R, Guedj J
Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates.
PLoS computational biology 2023, 19, e1010721.
Clairon Q, Prague M, Planas D, Bruel T, Hocqueloux L, Prazuck T, Schwartz O, Thiébaut R, Guedj J
Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2.
PLoS computational biology 2023, 19, e1011282.
Dinh A, Drouet F, Dechartres A, Yordanov Y, Duran C, Schmidt N, Banzet A, Perrier MH, Mosquet N, Lescure FX, Jourdain P, Nizard J, Masingue X, AP-HP/Universities/Inserm COVID-19 research collaboration
Pregnant women with mild COVID-19 followed in community setting by telemedicine, and factors associated with unfavorable outcome.
PloS One 2023, 18, e0288845.
Mansour I, Godono A, Sansone E, Visci G, Spiteri G, Lourdes Monaco MG, Mates D, Rascu A, Duval X, Pira E, Ciocan C, Violante F, Lodi V, De Palma G, Sala E, Dell'Olmo M, Negro C, Casolari L, Abedini M, Ditano G, Asafo S, Boffetta P, Working Group OW
Factors Associated with SARS-CoV-2 Infection before Vaccination among European Health Care Workers.
La Medicina Del Lavoro 2023, 114, e2023022.
Rose AM, Nicolay N, Sandonis Martín V, Mazagatos C, Petrović G, Niessen FA, Machado A, Launay O, Denayer S, Seyler L, Baruch J, Burgui C, Loghin II, Domegan L, Vaikutytė R, Husa P, Panagiotakopoulos G, Aouali N, Dürrwald R, Howard J, Pozo F, Sastre-Palou B, Nonković D, Knol MJ, Kislaya I, Luong Nguyen LB, Bossuyt N, Demuyser T, Džiugytė A, Martínez-Baz I, Popescu C, Duffy R, Kuliešė M, Součková L, Michelaki S, Simon M, Reiche J, Otero-Barrós MT, Lovrić Makarić Z, Bruijning-Verhagen PC, Gomez V, Lesieur Z, Barbezange C, Van Nedervelde E, Borg ML, Castilla J, Lazar M, O'Donnell J, Jonikaitė I, Demlová R, Amerali M, Wirtz G, Tolksdorf K, Valenciano M, Bacci S, Kissling E, I-MOVE-COVID-19 hospital study team, VEBIS hospital study team, Members of the I-MOVE-COVID-19 and VEBIS hospital study teams (in addition to the named authors)
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2023, 28, 2300186.
Rose AM, Nicolay N, Sandonis Martín V, Mazagatos C, Petrović G, Baruch J, Denayer S, Seyler L, Domegan L, Launay O, Machado A, Burgui C, Vaikutyte R, Niessen FA, Loghin II, Husa P, Aouali N, Panagiotakopoulos G, Tolksdorf K, Horváth JK, Howard J, Pozo F, Gallardo V, Nonković D, Džiugytė A, Bossuyt N, Demuyser T, Duffy R, Luong Nguyen LB, Kislaya I, Martínez-Baz I, Gefenaite G, Knol MJ, Popescu C, Součková L, Simon M, Michelaki S, Reiche J, Ferenczi A, Delgado-Sanz C, Lovrić Makarić Z, Cauchi JP, Barbezange C, Van Nedervelde E, O'Donnell J, Durier C, Guiomar R, Castilla J, Jonikaite I, Bruijning-Verhagen PC, Lazar M, Demlová R, Wirtz G, Amerali M, Dürrwald R, Kunstár MP, Kissling E, Bacci S, Valenciano M, I-MOVE-COVID-19 hospital study team, VEBIS hospital study team, Members of the I-MOVE-COVID-19 and VEBIS hospital study teams (in addition to authors above)
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2023, 28, 2300187.
Morat B, Lucidarme N, Gibert A, Harbulot C, Lachaume N, Gréteau S, Basmaci R
Impact of lockdown on children with type-1 diabetes: returning to the community was associated with a decrease in HbA1c.
Frontiers in Pediatrics 2023, 11, 1245861.
Bornand E, Letourneux F, Deschanvres C, Boutoille D, Lucet JC, Lepelletier D, Leclere B, Mayol S, Peiffer-Smadja N, Birgand G
Social representations of mask wearing in the general population during the COVID-19 pandemic.
Frontiers in Public Health 2023, 11, 1136980.
Nel I, Parmentier C, Dehoux L, Minier M, Duneton C, Charbit M, Baudouin V, Bidet P, Carol A, Cheyssac E, Delbet JD, Guérin-El Khourouj V, Louillet F, Ulinski T, Delaugerre C, Carcelain G, Hogan J
Optimizing COVID-19 Vaccination Strategy in Pediatric Kidney Transplant Recipients: Humoral and Cellular Response to SARS-CoV-2 mRNA Vaccination.
Transplant International: Official Journal of the European Society for Organ Transplantation 2023, 36, 11153.
Wicky PH, Dupuis C, Cerf C, Siami S, Cohen Y, Laurent V, Mourvillier B, Reignier J, Goldgran-Toledano D, Schwebel C, Ruckly S, de Montmollin E, Buetti N, Timsit JF
Ventilator-Associated Pneumonia in COVID-19 Patients Admitted in Intensive Care Units: Relapse, Therapeutic Failure and Attributable Mortality-A Multicentric Observational Study from the OutcomeRea Network.
Journal of Clinical Medicine 2023, 12, 1298.
Rezzoug I, Visseaux B, Bertine M, Parisey M, Bonnal C, Ruppe E, Descamps D, Timsit JF, Yazdanpanah Y, Armand-Lefevre L, Houze S, Argy N
Faecal Viral Excretion and Gastrointestinal Co-Infection Do Not Explain Digestive Presentation in COVID-19 Patients.
Microorganisms 2023, 11, 1780.
de Crane D'Heysselaer S, Parisi G, Lisson M, Bruyère O, Donneau AF, Fontaine S, Gillet L, Bureau F, Darcis G, Thiry E, Ducatez M, Snoeck CJ, Zientara S, Haddad N, Humblet MF, Ludwig-Begall LF, Daube G, Thiry D, Misset B, Lambermont B, Tandjaoui-Lambiotte Y, Zahar JR, Sartor K, Noël C, Saegerman C, Haubruge E
Systematic Review of the Key Factors Influencing the Indoor Airborne Spread of SARS-CoV-2.
Pathogens (Basel, Switzerland) 2023, 12, 382.
Claudet A, De Luca D, Mosnino E, Mattern J, Picone O, Sibiude J, Wafo E, Tsatsaris V, Giral E, Grefenstette I, Carrara J, Badr DA, Saint-Frison MH, Prevot S, Benachi A, Vivanti AJ
Impact of SARS-CoV-2 Infection on Unvaccinated Pregnant Women: Non-Reassuring Fetal Heart Rate Tracing Because of Placentitis.
Viruses 2023, 15, 1069.
Azzini AM, Canziani LM, Davis RJ, Mirandola M, Hoelscher M, Meyer L, Laouénan C, Giannella M, Rodríguez-Baño J, Boffetta P, Mates D, Malhotra-Kumar S, Scipione G, Stellmach C, Rinaldi E, Hasenauer J, Tacconelli E
How European Research Projects Can Support Vaccination Strategies: The Case of the ORCHESTRA Project for SARS-CoV-2.
Vaccines 2023, 11, 1361.
Coppée R, Blanquart F, Jary A, Leducq V, Ferré VM, Franco Yusti AM, Daniel L, Charpentier C, Lebourgeois S, Zafilaza K, Calvez V, Descamps D, Marcelin AG, Visseaux B, Bridier-Nahmias A
Phylodynamics of SARS-CoV-2 in France, Europe, and the world in 2020.
eLife 2023, 12, e82538.
Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical Trial.
JAMA internal medicine 2023, 183, 520-531.
Camirand-Lemyre F, Merson L, Tirupakuzhi Vijayaraghavan BK, Burrell AJC, Citarella BW, Domingue MP, Lévesque S, Usuf E, Wils EJ, Ohshimo S, Martin-Loeches I, Sandulescu O, Laake JH, Lamontagne F, ISARIC Clinical Characterisation Group
Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19.
JAMA network open 2023, 6, e2346502.
Sorin B, Gaigne L, Garzaro M, Moulis G, Mageau A, Lopez C, Roy-Peaud F, Jeandel PY, Crickx E, Dossier A, Gobert D, Hadjadj J, Puyade M, Languille L, Rasmussen C, Terrier B, Ebbo M, Bonnotte B, Audia S, Galicier L, Michel M, Mahevas M, Viallard JF, Godeau B, CERECAI (Centre de Référence des Cytopénies Auto-Immunes de L'adulte)
Severe SARS-CoV-2 infection in rituximab-treated patients with autoimmune cytopenia: A multicenter observational study.
American Journal of Hematology 2023, 98, E259-E262.
Gault N, Bachelet D, Laouénan C, Borie R, Cracowski C, Poissy J, Faure K, Lainé F, Lefèvre B, Isnard M, Patrier J, Launay O, Costagliola D, Ghosn J, Bouadma L, French COVID Cohort Study Group and The French COVID Investigators Study Group
Impact of corticosteroids use on midterm sequelae in survivors of COVID-19 admitted to hospital: A prospective cohort study.
Journal of Medical Virology 2023, 95, e28819.
Chenane HR, Lingas G, Menidjel R, Laouenan C, Tubiana S, Descamps D, Le Hingrat Q, Abel L, Guedj J, Malhotra S, Kumar-Singh S, Visseaux B, Ghosn J, Charpentier C, Lebourgeois S, French COVID Cohort Study Group
High sera levels of SARS-CoV-2 N antigen are associated with death in hospitalized COVID-19 patients.
Journal of Medical Virology 2023, 95, e29247.
Mercier N, Belhadi D, DeChanet A, Delmas C, Saillard J, Dumousseaux M, Le Mestre S, Fougerou-Leurent C, Ferrane A, Burdet C, Espérou H, Ader F, Hites M, Peiffer-Smadja N, Poissy J, Andrejak C, Paiva JA, Tacconelli E, Staub T, Greil R, Costagliola D, Mentre F, Yazdanpanah Y, Diallo A, DisCoVeRy Safety Working group
Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial.
Pharmacology Research & Perspectives 2023, 11, e01072.
Néant N, Lingas G, Gaymard A, Belhadi D, Hites M, Staub T, Greil R, Paiva JA, Poissy J, Peiffer-Smadja N, Costagliola D, Yazdanpanah Y, Bouscambert-Duchamp M, Gagneux-Brunon A, Ader F, Mentré F, Wallet F, Burdet C, Guedj J, DisCoVeRy study group
Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients.
CPT: pharmacometrics & systems pharmacology 2023, 12, 2027-2037.
Hocini H, Wiedemann A, Blengio F, Lefebvre C, Cervantes-Gonzalez M, Foucat E, Tisserand P, Surenaud M, Coléon S, Prague M, Guillaumat L, Krief C, Fenwick C, Laouénan C, Bouadma L, Ghosn J, Pantaleo G, Thiébaut R, French COVID cohort study group, Lévy Y
Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19.
Journal of Clinical Immunology 2023, 43, 882-893.
Beaumont AL, Rozencwajg S, Peiffer-Smadja N, Montravers P
COVID-19: Brief overview of therapeutic strategies.
Anaesthesia, Critical Care & Pain Medicine 2023, 42, 101181.
Amarsy R, Fournier S, Trystram D, Monteil C, Raynaud X, Jarlier V, Robert J
Decrease of hospital- and community-acquired bloodstream infections due to Streptococcus pneumoniae and Streptococcus pyogenes during the first year of the COVID-19 pandemic: A time-series analysis in Paris region..
American journal of infection control 2023, 51, 475-477.
Lefebvre T, Boutten A, Raulet-Bussian C, Raynor A, Manceau H, Puy H, Moulouel B, Schmitt C, Timsit JF, Lefort A, Weiss E, Lescure FX, Ricard JD, Sonneville R, Peoc'h K
Evaluation of iron metabolism in hospitalized COVID-19 patients.
Clinica Chimica Acta; International Journal of Clinical Chemistry 2023, 548, 117509.
Fougerou-Leurent C, Delmas C, Saillard J, Dumousseaux M, Ferrane A, Mercier N, Terzic V, Le Mestre S, Dechanet A, Belhadi D, Metois A, Burdet C, Mentré F, Noret M, Diallo A, Petrov-Sanchez V, Couffin-Cadiergues S, Hites M, Ader F, Esperou H
Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20-15 DisCoVeRy study.
Contemporary Clinical Trials 2023, 131, 107267.
Ghosn J, Bachelet D, Livrozet M, Cervantes-Gonzalez M, Poissy J, Goehringer F, Gandonniere CS, Maillet M, Bani-Sadr F, Martin-Blondel G, Tattevin P, Launay O, Surgers L, Dudoignon E, Liegeon G, Zucman D, Joseph C, Senneville E, Yelnik C, Roger PM, Faure K, Gousseff M, Cabié A, Duval X, Chirouze C, Laouénan C, French COVID cohort Study Group and the French COVID cohort Investigators Group
Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 254.e7-254.e13.
Alidjinou EK, Demaret J, Corroyer-Simovic B, Vuotto F, Miczek S, Labreuche J, Goffard A, Trauet J, Lupau D, Dendooven A, Huvent-Grelle D, Podvin J, Dreuil D, Faure K, Deplanque D, Bocket L, Duhamel A, Sobaszek A, Hober D, Hisbergues M, Puisieux F, Autran B, Yazdanpanah Y, Labalette M, Lefèvre G
Serum neutralization of SARS coronavirus 2 Omicron sublineages BA.1 and BA.2 and cellular immune responses 3 months after booster vaccination.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 258.e1-258.e4.
Martin-Blondel G, Marcelin AG, Soulié C, Kaisaridi S, Lusivika-Nzinga C, Zafilaza K, Dorival C, Nailler L, Boston A, Ronchetti AM, Melenotte C, Cabié A, Choquet C, Trinh-Duc A, Lacombe K, Gaube G, Coustillères F, Pourcher V, Martellosio JP, Peiffer-Smadja N, Chauveau M, Housset P, Piroth L, Devaux M, Pialoux G, Martin A, Dubee V, Frey J, Le Bot A, Cazanave C, Petua P, Liblau R, Carrat F, Yordanov Y
Time to negative PCR conversion amongst high-risk patients with mild-to-moderate Omicron BA.1 and BA.2 COVID-19 treated with sotrovimab or nirmatrelvir.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 543.e5-543.e9.
Bouzid D, Kapfer T, Marot S, Ing V, Ferré VM, Chauvin A, Le Goff J, Ellouze S, Salmona M, Hermand C, Bourg A, Schnuriger A, Fémy F, Van Tinh MN, Brichler S, Veyer D, Le Borgne P, Fafi-Kremer S, L'Honneur AS, Augustin C, Simon T, Cachanado M, IMProving Emergency Care (IMPEC) FHU authors group, Freund Y
Outcomes of Omicron sub-lineages BA.1.1 and BA.2 infection compared with the sub-lineage BA.1 infection in emergency departments' patients.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 551-553.
Farfour E, Clichet V, Péan de Ponfilly G, Carbonnelle E, Vasse M
Impact of COVID-19 pandemic on blood culture practices and bacteremia epidemiology..
Diagnostic microbiology and infectious disease 2023, 107, 116002.
Gentilotti E, Górska A, Tami A, Gusinow R, Mirandola M, Rodríguez Baño J, Palacios Baena ZR, Rossi E, Hasenauer J, Lopes-Rafegas I, Righi E, Caroccia N, Cataudella S, Pasquini Z, Osmo T, Del Piccolo L, Savoldi A, Kumar-Singh S, Mazzaferri F, Caponcello MG, de Boer G, Hara GL, ORCHESTRA Study Group, De Nardo P, Malhotra S, Canziani LM, Ghosn J, Florence AM, Lafhej N, van der Gun BTF, Giannella M, Laouénan C, Tacconelli E
Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort.
EClinicalMedicine 2023, 62, 102107.
Wainstein M, Spyrison N, Dai D, Ghadimi M, Chávez-Iñiguez JS, Rizo-Topete L, Citarella BW, Merson L, Pole JD, Claure-Del Granado R, Johnson DW, Shrapnel S, ISARIC Characterization Group
Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19.
Kidney International Reports 2023
Hazan F, Verdonk C, Coutance G, Ferré VM, Marot S, Melo VDD, Legeai C, Lebreton G, Para M, Varnous S, Dorent R
Severity of SARS-CoV-2 Omicron variant infection in heart transplant recipients.
The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation 2023, 42, 558-561.
Tandjaoui-Lambiotte Y, Lomont A, Moenne-Locoz P, Seytre D, Zahar JR
Spread of viruses, which measures are the most apt to control COVID-19?.
Infectious Diseases Now 2023, 53, 104637.
Mageau A, Tchen J, Ferré VM, Nicaise-Roland P, Descamps D, Delory N, François C, Mendes C, Papo T, Goulenok T, Charles N, Sacré K
Impact of BNT162b2 mRNA anti-SARS-CoV-2 vaccine on interferon-alpha production by plasmacytoid dendritic cells and autoreactive T cells in patients with systemic lupus erythematosus: The COVALUS project.
Journal of Autoimmunity 2023, 134, 102987.
Hassold N, Brichler S, Gater Y, Leclerc D, Gordien E, Bouchaud O, Carbonnelle E, Mechai F, Cordel H, Delagreverie H
Mixed outcomes following a third SARS-CoV-2 vaccine dose in previously unresponsive people with HIV.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2023, 158, 105347.
Brebant D, Couffignal C, Manchon P, Duquesne S, Picone O, Vauloup-Fellous C
Transplacental transfer of anti-SARS-CoV-2 neutralizing antibodies in comparison to other pathogens total antibodies.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2023, 165, 105495.
Farfour E, Lebourgeois S, Chenane HR, Charpentier C, Pascreau T, Jolly E, Descamps D, Vasse M, Visseaux B
SARS-CoV-2 viability and viral RNA persistence on microbiological agar plates.
The Journal of Hospital Infection 2023, 132, 140-142.
de Lamballerie X, Martin-Blondel G, Dupont A, Izopet J, Mentré F, Kamar N, Autran B, Paintaud G, Caillard S, le Bourgeois A, Richez C, Couzi L, Xhaard A, Marjanovic Z, Avouac J, Jacquet C, Anglicheau D, Cheminant M, Yazdanpanah Y, Guyen SN, Terrier B, Gottenberg JE, Besson C, Letrou S, Kali S, Angoulvant D, Sanchez VP, Tardivon C, Blancho G, Lévy V
Low serum neutralization of Omicron variants a month after AZD7442 prophylaxis initiation.
The Journal of Infection 2023, 86, 66-117.
Touret F, Martin-Blondel G, de Lamballerie X, Dupont A, Izopet J, Mentré F, Kamar N, Autran B, Paintaud G, Caillard S, Richez C, Couzi L, Xhaard A, Marjanovic Z, Avouac J, Jacquet C, Anglicheau D, Cheminant M, Yazdanpanah Y, N'Guyen S, Terrier B, Gottenberg JE, Besson C, Letrou S, Kali S, Angoulvant D, Barthélémy K, Priet S, Nurtop E, Sanchez VP, Tardivon C, Blancho G, Le Bourgeois A, Lévy V
Low to undetectable Omicron BQ.1.1 neutralization by patient's sera a month after initiation of AZD7442 600 mg.
The Journal of Infection 2023, 86, e126-e129.
Picone O, Vivanti AJ, Sibiude J, Cordier AG, Alessandrini V, Kayem G, Borie C, Luton D, Manchon P, Couffignal C, Vauloup Fellous C, COVIPREG study group
SARS-COV-2 excretion and maternal-fetal transmission: Virological data of French prospective multi-center cohort study COVIPREG during the first wave.
Journal of Gynecology Obstetrics and Human Reproduction 2023, 52, 102547.
Poisson M, Sibiude J, Mosnino E, Koual M, Landraud L, Fidouh N, Mandelbrot L, Vauloup-Fellous C, Luton D, Benachi A, Vivanti AJ, Picone O
Impact of variants of SARS-CoV-2 on obstetrical and neonatal outcomes.
Journal of Gynecology Obstetrics and Human Reproduction 2023, 52, 102566.
Vivanti AJ, Vauloup-Fellous C, Khalil A, Badr DA, Raimondi F, Salome S, Prasad S, Portella G, Fiorenza M, Jani JC, Landraud L, Picone O, Pezza L, Bourgeois-Nicolaos N, Cordier AG, Vedovelli L, De Luca D
Nasopharyngeal SARS-CoV-2 load and perinatal outcomes after maternal infection diagnosed close to delivery.
Journal of Gynecology Obstetrics and Human Reproduction 2023, 52, 102569.
Lafay C, Assad Z, Ouldali N, Quoc EB, Clement A, Durand C, Fares S, Faye A, Eveillard LA, Kaguelidou F, Titah C, Valtuille Z, Vinit C, Meinzer U, Dumaine C
Increased Incidence of Pediatric Uveitis Associated with the COVID-19 Pandemic Occurring Before COVID-19 Vaccine Implementation: A Time-Series Analysis.
The Journal of Pediatrics 2023, 263, 113682.
Egloff C, Roques P, Picone O
Impact of COVID-19 on pregnant women's health: Consequences in obstetrics two years after the pandemic.
Journal of Reproductive Immunology 2023, 158, 103981.
Brault A, Tran-Kiem C, Couteaux C, Olié V, Paireau J, Yazdanpanah Y, Ghosn J, Martin-Blondel G, Bosetti P, Cauchemez S
Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna.
The Lancet Regional Health. Western Pacific 2023, 30, 100634.
Ardellier FD, Baloglu S, Sokolska M, Noblet V, Lersy F, Collange O, Ferré JC, Maamar A, Carsin-Nicol B, Helms J, Schenck M, Khalil A, Gaudemer A, Caillard S, Pottecher J, Lefèbvre N, Zorn PE, Matthieu M, Brisset JC, Boulay C, Mutschler V, Hansmann Y, Mertes PM, Schneider F, Fafi-Kremer S, Ohana M, Meziani F, Meyer N, Yousry T, Anheim M, Cotton F, Jäger HR, Kremer S, SFNR-COVID group
Cerebral perfusion using ASL in patients with COVID-19 and neurological manifestations: A retrospective multicenter observational study.
Journal of Neuroradiology = Journal De Neuroradiologie 2023, S0150-9861(23)00006-8.
Griffee MJ, Bozza PT, Reyes LF, Eddington DP, Rosenberger D, Merson L, Citarella BW, Fanning JP, Alexander PMA, Fraser J, Dalton H, Cho SM, ISARIC Clinical Characterisation Group
Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry.
Research and Practice in Thrombosis and Haemostasis 2023, 7, 102142.
Coppée R, Chenane HR, Bridier-Nahmias A, Tcherakian C, Catherinot E, Collin G, Lebourgeois S, Visseaux B, Descamps D, Vasse M, Farfour E
Temporal dynamics of RSV shedding and genetic diversity in adults during the COVID-19 pandemic in a French hospital, early 2021.
Virus Research 2023, 323, 198950.
Lefrançois T, Malvy D, Atlani-Duault L, Benamouzig D, Druais PL, Yazdanpanah Y, Delfraissy JF, Lina B
After 2 years of the COVID-19 pandemic, translating One Health into action is urgent.
Lancet (London, England) 2023, 401, 789-794.
Amstutz A, Speich B, Mentré F, Rueegg CS, Belhadi D, Assoumou L, Burdet C, Murthy S, Dodd LE, Wang Y, Tikkinen KAO, Ader F, Hites M, Bouscambert M, Trabaud MA, Fralick M, Lee TC, Pinto R, Barratt-Due A, Lund-Johansen F, Müller F, Nevalainen OPO, Cao B, Bonnett T, Griessbach A, Taji Heravi A, Schönenberger C, Janiaud P, Werlen L, Aghlmandi S, Schandelmaier S, Yazdanpanah Y, Costagliola D, Olsen IC, Briel M
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials.
The Lancet. Respiratory Medicine 2023, 11, 453-464.
COVID-19 Host Genetics Initiative
A second update on mapping the human genetic architecture of COVID-19.
Nature 2023, 621, E7-E26.
Mirouse A, Friol A, Moreau AS, Jung B, Jullien E, Bureau C, Djibré M, de Prost N, Zafrani L, Argaud L, Reuter D, Calvet L, de Montmollin E, Benghanem S, Pichereau C, Pham T, Cacoub P, Biard L, Saadoun D
Severe SARS-Cov2 pneumonia in vaccinated patients: a multicenter cohort study.
Scientific Reports 2023, 13, 1902.
Chabrol F, Traverson L, Hou R, Chotard L, Lucet JC, Peiffer-Smadja N, Bendjelloul G, Lescure FX, Yazdanpanah Y, Zinszer K, Ridde V
Adaptation and Response of a Major Parisian Referral Hospital to the COVID-19 Surge: A Qualitative Study.
Health Systems and Reform 2023, 9, 2165429.
Dagenais C, Kielende M, Coulibaly A, Gautier L, David PM, Peiffer-Smadja N, Honda A, de Araújo Oliveira SR, Traverson L, Zinszer K, Ridde V
Lessons Learned from Field Experiences on Hospitals' Resilience to the COVID-19 Pandemic: A Systematic Approach.
Health Systems and Reform 2023, 9, 2231644.
Cho SM, White N, Premraj L, Battaglini D, Fanning J, Suen J, Bassi GL, Fraser J, Robba C, Griffee M, Singh B, Citarella BW, Merson L, Solomon T, Thomson D, ISARIC Clinical Characterisation Group
Neurological manifestations of COVID-19 in adults and children.
Brain: A Journal of Neurology 2023, 146, 1648-1661.
Kartsonaki C, Baillie JK, Barrio NG, Baruch J, Beane A, Blumberg L, Bozza F, Broadley T, Burrell A, Carson G, Citarella BW, Dagens A, Dankwa EA, Donnelly CA, Dunning J, Elotmani L, Escher M, Farshait N, Goffard JC, Gonçalves BP, Hall M, Hashmi M, Sim Lim Heng B, Ho A, Jassat W, Pedrera Jiménez M, Laouenan C, Lissauer S, Martin-Loeches I, Mentré F, Merson L, Morton B, Munblit D, Nekliudov NA, Nichol AD, Singh Oinam BC, Ong D, Panda PK, Petrovic M, Pritchard MG, Ramakrishnan N, Ramos GV, Roger C, Sandulescu O, Semple MG, Sharma P, Sigfrid L, Somers EC, Streinu-Cercel A, Taccone F, Vecham PK, Kumar Tirupakuzhi Vijayaraghavan B, Wei J, Wils EJ, Ci Wong X, Horby P, Rojek A, Olliaro PL, ISARIC Clinical Characterisation Group
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19.
International Journal of Epidemiology 2023, 52, 355-376.
Leducq V, Zafilaza K, Fauchois A, Ghidaoui E, Sayon S, Dorival C, Meledje ML, Lusivika-Nzinga C, Yordanov Y, Martin-Blondel G, Carrat F, Marcelin AG, Soulie C, COCOPREV Study Group
Spike protein genetic evolution in patients at high-risk of severe COVID-19 treated by monoclonal antibodies.
The Journal of Infectious Diseases 2023, jiad523.
Sonneville R, Dangayach NS, Newcombe V
Neurological complications of critically ill COVID-19 patients.
Current Opinion in Critical Care 2023, 29, 61-67.
Cancella de Abreu M, Peyrony O, Hermand C, Bompard R, Bouzid D, Eyer X
Time to result advantage of point-of-care SARS-CoV-2 PCR testing to confirm COVID-19 in emergency department: a retrospective multicenter study.
European Journal of Emergency Medicine: Official Journal of the European Society for Emergency Medicine 2023, 30, 132-134.
Ghazali DA, Choquet C, Bouzid D, Peyrony O, Fontaine JP, Sonja C, Javaud N, Plaisance P, Revue E, Chauvin A, Casalino E
The Response of Emergency Departments (EDs) to the COVID-19 Pandemic: The Experience of 5 EDs in a Paris-Based Academic Hospital Trust.
Quality Management in Health Care 2023, 32, 46-52.
Lee D, Le Pen J, Yatim A, Dong B, Aquino Y, Ogishi M, Pescarmona R, Talouarn E, Rinchai D, Zhang P, Perret M, Liu Z, Jordan I, Elmas Bozdemir S, Bayhan GI, Beaufils C, Bizien L, Bisiaux A, Lei W, Hasan M, Chen J, Gaughan C, Asthana A, Libri V, Luna JM, Jaffré F, Hoffmann HH, Michailidis E, Moreews M, Seeleuthner Y, Bilguvar K, Mane S, Flores C, Zhang Y, Arias AA, Bailey R, Schlüter A, Milisavljevic B, Bigio B, Le Voyer T, Materna M, Gervais A, Moncada-Velez M, Pala F, Lazarov T, Levy R, Neehus AL, Rosain J, Peel J, Chan YH, Morin MP, Pino-Ramirez RM, Belkaya S, Lorenzo L, Anton J, Delafontaine S, Toubiana J, Bajolle F, Fumadó V, DeDiego ML, Fidouh N, Rozenberg F, Pérez-Tur J, Chen S, Evans T, Geissmann F, Lebon P, Weiss SR, Bonnet D, Duval X, CoV-Contact Cohort§, COVID Human Genetic Effort¶, Pan-Hammarström Q, Planas AM, Meyts I, Haerynck F, Pujol A, Sancho-Shimizu V, Dalgard CL, Bustamante J, Puel A, Boisson-Dupuis S, Boisson B, Maniatis T, Zhang Q, Bastard P, Notarangelo L, Béziat V, Perez de Diego R, Rodriguez-Gallego C, Su HC, Lifton RP, Jouanguy E, Cobat A, Alsina L, Keles S, Haddad E, Abel L, Belot A, Quintana-Murci L, Rice CM, Silverman RH, Zhang SY, Casanova JL
Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children.
Science (New York, N.Y.) 2023, 379, eabo3627.
Bastard P, Vazquez SE, Liu J, Laurie MT, Wang CY, Gervais A, Le Voyer T, Bizien L, Zamecnik C, Philippot Q, Rosain J, Catherinot E, Willmore A, Mitchell AM, Bair R, Garçon P, Kenney H, Fekkar A, Salagianni M, Poulakou G, Siouti E, Sahanic S, Tancevski I, Weiss G, Nagl L, Manry J, Duvlis S, Arroyo-Sánchez D, Paz Artal E, Rubio L, Perani C, Bezzi M, Sottini A, Quaresima V, Roussel L, Vinh DC, Reyes LF, Garzaro M, Hatipoglu N, Boutboul D, Tandjaoui-Lambiotte Y, Borghesi A, Aliberti A, Cassaniti I, Venet F, Monneret G, Halwani R, Sharif-Askari NS, Danielson J, Burrel S, Morbieu C, Stepanovskyy Y, Bondarenko A, Volokha A, Boyarchuk O, Gagro A, Neuville M, Neven B, Keles S, Hernu R, Bal A, Novelli A, Novelli G, Saker K, Ailioaie O, Antolí A, Jeziorski E, Rocamora-Blanch G, Teixeira C, Delaunay C, Lhuillier M, Le Turnier P, Zhang Y, Mahevas M, Pan-Hammarström Q, Abolhassani H, Bompoil T, Dorgham K, COVID HGE Consortium, French COVID Study Group, COMET Consortium, Gorochov G, Laouenan C, Rodríguez-Gallego C, Ng LFP, Renia L, Pujol A, Belot A, Raffi F, Allende LM, Martinez-Picado J, Ozcelik T, Imberti L, Notarangelo LD, Troya J, Solanich X, Zhang SY, Puel A, Wilson MR, Trouillet-Assant S, Abel L, Jouanguy E, Ye CJ, Cobat A, Thompson LM, Andreakos E, Zhang Q, Anderson MS, Casanova JL, DeRisi JL
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs.
Science Immunology 2023, 8, eabp8966.
Chommeloux J, Valentin S, Winiszewski H, Adda M, Pineton de Chambrun M, Moyon Q, Mathian A, Capellier G, Guervilly C, Levy B, Jaquet P, Sonneville R, Voiriot G, Demoule A, Boussouar S, Painvin B, Lebreton G, Combes A, Schmidt M
One-Year Mental and Physical Health Assessment in Survivors after Extracorporeal Membrane Oxygenation for COVID-19-related Acute Respiratory Distress Syndrome.
American Journal of Respiratory and Critical Care Medicine 2023, 207, 150-159.
Penaud V, Duburcq T, Bureau C, Salmon Gandonnière C, Arrestier R, Henri S, Dres M, Jacquier S, Prost ND, Giraud R, Ricard JD, Roux D, Uhel F, Legouis D, Verney C
Kidney Increase Natriuresis but Not Glomerular Filtration Under Veno-venous ECMO, a Retrospective Study.
Journal of Intensive Care Medicine 2023, 8850666231195755.
Pichon M, Cremniter J, Burucoa C
French national epidemiology of bacterial superinfections in ventilator-associated pneumonia in patients infected with COVID-19: the COVAP study..
Annals of clinical microbiology and antimicrobials 2023, 22, 50.
Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M, Ünal S, Schlegel M, Ader F, Lacombe K, Amdal CD, Rodrigues S, Tonby K, Gaudet A, Heggelund L, Mootien J, Johannessen A, Møller JH, Pollan BD, Tveita AA, Kildal AB, Richard JC, Dalgard O, Simensen VC, Baldé A, de Gastines L, Del Álamo M, Aydin B, Lund-Johansen F, Trabaud MA, Diallo A, Halvorsen B, Røttingen JA, Tacconelli E, Yazdanpanah Y, Olsen IC, Costagliola D, EU SolidAct study group
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
Critical Care (London, England) 2023, 27, 9.
Giabicani M, Le Terrier C, Poncet A, Guidet B, Rigaud JP, Quenot JP, Mamzer MF, Pugin J, Weiss E, Bourcier S
Limitation of life-sustaining therapies in critically ill patients with COVID-19: a descriptive epidemiological investigation from the COVID-ICU study..
Critical care (London, England) 2023, 27, 103.
Walter T, Ricard JD
Extended prone positioning for intubated ARDS: a review..
Critical care (London, England) 2023, 27, 264.
Matuozzo D, Talouarn E, Marchal A, Zhang P, Manry J, Seeleuthner Y, Zhang Y, Bolze A, Chaldebas M, Milisavljevic B, Gervais A, Bastard P, Asano T, Bizien L, Barzaghi F, Abolhassani H, Abou Tayoun A, Aiuti A, Alavi Darazam I, Allende LM, Alonso-Arias R, Arias AA, Aytekin G, Bergman P, Bondesan S, Bryceson YT, Bustos IG, Cabrera-Marante O, Carcel S, Carrera P, Casari G, Chaïbi K, Colobran R, Condino-Neto A, Covill LE, Delmonte OM, El Zein L, Flores C, Gregersen PK, Gut M, Haerynck F, Halwani R, Hancerli S, Hammarström L, Hatipoğlu N, Karbuz A, Keles S, Kyheng C, Leon-Lopez R, Franco JL, Mansouri D, Martinez-Picado J, Metin Akcan O, Migeotte I, Morange PE, Morelle G, Martin-Nalda A, Novelli G, Novelli A, Ozcelik T, Palabiyik F, Pan-Hammarström Q, de Diego RP, Planas-Serra L, Pleguezuelo DE, Prando C, Pujol A, Reyes LF, Rivière JG, Rodriguez-Gallego C, Rojas J, Rovere-Querini P, Schlüter A, Shahrooei M, Sobh A, Soler-Palacin P, Tandjaoui-Lambiotte Y, Tipu I, Tresoldi C, Troya J, van de Beek D, Zatz M, Zawadzki P, Al-Muhsen SZ, Alosaimi MF, Alsohime FM, Baris-Feldman H, Butte MJ, Constantinescu SN, Cooper MA, Dalgard CL, Fellay J, Heath JR, Lau YL, Lifton RP, Maniatis T, Mogensen TH, von Bernuth H, Lermine A, Vidaud M, Boland A, Deleuze JF, Nussbaum R, Kahn-Kirby A, Mentre F, Tubiana S, Gorochov G, Tubach F, Hausfater P, COVID Human Genetic Effort, COVIDeF Study Group, French COVID Cohort Study Group, CoV-Contact Cohort, COVID-STORM Clinicians, COVID Clinicians, Orchestra Working Group, Amsterdam UMC Covid-19 Biobank, NIAID-USUHS COVID Study Group, Meyts I, Zhang SY, Puel A, Notarangelo LD, Boisson-Dupuis S, Su HC, Boisson B, Jouanguy E, Casanova JL, Zhang Q, Abel L, Cobat A
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
Genome Medicine 2023, 15, 22.
Mekontso Dessap A, Papazian L, Schaller M, Nseir S, Megarbane B, Haudebourg L, Timsit JF, Teboul JL, Kuteifan K, Gainnier M, Slama M, Houeto P, Lecourt L, Mercat A, Vieillard-Baron A
Inhaled nitric oxide in patients with acute respiratory distress syndrome caused by COVID-19: treatment modalities, clinical response, and outcomes.
Annals of Intensive Care 2023, 13, 57.
Chevret S, Bouadma L, Dupuis C, Burdet C, Timsit JF, COVIDICUS RCT group
Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial.
Annals of Intensive Care 2023, 13, 75.
de Prost N, Audureau E, Préau S, Favory R, Guigon A, Bay P, Heming N, Gault E, Pham T, Chaghouri A, Voiriot G, Morand-Joubert L, Jochmans S, Pitsch A, Meireles S, Contou D, Henry A, Joseph A, Chaix ML, Uhel F, Descamps D, Emery M, Garcia-Sanchez C, Luyt CE, Marot S, Pène F, Lhonneur AS, Gaudry S, Brichler S, Picard L, Mekontso Dessap A, Rodriguez C, Pawlotsky JM, Fourati S, SEVARVIR investigators
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron variants BA.2, BA.5 and BQ.1.1 in critically ill patients with COVID-19: a prospective, multicenter cohort study.
Intensive Care Medicine Experimental 2023, 11, 48.
Marc A, Marlin R, Donati F, Prague M, Kerioui M, Hérate C, Alexandre M, Dereuddre-Bosquet N, Bertrand J, Contreras V, Behillil S, Maisonnasse P, Van Der Werf S, Le Grand R, Guedj J
Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates.
PLoS computational biology 2023, 19, e1010721.
Clairon Q, Prague M, Planas D, Bruel T, Hocqueloux L, Prazuck T, Schwartz O, Thiébaut R, Guedj J
Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2.
PLoS computational biology 2023, 19, e1011282.
Dinh A, Drouet F, Dechartres A, Yordanov Y, Duran C, Schmidt N, Banzet A, Perrier MH, Mosquet N, Lescure FX, Jourdain P, Nizard J, Masingue X, AP-HP/Universities/Inserm COVID-19 research collaboration
Pregnant women with mild COVID-19 followed in community setting by telemedicine, and factors associated with unfavorable outcome.
PloS One 2023, 18, e0288845.
Mansour I, Godono A, Sansone E, Visci G, Spiteri G, Lourdes Monaco MG, Mates D, Rascu A, Duval X, Pira E, Ciocan C, Violante F, Lodi V, De Palma G, Sala E, Dell'Olmo M, Negro C, Casolari L, Abedini M, Ditano G, Asafo S, Boffetta P, Working Group OW
Factors Associated with SARS-CoV-2 Infection before Vaccination among European Health Care Workers.
La Medicina Del Lavoro 2023, 114, e2023022.
Rose AM, Nicolay N, Sandonis Martín V, Mazagatos C, Petrović G, Niessen FA, Machado A, Launay O, Denayer S, Seyler L, Baruch J, Burgui C, Loghin II, Domegan L, Vaikutytė R, Husa P, Panagiotakopoulos G, Aouali N, Dürrwald R, Howard J, Pozo F, Sastre-Palou B, Nonković D, Knol MJ, Kislaya I, Luong Nguyen LB, Bossuyt N, Demuyser T, Džiugytė A, Martínez-Baz I, Popescu C, Duffy R, Kuliešė M, Součková L, Michelaki S, Simon M, Reiche J, Otero-Barrós MT, Lovrić Makarić Z, Bruijning-Verhagen PC, Gomez V, Lesieur Z, Barbezange C, Van Nedervelde E, Borg ML, Castilla J, Lazar M, O'Donnell J, Jonikaitė I, Demlová R, Amerali M, Wirtz G, Tolksdorf K, Valenciano M, Bacci S, Kissling E, I-MOVE-COVID-19 hospital study team, VEBIS hospital study team, Members of the I-MOVE-COVID-19 and VEBIS hospital study teams (in addition to the named authors)
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2023, 28, 2300186.
Rose AM, Nicolay N, Sandonis Martín V, Mazagatos C, Petrović G, Baruch J, Denayer S, Seyler L, Domegan L, Launay O, Machado A, Burgui C, Vaikutyte R, Niessen FA, Loghin II, Husa P, Aouali N, Panagiotakopoulos G, Tolksdorf K, Horváth JK, Howard J, Pozo F, Gallardo V, Nonković D, Džiugytė A, Bossuyt N, Demuyser T, Duffy R, Luong Nguyen LB, Kislaya I, Martínez-Baz I, Gefenaite G, Knol MJ, Popescu C, Součková L, Simon M, Michelaki S, Reiche J, Ferenczi A, Delgado-Sanz C, Lovrić Makarić Z, Cauchi JP, Barbezange C, Van Nedervelde E, O'Donnell J, Durier C, Guiomar R, Castilla J, Jonikaite I, Bruijning-Verhagen PC, Lazar M, Demlová R, Wirtz G, Amerali M, Dürrwald R, Kunstár MP, Kissling E, Bacci S, Valenciano M, I-MOVE-COVID-19 hospital study team, VEBIS hospital study team, Members of the I-MOVE-COVID-19 and VEBIS hospital study teams (in addition to authors above)
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2023, 28, 2300187.
Morat B, Lucidarme N, Gibert A, Harbulot C, Lachaume N, Gréteau S, Basmaci R
Impact of lockdown on children with type-1 diabetes: returning to the community was associated with a decrease in HbA1c.
Frontiers in Pediatrics 2023, 11, 1245861.
Bornand E, Letourneux F, Deschanvres C, Boutoille D, Lucet JC, Lepelletier D, Leclere B, Mayol S, Peiffer-Smadja N, Birgand G
Social representations of mask wearing in the general population during the COVID-19 pandemic.
Frontiers in Public Health 2023, 11, 1136980.
Nel I, Parmentier C, Dehoux L, Minier M, Duneton C, Charbit M, Baudouin V, Bidet P, Carol A, Cheyssac E, Delbet JD, Guérin-El Khourouj V, Louillet F, Ulinski T, Delaugerre C, Carcelain G, Hogan J
Optimizing COVID-19 Vaccination Strategy in Pediatric Kidney Transplant Recipients: Humoral and Cellular Response to SARS-CoV-2 mRNA Vaccination.
Transplant International: Official Journal of the European Society for Organ Transplantation 2023, 36, 11153.
Wicky PH, Dupuis C, Cerf C, Siami S, Cohen Y, Laurent V, Mourvillier B, Reignier J, Goldgran-Toledano D, Schwebel C, Ruckly S, de Montmollin E, Buetti N, Timsit JF
Ventilator-Associated Pneumonia in COVID-19 Patients Admitted in Intensive Care Units: Relapse, Therapeutic Failure and Attributable Mortality-A Multicentric Observational Study from the OutcomeRea Network.
Journal of Clinical Medicine 2023, 12, 1298.
Rezzoug I, Visseaux B, Bertine M, Parisey M, Bonnal C, Ruppe E, Descamps D, Timsit JF, Yazdanpanah Y, Armand-Lefevre L, Houze S, Argy N
Faecal Viral Excretion and Gastrointestinal Co-Infection Do Not Explain Digestive Presentation in COVID-19 Patients.
Microorganisms 2023, 11, 1780.
de Crane D'Heysselaer S, Parisi G, Lisson M, Bruyère O, Donneau AF, Fontaine S, Gillet L, Bureau F, Darcis G, Thiry E, Ducatez M, Snoeck CJ, Zientara S, Haddad N, Humblet MF, Ludwig-Begall LF, Daube G, Thiry D, Misset B, Lambermont B, Tandjaoui-Lambiotte Y, Zahar JR, Sartor K, Noël C, Saegerman C, Haubruge E
Systematic Review of the Key Factors Influencing the Indoor Airborne Spread of SARS-CoV-2.
Pathogens (Basel, Switzerland) 2023, 12, 382.
Claudet A, De Luca D, Mosnino E, Mattern J, Picone O, Sibiude J, Wafo E, Tsatsaris V, Giral E, Grefenstette I, Carrara J, Badr DA, Saint-Frison MH, Prevot S, Benachi A, Vivanti AJ
Impact of SARS-CoV-2 Infection on Unvaccinated Pregnant Women: Non-Reassuring Fetal Heart Rate Tracing Because of Placentitis.
Viruses 2023, 15, 1069.
Azzini AM, Canziani LM, Davis RJ, Mirandola M, Hoelscher M, Meyer L, Laouénan C, Giannella M, Rodríguez-Baño J, Boffetta P, Mates D, Malhotra-Kumar S, Scipione G, Stellmach C, Rinaldi E, Hasenauer J, Tacconelli E
How European Research Projects Can Support Vaccination Strategies: The Case of the ORCHESTRA Project for SARS-CoV-2.
Vaccines 2023, 11, 1361.
Coppée R, Blanquart F, Jary A, Leducq V, Ferré VM, Franco Yusti AM, Daniel L, Charpentier C, Lebourgeois S, Zafilaza K, Calvez V, Descamps D, Marcelin AG, Visseaux B, Bridier-Nahmias A
Phylodynamics of SARS-CoV-2 in France, Europe, and the world in 2020.
eLife 2023, 12, e82538.
2022
Bouadma L, Mekontso-Dessap A, Burdet C, Merdji H, Poissy J, Dupuis C, Guitton C, Schwebel C, Cohen Y, Bruel C, Marzouk M, Geri G, Cerf C, Mégarbane B, Garçon P, Kipnis E, Visseaux B, Beldjoudi N, Chevret S, Timsit JF, COVIDICUS Study Group
High-Dose Dexamethasone and Oxygen Support Strategies in Intensive Care Unit Patients With Severe COVID-19 Acute Hypoxemic Respiratory Failure: The COVIDICUS Randomized Clinical Trial.
JAMA internal medicine 2022, 182, 906-916.
Rybak A, Levy C, Angoulvant F, Auvrignon A, Gembara P, Danis K, Vaux S, Levy-Bruhl D, van der Werf S, Béchet S, Bonacorsi S, Assad Z, Lazzati A, Michel M, Kaguelidou F, Faye A, Cohen R, Varon E, Ouldali N
Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France.
JAMA network open 2022, 5, e2218959.
Solignac F, Ouldali N, Aupiais C, Casha P, Cohen R, Levy C, Angoulvant F
Analysis of COVID-19 Vaccination Status Among Parents of Hospitalized Children Younger Than 5 Years With SARS-CoV-2 Infection During the Delta and Omicron Waves.
JAMA network open 2022, 5, e2242295.
Villemonteix J, Cohen L, Guihot A, Guérin V, Moulin C, Caseris M, Carol A, Bonacorsi S, Carcelain G
Comparison between enzyme-linked immunospot assay and intracellular cytokine flow cytometry assays for the evaluation of T cell response to SARS-CoV-2 after symptomatic COVID-19.
Immunity, Inflammation and Disease 2022, 10, e617.
Houhou-Fidouh N, Bucau M, Bertine M, Minh TNT, Picone O, Salakos E, Luton D
Preliminary results on transmission of SARS-CoV-2 antibodies to the fetus and serum neutralizing activity.
International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics 2022, 158, 476-478.
Elie B, Roquebert B, Sofonea MT, Trombert-Paolantoni S, Foulongne V, Guedj J, Haim-Boukobza S, Alizon S
Variant-specific SARS-CoV-2 within-host kinetics.
Journal of Medical Virology 2022, 94, 3625-3633.
Ayrolles A, Ellul P, Trebossen V, Houhou-Fidouh N, Bonacorsi S, Descamps D, Delorme R
Is SARS-CoV-2 seroconversion a risk factor for severe and acute psychiatric symptoms in children?.
Neuropsychopharmacology Reports 2022, 42, 218-220.
Tallarico RT, Deniau B, Fong N, Ghosn J, Legrand M, French-COVID and the FROG-ICU Investigators
Differences in HADS and SF-36 scores 1 year after critical illness in COVID-19 patients.
Intensive Care Medicine 2022, 48, 1245-1247.
Foutel-Rodier F, Blanquart F, Courau P, Czuppon P, Duchamps JJ, Gamblin J, Kerdoncuff É, Kulathinal R, Régnier L, Vuduc L, Lambert A, Schertzer E
From individual-based epidemic models to McKendrick-von Foerster PDEs: a guide to modeling and inferring COVID-19 dynamics.
Journal of Mathematical Biology 2022, 85, 43.
Bolze A, Mogensen TH, Zhang SY, Abel L, Andreakos E, Arkin LM, Borghesi A, Brodin P, Hagin D, Novelli G, Okada S, Peter J, Renia L, Severe K, Tiberghien P, Vinh DC, COVID human genetic effort, Cirulli ET, Casanova JL, Hsieh EWY
Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis.
Journal of Clinical Immunology 2022, 42, 1354-1359.
Ferré VM, Peiffer-Smadja N, Visseaux B, Descamps D, Ghosn J, Charpentier C
Omicron SARS-CoV-2 variant: What we know and what we don't.
Anaesthesia, Critical Care & Pain Medicine 2022, 41, 100998.
Prague M, Alexandre M, Thiébaut R, Guedj J
Within-host models of SARS-CoV-2: What can it teach us on the biological factors driving virus pathogenesis and transmission?.
Anaesthesia, Critical Care & Pain Medicine 2022, 41, 101055.
Fillâtre P, Dufour MJ, Behillil S, Vatan R, Reusse P, Gabellec A, Velmans N, Montagne C, Geffroy Du Coudret S, Droumaguet E, Merour V, Enouf V, Buzelé R, Valence M, Guillotel E, Gagnière B, Baidaliuk A, Zhukova A, Tourdjman M, Thibault V, Grolhier C, Pronier C, Lescure FX, Simon-Loriere E, Costagliola D, Van Der Werf S, Tattevin P, Massart N
A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 298.e9-298.e15.
Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 202-221.
EU-Response investigators group, Diallo A, Trøseid M, Simensen VC, Boston A, Demotes J, Olsen IC, Chung F, Paiva JA, Hites M, Ader F, Arribas JR, Baratt-Due A, Melien Ø, Tacconelli E, Staub T, Greil R, Tsiodras S, Briel M, Esperou H, Mentré F, Eustace J, Saillard J, Delmas C, LeMestre S, Dumousseaux M, Costagliola D, Røttingen JA, Yazdanpanah Y
Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 1-5.
Trøseid M, Diallo A, Hites M, Røttingen JA, Yazdanpanah Y
Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 743-744.
Dinh A, Dahmane L, Dahoumane M, Masingue X, Jourdain P, Lescure FX
Impact of Omicron surge in community setting in greater Paris area.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, S1198-743X(22)00089-1.
Duvignaud A, Lhomme E, Onaisi R, Sitta R, Gelley A, Chastang J, Piroth L, Binquet C, Dupouy J, Makinson A, Lefèvre B, Naccache JM, Roussillon C, Landman R, Wallet C, Karcher S, Journot V, Nguyen D, Pistone T, Bouchet S, Lafon ME, Molimard M, Thiébaut R, de Lamballerie X, Joseph JP, Richert L, Saint-Lary O, Djabarouti S, Wittkop L, Anglaret X, Malvy D, Coverage Study Group
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE).
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, S1198-743X(22)00108-2.
Belan M, Charmet T, Schaeffer L, Tubiana S, Duval X, Lucet JC, Fontanet A, Birgand G, Kernéis S
SARS-CoV-2 exposures of healthcare workers from primary care, long-term care facilities and hospitals: a nationwide matched case-control study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 1471-1476.
Coléon S, Wiedemann A, Surénaud M, Lacabaratz C, Hue S, Prague M, Cervantes-Gonzalez M, Wang Z, Ellis J, Sansoni A, Pierini C, Bardin Q, Fabregue M, Sharkaoui S, Hoest P, Dupaty L, Picard F, El Hajj M, Centlivre M, Ghosn J, French COVID Cohort Study Group, Thiébaut R, Cardinaud S, Malissen B, Zurawski G, Zarubica A, Zurawski SM, Godot V, Lévy Y
Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine.
EBioMedicine 2022, 80, 104062.
Hermine O, Mariette X, Porcher R, Djossou F, Nguyen Y, Arlet JB, Savale L, Diehl JL, Georgin-Lavialle S, Cadranel J, Pialoux G, Lacombe K, Mekinian A, Gros H, Lescure X, Ghosn J, Coupez E, Grapin K, Rapp C, Michel M, Lecapitaine AL, Michot JM, Costedoat-Chalumeau N, Nguyen LBL, Semerano L, Raffi F, Aguillar C, Rouzaud C, Gottenberg JE, Hansmann Y, Bienvenu B, London J, Fantchou FS, Ackermann F, Gros A, Morel A, Gambier N, Sène D, Mégarbane B, Azoulay E, Bureau S, Dougados M, Emmerich J, Fartoukh M, Guidet B, Humbert M, Mahevas M, Pène F, Schlemmer F, Pourcher-Martinez V, Tibi A, Baron G, Perrodeau E, Baron S, Steg G, Yazdapanah Y, Simon T, Resche-Rigon M, Tharaux PL, Ravaud P
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group.
EClinicalMedicine 2022, 46, 101362.
Barrière J, Carles M, Audigier-Valette C, Re D, Adjtoutah Z, Seitz-Polski B, Gounant V, Descamps D, Zalcman G
Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article.
European Journal of Cancer (Oxford, England: 1990) 2022, 162, 182-193.
Barrière J, Zalcman G, Fignon L, Peiffer-Smadja N, Audigier-Valette C, Carles M
Omicron variant: A clear and present danger for patients with cancer.
European Journal of Cancer (Oxford, England: 1990) 2022, 165, 25-26.
Huré M, Peyronnet V, Sibiude J, Cazenave MG, Anselem O, Luton D, Vauloup-Fellous C, Deruelle P, Cordier AG, Benachi A, Mandelbrot L, Couffignal C, Pauphilet V, Vivanti AJ, Picone O
[SARS-Cov-2 vaccine's acceptance among pregnant women-A cross-sectional survey].
Gynecologie, Obstetrique, Fertilite & Senologie 2022, 50, 712-720.
Blot S, Ruppé E, Harbarth S, Asehnoune K, Poulakou G, Luyt CE, Rello J, Klompas M, Depuydt P, Eckmann C, Martin-Loeches I, Povoa P, Bouadma L, Timsit JF, Zahar JR
Healthcare-associated infections in adult intensive care unit patients: Changes in epidemiology, diagnosis, prevention and contributions of new technologies.
Intensive & Critical Care Nursing 2022, 70, 103227.
Husain M, Valayer S, Poey N, Rondinaud E, d'Humières C, Visseaux B, Lariven S, Lescure FX, Deconinck L
Pulmonary bacterial infections in adult patients hospitalized for COVID-19 in standard wards.
Infectious Diseases Now 2022, 52, 208-213.
Luong Ngyen LB, Bauer R, Lesieur Z, Galtier F, Duval X, Vanhems P, Lainé F, Tattevin P, Durier C, Launay O, FLUVAC Study group
Vaccine effectiveness against COVID-19 hospitalization in adults in France: A test negative case control study.
Infectious Diseases Now 2022, 52, 40-43.
Koch A, Vermel M, Hansmann Y, Lodi M, Mura C, Sananes A, Gallien S, Wurtz É, Bleibtreu A, Martinot M, Exinger J, Lescure X, Kerneis S, Lacombe K, Mootien JY, Shawali C, Lecointre L, Debry C, Lefebvre N, Sananes N
3D-printed simulator for nasopharyngeal swab collection for COVID-19.
Infectious Diseases Now 2022, S2666-9919(22)00035-5.
Cohen R, Rybak A, Ouldali N, Angoulvant F, Béchet S, Gajdos V, Hau I, Sellam A, El Aouane El Ghomari I, Elmerich F, Batard C, Auvrignon A, Grimprel E, Favier M, Jung C, Levy C
From the original SARS-CoV-2 strain to the Omicron variant: Predictors of COVID-19 in ambulatory symptomatic children.
Infectious Diseases Now 2022, 52, 432-440.
Amarsy R, Trystram D, Cambau E, Monteil C, Fournier S, Oliary J, Junot H, Sabatier P, Porcher R, Robert J, Jarlier V, “la Collégiale de Bactériologie–Virologie–Hygiène de l'Assistance Publique – Hôpitaux de Paris”
Surging bloodstream infections and antimicrobial resistance during the first wave of COVID-19: a study in a large multihospital institution in the Paris region.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2022, 114, 90-96.
Bachelard A, Sautereau A, Digumber M, Isernia V, Phung B, Lehur AC, Gac SL, Landman R, Yazdanpanah Y, Ghosn J
Risk Factors Associated with Severe/Critical COVID-19 in People Living with HIV-1.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2022, 122, 152-154.
Boussier J, Yatim N, Marchal A, Hadjadj J, Charbit B, El Sissy C, Carlier N, Pène F, Mouthon L, Tharaux PL, Bergeron A, Smadja DM, Rieux-Laucat F, Duffy D, Kernéis S, Frémeaux-Bacchi V, Terrier B
Severe COVID-19 is associated with hyperactivation of the alternative complement pathway.
The Journal of Allergy and Clinical Immunology 2022, 149, 550-556.e2.
Nagle S, Tandjaoui-Lambiotte Y, Boubaya M, Athenaïs G, Alloui C, Bloch-Queyrat C, Carbonnelle E, Brichler S, Cohen Y, Zahar JR, Delagrèverie H
Environmental SARS-CoV-2 contamination in hospital rooms of patients with acute COVID-19.
The Journal of Hospital Infection 2022, 126, 116-122.
Cosentino G, Bernard M, Ambroise J, Giannoli JM, Guedj J, Débarre F, Blanquart F
SARS-CoV-2 viral dynamics in infections with Alpha and Beta variants of concern in the French community.
The Journal of Infection 2022, 84, 94-118.
Lebourgeois S, Menidjel R, Chenane HR, Ferré VM, Collin G, Damond F, Coppée R, Yazdanpanah Y, Timsit JF, Houhou-Fidouh N, Descamps D, Charpentier C, Visseaux B
Alpha (B.1.1.7) and Delta (B.1.617.2 - AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage.
The Journal of Infection 2022, 84, 418-467.
Ferré VM, Lebourgeois S, Chenane HR, Menidjel R, Masson C, Collin G, Visseaux B, Descamps D, Fidouh N, Charpentier C
Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays.
The Journal of Infection 2022, S0163-4453(22)00126-8.
Martin-Blondel G, Marcelin AG, Soulié C, Kaisaridi S, Lusivika-Nzinga C, Dorival C, Nailler L, Boston A, Melenotte C, Cabié A, Choquet C, Coustillères F, Martellosio JP, Gaube G, Trinh-Duc A, Ronchetti AM, Pourcher V, Chauveau M, Lacombe K, Peiffer-Smadja N, Housset P, Perrot A, Pialoux G, Martin A, Dubee V, Devaux M, Frey J, Cazanave C, Liblau R, Carrat F, Yordanov Y
Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2.
The Journal of Infection 2022, 85, e104-e108.
Aubart M, Roux CJ, Durrleman C, Gins C, Hully M, Kossorotoff M, Gitiaux C, Levy R, Moulin F, Debray A, Belhadjer Z, Georget E, Kom T, Blanc P, Wehbi S, Mazeghrane M, Tencer J, Gajdos V, Rouget S, De Pontual L, Basmaci R, Yacouben K, Angoulvant F, Leruez-Ville M, Sterlin D, Rozenberg F, Robert MP, Zhang SY, Boddaert N, Desguerre I
Neuroinflammatory Disease following Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children.
The Journal of Pediatrics 2022, 247, 22-28.e2.
Gounant V, Ferré VM, Soussi G, Charpentier C, Flament H, Fidouh N, Collin G, Namour C, Assoun S, Bizot A, Brouk Z, Vicaut E, Teixeira L, Descamps D, Zalcman G
Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses.
Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 2022, 17, 239-251.
Farrar DS, Drouin O, Moore Hepburn C, Baerg K, Chan K, Cyr C, Donner EJ, Embree JE, Farrell C, Forgie S, Giroux R, Kang KT, King M, Laffin Thibodeau M, Orkin J, Ouldali N, Papenburg J, Pound CM, Price VE, Proulx-Gauthier JP, Purewal R, Ricci C, Sadarangani M, Salvadori MI, Thibeault R, Top KA, Viel-Thériault I, Kakkar F, Morris SK
Risk factors for severe COVID-19 in hospitalized children in Canada: A national prospective study from March 2020-May 2021.
Lancet Regional Health. Americas 2022, 15, 100337.
Alidjinou EK, Demaret J, Corroyer-Simovic B, Labreuche J, Goffard A, Trauet J, Lupau D, Miczek S, Vuotto F, Dendooven A, Huvent-Grelle D, Podvin J, Dreuil D, Faure K, Deplanque D, Bocket L, Duhamel A, Sobaszek A, Hober D, Hisbergues M, Puisieux F, Autran B, Yazdanpanah Y, Labalette M, Lefèvre G
Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years.
The Lancet Regional Health. Europe 2022, 17, 100385.
Ouldali N, Bagheri H, Salvo F, Antona D, Pariente A, Leblanc C, Tebacher M, Micallef J, Levy C, Cohen R, Javouhey E, Bader-Meunier B, Ovaert C, Renolleau S, Hentgen V, Kone-Paut I, Deschamps N, De Pontual L, Iriart X, Guen CGL, Angoulvant F, Belot A, “French Covid-19 Paediatric Inflammation Consortium”£ and the “French Pharmacovigilance network”*
Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study.
The Lancet Regional Health. Europe 2022, 17, 100393.
Tacconelli E, Gorska A, Carrara E, Davis RJ, Bonten M, Friedrich AW, Glasner C, Goossens H, Hasenauer J, Abad JMH, Peñalvo JL, Sanchez-Niubo A, Sialm A, Scipione G, Soriano G, Yazdanpanah Y, Vorstenbosch E, Jaenisch T
Challenges of data sharing in European Covid-19 projects: A learning opportunity for advancing pandemic preparedness and response.
The Lancet Regional Health. Europe 2022, 21, 100467.
Ouldali N, Bagheri H, Salvo F, Antona D, Pariente A, Leblanc C, Tebacher M, Micallef J, Levy C, Cohen R, Javouhey E, Bader-Meunier B, Ovaert C, Renolleau S, Hentgen V, Kone-Paut I, Deschamps N, De Pontual L, Iriart X, Guen CGL, Angoulvant F, Belot A, French Covid-19 Paediatric Inflammation Consortium, French Pharmacovigilance network
Correction to "Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study".
The Lancet Regional Health. Europe 2022, 21, 100468.
Cohen PR, Rybak A, Werner A, Béchet S, Desandes R, Hassid F, André JM, Gelbert N, Thiebault G, Kochert F, Cahn-Sellem F, Vié Le Sage F, Angoulvant PF, Ouldali N, Frandji B, Levy C
Trends in pediatric ambulatory community acquired infections before and during COVID-19 pandemic: A prospective multicentric surveillance study in France.
The Lancet Regional Health. Europe 2022, 22, 100497.
Wurtzer S, Waldman P, Levert M, Cluzel N, Almayrac JL, Charpentier C, Masnada S, Gillon-Ritz M, Mouchel JM, Maday Y, Boni M, OBEPINE Consortium, AP-HP Virologist Group, Marechal V, Moulin L
SARS-CoV-2 genome quantification in wastewaters at regional and city scale allows precise monitoring of the whole outbreaks dynamics and variants spreading in the population.
The Science of the Total Environment 2022, 810, 152213.
Burdet C, Ader F
Real-world effectiveness of oral antivirals for COVID-19.
Lancet (London, England) 2022, 400, 1175-1176.
Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Poissy J, Belhadi D, Diallo A, Lê MP, Peytavin G, Staub T, Greil R, Guedj J, Paiva JA, Costagliola D, Yazdanpanah Y, Burdet C, Mentré F, DisCoVeRy Study Group
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.
The Lancet. Infectious Diseases 2022, 22, 209-221.
Nasa P, Azoulay E, Chakrabarti A, Divatia JV, Jain R, Rodrigues C, Rosenthal VD, Alhazzani W, Arabi YM, Bakker J, Bassetti M, De Waele J, Dimopoulos G, Du B, Einav S, Evans L, Finfer S, Guérin C, Hammond NE, Jaber S, Kleinpell RM, Koh Y, Kollef M, Levy MM, Machado FR, Mancebo J, Martin-Loeches I, Mer M, Niederman MS, Pelosi P, Perner A, Peter JV, Phua J, Piquilloud L, Pletz MW, Rhodes A, Schultz MJ, Singer M, Timsit JF, Venkatesh B, Vincent JL, Welte T, Myatra SN
Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method.
The Lancet. Infectious Diseases 2022, 22, e74-e87.
Delaugerre C, Foissac F, Abdoul H, Masson G, Choupeaux L, Dufour E, Gastli N, Delarue SM, Néré ML, Minier M, Gabassi A, Salmona M, Seguineau M, Schmitt S, Tonglet S, Olivier A, Poyart C, Le Goff J, Lescure X, Kernéis S, Tréluyer JM, SPRING study group
Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial.
The Lancet. Infectious Diseases 2022, 22, 341-348.
Colosi E, Bassignana G, Contreras DA, Poirier C, Boëlle PY, Cauchemez S, Yazdanpanah Y, Lina B, Fontanet A, Barrat A, Colizza V
Screening and vaccination against COVID-19 to minimise school closure: a modelling study.
The Lancet. Infectious Diseases 2022, S1473-3099(22)00138-4.
Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Mentré F, Burdet C, DisCoVeRy Study Group
Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19.
The Lancet. Infectious Diseases 2022, 22, 764-765.
Gangneux JP, Dannaoui E, Fekkar A, Luyt CE, Botterel F, De Prost N, Tadié JM, Reizine F, Houzé S, Timsit JF, Iriart X, Riu-Poulenc B, Sendid B, Nseir S, Persat F, Wallet F, Le Pape P, Canet E, Novara A, Manai M, Cateau E, Thille AW, Brun S, Cohen Y, Alanio A, Mégarbane B, Cornet M, Terzi N, Lamhaut L, Sabourin E, Desoubeaux G, Ehrmann S, Hennequin C, Voiriot G, Nevez G, Aubron C, Letscher-Bru V, Meziani F, Blaize M, Mayaux J, Monsel A, Boquel F, Robert-Gangneux F, Le Tulzo Y, Seguin P, Guegan H, Autier B, Lesouhaitier M, Pelletier R, Belaz S, Bonnal C, Berry A, Leroy J, François N, Richard JC, Paulus S, Argaud L, Dupont D, Menotti J, Morio F, Soulié M, Schwebel C, Garnaud C, Guitard J, Le Gal S, Quinio D, Morcet J, Laviolle B, Zahar JR, Bougnoux ME
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study.
The Lancet. Respiratory Medicine 2022, 10, 180-190.
Gangneux JP, Morcet J, Laviolle B, Dannaoui E, Timsit JF, Ruckly S, Zahar JR, Bougnoux ME
Time-dependent bias when analysing COVID-19-associated pulmonary aspergillosis - Authors' reply.
The Lancet. Respiratory Medicine 2022, 10, e27.
CORIMUNO-19 Collaborative group
Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial.
The Lancet. Rheumatology 2022, 4, e24-e32.
Goulenok T, Delaval L, Delory N, François C, Papo T, Descamps D, Ferré VM, Sacré K
Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases.
The Lancet. Rheumatology 2022, 4, e458-e461.
Casalino E, Bouzid D, Ben Hammouda A, Wargon M, Curac S, Hellmann R, Choquet C, Ghazali DA
COVID-19 Preparedness Among Emergency Departments: A Cross-Sectional Study in France.
Disaster Medicine and Public Health Preparedness 2022, 16, 245-253.
Smith DRM, Duval A, Zahar JR, EMAE-MESuRS Working Group on Nosocomial SARS-CoV-2 Modelling, Opatowski L, Temime L
Rapid antigen testing as a reactive response to surges in nosocomial SARS-CoV-2 outbreak risk.
Nature Communications 2022, 13, 236.
Marlin R, Desjardins D, Contreras V, Lingas G, Solas C, Roques P, Naninck T, Pascal Q, Behillil S, Maisonnasse P, Lemaitre J, Kahlaoui N, Delache B, Pizzorno A, Nougairede A, Ludot C, Terrier O, Dereuddre-Bosquet N, Relouzat F, Chapon C, Ho Tsong Fang R, van der Werf S, Rosa Calatrava M, Malvy D, de Lamballerie X, Guedj J, Le Grand R
Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates.
Nature Communications 2022, 13, 5108.
de Prost N, Audureau E, Heming N, Gault E, Pham T, Chaghouri A, de Montmollin N, Voiriot G, Morand-Joubert L, Joseph A, Chaix ML, Préau S, Favory R, Guigon A, Luyt CE, Burrel S, Mayaux J, Marot S, Roux D, Descamps D, Meireles S, Pène F, Rozenberg F, Contou D, Henry A, Gaudry S, Brichler S, Timsit JF, Kimmoun A, Hartard C, Jandeaux LM, Fafi-Kremer S, Gabarre P, Emery M, Garcia-Sanchez C, Jochmans S, Pitsch A, Annane D, Azoulay E, Mekontso Dessap A, Rodriguez C, Pawlotsky JM, Fourati S
Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19.
Nature Communications 2022, 13, 6025.
Smith N, Possémé C, Bondet V, Sugrue J, Townsend L, Charbit B, Rouilly V, Saint-André V, Dott T, Pozo AR, Yatim N, Schwartz O, Cervantes-Gonzalez M, Ghosn J, Bastard P, Casanova JL, Szwebel TA, Terrier B, Conlon N, O'Farrelly C, Cheallaigh CN, Bourke NM, Duffy D
Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity.
Nature Communications 2022, 13, 7254.
ISARIC Clinical Characterization Group, Garcia-Gallo E, Merson L, Kennon K, Kelly S, Citarella BW, Fryer DV, Shrapnel S, Lee J, Duque S, Fuentes YV, Balan V, Smith S, Wei J, Gonçalves BP, Russell CD, Sigfrid L, Dagens A, Olliaro PL, Baruch J, Kartsonaki C, Dunning J, Rojek A, Rashan A, Beane A, Murthy S, Reyes LF
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19.
Scientific Data 2022, 9, 454.
Peyneau M, Granger V, Wicky PH, Khelifi-Touhami D, Timsit JF, Lescure FX, Yazdanpanah Y, Tran-Dinh A, Montravers P, Monteiro RC, Chollet-Martin S, Hurtado-Nedelec M, de Chaisemartin L
Innate immune deficiencies are associated with severity and poor prognosis in patients with COVID-19.
Scientific Reports 2022, 12, 638.
Leducq V, Jary A, Bridier-Nahmias A, Daniel L, Zafilaza K, Damond F, Goldstein V, Duval A, Blanquart F, Calvez V, Descamps D, Marcelin AG, Visseaux B
Nosocomial transmission clusters and lineage diversity characterized by SARS-CoV-2 genomes from two large hospitals in Paris, France, in 2020.
Scientific Reports 2022, 12, 1094.
Hausfater P, Boutolleau D, Lacombe K, Beurton A, Dumont M, Constantin JM, Ghosn J, Combes A, Cury N, Guedj R, Djibré M, Bompard R, Mazerand S, Pourcher V, Gimeno L, Marois C, Teyssou E, Marcelin AG, Hajage D, Tubach F
Cumulative incidence of SARS-CoV-2 infection and associated risk factors among frontline health care workers in Paris: the SEROCOV cohort study.
Scientific Reports 2022, 12, 7211.
Manry J, Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Michailidis E, Hoffmann HH, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Haljasmägi L, Migaud M, Särekannu K, Maslovskaja J, de Prost N, Tandjaoui-Lambiotte Y, Luyt CE, Amador-Borrero B, Gaudet A, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier JC, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux PL, Sene D, Stepanian A, Mégarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya JM, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Ozcelik T, Keles S, Bousfiha AA, El Bakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, van de Beek D, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau YL, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Venet F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari FS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Erikstrup C, Condino-Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, HGID Lab, COVID Clinicians, COVID-STORM Clinicians, NIAID Immune Response to COVID Group, NH-COVAIR Study Group, Danish CHGE, Danish Blood Donor Study, St. James's Hospital, SARS CoV2 Interest Group, French COVID Cohort Study Group, Imagine COVID-Group, Milieu Intérieur Consortium, CoV-Contact Cohort, Amsterdam UMC Covid-19 Biobank Investigators, COVID Human Genetic Effort, CP-COVID-19 Group, CONSTANCES cohort, 3C-Dijon Study, Cerba Health-Care, Etablissement Français du Sang Study group, Anderson MS, Boisson B, Béziat V, Zhang SY, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen TH, Rowen L, Mond J, Debette S, de Lamballerie X, Burdet C, Bouadma L, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Casanova JL, Abel L, Cobat A
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
Proceedings of the National Academy of Sciences of the United States of America 2022, 119, e2200413119.
Taillé C, Roche N, Tesson F, Tardivon C, Tran VT, Couffignal C
Belief and adherence to COVID 19-lockdown restrictions in patients with asthma versus other chronic diseases: results from a cross-sectional survey nested in the ComPaRe e-cohort, in France.
The Journal of Asthma: Official Journal of the Association for the Care of Asthma 2022, 59, 1491-1500.
Bouzid D, Mirault T, Ghazali A, Muller L, Casalino E, Peiffer Smadja N, Auber B, Guerin M, Sambet CH, Etienne I, De Lastours V, Badoual C, Lemogne C, Ruszniewski P, Université Paris Cité' Osce Study Group n, Faye A, Tran Dinh A
Feasibility of large-scale eOSCES: the simultaneous evaluation of 500 medical students during a mock examination.
Medical Education Online 2022, 27, 2084261.
Planchais C, Fernández I, Bruel T, de Melo GD, Prot M, Beretta M, Guardado-Calvo P, Dufloo J, Molinos-Albert LM, Backovic M, Chiaravalli J, Giraud E, Vesin B, Conquet L, Grzelak L, Planas D, Staropoli I, Guivel-Benhassine F, Hieu T, Boullé M, Cervantes-Gonzalez M, Ungeheuer MN, Charneau P, van der Werf S, Agou F, French COVID Cohort Study Group, CORSER Study Group, Dimitrov JD, Simon-Lorière E, Bourhy H, Montagutelli X, Rey FA, Schwartz O, Mouquet H
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.
The Journal of Experimental Medicine 2022, 219, e20220638.
Lingas G, Néant N, Gaymard A, Belhadi D, Peytavin G, Hites M, Staub T, Greil R, Paiva JA, Poissy J, Peiffer-Smadja N, Costagliola D, Yazdanpanah Y, Wallet F, Gagneux-Brunon A, Mentré F, Ader F, Burdet C, Guedj J, Bouscambert-Duchamp M
Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial.
The Journal of Antimicrobial Chemotherapy 2022, 77, 1404-1412.
Delaugerre C, Assoumou L, Maylin S, Minier M, Gabassi A, Genin M, Beniguel L, Ghosn J, de Lamballerie X, El Mouhebb M, Costagliola D, Carrat F, Molina JM, PREVENIR and SAPRIS-Sero Study Groups
Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among HIV-Negative Participants Using Tenofovir/Emtricitabine-Based Preexposure Prophylaxis in 2020: A Substudy of the French National Agency for Research on AIDS and Viral Hepatitis PREVENIR and Inserm SAPRIS-Sero Cohorts.
Open Forum Infectious Diseases 2022, 9, ofac188.
Jaquet P, Legouy C, Le Fevre L, Grinea A, Sinnah F, Franchineau G, Patrier J, Marzouk M, Wicky PH, Alexis Geoffroy P, Arnoult F, Vledouts S, de Montmollin E, Bouadma L, Timsit JF, Sharshar T, Sonneville R
Neurologic Outcomes of Survivors of COVID-19-Associated Acute Respiratory Distress Syndrome Requiring Intubation.
Critical Care Medicine 2022, 50, e674-e682.
Rybak A, Aupiais C, Cotillon M, Basmaci R, de Pontual L, Bonacorsi S, Mariani P, Landraud L, Brichler S, Poilane I, Ouldali N, Titomanlio L
Reassessing the Performance of the "Step-By-Step" Approach to Febrile Infants 90 Days of Age and Younger in the Context of the COVID-19 Pandemic: A Multicentric Retrospective Study.
The Pediatric Infectious Disease Journal 2022, 41, e365-e368.
Hassold N, Brichler S, Ouedraogo E, Leclerc D, Carroue S, Gater Y, Alloui C, Carbonnelle E, Bouchaud O, Mechai F, Cordel H, Delagreverie H
Impaired antibody response to COVID-19 vaccination in advanced HIV infection.
AIDS (London, England) 2022, 36, F1-F5.
Wicky PH, d'Humières C, Timsit JF
How common is ventilator-associated pneumonia after coronavirus disease 2019?.
Current Opinion in Infectious Diseases 2022, 35, 170-175.
Zahar JR, Timsit JF
Risk stratification for selecting empiric antibiotherapy during and after COVID-19.
Current Opinion in Infectious Diseases 2022, 35, 605-613.
Delaunay-Moisan A, Guilleminot T, Semeraro M, Briand N, Bader-Meunier B, Berthaud R, Morelle G, Quartier P, Galeotti C, Basmaci R, Benoist G, Gajdos V, Lorrot M, Rifai M, Crespin M, M'Sakni Z, Padavia F, Savetier-Leroy C, Lorenzi M, Maurin C, Behillil S, de Pontual L, Elenga N, Bouazza N, Moltrecht B, van der Werf S, Leruez-Ville M, Sermet-Gaudelus I
Saliva for molecular detection of SARS-CoV-2 in pre-school and school-age children.
Environmental Microbiology 2022, 24, 4725-4737.
Lapaillerie D, Charlier C, Guyonnet-Dupérat V, Murigneux E, Fernandes HS, Martins FG, Magalhães RP, Vieira TF, Richetta C, Subra F, Lebourgeois S, Charpentier C, Descamps D, Visseaux B, Weigel P, Favereaux A, Beauvineau C, Buron F, Teulade-Fichou MP, Routier S, Gallois-Montbrun S, Meertens L, Delelis O, Sousa SF, Parissi V
Selection of Bis-Indolyl Pyridines and Triphenylamines as New Inhibitors of SARS-CoV-2 Cellular Entry by Modulating the Spike Protein/ACE2 Interfaces.
Antimicrobial Agents and Chemotherapy 2022, 66, e0008322.
Ferré VM, Peiffer-Smadja N, Kramer L, Coppée R, Kante A, Debarge M, Choquet C, Saint Joannis T, Bouzid D, Messika J, Le Grand J, Thy M, Kernéis S, Descamps D, Visseaux B, Ghosn J
Dual Monoclonal Antibodies on Sars-Cov-2 Alpha and Delta Variants: Clinical and Virological Efficacy.
Microbiology Spectrum 2022, 10, e0215222.
Borocco C, Pouletty M, Galeotti C, Meinzer U, Faye A, Koné-Paut I, Ouldali N, Melki I
Response to: 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID19): a multicentre cohort'' by Mastrolia et al.
Annals of the Rheumatic Diseases 2022, 81, e219.
Chommeloux J, Pouletty M, Ouldali N, Kerneis M, Mathian A, Mestiri R, Rohmer J, Hekimian G, Melki I, Great Paris Region (GPR) Kawa-COVID-19 consortium
Response to: 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Ventura et al'.
Annals of the Rheumatic Diseases 2022, 81, e240.
Mageau A, Papo T, Ruckly S, Strukov A, van Gysel D, Sacre K, Timsit JF
Survival after COVID-19-associated organ failure among inpatients with systemic lupus erythematosus in France: a nationwide study.
Annals of the Rheumatic Diseases 2022, 81, 569-574.
Mageau A, Ferré VM, Goulenok T, Charpentier C, Delory N, Francois C, Houhou-Fidouh N, Papo T, Descamps D, Sacre K
Severely impaired humoral response against SARS-CoV-2 variants of concern following two doses of BNT162b2 vaccine in patients with systemic lupus erythematosus (SLE).
Annals of the Rheumatic Diseases 2022, 81, 1194-1196.
Legrand M, Fong N, Laouénan C, Ghosn J, Thill B, Faure K, Garot D, Goujard C, Curlier E, Resche-Rigon M, Rossignol P, Pirracchio R
Risk factors of long term symptoms and outcomes among patients discharged after covid-19: prospective, multicentre observational study.
BMJ medicine 2022, 1, e000093.
Labbe V, Contou D, Heming N, Megarbane B, Ait-Oufella H, Boissier F, Carreira S, Robert A, Vivier E, Fejjal M, Doyen D, Monchi M, Preau S, Noel-Savina E, Souweine B, Zucman N, Picos SA, Dres M, Juguet W, Mariotte E, Timsit JF, Turpin M, Razazi K, Gendreau S, Baloul S, Voiriot G, Fartoukh M, Audureau E, Mekontso Dessap A
Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trial.
BMJ open 2022, 12, e059383.
Marwali EM, Kekalih A, Yuliarto S, Wati DK, Rayhan M, Valerie IC, Cho HJ, Jassat W, Blumberg L, Masha M, Semple C, Swann OV, Kohns Vasconcelos M, Popielska J, Murthy S, Fowler RA, Guerguerian AM, Streinu-Cercel A, Pathmanathan MD, Rojek A, Kartsonaki C, Gonçalves BP, Citarella BW, Merson L, Olliaro PL, Dalton HJ, International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) Clinical Characterization Group Investigators
Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity.
BMJ paediatrics open 2022, 6, e001657.
Hajage D, Combes A, Guervilly C, Lebreton G, Mercat A, Pavot A, Nseir S, Mekontso-Dessap A, Mongardon N, Mira JP, Ricard JD, Beurton A, Tachon G, Kontar L, Le Terrier C, Richard JC, Mégarbane B, Keogh RH, Belot A, Maringe C, Leyrat C, Schmidt M, COVID-ICU Investigators
Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome Associated with COVID-19: An Emulated Target Trial Analysis.
American Journal of Respiratory and Critical Care Medicine 2022, 206, 281-294.
Vacheron CH, Lepape A, Savey A, Machut A, Timsit JF, Comparot S, Courno G, Vanhems P, Landel V, Lavigne T, Bailly S, Bettega F, Study Group RR, Maucort-Boulch D, Friggeri A
Attributable Mortality of Ventilator-associated Pneumonia Among COVID-19 Patients.
American Journal of Respiratory and Critical Care Medicine 2022
Beurnier A, Yordanov Y, Dechartres A, Dinh A, Debuc E, Lescure FX, Jourdain P, Jaulmes L, Humbert M
Characteristics and outcomes of asthmatic outpatients with COVID-19 who receive home telesurveillance.
ERJ open research 2022, 8, 00012-2022.
Chevret S, Timsit JF, Biard L
Challenges of using external data in clinical trials- an illustration in patients with COVID-19.
BMC medical research methodology 2022, 22, 321.
Martin-Blondel G, Lescure FX, Assoumou L, Charpentier C, Chapplain JM, Perpoint T, Grouteau G, Cordel H, Pialoux G, Pacanowski J, Thy M, Bauvois A, Laureillard D, Hamrouni F, Algarte-Genin M, Poissy J, Descamps D, Costagliola D, CoCliCo Study Group
Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study.
BMC infectious diseases 2022, 22, 540.
Bosetti P, Tran Kiem C, Andronico A, Colizza V, Yazdanpanah Y, Fontanet A, Benamouzig D, Cauchemez S
Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France.
BMC medicine 2022, 20, 33.
Dupont A, Couffignal C, Arias C, Salah K, Phillips-Houlbraq M, Le Brun M, Taillé C
Outcomes and risk factors with COVID-19 or influenza in hospitalized asthma patients.
Respiratory Research 2022, 23, 342.
Le Terrier C, Sigaud F, Lebbah S, Desmedt L, Hajage D, Guérin C, Pugin J, Primmaz S, Terzi N
Early prone positioning in acute respiratory distress syndrome related to COVID-19: a propensity score analysis from the multicentric cohort COVID-ICU network-the ProneCOVID study..
Critical care (London, England) 2022, 26, 71.
Roca O, Caritg O, Santafé M, Ramos FJ, Pacheco A, García-de-Acilu M, Ferrer R, Schultz MJ, Ricard JD
Closed-loop oxygen control improves oxygen therapy in acute hypoxemic respiratory failure patients under high flow nasal oxygen: a randomized cross-over study (the HILOOP study).
Critical Care (London, England) 2022, 26, 108.
Walter T, Zucman N, Mullaert J, Thiry I, Gernez C, Roux D, Ricard JD
Extended prone positioning duration for COVID-19-related ARDS: benefits and detriments.
Critical Care (London, England) 2022, 26, 208.
Reyes LF, Murthy S, Garcia-Gallo E, Merson L, Ibáñez-Prada ED, Rello J, Fuentes YV, Martin-Loeches I, Bozza F, Duque S, Taccone FS, Fowler RA, Kartsonaki C, Gonçalves BP, Citarella BW, Aryal D, Burhan E, Cummings MJ, Delmas C, Diaz R, Figueiredo-Mello C, Hashmi M, Panda PK, Jiménez MP, Rincon DFB, Thomson D, Nichol A, Marshall JC, Olliaro PL, ISARIC Characterization Group
Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study.
Critical Care (London, England) 2022, 26, 276.
Patrier J, Villageois-Tran K, Szychowiak P, Ruckly S, Gschwind R, Wicky PH, Gueye S, Armand-Lefevre L, Marzouk M, Sonneville R, Bouadma L, Petitjean M, Lamara F, de Montmollin E, Timsit JF, Ruppé E, French COVID Cohort Study Group
Oropharyngeal and intestinal concentrations of opportunistic pathogens are independently associated with death of SARS-CoV-2 critically ill adults.
Critical Care (London, England) 2022, 26, 300.
Buetti N, Tabah A, Loiodice A, Ruckly S, Aslan AT, Montrucchio G, Cortegiani A, Saltoglu N, Kayaaslan B, Aksoy F, Murat A, Akdoğan Ö, Saracoglu KT, Erdogan C, Leone M, Ferrer R, Paiva JA, Hayashi Y, Ramanan M, Conway Morris A, Barbier F, Timsit JF, Eurobact 2 study group
Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study.
Critical Care (London, England) 2022, 26, 319.
Szychowiak P, Villageois-Tran K, Patrier J, Timsit JF, Ruppé É
The role of the microbiota in the management of intensive care patients.
Annals of Intensive Care 2022, 12, 3.
Massart N, Maxime V, Fillatre P, Razazi K, Ferré A, Moine P, Legay F, Voiriot G, Amara M, Santi F, Nseir S, Marque-Juillet S, Bounab R, Barbarot N, Bruneel F, Luyt CE, COVID ICU Bacteremia Study Group on behalf of the COVID-ICU Investigators
Correction to: Characteristics and prognosis of bloodstream infection in patients with COVID‑19 admitted in the ICU: an ancillary study of the COVID‑ICU study.
Annals of Intensive Care 2022, 12, 4.
Durand C, Douriez E, Chappuis A, Poulain F, Yazdanpanah Y, Lariven S, Lescure FX, Peiffer-Smadja N
Contributions and challenges of community pharmacists during the COVID-19 pandemic: a qualitative study.
Journal of Pharmaceutical Policy and Practice 2022, 15, 43.
Nijman RG, Honeyford K, Farrugia R, Rose K, Bognar Z, Buonsenso D, Da Dalt L, De T, Maconochie IK, Parri N, Roland D, Alfven T, Aupiais C, Barrett M, Basmaci R, Borensztajn D, Castanhinha S, Vasilico C, Durnin S, Fitzpatrick P, Fodor L, Gomez B, Greber-Platzer S, Guedj R, Hartshorn S, Hey F, Jankauskaite L, Kohlfuerst D, Kolnik M, Lyttle MD, Mação P, Mascarenhas MI, Messahel S, Özkan EA, Pučuka Z, Reis S, Rybak A, Ryd Rinder M, Teksam O, Turan C, Thors VS, Velasco R, Bressan S, Moll HA, Oostenbrink R, Titomanlio L, in association with the REPEM network (Research in European Pediatric Emergency Medicine) as part of the EPISODES study group
Presentations of children to emergency departments across Europe and the COVID-19 pandemic: A multinational observational study.
PLoS medicine 2022, 19, e1003974.
Béraud G, Timsit JF, Leleu H
Remdesivir and dexamethasone as tools to relieve hospital care systems stressed by COVID-19: A modelling study on bed resources and budget impact.
PloS One 2022, 17, e0262462.
Egloff C, Couffignal C, Cordier AG, Deruelle P, Sibiude J, Anselem O, Benachi A, Luton D, Mandelbrot L, Vauloup-Fellous C, Vivanti AJ, Picone O
Pregnant women's perceptions of the COVID-19 vaccine: A French survey.
PloS One 2022, 17, e0263512.
Grandjean D, Elie C, Gallet C, Julien C, Roger V, Desquilbet L, Alvergnat G, Delarue S, Gabassi A, Minier M, Choupeaux L, Kerneis S, Delaugerre C, LE Goff J, Treluyer JM
Diagnostic accuracy of non-invasive detection of SARS-CoV-2 infection by canine olfaction.
PloS One 2022, 17, e0268382.
Bouiller K, Peiffer-Smadja N, Cevik M, Last K, Antunović IA, Šterbenc A, Lopes MJ, Barac A, Schweitzer V, Dellière S
Role and perception of clinical microbiology and infectious diseases trainees during the COVID-19 crisis.
Future Microbiology 2022, 17, 411-416.
Rapin A, Boyer FC, Mourvillier B, Giordano Orsini G, Launois C, Taiar R, Deslee G, Goury A, Carazo-Mendez S
Post-Intensive Care Syndrome Prevalence Six Months after Critical Covid-19: Comparison between First and Second Waves.
Journal of Rehabilitation Medicine 2022, 54, jrm00339.
Viriot D, Lucas E, de Barbeyrac B, Bébéar C, Fouéré S, Dupin N, Bertolotti A, Berçot B, Cazanave C, Delmas G, Pillonel J, Lot F, Ngangro NN
Use of healthcare reimbursement data to monitor bacterial sexually transmitted infection testing in France, 2006 to 2020.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2022, 27,
Alizon S, Selinger C, Sofonea MT, Haim-Boukobza S, Giannoli JM, Ninove L, Pillet S, Thibault V, de Rougemont A, Tumiotto C, Solis M, Stephan R, Bressollette-Bodin C, Salmona M, L'Honneur AS, Behillil S, Lefeuvre C, Dina J, Hantz S, Hartard C, Veyer D, Delagrèverie HM, Fourati S, Visseaux B, Henquell C, Lina B, Foulongne V, Burrel S, SFM COVID-19 study group
Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2022, 27,
Shirreff G, Zahar JR, Cauchemez S, Temime L, Opatowski L, EMEA-MESuRS Working Group on the Nosocomial Modelling of SARS-CoV-22
Measuring Basic Reproduction Number to Assess Effects of Nonpharmaceutical Interventions on Nosocomial SARS-CoV-2 Transmission.
Emerging Infectious Diseases 2022, 28, 1345-1354.
Lebourgeois S, David A, Chenane HR, Granger V, Menidjel R, Fidouh N, Noël B, Delelis O, Richetta C, Charpentier C, Chollet-Martin S, Descamps D, Visseaux B, de Chaisemartin L
Differential activation of human neutrophils by SARS-CoV-2 variants of concern.
Frontiers in Immunology 2022, 13, 1010140.
d'Humières C, Gaïa N, Gueye S, de Lastours V, Leflon-Guibout V, Maataoui N, Duprilot M, Lecronier M, Rousseau MA, Gamany N, Lescure FX, Senard O, Deconinck L, Dollat M, Isernia V, Le Hur AC, Petitjean M, Nazimoudine A, Le Gac S, Chalal S, Ferreira S, Lazarevic V, Guigon G, Gervasi G, Armand-Lefèvre L, Schrenzel J, Ruppé E
Contribution of Clinical Metagenomics to the Diagnosis of Bone and Joint Infections.
Frontiers in Microbiology 2022, 13, 863777.
Rybak A, Ouldali N, Angoulvant F, Minodier P, Biscardi S, Madhi F, Hau I, Santos A, Bouvy E, Dubos F, Martinot A, Dommergues MA, Gras-Le Guen C, Launay E, Levieux K, Zenkhri F, Craiu I, Lorrot M, Gillet Y, Mezgueldi E, Faye A, Béchet S, Varon E, Cohen R, Levy C
Shift in Clinical Profile of Hospitalized Pneumonia in Children in the Non-pharmaceutical Interventions Period During the COVID-19 Pandemic: A Prospective Multicenter Study.
Frontiers in Pediatrics 2022, 10, 782894.
Goupil de Bouillé J, Luong Nguyen LB, Crépey P, Garlantezec R, Doré V, Dumas A, Ben Mechlia M, Tattevin P, Gaudart J, Spire B, Lert F, Yazdanpanah Y, Delaugerre C, Noret M, Zeggagh J
Transmission of SARS-CoV-2 during indoor clubbing events: A clustered randomized, controlled, multicentre trial protocol.
Frontiers in Public Health 2022, 10, 981213.
de Montmollin E, Peoc'h K, Marzouk M, Ruckly S, Wicky PH, Patrier J, Jaquet P, Sonneville R, Bouadma L, Timsit JF
Mid-Regional Pro-Adrenomedullin as a Prognostic Factor for Severe COVID-19 ARDS.
Antibiotics (Basel, Switzerland) 2022, 11, 1166.
Delhommeau G, Buetti N, Neuville M, Siami S, Cohen Y, Laurent V, Mourvillier B, Reignier J, Goldgran-Toledano D, Schwebel C, Ruckly S, de Montmollin E, Souweine B, Timsit JF, Dupuis C
Bacterial Pulmonary Co-Infections on ICU Admission: Comparison in Patients with SARS-CoV-2 and Influenza Acute Respiratory Failure: A Multicentre Cohort Study.
Biomedicines 2022, 10, 2646.
Ousseine YM, Vaux S, Vandentorren S, Bonmarin I, Champenois K, Lydié N, Velter A
Predictors of Uncertainty and Unwillingness to Receive the COVID-19 Vaccine in Men Who Have Sex with Men in France.
International Journal of Environmental Research and Public Health 2022, 19, 5372.
Arnaud E, Elbattah M, Ammirati C, Dequen G, Ghazali DA
Use of Artificial Intelligence to Manage Patient Flow in Emergency Department during the COVID-19 Pandemic: A Prospective, Single-Center Study.
International Journal of Environmental Research and Public Health 2022, 19, 9667.
Zerbit J, Detroit M, Chevret S, Pene F, Luyt CE, Ghosn J, Eyvrard F, Martin-Blondel G, Sarton B, Clere-Jehl R, Moine P, Cransac A, Andreu P, Labruyère M, Albertini L, Huon JF, Roge P, Bernard L, Farines-Raffoul M, Villiet M, Venet A, Dumont LM, Kaiser JD, Chapuis C, Goehringer F, Barbier F, Desjardins S, Benzidi Y, Abbas N, Guerin C, Batista R, Llitjos JF, Kroemer M
Remdesivir for Patients Hospitalized with COVID-19 Severe Pneumonia: A National Cohort Study (Remdeco-19).
Journal of Clinical Medicine 2022, 11, 6545.
Bonnet C, Masse S, Benamar H, Vilcu AM, Swital M, Hanslik T, van der Werf S, Duval X, Carrat F, Falchi A, Blanchon T
Is the Alpha Variant of SARS-CoV-2 Associated with a Higher Viral Load than the Historical Strain in Saliva Samples in Patients with Mild to Moderate Symptoms?.
Life (Basel, Switzerland) 2022, 12, 163.
Fourati S, Audureau E, Arrestier R, Marot S, Dubois C, Voiriot G, Luyt CE, Urbina T, Mayaux J, Roque-Afonso AM, Pham T, Landraud L, Visseaux B, Roux D, Bellaiche R, L'honneur AS, Ait Hamou Z, Brichler S, Gaudry S, Salmona M, Clere-Jehl R, Azoulay E, Morand-Joubert L, Marcelin AG, Chaix ML, Descamps D, Mekontso Dessap A, Rodriguez C, Pawlotsky JM, de Prost N
SARS-CoV-2 Genomic Characteristics and Clinical Impact of SARS-CoV-2 Viral Diversity in Critically Ill COVID-19 Patients: A Prospective Multicenter Cohort Study.
Viruses 2022, 14, 1529.
Bouzid D, Visseaux B, Kassasseya C, Daoud A, Fémy F, Hermand C, Truchot J, Beaune S, Javaud N, Peyrony O, Chauvin A, Vaittinada Ayar P, Bourg A, Riou B, Marot S, Bloom B, Cachanado M, Simon T, Freund Y, IMProving Emergency Care (IMPEC) FHU Collaborators Group
Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments : A Retrospective Cohort Study.
Annals of Internal Medicine 2022, 175, 831-837.
Johnson MG, Puenpatom A, Moncada PA, Burgess L, Duke ER, Ohmagari N, Wolf T, Bassetti M, Bhagani S, Ghosn J, Zhang Y, Wan H, Williams-Diaz A, Brown ML, Paschke A, De Anda C
Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled Trial.
Annals of Internal Medicine 2022, 175, 1126-1134.
El Messaoudi S, Lemenuel-Diot A, Gonçalves A, Guedj J
A semi-mechanistic model to characterize the long-term dynamic of HBV markers during treatment with lamivudine and Peg-IFN.
Clinical Pharmacology & Therapeutics 2022
High-Dose Dexamethasone and Oxygen Support Strategies in Intensive Care Unit Patients With Severe COVID-19 Acute Hypoxemic Respiratory Failure: The COVIDICUS Randomized Clinical Trial.
JAMA internal medicine 2022, 182, 906-916.
Rybak A, Levy C, Angoulvant F, Auvrignon A, Gembara P, Danis K, Vaux S, Levy-Bruhl D, van der Werf S, Béchet S, Bonacorsi S, Assad Z, Lazzati A, Michel M, Kaguelidou F, Faye A, Cohen R, Varon E, Ouldali N
Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France.
JAMA network open 2022, 5, e2218959.
Solignac F, Ouldali N, Aupiais C, Casha P, Cohen R, Levy C, Angoulvant F
Analysis of COVID-19 Vaccination Status Among Parents of Hospitalized Children Younger Than 5 Years With SARS-CoV-2 Infection During the Delta and Omicron Waves.
JAMA network open 2022, 5, e2242295.
Villemonteix J, Cohen L, Guihot A, Guérin V, Moulin C, Caseris M, Carol A, Bonacorsi S, Carcelain G
Comparison between enzyme-linked immunospot assay and intracellular cytokine flow cytometry assays for the evaluation of T cell response to SARS-CoV-2 after symptomatic COVID-19.
Immunity, Inflammation and Disease 2022, 10, e617.
Houhou-Fidouh N, Bucau M, Bertine M, Minh TNT, Picone O, Salakos E, Luton D
Preliminary results on transmission of SARS-CoV-2 antibodies to the fetus and serum neutralizing activity.
International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics 2022, 158, 476-478.
Elie B, Roquebert B, Sofonea MT, Trombert-Paolantoni S, Foulongne V, Guedj J, Haim-Boukobza S, Alizon S
Variant-specific SARS-CoV-2 within-host kinetics.
Journal of Medical Virology 2022, 94, 3625-3633.
Ayrolles A, Ellul P, Trebossen V, Houhou-Fidouh N, Bonacorsi S, Descamps D, Delorme R
Is SARS-CoV-2 seroconversion a risk factor for severe and acute psychiatric symptoms in children?.
Neuropsychopharmacology Reports 2022, 42, 218-220.
Tallarico RT, Deniau B, Fong N, Ghosn J, Legrand M, French-COVID and the FROG-ICU Investigators
Differences in HADS and SF-36 scores 1 year after critical illness in COVID-19 patients.
Intensive Care Medicine 2022, 48, 1245-1247.
Foutel-Rodier F, Blanquart F, Courau P, Czuppon P, Duchamps JJ, Gamblin J, Kerdoncuff É, Kulathinal R, Régnier L, Vuduc L, Lambert A, Schertzer E
From individual-based epidemic models to McKendrick-von Foerster PDEs: a guide to modeling and inferring COVID-19 dynamics.
Journal of Mathematical Biology 2022, 85, 43.
Bolze A, Mogensen TH, Zhang SY, Abel L, Andreakos E, Arkin LM, Borghesi A, Brodin P, Hagin D, Novelli G, Okada S, Peter J, Renia L, Severe K, Tiberghien P, Vinh DC, COVID human genetic effort, Cirulli ET, Casanova JL, Hsieh EWY
Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis.
Journal of Clinical Immunology 2022, 42, 1354-1359.
Ferré VM, Peiffer-Smadja N, Visseaux B, Descamps D, Ghosn J, Charpentier C
Omicron SARS-CoV-2 variant: What we know and what we don't.
Anaesthesia, Critical Care & Pain Medicine 2022, 41, 100998.
Prague M, Alexandre M, Thiébaut R, Guedj J
Within-host models of SARS-CoV-2: What can it teach us on the biological factors driving virus pathogenesis and transmission?.
Anaesthesia, Critical Care & Pain Medicine 2022, 41, 101055.
Fillâtre P, Dufour MJ, Behillil S, Vatan R, Reusse P, Gabellec A, Velmans N, Montagne C, Geffroy Du Coudret S, Droumaguet E, Merour V, Enouf V, Buzelé R, Valence M, Guillotel E, Gagnière B, Baidaliuk A, Zhukova A, Tourdjman M, Thibault V, Grolhier C, Pronier C, Lescure FX, Simon-Loriere E, Costagliola D, Van Der Werf S, Tattevin P, Massart N
A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 298.e9-298.e15.
Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 202-221.
EU-Response investigators group, Diallo A, Trøseid M, Simensen VC, Boston A, Demotes J, Olsen IC, Chung F, Paiva JA, Hites M, Ader F, Arribas JR, Baratt-Due A, Melien Ø, Tacconelli E, Staub T, Greil R, Tsiodras S, Briel M, Esperou H, Mentré F, Eustace J, Saillard J, Delmas C, LeMestre S, Dumousseaux M, Costagliola D, Røttingen JA, Yazdanpanah Y
Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 1-5.
Trøseid M, Diallo A, Hites M, Røttingen JA, Yazdanpanah Y
Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 743-744.
Dinh A, Dahmane L, Dahoumane M, Masingue X, Jourdain P, Lescure FX
Impact of Omicron surge in community setting in greater Paris area.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, S1198-743X(22)00089-1.
Duvignaud A, Lhomme E, Onaisi R, Sitta R, Gelley A, Chastang J, Piroth L, Binquet C, Dupouy J, Makinson A, Lefèvre B, Naccache JM, Roussillon C, Landman R, Wallet C, Karcher S, Journot V, Nguyen D, Pistone T, Bouchet S, Lafon ME, Molimard M, Thiébaut R, de Lamballerie X, Joseph JP, Richert L, Saint-Lary O, Djabarouti S, Wittkop L, Anglaret X, Malvy D, Coverage Study Group
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE).
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, S1198-743X(22)00108-2.
Belan M, Charmet T, Schaeffer L, Tubiana S, Duval X, Lucet JC, Fontanet A, Birgand G, Kernéis S
SARS-CoV-2 exposures of healthcare workers from primary care, long-term care facilities and hospitals: a nationwide matched case-control study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 1471-1476.
Coléon S, Wiedemann A, Surénaud M, Lacabaratz C, Hue S, Prague M, Cervantes-Gonzalez M, Wang Z, Ellis J, Sansoni A, Pierini C, Bardin Q, Fabregue M, Sharkaoui S, Hoest P, Dupaty L, Picard F, El Hajj M, Centlivre M, Ghosn J, French COVID Cohort Study Group, Thiébaut R, Cardinaud S, Malissen B, Zurawski G, Zarubica A, Zurawski SM, Godot V, Lévy Y
Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine.
EBioMedicine 2022, 80, 104062.
Hermine O, Mariette X, Porcher R, Djossou F, Nguyen Y, Arlet JB, Savale L, Diehl JL, Georgin-Lavialle S, Cadranel J, Pialoux G, Lacombe K, Mekinian A, Gros H, Lescure X, Ghosn J, Coupez E, Grapin K, Rapp C, Michel M, Lecapitaine AL, Michot JM, Costedoat-Chalumeau N, Nguyen LBL, Semerano L, Raffi F, Aguillar C, Rouzaud C, Gottenberg JE, Hansmann Y, Bienvenu B, London J, Fantchou FS, Ackermann F, Gros A, Morel A, Gambier N, Sène D, Mégarbane B, Azoulay E, Bureau S, Dougados M, Emmerich J, Fartoukh M, Guidet B, Humbert M, Mahevas M, Pène F, Schlemmer F, Pourcher-Martinez V, Tibi A, Baron G, Perrodeau E, Baron S, Steg G, Yazdapanah Y, Simon T, Resche-Rigon M, Tharaux PL, Ravaud P
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group.
EClinicalMedicine 2022, 46, 101362.
Barrière J, Carles M, Audigier-Valette C, Re D, Adjtoutah Z, Seitz-Polski B, Gounant V, Descamps D, Zalcman G
Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article.
European Journal of Cancer (Oxford, England: 1990) 2022, 162, 182-193.
Barrière J, Zalcman G, Fignon L, Peiffer-Smadja N, Audigier-Valette C, Carles M
Omicron variant: A clear and present danger for patients with cancer.
European Journal of Cancer (Oxford, England: 1990) 2022, 165, 25-26.
Huré M, Peyronnet V, Sibiude J, Cazenave MG, Anselem O, Luton D, Vauloup-Fellous C, Deruelle P, Cordier AG, Benachi A, Mandelbrot L, Couffignal C, Pauphilet V, Vivanti AJ, Picone O
[SARS-Cov-2 vaccine's acceptance among pregnant women-A cross-sectional survey].
Gynecologie, Obstetrique, Fertilite & Senologie 2022, 50, 712-720.
Blot S, Ruppé E, Harbarth S, Asehnoune K, Poulakou G, Luyt CE, Rello J, Klompas M, Depuydt P, Eckmann C, Martin-Loeches I, Povoa P, Bouadma L, Timsit JF, Zahar JR
Healthcare-associated infections in adult intensive care unit patients: Changes in epidemiology, diagnosis, prevention and contributions of new technologies.
Intensive & Critical Care Nursing 2022, 70, 103227.
Husain M, Valayer S, Poey N, Rondinaud E, d'Humières C, Visseaux B, Lariven S, Lescure FX, Deconinck L
Pulmonary bacterial infections in adult patients hospitalized for COVID-19 in standard wards.
Infectious Diseases Now 2022, 52, 208-213.
Luong Ngyen LB, Bauer R, Lesieur Z, Galtier F, Duval X, Vanhems P, Lainé F, Tattevin P, Durier C, Launay O, FLUVAC Study group
Vaccine effectiveness against COVID-19 hospitalization in adults in France: A test negative case control study.
Infectious Diseases Now 2022, 52, 40-43.
Koch A, Vermel M, Hansmann Y, Lodi M, Mura C, Sananes A, Gallien S, Wurtz É, Bleibtreu A, Martinot M, Exinger J, Lescure X, Kerneis S, Lacombe K, Mootien JY, Shawali C, Lecointre L, Debry C, Lefebvre N, Sananes N
3D-printed simulator for nasopharyngeal swab collection for COVID-19.
Infectious Diseases Now 2022, S2666-9919(22)00035-5.
Cohen R, Rybak A, Ouldali N, Angoulvant F, Béchet S, Gajdos V, Hau I, Sellam A, El Aouane El Ghomari I, Elmerich F, Batard C, Auvrignon A, Grimprel E, Favier M, Jung C, Levy C
From the original SARS-CoV-2 strain to the Omicron variant: Predictors of COVID-19 in ambulatory symptomatic children.
Infectious Diseases Now 2022, 52, 432-440.
Amarsy R, Trystram D, Cambau E, Monteil C, Fournier S, Oliary J, Junot H, Sabatier P, Porcher R, Robert J, Jarlier V, “la Collégiale de Bactériologie–Virologie–Hygiène de l'Assistance Publique – Hôpitaux de Paris”
Surging bloodstream infections and antimicrobial resistance during the first wave of COVID-19: a study in a large multihospital institution in the Paris region.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2022, 114, 90-96.
Bachelard A, Sautereau A, Digumber M, Isernia V, Phung B, Lehur AC, Gac SL, Landman R, Yazdanpanah Y, Ghosn J
Risk Factors Associated with Severe/Critical COVID-19 in People Living with HIV-1.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2022, 122, 152-154.
Boussier J, Yatim N, Marchal A, Hadjadj J, Charbit B, El Sissy C, Carlier N, Pène F, Mouthon L, Tharaux PL, Bergeron A, Smadja DM, Rieux-Laucat F, Duffy D, Kernéis S, Frémeaux-Bacchi V, Terrier B
Severe COVID-19 is associated with hyperactivation of the alternative complement pathway.
The Journal of Allergy and Clinical Immunology 2022, 149, 550-556.e2.
Nagle S, Tandjaoui-Lambiotte Y, Boubaya M, Athenaïs G, Alloui C, Bloch-Queyrat C, Carbonnelle E, Brichler S, Cohen Y, Zahar JR, Delagrèverie H
Environmental SARS-CoV-2 contamination in hospital rooms of patients with acute COVID-19.
The Journal of Hospital Infection 2022, 126, 116-122.
Cosentino G, Bernard M, Ambroise J, Giannoli JM, Guedj J, Débarre F, Blanquart F
SARS-CoV-2 viral dynamics in infections with Alpha and Beta variants of concern in the French community.
The Journal of Infection 2022, 84, 94-118.
Lebourgeois S, Menidjel R, Chenane HR, Ferré VM, Collin G, Damond F, Coppée R, Yazdanpanah Y, Timsit JF, Houhou-Fidouh N, Descamps D, Charpentier C, Visseaux B
Alpha (B.1.1.7) and Delta (B.1.617.2 - AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage.
The Journal of Infection 2022, 84, 418-467.
Ferré VM, Lebourgeois S, Chenane HR, Menidjel R, Masson C, Collin G, Visseaux B, Descamps D, Fidouh N, Charpentier C
Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays.
The Journal of Infection 2022, S0163-4453(22)00126-8.
Martin-Blondel G, Marcelin AG, Soulié C, Kaisaridi S, Lusivika-Nzinga C, Dorival C, Nailler L, Boston A, Melenotte C, Cabié A, Choquet C, Coustillères F, Martellosio JP, Gaube G, Trinh-Duc A, Ronchetti AM, Pourcher V, Chauveau M, Lacombe K, Peiffer-Smadja N, Housset P, Perrot A, Pialoux G, Martin A, Dubee V, Devaux M, Frey J, Cazanave C, Liblau R, Carrat F, Yordanov Y
Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2.
The Journal of Infection 2022, 85, e104-e108.
Aubart M, Roux CJ, Durrleman C, Gins C, Hully M, Kossorotoff M, Gitiaux C, Levy R, Moulin F, Debray A, Belhadjer Z, Georget E, Kom T, Blanc P, Wehbi S, Mazeghrane M, Tencer J, Gajdos V, Rouget S, De Pontual L, Basmaci R, Yacouben K, Angoulvant F, Leruez-Ville M, Sterlin D, Rozenberg F, Robert MP, Zhang SY, Boddaert N, Desguerre I
Neuroinflammatory Disease following Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children.
The Journal of Pediatrics 2022, 247, 22-28.e2.
Gounant V, Ferré VM, Soussi G, Charpentier C, Flament H, Fidouh N, Collin G, Namour C, Assoun S, Bizot A, Brouk Z, Vicaut E, Teixeira L, Descamps D, Zalcman G
Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses.
Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 2022, 17, 239-251.
Farrar DS, Drouin O, Moore Hepburn C, Baerg K, Chan K, Cyr C, Donner EJ, Embree JE, Farrell C, Forgie S, Giroux R, Kang KT, King M, Laffin Thibodeau M, Orkin J, Ouldali N, Papenburg J, Pound CM, Price VE, Proulx-Gauthier JP, Purewal R, Ricci C, Sadarangani M, Salvadori MI, Thibeault R, Top KA, Viel-Thériault I, Kakkar F, Morris SK
Risk factors for severe COVID-19 in hospitalized children in Canada: A national prospective study from March 2020-May 2021.
Lancet Regional Health. Americas 2022, 15, 100337.
Alidjinou EK, Demaret J, Corroyer-Simovic B, Labreuche J, Goffard A, Trauet J, Lupau D, Miczek S, Vuotto F, Dendooven A, Huvent-Grelle D, Podvin J, Dreuil D, Faure K, Deplanque D, Bocket L, Duhamel A, Sobaszek A, Hober D, Hisbergues M, Puisieux F, Autran B, Yazdanpanah Y, Labalette M, Lefèvre G
Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years.
The Lancet Regional Health. Europe 2022, 17, 100385.
Ouldali N, Bagheri H, Salvo F, Antona D, Pariente A, Leblanc C, Tebacher M, Micallef J, Levy C, Cohen R, Javouhey E, Bader-Meunier B, Ovaert C, Renolleau S, Hentgen V, Kone-Paut I, Deschamps N, De Pontual L, Iriart X, Guen CGL, Angoulvant F, Belot A, “French Covid-19 Paediatric Inflammation Consortium”£ and the “French Pharmacovigilance network”*
Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study.
The Lancet Regional Health. Europe 2022, 17, 100393.
Tacconelli E, Gorska A, Carrara E, Davis RJ, Bonten M, Friedrich AW, Glasner C, Goossens H, Hasenauer J, Abad JMH, Peñalvo JL, Sanchez-Niubo A, Sialm A, Scipione G, Soriano G, Yazdanpanah Y, Vorstenbosch E, Jaenisch T
Challenges of data sharing in European Covid-19 projects: A learning opportunity for advancing pandemic preparedness and response.
The Lancet Regional Health. Europe 2022, 21, 100467.
Ouldali N, Bagheri H, Salvo F, Antona D, Pariente A, Leblanc C, Tebacher M, Micallef J, Levy C, Cohen R, Javouhey E, Bader-Meunier B, Ovaert C, Renolleau S, Hentgen V, Kone-Paut I, Deschamps N, De Pontual L, Iriart X, Guen CGL, Angoulvant F, Belot A, French Covid-19 Paediatric Inflammation Consortium, French Pharmacovigilance network
Correction to "Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study".
The Lancet Regional Health. Europe 2022, 21, 100468.
Cohen PR, Rybak A, Werner A, Béchet S, Desandes R, Hassid F, André JM, Gelbert N, Thiebault G, Kochert F, Cahn-Sellem F, Vié Le Sage F, Angoulvant PF, Ouldali N, Frandji B, Levy C
Trends in pediatric ambulatory community acquired infections before and during COVID-19 pandemic: A prospective multicentric surveillance study in France.
The Lancet Regional Health. Europe 2022, 22, 100497.
Wurtzer S, Waldman P, Levert M, Cluzel N, Almayrac JL, Charpentier C, Masnada S, Gillon-Ritz M, Mouchel JM, Maday Y, Boni M, OBEPINE Consortium, AP-HP Virologist Group, Marechal V, Moulin L
SARS-CoV-2 genome quantification in wastewaters at regional and city scale allows precise monitoring of the whole outbreaks dynamics and variants spreading in the population.
The Science of the Total Environment 2022, 810, 152213.
Burdet C, Ader F
Real-world effectiveness of oral antivirals for COVID-19.
Lancet (London, England) 2022, 400, 1175-1176.
Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Poissy J, Belhadi D, Diallo A, Lê MP, Peytavin G, Staub T, Greil R, Guedj J, Paiva JA, Costagliola D, Yazdanpanah Y, Burdet C, Mentré F, DisCoVeRy Study Group
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.
The Lancet. Infectious Diseases 2022, 22, 209-221.
Nasa P, Azoulay E, Chakrabarti A, Divatia JV, Jain R, Rodrigues C, Rosenthal VD, Alhazzani W, Arabi YM, Bakker J, Bassetti M, De Waele J, Dimopoulos G, Du B, Einav S, Evans L, Finfer S, Guérin C, Hammond NE, Jaber S, Kleinpell RM, Koh Y, Kollef M, Levy MM, Machado FR, Mancebo J, Martin-Loeches I, Mer M, Niederman MS, Pelosi P, Perner A, Peter JV, Phua J, Piquilloud L, Pletz MW, Rhodes A, Schultz MJ, Singer M, Timsit JF, Venkatesh B, Vincent JL, Welte T, Myatra SN
Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method.
The Lancet. Infectious Diseases 2022, 22, e74-e87.
Delaugerre C, Foissac F, Abdoul H, Masson G, Choupeaux L, Dufour E, Gastli N, Delarue SM, Néré ML, Minier M, Gabassi A, Salmona M, Seguineau M, Schmitt S, Tonglet S, Olivier A, Poyart C, Le Goff J, Lescure X, Kernéis S, Tréluyer JM, SPRING study group
Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial.
The Lancet. Infectious Diseases 2022, 22, 341-348.
Colosi E, Bassignana G, Contreras DA, Poirier C, Boëlle PY, Cauchemez S, Yazdanpanah Y, Lina B, Fontanet A, Barrat A, Colizza V
Screening and vaccination against COVID-19 to minimise school closure: a modelling study.
The Lancet. Infectious Diseases 2022, S1473-3099(22)00138-4.
Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Mentré F, Burdet C, DisCoVeRy Study Group
Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19.
The Lancet. Infectious Diseases 2022, 22, 764-765.
Gangneux JP, Dannaoui E, Fekkar A, Luyt CE, Botterel F, De Prost N, Tadié JM, Reizine F, Houzé S, Timsit JF, Iriart X, Riu-Poulenc B, Sendid B, Nseir S, Persat F, Wallet F, Le Pape P, Canet E, Novara A, Manai M, Cateau E, Thille AW, Brun S, Cohen Y, Alanio A, Mégarbane B, Cornet M, Terzi N, Lamhaut L, Sabourin E, Desoubeaux G, Ehrmann S, Hennequin C, Voiriot G, Nevez G, Aubron C, Letscher-Bru V, Meziani F, Blaize M, Mayaux J, Monsel A, Boquel F, Robert-Gangneux F, Le Tulzo Y, Seguin P, Guegan H, Autier B, Lesouhaitier M, Pelletier R, Belaz S, Bonnal C, Berry A, Leroy J, François N, Richard JC, Paulus S, Argaud L, Dupont D, Menotti J, Morio F, Soulié M, Schwebel C, Garnaud C, Guitard J, Le Gal S, Quinio D, Morcet J, Laviolle B, Zahar JR, Bougnoux ME
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study.
The Lancet. Respiratory Medicine 2022, 10, 180-190.
Gangneux JP, Morcet J, Laviolle B, Dannaoui E, Timsit JF, Ruckly S, Zahar JR, Bougnoux ME
Time-dependent bias when analysing COVID-19-associated pulmonary aspergillosis - Authors' reply.
The Lancet. Respiratory Medicine 2022, 10, e27.
CORIMUNO-19 Collaborative group
Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial.
The Lancet. Rheumatology 2022, 4, e24-e32.
Goulenok T, Delaval L, Delory N, François C, Papo T, Descamps D, Ferré VM, Sacré K
Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases.
The Lancet. Rheumatology 2022, 4, e458-e461.
Casalino E, Bouzid D, Ben Hammouda A, Wargon M, Curac S, Hellmann R, Choquet C, Ghazali DA
COVID-19 Preparedness Among Emergency Departments: A Cross-Sectional Study in France.
Disaster Medicine and Public Health Preparedness 2022, 16, 245-253.
Smith DRM, Duval A, Zahar JR, EMAE-MESuRS Working Group on Nosocomial SARS-CoV-2 Modelling, Opatowski L, Temime L
Rapid antigen testing as a reactive response to surges in nosocomial SARS-CoV-2 outbreak risk.
Nature Communications 2022, 13, 236.
Marlin R, Desjardins D, Contreras V, Lingas G, Solas C, Roques P, Naninck T, Pascal Q, Behillil S, Maisonnasse P, Lemaitre J, Kahlaoui N, Delache B, Pizzorno A, Nougairede A, Ludot C, Terrier O, Dereuddre-Bosquet N, Relouzat F, Chapon C, Ho Tsong Fang R, van der Werf S, Rosa Calatrava M, Malvy D, de Lamballerie X, Guedj J, Le Grand R
Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates.
Nature Communications 2022, 13, 5108.
de Prost N, Audureau E, Heming N, Gault E, Pham T, Chaghouri A, de Montmollin N, Voiriot G, Morand-Joubert L, Joseph A, Chaix ML, Préau S, Favory R, Guigon A, Luyt CE, Burrel S, Mayaux J, Marot S, Roux D, Descamps D, Meireles S, Pène F, Rozenberg F, Contou D, Henry A, Gaudry S, Brichler S, Timsit JF, Kimmoun A, Hartard C, Jandeaux LM, Fafi-Kremer S, Gabarre P, Emery M, Garcia-Sanchez C, Jochmans S, Pitsch A, Annane D, Azoulay E, Mekontso Dessap A, Rodriguez C, Pawlotsky JM, Fourati S
Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19.
Nature Communications 2022, 13, 6025.
Smith N, Possémé C, Bondet V, Sugrue J, Townsend L, Charbit B, Rouilly V, Saint-André V, Dott T, Pozo AR, Yatim N, Schwartz O, Cervantes-Gonzalez M, Ghosn J, Bastard P, Casanova JL, Szwebel TA, Terrier B, Conlon N, O'Farrelly C, Cheallaigh CN, Bourke NM, Duffy D
Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity.
Nature Communications 2022, 13, 7254.
ISARIC Clinical Characterization Group, Garcia-Gallo E, Merson L, Kennon K, Kelly S, Citarella BW, Fryer DV, Shrapnel S, Lee J, Duque S, Fuentes YV, Balan V, Smith S, Wei J, Gonçalves BP, Russell CD, Sigfrid L, Dagens A, Olliaro PL, Baruch J, Kartsonaki C, Dunning J, Rojek A, Rashan A, Beane A, Murthy S, Reyes LF
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19.
Scientific Data 2022, 9, 454.
Peyneau M, Granger V, Wicky PH, Khelifi-Touhami D, Timsit JF, Lescure FX, Yazdanpanah Y, Tran-Dinh A, Montravers P, Monteiro RC, Chollet-Martin S, Hurtado-Nedelec M, de Chaisemartin L
Innate immune deficiencies are associated with severity and poor prognosis in patients with COVID-19.
Scientific Reports 2022, 12, 638.
Leducq V, Jary A, Bridier-Nahmias A, Daniel L, Zafilaza K, Damond F, Goldstein V, Duval A, Blanquart F, Calvez V, Descamps D, Marcelin AG, Visseaux B
Nosocomial transmission clusters and lineage diversity characterized by SARS-CoV-2 genomes from two large hospitals in Paris, France, in 2020.
Scientific Reports 2022, 12, 1094.
Hausfater P, Boutolleau D, Lacombe K, Beurton A, Dumont M, Constantin JM, Ghosn J, Combes A, Cury N, Guedj R, Djibré M, Bompard R, Mazerand S, Pourcher V, Gimeno L, Marois C, Teyssou E, Marcelin AG, Hajage D, Tubach F
Cumulative incidence of SARS-CoV-2 infection and associated risk factors among frontline health care workers in Paris: the SEROCOV cohort study.
Scientific Reports 2022, 12, 7211.
Manry J, Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Michailidis E, Hoffmann HH, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Haljasmägi L, Migaud M, Särekannu K, Maslovskaja J, de Prost N, Tandjaoui-Lambiotte Y, Luyt CE, Amador-Borrero B, Gaudet A, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier JC, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux PL, Sene D, Stepanian A, Mégarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya JM, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Ozcelik T, Keles S, Bousfiha AA, El Bakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, van de Beek D, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau YL, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Venet F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari FS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Erikstrup C, Condino-Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, HGID Lab, COVID Clinicians, COVID-STORM Clinicians, NIAID Immune Response to COVID Group, NH-COVAIR Study Group, Danish CHGE, Danish Blood Donor Study, St. James's Hospital, SARS CoV2 Interest Group, French COVID Cohort Study Group, Imagine COVID-Group, Milieu Intérieur Consortium, CoV-Contact Cohort, Amsterdam UMC Covid-19 Biobank Investigators, COVID Human Genetic Effort, CP-COVID-19 Group, CONSTANCES cohort, 3C-Dijon Study, Cerba Health-Care, Etablissement Français du Sang Study group, Anderson MS, Boisson B, Béziat V, Zhang SY, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen TH, Rowen L, Mond J, Debette S, de Lamballerie X, Burdet C, Bouadma L, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Casanova JL, Abel L, Cobat A
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
Proceedings of the National Academy of Sciences of the United States of America 2022, 119, e2200413119.
Taillé C, Roche N, Tesson F, Tardivon C, Tran VT, Couffignal C
Belief and adherence to COVID 19-lockdown restrictions in patients with asthma versus other chronic diseases: results from a cross-sectional survey nested in the ComPaRe e-cohort, in France.
The Journal of Asthma: Official Journal of the Association for the Care of Asthma 2022, 59, 1491-1500.
Bouzid D, Mirault T, Ghazali A, Muller L, Casalino E, Peiffer Smadja N, Auber B, Guerin M, Sambet CH, Etienne I, De Lastours V, Badoual C, Lemogne C, Ruszniewski P, Université Paris Cité' Osce Study Group n, Faye A, Tran Dinh A
Feasibility of large-scale eOSCES: the simultaneous evaluation of 500 medical students during a mock examination.
Medical Education Online 2022, 27, 2084261.
Planchais C, Fernández I, Bruel T, de Melo GD, Prot M, Beretta M, Guardado-Calvo P, Dufloo J, Molinos-Albert LM, Backovic M, Chiaravalli J, Giraud E, Vesin B, Conquet L, Grzelak L, Planas D, Staropoli I, Guivel-Benhassine F, Hieu T, Boullé M, Cervantes-Gonzalez M, Ungeheuer MN, Charneau P, van der Werf S, Agou F, French COVID Cohort Study Group, CORSER Study Group, Dimitrov JD, Simon-Lorière E, Bourhy H, Montagutelli X, Rey FA, Schwartz O, Mouquet H
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.
The Journal of Experimental Medicine 2022, 219, e20220638.
Lingas G, Néant N, Gaymard A, Belhadi D, Peytavin G, Hites M, Staub T, Greil R, Paiva JA, Poissy J, Peiffer-Smadja N, Costagliola D, Yazdanpanah Y, Wallet F, Gagneux-Brunon A, Mentré F, Ader F, Burdet C, Guedj J, Bouscambert-Duchamp M
Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial.
The Journal of Antimicrobial Chemotherapy 2022, 77, 1404-1412.
Delaugerre C, Assoumou L, Maylin S, Minier M, Gabassi A, Genin M, Beniguel L, Ghosn J, de Lamballerie X, El Mouhebb M, Costagliola D, Carrat F, Molina JM, PREVENIR and SAPRIS-Sero Study Groups
Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among HIV-Negative Participants Using Tenofovir/Emtricitabine-Based Preexposure Prophylaxis in 2020: A Substudy of the French National Agency for Research on AIDS and Viral Hepatitis PREVENIR and Inserm SAPRIS-Sero Cohorts.
Open Forum Infectious Diseases 2022, 9, ofac188.
Jaquet P, Legouy C, Le Fevre L, Grinea A, Sinnah F, Franchineau G, Patrier J, Marzouk M, Wicky PH, Alexis Geoffroy P, Arnoult F, Vledouts S, de Montmollin E, Bouadma L, Timsit JF, Sharshar T, Sonneville R
Neurologic Outcomes of Survivors of COVID-19-Associated Acute Respiratory Distress Syndrome Requiring Intubation.
Critical Care Medicine 2022, 50, e674-e682.
Rybak A, Aupiais C, Cotillon M, Basmaci R, de Pontual L, Bonacorsi S, Mariani P, Landraud L, Brichler S, Poilane I, Ouldali N, Titomanlio L
Reassessing the Performance of the "Step-By-Step" Approach to Febrile Infants 90 Days of Age and Younger in the Context of the COVID-19 Pandemic: A Multicentric Retrospective Study.
The Pediatric Infectious Disease Journal 2022, 41, e365-e368.
Hassold N, Brichler S, Ouedraogo E, Leclerc D, Carroue S, Gater Y, Alloui C, Carbonnelle E, Bouchaud O, Mechai F, Cordel H, Delagreverie H
Impaired antibody response to COVID-19 vaccination in advanced HIV infection.
AIDS (London, England) 2022, 36, F1-F5.
Wicky PH, d'Humières C, Timsit JF
How common is ventilator-associated pneumonia after coronavirus disease 2019?.
Current Opinion in Infectious Diseases 2022, 35, 170-175.
Zahar JR, Timsit JF
Risk stratification for selecting empiric antibiotherapy during and after COVID-19.
Current Opinion in Infectious Diseases 2022, 35, 605-613.
Delaunay-Moisan A, Guilleminot T, Semeraro M, Briand N, Bader-Meunier B, Berthaud R, Morelle G, Quartier P, Galeotti C, Basmaci R, Benoist G, Gajdos V, Lorrot M, Rifai M, Crespin M, M'Sakni Z, Padavia F, Savetier-Leroy C, Lorenzi M, Maurin C, Behillil S, de Pontual L, Elenga N, Bouazza N, Moltrecht B, van der Werf S, Leruez-Ville M, Sermet-Gaudelus I
Saliva for molecular detection of SARS-CoV-2 in pre-school and school-age children.
Environmental Microbiology 2022, 24, 4725-4737.
Lapaillerie D, Charlier C, Guyonnet-Dupérat V, Murigneux E, Fernandes HS, Martins FG, Magalhães RP, Vieira TF, Richetta C, Subra F, Lebourgeois S, Charpentier C, Descamps D, Visseaux B, Weigel P, Favereaux A, Beauvineau C, Buron F, Teulade-Fichou MP, Routier S, Gallois-Montbrun S, Meertens L, Delelis O, Sousa SF, Parissi V
Selection of Bis-Indolyl Pyridines and Triphenylamines as New Inhibitors of SARS-CoV-2 Cellular Entry by Modulating the Spike Protein/ACE2 Interfaces.
Antimicrobial Agents and Chemotherapy 2022, 66, e0008322.
Ferré VM, Peiffer-Smadja N, Kramer L, Coppée R, Kante A, Debarge M, Choquet C, Saint Joannis T, Bouzid D, Messika J, Le Grand J, Thy M, Kernéis S, Descamps D, Visseaux B, Ghosn J
Dual Monoclonal Antibodies on Sars-Cov-2 Alpha and Delta Variants: Clinical and Virological Efficacy.
Microbiology Spectrum 2022, 10, e0215222.
Borocco C, Pouletty M, Galeotti C, Meinzer U, Faye A, Koné-Paut I, Ouldali N, Melki I
Response to: 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID19): a multicentre cohort'' by Mastrolia et al.
Annals of the Rheumatic Diseases 2022, 81, e219.
Chommeloux J, Pouletty M, Ouldali N, Kerneis M, Mathian A, Mestiri R, Rohmer J, Hekimian G, Melki I, Great Paris Region (GPR) Kawa-COVID-19 consortium
Response to: 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Ventura et al'.
Annals of the Rheumatic Diseases 2022, 81, e240.
Mageau A, Papo T, Ruckly S, Strukov A, van Gysel D, Sacre K, Timsit JF
Survival after COVID-19-associated organ failure among inpatients with systemic lupus erythematosus in France: a nationwide study.
Annals of the Rheumatic Diseases 2022, 81, 569-574.
Mageau A, Ferré VM, Goulenok T, Charpentier C, Delory N, Francois C, Houhou-Fidouh N, Papo T, Descamps D, Sacre K
Severely impaired humoral response against SARS-CoV-2 variants of concern following two doses of BNT162b2 vaccine in patients with systemic lupus erythematosus (SLE).
Annals of the Rheumatic Diseases 2022, 81, 1194-1196.
Legrand M, Fong N, Laouénan C, Ghosn J, Thill B, Faure K, Garot D, Goujard C, Curlier E, Resche-Rigon M, Rossignol P, Pirracchio R
Risk factors of long term symptoms and outcomes among patients discharged after covid-19: prospective, multicentre observational study.
BMJ medicine 2022, 1, e000093.
Labbe V, Contou D, Heming N, Megarbane B, Ait-Oufella H, Boissier F, Carreira S, Robert A, Vivier E, Fejjal M, Doyen D, Monchi M, Preau S, Noel-Savina E, Souweine B, Zucman N, Picos SA, Dres M, Juguet W, Mariotte E, Timsit JF, Turpin M, Razazi K, Gendreau S, Baloul S, Voiriot G, Fartoukh M, Audureau E, Mekontso Dessap A
Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trial.
BMJ open 2022, 12, e059383.
Marwali EM, Kekalih A, Yuliarto S, Wati DK, Rayhan M, Valerie IC, Cho HJ, Jassat W, Blumberg L, Masha M, Semple C, Swann OV, Kohns Vasconcelos M, Popielska J, Murthy S, Fowler RA, Guerguerian AM, Streinu-Cercel A, Pathmanathan MD, Rojek A, Kartsonaki C, Gonçalves BP, Citarella BW, Merson L, Olliaro PL, Dalton HJ, International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) Clinical Characterization Group Investigators
Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity.
BMJ paediatrics open 2022, 6, e001657.
Hajage D, Combes A, Guervilly C, Lebreton G, Mercat A, Pavot A, Nseir S, Mekontso-Dessap A, Mongardon N, Mira JP, Ricard JD, Beurton A, Tachon G, Kontar L, Le Terrier C, Richard JC, Mégarbane B, Keogh RH, Belot A, Maringe C, Leyrat C, Schmidt M, COVID-ICU Investigators
Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome Associated with COVID-19: An Emulated Target Trial Analysis.
American Journal of Respiratory and Critical Care Medicine 2022, 206, 281-294.
Vacheron CH, Lepape A, Savey A, Machut A, Timsit JF, Comparot S, Courno G, Vanhems P, Landel V, Lavigne T, Bailly S, Bettega F, Study Group RR, Maucort-Boulch D, Friggeri A
Attributable Mortality of Ventilator-associated Pneumonia Among COVID-19 Patients.
American Journal of Respiratory and Critical Care Medicine 2022
Beurnier A, Yordanov Y, Dechartres A, Dinh A, Debuc E, Lescure FX, Jourdain P, Jaulmes L, Humbert M
Characteristics and outcomes of asthmatic outpatients with COVID-19 who receive home telesurveillance.
ERJ open research 2022, 8, 00012-2022.
Chevret S, Timsit JF, Biard L
Challenges of using external data in clinical trials- an illustration in patients with COVID-19.
BMC medical research methodology 2022, 22, 321.
Martin-Blondel G, Lescure FX, Assoumou L, Charpentier C, Chapplain JM, Perpoint T, Grouteau G, Cordel H, Pialoux G, Pacanowski J, Thy M, Bauvois A, Laureillard D, Hamrouni F, Algarte-Genin M, Poissy J, Descamps D, Costagliola D, CoCliCo Study Group
Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study.
BMC infectious diseases 2022, 22, 540.
Bosetti P, Tran Kiem C, Andronico A, Colizza V, Yazdanpanah Y, Fontanet A, Benamouzig D, Cauchemez S
Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France.
BMC medicine 2022, 20, 33.
Dupont A, Couffignal C, Arias C, Salah K, Phillips-Houlbraq M, Le Brun M, Taillé C
Outcomes and risk factors with COVID-19 or influenza in hospitalized asthma patients.
Respiratory Research 2022, 23, 342.
Le Terrier C, Sigaud F, Lebbah S, Desmedt L, Hajage D, Guérin C, Pugin J, Primmaz S, Terzi N
Early prone positioning in acute respiratory distress syndrome related to COVID-19: a propensity score analysis from the multicentric cohort COVID-ICU network-the ProneCOVID study..
Critical care (London, England) 2022, 26, 71.
Roca O, Caritg O, Santafé M, Ramos FJ, Pacheco A, García-de-Acilu M, Ferrer R, Schultz MJ, Ricard JD
Closed-loop oxygen control improves oxygen therapy in acute hypoxemic respiratory failure patients under high flow nasal oxygen: a randomized cross-over study (the HILOOP study).
Critical Care (London, England) 2022, 26, 108.
Walter T, Zucman N, Mullaert J, Thiry I, Gernez C, Roux D, Ricard JD
Extended prone positioning duration for COVID-19-related ARDS: benefits and detriments.
Critical Care (London, England) 2022, 26, 208.
Reyes LF, Murthy S, Garcia-Gallo E, Merson L, Ibáñez-Prada ED, Rello J, Fuentes YV, Martin-Loeches I, Bozza F, Duque S, Taccone FS, Fowler RA, Kartsonaki C, Gonçalves BP, Citarella BW, Aryal D, Burhan E, Cummings MJ, Delmas C, Diaz R, Figueiredo-Mello C, Hashmi M, Panda PK, Jiménez MP, Rincon DFB, Thomson D, Nichol A, Marshall JC, Olliaro PL, ISARIC Characterization Group
Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study.
Critical Care (London, England) 2022, 26, 276.
Patrier J, Villageois-Tran K, Szychowiak P, Ruckly S, Gschwind R, Wicky PH, Gueye S, Armand-Lefevre L, Marzouk M, Sonneville R, Bouadma L, Petitjean M, Lamara F, de Montmollin E, Timsit JF, Ruppé E, French COVID Cohort Study Group
Oropharyngeal and intestinal concentrations of opportunistic pathogens are independently associated with death of SARS-CoV-2 critically ill adults.
Critical Care (London, England) 2022, 26, 300.
Buetti N, Tabah A, Loiodice A, Ruckly S, Aslan AT, Montrucchio G, Cortegiani A, Saltoglu N, Kayaaslan B, Aksoy F, Murat A, Akdoğan Ö, Saracoglu KT, Erdogan C, Leone M, Ferrer R, Paiva JA, Hayashi Y, Ramanan M, Conway Morris A, Barbier F, Timsit JF, Eurobact 2 study group
Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study.
Critical Care (London, England) 2022, 26, 319.
Szychowiak P, Villageois-Tran K, Patrier J, Timsit JF, Ruppé É
The role of the microbiota in the management of intensive care patients.
Annals of Intensive Care 2022, 12, 3.
Massart N, Maxime V, Fillatre P, Razazi K, Ferré A, Moine P, Legay F, Voiriot G, Amara M, Santi F, Nseir S, Marque-Juillet S, Bounab R, Barbarot N, Bruneel F, Luyt CE, COVID ICU Bacteremia Study Group on behalf of the COVID-ICU Investigators
Correction to: Characteristics and prognosis of bloodstream infection in patients with COVID‑19 admitted in the ICU: an ancillary study of the COVID‑ICU study.
Annals of Intensive Care 2022, 12, 4.
Durand C, Douriez E, Chappuis A, Poulain F, Yazdanpanah Y, Lariven S, Lescure FX, Peiffer-Smadja N
Contributions and challenges of community pharmacists during the COVID-19 pandemic: a qualitative study.
Journal of Pharmaceutical Policy and Practice 2022, 15, 43.
Nijman RG, Honeyford K, Farrugia R, Rose K, Bognar Z, Buonsenso D, Da Dalt L, De T, Maconochie IK, Parri N, Roland D, Alfven T, Aupiais C, Barrett M, Basmaci R, Borensztajn D, Castanhinha S, Vasilico C, Durnin S, Fitzpatrick P, Fodor L, Gomez B, Greber-Platzer S, Guedj R, Hartshorn S, Hey F, Jankauskaite L, Kohlfuerst D, Kolnik M, Lyttle MD, Mação P, Mascarenhas MI, Messahel S, Özkan EA, Pučuka Z, Reis S, Rybak A, Ryd Rinder M, Teksam O, Turan C, Thors VS, Velasco R, Bressan S, Moll HA, Oostenbrink R, Titomanlio L, in association with the REPEM network (Research in European Pediatric Emergency Medicine) as part of the EPISODES study group
Presentations of children to emergency departments across Europe and the COVID-19 pandemic: A multinational observational study.
PLoS medicine 2022, 19, e1003974.
Béraud G, Timsit JF, Leleu H
Remdesivir and dexamethasone as tools to relieve hospital care systems stressed by COVID-19: A modelling study on bed resources and budget impact.
PloS One 2022, 17, e0262462.
Egloff C, Couffignal C, Cordier AG, Deruelle P, Sibiude J, Anselem O, Benachi A, Luton D, Mandelbrot L, Vauloup-Fellous C, Vivanti AJ, Picone O
Pregnant women's perceptions of the COVID-19 vaccine: A French survey.
PloS One 2022, 17, e0263512.
Grandjean D, Elie C, Gallet C, Julien C, Roger V, Desquilbet L, Alvergnat G, Delarue S, Gabassi A, Minier M, Choupeaux L, Kerneis S, Delaugerre C, LE Goff J, Treluyer JM
Diagnostic accuracy of non-invasive detection of SARS-CoV-2 infection by canine olfaction.
PloS One 2022, 17, e0268382.
Bouiller K, Peiffer-Smadja N, Cevik M, Last K, Antunović IA, Šterbenc A, Lopes MJ, Barac A, Schweitzer V, Dellière S
Role and perception of clinical microbiology and infectious diseases trainees during the COVID-19 crisis.
Future Microbiology 2022, 17, 411-416.
Rapin A, Boyer FC, Mourvillier B, Giordano Orsini G, Launois C, Taiar R, Deslee G, Goury A, Carazo-Mendez S
Post-Intensive Care Syndrome Prevalence Six Months after Critical Covid-19: Comparison between First and Second Waves.
Journal of Rehabilitation Medicine 2022, 54, jrm00339.
Viriot D, Lucas E, de Barbeyrac B, Bébéar C, Fouéré S, Dupin N, Bertolotti A, Berçot B, Cazanave C, Delmas G, Pillonel J, Lot F, Ngangro NN
Use of healthcare reimbursement data to monitor bacterial sexually transmitted infection testing in France, 2006 to 2020.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2022, 27,
Alizon S, Selinger C, Sofonea MT, Haim-Boukobza S, Giannoli JM, Ninove L, Pillet S, Thibault V, de Rougemont A, Tumiotto C, Solis M, Stephan R, Bressollette-Bodin C, Salmona M, L'Honneur AS, Behillil S, Lefeuvre C, Dina J, Hantz S, Hartard C, Veyer D, Delagrèverie HM, Fourati S, Visseaux B, Henquell C, Lina B, Foulongne V, Burrel S, SFM COVID-19 study group
Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2022, 27,
Shirreff G, Zahar JR, Cauchemez S, Temime L, Opatowski L, EMEA-MESuRS Working Group on the Nosocomial Modelling of SARS-CoV-22
Measuring Basic Reproduction Number to Assess Effects of Nonpharmaceutical Interventions on Nosocomial SARS-CoV-2 Transmission.
Emerging Infectious Diseases 2022, 28, 1345-1354.
Lebourgeois S, David A, Chenane HR, Granger V, Menidjel R, Fidouh N, Noël B, Delelis O, Richetta C, Charpentier C, Chollet-Martin S, Descamps D, Visseaux B, de Chaisemartin L
Differential activation of human neutrophils by SARS-CoV-2 variants of concern.
Frontiers in Immunology 2022, 13, 1010140.
d'Humières C, Gaïa N, Gueye S, de Lastours V, Leflon-Guibout V, Maataoui N, Duprilot M, Lecronier M, Rousseau MA, Gamany N, Lescure FX, Senard O, Deconinck L, Dollat M, Isernia V, Le Hur AC, Petitjean M, Nazimoudine A, Le Gac S, Chalal S, Ferreira S, Lazarevic V, Guigon G, Gervasi G, Armand-Lefèvre L, Schrenzel J, Ruppé E
Contribution of Clinical Metagenomics to the Diagnosis of Bone and Joint Infections.
Frontiers in Microbiology 2022, 13, 863777.
Rybak A, Ouldali N, Angoulvant F, Minodier P, Biscardi S, Madhi F, Hau I, Santos A, Bouvy E, Dubos F, Martinot A, Dommergues MA, Gras-Le Guen C, Launay E, Levieux K, Zenkhri F, Craiu I, Lorrot M, Gillet Y, Mezgueldi E, Faye A, Béchet S, Varon E, Cohen R, Levy C
Shift in Clinical Profile of Hospitalized Pneumonia in Children in the Non-pharmaceutical Interventions Period During the COVID-19 Pandemic: A Prospective Multicenter Study.
Frontiers in Pediatrics 2022, 10, 782894.
Goupil de Bouillé J, Luong Nguyen LB, Crépey P, Garlantezec R, Doré V, Dumas A, Ben Mechlia M, Tattevin P, Gaudart J, Spire B, Lert F, Yazdanpanah Y, Delaugerre C, Noret M, Zeggagh J
Transmission of SARS-CoV-2 during indoor clubbing events: A clustered randomized, controlled, multicentre trial protocol.
Frontiers in Public Health 2022, 10, 981213.
de Montmollin E, Peoc'h K, Marzouk M, Ruckly S, Wicky PH, Patrier J, Jaquet P, Sonneville R, Bouadma L, Timsit JF
Mid-Regional Pro-Adrenomedullin as a Prognostic Factor for Severe COVID-19 ARDS.
Antibiotics (Basel, Switzerland) 2022, 11, 1166.
Delhommeau G, Buetti N, Neuville M, Siami S, Cohen Y, Laurent V, Mourvillier B, Reignier J, Goldgran-Toledano D, Schwebel C, Ruckly S, de Montmollin E, Souweine B, Timsit JF, Dupuis C
Bacterial Pulmonary Co-Infections on ICU Admission: Comparison in Patients with SARS-CoV-2 and Influenza Acute Respiratory Failure: A Multicentre Cohort Study.
Biomedicines 2022, 10, 2646.
Ousseine YM, Vaux S, Vandentorren S, Bonmarin I, Champenois K, Lydié N, Velter A
Predictors of Uncertainty and Unwillingness to Receive the COVID-19 Vaccine in Men Who Have Sex with Men in France.
International Journal of Environmental Research and Public Health 2022, 19, 5372.
Arnaud E, Elbattah M, Ammirati C, Dequen G, Ghazali DA
Use of Artificial Intelligence to Manage Patient Flow in Emergency Department during the COVID-19 Pandemic: A Prospective, Single-Center Study.
International Journal of Environmental Research and Public Health 2022, 19, 9667.
Zerbit J, Detroit M, Chevret S, Pene F, Luyt CE, Ghosn J, Eyvrard F, Martin-Blondel G, Sarton B, Clere-Jehl R, Moine P, Cransac A, Andreu P, Labruyère M, Albertini L, Huon JF, Roge P, Bernard L, Farines-Raffoul M, Villiet M, Venet A, Dumont LM, Kaiser JD, Chapuis C, Goehringer F, Barbier F, Desjardins S, Benzidi Y, Abbas N, Guerin C, Batista R, Llitjos JF, Kroemer M
Remdesivir for Patients Hospitalized with COVID-19 Severe Pneumonia: A National Cohort Study (Remdeco-19).
Journal of Clinical Medicine 2022, 11, 6545.
Bonnet C, Masse S, Benamar H, Vilcu AM, Swital M, Hanslik T, van der Werf S, Duval X, Carrat F, Falchi A, Blanchon T
Is the Alpha Variant of SARS-CoV-2 Associated with a Higher Viral Load than the Historical Strain in Saliva Samples in Patients with Mild to Moderate Symptoms?.
Life (Basel, Switzerland) 2022, 12, 163.
Fourati S, Audureau E, Arrestier R, Marot S, Dubois C, Voiriot G, Luyt CE, Urbina T, Mayaux J, Roque-Afonso AM, Pham T, Landraud L, Visseaux B, Roux D, Bellaiche R, L'honneur AS, Ait Hamou Z, Brichler S, Gaudry S, Salmona M, Clere-Jehl R, Azoulay E, Morand-Joubert L, Marcelin AG, Chaix ML, Descamps D, Mekontso Dessap A, Rodriguez C, Pawlotsky JM, de Prost N
SARS-CoV-2 Genomic Characteristics and Clinical Impact of SARS-CoV-2 Viral Diversity in Critically Ill COVID-19 Patients: A Prospective Multicenter Cohort Study.
Viruses 2022, 14, 1529.
Bouzid D, Visseaux B, Kassasseya C, Daoud A, Fémy F, Hermand C, Truchot J, Beaune S, Javaud N, Peyrony O, Chauvin A, Vaittinada Ayar P, Bourg A, Riou B, Marot S, Bloom B, Cachanado M, Simon T, Freund Y, IMProving Emergency Care (IMPEC) FHU Collaborators Group
Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments : A Retrospective Cohort Study.
Annals of Internal Medicine 2022, 175, 831-837.
Johnson MG, Puenpatom A, Moncada PA, Burgess L, Duke ER, Ohmagari N, Wolf T, Bassetti M, Bhagani S, Ghosn J, Zhang Y, Wan H, Williams-Diaz A, Brown ML, Paschke A, De Anda C
Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled Trial.
Annals of Internal Medicine 2022, 175, 1126-1134.
El Messaoudi S, Lemenuel-Diot A, Gonçalves A, Guedj J
A semi-mechanistic model to characterize the long-term dynamic of HBV markers during treatment with lamivudine and Peg-IFN.
Clinical Pharmacology & Therapeutics 2022
2021
Hermine O, Mariette X, Tharaux PL, Resche-Rigon M, Porcher R, Ravaud P, CORIMUNO-19 Collaborative Group
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.
JAMA internal medicine 2021, 181, 32-40.
Birgand G, Mutters NT, Otter J, Eichel VM, Lepelletier D, Morgan DJ, Lucet JC
Variation of National and International Guidelines on Respiratory Protection for Health Care Professionals During the COVID-19 Pandemic.
JAMA network open 2021, 4, e2119257.
Cousien A, Acquaviva E, Kernéis S, Yazdanpanah Y, Delorme R
Temporal Trends in Suicide Attempts Among Children in the Decade Before and During the COVID-19 Pandemic in Paris, France.
JAMA network open 2021, 4, e2128611.
Yazdanpanah Y, French COVID cohort investigators and study group
Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID-19 patients.
Journal of Medical Virology 2021, 93, 2149-2159.
Roussel A, Germanaud D, Bouchoucha Y, Ouldali N, Vedrenne-Cloquet M, Castelle M, Baruchel A
Cranial polyneuropathy as the first manifestation of a severe COVID-19 in a child.
Pediatric Blood & Cancer 2021, 68, e28707.
COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators
Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.
Intensive Care Medicine 2021, 47, 60-73.
Buetti N, Ruckly S, de Montmollin E, Reignier J, Terzi N, Cohen Y, Shiami S, Dupuis C, Timsit JF
COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network.
Intensive Care Medicine 2021, 47, 180-187.
Arabi YM, Azoulay E, Al-Dorzi HM, Phua J, Salluh J, Binnie A, Hodgson C, Angus DC, Cecconi M, Du B, Fowler R, Gomersall CD, Horby P, Juffermans NP, Kesecioglu J, Kleinpell RM, Machado FR, Martin GS, Meyfroidt G, Rhodes A, Rowan K, Timsit JF, Vincent JL, Citerio G
How the COVID-19 pandemic will change the future of critical care.
Intensive Care Medicine 2021, 47, 282-291.
Arabi YM, Derde LPG, Timsit JF
How COVID-19 will change the management of other respiratory viral infections.
Intensive Care Medicine 2021
Debray MP, Tarabay H, Males L, Chalhoub N, Mahdjoub E, Pavlovsky T, Visseaux B, Bouzid D, Borie R, Wackenheim C, Crestani B, Rioux C, Saker L, Choquet C, Mullaert J, Khalil A
Observer agreement and clinical significance of chest CT reporting in patients suspected of COVID-19.
European Radiology 2021, 31, 1081-1089.
Chomton M, Marsac L, Deho A, Maroni A, Geslain G, Frannais-Haverland K, Robert-Debré University Hospital Study Group, Nicolas-Robin A, Levy M
Transforming a paediatric ICU to an adult ICU for severe Covid-19: lessons learned.
European Journal of Pediatrics 2021, 180, 2319-2323.
Chomton M, Marsac L, Deho A, Maroni A, Geslain G, Frannais-Haverland K, Robert-Debré University Hospital Study Group, Nicolas-Robin A, Levy M
Correction to: Transforming a paediatric ICU to an adult ICU for severe Covid-19: lessons learned.
European Journal of Pediatrics 2021
Maataoui N, Chemali L, Patrier J, Tran Dinh A, Le Fèvre L, Lortat-Jacob B, Marzouk M, d'Humières C, Rondinaud E, Ruppé E, Montravers P, Timsit JF, Armand-Lefèvre L
Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2021, 40, 2227-2234.
Vauloup-Fellous C, Maylin S, Périllaud-Dubois C, Brichler S, Alloui C, Gordien E, Rameix-Welti MA, Gault E, Moreau F, Fourati S, Challine D, Pawlotsky JM, Houhou-Fidouh N, Damond F, Mackiewicz V, Charpentier C, Méritet JF, Rozenberg F, Podglajen I, Marot S, Petit H, Burrel S, Akhavan S, Leruez-Ville M, Avettand-Fenoel V, Fourgeaud J, Guilleminot T, Gardiennet E, Bonacorsi S, Carol A, Carcelain G, Villemonteix J, Boukli N, Gozlan J, Morand-Joubert L, Legoff J, Delaugerre C, Chaix ML, Roque-Afonso AM, Dortet L, Naas T, Ronat JB, Lepape S, Marcelin AG, Descamps D
Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2021, 40, 2235-2241.
Mascitti H, Jourdain P, Bleibtreu A, Jaulmes L, Dechartres A, Lescure X, Yordanov Y, Dinh A, AP-HP/Universities/INSERM COVID-19 research collaboration
Prognosis of rash and chilblain-like lesions among outpatients with COVID-19: a large cohort study.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2021, 40, 2243-2248.
Kernéis S, Elie C, Fourgeaud J, Choupeaux L, Delarue SM, Alby ML, Quentin P, Pavie J, Brazille P, Néré ML, Minier M, Gabassi A, Gibaud A, Gauthier S, Leroy C, Voirin-Mathieu E, Poyart C, Vidaud M, Parfait B, Delaugerre C, Tréluyer JM, LeGoff J
Accuracy of saliva and nasopharyngeal sampling for detection of SARS-CoV-2 in community screening: a multicentric cohort study.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2021, 40, 2379-2388.
ISARIC Clinical Characterisation Group
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study.
Infection 2021, 49, 889-905.
Peiffer-Smadja N, Rozencwajg S, Kherabi Y, Yazdanpanah Y, Montravers P
COVID-19 vaccines: a race against time.
Anaesthesia, Critical Care & Pain Medicine 2021, 100848.
Zahar JR, Allaouchiche B
Even vaccinated against COVID-19, we must continue to wear a mask.
Anaesthesia, Critical Care & Pain Medicine 2021, 40, 100849.
Mercier JC, Ouldali N, Melki I, Basmaci R, Levy M, Titomanlio L, Beyler C, Meinzer U
Severe acute respiratory syndrome coronavirus 2-related multisystem inflammatory syndrome in children mimicking Kawasaki disease.
Archives of Cardiovascular Diseases 2021, 114, 426-433.
Amarsy R, Jacquier H, Munier AL, Merimèche M, Berçot B, Mégarbane B
Outbreak of NDM-1-producing Klebsiella pneumoniae in the intensive care unit during the COVID-19 pandemic: Another nightmare.
American Journal of Infection Control 2021, 49, 1324-1326.
Gouel-Cheron A, Elmaleh Y, Couffignal C, Kantor E, Meslin S, Caillard A, Salome A, Hamada S, Cholley B, Mebazaa A, Longrois D, Bourgain JL, Billard V, Servin F, Montravers P
Effectiveness of anaesthesia ventilator use for mechanical ventilation in critically ill patients during the COVID-19 pandemic.
British Journal of Anaesthesia 2021, 127, e35-e37.
Fiolet T, Guihur A, Rebeaud ME, Mulot M, Peiffer-Smadja N, Mahamat-Saleh Y
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 19-27.
Fiolet T, Guihur A, Rebeaud ME, Mulot M, Peiffer-Smadja N, Mahamat-Saleh Y
Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 138-140.
Meppiel E, Peiffer-Smadja N, Maury A, Bekri I, Delorme C, Desestret V, Gorza L, Hautecloque-Raysz G, Landre S, Lannuzel A, Moulin S, Perrin P, Petitgas P, SellaI F, Wang A, Tattevin P, de Broucker T, contributors to the NeuroCOVID registry
Neurologic manifestations associated with COVID-19: a multicentre registry.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 458-466.
Gastli N, Loubinoux J, Daragon M, Lavigne JP, Saint-Sardos P, Pailhoriès H, Lemarié C, Benmansour H, d'Humières C, Broutin L, Dauwalder O, Levy M, Auger G, Kernéis S, Cattoir V, French FA-PP study group
Multicentric evaluation of BioFire FilmArray Pneumonia Panel for rapid bacteriological documentation of pneumonia.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1308-1314.
Tran VT, Mahévas M, Bani-Sadr F, Robineau O, Perpoint T, Perrodeau E, Gallay L, Ravaud P, Goehringer F, Lescure FX, COCORICO Collaborative Group
Corticosteroids in patients hospitalized for COVID-19 pneumonia who require oxygen: observational comparative study using routine care data.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 603-610.
Ghosn J, Piroth L, Epaulard O, Le Turnier P, Mentré F, Bachelet D, Laouénan C, French COVID cohort study and investigators groups
Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1041.e1-1041.e4.
Gallay L, Tran VT, Perrodeau E, Vignier N, Mahevas M, Bisio F, Forestier E, Lescure FX, COCO-OLD Study group
Fourteen-day survival among older adults with severe infection with severe acute respiratory syndrome coronavirus 2 treated with corticosteroid: a cohort study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1145-1150.
Yordanov Y, Dinh A, Bleibtreu A, Mensch A, Lescure FX, Debuc E, Jourdain P, Jaulmes L, Dechartres A, AP-HP/Universities/Inserm COVID-19 research collaboration
Clinical characteristics and factors associated with hospital admission or death in 43 103 adult outpatients with coronavirus disease 2019 managed with the Covidom telesurveillance solution: a prospective cohort study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1158-1166.
Ader F, Peiffer-Smadja N, Poissy J, Bouscambert-Duchamp M, Belhadi D, Diallo A, Delmas C, Saillard J, Dechanet A, Mercier N, Dupont A, Alfaiate T, Lescure FX, Raffi F, Goehringer F, Kimmoun A, Jaureguiberry S, Reignier J, Nseir S, Danion F, Clere-Jehl R, Bouiller K, Navellou JC, Tolsma V, Cabié A, Dubost C, Courjon J, Leroy S, Mootien J, Gaci R, Mourvillier B, Faure E, Pourcher V, Gallien S, Launay O, Lacombe K, Lanoix JP, Makinson A, Martin-Blondel G, Bouadma L, Botelho-Nevers E, Gagneux-Brunon A, Epaulard O, Piroth L, Wallet F, Richard JC, Reuter J, Staub T, Lina B, Noret M, Andrejak C, Lê MP, Peytavin G, Hites M, Costagliola D, Yazdanpanah Y, Burdet C, Mentré F, DisCoVeRy study group
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1826-1837.
Husain M, Rachline A, Cousien A, Rolland S, Rouzaud C, Ferre VM, Gomez MV, Le Teurnier M, Wicky-Thisse M, Descamps D, Yazdanpanah Y, Charpentier C, Pasquet-Cadre A
Impact of the COVID-19 pandemic on the homeless: results from a retrospective closed cohort in France (March-May 2020).
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1520.e1-1520.e5.
Dinh A, Jaulmes L, Dechartres A, Duran C, Mascitti H, Lescure X, Yordanov Y, Jourdain P, AP-HP/Universities/INSERM COVID-19 research collaboration, Data-sciences committee, Scientific committee, Covidom regional centre steering commitee
Time to resolution of respiratory and systemic coronavirus disease 2019 symptoms in community setting.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1862.e1-1862.e4.
Caméléna F, Moy AC, Dudoignon E, Poncin T, Deniau B, Guillemet L, Le Goff J, Budoo M, Benyamina M, Chaussard M, Coutrot M, Lafaurie M, Plaud B, Mebazaa A, Depret F, Berçot B
Performance of a multiplex polymerase chain reaction panel for identifying bacterial pathogens causing pneumonia in critically ill patients with COVID-19.
Diagnostic Microbiology and Infectious Disease 2021, 99, 115183.
Charpentier C, Pellissier G, Ichou H, Ferré VM, Larfi I, Phung BC, Vallois D, LeGac S, Aubier M, Descamps D, Fidouh-Houhou N, Bouvet E
Contribution of rapid lateral flow assays from capillary blood specimens to the diagnosis of COVID-19 in symptomatic healthcare workers: a pilot study in a university hospital, Paris, France.
Diagnostic Microbiology and Infectious Disease 2021, 101, 115430.
Eloy P, Le Grand R, Malvy D, Guedj J
Combined treatment of molnupiravir and favipiravir against SARS-CoV-2 infection: One + zero equals two?.
EBioMedicine 2021, 74, 103663.
Hcini N, Maamri F, Picone O, Carod JF, Lambert V, Mathieu M, Carles G, Pomar L
Maternal, fetal and neonatal outcomes of large series of SARS-CoV-2 positive pregnancies in peripartum period: A single-center prospective comparative study.
European Journal of Obstetrics, Gynecology, and Reproductive Biology 2021, 257, 11-18.
Maillet F, Pourbaix A, le Pluart D, Sirmai L, Postolache SA, Couvelard A, Houhou-Fidouh N, Males L, Deconinck L, Lescure FX
Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments.
IDCases 2021, 24, e01111.
Gourjault C, Tarhini H, Rahi M, Thy M, Le Pluart D, Rioux C, Parisey M, Ismael S, Al Rida Aidibi A, Paradis V, Ghosn J, Yazdanpanah Y, Lescure FX, Gervais A
Cholangitis in three critically ill patients after a severe CoVID-19 infection.
IDCases 2021, e01267.
Bouiller K, Catho G, Le Maréchal M, Gras J, Hentzien M, Peiffer-Smadja N, Bessis S, Cabon M, Dubee V, Lemaignen A, Thy M, Martins C, Thill P, Osei L, ReJIF (Réseau des Jeunes Infectiologues Français, Société de Pathologie Infectieuse de Langue Française)
The role of infectious disease trainees during the first wave of the COVID-19 pandemic: A national survey.
Infectious Diseases Now 2021, 51, 215-217.
Lacarra B, Mellon G, Ortega Perez I, D'Ortenzio E, Lescure FX
Bridging the gap between scientific discovery and clinical application during the COVID-19 epoch.
Infectious Diseases Now 2021, 51, 581-582.
Cohen R, Ashman M, Taha MK, Varon E, Angoulvant F, Levy C, Rybak A, Ouldali N, Guiso N, Grimprel E
Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?.
Infectious Diseases Now 2021, 51, 418-423.
Telford E, Ortega-Perez I, Mellon G, Lacarra B, Adjadj E, Madelaine C, D'Ortenzio E, Yazdanpanah Y
Chronicles of a pandemic: how France coordinated the scientific research response to COVID-19.
Infectious Diseases Now 2021, S2666-9919(21)00487-5.
Lebourgeois S, Storto A, Gout B, Le Hingrat Q, Ardila Tjader G, Cerdan MDC, English A, Pareja J, Love J, Houhou-Fidouh N, Manissero D, Descamps D, Visseaux B
Performance evaluation of the QIAstat-Dx® Respiratory SARS-CoV-2 Panel.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2021, 107, 179-181.
Caméléna F, Poncin T, Dudoignon E, Salmona M, Le Goff J, Donay JL, Lafaurie M, Darmon M, Azoulay E, Plaud B, Mebazaa A, Dépret F, Jacquier H, Berçot B
Rapid identification of bacteria from respiratory samples of patients hospitalized in intensive care units, with FilmArray Pneumonia Panel Plus.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2021, 108, 568-573.
Eloy P, Tardivon C, Martin-Blondel G, Isnard M, Turnier PL, Marechal ML, Cabié A, Launay O, Tattevin P, Senneville E, Ansart S, Goehringer F, Chirouze C, Bousson L, Laouénan C, Etienne M, Nguyen D, Ghosn J, Duval X, French COVID cohort study and investigators groups
Severity of self-reported symptoms and psychological burden 6-months after hospital admission for COVID-19: a prospective cohort study.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2021, 112, 247-253.
Lévy Y, Wiedemann A, Hejblum BP, Durand M, Lefebvre C, Surénaud M, Lacabaratz C, Perreau M, Foucat E, Déchenaud M, Tisserand P, Blengio F, Hivert B, Gauthier M, Cervantes-Gonzalez M, Bachelet D, Laouénan C, Bouadma L, Timsit JF, Yazdanpanah Y, Pantaleo G, Hocini H, Thiébaut R, French COVID cohort study group
CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death.
iScience 2021, 24, 102711.
Martin A, Storto A, Le Hingrat Q, Collin G, André B, Mallory A, Dangla R, Descamps D, Visseaux B, Gossner O
High-sensitivity SARS-CoV-2 group testing by digital PCR among symptomatic patients in hospital settings.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2021, 141, 104895.
Crescenzo-Chaigne B, Behillil S, Enouf V, Escriou N, Petres S, Ungeheuer MN, Ghosn J, Tubiana S, Bouadma L, van der Werf S, Demeret C, French COVID cohort study group
Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients.
Journal of Clinical Virology Plus 2021, 1, 100041.
Keta-Cov research group. Electronic address: vincent.mallet@aphp.fr, Keta-Cov research group
Intravenous ketamine and progressive cholangiopathy in COVID-19 patients.
Journal of Hepatology 2021, 74, 1243-1244.
Mallet V, Keta-Cov research group
Reply to: "Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered".
Journal of Hepatology 2021, 75, 990-992.
Klement-Frutos E, Burrel S, Peytavin G, Marot S, Lê MP, Godefroy N, Calvez V, Marcelin AG, Caumes E, Pourcher V, Boutolleau D
Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19.
The Journal of Infection 2021, 82, 159-198.
Grall I, Alloui CA, Tandjaoui-Lambiotte Y, Deslandes A, Seytre D, Chappe J, Carbonnelle E, Brichler S, Jacolot A, Zahar JR, Lomont A
Viral transmission in asymptomatic cases of SARS-CoV-2 infection.
The Journal of Infection 2021, 82, 282-327.
Tubiana S, Burdet C, Houhou N, Thy M, Manchon P, Blanquart F, Charpentier C, Guedj J, Alavoine L, Behillil S, Leclercq A, Lucet JC, Yazdanpanah Y, Attia M, Demeret C, Rose T, Bielicki JA, Bruijning-Verhagen P, Goossens H, Descamps D, van der Werf S, Lina B, Duval X, CoVCONTACT study group, Principal investigator, Sponsor: Inserm
High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohort.
The Journal of Infection 2021, 82, 186-230.
de Montmollin E, Faille D, Andrieu V, Ajzenberg N, Timsit JF
Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?.
The Journal of Infection 2021
Teyssou E, Soulie C, Visseaux B, Lambert-Niclot S, Ferre V, Marot S, Jary A, Sayon S, Zafilaza K, Leducq V, Schnuriger A, Abdi B, Wirden M, Houhou-Fidouh N, Charpentier C, Morand-Joubert L, Burrel S, Descamps D, Calvez V, Marcelin AG
The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients.
The Journal of Infection 2021, 83, 119-145.
Teyssou E, Delagrèverie H, Visseaux B, Lambert-Niclot S, Brichler S, Ferre V, Marot S, Jary A, Todesco E, Schnuriger A, Ghidaoui E, Abdi B, Akhavan S, Houhou-Fidouh N, Charpentier C, Morand-Joubert L, Boutolleau D, Descamps D, Calvez V, Marcelin A, Soulie C
The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19.
The Journal of Infection 2021, S0163-4453(21)00416-3.
Tsatsaris V, Mariaggi AA, Launay O, Couffignal C, Rousseau J, Ancel PY, Marcault E, Ville Y, Cordier AG, Vivanti A, Carrara J, Luton D, Dommergues M, Borie C, Kayem G, Alessandrini V, Lecomte L, Meritet JF, Leruez-Ville M, Goffinet F, Dubois C, Picone O, Vauloup Fellous C
SARS-COV-2 IgG antibody response in pregnant women at delivery.
Journal of Gynecology Obstetrics and Human Reproduction 2021, 50, 102041.
Bensoussan E, Ouldali N, Ashkenazi S, Angoulvant F, Cohen R, Levy C
Impact of Coronavirus Disease 2019 (COVID-19) Pandemic on Pediatric Infectious Disease Research.
The Journal of Pediatrics 2021, 230, 279-281.e2.
Visseaux B, Collin G, Houhou-Fidouh N, Le Hingrat Q, Ferré VM, Damond F, Ichou H, Descamps D, Charpentier C
Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirements.
Journal of Virological Methods 2021, 291, 114086.
Lefrancq N, Paireau J, Hozé N, Courtejoie N, Yazdanpanah Y, Bouadma L, Boëlle PY, Chereau F, Salje H, Cauchemez S
Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: A retrospective national surveillance data analysis.
The Lancet Regional Health. Europe 2021, 5, 100087.
Fournier M, Faille D, Dossier A, Mageau A, Nicaise Roland P, Ajzenberg N, Borie R, Bouadma L, Bunel V, Castier Y, Choquet C, Crestani B, Daugas E, Deconinck L, Descamps D, Descamps V, Dieudé P, Ducrocq G, Faucher N, Goulenok T, Guidoux C, Khalil A, Lavallée P, Lescure FX, Lortat-Jacob B, Mal H, Mutuon P, Pellenc Q, Steg PG, Taille C, Timsit JF, Yazdanpanah Y, Papo T, Sacré K
Arterial Thrombotic Events in Adult Inpatients With COVID-19.
Mayo Clinic Proceedings 2021, 96, 295-303.
Tarhini H, Husain M, Poey N, Lariven S, Lescure FX, Yazdanpanah Y, Gervais A
Jaundice in a patient treated with Anakinra in a context of Covid-19.
Infectious Diseases Now 2021, 51, 217-218.
Sallard E, Belhadi D, Lescure FX, Yazdanpanah Y, Peiffer-Smadja N
Clinical trial protocols of repurposed prophylaxis for COVID-19: A review.
Infectious Diseases Now 2021, 51, 7-13.
Maury A, Lyoubi A, Peiffer-Smadja N, de Broucker T, Meppiel E
Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
Revue Neurologique 2021, 177, 51-64.
Hansel B, Potier L, Chalopin S, Larger E, Gautier JF, Delestre F, Masdoua V, Visseaux B, Lucet JC, Kerneis S, Abouleka Y, Thebaut JF, Riveline JP, Kadouch D, Roussel R
The COVID-19 lockdown as an opportunity to change lifestyle and body weight in people with overweight/obesity and diabetes: Results from the national French COVIDIAB cohort.
Nutrition, metabolism, and cardiovascular diseases: NMCD 2021, 31, 2605-2611.
Frija-Masson J, Debray MP, Boussouar S, Khalil A, Bancal C, Motiejunaite J, Galarza-Jimenez MA, Benzaquen H, Penaud D, Laveneziana P, Malrin R, Redheuil A, Donciu V, Lucidarme O, Taillé C, Guerder A, Arnoult F, Vidal-Petiot E, Flamant M, Similowski T, Morelot-Panzini C, Faure M, Lescure FX, Straus C, d'Ortho MP, Gonzalez-Bermejo J
Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: The post Covid M3 study.
Respiratory Medicine 2021, 184, 106435.
ISARIC Clinical Characterisation Group
The value of open-source clinical science in pandemic response: lessons from ISARIC.
The Lancet. Infectious Diseases 2021, 21, 1623-1624.
Trøseid M, Hites M, Barratt-Due A, Ader F, Yazdanpanah Y
Assessing the evidence on remdesivir.
The Lancet. Infectious Diseases 2021, 21, 1630-1631.
CORIMUNO-19 Collaborative group
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial.
The Lancet. Respiratory Medicine 2021, 9, 295-304.
Lebreton G, Schmidt M, Ponnaiah M, Folliguet T, Para M, Guihaire J, Lansac E, Sage E, Cholley B, Mégarbane B, Cronier P, Zarka J, Da Silva D, Besset S, Lacombat I, Mongardon N, Richard C, Duranteau J, Cerf C, Saiydoun G, Sonneville R, Chiche JD, Nataf P, Longrois D, Combes A, Leprince P, Paris ECMO-COVID-19 investigators
Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study.
The Lancet. Respiratory Medicine 2021
Lescure FX, Honda H, Fowler RA, Lazar JS, Shi G, Wung P, Patel N, Hagino O, Sarilumab COVID-19 Global Study Group
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial.
The Lancet. Respiratory Medicine 2021, 9, 522-532.
Ehrmann S, Li J, Ibarra-Estrada M, Perez Y, Pavlov I, McNicholas B, Roca O, Mirza S, Vines D, Garcia-Salcido R, Aguirre-Avalos G, Trump MW, Nay MA, Dellamonica J, Nseir S, Mogri I, Cosgrave D, Jayaraman D, Masclans JR, Laffey JG, Tavernier E, Awake Prone Positioning Meta-Trial Group
Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial.
The Lancet. Respiratory Medicine 2021, 9, 1387-1395.
Lindan CE, Mankad K, Ram D, Kociolek LK, Silvera VM, Boddaert N, Stivaros SM, Palasis S, ASPNR PECOBIG Collaborator Group
Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study.
The Lancet. Child & Adolescent Health 2021, 5, 167-177.
Lachassinne E, de Pontual L, Caseris M, Lorrot M, Guilluy C, Naud A, Dommergues MA, Pinquier D, Wannepain E, Hausherr E, Jung C, Gajdos V, Cohen R, Zahar JR, Brichler S, Basmaci R, Boelle PY, Bloch-Queyrat C, Aupiais C, COVIDOCRECHE collaborators
SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study.
The Lancet. Child & Adolescent Health 2021, 5, 256-264.
Novelli G, Liu J, Biancolella M, Alonzi T, Novelli A, Patten JJ, Cocciadiferro D, Agolini E, Colona VL, Rizzacasa B, Giannini R, Bigio B, Goletti D, Capobianchi MR, Grelli S, Mann J, McKee TD, Cheng K, Amanat F, Krammer F, Guarracino A, Pepe G, Tomino C, Tandjaoui-Lambiotte Y, Uzunhan Y, Tubiana S, Ghosn J, COVID Human Genetic Effort, French COVID Cohort Study Group, CoV-Contact Cohort, Notarangelo LD, Su HC, Abel L, Cobat A, Elhanan G, Grzymski JJ, Latini A, Sidhu SS, Jain S, Davey RA, Casanova JL, Wei W, Pandolfi PP
Inhibition of HECT E3 ligases as potential therapy for COVID-19.
Cell Death & Disease 2021, 12, 310.
Driouich JS, Cochin M, Lingas G, Moureau G, Touret F, Petit PR, Piorkowski G, Barthélémy K, Laprie C, Coutard B, Guedj J, de Lamballerie X, Solas C, Nougairède A
Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model.
Nature Communications 2021, 12, 1735.
Perreau M, Suffiotti M, Marques-Vidal P, Wiedemann A, Levy Y, Laouénan C, Ghosn J, Fenwick C, Comte D, Roger T, Regina J, Vollenweider P, Waeber G, Oddo M, Calandra T, Pantaleo G
The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients.
Nature Communications 2021, 12, 4888.
Maisonnasse P, Aldon Y, Marc A, Marlin R, Dereuddre-Bosquet N, Kuzmina NA, Freyn AW, Snitselaar JL, Gonçalves A, Caniels TG, Burger JA, Poniman M, Bontjer I, Chesnais V, Diry S, Iershov A, Ronk AJ, Jangra S, Rathnasinghe R, Brouwer PJM, Bijl TPL, van Schooten J, Brinkkemper M, Liu H, Yuan M, Mire CE, van Breemen MJ, Contreras V, Naninck T, Lemaître J, Kahlaoui N, Relouzat F, Chapon C, Ho Tsong Fang R, McDanal C, Osei-Twum M, St-Amant N, Gagnon L, Montefiori DC, Wilson IA, Ginoux E, de Bree GJ, García-Sastre A, Schotsaert M, Coughlan L, Bukreyev A, van der Werf S, Guedj J, Sanders RW, van Gils MJ, Le Grand R
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models.
Nature Communications 2021, 12, 6097.
Flament H, Rouland M, Beaudoin L, Toubal A, Bertrand L, Lebourgeois S, Rousseau C, Soulard P, Gouda Z, Cagninacci L, Monteiro AC, Hurtado-Nedelec M, Luce S, Bailly K, Andrieu M, Saintpierre B, Letourneur F, Jouan Y, Si-Tahar M, Baranek T, Paget C, Boitard C, Vallet-Pichard A, Gautier JF, Ajzenberg N, Terrier B, Pène F, Ghosn J, Lescure X, Yazdanpanah Y, Visseaux B, Descamps D, Timsit JF, Monteiro RC, Lehuen A
Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity.
Nature Immunology 2021, 22, 322-335.
Smith N, Goncalves P, Charbit B, Grzelak L, Beretta M, Planchais C, Bruel T, Rouilly V, Bondet V, Hadjadj J, Yatim N, Pere H, Merkling SH, Ghozlane A, Kernéis S, Rieux-Laucat F, Terrier B, Schwartz O, Mouquet H, Duffy D, Di Santo JP
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.
Nature Immunology 2021, 22, 1428-1439.
LeGoff J, Kernéis S, Elie C, Mercier-Delarue S, Gastli N, Choupeaux L, Fourgeaud J, Alby ML, Quentin P, Pavie J, Brazille P, Néré ML, Minier M, Gabassi A, Leroy C, Parfait B, Tréluyer JM, Delaugerre C
Evaluation of a saliva molecular point of care for the detection of SARS-CoV-2 in ambulatory care.
Scientific Reports 2021, 11, 21126.
Crawford C, Vanoli E, Decorde B, Lancelot M, Duprat C, Josserand C, Jilesen J, Bouadma L, Timsit JF
Modeling of aerosol transmission of airborne pathogens in ICU rooms of COVID-19 patients with acute respiratory failure.
Scientific Reports 2021, 11, 11778.
Courties A, Boussier J, Hadjadj J, Yatim N, Barnabei L, Péré H, Veyer D, Kernéis S, Carlier N, Pène F, Rieux-Laucat F, Charbit B, Bondet V, Duffy D, Berenbaum F, Terrier B, Sellam J
Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients.
Scientific Reports 2021, 11, 11886.
WHO Solidarity Trial Consortium, Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, Alejandria MM, Hernández García C, Kieny MP, Malekzadeh R, Murthy S, Reddy KS, Roses Periago M, Abi Hanna P, Ader F, Al-Bader AM, Alhasawi A, Allum E, Alotaibi A, Alvarez-Moreno CA, Appadoo S, Asiri A, Aukrust P, Barratt-Due A, Bellani S, Branca M, Cappel-Porter HBC, Cerrato N, Chow TS, Como N, Eustace J, García PJ, Godbole S, Gotuzzo E, Griskevicius L, Hamra R, Hassan M, Hassany M, Hutton D, Irmansyah I, Jancoriene L, Kirwan J, Kumar S, Lennon P, Lopardo G, Lydon P, Magrini N, Maguire T, Manevska S, Manuel O, McGinty S, Medina MT, Mesa Rubio ML, Miranda-Montoya MC, Nel J, Nunes EP, Perola M, Portolés A, Rasmin MR, Raza A, Rees H, Reges PPS, Rogers CA, Salami K, Salvadori MI, Sinani N, Sterne JAC, Stevanovikj M, Tacconelli E, Tikkinen KAO, Trelle S, Zaid H, Røttingen JA, Swaminathan S
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
The New England Journal of Medicine 2021, 384, 497-511.
Bergwerk M, Gonen T, Lustig Y, Amit S, Lipsitch M, Cohen C, Mandelboim M, Levin EG, Rubin C, Indenbaum V, Tal I, Zavitan M, Zuckerman N, Bar-Chaim A, Kreiss Y, Regev-Yochay G
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
The New England Journal of Medicine 2021
Néant N, Lingas G, Le Hingrat Q, Ghosn J, Engelmann I, Lepiller Q, Gaymard A, Ferré V, Hartard C, Plantier JC, Thibault V, Marlet J, Montes B, Bouiller K, Lescure FX, Timsit JF, Faure E, Poissy J, Chidiac C, Raffi F, Kimmoun A, Etienne M, Richard JC, Tattevin P, Garot D, Le Moing V, Bachelet D, Tardivon C, Duval X, Yazdanpanah Y, Mentré F, Laouénan C, Visseaux B, Guedj J, French COVID Cohort Investigators and French Cohort Study groups
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort.
Proceedings of the National Academy of Sciences of the United States of America 2021, 118,
Poline J, Gaschignard J, Leblanc C, Madhi F, Foucaud E, Nattes E, Faye A, Bonacorsi S, Mariani P, Varon E, Smati-Lafarge M, Caseris M, Basmaci R, Lachaume N, Ouldali N
Systematic Severe Acute Respiratory Syndrome Coronavirus 2 Screening at Hospital Admission in Children: A French Prospective Multicenter Study.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 72, 2215-2217.
Veyer D, Kernéis S, Poulet G, Wack M, Robillard N, Taly V, L'Honneur AS, Rozenberg F, Laurent-Puig P, Bélec L, Hadjadj J, Terrier B, Péré H
Highly Sensitive Quantification of Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Sheds Light on its Potential Clinical Value.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 73, e2890-e2897.
Buetti N, Patrier J, Le Hingrat Q, Loiodice A, Bouadma L, Visseaux B, Timsit JF
Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Detection in Blood of Critically Ill Patients.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 72, e690-e691.
Temime L, Gustin MP, Duval A, Buetti N, Crépey P, Guillemot D, Thiébaut R, Vanhems P, Zahar JR, Smith DRM, Opatowski L
A Conceptual Discussion About the Basic Reproduction Number of Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Settings.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 72, 141-143.
Angoulvant F, Ouldali N, Yang DD, Filser M, Gajdos V, Rybak A, Guedj R, Soussan-Banini V, Basmaci R, Lefevre-Utile A, Brun-Ney D, Beaujouan L, Skurnik D
Coronavirus Disease 2019 Pandemic: Impact Caused by School Closure and National Lockdown on Pediatric Visits and Admissions for Viral and Nonviral Infections-a Time Series Analysis.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 72, 319-322.
Dudoignon E, Caméléna F, Deniau B, Habay A, Coutrot M, Ressaire Q, Plaud B, Berçot B, Dépret F
Bacterial Pneumonia in COVID-19 Critically Ill Patients: A Case Series.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 72, 905-906.
Contejean A, Leporrier J, Canouï E, Alby-Laurent F, Lafont E, Beaudeau L, Parize P, Lecieux F, Greffet A, Chéron G, Gauzit R, Fourgeaud J, L'Honneur AS, Tréluyer JM, Charlier C, Casetta A, Frange P, Leruez-Ville M, Rozenberg F, Lortholary O, Kernéis S
Comparing Dynamics and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 Transmissions Among Healthcare Workers of Adult and Pediatric Settings in Central Paris.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 72, 257-264.
Zucman N, Uhel F, Descamps D, Roux D, Ricard JD
Severe Reinfection With South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant 501Y.V2.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 73, 1945-1946.
Betton M, Livrozet M, Planas D, Fayol A, Monel B, Védie B, Bruel T, Tartour E, Robillard N, Manuguerra JC, Blanchard A, Ghosn J, Visseaux B, Péré H, Lebeaux D, Schwartz O, Veyer D, Hulot JS, French COVID Cohort Study Group
Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 73, e1337-e1344.
Bruneau T, Wack M, Poulet G, Robillard N, Philippe A, Laurent-Puig P, Bélec L, Hadjadj J, Xiao W, Kallberg JL, Kernéis S, Diehl JL, Terrier B, Smadja D, Taly V, Veyer D, Péré H
Circulating ubiquitous RNA, a highly predictive and prognostic biomarker in hospitalized COVID-19 patients.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, ciab997.
Tarhini H, Recoing A, Bridier-Nahmias A, Rahi M, Lambert C, Martres P, Lucet JC, Rioux C, Bouzid D, Lebourgeois S, Descamps D, Yazdanpanah Y, Le Hingrat Q, Lescure FX, Visseaux B
Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection.
The Journal of Infectious Diseases 2021, 223, 1522-1527.
Pelleau S, Woudenberg T, Rosado J, Donnadieu F, Garcia L, Obadia T, Gardais S, Elgharbawy Y, Velay A, Gonzalez M, Nizou JY, Khelil N, Zannis K, Cockram C, Merkling SH, Meola A, Kerneis S, Terrier B, de Seze J, Planas D, Schwartz O, Dejardin F, Petres S, von Platen C, Pellerin SF, Arowas L, de Facci LP, Duffy D, Cheallaigh CN, Dunne J, Conlon N, Townsend L, Duong V, Auerswald H, Pinaud L, Tondeur L, Backovic M, Hoen B, Fontanet A, Mueller I, Fafi-Kremer S, Bruel T, White M
Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection.
The Journal of Infectious Diseases 2021, 224, 1489-1499.
Lê MP, Peiffer-Smadja N, Guedj J, Neant N, Mentré F, Ader F, Yazdanpanah Y, Peytavin G, C21DFSC
Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response.
The Journal of Antimicrobial Chemotherapy 2021, 76, 277-279.
Bouzid D, Casalino E, Mullaert J, Laurent O, Duval X, Lescure FX, Peiffer Smadja N, Tubiana S, Armand Lefèvre L, Descamps D, Fidouh N, Choquet C, Lucet JC, Visseaux B
Added value of rapid respiratory syndromic testing at point of care versus central laboratory testing: a controlled clinical trial.
The Journal of Antimicrobial Chemotherapy 2021, 76, iii20-iii27.
Contejean A, Leporrier J, Canouï E, Fourgeaud J, Mariaggi AA, Alby-Laurent F, Lafont E, Beaudeau L, Rouzaud C, Lecieux F, Greffet A, L'Honneur AS, Tréluyer JM, Lanternier F, Casetta A, Frange P, Leruez-Ville M, Rozenberg F, Lortholary O, Kernéis S
Transmission Routes of Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers of a French University Hospital in Paris, France.
Open Forum Infectious Diseases 2021, 8, ofab054.
Kernéis S, Planas D, Imbeaud S, Staropoli I, Puech J, Robillard N, Rodary J, Bruel T, Vieillard T, Schwartz O, Belec L, Péré H, Veyer D
Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual.
Open Forum Infectious Diseases 2021, 8, ofab369.
Dupuis C, Bouadma L, de Montmollin E, Goldgran-Toledano D, Schwebel C, Reignier J, Neuville M, Ursino M, Siami S, Ruckly S, Alberti C, Mourvillier B, Bailly S, Grapin K, Laurent V, Buetti N, Gainnier M, Souweine B, Timsit JF
Association Between Early Invasive Mechanical Ventilation and Day-60 Mortality in Acute Hypoxemic Respiratory Failure Related to Coronavirus Disease-2019 Pneumonia.
Critical Care Explorations 2021, 3, e0329.
Lahens A, Mullaert J, Gressens S, Gault N, Flamant M, Deconinck L, Joly V, Yazdanpanah Y, Lescure FX, Vidal-Petiot E
Association between renin-angiotensin-aldosterone system blockers and outcome in coronavirus disease 2019: analysing in-hospital exposure generates a biased seemingly protective effect of treatment.
Journal of Hypertension 2021, 39, 367-375.
Hogan J, Kwon T, Paye-Jaouen A, Fait C, Cointe A, Baudouin V
Kidney Transplantation in a COVID-19 Positive Pediatric Recipient.
Transplantation 2021
Gault N, Esposito-Farese M, Revest M, Inamo J, Cabie A, Polard É, Hulot JS, Ghosn J, Chirouze C, Deconinck L, Diehl JL, Poissy J, Epaulard O, Lefèvre B, Piroth L, de Montmollin E, Oziol E, Etienne M, Laouenan C, Rossignol P, Costagliola D, Vidal-Petiot E, French-Covid cohort investigators and study group
Chronic use of Renin-Angiotensin-Aldosterone-System blockers and mortality in COVID-19: a multicenter prospective cohort and literature review.
Fundamental & Clinical Pharmacology 2021
Le Hingrat Q, Bouzid D, Choquet C, Laurent O, Lescure FX, Timsit JF, Houhou-Fidouh N, Casalino E, Lucet JC, Descamps D, Visseaux B
Viral epidemiology and SARS-CoV-2 co-infections with other respiratory viruses during the first COVID-19 wave in Paris, France.
Influenza and Other Respiratory Viruses 2021, 15, 425-428.
Pasquier G, Bounhiol A, Robert Gangneux F, Zahar JR, Gangneux JP, Novara A, Bougnoux ME, Dannaoui E
A review of significance of Aspergillus detection in airways of ICU COVID-19 patients.
Mycoses 2021, 64, 980-988.
Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann HH, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Haljasmägi L, Migaud M, Särekannu K, Maslovskaja J, de Prost N, Tandjaoui-Lambiotte Y, Luyt CE, Amador-Borrero B, Gaudet A, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier JC, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux PL, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya JM, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs C, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, El Bakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, van de Beek D, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau YL, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Venet F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino-Neto A, Prando C, Bonradenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, HGID Lab, COVID Clinicians, COVID-STORM Clinicians, NIAID Immune Response to COVID Group, NH-COVAIR Study Group, Danish CHGE, Danish Blood Donor Study, St. James's Hospital, SARS CoV2 Interest group, French COVID Cohort Study Group, Imagine COVID-Group, Milieu Intérieur Consortium, CoV-Contact Cohort, Amsterdam UMC Covid-19, Biobank Investigators, COVID Human Genetic Effort, CONSTANCES cohort, 3C-Dijon Study, Cerba Health-Care, Etablissement du Sang study group, Anderson MS, Boisson B, Béziat V, Zhang SY, Vandreakos E, Hermine O, Pujol A, Peterson P, Mogensen TH, Rowen L, Mond J, Debette S, de Lamballerie X, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova JL
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths.
Science Immunology 2021, 6, eabl4340.
Asano T, Boisson B, Onodi F, Matuozzo D, Moncada-Velez M, Maglorius Renkilaraj MRL, Zhang P, Meertens L, Bolze A, Materna M, Korniotis S, Gervais A, Talouarn E, Bigio B, Seeleuthner Y, Bilguvar K, Zhang Y, Neehus AL, Ogishi M, Pelham SJ, Le Voyer T, Rosain J, Philippot Q, Soler-Palacín P, Colobran R, Martin-Nalda A, Rivière JG, Tandjaoui-Lambiotte Y, Chaïbi K, Shahrooei M, Darazam IA, Olyaei NA, Mansouri D, Hatipoğlu N, Palabiyik F, Ozcelik T, Novelli G, Novelli A, Casari G, Aiuti A, Carrera P, Bondesan S, Barzaghi F, Rovere-Querini P, Tresoldi C, Franco JL, Rojas J, Reyes LF, Bustos IG, Arias AA, Morelle G, Christèle K, Troya J, Planas-Serra L, Schlüter A, Gut M, Pujol A, Allende LM, Rodriguez-Gallego C, Flores C, Cabrera-Marante O, Pleguezuelo DE, de Diego RP, Keles S, Aytekin G, Akcan OM, Bryceson YT, Bergman P, Brodin P, Smole D, Smith CIE, Norlin AC, Campbell TM, Covill LE, Hammarström L, Pan-Hammarström Q, Abolhassani H, Mane S, Marr N, Ata M, Al Ali F, Khan T, Spaan AN, Dalgard CL, Bonfanti P, Biondi A, Tubiana S, Burdet C, Nussbaum R, Kahn-Kirby A, Snow AL, COVID Human Genetic Effort, COVID-STORM Clinicians, COVID Clinicians, Imagine COVID Group, French COVID Cohort Study Group, CoV-Contact Cohort, Amsterdam UMC Covid-, Biobank, NIAID-USUHS COVID Study Group, Bustamante J, Puel A, Boisson-Dupuis S, Zhang SY, Béziat V, Lifton RP, Bastard P, Notarangelo LD, Abel L, Su HC, Jouanguy E, Amara A, Soumelis V, Cobat A, Zhang Q, Casanova JL
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.
Science Immunology 2021, 6, eabl4348.
Mageau A, Aldebert G, Van Gysel D, Papo T, Timsit JF, Sacre K
SARS-CoV-2 infection among inpatients with systemic lupus erythematosus in France: a nationwide epidemiological study.
Annals of the Rheumatic Diseases 2021
Voiriot G, Fartoukh M, Durand-Zaleski I, Berard L, Rousseau A, Armand-Lefevre L, Verdet C, Argaud L, Klouche K, Megarbane B, Patrier J, Richard JC, Reignier J, Schwebel C, Souweine B, Tandjaoui-Lambiotte Y, Simon T, Timsit JF, MULTI-CAP study group
Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units.
BMJ open 2021, 11, e048187.
Tavernier E, Barbier F, Meziani F, Quenot JP, Herbrecht JE, Landais M, Roux D, Seguin P, Schnell D, Veinstein A, Veber B, Lasocki S, Lu Q, Beduneau G, Ferrandiere M, Dahyot-Fizelier C, Plantefeve G, Nay MA, Merdji H, Andreu P, Vecellio L, Muller G, Cabrera M, Le Pennec D, Respaud R, Lanotte P, Gregoire N, Leclerc M, Helms J, Boulain T, Lacherade JC, Ehrmann S, REVA network and the CRICS-TRIGGESEP F-CRIN network
Inhaled amikacin versus placebo to prevent ventilator-associated pneumonia: the AMIKINHAL double-blind multicentre randomised controlled trial protocol.
BMJ open 2021, 11, e048591.
Mahamat-Saleh Y, Fiolet T, Rebeaud ME, Mulot M, Guihur A, El Fatouhi D, Laouali N, Peiffer-Smadja N, Aune D, Severi G
Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies.
BMJ open 2021, 11, e052777.
Rose K, Bressan S, Honeyford K, Bognar Z, Buonsenso D, Da Dalt L, De T, Farrugia R, Parri N, Oostenbrink R, Maconochie I, Moll HA, Roland D, Titomanlio L, Nijman R, in association with the REPEM network (Research in European Paediatric Emergency Medicine) as part of the EPISODES Study, in association with the REPEM network(Research in European Paediatric Emergency Medicine) as part of the EPISODES Study
Responses of paediatric emergency departments to the first wave of the COVID-19 pandemic in Europe: a cross-sectional survey study.
BMJ paediatrics open 2021, 5, e001269.
Ghanem M, Homps-Legrand M, Garnier M, Morer L, Goletto T, Frija-Masson J, Wicky PH, Jaquet P, Bancal C, Hurtado-Nedelec M, de Chaisemartin L, Jaillet M, Mailleux A, Quesnel C, Poté N, Debray MP, de Montmollin E, Neukirch C, Borie R, Taillé C, Crestani B, French COVID Cohort Study Group
Blood fibrocytes are associated with severity and prognosis in COVID-19 pneumonia.
American Journal of Physiology. Lung Cellular and Molecular Physiology 2021, 321, L847-L858.
Besançon L, Peiffer-Smadja N, Segalas C, Jiang H, Masuzzo P, Smout C, Billy E, Deforet M, Leyrat C
Open science saves lives: lessons from the COVID-19 pandemic.
BMC medical research methodology 2021, 21, 117.
von Cube M, Timsit JF, Kammerlander A, Schumacher M
Quantifying and communicating the burden of COVID-19.
BMC medical research methodology 2021, 21, 164.
Rahi M, Le Pluart D, Beaudet A, Ismaël S, Parisey M, Poey N, Tarhini H, Lescure FX, Yazdanpanah Y, Deconinck L
Sociodemographic characteristics and transmission risk factors in patients hospitalized for COVID-19 before and during the lockdown in France.
BMC infectious diseases 2021, 21, 812.
Passemard S, Faye A, Dubertret C, Peyre H, Vorms C, Boimare V, Auvin S, Flamant M, Ruszniewski P, Ricard JD
Covid-19 crisis impact on the next generation of physicians: a survey of 800 medical students.
BMC medical education 2021, 21, 529.
Ridde V, Gautier L, Dagenais C, Chabrol F, Hou R, Bonnet E, David PM, Cloos P, Duhoux A, Lucet JC, Traverson L, de Araujo Oliveira SR, Cazarin G, Peiffer-Smadja N, Touré L, Coulibaly A, Honda A, Noda S, Tamura T, Baba H, Kodoi H, Zinszer K
Learning from public health and hospital resilience to the SARS-CoV-2 pandemic: protocol for a multiple case study (Brazil, Canada, China, France, Japan, and Mali).
Health Research Policy and Systems 2021, 19, 76.
Wicky PH, Niedermann MS, Timsit JF
Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact?.
Critical Care (London, England) 2021, 25, 153.
COVID-ICU group, for the REVA network, COVID-ICU investigators
Benefits and risks of noninvasive oxygenation strategy in COVID-19: a multicenter, prospective cohort study (COVID-ICU) in 137 hospitals.
Critical Care (London, England) 2021, 25, 421.
Meyer A, Buetti N, Houhou-Fidouh N, Patrier J, Abdel-Nabey M, Jaquet P, Presente S, Girard T, Sayagh F, Ruckly S, Wicky PH, de Montmollin E, Bouadma L, Sonneville R, Descamps D, Timsit JF
HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients.
Critical Care (London, England) 2021, 25, 417.
Gagneux-Brunon A, Schilte C, Garcin A, Jolly N, Vray M, Schaeffer L, Duval X, Hoen B, Botelho-Nevers E
Acceptability of a COVID-19 pre-exposure prophylaxis trial with hydroxychloroquine in French healthcare workers during the first wave of COVID-19 pandemic.
Trials 2021, 22, 373.
Bonnet N, Martin O, Boubaya M, Levy V, Ebstein N, Karoubi P, Tandjaoui-Lambiotte Y, Van Der Meersch G, Oziel J, Soulie M, Ghalayini M, Winchenne A, Zahar JR, Ahmed P, Gaudry S, Cohen Y
High flow nasal oxygen therapy to avoid invasive mechanical ventilation in SARS-CoV-2 pneumonia: a retrospective study.
Annals of Intensive Care 2021, 11, 37.
Dres M, Hajage D, Lebbah S, Kimmoun A, Pham T, Béduneau G, Combes A, Mercat A, Guidet B, Demoule A, Schmidt M, COVID-ICU investigators
Characteristics, management, and prognosis of elderly patients with COVID-19 admitted in the ICU during the first wave: insights from the COVID-ICU study : Prognosis of COVID-19 elderly critically ill patients in the ICU.
Annals of Intensive Care 2021, 11, 77.
Yatim N, Boussier J, Chocron R, Hadjadj J, Philippe A, Gendron N, Barnabei L, Charbit B, Szwebel TA, Carlier N, Pène F, Azoulay C, Khider L, Mirault T, Diehl JL, Guerin CL, Rieux-Laucat F, Duffy D, Kernéis S, Smadja DM, Terrier B
Platelet activation in critically ill COVID-19 patients.
Annals of Intensive Care 2021, 11, 113.
Sanchez MA, Vuagnat A, Grimaud O, Leray E, Philippe JM, Lescure FX, Boutonnet M, Coignard H, Hibon AR, Sanchez S, Pottecher J
Impact of ICU transfers on the mortality rate of patients with COVID-19: insights from comprehensive national database in France.
Annals of Intensive Care 2021, 11, 151.
Chelly J, Plantefève G, Kamel T, Bruel C, Nseir S, Lai C, Cirillo G, Skripkina E, Ehrminger S, Berdaguer-Ferrari FD, Le Marec J, Paul M, Autret A, Deye N, ACICOVID-19 study group
Incidence, clinical characteristics, and outcome after unexpected cardiac arrest among critically ill adults with COVID-19: insight from the multicenter prospective ACICOVID-19 registry.
Annals of Intensive Care 2021, 11, 155.
Schmidt M, Guidet B, Demoule A, Ponnaiah M, Fartoukh M, Puybasset L, Combes A, Hajage D, COVID-ICU Investigators
Predicting 90-day survival of patients with COVID-19: Survival of Severely Ill COVID (SOSIC) scores.
Annals of Intensive Care 2021, 11, 170.
Massart N, Maxime V, Fillatre P, Razazi K, Ferré A, Moine P, Legay F, Voiriot G, Amara M, Santi F, Nseir S, Marque-Juillet S, Bounab R, Barbarot N, Bruneel F, Luyt CE, COVID ICU Bacteremia Study Group on behalf of the COVID-ICU Investigators
Characteristics and prognosis of bloodstream infection in patients with COVID-19 admitted in the ICU: an ancillary study of the COVID-ICU study.
Annals of Intensive Care 2021, 11, 183.
Deschanvres C, Haudebourg T, Peiffer-Smadja N, Blanckaert K, Boutoille D, Lucet JC, Birgand G
How do the general population behave with facemasks to prevent COVID-19 in the community? A multi-site observational study.
Antimicrobial Resistance and Infection Control 2021, 10, 61.
Czuppon P, Débarre F, Gonçalves A, Tenaillon O, Perelson AS, Guedj J, Blanquart F
Success of prophylactic antiviral therapy for SARS-CoV-2: Predicted critical efficacies and impact of different drug-specific mechanisms of action.
PLoS computational biology 2021, 17, e1008752.
Gonçalves A, Maisonnasse P, Donati F, Albert M, Behillil S, Contreras V, Naninck T, Marlin R, Solas C, Pizzorno A, Lemaitre J, Kahlaoui N, Terrier O, Ho Tsong Fang R, Enouf V, Dereuddre-Bosquet N, Brisebarre A, Touret F, Chapon C, Hoen B, Lina B, Rosa Calatrava M, de Lamballerie X, Mentré F, Le Grand R, van der Werf S, Guedj J
SARS-CoV-2 viral dynamics in non-human primates.
PLoS computational biology 2021, 17, e1008785.
Epelboin S, Labrosse J, De Mouzon J, Fauque P, Gervoise-Boyer MJ, Levy R, Sermondade N, Hesters L, Bergère M, Devienne C, Jonveaux P, Ghosn J, Pessione F
Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study.
PLoS medicine 2021, 18, e1003857.
d'Humières C, Patrier J, Lortat-Jacob B, Tran-Dinh A, Chemali L, Maataoui N, Rondinaud E, Ruppé E, Burdet C, Ruckly S, Montravers P, Timsit JF, Armand-Lefevre L
Two original observations concerning bacterial infections in COVID-19 patients hospitalized in intensive care units during the first wave of the epidemic in France.
PloS One 2021, 16, e0250728.
Dupuis C, de Montmollin E, Buetti N, Goldgran-Toledano D, Reignier J, Schwebel C, Domitile J, Neuville M, Ursino M, Siami S, Ruckly S, Alberti C, Mourvillier B, Bailly S, Laurent V, Gainnier M, Souweine B, Timsit JF, OutcomeReaTM research network
Impact of early corticosteroids on 60-day mortality in critically ill patients with COVID-19: A multicenter cohort study of the OUTCOMEREA network.
PloS One 2021, 16, e0255644.
Deruelle P, Couffignal C, Sibiude J, Vivanti AJ, Anselem O, Luton D, Benachi A, Mandelbrot L, Vauloup-Fellous C, Cordier AG, Picone O
Prenatal care providers' perceptions of the SARS-Cov-2 vaccine for themselves and for pregnant women.
PloS One 2021, 16, e0256080.
Delaroche L, Bertine M, Oger P, Descamps D, Damond F, Genauzeau E, Meicler P, Le Hingrat Q, Lamazou F, Gschwind R, Ruppé E, Visseaux B
Evaluation of SARS-CoV-2 in semen, seminal plasma, and spermatozoa pellet of COVID-19 patients in the acute stage of infection.
PloS One 2021, 16, e0260187.
Evrard D, Jurcisin I, Assadi M, Patrier J, Tafani V, Ullmann N, Timsit JF, Montravers P, Barry B, Weiss E, Rozencwajg S
Tracheostomy in COVID-19 acute respiratory distress syndrome patients and follow-up: A parisian bicentric retrospective cohort.
PloS One 2021, 16, e0261024.
Denis F, Fontanet A, Le Douarin YM, Le Goff F, Jeanneau S, Lescure FX
A Self-Assessment Web-Based App to Assess Trends of the COVID-19 Pandemic in France: Observational Study.
Journal of Medical Internet Research 2021, 23, e26182.
Denis F, Septans AL, Le Goff F, Jeanneau S, Lescure FX
Analysis of COVID-19 Transmission Sources in France by Self-Assessment Before and After the Partial Lockdown: Observational Study.
Journal of Medical Internet Research 2021, 23, e26932.
Geslain G, Miatello J, Barreault S, DE Melo C, Durand P, Deho A, Naudin J, Zitvogel F, Tissieres P, Dauger S, Guilbert AS, Levy M
Pediatric Intensive Care Unit mutation to adult unit during the initial COVID-19 wave: does it make sense?.
Minerva anestesiologica 2021, 87, 121-123.
Bosetti P, Kiem CT, Yazdanpanah Y, Fontanet A, Lina B, Colizza V, Cauchemez S
Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2021, 26,
Tran Kiem C, Crépey P, Bosetti P, Levy Bruhl D, Yazdanpanah Y, Salje H, Boëlle PY, Cauchemez S
Lockdown as a last resort option in case of COVID-19 epidemic rebound: a modelling study.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2021, 26,
Badr DA, Picone O, Bevilacqua E, Carlin A, Meli F, Sibiude J, Mattern J, Fils JF, Mandelbrot L, Lanzone A, De Luca D, Jani JC, Vivanti AJ
Severe Acute Respiratory Syndrome Coronavirus 2 and Pregnancy Outcomes According to Gestational Age at Time of Infection.
Emerging Infectious Diseases 2021, 27, 2535-2543.
Brousse V, Holvoet L, Pescarmona R, Viel S, Perret M, Visseaux B, Ferre VM, Ithier G, Le Van Kim C, Benkerrou M, Missud F, Koehl B
Low incidence of COVID-19 severe complications in a large cohort of children with sickle cell disease: a protective role for basal interferon-1 activation?.
Haematologica 2021
Lebourgeois S, Chenane HR, Houhou-Fidouh N, Menidjel R, Ferré VM, Collin G, Benmalek N, Coppée R, Larrouy L, Yazdanpanah Y, Timsit JF, Charpentier C, Descamps D, Visseaux B
Earlier In Vitro Viral Production With SARS-CoV-2 Alpha Than With Beta, Gamma, B, or A.27 Variants.
Frontiers in Cellular and Infection Microbiology 2021, 11, 792202.
Charbonnier L, Rouprêt-Serzec J, Caseris M, Danse M, Cointe A, Cohen L, Faye A, Ouldali N, Gaschignard J
Contribution of Serological Rapid Diagnostic Tests to the Strategy of Contact Tracing in Households Following SARS-CoV-2 Infection Diagnosis in Children.
Frontiers in Pediatrics 2021, 9, 638502.
Bonil L, Lingas G, Coupeau D, Lucet JC, Guedj J, Visseaux B, Muylkens B
Survival of SARS-CoV-2 on Non-Porous Materials in an Experimental Setting Representative of Fomites.
Coatings 2021, 11, 371.
Ursino M, Dupuis C, Buetti N, de Montmollin E, Bouadma L, Golgran-Toledano D, Ruckly S, Neuville M, Cohen Y, Mourvillier B, Souweine B, Gainnier M, Laurent V, Terzi N, Shiami S, Reignier J, Alberti C, Timsit JF, On Behalf Of The Outcomerea Study Group n
Multistate Modeling of COVID-19 Patients Using a Large Multicentric Prospective Cohort of Critically Ill Patients.
Journal of Clinical Medicine 2021, 10,
Rybak A, Yang DD, Schrimpf C, Guedj R, Levy C, Cohen R, Gajdos V, Tort J, Skurnik D, Ouldali N, Angoulvant F
Fall of Community-Acquired Pneumonia in Children following COVID-19 Non-Pharmaceutical Interventions: A Time Series Analysis.
Pathogens (Basel, Switzerland) 2021, 10, 1375.
Peiffer-Smadja N, Bridier-Nahmias A, Ferré VM, Charpentier C, Garé M, Rioux C, Allemand A, Lavallée P, Ghosn J, Kramer L, Descamps D, Yazdanpanah Y, Visseaux B
Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2.
Viruses 2021, 13, 1642.
Ghazali DA, Choquet C, Bouzid D, Colosi L, Ben Hammouda A, Wargon M, Gay M, Vaittinada Ayar P, Douay B, Revue E, Soulat L, Hellmann R, Casalino E
Analysis of the Feasibility of a Vaccination Campaign against Influenza Epidemic and COVID-19 Pandemic in French Emergency Departments: A National Survey.
Vaccines 2021, 9, 400.
Michiels Y, Houhou-Fidouh N, Collin G, Berger J, Kohli E
Impact of Low-Dose Methotrexate-Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis.
Vaccines 2021, 9, 883.
Michiels Y, Houhou-Fidouh N, Collin G, Berger J, Kohli E
Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient.
Vaccines 2021, 9, 1140.
Stilma W, Åkerman E, Artigas A, Bentley A, Bos LD, Bosman TJC, de Bruin H, Brummaier T, Buiteman-Kruizinga LA, Carcò F, Chesney G, Chu C, Dark P, Dondorp AM, Gijsbers HJH, Gilder ME, Grieco DL, Inglis R, Laffey JG, Landoni G, Lu W, Maduro LMN, McGready R, McNicholas B, de Mendoza D, Morales-Quinteros L, Nosten F, Papali A, Paternoster G, Paulus F, Pisani L, Prud'homme E, Ricard JD, Roca O, Sartini C, Scaravilli V, Schultz MJ, Sivakorn C, Spronk PE, Sztajnbok J, Trigui Y, Vollman KM, van der Woude MCE
Awake Proning as an Adjunctive Therapy for Refractory Hypoxemia in Non-Intubated Patients with COVID-19 Acute Respiratory Failure: Guidance from an International Group of Healthcare Workers.
The American Journal of Tropical Medicine and Hygiene 2021
COVID-19 Research Prioritization Group on MNCAH
Global research priorities on COVID-19 for maternal, newborn, child and adolescent health.
Journal of Global Health 2021, 11, 04071.
Marc A, Kerioui M, Blanquart F, Bertrand J, Mitjà O, Corbacho-Monné M, Marks M, Guedj J
Quantifying the relationship between SARS-CoV-2 viral load and infectiousness.
eLife 2021, 10, e69302.
ISARIC Clinical Characterisation Group, Hall MD, Baruch J, Carson G, Citarella BW, Dagens A, Dankwa EA, Donnelly CA, Dunning J, Escher M, Kartsonaki C, Merson L, Pritchard M, Wei J, Horby PW, Rojek A, Olliaro PL
Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort.
eLife 2021, 10, e70970.
Mercier JC, Ouldali N, Basmaci R
[Multisystemic inflammatory syndrome in children (MIS-C) associated with Covid].
La Revue Du Praticien 2021, 71, 1009-1015.
Driouich JS, Cochin M, Lingas G, Moureau G, Touret F, Petit PR, Piorkowski G, Barthélémy K, Laprie C, Coutard B
Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model.
Nature communications 2021, 12, 1–13.
Onaisi R, Duvignaud A, Nguyen A, Dupouy J, Chastang J, le Bel J, Landman R, Naccache JM, Lefevre B, Piroth L, Binquet C, Makinson A, Darnaud T, Begue C, Weiss L, Richert L, Anglaret X, Malvy D, Joseph JP, Druais PL, Darmon D, Ral C, Lhomme E, Saint-Lary O
Randomized trial to evaluate the safety and efficacy of outpatient treatments in individuals with Covid-19 with risk factors. COVERAGE France Trial: a structured summary.
Exercer-La Revue Francophone De Medecine Generale 2021, 451-458.
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.
JAMA internal medicine 2021, 181, 32-40.
Birgand G, Mutters NT, Otter J, Eichel VM, Lepelletier D, Morgan DJ, Lucet JC
Variation of National and International Guidelines on Respiratory Protection for Health Care Professionals During the COVID-19 Pandemic.
JAMA network open 2021, 4, e2119257.
Cousien A, Acquaviva E, Kernéis S, Yazdanpanah Y, Delorme R
Temporal Trends in Suicide Attempts Among Children in the Decade Before and During the COVID-19 Pandemic in Paris, France.
JAMA network open 2021, 4, e2128611.
Yazdanpanah Y, French COVID cohort investigators and study group
Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID-19 patients.
Journal of Medical Virology 2021, 93, 2149-2159.
Roussel A, Germanaud D, Bouchoucha Y, Ouldali N, Vedrenne-Cloquet M, Castelle M, Baruchel A
Cranial polyneuropathy as the first manifestation of a severe COVID-19 in a child.
Pediatric Blood & Cancer 2021, 68, e28707.
COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators
Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.
Intensive Care Medicine 2021, 47, 60-73.
Buetti N, Ruckly S, de Montmollin E, Reignier J, Terzi N, Cohen Y, Shiami S, Dupuis C, Timsit JF
COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network.
Intensive Care Medicine 2021, 47, 180-187.
Arabi YM, Azoulay E, Al-Dorzi HM, Phua J, Salluh J, Binnie A, Hodgson C, Angus DC, Cecconi M, Du B, Fowler R, Gomersall CD, Horby P, Juffermans NP, Kesecioglu J, Kleinpell RM, Machado FR, Martin GS, Meyfroidt G, Rhodes A, Rowan K, Timsit JF, Vincent JL, Citerio G
How the COVID-19 pandemic will change the future of critical care.
Intensive Care Medicine 2021, 47, 282-291.
Arabi YM, Derde LPG, Timsit JF
How COVID-19 will change the management of other respiratory viral infections.
Intensive Care Medicine 2021
Debray MP, Tarabay H, Males L, Chalhoub N, Mahdjoub E, Pavlovsky T, Visseaux B, Bouzid D, Borie R, Wackenheim C, Crestani B, Rioux C, Saker L, Choquet C, Mullaert J, Khalil A
Observer agreement and clinical significance of chest CT reporting in patients suspected of COVID-19.
European Radiology 2021, 31, 1081-1089.
Chomton M, Marsac L, Deho A, Maroni A, Geslain G, Frannais-Haverland K, Robert-Debré University Hospital Study Group, Nicolas-Robin A, Levy M
Transforming a paediatric ICU to an adult ICU for severe Covid-19: lessons learned.
European Journal of Pediatrics 2021, 180, 2319-2323.
Chomton M, Marsac L, Deho A, Maroni A, Geslain G, Frannais-Haverland K, Robert-Debré University Hospital Study Group, Nicolas-Robin A, Levy M
Correction to: Transforming a paediatric ICU to an adult ICU for severe Covid-19: lessons learned.
European Journal of Pediatrics 2021
Maataoui N, Chemali L, Patrier J, Tran Dinh A, Le Fèvre L, Lortat-Jacob B, Marzouk M, d'Humières C, Rondinaud E, Ruppé E, Montravers P, Timsit JF, Armand-Lefèvre L
Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2021, 40, 2227-2234.
Vauloup-Fellous C, Maylin S, Périllaud-Dubois C, Brichler S, Alloui C, Gordien E, Rameix-Welti MA, Gault E, Moreau F, Fourati S, Challine D, Pawlotsky JM, Houhou-Fidouh N, Damond F, Mackiewicz V, Charpentier C, Méritet JF, Rozenberg F, Podglajen I, Marot S, Petit H, Burrel S, Akhavan S, Leruez-Ville M, Avettand-Fenoel V, Fourgeaud J, Guilleminot T, Gardiennet E, Bonacorsi S, Carol A, Carcelain G, Villemonteix J, Boukli N, Gozlan J, Morand-Joubert L, Legoff J, Delaugerre C, Chaix ML, Roque-Afonso AM, Dortet L, Naas T, Ronat JB, Lepape S, Marcelin AG, Descamps D
Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2021, 40, 2235-2241.
Mascitti H, Jourdain P, Bleibtreu A, Jaulmes L, Dechartres A, Lescure X, Yordanov Y, Dinh A, AP-HP/Universities/INSERM COVID-19 research collaboration
Prognosis of rash and chilblain-like lesions among outpatients with COVID-19: a large cohort study.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2021, 40, 2243-2248.
Kernéis S, Elie C, Fourgeaud J, Choupeaux L, Delarue SM, Alby ML, Quentin P, Pavie J, Brazille P, Néré ML, Minier M, Gabassi A, Gibaud A, Gauthier S, Leroy C, Voirin-Mathieu E, Poyart C, Vidaud M, Parfait B, Delaugerre C, Tréluyer JM, LeGoff J
Accuracy of saliva and nasopharyngeal sampling for detection of SARS-CoV-2 in community screening: a multicentric cohort study.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2021, 40, 2379-2388.
ISARIC Clinical Characterisation Group
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study.
Infection 2021, 49, 889-905.
Peiffer-Smadja N, Rozencwajg S, Kherabi Y, Yazdanpanah Y, Montravers P
COVID-19 vaccines: a race against time.
Anaesthesia, Critical Care & Pain Medicine 2021, 100848.
Zahar JR, Allaouchiche B
Even vaccinated against COVID-19, we must continue to wear a mask.
Anaesthesia, Critical Care & Pain Medicine 2021, 40, 100849.
Mercier JC, Ouldali N, Melki I, Basmaci R, Levy M, Titomanlio L, Beyler C, Meinzer U
Severe acute respiratory syndrome coronavirus 2-related multisystem inflammatory syndrome in children mimicking Kawasaki disease.
Archives of Cardiovascular Diseases 2021, 114, 426-433.
Amarsy R, Jacquier H, Munier AL, Merimèche M, Berçot B, Mégarbane B
Outbreak of NDM-1-producing Klebsiella pneumoniae in the intensive care unit during the COVID-19 pandemic: Another nightmare.
American Journal of Infection Control 2021, 49, 1324-1326.
Gouel-Cheron A, Elmaleh Y, Couffignal C, Kantor E, Meslin S, Caillard A, Salome A, Hamada S, Cholley B, Mebazaa A, Longrois D, Bourgain JL, Billard V, Servin F, Montravers P
Effectiveness of anaesthesia ventilator use for mechanical ventilation in critically ill patients during the COVID-19 pandemic.
British Journal of Anaesthesia 2021, 127, e35-e37.
Fiolet T, Guihur A, Rebeaud ME, Mulot M, Peiffer-Smadja N, Mahamat-Saleh Y
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 19-27.
Fiolet T, Guihur A, Rebeaud ME, Mulot M, Peiffer-Smadja N, Mahamat-Saleh Y
Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 138-140.
Meppiel E, Peiffer-Smadja N, Maury A, Bekri I, Delorme C, Desestret V, Gorza L, Hautecloque-Raysz G, Landre S, Lannuzel A, Moulin S, Perrin P, Petitgas P, SellaI F, Wang A, Tattevin P, de Broucker T, contributors to the NeuroCOVID registry
Neurologic manifestations associated with COVID-19: a multicentre registry.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 458-466.
Gastli N, Loubinoux J, Daragon M, Lavigne JP, Saint-Sardos P, Pailhoriès H, Lemarié C, Benmansour H, d'Humières C, Broutin L, Dauwalder O, Levy M, Auger G, Kernéis S, Cattoir V, French FA-PP study group
Multicentric evaluation of BioFire FilmArray Pneumonia Panel for rapid bacteriological documentation of pneumonia.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1308-1314.
Tran VT, Mahévas M, Bani-Sadr F, Robineau O, Perpoint T, Perrodeau E, Gallay L, Ravaud P, Goehringer F, Lescure FX, COCORICO Collaborative Group
Corticosteroids in patients hospitalized for COVID-19 pneumonia who require oxygen: observational comparative study using routine care data.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 603-610.
Ghosn J, Piroth L, Epaulard O, Le Turnier P, Mentré F, Bachelet D, Laouénan C, French COVID cohort study and investigators groups
Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1041.e1-1041.e4.
Gallay L, Tran VT, Perrodeau E, Vignier N, Mahevas M, Bisio F, Forestier E, Lescure FX, COCO-OLD Study group
Fourteen-day survival among older adults with severe infection with severe acute respiratory syndrome coronavirus 2 treated with corticosteroid: a cohort study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1145-1150.
Yordanov Y, Dinh A, Bleibtreu A, Mensch A, Lescure FX, Debuc E, Jourdain P, Jaulmes L, Dechartres A, AP-HP/Universities/Inserm COVID-19 research collaboration
Clinical characteristics and factors associated with hospital admission or death in 43 103 adult outpatients with coronavirus disease 2019 managed with the Covidom telesurveillance solution: a prospective cohort study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1158-1166.
Ader F, Peiffer-Smadja N, Poissy J, Bouscambert-Duchamp M, Belhadi D, Diallo A, Delmas C, Saillard J, Dechanet A, Mercier N, Dupont A, Alfaiate T, Lescure FX, Raffi F, Goehringer F, Kimmoun A, Jaureguiberry S, Reignier J, Nseir S, Danion F, Clere-Jehl R, Bouiller K, Navellou JC, Tolsma V, Cabié A, Dubost C, Courjon J, Leroy S, Mootien J, Gaci R, Mourvillier B, Faure E, Pourcher V, Gallien S, Launay O, Lacombe K, Lanoix JP, Makinson A, Martin-Blondel G, Bouadma L, Botelho-Nevers E, Gagneux-Brunon A, Epaulard O, Piroth L, Wallet F, Richard JC, Reuter J, Staub T, Lina B, Noret M, Andrejak C, Lê MP, Peytavin G, Hites M, Costagliola D, Yazdanpanah Y, Burdet C, Mentré F, DisCoVeRy study group
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1826-1837.
Husain M, Rachline A, Cousien A, Rolland S, Rouzaud C, Ferre VM, Gomez MV, Le Teurnier M, Wicky-Thisse M, Descamps D, Yazdanpanah Y, Charpentier C, Pasquet-Cadre A
Impact of the COVID-19 pandemic on the homeless: results from a retrospective closed cohort in France (March-May 2020).
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1520.e1-1520.e5.
Dinh A, Jaulmes L, Dechartres A, Duran C, Mascitti H, Lescure X, Yordanov Y, Jourdain P, AP-HP/Universities/INSERM COVID-19 research collaboration, Data-sciences committee, Scientific committee, Covidom regional centre steering commitee
Time to resolution of respiratory and systemic coronavirus disease 2019 symptoms in community setting.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1862.e1-1862.e4.
Caméléna F, Moy AC, Dudoignon E, Poncin T, Deniau B, Guillemet L, Le Goff J, Budoo M, Benyamina M, Chaussard M, Coutrot M, Lafaurie M, Plaud B, Mebazaa A, Depret F, Berçot B
Performance of a multiplex polymerase chain reaction panel for identifying bacterial pathogens causing pneumonia in critically ill patients with COVID-19.
Diagnostic Microbiology and Infectious Disease 2021, 99, 115183.
Charpentier C, Pellissier G, Ichou H, Ferré VM, Larfi I, Phung BC, Vallois D, LeGac S, Aubier M, Descamps D, Fidouh-Houhou N, Bouvet E
Contribution of rapid lateral flow assays from capillary blood specimens to the diagnosis of COVID-19 in symptomatic healthcare workers: a pilot study in a university hospital, Paris, France.
Diagnostic Microbiology and Infectious Disease 2021, 101, 115430.
Eloy P, Le Grand R, Malvy D, Guedj J
Combined treatment of molnupiravir and favipiravir against SARS-CoV-2 infection: One + zero equals two?.
EBioMedicine 2021, 74, 103663.
Hcini N, Maamri F, Picone O, Carod JF, Lambert V, Mathieu M, Carles G, Pomar L
Maternal, fetal and neonatal outcomes of large series of SARS-CoV-2 positive pregnancies in peripartum period: A single-center prospective comparative study.
European Journal of Obstetrics, Gynecology, and Reproductive Biology 2021, 257, 11-18.
Maillet F, Pourbaix A, le Pluart D, Sirmai L, Postolache SA, Couvelard A, Houhou-Fidouh N, Males L, Deconinck L, Lescure FX
Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments.
IDCases 2021, 24, e01111.
Gourjault C, Tarhini H, Rahi M, Thy M, Le Pluart D, Rioux C, Parisey M, Ismael S, Al Rida Aidibi A, Paradis V, Ghosn J, Yazdanpanah Y, Lescure FX, Gervais A
Cholangitis in three critically ill patients after a severe CoVID-19 infection.
IDCases 2021, e01267.
Bouiller K, Catho G, Le Maréchal M, Gras J, Hentzien M, Peiffer-Smadja N, Bessis S, Cabon M, Dubee V, Lemaignen A, Thy M, Martins C, Thill P, Osei L, ReJIF (Réseau des Jeunes Infectiologues Français, Société de Pathologie Infectieuse de Langue Française)
The role of infectious disease trainees during the first wave of the COVID-19 pandemic: A national survey.
Infectious Diseases Now 2021, 51, 215-217.
Lacarra B, Mellon G, Ortega Perez I, D'Ortenzio E, Lescure FX
Bridging the gap between scientific discovery and clinical application during the COVID-19 epoch.
Infectious Diseases Now 2021, 51, 581-582.
Cohen R, Ashman M, Taha MK, Varon E, Angoulvant F, Levy C, Rybak A, Ouldali N, Guiso N, Grimprel E
Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?.
Infectious Diseases Now 2021, 51, 418-423.
Telford E, Ortega-Perez I, Mellon G, Lacarra B, Adjadj E, Madelaine C, D'Ortenzio E, Yazdanpanah Y
Chronicles of a pandemic: how France coordinated the scientific research response to COVID-19.
Infectious Diseases Now 2021, S2666-9919(21)00487-5.
Lebourgeois S, Storto A, Gout B, Le Hingrat Q, Ardila Tjader G, Cerdan MDC, English A, Pareja J, Love J, Houhou-Fidouh N, Manissero D, Descamps D, Visseaux B
Performance evaluation of the QIAstat-Dx® Respiratory SARS-CoV-2 Panel.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2021, 107, 179-181.
Caméléna F, Poncin T, Dudoignon E, Salmona M, Le Goff J, Donay JL, Lafaurie M, Darmon M, Azoulay E, Plaud B, Mebazaa A, Dépret F, Jacquier H, Berçot B
Rapid identification of bacteria from respiratory samples of patients hospitalized in intensive care units, with FilmArray Pneumonia Panel Plus.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2021, 108, 568-573.
Eloy P, Tardivon C, Martin-Blondel G, Isnard M, Turnier PL, Marechal ML, Cabié A, Launay O, Tattevin P, Senneville E, Ansart S, Goehringer F, Chirouze C, Bousson L, Laouénan C, Etienne M, Nguyen D, Ghosn J, Duval X, French COVID cohort study and investigators groups
Severity of self-reported symptoms and psychological burden 6-months after hospital admission for COVID-19: a prospective cohort study.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2021, 112, 247-253.
Lévy Y, Wiedemann A, Hejblum BP, Durand M, Lefebvre C, Surénaud M, Lacabaratz C, Perreau M, Foucat E, Déchenaud M, Tisserand P, Blengio F, Hivert B, Gauthier M, Cervantes-Gonzalez M, Bachelet D, Laouénan C, Bouadma L, Timsit JF, Yazdanpanah Y, Pantaleo G, Hocini H, Thiébaut R, French COVID cohort study group
CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death.
iScience 2021, 24, 102711.
Martin A, Storto A, Le Hingrat Q, Collin G, André B, Mallory A, Dangla R, Descamps D, Visseaux B, Gossner O
High-sensitivity SARS-CoV-2 group testing by digital PCR among symptomatic patients in hospital settings.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2021, 141, 104895.
Crescenzo-Chaigne B, Behillil S, Enouf V, Escriou N, Petres S, Ungeheuer MN, Ghosn J, Tubiana S, Bouadma L, van der Werf S, Demeret C, French COVID cohort study group
Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients.
Journal of Clinical Virology Plus 2021, 1, 100041.
Keta-Cov research group. Electronic address: vincent.mallet@aphp.fr, Keta-Cov research group
Intravenous ketamine and progressive cholangiopathy in COVID-19 patients.
Journal of Hepatology 2021, 74, 1243-1244.
Mallet V, Keta-Cov research group
Reply to: "Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered".
Journal of Hepatology 2021, 75, 990-992.
Klement-Frutos E, Burrel S, Peytavin G, Marot S, Lê MP, Godefroy N, Calvez V, Marcelin AG, Caumes E, Pourcher V, Boutolleau D
Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19.
The Journal of Infection 2021, 82, 159-198.
Grall I, Alloui CA, Tandjaoui-Lambiotte Y, Deslandes A, Seytre D, Chappe J, Carbonnelle E, Brichler S, Jacolot A, Zahar JR, Lomont A
Viral transmission in asymptomatic cases of SARS-CoV-2 infection.
The Journal of Infection 2021, 82, 282-327.
Tubiana S, Burdet C, Houhou N, Thy M, Manchon P, Blanquart F, Charpentier C, Guedj J, Alavoine L, Behillil S, Leclercq A, Lucet JC, Yazdanpanah Y, Attia M, Demeret C, Rose T, Bielicki JA, Bruijning-Verhagen P, Goossens H, Descamps D, van der Werf S, Lina B, Duval X, CoVCONTACT study group, Principal investigator, Sponsor: Inserm
High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohort.
The Journal of Infection 2021, 82, 186-230.
de Montmollin E, Faille D, Andrieu V, Ajzenberg N, Timsit JF
Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?.
The Journal of Infection 2021
Teyssou E, Soulie C, Visseaux B, Lambert-Niclot S, Ferre V, Marot S, Jary A, Sayon S, Zafilaza K, Leducq V, Schnuriger A, Abdi B, Wirden M, Houhou-Fidouh N, Charpentier C, Morand-Joubert L, Burrel S, Descamps D, Calvez V, Marcelin AG
The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients.
The Journal of Infection 2021, 83, 119-145.
Teyssou E, Delagrèverie H, Visseaux B, Lambert-Niclot S, Brichler S, Ferre V, Marot S, Jary A, Todesco E, Schnuriger A, Ghidaoui E, Abdi B, Akhavan S, Houhou-Fidouh N, Charpentier C, Morand-Joubert L, Boutolleau D, Descamps D, Calvez V, Marcelin A, Soulie C
The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19.
The Journal of Infection 2021, S0163-4453(21)00416-3.
Tsatsaris V, Mariaggi AA, Launay O, Couffignal C, Rousseau J, Ancel PY, Marcault E, Ville Y, Cordier AG, Vivanti A, Carrara J, Luton D, Dommergues M, Borie C, Kayem G, Alessandrini V, Lecomte L, Meritet JF, Leruez-Ville M, Goffinet F, Dubois C, Picone O, Vauloup Fellous C
SARS-COV-2 IgG antibody response in pregnant women at delivery.
Journal of Gynecology Obstetrics and Human Reproduction 2021, 50, 102041.
Bensoussan E, Ouldali N, Ashkenazi S, Angoulvant F, Cohen R, Levy C
Impact of Coronavirus Disease 2019 (COVID-19) Pandemic on Pediatric Infectious Disease Research.
The Journal of Pediatrics 2021, 230, 279-281.e2.
Visseaux B, Collin G, Houhou-Fidouh N, Le Hingrat Q, Ferré VM, Damond F, Ichou H, Descamps D, Charpentier C
Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirements.
Journal of Virological Methods 2021, 291, 114086.
Lefrancq N, Paireau J, Hozé N, Courtejoie N, Yazdanpanah Y, Bouadma L, Boëlle PY, Chereau F, Salje H, Cauchemez S
Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: A retrospective national surveillance data analysis.
The Lancet Regional Health. Europe 2021, 5, 100087.
Fournier M, Faille D, Dossier A, Mageau A, Nicaise Roland P, Ajzenberg N, Borie R, Bouadma L, Bunel V, Castier Y, Choquet C, Crestani B, Daugas E, Deconinck L, Descamps D, Descamps V, Dieudé P, Ducrocq G, Faucher N, Goulenok T, Guidoux C, Khalil A, Lavallée P, Lescure FX, Lortat-Jacob B, Mal H, Mutuon P, Pellenc Q, Steg PG, Taille C, Timsit JF, Yazdanpanah Y, Papo T, Sacré K
Arterial Thrombotic Events in Adult Inpatients With COVID-19.
Mayo Clinic Proceedings 2021, 96, 295-303.
Tarhini H, Husain M, Poey N, Lariven S, Lescure FX, Yazdanpanah Y, Gervais A
Jaundice in a patient treated with Anakinra in a context of Covid-19.
Infectious Diseases Now 2021, 51, 217-218.
Sallard E, Belhadi D, Lescure FX, Yazdanpanah Y, Peiffer-Smadja N
Clinical trial protocols of repurposed prophylaxis for COVID-19: A review.
Infectious Diseases Now 2021, 51, 7-13.
Maury A, Lyoubi A, Peiffer-Smadja N, de Broucker T, Meppiel E
Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
Revue Neurologique 2021, 177, 51-64.
Hansel B, Potier L, Chalopin S, Larger E, Gautier JF, Delestre F, Masdoua V, Visseaux B, Lucet JC, Kerneis S, Abouleka Y, Thebaut JF, Riveline JP, Kadouch D, Roussel R
The COVID-19 lockdown as an opportunity to change lifestyle and body weight in people with overweight/obesity and diabetes: Results from the national French COVIDIAB cohort.
Nutrition, metabolism, and cardiovascular diseases: NMCD 2021, 31, 2605-2611.
Frija-Masson J, Debray MP, Boussouar S, Khalil A, Bancal C, Motiejunaite J, Galarza-Jimenez MA, Benzaquen H, Penaud D, Laveneziana P, Malrin R, Redheuil A, Donciu V, Lucidarme O, Taillé C, Guerder A, Arnoult F, Vidal-Petiot E, Flamant M, Similowski T, Morelot-Panzini C, Faure M, Lescure FX, Straus C, d'Ortho MP, Gonzalez-Bermejo J
Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: The post Covid M3 study.
Respiratory Medicine 2021, 184, 106435.
ISARIC Clinical Characterisation Group
The value of open-source clinical science in pandemic response: lessons from ISARIC.
The Lancet. Infectious Diseases 2021, 21, 1623-1624.
Trøseid M, Hites M, Barratt-Due A, Ader F, Yazdanpanah Y
Assessing the evidence on remdesivir.
The Lancet. Infectious Diseases 2021, 21, 1630-1631.
CORIMUNO-19 Collaborative group
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial.
The Lancet. Respiratory Medicine 2021, 9, 295-304.
Lebreton G, Schmidt M, Ponnaiah M, Folliguet T, Para M, Guihaire J, Lansac E, Sage E, Cholley B, Mégarbane B, Cronier P, Zarka J, Da Silva D, Besset S, Lacombat I, Mongardon N, Richard C, Duranteau J, Cerf C, Saiydoun G, Sonneville R, Chiche JD, Nataf P, Longrois D, Combes A, Leprince P, Paris ECMO-COVID-19 investigators
Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study.
The Lancet. Respiratory Medicine 2021
Lescure FX, Honda H, Fowler RA, Lazar JS, Shi G, Wung P, Patel N, Hagino O, Sarilumab COVID-19 Global Study Group
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial.
The Lancet. Respiratory Medicine 2021, 9, 522-532.
Ehrmann S, Li J, Ibarra-Estrada M, Perez Y, Pavlov I, McNicholas B, Roca O, Mirza S, Vines D, Garcia-Salcido R, Aguirre-Avalos G, Trump MW, Nay MA, Dellamonica J, Nseir S, Mogri I, Cosgrave D, Jayaraman D, Masclans JR, Laffey JG, Tavernier E, Awake Prone Positioning Meta-Trial Group
Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial.
The Lancet. Respiratory Medicine 2021, 9, 1387-1395.
Lindan CE, Mankad K, Ram D, Kociolek LK, Silvera VM, Boddaert N, Stivaros SM, Palasis S, ASPNR PECOBIG Collaborator Group
Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study.
The Lancet. Child & Adolescent Health 2021, 5, 167-177.
Lachassinne E, de Pontual L, Caseris M, Lorrot M, Guilluy C, Naud A, Dommergues MA, Pinquier D, Wannepain E, Hausherr E, Jung C, Gajdos V, Cohen R, Zahar JR, Brichler S, Basmaci R, Boelle PY, Bloch-Queyrat C, Aupiais C, COVIDOCRECHE collaborators
SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study.
The Lancet. Child & Adolescent Health 2021, 5, 256-264.
Novelli G, Liu J, Biancolella M, Alonzi T, Novelli A, Patten JJ, Cocciadiferro D, Agolini E, Colona VL, Rizzacasa B, Giannini R, Bigio B, Goletti D, Capobianchi MR, Grelli S, Mann J, McKee TD, Cheng K, Amanat F, Krammer F, Guarracino A, Pepe G, Tomino C, Tandjaoui-Lambiotte Y, Uzunhan Y, Tubiana S, Ghosn J, COVID Human Genetic Effort, French COVID Cohort Study Group, CoV-Contact Cohort, Notarangelo LD, Su HC, Abel L, Cobat A, Elhanan G, Grzymski JJ, Latini A, Sidhu SS, Jain S, Davey RA, Casanova JL, Wei W, Pandolfi PP
Inhibition of HECT E3 ligases as potential therapy for COVID-19.
Cell Death & Disease 2021, 12, 310.
Driouich JS, Cochin M, Lingas G, Moureau G, Touret F, Petit PR, Piorkowski G, Barthélémy K, Laprie C, Coutard B, Guedj J, de Lamballerie X, Solas C, Nougairède A
Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model.
Nature Communications 2021, 12, 1735.
Perreau M, Suffiotti M, Marques-Vidal P, Wiedemann A, Levy Y, Laouénan C, Ghosn J, Fenwick C, Comte D, Roger T, Regina J, Vollenweider P, Waeber G, Oddo M, Calandra T, Pantaleo G
The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients.
Nature Communications 2021, 12, 4888.
Maisonnasse P, Aldon Y, Marc A, Marlin R, Dereuddre-Bosquet N, Kuzmina NA, Freyn AW, Snitselaar JL, Gonçalves A, Caniels TG, Burger JA, Poniman M, Bontjer I, Chesnais V, Diry S, Iershov A, Ronk AJ, Jangra S, Rathnasinghe R, Brouwer PJM, Bijl TPL, van Schooten J, Brinkkemper M, Liu H, Yuan M, Mire CE, van Breemen MJ, Contreras V, Naninck T, Lemaître J, Kahlaoui N, Relouzat F, Chapon C, Ho Tsong Fang R, McDanal C, Osei-Twum M, St-Amant N, Gagnon L, Montefiori DC, Wilson IA, Ginoux E, de Bree GJ, García-Sastre A, Schotsaert M, Coughlan L, Bukreyev A, van der Werf S, Guedj J, Sanders RW, van Gils MJ, Le Grand R
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models.
Nature Communications 2021, 12, 6097.
Flament H, Rouland M, Beaudoin L, Toubal A, Bertrand L, Lebourgeois S, Rousseau C, Soulard P, Gouda Z, Cagninacci L, Monteiro AC, Hurtado-Nedelec M, Luce S, Bailly K, Andrieu M, Saintpierre B, Letourneur F, Jouan Y, Si-Tahar M, Baranek T, Paget C, Boitard C, Vallet-Pichard A, Gautier JF, Ajzenberg N, Terrier B, Pène F, Ghosn J, Lescure X, Yazdanpanah Y, Visseaux B, Descamps D, Timsit JF, Monteiro RC, Lehuen A
Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity.
Nature Immunology 2021, 22, 322-335.
Smith N, Goncalves P, Charbit B, Grzelak L, Beretta M, Planchais C, Bruel T, Rouilly V, Bondet V, Hadjadj J, Yatim N, Pere H, Merkling SH, Ghozlane A, Kernéis S, Rieux-Laucat F, Terrier B, Schwartz O, Mouquet H, Duffy D, Di Santo JP
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.
Nature Immunology 2021, 22, 1428-1439.
LeGoff J, Kernéis S, Elie C, Mercier-Delarue S, Gastli N, Choupeaux L, Fourgeaud J, Alby ML, Quentin P, Pavie J, Brazille P, Néré ML, Minier M, Gabassi A, Leroy C, Parfait B, Tréluyer JM, Delaugerre C
Evaluation of a saliva molecular point of care for the detection of SARS-CoV-2 in ambulatory care.
Scientific Reports 2021, 11, 21126.
Crawford C, Vanoli E, Decorde B, Lancelot M, Duprat C, Josserand C, Jilesen J, Bouadma L, Timsit JF
Modeling of aerosol transmission of airborne pathogens in ICU rooms of COVID-19 patients with acute respiratory failure.
Scientific Reports 2021, 11, 11778.
Courties A, Boussier J, Hadjadj J, Yatim N, Barnabei L, Péré H, Veyer D, Kernéis S, Carlier N, Pène F, Rieux-Laucat F, Charbit B, Bondet V, Duffy D, Berenbaum F, Terrier B, Sellam J
Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients.
Scientific Reports 2021, 11, 11886.
WHO Solidarity Trial Consortium, Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, Alejandria MM, Hernández García C, Kieny MP, Malekzadeh R, Murthy S, Reddy KS, Roses Periago M, Abi Hanna P, Ader F, Al-Bader AM, Alhasawi A, Allum E, Alotaibi A, Alvarez-Moreno CA, Appadoo S, Asiri A, Aukrust P, Barratt-Due A, Bellani S, Branca M, Cappel-Porter HBC, Cerrato N, Chow TS, Como N, Eustace J, García PJ, Godbole S, Gotuzzo E, Griskevicius L, Hamra R, Hassan M, Hassany M, Hutton D, Irmansyah I, Jancoriene L, Kirwan J, Kumar S, Lennon P, Lopardo G, Lydon P, Magrini N, Maguire T, Manevska S, Manuel O, McGinty S, Medina MT, Mesa Rubio ML, Miranda-Montoya MC, Nel J, Nunes EP, Perola M, Portolés A, Rasmin MR, Raza A, Rees H, Reges PPS, Rogers CA, Salami K, Salvadori MI, Sinani N, Sterne JAC, Stevanovikj M, Tacconelli E, Tikkinen KAO, Trelle S, Zaid H, Røttingen JA, Swaminathan S
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
The New England Journal of Medicine 2021, 384, 497-511.
Bergwerk M, Gonen T, Lustig Y, Amit S, Lipsitch M, Cohen C, Mandelboim M, Levin EG, Rubin C, Indenbaum V, Tal I, Zavitan M, Zuckerman N, Bar-Chaim A, Kreiss Y, Regev-Yochay G
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
The New England Journal of Medicine 2021
Néant N, Lingas G, Le Hingrat Q, Ghosn J, Engelmann I, Lepiller Q, Gaymard A, Ferré V, Hartard C, Plantier JC, Thibault V, Marlet J, Montes B, Bouiller K, Lescure FX, Timsit JF, Faure E, Poissy J, Chidiac C, Raffi F, Kimmoun A, Etienne M, Richard JC, Tattevin P, Garot D, Le Moing V, Bachelet D, Tardivon C, Duval X, Yazdanpanah Y, Mentré F, Laouénan C, Visseaux B, Guedj J, French COVID Cohort Investigators and French Cohort Study groups
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort.
Proceedings of the National Academy of Sciences of the United States of America 2021, 118,
Poline J, Gaschignard J, Leblanc C, Madhi F, Foucaud E, Nattes E, Faye A, Bonacorsi S, Mariani P, Varon E, Smati-Lafarge M, Caseris M, Basmaci R, Lachaume N, Ouldali N
Systematic Severe Acute Respiratory Syndrome Coronavirus 2 Screening at Hospital Admission in Children: A French Prospective Multicenter Study.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 72, 2215-2217.
Veyer D, Kernéis S, Poulet G, Wack M, Robillard N, Taly V, L'Honneur AS, Rozenberg F, Laurent-Puig P, Bélec L, Hadjadj J, Terrier B, Péré H
Highly Sensitive Quantification of Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Sheds Light on its Potential Clinical Value.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 73, e2890-e2897.
Buetti N, Patrier J, Le Hingrat Q, Loiodice A, Bouadma L, Visseaux B, Timsit JF
Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Detection in Blood of Critically Ill Patients.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 72, e690-e691.
Temime L, Gustin MP, Duval A, Buetti N, Crépey P, Guillemot D, Thiébaut R, Vanhems P, Zahar JR, Smith DRM, Opatowski L
A Conceptual Discussion About the Basic Reproduction Number of Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Settings.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 72, 141-143.
Angoulvant F, Ouldali N, Yang DD, Filser M, Gajdos V, Rybak A, Guedj R, Soussan-Banini V, Basmaci R, Lefevre-Utile A, Brun-Ney D, Beaujouan L, Skurnik D
Coronavirus Disease 2019 Pandemic: Impact Caused by School Closure and National Lockdown on Pediatric Visits and Admissions for Viral and Nonviral Infections-a Time Series Analysis.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 72, 319-322.
Dudoignon E, Caméléna F, Deniau B, Habay A, Coutrot M, Ressaire Q, Plaud B, Berçot B, Dépret F
Bacterial Pneumonia in COVID-19 Critically Ill Patients: A Case Series.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 72, 905-906.
Contejean A, Leporrier J, Canouï E, Alby-Laurent F, Lafont E, Beaudeau L, Parize P, Lecieux F, Greffet A, Chéron G, Gauzit R, Fourgeaud J, L'Honneur AS, Tréluyer JM, Charlier C, Casetta A, Frange P, Leruez-Ville M, Rozenberg F, Lortholary O, Kernéis S
Comparing Dynamics and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 Transmissions Among Healthcare Workers of Adult and Pediatric Settings in Central Paris.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 72, 257-264.
Zucman N, Uhel F, Descamps D, Roux D, Ricard JD
Severe Reinfection With South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant 501Y.V2.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 73, 1945-1946.
Betton M, Livrozet M, Planas D, Fayol A, Monel B, Védie B, Bruel T, Tartour E, Robillard N, Manuguerra JC, Blanchard A, Ghosn J, Visseaux B, Péré H, Lebeaux D, Schwartz O, Veyer D, Hulot JS, French COVID Cohort Study Group
Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 73, e1337-e1344.
Bruneau T, Wack M, Poulet G, Robillard N, Philippe A, Laurent-Puig P, Bélec L, Hadjadj J, Xiao W, Kallberg JL, Kernéis S, Diehl JL, Terrier B, Smadja D, Taly V, Veyer D, Péré H
Circulating ubiquitous RNA, a highly predictive and prognostic biomarker in hospitalized COVID-19 patients.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, ciab997.
Tarhini H, Recoing A, Bridier-Nahmias A, Rahi M, Lambert C, Martres P, Lucet JC, Rioux C, Bouzid D, Lebourgeois S, Descamps D, Yazdanpanah Y, Le Hingrat Q, Lescure FX, Visseaux B
Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection.
The Journal of Infectious Diseases 2021, 223, 1522-1527.
Pelleau S, Woudenberg T, Rosado J, Donnadieu F, Garcia L, Obadia T, Gardais S, Elgharbawy Y, Velay A, Gonzalez M, Nizou JY, Khelil N, Zannis K, Cockram C, Merkling SH, Meola A, Kerneis S, Terrier B, de Seze J, Planas D, Schwartz O, Dejardin F, Petres S, von Platen C, Pellerin SF, Arowas L, de Facci LP, Duffy D, Cheallaigh CN, Dunne J, Conlon N, Townsend L, Duong V, Auerswald H, Pinaud L, Tondeur L, Backovic M, Hoen B, Fontanet A, Mueller I, Fafi-Kremer S, Bruel T, White M
Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection.
The Journal of Infectious Diseases 2021, 224, 1489-1499.
Lê MP, Peiffer-Smadja N, Guedj J, Neant N, Mentré F, Ader F, Yazdanpanah Y, Peytavin G, C21DFSC
Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response.
The Journal of Antimicrobial Chemotherapy 2021, 76, 277-279.
Bouzid D, Casalino E, Mullaert J, Laurent O, Duval X, Lescure FX, Peiffer Smadja N, Tubiana S, Armand Lefèvre L, Descamps D, Fidouh N, Choquet C, Lucet JC, Visseaux B
Added value of rapid respiratory syndromic testing at point of care versus central laboratory testing: a controlled clinical trial.
The Journal of Antimicrobial Chemotherapy 2021, 76, iii20-iii27.
Contejean A, Leporrier J, Canouï E, Fourgeaud J, Mariaggi AA, Alby-Laurent F, Lafont E, Beaudeau L, Rouzaud C, Lecieux F, Greffet A, L'Honneur AS, Tréluyer JM, Lanternier F, Casetta A, Frange P, Leruez-Ville M, Rozenberg F, Lortholary O, Kernéis S
Transmission Routes of Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers of a French University Hospital in Paris, France.
Open Forum Infectious Diseases 2021, 8, ofab054.
Kernéis S, Planas D, Imbeaud S, Staropoli I, Puech J, Robillard N, Rodary J, Bruel T, Vieillard T, Schwartz O, Belec L, Péré H, Veyer D
Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual.
Open Forum Infectious Diseases 2021, 8, ofab369.
Dupuis C, Bouadma L, de Montmollin E, Goldgran-Toledano D, Schwebel C, Reignier J, Neuville M, Ursino M, Siami S, Ruckly S, Alberti C, Mourvillier B, Bailly S, Grapin K, Laurent V, Buetti N, Gainnier M, Souweine B, Timsit JF
Association Between Early Invasive Mechanical Ventilation and Day-60 Mortality in Acute Hypoxemic Respiratory Failure Related to Coronavirus Disease-2019 Pneumonia.
Critical Care Explorations 2021, 3, e0329.
Lahens A, Mullaert J, Gressens S, Gault N, Flamant M, Deconinck L, Joly V, Yazdanpanah Y, Lescure FX, Vidal-Petiot E
Association between renin-angiotensin-aldosterone system blockers and outcome in coronavirus disease 2019: analysing in-hospital exposure generates a biased seemingly protective effect of treatment.
Journal of Hypertension 2021, 39, 367-375.
Hogan J, Kwon T, Paye-Jaouen A, Fait C, Cointe A, Baudouin V
Kidney Transplantation in a COVID-19 Positive Pediatric Recipient.
Transplantation 2021
Gault N, Esposito-Farese M, Revest M, Inamo J, Cabie A, Polard É, Hulot JS, Ghosn J, Chirouze C, Deconinck L, Diehl JL, Poissy J, Epaulard O, Lefèvre B, Piroth L, de Montmollin E, Oziol E, Etienne M, Laouenan C, Rossignol P, Costagliola D, Vidal-Petiot E, French-Covid cohort investigators and study group
Chronic use of Renin-Angiotensin-Aldosterone-System blockers and mortality in COVID-19: a multicenter prospective cohort and literature review.
Fundamental & Clinical Pharmacology 2021
Le Hingrat Q, Bouzid D, Choquet C, Laurent O, Lescure FX, Timsit JF, Houhou-Fidouh N, Casalino E, Lucet JC, Descamps D, Visseaux B
Viral epidemiology and SARS-CoV-2 co-infections with other respiratory viruses during the first COVID-19 wave in Paris, France.
Influenza and Other Respiratory Viruses 2021, 15, 425-428.
Pasquier G, Bounhiol A, Robert Gangneux F, Zahar JR, Gangneux JP, Novara A, Bougnoux ME, Dannaoui E
A review of significance of Aspergillus detection in airways of ICU COVID-19 patients.
Mycoses 2021, 64, 980-988.
Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann HH, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Haljasmägi L, Migaud M, Särekannu K, Maslovskaja J, de Prost N, Tandjaoui-Lambiotte Y, Luyt CE, Amador-Borrero B, Gaudet A, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier JC, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux PL, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya JM, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs C, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, El Bakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, van de Beek D, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau YL, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Venet F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino-Neto A, Prando C, Bonradenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, HGID Lab, COVID Clinicians, COVID-STORM Clinicians, NIAID Immune Response to COVID Group, NH-COVAIR Study Group, Danish CHGE, Danish Blood Donor Study, St. James's Hospital, SARS CoV2 Interest group, French COVID Cohort Study Group, Imagine COVID-Group, Milieu Intérieur Consortium, CoV-Contact Cohort, Amsterdam UMC Covid-19, Biobank Investigators, COVID Human Genetic Effort, CONSTANCES cohort, 3C-Dijon Study, Cerba Health-Care, Etablissement du Sang study group, Anderson MS, Boisson B, Béziat V, Zhang SY, Vandreakos E, Hermine O, Pujol A, Peterson P, Mogensen TH, Rowen L, Mond J, Debette S, de Lamballerie X, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova JL
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths.
Science Immunology 2021, 6, eabl4340.
Asano T, Boisson B, Onodi F, Matuozzo D, Moncada-Velez M, Maglorius Renkilaraj MRL, Zhang P, Meertens L, Bolze A, Materna M, Korniotis S, Gervais A, Talouarn E, Bigio B, Seeleuthner Y, Bilguvar K, Zhang Y, Neehus AL, Ogishi M, Pelham SJ, Le Voyer T, Rosain J, Philippot Q, Soler-Palacín P, Colobran R, Martin-Nalda A, Rivière JG, Tandjaoui-Lambiotte Y, Chaïbi K, Shahrooei M, Darazam IA, Olyaei NA, Mansouri D, Hatipoğlu N, Palabiyik F, Ozcelik T, Novelli G, Novelli A, Casari G, Aiuti A, Carrera P, Bondesan S, Barzaghi F, Rovere-Querini P, Tresoldi C, Franco JL, Rojas J, Reyes LF, Bustos IG, Arias AA, Morelle G, Christèle K, Troya J, Planas-Serra L, Schlüter A, Gut M, Pujol A, Allende LM, Rodriguez-Gallego C, Flores C, Cabrera-Marante O, Pleguezuelo DE, de Diego RP, Keles S, Aytekin G, Akcan OM, Bryceson YT, Bergman P, Brodin P, Smole D, Smith CIE, Norlin AC, Campbell TM, Covill LE, Hammarström L, Pan-Hammarström Q, Abolhassani H, Mane S, Marr N, Ata M, Al Ali F, Khan T, Spaan AN, Dalgard CL, Bonfanti P, Biondi A, Tubiana S, Burdet C, Nussbaum R, Kahn-Kirby A, Snow AL, COVID Human Genetic Effort, COVID-STORM Clinicians, COVID Clinicians, Imagine COVID Group, French COVID Cohort Study Group, CoV-Contact Cohort, Amsterdam UMC Covid-, Biobank, NIAID-USUHS COVID Study Group, Bustamante J, Puel A, Boisson-Dupuis S, Zhang SY, Béziat V, Lifton RP, Bastard P, Notarangelo LD, Abel L, Su HC, Jouanguy E, Amara A, Soumelis V, Cobat A, Zhang Q, Casanova JL
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.
Science Immunology 2021, 6, eabl4348.
Mageau A, Aldebert G, Van Gysel D, Papo T, Timsit JF, Sacre K
SARS-CoV-2 infection among inpatients with systemic lupus erythematosus in France: a nationwide epidemiological study.
Annals of the Rheumatic Diseases 2021
Voiriot G, Fartoukh M, Durand-Zaleski I, Berard L, Rousseau A, Armand-Lefevre L, Verdet C, Argaud L, Klouche K, Megarbane B, Patrier J, Richard JC, Reignier J, Schwebel C, Souweine B, Tandjaoui-Lambiotte Y, Simon T, Timsit JF, MULTI-CAP study group
Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units.
BMJ open 2021, 11, e048187.
Tavernier E, Barbier F, Meziani F, Quenot JP, Herbrecht JE, Landais M, Roux D, Seguin P, Schnell D, Veinstein A, Veber B, Lasocki S, Lu Q, Beduneau G, Ferrandiere M, Dahyot-Fizelier C, Plantefeve G, Nay MA, Merdji H, Andreu P, Vecellio L, Muller G, Cabrera M, Le Pennec D, Respaud R, Lanotte P, Gregoire N, Leclerc M, Helms J, Boulain T, Lacherade JC, Ehrmann S, REVA network and the CRICS-TRIGGESEP F-CRIN network
Inhaled amikacin versus placebo to prevent ventilator-associated pneumonia: the AMIKINHAL double-blind multicentre randomised controlled trial protocol.
BMJ open 2021, 11, e048591.
Mahamat-Saleh Y, Fiolet T, Rebeaud ME, Mulot M, Guihur A, El Fatouhi D, Laouali N, Peiffer-Smadja N, Aune D, Severi G
Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies.
BMJ open 2021, 11, e052777.
Rose K, Bressan S, Honeyford K, Bognar Z, Buonsenso D, Da Dalt L, De T, Farrugia R, Parri N, Oostenbrink R, Maconochie I, Moll HA, Roland D, Titomanlio L, Nijman R, in association with the REPEM network (Research in European Paediatric Emergency Medicine) as part of the EPISODES Study, in association with the REPEM network(Research in European Paediatric Emergency Medicine) as part of the EPISODES Study
Responses of paediatric emergency departments to the first wave of the COVID-19 pandemic in Europe: a cross-sectional survey study.
BMJ paediatrics open 2021, 5, e001269.
Ghanem M, Homps-Legrand M, Garnier M, Morer L, Goletto T, Frija-Masson J, Wicky PH, Jaquet P, Bancal C, Hurtado-Nedelec M, de Chaisemartin L, Jaillet M, Mailleux A, Quesnel C, Poté N, Debray MP, de Montmollin E, Neukirch C, Borie R, Taillé C, Crestani B, French COVID Cohort Study Group
Blood fibrocytes are associated with severity and prognosis in COVID-19 pneumonia.
American Journal of Physiology. Lung Cellular and Molecular Physiology 2021, 321, L847-L858.
Besançon L, Peiffer-Smadja N, Segalas C, Jiang H, Masuzzo P, Smout C, Billy E, Deforet M, Leyrat C
Open science saves lives: lessons from the COVID-19 pandemic.
BMC medical research methodology 2021, 21, 117.
von Cube M, Timsit JF, Kammerlander A, Schumacher M
Quantifying and communicating the burden of COVID-19.
BMC medical research methodology 2021, 21, 164.
Rahi M, Le Pluart D, Beaudet A, Ismaël S, Parisey M, Poey N, Tarhini H, Lescure FX, Yazdanpanah Y, Deconinck L
Sociodemographic characteristics and transmission risk factors in patients hospitalized for COVID-19 before and during the lockdown in France.
BMC infectious diseases 2021, 21, 812.
Passemard S, Faye A, Dubertret C, Peyre H, Vorms C, Boimare V, Auvin S, Flamant M, Ruszniewski P, Ricard JD
Covid-19 crisis impact on the next generation of physicians: a survey of 800 medical students.
BMC medical education 2021, 21, 529.
Ridde V, Gautier L, Dagenais C, Chabrol F, Hou R, Bonnet E, David PM, Cloos P, Duhoux A, Lucet JC, Traverson L, de Araujo Oliveira SR, Cazarin G, Peiffer-Smadja N, Touré L, Coulibaly A, Honda A, Noda S, Tamura T, Baba H, Kodoi H, Zinszer K
Learning from public health and hospital resilience to the SARS-CoV-2 pandemic: protocol for a multiple case study (Brazil, Canada, China, France, Japan, and Mali).
Health Research Policy and Systems 2021, 19, 76.
Wicky PH, Niedermann MS, Timsit JF
Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact?.
Critical Care (London, England) 2021, 25, 153.
COVID-ICU group, for the REVA network, COVID-ICU investigators
Benefits and risks of noninvasive oxygenation strategy in COVID-19: a multicenter, prospective cohort study (COVID-ICU) in 137 hospitals.
Critical Care (London, England) 2021, 25, 421.
Meyer A, Buetti N, Houhou-Fidouh N, Patrier J, Abdel-Nabey M, Jaquet P, Presente S, Girard T, Sayagh F, Ruckly S, Wicky PH, de Montmollin E, Bouadma L, Sonneville R, Descamps D, Timsit JF
HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients.
Critical Care (London, England) 2021, 25, 417.
Gagneux-Brunon A, Schilte C, Garcin A, Jolly N, Vray M, Schaeffer L, Duval X, Hoen B, Botelho-Nevers E
Acceptability of a COVID-19 pre-exposure prophylaxis trial with hydroxychloroquine in French healthcare workers during the first wave of COVID-19 pandemic.
Trials 2021, 22, 373.
Bonnet N, Martin O, Boubaya M, Levy V, Ebstein N, Karoubi P, Tandjaoui-Lambiotte Y, Van Der Meersch G, Oziel J, Soulie M, Ghalayini M, Winchenne A, Zahar JR, Ahmed P, Gaudry S, Cohen Y
High flow nasal oxygen therapy to avoid invasive mechanical ventilation in SARS-CoV-2 pneumonia: a retrospective study.
Annals of Intensive Care 2021, 11, 37.
Dres M, Hajage D, Lebbah S, Kimmoun A, Pham T, Béduneau G, Combes A, Mercat A, Guidet B, Demoule A, Schmidt M, COVID-ICU investigators
Characteristics, management, and prognosis of elderly patients with COVID-19 admitted in the ICU during the first wave: insights from the COVID-ICU study : Prognosis of COVID-19 elderly critically ill patients in the ICU.
Annals of Intensive Care 2021, 11, 77.
Yatim N, Boussier J, Chocron R, Hadjadj J, Philippe A, Gendron N, Barnabei L, Charbit B, Szwebel TA, Carlier N, Pène F, Azoulay C, Khider L, Mirault T, Diehl JL, Guerin CL, Rieux-Laucat F, Duffy D, Kernéis S, Smadja DM, Terrier B
Platelet activation in critically ill COVID-19 patients.
Annals of Intensive Care 2021, 11, 113.
Sanchez MA, Vuagnat A, Grimaud O, Leray E, Philippe JM, Lescure FX, Boutonnet M, Coignard H, Hibon AR, Sanchez S, Pottecher J
Impact of ICU transfers on the mortality rate of patients with COVID-19: insights from comprehensive national database in France.
Annals of Intensive Care 2021, 11, 151.
Chelly J, Plantefève G, Kamel T, Bruel C, Nseir S, Lai C, Cirillo G, Skripkina E, Ehrminger S, Berdaguer-Ferrari FD, Le Marec J, Paul M, Autret A, Deye N, ACICOVID-19 study group
Incidence, clinical characteristics, and outcome after unexpected cardiac arrest among critically ill adults with COVID-19: insight from the multicenter prospective ACICOVID-19 registry.
Annals of Intensive Care 2021, 11, 155.
Schmidt M, Guidet B, Demoule A, Ponnaiah M, Fartoukh M, Puybasset L, Combes A, Hajage D, COVID-ICU Investigators
Predicting 90-day survival of patients with COVID-19: Survival of Severely Ill COVID (SOSIC) scores.
Annals of Intensive Care 2021, 11, 170.
Massart N, Maxime V, Fillatre P, Razazi K, Ferré A, Moine P, Legay F, Voiriot G, Amara M, Santi F, Nseir S, Marque-Juillet S, Bounab R, Barbarot N, Bruneel F, Luyt CE, COVID ICU Bacteremia Study Group on behalf of the COVID-ICU Investigators
Characteristics and prognosis of bloodstream infection in patients with COVID-19 admitted in the ICU: an ancillary study of the COVID-ICU study.
Annals of Intensive Care 2021, 11, 183.
Deschanvres C, Haudebourg T, Peiffer-Smadja N, Blanckaert K, Boutoille D, Lucet JC, Birgand G
How do the general population behave with facemasks to prevent COVID-19 in the community? A multi-site observational study.
Antimicrobial Resistance and Infection Control 2021, 10, 61.
Czuppon P, Débarre F, Gonçalves A, Tenaillon O, Perelson AS, Guedj J, Blanquart F
Success of prophylactic antiviral therapy for SARS-CoV-2: Predicted critical efficacies and impact of different drug-specific mechanisms of action.
PLoS computational biology 2021, 17, e1008752.
Gonçalves A, Maisonnasse P, Donati F, Albert M, Behillil S, Contreras V, Naninck T, Marlin R, Solas C, Pizzorno A, Lemaitre J, Kahlaoui N, Terrier O, Ho Tsong Fang R, Enouf V, Dereuddre-Bosquet N, Brisebarre A, Touret F, Chapon C, Hoen B, Lina B, Rosa Calatrava M, de Lamballerie X, Mentré F, Le Grand R, van der Werf S, Guedj J
SARS-CoV-2 viral dynamics in non-human primates.
PLoS computational biology 2021, 17, e1008785.
Epelboin S, Labrosse J, De Mouzon J, Fauque P, Gervoise-Boyer MJ, Levy R, Sermondade N, Hesters L, Bergère M, Devienne C, Jonveaux P, Ghosn J, Pessione F
Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study.
PLoS medicine 2021, 18, e1003857.
d'Humières C, Patrier J, Lortat-Jacob B, Tran-Dinh A, Chemali L, Maataoui N, Rondinaud E, Ruppé E, Burdet C, Ruckly S, Montravers P, Timsit JF, Armand-Lefevre L
Two original observations concerning bacterial infections in COVID-19 patients hospitalized in intensive care units during the first wave of the epidemic in France.
PloS One 2021, 16, e0250728.
Dupuis C, de Montmollin E, Buetti N, Goldgran-Toledano D, Reignier J, Schwebel C, Domitile J, Neuville M, Ursino M, Siami S, Ruckly S, Alberti C, Mourvillier B, Bailly S, Laurent V, Gainnier M, Souweine B, Timsit JF, OutcomeReaTM research network
Impact of early corticosteroids on 60-day mortality in critically ill patients with COVID-19: A multicenter cohort study of the OUTCOMEREA network.
PloS One 2021, 16, e0255644.
Deruelle P, Couffignal C, Sibiude J, Vivanti AJ, Anselem O, Luton D, Benachi A, Mandelbrot L, Vauloup-Fellous C, Cordier AG, Picone O
Prenatal care providers' perceptions of the SARS-Cov-2 vaccine for themselves and for pregnant women.
PloS One 2021, 16, e0256080.
Delaroche L, Bertine M, Oger P, Descamps D, Damond F, Genauzeau E, Meicler P, Le Hingrat Q, Lamazou F, Gschwind R, Ruppé E, Visseaux B
Evaluation of SARS-CoV-2 in semen, seminal plasma, and spermatozoa pellet of COVID-19 patients in the acute stage of infection.
PloS One 2021, 16, e0260187.
Evrard D, Jurcisin I, Assadi M, Patrier J, Tafani V, Ullmann N, Timsit JF, Montravers P, Barry B, Weiss E, Rozencwajg S
Tracheostomy in COVID-19 acute respiratory distress syndrome patients and follow-up: A parisian bicentric retrospective cohort.
PloS One 2021, 16, e0261024.
Denis F, Fontanet A, Le Douarin YM, Le Goff F, Jeanneau S, Lescure FX
A Self-Assessment Web-Based App to Assess Trends of the COVID-19 Pandemic in France: Observational Study.
Journal of Medical Internet Research 2021, 23, e26182.
Denis F, Septans AL, Le Goff F, Jeanneau S, Lescure FX
Analysis of COVID-19 Transmission Sources in France by Self-Assessment Before and After the Partial Lockdown: Observational Study.
Journal of Medical Internet Research 2021, 23, e26932.
Geslain G, Miatello J, Barreault S, DE Melo C, Durand P, Deho A, Naudin J, Zitvogel F, Tissieres P, Dauger S, Guilbert AS, Levy M
Pediatric Intensive Care Unit mutation to adult unit during the initial COVID-19 wave: does it make sense?.
Minerva anestesiologica 2021, 87, 121-123.
Bosetti P, Kiem CT, Yazdanpanah Y, Fontanet A, Lina B, Colizza V, Cauchemez S
Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2021, 26,
Tran Kiem C, Crépey P, Bosetti P, Levy Bruhl D, Yazdanpanah Y, Salje H, Boëlle PY, Cauchemez S
Lockdown as a last resort option in case of COVID-19 epidemic rebound: a modelling study.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2021, 26,
Badr DA, Picone O, Bevilacqua E, Carlin A, Meli F, Sibiude J, Mattern J, Fils JF, Mandelbrot L, Lanzone A, De Luca D, Jani JC, Vivanti AJ
Severe Acute Respiratory Syndrome Coronavirus 2 and Pregnancy Outcomes According to Gestational Age at Time of Infection.
Emerging Infectious Diseases 2021, 27, 2535-2543.
Brousse V, Holvoet L, Pescarmona R, Viel S, Perret M, Visseaux B, Ferre VM, Ithier G, Le Van Kim C, Benkerrou M, Missud F, Koehl B
Low incidence of COVID-19 severe complications in a large cohort of children with sickle cell disease: a protective role for basal interferon-1 activation?.
Haematologica 2021
Lebourgeois S, Chenane HR, Houhou-Fidouh N, Menidjel R, Ferré VM, Collin G, Benmalek N, Coppée R, Larrouy L, Yazdanpanah Y, Timsit JF, Charpentier C, Descamps D, Visseaux B
Earlier In Vitro Viral Production With SARS-CoV-2 Alpha Than With Beta, Gamma, B, or A.27 Variants.
Frontiers in Cellular and Infection Microbiology 2021, 11, 792202.
Charbonnier L, Rouprêt-Serzec J, Caseris M, Danse M, Cointe A, Cohen L, Faye A, Ouldali N, Gaschignard J
Contribution of Serological Rapid Diagnostic Tests to the Strategy of Contact Tracing in Households Following SARS-CoV-2 Infection Diagnosis in Children.
Frontiers in Pediatrics 2021, 9, 638502.
Bonil L, Lingas G, Coupeau D, Lucet JC, Guedj J, Visseaux B, Muylkens B
Survival of SARS-CoV-2 on Non-Porous Materials in an Experimental Setting Representative of Fomites.
Coatings 2021, 11, 371.
Ursino M, Dupuis C, Buetti N, de Montmollin E, Bouadma L, Golgran-Toledano D, Ruckly S, Neuville M, Cohen Y, Mourvillier B, Souweine B, Gainnier M, Laurent V, Terzi N, Shiami S, Reignier J, Alberti C, Timsit JF, On Behalf Of The Outcomerea Study Group n
Multistate Modeling of COVID-19 Patients Using a Large Multicentric Prospective Cohort of Critically Ill Patients.
Journal of Clinical Medicine 2021, 10,
Rybak A, Yang DD, Schrimpf C, Guedj R, Levy C, Cohen R, Gajdos V, Tort J, Skurnik D, Ouldali N, Angoulvant F
Fall of Community-Acquired Pneumonia in Children following COVID-19 Non-Pharmaceutical Interventions: A Time Series Analysis.
Pathogens (Basel, Switzerland) 2021, 10, 1375.
Peiffer-Smadja N, Bridier-Nahmias A, Ferré VM, Charpentier C, Garé M, Rioux C, Allemand A, Lavallée P, Ghosn J, Kramer L, Descamps D, Yazdanpanah Y, Visseaux B
Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2.
Viruses 2021, 13, 1642.
Ghazali DA, Choquet C, Bouzid D, Colosi L, Ben Hammouda A, Wargon M, Gay M, Vaittinada Ayar P, Douay B, Revue E, Soulat L, Hellmann R, Casalino E
Analysis of the Feasibility of a Vaccination Campaign against Influenza Epidemic and COVID-19 Pandemic in French Emergency Departments: A National Survey.
Vaccines 2021, 9, 400.
Michiels Y, Houhou-Fidouh N, Collin G, Berger J, Kohli E
Impact of Low-Dose Methotrexate-Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis.
Vaccines 2021, 9, 883.
Michiels Y, Houhou-Fidouh N, Collin G, Berger J, Kohli E
Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient.
Vaccines 2021, 9, 1140.
Stilma W, Åkerman E, Artigas A, Bentley A, Bos LD, Bosman TJC, de Bruin H, Brummaier T, Buiteman-Kruizinga LA, Carcò F, Chesney G, Chu C, Dark P, Dondorp AM, Gijsbers HJH, Gilder ME, Grieco DL, Inglis R, Laffey JG, Landoni G, Lu W, Maduro LMN, McGready R, McNicholas B, de Mendoza D, Morales-Quinteros L, Nosten F, Papali A, Paternoster G, Paulus F, Pisani L, Prud'homme E, Ricard JD, Roca O, Sartini C, Scaravilli V, Schultz MJ, Sivakorn C, Spronk PE, Sztajnbok J, Trigui Y, Vollman KM, van der Woude MCE
Awake Proning as an Adjunctive Therapy for Refractory Hypoxemia in Non-Intubated Patients with COVID-19 Acute Respiratory Failure: Guidance from an International Group of Healthcare Workers.
The American Journal of Tropical Medicine and Hygiene 2021
COVID-19 Research Prioritization Group on MNCAH
Global research priorities on COVID-19 for maternal, newborn, child and adolescent health.
Journal of Global Health 2021, 11, 04071.
Marc A, Kerioui M, Blanquart F, Bertrand J, Mitjà O, Corbacho-Monné M, Marks M, Guedj J
Quantifying the relationship between SARS-CoV-2 viral load and infectiousness.
eLife 2021, 10, e69302.
ISARIC Clinical Characterisation Group, Hall MD, Baruch J, Carson G, Citarella BW, Dagens A, Dankwa EA, Donnelly CA, Dunning J, Escher M, Kartsonaki C, Merson L, Pritchard M, Wei J, Horby PW, Rojek A, Olliaro PL
Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort.
eLife 2021, 10, e70970.
Mercier JC, Ouldali N, Basmaci R
[Multisystemic inflammatory syndrome in children (MIS-C) associated with Covid].
La Revue Du Praticien 2021, 71, 1009-1015.
Driouich JS, Cochin M, Lingas G, Moureau G, Touret F, Petit PR, Piorkowski G, Barthélémy K, Laprie C, Coutard B
Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model.
Nature communications 2021, 12, 1–13.
Onaisi R, Duvignaud A, Nguyen A, Dupouy J, Chastang J, le Bel J, Landman R, Naccache JM, Lefevre B, Piroth L, Binquet C, Makinson A, Darnaud T, Begue C, Weiss L, Richert L, Anglaret X, Malvy D, Joseph JP, Druais PL, Darmon D, Ral C, Lhomme E, Saint-Lary O
Randomized trial to evaluate the safety and efficacy of outpatient treatments in individuals with Covid-19 with risk factors. COVERAGE France Trial: a structured summary.
Exercer-La Revue Francophone De Medecine Generale 2021, 451-458.
2020
Dequin PF, Heming N, Meziani F, Plantefève G, Voiriot G, Badié J, François B, Aubron C, Ricard JD, Ehrmann S, Jouan Y, Guillon A, Leclerc M, Coffre C, Bourgoin H, Lengellé C, Caille-Fénérol C, Tavernier E, Zohar S, Giraudeau B, Annane D, Le Gouge A, CAPE COVID Trial Group and the CRICS-TriGGERSep Network
Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
JAMA 2020, 324, 1298-1306.
Birgand G, Peiffer-Smadja N, Fournier S, Kerneis S, Lescure FX, Lucet JC
Assessment of Air Contamination by SARS-CoV-2 in Hospital Settings.
JAMA network open 2020, 3, e2033232.
Moszkowicz D, Duboc H, Dubertret C, Roux D, Bretagnol F
Daily medical education for confined students during coronavirus disease 2019 pandemic: A simple videoconference solution.
Clinical Anatomy (New York, N.Y.) 2020, 33, 927-928.
Eloy P, Solas C, Touret F, Mentré F, Malvy D, de Lamballerie X, Guedj J
Dose rationale for favipiravir use in patients infected with SARS-CoV-2.
Clinical Pharmacology and Therapeutics 2020
Gonçalves A, Bertrand J, Ke R, Comets E, de Lamballerie X, Malvy D, Pizzorno A, Terrier O, Rosa Calatrava M, Mentré F, Smith P, Perelson AS, Guedj J
Timing of Antiviral Treatment Initiation is Critical to Reduce SARS-CoV-2 Viral Load.
CPT: pharmacometrics & systems pharmacology 2020, 9, 509-514.
Zucman N, Mullaert J, Roux D, Roca O, Ricard JD, Contributors
Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure.
Intensive Care Medicine 2020, 46, 1924-1926.
Bassetti M, Kollef MH, Timsit JF
Bacterial and fungal superinfections in critically ill patients with COVID-19.
Intensive Care Medicine 2020, 46, 2071-2074.
Farfour E, Visseaux B, Pascreau T, Jolly E, Houhou N, Mazaux L, Asso-Bonnet M, Vasse M
The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis?.
European Journal of Clinical Microbiology & Infectious Diseases 2020, 39, 1997-2000.
Bouadma L, Wiedemann A, Patrier J, Surénaud M, Wicky PH, Foucat E, Diehl JL, Hejblum BP, Sinnah F, de Montmollin E, Lacabaratz C, Thiébaut R, Timsit JF, Lévy Y
Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome.
Journal of Clinical Immunology 2020, 40, 1082-1092.
Gouel-Cheron A, Couffignal C, Elmaleh Y, Kantor E, Montravers P
Preliminary observations of anaesthesia ventilators use for prolonged mechanical ventilation in intensive care unit patients during the COVID-19 pandemic.
Anaesthesia, Critical Care & Pain Medicine 2020, 39, 371-372.
Rello J, Belliato M, Dimopoulos MA, Giamarellos-Bourboulis EJ, Jaksic V, Martin-Loeches I, Mporas I, Pelosi P, Poulakou G, Pournaras S, Tamae-Kakazu M, Timsit JF, Waterer G, Tejada S, Dimopoulos G
Update in COVID-19 in the intensive care unit from the 2020 HELLENIC Athens International symposium.
Anaesthesia, Critical Care & Pain Medicine 2020, 39, 723-730.
Louchet M, Sibiude J, Peytavin G, Picone O, Tréluyer JM, Mandelbrot L
Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019.
American journal of obstetrics & gynecology MFM 2020, 2, 100159.
Sallard E, Lescure FX, Yazdanpanah Y, Mentre F, Peiffer-Smadja N
Type 1 interferons as a potential treatment against COVID-19.
Antiviral Research 2020, 178, 104791.
Venisse N, Peytavin G, Bouchet S, Gagnieu MC, Garraffo R, Guilhaumou R, Solas C
Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection.
Antiviral Research 2020, 181, 104866.
Peiffer-Smadja N, Lucet JC, Bendjelloul G, Bouadma L, Gerard S, Choquet C, Jacques S, Khalil A, Maisani P, Casalino E, Descamps D, Timsit JF, Yazdanpanah Y, Lescure FX
Challenges and issues about organising a hospital to respond to the COVID-19 outbreak: experience from a French reference centre.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020
Fragkou PC, Belhadi D, Peiffer-Smadja N, Moschopoulos CD, Lescure FX, Janocha H, Karofylakis E, Yazdanpanah Y, Mentré F, Skevaki C, Laouénan C, Tsiodras S, ESCMID Study Group for Respiratory Viruses
Review of trials currently testing treatment and prevention of COVID-19.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, 26, 988-998.
Hingrat QL, Visseaux B, Laouenan C, Tubiana S, Bouadma L, Yazdanpanah Y, Duval X, Burdet C, Ichou H, Damond F, Bertine M, Benmalek N, Choquet C, Timsit JF, Ghosn J, Charpentier C, Descamps D, Houhou-Fidouh N, French COVID cohort management committee, CoV-CONTACT study group, members of the French-COVID cohort study group (by alphabetical order), member of the CoV-CONTACT study group. Principal investigator, Steering Committee, CoV-CONTACT Clinical Centers, Coordination and statistical analyses, Virological Lab, Biological Center, Partners, Sponsor, Genetic
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, S1198-743X(20)30721-7.
Peyronnet V, Sibiude J, Deruelle P, Huissoud C, Lescure X, Lucet JC, Mandelbrot L, Nisand I, Vayssière C, Yazpandanah Y, Luton D, Picone O
[SARS-CoV-2 infection during pregnancy. Information and proposal of management care. CNGOF].
Gynecologie, Obstetrique, Fertilite & Senologie 2020, 48, 436-443.
Peyronnet V, Sibiude J, Huissoud C, Lescure FX, Lucet JC, Mandelbrot L, Nisand I, Belaish-Allart J, Vayssière C, Yazpandanah Y, Luton D, Picone O
[Infection with SARS-CoV-2 in pregnancy. Update of Information and proposed care. CNGOF].
Gynecologie, Obstetrique, Fertilite & Senologie 2020, 48, 858-870.
Ouersighni A, Ghazali DA
Contribution of certified registered nurse anaesthetists to the management of the COVID-19 pandemic health crisis.
Intensive & Critical Care Nursing 2020, 60, 102888.
Deslandes A, Berti V, Tandjaoui-Lambotte Y, Alloui C, Carbonnelle E, Zahar JR, Brichler S, Cohen Y
SARS-CoV-2 was already spreading in France in late December 2019.
International Journal of Antimicrobial Agents 2020, 55, 106006.
Peyrony O, Ellouze S, Fontaine JP, Thegat-Le Cam M, Salmona M, Feghoul L, Mahjoub N, Mercier-Delarue S, Gabassi A, Delaugerre C, Le Goff J, Saint-Louis CORE (COvid REsearch) group
Surfaces and equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the emergency department at a university hospital.
International Journal of Hygiene and Environmental Health 2020, 230, 113600.
Dubert M, Visseaux B, Isernia V, Bouadma L, Deconinck L, Patrier J, Wicky PH, Le Pluart D, Kramer L, Rioux C, Le Hingrat Q, Houhou-Fidouh N, Yazdanpanah Y, Ghosn J, Lescure FX
Case report study of the first five COVID-19 patients treated with remdesivir in France.
International Journal of Infectious Diseases 2020, 98, 290-293.
Isernia V, Julia Z, Le Gac S, Bachelard A, Landman R, Lariven S, Joly V, Deconinck L, Rioux C, Lescure X, Yazdanpanah Y, Ghosn J
SARS-COV2 infection in 30 HIV-infected patients followed-up in a French University Hospital.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2020, 101, 49-51.
Battesti G, El Khalifa J, Abdelhedi N, Ferre V, Bouscarat F, Picard-Dahan C, Brunet-Possenti F, Collin G, Lavaud J, Le Bozec P, Rousselot M, Tournier A, Lheure C, Couvelard A, Hacein-Bey-Abina S, Abina AM, Charpentier C, Mignot S, Nicaise P, Descamps D, Deschamps L, Descamps V
New insights in COVID-19–associated chilblains: A comparative study with chilblain lupus erythematosus.
Journal of the American Academy of Dermatology 2020, 83, 1219-1222.
Le Breton C, Besset S, Freita-Ramos S, Amouretti M, Billiet PA, Dao M, Dumont LM, Federici L, Gaborieau B, Longrois D, Postel-Vinay P, Vuillard C, Zucman N, Lebreton G, Combes A, Dreyfuss D, Ricard JD, Roux D
Extracorporeal membrane oxygenation for refractory COVID-19 acute respiratory distress syndrome.
Journal of Critical Care 2020, 60, 10-12.
Egloff C, Vauloup-Fellous C, Picone O, Mandelbrot L, Roques P
Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-2.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2020, 128, 104447.
Visseaux B, Le Hingrat Q, Collin G, Ferré V, Storto A, Ichou H, Bouzid D, Poey N, de Montmollin E, Descamps D, Houhou-Fidouh N
Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection.
Journal of Clinical Virology 2020, 129, 104520.
Wirden M, Feghoul L, Bertine M, Nere ML, Le Hingrat Q, Abdi B, Boutolleau D, Ferre VM, Jary A, Delaugerre C, Marcelin AG, Descamps D, Legoff J, Visseaux B, Chaix ML
Multicenter comparison of the Cobas 6800 system with the RealStar RT-PCR kit for the detection of SARS-CoV-2.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2020, 130, 104573.
Charpentier C, Ichou H, Damond F, Bouvet E, Chaix ML, Ferré V, Delaugerre C, Mahjoub N, Larrouy L, Le Hingrat Q, Visseaux B, Mackiewicz V, Descamps D, Fidouh-Houhou N
Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott).
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2020, 132, 104618.
Nguyen Y, Corre F, Honsel V, Curac S, Zarrouk V, Fantin B, Galy A
Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19.
The Journal of Infection 2020, 81, e96-e98.
Gousseff M, Penot P, Gallay L, Batisse D, Benech N, Bouiller K, Collarino R, Conrad A, Slama D, Joseph C, Lemaignen A, Lescure FX, Levy B, Mahevas M, Pozzetto B, Vignier N, Wyplosz B, Salmon D, Goehringer F, Botelho-Nevers E, in behalf of the COCOREC study group
Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?.
The Journal of Infection 2020, 81, 816-846.
Cancella de Abreu M, Choquet C, Petit H, Bouzid D, Damond F, Marot S, Ferre VM, Burrel S, Boutolleau D, Houdou-Fidouh N, Marcelin AG, Descamps D, Hausfater P
SARS-CoV-2 IGM and IGG rapid serologic test for the diagnosis of COVID-19 in the emergency department.
The Journal of Infection 2020, 81, 816-846.
Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, Doucet L, Berkani S, Oliosi E, Mallart E, Corre F, Zarrouk V, Moyer JD, Galy A, Honsel V, Fantin B, Nguyen Y
Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19.
The Journal of Infection 2020, 81, e4-e6.
Vivanti AJ, Deruelle P, Picone O, Guillaume S, Roze JC, Mulin B, Kochert F, De Beco I, Mahut S, Gantois A, Barasinski C, Petitprez K, Pauchet-Traversat AF, Droy A, Benachi A
Follow-up for pregnant women during the COVID-19 pandemic: French national authority for health recommendations.
Journal of Gynecology Obstetrics and Human Reproduction 2020, 49, 101804.
Vivanti AJ, Deruelle P, Picone O, Guillaume S, Roze JC, Mulin B, Kochert F, De Beco I, Mahut S, Gantois A, Barasinski C, Petitprez K, Pauchet-Traversat AF, Droy A, Benachi A
Post-natal follow-up for women and neonates during the COVID-19 pandemic: French National Authority for Health recommendations.
Journal of Gynecology Obstetrics and Human Reproduction 2020, 49, 101805.
Kayem G, Lecarpentier E, Deruelle P, Bretelle F, Azria E, Blanc J, Bohec C, Bornes M, Ceccaldi PF, Chalet Y, Chauleur C, Cordier AG, Desbrière R, Doret M, Dreyfus M, Driessen M, Fermaut M, Gallot D, Garabédian C, Huissoud C, Luton D, Morel O, Perrotin F, Picone O, Rozenberg P, Sentilhes L, Sroussi J, Vayssière C, Verspyck E, Vivanti AJ, Winer N, Alessandrini V, Schmitz T
A snapshot of the Covid-19 pandemic among pregnant women in France.
Journal of Gynecology Obstetrics and Human Reproduction 2020, 49, 101826.
Athiel Y, Civadier MS, Luton D, Ceccaldi PF, Bourret A, Sroussi J, Mandelbrot L, Ville Y, Nizard J, Sibony O, Darai E, Delorme P, Fernandez H, Le Begat G, Nublat M, Benachi A, Deffieux X
Impact of the outbreak of SARS-CoV-2 infection on urgent gynecological care.
Journal of Gynecology Obstetrics and Human Reproduction 2020, 49, 101841.
Amarsy R, Pean de Ponfilly GR, Benmansour HA, Jacquier H, Cambau EE, Mégarbane B
Serratia marcescens outbreak in the intensive care unit during the COVID-19 pandemic: A paradoxical risk?.
Medecine Et Maladies Infectieuses 2020, 50, 750-751.
Wuyts W, Marin J, Brusselaers J, Vrancken K
Circular economy as a COVID-19 cure?.
Resources, conservation, and recycling 2020, 162, 105016.
Pizzorno A, Padey B, Julien T, Trouillet-Assant S, Traversier A, Errazuriz-Cerda E, Fouret J, Dubois J, Gaymard A, Lescure FX, Dulière V, Brun P, Constant S, Poissy J, Lina B, Yazdanpanah Y, Terrier O, Rosa-Calatrava M
Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia.
Cell Reports Medicine 2020, 1, 100059.
Gilbert M, Pullano G, Pinotti F, Valdano E, Poletto C, Boëlle PY, D'Ortenzio E, Yazdanpanah Y, Eholie SP, Altmann M, Gutierrez B, Kraemer MUG, Colizza V
Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study.
The Lancet 2020, 395, 871-877.
Norton A, Mphahlele J, Yazdanpanah Y, Piot P, Bayona MT
Strengthening the global effort on COVID-19 research.
The Lancet 2020, S0140673620315981.
Lescure FX, Bouadma L, Nguyen D, Parisey M, Wicky PH, Behillil S, Gaymard A, Bouscambert-Duchamp M, Donati F, Le Hingrat Q, Enouf V, Houhou-Fidouh N, Valette M, Mailles A, Lucet JC, Mentre F, Duval X, Descamps D, Malvy D, Timsit JF, Lina B, van-der-Werf S, Yazdanpanah Y
Clinical and virological data of the first cases of COVID-19 in Europe: a case series.
The Lancet. Infectious Diseases 2020, 20, 697-706.
ISARIC clinical characterisation group
Global outbreak research: harmony not hegemony.
The Lancet. Infectious Diseases 2020, 20, 770-772.
Bielicki JA, Duval X, Gobat N, Goossens H, Koopmans M, Tacconelli E, van der Werf S
Monitoring approaches for health-care workers during the COVID-19 pandemic.
The Lancet. Infectious Diseases 2020, 20, e261-e267.
Brendish NJ, Poole S, Naidu VV, Mansbridge CT, Norton NJ, Wheeler H, Presland L, Kidd S, Cortes NJ, Borca F, Phan H, Babbage G, Visseaux B, Ewings S, Clark TW
Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study.
The Lancet. Respiratory Medicine 2020, 8, 1192-1200.
Ouldali N, Pouletty M, Mariani P, Beyler C, Blachier A, Bonacorsi S, Danis K, Chomton M, Maurice L, Le Bourgeois F, Caseris M, Gaschignard J, Poline J, Cohen R, Titomanlio L, Faye A, Melki I, Meinzer U
Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis.
The Lancet. Child & Adolescent Health 2020, 4, 662-668.
Atlani-Duault L, Lina B, Malvy D, Yazdanpanah Y, Chauvin F, Delfraissy JF
COVID-19: France grapples with the pragmatics of isolation.
The Lancet. Public Health 2020, 5, e573-e574.
Ghazali DA, Ouersighni A, Gay M, Audebault V, Pavlovsky T, Casalino E
Feedback to Prepare EMS Teams to Manage Infected Patients with COVID-19: A Case Series.
Prehospital and Disaster Medicine 2020, 35, 451-453.
Maisonnasse P, Guedj J, Contreras V, Behillil S, Solas C, Marlin R, Naninck T, Pizzorno A, Lemaitre J, Gonçalves A, Kahlaoui N, Terrier O, Fang RHT, Enouf V, Dereuddre-Bosquet N, Brisebarre A, Touret F, Chapon C, Hoen B, Lina B, Calatrava MR, van der Werf S, de Lamballerie X, Le Grand R
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.
Nature 2020, 585, 584-587.
Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, Feldt T, Green G, Green ML, Lescure FX, Nicastri E, Oda R, Yo K, Quiros-Roldan E, Studemeister A, Redinski J, Ahmed S, Bernett J, Chelliah D, Chen D, Chihara S, Cohen SH, Cunningham J, D'Arminio Monforte A, Ismail S, Kato H, Lapadula G, L'Her E, Maeno T, Majumder S, Massari M, Mora-Rillo M, Mutoh Y, Nguyen D, Verweij E, Zoufaly A, Osinusi AO, DeZure A, Zhao Y, Zhong L, Chokkalingam A, Elboudwarej E, Telep L, Timbs L, Henne I, Sellers S, Cao H, Tan SK, Winterbourne L, Desai P, Mera R, Gaggar A, Myers RP, Brainard DM, Childs R, Flanigan T
Compassionate Use of Remdesivir for Patients with Severe Covid-19.
The New England Journal of Medicine 2020
Nguyen Y, Corre F, Honsel V, Curac S, Zarrouk V, Burtz CP, Weiss E, Moyer JD, Gauss T, Grégory J, Bert F, Trichet C, Peoc'h K, Vilgrain V, Rebours V, Fantin B, Galy A
A nomogram to predict the risk of unfavourable outcome in COVID-19: a retrospective cohort of 279 hospitalized patients in Paris area.
Annals of Medicine 2020, 52, 367-375.
Teles Abrao Trad A, Ibirogba ER, Elrefaei A, Narang K, Tonni G, Picone O, Suy A, Carreras Moratonas E, Kilby MD, Ruano R
Complications and outcomes of SARS-CoV-2 in pregnancy: where and what is the evidence?.
Hypertension in Pregnancy 2020, 39, 361-369.
Lê MP, Peiffer-Smadja N, Guedj J, Néant N, Mentré F, Ader F, Yazdanpanah Y, Peytavin G
Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.
The Journal of Antimicrobial Chemotherapy 2020, 75, 2376-2380.
Kauv J, Lê MP, Veyrier M, Le Hingrat Q, Visseaux B, Massias L, Chauveheid MP, Descamps D, Ghosn J, Peytavin G
Failure of hydroxychloroquine pre-exposure prophylaxis in COVID-19 infection? A case report.
The Journal of Antimicrobial Chemotherapy 2020, 75, 2706-2707.
Peiffer-Smadja N, Lescure FX, Sallard E, Ravaud P, Vegreville B, Zeitoun JD
Anticovid, a comprehensive open-access real-time platform of registered clinical studies for COVID-19.
Journal of Antimicrobial Chemotherapy 2020, 75, 2708-2710.
Lê MP, Jaquet P, Patrier J, Wicky PH, Le Hingrat Q, Veyrier M, Kauv J, Sonneville R, Visseaux B, Laouénan C, Bouadma L, Descamps D, de Montmollin E, Peytavin G, Timsit JF
Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients.
The Journal of Antimicrobial Chemotherapy 2020, 75, 2657-2660.
Levy C, Basmaci R, Bensaid P, Bru CB, Coinde E, Dessioux E, Fournial C, Gashignard J, Haas H, Hentgen V, Huet F, Lalande M, Martinot A, Pons C, Romain AS, Ursulescu N, Le Sage FV, Raymond J, Béchet S, Toubiana J, Cohen R
Changes in Reverse Transcription Polymerase Chain Reaction-positive Severe Acute Respiratory Syndrome Coronavirus 2 Rates in Adults and Children According to the Epidemic Stages.
The Pediatric Infectious Disease Journal 2020, 39, e369-e372.
Tiberghien P, de Lamballerie X, Morel P, Gallian P, Lacombe K, Yazdanpanah Y
Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?.
Vox Sanguinis 2020, 115, 488-494.
Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, Péré H, Charbit B, Bondet V, Chenevier-Gobeaux C, Breillat P, Carlier N, Gauzit R, Morbieu C, Pène F, Marin N, Roche N, Szwebel TA, Merkling SH, Treluyer JM, Veyer D, Mouthon L, Blanc C, Tharaux PL, Rozenberg F, Fischer A, Duffy D, Rieux-Laucat F, Kernéis S, Terrier B
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.
Science (New York, N.Y.) 2020, 369, 718-724.
Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, Ogishi M, Sabli IKD, Hodeib S, Korol C, Rosain J, Bilguvar K, Ye J, Bolze A, Bigio B, Yang R, Arias AA, Zhou Q, Zhang Y, Onodi F, Korniotis S, Karpf L, Philippot Q, Chbihi M, Bonnet-Madin L, Dorgham K, Smith N, Schneider WM, Razooky BS, Hoffmann HH, Michailidis E, Moens L, Han JE, Lorenzo L, Bizien L, Meade P, Neehus AL, Ugurbil AC, Corneau A, Kerner G, Zhang P, Rapaport F, Seeleuthner Y, Manry J, Masson C, Schmitt Y, Schlüter A, Le Voyer T, Khan T, Li J, Fellay J, Roussel L, Shahrooei M, Alosaimi MF, Mansouri D, Al-Saud H, Al-Mulla F, Almourfi F, Al-Muhsen SZ, Alsohime F, Al Turki S, Hasanato R, van de Beek D, Biondi A, Bettini LR, D'Angio' M, Bonfanti P, Imberti L, Sottini A, Paghera S, Quiros-Roldan E, Rossi C, Oler AJ, Tompkins MF, Alba C, Vandernoot I, Goffard JC, Smits G, Migeotte I, Haerynck F, Soler-Palacin P, Martin-Nalda A, Colobran R, Morange PE, Keles S, Çölkesen F, Ozcelik T, Yasar KK, Senoglu S, Karabela ŞN, Rodríguez-Gallego C, Novelli G, Hraiech S, Tandjaoui-Lambiotte Y, Duval X, Laouénan C, COVID-STORM Clinicians, COVID Clinicians, Imagine COVID Group, French COVID Cohort Study Group, CoV-Contact Cohort, Amsterdam UMC Covid-19 Biobank, COVID Human Genetic Effort, NIAID-USUHS/TAGC COVID Immunity Group, Snow AL, Dalgard CL, Milner JD, Vinh DC, Mogensen TH, Marr N, Spaan AN, Boisson B, Boisson-Dupuis S, Bustamante J, Puel A, Ciancanelli MJ, Meyts I, Maniatis T, Soumelis V, Amara A, Nussenzweig M, García-Sastre A, Krammer F, Pujol A, Duffy D, Lifton RP, Zhang SY, Gorochov G, Béziat V, Jouanguy E, Sancho-Shimizu V, Rice CM, Abel L, Notarangelo LD, Cobat A, Su HC, Casanova JL
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
Science (New York, N.Y.) 2020, 370,
Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, Dorgham K, Philippot Q, Rosain J, Béziat V, Manry J, Shaw E, Haljasmägi L, Peterson P, Lorenzo L, Bizien L, Trouillet-Assant S, Dobbs K, de Jesus AA, Belot A, Kallaste A, Catherinot E, Tandjaoui-Lambiotte Y, Le Pen J, Kerner G, Bigio B, Seeleuthner Y, Yang R, Bolze A, Spaan AN, Delmonte OM, Abers MS, Aiuti A, Casari G, Lampasona V, Piemonti L, Ciceri F, Bilguvar K, Lifton RP, Vasse M, Smadja DM, Migaud M, Hadjadj J, Terrier B, Duffy D, Quintana-Murci L, van de Beek D, Roussel L, Vinh DC, Tangye SG, Haerynck F, Dalmau D, Martinez-Picado J, Brodin P, Nussenzweig MC, Boisson-Dupuis S, Rodríguez-Gallego C, Vogt G, Mogensen TH, Oler AJ, Gu J, Burbelo PD, Cohen JI, Biondi A, Bettini LR, D'Angio M, Bonfanti P, Rossignol P, Mayaux J, Rieux-Laucat F, Husebye ES, Fusco F, Ursini MV, Imberti L, Sottini A, Paghera S, Quiros-Roldan E, Rossi C, Castagnoli R, Montagna D, Licari A, Marseglia GL, Duval X, Ghosn J, HGID Lab, NIAID-USUHS Immune Response to COVID Group, COVID Clinicians, COVID-STORM Clinicians, Imagine COVID Group, French COVID Cohort Study Group, Milieu Intérieur Consortium, CoV-Contact Cohort, Amsterdam UMC Covid-19 Biobank, COVID Human Genetic Effort, Tsang JS, Goldbach-Mansky R, Kisand K, Lionakis MS, Puel A, Zhang SY, Holland SM, Gorochov G, Jouanguy E, Rice CM, Cobat A, Notarangelo LD, Abel L, Su HC, Casanova JL
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.
Science (New York, N.Y.) 2020, 370, eabd4585.
Grzelak L, Temmam S, Planchais C, Demeret C, Tondeur L, Huon C, Guivel-Benhassine F, Staropoli I, Chazal M, Dufloo J, Planas D, Buchrieser J, Rajah MM, Robinot R, Porrot F, Albert M, Chen KY, Crescenzo-Chaigne B, Donati F, Anna F, Souque P, Gransagne M, Bellalou J, Nowakowski M, Backovic M, Bouadma L, Le Fevre L, Le Hingrat Q, Descamps D, Pourbaix A, Laouénan C, Ghosn J, Yazdanpanah Y, Besombes C, Jolly N, Pellerin-Fernandes S, Cheny O, Ungeheuer MN, Mellon G, Morel P, Rolland S, Rey FA, Behillil S, Enouf V, Lemaitre A, Créach MA, Petres S, Escriou N, Charneau P, Fontanet A, Hoen B, Bruel T, Eloit M, Mouquet H, Schwartz O, van der Werf S
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.
Science Translational Medicine 2020, 12,
Lê MP, Le Hingrat Q, Jaquet P, Wicky PH, Bunel V, Massias L, Visseaux B, Messika J, Descamps D, Mal H, Timsit JF, Peytavin G
Removal of Remdesivir's Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19.
Antimicrobial Agents and Chemotherapy 2020, 64,
Lê MP, Le Beller C, Le Hingrat Q, Jaquet P, Wicky PH, Bunel V, Massias L, Visseaux B, Messika J, Descamps D, Mal H, Timsit JF, Peytavin G
Reply to Yan and Muller, "Captisol and GS-704277, but Not GS-441524, Are Credible Mediators of Remdesivir's Nephrotoxicity".
Antimicrobial Agents and Chemotherapy 2020, 64,
Visseaux B, Le Hingrat Q, Collin G, Bouzid D, Lebourgeois S, Le Pluart D, Deconinck L, Lescure FX, Lucet JC, Bouadma L, Timsit JF, Descamps D, Yazdanpanah Y, Casalino E, Houhou-Fidouh N, McAdam AJ
Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the First Rapid Multiplex PCR Commercial Assay for SARS-CoV-2 Detection.
Journal of Clinical Microbiology 2020, 58, e00630-20, /jcm/58/8/JCM.00630-20.atom.
Pouletty M, Borocco C, Ouldali N, Caseris M, Basmaci R, Lachaume N, Bensaid P, Pichard S, Kouider H, Morelle G, Craiu I, Pondarre C, Deho A, Maroni A, Oualha M, Amoura Z, Haroche J, Chommeloux J, Bajolle F, Beyler C, Bonacorsi S, Carcelain G, Koné-Paut I, Bader-Meunier B, Faye A, Meinzer U, Galeotti C, Melki I
Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort.
Annals of the Rheumatic Diseases 2020, 79, 999-1006.
Ouldali N, Pouletty M, Lokmer J, Benzouid C, Beyler C, Deho A, Meinzer U, Faye A, Melki I, Great Paris Region (GPR) Kawa-COVID-19 consortium
Response to: 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Pouletty et al' by Pino et al.
Annals of the Rheumatic Diseases 2020, annrheumdis-2020-218614.
Pouletty M, Dingulu G, Ouldali N, Corseri O, Ducrocq C, Meinzer U, Faye A, Galeotti C, Melki I, GPR(KC1c
Response to: 'Exaggerated neutrophil extracellular trap formation in Kawasaki disease: a key phenomenon behind the outbreak in western countries?' by Yamashita et al.
Annals of the Rheumatic Diseases 2020
Federici L, Picone O, Dreyfuss D, Sibiude J
Successful continuation of pregnancy in a patient with COVID-19-related ARDS.
BMJ case reports 2020, 13,
Mahévas M, Tran VT, Roumier M, Chabrol A, Paule R, Guillaud C, Fois E, Lepeule R, Szwebel TA, Lescure FX, Schlemmer F, Matignon M, Khellaf M, Crickx E, Terrier B, Morbieu C, Legendre P, Dang J, Schoindre Y, Pawlotsky JM, Michel M, Perrodeau E, Carlier N, Roche N, de Lastours V, Ourghanlian C, Kerneis S, Ménager P, Mouthon L, Audureau E, Ravaud P, Godeau B, Gallien S, Costedoat-Chalumeau N
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data.
BMJ 2020, m1844.
Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, Debray A, Basmaci R, Salvador E, Biscardi S, Frange P, Chalumeau M, Casanova JL, Cohen JF, Allali S
Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study.
BMJ (Clinical research ed.) 2020, 369, m2094.
Ader F, Discovery French Trial Management Team
Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults.
BMJ open 2020, 10, e041437.
Dodd LE, Follmann D, Wang J, Koenig F, Korn LL, Schoergenhofer C, Proschan M, Hunsberger S, Bonnett T, Makowski M, Belhadi D, Wang Y, Cao B, Mentre F, Jaki T
Endpoints for randomized controlled clinical trials for COVID-19 treatments.
Clinical Trials (London, England) 2020, 17, 472-482.
Ong CWM, Migliori GB, Raviglione M, MacGregor-Skinner G, Sotgiu G, Alffenaar JW, Tiberi S, Adlhoch C, Alonzi T, Archuleta S, Brusin S, Cambau E, Capobianchi MR, Castilletti C, Centis R, Cirillo DM, D'Ambrosio L, Delogu G, Esposito SMR, Figueroa J, Friedland JS, Ho BCH, Ippolito G, Jankovic M, Kim HY, Rosales Klintz S, Ködmön C, Lalle E, Leo YS, Leung CC, Märtson AG, Melazzini MG, Najafi Fard S, Penttinen P, Petrone L, Petruccioli E, Pontali E, Saderi L, Santin M, Spanevello A, van Crevel R, van der Werf MJ, Visca D, Viveiros M, Zellweger JP, Zumla A, Goletti D
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).
The European Respiratory Journal 2020, 56,
Lomont A, Boubaya M, Khamis W, Deslandes A, Cordel H, Seytre D, Alloui C, Malaure C, Bonnet N, Carbonnelle E, Cohen Y, Nunes H, Bouchaud O, Zahar JR, Tandjaoui-Lambiotte Y
Environmental contamination related to SARS-CoV-2 in ICU patients.
ERJ open research 2020
Peiffer-Smadja N, Bouadma L, Mathy V, Allouche K, Patrier J, Reboul M, Montravers P, Timsit JF, Armand-Lefevre L
Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia.
Critical Care (London, England) 2020, 24, 366.
Monard C, Pehlivan J, Auger G, Alviset S, Tran Dinh A, Duquaire P, Gastli N, d'Humières C, Maamar A, Boibieux A, Baldeyrou M, Loubinoux J, Dauwalder O, Cattoir V, Armand-Lefèvre L, Kernéis S, ADAPT study group
Multicenter evaluation of a syndromic rapid multiplex PCR test for early adaptation of antimicrobial therapy in adult patients with pneumonia.
Critical Care (London, England) 2020, 24, 434.
Buetti N, Wicky PH, Le Hingrat Q, Ruckly S, Mazzuchelli T, Loiodice A, Trimboli P, Forni Ogna V, de Montmollin E, Bernasconi E, Visseaux B, Timsit JF
SARS-CoV-2 detection in the lower respiratory tract of invasively ventilated ARDS patients.
Critical Care (London, England) 2020, 24, 610.
Duvignaud A, Lhomme E, Pistone T, Onaisi R, Sitta R, Journot V, Nguyen D, Peiffer-Smadja N, Crémer A, Bouchet S, Darnaud T, Poitrenaud D, Piroth L, Binquet C, Michel JF, Lefèvre B, Lebeaux D, Lebel J, Dupouy J, Roussillon C, Gimbert A, Wittkop L, Thiébaut R, Orne-Gliemann J, Joseph JP, Richert L, Anglaret X, Malvy D, COVERAGE study group
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
Trials 2020, 21, 846.
Bouzid D, Mullaert J, Le Hingrat Q, Laurent O, Duval X, Lescure X, Timsit JF, Descamps D, Montravers P, Choquet C, Lucet JC, Casalino E, Visseaux B, ED influenza study group
Characteristics associated with COVID-19 or other respiratory viruses' infections at a single-center emergency department.
PloS One 2020, 15, e0243261.
Borie R, Savale L, Dossier A, Ghosn J, Taillé C, Visseaux B, Jebreen K, Diallo A, Tesmoingt C, Morer L, Goletto T, Faucher N, Hajouji L, Neukirch C, Phillips M, Stelianides S, Bouadma L, Brosseau S, Ottaviani S, Pluvy J, Le Pluart D, Debray MP, Raynaud-Simon A, Descamps D, Khalil A, Timsit JF, Lescure FX, Descamps V, Papo T, Humbert M, Crestani B, Dieude P, Vicaut E, Zalcman G, Bichat & Kremlin-Bicêtre AP-HP COVID teams
Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study.
PloS One 2020, 15, e0243961.
Egloff C, Picone O, Vauloup-Fellous C, Roques P
Mother to Child SARS-CoV-2 Transmission: Fact or Fantasy.
Virologie (Montrouge, France) 2020, 24, 142-146.
Denis F, Galmiche S, Dinh A, Fontanet A, Scherpereel A, Benezit F, Lescure FX
Epidemiological Observations on the Association Between Anosmia and COVID-19 Infection: Analysis of Data From a Self-Assessment Web Application.
Journal of Medical Internet Research 2020, 22, e19855.
Yordanov Y, Dechartres A, Lescure X, Apra C, Villie P, Marchand-Arvier J, Debuc E, Dinh A, Jourdain P, AP-HP / Universities / Inserm COVID-19 Research Collaboration
Covidom, a Telesurveillance Solution for Home Monitoring Patients With COVID-19.
Journal of Medical Internet Research 2020, 22, e20748.
Galmiche S, Rahbe E, Fontanet A, Dinh A, Bénézit F, Lescure FX, Denis F
Implementation of a Self-Triage Web Application for Suspected COVID-19 and Its Impact on Emergency Call Centers: Observational Study.
Journal of Medical Internet Research 2020, 22, e22924.
Bernard Stoecklin S, Rolland P, Silue Y, Mailles A, Campese C, Simondon A, Mechain M, Meurice L, Nguyen M, Bassi C, Yamani E, Behillil S, Ismael S, Nguyen D, Malvy D, Lescure FX, Georges S, Lazarus C, Tabaï A, Stempfelet M, Enouf V, Coignard B, Levy-Bruhl D, Investigation team
First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020.
Eurosurveillance 2020, 25,
Okba NMA, Müller MA, Li W, Wang C, GeurtsvanKessel CH, Corman VM, Lamers MM, Sikkema RS, de Bruin E, Chandler FD, Yazdanpanah Y, Le Hingrat Q, Descamps D, Houhou-Fidouh N, Reusken CBEM, Bosch BJ, Drosten C, Koopmans MPG, Haagmans BL
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients.
Emerging Infectious Diseases 2020, 26,
Vivanti AJ, Mattern J, Vauloup-Fellous C, Jani J, Rigonnot L, El Hachem L, Le Gouez A, Desconclois C, Ben M'Barek I, Sibiude J, Benachi A, Picone O, Cordier AG
Retrospective Description of Pregnant Women Infected with Severe Acute Respiratory Syndrome Coronavirus 2, France.
Emerging Infectious Diseases 2020, 26, 2069-2076.
Sangare A, Dong A, Valente M, Pyatigorskaya N, Cao A, Altmayer V, Zyss J, Lambrecq V, Roux D, Morlon Q, Perez P, Ben Salah A, Virolle S, Puybasset L, Sitt JD, Rohaut B, Naccache L
Neuroprognostication of Consciousness Recovery in a Patient with COVID-19 Related Encephalitis: Preliminary Findings from a Multimodal Approach.
Brain Sciences 2020, 10,
Casalino E, Choquet C, Bouzid D, Peyrony O, Curac S, Revue E, Fontaine JP, Plaisance P, Chauvin A, Ghazali DA
Analysis of Emergency Department Visits and Hospital Activity during Influenza Season, COVID-19 Epidemic, and Lockdown Periods in View of Managing a Future Disaster Risk: A Multicenter Observational Study.
International Journal of Environmental Research and Public Health 2020, 17, 8302.
Narang K, Ibirogba ER, Elrefaei A, Trad ATA, Theiler R, Nomura R, Picone O, Kilby M, Escuriet R, Suy A, Carreras E, Tonni G, Ruano R
SARS-CoV-2 in Pregnancy: A Comprehensive Summary of Current Guidelines.
Journal of Clinical Medicine 2020
Belaroussi Y, Roblot P, Peiffer-Smadja N, Delaye T, Mathoulin-Pelissier S, Lemeux J, Le Moal G, Caumes E, Roblot F, Bleibtreu A
Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19?.
Journal of Clinical Medicine 2020, 9, E3691.
Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
JAMA 2020, 324, 1298-1306.
Birgand G, Peiffer-Smadja N, Fournier S, Kerneis S, Lescure FX, Lucet JC
Assessment of Air Contamination by SARS-CoV-2 in Hospital Settings.
JAMA network open 2020, 3, e2033232.
Moszkowicz D, Duboc H, Dubertret C, Roux D, Bretagnol F
Daily medical education for confined students during coronavirus disease 2019 pandemic: A simple videoconference solution.
Clinical Anatomy (New York, N.Y.) 2020, 33, 927-928.
Eloy P, Solas C, Touret F, Mentré F, Malvy D, de Lamballerie X, Guedj J
Dose rationale for favipiravir use in patients infected with SARS-CoV-2.
Clinical Pharmacology and Therapeutics 2020
Gonçalves A, Bertrand J, Ke R, Comets E, de Lamballerie X, Malvy D, Pizzorno A, Terrier O, Rosa Calatrava M, Mentré F, Smith P, Perelson AS, Guedj J
Timing of Antiviral Treatment Initiation is Critical to Reduce SARS-CoV-2 Viral Load.
CPT: pharmacometrics & systems pharmacology 2020, 9, 509-514.
Zucman N, Mullaert J, Roux D, Roca O, Ricard JD, Contributors
Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure.
Intensive Care Medicine 2020, 46, 1924-1926.
Bassetti M, Kollef MH, Timsit JF
Bacterial and fungal superinfections in critically ill patients with COVID-19.
Intensive Care Medicine 2020, 46, 2071-2074.
Farfour E, Visseaux B, Pascreau T, Jolly E, Houhou N, Mazaux L, Asso-Bonnet M, Vasse M
The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis?.
European Journal of Clinical Microbiology & Infectious Diseases 2020, 39, 1997-2000.
Bouadma L, Wiedemann A, Patrier J, Surénaud M, Wicky PH, Foucat E, Diehl JL, Hejblum BP, Sinnah F, de Montmollin E, Lacabaratz C, Thiébaut R, Timsit JF, Lévy Y
Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome.
Journal of Clinical Immunology 2020, 40, 1082-1092.
Gouel-Cheron A, Couffignal C, Elmaleh Y, Kantor E, Montravers P
Preliminary observations of anaesthesia ventilators use for prolonged mechanical ventilation in intensive care unit patients during the COVID-19 pandemic.
Anaesthesia, Critical Care & Pain Medicine 2020, 39, 371-372.
Rello J, Belliato M, Dimopoulos MA, Giamarellos-Bourboulis EJ, Jaksic V, Martin-Loeches I, Mporas I, Pelosi P, Poulakou G, Pournaras S, Tamae-Kakazu M, Timsit JF, Waterer G, Tejada S, Dimopoulos G
Update in COVID-19 in the intensive care unit from the 2020 HELLENIC Athens International symposium.
Anaesthesia, Critical Care & Pain Medicine 2020, 39, 723-730.
Louchet M, Sibiude J, Peytavin G, Picone O, Tréluyer JM, Mandelbrot L
Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019.
American journal of obstetrics & gynecology MFM 2020, 2, 100159.
Sallard E, Lescure FX, Yazdanpanah Y, Mentre F, Peiffer-Smadja N
Type 1 interferons as a potential treatment against COVID-19.
Antiviral Research 2020, 178, 104791.
Venisse N, Peytavin G, Bouchet S, Gagnieu MC, Garraffo R, Guilhaumou R, Solas C
Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection.
Antiviral Research 2020, 181, 104866.
Peiffer-Smadja N, Lucet JC, Bendjelloul G, Bouadma L, Gerard S, Choquet C, Jacques S, Khalil A, Maisani P, Casalino E, Descamps D, Timsit JF, Yazdanpanah Y, Lescure FX
Challenges and issues about organising a hospital to respond to the COVID-19 outbreak: experience from a French reference centre.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020
Fragkou PC, Belhadi D, Peiffer-Smadja N, Moschopoulos CD, Lescure FX, Janocha H, Karofylakis E, Yazdanpanah Y, Mentré F, Skevaki C, Laouénan C, Tsiodras S, ESCMID Study Group for Respiratory Viruses
Review of trials currently testing treatment and prevention of COVID-19.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, 26, 988-998.
Hingrat QL, Visseaux B, Laouenan C, Tubiana S, Bouadma L, Yazdanpanah Y, Duval X, Burdet C, Ichou H, Damond F, Bertine M, Benmalek N, Choquet C, Timsit JF, Ghosn J, Charpentier C, Descamps D, Houhou-Fidouh N, French COVID cohort management committee, CoV-CONTACT study group, members of the French-COVID cohort study group (by alphabetical order), member of the CoV-CONTACT study group. Principal investigator, Steering Committee, CoV-CONTACT Clinical Centers, Coordination and statistical analyses, Virological Lab, Biological Center, Partners, Sponsor, Genetic
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, S1198-743X(20)30721-7.
Peyronnet V, Sibiude J, Deruelle P, Huissoud C, Lescure X, Lucet JC, Mandelbrot L, Nisand I, Vayssière C, Yazpandanah Y, Luton D, Picone O
[SARS-CoV-2 infection during pregnancy. Information and proposal of management care. CNGOF].
Gynecologie, Obstetrique, Fertilite & Senologie 2020, 48, 436-443.
Peyronnet V, Sibiude J, Huissoud C, Lescure FX, Lucet JC, Mandelbrot L, Nisand I, Belaish-Allart J, Vayssière C, Yazpandanah Y, Luton D, Picone O
[Infection with SARS-CoV-2 in pregnancy. Update of Information and proposed care. CNGOF].
Gynecologie, Obstetrique, Fertilite & Senologie 2020, 48, 858-870.
Ouersighni A, Ghazali DA
Contribution of certified registered nurse anaesthetists to the management of the COVID-19 pandemic health crisis.
Intensive & Critical Care Nursing 2020, 60, 102888.
Deslandes A, Berti V, Tandjaoui-Lambotte Y, Alloui C, Carbonnelle E, Zahar JR, Brichler S, Cohen Y
SARS-CoV-2 was already spreading in France in late December 2019.
International Journal of Antimicrobial Agents 2020, 55, 106006.
Peyrony O, Ellouze S, Fontaine JP, Thegat-Le Cam M, Salmona M, Feghoul L, Mahjoub N, Mercier-Delarue S, Gabassi A, Delaugerre C, Le Goff J, Saint-Louis CORE (COvid REsearch) group
Surfaces and equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the emergency department at a university hospital.
International Journal of Hygiene and Environmental Health 2020, 230, 113600.
Dubert M, Visseaux B, Isernia V, Bouadma L, Deconinck L, Patrier J, Wicky PH, Le Pluart D, Kramer L, Rioux C, Le Hingrat Q, Houhou-Fidouh N, Yazdanpanah Y, Ghosn J, Lescure FX
Case report study of the first five COVID-19 patients treated with remdesivir in France.
International Journal of Infectious Diseases 2020, 98, 290-293.
Isernia V, Julia Z, Le Gac S, Bachelard A, Landman R, Lariven S, Joly V, Deconinck L, Rioux C, Lescure X, Yazdanpanah Y, Ghosn J
SARS-COV2 infection in 30 HIV-infected patients followed-up in a French University Hospital.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2020, 101, 49-51.
Battesti G, El Khalifa J, Abdelhedi N, Ferre V, Bouscarat F, Picard-Dahan C, Brunet-Possenti F, Collin G, Lavaud J, Le Bozec P, Rousselot M, Tournier A, Lheure C, Couvelard A, Hacein-Bey-Abina S, Abina AM, Charpentier C, Mignot S, Nicaise P, Descamps D, Deschamps L, Descamps V
New insights in COVID-19–associated chilblains: A comparative study with chilblain lupus erythematosus.
Journal of the American Academy of Dermatology 2020, 83, 1219-1222.
Le Breton C, Besset S, Freita-Ramos S, Amouretti M, Billiet PA, Dao M, Dumont LM, Federici L, Gaborieau B, Longrois D, Postel-Vinay P, Vuillard C, Zucman N, Lebreton G, Combes A, Dreyfuss D, Ricard JD, Roux D
Extracorporeal membrane oxygenation for refractory COVID-19 acute respiratory distress syndrome.
Journal of Critical Care 2020, 60, 10-12.
Egloff C, Vauloup-Fellous C, Picone O, Mandelbrot L, Roques P
Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-2.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2020, 128, 104447.
Visseaux B, Le Hingrat Q, Collin G, Ferré V, Storto A, Ichou H, Bouzid D, Poey N, de Montmollin E, Descamps D, Houhou-Fidouh N
Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection.
Journal of Clinical Virology 2020, 129, 104520.
Wirden M, Feghoul L, Bertine M, Nere ML, Le Hingrat Q, Abdi B, Boutolleau D, Ferre VM, Jary A, Delaugerre C, Marcelin AG, Descamps D, Legoff J, Visseaux B, Chaix ML
Multicenter comparison of the Cobas 6800 system with the RealStar RT-PCR kit for the detection of SARS-CoV-2.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2020, 130, 104573.
Charpentier C, Ichou H, Damond F, Bouvet E, Chaix ML, Ferré V, Delaugerre C, Mahjoub N, Larrouy L, Le Hingrat Q, Visseaux B, Mackiewicz V, Descamps D, Fidouh-Houhou N
Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott).
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2020, 132, 104618.
Nguyen Y, Corre F, Honsel V, Curac S, Zarrouk V, Fantin B, Galy A
Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19.
The Journal of Infection 2020, 81, e96-e98.
Gousseff M, Penot P, Gallay L, Batisse D, Benech N, Bouiller K, Collarino R, Conrad A, Slama D, Joseph C, Lemaignen A, Lescure FX, Levy B, Mahevas M, Pozzetto B, Vignier N, Wyplosz B, Salmon D, Goehringer F, Botelho-Nevers E, in behalf of the COCOREC study group
Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?.
The Journal of Infection 2020, 81, 816-846.
Cancella de Abreu M, Choquet C, Petit H, Bouzid D, Damond F, Marot S, Ferre VM, Burrel S, Boutolleau D, Houdou-Fidouh N, Marcelin AG, Descamps D, Hausfater P
SARS-CoV-2 IGM and IGG rapid serologic test for the diagnosis of COVID-19 in the emergency department.
The Journal of Infection 2020, 81, 816-846.
Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, Doucet L, Berkani S, Oliosi E, Mallart E, Corre F, Zarrouk V, Moyer JD, Galy A, Honsel V, Fantin B, Nguyen Y
Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19.
The Journal of Infection 2020, 81, e4-e6.
Vivanti AJ, Deruelle P, Picone O, Guillaume S, Roze JC, Mulin B, Kochert F, De Beco I, Mahut S, Gantois A, Barasinski C, Petitprez K, Pauchet-Traversat AF, Droy A, Benachi A
Follow-up for pregnant women during the COVID-19 pandemic: French national authority for health recommendations.
Journal of Gynecology Obstetrics and Human Reproduction 2020, 49, 101804.
Vivanti AJ, Deruelle P, Picone O, Guillaume S, Roze JC, Mulin B, Kochert F, De Beco I, Mahut S, Gantois A, Barasinski C, Petitprez K, Pauchet-Traversat AF, Droy A, Benachi A
Post-natal follow-up for women and neonates during the COVID-19 pandemic: French National Authority for Health recommendations.
Journal of Gynecology Obstetrics and Human Reproduction 2020, 49, 101805.
Kayem G, Lecarpentier E, Deruelle P, Bretelle F, Azria E, Blanc J, Bohec C, Bornes M, Ceccaldi PF, Chalet Y, Chauleur C, Cordier AG, Desbrière R, Doret M, Dreyfus M, Driessen M, Fermaut M, Gallot D, Garabédian C, Huissoud C, Luton D, Morel O, Perrotin F, Picone O, Rozenberg P, Sentilhes L, Sroussi J, Vayssière C, Verspyck E, Vivanti AJ, Winer N, Alessandrini V, Schmitz T
A snapshot of the Covid-19 pandemic among pregnant women in France.
Journal of Gynecology Obstetrics and Human Reproduction 2020, 49, 101826.
Athiel Y, Civadier MS, Luton D, Ceccaldi PF, Bourret A, Sroussi J, Mandelbrot L, Ville Y, Nizard J, Sibony O, Darai E, Delorme P, Fernandez H, Le Begat G, Nublat M, Benachi A, Deffieux X
Impact of the outbreak of SARS-CoV-2 infection on urgent gynecological care.
Journal of Gynecology Obstetrics and Human Reproduction 2020, 49, 101841.
Amarsy R, Pean de Ponfilly GR, Benmansour HA, Jacquier H, Cambau EE, Mégarbane B
Serratia marcescens outbreak in the intensive care unit during the COVID-19 pandemic: A paradoxical risk?.
Medecine Et Maladies Infectieuses 2020, 50, 750-751.
Wuyts W, Marin J, Brusselaers J, Vrancken K
Circular economy as a COVID-19 cure?.
Resources, conservation, and recycling 2020, 162, 105016.
Pizzorno A, Padey B, Julien T, Trouillet-Assant S, Traversier A, Errazuriz-Cerda E, Fouret J, Dubois J, Gaymard A, Lescure FX, Dulière V, Brun P, Constant S, Poissy J, Lina B, Yazdanpanah Y, Terrier O, Rosa-Calatrava M
Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia.
Cell Reports Medicine 2020, 1, 100059.
Gilbert M, Pullano G, Pinotti F, Valdano E, Poletto C, Boëlle PY, D'Ortenzio E, Yazdanpanah Y, Eholie SP, Altmann M, Gutierrez B, Kraemer MUG, Colizza V
Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study.
The Lancet 2020, 395, 871-877.
Norton A, Mphahlele J, Yazdanpanah Y, Piot P, Bayona MT
Strengthening the global effort on COVID-19 research.
The Lancet 2020, S0140673620315981.
Lescure FX, Bouadma L, Nguyen D, Parisey M, Wicky PH, Behillil S, Gaymard A, Bouscambert-Duchamp M, Donati F, Le Hingrat Q, Enouf V, Houhou-Fidouh N, Valette M, Mailles A, Lucet JC, Mentre F, Duval X, Descamps D, Malvy D, Timsit JF, Lina B, van-der-Werf S, Yazdanpanah Y
Clinical and virological data of the first cases of COVID-19 in Europe: a case series.
The Lancet. Infectious Diseases 2020, 20, 697-706.
ISARIC clinical characterisation group
Global outbreak research: harmony not hegemony.
The Lancet. Infectious Diseases 2020, 20, 770-772.
Bielicki JA, Duval X, Gobat N, Goossens H, Koopmans M, Tacconelli E, van der Werf S
Monitoring approaches for health-care workers during the COVID-19 pandemic.
The Lancet. Infectious Diseases 2020, 20, e261-e267.
Brendish NJ, Poole S, Naidu VV, Mansbridge CT, Norton NJ, Wheeler H, Presland L, Kidd S, Cortes NJ, Borca F, Phan H, Babbage G, Visseaux B, Ewings S, Clark TW
Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study.
The Lancet. Respiratory Medicine 2020, 8, 1192-1200.
Ouldali N, Pouletty M, Mariani P, Beyler C, Blachier A, Bonacorsi S, Danis K, Chomton M, Maurice L, Le Bourgeois F, Caseris M, Gaschignard J, Poline J, Cohen R, Titomanlio L, Faye A, Melki I, Meinzer U
Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis.
The Lancet. Child & Adolescent Health 2020, 4, 662-668.
Atlani-Duault L, Lina B, Malvy D, Yazdanpanah Y, Chauvin F, Delfraissy JF
COVID-19: France grapples with the pragmatics of isolation.
The Lancet. Public Health 2020, 5, e573-e574.
Ghazali DA, Ouersighni A, Gay M, Audebault V, Pavlovsky T, Casalino E
Feedback to Prepare EMS Teams to Manage Infected Patients with COVID-19: A Case Series.
Prehospital and Disaster Medicine 2020, 35, 451-453.
Maisonnasse P, Guedj J, Contreras V, Behillil S, Solas C, Marlin R, Naninck T, Pizzorno A, Lemaitre J, Gonçalves A, Kahlaoui N, Terrier O, Fang RHT, Enouf V, Dereuddre-Bosquet N, Brisebarre A, Touret F, Chapon C, Hoen B, Lina B, Calatrava MR, van der Werf S, de Lamballerie X, Le Grand R
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.
Nature 2020, 585, 584-587.
Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, Feldt T, Green G, Green ML, Lescure FX, Nicastri E, Oda R, Yo K, Quiros-Roldan E, Studemeister A, Redinski J, Ahmed S, Bernett J, Chelliah D, Chen D, Chihara S, Cohen SH, Cunningham J, D'Arminio Monforte A, Ismail S, Kato H, Lapadula G, L'Her E, Maeno T, Majumder S, Massari M, Mora-Rillo M, Mutoh Y, Nguyen D, Verweij E, Zoufaly A, Osinusi AO, DeZure A, Zhao Y, Zhong L, Chokkalingam A, Elboudwarej E, Telep L, Timbs L, Henne I, Sellers S, Cao H, Tan SK, Winterbourne L, Desai P, Mera R, Gaggar A, Myers RP, Brainard DM, Childs R, Flanigan T
Compassionate Use of Remdesivir for Patients with Severe Covid-19.
The New England Journal of Medicine 2020
Nguyen Y, Corre F, Honsel V, Curac S, Zarrouk V, Burtz CP, Weiss E, Moyer JD, Gauss T, Grégory J, Bert F, Trichet C, Peoc'h K, Vilgrain V, Rebours V, Fantin B, Galy A
A nomogram to predict the risk of unfavourable outcome in COVID-19: a retrospective cohort of 279 hospitalized patients in Paris area.
Annals of Medicine 2020, 52, 367-375.
Teles Abrao Trad A, Ibirogba ER, Elrefaei A, Narang K, Tonni G, Picone O, Suy A, Carreras Moratonas E, Kilby MD, Ruano R
Complications and outcomes of SARS-CoV-2 in pregnancy: where and what is the evidence?.
Hypertension in Pregnancy 2020, 39, 361-369.
Lê MP, Peiffer-Smadja N, Guedj J, Néant N, Mentré F, Ader F, Yazdanpanah Y, Peytavin G
Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.
The Journal of Antimicrobial Chemotherapy 2020, 75, 2376-2380.
Kauv J, Lê MP, Veyrier M, Le Hingrat Q, Visseaux B, Massias L, Chauveheid MP, Descamps D, Ghosn J, Peytavin G
Failure of hydroxychloroquine pre-exposure prophylaxis in COVID-19 infection? A case report.
The Journal of Antimicrobial Chemotherapy 2020, 75, 2706-2707.
Peiffer-Smadja N, Lescure FX, Sallard E, Ravaud P, Vegreville B, Zeitoun JD
Anticovid, a comprehensive open-access real-time platform of registered clinical studies for COVID-19.
Journal of Antimicrobial Chemotherapy 2020, 75, 2708-2710.
Lê MP, Jaquet P, Patrier J, Wicky PH, Le Hingrat Q, Veyrier M, Kauv J, Sonneville R, Visseaux B, Laouénan C, Bouadma L, Descamps D, de Montmollin E, Peytavin G, Timsit JF
Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients.
The Journal of Antimicrobial Chemotherapy 2020, 75, 2657-2660.
Levy C, Basmaci R, Bensaid P, Bru CB, Coinde E, Dessioux E, Fournial C, Gashignard J, Haas H, Hentgen V, Huet F, Lalande M, Martinot A, Pons C, Romain AS, Ursulescu N, Le Sage FV, Raymond J, Béchet S, Toubiana J, Cohen R
Changes in Reverse Transcription Polymerase Chain Reaction-positive Severe Acute Respiratory Syndrome Coronavirus 2 Rates in Adults and Children According to the Epidemic Stages.
The Pediatric Infectious Disease Journal 2020, 39, e369-e372.
Tiberghien P, de Lamballerie X, Morel P, Gallian P, Lacombe K, Yazdanpanah Y
Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?.
Vox Sanguinis 2020, 115, 488-494.
Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, Péré H, Charbit B, Bondet V, Chenevier-Gobeaux C, Breillat P, Carlier N, Gauzit R, Morbieu C, Pène F, Marin N, Roche N, Szwebel TA, Merkling SH, Treluyer JM, Veyer D, Mouthon L, Blanc C, Tharaux PL, Rozenberg F, Fischer A, Duffy D, Rieux-Laucat F, Kernéis S, Terrier B
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.
Science (New York, N.Y.) 2020, 369, 718-724.
Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, Ogishi M, Sabli IKD, Hodeib S, Korol C, Rosain J, Bilguvar K, Ye J, Bolze A, Bigio B, Yang R, Arias AA, Zhou Q, Zhang Y, Onodi F, Korniotis S, Karpf L, Philippot Q, Chbihi M, Bonnet-Madin L, Dorgham K, Smith N, Schneider WM, Razooky BS, Hoffmann HH, Michailidis E, Moens L, Han JE, Lorenzo L, Bizien L, Meade P, Neehus AL, Ugurbil AC, Corneau A, Kerner G, Zhang P, Rapaport F, Seeleuthner Y, Manry J, Masson C, Schmitt Y, Schlüter A, Le Voyer T, Khan T, Li J, Fellay J, Roussel L, Shahrooei M, Alosaimi MF, Mansouri D, Al-Saud H, Al-Mulla F, Almourfi F, Al-Muhsen SZ, Alsohime F, Al Turki S, Hasanato R, van de Beek D, Biondi A, Bettini LR, D'Angio' M, Bonfanti P, Imberti L, Sottini A, Paghera S, Quiros-Roldan E, Rossi C, Oler AJ, Tompkins MF, Alba C, Vandernoot I, Goffard JC, Smits G, Migeotte I, Haerynck F, Soler-Palacin P, Martin-Nalda A, Colobran R, Morange PE, Keles S, Çölkesen F, Ozcelik T, Yasar KK, Senoglu S, Karabela ŞN, Rodríguez-Gallego C, Novelli G, Hraiech S, Tandjaoui-Lambiotte Y, Duval X, Laouénan C, COVID-STORM Clinicians, COVID Clinicians, Imagine COVID Group, French COVID Cohort Study Group, CoV-Contact Cohort, Amsterdam UMC Covid-19 Biobank, COVID Human Genetic Effort, NIAID-USUHS/TAGC COVID Immunity Group, Snow AL, Dalgard CL, Milner JD, Vinh DC, Mogensen TH, Marr N, Spaan AN, Boisson B, Boisson-Dupuis S, Bustamante J, Puel A, Ciancanelli MJ, Meyts I, Maniatis T, Soumelis V, Amara A, Nussenzweig M, García-Sastre A, Krammer F, Pujol A, Duffy D, Lifton RP, Zhang SY, Gorochov G, Béziat V, Jouanguy E, Sancho-Shimizu V, Rice CM, Abel L, Notarangelo LD, Cobat A, Su HC, Casanova JL
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
Science (New York, N.Y.) 2020, 370,
Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, Dorgham K, Philippot Q, Rosain J, Béziat V, Manry J, Shaw E, Haljasmägi L, Peterson P, Lorenzo L, Bizien L, Trouillet-Assant S, Dobbs K, de Jesus AA, Belot A, Kallaste A, Catherinot E, Tandjaoui-Lambiotte Y, Le Pen J, Kerner G, Bigio B, Seeleuthner Y, Yang R, Bolze A, Spaan AN, Delmonte OM, Abers MS, Aiuti A, Casari G, Lampasona V, Piemonti L, Ciceri F, Bilguvar K, Lifton RP, Vasse M, Smadja DM, Migaud M, Hadjadj J, Terrier B, Duffy D, Quintana-Murci L, van de Beek D, Roussel L, Vinh DC, Tangye SG, Haerynck F, Dalmau D, Martinez-Picado J, Brodin P, Nussenzweig MC, Boisson-Dupuis S, Rodríguez-Gallego C, Vogt G, Mogensen TH, Oler AJ, Gu J, Burbelo PD, Cohen JI, Biondi A, Bettini LR, D'Angio M, Bonfanti P, Rossignol P, Mayaux J, Rieux-Laucat F, Husebye ES, Fusco F, Ursini MV, Imberti L, Sottini A, Paghera S, Quiros-Roldan E, Rossi C, Castagnoli R, Montagna D, Licari A, Marseglia GL, Duval X, Ghosn J, HGID Lab, NIAID-USUHS Immune Response to COVID Group, COVID Clinicians, COVID-STORM Clinicians, Imagine COVID Group, French COVID Cohort Study Group, Milieu Intérieur Consortium, CoV-Contact Cohort, Amsterdam UMC Covid-19 Biobank, COVID Human Genetic Effort, Tsang JS, Goldbach-Mansky R, Kisand K, Lionakis MS, Puel A, Zhang SY, Holland SM, Gorochov G, Jouanguy E, Rice CM, Cobat A, Notarangelo LD, Abel L, Su HC, Casanova JL
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.
Science (New York, N.Y.) 2020, 370, eabd4585.
Grzelak L, Temmam S, Planchais C, Demeret C, Tondeur L, Huon C, Guivel-Benhassine F, Staropoli I, Chazal M, Dufloo J, Planas D, Buchrieser J, Rajah MM, Robinot R, Porrot F, Albert M, Chen KY, Crescenzo-Chaigne B, Donati F, Anna F, Souque P, Gransagne M, Bellalou J, Nowakowski M, Backovic M, Bouadma L, Le Fevre L, Le Hingrat Q, Descamps D, Pourbaix A, Laouénan C, Ghosn J, Yazdanpanah Y, Besombes C, Jolly N, Pellerin-Fernandes S, Cheny O, Ungeheuer MN, Mellon G, Morel P, Rolland S, Rey FA, Behillil S, Enouf V, Lemaitre A, Créach MA, Petres S, Escriou N, Charneau P, Fontanet A, Hoen B, Bruel T, Eloit M, Mouquet H, Schwartz O, van der Werf S
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.
Science Translational Medicine 2020, 12,
Lê MP, Le Hingrat Q, Jaquet P, Wicky PH, Bunel V, Massias L, Visseaux B, Messika J, Descamps D, Mal H, Timsit JF, Peytavin G
Removal of Remdesivir's Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19.
Antimicrobial Agents and Chemotherapy 2020, 64,
Lê MP, Le Beller C, Le Hingrat Q, Jaquet P, Wicky PH, Bunel V, Massias L, Visseaux B, Messika J, Descamps D, Mal H, Timsit JF, Peytavin G
Reply to Yan and Muller, "Captisol and GS-704277, but Not GS-441524, Are Credible Mediators of Remdesivir's Nephrotoxicity".
Antimicrobial Agents and Chemotherapy 2020, 64,
Visseaux B, Le Hingrat Q, Collin G, Bouzid D, Lebourgeois S, Le Pluart D, Deconinck L, Lescure FX, Lucet JC, Bouadma L, Timsit JF, Descamps D, Yazdanpanah Y, Casalino E, Houhou-Fidouh N, McAdam AJ
Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the First Rapid Multiplex PCR Commercial Assay for SARS-CoV-2 Detection.
Journal of Clinical Microbiology 2020, 58, e00630-20, /jcm/58/8/JCM.00630-20.atom.
Pouletty M, Borocco C, Ouldali N, Caseris M, Basmaci R, Lachaume N, Bensaid P, Pichard S, Kouider H, Morelle G, Craiu I, Pondarre C, Deho A, Maroni A, Oualha M, Amoura Z, Haroche J, Chommeloux J, Bajolle F, Beyler C, Bonacorsi S, Carcelain G, Koné-Paut I, Bader-Meunier B, Faye A, Meinzer U, Galeotti C, Melki I
Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort.
Annals of the Rheumatic Diseases 2020, 79, 999-1006.
Ouldali N, Pouletty M, Lokmer J, Benzouid C, Beyler C, Deho A, Meinzer U, Faye A, Melki I, Great Paris Region (GPR) Kawa-COVID-19 consortium
Response to: 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Pouletty et al' by Pino et al.
Annals of the Rheumatic Diseases 2020, annrheumdis-2020-218614.
Pouletty M, Dingulu G, Ouldali N, Corseri O, Ducrocq C, Meinzer U, Faye A, Galeotti C, Melki I, GPR(KC1c
Response to: 'Exaggerated neutrophil extracellular trap formation in Kawasaki disease: a key phenomenon behind the outbreak in western countries?' by Yamashita et al.
Annals of the Rheumatic Diseases 2020
Federici L, Picone O, Dreyfuss D, Sibiude J
Successful continuation of pregnancy in a patient with COVID-19-related ARDS.
BMJ case reports 2020, 13,
Mahévas M, Tran VT, Roumier M, Chabrol A, Paule R, Guillaud C, Fois E, Lepeule R, Szwebel TA, Lescure FX, Schlemmer F, Matignon M, Khellaf M, Crickx E, Terrier B, Morbieu C, Legendre P, Dang J, Schoindre Y, Pawlotsky JM, Michel M, Perrodeau E, Carlier N, Roche N, de Lastours V, Ourghanlian C, Kerneis S, Ménager P, Mouthon L, Audureau E, Ravaud P, Godeau B, Gallien S, Costedoat-Chalumeau N
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data.
BMJ 2020, m1844.
Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, Debray A, Basmaci R, Salvador E, Biscardi S, Frange P, Chalumeau M, Casanova JL, Cohen JF, Allali S
Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study.
BMJ (Clinical research ed.) 2020, 369, m2094.
Ader F, Discovery French Trial Management Team
Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults.
BMJ open 2020, 10, e041437.
Dodd LE, Follmann D, Wang J, Koenig F, Korn LL, Schoergenhofer C, Proschan M, Hunsberger S, Bonnett T, Makowski M, Belhadi D, Wang Y, Cao B, Mentre F, Jaki T
Endpoints for randomized controlled clinical trials for COVID-19 treatments.
Clinical Trials (London, England) 2020, 17, 472-482.
Ong CWM, Migliori GB, Raviglione M, MacGregor-Skinner G, Sotgiu G, Alffenaar JW, Tiberi S, Adlhoch C, Alonzi T, Archuleta S, Brusin S, Cambau E, Capobianchi MR, Castilletti C, Centis R, Cirillo DM, D'Ambrosio L, Delogu G, Esposito SMR, Figueroa J, Friedland JS, Ho BCH, Ippolito G, Jankovic M, Kim HY, Rosales Klintz S, Ködmön C, Lalle E, Leo YS, Leung CC, Märtson AG, Melazzini MG, Najafi Fard S, Penttinen P, Petrone L, Petruccioli E, Pontali E, Saderi L, Santin M, Spanevello A, van Crevel R, van der Werf MJ, Visca D, Viveiros M, Zellweger JP, Zumla A, Goletti D
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).
The European Respiratory Journal 2020, 56,
Lomont A, Boubaya M, Khamis W, Deslandes A, Cordel H, Seytre D, Alloui C, Malaure C, Bonnet N, Carbonnelle E, Cohen Y, Nunes H, Bouchaud O, Zahar JR, Tandjaoui-Lambiotte Y
Environmental contamination related to SARS-CoV-2 in ICU patients.
ERJ open research 2020
Peiffer-Smadja N, Bouadma L, Mathy V, Allouche K, Patrier J, Reboul M, Montravers P, Timsit JF, Armand-Lefevre L
Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia.
Critical Care (London, England) 2020, 24, 366.
Monard C, Pehlivan J, Auger G, Alviset S, Tran Dinh A, Duquaire P, Gastli N, d'Humières C, Maamar A, Boibieux A, Baldeyrou M, Loubinoux J, Dauwalder O, Cattoir V, Armand-Lefèvre L, Kernéis S, ADAPT study group
Multicenter evaluation of a syndromic rapid multiplex PCR test for early adaptation of antimicrobial therapy in adult patients with pneumonia.
Critical Care (London, England) 2020, 24, 434.
Buetti N, Wicky PH, Le Hingrat Q, Ruckly S, Mazzuchelli T, Loiodice A, Trimboli P, Forni Ogna V, de Montmollin E, Bernasconi E, Visseaux B, Timsit JF
SARS-CoV-2 detection in the lower respiratory tract of invasively ventilated ARDS patients.
Critical Care (London, England) 2020, 24, 610.
Duvignaud A, Lhomme E, Pistone T, Onaisi R, Sitta R, Journot V, Nguyen D, Peiffer-Smadja N, Crémer A, Bouchet S, Darnaud T, Poitrenaud D, Piroth L, Binquet C, Michel JF, Lefèvre B, Lebeaux D, Lebel J, Dupouy J, Roussillon C, Gimbert A, Wittkop L, Thiébaut R, Orne-Gliemann J, Joseph JP, Richert L, Anglaret X, Malvy D, COVERAGE study group
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
Trials 2020, 21, 846.
Bouzid D, Mullaert J, Le Hingrat Q, Laurent O, Duval X, Lescure X, Timsit JF, Descamps D, Montravers P, Choquet C, Lucet JC, Casalino E, Visseaux B, ED influenza study group
Characteristics associated with COVID-19 or other respiratory viruses' infections at a single-center emergency department.
PloS One 2020, 15, e0243261.
Borie R, Savale L, Dossier A, Ghosn J, Taillé C, Visseaux B, Jebreen K, Diallo A, Tesmoingt C, Morer L, Goletto T, Faucher N, Hajouji L, Neukirch C, Phillips M, Stelianides S, Bouadma L, Brosseau S, Ottaviani S, Pluvy J, Le Pluart D, Debray MP, Raynaud-Simon A, Descamps D, Khalil A, Timsit JF, Lescure FX, Descamps V, Papo T, Humbert M, Crestani B, Dieude P, Vicaut E, Zalcman G, Bichat & Kremlin-Bicêtre AP-HP COVID teams
Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study.
PloS One 2020, 15, e0243961.
Egloff C, Picone O, Vauloup-Fellous C, Roques P
Mother to Child SARS-CoV-2 Transmission: Fact or Fantasy.
Virologie (Montrouge, France) 2020, 24, 142-146.
Denis F, Galmiche S, Dinh A, Fontanet A, Scherpereel A, Benezit F, Lescure FX
Epidemiological Observations on the Association Between Anosmia and COVID-19 Infection: Analysis of Data From a Self-Assessment Web Application.
Journal of Medical Internet Research 2020, 22, e19855.
Yordanov Y, Dechartres A, Lescure X, Apra C, Villie P, Marchand-Arvier J, Debuc E, Dinh A, Jourdain P, AP-HP / Universities / Inserm COVID-19 Research Collaboration
Covidom, a Telesurveillance Solution for Home Monitoring Patients With COVID-19.
Journal of Medical Internet Research 2020, 22, e20748.
Galmiche S, Rahbe E, Fontanet A, Dinh A, Bénézit F, Lescure FX, Denis F
Implementation of a Self-Triage Web Application for Suspected COVID-19 and Its Impact on Emergency Call Centers: Observational Study.
Journal of Medical Internet Research 2020, 22, e22924.
Bernard Stoecklin S, Rolland P, Silue Y, Mailles A, Campese C, Simondon A, Mechain M, Meurice L, Nguyen M, Bassi C, Yamani E, Behillil S, Ismael S, Nguyen D, Malvy D, Lescure FX, Georges S, Lazarus C, Tabaï A, Stempfelet M, Enouf V, Coignard B, Levy-Bruhl D, Investigation team
First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020.
Eurosurveillance 2020, 25,
Okba NMA, Müller MA, Li W, Wang C, GeurtsvanKessel CH, Corman VM, Lamers MM, Sikkema RS, de Bruin E, Chandler FD, Yazdanpanah Y, Le Hingrat Q, Descamps D, Houhou-Fidouh N, Reusken CBEM, Bosch BJ, Drosten C, Koopmans MPG, Haagmans BL
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients.
Emerging Infectious Diseases 2020, 26,
Vivanti AJ, Mattern J, Vauloup-Fellous C, Jani J, Rigonnot L, El Hachem L, Le Gouez A, Desconclois C, Ben M'Barek I, Sibiude J, Benachi A, Picone O, Cordier AG
Retrospective Description of Pregnant Women Infected with Severe Acute Respiratory Syndrome Coronavirus 2, France.
Emerging Infectious Diseases 2020, 26, 2069-2076.
Sangare A, Dong A, Valente M, Pyatigorskaya N, Cao A, Altmayer V, Zyss J, Lambrecq V, Roux D, Morlon Q, Perez P, Ben Salah A, Virolle S, Puybasset L, Sitt JD, Rohaut B, Naccache L
Neuroprognostication of Consciousness Recovery in a Patient with COVID-19 Related Encephalitis: Preliminary Findings from a Multimodal Approach.
Brain Sciences 2020, 10,
Casalino E, Choquet C, Bouzid D, Peyrony O, Curac S, Revue E, Fontaine JP, Plaisance P, Chauvin A, Ghazali DA
Analysis of Emergency Department Visits and Hospital Activity during Influenza Season, COVID-19 Epidemic, and Lockdown Periods in View of Managing a Future Disaster Risk: A Multicenter Observational Study.
International Journal of Environmental Research and Public Health 2020, 17, 8302.
Narang K, Ibirogba ER, Elrefaei A, Trad ATA, Theiler R, Nomura R, Picone O, Kilby M, Escuriet R, Suy A, Carreras E, Tonni G, Ruano R
SARS-CoV-2 in Pregnancy: A Comprehensive Summary of Current Guidelines.
Journal of Clinical Medicine 2020
Belaroussi Y, Roblot P, Peiffer-Smadja N, Delaye T, Mathoulin-Pelissier S, Lemeux J, Le Moal G, Caumes E, Roblot F, Bleibtreu A
Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19?.
Journal of Clinical Medicine 2020, 9, E3691.
DeSCID exhaustive list of publications
(click to expand or collapse)
2024
Lavalley-Morelle A, Peiffer-Smadja N, Gressens SB, Souhail B, Lahens A, Bounhiol A, Lescure FX, Mentré F, Mullaert J
Multivariate joint model under competing risks to predict death of hospitalized patients for SARS-CoV-2 infection.
Biometrical Journal. Biometrische Zeitschrift 2024, 66, e2300049.
Lingas G, Planas D, Péré H, Porrot F, Guivel-Benhassine F, Staropoli I, Duffy D, Chapuis N, Gobeaux C, Veyer D, Delaugerre C, Le Goff J, Getten P, Hadjadj J, Bellino A, Parfait B, Treluyer JM, Schwartz O, Guedj J, Kernéis S, Terrier B
Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection: A Modeling Analysis.
Clinical Pharmacology and Therapeutics 2024, 115, 86-94.
Multivariate joint model under competing risks to predict death of hospitalized patients for SARS-CoV-2 infection.
Biometrical Journal. Biometrische Zeitschrift 2024, 66, e2300049.
Lingas G, Planas D, Péré H, Porrot F, Guivel-Benhassine F, Staropoli I, Duffy D, Chapuis N, Gobeaux C, Veyer D, Delaugerre C, Le Goff J, Getten P, Hadjadj J, Bellino A, Parfait B, Treluyer JM, Schwartz O, Guedj J, Kernéis S, Terrier B
Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection: A Modeling Analysis.
Clinical Pharmacology and Therapeutics 2024, 115, 86-94.
2023
Blanchet FX, Rahi M, Merlant M, Gare M, Brunet-Possenti F, Descamps V, Bouscarat F
Genital Pseudotumor as a Manifestation of Mpox Virus Infection.
JAMA dermatology 2023, 159, 563-564.
Labbé V, Contou D, Heming N, Megarbane B, Razazi K, Boissier F, Ait-Oufella H, Turpin M, Carreira S, Robert A, Monchi M, Souweine B, Preau S, Doyen D, Vivier E, Zucman N, Dres M, Fejjal M, Noel-Savina E, Bachir M, Jaffal K, Timsit JF, Picos SA, Mariotte E, Martis N, Juguet W, Melica G, Rondeau P, Audureau E, Mekontso Dessap A, ANTICOVID Investigators
Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical Trial.
JAMA internal medicine 2023, 183, 520-531.
Sorin B, Gaigne L, Garzaro M, Moulis G, Mageau A, Lopez C, Roy-Peaud F, Jeandel PY, Crickx E, Dossier A, Gobert D, Hadjadj J, Puyade M, Languille L, Rasmussen C, Terrier B, Ebbo M, Bonnotte B, Audia S, Galicier L, Michel M, Mahevas M, Viallard JF, Godeau B, CERECAI (Centre de Référence des Cytopénies Auto-Immunes de L'adulte)
Severe SARS-CoV-2 infection in rituximab-treated patients with autoimmune cytopenia: A multicenter observational study.
American Journal of Hematology 2023, 98, E259-E262.
Cortier M, Raphael E, Mailhe M, Thy M, Bertin C, Vallois D, Lescure X, Ghosn J
An unusual case of human monkeypox with successive asynchronous rashes.
Journal of Medical Virology 2023, 95, e28180.
Ferré VM, Bitty-Anderson AM, Peytavin G, Lê MP, Dagnra CA, Coppée R, Gbeasor-Komlanvi FA, Descamps D, Charpentier C, Ekouevi DK
Pharmaco-virological algorithm to target risk of drug resistance among a population of HIV-infected key populations in Togo.
Journal of Medical Virology 2023, 95, e28535.
Gault N, Bachelet D, Laouénan C, Borie R, Cracowski C, Poissy J, Faure K, Lainé F, Lefèvre B, Isnard M, Patrier J, Launay O, Costagliola D, Ghosn J, Bouadma L, French COVID Cohort Study Group and The French COVID Investigators Study Group
Impact of corticosteroids use on midterm sequelae in survivors of COVID-19 admitted to hospital: A prospective cohort study.
Journal of Medical Virology 2023, 95, e28819.
Piorkowski G, Ghosn J, Coppée R, Mailhé M, Ferré VM, Houhou-Fidouh N, Yazdanpanah Y, Le Hingrat Q, Raoul H, Charpentier C, Descamps D, de Lamballerie X
Genomic diversity of mpox virus in Paris area (France) during the 2022 outbreak.
Journal of Medical Virology 2023, 95, e28853.
Chenane HR, Lingas G, Menidjel R, Laouenan C, Tubiana S, Descamps D, Le Hingrat Q, Abel L, Guedj J, Malhotra S, Kumar-Singh S, Visseaux B, Ghosn J, Charpentier C, Lebourgeois S, French COVID Cohort Study Group
High sera levels of SARS-CoV-2 N antigen are associated with death in hospitalized COVID-19 patients.
Journal of Medical Virology 2023, 95, e29247.
Bensaid S, Contejean A, Morand P, Enser M, Eyrolle L, Charlier C, Kernéis S, Anract P, Biau D, Canouï E, Other Members of the CRIOACochin Group
Surgical site infection after pelvic bone and soft tissue sarcoma resection: Risk factors, microbiology, and impact of extended postoperative antibiotic prophylaxis.
Journal of Surgical Oncology 2023, 128, 344-349.
Mercier N, Belhadi D, DeChanet A, Delmas C, Saillard J, Dumousseaux M, Le Mestre S, Fougerou-Leurent C, Ferrane A, Burdet C, Espérou H, Ader F, Hites M, Peiffer-Smadja N, Poissy J, Andrejak C, Paiva JA, Tacconelli E, Staub T, Greil R, Costagliola D, Mentre F, Yazdanpanah Y, Diallo A, DisCoVeRy Safety Working group
Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial.
Pharmacology Research & Perspectives 2023, 11, e01072.
Néant N, Lingas G, Gaymard A, Belhadi D, Hites M, Staub T, Greil R, Paiva JA, Poissy J, Peiffer-Smadja N, Costagliola D, Yazdanpanah Y, Bouscambert-Duchamp M, Gagneux-Brunon A, Ader F, Mentré F, Wallet F, Burdet C, Guedj J, DisCoVeRy study group
Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients.
CPT: pharmacometrics & systems pharmacology 2023, 12, 2027-2037.
Périllaud-Dubois C, Hachicha-Maalej N, Lepers C, Letamendia E, Teissier N, Cousien A, Sibiude J, Deuffic-Burban S, Vauloup-Fellous C, Picone O
Cost-effectiveness of screening and valacyclovir-based treatment strategies for first-trimester cytomegalovirus primary infection in pregnant women in France.
Ultrasound in Obstetrics & Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology 2023, 62, 573-584.
Tabah A, Buetti N, Staiquly Q, Ruckly S, Akova M, Aslan AT, Leone M, Conway Morris A, Bassetti M, Arvaniti K, Lipman J, Ferrer R, Qiu H, Paiva JA, Povoa P, De Bus L, De Waele J, Zand F, Gurjar M, Alsisi A, Abidi K, Bracht H, Hayashi Y, Jeon K, Elhadi M, Barbier F, Timsit JF, EUROBACT-2 Study Group, ESICM, ESCMID ESGCIP and the OUTCOMEREA Network
Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study.
Intensive Care Medicine 2023, 49, 178-190.
Gaillet A, Bay P, Péju E, Ait-Oufella H, Azoulay E, Benchabane N, Cerf C, Cohen Y, de Prost N, Faguer S, Geri G, Grangé S, Kahn JE, Kreitmann L, Larcher R, Lefèvre G, Mabrouki A, Mekonsto-Dessap A, Panel K, Pène F, Pineton de Chambrun M, Quenot JP, Tandjaoui-Lambiotte Y, Timsit JF, Vieillard-Baron A, Dargent A, Herault A, Groh M
Epidemiology, clinical presentation, and outcomes of 620 patients with eosinophilia in the intensive care unit.
Intensive Care Medicine 2023, 49, 291-301.
Park S, Robba C, Sonneville R
Neuromonitoring for prognostication under ECMO.
Intensive Care Medicine 2023, 49, 451-454.
Sonneville R, de Montmollin E, Contou D, Ferrer R, Gurjar M, Klouche K, Sarton B, Demeret S, Bailly P, da Silva D, Escudier E, Le Guennec L, Chabanne R, Argaud L, Ben Hadj Salem O, Thyrault M, Frerou A, Louis G, De Pascale G, Horn J, Helbok R, Geri G, Bruneel F, Martin-Loeches I, Taccone FS, De Waele JJ, Ruckly S, Staiquly Q, Citerio G, Timsit JF, EURECA Investigator Study Group
Clinical features, etiologies, and outcomes in adult patients with meningoencephalitis requiring intensive care (EURECA): an international prospective multicenter cohort study.
Intensive Care Medicine 2023, 49, 517-529.
Sonneville R, de Montmollin E, Gaudemer A, Ruckly S, Timsit JF
Meningoencephalitis requiring intensive care and neuromonitorization. Author's reply.
Intensive Care Medicine 2023, 49, 884-885.
Newcombe V, Muehlschlegel S, Sonneville R
Neurological diseases in intensive care.
Intensive Care Medicine 2023, 49, 987-990.
Ravalihasy A, Ante-Testard PA, Kardas-Sloma L, Yazdanpanah Y, De Allegri M, Ridde V
Quantitative Methods Used to Evaluate Impact of Combination HIV Prevention Intervention: A Methodological Systematic Review.
AIDS and behavior 2023, 1-11.
Hocini H, Wiedemann A, Blengio F, Lefebvre C, Cervantes-Gonzalez M, Foucat E, Tisserand P, Surenaud M, Coléon S, Prague M, Guillaumat L, Krief C, Fenwick C, Laouénan C, Bouadma L, Ghosn J, Pantaleo G, Thiébaut R, French COVID cohort study group, Lévy Y
Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19.
Journal of Clinical Immunology 2023, 43, 882-893.
Renggli L, Gasser M, Buetti N, Kronenberg A, Swiss Centre for Antibiotic Resistance
Increase in methicillin-susceptible Staphylococcus aureus bloodstream infections in Switzerland: a nationwide surveillance study (2008-2021).
Infection 2023
Boukobza M, Ilic-Habensus E, Mourvillier B, Duval X, Laissy JP
Brain abscesses in infective endocarditis: contemporary profile and neuroradiological findings.
Infection 2023, 51, 1431-1444.
Beaumont AL, Rozencwajg S, Peiffer-Smadja N, Montravers P
COVID-19: Brief overview of therapeutic strategies.
Anaesthesia, Critical Care & Pain Medicine 2023, 42, 101181.
Celestin B, Habensus EI, Tubiana S, Préau M, Millot S, Lescure FX, Kerneis C, Para M, Duval X, Iung B, POST-IMAGE study group
Determinants of adherence to oral hygiene prophylaxis guidelines in patients with previous infective endocarditis.
Archives of Cardiovascular Diseases 2023, 116, 176-182.
Ghazali DA, Rousseau R, Breque C, Oriot D
Effect of real-time feedback device compared to use or non-use of a checklist performance aid on post-training performance and retention of infant cardiopulmonary resuscitation: A randomized simulation-based trial.
Australasian Emergency Care 2023, 26, 36-44.
Lefebvre T, Boutten A, Raulet-Bussian C, Raynor A, Manceau H, Puy H, Moulouel B, Schmitt C, Timsit JF, Lefort A, Weiss E, Lescure FX, Ricard JD, Sonneville R, Peoc'h K
Evaluation of iron metabolism in hospitalized COVID-19 patients.
Clinica Chimica Acta; International Journal of Clinical Chemistry 2023, 548, 117509.
Mailhe M, Beaumont AL, Thy M, Le Pluart D, Perrineau S, Houhou-Fidouh N, Deconinck L, Bertin C, Ferré VM, Cortier M, De La Porte Des Vaux C, Phung BC, Mollo B, Cresta M, Bouscarat F, Choquet C, Descamps D, Ghosn J, Lescure FX, Yazdanpanah Y, Joly V, Peiffer-Smadja N
Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 233-239.
Ghosn J, Bachelet D, Livrozet M, Cervantes-Gonzalez M, Poissy J, Goehringer F, Gandonniere CS, Maillet M, Bani-Sadr F, Martin-Blondel G, Tattevin P, Launay O, Surgers L, Dudoignon E, Liegeon G, Zucman D, Joseph C, Senneville E, Yelnik C, Roger PM, Faure K, Gousseff M, Cabié A, Duval X, Chirouze C, Laouénan C, French COVID cohort Study Group and the French COVID cohort Investigators Group
Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 254.e7-254.e13.
Alidjinou EK, Demaret J, Corroyer-Simovic B, Vuotto F, Miczek S, Labreuche J, Goffard A, Trauet J, Lupau D, Dendooven A, Huvent-Grelle D, Podvin J, Dreuil D, Faure K, Deplanque D, Bocket L, Duhamel A, Sobaszek A, Hober D, Hisbergues M, Puisieux F, Autran B, Yazdanpanah Y, Labalette M, Lefèvre G
Serum neutralization of SARS coronavirus 2 Omicron sublineages BA.1 and BA.2 and cellular immune responses 3 months after booster vaccination.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 258.e1-258.e4.
Dumont M, Guilhou T, Gerin M, Frémont-Goudot G, Nivose PL, Koubbi A, Joly V, Bouadma L, Yazdanpanah Y, André MH, de La Porte des Vaux C
Myocarditis in monkeypox-infected patients: a case series.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 390.e5-390.e7.
Martin-Blondel G, Marcelin AG, Soulié C, Kaisaridi S, Lusivika-Nzinga C, Zafilaza K, Dorival C, Nailler L, Boston A, Ronchetti AM, Melenotte C, Cabié A, Choquet C, Trinh-Duc A, Lacombe K, Gaube G, Coustillères F, Pourcher V, Martellosio JP, Peiffer-Smadja N, Chauveau M, Housset P, Piroth L, Devaux M, Pialoux G, Martin A, Dubee V, Frey J, Le Bot A, Cazanave C, Petua P, Liblau R, Carrat F, Yordanov Y
Time to negative PCR conversion amongst high-risk patients with mild-to-moderate Omicron BA.1 and BA.2 COVID-19 treated with sotrovimab or nirmatrelvir.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 543.e5-543.e9.
Bouzid D, Hingrat QL, Salipante F, Ferré VM, Chevallier T, Tubiana S, Lucet JC, Choquet C, Yazdanpanah Y, Timsit JF, Descamps D, Houhou N, Visseaux B, Loubet P
Agreement of respiratory viruses' detection between nasopharyngeal swab and bronchoalveolar lavage in adults admitted for pneumonia: a retrospective study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 942.e1-942.e6.
Bouzid D, Kapfer T, Marot S, Ing V, Ferré VM, Chauvin A, Le Goff J, Ellouze S, Salmona M, Hermand C, Bourg A, Schnuriger A, Fémy F, Van Tinh MN, Brichler S, Veyer D, Le Borgne P, Fafi-Kremer S, L'Honneur AS, Augustin C, Simon T, Cachanado M, IMProving Emergency Care (IMPEC) FHU authors group, Freund Y
Outcomes of Omicron sub-lineages BA.1.1 and BA.2 infection compared with the sub-lineage BA.1 infection in emergency departments' patients.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 551-553.
Buetti N, Marschall J, Catho G, Timsit JF, Mermel L
Which trial do we need? Infectious and non-infectious complications of peripherally inserted central venous catheters and midline catheters.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 568-569.
Celante H, Oubaya N, Fourati S, Beaune S, Khellaf M, Casalino E, Ricard JD, Vieillard-Baron A, Heming N, Mekontso Dessap A, de Montmollin E, Benghanem S, Epaillard N, Layese R, de Prost N, Prono-RSV study group of the clinical data warehouse of Greater Paris University Hospitals
Prognosis of hospitalised adult patients with respiratory syncytial virus infection: a multicentre retrospective cohort study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 943.e1-943.e8.
Buetti N, Ruckly S, Souweine B, Mimoz O, Timsit JF
Risk of infections in intravascular catheters in situ for more than 10 days: a post hoc analysis of randomized controlled trials.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 1200.e1-1200.e5.
Thy M, Cosson G, Danjou W, Kramer L, Pourcher V, Lescure FX
Comparison between targeted and vaccinated populations during the mpox vaccination campaign in France.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 1351-1353.
Bouzid D, Visseaux B, Ferré VM, Peiffer-Smadja N, Le Hingrat Q, Loubet P
Respiratory syncytial virus in adults with comorbidities: an update on epidemiology, vaccines, and treatments.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, S1198-743X(23)00412-3.
McLean C, Barry H, Kieh M, Anywaine Z, Tapima Rogers B, Doumbia S, Sirima SB, Serry-Bangura A, Habib Beavogui A, Gaddah A, Katwere M, Hendriks J, Keshinro B, Eholie S, Kibuuka H, Kennedy SB, Anzala O, Samai M, D'Ortenzio E, Leigh B, Sow S, Thiébaut R, Greenwood B, Watson-Jones D, Douoguih M, Luhn K, Robinson C
Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory.
EBioMedicine 2023, 91, 104562.
Sax PE, Arribas JR, Orkin C, Lazzarin A, Pozniak A, DeJesus E, Maggiolo F, Stellbrink HJ, Yazdanpanah Y, Acosta R, Huang H, Hindman JT, Martin H, Baeten JM, Wohl D, GS-US-380-1489 and GS-US-380-1490 study investigators
Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials.
EClinicalMedicine 2023, 59, 101991.
Gentilotti E, Górska A, Tami A, Gusinow R, Mirandola M, Rodríguez Baño J, Palacios Baena ZR, Rossi E, Hasenauer J, Lopes-Rafegas I, Righi E, Caroccia N, Cataudella S, Pasquini Z, Osmo T, Del Piccolo L, Savoldi A, Kumar-Singh S, Mazzaferri F, Caponcello MG, de Boer G, Hara GL, ORCHESTRA Study Group, De Nardo P, Malhotra S, Canziani LM, Ghosn J, Florence AM, Lafhej N, van der Gun BTF, Giannella M, Laouénan C, Tacconelli E
Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort.
EClinicalMedicine 2023, 62, 102107.
Taheri N, Mageau A, Chauveheid MP, Dossier A, Farhi F, Mendes C, Papo T, Goulenok T, Sacre K
Impact of adherence to EULAR quality indicators on the quality of life of patients with systemic lupus erythematosus.
European Journal of Internal Medicine 2023, 109, 68-72.
Goulenok T, Ferré VM, Mageau A, Papo T, Sacré K
Risk factors for high-risk human papillomavirus cervical infection and clearance in patients with systemic lupus erythematosus.
European Journal of Internal Medicine 2023, 116, 149-151.
Hazan F, Verdonk C, Coutance G, Ferré VM, Marot S, Melo VDD, Legeai C, Lebreton G, Para M, Varnous S, Dorent R
Severity of SARS-CoV-2 Omicron variant infection in heart transplant recipients.
The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation 2023, 42, 558-561.
Blot S, Timsit JF, Zahar JR
Preventing healthcare-acquired infections in cancer patients with febrile neutropenia in intensive care units: The role of granulocyte-colony stimulating factor prophylaxis.
Intensive & Critical Care Nursing 2023, 78, 103466.
Zahar JR, Blot S
Carbapenem-resistant Enterobacterales (CRE): The storm is coming.
Intensive & Critical Care Nursing 2023, 79, 103526.
Parisey M, Houze S, Bailly J, Taudon N, Jaffal K, Argy N, Rouzaud C, Mégarbane B, Lariven S, Yazdanpanah Y, Matheron S
Late dihydroartemisinin-piperaquine treatment failure of P. falciparum malaria attack related to insufficient dosing in an obese patient.
IDCases 2023, 33, e01847.
Méchaï F, Kolakowska A, Carbonnelle E, Bouchaud O, Tresallet C, Jaureguy F
Intra-abdominal abscesses: Microbiological epidemiology and empirical antibiotherapy.
Infectious Diseases Now 2023, 53, 104604.
Tandjaoui-Lambiotte Y, Lomont A, Moenne-Locoz P, Seytre D, Zahar JR
Spread of viruses, which measures are the most apt to control COVID-19?.
Infectious Diseases Now 2023, 53, 104637.
Deniaud F, Vignier N, Raynal G, Boo N, Collignon A, Hennequin C
Schistosoma haematobium urinary tract complications in African migrants attending primary care facilities in Paris, France: A retrospective cohort study (2004-2018).
Infectious Diseases Now 2023, 53, 104715.
Scanvion A, Vignier N, Durand F, Poupon-Ferron S, Billaud E
Heterogeneity of HIV testing practices in free healthcare centers in France: A national demonstration study.
Infectious Diseases Now 2023, 53, 104726.
Alviset S, Rodari S, Poupet H, Mizrahi A, Gastli N, Philippart F, Charpentier J, Pilmis B, Kernéis S
Potential impact of real-time processing and rapid susceptibility testing of blood samples in Gram-negative bloodstream infections in intensive care patients.
Infectious Diseases Now 2023, 53, 104773.
Goulenok T, Seurat J, Selle AdL, Jullien V, Leflon-Guibout V, Grall N, Lescure FX, Lepeule R, Bertrand J, Fantin B, Burdet C, Lefort A
Pharmacokinetic interaction between rifampicin and clindamycin in staphylococcal osteoarticular infections.
International Journal of Antimicrobial Agents 2023, 62, 106885.
Paccoud O, Chamillard X, Kendjo E, Vinatier I, Surgers L, Magne D, Wyplosz B, Angoulvant A, Bouchaud O, Izri A, Matheron S, Houzé S, Thellier M, Ndour AP, Buffet P, Caumes E, Jauréguiberry S, French National Reference Center for Imported Malaria Study Group
Favorable outcome without corticosteroids during post-artesunate delayed hemolysis with positive direct antiglobulin test in severe imported Plasmodium falciparum malaria, France.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2023, 137, 144-148.
Tsopra R, Peiffer-Smadja N, Charlier C, Campeotto F, Lemogne C, Ruszniewski P, Vivien B, Burgun A
Putting undergraduate medical students in AI-CDSS designers' shoes: An innovative teaching method to develop digital health critical thinking.
International Journal of Medical Informatics 2023, 171, 104980.
Rousset P, Dalle S, Mortier L, Dereure O, Dalac S, Dutriaux C, Leccia MT, Legoupil D, Brunet-Possenti F, De Quatrebarbes J, Grob JJ, Saiag P, Maubec E, Stoebner PE, Granel-Brocard F, Arnault JP, Allayous C, Oriano B, Lebbe C, Montaudié H
Impact of systemic therapies in metastatic melanoma of unknown primary: A study from MELBASE, a French multicentric prospective cohort.
Journal of the American Academy of Dermatology 2023, 88, 808-815.
Mageau A, Tchen J, Ferré VM, Nicaise-Roland P, Descamps D, Delory N, François C, Mendes C, Papo T, Goulenok T, Charles N, Sacré K
Impact of BNT162b2 mRNA anti-SARS-CoV-2 vaccine on interferon-alpha production by plasmacytoid dendritic cells and autoreactive T cells in patients with systemic lupus erythematosus: The COVALUS project.
Journal of Autoimmunity 2023, 134, 102987.
Robert M, Berleur M, Gaudemer A, Crow YJ, Frémond ML, Sacré K
VEXAS syndrome: Expanding the clinical and molecular spectrum.
Joint Bone Spine 2023, 90, 105531.
Zuercher P, Moser A, Frey MC, Pagani JL, Buetti N, Eggimann P, Daneman N, Fowler R, Que YA, Prazak J
The effect of duration of antimicrobial treatment for bacteremia in critically ill patients on in-hospital mortality - Retrospective double center analysis.
Journal of Critical Care 2023, 74, 154257.
Hassold N, Brichler S, Gater Y, Leclerc D, Gordien E, Bouchaud O, Carbonnelle E, Mechai F, Cordel H, Delagreverie H
Mixed outcomes following a third SARS-CoV-2 vaccine dose in previously unresponsive people with HIV.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2023, 158, 105347.
Jousset AB, Bernabeu S, Emeraud C, Bonnin RA, Lomont A, Zahar JR, Merens A, Isnard C, Soismier N, Farfour E, Fihman V, Yin N, Barraud O, Jacquier H, Ranc AG, Laurent F, Corvec S, d'Epenoux LR, Bille E, Degand N, Plouzeau C, Guillard T, Cattoir V, Mizrahi A, Grillon A, Janvier F, Brun CL, Amara M, Bastide M, Lemonnier A, Dortet L, GMC-study Group
Evaluation of ceftolozane-tazobactam susceptibility on a French nationwide collection of Enterobacterales.
Journal of Global Antimicrobial Resistance 2023, 32, 78-84.
Hachicha-Maalej N, Collins IJ, Ades AE, Scott K, Judd A, Mostafa A, Chappell E, Hamdy-El-Sayed M, Gibb D, Pett S, Mariné-Barjoan E, Volokha A, Yazdanpanah Y, Deuffic-Burban S
Modelling the potential effectiveness of hepatitis C screening and treatment strategies during pregnancy in Egypt and Ukraine.
Journal of Hepatology 2023, 78, 937-946.
Farfour E, Lebourgeois S, Chenane HR, Charpentier C, Pascreau T, Jolly E, Descamps D, Vasse M, Visseaux B
SARS-CoV-2 viability and viral RNA persistence on microbiological agar plates.
The Journal of Hospital Infection 2023, 132, 140-142.
Hassoun-Kheir N, Buetti N, Olivier V, Perez M, Frossard J, Renzi G, Schrenzel J, Saudan P, Harbarth S
Targeted mupirocin-based decolonization for Staphylococcus aureus carriers and the subsequent risk of mupirocin resistance in haemodialysis patients - a longitudinal study over 20 years.
The Journal of Hospital Infection 2023, 135, 55-58.
Henoun Loukili N, Loquet A, Perrin A, Gaillot O, Bruandet A, Sendid B, Zahar JR, Nseir S
Time to intestinal clearance of carbapenemase-producing Enterobacterales in hospital patients: a longitudinal retrospective observational cohort study.
The Journal of Hospital Infection 2023, 135, 4-10.
Halouani H, Lomont A, Jaureguy F, Carbonnelle E, Seytre D, Zahar JR
Interest of broth enrichment for rectal screening in a low carbapenemase-producing Enterobacterales prevalence country.
The Journal of Hospital Infection 2023, 138, 97-98.
Catho G, Rosa Mangeret F, Sauvan V, Chraïti MN, Pfister R, Baud O, Harbarth S, Buetti N
Risk of catheter-associated bloodstream infection by catheter type in a neonatal intensive care unit: a large cohort study of more than 1100 intravascular catheters.
The Journal of Hospital Infection 2023, 139, 6-10.
Smith DRM, Chervet S, Pinettes T, Shirreff G, Jijón S, Oodally A, Jean K, Opatowski L, Kernéis S, Temime L
How have mathematical models contributed to understanding the transmission and control of SARS-CoV-2 in healthcare settings? A systematic search and review.
The Journal of Hospital Infection 2023, 141, 132-141.
Legouge C, Bidet P, Gits-Muselli M, Cointe A, Courroux C, Birgy A, Bonacorsi S
Rapid, simple multi-locus variable number tandem repeat analysis: a reliable tool for Klebsiella pneumoniae outbreak screening.
The Journal of Hospital Infection 2023, 141, 41-48.
de Lamballerie X, Martin-Blondel G, Dupont A, Izopet J, Mentré F, Kamar N, Autran B, Paintaud G, Caillard S, le Bourgeois A, Richez C, Couzi L, Xhaard A, Marjanovic Z, Avouac J, Jacquet C, Anglicheau D, Cheminant M, Yazdanpanah Y, Guyen SN, Terrier B, Gottenberg JE, Besson C, Letrou S, Kali S, Angoulvant D, Sanchez VP, Tardivon C, Blancho G, Lévy V
Low serum neutralization of Omicron variants a month after AZD7442 prophylaxis initiation.
The Journal of Infection 2023, 86, 66-117.
Mellon G, Rubenstein E, Antoine M, Ferré VM, Gabassi A, Molina JM, Delaugerre C, LeGoff J
Air detection of monkeypox virus in a dedicated outpatient clinic room for monkeypox infection diagnosis.
The Journal of Infection 2023, 86, 256-308.
Touret F, Martin-Blondel G, de Lamballerie X, Dupont A, Izopet J, Mentré F, Kamar N, Autran B, Paintaud G, Caillard S, Richez C, Couzi L, Xhaard A, Marjanovic Z, Avouac J, Jacquet C, Anglicheau D, Cheminant M, Yazdanpanah Y, N'Guyen S, Terrier B, Gottenberg JE, Besson C, Letrou S, Kali S, Angoulvant D, Barthélémy K, Priet S, Nurtop E, Sanchez VP, Tardivon C, Blancho G, Le Bourgeois A, Lévy V
Low to undetectable Omicron BQ.1.1 neutralization by patient's sera a month after initiation of AZD7442 600 mg.
The Journal of Infection 2023, 86, e126-e129.
Pellenc Q, Renard R, Gaudemer A, Amarenco P, Lavallée P
Bypass grafting to the third segment of the vertebral artery for symptomatic extensive vertebrobasilar atherosclerotic disease.
Journal of Vascular Surgery Cases and Innovative Techniques 2023, 9, 101260.
Brault A, Tran-Kiem C, Couteaux C, Olié V, Paireau J, Yazdanpanah Y, Ghosn J, Martin-Blondel G, Bosetti P, Cauchemez S
Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna.
The Lancet Regional Health. Western Pacific 2023, 30, 100634.
Roblot P, Belaroussi Y, Peiffer-Smadja N, Lafarge X, Cotto E, Colombat M, Blohorn L, Gardere M, Kerdiles G, Le Petit L, Wavasseur T, Liguoro D, Jecko V, Vignes JR
Effect of microorganisms isolated by preoperative osseous sampling on surgical site infection after autologous cranioplasty: A single-center experience.
Neuro-Chirurgie 2023, 69, 101458.
Ardellier FD, Baloglu S, Sokolska M, Noblet V, Lersy F, Collange O, Ferré JC, Maamar A, Carsin-Nicol B, Helms J, Schenck M, Khalil A, Gaudemer A, Caillard S, Pottecher J, Lefèbvre N, Zorn PE, Matthieu M, Brisset JC, Boulay C, Mutschler V, Hansmann Y, Mertes PM, Schneider F, Fafi-Kremer S, Ohana M, Meziani F, Meyer N, Yousry T, Anheim M, Cotton F, Jäger HR, Kremer S, SFNR-COVID group
Cerebral perfusion using ASL in patients with COVID-19 and neurological manifestations: A retrospective multicenter observational study.
Journal of Neuroradiology = Journal De Neuroradiologie 2023, S0150-9861(23)00006-8.
Ballul T, Mageau A, Roland Nicaise P, Ajzenberg N, Strukov A, Dossier A, Rouzaud D, Papo T, Sacré K
Recurrent thrombotic events after disappearance of antiphospholipid autoantibodies: A long-term longitudinal study in patients with antiphospholipid syndrome.
Thrombosis Research 2023, 224, 1-3.
Gros C, Barral T, Mageau A, Roland Nicaise P, Vivier V, Papo T, Bourgeois-Moine A, Goulenok T, Sacre K
Unexplained fetal death, pre-eclampsia and fetal growth restriction in pregnancy: Who is screened for antiphospholipid syndrome?.
Thrombosis Research 2023, 228, 61-63.
Coppée R, Chenane HR, Bridier-Nahmias A, Tcherakian C, Catherinot E, Collin G, Lebourgeois S, Visseaux B, Descamps D, Vasse M, Farfour E
Temporal dynamics of RSV shedding and genetic diversity in adults during the COVID-19 pandemic in a French hospital, early 2021.
Virus Research 2023, 323, 198950.
Lefrançois T, Malvy D, Atlani-Duault L, Benamouzig D, Druais PL, Yazdanpanah Y, Delfraissy JF, Lina B
After 2 years of the COVID-19 pandemic, translating One Health into action is urgent.
Lancet (London, England) 2023, 401, 789-794.
Mitjà O, Alemany A, Marks M, Lezama Mora JI, Rodríguez-Aldama JC, Torres Silva MS, Corral Herrera EA, Crabtree-Ramirez B, Blanco JL, Girometti N, Mazzotta V, Hazra A, Silva M, Montenegro-Idrogo JJ, Gebo K, Ghosn J, Peña Vázquez MF, Matos Prado E, Unigwe U, Villar-García J, Wald-Dickler N, Zucker J, Paredes R, Calmy A, Waters L, Galvan-Casas C, Walmsley S, Orkin CM, SHARE-NET writing group
Mpox in people with advanced HIV infection: a global case series.
Lancet (London, England) 2023, 401, 939-949.
Beaumont AL, Raphaël E, Bertin C, Lariven S, Peiffer-Smadja N
Mpox lesions on a tattoo.
The Lancet. Infectious Diseases 2023, 23, 762.
Beaumont AL, Peiffer-Smadja N
Mpox: a new name for a new disease?.
The Lancet. Infectious Diseases 2023, 23, 516-517.
Amstutz A, Speich B, Mentré F, Rueegg CS, Belhadi D, Assoumou L, Burdet C, Murthy S, Dodd LE, Wang Y, Tikkinen KAO, Ader F, Hites M, Bouscambert M, Trabaud MA, Fralick M, Lee TC, Pinto R, Barratt-Due A, Lund-Johansen F, Müller F, Nevalainen OPO, Cao B, Bonnett T, Griessbach A, Taji Heravi A, Schönenberger C, Janiaud P, Werlen L, Aghlmandi S, Schandelmaier S, Yazdanpanah Y, Costagliola D, Olsen IC, Briel M
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials.
The Lancet. Respiratory Medicine 2023, 11, 453-464.
Reignier J, Plantefeve G, Mira JP, Argaud L, Asfar P, Aissaoui N, Badie J, Botoc NV, Brisard L, Bui HN, Chatellier D, Chauvelot L, Combes A, Cracco C, Darmon M, Das V, Debarre M, Delbove A, Devaquet J, Dumont LM, Gontier O, Groyer S, Guérin L, Guidet B, Hourmant Y, Jaber S, Lambiotte F, Leroy C, Letocart P, Madeux B, Maizel J, Martinet O, Martino F, Maxime V, Mercier E, Nay MA, Nseir S, Oziel J, Picard W, Piton G, Quenot JP, Reizine F, Renault A, Richecoeur J, Rigaud JP, Schneider F, Silva D, Sirodot M, Souweine B, Tamion F, Terzi N, Thévenin D, Thiery G, Thieulot-Rolin N, Timsit JF, Tinturier F, Tirot P, Vanderlinden T, Vinatier I, Vinsonneau C, Voicu S, Lascarrou JB, Le Gouge A, NUTRIREA-3 Trial Investigators, Clinical Research in Intensive Care, Sepsis (CRICS-TRIGGERSEP)Group
Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3).
The Lancet. Respiratory Medicine 2023, 11, 602-612.
Charani E, Mendelson M, Pallett SJC, Ahmad R, Mpundu M, Mbamalu O, Bonaconsa C, Nampoothiri V, Singh S, Peiffer-Smadja N, Anton-Vazquez V, Moore LSP, Schouten J, Kostyanev T, Vlahović-Palčevski V, Kofteridis D, Corrêa JS, Holmes AH
An analysis of existing national action plans for antimicrobial resistance-gaps and opportunities in strategies optimising antibiotic use in human populations.
The Lancet. Global Health 2023, 11, e466-e474.
Ogbuagu O, Segal-Maurer S, Ratanasuwan W, Avihingsanon A, Brinson C, Workowski K, Antinori A, Yazdanpanah Y, Trottier B, Wang H, Margot N, Dvory-Sobol H, Rhee MS, Baeten JM, Molina JM, GS-US-200-4625 investigators
Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial.
The lancet. HIV 2023, 10, e497-e505.
Guémas E, Coppée R, Ménard S, du Manoir M, Nsango S, Makaba Mvumbi D, Nakoune E, Eboumbou Moukoko CE, Bouyou Akotet MK, Mirabeau TY, Manguin S, Malekita Yobi D, Akiana J, Kouna LC, Mawili Mboumba DP, Voumbo-Matoumona DF, Otam AL, Rubbo PA, Lombart JP, Kwanai E, Cohen O, Iriart X, Ayong L, Lekana-Douki JB, Ariey F, Berry A
Evolution and spread of Plasmodium falciparum mutations associated with resistance to sulfadoxine-pyrimethamine in central Africa: a cross-sectional study.
The Lancet. Microbe 2023, S2666-5247(23)00211-2.
Landelle C, Birgand G, Price JR, Mutters NT, Morgan DJ, Lucet JC, Kerneis S, Zingg W
Considerations for de-escalating universal masking in healthcare centers.
Antimicrobial stewardship & healthcare epidemiology: ASHE 2023, 3, e128.
Yokoe DS, Advani SD, Anderson DJ, Babcock HM, Bell M, Berenholtz SM, Bryant KA, Buetti N, Calderwood MS, Calfee DP, Dubberke ER, Ellingson KD, Fishman NO, Gerding DN, Glowicz J, Hayden MK, Kaye KS, Klompas M, Kociolek LK, Landon E, Larson EL, Malani AN, Marschall J, Meddings J, Mermel LA, Patel PK, Perl TM, Popovich KJ, Schaffzin JK, Septimus E, Trivedi KK, Weinstein RA, Maragakis LL
Executive Summary: A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute-Care Hospitals: 2022 Updates.
Infection Control and Hospital Epidemiology 2023, 44, 1540-1554.
Grant RL, Sauser J, Atkinson A, D'Incau S, Buetti N, Zanella MC, Harbarth S, Marschall J, Catho G, CH-SUR Collaborative Network
Comparison of clinical outcomes over time of inpatients with healthcare-associated or community-acquired coronavirus disease 2019 (COVID-19): A multicenter, prospective cohort study.
Infection Control and Hospital Epidemiology 2023, 1-7.
Yokoe DS, Advani SD, Anderson DJ, Babcock HM, Bell M, Berenholtz SM, Bryant KA, Buetti N, Calderwood MS, Calfee DP, Deloney VM, Dubberke ER, Ellingson KD, Fishman NO, Gerding DN, Glowicz J, Hayden MK, Kaye KS, Kociolek LK, Landon E, Larson EL, Malani AN, Marschall J, Meddings J, Mermel LA, Patel PK, Perl TM, Popovich KJ, Schaffzin JK, Septimus E, Trivedi KK, Weinstein RA, Maragakis LL
Introduction to A Compendium of Strategies to Prevent Healthcare-Associated Infections In Acute-Care Hospitals: 2022 Updates.
Infection Control and Hospital Epidemiology 2023, 44, 1533-1539.
Garrouste-Orgeas M, Marché V, Pujol N, Michel D, Evin A, Fossez-Diaz V, Perruchio S, Vanbésien A, Verlaine C, Copel L, Kaczmarek W, Birkui de Francqueville L, Michonneau-Gandon V, de Larivière E, Poupardin C, Touzet L, Guastella V, Mathias C, Mhalla A, Bouquet G, Richard B, Gracia D, Bienfait F, Verliac V, Ranchou G, Kirsch S, Flahault C, Loiodice A, Bailly S, Ruckly S, Timsit JF
Incidence and risk factors of prolonged grief in relatives of patients with terminal cancer in French palliative care units: The Fami-Life multicenter cohort study.
Palliative & Supportive Care 2023, 1-10.
Le Hingrat Q, Sette P, Xu C, Rahmberg AR, Tarnus L, Annapureddy H, Kleinman A, Brocca-Cofano E, Sivanandham R, Sivanandham S, He T, Capreri DJ, Ma D, Estes JD, Brenchley JM, Apetrei C, Pandrea I
Prolonged experimental CD4+ T-cell depletion does not cause disease progression in SIV-infected African green monkeys.
Nature Communications 2023, 14, 979.
Telford E, Grinsztejn B, Olsen IC, Pulik N, Mentré F, Haviari S, Hentzien M, Ségéral O, Ekkelenkamp MB, Ogoina D, Strub-Wourgaft N, Diallo A, Yazdanpanah Y, Calmy A
The international Unity study for antivirals against mpox is a blueprint for future epidemics.
Nature Medicine 2023, 29, 1894-1895.
Mirouse A, Friol A, Moreau AS, Jung B, Jullien E, Bureau C, Djibré M, de Prost N, Zafrani L, Argaud L, Reuter D, Calvet L, de Montmollin E, Benghanem S, Pichereau C, Pham T, Cacoub P, Biard L, Saadoun D
Severe SARS-Cov2 pneumonia in vaccinated patients: a multicenter cohort study.
Scientific Reports 2023, 13, 1902.
de Roquetaillade C, Laouenan C, Mira JP, Roy C, Thuong M, Azoulay É, Gruson D, Jacobs F, Chommeloux J, Raffi F, Hocqueloux L, Imbert P, Jeantils V, Delassus JL, Matheron S, Fitting C, Timsit JF, Bruneel F
Cytokine profiles in adults with imported malaria.
Scientific Reports 2023, 13, 10347.
Arnaud E, Elbattah M, Ammirati C, Dequen G, Ghazali DA
Predictive models in emergency medicine and their missing data strategies: a systematic review.
NPJ digital medicine 2023, 6, 28.
Nguyen Y, Nuzzo A, Gross A, Minka O, Lilamand M, Rossi G, Sanchez M, Legué C, Pourbaix A, Tran Dinh A, Rozencwajg S, Khider L, Peiffer-Smadja N, Bouzid D, Faye A, Mirault T, de Lastours V
Prior participation as a standardized patient improves OSCE scores of third-year medical students: A pilot comparative study at Université Paris Cité Medical School.
Medical Teacher 2023, 45, 1177-1182.
Mageau A, Ambert-Balay K, Boutolleau D, Schuffenecker I, Burrel S, Kaplon J, Nguyen Quoc S, Uzunov M, Souchet L, de Rougemont A, Roos-Weil D, Baron M
Norovirus and sapovirus infections after allogeneic hematopoietic stem cell transplantation: is it worth it to look for them?.
Leukemia & Lymphoma 2023, 64, 1295-1303.
Chabrol F, Traverson L, Hou R, Chotard L, Lucet JC, Peiffer-Smadja N, Bendjelloul G, Lescure FX, Yazdanpanah Y, Zinszer K, Ridde V
Adaptation and Response of a Major Parisian Referral Hospital to the COVID-19 Surge: A Qualitative Study.
Health Systems and Reform 2023, 9, 2165429.
Dagenais C, Kielende M, Coulibaly A, Gautier L, David PM, Peiffer-Smadja N, Honda A, de Araújo Oliveira SR, Traverson L, Zinszer K, Ridde V
Lessons Learned from Field Experiences on Hospitals' Resilience to the COVID-19 Pandemic: A Systematic Approach.
Health Systems and Reform 2023, 9, 2231644.
Nguyen LBL, Soumah AA, Hoang VT, Nguyen AT, Pham TH, Royer-Devaux S, Madec Y
Performances of Dried Blood Spots and Point-of-Care Devices to Identify Virological Failure in HIV-Infected Patients: A Systematic Review and Meta-Analysis.
AIDS patient care and STDs 2023, 37, 66-83.
Bertin C, Tarhini H, Rahi M, Deconinck L, Perrineau S, Merlant M, Ghosn J, Peiffer-Smadja N
Complicated scarring following mpox infection.
The British Journal of Dermatology 2023, 189, 225-226.
Lutz W, Bertin C, Merlant M, Mailhe M, Le Hingrat Q, Descamps V, Guilhou T, Maisonobe L, Yazdanpanah Y, Deschamps L, Charpentier C, Lariven S
Mpox presenting as a chronic cutaneous ulcer in a patient with advanced HIV infection.
Clinical and Experimental Dermatology 2023, llad258.
Sibiude J, Le Chenadec J, Mandelbrot L, Hoctin A, Dollfus C, Faye A, Bui E, Pannier E, Ghosn J, Garrait V, Avettand-Fenoel V, Frange P, Warszawski J, Tubiana R
Update of Perinatal Human Immunodeficiency Virus Type 1 Transmission in France: Zero Transmission for 5482 Mothers on Continuous Antiretroviral Therapy From Conception and With Undetectable Viral Load at Delivery.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2023, 76, e590-e598.
Coppée R, Sarrasin V, Zaffaroulah R, Bouzayene A, Thellier M, Noël H, Clain J, Houzé S, Investigation Study Group
Nosocomial Malaria Transmissions Resolved by Genomic Analyses-A Retrospective Case Report Study in France: 2007-2021.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2023, 76, 631-639.
Chalali F, Merlant M, Truong A, Ghosn J, Phung BC, Mollo B, Perrineau S, Rahi M, Fidouh-Houhou N, Ferré VM, Brunet-Possenti F, Descamps V, Bouscarat F, Yazdanpanah Y, Deschamps L, Bertin C
Histological Features Associated With Human Mpox Virus Infection in 2022 Outbreak in a Nonendemic Country.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2023, 76, 1132-1135.
de Salazar A, Viñuela L, Fuentes A, Teyssou E, Charpentier C, Lambert-Niclot S, Serrano-Conde E, Pingarilho M, Fabeni L, De Monte A, Stefic K, Perno CF, Aguilera A, Falces I, Delgado R, Fernandes S, Diogo I, Gomes P, Paraskevis D, Santoro MM, Ceccherini-Silberstein F, Marcelin AG, Garcia F
Transmitted Drug Resistance to Integrase-Based First-Line Human Immunodeficiency Virus Antiretroviral Regimens in Mediterranean Europe.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2023, 76, 1628-1635.
Laurent C, Yaya I, Cuer B, Sagaon-Teyssier L, Mensah E, Dah TTE, Coulibaly A, Kouamé MJB, Peytavin G, Serrano L, Eubanks A, Traoré I, Diallo F, Riegel L, Rojas Castro D, Dagnra CA, Anoma C, Vuylsteke B, Dembélé Keita B, Spire B, CohMSM-PrEP Study Group
Human Immunodeficiency Virus Seroconversion Among Men Who Have Sex With Men Who Use Event-Driven or Daily Oral Pre-Exposure Prophylaxis (CohMSM-PrEP): A Multi-Country Demonstration Study From West Africa.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2023, 77, 606-614.
Stern J, Dupuis C, Kpeglo H, Reuter J, Vinclair C, Para M, Nataf P, Pelletier AL, de Montmollin E, Bouadma L, Timsit JF, Sonneville R
Upper gastrointestinal bleeding in adults treated with veno-arterial extracorporeal membrane oxygenation: a cohort study.
European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 2023, 63, ezad083.
von Cube M, Schumacher M, Timsit JF, Decruyenaere J, Steen J
The population-attributable fraction for time-to-event data.
International Journal of Epidemiology 2023, 52, 837-845.
Joste V, Colard-Itté E, Guillochon É, Ariey F, Coppée R, Clain J, Houzé S, French National Reference Center for Imported Malaria Study Group
Genetic Profiling of Plasmodium ovale wallikeri Relapses With Microsatellite Markers and Whole-Genome Sequencing.
The Journal of Infectious Diseases 2023, 228, 1089-1098.
Guilbaud R, Franco Yusti AM, Leducq V, Zafilaza K, Bridier-Nahmias A, Todesco E, Soulie C, Fauchois A, Le Hingrat Q, Kramer L, Goulenok T, Salpin M, Daugas E, Dorent R, Ottaviani S, Zalcman G, Ghosn J, Choquet S, Cacoub P, Amoura Z, Barroux B, Pourcher V, Spano JP, Louet M, Marcelin AG, Calvez V, Charpentier C, Descamps D, Marot S, Ferré VM, Coppée R
Higher levels of SARS-CoV-2 genetic variation in immunocompromised patients: a retrospective case-control study.
The Journal of Infectious Diseases 2023, jiad499.
Bachelard A, Isernia V, Charpentier C, Benalycherif A, Mora M, Donadille C, Duvivier C, Lacombe K, El Mouhebb M, Spire B, Landman R, Descamps D, Peytavin G, Assoumou L, Ghosn J, FAST study group
Same-day initiation of bictegravir/emtricitabine/tenofovir alafenamide: Week 48 results of the FAST study-IMEA 055.
The Journal of Antimicrobial Chemotherapy 2023, 78, 769-778.
Lafaurie M, Montlahuc C, Kerneis S, de Lastours V, Abgrall S, Manceron V, Couzigou C, Chabrol A, de Raigniac A, Lescure X, Longuet P, Lesprit P, Vanjak D, Lepeule R, Groupe des référents en Infectiologie d’Ile de France (GRIF)
Efficacy of vancomycin lock therapy for totally implantable venous access port-related infection due to coagulase-negative staphylococci in 100 patients with cancer.
The Journal of Antimicrobial Chemotherapy 2023, 78, 1253-1258.
Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, Descamps D, Ceccherini-Silberstein F, Marcelin AG, Flandre P
Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings.
The Journal of Antimicrobial Chemotherapy 2023, 78, 1415-1422.
Lambert-Niclot S, Abdi B, Bellet J, Fofana D, De Truchis P, Amat K, Alvarez JC, Surgers L, Allavena C, Zaegell-Faucher O, Morlat P, Palich R, Gibowski S, Costagliola D, Girard PM, Landman R, Assoumou L, Morand-Joubert L, ANRS 170 QUATUOR study group
Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR): substudies of reservoirs and ultrasensitive drug resistance.
The Journal of Antimicrobial Chemotherapy 2023, 78, 1510-1521.
Mandelbrot L, Tubiana R, Frange P, Peytavin G, Le Chenadec J, Canestri A, Morlat P, Brunet-Cartier C, Sibiude J, Peretti D, Chambrin V, Chabrol A, Bui E, Simon-Toulza C, Marchand L, Paul C, Delmas S, Avettand-Fenoel V, Warszawski J, Monogest study group
Maintenance darunavir/ritonavir monotherapy to prevent perinatal HIV transmission, ANRS-MIE 168 MONOGEST study.
The Journal of Antimicrobial Chemotherapy 2023, 78, 1711-1722.
Duhant A, Kusinza B, Tantet C, Bisimwa B, Gare M, Masemo B, Alloui C, Ntakwinjan M, Mechai F, Le MP, Gerber A, Muhigirwa B, Peytavin G, Gordien E, Brichler S, Mukwege M, Le Gal F
HIV-1 infection in South Kivu (Democratic Republic of Congo): high genotypic resistance to antiretrovirals.
The Journal of Antimicrobial Chemotherapy 2023, 78, 1732-1739.
Contejean A, Maillard A, Canouï E, Kernéis S, Fantin B, Bouscary D, Parize P, Garcia-Vidal C, Charlier C
Advances in antibacterial treatment of adults with high-risk febrile neutropenia.
The Journal of Antimicrobial Chemotherapy 2023, 78, 2109-2120.
Aslan AT, Tabah A, Köylü B, Kalem AK, Aksoy F, Erol Ç, Karaali R, Tunay B, Guzeldağ S, Batirel A, Dindar EK, Akdoğan Ö, Bilir Y, Ersöz G, Öztürk B, Selçuk M, Yilmaz M, Akyol A, Akbaş T, Sungurtekin H, Timuroğlu A, Gürbüz Y, Çolak O, Bayindir Y, Eroğlu A, Ferlicolak L, Çeşme U, Dağ O, Buetti N, Barbier F, Ruckly S, Staiquly Q, Timsit JF, Akova M
Epidemiology and risk factors of 28-day mortality of hospital-acquired bloodstream infection in Turkish intensive care units: a prospective observational cohort study.
The Journal of Antimicrobial Chemotherapy 2023, 78, 1757-1768.
Mazouz F, Bertine M, Coppée R, Storto A, Katlama C, Landman R, Cabié A, Peytavin G, Raffi F, Yazdanpanah Y, Descamps D, Joly V, Ghosn J, Charpentier C, LAMIDOL Study Group
Proportion of APOBEC3-induced defective HIV DNA after 1 year of dolutegravir + lamivudine simplification in the ANRS 167 LAMIDOL trial.
The Journal of Antimicrobial Chemotherapy 2023, dkad344.
Rondinaud E, Clermont O, Petitjean M, Ruppé E, Esposito-Farèse M, Nazimoudine A, VOYAG-R Study Group, Coignard B, Matheron S, Andremont A, Denamur E, Armand-Lefevre L
Acquisition of Enterobacterales carrying the colistin resistance gene mcr following travel to the tropics.
Journal of Travel Medicine 2023, 30, taac141.
de Malliard I, Houist AL, Peytavin G, L'Yavanc T, Bouvier M, Cappy P, Lelièvre JD, Feredj E, Vindrios W, Gallien S, Melica G
Gynoid Fat Distribution and Adipocyte Trapping May Explain Virological Failure With Intramuscular Long-Acting Cabotegravir and Rilpivirine.
Open Forum Infectious Diseases 2023, 10, ofad217.
Gaborit B, Vanhove B, Lacombe K, Guimard T, Hocqueloux L, Perrier L, Dubee V, Ferre V, Bressollette C, Josien R, Thuaut AL, Vibet MA, Jobert A, Dailly E, Ader F, Brouard S, Duvaux O, Raffi F, POLYCOR study group
Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled Trial.
Open Forum Infectious Diseases 2023, 10, ofad525.
Tin Y, Castry M, Bowers-Sword R, Shantharam S, Aldridge A, Zarkin GA, Starbird L, Linas BP, Barocas JA, Morgan JR
Establishing a Protocol for Determining the Costs of an Integrated Set of Evidence-based Practices Aimed at Reducing Opioid Overdose Deaths.
Journal of Addiction Medicine 2023
Galerneau LM, Bailly S, Terzi N, Ruckly S, Garrouste-Orgeas M, Cohen Y, Hong Tuan Ha V, Gainnier M, Siami S, Dupuis C, Darmon M, Forel JM, Rigault G, Adrie C, Goldgran-Toledano D, Laurent V, de Montmollin E, Argaud L, Reignier J, Pepin JL, Timsit JF, OUTCOMEREA Network
Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease in the ICU: An Observational Study From the OUTCOMEREA Database, 1997-2018.
Critical Care Medicine 2023, 51, 753-764.
Vacheron CH, Friggeri A, Gerbaud-Coulas C, Dagonneau T, Timsit JF, Allaouchiche B, Wallet F, Bohe J, Piriou V, Maucort-Boulch D, Fauvernier M
Improved 30-Day Survival Estimation in ICU Patients: A Comparative Analysis of Different Approaches With Real-World Data.
Critical Care Medicine 2023
Sonneville R, Dangayach NS, Newcombe V
Neurological complications of critically ill COVID-19 patients.
Current Opinion in Critical Care 2023, 29, 61-67.
Thy M, de Montmollin E, Bouadma L, Timsit JF, Sonneville R
Severe meningoencephalitis: epidemiology and outcomes.
Current Opinion in Critical Care 2023, 29, 415-422.
Tubiana S, Epelboin L, Casalino E, Naccache JM, Feydy A, Khalil A, Hausfater P, Duval X, Claessens YE, ESCAPED study group
Effect of diagnosis level of certainty on adherence to antibiotics' guidelines in ED patients with pneumonia: a post-hoc analysis of an interventional trial.
European Journal of Emergency Medicine: Official Journal of the European Society for Emergency Medicine 2023, 30, 102-109.
Cancella de Abreu M, Peyrony O, Hermand C, Bompard R, Bouzid D, Eyer X
Time to result advantage of point-of-care SARS-CoV-2 PCR testing to confirm COVID-19 in emergency department: a retrospective multicenter study.
European Journal of Emergency Medicine: Official Journal of the European Society for Emergency Medicine 2023, 30, 132-134.
Abensur Vuillaume L, Gennai S, Casalino E, Tazarourte K, Bilbault P
An emergency department organizational assessment questionnaire: a Delphi study to create standardized comparators for emergency department directors.
European Journal of Emergency Medicine: Official Journal of the European Society for Emergency Medicine 2023, 30, 209-210.
Antoine M, Rubenstein E, Lascoux-Combe C, Chawki S, Zeggagh J, Pintado C, Tateo M, Ponscarme D, Ferre VM, Descamps D, Molina JM
Clinical Description of Sixty-Six Cases of Monkeypox Virus (MKPV) Infection Among Men Who Have Sex With Men (MSM) in an HIV/PrEP French Clinic.
Journal of Acquired Immune Deficiency Syndromes (1999) 2023, 92, e11-e14.
Barbier F, Woerther PL, Timsit JF
Rapid diagnostics for skin and soft tissue infections: the current landscape and future potential.
Current Opinion in Infectious Diseases 2023, 36, 57-66.
Do Rego H, Timsit JF
Management strategies for severe Pseudomonas aeruginosa infections.
Current Opinion in Infectious Diseases 2023, 36, 585-595.
Ghazali DA, Choquet C, Bouzid D, Peyrony O, Fontaine JP, Sonja C, Javaud N, Plaisance P, Revue E, Chauvin A, Casalino E
The Response of Emergency Departments (EDs) to the COVID-19 Pandemic: The Experience of 5 EDs in a Paris-Based Academic Hospital Trust.
Quality Management in Health Care 2023, 32, 46-52.
Terzić V, Levoyer L, Figarella M, Bigagli E, Mercier N, De Gastines L, Gibowski S, Trøseid M, Demotes J, Olsen IC, Hites M, Ader F, Lopez JRA, Mentré F, Espérou H, Costagliola D, Røttingen JA, Poissy J, Rozé JC, Warris A, O'Leary J, Fernandes RM, Assoumou L, Hankard R, Turner MA, Yazdanpanah Y, Diallo A, EU-Response safety group, c4c safety group
Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia.
British Journal of Clinical Pharmacology 2023, 89, 1318-1328.
Lemaitre F, Lagoutte-Renosi J, Gagnieu MC, Parant F, Venisse N, Grégoire M, Bouchet S, Garraffo R, Lê MP, Muret P, Comets E, Solas C, Peytavin G, ANRS-MIE-BIRIDER Study group on behalf of the Clinical Pharmacology Group of ANRS-MIE AC43
Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1-infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER study).
British Journal of Clinical Pharmacology 2023
Rekik S, Pluart DL, Ferré V, Charpentier C, Laurain A, Ghosn J, Abramowitz L
Anogenital symptoms and lesions in a series of 20 patients infected with monkeypox virus.
Colorectal Disease: The Official Journal of the Association of Coloproctology of Great Britain and Ireland 2023, 25, 1002-1005.
Liegeon G, Ghosn J
Long-acting injectable cabotegravir for PrEP: A game-changer in HIV prevention?.
HIV medicine 2023, 24, 653-663.
Hocqueloux L, Menard A, Arvieux C, Joly V, Becker A, Chéret A, Duvivier C, Cabié A, Delpierre C, Allavena C, Dat'AIDS Study Group
Weight gain following the single substitution of tenofovir disoproxil fumarate by tenofovir alafenamide in HIV-infected people from the French Dat'AIDS cohort: A propensity score-matched analysis.
HIV medicine 2023, 24, 925-932.
Protiere C, Sagaon-Teyssier L, Donadille C, Sow A, Gaubert G, Girard G, Mora M, Assoumou L, Beniguel L, Michels D, Ghosn J, Costagliola D, Rojas Castro D, Molina JM, Spire B, ANRS PREVENIR Study-Group
Perception of PrEP-related stigma in PrEP users: Results from the ANRS-PREVENIR cohort.
HIV medicine 2023, 24, 938-945.
Moghadam P, Herms F, Baroudjian B, Tetu P, Delyon J, Jouenne F, Boisson M, Louveau B, Mourah S, Brunet-Possenti F, Duverger L, Gounant V, Lebbé C, Basset-Seguin N
Eruptive squamous cell carcinomas following an acute skin inflammatory disease: A series of four cases.
Journal of the European Academy of Dermatology and Venereology: JEADV 2023, 37, e119-e121.
Bertin C, Beaumont AL, Merlant M, Mailhe M, Le Pluart D, Deconinck L, Thy M, Cortier M, Garé M, Dollat M, Rahi M, Joly V, Lariven S, Rioux C, Truong A, Deschamps L, Ferré VM, Charpentier C, Lescure FX, Bouscarat F, Descamps V, Yazdanpanah Y, Peiffer-Smadja N
Erythematous maculopapular rash in monkeypox virus infection: A retrospective case series of 30 patients.
Journal of the European Academy of Dermatology and Venereology: JEADV 2023, 37, e638-e641.
Khelef K, Maubec E, Jeudy G, Bonniaud B, Pham-Ledard A, Herms F, Aubin F, Beneton N, Dinulescu M, Jannic A, Duval-Modeste A, Archier E, Berthin C, Grange F, Arnault J, Heidelberger V, Moncourier M, Mansard S, Brunet-Possenti F, Triller R, Pracht M, Dumas M, Lauche O, Mortier L, Bedane C, Dalac Rat S
Duration of treatment with cemiplimab in advanced cutaneous squamous cell carcinoma in complete response: Real-life study.
Journal of the European Academy of Dermatology and Venereology: JEADV 2023
Allavena C, Bastides F, Moroy A, Occhipinti S, Durand F, Barriere G, Micoulaud-Franchi JA, Ghosn J
The screening and management of sleep disturbances in people living with HIV: Delphi consensus.
Journal of Sleep Research 2023, e14070.
Ghazali DA, Ilha-Schuelter P, Oriot D
Performing complex interdisciplinary procedures: Never on the patient the first time!.
Medical Education 2023
Bonello K, Figoni H, Blanchard E, Vignier N, Avenin G, Melchior M, Cadwallader JS, Chastang J, Ibanez G
Prevalence of smoking during pregnancy and associated social inequalities in developed countries over the 1995-2020 period: A systematic review.
Paediatric and Perinatal Epidemiology 2023
Bastard P, Vazquez SE, Liu J, Laurie MT, Wang CY, Gervais A, Le Voyer T, Bizien L, Zamecnik C, Philippot Q, Rosain J, Catherinot E, Willmore A, Mitchell AM, Bair R, Garçon P, Kenney H, Fekkar A, Salagianni M, Poulakou G, Siouti E, Sahanic S, Tancevski I, Weiss G, Nagl L, Manry J, Duvlis S, Arroyo-Sánchez D, Paz Artal E, Rubio L, Perani C, Bezzi M, Sottini A, Quaresima V, Roussel L, Vinh DC, Reyes LF, Garzaro M, Hatipoglu N, Boutboul D, Tandjaoui-Lambiotte Y, Borghesi A, Aliberti A, Cassaniti I, Venet F, Monneret G, Halwani R, Sharif-Askari NS, Danielson J, Burrel S, Morbieu C, Stepanovskyy Y, Bondarenko A, Volokha A, Boyarchuk O, Gagro A, Neuville M, Neven B, Keles S, Hernu R, Bal A, Novelli A, Novelli G, Saker K, Ailioaie O, Antolí A, Jeziorski E, Rocamora-Blanch G, Teixeira C, Delaunay C, Lhuillier M, Le Turnier P, Zhang Y, Mahevas M, Pan-Hammarström Q, Abolhassani H, Bompoil T, Dorgham K, COVID HGE Consortium, French COVID Study Group, COMET Consortium, Gorochov G, Laouenan C, Rodríguez-Gallego C, Ng LFP, Renia L, Pujol A, Belot A, Raffi F, Allende LM, Martinez-Picado J, Ozcelik T, Imberti L, Notarangelo LD, Troya J, Solanich X, Zhang SY, Puel A, Wilson MR, Trouillet-Assant S, Abel L, Jouanguy E, Ye CJ, Cobat A, Thompson LM, Andreakos E, Zhang Q, Anderson MS, Casanova JL, DeRisi JL
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs.
Science Immunology 2023, 8, eabp8966.
Presente S, Bonnal C, Normand AC, Gaudonnet Y, Fekkar A, Timsit JF, Kernéis S
Hospital Clonal Outbreak of Fluconazole-Resistant Candida parapsilosis Harboring the Y132F ERG11p Substitution in a French Intensive Care Unit.
Antimicrobial Agents and Chemotherapy 2023, 67, e0113022.
Guiraud V, Bocobza J, Desmonet M, Damond F, Plantier JC, Moreau G, Wirden M, Stefic K, Barin F, Gautheret-Dejean A
Are Confirmatory Assays Reliable for HIV-1/HIV-2 Infection Differentiation? A Multicenter Study.
Journal of Clinical Microbiology 2023, 61, e0061923.
Khan MS, Kim E, Le Hingrat Q, Kleinman A, Ferrari A, Sammartino JC, Percivalle E, Xu C, Huang S, Kenniston TW, Cassaniti I, Baldanti F, Pandrea I, Gambotto A, Apetrei C
Tetravalent SARS-CoV-2 S1 subunit protein vaccination elicits robust humoral and cellular immune responses in SIV-infected rhesus macaque controllers.
mBio 2023, e0207023.
Lacombe K, Hueso T, Porcher R, Mekinian A, Chiarabini T, Georgin-Lavialle S, Ader F, Saison J, Martin-Blondel G, De Castro N, Bonnet F, Cazanave C, Francois A, Morel P, Hermine O, Pourcher V, Michel M, Lescure X, Soussi N, Brun P, Pommeret F, Sellier P, Rousset S, Piroth L, Michot JM, Baron G, de Lamballerie X, Mariette X, Tharaux PL, Resche-Rigon M, Ravaud P, Simon T, Tiberghien P
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial.
BMJ medicine 2023, 2, e000427.
Foucrier A, Roquilly A, Bachelet D, Martin-Loeches I, Bougle A, Timsit JF, Montravers P, Zahar JR, Eloy P, Weiss E, ASPIC study group
Antimicrobial Stewardship for Ventilator Associated Pneumonia in Intensive Care (the ASPIC trial): study protocol for a randomised controlled trial.
BMJ open 2023, 13, e065293.
Jaquet P, Couffignal C, Tardivon C, Godard V, Bellot R, Assouline B, Benghanem S, Da Silva D, Decavèle M, Dessajan J, Hermann B, Rambaud T, Voiriot G, Sonneville R, PODIUM Study Group
PupillOmetry for preDIction of DeliriUM in ICU (PODIUM): protocol for a prospective multicentre cohort study.
BMJ open 2023, 13, e072095.
Bouzid D, Tran-Dinh A, Lortat-Jacob B, Atchade E, Jean-Baptiste S, Tashk P, Snauwaert A, Zappella N, Augustin P, Pellenc Q, Castier Y, Ribeiro L, Gaudemer A, Khalil A, Montravers P, Tanaka S, Bichat stab wounds injury study group
Ultrasonography in thoracic and abdominal stab wound injury: results from the FETTHA study.
Emergency medicine journal: EMJ 2023, emermed-2023-213078.
Sonneville R, Mazighi M, Collet M, Gayat E, Degos V, Duranteau J, Grégoire C, Sharshar T, Naim G, Cortier D, Jost PH, Foucrier A, Bagate F, de Montmollin E, Papin G, Magalhaes E, Guidet B, Ben Hadj Salem O, Benghanem S, le Guennec L, Delpierre E, Legriel S, Megarbane B, Toumert K, Tran M, Geri G, Monchi M, Bodiguel E, Mariotte E, Demoule A, Zarka J, Diehl JL, Roux D, Barré E, Tanaka S, Osman D, Pasquier P, Lamara F, Crassard I, Boursin P, Ruckly S, Staiquly Q, Timsit JF, Woimant F, SPICE Investigators
One-Year Outcomes in Patients With Acute Stroke Requiring Mechanical Ventilation.
Stroke 2023, 54, 2328-2337.
Chommeloux J, Valentin S, Winiszewski H, Adda M, Pineton de Chambrun M, Moyon Q, Mathian A, Capellier G, Guervilly C, Levy B, Jaquet P, Sonneville R, Voiriot G, Demoule A, Boussouar S, Painvin B, Lebreton G, Combes A, Schmidt M
One-Year Mental and Physical Health Assessment in Survivors after Extracorporeal Membrane Oxygenation for COVID-19-related Acute Respiratory Distress Syndrome.
American Journal of Respiratory and Critical Care Medicine 2023, 207, 150-159.
Sadio AJ, Ferré VM, Konu RY, Dagnra AC, Descamps D, Ekouevi DK, Charpentier C
High SARS-CoV-2 seroprevalence among street adolescents in Lomé, Togo, 2021.
BMC infectious diseases 2023, 23, 200.
Sawras V, Deuffic-Burban S, Préau M, Spire B, Yazdanpanah Y, Champenois K
Assessing complex interventions: a systematic review of outcomes used in randomised controlled trials on STI partner notification in high-income countries.
BMC public health 2023, 23, 1838.
Perrichot A, Vaittinada Ayar P, Taboulet P, Choquet C, Gay M, Casalino E, Steg PG, Curac S, Vaittinada Ayar P
Assessment of real-time electrocardiogram effects on interpretation quality by emergency physicians.
BMC medical education 2023, 23, 677.
Sette AL, François P, Lesprit P, Vitrat V, Rogeaux O, Breugnon E, Baldeyrou M, Mondain V, Issartel B, Kerneis S, Diamantis S, Poitrenaud D, Boussat B, Pavese P
Infectious disease hotlines to provide advice to general practitioners: a prospective study.
BMC health services research 2023, 23, 502.
Yade MS, Dièye B, Coppée R, Mbaye A, Diallo MA, Diongue K, Bailly J, Mama A, Fall A, Thiaw AB, Ndiaye IM, Ndiaye T, Gaye A, Tine A, Diédhiou Y, Mbaye AM, Doderer-Lang C, Garba MN, Bei AK, Ménard D, Ndiaye D
Ex vivo RSA and pfkelch13 targeted-amplicon deep sequencing reveal parasites susceptibility to artemisinin in Senegal, 2017.
Malaria Journal 2023, 22, 167.
De Castro N, Brun A, Sellier P, Hamet G, Mechaï F, Garrait V, Chabrol A, Bouldouyre MA, Froguel E, Troisvallets D, Caraux-Paz P, Delaugerre C, Rozenbaum W, Molina JM
Safety and efficacy of switching to elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate in treatment-experienced people with HIV: a multicenter cohort study.
AIDS research and therapy 2023, 20, 1.
de Villiers de la Noue V, Théry G, Faroux L, Belkessa N, Rubin S, Mourvillier B, Goury A
Left atrial dissection after a supra-annular mitral valve replacement for endocarditis.
Journal of Cardiothoracic Surgery 2023, 18, 75.
Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M, Ünal S, Schlegel M, Ader F, Lacombe K, Amdal CD, Rodrigues S, Tonby K, Gaudet A, Heggelund L, Mootien J, Johannessen A, Møller JH, Pollan BD, Tveita AA, Kildal AB, Richard JC, Dalgard O, Simensen VC, Baldé A, de Gastines L, Del Álamo M, Aydin B, Lund-Johansen F, Trabaud MA, Diallo A, Halvorsen B, Røttingen JA, Tacconelli E, Yazdanpanah Y, Olsen IC, Costagliola D, EU SolidAct study group
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
Critical Care (London, England) 2023, 27, 9.
Moreno R, Rhodes A, Piquilloud L, Hernandez G, Takala J, Gershengorn HB, Tavares M, Coopersmith CM, Myatra SN, Singer M, Rezende E, Prescott HC, Soares M, Timsit JF, de Lange DW, Jung C, De Waele JJ, Martin GS, Summers C, Azoulay E, Fujii T, McLean AS, Vincent JL
The Sequential Organ Failure Assessment (SOFA) Score: has the time come for an update?.
Critical Care (London, England) 2023, 27, 15.
Sharshar T, Porcher R, Asfar P, Grimaldi L, Jabot J, Argaud L, Lebert C, Bollaert PE, Harlay ML, Chillet P, Maury E, Santoli F, Blanc P, Sonneville R, Vu DC, Rohaut B, Mazeraud A, Alvarez JC, Navarro V, Clair B, Outin H, Valse investigators and for the Groupe d’Explorations Neurologiques en Reanimation (GENER)
Valproic acid as adjuvant treatment for convulsive status epilepticus: a randomised clinical trial.
Critical Care (London, England) 2023, 27, 8.
Gaillet A, Azoulay E, de Montmollin E, Garrouste-Orgeas M, Cohen Y, Dupuis C, Schwebel C, Reignier J, Siami S, Argaud L, Adrie C, Mourvillier B, Ruckly S, Forel JM, Timsit JF
Outcomes in critically Ill HIV-infected patients between 1997 and 2020: analysis of the OUTCOMEREA multicenter cohort.
Critical Care (London, England) 2023, 27, 108.
Contou D, Béduneau G, Rabault C, Sonneville R, Marchalot A, Coudroy R, Roux D, Cour M, Massol J, Préau S, de Prost N, HOPEFUL Study Group
Skin biopsy in adult patients with meningococcal purpura fulminans: a multicenter retrospective cohort study.
Critical Care (London, England) 2023, 27, 166.
Williams PG, Tabah A, Cotta MO, Sandaradura I, Kanji S, Scheetz MH, Imani S, Elhadi M, Luque-Pardos S, Schellack N, Sanches C, Timsit JF, Xie J, Farkas A, Wilks K, Roberts JA, National Coordinators on behalf of the European Society of Intensive Care Medicine (ESICM) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Infections in Critically Ill Patients [ESGCIP]
International survey of antibiotic dosing and monitoring in adult intensive care units.
Critical Care (London, England) 2023, 27, 241.
Giacobbe DR, Dettori S, Di Pilato V, Asperges E, Ball L, Berti E, Blennow O, Bruzzone B, Calvet L, Capra Marzani F, Casabella A, Choudaly S, Dartevel A, De Pascale G, Di Meco G, Fallon M, Galerneau LM, Gallego M, Giacomini M, González Sáez A, Hänsel L, Icardi G, Koehler P, Lagrou K, Lahmer T, Lewis White P, Magnasco L, Marchese A, Marelli C, Marín-Arriaza M, Martin-Loeches I, Mekontso-Dessap A, Mikulska M, Mularoni A, Nordlander A, Poissy J, Russelli G, Signori A, Tascini C, Vaconsin LM, Vargas J, Vena A, Wauters J, Pelosi P, Timsit JF, Bassetti M, JIR-ICU investigators (collaborators), Critically Ill Patients Study Group of the European Society of Clinical Microbiology and Infectious Diseases (ESGCIP), and the Fungal Infection Study Group of the European Society of Clinical Microbiology and Infectious Diseases (EFISG)
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG.
Critical Care (London, England) 2023, 27, 323.
Galerneau LM, Bailly S, Terzi N, Ruckly S, Garrouste-Orgeas M, Oziel J, Hong Tuan Ha V, Gainnier M, Siami S, Dupuis C, Forel JM, Dartevel A, Dessajan J, Adrie C, Goldgran-Toledano D, Laurent V, Argaud L, Reignier J, Pepin JL, Darmon M, Timsit JF, OUTCOME R. E. A. network
Non-ventilator-associated ICU-acquired pneumonia (NV-ICU-AP) in patients with acute exacerbation of COPD: From the French OUTCOMEREA cohort.
Critical Care (London, England) 2023, 27, 359.
Sonneville R, Benghanem S, Jeantin L, de Montmollin E, Doman M, Gaudemer A, Thy M, Timsit JF
The spectrum of sepsis-associated encephalopathy: a clinical perspective.
Critical Care (London, England) 2023, 27, 386.
Martin-Loeches I, Shorr AF, Wunderink RG, Kollef MH, Timsit JF, Yu B, Huntington JA, Jensen E, Bruno CJ
Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial.
Annals of Intensive Care 2023, 13, 8.
Iachkine J, Buetti N, de Grooth HJ, Briant AR, Mimoz O, Mégarbane B, Mira JP, Valette X, Daubin C, du Cheyron D, Mermel LA, Timsit JF, Parienti JJ
Development and validation of a multivariable model predicting the required catheter dwell time among mechanically ventilated critically ill patients in three randomized trials.
Annals of Intensive Care 2023, 13, 5.
Jeantin L, Dupuis C, Vellieux G, Jaquet P, de Montmollin E, Timsit JF, Sonneville R, ENCEPHALITICA Study Group
Electroencephalography for prognostication of outcome in adults with severe herpes simplex encephalitis.
Annals of Intensive Care 2023, 13, 10.
Bourcier S, Coutrot M, Ferré A, Van Grunderbeeck N, Charpentier J, Hraiech S, Azoulay E, Nseir S, Aissaoui N, Messika J, Fillatre P, Persichini R, Carreira S, Lautrette A, Delmas C, Terzi N, Mégarbane B, Lascarrou JB, Razazi K, Repessé X, Pichereau C, Contou D, Frérou A, Barbier F, Ehrmann S, de Montmollin E, Sztrymf B, Morawiec E, Bigé N, Reuter D, Schnell D, Ellrodt O, Dellamonica J, Combes A, Schmidt M
Critically ill severe hypothyroidism: a retrospective multicenter cohort study.
Annals of Intensive Care 2023, 13, 15.
Mekontso Dessap A, Papazian L, Schaller M, Nseir S, Megarbane B, Haudebourg L, Timsit JF, Teboul JL, Kuteifan K, Gainnier M, Slama M, Houeto P, Lecourt L, Mercat A, Vieillard-Baron A
Inhaled nitric oxide in patients with acute respiratory distress syndrome caused by COVID-19: treatment modalities, clinical response, and outcomes.
Annals of Intensive Care 2023, 13, 57.
Barbier F, Hraiech S, Kernéis S, Veluppillai N, Pajot O, Poissy J, Roux D, Zahar JR, French Intensive Care Society
Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients.
Annals of Intensive Care 2023, 13, 65.
Helms J, Poissy J, Dequin PF, Timsit JF
Treatment of immunothrombosis dysregulation: high-dose corticosteroids is not the good option.
Annals of Intensive Care 2023, 13, 58.
Chevret S, Bouadma L, Dupuis C, Burdet C, Timsit JF, COVIDICUS RCT group
Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial.
Annals of Intensive Care 2023, 13, 75.
Szychowiak P, Boulain T, Timsit JF, Elabaddi A, Argaud L, Ehrmann S, Issa N, Canet E, Martino F, Bruneel F, Quenot JP, Wallet F, Azoulay É, Barbier F
Clinical spectrum and prognostic impact of cancer in critically ill patients with HIV: a multicentre cohort study.
Annals of Intensive Care 2023, 13, 74.
Laurichesse G, Schwebel C, Buetti N, Neuville M, Siami S, Cohen Y, Laurent V, Mourvillier B, Reignier J, Goldgran-Toledano D, Ruckly S, de Montmollin E, Souweine B, Timsit JF, Dupuis C, OUTCOME R. E. A. network
Mortality, incidence, and microbiological documentation of ventilated acquired pneumonia (VAP) in critically ill patients with COVID-19 or influenza.
Annals of Intensive Care 2023, 13, 108.
Yi G, de Kraker MEA, Buetti N, Zhong X, Li J, Yuan Z, Zhu W, Zhou J, Zhou H
Risk factors for in-hospital mortality and secondary bacterial pneumonia among hospitalized adult patients with community-acquired influenza: a large retrospective cohort study.
Antimicrobial Resistance and Infection Control 2023, 12, 25.
Januel JM, Lotfinejad N, Grant R, Tschudin-Sutter S, Schreiber PW, Grandbastien B, Jent P, Lo Priore E, Scherrer A, Harbarth S, Catho G, Buetti N, Swissnoso
Predictive performance of automated surveillance algorithms for intravascular catheter bloodstream infections: a systematic review and meta-analysis.
Antimicrobial Resistance and Infection Control 2023, 12, 87.
de Prost N, Audureau E, Préau S, Favory R, Guigon A, Bay P, Heming N, Gault E, Pham T, Chaghouri A, Voiriot G, Morand-Joubert L, Jochmans S, Pitsch A, Meireles S, Contou D, Henry A, Joseph A, Chaix ML, Uhel F, Descamps D, Emery M, Garcia-Sanchez C, Luyt CE, Marot S, Pène F, Lhonneur AS, Gaudry S, Brichler S, Picard L, Mekontso Dessap A, Rodriguez C, Pawlotsky JM, Fourati S, SEVARVIR investigators
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron variants BA.2, BA.5 and BQ.1.1 in critically ill patients with COVID-19: a prospective, multicenter cohort study.
Intensive Care Medicine Experimental 2023, 11, 48.
Tchoubou T, El-Hosni R, Dollat M, Jaquet P, Tournus C, Tandjaoui-Lambiotte Y, Da Silva D
Acute Respiratory Distress Syndrome due to Monkeypox Virus.
European Journal of Case Reports in Internal Medicine 2023, 10, 004126.
Inzaule SC, Siedner MJ, Little SJ, Avila-Rios S, Ayitewala A, Bosch RJ, Calvez V, Ceccherini-Silberstein F, Charpentier C, Descamps D, Eshleman SH, Fokam J, Frenkel LM, Gupta RK, Ioannidis JPA, Kaleebu P, Kantor R, Kassaye SG, Kosakovsky Pond SL, Kouamou V, Kouyos RD, Kuritzkes DR, Lessells R, Marcelin AG, Mbuagbaw L, Minalga B, Ndembi N, Neher RA, Paredes R, Pillay D, Raizes EG, Rhee SY, Richman DD, Ruxrungtham K, Sabeti PC, Schapiro JM, Sirivichayakul S, Steegen K, Sugiura W, van Zyl GU, Vandamme AM, Wensing AMJ, Wertheim JO, Gunthard HF, Jordan MR, Shafer RW
Recommendations on data sharing in HIV drug resistance research.
PLoS medicine 2023, 20, e1004293.
Reingruber J, Papale A, Ruckly S, Timsit JF, Holcman D
Data-driven multiscale dynamical framework to control a pandemic evolution with non-pharmaceutical interventions.
PloS One 2023, 18, e0278882.
Della Vecchia C, Ebah JV, Tubiana S, Guimard T, Piroth L, Jaffuel S, Gorenne I, Mourvillier B, Hoen B, Duval X, Préau M
Mid-term health-related quality of life in community-acquired bacterial meningitis survivors; the COMBAT study.
PloS One 2023, 18, e0281544.
Tchounga BK, Bertine M, Damond F, Ferré VM, Inwoley A, Boni SP, Moisan A, Plantier JC, Descamps D, Ekouevi DK, Charpentier C
Molecular confirmation of HIV-1 and HIV-2 coinfections among initially serologically dually-reactive samples from patients living in West Africa.
PloS One 2023, 18, e0283602.
Galerneau LM, Bailly S, Terzi N, Ruckly S, Garrouste-Orgeas M, Cohen Y, Hong Tuan Ha V, Gainnier M, Siami S, Dupuis C, Darmon M, Azoulay E, Forel JM, Sigaud F, Adrie C, Goldgran-Toledano D, Ferré A, de Montmollin E, Argaud L, Reignier J, Pepin JL, Timsit JF, OUTCOMEREA network
Corticosteroids for severe acute exacerbations of chronic obstructive pulmonary disease in intensive care: From the French OUTCOMEREA cohort.
PloS One 2023, 18, e0284591.
Dinh A, Drouet F, Dechartres A, Yordanov Y, Duran C, Schmidt N, Banzet A, Perrier MH, Mosquet N, Lescure FX, Jourdain P, Nizard J, Masingue X, AP-HP/Universities/Inserm COVID-19 research collaboration
Pregnant women with mild COVID-19 followed in community setting by telemedicine, and factors associated with unfavorable outcome.
PloS One 2023, 18, e0288845.
Tarhini H, Waked R, Rahi M, Haddad N, Dorent R, Randoux C, Bunel V, Lariven S, Deconinck L, Rioux C, Yazdanpanah Y, Joly V, Ghosn J
Investigating infectious outcomes in adult patients undergoing solid organ transplantation: A retrospective single-center experience, Paris, France.
PloS One 2023, 18, e0291860.
Kali S, Bourner J, Calmy A, Laouénan C, Merson L, Cervantes-Gonzalez M, Rojek A, Pesonel E, Guiraud L, Tardivon C, Descamps D, Diallo A, Gibowski S, Rosenthal E, Petrov-Sanchez V, Letrou S, Hoffmann I, Le Mestre S, Mentré F, Yazdanpanah Y, Olliaro P, Lescure FX
MOSAIC: a European cohort study of human Mpox - the challenges of clinical research in outbreaks.
Virologie (Montrouge, France) 2023, 27, 12-15.
Friedman D, Grimaldi L, Cariou A, Aegerter P, Gaudry S, Ben Salah A, Oueslati H, Megarbane B, Meunier-Beillard N, Quenot JP, Schwebel C, Jacob L, Robin Lagandré S, Kalfon P, Sonneville R, Siami S, Mazeraud A, Sharshar T
Correction: Impact of a Postintensive Care Unit Multidisciplinary Follow-up on the Quality of Life (SUIVI-REA): Protocol for a Multicenter Randomized Controlled Trial.
JMIR research protocols 2023, 12, e47929.
Jolivet S, Couturier J, Grohs P, Vilfaillot A, Zahar JR, Frange P, Casetta A, Moulin V, Lawrence C, Baune P, Bourgeois C, Bouffier A, Laussucq C, Sienzonit L, Picard S, Podglajen I, Kassis-Chikhani N, Barbut F
Prevalence and risk factors of toxigenic Clostridioides difficile asymptomatic carriage in 11 French hospitals.
Frontiers in Medicine 2023, 10, 1221363.
Bornand E, Letourneux F, Deschanvres C, Boutoille D, Lucet JC, Lepelletier D, Leclere B, Mayol S, Peiffer-Smadja N, Birgand G
Social representations of mask wearing in the general population during the COVID-19 pandemic.
Frontiers in Public Health 2023, 11, 1136980.
Brun-Rambaud G, Alcouffe L, Tareau MA, Adenis A, Vignier N
Access to health care for migrants in French Guiana in 2022: a qualitative study of health care system actors.
Frontiers in Public Health 2023, 11, 1185341.
de Tymowski C, Sahnoun T, Provenchere S, Para M, Derre N, Mutuon P, Duval X, Grall N, Iung B, Kernéis S, Lucet JC, Montravers P
Impact of Antibiotic Prophylaxis on Surgical Site Infections in Cardiac Surgery.
Antibiotics (Basel, Switzerland) 2023, 12, 85.
Chaïbi K, Jaureguy F, Do Rego H, Ruiz P, Mory C, El Helali N, Mrabet S, Mizrahi A, Zahar JR, Pilmis B
What to Do with the New Antibiotics?.
Antibiotics (Basel, Switzerland) 2023, 12, 654.
Thy M, Timsit JF, de Montmollin E
Aminoglycosides for the Treatment of Severe Infection Due to Resistant Gram-Negative Pathogens.
Antibiotics (Basel, Switzerland) 2023, 12, 860.
Wicky PH, Poiraud J, Alves M, Patrier J, d'Humières C, Lê M, Kramer L, de Montmollin É, Massias L, Armand-Lefèvre L, Timsit JF
Cefiderocol Treatment for Severe Infections due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case Series and Narrative Literature Review.
Antibiotics (Basel, Switzerland) 2023, 12, 991.
Pilmis B, Kherabi Y, Huriez P, Zahar JR, Mokart D
Infectious Complications of Targeted Therapies for Solid Cancers or Leukemias/Lymphomas.
Cancers 2023, 15, 1989.
Nardin C, Hennemann A, Diallo K, Funck-Brentano E, Puzenat E, Heidelberger V, Jeudy G, Samimi M, Lesage C, Boussemart L, Peuvrel L, Rouanet J, Brunet-Possenti F, Gerard E, Seris A, Jouary T, Saint-Jean M, Puyraveau M, Saiag P, Aubin F
Efficacy of Immune Checkpoint Inhibitor (ICI) Rechallenge in Advanced Melanoma Patients' Responders to a First Course of ICI: A Multicenter National Retrospective Study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC).
Cancers 2023, 15, 3564.
Reichert C, Baldini C, Mezghani S, Maubec E, Longvert C, Mortier L, Quereux G, Jannic A, Machet L, de Quatrebarbes J, Nardin C, Beneton N, Amini Adle M, Funck-Brentano E, Descamps V, Hachon L, Malissen N, Baroudjian B, Brunet-Possenti F, Groupe de Cancérologie Cutanée
Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients.
Cancers 2023, 15, 4330.
Ghazali DA, Bouzid D, Frachon A, Ait-Abdesselam S, Kenway P, Choquet C, Casalino E
Pain Self-Management with Inhaled Methoxyflurane by Emergency Department Trauma Patients: A Prospective, Interventional, Single-Center Study.
International Journal of Environmental Research and Public Health 2023, 20, 6107.
Wicky PH, Dupuis C, Cerf C, Siami S, Cohen Y, Laurent V, Mourvillier B, Reignier J, Goldgran-Toledano D, Schwebel C, Ruckly S, de Montmollin E, Buetti N, Timsit JF
Ventilator-Associated Pneumonia in COVID-19 Patients Admitted in Intensive Care Units: Relapse, Therapeutic Failure and Attributable Mortality-A Multicentric Observational Study from the OutcomeRea Network.
Journal of Clinical Medicine 2023, 12, 1298.
Timsit JF
After SARS-CoV-2 Pandemics: New Insights into ICU-Acquired Pneumonia.
Journal of Clinical Medicine 2023, 12, 2160.
Sellem B, Abdi B, Lê M, Tubiana R, Valantin MA, Seang S, Schneider L, Fayçal A, Peytavin G, Soulié C, Marcelin AG, Katlama C, Pourcher V, Palich R
Intermittent Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment Maintains High Level of Viral Suppression in Virally Suppressed People Living with HIV.
Journal of Personalized Medicine 2023, 13, 583.
Rezzoug I, Visseaux B, Bertine M, Parisey M, Bonnal C, Ruppe E, Descamps D, Timsit JF, Yazdanpanah Y, Armand-Lefevre L, Houze S, Argy N
Faecal Viral Excretion and Gastrointestinal Co-Infection Do Not Explain Digestive Presentation in COVID-19 Patients.
Microorganisms 2023, 11, 1780.
Eid R, Zahar JR, Ait Ali C, Mizrahi A, Ibrahim R, Banh E, Halouani H, Jauréguy F, Pilmis B, Saliba R
Bloodstream Infections: Comparison of Diagnostic Methods and Therapeutic Consequences between a Hospital in a Resource-Limited Setting and Two French Hospitals.
Microorganisms 2023, 11, 2136.
Saliba R, Zahar JR, Dabar G, Riachy M, Karam-Sarkis D, Husni R
Limiting the Spread of Multidrug-Resistant Bacteria in Low-to-Middle-Income Countries: One Size Does Not Fit All.
Pathogens (Basel, Switzerland) 2023, 12, 144.
de Crane D'Heysselaer S, Parisi G, Lisson M, Bruyère O, Donneau AF, Fontaine S, Gillet L, Bureau F, Darcis G, Thiry E, Ducatez M, Snoeck CJ, Zientara S, Haddad N, Humblet MF, Ludwig-Begall LF, Daube G, Thiry D, Misset B, Lambermont B, Tandjaoui-Lambiotte Y, Zahar JR, Sartor K, Noël C, Saegerman C, Haubruge E
Systematic Review of the Key Factors Influencing the Indoor Airborne Spread of SARS-CoV-2.
Pathogens (Basel, Switzerland) 2023, 12, 382.
Charpentier C, Le Hingrat Q, Ferré VM, Damond F, Descamps D
Future of Antiretroviral Drugs and Evolution of HIV-1 Drug Resistance.
Viruses 2023, 15, 540.
Goulenok T, Mendes C, Dayan L, Ferre VM, Bucau M, Farhi F, Papo T, Sacré K
Improving Human Papillomavirus-Related Cervical Cancer Screening in Patients With Systemic Lupus Erythematosus.
The Journal of Rheumatology 2023, jrheum.2022-1335.
Mignot S, Berthome AC, Andre M, Breque C, Richer JP, Ghazali D, Oriot D
Development and validation of a performance assessment checklist for insertion of an intra-uterine device (IUD).
Ginekologia Polska 2023
Coppée R, Blanquart F, Jary A, Leducq V, Ferré VM, Franco Yusti AM, Daniel L, Charpentier C, Lebourgeois S, Zafilaza K, Calvez V, Descamps D, Marcelin AG, Visseaux B, Bridier-Nahmias A
Phylodynamics of SARS-CoV-2 in France, Europe, and the world in 2020.
eLife 2023, 12, e82538.
Genital Pseudotumor as a Manifestation of Mpox Virus Infection.
JAMA dermatology 2023, 159, 563-564.
Labbé V, Contou D, Heming N, Megarbane B, Razazi K, Boissier F, Ait-Oufella H, Turpin M, Carreira S, Robert A, Monchi M, Souweine B, Preau S, Doyen D, Vivier E, Zucman N, Dres M, Fejjal M, Noel-Savina E, Bachir M, Jaffal K, Timsit JF, Picos SA, Mariotte E, Martis N, Juguet W, Melica G, Rondeau P, Audureau E, Mekontso Dessap A, ANTICOVID Investigators
Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical Trial.
JAMA internal medicine 2023, 183, 520-531.
Sorin B, Gaigne L, Garzaro M, Moulis G, Mageau A, Lopez C, Roy-Peaud F, Jeandel PY, Crickx E, Dossier A, Gobert D, Hadjadj J, Puyade M, Languille L, Rasmussen C, Terrier B, Ebbo M, Bonnotte B, Audia S, Galicier L, Michel M, Mahevas M, Viallard JF, Godeau B, CERECAI (Centre de Référence des Cytopénies Auto-Immunes de L'adulte)
Severe SARS-CoV-2 infection in rituximab-treated patients with autoimmune cytopenia: A multicenter observational study.
American Journal of Hematology 2023, 98, E259-E262.
Cortier M, Raphael E, Mailhe M, Thy M, Bertin C, Vallois D, Lescure X, Ghosn J
An unusual case of human monkeypox with successive asynchronous rashes.
Journal of Medical Virology 2023, 95, e28180.
Ferré VM, Bitty-Anderson AM, Peytavin G, Lê MP, Dagnra CA, Coppée R, Gbeasor-Komlanvi FA, Descamps D, Charpentier C, Ekouevi DK
Pharmaco-virological algorithm to target risk of drug resistance among a population of HIV-infected key populations in Togo.
Journal of Medical Virology 2023, 95, e28535.
Gault N, Bachelet D, Laouénan C, Borie R, Cracowski C, Poissy J, Faure K, Lainé F, Lefèvre B, Isnard M, Patrier J, Launay O, Costagliola D, Ghosn J, Bouadma L, French COVID Cohort Study Group and The French COVID Investigators Study Group
Impact of corticosteroids use on midterm sequelae in survivors of COVID-19 admitted to hospital: A prospective cohort study.
Journal of Medical Virology 2023, 95, e28819.
Piorkowski G, Ghosn J, Coppée R, Mailhé M, Ferré VM, Houhou-Fidouh N, Yazdanpanah Y, Le Hingrat Q, Raoul H, Charpentier C, Descamps D, de Lamballerie X
Genomic diversity of mpox virus in Paris area (France) during the 2022 outbreak.
Journal of Medical Virology 2023, 95, e28853.
Chenane HR, Lingas G, Menidjel R, Laouenan C, Tubiana S, Descamps D, Le Hingrat Q, Abel L, Guedj J, Malhotra S, Kumar-Singh S, Visseaux B, Ghosn J, Charpentier C, Lebourgeois S, French COVID Cohort Study Group
High sera levels of SARS-CoV-2 N antigen are associated with death in hospitalized COVID-19 patients.
Journal of Medical Virology 2023, 95, e29247.
Bensaid S, Contejean A, Morand P, Enser M, Eyrolle L, Charlier C, Kernéis S, Anract P, Biau D, Canouï E, Other Members of the CRIOACochin Group
Surgical site infection after pelvic bone and soft tissue sarcoma resection: Risk factors, microbiology, and impact of extended postoperative antibiotic prophylaxis.
Journal of Surgical Oncology 2023, 128, 344-349.
Mercier N, Belhadi D, DeChanet A, Delmas C, Saillard J, Dumousseaux M, Le Mestre S, Fougerou-Leurent C, Ferrane A, Burdet C, Espérou H, Ader F, Hites M, Peiffer-Smadja N, Poissy J, Andrejak C, Paiva JA, Tacconelli E, Staub T, Greil R, Costagliola D, Mentre F, Yazdanpanah Y, Diallo A, DisCoVeRy Safety Working group
Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial.
Pharmacology Research & Perspectives 2023, 11, e01072.
Néant N, Lingas G, Gaymard A, Belhadi D, Hites M, Staub T, Greil R, Paiva JA, Poissy J, Peiffer-Smadja N, Costagliola D, Yazdanpanah Y, Bouscambert-Duchamp M, Gagneux-Brunon A, Ader F, Mentré F, Wallet F, Burdet C, Guedj J, DisCoVeRy study group
Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients.
CPT: pharmacometrics & systems pharmacology 2023, 12, 2027-2037.
Périllaud-Dubois C, Hachicha-Maalej N, Lepers C, Letamendia E, Teissier N, Cousien A, Sibiude J, Deuffic-Burban S, Vauloup-Fellous C, Picone O
Cost-effectiveness of screening and valacyclovir-based treatment strategies for first-trimester cytomegalovirus primary infection in pregnant women in France.
Ultrasound in Obstetrics & Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology 2023, 62, 573-584.
Tabah A, Buetti N, Staiquly Q, Ruckly S, Akova M, Aslan AT, Leone M, Conway Morris A, Bassetti M, Arvaniti K, Lipman J, Ferrer R, Qiu H, Paiva JA, Povoa P, De Bus L, De Waele J, Zand F, Gurjar M, Alsisi A, Abidi K, Bracht H, Hayashi Y, Jeon K, Elhadi M, Barbier F, Timsit JF, EUROBACT-2 Study Group, ESICM, ESCMID ESGCIP and the OUTCOMEREA Network
Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study.
Intensive Care Medicine 2023, 49, 178-190.
Gaillet A, Bay P, Péju E, Ait-Oufella H, Azoulay E, Benchabane N, Cerf C, Cohen Y, de Prost N, Faguer S, Geri G, Grangé S, Kahn JE, Kreitmann L, Larcher R, Lefèvre G, Mabrouki A, Mekonsto-Dessap A, Panel K, Pène F, Pineton de Chambrun M, Quenot JP, Tandjaoui-Lambiotte Y, Timsit JF, Vieillard-Baron A, Dargent A, Herault A, Groh M
Epidemiology, clinical presentation, and outcomes of 620 patients with eosinophilia in the intensive care unit.
Intensive Care Medicine 2023, 49, 291-301.
Park S, Robba C, Sonneville R
Neuromonitoring for prognostication under ECMO.
Intensive Care Medicine 2023, 49, 451-454.
Sonneville R, de Montmollin E, Contou D, Ferrer R, Gurjar M, Klouche K, Sarton B, Demeret S, Bailly P, da Silva D, Escudier E, Le Guennec L, Chabanne R, Argaud L, Ben Hadj Salem O, Thyrault M, Frerou A, Louis G, De Pascale G, Horn J, Helbok R, Geri G, Bruneel F, Martin-Loeches I, Taccone FS, De Waele JJ, Ruckly S, Staiquly Q, Citerio G, Timsit JF, EURECA Investigator Study Group
Clinical features, etiologies, and outcomes in adult patients with meningoencephalitis requiring intensive care (EURECA): an international prospective multicenter cohort study.
Intensive Care Medicine 2023, 49, 517-529.
Sonneville R, de Montmollin E, Gaudemer A, Ruckly S, Timsit JF
Meningoencephalitis requiring intensive care and neuromonitorization. Author's reply.
Intensive Care Medicine 2023, 49, 884-885.
Newcombe V, Muehlschlegel S, Sonneville R
Neurological diseases in intensive care.
Intensive Care Medicine 2023, 49, 987-990.
Ravalihasy A, Ante-Testard PA, Kardas-Sloma L, Yazdanpanah Y, De Allegri M, Ridde V
Quantitative Methods Used to Evaluate Impact of Combination HIV Prevention Intervention: A Methodological Systematic Review.
AIDS and behavior 2023, 1-11.
Hocini H, Wiedemann A, Blengio F, Lefebvre C, Cervantes-Gonzalez M, Foucat E, Tisserand P, Surenaud M, Coléon S, Prague M, Guillaumat L, Krief C, Fenwick C, Laouénan C, Bouadma L, Ghosn J, Pantaleo G, Thiébaut R, French COVID cohort study group, Lévy Y
Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19.
Journal of Clinical Immunology 2023, 43, 882-893.
Renggli L, Gasser M, Buetti N, Kronenberg A, Swiss Centre for Antibiotic Resistance
Increase in methicillin-susceptible Staphylococcus aureus bloodstream infections in Switzerland: a nationwide surveillance study (2008-2021).
Infection 2023
Boukobza M, Ilic-Habensus E, Mourvillier B, Duval X, Laissy JP
Brain abscesses in infective endocarditis: contemporary profile and neuroradiological findings.
Infection 2023, 51, 1431-1444.
Beaumont AL, Rozencwajg S, Peiffer-Smadja N, Montravers P
COVID-19: Brief overview of therapeutic strategies.
Anaesthesia, Critical Care & Pain Medicine 2023, 42, 101181.
Celestin B, Habensus EI, Tubiana S, Préau M, Millot S, Lescure FX, Kerneis C, Para M, Duval X, Iung B, POST-IMAGE study group
Determinants of adherence to oral hygiene prophylaxis guidelines in patients with previous infective endocarditis.
Archives of Cardiovascular Diseases 2023, 116, 176-182.
Ghazali DA, Rousseau R, Breque C, Oriot D
Effect of real-time feedback device compared to use or non-use of a checklist performance aid on post-training performance and retention of infant cardiopulmonary resuscitation: A randomized simulation-based trial.
Australasian Emergency Care 2023, 26, 36-44.
Lefebvre T, Boutten A, Raulet-Bussian C, Raynor A, Manceau H, Puy H, Moulouel B, Schmitt C, Timsit JF, Lefort A, Weiss E, Lescure FX, Ricard JD, Sonneville R, Peoc'h K
Evaluation of iron metabolism in hospitalized COVID-19 patients.
Clinica Chimica Acta; International Journal of Clinical Chemistry 2023, 548, 117509.
Mailhe M, Beaumont AL, Thy M, Le Pluart D, Perrineau S, Houhou-Fidouh N, Deconinck L, Bertin C, Ferré VM, Cortier M, De La Porte Des Vaux C, Phung BC, Mollo B, Cresta M, Bouscarat F, Choquet C, Descamps D, Ghosn J, Lescure FX, Yazdanpanah Y, Joly V, Peiffer-Smadja N
Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 233-239.
Ghosn J, Bachelet D, Livrozet M, Cervantes-Gonzalez M, Poissy J, Goehringer F, Gandonniere CS, Maillet M, Bani-Sadr F, Martin-Blondel G, Tattevin P, Launay O, Surgers L, Dudoignon E, Liegeon G, Zucman D, Joseph C, Senneville E, Yelnik C, Roger PM, Faure K, Gousseff M, Cabié A, Duval X, Chirouze C, Laouénan C, French COVID cohort Study Group and the French COVID cohort Investigators Group
Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 254.e7-254.e13.
Alidjinou EK, Demaret J, Corroyer-Simovic B, Vuotto F, Miczek S, Labreuche J, Goffard A, Trauet J, Lupau D, Dendooven A, Huvent-Grelle D, Podvin J, Dreuil D, Faure K, Deplanque D, Bocket L, Duhamel A, Sobaszek A, Hober D, Hisbergues M, Puisieux F, Autran B, Yazdanpanah Y, Labalette M, Lefèvre G
Serum neutralization of SARS coronavirus 2 Omicron sublineages BA.1 and BA.2 and cellular immune responses 3 months after booster vaccination.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 258.e1-258.e4.
Dumont M, Guilhou T, Gerin M, Frémont-Goudot G, Nivose PL, Koubbi A, Joly V, Bouadma L, Yazdanpanah Y, André MH, de La Porte des Vaux C
Myocarditis in monkeypox-infected patients: a case series.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 390.e5-390.e7.
Martin-Blondel G, Marcelin AG, Soulié C, Kaisaridi S, Lusivika-Nzinga C, Zafilaza K, Dorival C, Nailler L, Boston A, Ronchetti AM, Melenotte C, Cabié A, Choquet C, Trinh-Duc A, Lacombe K, Gaube G, Coustillères F, Pourcher V, Martellosio JP, Peiffer-Smadja N, Chauveau M, Housset P, Piroth L, Devaux M, Pialoux G, Martin A, Dubee V, Frey J, Le Bot A, Cazanave C, Petua P, Liblau R, Carrat F, Yordanov Y
Time to negative PCR conversion amongst high-risk patients with mild-to-moderate Omicron BA.1 and BA.2 COVID-19 treated with sotrovimab or nirmatrelvir.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 543.e5-543.e9.
Bouzid D, Hingrat QL, Salipante F, Ferré VM, Chevallier T, Tubiana S, Lucet JC, Choquet C, Yazdanpanah Y, Timsit JF, Descamps D, Houhou N, Visseaux B, Loubet P
Agreement of respiratory viruses' detection between nasopharyngeal swab and bronchoalveolar lavage in adults admitted for pneumonia: a retrospective study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 942.e1-942.e6.
Bouzid D, Kapfer T, Marot S, Ing V, Ferré VM, Chauvin A, Le Goff J, Ellouze S, Salmona M, Hermand C, Bourg A, Schnuriger A, Fémy F, Van Tinh MN, Brichler S, Veyer D, Le Borgne P, Fafi-Kremer S, L'Honneur AS, Augustin C, Simon T, Cachanado M, IMProving Emergency Care (IMPEC) FHU authors group, Freund Y
Outcomes of Omicron sub-lineages BA.1.1 and BA.2 infection compared with the sub-lineage BA.1 infection in emergency departments' patients.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 551-553.
Buetti N, Marschall J, Catho G, Timsit JF, Mermel L
Which trial do we need? Infectious and non-infectious complications of peripherally inserted central venous catheters and midline catheters.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 568-569.
Celante H, Oubaya N, Fourati S, Beaune S, Khellaf M, Casalino E, Ricard JD, Vieillard-Baron A, Heming N, Mekontso Dessap A, de Montmollin E, Benghanem S, Epaillard N, Layese R, de Prost N, Prono-RSV study group of the clinical data warehouse of Greater Paris University Hospitals
Prognosis of hospitalised adult patients with respiratory syncytial virus infection: a multicentre retrospective cohort study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 943.e1-943.e8.
Buetti N, Ruckly S, Souweine B, Mimoz O, Timsit JF
Risk of infections in intravascular catheters in situ for more than 10 days: a post hoc analysis of randomized controlled trials.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 1200.e1-1200.e5.
Thy M, Cosson G, Danjou W, Kramer L, Pourcher V, Lescure FX
Comparison between targeted and vaccinated populations during the mpox vaccination campaign in France.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 1351-1353.
Bouzid D, Visseaux B, Ferré VM, Peiffer-Smadja N, Le Hingrat Q, Loubet P
Respiratory syncytial virus in adults with comorbidities: an update on epidemiology, vaccines, and treatments.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, S1198-743X(23)00412-3.
McLean C, Barry H, Kieh M, Anywaine Z, Tapima Rogers B, Doumbia S, Sirima SB, Serry-Bangura A, Habib Beavogui A, Gaddah A, Katwere M, Hendriks J, Keshinro B, Eholie S, Kibuuka H, Kennedy SB, Anzala O, Samai M, D'Ortenzio E, Leigh B, Sow S, Thiébaut R, Greenwood B, Watson-Jones D, Douoguih M, Luhn K, Robinson C
Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory.
EBioMedicine 2023, 91, 104562.
Sax PE, Arribas JR, Orkin C, Lazzarin A, Pozniak A, DeJesus E, Maggiolo F, Stellbrink HJ, Yazdanpanah Y, Acosta R, Huang H, Hindman JT, Martin H, Baeten JM, Wohl D, GS-US-380-1489 and GS-US-380-1490 study investigators
Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials.
EClinicalMedicine 2023, 59, 101991.
Gentilotti E, Górska A, Tami A, Gusinow R, Mirandola M, Rodríguez Baño J, Palacios Baena ZR, Rossi E, Hasenauer J, Lopes-Rafegas I, Righi E, Caroccia N, Cataudella S, Pasquini Z, Osmo T, Del Piccolo L, Savoldi A, Kumar-Singh S, Mazzaferri F, Caponcello MG, de Boer G, Hara GL, ORCHESTRA Study Group, De Nardo P, Malhotra S, Canziani LM, Ghosn J, Florence AM, Lafhej N, van der Gun BTF, Giannella M, Laouénan C, Tacconelli E
Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort.
EClinicalMedicine 2023, 62, 102107.
Taheri N, Mageau A, Chauveheid MP, Dossier A, Farhi F, Mendes C, Papo T, Goulenok T, Sacre K
Impact of adherence to EULAR quality indicators on the quality of life of patients with systemic lupus erythematosus.
European Journal of Internal Medicine 2023, 109, 68-72.
Goulenok T, Ferré VM, Mageau A, Papo T, Sacré K
Risk factors for high-risk human papillomavirus cervical infection and clearance in patients with systemic lupus erythematosus.
European Journal of Internal Medicine 2023, 116, 149-151.
Hazan F, Verdonk C, Coutance G, Ferré VM, Marot S, Melo VDD, Legeai C, Lebreton G, Para M, Varnous S, Dorent R
Severity of SARS-CoV-2 Omicron variant infection in heart transplant recipients.
The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation 2023, 42, 558-561.
Blot S, Timsit JF, Zahar JR
Preventing healthcare-acquired infections in cancer patients with febrile neutropenia in intensive care units: The role of granulocyte-colony stimulating factor prophylaxis.
Intensive & Critical Care Nursing 2023, 78, 103466.
Zahar JR, Blot S
Carbapenem-resistant Enterobacterales (CRE): The storm is coming.
Intensive & Critical Care Nursing 2023, 79, 103526.
Parisey M, Houze S, Bailly J, Taudon N, Jaffal K, Argy N, Rouzaud C, Mégarbane B, Lariven S, Yazdanpanah Y, Matheron S
Late dihydroartemisinin-piperaquine treatment failure of P. falciparum malaria attack related to insufficient dosing in an obese patient.
IDCases 2023, 33, e01847.
Méchaï F, Kolakowska A, Carbonnelle E, Bouchaud O, Tresallet C, Jaureguy F
Intra-abdominal abscesses: Microbiological epidemiology and empirical antibiotherapy.
Infectious Diseases Now 2023, 53, 104604.
Tandjaoui-Lambiotte Y, Lomont A, Moenne-Locoz P, Seytre D, Zahar JR
Spread of viruses, which measures are the most apt to control COVID-19?.
Infectious Diseases Now 2023, 53, 104637.
Deniaud F, Vignier N, Raynal G, Boo N, Collignon A, Hennequin C
Schistosoma haematobium urinary tract complications in African migrants attending primary care facilities in Paris, France: A retrospective cohort study (2004-2018).
Infectious Diseases Now 2023, 53, 104715.
Scanvion A, Vignier N, Durand F, Poupon-Ferron S, Billaud E
Heterogeneity of HIV testing practices in free healthcare centers in France: A national demonstration study.
Infectious Diseases Now 2023, 53, 104726.
Alviset S, Rodari S, Poupet H, Mizrahi A, Gastli N, Philippart F, Charpentier J, Pilmis B, Kernéis S
Potential impact of real-time processing and rapid susceptibility testing of blood samples in Gram-negative bloodstream infections in intensive care patients.
Infectious Diseases Now 2023, 53, 104773.
Goulenok T, Seurat J, Selle AdL, Jullien V, Leflon-Guibout V, Grall N, Lescure FX, Lepeule R, Bertrand J, Fantin B, Burdet C, Lefort A
Pharmacokinetic interaction between rifampicin and clindamycin in staphylococcal osteoarticular infections.
International Journal of Antimicrobial Agents 2023, 62, 106885.
Paccoud O, Chamillard X, Kendjo E, Vinatier I, Surgers L, Magne D, Wyplosz B, Angoulvant A, Bouchaud O, Izri A, Matheron S, Houzé S, Thellier M, Ndour AP, Buffet P, Caumes E, Jauréguiberry S, French National Reference Center for Imported Malaria Study Group
Favorable outcome without corticosteroids during post-artesunate delayed hemolysis with positive direct antiglobulin test in severe imported Plasmodium falciparum malaria, France.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2023, 137, 144-148.
Tsopra R, Peiffer-Smadja N, Charlier C, Campeotto F, Lemogne C, Ruszniewski P, Vivien B, Burgun A
Putting undergraduate medical students in AI-CDSS designers' shoes: An innovative teaching method to develop digital health critical thinking.
International Journal of Medical Informatics 2023, 171, 104980.
Rousset P, Dalle S, Mortier L, Dereure O, Dalac S, Dutriaux C, Leccia MT, Legoupil D, Brunet-Possenti F, De Quatrebarbes J, Grob JJ, Saiag P, Maubec E, Stoebner PE, Granel-Brocard F, Arnault JP, Allayous C, Oriano B, Lebbe C, Montaudié H
Impact of systemic therapies in metastatic melanoma of unknown primary: A study from MELBASE, a French multicentric prospective cohort.
Journal of the American Academy of Dermatology 2023, 88, 808-815.
Mageau A, Tchen J, Ferré VM, Nicaise-Roland P, Descamps D, Delory N, François C, Mendes C, Papo T, Goulenok T, Charles N, Sacré K
Impact of BNT162b2 mRNA anti-SARS-CoV-2 vaccine on interferon-alpha production by plasmacytoid dendritic cells and autoreactive T cells in patients with systemic lupus erythematosus: The COVALUS project.
Journal of Autoimmunity 2023, 134, 102987.
Robert M, Berleur M, Gaudemer A, Crow YJ, Frémond ML, Sacré K
VEXAS syndrome: Expanding the clinical and molecular spectrum.
Joint Bone Spine 2023, 90, 105531.
Zuercher P, Moser A, Frey MC, Pagani JL, Buetti N, Eggimann P, Daneman N, Fowler R, Que YA, Prazak J
The effect of duration of antimicrobial treatment for bacteremia in critically ill patients on in-hospital mortality - Retrospective double center analysis.
Journal of Critical Care 2023, 74, 154257.
Hassold N, Brichler S, Gater Y, Leclerc D, Gordien E, Bouchaud O, Carbonnelle E, Mechai F, Cordel H, Delagreverie H
Mixed outcomes following a third SARS-CoV-2 vaccine dose in previously unresponsive people with HIV.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2023, 158, 105347.
Jousset AB, Bernabeu S, Emeraud C, Bonnin RA, Lomont A, Zahar JR, Merens A, Isnard C, Soismier N, Farfour E, Fihman V, Yin N, Barraud O, Jacquier H, Ranc AG, Laurent F, Corvec S, d'Epenoux LR, Bille E, Degand N, Plouzeau C, Guillard T, Cattoir V, Mizrahi A, Grillon A, Janvier F, Brun CL, Amara M, Bastide M, Lemonnier A, Dortet L, GMC-study Group
Evaluation of ceftolozane-tazobactam susceptibility on a French nationwide collection of Enterobacterales.
Journal of Global Antimicrobial Resistance 2023, 32, 78-84.
Hachicha-Maalej N, Collins IJ, Ades AE, Scott K, Judd A, Mostafa A, Chappell E, Hamdy-El-Sayed M, Gibb D, Pett S, Mariné-Barjoan E, Volokha A, Yazdanpanah Y, Deuffic-Burban S
Modelling the potential effectiveness of hepatitis C screening and treatment strategies during pregnancy in Egypt and Ukraine.
Journal of Hepatology 2023, 78, 937-946.
Farfour E, Lebourgeois S, Chenane HR, Charpentier C, Pascreau T, Jolly E, Descamps D, Vasse M, Visseaux B
SARS-CoV-2 viability and viral RNA persistence on microbiological agar plates.
The Journal of Hospital Infection 2023, 132, 140-142.
Hassoun-Kheir N, Buetti N, Olivier V, Perez M, Frossard J, Renzi G, Schrenzel J, Saudan P, Harbarth S
Targeted mupirocin-based decolonization for Staphylococcus aureus carriers and the subsequent risk of mupirocin resistance in haemodialysis patients - a longitudinal study over 20 years.
The Journal of Hospital Infection 2023, 135, 55-58.
Henoun Loukili N, Loquet A, Perrin A, Gaillot O, Bruandet A, Sendid B, Zahar JR, Nseir S
Time to intestinal clearance of carbapenemase-producing Enterobacterales in hospital patients: a longitudinal retrospective observational cohort study.
The Journal of Hospital Infection 2023, 135, 4-10.
Halouani H, Lomont A, Jaureguy F, Carbonnelle E, Seytre D, Zahar JR
Interest of broth enrichment for rectal screening in a low carbapenemase-producing Enterobacterales prevalence country.
The Journal of Hospital Infection 2023, 138, 97-98.
Catho G, Rosa Mangeret F, Sauvan V, Chraïti MN, Pfister R, Baud O, Harbarth S, Buetti N
Risk of catheter-associated bloodstream infection by catheter type in a neonatal intensive care unit: a large cohort study of more than 1100 intravascular catheters.
The Journal of Hospital Infection 2023, 139, 6-10.
Smith DRM, Chervet S, Pinettes T, Shirreff G, Jijón S, Oodally A, Jean K, Opatowski L, Kernéis S, Temime L
How have mathematical models contributed to understanding the transmission and control of SARS-CoV-2 in healthcare settings? A systematic search and review.
The Journal of Hospital Infection 2023, 141, 132-141.
Legouge C, Bidet P, Gits-Muselli M, Cointe A, Courroux C, Birgy A, Bonacorsi S
Rapid, simple multi-locus variable number tandem repeat analysis: a reliable tool for Klebsiella pneumoniae outbreak screening.
The Journal of Hospital Infection 2023, 141, 41-48.
de Lamballerie X, Martin-Blondel G, Dupont A, Izopet J, Mentré F, Kamar N, Autran B, Paintaud G, Caillard S, le Bourgeois A, Richez C, Couzi L, Xhaard A, Marjanovic Z, Avouac J, Jacquet C, Anglicheau D, Cheminant M, Yazdanpanah Y, Guyen SN, Terrier B, Gottenberg JE, Besson C, Letrou S, Kali S, Angoulvant D, Sanchez VP, Tardivon C, Blancho G, Lévy V
Low serum neutralization of Omicron variants a month after AZD7442 prophylaxis initiation.
The Journal of Infection 2023, 86, 66-117.
Mellon G, Rubenstein E, Antoine M, Ferré VM, Gabassi A, Molina JM, Delaugerre C, LeGoff J
Air detection of monkeypox virus in a dedicated outpatient clinic room for monkeypox infection diagnosis.
The Journal of Infection 2023, 86, 256-308.
Touret F, Martin-Blondel G, de Lamballerie X, Dupont A, Izopet J, Mentré F, Kamar N, Autran B, Paintaud G, Caillard S, Richez C, Couzi L, Xhaard A, Marjanovic Z, Avouac J, Jacquet C, Anglicheau D, Cheminant M, Yazdanpanah Y, N'Guyen S, Terrier B, Gottenberg JE, Besson C, Letrou S, Kali S, Angoulvant D, Barthélémy K, Priet S, Nurtop E, Sanchez VP, Tardivon C, Blancho G, Le Bourgeois A, Lévy V
Low to undetectable Omicron BQ.1.1 neutralization by patient's sera a month after initiation of AZD7442 600 mg.
The Journal of Infection 2023, 86, e126-e129.
Pellenc Q, Renard R, Gaudemer A, Amarenco P, Lavallée P
Bypass grafting to the third segment of the vertebral artery for symptomatic extensive vertebrobasilar atherosclerotic disease.
Journal of Vascular Surgery Cases and Innovative Techniques 2023, 9, 101260.
Brault A, Tran-Kiem C, Couteaux C, Olié V, Paireau J, Yazdanpanah Y, Ghosn J, Martin-Blondel G, Bosetti P, Cauchemez S
Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna.
The Lancet Regional Health. Western Pacific 2023, 30, 100634.
Roblot P, Belaroussi Y, Peiffer-Smadja N, Lafarge X, Cotto E, Colombat M, Blohorn L, Gardere M, Kerdiles G, Le Petit L, Wavasseur T, Liguoro D, Jecko V, Vignes JR
Effect of microorganisms isolated by preoperative osseous sampling on surgical site infection after autologous cranioplasty: A single-center experience.
Neuro-Chirurgie 2023, 69, 101458.
Ardellier FD, Baloglu S, Sokolska M, Noblet V, Lersy F, Collange O, Ferré JC, Maamar A, Carsin-Nicol B, Helms J, Schenck M, Khalil A, Gaudemer A, Caillard S, Pottecher J, Lefèbvre N, Zorn PE, Matthieu M, Brisset JC, Boulay C, Mutschler V, Hansmann Y, Mertes PM, Schneider F, Fafi-Kremer S, Ohana M, Meziani F, Meyer N, Yousry T, Anheim M, Cotton F, Jäger HR, Kremer S, SFNR-COVID group
Cerebral perfusion using ASL in patients with COVID-19 and neurological manifestations: A retrospective multicenter observational study.
Journal of Neuroradiology = Journal De Neuroradiologie 2023, S0150-9861(23)00006-8.
Ballul T, Mageau A, Roland Nicaise P, Ajzenberg N, Strukov A, Dossier A, Rouzaud D, Papo T, Sacré K
Recurrent thrombotic events after disappearance of antiphospholipid autoantibodies: A long-term longitudinal study in patients with antiphospholipid syndrome.
Thrombosis Research 2023, 224, 1-3.
Gros C, Barral T, Mageau A, Roland Nicaise P, Vivier V, Papo T, Bourgeois-Moine A, Goulenok T, Sacre K
Unexplained fetal death, pre-eclampsia and fetal growth restriction in pregnancy: Who is screened for antiphospholipid syndrome?.
Thrombosis Research 2023, 228, 61-63.
Coppée R, Chenane HR, Bridier-Nahmias A, Tcherakian C, Catherinot E, Collin G, Lebourgeois S, Visseaux B, Descamps D, Vasse M, Farfour E
Temporal dynamics of RSV shedding and genetic diversity in adults during the COVID-19 pandemic in a French hospital, early 2021.
Virus Research 2023, 323, 198950.
Lefrançois T, Malvy D, Atlani-Duault L, Benamouzig D, Druais PL, Yazdanpanah Y, Delfraissy JF, Lina B
After 2 years of the COVID-19 pandemic, translating One Health into action is urgent.
Lancet (London, England) 2023, 401, 789-794.
Mitjà O, Alemany A, Marks M, Lezama Mora JI, Rodríguez-Aldama JC, Torres Silva MS, Corral Herrera EA, Crabtree-Ramirez B, Blanco JL, Girometti N, Mazzotta V, Hazra A, Silva M, Montenegro-Idrogo JJ, Gebo K, Ghosn J, Peña Vázquez MF, Matos Prado E, Unigwe U, Villar-García J, Wald-Dickler N, Zucker J, Paredes R, Calmy A, Waters L, Galvan-Casas C, Walmsley S, Orkin CM, SHARE-NET writing group
Mpox in people with advanced HIV infection: a global case series.
Lancet (London, England) 2023, 401, 939-949.
Beaumont AL, Raphaël E, Bertin C, Lariven S, Peiffer-Smadja N
Mpox lesions on a tattoo.
The Lancet. Infectious Diseases 2023, 23, 762.
Beaumont AL, Peiffer-Smadja N
Mpox: a new name for a new disease?.
The Lancet. Infectious Diseases 2023, 23, 516-517.
Amstutz A, Speich B, Mentré F, Rueegg CS, Belhadi D, Assoumou L, Burdet C, Murthy S, Dodd LE, Wang Y, Tikkinen KAO, Ader F, Hites M, Bouscambert M, Trabaud MA, Fralick M, Lee TC, Pinto R, Barratt-Due A, Lund-Johansen F, Müller F, Nevalainen OPO, Cao B, Bonnett T, Griessbach A, Taji Heravi A, Schönenberger C, Janiaud P, Werlen L, Aghlmandi S, Schandelmaier S, Yazdanpanah Y, Costagliola D, Olsen IC, Briel M
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials.
The Lancet. Respiratory Medicine 2023, 11, 453-464.
Reignier J, Plantefeve G, Mira JP, Argaud L, Asfar P, Aissaoui N, Badie J, Botoc NV, Brisard L, Bui HN, Chatellier D, Chauvelot L, Combes A, Cracco C, Darmon M, Das V, Debarre M, Delbove A, Devaquet J, Dumont LM, Gontier O, Groyer S, Guérin L, Guidet B, Hourmant Y, Jaber S, Lambiotte F, Leroy C, Letocart P, Madeux B, Maizel J, Martinet O, Martino F, Maxime V, Mercier E, Nay MA, Nseir S, Oziel J, Picard W, Piton G, Quenot JP, Reizine F, Renault A, Richecoeur J, Rigaud JP, Schneider F, Silva D, Sirodot M, Souweine B, Tamion F, Terzi N, Thévenin D, Thiery G, Thieulot-Rolin N, Timsit JF, Tinturier F, Tirot P, Vanderlinden T, Vinatier I, Vinsonneau C, Voicu S, Lascarrou JB, Le Gouge A, NUTRIREA-3 Trial Investigators, Clinical Research in Intensive Care, Sepsis (CRICS-TRIGGERSEP)Group
Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3).
The Lancet. Respiratory Medicine 2023, 11, 602-612.
Charani E, Mendelson M, Pallett SJC, Ahmad R, Mpundu M, Mbamalu O, Bonaconsa C, Nampoothiri V, Singh S, Peiffer-Smadja N, Anton-Vazquez V, Moore LSP, Schouten J, Kostyanev T, Vlahović-Palčevski V, Kofteridis D, Corrêa JS, Holmes AH
An analysis of existing national action plans for antimicrobial resistance-gaps and opportunities in strategies optimising antibiotic use in human populations.
The Lancet. Global Health 2023, 11, e466-e474.
Ogbuagu O, Segal-Maurer S, Ratanasuwan W, Avihingsanon A, Brinson C, Workowski K, Antinori A, Yazdanpanah Y, Trottier B, Wang H, Margot N, Dvory-Sobol H, Rhee MS, Baeten JM, Molina JM, GS-US-200-4625 investigators
Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial.
The lancet. HIV 2023, 10, e497-e505.
Guémas E, Coppée R, Ménard S, du Manoir M, Nsango S, Makaba Mvumbi D, Nakoune E, Eboumbou Moukoko CE, Bouyou Akotet MK, Mirabeau TY, Manguin S, Malekita Yobi D, Akiana J, Kouna LC, Mawili Mboumba DP, Voumbo-Matoumona DF, Otam AL, Rubbo PA, Lombart JP, Kwanai E, Cohen O, Iriart X, Ayong L, Lekana-Douki JB, Ariey F, Berry A
Evolution and spread of Plasmodium falciparum mutations associated with resistance to sulfadoxine-pyrimethamine in central Africa: a cross-sectional study.
The Lancet. Microbe 2023, S2666-5247(23)00211-2.
Landelle C, Birgand G, Price JR, Mutters NT, Morgan DJ, Lucet JC, Kerneis S, Zingg W
Considerations for de-escalating universal masking in healthcare centers.
Antimicrobial stewardship & healthcare epidemiology: ASHE 2023, 3, e128.
Yokoe DS, Advani SD, Anderson DJ, Babcock HM, Bell M, Berenholtz SM, Bryant KA, Buetti N, Calderwood MS, Calfee DP, Dubberke ER, Ellingson KD, Fishman NO, Gerding DN, Glowicz J, Hayden MK, Kaye KS, Klompas M, Kociolek LK, Landon E, Larson EL, Malani AN, Marschall J, Meddings J, Mermel LA, Patel PK, Perl TM, Popovich KJ, Schaffzin JK, Septimus E, Trivedi KK, Weinstein RA, Maragakis LL
Executive Summary: A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute-Care Hospitals: 2022 Updates.
Infection Control and Hospital Epidemiology 2023, 44, 1540-1554.
Grant RL, Sauser J, Atkinson A, D'Incau S, Buetti N, Zanella MC, Harbarth S, Marschall J, Catho G, CH-SUR Collaborative Network
Comparison of clinical outcomes over time of inpatients with healthcare-associated or community-acquired coronavirus disease 2019 (COVID-19): A multicenter, prospective cohort study.
Infection Control and Hospital Epidemiology 2023, 1-7.
Yokoe DS, Advani SD, Anderson DJ, Babcock HM, Bell M, Berenholtz SM, Bryant KA, Buetti N, Calderwood MS, Calfee DP, Deloney VM, Dubberke ER, Ellingson KD, Fishman NO, Gerding DN, Glowicz J, Hayden MK, Kaye KS, Kociolek LK, Landon E, Larson EL, Malani AN, Marschall J, Meddings J, Mermel LA, Patel PK, Perl TM, Popovich KJ, Schaffzin JK, Septimus E, Trivedi KK, Weinstein RA, Maragakis LL
Introduction to A Compendium of Strategies to Prevent Healthcare-Associated Infections In Acute-Care Hospitals: 2022 Updates.
Infection Control and Hospital Epidemiology 2023, 44, 1533-1539.
Garrouste-Orgeas M, Marché V, Pujol N, Michel D, Evin A, Fossez-Diaz V, Perruchio S, Vanbésien A, Verlaine C, Copel L, Kaczmarek W, Birkui de Francqueville L, Michonneau-Gandon V, de Larivière E, Poupardin C, Touzet L, Guastella V, Mathias C, Mhalla A, Bouquet G, Richard B, Gracia D, Bienfait F, Verliac V, Ranchou G, Kirsch S, Flahault C, Loiodice A, Bailly S, Ruckly S, Timsit JF
Incidence and risk factors of prolonged grief in relatives of patients with terminal cancer in French palliative care units: The Fami-Life multicenter cohort study.
Palliative & Supportive Care 2023, 1-10.
Le Hingrat Q, Sette P, Xu C, Rahmberg AR, Tarnus L, Annapureddy H, Kleinman A, Brocca-Cofano E, Sivanandham R, Sivanandham S, He T, Capreri DJ, Ma D, Estes JD, Brenchley JM, Apetrei C, Pandrea I
Prolonged experimental CD4+ T-cell depletion does not cause disease progression in SIV-infected African green monkeys.
Nature Communications 2023, 14, 979.
Telford E, Grinsztejn B, Olsen IC, Pulik N, Mentré F, Haviari S, Hentzien M, Ségéral O, Ekkelenkamp MB, Ogoina D, Strub-Wourgaft N, Diallo A, Yazdanpanah Y, Calmy A
The international Unity study for antivirals against mpox is a blueprint for future epidemics.
Nature Medicine 2023, 29, 1894-1895.
Mirouse A, Friol A, Moreau AS, Jung B, Jullien E, Bureau C, Djibré M, de Prost N, Zafrani L, Argaud L, Reuter D, Calvet L, de Montmollin E, Benghanem S, Pichereau C, Pham T, Cacoub P, Biard L, Saadoun D
Severe SARS-Cov2 pneumonia in vaccinated patients: a multicenter cohort study.
Scientific Reports 2023, 13, 1902.
de Roquetaillade C, Laouenan C, Mira JP, Roy C, Thuong M, Azoulay É, Gruson D, Jacobs F, Chommeloux J, Raffi F, Hocqueloux L, Imbert P, Jeantils V, Delassus JL, Matheron S, Fitting C, Timsit JF, Bruneel F
Cytokine profiles in adults with imported malaria.
Scientific Reports 2023, 13, 10347.
Arnaud E, Elbattah M, Ammirati C, Dequen G, Ghazali DA
Predictive models in emergency medicine and their missing data strategies: a systematic review.
NPJ digital medicine 2023, 6, 28.
Nguyen Y, Nuzzo A, Gross A, Minka O, Lilamand M, Rossi G, Sanchez M, Legué C, Pourbaix A, Tran Dinh A, Rozencwajg S, Khider L, Peiffer-Smadja N, Bouzid D, Faye A, Mirault T, de Lastours V
Prior participation as a standardized patient improves OSCE scores of third-year medical students: A pilot comparative study at Université Paris Cité Medical School.
Medical Teacher 2023, 45, 1177-1182.
Mageau A, Ambert-Balay K, Boutolleau D, Schuffenecker I, Burrel S, Kaplon J, Nguyen Quoc S, Uzunov M, Souchet L, de Rougemont A, Roos-Weil D, Baron M
Norovirus and sapovirus infections after allogeneic hematopoietic stem cell transplantation: is it worth it to look for them?.
Leukemia & Lymphoma 2023, 64, 1295-1303.
Chabrol F, Traverson L, Hou R, Chotard L, Lucet JC, Peiffer-Smadja N, Bendjelloul G, Lescure FX, Yazdanpanah Y, Zinszer K, Ridde V
Adaptation and Response of a Major Parisian Referral Hospital to the COVID-19 Surge: A Qualitative Study.
Health Systems and Reform 2023, 9, 2165429.
Dagenais C, Kielende M, Coulibaly A, Gautier L, David PM, Peiffer-Smadja N, Honda A, de Araújo Oliveira SR, Traverson L, Zinszer K, Ridde V
Lessons Learned from Field Experiences on Hospitals' Resilience to the COVID-19 Pandemic: A Systematic Approach.
Health Systems and Reform 2023, 9, 2231644.
Nguyen LBL, Soumah AA, Hoang VT, Nguyen AT, Pham TH, Royer-Devaux S, Madec Y
Performances of Dried Blood Spots and Point-of-Care Devices to Identify Virological Failure in HIV-Infected Patients: A Systematic Review and Meta-Analysis.
AIDS patient care and STDs 2023, 37, 66-83.
Bertin C, Tarhini H, Rahi M, Deconinck L, Perrineau S, Merlant M, Ghosn J, Peiffer-Smadja N
Complicated scarring following mpox infection.
The British Journal of Dermatology 2023, 189, 225-226.
Lutz W, Bertin C, Merlant M, Mailhe M, Le Hingrat Q, Descamps V, Guilhou T, Maisonobe L, Yazdanpanah Y, Deschamps L, Charpentier C, Lariven S
Mpox presenting as a chronic cutaneous ulcer in a patient with advanced HIV infection.
Clinical and Experimental Dermatology 2023, llad258.
Sibiude J, Le Chenadec J, Mandelbrot L, Hoctin A, Dollfus C, Faye A, Bui E, Pannier E, Ghosn J, Garrait V, Avettand-Fenoel V, Frange P, Warszawski J, Tubiana R
Update of Perinatal Human Immunodeficiency Virus Type 1 Transmission in France: Zero Transmission for 5482 Mothers on Continuous Antiretroviral Therapy From Conception and With Undetectable Viral Load at Delivery.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2023, 76, e590-e598.
Coppée R, Sarrasin V, Zaffaroulah R, Bouzayene A, Thellier M, Noël H, Clain J, Houzé S, Investigation Study Group
Nosocomial Malaria Transmissions Resolved by Genomic Analyses-A Retrospective Case Report Study in France: 2007-2021.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2023, 76, 631-639.
Chalali F, Merlant M, Truong A, Ghosn J, Phung BC, Mollo B, Perrineau S, Rahi M, Fidouh-Houhou N, Ferré VM, Brunet-Possenti F, Descamps V, Bouscarat F, Yazdanpanah Y, Deschamps L, Bertin C
Histological Features Associated With Human Mpox Virus Infection in 2022 Outbreak in a Nonendemic Country.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2023, 76, 1132-1135.
de Salazar A, Viñuela L, Fuentes A, Teyssou E, Charpentier C, Lambert-Niclot S, Serrano-Conde E, Pingarilho M, Fabeni L, De Monte A, Stefic K, Perno CF, Aguilera A, Falces I, Delgado R, Fernandes S, Diogo I, Gomes P, Paraskevis D, Santoro MM, Ceccherini-Silberstein F, Marcelin AG, Garcia F
Transmitted Drug Resistance to Integrase-Based First-Line Human Immunodeficiency Virus Antiretroviral Regimens in Mediterranean Europe.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2023, 76, 1628-1635.
Laurent C, Yaya I, Cuer B, Sagaon-Teyssier L, Mensah E, Dah TTE, Coulibaly A, Kouamé MJB, Peytavin G, Serrano L, Eubanks A, Traoré I, Diallo F, Riegel L, Rojas Castro D, Dagnra CA, Anoma C, Vuylsteke B, Dembélé Keita B, Spire B, CohMSM-PrEP Study Group
Human Immunodeficiency Virus Seroconversion Among Men Who Have Sex With Men Who Use Event-Driven or Daily Oral Pre-Exposure Prophylaxis (CohMSM-PrEP): A Multi-Country Demonstration Study From West Africa.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2023, 77, 606-614.
Stern J, Dupuis C, Kpeglo H, Reuter J, Vinclair C, Para M, Nataf P, Pelletier AL, de Montmollin E, Bouadma L, Timsit JF, Sonneville R
Upper gastrointestinal bleeding in adults treated with veno-arterial extracorporeal membrane oxygenation: a cohort study.
European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 2023, 63, ezad083.
von Cube M, Schumacher M, Timsit JF, Decruyenaere J, Steen J
The population-attributable fraction for time-to-event data.
International Journal of Epidemiology 2023, 52, 837-845.
Joste V, Colard-Itté E, Guillochon É, Ariey F, Coppée R, Clain J, Houzé S, French National Reference Center for Imported Malaria Study Group
Genetic Profiling of Plasmodium ovale wallikeri Relapses With Microsatellite Markers and Whole-Genome Sequencing.
The Journal of Infectious Diseases 2023, 228, 1089-1098.
Guilbaud R, Franco Yusti AM, Leducq V, Zafilaza K, Bridier-Nahmias A, Todesco E, Soulie C, Fauchois A, Le Hingrat Q, Kramer L, Goulenok T, Salpin M, Daugas E, Dorent R, Ottaviani S, Zalcman G, Ghosn J, Choquet S, Cacoub P, Amoura Z, Barroux B, Pourcher V, Spano JP, Louet M, Marcelin AG, Calvez V, Charpentier C, Descamps D, Marot S, Ferré VM, Coppée R
Higher levels of SARS-CoV-2 genetic variation in immunocompromised patients: a retrospective case-control study.
The Journal of Infectious Diseases 2023, jiad499.
Bachelard A, Isernia V, Charpentier C, Benalycherif A, Mora M, Donadille C, Duvivier C, Lacombe K, El Mouhebb M, Spire B, Landman R, Descamps D, Peytavin G, Assoumou L, Ghosn J, FAST study group
Same-day initiation of bictegravir/emtricitabine/tenofovir alafenamide: Week 48 results of the FAST study-IMEA 055.
The Journal of Antimicrobial Chemotherapy 2023, 78, 769-778.
Lafaurie M, Montlahuc C, Kerneis S, de Lastours V, Abgrall S, Manceron V, Couzigou C, Chabrol A, de Raigniac A, Lescure X, Longuet P, Lesprit P, Vanjak D, Lepeule R, Groupe des référents en Infectiologie d’Ile de France (GRIF)
Efficacy of vancomycin lock therapy for totally implantable venous access port-related infection due to coagulase-negative staphylococci in 100 patients with cancer.
The Journal of Antimicrobial Chemotherapy 2023, 78, 1253-1258.
Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, Descamps D, Ceccherini-Silberstein F, Marcelin AG, Flandre P
Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings.
The Journal of Antimicrobial Chemotherapy 2023, 78, 1415-1422.
Lambert-Niclot S, Abdi B, Bellet J, Fofana D, De Truchis P, Amat K, Alvarez JC, Surgers L, Allavena C, Zaegell-Faucher O, Morlat P, Palich R, Gibowski S, Costagliola D, Girard PM, Landman R, Assoumou L, Morand-Joubert L, ANRS 170 QUATUOR study group
Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR): substudies of reservoirs and ultrasensitive drug resistance.
The Journal of Antimicrobial Chemotherapy 2023, 78, 1510-1521.
Mandelbrot L, Tubiana R, Frange P, Peytavin G, Le Chenadec J, Canestri A, Morlat P, Brunet-Cartier C, Sibiude J, Peretti D, Chambrin V, Chabrol A, Bui E, Simon-Toulza C, Marchand L, Paul C, Delmas S, Avettand-Fenoel V, Warszawski J, Monogest study group
Maintenance darunavir/ritonavir monotherapy to prevent perinatal HIV transmission, ANRS-MIE 168 MONOGEST study.
The Journal of Antimicrobial Chemotherapy 2023, 78, 1711-1722.
Duhant A, Kusinza B, Tantet C, Bisimwa B, Gare M, Masemo B, Alloui C, Ntakwinjan M, Mechai F, Le MP, Gerber A, Muhigirwa B, Peytavin G, Gordien E, Brichler S, Mukwege M, Le Gal F
HIV-1 infection in South Kivu (Democratic Republic of Congo): high genotypic resistance to antiretrovirals.
The Journal of Antimicrobial Chemotherapy 2023, 78, 1732-1739.
Contejean A, Maillard A, Canouï E, Kernéis S, Fantin B, Bouscary D, Parize P, Garcia-Vidal C, Charlier C
Advances in antibacterial treatment of adults with high-risk febrile neutropenia.
The Journal of Antimicrobial Chemotherapy 2023, 78, 2109-2120.
Aslan AT, Tabah A, Köylü B, Kalem AK, Aksoy F, Erol Ç, Karaali R, Tunay B, Guzeldağ S, Batirel A, Dindar EK, Akdoğan Ö, Bilir Y, Ersöz G, Öztürk B, Selçuk M, Yilmaz M, Akyol A, Akbaş T, Sungurtekin H, Timuroğlu A, Gürbüz Y, Çolak O, Bayindir Y, Eroğlu A, Ferlicolak L, Çeşme U, Dağ O, Buetti N, Barbier F, Ruckly S, Staiquly Q, Timsit JF, Akova M
Epidemiology and risk factors of 28-day mortality of hospital-acquired bloodstream infection in Turkish intensive care units: a prospective observational cohort study.
The Journal of Antimicrobial Chemotherapy 2023, 78, 1757-1768.
Mazouz F, Bertine M, Coppée R, Storto A, Katlama C, Landman R, Cabié A, Peytavin G, Raffi F, Yazdanpanah Y, Descamps D, Joly V, Ghosn J, Charpentier C, LAMIDOL Study Group
Proportion of APOBEC3-induced defective HIV DNA after 1 year of dolutegravir + lamivudine simplification in the ANRS 167 LAMIDOL trial.
The Journal of Antimicrobial Chemotherapy 2023, dkad344.
Rondinaud E, Clermont O, Petitjean M, Ruppé E, Esposito-Farèse M, Nazimoudine A, VOYAG-R Study Group, Coignard B, Matheron S, Andremont A, Denamur E, Armand-Lefevre L
Acquisition of Enterobacterales carrying the colistin resistance gene mcr following travel to the tropics.
Journal of Travel Medicine 2023, 30, taac141.
de Malliard I, Houist AL, Peytavin G, L'Yavanc T, Bouvier M, Cappy P, Lelièvre JD, Feredj E, Vindrios W, Gallien S, Melica G
Gynoid Fat Distribution and Adipocyte Trapping May Explain Virological Failure With Intramuscular Long-Acting Cabotegravir and Rilpivirine.
Open Forum Infectious Diseases 2023, 10, ofad217.
Gaborit B, Vanhove B, Lacombe K, Guimard T, Hocqueloux L, Perrier L, Dubee V, Ferre V, Bressollette C, Josien R, Thuaut AL, Vibet MA, Jobert A, Dailly E, Ader F, Brouard S, Duvaux O, Raffi F, POLYCOR study group
Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled Trial.
Open Forum Infectious Diseases 2023, 10, ofad525.
Tin Y, Castry M, Bowers-Sword R, Shantharam S, Aldridge A, Zarkin GA, Starbird L, Linas BP, Barocas JA, Morgan JR
Establishing a Protocol for Determining the Costs of an Integrated Set of Evidence-based Practices Aimed at Reducing Opioid Overdose Deaths.
Journal of Addiction Medicine 2023
Galerneau LM, Bailly S, Terzi N, Ruckly S, Garrouste-Orgeas M, Cohen Y, Hong Tuan Ha V, Gainnier M, Siami S, Dupuis C, Darmon M, Forel JM, Rigault G, Adrie C, Goldgran-Toledano D, Laurent V, de Montmollin E, Argaud L, Reignier J, Pepin JL, Timsit JF, OUTCOMEREA Network
Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease in the ICU: An Observational Study From the OUTCOMEREA Database, 1997-2018.
Critical Care Medicine 2023, 51, 753-764.
Vacheron CH, Friggeri A, Gerbaud-Coulas C, Dagonneau T, Timsit JF, Allaouchiche B, Wallet F, Bohe J, Piriou V, Maucort-Boulch D, Fauvernier M
Improved 30-Day Survival Estimation in ICU Patients: A Comparative Analysis of Different Approaches With Real-World Data.
Critical Care Medicine 2023
Sonneville R, Dangayach NS, Newcombe V
Neurological complications of critically ill COVID-19 patients.
Current Opinion in Critical Care 2023, 29, 61-67.
Thy M, de Montmollin E, Bouadma L, Timsit JF, Sonneville R
Severe meningoencephalitis: epidemiology and outcomes.
Current Opinion in Critical Care 2023, 29, 415-422.
Tubiana S, Epelboin L, Casalino E, Naccache JM, Feydy A, Khalil A, Hausfater P, Duval X, Claessens YE, ESCAPED study group
Effect of diagnosis level of certainty on adherence to antibiotics' guidelines in ED patients with pneumonia: a post-hoc analysis of an interventional trial.
European Journal of Emergency Medicine: Official Journal of the European Society for Emergency Medicine 2023, 30, 102-109.
Cancella de Abreu M, Peyrony O, Hermand C, Bompard R, Bouzid D, Eyer X
Time to result advantage of point-of-care SARS-CoV-2 PCR testing to confirm COVID-19 in emergency department: a retrospective multicenter study.
European Journal of Emergency Medicine: Official Journal of the European Society for Emergency Medicine 2023, 30, 132-134.
Abensur Vuillaume L, Gennai S, Casalino E, Tazarourte K, Bilbault P
An emergency department organizational assessment questionnaire: a Delphi study to create standardized comparators for emergency department directors.
European Journal of Emergency Medicine: Official Journal of the European Society for Emergency Medicine 2023, 30, 209-210.
Antoine M, Rubenstein E, Lascoux-Combe C, Chawki S, Zeggagh J, Pintado C, Tateo M, Ponscarme D, Ferre VM, Descamps D, Molina JM
Clinical Description of Sixty-Six Cases of Monkeypox Virus (MKPV) Infection Among Men Who Have Sex With Men (MSM) in an HIV/PrEP French Clinic.
Journal of Acquired Immune Deficiency Syndromes (1999) 2023, 92, e11-e14.
Barbier F, Woerther PL, Timsit JF
Rapid diagnostics for skin and soft tissue infections: the current landscape and future potential.
Current Opinion in Infectious Diseases 2023, 36, 57-66.
Do Rego H, Timsit JF
Management strategies for severe Pseudomonas aeruginosa infections.
Current Opinion in Infectious Diseases 2023, 36, 585-595.
Ghazali DA, Choquet C, Bouzid D, Peyrony O, Fontaine JP, Sonja C, Javaud N, Plaisance P, Revue E, Chauvin A, Casalino E
The Response of Emergency Departments (EDs) to the COVID-19 Pandemic: The Experience of 5 EDs in a Paris-Based Academic Hospital Trust.
Quality Management in Health Care 2023, 32, 46-52.
Terzić V, Levoyer L, Figarella M, Bigagli E, Mercier N, De Gastines L, Gibowski S, Trøseid M, Demotes J, Olsen IC, Hites M, Ader F, Lopez JRA, Mentré F, Espérou H, Costagliola D, Røttingen JA, Poissy J, Rozé JC, Warris A, O'Leary J, Fernandes RM, Assoumou L, Hankard R, Turner MA, Yazdanpanah Y, Diallo A, EU-Response safety group, c4c safety group
Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia.
British Journal of Clinical Pharmacology 2023, 89, 1318-1328.
Lemaitre F, Lagoutte-Renosi J, Gagnieu MC, Parant F, Venisse N, Grégoire M, Bouchet S, Garraffo R, Lê MP, Muret P, Comets E, Solas C, Peytavin G, ANRS-MIE-BIRIDER Study group on behalf of the Clinical Pharmacology Group of ANRS-MIE AC43
Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1-infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER study).
British Journal of Clinical Pharmacology 2023
Rekik S, Pluart DL, Ferré V, Charpentier C, Laurain A, Ghosn J, Abramowitz L
Anogenital symptoms and lesions in a series of 20 patients infected with monkeypox virus.
Colorectal Disease: The Official Journal of the Association of Coloproctology of Great Britain and Ireland 2023, 25, 1002-1005.
Liegeon G, Ghosn J
Long-acting injectable cabotegravir for PrEP: A game-changer in HIV prevention?.
HIV medicine 2023, 24, 653-663.
Hocqueloux L, Menard A, Arvieux C, Joly V, Becker A, Chéret A, Duvivier C, Cabié A, Delpierre C, Allavena C, Dat'AIDS Study Group
Weight gain following the single substitution of tenofovir disoproxil fumarate by tenofovir alafenamide in HIV-infected people from the French Dat'AIDS cohort: A propensity score-matched analysis.
HIV medicine 2023, 24, 925-932.
Protiere C, Sagaon-Teyssier L, Donadille C, Sow A, Gaubert G, Girard G, Mora M, Assoumou L, Beniguel L, Michels D, Ghosn J, Costagliola D, Rojas Castro D, Molina JM, Spire B, ANRS PREVENIR Study-Group
Perception of PrEP-related stigma in PrEP users: Results from the ANRS-PREVENIR cohort.
HIV medicine 2023, 24, 938-945.
Moghadam P, Herms F, Baroudjian B, Tetu P, Delyon J, Jouenne F, Boisson M, Louveau B, Mourah S, Brunet-Possenti F, Duverger L, Gounant V, Lebbé C, Basset-Seguin N
Eruptive squamous cell carcinomas following an acute skin inflammatory disease: A series of four cases.
Journal of the European Academy of Dermatology and Venereology: JEADV 2023, 37, e119-e121.
Bertin C, Beaumont AL, Merlant M, Mailhe M, Le Pluart D, Deconinck L, Thy M, Cortier M, Garé M, Dollat M, Rahi M, Joly V, Lariven S, Rioux C, Truong A, Deschamps L, Ferré VM, Charpentier C, Lescure FX, Bouscarat F, Descamps V, Yazdanpanah Y, Peiffer-Smadja N
Erythematous maculopapular rash in monkeypox virus infection: A retrospective case series of 30 patients.
Journal of the European Academy of Dermatology and Venereology: JEADV 2023, 37, e638-e641.
Khelef K, Maubec E, Jeudy G, Bonniaud B, Pham-Ledard A, Herms F, Aubin F, Beneton N, Dinulescu M, Jannic A, Duval-Modeste A, Archier E, Berthin C, Grange F, Arnault J, Heidelberger V, Moncourier M, Mansard S, Brunet-Possenti F, Triller R, Pracht M, Dumas M, Lauche O, Mortier L, Bedane C, Dalac Rat S
Duration of treatment with cemiplimab in advanced cutaneous squamous cell carcinoma in complete response: Real-life study.
Journal of the European Academy of Dermatology and Venereology: JEADV 2023
Allavena C, Bastides F, Moroy A, Occhipinti S, Durand F, Barriere G, Micoulaud-Franchi JA, Ghosn J
The screening and management of sleep disturbances in people living with HIV: Delphi consensus.
Journal of Sleep Research 2023, e14070.
Ghazali DA, Ilha-Schuelter P, Oriot D
Performing complex interdisciplinary procedures: Never on the patient the first time!.
Medical Education 2023
Bonello K, Figoni H, Blanchard E, Vignier N, Avenin G, Melchior M, Cadwallader JS, Chastang J, Ibanez G
Prevalence of smoking during pregnancy and associated social inequalities in developed countries over the 1995-2020 period: A systematic review.
Paediatric and Perinatal Epidemiology 2023
Bastard P, Vazquez SE, Liu J, Laurie MT, Wang CY, Gervais A, Le Voyer T, Bizien L, Zamecnik C, Philippot Q, Rosain J, Catherinot E, Willmore A, Mitchell AM, Bair R, Garçon P, Kenney H, Fekkar A, Salagianni M, Poulakou G, Siouti E, Sahanic S, Tancevski I, Weiss G, Nagl L, Manry J, Duvlis S, Arroyo-Sánchez D, Paz Artal E, Rubio L, Perani C, Bezzi M, Sottini A, Quaresima V, Roussel L, Vinh DC, Reyes LF, Garzaro M, Hatipoglu N, Boutboul D, Tandjaoui-Lambiotte Y, Borghesi A, Aliberti A, Cassaniti I, Venet F, Monneret G, Halwani R, Sharif-Askari NS, Danielson J, Burrel S, Morbieu C, Stepanovskyy Y, Bondarenko A, Volokha A, Boyarchuk O, Gagro A, Neuville M, Neven B, Keles S, Hernu R, Bal A, Novelli A, Novelli G, Saker K, Ailioaie O, Antolí A, Jeziorski E, Rocamora-Blanch G, Teixeira C, Delaunay C, Lhuillier M, Le Turnier P, Zhang Y, Mahevas M, Pan-Hammarström Q, Abolhassani H, Bompoil T, Dorgham K, COVID HGE Consortium, French COVID Study Group, COMET Consortium, Gorochov G, Laouenan C, Rodríguez-Gallego C, Ng LFP, Renia L, Pujol A, Belot A, Raffi F, Allende LM, Martinez-Picado J, Ozcelik T, Imberti L, Notarangelo LD, Troya J, Solanich X, Zhang SY, Puel A, Wilson MR, Trouillet-Assant S, Abel L, Jouanguy E, Ye CJ, Cobat A, Thompson LM, Andreakos E, Zhang Q, Anderson MS, Casanova JL, DeRisi JL
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs.
Science Immunology 2023, 8, eabp8966.
Presente S, Bonnal C, Normand AC, Gaudonnet Y, Fekkar A, Timsit JF, Kernéis S
Hospital Clonal Outbreak of Fluconazole-Resistant Candida parapsilosis Harboring the Y132F ERG11p Substitution in a French Intensive Care Unit.
Antimicrobial Agents and Chemotherapy 2023, 67, e0113022.
Guiraud V, Bocobza J, Desmonet M, Damond F, Plantier JC, Moreau G, Wirden M, Stefic K, Barin F, Gautheret-Dejean A
Are Confirmatory Assays Reliable for HIV-1/HIV-2 Infection Differentiation? A Multicenter Study.
Journal of Clinical Microbiology 2023, 61, e0061923.
Khan MS, Kim E, Le Hingrat Q, Kleinman A, Ferrari A, Sammartino JC, Percivalle E, Xu C, Huang S, Kenniston TW, Cassaniti I, Baldanti F, Pandrea I, Gambotto A, Apetrei C
Tetravalent SARS-CoV-2 S1 subunit protein vaccination elicits robust humoral and cellular immune responses in SIV-infected rhesus macaque controllers.
mBio 2023, e0207023.
Lacombe K, Hueso T, Porcher R, Mekinian A, Chiarabini T, Georgin-Lavialle S, Ader F, Saison J, Martin-Blondel G, De Castro N, Bonnet F, Cazanave C, Francois A, Morel P, Hermine O, Pourcher V, Michel M, Lescure X, Soussi N, Brun P, Pommeret F, Sellier P, Rousset S, Piroth L, Michot JM, Baron G, de Lamballerie X, Mariette X, Tharaux PL, Resche-Rigon M, Ravaud P, Simon T, Tiberghien P
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial.
BMJ medicine 2023, 2, e000427.
Foucrier A, Roquilly A, Bachelet D, Martin-Loeches I, Bougle A, Timsit JF, Montravers P, Zahar JR, Eloy P, Weiss E, ASPIC study group
Antimicrobial Stewardship for Ventilator Associated Pneumonia in Intensive Care (the ASPIC trial): study protocol for a randomised controlled trial.
BMJ open 2023, 13, e065293.
Jaquet P, Couffignal C, Tardivon C, Godard V, Bellot R, Assouline B, Benghanem S, Da Silva D, Decavèle M, Dessajan J, Hermann B, Rambaud T, Voiriot G, Sonneville R, PODIUM Study Group
PupillOmetry for preDIction of DeliriUM in ICU (PODIUM): protocol for a prospective multicentre cohort study.
BMJ open 2023, 13, e072095.
Bouzid D, Tran-Dinh A, Lortat-Jacob B, Atchade E, Jean-Baptiste S, Tashk P, Snauwaert A, Zappella N, Augustin P, Pellenc Q, Castier Y, Ribeiro L, Gaudemer A, Khalil A, Montravers P, Tanaka S, Bichat stab wounds injury study group
Ultrasonography in thoracic and abdominal stab wound injury: results from the FETTHA study.
Emergency medicine journal: EMJ 2023, emermed-2023-213078.
Sonneville R, Mazighi M, Collet M, Gayat E, Degos V, Duranteau J, Grégoire C, Sharshar T, Naim G, Cortier D, Jost PH, Foucrier A, Bagate F, de Montmollin E, Papin G, Magalhaes E, Guidet B, Ben Hadj Salem O, Benghanem S, le Guennec L, Delpierre E, Legriel S, Megarbane B, Toumert K, Tran M, Geri G, Monchi M, Bodiguel E, Mariotte E, Demoule A, Zarka J, Diehl JL, Roux D, Barré E, Tanaka S, Osman D, Pasquier P, Lamara F, Crassard I, Boursin P, Ruckly S, Staiquly Q, Timsit JF, Woimant F, SPICE Investigators
One-Year Outcomes in Patients With Acute Stroke Requiring Mechanical Ventilation.
Stroke 2023, 54, 2328-2337.
Chommeloux J, Valentin S, Winiszewski H, Adda M, Pineton de Chambrun M, Moyon Q, Mathian A, Capellier G, Guervilly C, Levy B, Jaquet P, Sonneville R, Voiriot G, Demoule A, Boussouar S, Painvin B, Lebreton G, Combes A, Schmidt M
One-Year Mental and Physical Health Assessment in Survivors after Extracorporeal Membrane Oxygenation for COVID-19-related Acute Respiratory Distress Syndrome.
American Journal of Respiratory and Critical Care Medicine 2023, 207, 150-159.
Sadio AJ, Ferré VM, Konu RY, Dagnra AC, Descamps D, Ekouevi DK, Charpentier C
High SARS-CoV-2 seroprevalence among street adolescents in Lomé, Togo, 2021.
BMC infectious diseases 2023, 23, 200.
Sawras V, Deuffic-Burban S, Préau M, Spire B, Yazdanpanah Y, Champenois K
Assessing complex interventions: a systematic review of outcomes used in randomised controlled trials on STI partner notification in high-income countries.
BMC public health 2023, 23, 1838.
Perrichot A, Vaittinada Ayar P, Taboulet P, Choquet C, Gay M, Casalino E, Steg PG, Curac S, Vaittinada Ayar P
Assessment of real-time electrocardiogram effects on interpretation quality by emergency physicians.
BMC medical education 2023, 23, 677.
Sette AL, François P, Lesprit P, Vitrat V, Rogeaux O, Breugnon E, Baldeyrou M, Mondain V, Issartel B, Kerneis S, Diamantis S, Poitrenaud D, Boussat B, Pavese P
Infectious disease hotlines to provide advice to general practitioners: a prospective study.
BMC health services research 2023, 23, 502.
Yade MS, Dièye B, Coppée R, Mbaye A, Diallo MA, Diongue K, Bailly J, Mama A, Fall A, Thiaw AB, Ndiaye IM, Ndiaye T, Gaye A, Tine A, Diédhiou Y, Mbaye AM, Doderer-Lang C, Garba MN, Bei AK, Ménard D, Ndiaye D
Ex vivo RSA and pfkelch13 targeted-amplicon deep sequencing reveal parasites susceptibility to artemisinin in Senegal, 2017.
Malaria Journal 2023, 22, 167.
De Castro N, Brun A, Sellier P, Hamet G, Mechaï F, Garrait V, Chabrol A, Bouldouyre MA, Froguel E, Troisvallets D, Caraux-Paz P, Delaugerre C, Rozenbaum W, Molina JM
Safety and efficacy of switching to elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate in treatment-experienced people with HIV: a multicenter cohort study.
AIDS research and therapy 2023, 20, 1.
de Villiers de la Noue V, Théry G, Faroux L, Belkessa N, Rubin S, Mourvillier B, Goury A
Left atrial dissection after a supra-annular mitral valve replacement for endocarditis.
Journal of Cardiothoracic Surgery 2023, 18, 75.
Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M, Ünal S, Schlegel M, Ader F, Lacombe K, Amdal CD, Rodrigues S, Tonby K, Gaudet A, Heggelund L, Mootien J, Johannessen A, Møller JH, Pollan BD, Tveita AA, Kildal AB, Richard JC, Dalgard O, Simensen VC, Baldé A, de Gastines L, Del Álamo M, Aydin B, Lund-Johansen F, Trabaud MA, Diallo A, Halvorsen B, Røttingen JA, Tacconelli E, Yazdanpanah Y, Olsen IC, Costagliola D, EU SolidAct study group
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
Critical Care (London, England) 2023, 27, 9.
Moreno R, Rhodes A, Piquilloud L, Hernandez G, Takala J, Gershengorn HB, Tavares M, Coopersmith CM, Myatra SN, Singer M, Rezende E, Prescott HC, Soares M, Timsit JF, de Lange DW, Jung C, De Waele JJ, Martin GS, Summers C, Azoulay E, Fujii T, McLean AS, Vincent JL
The Sequential Organ Failure Assessment (SOFA) Score: has the time come for an update?.
Critical Care (London, England) 2023, 27, 15.
Sharshar T, Porcher R, Asfar P, Grimaldi L, Jabot J, Argaud L, Lebert C, Bollaert PE, Harlay ML, Chillet P, Maury E, Santoli F, Blanc P, Sonneville R, Vu DC, Rohaut B, Mazeraud A, Alvarez JC, Navarro V, Clair B, Outin H, Valse investigators and for the Groupe d’Explorations Neurologiques en Reanimation (GENER)
Valproic acid as adjuvant treatment for convulsive status epilepticus: a randomised clinical trial.
Critical Care (London, England) 2023, 27, 8.
Gaillet A, Azoulay E, de Montmollin E, Garrouste-Orgeas M, Cohen Y, Dupuis C, Schwebel C, Reignier J, Siami S, Argaud L, Adrie C, Mourvillier B, Ruckly S, Forel JM, Timsit JF
Outcomes in critically Ill HIV-infected patients between 1997 and 2020: analysis of the OUTCOMEREA multicenter cohort.
Critical Care (London, England) 2023, 27, 108.
Contou D, Béduneau G, Rabault C, Sonneville R, Marchalot A, Coudroy R, Roux D, Cour M, Massol J, Préau S, de Prost N, HOPEFUL Study Group
Skin biopsy in adult patients with meningococcal purpura fulminans: a multicenter retrospective cohort study.
Critical Care (London, England) 2023, 27, 166.
Williams PG, Tabah A, Cotta MO, Sandaradura I, Kanji S, Scheetz MH, Imani S, Elhadi M, Luque-Pardos S, Schellack N, Sanches C, Timsit JF, Xie J, Farkas A, Wilks K, Roberts JA, National Coordinators on behalf of the European Society of Intensive Care Medicine (ESICM) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Infections in Critically Ill Patients [ESGCIP]
International survey of antibiotic dosing and monitoring in adult intensive care units.
Critical Care (London, England) 2023, 27, 241.
Giacobbe DR, Dettori S, Di Pilato V, Asperges E, Ball L, Berti E, Blennow O, Bruzzone B, Calvet L, Capra Marzani F, Casabella A, Choudaly S, Dartevel A, De Pascale G, Di Meco G, Fallon M, Galerneau LM, Gallego M, Giacomini M, González Sáez A, Hänsel L, Icardi G, Koehler P, Lagrou K, Lahmer T, Lewis White P, Magnasco L, Marchese A, Marelli C, Marín-Arriaza M, Martin-Loeches I, Mekontso-Dessap A, Mikulska M, Mularoni A, Nordlander A, Poissy J, Russelli G, Signori A, Tascini C, Vaconsin LM, Vargas J, Vena A, Wauters J, Pelosi P, Timsit JF, Bassetti M, JIR-ICU investigators (collaborators), Critically Ill Patients Study Group of the European Society of Clinical Microbiology and Infectious Diseases (ESGCIP), and the Fungal Infection Study Group of the European Society of Clinical Microbiology and Infectious Diseases (EFISG)
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG.
Critical Care (London, England) 2023, 27, 323.
Galerneau LM, Bailly S, Terzi N, Ruckly S, Garrouste-Orgeas M, Oziel J, Hong Tuan Ha V, Gainnier M, Siami S, Dupuis C, Forel JM, Dartevel A, Dessajan J, Adrie C, Goldgran-Toledano D, Laurent V, Argaud L, Reignier J, Pepin JL, Darmon M, Timsit JF, OUTCOME R. E. A. network
Non-ventilator-associated ICU-acquired pneumonia (NV-ICU-AP) in patients with acute exacerbation of COPD: From the French OUTCOMEREA cohort.
Critical Care (London, England) 2023, 27, 359.
Sonneville R, Benghanem S, Jeantin L, de Montmollin E, Doman M, Gaudemer A, Thy M, Timsit JF
The spectrum of sepsis-associated encephalopathy: a clinical perspective.
Critical Care (London, England) 2023, 27, 386.
Martin-Loeches I, Shorr AF, Wunderink RG, Kollef MH, Timsit JF, Yu B, Huntington JA, Jensen E, Bruno CJ
Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial.
Annals of Intensive Care 2023, 13, 8.
Iachkine J, Buetti N, de Grooth HJ, Briant AR, Mimoz O, Mégarbane B, Mira JP, Valette X, Daubin C, du Cheyron D, Mermel LA, Timsit JF, Parienti JJ
Development and validation of a multivariable model predicting the required catheter dwell time among mechanically ventilated critically ill patients in three randomized trials.
Annals of Intensive Care 2023, 13, 5.
Jeantin L, Dupuis C, Vellieux G, Jaquet P, de Montmollin E, Timsit JF, Sonneville R, ENCEPHALITICA Study Group
Electroencephalography for prognostication of outcome in adults with severe herpes simplex encephalitis.
Annals of Intensive Care 2023, 13, 10.
Bourcier S, Coutrot M, Ferré A, Van Grunderbeeck N, Charpentier J, Hraiech S, Azoulay E, Nseir S, Aissaoui N, Messika J, Fillatre P, Persichini R, Carreira S, Lautrette A, Delmas C, Terzi N, Mégarbane B, Lascarrou JB, Razazi K, Repessé X, Pichereau C, Contou D, Frérou A, Barbier F, Ehrmann S, de Montmollin E, Sztrymf B, Morawiec E, Bigé N, Reuter D, Schnell D, Ellrodt O, Dellamonica J, Combes A, Schmidt M
Critically ill severe hypothyroidism: a retrospective multicenter cohort study.
Annals of Intensive Care 2023, 13, 15.
Mekontso Dessap A, Papazian L, Schaller M, Nseir S, Megarbane B, Haudebourg L, Timsit JF, Teboul JL, Kuteifan K, Gainnier M, Slama M, Houeto P, Lecourt L, Mercat A, Vieillard-Baron A
Inhaled nitric oxide in patients with acute respiratory distress syndrome caused by COVID-19: treatment modalities, clinical response, and outcomes.
Annals of Intensive Care 2023, 13, 57.
Barbier F, Hraiech S, Kernéis S, Veluppillai N, Pajot O, Poissy J, Roux D, Zahar JR, French Intensive Care Society
Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients.
Annals of Intensive Care 2023, 13, 65.
Helms J, Poissy J, Dequin PF, Timsit JF
Treatment of immunothrombosis dysregulation: high-dose corticosteroids is not the good option.
Annals of Intensive Care 2023, 13, 58.
Chevret S, Bouadma L, Dupuis C, Burdet C, Timsit JF, COVIDICUS RCT group
Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial.
Annals of Intensive Care 2023, 13, 75.
Szychowiak P, Boulain T, Timsit JF, Elabaddi A, Argaud L, Ehrmann S, Issa N, Canet E, Martino F, Bruneel F, Quenot JP, Wallet F, Azoulay É, Barbier F
Clinical spectrum and prognostic impact of cancer in critically ill patients with HIV: a multicentre cohort study.
Annals of Intensive Care 2023, 13, 74.
Laurichesse G, Schwebel C, Buetti N, Neuville M, Siami S, Cohen Y, Laurent V, Mourvillier B, Reignier J, Goldgran-Toledano D, Ruckly S, de Montmollin E, Souweine B, Timsit JF, Dupuis C, OUTCOME R. E. A. network
Mortality, incidence, and microbiological documentation of ventilated acquired pneumonia (VAP) in critically ill patients with COVID-19 or influenza.
Annals of Intensive Care 2023, 13, 108.
Yi G, de Kraker MEA, Buetti N, Zhong X, Li J, Yuan Z, Zhu W, Zhou J, Zhou H
Risk factors for in-hospital mortality and secondary bacterial pneumonia among hospitalized adult patients with community-acquired influenza: a large retrospective cohort study.
Antimicrobial Resistance and Infection Control 2023, 12, 25.
Januel JM, Lotfinejad N, Grant R, Tschudin-Sutter S, Schreiber PW, Grandbastien B, Jent P, Lo Priore E, Scherrer A, Harbarth S, Catho G, Buetti N, Swissnoso
Predictive performance of automated surveillance algorithms for intravascular catheter bloodstream infections: a systematic review and meta-analysis.
Antimicrobial Resistance and Infection Control 2023, 12, 87.
de Prost N, Audureau E, Préau S, Favory R, Guigon A, Bay P, Heming N, Gault E, Pham T, Chaghouri A, Voiriot G, Morand-Joubert L, Jochmans S, Pitsch A, Meireles S, Contou D, Henry A, Joseph A, Chaix ML, Uhel F, Descamps D, Emery M, Garcia-Sanchez C, Luyt CE, Marot S, Pène F, Lhonneur AS, Gaudry S, Brichler S, Picard L, Mekontso Dessap A, Rodriguez C, Pawlotsky JM, Fourati S, SEVARVIR investigators
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron variants BA.2, BA.5 and BQ.1.1 in critically ill patients with COVID-19: a prospective, multicenter cohort study.
Intensive Care Medicine Experimental 2023, 11, 48.
Tchoubou T, El-Hosni R, Dollat M, Jaquet P, Tournus C, Tandjaoui-Lambiotte Y, Da Silva D
Acute Respiratory Distress Syndrome due to Monkeypox Virus.
European Journal of Case Reports in Internal Medicine 2023, 10, 004126.
Inzaule SC, Siedner MJ, Little SJ, Avila-Rios S, Ayitewala A, Bosch RJ, Calvez V, Ceccherini-Silberstein F, Charpentier C, Descamps D, Eshleman SH, Fokam J, Frenkel LM, Gupta RK, Ioannidis JPA, Kaleebu P, Kantor R, Kassaye SG, Kosakovsky Pond SL, Kouamou V, Kouyos RD, Kuritzkes DR, Lessells R, Marcelin AG, Mbuagbaw L, Minalga B, Ndembi N, Neher RA, Paredes R, Pillay D, Raizes EG, Rhee SY, Richman DD, Ruxrungtham K, Sabeti PC, Schapiro JM, Sirivichayakul S, Steegen K, Sugiura W, van Zyl GU, Vandamme AM, Wensing AMJ, Wertheim JO, Gunthard HF, Jordan MR, Shafer RW
Recommendations on data sharing in HIV drug resistance research.
PLoS medicine 2023, 20, e1004293.
Reingruber J, Papale A, Ruckly S, Timsit JF, Holcman D
Data-driven multiscale dynamical framework to control a pandemic evolution with non-pharmaceutical interventions.
PloS One 2023, 18, e0278882.
Della Vecchia C, Ebah JV, Tubiana S, Guimard T, Piroth L, Jaffuel S, Gorenne I, Mourvillier B, Hoen B, Duval X, Préau M
Mid-term health-related quality of life in community-acquired bacterial meningitis survivors; the COMBAT study.
PloS One 2023, 18, e0281544.
Tchounga BK, Bertine M, Damond F, Ferré VM, Inwoley A, Boni SP, Moisan A, Plantier JC, Descamps D, Ekouevi DK, Charpentier C
Molecular confirmation of HIV-1 and HIV-2 coinfections among initially serologically dually-reactive samples from patients living in West Africa.
PloS One 2023, 18, e0283602.
Galerneau LM, Bailly S, Terzi N, Ruckly S, Garrouste-Orgeas M, Cohen Y, Hong Tuan Ha V, Gainnier M, Siami S, Dupuis C, Darmon M, Azoulay E, Forel JM, Sigaud F, Adrie C, Goldgran-Toledano D, Ferré A, de Montmollin E, Argaud L, Reignier J, Pepin JL, Timsit JF, OUTCOMEREA network
Corticosteroids for severe acute exacerbations of chronic obstructive pulmonary disease in intensive care: From the French OUTCOMEREA cohort.
PloS One 2023, 18, e0284591.
Dinh A, Drouet F, Dechartres A, Yordanov Y, Duran C, Schmidt N, Banzet A, Perrier MH, Mosquet N, Lescure FX, Jourdain P, Nizard J, Masingue X, AP-HP/Universities/Inserm COVID-19 research collaboration
Pregnant women with mild COVID-19 followed in community setting by telemedicine, and factors associated with unfavorable outcome.
PloS One 2023, 18, e0288845.
Tarhini H, Waked R, Rahi M, Haddad N, Dorent R, Randoux C, Bunel V, Lariven S, Deconinck L, Rioux C, Yazdanpanah Y, Joly V, Ghosn J
Investigating infectious outcomes in adult patients undergoing solid organ transplantation: A retrospective single-center experience, Paris, France.
PloS One 2023, 18, e0291860.
Kali S, Bourner J, Calmy A, Laouénan C, Merson L, Cervantes-Gonzalez M, Rojek A, Pesonel E, Guiraud L, Tardivon C, Descamps D, Diallo A, Gibowski S, Rosenthal E, Petrov-Sanchez V, Letrou S, Hoffmann I, Le Mestre S, Mentré F, Yazdanpanah Y, Olliaro P, Lescure FX
MOSAIC: a European cohort study of human Mpox - the challenges of clinical research in outbreaks.
Virologie (Montrouge, France) 2023, 27, 12-15.
Friedman D, Grimaldi L, Cariou A, Aegerter P, Gaudry S, Ben Salah A, Oueslati H, Megarbane B, Meunier-Beillard N, Quenot JP, Schwebel C, Jacob L, Robin Lagandré S, Kalfon P, Sonneville R, Siami S, Mazeraud A, Sharshar T
Correction: Impact of a Postintensive Care Unit Multidisciplinary Follow-up on the Quality of Life (SUIVI-REA): Protocol for a Multicenter Randomized Controlled Trial.
JMIR research protocols 2023, 12, e47929.
Jolivet S, Couturier J, Grohs P, Vilfaillot A, Zahar JR, Frange P, Casetta A, Moulin V, Lawrence C, Baune P, Bourgeois C, Bouffier A, Laussucq C, Sienzonit L, Picard S, Podglajen I, Kassis-Chikhani N, Barbut F
Prevalence and risk factors of toxigenic Clostridioides difficile asymptomatic carriage in 11 French hospitals.
Frontiers in Medicine 2023, 10, 1221363.
Bornand E, Letourneux F, Deschanvres C, Boutoille D, Lucet JC, Lepelletier D, Leclere B, Mayol S, Peiffer-Smadja N, Birgand G
Social representations of mask wearing in the general population during the COVID-19 pandemic.
Frontiers in Public Health 2023, 11, 1136980.
Brun-Rambaud G, Alcouffe L, Tareau MA, Adenis A, Vignier N
Access to health care for migrants in French Guiana in 2022: a qualitative study of health care system actors.
Frontiers in Public Health 2023, 11, 1185341.
de Tymowski C, Sahnoun T, Provenchere S, Para M, Derre N, Mutuon P, Duval X, Grall N, Iung B, Kernéis S, Lucet JC, Montravers P
Impact of Antibiotic Prophylaxis on Surgical Site Infections in Cardiac Surgery.
Antibiotics (Basel, Switzerland) 2023, 12, 85.
Chaïbi K, Jaureguy F, Do Rego H, Ruiz P, Mory C, El Helali N, Mrabet S, Mizrahi A, Zahar JR, Pilmis B
What to Do with the New Antibiotics?.
Antibiotics (Basel, Switzerland) 2023, 12, 654.
Thy M, Timsit JF, de Montmollin E
Aminoglycosides for the Treatment of Severe Infection Due to Resistant Gram-Negative Pathogens.
Antibiotics (Basel, Switzerland) 2023, 12, 860.
Wicky PH, Poiraud J, Alves M, Patrier J, d'Humières C, Lê M, Kramer L, de Montmollin É, Massias L, Armand-Lefèvre L, Timsit JF
Cefiderocol Treatment for Severe Infections due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case Series and Narrative Literature Review.
Antibiotics (Basel, Switzerland) 2023, 12, 991.
Pilmis B, Kherabi Y, Huriez P, Zahar JR, Mokart D
Infectious Complications of Targeted Therapies for Solid Cancers or Leukemias/Lymphomas.
Cancers 2023, 15, 1989.
Nardin C, Hennemann A, Diallo K, Funck-Brentano E, Puzenat E, Heidelberger V, Jeudy G, Samimi M, Lesage C, Boussemart L, Peuvrel L, Rouanet J, Brunet-Possenti F, Gerard E, Seris A, Jouary T, Saint-Jean M, Puyraveau M, Saiag P, Aubin F
Efficacy of Immune Checkpoint Inhibitor (ICI) Rechallenge in Advanced Melanoma Patients' Responders to a First Course of ICI: A Multicenter National Retrospective Study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC).
Cancers 2023, 15, 3564.
Reichert C, Baldini C, Mezghani S, Maubec E, Longvert C, Mortier L, Quereux G, Jannic A, Machet L, de Quatrebarbes J, Nardin C, Beneton N, Amini Adle M, Funck-Brentano E, Descamps V, Hachon L, Malissen N, Baroudjian B, Brunet-Possenti F, Groupe de Cancérologie Cutanée
Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients.
Cancers 2023, 15, 4330.
Ghazali DA, Bouzid D, Frachon A, Ait-Abdesselam S, Kenway P, Choquet C, Casalino E
Pain Self-Management with Inhaled Methoxyflurane by Emergency Department Trauma Patients: A Prospective, Interventional, Single-Center Study.
International Journal of Environmental Research and Public Health 2023, 20, 6107.
Wicky PH, Dupuis C, Cerf C, Siami S, Cohen Y, Laurent V, Mourvillier B, Reignier J, Goldgran-Toledano D, Schwebel C, Ruckly S, de Montmollin E, Buetti N, Timsit JF
Ventilator-Associated Pneumonia in COVID-19 Patients Admitted in Intensive Care Units: Relapse, Therapeutic Failure and Attributable Mortality-A Multicentric Observational Study from the OutcomeRea Network.
Journal of Clinical Medicine 2023, 12, 1298.
Timsit JF
After SARS-CoV-2 Pandemics: New Insights into ICU-Acquired Pneumonia.
Journal of Clinical Medicine 2023, 12, 2160.
Sellem B, Abdi B, Lê M, Tubiana R, Valantin MA, Seang S, Schneider L, Fayçal A, Peytavin G, Soulié C, Marcelin AG, Katlama C, Pourcher V, Palich R
Intermittent Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment Maintains High Level of Viral Suppression in Virally Suppressed People Living with HIV.
Journal of Personalized Medicine 2023, 13, 583.
Rezzoug I, Visseaux B, Bertine M, Parisey M, Bonnal C, Ruppe E, Descamps D, Timsit JF, Yazdanpanah Y, Armand-Lefevre L, Houze S, Argy N
Faecal Viral Excretion and Gastrointestinal Co-Infection Do Not Explain Digestive Presentation in COVID-19 Patients.
Microorganisms 2023, 11, 1780.
Eid R, Zahar JR, Ait Ali C, Mizrahi A, Ibrahim R, Banh E, Halouani H, Jauréguy F, Pilmis B, Saliba R
Bloodstream Infections: Comparison of Diagnostic Methods and Therapeutic Consequences between a Hospital in a Resource-Limited Setting and Two French Hospitals.
Microorganisms 2023, 11, 2136.
Saliba R, Zahar JR, Dabar G, Riachy M, Karam-Sarkis D, Husni R
Limiting the Spread of Multidrug-Resistant Bacteria in Low-to-Middle-Income Countries: One Size Does Not Fit All.
Pathogens (Basel, Switzerland) 2023, 12, 144.
de Crane D'Heysselaer S, Parisi G, Lisson M, Bruyère O, Donneau AF, Fontaine S, Gillet L, Bureau F, Darcis G, Thiry E, Ducatez M, Snoeck CJ, Zientara S, Haddad N, Humblet MF, Ludwig-Begall LF, Daube G, Thiry D, Misset B, Lambermont B, Tandjaoui-Lambiotte Y, Zahar JR, Sartor K, Noël C, Saegerman C, Haubruge E
Systematic Review of the Key Factors Influencing the Indoor Airborne Spread of SARS-CoV-2.
Pathogens (Basel, Switzerland) 2023, 12, 382.
Charpentier C, Le Hingrat Q, Ferré VM, Damond F, Descamps D
Future of Antiretroviral Drugs and Evolution of HIV-1 Drug Resistance.
Viruses 2023, 15, 540.
Goulenok T, Mendes C, Dayan L, Ferre VM, Bucau M, Farhi F, Papo T, Sacré K
Improving Human Papillomavirus-Related Cervical Cancer Screening in Patients With Systemic Lupus Erythematosus.
The Journal of Rheumatology 2023, jrheum.2022-1335.
Mignot S, Berthome AC, Andre M, Breque C, Richer JP, Ghazali D, Oriot D
Development and validation of a performance assessment checklist for insertion of an intra-uterine device (IUD).
Ginekologia Polska 2023
Coppée R, Blanquart F, Jary A, Leducq V, Ferré VM, Franco Yusti AM, Daniel L, Charpentier C, Lebourgeois S, Zafilaza K, Calvez V, Descamps D, Marcelin AG, Visseaux B, Bridier-Nahmias A
Phylodynamics of SARS-CoV-2 in France, Europe, and the world in 2020.
eLife 2023, 12, e82538.
2022
Bouadma L, Mekontso-Dessap A, Burdet C, Merdji H, Poissy J, Dupuis C, Guitton C, Schwebel C, Cohen Y, Bruel C, Marzouk M, Geri G, Cerf C, Mégarbane B, Garçon P, Kipnis E, Visseaux B, Beldjoudi N, Chevret S, Timsit JF, COVIDICUS Study Group
High-Dose Dexamethasone and Oxygen Support Strategies in Intensive Care Unit Patients With Severe COVID-19 Acute Hypoxemic Respiratory Failure: The COVIDICUS Randomized Clinical Trial.
JAMA internal medicine 2022, 182, 906-916.
Ningarhari M, Mourad A, Delacôte C, Ntandja Wandji LC, Lassailly G, Louvet A, Dharancy S, Mathurin P, Deuffic-Burban S
Benefits of tailored hepatocellular carcinoma screening in patients with cirrhosis on cancer-specific and overall mortality: A modeling approach.
Hepatology Communications 2022, 6, 2964-2974.
Houhou-Fidouh N, Bucau M, Bertine M, Minh TNT, Picone O, Salakos E, Luton D
Preliminary results on transmission of SARS-CoV-2 antibodies to the fetus and serum neutralizing activity.
International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics 2022, 158, 476-478.
Castry M, Cousien A, Champenois K, Supervie V, Velter A, Ghosn J, Yazdanpanah Y, Paltiel AD, Deuffic-Burban S
Cost-effectiveness of hepatitis C virus test-and-treat and risk reduction strategies among men who have sex with men living with HIV in France.
Journal of the International AIDS Society 2022, 25, e26035.
Khellaf L, Bouscarat F, Burrel S, Fidouh N, Hachon L, Bucau M, Lariven S, Boutolleau D, Joly V, Ghosn J, Le Pluart D, Thy M
Novel mutations in antiviral multiresistant HSV-2 genital lesion: A case report.
Journal of Medical Virology 2022, 94, 6122-6126.
Ayrolles A, Ellul P, Trebossen V, Houhou-Fidouh N, Bonacorsi S, Descamps D, Delorme R
Is SARS-CoV-2 seroconversion a risk factor for severe and acute psychiatric symptoms in children?.
Neuropsychopharmacology Reports 2022, 42, 218-220.
Lavalley-Morelle A, Timsit JF, Mentré F, Mullaert J, OUTCOMEREA network
Joint modeling under competing risks: Application to survival prediction in patients admitted in Intensive Care Unit for sepsis with daily Sequential Organ Failure Assessment score assessments.
CPT: pharmacometrics & systems pharmacology 2022, 11, 1472-1484.
Ghazali DA, Ilha-Schuelter P, Barreyre L, Stephan O, Barbosa SS, Oriot D, Tourinho FSV, Plaisance P
Development and validation of the first performance assessment scale for interdisciplinary chest tube insertion: a prospective multicenter study.
European Journal of Trauma and Emergency Surgery: Official Publication of the European Trauma Society 2022
Buetti N, Rickard CM, Timsit JF
Catheter dressings.
Intensive Care Medicine 2022
Timsit JF, Tabah A, Mimoz O
Update on prevention of intra-vascular accesses complications.
Intensive Care Medicine 2022
Rouzé A, Estella Á, Timsit JF
Is (1,3)-β-D-glucan useless to guide antifungal therapy in ICU?.
Intensive Care Medicine 2022, 48, 930-932.
Tallarico RT, Deniau B, Fong N, Ghosn J, Legrand M, French-COVID and the FROG-ICU Investigators
Differences in HADS and SF-36 scores 1 year after critical illness in COVID-19 patients.
Intensive Care Medicine 2022, 48, 1245-1247.
De Pascale G, Antonelli M, Deschepper M, Arvaniti K, Blot K, Brown BC, de Lange D, De Waele J, Dikmen Y, Dimopoulos G, Eckmann C, Francois G, Girardis M, Koulenti D, Labeau S, Lipman J, Lipovetsky F, Maseda E, Montravers P, Mikstacki A, Paiva JA, Pereyra C, Rello J, Timsit JF, Vogelaers D, Blot S, Abdominal Sepsis Study (AbSeS) group and the Trials Group of the European Society of Intensive Care Medicine
Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis.
Intensive Care Medicine 2022, 48, 1593-1606.
Di Ciaccio M, Delabre RM, Vilotitch A, Corbelli GM, Villes V, Ros Sánchez A, Zantkuijl P, Sweers H, Sanchez F, Meulbroek M, Cairns G, Bernier A, Ghosn J, Carvalho Rocha LM, Cosmaro ML, Duken SB, Dan M, Schlegel V, Stranz R, Jonas KJ, Spire B, Rojas Castro D
PrEP in the Context of Other HIV Risk Reduction Strategies Among Men Who Have Sex with Men: Results from the Flash! PrEP in Europe Survey.
Archives of Sexual Behavior 2022, 51, 2451-2464.
Bassetti M, Vena A, Giacobbe DR, Trucchi C, Ansaldi F, Antonelli M, Adamkova V, Alicino C, Almyroudi MP, Atchade E, Azzini AM, Brugnaro P, Carannante N, Peghin M, Berruti M, Carnelutti A, Castaldo N, Corcione S, Cortegiani A, Dimopoulos G, Dubler S, García-Garmendia JL, Girardis M, Cornely OA, Ianniruberto S, Kullberg BJ, Lagrou K, Lebihan C, Luzzati R, Malbrain M, Merelli M, Marques AJ, Martin-Loeches I, Mesini A, Paiva JA, Raineri SM, Rautemaa-Richardson R, Schouten J, Spapen H, Tasioudis P, Timsit JF, Tisa V, Tumbarello M, Van den Berg CHSB, Veber B, Venditti M, Voiriot G, Wauters J, Zappella N, Montravers P, from the Study Group for Infections in Critically Ill Patients (ESGCIP) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study.
Infectious Diseases and Therapy 2022, 11, 827-840.
Ferré VM, Peiffer-Smadja N, Visseaux B, Descamps D, Ghosn J, Charpentier C
Omicron SARS-CoV-2 variant: What we know and what we don't.
Anaesthesia, Critical Care & Pain Medicine 2022, 41, 100998.
Buetti N, Mermel LA, Timsit JF
Routine catheter-tip cultures for assessing catheter-related bloodstream infections in randomised-controlled trials.
Anaesthesia, Critical Care & Pain Medicine 2022, 41, 101006.
Atchade E, Goldstein V, Viane S, Van Gysel D, Lolom I, Lortat-Jacob B, Tran-Dinh A, Ben Rehouma M, Lucet JC, Montravers P
Economic impact of an outbreak of carbapenemase producing-Enterobacteriaceae in a surgical intensive care unit.
Anaesthesia, Critical Care & Pain Medicine 2022, 101093.
Gouel-Cheron A, Kantor E, Rioux C, Kerneis S, Montravers P
Monkeypox-infected patients in the perioperative context: Recommendations from an expert centre.
Anaesthesia, Critical Care & Pain Medicine 2022, 41, 101122.
Fillâtre P, Dufour MJ, Behillil S, Vatan R, Reusse P, Gabellec A, Velmans N, Montagne C, Geffroy Du Coudret S, Droumaguet E, Merour V, Enouf V, Buzelé R, Valence M, Guillotel E, Gagnière B, Baidaliuk A, Zhukova A, Tourdjman M, Thibault V, Grolhier C, Pronier C, Lescure FX, Simon-Loriere E, Costagliola D, Van Der Werf S, Tattevin P, Massart N
A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 298.e9-298.e15.
Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 202-221.
EU-Response investigators group, Diallo A, Trøseid M, Simensen VC, Boston A, Demotes J, Olsen IC, Chung F, Paiva JA, Hites M, Ader F, Arribas JR, Baratt-Due A, Melien Ø, Tacconelli E, Staub T, Greil R, Tsiodras S, Briel M, Esperou H, Mentré F, Eustace J, Saillard J, Delmas C, LeMestre S, Dumousseaux M, Costagliola D, Røttingen JA, Yazdanpanah Y
Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 1-5.
Trøseid M, Diallo A, Hites M, Røttingen JA, Yazdanpanah Y
Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 743-744.
Dinh A, Dahmane L, Dahoumane M, Masingue X, Jourdain P, Lescure FX
Impact of Omicron surge in community setting in greater Paris area.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, S1198-743X(22)00089-1.
Duvignaud A, Lhomme E, Onaisi R, Sitta R, Gelley A, Chastang J, Piroth L, Binquet C, Dupouy J, Makinson A, Lefèvre B, Naccache JM, Roussillon C, Landman R, Wallet C, Karcher S, Journot V, Nguyen D, Pistone T, Bouchet S, Lafon ME, Molimard M, Thiébaut R, de Lamballerie X, Joseph JP, Richert L, Saint-Lary O, Djabarouti S, Wittkop L, Anglaret X, Malvy D, Coverage Study Group
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE).
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, S1198-743X(22)00108-2.
Belan M, Charmet T, Schaeffer L, Tubiana S, Duval X, Lucet JC, Fontanet A, Birgand G, Kernéis S
SARS-CoV-2 exposures of healthcare workers from primary care, long-term care facilities and hospitals: a nationwide matched case-control study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 1471-1476.
Pilmis B, Weiss E, Scemla A, Monnier AL, Grossi PA, Slavin MA, Van Delden C, Lortholary O, Paugam-Burtz C, Zahar JR
Multidrug-resistant enterobacterales infections in abdominal solid organ transplantation.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, S1198-743X(22)00318-4.
Danjean M, Hobson CA, Gits-Muselli M, Courroux C, Monjault A, Bonacorsi S, Birgy A
Evaluation of the inoculum effect of new antibiotics against carbapenem-resistant enterobacterales.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 1503.e1-1503.e3.
Coléon S, Wiedemann A, Surénaud M, Lacabaratz C, Hue S, Prague M, Cervantes-Gonzalez M, Wang Z, Ellis J, Sansoni A, Pierini C, Bardin Q, Fabregue M, Sharkaoui S, Hoest P, Dupaty L, Picard F, El Hajj M, Centlivre M, Ghosn J, French COVID Cohort Study Group, Thiébaut R, Cardinaud S, Malissen B, Zurawski G, Zarubica A, Zurawski SM, Godot V, Lévy Y
Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine.
EBioMedicine 2022, 80, 104062.
Hermine O, Mariette X, Porcher R, Djossou F, Nguyen Y, Arlet JB, Savale L, Diehl JL, Georgin-Lavialle S, Cadranel J, Pialoux G, Lacombe K, Mekinian A, Gros H, Lescure X, Ghosn J, Coupez E, Grapin K, Rapp C, Michel M, Lecapitaine AL, Michot JM, Costedoat-Chalumeau N, Nguyen LBL, Semerano L, Raffi F, Aguillar C, Rouzaud C, Gottenberg JE, Hansmann Y, Bienvenu B, London J, Fantchou FS, Ackermann F, Gros A, Morel A, Gambier N, Sène D, Mégarbane B, Azoulay E, Bureau S, Dougados M, Emmerich J, Fartoukh M, Guidet B, Humbert M, Mahevas M, Pène F, Schlemmer F, Pourcher-Martinez V, Tibi A, Baron G, Perrodeau E, Baron S, Steg G, Yazdapanah Y, Simon T, Resche-Rigon M, Tharaux PL, Ravaud P
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group.
EClinicalMedicine 2022, 46, 101362.
Barrière J, Carles M, Audigier-Valette C, Re D, Adjtoutah Z, Seitz-Polski B, Gounant V, Descamps D, Zalcman G
Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article.
European Journal of Cancer (Oxford, England: 1990) 2022, 162, 182-193.
Barrière J, Zalcman G, Fignon L, Peiffer-Smadja N, Audigier-Valette C, Carles M
Omicron variant: A clear and present danger for patients with cancer.
European Journal of Cancer (Oxford, England: 1990) 2022, 165, 25-26.
Eshagh D, Mageau A, Papo T, Benali K, Sacre K
Persistent FDG uptake in large vessels and risk of relapse in giant cell arteritis.
European Journal of Internal Medicine 2022, 106, 158-160.
Blot S, Ruppé E, Harbarth S, Asehnoune K, Poulakou G, Luyt CE, Rello J, Klompas M, Depuydt P, Eckmann C, Martin-Loeches I, Povoa P, Bouadma L, Timsit JF, Zahar JR
Healthcare-associated infections in adult intensive care unit patients: Changes in epidemiology, diagnosis, prevention and contributions of new technologies.
Intensive & Critical Care Nursing 2022, 70, 103227.
Husain M, Valayer S, Poey N, Rondinaud E, d'Humières C, Visseaux B, Lariven S, Lescure FX, Deconinck L
Pulmonary bacterial infections in adult patients hospitalized for COVID-19 in standard wards.
Infectious Diseases Now 2022, 52, 208-213.
Landman R, Marcelin AG, Bennani M, Philippe C, Kousignian P, Finkielsztejn L, Roustand L, Nachbaur G, Pourcher V
COPEDOL: A two-year observational study in pretreated HIV-1-infected patients switching to a dolutegravir-based regimen.
Infectious Diseases Now 2022, 52, 93-100.
Koch A, Vermel M, Hansmann Y, Lodi M, Mura C, Sananes A, Gallien S, Wurtz É, Bleibtreu A, Martinot M, Exinger J, Lescure X, Kerneis S, Lacombe K, Mootien JY, Shawali C, Lecointre L, Debry C, Lefebvre N, Sananes N
3D-printed simulator for nasopharyngeal swab collection for COVID-19.
Infectious Diseases Now 2022, S2666-9919(22)00035-5.
Grall-Zahar I, Rucly S, Billard-Pomares T, Gasnier-Besnardeau K, Al Mouft O, Zahar JR, Zirnhelt I
Prevalence and risk factors for carriage of extended-spectrum β-lactamase-producing enterobacteriaceae in rehabilitation wards in France.
Infectious Diseases Now 2022, 52, 403-407.
Méchaï F, Bachelet D, Han L, Dubert M, Parisey M, Cordel H, Bourgarit A, Bertrac C, Chauveau S, Billard-Pomares T, Carbonnelle E, Bouchaud O, Yazdanpanah Y, Vignier N, Laouénan C
Tuberculosis treatment outcomes among precarious patients in France.
Infectious Diseases Now 2022, 52, 389-395.
Pugliese P, Arvieux C, Huleux T, Pialoux G, Vignier N
Proposal of the French HIV Society on the CD4 threshold below which patients living with HIV who wish to be vaccinated against Monkeypox should receive a 3-dose regimen.
Infectious Diseases Now 2022, 52, 459-460.
Saliba R, Lomont A, Eudesson JL, Seytre D, Zahar JR, Pilmis B
Significant variation in the faecal relative abundance of carbapenemase-producing Enterobacteriaceae of colonised patients during hospitalisation: a preliminary study.
International Journal of Antimicrobial Agents 2022, 59, 106479.
Arvaniti K, Dimopoulos G, Antonelli M, Blot K, Creagh-Brown B, Deschepper M, de Lange D, De Waele J, Dikmen Y, Eckmann C, Einav S, Francois G, Fjeldsoee-Nielsen H, Girardis M, Jovanovic B, Lindner M, Koulenti D, Labeau S, Lipman J, Lipovestky F, Makikado LDU, Maseda E, Mikstacki A, Montravers P, Paiva JA, Pereyra C, Rello J, Timsit JF, Tomescu D, Vogelaers D, Blot S, Abdominal Sepsis Study (AbSeS) group on behalf of the Trials Group of the European Society of Intensive Care Medicine
Epidemiology and Age-Related Mortality in Critically Ill Patients With Intra-Abdominal Infection or Sepsis: An International Cohort Study.
International Journal of Antimicrobial Agents 2022, 106591.
Bouzid D, Hadad O, Bertine M, Houhou-Fidouh N, Mirand A, Duval X, Bunel V, Borie R, Lucet JC, Descamps D, Visseaux B
Rhinoviruses: molecular diversity and clinical characteristics.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2022, 118, 144-149.
Bachelard A, Sautereau A, Digumber M, Isernia V, Phung B, Lehur AC, Gac SL, Landman R, Yazdanpanah Y, Ghosn J
Risk Factors Associated with Severe/Critical COVID-19 in People Living with HIV-1.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2022, 122, 152-154.
Boussier J, Yatim N, Marchal A, Hadjadj J, Charbit B, El Sissy C, Carlier N, Pène F, Mouthon L, Tharaux PL, Bergeron A, Smadja DM, Rieux-Laucat F, Duffy D, Kernéis S, Frémeaux-Bacchi V, Terrier B
Severe COVID-19 is associated with hyperactivation of the alternative complement pathway.
The Journal of Allergy and Clinical Immunology 2022, 149, 550-556.e2.
Durand C, Chappuis A, Douriez E, Poulain F, Ahmad R, Lescure FX, Peiffer-Smadja N
Perceptions, current practices, and interventions of community pharmacists regarding antimicrobial stewardship: A qualitative study.
Journal of the American Pharmacists Association: JAPhA 2022, S1544-3191(22)00056-5.
Hassold N, Saidenberg N, Sigaux J, Lacroix M, Cruaud P, Walewski V, Bouchaud O, Méchaï F
Asymptomatic bacteriuria before biotherapy for rheumatic diseases: Shall we treat?.
Joint Bone Spine 2022, 89, 105327.
Magréault S, Jaureguy F, Zahar JR, Méchaï F, Toinon D, Cohen Y, Carbonnelle E, Jullien V
Automated HPLC-MS/MS assay for the simultaneous determination of ten plasma antibiotic concentrations.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2022, 1211, 123496.
Santoro MM, Armenia D, Teyssou E, Santos JR, Charpentier C, Lambert-Niclot S, Antinori A, Katlama C, Descamps D, Perno CF, Calvez V, Paredes R, Ceccherini-Silberstein F, Marcelin AG, LAMRES Study Group
Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES study.
Journal of Global Antimicrobial Resistance 2022, 31, 52-62.
De Broucker C, Plessier A, Ollivier-Hourmand I, Dharancy S, Bureau C, Cervoni JP, Sogni P, Goria O, Corcos O, Sartoris R, Ronot M, Vilgrain V, de Raucourt E, Zekrini K, Davy H, Durand F, Payancé A, Fidouh-Houhou N, Yazdanpanah Y, Valla D, Rautou PE
Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus disease.
Journal of Hepatology 2022, 76, 115-122.
Saliba R, Karam-Sarkis D, Zahar JR, Glélé LSA
Adverse events associated with patient isolation: a systematic literature review and meta-analysis.
The Journal of Hospital Infection 2022, 119, 54-63.
Nagle S, Tandjaoui-Lambiotte Y, Boubaya M, Athenaïs G, Alloui C, Bloch-Queyrat C, Carbonnelle E, Brichler S, Cohen Y, Zahar JR, Delagrèverie H
Environmental SARS-CoV-2 contamination in hospital rooms of patients with acute COVID-19.
The Journal of Hospital Infection 2022, 126, 116-122.
Le Monnier A, Candela T, Mizrahi A, Bille E, Bourgeois-Nicolaos N, Cattoir V, Farfour E, Grall I, Lecointe D, Limelette A, Marcade G, Poilane I, Poupy P, Kansau I, Zahar JR, Pilmis B, GMC group
One-day prevalence of asymptomatic carriage of toxigenic and non-toxigenic Clostridioides difficile in 10 French hospitals.
The Journal of Hospital Infection 2022, S0195-6701(22)00162-1.
Ferré VM, Lebourgeois S, Menidjel R, Collin G, Chenane HR, Guindi MO, Yazdanpanah Y, Timsit JF, Charpentier C, Descamps D, Fidouh N, Visseaux B
Decreasing humoral response among healthcare workers up to 4 months after two doses of BNT162b2 vaccine.
The Journal of Infection 2022, 84, 248-288.
Lebourgeois S, Menidjel R, Chenane HR, Ferré VM, Collin G, Damond F, Coppée R, Yazdanpanah Y, Timsit JF, Houhou-Fidouh N, Descamps D, Charpentier C, Visseaux B
Alpha (B.1.1.7) and Delta (B.1.617.2 - AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage.
The Journal of Infection 2022, 84, 418-467.
Ferré VM, Lebourgeois S, Chenane HR, Menidjel R, Masson C, Collin G, Visseaux B, Descamps D, Fidouh N, Charpentier C
Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays.
The Journal of Infection 2022, S0163-4453(22)00126-8.
Martin-Blondel G, Marcelin AG, Soulié C, Kaisaridi S, Lusivika-Nzinga C, Dorival C, Nailler L, Boston A, Melenotte C, Cabié A, Choquet C, Coustillères F, Martellosio JP, Gaube G, Trinh-Duc A, Ronchetti AM, Pourcher V, Chauveau M, Lacombe K, Peiffer-Smadja N, Housset P, Perrot A, Pialoux G, Martin A, Dubee V, Devaux M, Frey J, Cazanave C, Liblau R, Carrat F, Yordanov Y
Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2.
The Journal of Infection 2022, 85, e104-e108.
Gounant V, Ferré VM, Soussi G, Charpentier C, Flament H, Fidouh N, Collin G, Namour C, Assoun S, Bizot A, Brouk Z, Vicaut E, Teixeira L, Descamps D, Zalcman G
Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses.
Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 2022, 17, 239-251.
Alidjinou EK, Demaret J, Corroyer-Simovic B, Labreuche J, Goffard A, Trauet J, Lupau D, Miczek S, Vuotto F, Dendooven A, Huvent-Grelle D, Podvin J, Dreuil D, Faure K, Deplanque D, Bocket L, Duhamel A, Sobaszek A, Hober D, Hisbergues M, Puisieux F, Autran B, Yazdanpanah Y, Labalette M, Lefèvre G
Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years.
The Lancet Regional Health. Europe 2022, 17, 100385.
Tacconelli E, Gorska A, Carrara E, Davis RJ, Bonten M, Friedrich AW, Glasner C, Goossens H, Hasenauer J, Abad JMH, Peñalvo JL, Sanchez-Niubo A, Sialm A, Scipione G, Soriano G, Yazdanpanah Y, Vorstenbosch E, Jaenisch T
Challenges of data sharing in European Covid-19 projects: A learning opportunity for advancing pandemic preparedness and response.
The Lancet Regional Health. Europe 2022, 21, 100467.
Sonneville R, Jaquet P, Vellieux G, de Montmollin E, Visseaux B
Intensive care management of patients with viral encephalitis.
Revue Neurologique 2022, 178, 48-56.
Wurtzer S, Waldman P, Levert M, Cluzel N, Almayrac JL, Charpentier C, Masnada S, Gillon-Ritz M, Mouchel JM, Maday Y, Boni M, OBEPINE Consortium, AP-HP Virologist Group, Marechal V, Moulin L
SARS-CoV-2 genome quantification in wastewaters at regional and city scale allows precise monitoring of the whole outbreaks dynamics and variants spreading in the population.
The Science of the Total Environment 2022, 810, 152213.
Deplanque D, Cviklinski S, Bardou M, Ader F, Blanchard H, Barthélémy P, David I, D'Ortenzio E, Espérou H, Launay O, Lazarevic M, Lechat P, Lethiec F, Levy Y, Pérol D, Rage V, Roustit M, Thabut G
Health crisis: What opportunities for clinical drug research?.
Therapie 2022, 77, 59-67.
Cortier M, de La Porte C, Papot E, Goudjo A, Guenneau L, Riou F, Cervantes-Gonzalez M, Prioux M, Yazdanpanah Y, Galy A
Health status and healthcare trajectory of vulnerable asylum seekers hosted in a French Reception Center.
Travel Medicine and Infectious Disease 2022, 46, 102180.
Thornhill JP, Palich R, Ghosn J, Walmsley S, Moschese D, Cortes CP, Galliez RM, Garlin AB, Nozza S, Mitja O, Radix AE, Blanco JL, Crabtree-Ramirez B, Thompson M, Wiese L, Schulbin H, Levcovich A, Falcone M, Lucchini A, Sendagorta E, Treutiger CJ, Byrne R, Coyne K, Meyerowitz EA, Grahn AM, Hansen ABE, Pourcher V, DellaPiazza M, Lee R, Stoeckle M, Hazra A, Apea V, Rubenstein E, Jones J, Wilkin A, Ganesan A, Henao-Martínez AF, Chow EJ, Titanji BK, Zucker JE, Ogoina D, Orkin CM, Share-Net writing group
Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series.
Lancet (London, England) 2022, 400, 1953-1965.
Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Poissy J, Belhadi D, Diallo A, Lê MP, Peytavin G, Staub T, Greil R, Guedj J, Paiva JA, Costagliola D, Yazdanpanah Y, Burdet C, Mentré F, DisCoVeRy Study Group
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.
The Lancet. Infectious Diseases 2022, 22, 209-221.
Nasa P, Azoulay E, Chakrabarti A, Divatia JV, Jain R, Rodrigues C, Rosenthal VD, Alhazzani W, Arabi YM, Bakker J, Bassetti M, De Waele J, Dimopoulos G, Du B, Einav S, Evans L, Finfer S, Guérin C, Hammond NE, Jaber S, Kleinpell RM, Koh Y, Kollef M, Levy MM, Machado FR, Mancebo J, Martin-Loeches I, Mer M, Niederman MS, Pelosi P, Perner A, Peter JV, Phua J, Piquilloud L, Pletz MW, Rhodes A, Schultz MJ, Singer M, Timsit JF, Venkatesh B, Vincent JL, Welte T, Myatra SN
Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method.
The Lancet. Infectious Diseases 2022, 22, e74-e87.
Delaugerre C, Foissac F, Abdoul H, Masson G, Choupeaux L, Dufour E, Gastli N, Delarue SM, Néré ML, Minier M, Gabassi A, Salmona M, Seguineau M, Schmitt S, Tonglet S, Olivier A, Poyart C, Le Goff J, Lescure X, Kernéis S, Tréluyer JM, SPRING study group
Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial.
The Lancet. Infectious Diseases 2022, 22, 341-348.
Colosi E, Bassignana G, Contreras DA, Poirier C, Boëlle PY, Cauchemez S, Yazdanpanah Y, Lina B, Fontanet A, Barrat A, Colizza V
Screening and vaccination against COVID-19 to minimise school closure: a modelling study.
The Lancet. Infectious Diseases 2022, S1473-3099(22)00138-4.
Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Mentré F, Burdet C, DisCoVeRy Study Group
Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19.
The Lancet. Infectious Diseases 2022, 22, 764-765.
Hentzien M, Autran B, Piroth L, Yazdanpanah Y, Calmy A
A monoclonal antibody stands out against omicron subvariants: a call to action for a wider access to bebtelovimab.
The Lancet. Infectious Diseases 2022, S1473-3099(22)00495-9.
Gangneux JP, Dannaoui E, Fekkar A, Luyt CE, Botterel F, De Prost N, Tadié JM, Reizine F, Houzé S, Timsit JF, Iriart X, Riu-Poulenc B, Sendid B, Nseir S, Persat F, Wallet F, Le Pape P, Canet E, Novara A, Manai M, Cateau E, Thille AW, Brun S, Cohen Y, Alanio A, Mégarbane B, Cornet M, Terzi N, Lamhaut L, Sabourin E, Desoubeaux G, Ehrmann S, Hennequin C, Voiriot G, Nevez G, Aubron C, Letscher-Bru V, Meziani F, Blaize M, Mayaux J, Monsel A, Boquel F, Robert-Gangneux F, Le Tulzo Y, Seguin P, Guegan H, Autier B, Lesouhaitier M, Pelletier R, Belaz S, Bonnal C, Berry A, Leroy J, François N, Richard JC, Paulus S, Argaud L, Dupont D, Menotti J, Morio F, Soulié M, Schwebel C, Garnaud C, Guitard J, Le Gal S, Quinio D, Morcet J, Laviolle B, Zahar JR, Bougnoux ME
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study.
The Lancet. Respiratory Medicine 2022, 10, 180-190.
Gangneux JP, Morcet J, Laviolle B, Dannaoui E, Timsit JF, Ruckly S, Zahar JR, Bougnoux ME
Time-dependent bias when analysing COVID-19-associated pulmonary aspergillosis - Authors' reply.
The Lancet. Respiratory Medicine 2022, 10, e27.
Landman R, de Truchis P, Assoumou L, Lambert S, Bellet J, Amat K, Lefebvre B, Allavena C, Katlama C, Yazdanpanah Y, Molina JM, Petrov-Sanchez V, Gibowski S, Alvarez JC, Leibowitch J, Capeau J, Fellahi S, Duracinsky M, Morand-Joubert L, Costagliola D, Alvarez JC, Girard PM, ANRS 170 QUATUOR study group
A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial.
The lancet. HIV 2022, 9, e79-e90.
Molina JM, Ghosn J, Assoumou L, Delaugerre C, Algarte-Genin M, Pialoux G, Katlama C, Slama L, Liegeon G, Beniguel L, Ohayon M, Mouhim H, Goldwirt L, Spire B, Loze B, Surgers L, Pavie J, Lourenco J, Ben-Mechlia M, Le Mestre S, Rojas-Castro D, Costagliola D, ANRS PREVENIR Study Group
Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.
The lancet. HIV 2022, 9, e554-e562.
Schramm B, Temfack E, Descamps D, Nicholas S, Peytavin G, Bitilinyu-Bangoh JE, Storto A, Lê MP, Abdi B, Ousley J, Kalua T, Calvez V, Jahn A, Marcelin AG, Szumilin E
Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study.
The lancet. HIV 2022, 9, e544-e553.
Goulenok T, Delaval L, Delory N, François C, Papo T, Descamps D, Ferré VM, Sacré K
Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases.
The Lancet. Rheumatology 2022, 4, e458-e461.
Casalino E, Bouzid D, Ben Hammouda A, Wargon M, Curac S, Hellmann R, Choquet C, Ghazali DA
COVID-19 Preparedness Among Emergency Departments: A Cross-Sectional Study in France.
Disaster Medicine and Public Health Preparedness 2022, 16, 245-253.
Pavlovsky T, Obadia M, Ragot S, Douay B, Casalino E, Ghazali DA
Predictors of Risk Stratification and Value of Point-of-Care of High-Sensitivity Cardiac Troponin-I in EMS Management of Non-ST-Segment Elevation Myocardial Infarction: A Retrospective Study.
Prehospital and Disaster Medicine 2022, 37, 365-372.
Luong Nguyen LB, Ghosn J, Durier C, Tachot C, Tartour E, Touati A, Simon T, Autran B, Ortega Perez I, Telford E, Ward JK, Michels D, Meyer L, Rousseau A, Berard L, de Lamballerie X, Launay O
A prospective national cohort evaluating ring MVA vaccination as post-exposure prophylaxis for monkeypox.
Nature Medicine 2022, 28, 1983-1984.
Smith DRM, Duval A, Zahar JR, EMAE-MESuRS Working Group on Nosocomial SARS-CoV-2 Modelling, Opatowski L, Temime L
Rapid antigen testing as a reactive response to surges in nosocomial SARS-CoV-2 outbreak risk.
Nature Communications 2022, 13, 236.
de Prost N, Audureau E, Heming N, Gault E, Pham T, Chaghouri A, de Montmollin N, Voiriot G, Morand-Joubert L, Joseph A, Chaix ML, Préau S, Favory R, Guigon A, Luyt CE, Burrel S, Mayaux J, Marot S, Roux D, Descamps D, Meireles S, Pène F, Rozenberg F, Contou D, Henry A, Gaudry S, Brichler S, Timsit JF, Kimmoun A, Hartard C, Jandeaux LM, Fafi-Kremer S, Gabarre P, Emery M, Garcia-Sanchez C, Jochmans S, Pitsch A, Annane D, Azoulay E, Mekontso Dessap A, Rodriguez C, Pawlotsky JM, Fourati S
Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19.
Nature Communications 2022, 13, 6025.
Smith N, Possémé C, Bondet V, Sugrue J, Townsend L, Charbit B, Rouilly V, Saint-André V, Dott T, Pozo AR, Yatim N, Schwartz O, Cervantes-Gonzalez M, Ghosn J, Bastard P, Casanova JL, Szwebel TA, Terrier B, Conlon N, O'Farrelly C, Cheallaigh CN, Bourke NM, Duffy D
Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity.
Nature Communications 2022, 13, 7254.
Peyneau M, Granger V, Wicky PH, Khelifi-Touhami D, Timsit JF, Lescure FX, Yazdanpanah Y, Tran-Dinh A, Montravers P, Monteiro RC, Chollet-Martin S, Hurtado-Nedelec M, de Chaisemartin L
Innate immune deficiencies are associated with severity and poor prognosis in patients with COVID-19.
Scientific Reports 2022, 12, 638.
Leducq V, Jary A, Bridier-Nahmias A, Daniel L, Zafilaza K, Damond F, Goldstein V, Duval A, Blanquart F, Calvez V, Descamps D, Marcelin AG, Visseaux B
Nosocomial transmission clusters and lineage diversity characterized by SARS-CoV-2 genomes from two large hospitals in Paris, France, in 2020.
Scientific Reports 2022, 12, 1094.
Hausfater P, Boutolleau D, Lacombe K, Beurton A, Dumont M, Constantin JM, Ghosn J, Combes A, Cury N, Guedj R, Djibré M, Bompard R, Mazerand S, Pourcher V, Gimeno L, Marois C, Teyssou E, Marcelin AG, Hajage D, Tubach F
Cumulative incidence of SARS-CoV-2 infection and associated risk factors among frontline health care workers in Paris: the SEROCOV cohort study.
Scientific Reports 2022, 12, 7211.
Beydon M, Nicaise-Roland P, Mageau A, Farkh C, Daugas E, Descamps V, Dieude P, Dossier A, Goulenok T, Farhi F, Mutuon P, Timsit JF, Papo T, Sacre K
Autoantibodies against IFNα in patients with systemic lupus erythematosus and susceptibility for infection: a retrospective case-control study.
Scientific Reports 2022, 12, 11244.
Wicky PH, Martin-Loeches I, Timsit JF
HAP and VAP after Guidelines.
Seminars in Respiratory and Critical Care Medicine 2022, 43, 248-254.
Thy M, Peiffer-Smadja N, Mailhe M, Kramer L, Ferré VM, Houhou N, Tarhini H, Bertin C, Beaumont AL, Garé M, Le Pluart D, Perrineau S, Rahi M, Deconinck L, Phung B, Mollo B, Cortier M, Cresta M, De La Porte Des Vaux C, Joly V, Lariven S, Rioux C, Somarriba C, Lescure FX, Charpentier C, Yazdanpanah Y, Ghosn J
Breakthrough Infections after Postexposure Vaccination against Mpox.
The New England Journal of Medicine 2022, 387, 2477-2479.
PREVAC Study Team, Kieh M, Richert L, Beavogui AH, Grund B, Leigh B, D'Ortenzio E, Doumbia S, Lhomme E, Sow S, Vatrinet R, Roy C, Kennedy SB, Faye S, Lees S, Millimouno NP, Camara AM, Samai M, Deen GF, Doumbia M, Espérou H, Pierson J, Watson-Jones D, Diallo A, Wentworth D, McLean C, Simon J, Wiedemann A, Dighero-Kemp B, Hensley L, Lane HC, Levy Y, Piot P, Greenwood B, Chêne G, Neaton J, Yazdanpanah Y
Randomized Trial of Vaccines for Zaire Ebola Virus Disease.
The New England Journal of Medicine 2022, 387, 2411-2424.
Gessain A, Nakoune E, Yazdanpanah Y
Monkeypox.
The New England Journal of Medicine 2022, 387, 1783-1793.
Manry J, Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Michailidis E, Hoffmann HH, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Haljasmägi L, Migaud M, Särekannu K, Maslovskaja J, de Prost N, Tandjaoui-Lambiotte Y, Luyt CE, Amador-Borrero B, Gaudet A, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier JC, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux PL, Sene D, Stepanian A, Mégarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya JM, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Ozcelik T, Keles S, Bousfiha AA, El Bakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, van de Beek D, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau YL, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Venet F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari FS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Erikstrup C, Condino-Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, HGID Lab, COVID Clinicians, COVID-STORM Clinicians, NIAID Immune Response to COVID Group, NH-COVAIR Study Group, Danish CHGE, Danish Blood Donor Study, St. James's Hospital, SARS CoV2 Interest Group, French COVID Cohort Study Group, Imagine COVID-Group, Milieu Intérieur Consortium, CoV-Contact Cohort, Amsterdam UMC Covid-19 Biobank Investigators, COVID Human Genetic Effort, CP-COVID-19 Group, CONSTANCES cohort, 3C-Dijon Study, Cerba Health-Care, Etablissement Français du Sang Study group, Anderson MS, Boisson B, Béziat V, Zhang SY, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen TH, Rowen L, Mond J, Debette S, de Lamballerie X, Burdet C, Bouadma L, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Casanova JL, Abel L, Cobat A
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
Proceedings of the National Academy of Sciences of the United States of America 2022, 119, e2200413119.
Bouzid D, Mirault T, Ghazali A, Muller L, Casalino E, Peiffer Smadja N, Auber B, Guerin M, Sambet CH, Etienne I, De Lastours V, Badoual C, Lemogne C, Ruszniewski P, Université Paris Cité' Osce Study Group n, Faye A, Tran Dinh A
Feasibility of large-scale eOSCES: the simultaneous evaluation of 500 medical students during a mock examination.
Medical Education Online 2022, 27, 2084261.
Rienzo M, Skirecki T, Monneret G, Timsit JF
Immune checkpoint inhibitors for the treatment of sepsis:insights from preclinical and clinical development.
Expert Opinion on Investigational Drugs 2022, 31, 885-894.
Giacobbe DR, Roberts JA, Abdul-Aziz MH, de Montmollin E, Timsit JF, Bassetti M
Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective.
Expert Review of Anti-Infective Therapy 2022, 1-17.
Casalino E, Bouzid D, Antoniol S, Choquet C, Colosi L, Pereira L, Agbessi A, Kenway P, Yazdanpanah Y, Ghazali DA
Assessment of HIV-postexposure prophylaxis prescription quality after a training programme and assistance in decisions provided by a computer-based decision program: a cross-over study.
Acta Clinica Belgica 2022, 77, 495-509.
Timsit JF, Paul M, Shields RK, Echols R, Baba T, Yamano Y, Portsmouth S
Cefiderocol for the Treatment of Infections Due To Metallo-Beta-Lactamase-Producing Pathogens in the CREDIBLE-CR And APEKS-NP Phase 3 Randomized Studies.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2022, ciac078.
Eimer J, Fréchet-Jachym M, Le Dû D, Caumes E, El-Helali N, Marigot-Outtandy D, Mechai F, Peytavin G, Pourcher V, Rioux C, Yazdanpanah Y, Robert J, Guglielmetti L, LZDM group
Increased linezolid plasma concentrations are associated with the development of severe toxicity in MDR-TB treatment.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2022, ciac485.
Ghosn J, Assoumou L, Lascoux-Combe C, Peytavin G, Amat K, Gabassi A, Le MP, Nzalakanda R, Valin N, Landman R, Chaix ML, Delaugerre C
HIV-1 RNA Kinetics in Blood Plasma and in Seminal Plasma of Men Starting a Dolutegravir-Based Triple-Combination Regimen at the Time of Primary HIV-1 Infection.
The Journal of Infectious Diseases 2022, 225, 116-120.
Le Hingrat Q, Collin G, Damond F, Peytavin G, Lebourgeois S, Ghosn J, Bachelard A, Ferré VM, Matheron S, Descamps D, Charpentier C
In vitro analysis of the replicative capacity and phenotypic susceptibility to integrase inhibitors of HIV-2 mutants with integrase insertions.
The Journal of Antimicrobial Chemotherapy 2022, 77, 409-412.
Delory T, Le Bel J, Lariven S, Peiffer-Smadja N, Lescure FX, Bouvet E, Jeanmougin P, Tubach F, Boëlle PY
Computerized decision support system (CDSS) use for surveillance of antimicrobial resistance in urinary tract infections in primary care.
The Journal of Antimicrobial Chemotherapy 2022, 77, 524-530.
Lê MP, Ferré VM, Mazy F, Bourgeois-Moine A, Damond F, Matheron S, Descamps D, Ghosn J, Peytavin G
Bictegravir pharmacokinetics in a late-presenting HIV-1-infected pregnant woman: a case report.
The Journal of Antimicrobial Chemotherapy 2022, 77, 851-853.
Martin-Loeches I, Timsit JF, Kollef MH, Wunderink RG, Shime N, Nováček M, Kivistik Ü, Réa-Neto Á, Bruno CJ, Huntington JA, Lin G, Jensen EH, Motyl M, Yu B, Gates D, Butterton JR, Rhee EG
Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia.
The Journal of Antimicrobial Chemotherapy 2022, 77, 1166-1177.
Canouï E, Kerneis S, Morand P, Enser M, Gauzit R, Eyrolle L, Leclerc P, Contejean A, Zheng Y, Anract P, Hirt D, Treluyer JM, Bouazza N, Benaboud S
Oral levofloxacin: population pharmacokinetics model and pharmacodynamics study in bone and joint infections.
The Journal of Antimicrobial Chemotherapy 2022, 77, 1344-1352.
Lingas G, Néant N, Gaymard A, Belhadi D, Peytavin G, Hites M, Staub T, Greil R, Paiva JA, Poissy J, Peiffer-Smadja N, Costagliola D, Yazdanpanah Y, Wallet F, Gagneux-Brunon A, Mentré F, Ader F, Burdet C, Guedj J, Bouscambert-Duchamp M
Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial.
The Journal of Antimicrobial Chemotherapy 2022, 77, 1404-1412.
Buis DTP, Prins JM, Betica-Radic L, de Boer MGJ, Ekkelenkamp M, Kofteridis D, Peiffer-Smadja N, Schouten J, Spernovasilis N, Tattevin P, Ten Oever J, Sigaloff KCE
Current clinical practice in antibiotic treatment of Staphylococcus aureus bacteraemia: results from a survey in five European countries.
The Journal of Antimicrobial Chemotherapy 2022, 77, 2827-2834.
Breton G, Diallo OH, Cissé M, Diallo OH, Diallo NA, Soumaoro SA, Camara Y, Montoyo A, Rouzioux C, Koita Y, Peytavin G, Tubiana R, Frange P, ANRS 12344-DIAVINA study group
HIV stigma limits the effectiveness of PMTCT in Guinea: the ANRS 12344-DIAVINA study.
The Journal of Antimicrobial Chemotherapy 2022, 77, 3093-3101.
Grohs P, Vilfaillot A, Zahar JR, Barbut F, Frange P, Casetta A, Moulin V, Lawrence C, Baune P, Bourgeois C, Bouffier A, Laussucq C, Sienzonit L, Picard S, Podglajen I, Kassis-Chikhani N
Faecal carriage of multidrug-resistant bacteria and associated risk factors: results from a point prevalence study.
The Journal of Antimicrobial Chemotherapy 2022, 77, 2667-2678.
Liegeon G, Assoumou L, Ghosn J, El Mouhebb M, Palich R, Palacios C, Slama L, Surgers L, Genin M, Beniguel L, Goldwirt L, Duvivier C, Rojas Castro D, Costagliola D, Molina JM, ANRS-PREVENIR Study Group
Impact on renal function of daily and on-demand HIV pre-exposure prophylaxis in the ANRS-PREVENIR study.
The Journal of Antimicrobial Chemotherapy 2022, dkac336.
Hobson CA, Vigue L, Naimi S, Chassaing B, Magnan M, Bonacorsi S, Gachet B, El Meouche I, Birgy A, Tenaillon O
MiniBioReactor Array (MBRA) in vitro gut model: a reliable system to study microbiota-dependent response to antibiotic treatment.
JAC-antimicrobial resistance 2022, 4, dlac077.
Davido B, D'Anglejan E, Baudoin R, Dahmane L, Chaud A, Cortier M, Vauloup-Fellous C, De Truchis P, Ghosn J
Monkeypox outbreak 2022: an unusual case of peritonsillar abscess in a person previously vaccinated against smallpox.
Journal of Travel Medicine 2022, 29, taac082.
Pansu N, Le Moing V, Poizot-Martin I, Joly V, Allavena C, Hocqueloux L, Duvivier C, Lourenco J, Jovelin T, Reynes J, Makinson A
Pneumocystis jirovecii Pneumonia and Toxoplasmosis in PWH With HIV-Controlled Disease Treated for Solid Malignancies: A DAT'AIDS Study.
Open Forum Infectious Diseases 2022, 9, ofac109.
Delaugerre C, Assoumou L, Maylin S, Minier M, Gabassi A, Genin M, Beniguel L, Ghosn J, de Lamballerie X, El Mouhebb M, Costagliola D, Carrat F, Molina JM, PREVENIR and SAPRIS-Sero Study Groups
Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among HIV-Negative Participants Using Tenofovir/Emtricitabine-Based Preexposure Prophylaxis in 2020: A Substudy of the French National Agency for Research on AIDS and Viral Hepatitis PREVENIR and Inserm SAPRIS-Sero Cohorts.
Open Forum Infectious Diseases 2022, 9, ofac188.
De Castro N, Mechaï F, Bachelet D, Canestri A, Joly V, Vandenhende M, Boutoille D, Kerjouan M, Veziris N, Molina JM, Grall N, Tattevin P, Laouénan C, Yazdanpanah Y, FAST TB Study Group
Treatment With a Three-Drug Regimen for Pulmonary Tuberculosis Based on Rapid Molecular Detection of Isoniazid Resistance: A Noninferiority Randomized Trial (FAST-TB).
Open Forum Infectious Diseases 2022, 9, ofac353.
Le Pluart D, Ruyer-Thompson M, Ferré VM, Mailhe M, Descamps D, Bouscarat F, Lescure FX, Lucet JC, Yazdanpanah Y, Ghosn J
A Healthcare-Associated Infection With Monkeypox Virus of a Healthcare Worker During the 2022 Outbreak.
Open Forum Infectious Diseases 2022, 9, ofac520.
Abid S, Papin G, Vellieux G, de Montmollin E, Wicky PH, Patrier J, Jaquet P, Bouadma L, Rouvel-Tallec A, Timsit JF, Sonneville R
A Simplified Electroencephalography Montage and Interpretation for Evaluation of Comatose Patients in the ICU.
Critical Care Explorations 2022, 4, e0781.
Vacheron CH, Lepape A, Savey A, Machut A, Timsit JF, Vanhems P, Le QV, Egbeola J, Martin M, Maxime V, Pugliesi PS, Maucort-Boulch D, Friggeri A, REA-REZO Study Group
Increased Incidence of Ventilator-Acquired Pneumonia in Coronavirus Disease 2019 Patients: A Multicentric Cohort Study.
Critical Care Medicine 2022, 50, 449-459.
de Montmollin E, Dupuis C, Jaquet P, Sarton B, Sazio C, Susset V, Conrad M, Argaud L, Demeret S, Tadié JM, Barbier F, Wolff M, Timsit JF, Visseaux B, Sonneville R, ENCEPHALITICA Study Group
Herpes Simplex Virus Encephalitis With Initial Negative Polymerase Chain Reaction in the Cerebrospinal Fluid: Prevalence, Associated Factors, and Clinical Impact.
Critical Care Medicine 2022, 50, e643-e648.
Jaquet P, Legouy C, Le Fevre L, Grinea A, Sinnah F, Franchineau G, Patrier J, Marzouk M, Wicky PH, Alexis Geoffroy P, Arnoult F, Vledouts S, de Montmollin E, Bouadma L, Timsit JF, Sharshar T, Sonneville R
Neurologic Outcomes of Survivors of COVID-19-Associated Acute Respiratory Distress Syndrome Requiring Intubation.
Critical Care Medicine 2022, 50, e674-e682.
Guerra D, Vidal P, Paccoud O, Maillard A, Cachera L, Junot H, Gauzit R, Zahar JR, Abreu MA, Bleibtreu A
Dual beta-lactam treatment: Pros and cons.
Porto Biomedical Journal 2022, 7, e189.
Thy M, Gaudemer A, Vellieux G, Sonneville R
Critical care management of meningitis and encephalitis: an update.
Current Opinion in Critical Care 2022, 28, 486-494.
Durier C, Mercier-Delarue S, Verdière NCD, Meiffrédy V, Matheron S, Samri A, Resch M, Marchand L, Autran B, Launay O, Simon F, ANRS NOVAA EP46 study group
A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults.
AIDS (London, England) 2022, 36, 319-321.
Hassold N, Brichler S, Ouedraogo E, Leclerc D, Carroue S, Gater Y, Alloui C, Carbonnelle E, Bouchaud O, Mechai F, Cordel H, Delagreverie H
Impaired antibody response to COVID-19 vaccination in advanced HIV infection.
AIDS (London, England) 2022, 36, F1-F5.
Le Hingrat Q, Collin G, Bachelard A, Ghosn J, Chalal S, Pacanowski J, Peytavin G, Weinheimer S, Marsolais C, Damond F, Matheron S, Charpentier C, Descamps D, and the ANRS CO5 HIV-2 cohort
Ibalizumab shows in vitro activity against group A and group B HIV-2 clinical isolates.
AIDS (London, England) 2022
Pourcher V, Capeau J, Dudoit Y, Boccara F, Soulié C, Ndoadoumgue AL, Charlotte F, Fellahi S, Bastard JP, Béréziat V, Lagathu C, Marcelin AG, Peytavin G, Boutron-Ruault MC, Tubbax C, D'Avout D'Auerstaedt A, Valantin MA, Schneider L, Costagliola D, Katlama C, Assoumou L, Pourcher G
Comparison of HIV-infected and non-infected patients undergoing bariatric surgery: the ObeVIH study.
Journal of Acquired Immune Deficiency Syndromes (1999) 2022
Kherabi Y, de Castro N, Sellier PO, Hamet G, Brun A, Méchaï F, Joly V, Yazdanpanah Y, Molina JM
Efficacy and safety of efavirenz, raltegravir and dolutegravir in HIV-1/TB co-infection. A multicenter retrospective cohort study in France.
Journal of Acquired Immune Deficiency Syndromes (1999) 2022
Wicky PH, d'Humières C, Timsit JF
How common is ventilator-associated pneumonia after coronavirus disease 2019?.
Current Opinion in Infectious Diseases 2022, 35, 170-175.
Zahar JR, Timsit JF
Risk stratification for selecting empiric antibiotherapy during and after COVID-19.
Current Opinion in Infectious Diseases 2022, 35, 605-613.
Chotard E, Jacquier H, Bart G, Richette P, Rioux C, Joly V, Goossens J, Palazzo E, Forien M, Jelin G, Yazdanpanah Y, Dieudé P, Le Goff B, Ottaviani S
MRI Features Associated With the Detection of Microbial Pathogens by CT-Guided Biopsy in Septic Spondylodiscitis.
Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases 2022, 28, e189-e194.
Alkhalil R, Ouersighni A, Kenway P, Breque C, Oriot D, Ghazali DA
Impact of a Multidisciplinary Simulation-Based Training Program on the Multiple Techniques of Intraosseous Access: A Prospective Multicentric Study.
Simulation in Healthcare: Journal of the Society for Simulation in Healthcare 2022
Bienvenu AL, Pavese P, Leboucher G, Berger P, Roux S, Charmillon A, Foroni L, Menotti J, Lebeaux D, Mayan R, Mondain V, Robin C, Lesprit P, Alfandari S, Kernéis S
Practical checklist for implementation of antifungal stewardship programmes.
Journal of Medical Microbiology 2022, 71,
Henriot P, Castry M, Luong Nguyen LB, Shimakawa Y, Jean K, Temime L
Meta-analysis: Risk of hepatitis C virus infection associated with hospital-based invasive procedures.
Alimentary Pharmacology & Therapeutics 2022
Demouche S, Juge PA, Charles P, Descamps V, Benali K, Brunet-Possenti F
Safe use of tocilizumab in rheumatic patients with Kaposi's sarcoma.
Dermatologic Therapy 2022, 35, e15797.
Valade S, Picard M, Mokart D, Calvet L, Bruneel F, de Montmollin E, Aissaoui N, Champigneulle B, Bigé N, Boissier F, Pène F, Mayaux J, Argaud L, Moreau AS, Murgier M, Azoulay E, Darmon M
Critically ill patients with severe infections related to Geotrichum species: A French retrospective multicentre study.
Mycoses 2022, 65, 226-232.
Mageau A, Borie R, Crestani B, Timsit JF, Papo T, Sacre K
Epidemiology of interstitial lung disease in systemic lupus erythematosus in France: A nation-wide population-based study over 10 years.
Respirology (Carlton, Vic.) 2022
Kherabi Y, Messika J, Peiffer-Smadja N
Machine learning, antimicrobial stewardship, and solid organ transplantation: Is this the future?.
Transplant Infectious Disease: An Official Journal of the Transplantation Society 2022, 24, e13957.
Lapaillerie D, Charlier C, Guyonnet-Dupérat V, Murigneux E, Fernandes HS, Martins FG, Magalhães RP, Vieira TF, Richetta C, Subra F, Lebourgeois S, Charpentier C, Descamps D, Visseaux B, Weigel P, Favereaux A, Beauvineau C, Buron F, Teulade-Fichou MP, Routier S, Gallois-Montbrun S, Meertens L, Delelis O, Sousa SF, Parissi V
Selection of Bis-Indolyl Pyridines and Triphenylamines as New Inhibitors of SARS-CoV-2 Cellular Entry by Modulating the Spike Protein/ACE2 Interfaces.
Antimicrobial Agents and Chemotherapy 2022, 66, e0008322.
Hobson CA, Pierrat G, Tenaillon O, Bonacorsi S, Bercot B, Jaouen E, Jacquier H, Birgy A
Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview.
Antimicrobial Agents and Chemotherapy 2022, 66, e0044722.
Richetta C, Subra F, Malet I, Leh H, Charpentier C, Corona A, Collin G, Descamps D, Deprez E, Parissi V, Calvez V, Tramontano E, Marcelin AG, Delelis O
Mutations in the 3'-PPT Lead to HIV-1 Replication without Integration.
Journal of Virology 2022, 96, e0067622.
Ferré VM, Peiffer-Smadja N, Kramer L, Coppée R, Kante A, Debarge M, Choquet C, Saint Joannis T, Bouzid D, Messika J, Le Grand J, Thy M, Kernéis S, Descamps D, Visseaux B, Ghosn J
Dual Monoclonal Antibodies on Sars-Cov-2 Alpha and Delta Variants: Clinical and Virological Efficacy.
Microbiology Spectrum 2022, 10, e0215222.
Lo S, Lolom I, Goldstein V, Petitjean M, Rondinaud E, Bunel-Gourdy V, Tran Dinh A, Wicky PH, Ruppé E, d'Humières C, Lucet JC, Armand-Lefèvre L
Simultaneous Hospital Outbreaks of New Delhi Metallo-β-Lactamase-Producing Enterobacterales Unraveled Using Whole-Genome Sequencing.
Microbiology Spectrum 2022, 10, e0228721.
Mageau A, Papo T, Ruckly S, Strukov A, van Gysel D, Sacre K, Timsit JF
Survival after COVID-19-associated organ failure among inpatients with systemic lupus erythematosus in France: a nationwide study.
Annals of the Rheumatic Diseases 2022, 81, 569-574.
Mageau A, Ferré VM, Goulenok T, Charpentier C, Delory N, Francois C, Houhou-Fidouh N, Papo T, Descamps D, Sacre K
Severely impaired humoral response against SARS-CoV-2 variants of concern following two doses of BNT162b2 vaccine in patients with systemic lupus erythematosus (SLE).
Annals of the Rheumatic Diseases 2022, 81, 1194-1196.
Plaçais L, Dalle S, Dereure O, Trabelsi S, Dalac S, Legoupil D, Montaudié H, Arnault JP, De Quatrebarbes J, Saiag P, Brunet-Possenti F, Lesimple T, Maubec E, Aubin F, Granel-Brocard F, Grob JJ, Stoebner PE, Allayous C, Oriano B, Dutriaux C, Mortier L, Lebbe C
Risk of irAEs in patients with autoimmune diseases treated by immune checkpoint inhibitors for stage III or IV melanoma: results from a matched case-control study.
Annals of the Rheumatic Diseases 2022, 81, 1445-1452.
Legrand M, Fong N, Laouénan C, Ghosn J, Thill B, Faure K, Garot D, Goujard C, Curlier E, Resche-Rigon M, Rossignol P, Pirracchio R
Risk factors of long term symptoms and outcomes among patients discharged after covid-19: prospective, multicentre observational study.
BMJ medicine 2022, 1, e000093.
Labbe V, Contou D, Heming N, Megarbane B, Ait-Oufella H, Boissier F, Carreira S, Robert A, Vivier E, Fejjal M, Doyen D, Monchi M, Preau S, Noel-Savina E, Souweine B, Zucman N, Picos SA, Dres M, Juguet W, Mariotte E, Timsit JF, Turpin M, Razazi K, Gendreau S, Baloul S, Voiriot G, Fartoukh M, Audureau E, Mekontso Dessap A
Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trial.
BMJ open 2022, 12, e059383.
Vacheron CH, Lepape A, Savey A, Machut A, Timsit JF, Comparot S, Courno G, Vanhems P, Landel V, Lavigne T, Bailly S, Bettega F, Study Group RR, Maucort-Boulch D, Friggeri A
Attributable Mortality of Ventilator-associated Pneumonia Among COVID-19 Patients.
American Journal of Respiratory and Critical Care Medicine 2022
Guglielmetti L, Günther G, Leu C, Cirillo D, Duarte R, Garcia-Basteiro AL, Goletti D, Jankovic M, Kuksa L, Maurer FP, Méchaï F, Tiberi S, van Leth F, Veziris N, Lange C, Study Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC), European Society of Mycobacteriology (ESM), European Respiratory Society (ERS) and, Tuberculosis Network European Trials group (TBnet)
Rifapentine access in Europe: growing concerns over key tuberculosis treatment component.
The European Respiratory Journal 2022, 59, 2200388.
Beurnier A, Yordanov Y, Dechartres A, Dinh A, Debuc E, Lescure FX, Jourdain P, Jaulmes L, Humbert M
Characteristics and outcomes of asthmatic outpatients with COVID-19 who receive home telesurveillance.
ERJ open research 2022, 8, 00012-2022.
Chevret S, Timsit JF, Biard L
Challenges of using external data in clinical trials- an illustration in patients with COVID-19.
BMC medical research methodology 2022, 22, 321.
Martin-Blondel G, Lescure FX, Assoumou L, Charpentier C, Chapplain JM, Perpoint T, Grouteau G, Cordel H, Pialoux G, Pacanowski J, Thy M, Bauvois A, Laureillard D, Hamrouni F, Algarte-Genin M, Poissy J, Descamps D, Costagliola D, CoCliCo Study Group
Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study.
BMC infectious diseases 2022, 22, 540.
Tran-Dinh A, Bouzid D, El Kalai A, Atchade E, Tanaka S, Lortat-Jacob B, Jean-Baptiste S, Zappella N, Boudinet S, Castier Y, Mal H, Mordant P, Messika J, Montravers P
Favorable, arduous or fatal postoperative pathway within 90 days of lung transplantation.
BMC pulmonary medicine 2022, 22, 326.
Fasse L, Roche N, Flahault C, Garrouste-Orgeas M, Ximenes M, Pages A, Evin A, Dauchy S, Scotte F, Le Provost JB, Blot F, Mateus C
The APSY-SED study: protocol of an observational, longitudinal, mixed methods and multicenter study exploring the psychological adjustment of relatives and healthcare providers of patients with cancer with continuous deep sedation until death.
BMC palliative care 2022, 21, 217.
Bouzid D, Mullaert J, Ghazali A, Ferré VM, Mentré F, Lemogne C, Ruszniewski P, Faye A, Dinh AT, Mirault T, Université Paris Cité Osce study group
eOSCE stations live versus remote evaluation and scores variability.
BMC medical education 2022, 22, 861.
Hedible GB, Louart S, Neboua D, Catala L, Anago G, Sawadogo AG, Kargougou GD, Meda B, Kolié JS, Hema A, Keita S, Niome M, Savadogo AS, Peters-Bokol L, Agbeci H, Zair Z, Lenaud S, Vignon M, Ouedraogo Yugbare S, Abarry H, Diakite AA, Diallo IS, Lamontagne F, Briand V, Dahourou DL, Cousien A, Ridde V, Leroy V, AIRE Research Study Group
Evaluation of the routine implementation of pulse oximeters into integrated management of childhood illness (IMCI) guidelines at primary health care level in West Africa: the AIRE mixed-methods research protocol.
BMC health services research 2022, 22, 1579.
Bosetti P, Tran Kiem C, Andronico A, Colizza V, Yazdanpanah Y, Fontanet A, Benamouzig D, Cauchemez S
Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France.
BMC medicine 2022, 20, 33.
Coppée R, Mama A, Sarrasin V, Kamaliddin C, Adoux L, Palazzo L, Ndam NT, Letourneur F, Ariey F, Houzé S, Clain J
5WBF: a low-cost and straightforward whole blood filtration method suitable for whole-genome sequencing of Plasmodium falciparum clinical isolates.
Malaria Journal 2022, 21, 51.
Thouy F, Bohé J, Souweine B, Abidi H, Quenot JP, Thiollière F, Dellamonica J, Preiser JC, Timsit JF, Brunot V, Klich A, Sedillot N, Tchenio X, Roudaut JB, Mottard N, Hyvernat H, Wallet F, Danin PE, Badie J, Jospe R, Morel J, Mofredj A, Fatah A, Drai J, Mialon A, Ait Hssain A, Lautrette A, Fontaine E, Vacheron CH, Maucort-Boulch D, Klouche K, Dupuis C
Impact of prolonged requirement for insulin on 90-day mortality in critically ill patients without previous diabetic treatments: a post hoc analysis of the CONTROLING randomized control trial.
Critical Care (London, England) 2022, 26, 138.
Iachkine J, Buetti N, de Grooth HJ, Briant AR, Mimoz O, Mégarbane B, Mira JP, Ruckly S, Souweine B, du Cheyron D, Mermel LA, Timsit JF, Parienti JJ
Development and validation of a multivariable prediction model of central venous catheter-tip colonization in a cohort of five randomized trials.
Critical Care (London, England) 2022, 26, 205.
Patrier J, Villageois-Tran K, Szychowiak P, Ruckly S, Gschwind R, Wicky PH, Gueye S, Armand-Lefevre L, Marzouk M, Sonneville R, Bouadma L, Petitjean M, Lamara F, de Montmollin E, Timsit JF, Ruppé E, French COVID Cohort Study Group
Oropharyngeal and intestinal concentrations of opportunistic pathogens are independently associated with death of SARS-CoV-2 critically ill adults.
Critical Care (London, England) 2022, 26, 300.
Buetti N, Tabah A, Loiodice A, Ruckly S, Aslan AT, Montrucchio G, Cortegiani A, Saltoglu N, Kayaaslan B, Aksoy F, Murat A, Akdoğan Ö, Saracoglu KT, Erdogan C, Leone M, Ferrer R, Paiva JA, Hayashi Y, Ramanan M, Conway Morris A, Barbier F, Timsit JF, Eurobact 2 study group
Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study.
Critical Care (London, England) 2022, 26, 319.
Blet A, McNeil JB, Josse J, Cholley B, Cinotti R, Cotter G, Dauvergne A, Davison B, Duarte K, Duranteau J, Fournier MC, Gayat E, Jaber S, Lasocki S, Merkling T, Peoc'h K, Mayer I, Sadoune M, Laterre PF, Sonneville R, Ware L, Mebazaa A, Kimmoun A
Association between in-ICU red blood cells transfusion and 1-year mortality in ICU survivors.
Critical Care (London, England) 2022, 26, 307.
Kollef MH, Timsit JF, Martin-Loeches I, Wunderink RG, Huntington JA, Jensen EH, Yu B, Bruno CJ
Outcomes in participants with failure of initial antibacterial therapy for hospital-acquired/ventilator-associated bacterial pneumonia prior to enrollment in the randomized, controlled phase 3 ASPECT-NP trial of ceftolozane/tazobactam versus meropenem.
Critical Care (London, England) 2022, 26, 373.
Soum E, Timsit JF, Ruckly S, Gruson D, Canet E, Klouche K, Argaud L, Garrouste-Orgeas M, Mariat C, Vincent F, Cayot S, Darmon M, Bohé J, Schwebel C, Bouadma L, Dupuis C, Souweine B, Lautrette A
Predictive factors for severe long-term chronic kidney disease after acute kidney injury requiring renal replacement therapy in critically ill patients: an ancillary study of the ELVIS randomized controlled trial.
Critical Care (London, England) 2022, 26, 367.
Goletto T, Decaux S, Bunel V, Weisenburger G, Messika J, Najem S, Medraoui C, Godet C, Debray MP, Lortat-Jacob B, Mordant P, Castier Y, Bouadma L, Borie R, Mal H
Acute worsening of native lung fibrosis after single lung transplantation for pulmonary fibrosis: two case reports.
Journal of Medical Case Reports 2022, 16, 2.
Ghazali DA, Kenway P, Choquet C, Casalino E
Early diagnosis of sepsis using an E-health application for a clinical early warning system outside of the intensive care unit: a case report.
Journal of Medical Case Reports 2022, 16, 185.
Szychowiak P, Villageois-Tran K, Patrier J, Timsit JF, Ruppé É
The role of the microbiota in the management of intensive care patients.
Annals of Intensive Care 2022, 12, 3.
Egea A, Dupuis C, de Montmollin E, Wicky PH, Patrier J, Jaquet P, Lefèvre L, Sinnah F, Marzouk M, Sonneville R, Bouadma L, Souweine B, Timsit JF
Augmented renal clearance in the ICU: estimation, incidence, risk factors and consequences-a retrospective observational study.
Annals of Intensive Care 2022, 12, 88.
Rambaud T, de Montmollin E, Jaquet P, Gaudemer A, Mariotte E, Abid S, Para M, Cimadevilla C, Iung B, Duval X, Wolff M, Bouadma L, Timsit JF, Sonneville R
Cerebrovascular complications and outcomes of critically ill adult patients with infective endocarditis.
Annals of Intensive Care 2022, 12, 119.
Ravalihasy A, Kardaś-Słoma L, Yazdanpanah Y, Ridde V
Quantitative methods used to evaluate impact of health promotion interventions to prevent HIV infections: a methodological systematic review protocol.
Systematic Reviews 2022, 11, 87.
Eyebe S, Nana-Djeunga HC, Guewo-Fokeng M, Wafeu GS, Vouking MZ, Massoda S, Evina CD, Zoumabo AC, Ongolo-Zogo P, Zahar JR
Risk factors for colonization and infection with multidrug-resistant Pseudomonas aeruginosa in intensive care unit: protocol for a systematic review and meta-analysis.
Systematic Reviews 2022, 11, 270.
Berthod D, Alvarez D, Perozziello A, Chabrol F, Lucet JC
Are there reasons behind high Handrub consumption? A French National in-depth qualitative assessment.
Antimicrobial Resistance and Infection Control 2022, 11, 42.
Contejean A, Abbara S, Chentouh R, Alviset S, Grignano E, Gastli N, Casetta A, Willems L, Canouï E, Charlier C, Pène F, Charpentier J, Reboul-Marty J, Batista R, Bouscary D, Kernéis S
Antimicrobial stewardship in high-risk febrile neutropenia patients.
Antimicrobial Resistance and Infection Control 2022, 11, 52.
Kardaś-Słoma L, Fournier S, Dupont JC, Rochaix L, Birgand G, Zahar JR, Lescure FX, Kernéis S, Durand-Zaleski I, Lucet JC
Cost-effectiveness of strategies to control the spread of carbapenemase-producing Enterobacterales in hospitals: a modelling study.
Antimicrobial Resistance and Infection Control 2022, 11, 117.
Durand C, Douriez E, Chappuis A, Poulain F, Yazdanpanah Y, Lariven S, Lescure FX, Peiffer-Smadja N
Contributions and challenges of community pharmacists during the COVID-19 pandemic: a qualitative study.
Journal of Pharmaceutical Policy and Practice 2022, 15, 43.
Girod M, Dalle S, Mortier L, Dalac S, Leccia MT, Dutriaux C, Montaudié H, de Quatrebarbes J, Lesimple T, Brunet-Possenti F, Saiag P, Maubec E, Legoupil D, Stoebner PE, Arnault JP, Lefevre W, Lebbe C, Dereure O
Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National Cohort.
JCO precision oncology 2022, 6, e2200075.
Kherabi Y, Mollo B, Gerard S, Lescure FX, Rioux C, Yazdanpanah Y
Patient-centered approach to the management of drug-resistant tuberculosis in France: How far off the mark are we?.
PLOS global public health 2022, 2, e0000313.
Béraud G, Timsit JF, Leleu H
Remdesivir and dexamethasone as tools to relieve hospital care systems stressed by COVID-19: A modelling study on bed resources and budget impact.
PloS One 2022, 17, e0262462.
Flahault C, Vioulac C, Fasse L, Bailly S, Timsit JF, Garrouste-Orgeas M
"A story with gaps": An interpretative phenomenological analysis of ICU survivors' experience.
PloS One 2022, 17, e0264310.
Grandjean D, Elie C, Gallet C, Julien C, Roger V, Desquilbet L, Alvergnat G, Delarue S, Gabassi A, Minier M, Choupeaux L, Kerneis S, Delaugerre C, LE Goff J, Treluyer JM
Diagnostic accuracy of non-invasive detection of SARS-CoV-2 infection by canine olfaction.
PloS One 2022, 17, e0268382.
Tanaka S, De Tymowski C, Stern J, Bouzid D, Zappella N, Snauwaert A, Robert T, Lortat-Jacob B, Tran-Dinh A, Augustin P, Boutten A, Tashk P, Peoc'h K, Meilhac O, Montravers P
Relationship between liver dysfunction, lipoprotein concentration and mortality during sepsis.
PloS One 2022, 17, e0272352.
Vaittinada Ayar P, Taillé C, Vaittinada Ayar P, Gay M, Diallo A, Dara AF, Peyrony O, Chassany O, Casalino E
Assessment of Predictor Factors Associated with Multiple Emergency Department Attendance with Asthma Attack: A Qualitative and Multicentric Prospective Observational Study.
Journal of Asthma and Allergy 2022, 15, 303-313.
Gérardin C, Mageau A, Mékinian A, Tannier X, Carrat F
Construction of Cohorts of Similar Patients From Automatic Extraction of Medical Concepts: Phenotype Extraction Study.
JMIR medical informatics 2022, 10, e42379.
Bouiller K, Peiffer-Smadja N, Cevik M, Last K, Antunović IA, Šterbenc A, Lopes MJ, Barac A, Schweitzer V, Dellière S
Role and perception of clinical microbiology and infectious diseases trainees during the COVID-19 crisis.
Future Microbiology 2022, 17, 411-416.
Rapin A, Boyer FC, Mourvillier B, Giordano Orsini G, Launois C, Taiar R, Deslee G, Goury A, Carazo-Mendez S
Post-Intensive Care Syndrome Prevalence Six Months after Critical Covid-19: Comparison between First and Second Waves.
Journal of Rehabilitation Medicine 2022, 54, jrm00339.
Piezzi V, Wassilew N, Atkinson A, D'Incau S, Kaspar T, Seth-Smith HM, Casanova C, Bittel P, Jent P, Sommerstein R, Buetti N, Marschall J
Nosocomial outbreak of vancomycin-resistant Enterococcus faecium (VRE) ST796, Switzerland, 2017 to 2020.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2022, 27, 2200285.
Jordans CCE, Vasylyev M, Rae C, Jakobsen ML, Vassilenko A, Dauby N, Grevsen AL, Jakobsen SF, Raahauge A, Champenois K, Papot E, Malin JJ, Boender TS, Behrens GMN, Gruell H, Neumann A, Spinner CD, Valbert F, Akinosoglou K, Kostaki EG, Nozza S, Giacomelli A, Lapadula G, Mazzitelli M, Torti C, Matulionyte R, Matulyte E, Van Welzen BJ, Hensley KS, Thompson M, Ankiersztejn-Bartczak M, Skrzat-Klapaczyńska A, Săndulescu O, Streinu-Cercel A, Streinu-Cercel A, Miron VD, Pokrovskaya A, Hachfeld A, Dorokhina A, Sukach M, Lord E, Sullivan AK, Rokx C, Guidelines Review Group for the projects: Optimising testing and linkage to care for HIV across Europe (OptTEST by HiE) and the Joint Action on integrating prevention, testing and linkage to care strategies across HIV, viral hepatitis, TB and STIs in Euro
National medical specialty guidelines of HIV indicator conditions in Europe lack adequate HIV testing recommendations: a systematic guideline review.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2022, 27, 2200338.
Alizon S, Selinger C, Sofonea MT, Haim-Boukobza S, Giannoli JM, Ninove L, Pillet S, Thibault V, de Rougemont A, Tumiotto C, Solis M, Stephan R, Bressollette-Bodin C, Salmona M, L'Honneur AS, Behillil S, Lefeuvre C, Dina J, Hantz S, Hartard C, Veyer D, Delagrèverie HM, Fourati S, Visseaux B, Henquell C, Lina B, Foulongne V, Burrel S, SFM COVID-19 study group
Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2022, 27,
Shirreff G, Zahar JR, Cauchemez S, Temime L, Opatowski L, EMEA-MESuRS Working Group on the Nosocomial Modelling of SARS-CoV-22
Measuring Basic Reproduction Number to Assess Effects of Nonpharmaceutical Interventions on Nosocomial SARS-CoV-2 Transmission.
Emerging Infectious Diseases 2022, 28, 1345-1354.
Kherabi Y, Fréchet-Jachym M, Rioux C, Yazdanpanah Y, Méchaï F, Pourcher V, Robert J, Guglielmetti L, MDR-TB Management Group
Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006-2019.
Emerging Infectious Diseases 2022, 28, 1796-1804.
Lebourgeois S, David A, Chenane HR, Granger V, Menidjel R, Fidouh N, Noël B, Delelis O, Richetta C, Charpentier C, Chollet-Martin S, Descamps D, Visseaux B, de Chaisemartin L
Differential activation of human neutrophils by SARS-CoV-2 variants of concern.
Frontiers in Immunology 2022, 13, 1010140.
d'Humières C, Gaïa N, Gueye S, de Lastours V, Leflon-Guibout V, Maataoui N, Duprilot M, Lecronier M, Rousseau MA, Gamany N, Lescure FX, Senard O, Deconinck L, Dollat M, Isernia V, Le Hur AC, Petitjean M, Nazimoudine A, Le Gac S, Chalal S, Ferreira S, Lazarevic V, Guigon G, Gervasi G, Armand-Lefèvre L, Schrenzel J, Ruppé E
Contribution of Clinical Metagenomics to the Diagnosis of Bone and Joint Infections.
Frontiers in Microbiology 2022, 13, 863777.
Alcouffe L, Huber F, Creton PM, Bitan L, Gonzalez A, Volpellier M, Panfili B, Adenis A, Vignier N
Sexual vulnerability of migrant women in the multicultural context of French Guiana: A societal issue.
Frontiers in Public Health 2022, 10, 934049.
Vignier N, Moussaoui S, Marsaudon A, Wittwer J, Jusot F, Dourgnon P
Burden of infectious diseases among undocumented migrants in France: Results of the Premiers Pas survey.
Frontiers in Public Health 2022, 10, 934050.
Goupil de Bouillé J, Luong Nguyen LB, Crépey P, Garlantezec R, Doré V, Dumas A, Ben Mechlia M, Tattevin P, Gaudart J, Spire B, Lert F, Yazdanpanah Y, Delaugerre C, Noret M, Zeggagh J
Transmission of SARS-CoV-2 during indoor clubbing events: A clustered randomized, controlled, multicentre trial protocol.
Frontiers in Public Health 2022, 10, 981213.
Saliba R, Mizrahi A, Gauthier PdP, Alban LM, Zahar JR, Pilmis B
Antimicrobial Stewardship Program: Reducing Antibiotic's Spectrum of Activity Is not the Solution to Limit the Emergence of Multidrug-Resistant Bacteria.
Antibiotics (Basel, Switzerland) 2022, 11, 70.
Timsit JF, Wicky PH, de Montmollin E
Treatment of Severe Infections Due to Metallo-Betalactamases Enterobacterales in Critically Ill Patients.
Antibiotics (Basel, Switzerland) 2022, 11, 144.
Chaïbi K, Péan de Ponfilly G, Dortet L, Zahar JR, Pilmis B
Empiric Treatment in HAP/VAP: "Don't You Want to Take a Leap of Faith?".
Antibiotics (Basel, Switzerland) 2022, 11, 359.
Tabah A, Lipman J, Barbier F, Buetti N, Timsit JF, On Behalf Of The Escmid Study Group For Infections In Critically Ill Patients-Esgcip n
Use of Antimicrobials for Bloodstream Infections in the Intensive Care Unit, a Clinically Oriented Review.
Antibiotics (Basel, Switzerland) 2022, 11, 362.
Durand C, Alfandari S, Béraud G, Tsopra R, Lescure FX, Peiffer-Smadja N
Clinical Decision Support Systems for Antibiotic Prescribing: An Inventory of Current French Language Tools.
Antibiotics (Basel, Switzerland) 2022, 11, 384.
de Montmollin E, Peoc'h K, Marzouk M, Ruckly S, Wicky PH, Patrier J, Jaquet P, Sonneville R, Bouadma L, Timsit JF
Mid-Regional Pro-Adrenomedullin as a Prognostic Factor for Severe COVID-19 ARDS.
Antibiotics (Basel, Switzerland) 2022, 11, 1166.
Pajot O, Lakhal K, Lambert J, Gros A, Bruel C, Boulain T, Garot D, Das V, Timsit JF, Cerf C, Souweine B, Chaffaut C, Mentec H, Zahar JR, Mira JP, Jullien V
Empirical Antibiotic Therapy for Gram-Negative Bacilli Ventilator-Associated Pneumonia: Observational Study and Pharmacodynamic Assessment.
Antibiotics (Basel, Switzerland) 2022, 11, 1664.
Magréault S, Jauréguy F, Carbonnelle E, Zahar JR
When and How to Use MIC in Clinical Practice?.
Antibiotics (Basel, Switzerland) 2022, 11, 1748.
Delhommeau G, Buetti N, Neuville M, Siami S, Cohen Y, Laurent V, Mourvillier B, Reignier J, Goldgran-Toledano D, Schwebel C, Ruckly S, de Montmollin E, Souweine B, Timsit JF, Dupuis C
Bacterial Pulmonary Co-Infections on ICU Admission: Comparison in Patients with SARS-CoV-2 and Influenza Acute Respiratory Failure: A Multicentre Cohort Study.
Biomedicines 2022, 10, 2646.
Kandel M, Bardet A, Dalle S, Allayous C, Mortier L, Guillot B, Dutriaux C, Leccia MT, Dalac S, Montaudie H, Saiag P, Legoupil D, Brunet-Possenti F, Arnault JP, Quatrebarbes JD, Beylot-Barry M, Maubec E, Lesimple T, Aubin F, Grob JJ, Granel-Brocard F, Stoebner PE, Dupuy A, Dreno B, Michiels S, Lebbe C, Borget I
Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in France.
Current Oncology (Toronto, Ont.) 2022, 29, 9255-9270.
Ousseine YM, Vaux S, Vandentorren S, Bonmarin I, Champenois K, Lydié N, Velter A
Predictors of Uncertainty and Unwillingness to Receive the COVID-19 Vaccine in Men Who Have Sex with Men in France.
International Journal of Environmental Research and Public Health 2022, 19, 5372.
Arnaud E, Elbattah M, Ammirati C, Dequen G, Ghazali DA
Use of Artificial Intelligence to Manage Patient Flow in Emergency Department during the COVID-19 Pandemic: A Prospective, Single-Center Study.
International Journal of Environmental Research and Public Health 2022, 19, 9667.
Zerbit J, Detroit M, Chevret S, Pene F, Luyt CE, Ghosn J, Eyvrard F, Martin-Blondel G, Sarton B, Clere-Jehl R, Moine P, Cransac A, Andreu P, Labruyère M, Albertini L, Huon JF, Roge P, Bernard L, Farines-Raffoul M, Villiet M, Venet A, Dumont LM, Kaiser JD, Chapuis C, Goehringer F, Barbier F, Desjardins S, Benzidi Y, Abbas N, Guerin C, Batista R, Llitjos JF, Kroemer M
Remdesivir for Patients Hospitalized with COVID-19 Severe Pneumonia: A National Cohort Study (Remdeco-19).
Journal of Clinical Medicine 2022, 11, 6545.
Paccoud O, Vignier N, Boui M, Migaud M, Vironneau P, Kania R, Méchaï F, Brun S, Alanio A, Tauziède-Espariat A, Adle-Biassette H, Ouedraogo E, Bustamante J, Bouchaud O, Casanova JL, Puel A, Lanternier F
Invasive Rhinosinusitis Caused by Alternaria infectoria in a Patient with Autosomal Recessive CARD9 Deficiency and a Review of the Literature.
Journal of Fungi (Basel, Switzerland) 2022, 8, 446.
Billard-Pomares T, Marin J, Quagliaro P, Méchaï F, Walewski V, Dziri S, Carbonnelle E
Use of Whole-Genome Sequencing to Explore Mycobacterium tuberculosis Complex Circulating in a Hotspot Department in France.
Microorganisms 2022, 10, 1586.
Fourati S, Audureau E, Arrestier R, Marot S, Dubois C, Voiriot G, Luyt CE, Urbina T, Mayaux J, Roque-Afonso AM, Pham T, Landraud L, Visseaux B, Roux D, Bellaiche R, L'honneur AS, Ait Hamou Z, Brichler S, Gaudry S, Salmona M, Clere-Jehl R, Azoulay E, Morand-Joubert L, Marcelin AG, Chaix ML, Descamps D, Mekontso Dessap A, Rodriguez C, Pawlotsky JM, de Prost N
SARS-CoV-2 Genomic Characteristics and Clinical Impact of SARS-CoV-2 Viral Diversity in Critically Ill COVID-19 Patients: A Prospective Multicenter Cohort Study.
Viruses 2022, 14, 1529.
Bouzid D, Visseaux B, Kassasseya C, Daoud A, Fémy F, Hermand C, Truchot J, Beaune S, Javaud N, Peyrony O, Chauvin A, Vaittinada Ayar P, Bourg A, Riou B, Marot S, Bloom B, Cachanado M, Simon T, Freund Y, IMProving Emergency Care (IMPEC) FHU Collaborators Group
Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments : A Retrospective Cohort Study.
Annals of Internal Medicine 2022, 175, 831-837.
Johnson MG, Puenpatom A, Moncada PA, Burgess L, Duke ER, Ohmagari N, Wolf T, Bassetti M, Bhagani S, Ghosn J, Zhang Y, Wan H, Williams-Diaz A, Brown ML, Paschke A, De Anda C
Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled Trial.
Annals of Internal Medicine 2022, 175, 1126-1134.
Ferré VM, Bachelard A, Zaidi M, Armand-Lefevre L, Descamps D, Charpentier C, Ghosn J
Detection of Monkeypox Virus in Anorectal Swabs From Asymptomatic Men Who Have Sex With Men in a Sexually Transmitted Infection Screening Program in Paris, France.
Annals of Internal Medicine 2022, 175, 1491-1492.
Wensing AM, Calvez V, Ceccherini-Silberstein F, Charpentier C, Günthard HF, Paredes R, Shafer RW, Richman DD
2022 update of the drug resistance mutations in HIV-1.
Topics in Antiviral Medicine 2022, 30, 559-574.
High-Dose Dexamethasone and Oxygen Support Strategies in Intensive Care Unit Patients With Severe COVID-19 Acute Hypoxemic Respiratory Failure: The COVIDICUS Randomized Clinical Trial.
JAMA internal medicine 2022, 182, 906-916.
Ningarhari M, Mourad A, Delacôte C, Ntandja Wandji LC, Lassailly G, Louvet A, Dharancy S, Mathurin P, Deuffic-Burban S
Benefits of tailored hepatocellular carcinoma screening in patients with cirrhosis on cancer-specific and overall mortality: A modeling approach.
Hepatology Communications 2022, 6, 2964-2974.
Houhou-Fidouh N, Bucau M, Bertine M, Minh TNT, Picone O, Salakos E, Luton D
Preliminary results on transmission of SARS-CoV-2 antibodies to the fetus and serum neutralizing activity.
International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics 2022, 158, 476-478.
Castry M, Cousien A, Champenois K, Supervie V, Velter A, Ghosn J, Yazdanpanah Y, Paltiel AD, Deuffic-Burban S
Cost-effectiveness of hepatitis C virus test-and-treat and risk reduction strategies among men who have sex with men living with HIV in France.
Journal of the International AIDS Society 2022, 25, e26035.
Khellaf L, Bouscarat F, Burrel S, Fidouh N, Hachon L, Bucau M, Lariven S, Boutolleau D, Joly V, Ghosn J, Le Pluart D, Thy M
Novel mutations in antiviral multiresistant HSV-2 genital lesion: A case report.
Journal of Medical Virology 2022, 94, 6122-6126.
Ayrolles A, Ellul P, Trebossen V, Houhou-Fidouh N, Bonacorsi S, Descamps D, Delorme R
Is SARS-CoV-2 seroconversion a risk factor for severe and acute psychiatric symptoms in children?.
Neuropsychopharmacology Reports 2022, 42, 218-220.
Lavalley-Morelle A, Timsit JF, Mentré F, Mullaert J, OUTCOMEREA network
Joint modeling under competing risks: Application to survival prediction in patients admitted in Intensive Care Unit for sepsis with daily Sequential Organ Failure Assessment score assessments.
CPT: pharmacometrics & systems pharmacology 2022, 11, 1472-1484.
Ghazali DA, Ilha-Schuelter P, Barreyre L, Stephan O, Barbosa SS, Oriot D, Tourinho FSV, Plaisance P
Development and validation of the first performance assessment scale for interdisciplinary chest tube insertion: a prospective multicenter study.
European Journal of Trauma and Emergency Surgery: Official Publication of the European Trauma Society 2022
Buetti N, Rickard CM, Timsit JF
Catheter dressings.
Intensive Care Medicine 2022
Timsit JF, Tabah A, Mimoz O
Update on prevention of intra-vascular accesses complications.
Intensive Care Medicine 2022
Rouzé A, Estella Á, Timsit JF
Is (1,3)-β-D-glucan useless to guide antifungal therapy in ICU?.
Intensive Care Medicine 2022, 48, 930-932.
Tallarico RT, Deniau B, Fong N, Ghosn J, Legrand M, French-COVID and the FROG-ICU Investigators
Differences in HADS and SF-36 scores 1 year after critical illness in COVID-19 patients.
Intensive Care Medicine 2022, 48, 1245-1247.
De Pascale G, Antonelli M, Deschepper M, Arvaniti K, Blot K, Brown BC, de Lange D, De Waele J, Dikmen Y, Dimopoulos G, Eckmann C, Francois G, Girardis M, Koulenti D, Labeau S, Lipman J, Lipovetsky F, Maseda E, Montravers P, Mikstacki A, Paiva JA, Pereyra C, Rello J, Timsit JF, Vogelaers D, Blot S, Abdominal Sepsis Study (AbSeS) group and the Trials Group of the European Society of Intensive Care Medicine
Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis.
Intensive Care Medicine 2022, 48, 1593-1606.
Di Ciaccio M, Delabre RM, Vilotitch A, Corbelli GM, Villes V, Ros Sánchez A, Zantkuijl P, Sweers H, Sanchez F, Meulbroek M, Cairns G, Bernier A, Ghosn J, Carvalho Rocha LM, Cosmaro ML, Duken SB, Dan M, Schlegel V, Stranz R, Jonas KJ, Spire B, Rojas Castro D
PrEP in the Context of Other HIV Risk Reduction Strategies Among Men Who Have Sex with Men: Results from the Flash! PrEP in Europe Survey.
Archives of Sexual Behavior 2022, 51, 2451-2464.
Bassetti M, Vena A, Giacobbe DR, Trucchi C, Ansaldi F, Antonelli M, Adamkova V, Alicino C, Almyroudi MP, Atchade E, Azzini AM, Brugnaro P, Carannante N, Peghin M, Berruti M, Carnelutti A, Castaldo N, Corcione S, Cortegiani A, Dimopoulos G, Dubler S, García-Garmendia JL, Girardis M, Cornely OA, Ianniruberto S, Kullberg BJ, Lagrou K, Lebihan C, Luzzati R, Malbrain M, Merelli M, Marques AJ, Martin-Loeches I, Mesini A, Paiva JA, Raineri SM, Rautemaa-Richardson R, Schouten J, Spapen H, Tasioudis P, Timsit JF, Tisa V, Tumbarello M, Van den Berg CHSB, Veber B, Venditti M, Voiriot G, Wauters J, Zappella N, Montravers P, from the Study Group for Infections in Critically Ill Patients (ESGCIP) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study.
Infectious Diseases and Therapy 2022, 11, 827-840.
Ferré VM, Peiffer-Smadja N, Visseaux B, Descamps D, Ghosn J, Charpentier C
Omicron SARS-CoV-2 variant: What we know and what we don't.
Anaesthesia, Critical Care & Pain Medicine 2022, 41, 100998.
Buetti N, Mermel LA, Timsit JF
Routine catheter-tip cultures for assessing catheter-related bloodstream infections in randomised-controlled trials.
Anaesthesia, Critical Care & Pain Medicine 2022, 41, 101006.
Atchade E, Goldstein V, Viane S, Van Gysel D, Lolom I, Lortat-Jacob B, Tran-Dinh A, Ben Rehouma M, Lucet JC, Montravers P
Economic impact of an outbreak of carbapenemase producing-Enterobacteriaceae in a surgical intensive care unit.
Anaesthesia, Critical Care & Pain Medicine 2022, 101093.
Gouel-Cheron A, Kantor E, Rioux C, Kerneis S, Montravers P
Monkeypox-infected patients in the perioperative context: Recommendations from an expert centre.
Anaesthesia, Critical Care & Pain Medicine 2022, 41, 101122.
Fillâtre P, Dufour MJ, Behillil S, Vatan R, Reusse P, Gabellec A, Velmans N, Montagne C, Geffroy Du Coudret S, Droumaguet E, Merour V, Enouf V, Buzelé R, Valence M, Guillotel E, Gagnière B, Baidaliuk A, Zhukova A, Tourdjman M, Thibault V, Grolhier C, Pronier C, Lescure FX, Simon-Loriere E, Costagliola D, Van Der Werf S, Tattevin P, Massart N
A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 298.e9-298.e15.
Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 202-221.
EU-Response investigators group, Diallo A, Trøseid M, Simensen VC, Boston A, Demotes J, Olsen IC, Chung F, Paiva JA, Hites M, Ader F, Arribas JR, Baratt-Due A, Melien Ø, Tacconelli E, Staub T, Greil R, Tsiodras S, Briel M, Esperou H, Mentré F, Eustace J, Saillard J, Delmas C, LeMestre S, Dumousseaux M, Costagliola D, Røttingen JA, Yazdanpanah Y
Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 1-5.
Trøseid M, Diallo A, Hites M, Røttingen JA, Yazdanpanah Y
Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 743-744.
Dinh A, Dahmane L, Dahoumane M, Masingue X, Jourdain P, Lescure FX
Impact of Omicron surge in community setting in greater Paris area.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, S1198-743X(22)00089-1.
Duvignaud A, Lhomme E, Onaisi R, Sitta R, Gelley A, Chastang J, Piroth L, Binquet C, Dupouy J, Makinson A, Lefèvre B, Naccache JM, Roussillon C, Landman R, Wallet C, Karcher S, Journot V, Nguyen D, Pistone T, Bouchet S, Lafon ME, Molimard M, Thiébaut R, de Lamballerie X, Joseph JP, Richert L, Saint-Lary O, Djabarouti S, Wittkop L, Anglaret X, Malvy D, Coverage Study Group
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE).
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, S1198-743X(22)00108-2.
Belan M, Charmet T, Schaeffer L, Tubiana S, Duval X, Lucet JC, Fontanet A, Birgand G, Kernéis S
SARS-CoV-2 exposures of healthcare workers from primary care, long-term care facilities and hospitals: a nationwide matched case-control study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 1471-1476.
Pilmis B, Weiss E, Scemla A, Monnier AL, Grossi PA, Slavin MA, Van Delden C, Lortholary O, Paugam-Burtz C, Zahar JR
Multidrug-resistant enterobacterales infections in abdominal solid organ transplantation.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, S1198-743X(22)00318-4.
Danjean M, Hobson CA, Gits-Muselli M, Courroux C, Monjault A, Bonacorsi S, Birgy A
Evaluation of the inoculum effect of new antibiotics against carbapenem-resistant enterobacterales.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 1503.e1-1503.e3.
Coléon S, Wiedemann A, Surénaud M, Lacabaratz C, Hue S, Prague M, Cervantes-Gonzalez M, Wang Z, Ellis J, Sansoni A, Pierini C, Bardin Q, Fabregue M, Sharkaoui S, Hoest P, Dupaty L, Picard F, El Hajj M, Centlivre M, Ghosn J, French COVID Cohort Study Group, Thiébaut R, Cardinaud S, Malissen B, Zurawski G, Zarubica A, Zurawski SM, Godot V, Lévy Y
Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine.
EBioMedicine 2022, 80, 104062.
Hermine O, Mariette X, Porcher R, Djossou F, Nguyen Y, Arlet JB, Savale L, Diehl JL, Georgin-Lavialle S, Cadranel J, Pialoux G, Lacombe K, Mekinian A, Gros H, Lescure X, Ghosn J, Coupez E, Grapin K, Rapp C, Michel M, Lecapitaine AL, Michot JM, Costedoat-Chalumeau N, Nguyen LBL, Semerano L, Raffi F, Aguillar C, Rouzaud C, Gottenberg JE, Hansmann Y, Bienvenu B, London J, Fantchou FS, Ackermann F, Gros A, Morel A, Gambier N, Sène D, Mégarbane B, Azoulay E, Bureau S, Dougados M, Emmerich J, Fartoukh M, Guidet B, Humbert M, Mahevas M, Pène F, Schlemmer F, Pourcher-Martinez V, Tibi A, Baron G, Perrodeau E, Baron S, Steg G, Yazdapanah Y, Simon T, Resche-Rigon M, Tharaux PL, Ravaud P
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group.
EClinicalMedicine 2022, 46, 101362.
Barrière J, Carles M, Audigier-Valette C, Re D, Adjtoutah Z, Seitz-Polski B, Gounant V, Descamps D, Zalcman G
Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article.
European Journal of Cancer (Oxford, England: 1990) 2022, 162, 182-193.
Barrière J, Zalcman G, Fignon L, Peiffer-Smadja N, Audigier-Valette C, Carles M
Omicron variant: A clear and present danger for patients with cancer.
European Journal of Cancer (Oxford, England: 1990) 2022, 165, 25-26.
Eshagh D, Mageau A, Papo T, Benali K, Sacre K
Persistent FDG uptake in large vessels and risk of relapse in giant cell arteritis.
European Journal of Internal Medicine 2022, 106, 158-160.
Blot S, Ruppé E, Harbarth S, Asehnoune K, Poulakou G, Luyt CE, Rello J, Klompas M, Depuydt P, Eckmann C, Martin-Loeches I, Povoa P, Bouadma L, Timsit JF, Zahar JR
Healthcare-associated infections in adult intensive care unit patients: Changes in epidemiology, diagnosis, prevention and contributions of new technologies.
Intensive & Critical Care Nursing 2022, 70, 103227.
Husain M, Valayer S, Poey N, Rondinaud E, d'Humières C, Visseaux B, Lariven S, Lescure FX, Deconinck L
Pulmonary bacterial infections in adult patients hospitalized for COVID-19 in standard wards.
Infectious Diseases Now 2022, 52, 208-213.
Landman R, Marcelin AG, Bennani M, Philippe C, Kousignian P, Finkielsztejn L, Roustand L, Nachbaur G, Pourcher V
COPEDOL: A two-year observational study in pretreated HIV-1-infected patients switching to a dolutegravir-based regimen.
Infectious Diseases Now 2022, 52, 93-100.
Koch A, Vermel M, Hansmann Y, Lodi M, Mura C, Sananes A, Gallien S, Wurtz É, Bleibtreu A, Martinot M, Exinger J, Lescure X, Kerneis S, Lacombe K, Mootien JY, Shawali C, Lecointre L, Debry C, Lefebvre N, Sananes N
3D-printed simulator for nasopharyngeal swab collection for COVID-19.
Infectious Diseases Now 2022, S2666-9919(22)00035-5.
Grall-Zahar I, Rucly S, Billard-Pomares T, Gasnier-Besnardeau K, Al Mouft O, Zahar JR, Zirnhelt I
Prevalence and risk factors for carriage of extended-spectrum β-lactamase-producing enterobacteriaceae in rehabilitation wards in France.
Infectious Diseases Now 2022, 52, 403-407.
Méchaï F, Bachelet D, Han L, Dubert M, Parisey M, Cordel H, Bourgarit A, Bertrac C, Chauveau S, Billard-Pomares T, Carbonnelle E, Bouchaud O, Yazdanpanah Y, Vignier N, Laouénan C
Tuberculosis treatment outcomes among precarious patients in France.
Infectious Diseases Now 2022, 52, 389-395.
Pugliese P, Arvieux C, Huleux T, Pialoux G, Vignier N
Proposal of the French HIV Society on the CD4 threshold below which patients living with HIV who wish to be vaccinated against Monkeypox should receive a 3-dose regimen.
Infectious Diseases Now 2022, 52, 459-460.
Saliba R, Lomont A, Eudesson JL, Seytre D, Zahar JR, Pilmis B
Significant variation in the faecal relative abundance of carbapenemase-producing Enterobacteriaceae of colonised patients during hospitalisation: a preliminary study.
International Journal of Antimicrobial Agents 2022, 59, 106479.
Arvaniti K, Dimopoulos G, Antonelli M, Blot K, Creagh-Brown B, Deschepper M, de Lange D, De Waele J, Dikmen Y, Eckmann C, Einav S, Francois G, Fjeldsoee-Nielsen H, Girardis M, Jovanovic B, Lindner M, Koulenti D, Labeau S, Lipman J, Lipovestky F, Makikado LDU, Maseda E, Mikstacki A, Montravers P, Paiva JA, Pereyra C, Rello J, Timsit JF, Tomescu D, Vogelaers D, Blot S, Abdominal Sepsis Study (AbSeS) group on behalf of the Trials Group of the European Society of Intensive Care Medicine
Epidemiology and Age-Related Mortality in Critically Ill Patients With Intra-Abdominal Infection or Sepsis: An International Cohort Study.
International Journal of Antimicrobial Agents 2022, 106591.
Bouzid D, Hadad O, Bertine M, Houhou-Fidouh N, Mirand A, Duval X, Bunel V, Borie R, Lucet JC, Descamps D, Visseaux B
Rhinoviruses: molecular diversity and clinical characteristics.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2022, 118, 144-149.
Bachelard A, Sautereau A, Digumber M, Isernia V, Phung B, Lehur AC, Gac SL, Landman R, Yazdanpanah Y, Ghosn J
Risk Factors Associated with Severe/Critical COVID-19 in People Living with HIV-1.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2022, 122, 152-154.
Boussier J, Yatim N, Marchal A, Hadjadj J, Charbit B, El Sissy C, Carlier N, Pène F, Mouthon L, Tharaux PL, Bergeron A, Smadja DM, Rieux-Laucat F, Duffy D, Kernéis S, Frémeaux-Bacchi V, Terrier B
Severe COVID-19 is associated with hyperactivation of the alternative complement pathway.
The Journal of Allergy and Clinical Immunology 2022, 149, 550-556.e2.
Durand C, Chappuis A, Douriez E, Poulain F, Ahmad R, Lescure FX, Peiffer-Smadja N
Perceptions, current practices, and interventions of community pharmacists regarding antimicrobial stewardship: A qualitative study.
Journal of the American Pharmacists Association: JAPhA 2022, S1544-3191(22)00056-5.
Hassold N, Saidenberg N, Sigaux J, Lacroix M, Cruaud P, Walewski V, Bouchaud O, Méchaï F
Asymptomatic bacteriuria before biotherapy for rheumatic diseases: Shall we treat?.
Joint Bone Spine 2022, 89, 105327.
Magréault S, Jaureguy F, Zahar JR, Méchaï F, Toinon D, Cohen Y, Carbonnelle E, Jullien V
Automated HPLC-MS/MS assay for the simultaneous determination of ten plasma antibiotic concentrations.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2022, 1211, 123496.
Santoro MM, Armenia D, Teyssou E, Santos JR, Charpentier C, Lambert-Niclot S, Antinori A, Katlama C, Descamps D, Perno CF, Calvez V, Paredes R, Ceccherini-Silberstein F, Marcelin AG, LAMRES Study Group
Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES study.
Journal of Global Antimicrobial Resistance 2022, 31, 52-62.
De Broucker C, Plessier A, Ollivier-Hourmand I, Dharancy S, Bureau C, Cervoni JP, Sogni P, Goria O, Corcos O, Sartoris R, Ronot M, Vilgrain V, de Raucourt E, Zekrini K, Davy H, Durand F, Payancé A, Fidouh-Houhou N, Yazdanpanah Y, Valla D, Rautou PE
Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus disease.
Journal of Hepatology 2022, 76, 115-122.
Saliba R, Karam-Sarkis D, Zahar JR, Glélé LSA
Adverse events associated with patient isolation: a systematic literature review and meta-analysis.
The Journal of Hospital Infection 2022, 119, 54-63.
Nagle S, Tandjaoui-Lambiotte Y, Boubaya M, Athenaïs G, Alloui C, Bloch-Queyrat C, Carbonnelle E, Brichler S, Cohen Y, Zahar JR, Delagrèverie H
Environmental SARS-CoV-2 contamination in hospital rooms of patients with acute COVID-19.
The Journal of Hospital Infection 2022, 126, 116-122.
Le Monnier A, Candela T, Mizrahi A, Bille E, Bourgeois-Nicolaos N, Cattoir V, Farfour E, Grall I, Lecointe D, Limelette A, Marcade G, Poilane I, Poupy P, Kansau I, Zahar JR, Pilmis B, GMC group
One-day prevalence of asymptomatic carriage of toxigenic and non-toxigenic Clostridioides difficile in 10 French hospitals.
The Journal of Hospital Infection 2022, S0195-6701(22)00162-1.
Ferré VM, Lebourgeois S, Menidjel R, Collin G, Chenane HR, Guindi MO, Yazdanpanah Y, Timsit JF, Charpentier C, Descamps D, Fidouh N, Visseaux B
Decreasing humoral response among healthcare workers up to 4 months after two doses of BNT162b2 vaccine.
The Journal of Infection 2022, 84, 248-288.
Lebourgeois S, Menidjel R, Chenane HR, Ferré VM, Collin G, Damond F, Coppée R, Yazdanpanah Y, Timsit JF, Houhou-Fidouh N, Descamps D, Charpentier C, Visseaux B
Alpha (B.1.1.7) and Delta (B.1.617.2 - AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage.
The Journal of Infection 2022, 84, 418-467.
Ferré VM, Lebourgeois S, Chenane HR, Menidjel R, Masson C, Collin G, Visseaux B, Descamps D, Fidouh N, Charpentier C
Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays.
The Journal of Infection 2022, S0163-4453(22)00126-8.
Martin-Blondel G, Marcelin AG, Soulié C, Kaisaridi S, Lusivika-Nzinga C, Dorival C, Nailler L, Boston A, Melenotte C, Cabié A, Choquet C, Coustillères F, Martellosio JP, Gaube G, Trinh-Duc A, Ronchetti AM, Pourcher V, Chauveau M, Lacombe K, Peiffer-Smadja N, Housset P, Perrot A, Pialoux G, Martin A, Dubee V, Devaux M, Frey J, Cazanave C, Liblau R, Carrat F, Yordanov Y
Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2.
The Journal of Infection 2022, 85, e104-e108.
Gounant V, Ferré VM, Soussi G, Charpentier C, Flament H, Fidouh N, Collin G, Namour C, Assoun S, Bizot A, Brouk Z, Vicaut E, Teixeira L, Descamps D, Zalcman G
Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses.
Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 2022, 17, 239-251.
Alidjinou EK, Demaret J, Corroyer-Simovic B, Labreuche J, Goffard A, Trauet J, Lupau D, Miczek S, Vuotto F, Dendooven A, Huvent-Grelle D, Podvin J, Dreuil D, Faure K, Deplanque D, Bocket L, Duhamel A, Sobaszek A, Hober D, Hisbergues M, Puisieux F, Autran B, Yazdanpanah Y, Labalette M, Lefèvre G
Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years.
The Lancet Regional Health. Europe 2022, 17, 100385.
Tacconelli E, Gorska A, Carrara E, Davis RJ, Bonten M, Friedrich AW, Glasner C, Goossens H, Hasenauer J, Abad JMH, Peñalvo JL, Sanchez-Niubo A, Sialm A, Scipione G, Soriano G, Yazdanpanah Y, Vorstenbosch E, Jaenisch T
Challenges of data sharing in European Covid-19 projects: A learning opportunity for advancing pandemic preparedness and response.
The Lancet Regional Health. Europe 2022, 21, 100467.
Sonneville R, Jaquet P, Vellieux G, de Montmollin E, Visseaux B
Intensive care management of patients with viral encephalitis.
Revue Neurologique 2022, 178, 48-56.
Wurtzer S, Waldman P, Levert M, Cluzel N, Almayrac JL, Charpentier C, Masnada S, Gillon-Ritz M, Mouchel JM, Maday Y, Boni M, OBEPINE Consortium, AP-HP Virologist Group, Marechal V, Moulin L
SARS-CoV-2 genome quantification in wastewaters at regional and city scale allows precise monitoring of the whole outbreaks dynamics and variants spreading in the population.
The Science of the Total Environment 2022, 810, 152213.
Deplanque D, Cviklinski S, Bardou M, Ader F, Blanchard H, Barthélémy P, David I, D'Ortenzio E, Espérou H, Launay O, Lazarevic M, Lechat P, Lethiec F, Levy Y, Pérol D, Rage V, Roustit M, Thabut G
Health crisis: What opportunities for clinical drug research?.
Therapie 2022, 77, 59-67.
Cortier M, de La Porte C, Papot E, Goudjo A, Guenneau L, Riou F, Cervantes-Gonzalez M, Prioux M, Yazdanpanah Y, Galy A
Health status and healthcare trajectory of vulnerable asylum seekers hosted in a French Reception Center.
Travel Medicine and Infectious Disease 2022, 46, 102180.
Thornhill JP, Palich R, Ghosn J, Walmsley S, Moschese D, Cortes CP, Galliez RM, Garlin AB, Nozza S, Mitja O, Radix AE, Blanco JL, Crabtree-Ramirez B, Thompson M, Wiese L, Schulbin H, Levcovich A, Falcone M, Lucchini A, Sendagorta E, Treutiger CJ, Byrne R, Coyne K, Meyerowitz EA, Grahn AM, Hansen ABE, Pourcher V, DellaPiazza M, Lee R, Stoeckle M, Hazra A, Apea V, Rubenstein E, Jones J, Wilkin A, Ganesan A, Henao-Martínez AF, Chow EJ, Titanji BK, Zucker JE, Ogoina D, Orkin CM, Share-Net writing group
Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series.
Lancet (London, England) 2022, 400, 1953-1965.
Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Poissy J, Belhadi D, Diallo A, Lê MP, Peytavin G, Staub T, Greil R, Guedj J, Paiva JA, Costagliola D, Yazdanpanah Y, Burdet C, Mentré F, DisCoVeRy Study Group
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.
The Lancet. Infectious Diseases 2022, 22, 209-221.
Nasa P, Azoulay E, Chakrabarti A, Divatia JV, Jain R, Rodrigues C, Rosenthal VD, Alhazzani W, Arabi YM, Bakker J, Bassetti M, De Waele J, Dimopoulos G, Du B, Einav S, Evans L, Finfer S, Guérin C, Hammond NE, Jaber S, Kleinpell RM, Koh Y, Kollef M, Levy MM, Machado FR, Mancebo J, Martin-Loeches I, Mer M, Niederman MS, Pelosi P, Perner A, Peter JV, Phua J, Piquilloud L, Pletz MW, Rhodes A, Schultz MJ, Singer M, Timsit JF, Venkatesh B, Vincent JL, Welte T, Myatra SN
Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method.
The Lancet. Infectious Diseases 2022, 22, e74-e87.
Delaugerre C, Foissac F, Abdoul H, Masson G, Choupeaux L, Dufour E, Gastli N, Delarue SM, Néré ML, Minier M, Gabassi A, Salmona M, Seguineau M, Schmitt S, Tonglet S, Olivier A, Poyart C, Le Goff J, Lescure X, Kernéis S, Tréluyer JM, SPRING study group
Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial.
The Lancet. Infectious Diseases 2022, 22, 341-348.
Colosi E, Bassignana G, Contreras DA, Poirier C, Boëlle PY, Cauchemez S, Yazdanpanah Y, Lina B, Fontanet A, Barrat A, Colizza V
Screening and vaccination against COVID-19 to minimise school closure: a modelling study.
The Lancet. Infectious Diseases 2022, S1473-3099(22)00138-4.
Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Mentré F, Burdet C, DisCoVeRy Study Group
Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19.
The Lancet. Infectious Diseases 2022, 22, 764-765.
Hentzien M, Autran B, Piroth L, Yazdanpanah Y, Calmy A
A monoclonal antibody stands out against omicron subvariants: a call to action for a wider access to bebtelovimab.
The Lancet. Infectious Diseases 2022, S1473-3099(22)00495-9.
Gangneux JP, Dannaoui E, Fekkar A, Luyt CE, Botterel F, De Prost N, Tadié JM, Reizine F, Houzé S, Timsit JF, Iriart X, Riu-Poulenc B, Sendid B, Nseir S, Persat F, Wallet F, Le Pape P, Canet E, Novara A, Manai M, Cateau E, Thille AW, Brun S, Cohen Y, Alanio A, Mégarbane B, Cornet M, Terzi N, Lamhaut L, Sabourin E, Desoubeaux G, Ehrmann S, Hennequin C, Voiriot G, Nevez G, Aubron C, Letscher-Bru V, Meziani F, Blaize M, Mayaux J, Monsel A, Boquel F, Robert-Gangneux F, Le Tulzo Y, Seguin P, Guegan H, Autier B, Lesouhaitier M, Pelletier R, Belaz S, Bonnal C, Berry A, Leroy J, François N, Richard JC, Paulus S, Argaud L, Dupont D, Menotti J, Morio F, Soulié M, Schwebel C, Garnaud C, Guitard J, Le Gal S, Quinio D, Morcet J, Laviolle B, Zahar JR, Bougnoux ME
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study.
The Lancet. Respiratory Medicine 2022, 10, 180-190.
Gangneux JP, Morcet J, Laviolle B, Dannaoui E, Timsit JF, Ruckly S, Zahar JR, Bougnoux ME
Time-dependent bias when analysing COVID-19-associated pulmonary aspergillosis - Authors' reply.
The Lancet. Respiratory Medicine 2022, 10, e27.
Landman R, de Truchis P, Assoumou L, Lambert S, Bellet J, Amat K, Lefebvre B, Allavena C, Katlama C, Yazdanpanah Y, Molina JM, Petrov-Sanchez V, Gibowski S, Alvarez JC, Leibowitch J, Capeau J, Fellahi S, Duracinsky M, Morand-Joubert L, Costagliola D, Alvarez JC, Girard PM, ANRS 170 QUATUOR study group
A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial.
The lancet. HIV 2022, 9, e79-e90.
Molina JM, Ghosn J, Assoumou L, Delaugerre C, Algarte-Genin M, Pialoux G, Katlama C, Slama L, Liegeon G, Beniguel L, Ohayon M, Mouhim H, Goldwirt L, Spire B, Loze B, Surgers L, Pavie J, Lourenco J, Ben-Mechlia M, Le Mestre S, Rojas-Castro D, Costagliola D, ANRS PREVENIR Study Group
Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.
The lancet. HIV 2022, 9, e554-e562.
Schramm B, Temfack E, Descamps D, Nicholas S, Peytavin G, Bitilinyu-Bangoh JE, Storto A, Lê MP, Abdi B, Ousley J, Kalua T, Calvez V, Jahn A, Marcelin AG, Szumilin E
Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study.
The lancet. HIV 2022, 9, e544-e553.
Goulenok T, Delaval L, Delory N, François C, Papo T, Descamps D, Ferré VM, Sacré K
Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases.
The Lancet. Rheumatology 2022, 4, e458-e461.
Casalino E, Bouzid D, Ben Hammouda A, Wargon M, Curac S, Hellmann R, Choquet C, Ghazali DA
COVID-19 Preparedness Among Emergency Departments: A Cross-Sectional Study in France.
Disaster Medicine and Public Health Preparedness 2022, 16, 245-253.
Pavlovsky T, Obadia M, Ragot S, Douay B, Casalino E, Ghazali DA
Predictors of Risk Stratification and Value of Point-of-Care of High-Sensitivity Cardiac Troponin-I in EMS Management of Non-ST-Segment Elevation Myocardial Infarction: A Retrospective Study.
Prehospital and Disaster Medicine 2022, 37, 365-372.
Luong Nguyen LB, Ghosn J, Durier C, Tachot C, Tartour E, Touati A, Simon T, Autran B, Ortega Perez I, Telford E, Ward JK, Michels D, Meyer L, Rousseau A, Berard L, de Lamballerie X, Launay O
A prospective national cohort evaluating ring MVA vaccination as post-exposure prophylaxis for monkeypox.
Nature Medicine 2022, 28, 1983-1984.
Smith DRM, Duval A, Zahar JR, EMAE-MESuRS Working Group on Nosocomial SARS-CoV-2 Modelling, Opatowski L, Temime L
Rapid antigen testing as a reactive response to surges in nosocomial SARS-CoV-2 outbreak risk.
Nature Communications 2022, 13, 236.
de Prost N, Audureau E, Heming N, Gault E, Pham T, Chaghouri A, de Montmollin N, Voiriot G, Morand-Joubert L, Joseph A, Chaix ML, Préau S, Favory R, Guigon A, Luyt CE, Burrel S, Mayaux J, Marot S, Roux D, Descamps D, Meireles S, Pène F, Rozenberg F, Contou D, Henry A, Gaudry S, Brichler S, Timsit JF, Kimmoun A, Hartard C, Jandeaux LM, Fafi-Kremer S, Gabarre P, Emery M, Garcia-Sanchez C, Jochmans S, Pitsch A, Annane D, Azoulay E, Mekontso Dessap A, Rodriguez C, Pawlotsky JM, Fourati S
Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19.
Nature Communications 2022, 13, 6025.
Smith N, Possémé C, Bondet V, Sugrue J, Townsend L, Charbit B, Rouilly V, Saint-André V, Dott T, Pozo AR, Yatim N, Schwartz O, Cervantes-Gonzalez M, Ghosn J, Bastard P, Casanova JL, Szwebel TA, Terrier B, Conlon N, O'Farrelly C, Cheallaigh CN, Bourke NM, Duffy D
Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity.
Nature Communications 2022, 13, 7254.
Peyneau M, Granger V, Wicky PH, Khelifi-Touhami D, Timsit JF, Lescure FX, Yazdanpanah Y, Tran-Dinh A, Montravers P, Monteiro RC, Chollet-Martin S, Hurtado-Nedelec M, de Chaisemartin L
Innate immune deficiencies are associated with severity and poor prognosis in patients with COVID-19.
Scientific Reports 2022, 12, 638.
Leducq V, Jary A, Bridier-Nahmias A, Daniel L, Zafilaza K, Damond F, Goldstein V, Duval A, Blanquart F, Calvez V, Descamps D, Marcelin AG, Visseaux B
Nosocomial transmission clusters and lineage diversity characterized by SARS-CoV-2 genomes from two large hospitals in Paris, France, in 2020.
Scientific Reports 2022, 12, 1094.
Hausfater P, Boutolleau D, Lacombe K, Beurton A, Dumont M, Constantin JM, Ghosn J, Combes A, Cury N, Guedj R, Djibré M, Bompard R, Mazerand S, Pourcher V, Gimeno L, Marois C, Teyssou E, Marcelin AG, Hajage D, Tubach F
Cumulative incidence of SARS-CoV-2 infection and associated risk factors among frontline health care workers in Paris: the SEROCOV cohort study.
Scientific Reports 2022, 12, 7211.
Beydon M, Nicaise-Roland P, Mageau A, Farkh C, Daugas E, Descamps V, Dieude P, Dossier A, Goulenok T, Farhi F, Mutuon P, Timsit JF, Papo T, Sacre K
Autoantibodies against IFNα in patients with systemic lupus erythematosus and susceptibility for infection: a retrospective case-control study.
Scientific Reports 2022, 12, 11244.
Wicky PH, Martin-Loeches I, Timsit JF
HAP and VAP after Guidelines.
Seminars in Respiratory and Critical Care Medicine 2022, 43, 248-254.
Thy M, Peiffer-Smadja N, Mailhe M, Kramer L, Ferré VM, Houhou N, Tarhini H, Bertin C, Beaumont AL, Garé M, Le Pluart D, Perrineau S, Rahi M, Deconinck L, Phung B, Mollo B, Cortier M, Cresta M, De La Porte Des Vaux C, Joly V, Lariven S, Rioux C, Somarriba C, Lescure FX, Charpentier C, Yazdanpanah Y, Ghosn J
Breakthrough Infections after Postexposure Vaccination against Mpox.
The New England Journal of Medicine 2022, 387, 2477-2479.
PREVAC Study Team, Kieh M, Richert L, Beavogui AH, Grund B, Leigh B, D'Ortenzio E, Doumbia S, Lhomme E, Sow S, Vatrinet R, Roy C, Kennedy SB, Faye S, Lees S, Millimouno NP, Camara AM, Samai M, Deen GF, Doumbia M, Espérou H, Pierson J, Watson-Jones D, Diallo A, Wentworth D, McLean C, Simon J, Wiedemann A, Dighero-Kemp B, Hensley L, Lane HC, Levy Y, Piot P, Greenwood B, Chêne G, Neaton J, Yazdanpanah Y
Randomized Trial of Vaccines for Zaire Ebola Virus Disease.
The New England Journal of Medicine 2022, 387, 2411-2424.
Gessain A, Nakoune E, Yazdanpanah Y
Monkeypox.
The New England Journal of Medicine 2022, 387, 1783-1793.
Manry J, Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Michailidis E, Hoffmann HH, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Haljasmägi L, Migaud M, Särekannu K, Maslovskaja J, de Prost N, Tandjaoui-Lambiotte Y, Luyt CE, Amador-Borrero B, Gaudet A, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier JC, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux PL, Sene D, Stepanian A, Mégarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya JM, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Ozcelik T, Keles S, Bousfiha AA, El Bakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, van de Beek D, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau YL, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Venet F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari FS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Erikstrup C, Condino-Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, HGID Lab, COVID Clinicians, COVID-STORM Clinicians, NIAID Immune Response to COVID Group, NH-COVAIR Study Group, Danish CHGE, Danish Blood Donor Study, St. James's Hospital, SARS CoV2 Interest Group, French COVID Cohort Study Group, Imagine COVID-Group, Milieu Intérieur Consortium, CoV-Contact Cohort, Amsterdam UMC Covid-19 Biobank Investigators, COVID Human Genetic Effort, CP-COVID-19 Group, CONSTANCES cohort, 3C-Dijon Study, Cerba Health-Care, Etablissement Français du Sang Study group, Anderson MS, Boisson B, Béziat V, Zhang SY, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen TH, Rowen L, Mond J, Debette S, de Lamballerie X, Burdet C, Bouadma L, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Casanova JL, Abel L, Cobat A
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
Proceedings of the National Academy of Sciences of the United States of America 2022, 119, e2200413119.
Bouzid D, Mirault T, Ghazali A, Muller L, Casalino E, Peiffer Smadja N, Auber B, Guerin M, Sambet CH, Etienne I, De Lastours V, Badoual C, Lemogne C, Ruszniewski P, Université Paris Cité' Osce Study Group n, Faye A, Tran Dinh A
Feasibility of large-scale eOSCES: the simultaneous evaluation of 500 medical students during a mock examination.
Medical Education Online 2022, 27, 2084261.
Rienzo M, Skirecki T, Monneret G, Timsit JF
Immune checkpoint inhibitors for the treatment of sepsis:insights from preclinical and clinical development.
Expert Opinion on Investigational Drugs 2022, 31, 885-894.
Giacobbe DR, Roberts JA, Abdul-Aziz MH, de Montmollin E, Timsit JF, Bassetti M
Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective.
Expert Review of Anti-Infective Therapy 2022, 1-17.
Casalino E, Bouzid D, Antoniol S, Choquet C, Colosi L, Pereira L, Agbessi A, Kenway P, Yazdanpanah Y, Ghazali DA
Assessment of HIV-postexposure prophylaxis prescription quality after a training programme and assistance in decisions provided by a computer-based decision program: a cross-over study.
Acta Clinica Belgica 2022, 77, 495-509.
Timsit JF, Paul M, Shields RK, Echols R, Baba T, Yamano Y, Portsmouth S
Cefiderocol for the Treatment of Infections Due To Metallo-Beta-Lactamase-Producing Pathogens in the CREDIBLE-CR And APEKS-NP Phase 3 Randomized Studies.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2022, ciac078.
Eimer J, Fréchet-Jachym M, Le Dû D, Caumes E, El-Helali N, Marigot-Outtandy D, Mechai F, Peytavin G, Pourcher V, Rioux C, Yazdanpanah Y, Robert J, Guglielmetti L, LZDM group
Increased linezolid plasma concentrations are associated with the development of severe toxicity in MDR-TB treatment.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2022, ciac485.
Ghosn J, Assoumou L, Lascoux-Combe C, Peytavin G, Amat K, Gabassi A, Le MP, Nzalakanda R, Valin N, Landman R, Chaix ML, Delaugerre C
HIV-1 RNA Kinetics in Blood Plasma and in Seminal Plasma of Men Starting a Dolutegravir-Based Triple-Combination Regimen at the Time of Primary HIV-1 Infection.
The Journal of Infectious Diseases 2022, 225, 116-120.
Le Hingrat Q, Collin G, Damond F, Peytavin G, Lebourgeois S, Ghosn J, Bachelard A, Ferré VM, Matheron S, Descamps D, Charpentier C
In vitro analysis of the replicative capacity and phenotypic susceptibility to integrase inhibitors of HIV-2 mutants with integrase insertions.
The Journal of Antimicrobial Chemotherapy 2022, 77, 409-412.
Delory T, Le Bel J, Lariven S, Peiffer-Smadja N, Lescure FX, Bouvet E, Jeanmougin P, Tubach F, Boëlle PY
Computerized decision support system (CDSS) use for surveillance of antimicrobial resistance in urinary tract infections in primary care.
The Journal of Antimicrobial Chemotherapy 2022, 77, 524-530.
Lê MP, Ferré VM, Mazy F, Bourgeois-Moine A, Damond F, Matheron S, Descamps D, Ghosn J, Peytavin G
Bictegravir pharmacokinetics in a late-presenting HIV-1-infected pregnant woman: a case report.
The Journal of Antimicrobial Chemotherapy 2022, 77, 851-853.
Martin-Loeches I, Timsit JF, Kollef MH, Wunderink RG, Shime N, Nováček M, Kivistik Ü, Réa-Neto Á, Bruno CJ, Huntington JA, Lin G, Jensen EH, Motyl M, Yu B, Gates D, Butterton JR, Rhee EG
Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia.
The Journal of Antimicrobial Chemotherapy 2022, 77, 1166-1177.
Canouï E, Kerneis S, Morand P, Enser M, Gauzit R, Eyrolle L, Leclerc P, Contejean A, Zheng Y, Anract P, Hirt D, Treluyer JM, Bouazza N, Benaboud S
Oral levofloxacin: population pharmacokinetics model and pharmacodynamics study in bone and joint infections.
The Journal of Antimicrobial Chemotherapy 2022, 77, 1344-1352.
Lingas G, Néant N, Gaymard A, Belhadi D, Peytavin G, Hites M, Staub T, Greil R, Paiva JA, Poissy J, Peiffer-Smadja N, Costagliola D, Yazdanpanah Y, Wallet F, Gagneux-Brunon A, Mentré F, Ader F, Burdet C, Guedj J, Bouscambert-Duchamp M
Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial.
The Journal of Antimicrobial Chemotherapy 2022, 77, 1404-1412.
Buis DTP, Prins JM, Betica-Radic L, de Boer MGJ, Ekkelenkamp M, Kofteridis D, Peiffer-Smadja N, Schouten J, Spernovasilis N, Tattevin P, Ten Oever J, Sigaloff KCE
Current clinical practice in antibiotic treatment of Staphylococcus aureus bacteraemia: results from a survey in five European countries.
The Journal of Antimicrobial Chemotherapy 2022, 77, 2827-2834.
Breton G, Diallo OH, Cissé M, Diallo OH, Diallo NA, Soumaoro SA, Camara Y, Montoyo A, Rouzioux C, Koita Y, Peytavin G, Tubiana R, Frange P, ANRS 12344-DIAVINA study group
HIV stigma limits the effectiveness of PMTCT in Guinea: the ANRS 12344-DIAVINA study.
The Journal of Antimicrobial Chemotherapy 2022, 77, 3093-3101.
Grohs P, Vilfaillot A, Zahar JR, Barbut F, Frange P, Casetta A, Moulin V, Lawrence C, Baune P, Bourgeois C, Bouffier A, Laussucq C, Sienzonit L, Picard S, Podglajen I, Kassis-Chikhani N
Faecal carriage of multidrug-resistant bacteria and associated risk factors: results from a point prevalence study.
The Journal of Antimicrobial Chemotherapy 2022, 77, 2667-2678.
Liegeon G, Assoumou L, Ghosn J, El Mouhebb M, Palich R, Palacios C, Slama L, Surgers L, Genin M, Beniguel L, Goldwirt L, Duvivier C, Rojas Castro D, Costagliola D, Molina JM, ANRS-PREVENIR Study Group
Impact on renal function of daily and on-demand HIV pre-exposure prophylaxis in the ANRS-PREVENIR study.
The Journal of Antimicrobial Chemotherapy 2022, dkac336.
Hobson CA, Vigue L, Naimi S, Chassaing B, Magnan M, Bonacorsi S, Gachet B, El Meouche I, Birgy A, Tenaillon O
MiniBioReactor Array (MBRA) in vitro gut model: a reliable system to study microbiota-dependent response to antibiotic treatment.
JAC-antimicrobial resistance 2022, 4, dlac077.
Davido B, D'Anglejan E, Baudoin R, Dahmane L, Chaud A, Cortier M, Vauloup-Fellous C, De Truchis P, Ghosn J
Monkeypox outbreak 2022: an unusual case of peritonsillar abscess in a person previously vaccinated against smallpox.
Journal of Travel Medicine 2022, 29, taac082.
Pansu N, Le Moing V, Poizot-Martin I, Joly V, Allavena C, Hocqueloux L, Duvivier C, Lourenco J, Jovelin T, Reynes J, Makinson A
Pneumocystis jirovecii Pneumonia and Toxoplasmosis in PWH With HIV-Controlled Disease Treated for Solid Malignancies: A DAT'AIDS Study.
Open Forum Infectious Diseases 2022, 9, ofac109.
Delaugerre C, Assoumou L, Maylin S, Minier M, Gabassi A, Genin M, Beniguel L, Ghosn J, de Lamballerie X, El Mouhebb M, Costagliola D, Carrat F, Molina JM, PREVENIR and SAPRIS-Sero Study Groups
Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among HIV-Negative Participants Using Tenofovir/Emtricitabine-Based Preexposure Prophylaxis in 2020: A Substudy of the French National Agency for Research on AIDS and Viral Hepatitis PREVENIR and Inserm SAPRIS-Sero Cohorts.
Open Forum Infectious Diseases 2022, 9, ofac188.
De Castro N, Mechaï F, Bachelet D, Canestri A, Joly V, Vandenhende M, Boutoille D, Kerjouan M, Veziris N, Molina JM, Grall N, Tattevin P, Laouénan C, Yazdanpanah Y, FAST TB Study Group
Treatment With a Three-Drug Regimen for Pulmonary Tuberculosis Based on Rapid Molecular Detection of Isoniazid Resistance: A Noninferiority Randomized Trial (FAST-TB).
Open Forum Infectious Diseases 2022, 9, ofac353.
Le Pluart D, Ruyer-Thompson M, Ferré VM, Mailhe M, Descamps D, Bouscarat F, Lescure FX, Lucet JC, Yazdanpanah Y, Ghosn J
A Healthcare-Associated Infection With Monkeypox Virus of a Healthcare Worker During the 2022 Outbreak.
Open Forum Infectious Diseases 2022, 9, ofac520.
Abid S, Papin G, Vellieux G, de Montmollin E, Wicky PH, Patrier J, Jaquet P, Bouadma L, Rouvel-Tallec A, Timsit JF, Sonneville R
A Simplified Electroencephalography Montage and Interpretation for Evaluation of Comatose Patients in the ICU.
Critical Care Explorations 2022, 4, e0781.
Vacheron CH, Lepape A, Savey A, Machut A, Timsit JF, Vanhems P, Le QV, Egbeola J, Martin M, Maxime V, Pugliesi PS, Maucort-Boulch D, Friggeri A, REA-REZO Study Group
Increased Incidence of Ventilator-Acquired Pneumonia in Coronavirus Disease 2019 Patients: A Multicentric Cohort Study.
Critical Care Medicine 2022, 50, 449-459.
de Montmollin E, Dupuis C, Jaquet P, Sarton B, Sazio C, Susset V, Conrad M, Argaud L, Demeret S, Tadié JM, Barbier F, Wolff M, Timsit JF, Visseaux B, Sonneville R, ENCEPHALITICA Study Group
Herpes Simplex Virus Encephalitis With Initial Negative Polymerase Chain Reaction in the Cerebrospinal Fluid: Prevalence, Associated Factors, and Clinical Impact.
Critical Care Medicine 2022, 50, e643-e648.
Jaquet P, Legouy C, Le Fevre L, Grinea A, Sinnah F, Franchineau G, Patrier J, Marzouk M, Wicky PH, Alexis Geoffroy P, Arnoult F, Vledouts S, de Montmollin E, Bouadma L, Timsit JF, Sharshar T, Sonneville R
Neurologic Outcomes of Survivors of COVID-19-Associated Acute Respiratory Distress Syndrome Requiring Intubation.
Critical Care Medicine 2022, 50, e674-e682.
Guerra D, Vidal P, Paccoud O, Maillard A, Cachera L, Junot H, Gauzit R, Zahar JR, Abreu MA, Bleibtreu A
Dual beta-lactam treatment: Pros and cons.
Porto Biomedical Journal 2022, 7, e189.
Thy M, Gaudemer A, Vellieux G, Sonneville R
Critical care management of meningitis and encephalitis: an update.
Current Opinion in Critical Care 2022, 28, 486-494.
Durier C, Mercier-Delarue S, Verdière NCD, Meiffrédy V, Matheron S, Samri A, Resch M, Marchand L, Autran B, Launay O, Simon F, ANRS NOVAA EP46 study group
A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults.
AIDS (London, England) 2022, 36, 319-321.
Hassold N, Brichler S, Ouedraogo E, Leclerc D, Carroue S, Gater Y, Alloui C, Carbonnelle E, Bouchaud O, Mechai F, Cordel H, Delagreverie H
Impaired antibody response to COVID-19 vaccination in advanced HIV infection.
AIDS (London, England) 2022, 36, F1-F5.
Le Hingrat Q, Collin G, Bachelard A, Ghosn J, Chalal S, Pacanowski J, Peytavin G, Weinheimer S, Marsolais C, Damond F, Matheron S, Charpentier C, Descamps D, and the ANRS CO5 HIV-2 cohort
Ibalizumab shows in vitro activity against group A and group B HIV-2 clinical isolates.
AIDS (London, England) 2022
Pourcher V, Capeau J, Dudoit Y, Boccara F, Soulié C, Ndoadoumgue AL, Charlotte F, Fellahi S, Bastard JP, Béréziat V, Lagathu C, Marcelin AG, Peytavin G, Boutron-Ruault MC, Tubbax C, D'Avout D'Auerstaedt A, Valantin MA, Schneider L, Costagliola D, Katlama C, Assoumou L, Pourcher G
Comparison of HIV-infected and non-infected patients undergoing bariatric surgery: the ObeVIH study.
Journal of Acquired Immune Deficiency Syndromes (1999) 2022
Kherabi Y, de Castro N, Sellier PO, Hamet G, Brun A, Méchaï F, Joly V, Yazdanpanah Y, Molina JM
Efficacy and safety of efavirenz, raltegravir and dolutegravir in HIV-1/TB co-infection. A multicenter retrospective cohort study in France.
Journal of Acquired Immune Deficiency Syndromes (1999) 2022
Wicky PH, d'Humières C, Timsit JF
How common is ventilator-associated pneumonia after coronavirus disease 2019?.
Current Opinion in Infectious Diseases 2022, 35, 170-175.
Zahar JR, Timsit JF
Risk stratification for selecting empiric antibiotherapy during and after COVID-19.
Current Opinion in Infectious Diseases 2022, 35, 605-613.
Chotard E, Jacquier H, Bart G, Richette P, Rioux C, Joly V, Goossens J, Palazzo E, Forien M, Jelin G, Yazdanpanah Y, Dieudé P, Le Goff B, Ottaviani S
MRI Features Associated With the Detection of Microbial Pathogens by CT-Guided Biopsy in Septic Spondylodiscitis.
Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases 2022, 28, e189-e194.
Alkhalil R, Ouersighni A, Kenway P, Breque C, Oriot D, Ghazali DA
Impact of a Multidisciplinary Simulation-Based Training Program on the Multiple Techniques of Intraosseous Access: A Prospective Multicentric Study.
Simulation in Healthcare: Journal of the Society for Simulation in Healthcare 2022
Bienvenu AL, Pavese P, Leboucher G, Berger P, Roux S, Charmillon A, Foroni L, Menotti J, Lebeaux D, Mayan R, Mondain V, Robin C, Lesprit P, Alfandari S, Kernéis S
Practical checklist for implementation of antifungal stewardship programmes.
Journal of Medical Microbiology 2022, 71,
Henriot P, Castry M, Luong Nguyen LB, Shimakawa Y, Jean K, Temime L
Meta-analysis: Risk of hepatitis C virus infection associated with hospital-based invasive procedures.
Alimentary Pharmacology & Therapeutics 2022
Demouche S, Juge PA, Charles P, Descamps V, Benali K, Brunet-Possenti F
Safe use of tocilizumab in rheumatic patients with Kaposi's sarcoma.
Dermatologic Therapy 2022, 35, e15797.
Valade S, Picard M, Mokart D, Calvet L, Bruneel F, de Montmollin E, Aissaoui N, Champigneulle B, Bigé N, Boissier F, Pène F, Mayaux J, Argaud L, Moreau AS, Murgier M, Azoulay E, Darmon M
Critically ill patients with severe infections related to Geotrichum species: A French retrospective multicentre study.
Mycoses 2022, 65, 226-232.
Mageau A, Borie R, Crestani B, Timsit JF, Papo T, Sacre K
Epidemiology of interstitial lung disease in systemic lupus erythematosus in France: A nation-wide population-based study over 10 years.
Respirology (Carlton, Vic.) 2022
Kherabi Y, Messika J, Peiffer-Smadja N
Machine learning, antimicrobial stewardship, and solid organ transplantation: Is this the future?.
Transplant Infectious Disease: An Official Journal of the Transplantation Society 2022, 24, e13957.
Lapaillerie D, Charlier C, Guyonnet-Dupérat V, Murigneux E, Fernandes HS, Martins FG, Magalhães RP, Vieira TF, Richetta C, Subra F, Lebourgeois S, Charpentier C, Descamps D, Visseaux B, Weigel P, Favereaux A, Beauvineau C, Buron F, Teulade-Fichou MP, Routier S, Gallois-Montbrun S, Meertens L, Delelis O, Sousa SF, Parissi V
Selection of Bis-Indolyl Pyridines and Triphenylamines as New Inhibitors of SARS-CoV-2 Cellular Entry by Modulating the Spike Protein/ACE2 Interfaces.
Antimicrobial Agents and Chemotherapy 2022, 66, e0008322.
Hobson CA, Pierrat G, Tenaillon O, Bonacorsi S, Bercot B, Jaouen E, Jacquier H, Birgy A
Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview.
Antimicrobial Agents and Chemotherapy 2022, 66, e0044722.
Richetta C, Subra F, Malet I, Leh H, Charpentier C, Corona A, Collin G, Descamps D, Deprez E, Parissi V, Calvez V, Tramontano E, Marcelin AG, Delelis O
Mutations in the 3'-PPT Lead to HIV-1 Replication without Integration.
Journal of Virology 2022, 96, e0067622.
Ferré VM, Peiffer-Smadja N, Kramer L, Coppée R, Kante A, Debarge M, Choquet C, Saint Joannis T, Bouzid D, Messika J, Le Grand J, Thy M, Kernéis S, Descamps D, Visseaux B, Ghosn J
Dual Monoclonal Antibodies on Sars-Cov-2 Alpha and Delta Variants: Clinical and Virological Efficacy.
Microbiology Spectrum 2022, 10, e0215222.
Lo S, Lolom I, Goldstein V, Petitjean M, Rondinaud E, Bunel-Gourdy V, Tran Dinh A, Wicky PH, Ruppé E, d'Humières C, Lucet JC, Armand-Lefèvre L
Simultaneous Hospital Outbreaks of New Delhi Metallo-β-Lactamase-Producing Enterobacterales Unraveled Using Whole-Genome Sequencing.
Microbiology Spectrum 2022, 10, e0228721.
Mageau A, Papo T, Ruckly S, Strukov A, van Gysel D, Sacre K, Timsit JF
Survival after COVID-19-associated organ failure among inpatients with systemic lupus erythematosus in France: a nationwide study.
Annals of the Rheumatic Diseases 2022, 81, 569-574.
Mageau A, Ferré VM, Goulenok T, Charpentier C, Delory N, Francois C, Houhou-Fidouh N, Papo T, Descamps D, Sacre K
Severely impaired humoral response against SARS-CoV-2 variants of concern following two doses of BNT162b2 vaccine in patients with systemic lupus erythematosus (SLE).
Annals of the Rheumatic Diseases 2022, 81, 1194-1196.
Plaçais L, Dalle S, Dereure O, Trabelsi S, Dalac S, Legoupil D, Montaudié H, Arnault JP, De Quatrebarbes J, Saiag P, Brunet-Possenti F, Lesimple T, Maubec E, Aubin F, Granel-Brocard F, Grob JJ, Stoebner PE, Allayous C, Oriano B, Dutriaux C, Mortier L, Lebbe C
Risk of irAEs in patients with autoimmune diseases treated by immune checkpoint inhibitors for stage III or IV melanoma: results from a matched case-control study.
Annals of the Rheumatic Diseases 2022, 81, 1445-1452.
Legrand M, Fong N, Laouénan C, Ghosn J, Thill B, Faure K, Garot D, Goujard C, Curlier E, Resche-Rigon M, Rossignol P, Pirracchio R
Risk factors of long term symptoms and outcomes among patients discharged after covid-19: prospective, multicentre observational study.
BMJ medicine 2022, 1, e000093.
Labbe V, Contou D, Heming N, Megarbane B, Ait-Oufella H, Boissier F, Carreira S, Robert A, Vivier E, Fejjal M, Doyen D, Monchi M, Preau S, Noel-Savina E, Souweine B, Zucman N, Picos SA, Dres M, Juguet W, Mariotte E, Timsit JF, Turpin M, Razazi K, Gendreau S, Baloul S, Voiriot G, Fartoukh M, Audureau E, Mekontso Dessap A
Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trial.
BMJ open 2022, 12, e059383.
Vacheron CH, Lepape A, Savey A, Machut A, Timsit JF, Comparot S, Courno G, Vanhems P, Landel V, Lavigne T, Bailly S, Bettega F, Study Group RR, Maucort-Boulch D, Friggeri A
Attributable Mortality of Ventilator-associated Pneumonia Among COVID-19 Patients.
American Journal of Respiratory and Critical Care Medicine 2022
Guglielmetti L, Günther G, Leu C, Cirillo D, Duarte R, Garcia-Basteiro AL, Goletti D, Jankovic M, Kuksa L, Maurer FP, Méchaï F, Tiberi S, van Leth F, Veziris N, Lange C, Study Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC), European Society of Mycobacteriology (ESM), European Respiratory Society (ERS) and, Tuberculosis Network European Trials group (TBnet)
Rifapentine access in Europe: growing concerns over key tuberculosis treatment component.
The European Respiratory Journal 2022, 59, 2200388.
Beurnier A, Yordanov Y, Dechartres A, Dinh A, Debuc E, Lescure FX, Jourdain P, Jaulmes L, Humbert M
Characteristics and outcomes of asthmatic outpatients with COVID-19 who receive home telesurveillance.
ERJ open research 2022, 8, 00012-2022.
Chevret S, Timsit JF, Biard L
Challenges of using external data in clinical trials- an illustration in patients with COVID-19.
BMC medical research methodology 2022, 22, 321.
Martin-Blondel G, Lescure FX, Assoumou L, Charpentier C, Chapplain JM, Perpoint T, Grouteau G, Cordel H, Pialoux G, Pacanowski J, Thy M, Bauvois A, Laureillard D, Hamrouni F, Algarte-Genin M, Poissy J, Descamps D, Costagliola D, CoCliCo Study Group
Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study.
BMC infectious diseases 2022, 22, 540.
Tran-Dinh A, Bouzid D, El Kalai A, Atchade E, Tanaka S, Lortat-Jacob B, Jean-Baptiste S, Zappella N, Boudinet S, Castier Y, Mal H, Mordant P, Messika J, Montravers P
Favorable, arduous or fatal postoperative pathway within 90 days of lung transplantation.
BMC pulmonary medicine 2022, 22, 326.
Fasse L, Roche N, Flahault C, Garrouste-Orgeas M, Ximenes M, Pages A, Evin A, Dauchy S, Scotte F, Le Provost JB, Blot F, Mateus C
The APSY-SED study: protocol of an observational, longitudinal, mixed methods and multicenter study exploring the psychological adjustment of relatives and healthcare providers of patients with cancer with continuous deep sedation until death.
BMC palliative care 2022, 21, 217.
Bouzid D, Mullaert J, Ghazali A, Ferré VM, Mentré F, Lemogne C, Ruszniewski P, Faye A, Dinh AT, Mirault T, Université Paris Cité Osce study group
eOSCE stations live versus remote evaluation and scores variability.
BMC medical education 2022, 22, 861.
Hedible GB, Louart S, Neboua D, Catala L, Anago G, Sawadogo AG, Kargougou GD, Meda B, Kolié JS, Hema A, Keita S, Niome M, Savadogo AS, Peters-Bokol L, Agbeci H, Zair Z, Lenaud S, Vignon M, Ouedraogo Yugbare S, Abarry H, Diakite AA, Diallo IS, Lamontagne F, Briand V, Dahourou DL, Cousien A, Ridde V, Leroy V, AIRE Research Study Group
Evaluation of the routine implementation of pulse oximeters into integrated management of childhood illness (IMCI) guidelines at primary health care level in West Africa: the AIRE mixed-methods research protocol.
BMC health services research 2022, 22, 1579.
Bosetti P, Tran Kiem C, Andronico A, Colizza V, Yazdanpanah Y, Fontanet A, Benamouzig D, Cauchemez S
Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France.
BMC medicine 2022, 20, 33.
Coppée R, Mama A, Sarrasin V, Kamaliddin C, Adoux L, Palazzo L, Ndam NT, Letourneur F, Ariey F, Houzé S, Clain J
5WBF: a low-cost and straightforward whole blood filtration method suitable for whole-genome sequencing of Plasmodium falciparum clinical isolates.
Malaria Journal 2022, 21, 51.
Thouy F, Bohé J, Souweine B, Abidi H, Quenot JP, Thiollière F, Dellamonica J, Preiser JC, Timsit JF, Brunot V, Klich A, Sedillot N, Tchenio X, Roudaut JB, Mottard N, Hyvernat H, Wallet F, Danin PE, Badie J, Jospe R, Morel J, Mofredj A, Fatah A, Drai J, Mialon A, Ait Hssain A, Lautrette A, Fontaine E, Vacheron CH, Maucort-Boulch D, Klouche K, Dupuis C
Impact of prolonged requirement for insulin on 90-day mortality in critically ill patients without previous diabetic treatments: a post hoc analysis of the CONTROLING randomized control trial.
Critical Care (London, England) 2022, 26, 138.
Iachkine J, Buetti N, de Grooth HJ, Briant AR, Mimoz O, Mégarbane B, Mira JP, Ruckly S, Souweine B, du Cheyron D, Mermel LA, Timsit JF, Parienti JJ
Development and validation of a multivariable prediction model of central venous catheter-tip colonization in a cohort of five randomized trials.
Critical Care (London, England) 2022, 26, 205.
Patrier J, Villageois-Tran K, Szychowiak P, Ruckly S, Gschwind R, Wicky PH, Gueye S, Armand-Lefevre L, Marzouk M, Sonneville R, Bouadma L, Petitjean M, Lamara F, de Montmollin E, Timsit JF, Ruppé E, French COVID Cohort Study Group
Oropharyngeal and intestinal concentrations of opportunistic pathogens are independently associated with death of SARS-CoV-2 critically ill adults.
Critical Care (London, England) 2022, 26, 300.
Buetti N, Tabah A, Loiodice A, Ruckly S, Aslan AT, Montrucchio G, Cortegiani A, Saltoglu N, Kayaaslan B, Aksoy F, Murat A, Akdoğan Ö, Saracoglu KT, Erdogan C, Leone M, Ferrer R, Paiva JA, Hayashi Y, Ramanan M, Conway Morris A, Barbier F, Timsit JF, Eurobact 2 study group
Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study.
Critical Care (London, England) 2022, 26, 319.
Blet A, McNeil JB, Josse J, Cholley B, Cinotti R, Cotter G, Dauvergne A, Davison B, Duarte K, Duranteau J, Fournier MC, Gayat E, Jaber S, Lasocki S, Merkling T, Peoc'h K, Mayer I, Sadoune M, Laterre PF, Sonneville R, Ware L, Mebazaa A, Kimmoun A
Association between in-ICU red blood cells transfusion and 1-year mortality in ICU survivors.
Critical Care (London, England) 2022, 26, 307.
Kollef MH, Timsit JF, Martin-Loeches I, Wunderink RG, Huntington JA, Jensen EH, Yu B, Bruno CJ
Outcomes in participants with failure of initial antibacterial therapy for hospital-acquired/ventilator-associated bacterial pneumonia prior to enrollment in the randomized, controlled phase 3 ASPECT-NP trial of ceftolozane/tazobactam versus meropenem.
Critical Care (London, England) 2022, 26, 373.
Soum E, Timsit JF, Ruckly S, Gruson D, Canet E, Klouche K, Argaud L, Garrouste-Orgeas M, Mariat C, Vincent F, Cayot S, Darmon M, Bohé J, Schwebel C, Bouadma L, Dupuis C, Souweine B, Lautrette A
Predictive factors for severe long-term chronic kidney disease after acute kidney injury requiring renal replacement therapy in critically ill patients: an ancillary study of the ELVIS randomized controlled trial.
Critical Care (London, England) 2022, 26, 367.
Goletto T, Decaux S, Bunel V, Weisenburger G, Messika J, Najem S, Medraoui C, Godet C, Debray MP, Lortat-Jacob B, Mordant P, Castier Y, Bouadma L, Borie R, Mal H
Acute worsening of native lung fibrosis after single lung transplantation for pulmonary fibrosis: two case reports.
Journal of Medical Case Reports 2022, 16, 2.
Ghazali DA, Kenway P, Choquet C, Casalino E
Early diagnosis of sepsis using an E-health application for a clinical early warning system outside of the intensive care unit: a case report.
Journal of Medical Case Reports 2022, 16, 185.
Szychowiak P, Villageois-Tran K, Patrier J, Timsit JF, Ruppé É
The role of the microbiota in the management of intensive care patients.
Annals of Intensive Care 2022, 12, 3.
Egea A, Dupuis C, de Montmollin E, Wicky PH, Patrier J, Jaquet P, Lefèvre L, Sinnah F, Marzouk M, Sonneville R, Bouadma L, Souweine B, Timsit JF
Augmented renal clearance in the ICU: estimation, incidence, risk factors and consequences-a retrospective observational study.
Annals of Intensive Care 2022, 12, 88.
Rambaud T, de Montmollin E, Jaquet P, Gaudemer A, Mariotte E, Abid S, Para M, Cimadevilla C, Iung B, Duval X, Wolff M, Bouadma L, Timsit JF, Sonneville R
Cerebrovascular complications and outcomes of critically ill adult patients with infective endocarditis.
Annals of Intensive Care 2022, 12, 119.
Ravalihasy A, Kardaś-Słoma L, Yazdanpanah Y, Ridde V
Quantitative methods used to evaluate impact of health promotion interventions to prevent HIV infections: a methodological systematic review protocol.
Systematic Reviews 2022, 11, 87.
Eyebe S, Nana-Djeunga HC, Guewo-Fokeng M, Wafeu GS, Vouking MZ, Massoda S, Evina CD, Zoumabo AC, Ongolo-Zogo P, Zahar JR
Risk factors for colonization and infection with multidrug-resistant Pseudomonas aeruginosa in intensive care unit: protocol for a systematic review and meta-analysis.
Systematic Reviews 2022, 11, 270.
Berthod D, Alvarez D, Perozziello A, Chabrol F, Lucet JC
Are there reasons behind high Handrub consumption? A French National in-depth qualitative assessment.
Antimicrobial Resistance and Infection Control 2022, 11, 42.
Contejean A, Abbara S, Chentouh R, Alviset S, Grignano E, Gastli N, Casetta A, Willems L, Canouï E, Charlier C, Pène F, Charpentier J, Reboul-Marty J, Batista R, Bouscary D, Kernéis S
Antimicrobial stewardship in high-risk febrile neutropenia patients.
Antimicrobial Resistance and Infection Control 2022, 11, 52.
Kardaś-Słoma L, Fournier S, Dupont JC, Rochaix L, Birgand G, Zahar JR, Lescure FX, Kernéis S, Durand-Zaleski I, Lucet JC
Cost-effectiveness of strategies to control the spread of carbapenemase-producing Enterobacterales in hospitals: a modelling study.
Antimicrobial Resistance and Infection Control 2022, 11, 117.
Durand C, Douriez E, Chappuis A, Poulain F, Yazdanpanah Y, Lariven S, Lescure FX, Peiffer-Smadja N
Contributions and challenges of community pharmacists during the COVID-19 pandemic: a qualitative study.
Journal of Pharmaceutical Policy and Practice 2022, 15, 43.
Girod M, Dalle S, Mortier L, Dalac S, Leccia MT, Dutriaux C, Montaudié H, de Quatrebarbes J, Lesimple T, Brunet-Possenti F, Saiag P, Maubec E, Legoupil D, Stoebner PE, Arnault JP, Lefevre W, Lebbe C, Dereure O
Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National Cohort.
JCO precision oncology 2022, 6, e2200075.
Kherabi Y, Mollo B, Gerard S, Lescure FX, Rioux C, Yazdanpanah Y
Patient-centered approach to the management of drug-resistant tuberculosis in France: How far off the mark are we?.
PLOS global public health 2022, 2, e0000313.
Béraud G, Timsit JF, Leleu H
Remdesivir and dexamethasone as tools to relieve hospital care systems stressed by COVID-19: A modelling study on bed resources and budget impact.
PloS One 2022, 17, e0262462.
Flahault C, Vioulac C, Fasse L, Bailly S, Timsit JF, Garrouste-Orgeas M
"A story with gaps": An interpretative phenomenological analysis of ICU survivors' experience.
PloS One 2022, 17, e0264310.
Grandjean D, Elie C, Gallet C, Julien C, Roger V, Desquilbet L, Alvergnat G, Delarue S, Gabassi A, Minier M, Choupeaux L, Kerneis S, Delaugerre C, LE Goff J, Treluyer JM
Diagnostic accuracy of non-invasive detection of SARS-CoV-2 infection by canine olfaction.
PloS One 2022, 17, e0268382.
Tanaka S, De Tymowski C, Stern J, Bouzid D, Zappella N, Snauwaert A, Robert T, Lortat-Jacob B, Tran-Dinh A, Augustin P, Boutten A, Tashk P, Peoc'h K, Meilhac O, Montravers P
Relationship between liver dysfunction, lipoprotein concentration and mortality during sepsis.
PloS One 2022, 17, e0272352.
Vaittinada Ayar P, Taillé C, Vaittinada Ayar P, Gay M, Diallo A, Dara AF, Peyrony O, Chassany O, Casalino E
Assessment of Predictor Factors Associated with Multiple Emergency Department Attendance with Asthma Attack: A Qualitative and Multicentric Prospective Observational Study.
Journal of Asthma and Allergy 2022, 15, 303-313.
Gérardin C, Mageau A, Mékinian A, Tannier X, Carrat F
Construction of Cohorts of Similar Patients From Automatic Extraction of Medical Concepts: Phenotype Extraction Study.
JMIR medical informatics 2022, 10, e42379.
Bouiller K, Peiffer-Smadja N, Cevik M, Last K, Antunović IA, Šterbenc A, Lopes MJ, Barac A, Schweitzer V, Dellière S
Role and perception of clinical microbiology and infectious diseases trainees during the COVID-19 crisis.
Future Microbiology 2022, 17, 411-416.
Rapin A, Boyer FC, Mourvillier B, Giordano Orsini G, Launois C, Taiar R, Deslee G, Goury A, Carazo-Mendez S
Post-Intensive Care Syndrome Prevalence Six Months after Critical Covid-19: Comparison between First and Second Waves.
Journal of Rehabilitation Medicine 2022, 54, jrm00339.
Piezzi V, Wassilew N, Atkinson A, D'Incau S, Kaspar T, Seth-Smith HM, Casanova C, Bittel P, Jent P, Sommerstein R, Buetti N, Marschall J
Nosocomial outbreak of vancomycin-resistant Enterococcus faecium (VRE) ST796, Switzerland, 2017 to 2020.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2022, 27, 2200285.
Jordans CCE, Vasylyev M, Rae C, Jakobsen ML, Vassilenko A, Dauby N, Grevsen AL, Jakobsen SF, Raahauge A, Champenois K, Papot E, Malin JJ, Boender TS, Behrens GMN, Gruell H, Neumann A, Spinner CD, Valbert F, Akinosoglou K, Kostaki EG, Nozza S, Giacomelli A, Lapadula G, Mazzitelli M, Torti C, Matulionyte R, Matulyte E, Van Welzen BJ, Hensley KS, Thompson M, Ankiersztejn-Bartczak M, Skrzat-Klapaczyńska A, Săndulescu O, Streinu-Cercel A, Streinu-Cercel A, Miron VD, Pokrovskaya A, Hachfeld A, Dorokhina A, Sukach M, Lord E, Sullivan AK, Rokx C, Guidelines Review Group for the projects: Optimising testing and linkage to care for HIV across Europe (OptTEST by HiE) and the Joint Action on integrating prevention, testing and linkage to care strategies across HIV, viral hepatitis, TB and STIs in Euro
National medical specialty guidelines of HIV indicator conditions in Europe lack adequate HIV testing recommendations: a systematic guideline review.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2022, 27, 2200338.
Alizon S, Selinger C, Sofonea MT, Haim-Boukobza S, Giannoli JM, Ninove L, Pillet S, Thibault V, de Rougemont A, Tumiotto C, Solis M, Stephan R, Bressollette-Bodin C, Salmona M, L'Honneur AS, Behillil S, Lefeuvre C, Dina J, Hantz S, Hartard C, Veyer D, Delagrèverie HM, Fourati S, Visseaux B, Henquell C, Lina B, Foulongne V, Burrel S, SFM COVID-19 study group
Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2022, 27,
Shirreff G, Zahar JR, Cauchemez S, Temime L, Opatowski L, EMEA-MESuRS Working Group on the Nosocomial Modelling of SARS-CoV-22
Measuring Basic Reproduction Number to Assess Effects of Nonpharmaceutical Interventions on Nosocomial SARS-CoV-2 Transmission.
Emerging Infectious Diseases 2022, 28, 1345-1354.
Kherabi Y, Fréchet-Jachym M, Rioux C, Yazdanpanah Y, Méchaï F, Pourcher V, Robert J, Guglielmetti L, MDR-TB Management Group
Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006-2019.
Emerging Infectious Diseases 2022, 28, 1796-1804.
Lebourgeois S, David A, Chenane HR, Granger V, Menidjel R, Fidouh N, Noël B, Delelis O, Richetta C, Charpentier C, Chollet-Martin S, Descamps D, Visseaux B, de Chaisemartin L
Differential activation of human neutrophils by SARS-CoV-2 variants of concern.
Frontiers in Immunology 2022, 13, 1010140.
d'Humières C, Gaïa N, Gueye S, de Lastours V, Leflon-Guibout V, Maataoui N, Duprilot M, Lecronier M, Rousseau MA, Gamany N, Lescure FX, Senard O, Deconinck L, Dollat M, Isernia V, Le Hur AC, Petitjean M, Nazimoudine A, Le Gac S, Chalal S, Ferreira S, Lazarevic V, Guigon G, Gervasi G, Armand-Lefèvre L, Schrenzel J, Ruppé E
Contribution of Clinical Metagenomics to the Diagnosis of Bone and Joint Infections.
Frontiers in Microbiology 2022, 13, 863777.
Alcouffe L, Huber F, Creton PM, Bitan L, Gonzalez A, Volpellier M, Panfili B, Adenis A, Vignier N
Sexual vulnerability of migrant women in the multicultural context of French Guiana: A societal issue.
Frontiers in Public Health 2022, 10, 934049.
Vignier N, Moussaoui S, Marsaudon A, Wittwer J, Jusot F, Dourgnon P
Burden of infectious diseases among undocumented migrants in France: Results of the Premiers Pas survey.
Frontiers in Public Health 2022, 10, 934050.
Goupil de Bouillé J, Luong Nguyen LB, Crépey P, Garlantezec R, Doré V, Dumas A, Ben Mechlia M, Tattevin P, Gaudart J, Spire B, Lert F, Yazdanpanah Y, Delaugerre C, Noret M, Zeggagh J
Transmission of SARS-CoV-2 during indoor clubbing events: A clustered randomized, controlled, multicentre trial protocol.
Frontiers in Public Health 2022, 10, 981213.
Saliba R, Mizrahi A, Gauthier PdP, Alban LM, Zahar JR, Pilmis B
Antimicrobial Stewardship Program: Reducing Antibiotic's Spectrum of Activity Is not the Solution to Limit the Emergence of Multidrug-Resistant Bacteria.
Antibiotics (Basel, Switzerland) 2022, 11, 70.
Timsit JF, Wicky PH, de Montmollin E
Treatment of Severe Infections Due to Metallo-Betalactamases Enterobacterales in Critically Ill Patients.
Antibiotics (Basel, Switzerland) 2022, 11, 144.
Chaïbi K, Péan de Ponfilly G, Dortet L, Zahar JR, Pilmis B
Empiric Treatment in HAP/VAP: "Don't You Want to Take a Leap of Faith?".
Antibiotics (Basel, Switzerland) 2022, 11, 359.
Tabah A, Lipman J, Barbier F, Buetti N, Timsit JF, On Behalf Of The Escmid Study Group For Infections In Critically Ill Patients-Esgcip n
Use of Antimicrobials for Bloodstream Infections in the Intensive Care Unit, a Clinically Oriented Review.
Antibiotics (Basel, Switzerland) 2022, 11, 362.
Durand C, Alfandari S, Béraud G, Tsopra R, Lescure FX, Peiffer-Smadja N
Clinical Decision Support Systems for Antibiotic Prescribing: An Inventory of Current French Language Tools.
Antibiotics (Basel, Switzerland) 2022, 11, 384.
de Montmollin E, Peoc'h K, Marzouk M, Ruckly S, Wicky PH, Patrier J, Jaquet P, Sonneville R, Bouadma L, Timsit JF
Mid-Regional Pro-Adrenomedullin as a Prognostic Factor for Severe COVID-19 ARDS.
Antibiotics (Basel, Switzerland) 2022, 11, 1166.
Pajot O, Lakhal K, Lambert J, Gros A, Bruel C, Boulain T, Garot D, Das V, Timsit JF, Cerf C, Souweine B, Chaffaut C, Mentec H, Zahar JR, Mira JP, Jullien V
Empirical Antibiotic Therapy for Gram-Negative Bacilli Ventilator-Associated Pneumonia: Observational Study and Pharmacodynamic Assessment.
Antibiotics (Basel, Switzerland) 2022, 11, 1664.
Magréault S, Jauréguy F, Carbonnelle E, Zahar JR
When and How to Use MIC in Clinical Practice?.
Antibiotics (Basel, Switzerland) 2022, 11, 1748.
Delhommeau G, Buetti N, Neuville M, Siami S, Cohen Y, Laurent V, Mourvillier B, Reignier J, Goldgran-Toledano D, Schwebel C, Ruckly S, de Montmollin E, Souweine B, Timsit JF, Dupuis C
Bacterial Pulmonary Co-Infections on ICU Admission: Comparison in Patients with SARS-CoV-2 and Influenza Acute Respiratory Failure: A Multicentre Cohort Study.
Biomedicines 2022, 10, 2646.
Kandel M, Bardet A, Dalle S, Allayous C, Mortier L, Guillot B, Dutriaux C, Leccia MT, Dalac S, Montaudie H, Saiag P, Legoupil D, Brunet-Possenti F, Arnault JP, Quatrebarbes JD, Beylot-Barry M, Maubec E, Lesimple T, Aubin F, Grob JJ, Granel-Brocard F, Stoebner PE, Dupuy A, Dreno B, Michiels S, Lebbe C, Borget I
Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in France.
Current Oncology (Toronto, Ont.) 2022, 29, 9255-9270.
Ousseine YM, Vaux S, Vandentorren S, Bonmarin I, Champenois K, Lydié N, Velter A
Predictors of Uncertainty and Unwillingness to Receive the COVID-19 Vaccine in Men Who Have Sex with Men in France.
International Journal of Environmental Research and Public Health 2022, 19, 5372.
Arnaud E, Elbattah M, Ammirati C, Dequen G, Ghazali DA
Use of Artificial Intelligence to Manage Patient Flow in Emergency Department during the COVID-19 Pandemic: A Prospective, Single-Center Study.
International Journal of Environmental Research and Public Health 2022, 19, 9667.
Zerbit J, Detroit M, Chevret S, Pene F, Luyt CE, Ghosn J, Eyvrard F, Martin-Blondel G, Sarton B, Clere-Jehl R, Moine P, Cransac A, Andreu P, Labruyère M, Albertini L, Huon JF, Roge P, Bernard L, Farines-Raffoul M, Villiet M, Venet A, Dumont LM, Kaiser JD, Chapuis C, Goehringer F, Barbier F, Desjardins S, Benzidi Y, Abbas N, Guerin C, Batista R, Llitjos JF, Kroemer M
Remdesivir for Patients Hospitalized with COVID-19 Severe Pneumonia: A National Cohort Study (Remdeco-19).
Journal of Clinical Medicine 2022, 11, 6545.
Paccoud O, Vignier N, Boui M, Migaud M, Vironneau P, Kania R, Méchaï F, Brun S, Alanio A, Tauziède-Espariat A, Adle-Biassette H, Ouedraogo E, Bustamante J, Bouchaud O, Casanova JL, Puel A, Lanternier F
Invasive Rhinosinusitis Caused by Alternaria infectoria in a Patient with Autosomal Recessive CARD9 Deficiency and a Review of the Literature.
Journal of Fungi (Basel, Switzerland) 2022, 8, 446.
Billard-Pomares T, Marin J, Quagliaro P, Méchaï F, Walewski V, Dziri S, Carbonnelle E
Use of Whole-Genome Sequencing to Explore Mycobacterium tuberculosis Complex Circulating in a Hotspot Department in France.
Microorganisms 2022, 10, 1586.
Fourati S, Audureau E, Arrestier R, Marot S, Dubois C, Voiriot G, Luyt CE, Urbina T, Mayaux J, Roque-Afonso AM, Pham T, Landraud L, Visseaux B, Roux D, Bellaiche R, L'honneur AS, Ait Hamou Z, Brichler S, Gaudry S, Salmona M, Clere-Jehl R, Azoulay E, Morand-Joubert L, Marcelin AG, Chaix ML, Descamps D, Mekontso Dessap A, Rodriguez C, Pawlotsky JM, de Prost N
SARS-CoV-2 Genomic Characteristics and Clinical Impact of SARS-CoV-2 Viral Diversity in Critically Ill COVID-19 Patients: A Prospective Multicenter Cohort Study.
Viruses 2022, 14, 1529.
Bouzid D, Visseaux B, Kassasseya C, Daoud A, Fémy F, Hermand C, Truchot J, Beaune S, Javaud N, Peyrony O, Chauvin A, Vaittinada Ayar P, Bourg A, Riou B, Marot S, Bloom B, Cachanado M, Simon T, Freund Y, IMProving Emergency Care (IMPEC) FHU Collaborators Group
Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments : A Retrospective Cohort Study.
Annals of Internal Medicine 2022, 175, 831-837.
Johnson MG, Puenpatom A, Moncada PA, Burgess L, Duke ER, Ohmagari N, Wolf T, Bassetti M, Bhagani S, Ghosn J, Zhang Y, Wan H, Williams-Diaz A, Brown ML, Paschke A, De Anda C
Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled Trial.
Annals of Internal Medicine 2022, 175, 1126-1134.
Ferré VM, Bachelard A, Zaidi M, Armand-Lefevre L, Descamps D, Charpentier C, Ghosn J
Detection of Monkeypox Virus in Anorectal Swabs From Asymptomatic Men Who Have Sex With Men in a Sexually Transmitted Infection Screening Program in Paris, France.
Annals of Internal Medicine 2022, 175, 1491-1492.
Wensing AM, Calvez V, Ceccherini-Silberstein F, Charpentier C, Günthard HF, Paredes R, Shafer RW, Richman DD
2022 update of the drug resistance mutations in HIV-1.
Topics in Antiviral Medicine 2022, 30, 559-574.
2021
Sarton B, Jaquet P, Belkacemi D, de Montmollin E, Bonneville F, Sazio C, Frérou A, Conrad M, Daubin D, Chabanne R, Argaud L, Dailler F, Brulé N, Lerolle N, Maestraggi Q, Marechal J, Bailly P, Razazi K, Mateos F, Guidet B, Levrat A, Susset V, Lautrette A, Mira JP, El Kalioubie A, Robert A, Massri A, Albucher JF, Olivot JM, Conil JM, Boudma L, Timsit JF, Sonneville R, Silva S, ENCEPHALITICA Consortium
Assessment of Magnetic Resonance Imaging Changes and Functional Outcomes Among Adults With Severe Herpes Simplex Encephalitis.
JAMA network open 2021, 4, e2114328.
Birgand G, Mutters NT, Otter J, Eichel VM, Lepelletier D, Morgan DJ, Lucet JC
Variation of National and International Guidelines on Respiratory Protection for Health Care Professionals During the COVID-19 Pandemic.
JAMA network open 2021, 4, e2119257.
Cousien A, Acquaviva E, Kernéis S, Yazdanpanah Y, Delorme R
Temporal Trends in Suicide Attempts Among Children in the Decade Before and During the COVID-19 Pandemic in Paris, France.
JAMA network open 2021, 4, e2128611.
Atkinson A, Miro JM, Mocroft A, Reiss P, Kirk O, Morlat P, Ghosn J, Stephan C, Mussini C, Antoniadou A, Doerholt K, Girardi E, De Wit S, Kraus D, Zwahlen M, Furrer H, Opportunistic Infections Working Group of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCOORD
No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL.
Journal of the International AIDS Society 2021, 24, e25726.
Yazdanpanah Y, French COVID cohort investigators and study group
Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID-19 patients.
Journal of Medical Virology 2021, 93, 2149-2159.
Buetti N, Souweine B, Mermel L, Mimoz O, Ruckly S, Loiodice A, Mongardon N, Lucet JC, Parienti JJ, Timsit JF
Obesity and risk of catheter-related infections in the ICU. A post hoc analysis of four large randomized controlled trials.
Intensive Care Medicine 2021, 47, 435-443.
Buetti N, Ruckly S, de Montmollin E, Reignier J, Terzi N, Cohen Y, Shiami S, Dupuis C, Timsit JF
COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network.
Intensive Care Medicine 2021, 47, 180-187.
Arabi YM, Azoulay E, Al-Dorzi HM, Phua J, Salluh J, Binnie A, Hodgson C, Angus DC, Cecconi M, Du B, Fowler R, Gomersall CD, Horby P, Juffermans NP, Kesecioglu J, Kleinpell RM, Machado FR, Martin GS, Meyfroidt G, Rhodes A, Rowan K, Timsit JF, Vincent JL, Citerio G
How the COVID-19 pandemic will change the future of critical care.
Intensive Care Medicine 2021, 47, 282-291.
Buetti N, Mimoz O, Mongardon N, Parienti JJ, Timsit JF
Ultrasound-guided catheterization and infectious risk in obese ICU patients.
Intensive Care Medicine 2021, 47, 632-634.
Arabi YM, Derde LPG, Timsit JF
How COVID-19 will change the management of other respiratory viral infections.
Intensive Care Medicine 2021
Bohé J, Abidi H, Brunot V, Klich A, Klouche K, Sedillot N, Tchenio X, Quenot JP, Roudaut JB, Mottard N, Thiollière F, Dellamonica J, Wallet F, Souweine B, Lautrette A, Preiser JC, Timsit JF, Vacheron CH, Ait Hssain A, Maucort-Boulch D, CONTROLe INdividualisé de la Glycémie (CONTROLING) Study Group
Individualised versus conventional glucose control in critically-ill patients: the CONTROLING study-a randomized clinical trial.
Intensive Care Medicine 2021, 47, 1271-1283.
Debray MP, Tarabay H, Males L, Chalhoub N, Mahdjoub E, Pavlovsky T, Visseaux B, Bouzid D, Borie R, Wackenheim C, Crestani B, Rioux C, Saker L, Choquet C, Mullaert J, Khalil A
Observer agreement and clinical significance of chest CT reporting in patients suspected of COVID-19.
European Radiology 2021, 31, 1081-1089.
Poline J, Postaire M, Parize P, Pilmis B, Bille E, Zahar JR, Frange P, Cohen JF, Lortholary O, Toubiana J
Stewardship program on carbapenem prescriptions in a tertiary hospital for adults and children in France: a cohort study.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2021, 40, 1039-1048.
Maataoui N, Chemali L, Patrier J, Tran Dinh A, Le Fèvre L, Lortat-Jacob B, Marzouk M, d'Humières C, Rondinaud E, Ruppé E, Montravers P, Timsit JF, Armand-Lefèvre L
Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2021, 40, 2227-2234.
Vauloup-Fellous C, Maylin S, Périllaud-Dubois C, Brichler S, Alloui C, Gordien E, Rameix-Welti MA, Gault E, Moreau F, Fourati S, Challine D, Pawlotsky JM, Houhou-Fidouh N, Damond F, Mackiewicz V, Charpentier C, Méritet JF, Rozenberg F, Podglajen I, Marot S, Petit H, Burrel S, Akhavan S, Leruez-Ville M, Avettand-Fenoel V, Fourgeaud J, Guilleminot T, Gardiennet E, Bonacorsi S, Carol A, Carcelain G, Villemonteix J, Boukli N, Gozlan J, Morand-Joubert L, Legoff J, Delaugerre C, Chaix ML, Roque-Afonso AM, Dortet L, Naas T, Ronat JB, Lepape S, Marcelin AG, Descamps D
Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2021, 40, 2235-2241.
Mascitti H, Jourdain P, Bleibtreu A, Jaulmes L, Dechartres A, Lescure X, Yordanov Y, Dinh A, AP-HP/Universities/INSERM COVID-19 research collaboration
Prognosis of rash and chilblain-like lesions among outpatients with COVID-19: a large cohort study.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2021, 40, 2243-2248.
Kernéis S, Elie C, Fourgeaud J, Choupeaux L, Delarue SM, Alby ML, Quentin P, Pavie J, Brazille P, Néré ML, Minier M, Gabassi A, Gibaud A, Gauthier S, Leroy C, Voirin-Mathieu E, Poyart C, Vidaud M, Parfait B, Delaugerre C, Tréluyer JM, LeGoff J
Accuracy of saliva and nasopharyngeal sampling for detection of SARS-CoV-2 in community screening: a multicentric cohort study.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2021, 40, 2379-2388.
Maraolo AE, Corcione S, Grossi A, Signori A, Alicino C, Hussein K, Trecarichi EM, Viale P, Timsit JF, Veeraraghavan B, Villegas MV, Rahav G, Daikos GL, Vardakas KZ, Roilides E, Uhlemann AC, Ghafur AK, Mornese Pinna S, Bassetti M, Kohler PP, Giacobbe DR
The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients.
Infectious Diseases and Therapy 2021
Muff S, Tabah A, Que YA, Timsit JF, Mermel L, Harbarth S, Buetti N
Short-Course Versus Long-Course Systemic Antibiotic Treatment for Uncomplicated Intravascular Catheter-Related Bloodstream Infections due to Gram-Negative Bacteria, Enterococci or Coagulase-Negative Staphylococci: A Systematic Review.
Infectious Diseases and Therapy 2021, 10, 1591-1605.
Peiffer-Smadja N, Rozencwajg S, Kherabi Y, Yazdanpanah Y, Montravers P
COVID-19 vaccines: a race against time.
Anaesthesia, Critical Care & Pain Medicine 2021, 100848.
Zahar JR, Allaouchiche B
Even vaccinated against COVID-19, we must continue to wear a mask.
Anaesthesia, Critical Care & Pain Medicine 2021, 40, 100849.
Bailey RL, Ramanan M, Litton E, Yan Kai NS, Coyer FM, Garrouste-Orgeas M, Tabah A, Welcome ICU contributors
Staff perceptions of family access and visitation policies in Australian and New Zealand intensive care units: The WELCOME-ICU survey.
Australian Critical Care: Official Journal of the Confederation of Australian Critical Care Nurses 2021, S1036-7314(21)00108-9.
Boyer A, Timsit JF, Klouche K, Canet E, Phan TN, Bohé J, Rubin S, Orieux A, Lautrette A, Gruson D, Souweine B
Aminoglycosides in Critically Ill Septic Patients With Acute Kidney Injury Receiving Continuous Renal Replacement Therapy: A Multicenter, Observational Study.
Clinical Therapeutics 2021, S0149-2918(21)00206-X.
Boyer A, Timsit JF, Klouche K, Canet E, Phan TN, Bohé J, Rubin S, Orieux A, Lautrette A, Gruson D, Souweine B
Aminoglycosides in Critically Ill Septic Patients With Acute Kidney Injury Receiving Intermittent Hemodialysis: A Multicenter, Observational Study.
Clinical Therapeutics 2021, S0149-2918(21)00210-1.
Bouzid D, Zanella MC, Kerneis S, Visseaux B, May L, Schrenzel J, Cattoir V
Rapid diagnostic tests for infectious diseases in the emergency department.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 182-191.
Fiolet T, Guihur A, Rebeaud ME, Mulot M, Peiffer-Smadja N, Mahamat-Saleh Y
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 19-27.
Fiolet T, Guihur A, Rebeaud ME, Mulot M, Peiffer-Smadja N, Mahamat-Saleh Y
Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 138-140.
Meppiel E, Peiffer-Smadja N, Maury A, Bekri I, Delorme C, Desestret V, Gorza L, Hautecloque-Raysz G, Landre S, Lannuzel A, Moulin S, Perrin P, Petitgas P, SellaI F, Wang A, Tattevin P, de Broucker T, contributors to the NeuroCOVID registry
Neurologic manifestations associated with COVID-19: a multicentre registry.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 458-466.
Tran VT, Mahévas M, Bani-Sadr F, Robineau O, Perpoint T, Perrodeau E, Gallay L, Ravaud P, Goehringer F, Lescure FX, COCORICO Collaborative Group
Corticosteroids in patients hospitalized for COVID-19 pneumonia who require oxygen: observational comparative study using routine care data.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 603-610.
van Rooden SM, Aspevall O, Carrara E, Gubbels S, Johansson A, Lucet JC, Mookerjee S, Palacios-Baena ZR, Presterl E, Tacconelli E, Abbas M, Behnke M, Gastmeier P, van Mourik MSM, PRAISE network
Governance aspects of large-scale implementation of automated surveillance of healthcare-associated infections.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27 Suppl 1, S20-S28.
van Mourik MSM, van Rooden SM, Abbas M, Aspevall O, Astagneau P, Bonten MJM, Carrara E, Gomila-Grange A, de Greeff SC, Gubbels S, Harrison W, Humphreys H, Johansson A, Koek MBG, Kristensen B, Lepape A, Lucet JC, Mookerjee S, Naucler P, Palacios-Baena ZR, Presterl E, Pujol M, Reilly J, Roberts C, Tacconelli E, Teixeira D, Tängdén T, Valik JK, Behnke M, Gastmeier P, PRAISE network
PRAISE: providing a roadmap for automated infection surveillance in Europe.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27 Suppl 1, S3-S19.
Ghosn J, Piroth L, Epaulard O, Le Turnier P, Mentré F, Bachelet D, Laouénan C, French COVID cohort study and investigators groups
Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1041.e1-1041.e4.
Gallay L, Tran VT, Perrodeau E, Vignier N, Mahevas M, Bisio F, Forestier E, Lescure FX, COCO-OLD Study group
Fourteen-day survival among older adults with severe infection with severe acute respiratory syndrome coronavirus 2 treated with corticosteroid: a cohort study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1145-1150.
Yordanov Y, Dinh A, Bleibtreu A, Mensch A, Lescure FX, Debuc E, Jourdain P, Jaulmes L, Dechartres A, AP-HP/Universities/Inserm COVID-19 research collaboration
Clinical characteristics and factors associated with hospital admission or death in 43 103 adult outpatients with coronavirus disease 2019 managed with the Covidom telesurveillance solution: a prospective cohort study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1158-1166.
Buetti N, Marschall J, Timsit JF, Atkinson A, Kronenberg A, Sommerstein R, Swiss Centre for Antibiotic Resistance (ANRESIS)
Distribution of pathogens and antimicrobial resistance in bacteraemia according to hospitalization duration: a nationwide surveillance study in Switzerland.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, S1198-743X(21)00212-3.
Ader F, Peiffer-Smadja N, Poissy J, Bouscambert-Duchamp M, Belhadi D, Diallo A, Delmas C, Saillard J, Dechanet A, Mercier N, Dupont A, Alfaiate T, Lescure FX, Raffi F, Goehringer F, Kimmoun A, Jaureguiberry S, Reignier J, Nseir S, Danion F, Clere-Jehl R, Bouiller K, Navellou JC, Tolsma V, Cabié A, Dubost C, Courjon J, Leroy S, Mootien J, Gaci R, Mourvillier B, Faure E, Pourcher V, Gallien S, Launay O, Lacombe K, Lanoix JP, Makinson A, Martin-Blondel G, Bouadma L, Botelho-Nevers E, Gagneux-Brunon A, Epaulard O, Piroth L, Wallet F, Richard JC, Reuter J, Staub T, Lina B, Noret M, Andrejak C, Lê MP, Peytavin G, Hites M, Costagliola D, Yazdanpanah Y, Burdet C, Mentré F, DisCoVeRy study group
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1826-1837.
Husain M, Rachline A, Cousien A, Rolland S, Rouzaud C, Ferre VM, Gomez MV, Le Teurnier M, Wicky-Thisse M, Descamps D, Yazdanpanah Y, Charpentier C, Pasquet-Cadre A
Impact of the COVID-19 pandemic on the homeless: results from a retrospective closed cohort in France (March-May 2020).
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1520.e1-1520.e5.
Dinh A, Jaulmes L, Dechartres A, Duran C, Mascitti H, Lescure X, Yordanov Y, Jourdain P, AP-HP/Universities/INSERM COVID-19 research collaboration, Data-sciences committee, Scientific committee, Covidom regional centre steering commitee
Time to resolution of respiratory and systemic coronavirus disease 2019 symptoms in community setting.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1862.e1-1862.e4.
Farfour E, Lomont A, Fihman V, Lecuru M, Hüssler S, Ouzani S, Zahar JR, Dortet L, GMC study group
Rapid and accurate eXDR screening: use Xpert Carba-R® with FecalSwab®.
Diagnostic Microbiology and Infectious Disease 2021, 99, 115279.
Charpentier C, Pellissier G, Ichou H, Ferré VM, Larfi I, Phung BC, Vallois D, LeGac S, Aubier M, Descamps D, Fidouh-Houhou N, Bouvet E
Contribution of rapid lateral flow assays from capillary blood specimens to the diagnosis of COVID-19 in symptomatic healthcare workers: a pilot study in a university hospital, Paris, France.
Diagnostic Microbiology and Infectious Disease 2021, 101, 115430.
Louchet M, Peytavin G, Didelot H, Lê M, Bourgeois-Moine A, Carbillon L, Luton D, Matheron I, Rigonnot L, Mandelbrot L
Frequency of differential placental transfer to twins of maternal antiretroviral medications.
European Journal of Obstetrics, Gynecology, and Reproductive Biology 2021, 256, 405-411.
Maillet F, Pourbaix A, le Pluart D, Sirmai L, Postolache SA, Couvelard A, Houhou-Fidouh N, Males L, Deconinck L, Lescure FX
Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments.
IDCases 2021, 24, e01111.
Gourjault C, Tarhini H, Rahi M, Thy M, Le Pluart D, Rioux C, Parisey M, Ismael S, Al Rida Aidibi A, Paradis V, Ghosn J, Yazdanpanah Y, Lescure FX, Gervais A
Cholangitis in three critically ill patients after a severe CoVID-19 infection.
IDCases 2021, e01267.
Bouiller K, Catho G, Le Maréchal M, Gras J, Hentzien M, Peiffer-Smadja N, Bessis S, Cabon M, Dubee V, Lemaignen A, Thy M, Martins C, Thill P, Osei L, ReJIF (Réseau des Jeunes Infectiologues Français, Société de Pathologie Infectieuse de Langue Française)
The role of infectious disease trainees during the first wave of the COVID-19 pandemic: A national survey.
Infectious Diseases Now 2021, 51, 215-217.
Lacarra B, Mellon G, Ortega Perez I, D'Ortenzio E, Lescure FX
Bridging the gap between scientific discovery and clinical application during the COVID-19 epoch.
Infectious Diseases Now 2021, 51, 581-582.
Castan B, Akrich B, Levy-Bachelot L, Amode A, Berthelot A, Mackosso C, Mathis L, Mootien J, Ruimy R, Ruiz F, Timsit JF, Boutoille D
Real-world evaluation of ceftolozane/tazobactam therapy and clinical outcomes in France.
Infectious Diseases Now 2021, S2666-9919(21)00111-1.
Pilmis B, de Ponfilly GP, Farfour E, Ranc AG, Fihman V, Bille E, Dortet L, Degand N, Morand P, Potron A, Mizrahi A, Laurent F, Le Brun C, Guillard T, Héry-Arnaud G, Piau C, Barraud O, Ruffier d'Epenoux L, Zahar JR, Le Monnier A, GMC study group
Epidemiology and clinical characteristics of Klebsiella spp. meningitis in France.
Infectious Diseases Now 2021, S2666-9919(21)00115-9.
Huriez P, Lourtet-Hascoet J, Zahar JR, Le Monnier A, Pilmis B
Frequency of surface bacterial contamination in family physicians' offices.
Infectious Diseases Now 2021, S2666-9919(21)00117-2.
Dupré A, Argy N, Houze S, Leleu A, Choquet C, Matheron S, Bleibtreu A
Imported malaria in metropolitan France, from recommendations to clinical practice - proposal for improvement.
Infectious Diseases Now 2021, 51, 667-672.
Telford E, Ortega-Perez I, Mellon G, Lacarra B, Adjadj E, Madelaine C, D'Ortenzio E, Yazdanpanah Y
Chronicles of a pandemic: how France coordinated the scientific research response to COVID-19.
Infectious Diseases Now 2021, S2666-9919(21)00487-5.
Woerther PL, d'Humières C, Lescure X, Dubreuil L, Rodriguez C, Barbier F, Fihman V, Ruppé E
Is the term "anti-anaerobic" still relevant?.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2021, 102, 178-180.
Pilmis B, Jiang O, Mizrahi A, Nguyen Van JC, Lourtet-Hascoët J, Voisin O, Le Lorc'h E, Hubert S, Ménage E, Azria P, Borie MF, Mahé A, Mourad JJ, Trabattoni E, Ganansia O, Zahar JR, Le Monnier A
No significant difference between ceftriaxone and cefotaxime in the emergence of antibiotic resistance in the gut microbiota of hospitalized patients: A pilot study.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2021, 104, 617-623.
Meybeck A, Tetart M, Baclet V, Alcaraz I, Blondiaux N, Peytavin G, Veyziris N, Robineau O, Senneville E
A disseminated Mycobacterium marinum infection in a renal transplant HIV-infected patient successfully treated with a bedaquiline-containing antimycobacterial treatment: a case report.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2021
Lebourgeois S, Storto A, Gout B, Le Hingrat Q, Ardila Tjader G, Cerdan MDC, English A, Pareja J, Love J, Houhou-Fidouh N, Manissero D, Descamps D, Visseaux B
Performance evaluation of the QIAstat-Dx® Respiratory SARS-CoV-2 Panel.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2021, 107, 179-181.
Nyirenda T, Bockarie M, Machingaidze S, Nderu M, Singh M, Fakier N, Habarugira JM, Beattie P, Pandya L, Jajkowicz D, Yazdanpanah Y, Hankins C, Makanga M
Strengthening capacity for clinical research in sub-Saharan Africa: partnerships and networks.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2021, 110, 54-61.
Eloy P, Tardivon C, Martin-Blondel G, Isnard M, Turnier PL, Marechal ML, Cabié A, Launay O, Tattevin P, Senneville E, Ansart S, Goehringer F, Chirouze C, Bousson L, Laouénan C, Etienne M, Nguyen D, Ghosn J, Duval X, French COVID cohort study and investigators groups
Severity of self-reported symptoms and psychological burden 6-months after hospital admission for COVID-19: a prospective cohort study.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2021, 112, 247-253.
Lévy Y, Wiedemann A, Hejblum BP, Durand M, Lefebvre C, Surénaud M, Lacabaratz C, Perreau M, Foucat E, Déchenaud M, Tisserand P, Blengio F, Hivert B, Gauthier M, Cervantes-Gonzalez M, Bachelet D, Laouénan C, Bouadma L, Timsit JF, Yazdanpanah Y, Pantaleo G, Hocini H, Thiébaut R, French COVID cohort study group
CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death.
iScience 2021, 24, 102711.
Martin A, Storto A, Le Hingrat Q, Collin G, André B, Mallory A, Dangla R, Descamps D, Visseaux B, Gossner O
High-sensitivity SARS-CoV-2 group testing by digital PCR among symptomatic patients in hospital settings.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2021, 141, 104895.
Crescenzo-Chaigne B, Behillil S, Enouf V, Escriou N, Petres S, Ungeheuer MN, Ghosn J, Tubiana S, Bouadma L, van der Werf S, Demeret C, French COVID cohort study group
Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients.
Journal of Clinical Virology Plus 2021, 1, 100041.
Saliba R, Ghelfenstein-Ferreira T, Lomont A, Pilmis B, Carbonnelle E, Seytre D, Nasser-Ayoub E, Zahar JR, Karam-Sarkis D
Risk factors for the environmental spread of different multidrug-resistant organisms: a prospective cohort study.
The Journal of Hospital Infection 2021, 111, 155-161.
Pilmis B, Mizrahi A, Péan de Ponfilly G, Philippart F, Bruel C, Zahar JR, Le Monnier A
Relative faecal abundance of extended-spectrum β-lactamase-producing Enterobacterales and its impact on infections among intensive care unit patients: a pilot study.
The Journal of Hospital Infection 2021, 112, 92-95.
de Lafforest S, Magnier A, Vallée M, Bey E, Le Goux C, Saint F, Therby A, Zahar JR, Sotto A, Bruyere F, Grammatico-Guillon L
FUrTIHF: French Urinary Tract Infections in Healthcare Facilities French Urinary Tract Infections in Healthcare Facilities: 5-year historic cohort 2014-2018.
The Journal of Hospital Infection 2021, S0195-6701(21)00225-5.
Lepape A, Machut A, Gerbier-Colomban S, Kuczewski E, Rasigade JP, Timsit JF, Vanhems P, Wallet F, Savey A, Friggeri A, REA-REZO Group
Automated surveillance in French ICUs: is it feasible? Results from a survey in French ICUs participating in a surveillance network.
The Journal of Hospital Infection 2021, 115, 1-4.
Klement-Frutos E, Burrel S, Peytavin G, Marot S, Lê MP, Godefroy N, Calvez V, Marcelin AG, Caumes E, Pourcher V, Boutolleau D
Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19.
The Journal of Infection 2021, 82, 159-198.
Grall I, Alloui CA, Tandjaoui-Lambiotte Y, Deslandes A, Seytre D, Chappe J, Carbonnelle E, Brichler S, Jacolot A, Zahar JR, Lomont A
Viral transmission in asymptomatic cases of SARS-CoV-2 infection.
The Journal of Infection 2021, 82, 282-327.
Tubiana S, Burdet C, Houhou N, Thy M, Manchon P, Blanquart F, Charpentier C, Guedj J, Alavoine L, Behillil S, Leclercq A, Lucet JC, Yazdanpanah Y, Attia M, Demeret C, Rose T, Bielicki JA, Bruijning-Verhagen P, Goossens H, Descamps D, van der Werf S, Lina B, Duval X, CoVCONTACT study group, Principal investigator, Sponsor: Inserm
High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohort.
The Journal of Infection 2021, 82, 186-230.
de Montmollin E, Faille D, Andrieu V, Ajzenberg N, Timsit JF
Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?.
The Journal of Infection 2021
Velly L, Volant S, Fitting C, Ghazali DA, Salipante F, Mayaux J, Monsel G, Cavaillon JM, Hausfater P
Optimal combination of early biomarkers for infection and sepsis diagnosis in the emergency department: The BIPS study.
The Journal of Infection 2021, 82, 11-21.
Teyssou E, Soulie C, Visseaux B, Lambert-Niclot S, Ferre V, Marot S, Jary A, Sayon S, Zafilaza K, Leducq V, Schnuriger A, Abdi B, Wirden M, Houhou-Fidouh N, Charpentier C, Morand-Joubert L, Burrel S, Descamps D, Calvez V, Marcelin AG
The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients.
The Journal of Infection 2021, 83, 119-145.
Teyssou E, Delagrèverie H, Visseaux B, Lambert-Niclot S, Brichler S, Ferre V, Marot S, Jary A, Todesco E, Schnuriger A, Ghidaoui E, Abdi B, Akhavan S, Houhou-Fidouh N, Charpentier C, Morand-Joubert L, Boutolleau D, Descamps D, Calvez V, Marcelin A, Soulie C
The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19.
The Journal of Infection 2021, S0163-4453(21)00416-3.
Visseaux B, Collin G, Houhou-Fidouh N, Le Hingrat Q, Ferré VM, Damond F, Ichou H, Descamps D, Charpentier C
Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirements.
Journal of Virological Methods 2021, 291, 114086.
Lefrancq N, Paireau J, Hozé N, Courtejoie N, Yazdanpanah Y, Bouadma L, Boëlle PY, Chereau F, Salje H, Cauchemez S
Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: A retrospective national surveillance data analysis.
The Lancet Regional Health. Europe 2021, 5, 100087.
Fournier M, Faille D, Dossier A, Mageau A, Nicaise Roland P, Ajzenberg N, Borie R, Bouadma L, Bunel V, Castier Y, Choquet C, Crestani B, Daugas E, Deconinck L, Descamps D, Descamps V, Dieudé P, Ducrocq G, Faucher N, Goulenok T, Guidoux C, Khalil A, Lavallée P, Lescure FX, Lortat-Jacob B, Mal H, Mutuon P, Pellenc Q, Steg PG, Taille C, Timsit JF, Yazdanpanah Y, Papo T, Sacré K
Arterial Thrombotic Events in Adult Inpatients With COVID-19.
Mayo Clinic Proceedings 2021, 96, 295-303.
Tarhini H, Husain M, Poey N, Lariven S, Lescure FX, Yazdanpanah Y, Gervais A
Jaundice in a patient treated with Anakinra in a context of Covid-19.
Infectious Diseases Now 2021, 51, 217-218.
Sallard E, Belhadi D, Lescure FX, Yazdanpanah Y, Peiffer-Smadja N
Clinical trial protocols of repurposed prophylaxis for COVID-19: A review.
Infectious Diseases Now 2021, 51, 7-13.
Gressens SB, Billard-Pomares T, Leboité H, Cruaud P, Bouchaud O, Carbonnelle E, Méchaï F
Pulmonary tuberculosis: Evaluation of current diagnostic strategy.
Infectious Diseases Now 2021, 51, 273-278.
Bendjelloul G, Gerard S, Birgand G, Lenne F, Rioux C, Lescure X, Yazdanpanah Y, Lucet JC
Impact of admission to high-risk isolation room on patients' and healthcare workers' perceptions: A qualitative cross-assessment Approach.
Infectious Diseases Now 2021, 51, 247-252.
Akhoundi M, Marteau A, Mechaï F, Mantelet S, Izri A
Molecular characterization and genetic diversity of Loa loa parasites responsible of a long-delayed filarial infection in an immigrant patient inhabited in Paris.
Microbial Pathogenesis 2021, 158, 105101.
Maury A, Lyoubi A, Peiffer-Smadja N, de Broucker T, Meppiel E
Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
Revue Neurologique 2021, 177, 51-64.
Hansel B, Potier L, Chalopin S, Larger E, Gautier JF, Delestre F, Masdoua V, Visseaux B, Lucet JC, Kerneis S, Abouleka Y, Thebaut JF, Riveline JP, Kadouch D, Roussel R
The COVID-19 lockdown as an opportunity to change lifestyle and body weight in people with overweight/obesity and diabetes: Results from the national French COVIDIAB cohort.
Nutrition, metabolism, and cardiovascular diseases: NMCD 2021, 31, 2605-2611.
Frija-Masson J, Debray MP, Boussouar S, Khalil A, Bancal C, Motiejunaite J, Galarza-Jimenez MA, Benzaquen H, Penaud D, Laveneziana P, Malrin R, Redheuil A, Donciu V, Lucidarme O, Taillé C, Guerder A, Arnoult F, Vidal-Petiot E, Flamant M, Similowski T, Morelot-Panzini C, Faure M, Lescure FX, Straus C, d'Ortho MP, Gonzalez-Bermejo J
Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: The post Covid M3 study.
Respiratory Medicine 2021, 184, 106435.
Wunderink RG, Matsunaga Y, Ariyasu M, Clevenbergh P, Echols R, Kaye KS, Kollef M, Menon A, Pogue JM, Shorr AF, Timsit JF, Zeitlinger M, Nagata TD
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial.
The Lancet. Infectious Diseases 2021, 21, 213-225.
Bettuzzi T, Jourdes A, Robineau O, Alcaraz I, Manda V, Molina JM, Mehlen M, Cazanave C, Tattevin P, Mensi S, Terrier B, Régent A, Ghosn J, Charlier C, Martin-Blondel G, Dupin N
Ceftriaxone compared with benzylpenicillin in the treatment of neurosyphilis in France: a retrospective multicentre study.
The Lancet. Infectious Diseases 2021, 21, 1441-1447.
Trøseid M, Hites M, Barratt-Due A, Ader F, Yazdanpanah Y
Assessing the evidence on remdesivir.
The Lancet. Infectious Diseases 2021, 21, 1630-1631.
Lescure FX, Honda H, Fowler RA, Lazar JS, Shi G, Wung P, Patel N, Hagino O, Sarilumab COVID-19 Global Study Group
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial.
The Lancet. Respiratory Medicine 2021, 9, 522-532.
Molina JM, Yazdanpanah Y, Afani Saud A, Bettacchi C, Chahin Anania C, DeJesus E, Olsen Klopfer S, Grandhi A, Eves K, Robertson MN, Correll T, Hwang C, Hanna GJ, Sklar P
Islatravir in combination with doravirine for treatment-naive adults with HIV-1 infection receiving initial treatment with islatravir, doravirine, and lamivudine: a phase 2b, randomised, double-blind, dose-ranging trial.
The lancet. HIV 2021, 8, e324-e333.
Wei F, Gaisa MM, D'Souza G, Xia N, Giuliano AR, Hawes SE, Gao L, Cheng SH, Donà MG, Goldstone SE, Schim van der Loeff MF, Neukam K, Meites E, Poynten IM, Dai J, Combes JD, Wieland U, Burgos J, Wilkin TJ, Hernandez AL, Iribarren Díaz M, Hidalgo-Tenorio C, Valencia Arredondo M, Nyitray AG, Wentzensen N, Chow EP, Smelov V, Nowak RG, Phanuphak N, Woo YL, Choi Y, Hu Y, Schofield AM, Woestenberg PJ, Chikandiwa AT, Hickey AC, de Pokomandy A, Murenzi G, Péré H, Del Pino M, Ortiz AP, Charnot-Katsikas A, Liu X, Chariyalertsak S, Strong C, Ong JJ, Yunihastuti E, Etienney I, Ferré VM, Zou H, Segondy M, Chinyowa S, Alberts CJ, Clifford GM
Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studies.
The lancet. HIV 2021, 8, e531-e543.
Lachassinne E, de Pontual L, Caseris M, Lorrot M, Guilluy C, Naud A, Dommergues MA, Pinquier D, Wannepain E, Hausherr E, Jung C, Gajdos V, Cohen R, Zahar JR, Brichler S, Basmaci R, Boelle PY, Bloch-Queyrat C, Aupiais C, COVIDOCRECHE collaborators
SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study.
The Lancet. Child & Adolescent Health 2021, 5, 256-264.
Ghazali DA, Delaire C, Blottiaux E, Lardeur JY, Jost D, Violeau M, Breque C, Oriot D
Development of a Performance Assessment Scale for Simulated Dispatcher-Assisted Cardiopulmonary Resuscitation (Telephone-CPR): A Multi-Center Randomized Simulation-Based Clinical Trial.
Prehospital and Disaster Medicine 2021, 36, 561-569.
Novelli G, Liu J, Biancolella M, Alonzi T, Novelli A, Patten JJ, Cocciadiferro D, Agolini E, Colona VL, Rizzacasa B, Giannini R, Bigio B, Goletti D, Capobianchi MR, Grelli S, Mann J, McKee TD, Cheng K, Amanat F, Krammer F, Guarracino A, Pepe G, Tomino C, Tandjaoui-Lambiotte Y, Uzunhan Y, Tubiana S, Ghosn J, COVID Human Genetic Effort, French COVID Cohort Study Group, CoV-Contact Cohort, Notarangelo LD, Su HC, Abel L, Cobat A, Elhanan G, Grzymski JJ, Latini A, Sidhu SS, Jain S, Davey RA, Casanova JL, Wei W, Pandolfi PP
Inhibition of HECT E3 ligases as potential therapy for COVID-19.
Cell Death & Disease 2021, 12, 310.
Lepers C, Billiard S, Porte M, Méléard S, Tran VC
Inference with selection, varying population size, and evolving population structure: application of ABC to a forward-backward coalescent process with interactions.
Heredity 2021, 126, 335-350.
Perreau M, Suffiotti M, Marques-Vidal P, Wiedemann A, Levy Y, Laouénan C, Ghosn J, Fenwick C, Comte D, Roger T, Regina J, Vollenweider P, Waeber G, Oddo M, Calandra T, Pantaleo G
The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients.
Nature Communications 2021, 12, 4888.
Flament H, Rouland M, Beaudoin L, Toubal A, Bertrand L, Lebourgeois S, Rousseau C, Soulard P, Gouda Z, Cagninacci L, Monteiro AC, Hurtado-Nedelec M, Luce S, Bailly K, Andrieu M, Saintpierre B, Letourneur F, Jouan Y, Si-Tahar M, Baranek T, Paget C, Boitard C, Vallet-Pichard A, Gautier JF, Ajzenberg N, Terrier B, Pène F, Ghosn J, Lescure X, Yazdanpanah Y, Visseaux B, Descamps D, Timsit JF, Monteiro RC, Lehuen A
Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity.
Nature Immunology 2021, 22, 322-335.
Smith N, Goncalves P, Charbit B, Grzelak L, Beretta M, Planchais C, Bruel T, Rouilly V, Bondet V, Hadjadj J, Yatim N, Pere H, Merkling SH, Ghozlane A, Kernéis S, Rieux-Laucat F, Terrier B, Schwartz O, Mouquet H, Duffy D, Di Santo JP
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.
Nature Immunology 2021, 22, 1428-1439.
LeGoff J, Kernéis S, Elie C, Mercier-Delarue S, Gastli N, Choupeaux L, Fourgeaud J, Alby ML, Quentin P, Pavie J, Brazille P, Néré ML, Minier M, Gabassi A, Leroy C, Parfait B, Tréluyer JM, Delaugerre C
Evaluation of a saliva molecular point of care for the detection of SARS-CoV-2 in ambulatory care.
Scientific Reports 2021, 11, 21126.
Zaki SA, Naous J, Ghanem A, Abou Abbas D, Tomb R, Ghosn J, Assi A
Prevalence of STIs, sexual practices and substance use among 2083 sexually active unmarried women in Lebanon.
Scientific Reports 2021, 11, 9855.
Crawford C, Vanoli E, Decorde B, Lancelot M, Duprat C, Josserand C, Jilesen J, Bouadma L, Timsit JF
Modeling of aerosol transmission of airborne pathogens in ICU rooms of COVID-19 patients with acute respiratory failure.
Scientific Reports 2021, 11, 11778.
Courties A, Boussier J, Hadjadj J, Yatim N, Barnabei L, Péré H, Veyer D, Kernéis S, Carlier N, Pène F, Rieux-Laucat F, Charbit B, Bondet V, Duffy D, Berenbaum F, Terrier B, Sellam J
Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients.
Scientific Reports 2021, 11, 11886.
de Montmollin E, Timsit JF
How Antibiotics Stewardship Can Be Safely Implemented in Patients with Septic Shock?.
Seminars in Respiratory and Critical Care Medicine 2021, 42, 689-697.
Bergwerk M, Gonen T, Lustig Y, Amit S, Lipsitch M, Cohen C, Mandelboim M, Levin EG, Rubin C, Indenbaum V, Tal I, Zavitan M, Zuckerman N, Bar-Chaim A, Kreiss Y, Regev-Yochay G
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
The New England Journal of Medicine 2021
Néant N, Lingas G, Le Hingrat Q, Ghosn J, Engelmann I, Lepiller Q, Gaymard A, Ferré V, Hartard C, Plantier JC, Thibault V, Marlet J, Montes B, Bouiller K, Lescure FX, Timsit JF, Faure E, Poissy J, Chidiac C, Raffi F, Kimmoun A, Etienne M, Richard JC, Tattevin P, Garot D, Le Moing V, Bachelet D, Tardivon C, Duval X, Yazdanpanah Y, Mentré F, Laouénan C, Visseaux B, Guedj J, French COVID Cohort Investigators and French Cohort Study groups
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort.
Proceedings of the National Academy of Sciences of the United States of America 2021, 118,
Dupuis C, Timsit JF
Antibiotics in the first hour: is there new evidence?.
Expert Review of Anti-Infective Therapy 2021, 19, 45-54.
Diallo MS, Samri A, Charpentier C, Bertine M, Cheynier R, Thiébaut R, Matheron S, Collin F, Braibant M, Candotti D, Brun-Vézinet F, Autran B, ANRS CO5 IMMUNOVIR-2 and ANRS CO15 ALT Study Groups
A Comparison of Cell Activation, Exhaustion, and Expression of HIV Coreceptors and Restriction Factors in HIV-1- and HIV-2-Infected Nonprogressors.
AIDS research and human retroviruses 2021, 37, 214-223.
Ghosn J, Abdoul H, Fellahi S, Merlet A, Salmon D, Morini JP, Deleuze J, Blacher J, Capeau J, Bastard JP, Viard JP
Prevalence of Silent Atherosclerosis and Other Comorbidities in an Outpatient Cohort of Adults Living with HIV: Associations with HIV Parameters and Biomarkers.
AIDS research and human retroviruses 2021, 37, 101-108.
Heilmann E, Gregoriano C, Annane D, Reinhart K, Bouadma L, Wolff M, Chastre J, Luyt CE, Tubach F, Branche AR, Briel M, Christ-Crain M, Welte T, Corti C, de Jong E, Nijsten M, de Lange DW, van Oers JAH, Beishuizen A, Girbes ARJ, Deliberato RO, Schroeder S, Kristoffersen KB, Layios N, Damas P, Lima SSS, Nobre V, Wei L, Oliveira CF, Shehabi Y, Stolz D, Tamm M, Verduri A, Wang JX, Drevet S, Gavazzi G, Mueller B, Schuetz P
Duration of antibiotic treatment using procalcitonin-guided treatment algorithms in older patients: a patient-level meta-analysis from randomized controlled trials.
Age and Ageing 2021, 50, 1546-1556.
Veyer D, Kernéis S, Poulet G, Wack M, Robillard N, Taly V, L'Honneur AS, Rozenberg F, Laurent-Puig P, Bélec L, Hadjadj J, Terrier B, Péré H
Highly Sensitive Quantification of Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Sheds Light on its Potential Clinical Value.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 73, e2890-e2897.
Buetti N, Patrier J, Le Hingrat Q, Loiodice A, Bouadma L, Visseaux B, Timsit JF
Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Detection in Blood of Critically Ill Patients.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 72, e690-e691.
Buetti N, Mimoz O, Mermel L, Ruckly S, Mongardon N, Dupuis C, Mira JP, Lucet JC, Mégarbane B, Bailly S, Parienti JJ, Timsit JF
Ultrasound Guidance and Risk for Central Venous Catheter-Related Infections in the Intensive Care Unit: A Post Hoc Analysis of Individual Data of 3 Multicenter Randomized Trials.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 73, e1054-e1061.
Berzow D, Descamps D, Obermeier M, Charpentier C, Kaiser R, Guertler L, Eberle J, Wensing A, Sierra S, Ruelle J, Gomes P, Mansinho K, Taylor N, Jensen B, Döring M, Stürmer M, Rockstroh J, Camacho R
Human Immunodeficiency Virus-2 (HIV-2): A Summary of the Present Standard of Care and Treatment Options for Individuals Living with HIV-2 in Western Europe.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 72, 503-509.
Atkinson A, Zwahlen M, Barger D, d'Arminio Monforte A, De Wit S, Ghosn J, Girardi E, Svedhem V, Morlat P, Mussini C, Noguera-Julian A, Stephan C, Touloumi G, Kirk O, Mocroft A, Reiss P, Miro JM, Carpenter JR, Furrer H, Opportunistic Infections Project Working Group of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord
Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHERE.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 73, 195-202.
Temime L, Gustin MP, Duval A, Buetti N, Crépey P, Guillemot D, Thiébaut R, Vanhems P, Zahar JR, Smith DRM, Opatowski L
A Conceptual Discussion About the Basic Reproduction Number of Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Settings.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 72, 141-143.
Contejean A, Leporrier J, Canouï E, Alby-Laurent F, Lafont E, Beaudeau L, Parize P, Lecieux F, Greffet A, Chéron G, Gauzit R, Fourgeaud J, L'Honneur AS, Tréluyer JM, Charlier C, Casetta A, Frange P, Leruez-Ville M, Rozenberg F, Lortholary O, Kernéis S
Comparing Dynamics and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 Transmissions Among Healthcare Workers of Adult and Pediatric Settings in Central Paris.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 72, 257-264.
Sax PE, Rockstroh JK, Luetkemeyer AF, Yazdanpanah Y, Ward D, Trottier B, Rieger A, Liu H, Acosta R, Collins SE, Brainard DM, Martin H, GS-US-380–4030 Investigators
Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 73, e485-e493.
Zucman N, Uhel F, Descamps D, Roux D, Ricard JD
Severe Reinfection With South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant 501Y.V2.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 73, 1945-1946.
Betton M, Livrozet M, Planas D, Fayol A, Monel B, Védie B, Bruel T, Tartour E, Robillard N, Manuguerra JC, Blanchard A, Ghosn J, Visseaux B, Péré H, Lebeaux D, Schwartz O, Veyer D, Hulot JS, French COVID Cohort Study Group
Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 73, e1337-e1344.
Bruneau T, Wack M, Poulet G, Robillard N, Philippe A, Laurent-Puig P, Bélec L, Hadjadj J, Xiao W, Kallberg JL, Kernéis S, Diehl JL, Terrier B, Smadja D, Taly V, Veyer D, Péré H
Circulating ubiquitous RNA, a highly predictive and prognostic biomarker in hospitalized COVID-19 patients.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, ciab997.
Tarhini H, Recoing A, Bridier-Nahmias A, Rahi M, Lambert C, Martres P, Lucet JC, Rioux C, Bouzid D, Lebourgeois S, Descamps D, Yazdanpanah Y, Le Hingrat Q, Lescure FX, Visseaux B
Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection.
The Journal of Infectious Diseases 2021, 223, 1522-1527.
Pelleau S, Woudenberg T, Rosado J, Donnadieu F, Garcia L, Obadia T, Gardais S, Elgharbawy Y, Velay A, Gonzalez M, Nizou JY, Khelil N, Zannis K, Cockram C, Merkling SH, Meola A, Kerneis S, Terrier B, de Seze J, Planas D, Schwartz O, Dejardin F, Petres S, von Platen C, Pellerin SF, Arowas L, de Facci LP, Duffy D, Cheallaigh CN, Dunne J, Conlon N, Townsend L, Duong V, Auerswald H, Pinaud L, Tondeur L, Backovic M, Hoen B, Fontanet A, Mueller I, Fafi-Kremer S, Bruel T, White M
Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection.
The Journal of Infectious Diseases 2021, 224, 1489-1499.
Lê MP, Peiffer-Smadja N, Guedj J, Neant N, Mentré F, Ader F, Yazdanpanah Y, Peytavin G, C21DFSC
Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response.
The Journal of Antimicrobial Chemotherapy 2021, 76, 277-279.
Palich R, Allavena C, Peytavin G, Soulie C, Tubiana R, Weiss L, Montoya Ferrer A, Duvivier C, Bouchaud O, Bottero J, Durand A, Lê MP, Marcelin AG, Dudoit Y, Assoumou L, Katlama C, ETRAL QD study group
Once-daily etravirine/raltegravir (400/800 mg q24h) dual therapy maintains viral suppression over 48 weeks in HIV-infected patients switching from a twice-daily etravirine/raltegravir (200/400 mg q12h) regimen.
The Journal of Antimicrobial Chemotherapy 2021, 76, 477-481.
Force G, Ghout I, Ropers J, Carcelain G, Marigot-Outtandy D, Hahn V, Darchy N, Defferriere H, Bouaziz-Amar E, Carlier R, Dorgham K, Callebert J, Peytavin G, Delaugerre C, de Truchis P, NEURO+3 STUDY GROUP
Improvement of HIV-associated neurocognitive disorders after antiretroviral therapy intensification: the Neuro+3 study.
The Journal of Antimicrobial Chemotherapy 2021, 76, 743-752.
Kernéis S, Lucet JC, Santoro A, Meschiari M
Individual and collective impact of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in patients admitted to the ICU.
The Journal of Antimicrobial Chemotherapy 2021, 76, i19-i26.
Contejean A, Tisseyre M, Canouï E, Treluyer JM, Kerneis S, Chouchana L
Combination of vancomycin plus piperacillin and risk of acute kidney injury: a worldwide pharmacovigilance database analysis.
The Journal of Antimicrobial Chemotherapy 2021, 76, 1311-1314.
Palich R, Abdi B, Wirden M, Lourida G, Tubiana R, Faycal A, Valantin MA, Schneider L, Seang S, Agher R, Simon A, Soulie C, Le MP, Peytavin G, Calvez V, Marcelin AG, Katlama C
Intermittent two-drug antiretroviral therapies maintain long-term viral suppression in real life in highly experienced HIV-infected patients.
The Journal of Antimicrobial Chemotherapy 2021, 76, 1893-1897.
Contejean A, Charlier C, Treluyer JM, Kernéis S, Chouchana L
A worldwide pharmacovigilance database analysis to assess the risk of acute kidney injury in patients receiving teicoplanin in association with piperacillin, cefepime or meropenem.
The Journal of Antimicrobial Chemotherapy 2021, 76, 2221-2223.
Charpentier C, Storto A, Soulié C, Ferré VM, Wirden M, Joly V, Lambert-Niclot S, Palich R, Morand-Joubert L, Landman R, Lacombe K, Katlama C, Ghosn J, Marcelin AG, Calvez V, Descamps D
Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients.
The Journal of Antimicrobial Chemotherapy 2021, 76, 2983-2987.
Bachelard A, Isernia V, Vallois D, Le Gac S, Chalal L, Landman R, Damond F, Descamps D, Yazdanpanah Y, Peytavin G, Ghosn J
Efficacy and tolerability of combined antiretroviral treatment with bictegravir/emtricitabine/tenofovir alafenamide initiated at the time of primary HIV infection.
The Journal of Antimicrobial Chemotherapy 2021, 76, 2484-2485.
Marcelin AG, Charpentier C, Bellecave P, Abdi B, Chaix ML, Ferre V, Raymond S, Fofana D, Bocket L, Mirand A, Le Guillou-Guillemette H, Montes B, Amiel C, Pallier C, Fafi-Kremer S, De Monte A, Alessandri-Gradt E, Scholtes C, Maillard A, Jeulin H, Bouvier-Alias M, Roussel C, Dos Santos G, Signori-Schmuck A, Dina J, Vallet S, Stefic K, Soulié C, Calvez V, Descamps D, Flandre P, ANRS-MIE AC43 Group
Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey.
The Journal of Antimicrobial Chemotherapy 2021, 76, 2400-2406.
Martin C, Gracias S, Charpentier C, Descamps D, Le Hingrat Q, Plantier JC, Alessandri-Gradt E
HIV-1 non-group M phenotypic susceptibility in vitro to bictegravir and cabotegravir.
The Journal of Antimicrobial Chemotherapy 2021, 76, 2306-2309.
Lê MP, Pencolé L, Peytavin G, Bouchet-Crivat F, Mandelbrot L
Placental transfer of doravirine, a recent HIV-1 NNRTI in the ex vivo human cotyledon perfusion model.
The Journal of Antimicrobial Chemotherapy 2021, 76, 2364-2367.
Bouzid D, Casalino E, Mullaert J, Laurent O, Duval X, Lescure FX, Peiffer Smadja N, Tubiana S, Armand Lefèvre L, Descamps D, Fidouh N, Choquet C, Lucet JC, Visseaux B
Added value of rapid respiratory syndromic testing at point of care versus central laboratory testing: a controlled clinical trial.
The Journal of Antimicrobial Chemotherapy 2021, 76, iii20-iii27.
Bouzid D, Vila J, Hansen G, Manissero D, Pareja J, Rao SN, Visseaux B
Systematic review on the association between respiratory virus real-time PCR cycle threshold values and clinical presentation or outcomes.
The Journal of Antimicrobial Chemotherapy 2021, 76, iii33-iii49.
Deschanvres C, Reynes J, Lamaury I, Rey D, Palich R, Bani-Sadr F, Robineau O, Duvivier C, Hocqueloux L, Cuzin L, Joly V, Raffi F, Cabie A, Allavena C, Dat’AIDS Study Group
Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting.
The Journal of Antimicrobial Chemotherapy 2021, 77, 196-204.
Contejean A, Leporrier J, Canouï E, Fourgeaud J, Mariaggi AA, Alby-Laurent F, Lafont E, Beaudeau L, Rouzaud C, Lecieux F, Greffet A, L'Honneur AS, Tréluyer JM, Lanternier F, Casetta A, Frange P, Leruez-Ville M, Rozenberg F, Lortholary O, Kernéis S
Transmission Routes of Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers of a French University Hospital in Paris, France.
Open Forum Infectious Diseases 2021, 8, ofab054.
Dupuis C, Le Bihan C, Maubon D, Calvet L, Ruckly S, Schwebel C, Bouadma L, Azoulay E, Cornet M, Timsit JF, Empiricus Study Group
Performance of Repeated Measures of (1-3)-β-D-Glucan, Mannan Antigen, and Antimannan Antibodies for the Diagnosis of Invasive Candidiasis in ICU Patients: A Preplanned Ancillary Analysis of the EMPIRICUS Randomized Clinical Trial.
Open Forum Infectious Diseases 2021, 8, ofab080.
Kernéis S, Planas D, Imbeaud S, Staropoli I, Puech J, Robillard N, Rodary J, Bruel T, Vieillard T, Schwartz O, Belec L, Péré H, Veyer D
Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual.
Open Forum Infectious Diseases 2021, 8, ofab369.
Smith GHR, Henry WK, Podzamczer D, Masiá MDM, Bettacchi CJ, Arasteh K, Jaeger H, Khuong-Josses MA, Montes-Ramírez ML, Stellbrink HJ, Yazdanpanah Y, Richmond GJ, Sutton KC, Zhang F, McCoig CC, St Clair MH, Vandermeulen K, Van Solingen-Ristea R, Smith KY, Margolis DA, Spreen WR
Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study.
Open Forum Infectious Diseases 2021, 8, ofab439.
Visseaux B, Bertine M, Le Hingrat Q, Ferré V, Charpentier C, Collin F, Damond F, Matheron S, Hué S, Descamps D
HIV-2 diversity displays two clades within group A with distinct geographical distribution and evolution.
Virus Evolution 2021, 7, veab024.
Dupuis C, Bouadma L, de Montmollin E, Goldgran-Toledano D, Schwebel C, Reignier J, Neuville M, Ursino M, Siami S, Ruckly S, Alberti C, Mourvillier B, Bailly S, Grapin K, Laurent V, Buetti N, Gainnier M, Souweine B, Timsit JF
Association Between Early Invasive Mechanical Ventilation and Day-60 Mortality in Acute Hypoxemic Respiratory Failure Related to Coronavirus Disease-2019 Pneumonia.
Critical Care Explorations 2021, 3, e0329.
de Montmollin E, Schwebel C, Dupuis C, Garrouste-Orgeas M, da Silva D, Azoulay E, Laurent V, Thiéry G, Grinea A, Marcotte G, Oziel J, Gainnier M, Siami S, Reignier J, Sztrymf B, Adrie C, Ruckly S, Sonneville R, Timsit JF
Life Support Limitations in Mechanically Ventilated Stroke Patients.
Critical Care Explorations 2021, 3, e0341.
Flahault C, Trosdorf M, Sonrier M, Vioulac C, Fasse L, Timsit JF, Bailly S, Garrouste-Orgeas M
ICU Survivors Experience of ICU Diaries: An Ancillary Qualitative Analysis of the ICU Diary Study.
Critical Care Explorations 2021, 3, e0384.
Legouy C, Girard-Stein L, Wanono R, de Montmollin E, Vellieux G, Bouadma L, Dupuis C, Abid S, Vinclair C, Ruckly S, Rouvel-Tallec A, d'Ortho MP, Timsit JF, Sonneville R
Association of Standard Electroencephalography Findings With Mortality and Command Following in Mechanically Ventilated Patients Remaining Unresponsive After Sedation Interruption.
Critical Care Medicine 2021, 49, e423-e432.
Lahens A, Mullaert J, Gressens S, Gault N, Flamant M, Deconinck L, Joly V, Yazdanpanah Y, Lescure FX, Vidal-Petiot E
Association between renin-angiotensin-aldosterone system blockers and outcome in coronavirus disease 2019: analysing in-hospital exposure generates a biased seemingly protective effect of treatment.
Journal of Hypertension 2021, 39, 367-375.
Ansquer R, Oriot D, Ghazali DA
Evaluation of Learning Effectiveness After a Simulation-Based Training Pediatric Course for Emergency Physicians.
Pediatric Emergency Care 2021, 37, e1186-e1191.
Oriot D, Trigolet M, Kessler DO, Auerbach MA, Ghazali DA
Stress: A Factor Explaining the Gap Between Simulated and Clinical Procedure Success.
Pediatric Emergency Care 2021, 37, e1192-e1196.
Aubin J, Rivolet O, Taunay AL, Ragot S, Ghazali DA, Oriot D
Benefit of Simulation-Based Training in Medical Adverse Events Disclosure in Pediatrics.
Pediatric Emergency Care 2021
Sibiude J, Le Chenadec J, Mandelbrot L, Dollfus C, Matheron S, Lelong N, Avettand-Fenoel V, Brossard M, Frange P, Reliquet V, Warszawski J, Tubiana R, EPF study group
Risk of birth defects and perinatal outcomes in HIV-infected women exposed to integrase strand inhibitors during pregnancy.
AIDS (London, England) 2021, 35, 219-226.
Hassold N, Baltes V, Martin A, Méchaï F, Bouchaud O, Cordel H
Hemorrhagic cystitis from BK virus in a patient with AIDS.
AIDS (London, England) 2021, 35, 999-1001.
Ronchetti AM, Matheron S, Galicier L, Damond F, Mahjoub N, Chaghil N, Meignin V, Mechaï F, Simon F, Oksenhendler E, Gérard L
Lymphoma in HIV-2-infected patients in combination antiretroviral therapy era.
AIDS (London, England) 2021, 35, 2299-2309.
Chas J, Bauer R, Larabi IA, Peytavin G, Roux P, Cua E, Cotte L, Pasquet A, Capitant C, Meyer L, Raffi F, Spire B, Pialoux G, Molina JM, Alvarez JC
Evaluation of Drug Abuse by Hair Analysis and Self-Reported Use Among MSM Under PrEP: Results From a French Substudy of the ANRS-IPERGAY Trial.
Journal of Acquired Immune Deficiency Syndromes (1999) 2021, 86, 552-561.
Kerneis S, Visseaux B, Armand-Lefevre L, Timsit JF
Molecular diagnostic methods for pneumonia: how can they be applied in practice?.
Current Opinion in Infectious Diseases 2021, 34, 118-125.
Tabah A, Buetti N, Barbier F, Timsit JF
Current opinion in management of septic shock due to Gram-negative bacteria.
Current Opinion in Infectious Diseases 2021, 34, 718-727.
Armand-Lefèvre L, Rondinaud E, Desvillechabrol D, Mullaert J, Clermont O, Petitjean M, Ruppe E, Cokelaer T, Bouchier C, Tenaillon O, Ma L, Nooroya Y, Matheron S, The Voyag-R Study Group , Andremont A, Denamur E, Kennedy SP
Dynamics of extended-spectrum beta-lactamase-producing Enterobacterales colonization in long-term carriers following travel abroad.
Microbial Genomics 2021, 7, 000576.
Abe E, Assoumou L, de Truchis P, Amat K, Gibowski S, Gras G, Bellet J, Saillard J, Katlama C, Costagliola D, Girard PM, Landman R, Alvarez JC
Pharmacological data of a successful 4-days-a-week regimen in HIV antiretroviral therapy (ANRS 162-4D trial).
British Journal of Clinical Pharmacology 2021, 87, 1930-1939.
Gault N, Esposito-Farese M, Revest M, Inamo J, Cabie A, Polard É, Hulot JS, Ghosn J, Chirouze C, Deconinck L, Diehl JL, Poissy J, Epaulard O, Lefèvre B, Piroth L, de Montmollin E, Oziol E, Etienne M, Laouenan C, Rossignol P, Costagliola D, Vidal-Petiot E, French-Covid cohort investigators and study group
Chronic use of Renin-Angiotensin-Aldosterone-System blockers and mortality in COVID-19: a multicenter prospective cohort and literature review.
Fundamental & Clinical Pharmacology 2021
Le Hingrat Q, Bouzid D, Choquet C, Laurent O, Lescure FX, Timsit JF, Houhou-Fidouh N, Casalino E, Lucet JC, Descamps D, Visseaux B
Viral epidemiology and SARS-CoV-2 co-infections with other respiratory viruses during the first COVID-19 wave in Paris, France.
Influenza and Other Respiratory Viruses 2021, 15, 425-428.
Bauvin P, Delacôte C, Lassailly G, Ntandja Wandji LC, Gnemmi V, Dautrecque F, Louvet A, Caiazzo R, Raverdy V, Leteurtre E, Pattou F, Deuffic-Burban S, Mathurin P
A tool to predict progression of non-alcoholic fatty liver disease in severely obese patients.
Liver International: Official Journal of the International Association for the Study of the Liver 2021, 41, 91-100.
Pasquier G, Bounhiol A, Robert Gangneux F, Zahar JR, Gangneux JP, Novara A, Bougnoux ME, Dannaoui E
A review of significance of Aspergillus detection in airways of ICU COVID-19 patients.
Mycoses 2021, 64, 980-988.
Ghelfenstein-Ferreira T, Beaumont AL, Dellière S, Peiffer-Smadja N, Pineros N, Carbonnelle E, Greub G, Abbara S, Luong Nguyen LB, Lescat M
An Educational Game Evening for Medical Residents: A Proof of Concept to Evaluate the Impact on Learning of the Use of Games.
Journal of Microbiology & Biology Education 2021, 22, e00119-21.
Mageau A, Aldebert G, Van Gysel D, Papo T, Timsit JF, Sacre K
SARS-CoV-2 infection among inpatients with systemic lupus erythematosus in France: a nationwide epidemiological study.
Annals of the Rheumatic Diseases 2021
Reignier J, Le Gouge A, Lascarrou JB, Annane D, Argaud L, Hourmant Y, Asfar P, Badie J, Nay MA, Botoc NV, Brisard L, Bui HN, Chatellier D, Chauvelot L, Combes A, Cracco C, Darmon M, Das V, Debarre M, Delbove A, Devaquet J, Voicu S, Aissaoui-Balanant N, Dumont LM, Oziel J, Gontier O, Groyer S, Guidet B, Jaber S, Lambiotte F, Leroy C, Letocart P, Madeux B, Maizel J, Martinet O, Martino F, Mercier E, Mira JP, Nseir S, Picard W, Piton G, Plantefeve G, Quenot JP, Renault A, Guérin L, Richecoeur J, Rigaud JP, Schneider F, Silva D, Sirodot M, Souweine B, Reizine F, Tamion F, Terzi N, Thévenin D, Thiéry G, Thieulot-Rolin N, Timsit JF, Tinturier F, Tirot P, Vanderlinden T, Vinatier I, Vinsonneau C, Maugars D, Giraudeau B
Impact of early low-calorie low-protein versus standard-calorie standard-protein feeding on outcomes of ventilated adults with shock: design and conduct of a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3).
BMJ open 2021, 11, e045041.
Papot E, Kalampalikis N, Doumergue M, Pilorgé F, Quatremère G, Yazdanpanah Y, Préau M, ANRS-GOTA study group
Can we talk about price with patients when choosing antiretroviral therapy? A survey with people living with HIV and prescribers in France.
BMJ open 2021, 11, e046212.
Voiriot G, Fartoukh M, Durand-Zaleski I, Berard L, Rousseau A, Armand-Lefevre L, Verdet C, Argaud L, Klouche K, Megarbane B, Patrier J, Richard JC, Reignier J, Schwebel C, Souweine B, Tandjaoui-Lambiotte Y, Simon T, Timsit JF, MULTI-CAP study group
Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units.
BMJ open 2021, 11, e048187.
Mora M, Rincon G, Bourrelly M, Maradan G, Freire Maresca A, Michard F, Rouveix E, Pannetier J, Leriche D, Alain T, Yazdanpanah Y, Michels D, Spire B
Living conditions, HIV and gender affirmation care pathways of transgender people living with HIV in France: a nationwide, comprehensive, cross-sectional, community-based research protocol (ANRS Trans&HIV).
BMJ open 2021, 11, e052691.
Mahamat-Saleh Y, Fiolet T, Rebeaud ME, Mulot M, Guihur A, El Fatouhi D, Laouali N, Peiffer-Smadja N, Aune D, Severi G
Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies.
BMJ open 2021, 11, e052777.
Isernia V, Phung B, Lepretre AM, Azadi B, Rincon G, Zelie J, Le Gac S, Deprez A, Michard F, Yazdanpanah Y, Ghosn J
Pre-exposure HIV prophylaxis (PrEP) among transgender women: 3 years of follow-up in a university hospital in Paris.
Sexually Transmitted Infections 2021, 97, 465-466.
Ghanem M, Homps-Legrand M, Garnier M, Morer L, Goletto T, Frija-Masson J, Wicky PH, Jaquet P, Bancal C, Hurtado-Nedelec M, de Chaisemartin L, Jaillet M, Mailleux A, Quesnel C, Poté N, Debray MP, de Montmollin E, Neukirch C, Borie R, Taillé C, Crestani B, French COVID Cohort Study Group
Blood fibrocytes are associated with severity and prognosis in COVID-19 pneumonia.
American Journal of Physiology. Lung Cellular and Molecular Physiology 2021, 321, L847-L858.
Buetti N, Mimoz O, Schwebel C, Ruckly S, Castry M, Dupuis C, Souweine B, Lucet JC, Timsit JF
Insertion Site and Infection Risk among Peripheral Arterial Catheters.
American Journal of Respiratory and Critical Care Medicine 2021, 203, 630-633.
Dumas G, Lemiale V, Rathi N, Cortegiani A, Pène F, Bonny V, Salluh J, Albaiceta GM, Soares M, Soubani AO, Canet E, Hanane T, Kouatchet A, Mokart D, Lebiedz P, Türkoğlu M, Coudroy R, Jeon K, Demoule A, Mehta S, Caruso P, Frat JP, Yang KY, Roca O, Laffey J, Timsit JF, Azoulay E, Darmon M
Survival in Immunocompromised Patients Ultimately Requiring Invasive Mechanical Ventilation: A Pooled Individual Patient Data Analysis.
American Journal of Respiratory and Critical Care Medicine 2021, 204, 187-196.
Tandjaoui-Lambiotte Y, Timsit JF, Alloui C, Zahar JR, Vanoli E
Viral Dispersion in the Intensive Care Unit: The Wind Effect.
American Journal of Respiratory and Critical Care Medicine 2021
Besançon L, Peiffer-Smadja N, Segalas C, Jiang H, Masuzzo P, Smout C, Billy E, Deforet M, Leyrat C
Open science saves lives: lessons from the COVID-19 pandemic.
BMC medical research methodology 2021, 21, 117.
von Cube M, Timsit JF, Kammerlander A, Schumacher M
Quantifying and communicating the burden of COVID-19.
BMC medical research methodology 2021, 21, 164.
Marih L, Sawras V, Pavie J, Sodqi M, Malmoussi M, Tassi N, Bensghir R, Nani S, Lahsen AO, Laureillard D, El Filali KM, Champenois K, Weiss L
Missed opportunities for HIV testing in patients newly diagnosed with HIV in Morocco.
BMC infectious diseases 2021, 21, 48.
Rahi M, Le Pluart D, Beaudet A, Ismaël S, Parisey M, Poey N, Tarhini H, Lescure FX, Yazdanpanah Y, Deconinck L
Sociodemographic characteristics and transmission risk factors in patients hospitalized for COVID-19 before and during the lockdown in France.
BMC infectious diseases 2021, 21, 812.
Tchankoni MK, Bitty-Anderson AM, Sadio AJ, Gbeasor-Komlanvi FA, Ferré VM, Zida-Compaore WIC, Dorkenoo AM, Saka B, Dagnra AC, Charpentier C, Ekouevi DK
Prevalence and factors associated with trichomonas vaginalis infection among female sex workers in Togo, 2017.
BMC infectious diseases 2021, 21, 775.
Blanc E, Chaize G, Fievez S, Féger C, Herquelot E, Vainchtock A, Timsit JF, Gaillat J
The impact of comorbidities and their stacking on short- and long-term prognosis of patients over 50 with community-acquired pneumonia.
BMC infectious diseases 2021, 21, 949.
Gheerbrant H, Timsit JF, Terzi N, Ruckly S, Laramas M, Levra MG, Jacquet E, Falque L, Moro-Sibilot D, Toffart AC
Factors associated with survival of patients with solid Cancer alive after intensive care unit discharge between 2005 and 2013.
BMC cancer 2021, 21, 9.
Hellmann R, Feral-Pierssens AL, Michault A, Casalino E, Ricard-Hibon A, Adnet F, Brun-Ney D, Bouzid D, Menu A, Wargon M
The analysis of the geographical distribution of emergency departments' frequent users: a tool to prioritize public health policies?.
BMC public health 2021, 21, 1689.
Le Roux E, Mari Muro M, Mognon K, Saïd M, Caillavet V, Matheron S, Ledoux S, Decq P, Vorspan F, Le Strat Y, Delaugerre C, Le Bras M, Alberti C, Ruszniewski P, Zerr P, Faye A
A governmental program to encourage medical students to deliver primary prevention: experiment and evaluation in a French faculty of medicine.
BMC medical education 2021, 21, 47.
Ridde V, Gautier L, Dagenais C, Chabrol F, Hou R, Bonnet E, David PM, Cloos P, Duhoux A, Lucet JC, Traverson L, de Araujo Oliveira SR, Cazarin G, Peiffer-Smadja N, Touré L, Coulibaly A, Honda A, Noda S, Tamura T, Baba H, Kodoi H, Zinszer K
Learning from public health and hospital resilience to the SARS-CoV-2 pandemic: protocol for a multiple case study (Brazil, Canada, China, France, Japan, and Mali).
Health Research Policy and Systems 2021, 19, 76.
Dupuis C, Sabra A, Patrier J, Chaize G, Saighi A, Féger C, Vainchtock A, Gaillat J, Timsit JF
Burden of pneumococcal pneumonia requiring ICU admission in France: 1-year prognosis, resources use, and costs.
Critical Care (London, England) 2021, 25, 24.
Buetti N, Ruckly S, Lucet JC, Mimoz O, Souweine B, Timsit JF
Factors influencing local signs at catheter insertion site regardless of catheter-related bloodstream infections.
Critical Care (London, England) 2021, 25, 71.
Wicky PH, Niedermann MS, Timsit JF
Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact?.
Critical Care (London, England) 2021, 25, 153.
Timsit JF, Huntington JA, Wunderink RG, Shime N, Kollef MH, Kivistik Ü, Nováček M, Réa-Neto Á, Martin-Loeches I, Yu B, Jensen EH, Butterton JR, Wolf DJ, Rhee EG, Bruno CJ
Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial.
Critical Care (London, England) 2021, 25, 290.
Niederman MS, Baron RM, Bouadma L, Calandra T, Daneman N, DeWaele J, Kollef MH, Lipman J, Nair GB
Initial antimicrobial management of sepsis.
Critical Care (London, England) 2021, 25, 307.
Kollef MH, Shorr AF, Bassetti M, Timsit JF, Micek ST, Michelson AP, Garnacho-Montero J
Timing of antibiotic therapy in the ICU.
Critical Care (London, England) 2021, 25, 360.
Meyer A, Buetti N, Houhou-Fidouh N, Patrier J, Abdel-Nabey M, Jaquet P, Presente S, Girard T, Sayagh F, Ruckly S, Wicky PH, de Montmollin E, Bouadma L, Sonneville R, Descamps D, Timsit JF
HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients.
Critical Care (London, England) 2021, 25, 417.
Badio M, Lhomme E, Kieh M, Beavogui AH, Kennedy SB, Doumbia S, Leigh B, Sow SO, Diallo A, Fusco D, Kirchoff M, Termote M, Vatrinet R, Wentworth D, Esperou H, Lane HC, Pierson J, Watson-Jones D, Roy C, D'Ortenzio E, Greenwood B, Chêne G, Richert L, Neaton JD, Yazdanpanah Y, PREVAC study team
Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.
Trials 2021, 22, 86.
Lemiale V, Dumas G, Demoule A, Pène F, Kouatchet A, Bisbal M, Nseir S, Argaud L, Kontar L, Klouche K, Barbier F, Seguin A, Louis G, Constantin JM, Mayaux J, Wallet F, Peigne V, Girault C, Oziel J, Nyunga M, Terzi N, Bouadma L, Lautrette A, Bige N, Raphalen JH, Papazian L, Bruneel F, Lebert C, Benoit D, Meert AP, Jaber S, Mokart D, Darmon M, Azoulay E, Groupe de Recherche en Reanimation Respiratoire du patient d’Onco-Hématologie (GRRR-OH)
Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failure.
Annals of Intensive Care 2021, 11, 17.
Bonnet N, Martin O, Boubaya M, Levy V, Ebstein N, Karoubi P, Tandjaoui-Lambiotte Y, Van Der Meersch G, Oziel J, Soulie M, Ghalayini M, Winchenne A, Zahar JR, Ahmed P, Gaudry S, Cohen Y
High flow nasal oxygen therapy to avoid invasive mechanical ventilation in SARS-CoV-2 pneumonia: a retrospective study.
Annals of Intensive Care 2021, 11, 37.
Touchard C, Cartailler J, Vellieux G, de Montmollin E, Jaquet P, Wanono R, Reuter J, Para M, Bouadma L, Timsit JF, d'Ortho MP, Kubis N, Rouvel Tallec A, Sonneville R, DINAMO Study Group
Simplified frontal EEG in adults under veno-arterial extracorporeal membrane oxygenation.
Annals of Intensive Care 2021, 11, 76.
Fartoukh M, Voiriot G, Guérin L, Ricard JD, Combes A, Faure M, Benghanem S, de Montmollin E, Tandjaoui-Lambiotte Y, Vieillard-Baron A, Maury E, Diehl JL, Razazi K, Lemiale V, Trouiller P, Planquette B, Savale L, Heming N, Marey J, AP-HP Clinical Data Warehouse, Carrat F, Lapidus N, EPIcuFLU_APHP Group
Seasonal burden of severe influenza virus infection in the critically ill patients, using the Assistance Publique-Hôpitaux de Paris clinical data warehouse: a pilot study.
Annals of Intensive Care 2021, 11, 117.
Yatim N, Boussier J, Chocron R, Hadjadj J, Philippe A, Gendron N, Barnabei L, Charbit B, Szwebel TA, Carlier N, Pène F, Azoulay C, Khider L, Mirault T, Diehl JL, Guerin CL, Rieux-Laucat F, Duffy D, Kernéis S, Smadja DM, Terrier B
Platelet activation in critically ill COVID-19 patients.
Annals of Intensive Care 2021, 11, 113.
Jung B, Le Bihan C, Portales P, Bourgeois N, Vincent T, Lachaud L, Chanques G, Conseil M, Corne P, Massanet P, Timsit JF, Jaber S
Monocyte human leukocyte antigen-DR but not β-D-glucan may help early diagnosing invasive Candida infection in critically ill patients.
Annals of Intensive Care 2021, 11, 129.
Sanchez MA, Vuagnat A, Grimaud O, Leray E, Philippe JM, Lescure FX, Boutonnet M, Coignard H, Hibon AR, Sanchez S, Pottecher J
Impact of ICU transfers on the mortality rate of patients with COVID-19: insights from comprehensive national database in France.
Annals of Intensive Care 2021, 11, 151.
Buetti N, Ruckly S, Lucet JC, Mageau A, Dupuis C, Souweine B, Mimoz O, Timsit JF
Practices and intravascular catheter infection during on- and off-hours in critically ill patients.
Annals of Intensive Care 2021, 11, 153.
Gibelin A, Dumas G, Valade S, de Chambrun MP, Bagate F, Neuville M, Schneider F, Baboi L, Groh M, Raphalen JH, Chiche JD, De Prost N, Luyt CE, Guérin C, Maury E, de Montmollin E, Hertig A, Parrot A, Clere-Jehl R, Fartoukh M
Causes of acute respiratory failure in patients with small-vessel vasculitis admitted to intensive care units: a multicenter retrospective study.
Annals of Intensive Care 2021, 11, 158.
Diab-El Schahawi M, Zingg W, Vos M, Humphreys H, Lopez-Cerero L, Fueszl A, Zahar JR, Presterl E, ESCMID Study Group on Nosocomial Infections “The decontamination research working group”
Ultraviolet disinfection robots to improve hospital cleaning: Real promise or just a gimmick?.
Antimicrobial Resistance and Infection Control 2021, 10, 33.
Andolfo A, Maatoug R, Peiffer-Smadja N, Fayolle C, Blanckaert K
Emergency ward ultrasound: clinical audit on disinfection practices during routine and sterile examinations.
Antimicrobial Resistance and Infection Control 2021, 10, 25.
Deschanvres C, Haudebourg T, Peiffer-Smadja N, Blanckaert K, Boutoille D, Lucet JC, Birgand G
How do the general population behave with facemasks to prevent COVID-19 in the community? A multi-site observational study.
Antimicrobial Resistance and Infection Control 2021, 10, 61.
Epelboin S, Labrosse J, De Mouzon J, Fauque P, Gervoise-Boyer MJ, Levy R, Sermondade N, Hesters L, Bergère M, Devienne C, Jonveaux P, Ghosn J, Pessione F
Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study.
PLoS medicine 2021, 18, e1003857.
Heid-Picard B, Cochand-Priollet B, Rozenberg F, Giang-Phang D, Viard JP, La Torre V, Ghosn J
Ambulatory anal self-sampling in MSM living with HIV, an acceptable and reliable screening method.
PloS One 2021, 16, e0246338.
Farfour E, Dimi S, Chassany O, Fouéré S, Valin N, Timsit J, Ghosn J, Duvivier C, Duracinsky M, Zucman D, DRIVER study group
Trends in asymptomatic STI among HIV-positive MSM and lessons for systematic screening.
PloS One 2021, 16, e0250557.
d'Humières C, Patrier J, Lortat-Jacob B, Tran-Dinh A, Chemali L, Maataoui N, Rondinaud E, Ruppé E, Burdet C, Ruckly S, Montravers P, Timsit JF, Armand-Lefevre L
Two original observations concerning bacterial infections in COVID-19 patients hospitalized in intensive care units during the first wave of the epidemic in France.
PloS One 2021, 16, e0250728.
Papin G, Bailly S, Dupuis C, Ruckly S, Gainnier M, Argaud L, Azoulay E, Adrie C, Souweine B, Goldgran-Toledano D, Marcotte G, Gros A, Reignier J, Mourvillier B, Forel JM, Sonneville R, Dumenil AS, Darmon M, Garrouste-Orgeas M, Schwebel C, Timsit JF, OUTCOMEREA study group
Clinical and biological clusters of sepsis patients using hierarchical clustering.
PloS One 2021, 16, e0252793.
Dupuis C, de Montmollin E, Buetti N, Goldgran-Toledano D, Reignier J, Schwebel C, Domitile J, Neuville M, Ursino M, Siami S, Ruckly S, Alberti C, Mourvillier B, Bailly S, Laurent V, Gainnier M, Souweine B, Timsit JF, OutcomeReaTM research network
Impact of early corticosteroids on 60-day mortality in critically ill patients with COVID-19: A multicenter cohort study of the OUTCOMEREA network.
PloS One 2021, 16, e0255644.
Bitty-Anderson AM, Ferré V, Gbeasor-Komlanvi FA, Tchankoni MK, Sadio A, Salou M, Descamps D, Dagnra CA, Charpentier C, Ekouevi DK, Coffie PA
Prevalence of hepatitis B and C among female sex workers in Togo, West Africa.
PloS One 2021, 16, e0259891.
Delaroche L, Bertine M, Oger P, Descamps D, Damond F, Genauzeau E, Meicler P, Le Hingrat Q, Lamazou F, Gschwind R, Ruppé E, Visseaux B
Evaluation of SARS-CoV-2 in semen, seminal plasma, and spermatozoa pellet of COVID-19 patients in the acute stage of infection.
PloS One 2021, 16, e0260187.
Evrard D, Jurcisin I, Assadi M, Patrier J, Tafani V, Ullmann N, Timsit JF, Montravers P, Barry B, Weiss E, Rozencwajg S
Tracheostomy in COVID-19 acute respiratory distress syndrome patients and follow-up: A parisian bicentric retrospective cohort.
PloS One 2021, 16, e0261024.
Maatoug R, Peiffer-Smadja N, Delval G, Brochu T, Pitrat B, Millet B
Ecological Momentary Assessment Using Smartphones in Patients With Depression: Feasibility Study.
JMIR formative research 2021, 5, e14179.
Denis F, Fontanet A, Le Douarin YM, Le Goff F, Jeanneau S, Lescure FX
A Self-Assessment Web-Based App to Assess Trends of the COVID-19 Pandemic in France: Observational Study.
Journal of Medical Internet Research 2021, 23, e26182.
Denis F, Septans AL, Le Goff F, Jeanneau S, Lescure FX
Analysis of COVID-19 Transmission Sources in France by Self-Assessment Before and After the Partial Lockdown: Observational Study.
Journal of Medical Internet Research 2021, 23, e26932.
Dellière S, Peiffer-Smadja N, João-Lopes M, Cevik M, Pichon M, Bleibtreu A, Schweitzer V, Last K, Ferreira TG, Lemaignen A, Barac A
Aims and challenges of building national trainee networks in clinical microbiology and infectious disease disciplines.
Future Microbiology 2021, 16, 687-695.
Bosetti P, Kiem CT, Yazdanpanah Y, Fontanet A, Lina B, Colizza V, Cauchemez S
Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2021, 26,
Jolivet S, Couturier J, Vuillemin X, Gouot C, Nesa D, Adam M, Brissot E, Mohty M, Bonnin RA, Dortet L, Barbut F
Outbreak of OXA-48-producing Enterobacterales in a haematological ward associated with an uncommon environmental reservoir, France, 2016 to 2019.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2021, 26,
Tran Kiem C, Crépey P, Bosetti P, Levy Bruhl D, Yazdanpanah Y, Salje H, Boëlle PY, Cauchemez S
Lockdown as a last resort option in case of COVID-19 epidemic rebound: a modelling study.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2021, 26,
Castry M, Cousien A, Bellet J, Champenois K, Pialoux G, Yazdanpanah Y, Costagliola D, Grabar S, Deuffic-Burban S, French Hospital Database on HIV (ANRS CO4-FHDH Cohort)
Hepatitis C virus (HCV) incidence among men who have sex with men (MSM) living with HIV: results from the French Hospital Database on HIV (ANRS CO4-FHDH) cohort study, 2014 to 2017.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2021, 26,
Travert B, Dossier A, Jamme M, Cointe A, Delmas Y, Malot S, Wynckel A, Seguin A, Presne C, Hie M, Benhamou Y, Ribes D, Choukroun G, Grangé S, Hertig A, Le Gall EC, Galicier L, Daugas E, Bouadma L, Weill FX, Azoulay E, Fakhouri F, Veyradier A, Bonacorsi S, Hogan J, Frémeaux-Bacchi V, Rondeau E, Mariani-Kurkdjian P, Coppo P, Centre de Référence des Microangiopathies Thrombotiques2
Shiga Toxin-Associated Hemolytic Uremic Syndrome in Adults, France, 2009-2017.
Emerging Infectious Diseases 2021, 27, 1876-1885.
Brousse V, Holvoet L, Pescarmona R, Viel S, Perret M, Visseaux B, Ferre VM, Ithier G, Le Van Kim C, Benkerrou M, Missud F, Koehl B
Low incidence of COVID-19 severe complications in a large cohort of children with sickle cell disease: a protective role for basal interferon-1 activation?.
Haematologica 2021
Lebourgeois S, Chenane HR, Houhou-Fidouh N, Menidjel R, Ferré VM, Collin G, Benmalek N, Coppée R, Larrouy L, Yazdanpanah Y, Timsit JF, Charpentier C, Descamps D, Visseaux B
Earlier In Vitro Viral Production With SARS-CoV-2 Alpha Than With Beta, Gamma, B, or A.27 Variants.
Frontiers in Cellular and Infection Microbiology 2021, 11, 792202.
Bonacorsi S, Visseaux B, Bouzid D, Pareja J, Rao SN, Manissero D, Hansen G, Vila J
Systematic Review on the Correlation of Quantitative PCR Cycle Threshold Values of Gastrointestinal Pathogens With Patient Clinical Presentation and Outcomes.
Frontiers in Medicine 2021, 8, 711809.
Sarda-Mantel L, Kaoutar J, Alfaiate T, Lopes A, Paycha F, Benali K, Mikail N, Soussan M, Lemarignier C, Méchaï F, Nagat SL, Montravers F, Deradji O, Durand E, Goulenok T, Ponscarme D, Yéni P, Laouénan C, Rioux C
[ 18 F]FDG Positron Emission Tomography for Initial Staging and Healing Assessment at the End of Therapy in Lymph Nodes and Bone Tuberculosis.
Frontiers in Medicine 2021, 8, 715115.
Bizot E, Bousquet A, Charpié M, Coquelin F, Lefevre S, Le Lorier J, Patin M, Sée P, Sarfati E, Walle S, Visseaux B, Basmaci R
Rhinovirus: A Narrative Review on Its Genetic Characteristics, Pediatric Clinical Presentations, and Pathogenesis.
Frontiers in Pediatrics 2021, 9, 643219.
Faraut B, Tonetti L, Malmartel A, Grabar S, Ghosn J, Viard JP, Natale V, Léger D
Sleep, Prospective Memory, and Immune Status among People Living with HIV.
International Journal of Environmental Research and Public Health 2021, 18,
Ursino M, Dupuis C, Buetti N, de Montmollin E, Bouadma L, Golgran-Toledano D, Ruckly S, Neuville M, Cohen Y, Mourvillier B, Souweine B, Gainnier M, Laurent V, Terzi N, Shiami S, Reignier J, Alberti C, Timsit JF, On Behalf Of The Outcomerea Study Group n
Multistate Modeling of COVID-19 Patients Using a Large Multicentric Prospective Cohort of Critically Ill Patients.
Journal of Clinical Medicine 2021, 10,
Peyrony O, Gamelon D, Brune R, Chauvin A, Ghazali DA, Yordanov Y, Arsicaud A, Gilleron P, Curac S, Richard MC, Feral-Pierssens AL, Villoing B, Beaune S, Goulet H, Fontaine JP, François A, Pirenne F
Red Blood Cell Transfusion in the Emergency Department: An Observational Cross-Sectional Multicenter Study.
Journal of Clinical Medicine 2021, 10, 2475.
Xu E, Pérez-Torres D, Fragkou PC, Zahar JR, Koulenti D
Nosocomial Pneumonia in the Era of Multidrug-Resistance: Updates in Diagnosis and Management.
Microorganisms 2021
Brossas JY, Griselda B, Bisio M, Guihenneuc J, Gulin JEN, Jauréguiberry S, Lescure FX, Fekkar A, Mazier D, Altcheh J, Paris L
Evaluation of the Chagas Western Blot IgG Assay for the Diagnosis of Chagas Disease.
Pathogens (Basel, Switzerland) 2021, 10, 1455.
Peiffer-Smadja N, Bridier-Nahmias A, Ferré VM, Charpentier C, Garé M, Rioux C, Allemand A, Lavallée P, Ghosn J, Kramer L, Descamps D, Yazdanpanah Y, Visseaux B
Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2.
Viruses 2021, 13, 1642.
Ghazali DA, Choquet C, Bouzid D, Colosi L, Ben Hammouda A, Wargon M, Gay M, Vaittinada Ayar P, Douay B, Revue E, Soulat L, Hellmann R, Casalino E
Analysis of the Feasibility of a Vaccination Campaign against Influenza Epidemic and COVID-19 Pandemic in French Emergency Departments: A National Survey.
Vaccines 2021, 9, 400.
Michiels Y, Houhou-Fidouh N, Collin G, Berger J, Kohli E
Impact of Low-Dose Methotrexate-Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis.
Vaccines 2021, 9, 883.
Michiels Y, Houhou-Fidouh N, Collin G, Berger J, Kohli E
Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient.
Vaccines 2021, 9, 1140.
Prodel M, Finkielsztejn L, Roustand L, Nachbaur G, De Leotoing L, Genreau M, Bonnet F, Ghosn J
Costs and mortality associated with HIV: a machine learning analysis of the French national health insurance database.
Journal of Public Health Research 2021, 11,
Luan L, Fraisse P, Cordel H, Charlois C, Méchaï F, Ibanez G, Hargreaves S, Mechain M, Vignier N
Screening for active and latent TB among migrants in France.
The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union Against Tuberculosis and Lung Disease 2021, 25, 903-910.
Casalino E, Bouzid D, Antoniol S, Pinto A, Choquet C, Pereira L, Pavlovsky T, Ing V, Yazdanpanah Y, Ghosn J, Ghazali DA
Characteristics of human immunodeficiency virus exposure and predictors of time until access to postexposure prophylaxis: a prospective observational study.
Emergencias: Revista De La Sociedad Espanola De Medicina De Emergencias 2021, 33, 35-41.
Assessment of Magnetic Resonance Imaging Changes and Functional Outcomes Among Adults With Severe Herpes Simplex Encephalitis.
JAMA network open 2021, 4, e2114328.
Birgand G, Mutters NT, Otter J, Eichel VM, Lepelletier D, Morgan DJ, Lucet JC
Variation of National and International Guidelines on Respiratory Protection for Health Care Professionals During the COVID-19 Pandemic.
JAMA network open 2021, 4, e2119257.
Cousien A, Acquaviva E, Kernéis S, Yazdanpanah Y, Delorme R
Temporal Trends in Suicide Attempts Among Children in the Decade Before and During the COVID-19 Pandemic in Paris, France.
JAMA network open 2021, 4, e2128611.
Atkinson A, Miro JM, Mocroft A, Reiss P, Kirk O, Morlat P, Ghosn J, Stephan C, Mussini C, Antoniadou A, Doerholt K, Girardi E, De Wit S, Kraus D, Zwahlen M, Furrer H, Opportunistic Infections Working Group of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCOORD
No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL.
Journal of the International AIDS Society 2021, 24, e25726.
Yazdanpanah Y, French COVID cohort investigators and study group
Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID-19 patients.
Journal of Medical Virology 2021, 93, 2149-2159.
Buetti N, Souweine B, Mermel L, Mimoz O, Ruckly S, Loiodice A, Mongardon N, Lucet JC, Parienti JJ, Timsit JF
Obesity and risk of catheter-related infections in the ICU. A post hoc analysis of four large randomized controlled trials.
Intensive Care Medicine 2021, 47, 435-443.
Buetti N, Ruckly S, de Montmollin E, Reignier J, Terzi N, Cohen Y, Shiami S, Dupuis C, Timsit JF
COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network.
Intensive Care Medicine 2021, 47, 180-187.
Arabi YM, Azoulay E, Al-Dorzi HM, Phua J, Salluh J, Binnie A, Hodgson C, Angus DC, Cecconi M, Du B, Fowler R, Gomersall CD, Horby P, Juffermans NP, Kesecioglu J, Kleinpell RM, Machado FR, Martin GS, Meyfroidt G, Rhodes A, Rowan K, Timsit JF, Vincent JL, Citerio G
How the COVID-19 pandemic will change the future of critical care.
Intensive Care Medicine 2021, 47, 282-291.
Buetti N, Mimoz O, Mongardon N, Parienti JJ, Timsit JF
Ultrasound-guided catheterization and infectious risk in obese ICU patients.
Intensive Care Medicine 2021, 47, 632-634.
Arabi YM, Derde LPG, Timsit JF
How COVID-19 will change the management of other respiratory viral infections.
Intensive Care Medicine 2021
Bohé J, Abidi H, Brunot V, Klich A, Klouche K, Sedillot N, Tchenio X, Quenot JP, Roudaut JB, Mottard N, Thiollière F, Dellamonica J, Wallet F, Souweine B, Lautrette A, Preiser JC, Timsit JF, Vacheron CH, Ait Hssain A, Maucort-Boulch D, CONTROLe INdividualisé de la Glycémie (CONTROLING) Study Group
Individualised versus conventional glucose control in critically-ill patients: the CONTROLING study-a randomized clinical trial.
Intensive Care Medicine 2021, 47, 1271-1283.
Debray MP, Tarabay H, Males L, Chalhoub N, Mahdjoub E, Pavlovsky T, Visseaux B, Bouzid D, Borie R, Wackenheim C, Crestani B, Rioux C, Saker L, Choquet C, Mullaert J, Khalil A
Observer agreement and clinical significance of chest CT reporting in patients suspected of COVID-19.
European Radiology 2021, 31, 1081-1089.
Poline J, Postaire M, Parize P, Pilmis B, Bille E, Zahar JR, Frange P, Cohen JF, Lortholary O, Toubiana J
Stewardship program on carbapenem prescriptions in a tertiary hospital for adults and children in France: a cohort study.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2021, 40, 1039-1048.
Maataoui N, Chemali L, Patrier J, Tran Dinh A, Le Fèvre L, Lortat-Jacob B, Marzouk M, d'Humières C, Rondinaud E, Ruppé E, Montravers P, Timsit JF, Armand-Lefèvre L
Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2021, 40, 2227-2234.
Vauloup-Fellous C, Maylin S, Périllaud-Dubois C, Brichler S, Alloui C, Gordien E, Rameix-Welti MA, Gault E, Moreau F, Fourati S, Challine D, Pawlotsky JM, Houhou-Fidouh N, Damond F, Mackiewicz V, Charpentier C, Méritet JF, Rozenberg F, Podglajen I, Marot S, Petit H, Burrel S, Akhavan S, Leruez-Ville M, Avettand-Fenoel V, Fourgeaud J, Guilleminot T, Gardiennet E, Bonacorsi S, Carol A, Carcelain G, Villemonteix J, Boukli N, Gozlan J, Morand-Joubert L, Legoff J, Delaugerre C, Chaix ML, Roque-Afonso AM, Dortet L, Naas T, Ronat JB, Lepape S, Marcelin AG, Descamps D
Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2021, 40, 2235-2241.
Mascitti H, Jourdain P, Bleibtreu A, Jaulmes L, Dechartres A, Lescure X, Yordanov Y, Dinh A, AP-HP/Universities/INSERM COVID-19 research collaboration
Prognosis of rash and chilblain-like lesions among outpatients with COVID-19: a large cohort study.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2021, 40, 2243-2248.
Kernéis S, Elie C, Fourgeaud J, Choupeaux L, Delarue SM, Alby ML, Quentin P, Pavie J, Brazille P, Néré ML, Minier M, Gabassi A, Gibaud A, Gauthier S, Leroy C, Voirin-Mathieu E, Poyart C, Vidaud M, Parfait B, Delaugerre C, Tréluyer JM, LeGoff J
Accuracy of saliva and nasopharyngeal sampling for detection of SARS-CoV-2 in community screening: a multicentric cohort study.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2021, 40, 2379-2388.
Maraolo AE, Corcione S, Grossi A, Signori A, Alicino C, Hussein K, Trecarichi EM, Viale P, Timsit JF, Veeraraghavan B, Villegas MV, Rahav G, Daikos GL, Vardakas KZ, Roilides E, Uhlemann AC, Ghafur AK, Mornese Pinna S, Bassetti M, Kohler PP, Giacobbe DR
The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients.
Infectious Diseases and Therapy 2021
Muff S, Tabah A, Que YA, Timsit JF, Mermel L, Harbarth S, Buetti N
Short-Course Versus Long-Course Systemic Antibiotic Treatment for Uncomplicated Intravascular Catheter-Related Bloodstream Infections due to Gram-Negative Bacteria, Enterococci or Coagulase-Negative Staphylococci: A Systematic Review.
Infectious Diseases and Therapy 2021, 10, 1591-1605.
Peiffer-Smadja N, Rozencwajg S, Kherabi Y, Yazdanpanah Y, Montravers P
COVID-19 vaccines: a race against time.
Anaesthesia, Critical Care & Pain Medicine 2021, 100848.
Zahar JR, Allaouchiche B
Even vaccinated against COVID-19, we must continue to wear a mask.
Anaesthesia, Critical Care & Pain Medicine 2021, 40, 100849.
Bailey RL, Ramanan M, Litton E, Yan Kai NS, Coyer FM, Garrouste-Orgeas M, Tabah A, Welcome ICU contributors
Staff perceptions of family access and visitation policies in Australian and New Zealand intensive care units: The WELCOME-ICU survey.
Australian Critical Care: Official Journal of the Confederation of Australian Critical Care Nurses 2021, S1036-7314(21)00108-9.
Boyer A, Timsit JF, Klouche K, Canet E, Phan TN, Bohé J, Rubin S, Orieux A, Lautrette A, Gruson D, Souweine B
Aminoglycosides in Critically Ill Septic Patients With Acute Kidney Injury Receiving Continuous Renal Replacement Therapy: A Multicenter, Observational Study.
Clinical Therapeutics 2021, S0149-2918(21)00206-X.
Boyer A, Timsit JF, Klouche K, Canet E, Phan TN, Bohé J, Rubin S, Orieux A, Lautrette A, Gruson D, Souweine B
Aminoglycosides in Critically Ill Septic Patients With Acute Kidney Injury Receiving Intermittent Hemodialysis: A Multicenter, Observational Study.
Clinical Therapeutics 2021, S0149-2918(21)00210-1.
Bouzid D, Zanella MC, Kerneis S, Visseaux B, May L, Schrenzel J, Cattoir V
Rapid diagnostic tests for infectious diseases in the emergency department.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 182-191.
Fiolet T, Guihur A, Rebeaud ME, Mulot M, Peiffer-Smadja N, Mahamat-Saleh Y
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 19-27.
Fiolet T, Guihur A, Rebeaud ME, Mulot M, Peiffer-Smadja N, Mahamat-Saleh Y
Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 138-140.
Meppiel E, Peiffer-Smadja N, Maury A, Bekri I, Delorme C, Desestret V, Gorza L, Hautecloque-Raysz G, Landre S, Lannuzel A, Moulin S, Perrin P, Petitgas P, SellaI F, Wang A, Tattevin P, de Broucker T, contributors to the NeuroCOVID registry
Neurologic manifestations associated with COVID-19: a multicentre registry.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 458-466.
Tran VT, Mahévas M, Bani-Sadr F, Robineau O, Perpoint T, Perrodeau E, Gallay L, Ravaud P, Goehringer F, Lescure FX, COCORICO Collaborative Group
Corticosteroids in patients hospitalized for COVID-19 pneumonia who require oxygen: observational comparative study using routine care data.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 603-610.
van Rooden SM, Aspevall O, Carrara E, Gubbels S, Johansson A, Lucet JC, Mookerjee S, Palacios-Baena ZR, Presterl E, Tacconelli E, Abbas M, Behnke M, Gastmeier P, van Mourik MSM, PRAISE network
Governance aspects of large-scale implementation of automated surveillance of healthcare-associated infections.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27 Suppl 1, S20-S28.
van Mourik MSM, van Rooden SM, Abbas M, Aspevall O, Astagneau P, Bonten MJM, Carrara E, Gomila-Grange A, de Greeff SC, Gubbels S, Harrison W, Humphreys H, Johansson A, Koek MBG, Kristensen B, Lepape A, Lucet JC, Mookerjee S, Naucler P, Palacios-Baena ZR, Presterl E, Pujol M, Reilly J, Roberts C, Tacconelli E, Teixeira D, Tängdén T, Valik JK, Behnke M, Gastmeier P, PRAISE network
PRAISE: providing a roadmap for automated infection surveillance in Europe.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27 Suppl 1, S3-S19.
Ghosn J, Piroth L, Epaulard O, Le Turnier P, Mentré F, Bachelet D, Laouénan C, French COVID cohort study and investigators groups
Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1041.e1-1041.e4.
Gallay L, Tran VT, Perrodeau E, Vignier N, Mahevas M, Bisio F, Forestier E, Lescure FX, COCO-OLD Study group
Fourteen-day survival among older adults with severe infection with severe acute respiratory syndrome coronavirus 2 treated with corticosteroid: a cohort study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1145-1150.
Yordanov Y, Dinh A, Bleibtreu A, Mensch A, Lescure FX, Debuc E, Jourdain P, Jaulmes L, Dechartres A, AP-HP/Universities/Inserm COVID-19 research collaboration
Clinical characteristics and factors associated with hospital admission or death in 43 103 adult outpatients with coronavirus disease 2019 managed with the Covidom telesurveillance solution: a prospective cohort study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1158-1166.
Buetti N, Marschall J, Timsit JF, Atkinson A, Kronenberg A, Sommerstein R, Swiss Centre for Antibiotic Resistance (ANRESIS)
Distribution of pathogens and antimicrobial resistance in bacteraemia according to hospitalization duration: a nationwide surveillance study in Switzerland.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, S1198-743X(21)00212-3.
Ader F, Peiffer-Smadja N, Poissy J, Bouscambert-Duchamp M, Belhadi D, Diallo A, Delmas C, Saillard J, Dechanet A, Mercier N, Dupont A, Alfaiate T, Lescure FX, Raffi F, Goehringer F, Kimmoun A, Jaureguiberry S, Reignier J, Nseir S, Danion F, Clere-Jehl R, Bouiller K, Navellou JC, Tolsma V, Cabié A, Dubost C, Courjon J, Leroy S, Mootien J, Gaci R, Mourvillier B, Faure E, Pourcher V, Gallien S, Launay O, Lacombe K, Lanoix JP, Makinson A, Martin-Blondel G, Bouadma L, Botelho-Nevers E, Gagneux-Brunon A, Epaulard O, Piroth L, Wallet F, Richard JC, Reuter J, Staub T, Lina B, Noret M, Andrejak C, Lê MP, Peytavin G, Hites M, Costagliola D, Yazdanpanah Y, Burdet C, Mentré F, DisCoVeRy study group
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1826-1837.
Husain M, Rachline A, Cousien A, Rolland S, Rouzaud C, Ferre VM, Gomez MV, Le Teurnier M, Wicky-Thisse M, Descamps D, Yazdanpanah Y, Charpentier C, Pasquet-Cadre A
Impact of the COVID-19 pandemic on the homeless: results from a retrospective closed cohort in France (March-May 2020).
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1520.e1-1520.e5.
Dinh A, Jaulmes L, Dechartres A, Duran C, Mascitti H, Lescure X, Yordanov Y, Jourdain P, AP-HP/Universities/INSERM COVID-19 research collaboration, Data-sciences committee, Scientific committee, Covidom regional centre steering commitee
Time to resolution of respiratory and systemic coronavirus disease 2019 symptoms in community setting.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1862.e1-1862.e4.
Farfour E, Lomont A, Fihman V, Lecuru M, Hüssler S, Ouzani S, Zahar JR, Dortet L, GMC study group
Rapid and accurate eXDR screening: use Xpert Carba-R® with FecalSwab®.
Diagnostic Microbiology and Infectious Disease 2021, 99, 115279.
Charpentier C, Pellissier G, Ichou H, Ferré VM, Larfi I, Phung BC, Vallois D, LeGac S, Aubier M, Descamps D, Fidouh-Houhou N, Bouvet E
Contribution of rapid lateral flow assays from capillary blood specimens to the diagnosis of COVID-19 in symptomatic healthcare workers: a pilot study in a university hospital, Paris, France.
Diagnostic Microbiology and Infectious Disease 2021, 101, 115430.
Louchet M, Peytavin G, Didelot H, Lê M, Bourgeois-Moine A, Carbillon L, Luton D, Matheron I, Rigonnot L, Mandelbrot L
Frequency of differential placental transfer to twins of maternal antiretroviral medications.
European Journal of Obstetrics, Gynecology, and Reproductive Biology 2021, 256, 405-411.
Maillet F, Pourbaix A, le Pluart D, Sirmai L, Postolache SA, Couvelard A, Houhou-Fidouh N, Males L, Deconinck L, Lescure FX
Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments.
IDCases 2021, 24, e01111.
Gourjault C, Tarhini H, Rahi M, Thy M, Le Pluart D, Rioux C, Parisey M, Ismael S, Al Rida Aidibi A, Paradis V, Ghosn J, Yazdanpanah Y, Lescure FX, Gervais A
Cholangitis in three critically ill patients after a severe CoVID-19 infection.
IDCases 2021, e01267.
Bouiller K, Catho G, Le Maréchal M, Gras J, Hentzien M, Peiffer-Smadja N, Bessis S, Cabon M, Dubee V, Lemaignen A, Thy M, Martins C, Thill P, Osei L, ReJIF (Réseau des Jeunes Infectiologues Français, Société de Pathologie Infectieuse de Langue Française)
The role of infectious disease trainees during the first wave of the COVID-19 pandemic: A national survey.
Infectious Diseases Now 2021, 51, 215-217.
Lacarra B, Mellon G, Ortega Perez I, D'Ortenzio E, Lescure FX
Bridging the gap between scientific discovery and clinical application during the COVID-19 epoch.
Infectious Diseases Now 2021, 51, 581-582.
Castan B, Akrich B, Levy-Bachelot L, Amode A, Berthelot A, Mackosso C, Mathis L, Mootien J, Ruimy R, Ruiz F, Timsit JF, Boutoille D
Real-world evaluation of ceftolozane/tazobactam therapy and clinical outcomes in France.
Infectious Diseases Now 2021, S2666-9919(21)00111-1.
Pilmis B, de Ponfilly GP, Farfour E, Ranc AG, Fihman V, Bille E, Dortet L, Degand N, Morand P, Potron A, Mizrahi A, Laurent F, Le Brun C, Guillard T, Héry-Arnaud G, Piau C, Barraud O, Ruffier d'Epenoux L, Zahar JR, Le Monnier A, GMC study group
Epidemiology and clinical characteristics of Klebsiella spp. meningitis in France.
Infectious Diseases Now 2021, S2666-9919(21)00115-9.
Huriez P, Lourtet-Hascoet J, Zahar JR, Le Monnier A, Pilmis B
Frequency of surface bacterial contamination in family physicians' offices.
Infectious Diseases Now 2021, S2666-9919(21)00117-2.
Dupré A, Argy N, Houze S, Leleu A, Choquet C, Matheron S, Bleibtreu A
Imported malaria in metropolitan France, from recommendations to clinical practice - proposal for improvement.
Infectious Diseases Now 2021, 51, 667-672.
Telford E, Ortega-Perez I, Mellon G, Lacarra B, Adjadj E, Madelaine C, D'Ortenzio E, Yazdanpanah Y
Chronicles of a pandemic: how France coordinated the scientific research response to COVID-19.
Infectious Diseases Now 2021, S2666-9919(21)00487-5.
Woerther PL, d'Humières C, Lescure X, Dubreuil L, Rodriguez C, Barbier F, Fihman V, Ruppé E
Is the term "anti-anaerobic" still relevant?.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2021, 102, 178-180.
Pilmis B, Jiang O, Mizrahi A, Nguyen Van JC, Lourtet-Hascoët J, Voisin O, Le Lorc'h E, Hubert S, Ménage E, Azria P, Borie MF, Mahé A, Mourad JJ, Trabattoni E, Ganansia O, Zahar JR, Le Monnier A
No significant difference between ceftriaxone and cefotaxime in the emergence of antibiotic resistance in the gut microbiota of hospitalized patients: A pilot study.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2021, 104, 617-623.
Meybeck A, Tetart M, Baclet V, Alcaraz I, Blondiaux N, Peytavin G, Veyziris N, Robineau O, Senneville E
A disseminated Mycobacterium marinum infection in a renal transplant HIV-infected patient successfully treated with a bedaquiline-containing antimycobacterial treatment: a case report.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2021
Lebourgeois S, Storto A, Gout B, Le Hingrat Q, Ardila Tjader G, Cerdan MDC, English A, Pareja J, Love J, Houhou-Fidouh N, Manissero D, Descamps D, Visseaux B
Performance evaluation of the QIAstat-Dx® Respiratory SARS-CoV-2 Panel.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2021, 107, 179-181.
Nyirenda T, Bockarie M, Machingaidze S, Nderu M, Singh M, Fakier N, Habarugira JM, Beattie P, Pandya L, Jajkowicz D, Yazdanpanah Y, Hankins C, Makanga M
Strengthening capacity for clinical research in sub-Saharan Africa: partnerships and networks.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2021, 110, 54-61.
Eloy P, Tardivon C, Martin-Blondel G, Isnard M, Turnier PL, Marechal ML, Cabié A, Launay O, Tattevin P, Senneville E, Ansart S, Goehringer F, Chirouze C, Bousson L, Laouénan C, Etienne M, Nguyen D, Ghosn J, Duval X, French COVID cohort study and investigators groups
Severity of self-reported symptoms and psychological burden 6-months after hospital admission for COVID-19: a prospective cohort study.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2021, 112, 247-253.
Lévy Y, Wiedemann A, Hejblum BP, Durand M, Lefebvre C, Surénaud M, Lacabaratz C, Perreau M, Foucat E, Déchenaud M, Tisserand P, Blengio F, Hivert B, Gauthier M, Cervantes-Gonzalez M, Bachelet D, Laouénan C, Bouadma L, Timsit JF, Yazdanpanah Y, Pantaleo G, Hocini H, Thiébaut R, French COVID cohort study group
CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death.
iScience 2021, 24, 102711.
Martin A, Storto A, Le Hingrat Q, Collin G, André B, Mallory A, Dangla R, Descamps D, Visseaux B, Gossner O
High-sensitivity SARS-CoV-2 group testing by digital PCR among symptomatic patients in hospital settings.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2021, 141, 104895.
Crescenzo-Chaigne B, Behillil S, Enouf V, Escriou N, Petres S, Ungeheuer MN, Ghosn J, Tubiana S, Bouadma L, van der Werf S, Demeret C, French COVID cohort study group
Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients.
Journal of Clinical Virology Plus 2021, 1, 100041.
Saliba R, Ghelfenstein-Ferreira T, Lomont A, Pilmis B, Carbonnelle E, Seytre D, Nasser-Ayoub E, Zahar JR, Karam-Sarkis D
Risk factors for the environmental spread of different multidrug-resistant organisms: a prospective cohort study.
The Journal of Hospital Infection 2021, 111, 155-161.
Pilmis B, Mizrahi A, Péan de Ponfilly G, Philippart F, Bruel C, Zahar JR, Le Monnier A
Relative faecal abundance of extended-spectrum β-lactamase-producing Enterobacterales and its impact on infections among intensive care unit patients: a pilot study.
The Journal of Hospital Infection 2021, 112, 92-95.
de Lafforest S, Magnier A, Vallée M, Bey E, Le Goux C, Saint F, Therby A, Zahar JR, Sotto A, Bruyere F, Grammatico-Guillon L
FUrTIHF: French Urinary Tract Infections in Healthcare Facilities French Urinary Tract Infections in Healthcare Facilities: 5-year historic cohort 2014-2018.
The Journal of Hospital Infection 2021, S0195-6701(21)00225-5.
Lepape A, Machut A, Gerbier-Colomban S, Kuczewski E, Rasigade JP, Timsit JF, Vanhems P, Wallet F, Savey A, Friggeri A, REA-REZO Group
Automated surveillance in French ICUs: is it feasible? Results from a survey in French ICUs participating in a surveillance network.
The Journal of Hospital Infection 2021, 115, 1-4.
Klement-Frutos E, Burrel S, Peytavin G, Marot S, Lê MP, Godefroy N, Calvez V, Marcelin AG, Caumes E, Pourcher V, Boutolleau D
Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19.
The Journal of Infection 2021, 82, 159-198.
Grall I, Alloui CA, Tandjaoui-Lambiotte Y, Deslandes A, Seytre D, Chappe J, Carbonnelle E, Brichler S, Jacolot A, Zahar JR, Lomont A
Viral transmission in asymptomatic cases of SARS-CoV-2 infection.
The Journal of Infection 2021, 82, 282-327.
Tubiana S, Burdet C, Houhou N, Thy M, Manchon P, Blanquart F, Charpentier C, Guedj J, Alavoine L, Behillil S, Leclercq A, Lucet JC, Yazdanpanah Y, Attia M, Demeret C, Rose T, Bielicki JA, Bruijning-Verhagen P, Goossens H, Descamps D, van der Werf S, Lina B, Duval X, CoVCONTACT study group, Principal investigator, Sponsor: Inserm
High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohort.
The Journal of Infection 2021, 82, 186-230.
de Montmollin E, Faille D, Andrieu V, Ajzenberg N, Timsit JF
Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?.
The Journal of Infection 2021
Velly L, Volant S, Fitting C, Ghazali DA, Salipante F, Mayaux J, Monsel G, Cavaillon JM, Hausfater P
Optimal combination of early biomarkers for infection and sepsis diagnosis in the emergency department: The BIPS study.
The Journal of Infection 2021, 82, 11-21.
Teyssou E, Soulie C, Visseaux B, Lambert-Niclot S, Ferre V, Marot S, Jary A, Sayon S, Zafilaza K, Leducq V, Schnuriger A, Abdi B, Wirden M, Houhou-Fidouh N, Charpentier C, Morand-Joubert L, Burrel S, Descamps D, Calvez V, Marcelin AG
The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients.
The Journal of Infection 2021, 83, 119-145.
Teyssou E, Delagrèverie H, Visseaux B, Lambert-Niclot S, Brichler S, Ferre V, Marot S, Jary A, Todesco E, Schnuriger A, Ghidaoui E, Abdi B, Akhavan S, Houhou-Fidouh N, Charpentier C, Morand-Joubert L, Boutolleau D, Descamps D, Calvez V, Marcelin A, Soulie C
The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19.
The Journal of Infection 2021, S0163-4453(21)00416-3.
Visseaux B, Collin G, Houhou-Fidouh N, Le Hingrat Q, Ferré VM, Damond F, Ichou H, Descamps D, Charpentier C
Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirements.
Journal of Virological Methods 2021, 291, 114086.
Lefrancq N, Paireau J, Hozé N, Courtejoie N, Yazdanpanah Y, Bouadma L, Boëlle PY, Chereau F, Salje H, Cauchemez S
Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: A retrospective national surveillance data analysis.
The Lancet Regional Health. Europe 2021, 5, 100087.
Fournier M, Faille D, Dossier A, Mageau A, Nicaise Roland P, Ajzenberg N, Borie R, Bouadma L, Bunel V, Castier Y, Choquet C, Crestani B, Daugas E, Deconinck L, Descamps D, Descamps V, Dieudé P, Ducrocq G, Faucher N, Goulenok T, Guidoux C, Khalil A, Lavallée P, Lescure FX, Lortat-Jacob B, Mal H, Mutuon P, Pellenc Q, Steg PG, Taille C, Timsit JF, Yazdanpanah Y, Papo T, Sacré K
Arterial Thrombotic Events in Adult Inpatients With COVID-19.
Mayo Clinic Proceedings 2021, 96, 295-303.
Tarhini H, Husain M, Poey N, Lariven S, Lescure FX, Yazdanpanah Y, Gervais A
Jaundice in a patient treated with Anakinra in a context of Covid-19.
Infectious Diseases Now 2021, 51, 217-218.
Sallard E, Belhadi D, Lescure FX, Yazdanpanah Y, Peiffer-Smadja N
Clinical trial protocols of repurposed prophylaxis for COVID-19: A review.
Infectious Diseases Now 2021, 51, 7-13.
Gressens SB, Billard-Pomares T, Leboité H, Cruaud P, Bouchaud O, Carbonnelle E, Méchaï F
Pulmonary tuberculosis: Evaluation of current diagnostic strategy.
Infectious Diseases Now 2021, 51, 273-278.
Bendjelloul G, Gerard S, Birgand G, Lenne F, Rioux C, Lescure X, Yazdanpanah Y, Lucet JC
Impact of admission to high-risk isolation room on patients' and healthcare workers' perceptions: A qualitative cross-assessment Approach.
Infectious Diseases Now 2021, 51, 247-252.
Akhoundi M, Marteau A, Mechaï F, Mantelet S, Izri A
Molecular characterization and genetic diversity of Loa loa parasites responsible of a long-delayed filarial infection in an immigrant patient inhabited in Paris.
Microbial Pathogenesis 2021, 158, 105101.
Maury A, Lyoubi A, Peiffer-Smadja N, de Broucker T, Meppiel E
Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
Revue Neurologique 2021, 177, 51-64.
Hansel B, Potier L, Chalopin S, Larger E, Gautier JF, Delestre F, Masdoua V, Visseaux B, Lucet JC, Kerneis S, Abouleka Y, Thebaut JF, Riveline JP, Kadouch D, Roussel R
The COVID-19 lockdown as an opportunity to change lifestyle and body weight in people with overweight/obesity and diabetes: Results from the national French COVIDIAB cohort.
Nutrition, metabolism, and cardiovascular diseases: NMCD 2021, 31, 2605-2611.
Frija-Masson J, Debray MP, Boussouar S, Khalil A, Bancal C, Motiejunaite J, Galarza-Jimenez MA, Benzaquen H, Penaud D, Laveneziana P, Malrin R, Redheuil A, Donciu V, Lucidarme O, Taillé C, Guerder A, Arnoult F, Vidal-Petiot E, Flamant M, Similowski T, Morelot-Panzini C, Faure M, Lescure FX, Straus C, d'Ortho MP, Gonzalez-Bermejo J
Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: The post Covid M3 study.
Respiratory Medicine 2021, 184, 106435.
Wunderink RG, Matsunaga Y, Ariyasu M, Clevenbergh P, Echols R, Kaye KS, Kollef M, Menon A, Pogue JM, Shorr AF, Timsit JF, Zeitlinger M, Nagata TD
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial.
The Lancet. Infectious Diseases 2021, 21, 213-225.
Bettuzzi T, Jourdes A, Robineau O, Alcaraz I, Manda V, Molina JM, Mehlen M, Cazanave C, Tattevin P, Mensi S, Terrier B, Régent A, Ghosn J, Charlier C, Martin-Blondel G, Dupin N
Ceftriaxone compared with benzylpenicillin in the treatment of neurosyphilis in France: a retrospective multicentre study.
The Lancet. Infectious Diseases 2021, 21, 1441-1447.
Trøseid M, Hites M, Barratt-Due A, Ader F, Yazdanpanah Y
Assessing the evidence on remdesivir.
The Lancet. Infectious Diseases 2021, 21, 1630-1631.
Lescure FX, Honda H, Fowler RA, Lazar JS, Shi G, Wung P, Patel N, Hagino O, Sarilumab COVID-19 Global Study Group
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial.
The Lancet. Respiratory Medicine 2021, 9, 522-532.
Molina JM, Yazdanpanah Y, Afani Saud A, Bettacchi C, Chahin Anania C, DeJesus E, Olsen Klopfer S, Grandhi A, Eves K, Robertson MN, Correll T, Hwang C, Hanna GJ, Sklar P
Islatravir in combination with doravirine for treatment-naive adults with HIV-1 infection receiving initial treatment with islatravir, doravirine, and lamivudine: a phase 2b, randomised, double-blind, dose-ranging trial.
The lancet. HIV 2021, 8, e324-e333.
Wei F, Gaisa MM, D'Souza G, Xia N, Giuliano AR, Hawes SE, Gao L, Cheng SH, Donà MG, Goldstone SE, Schim van der Loeff MF, Neukam K, Meites E, Poynten IM, Dai J, Combes JD, Wieland U, Burgos J, Wilkin TJ, Hernandez AL, Iribarren Díaz M, Hidalgo-Tenorio C, Valencia Arredondo M, Nyitray AG, Wentzensen N, Chow EP, Smelov V, Nowak RG, Phanuphak N, Woo YL, Choi Y, Hu Y, Schofield AM, Woestenberg PJ, Chikandiwa AT, Hickey AC, de Pokomandy A, Murenzi G, Péré H, Del Pino M, Ortiz AP, Charnot-Katsikas A, Liu X, Chariyalertsak S, Strong C, Ong JJ, Yunihastuti E, Etienney I, Ferré VM, Zou H, Segondy M, Chinyowa S, Alberts CJ, Clifford GM
Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studies.
The lancet. HIV 2021, 8, e531-e543.
Lachassinne E, de Pontual L, Caseris M, Lorrot M, Guilluy C, Naud A, Dommergues MA, Pinquier D, Wannepain E, Hausherr E, Jung C, Gajdos V, Cohen R, Zahar JR, Brichler S, Basmaci R, Boelle PY, Bloch-Queyrat C, Aupiais C, COVIDOCRECHE collaborators
SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study.
The Lancet. Child & Adolescent Health 2021, 5, 256-264.
Ghazali DA, Delaire C, Blottiaux E, Lardeur JY, Jost D, Violeau M, Breque C, Oriot D
Development of a Performance Assessment Scale for Simulated Dispatcher-Assisted Cardiopulmonary Resuscitation (Telephone-CPR): A Multi-Center Randomized Simulation-Based Clinical Trial.
Prehospital and Disaster Medicine 2021, 36, 561-569.
Novelli G, Liu J, Biancolella M, Alonzi T, Novelli A, Patten JJ, Cocciadiferro D, Agolini E, Colona VL, Rizzacasa B, Giannini R, Bigio B, Goletti D, Capobianchi MR, Grelli S, Mann J, McKee TD, Cheng K, Amanat F, Krammer F, Guarracino A, Pepe G, Tomino C, Tandjaoui-Lambiotte Y, Uzunhan Y, Tubiana S, Ghosn J, COVID Human Genetic Effort, French COVID Cohort Study Group, CoV-Contact Cohort, Notarangelo LD, Su HC, Abel L, Cobat A, Elhanan G, Grzymski JJ, Latini A, Sidhu SS, Jain S, Davey RA, Casanova JL, Wei W, Pandolfi PP
Inhibition of HECT E3 ligases as potential therapy for COVID-19.
Cell Death & Disease 2021, 12, 310.
Lepers C, Billiard S, Porte M, Méléard S, Tran VC
Inference with selection, varying population size, and evolving population structure: application of ABC to a forward-backward coalescent process with interactions.
Heredity 2021, 126, 335-350.
Perreau M, Suffiotti M, Marques-Vidal P, Wiedemann A, Levy Y, Laouénan C, Ghosn J, Fenwick C, Comte D, Roger T, Regina J, Vollenweider P, Waeber G, Oddo M, Calandra T, Pantaleo G
The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients.
Nature Communications 2021, 12, 4888.
Flament H, Rouland M, Beaudoin L, Toubal A, Bertrand L, Lebourgeois S, Rousseau C, Soulard P, Gouda Z, Cagninacci L, Monteiro AC, Hurtado-Nedelec M, Luce S, Bailly K, Andrieu M, Saintpierre B, Letourneur F, Jouan Y, Si-Tahar M, Baranek T, Paget C, Boitard C, Vallet-Pichard A, Gautier JF, Ajzenberg N, Terrier B, Pène F, Ghosn J, Lescure X, Yazdanpanah Y, Visseaux B, Descamps D, Timsit JF, Monteiro RC, Lehuen A
Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity.
Nature Immunology 2021, 22, 322-335.
Smith N, Goncalves P, Charbit B, Grzelak L, Beretta M, Planchais C, Bruel T, Rouilly V, Bondet V, Hadjadj J, Yatim N, Pere H, Merkling SH, Ghozlane A, Kernéis S, Rieux-Laucat F, Terrier B, Schwartz O, Mouquet H, Duffy D, Di Santo JP
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.
Nature Immunology 2021, 22, 1428-1439.
LeGoff J, Kernéis S, Elie C, Mercier-Delarue S, Gastli N, Choupeaux L, Fourgeaud J, Alby ML, Quentin P, Pavie J, Brazille P, Néré ML, Minier M, Gabassi A, Leroy C, Parfait B, Tréluyer JM, Delaugerre C
Evaluation of a saliva molecular point of care for the detection of SARS-CoV-2 in ambulatory care.
Scientific Reports 2021, 11, 21126.
Zaki SA, Naous J, Ghanem A, Abou Abbas D, Tomb R, Ghosn J, Assi A
Prevalence of STIs, sexual practices and substance use among 2083 sexually active unmarried women in Lebanon.
Scientific Reports 2021, 11, 9855.
Crawford C, Vanoli E, Decorde B, Lancelot M, Duprat C, Josserand C, Jilesen J, Bouadma L, Timsit JF
Modeling of aerosol transmission of airborne pathogens in ICU rooms of COVID-19 patients with acute respiratory failure.
Scientific Reports 2021, 11, 11778.
Courties A, Boussier J, Hadjadj J, Yatim N, Barnabei L, Péré H, Veyer D, Kernéis S, Carlier N, Pène F, Rieux-Laucat F, Charbit B, Bondet V, Duffy D, Berenbaum F, Terrier B, Sellam J
Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients.
Scientific Reports 2021, 11, 11886.
de Montmollin E, Timsit JF
How Antibiotics Stewardship Can Be Safely Implemented in Patients with Septic Shock?.
Seminars in Respiratory and Critical Care Medicine 2021, 42, 689-697.
Bergwerk M, Gonen T, Lustig Y, Amit S, Lipsitch M, Cohen C, Mandelboim M, Levin EG, Rubin C, Indenbaum V, Tal I, Zavitan M, Zuckerman N, Bar-Chaim A, Kreiss Y, Regev-Yochay G
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
The New England Journal of Medicine 2021
Néant N, Lingas G, Le Hingrat Q, Ghosn J, Engelmann I, Lepiller Q, Gaymard A, Ferré V, Hartard C, Plantier JC, Thibault V, Marlet J, Montes B, Bouiller K, Lescure FX, Timsit JF, Faure E, Poissy J, Chidiac C, Raffi F, Kimmoun A, Etienne M, Richard JC, Tattevin P, Garot D, Le Moing V, Bachelet D, Tardivon C, Duval X, Yazdanpanah Y, Mentré F, Laouénan C, Visseaux B, Guedj J, French COVID Cohort Investigators and French Cohort Study groups
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort.
Proceedings of the National Academy of Sciences of the United States of America 2021, 118,
Dupuis C, Timsit JF
Antibiotics in the first hour: is there new evidence?.
Expert Review of Anti-Infective Therapy 2021, 19, 45-54.
Diallo MS, Samri A, Charpentier C, Bertine M, Cheynier R, Thiébaut R, Matheron S, Collin F, Braibant M, Candotti D, Brun-Vézinet F, Autran B, ANRS CO5 IMMUNOVIR-2 and ANRS CO15 ALT Study Groups
A Comparison of Cell Activation, Exhaustion, and Expression of HIV Coreceptors and Restriction Factors in HIV-1- and HIV-2-Infected Nonprogressors.
AIDS research and human retroviruses 2021, 37, 214-223.
Ghosn J, Abdoul H, Fellahi S, Merlet A, Salmon D, Morini JP, Deleuze J, Blacher J, Capeau J, Bastard JP, Viard JP
Prevalence of Silent Atherosclerosis and Other Comorbidities in an Outpatient Cohort of Adults Living with HIV: Associations with HIV Parameters and Biomarkers.
AIDS research and human retroviruses 2021, 37, 101-108.
Heilmann E, Gregoriano C, Annane D, Reinhart K, Bouadma L, Wolff M, Chastre J, Luyt CE, Tubach F, Branche AR, Briel M, Christ-Crain M, Welte T, Corti C, de Jong E, Nijsten M, de Lange DW, van Oers JAH, Beishuizen A, Girbes ARJ, Deliberato RO, Schroeder S, Kristoffersen KB, Layios N, Damas P, Lima SSS, Nobre V, Wei L, Oliveira CF, Shehabi Y, Stolz D, Tamm M, Verduri A, Wang JX, Drevet S, Gavazzi G, Mueller B, Schuetz P
Duration of antibiotic treatment using procalcitonin-guided treatment algorithms in older patients: a patient-level meta-analysis from randomized controlled trials.
Age and Ageing 2021, 50, 1546-1556.
Veyer D, Kernéis S, Poulet G, Wack M, Robillard N, Taly V, L'Honneur AS, Rozenberg F, Laurent-Puig P, Bélec L, Hadjadj J, Terrier B, Péré H
Highly Sensitive Quantification of Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Sheds Light on its Potential Clinical Value.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 73, e2890-e2897.
Buetti N, Patrier J, Le Hingrat Q, Loiodice A, Bouadma L, Visseaux B, Timsit JF
Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Detection in Blood of Critically Ill Patients.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 72, e690-e691.
Buetti N, Mimoz O, Mermel L, Ruckly S, Mongardon N, Dupuis C, Mira JP, Lucet JC, Mégarbane B, Bailly S, Parienti JJ, Timsit JF
Ultrasound Guidance and Risk for Central Venous Catheter-Related Infections in the Intensive Care Unit: A Post Hoc Analysis of Individual Data of 3 Multicenter Randomized Trials.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 73, e1054-e1061.
Berzow D, Descamps D, Obermeier M, Charpentier C, Kaiser R, Guertler L, Eberle J, Wensing A, Sierra S, Ruelle J, Gomes P, Mansinho K, Taylor N, Jensen B, Döring M, Stürmer M, Rockstroh J, Camacho R
Human Immunodeficiency Virus-2 (HIV-2): A Summary of the Present Standard of Care and Treatment Options for Individuals Living with HIV-2 in Western Europe.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 72, 503-509.
Atkinson A, Zwahlen M, Barger D, d'Arminio Monforte A, De Wit S, Ghosn J, Girardi E, Svedhem V, Morlat P, Mussini C, Noguera-Julian A, Stephan C, Touloumi G, Kirk O, Mocroft A, Reiss P, Miro JM, Carpenter JR, Furrer H, Opportunistic Infections Project Working Group of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord
Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHERE.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 73, 195-202.
Temime L, Gustin MP, Duval A, Buetti N, Crépey P, Guillemot D, Thiébaut R, Vanhems P, Zahar JR, Smith DRM, Opatowski L
A Conceptual Discussion About the Basic Reproduction Number of Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Settings.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 72, 141-143.
Contejean A, Leporrier J, Canouï E, Alby-Laurent F, Lafont E, Beaudeau L, Parize P, Lecieux F, Greffet A, Chéron G, Gauzit R, Fourgeaud J, L'Honneur AS, Tréluyer JM, Charlier C, Casetta A, Frange P, Leruez-Ville M, Rozenberg F, Lortholary O, Kernéis S
Comparing Dynamics and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 Transmissions Among Healthcare Workers of Adult and Pediatric Settings in Central Paris.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 72, 257-264.
Sax PE, Rockstroh JK, Luetkemeyer AF, Yazdanpanah Y, Ward D, Trottier B, Rieger A, Liu H, Acosta R, Collins SE, Brainard DM, Martin H, GS-US-380–4030 Investigators
Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 73, e485-e493.
Zucman N, Uhel F, Descamps D, Roux D, Ricard JD
Severe Reinfection With South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant 501Y.V2.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 73, 1945-1946.
Betton M, Livrozet M, Planas D, Fayol A, Monel B, Védie B, Bruel T, Tartour E, Robillard N, Manuguerra JC, Blanchard A, Ghosn J, Visseaux B, Péré H, Lebeaux D, Schwartz O, Veyer D, Hulot JS, French COVID Cohort Study Group
Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 73, e1337-e1344.
Bruneau T, Wack M, Poulet G, Robillard N, Philippe A, Laurent-Puig P, Bélec L, Hadjadj J, Xiao W, Kallberg JL, Kernéis S, Diehl JL, Terrier B, Smadja D, Taly V, Veyer D, Péré H
Circulating ubiquitous RNA, a highly predictive and prognostic biomarker in hospitalized COVID-19 patients.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, ciab997.
Tarhini H, Recoing A, Bridier-Nahmias A, Rahi M, Lambert C, Martres P, Lucet JC, Rioux C, Bouzid D, Lebourgeois S, Descamps D, Yazdanpanah Y, Le Hingrat Q, Lescure FX, Visseaux B
Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection.
The Journal of Infectious Diseases 2021, 223, 1522-1527.
Pelleau S, Woudenberg T, Rosado J, Donnadieu F, Garcia L, Obadia T, Gardais S, Elgharbawy Y, Velay A, Gonzalez M, Nizou JY, Khelil N, Zannis K, Cockram C, Merkling SH, Meola A, Kerneis S, Terrier B, de Seze J, Planas D, Schwartz O, Dejardin F, Petres S, von Platen C, Pellerin SF, Arowas L, de Facci LP, Duffy D, Cheallaigh CN, Dunne J, Conlon N, Townsend L, Duong V, Auerswald H, Pinaud L, Tondeur L, Backovic M, Hoen B, Fontanet A, Mueller I, Fafi-Kremer S, Bruel T, White M
Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection.
The Journal of Infectious Diseases 2021, 224, 1489-1499.
Lê MP, Peiffer-Smadja N, Guedj J, Neant N, Mentré F, Ader F, Yazdanpanah Y, Peytavin G, C21DFSC
Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response.
The Journal of Antimicrobial Chemotherapy 2021, 76, 277-279.
Palich R, Allavena C, Peytavin G, Soulie C, Tubiana R, Weiss L, Montoya Ferrer A, Duvivier C, Bouchaud O, Bottero J, Durand A, Lê MP, Marcelin AG, Dudoit Y, Assoumou L, Katlama C, ETRAL QD study group
Once-daily etravirine/raltegravir (400/800 mg q24h) dual therapy maintains viral suppression over 48 weeks in HIV-infected patients switching from a twice-daily etravirine/raltegravir (200/400 mg q12h) regimen.
The Journal of Antimicrobial Chemotherapy 2021, 76, 477-481.
Force G, Ghout I, Ropers J, Carcelain G, Marigot-Outtandy D, Hahn V, Darchy N, Defferriere H, Bouaziz-Amar E, Carlier R, Dorgham K, Callebert J, Peytavin G, Delaugerre C, de Truchis P, NEURO+3 STUDY GROUP
Improvement of HIV-associated neurocognitive disorders after antiretroviral therapy intensification: the Neuro+3 study.
The Journal of Antimicrobial Chemotherapy 2021, 76, 743-752.
Kernéis S, Lucet JC, Santoro A, Meschiari M
Individual and collective impact of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in patients admitted to the ICU.
The Journal of Antimicrobial Chemotherapy 2021, 76, i19-i26.
Contejean A, Tisseyre M, Canouï E, Treluyer JM, Kerneis S, Chouchana L
Combination of vancomycin plus piperacillin and risk of acute kidney injury: a worldwide pharmacovigilance database analysis.
The Journal of Antimicrobial Chemotherapy 2021, 76, 1311-1314.
Palich R, Abdi B, Wirden M, Lourida G, Tubiana R, Faycal A, Valantin MA, Schneider L, Seang S, Agher R, Simon A, Soulie C, Le MP, Peytavin G, Calvez V, Marcelin AG, Katlama C
Intermittent two-drug antiretroviral therapies maintain long-term viral suppression in real life in highly experienced HIV-infected patients.
The Journal of Antimicrobial Chemotherapy 2021, 76, 1893-1897.
Contejean A, Charlier C, Treluyer JM, Kernéis S, Chouchana L
A worldwide pharmacovigilance database analysis to assess the risk of acute kidney injury in patients receiving teicoplanin in association with piperacillin, cefepime or meropenem.
The Journal of Antimicrobial Chemotherapy 2021, 76, 2221-2223.
Charpentier C, Storto A, Soulié C, Ferré VM, Wirden M, Joly V, Lambert-Niclot S, Palich R, Morand-Joubert L, Landman R, Lacombe K, Katlama C, Ghosn J, Marcelin AG, Calvez V, Descamps D
Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients.
The Journal of Antimicrobial Chemotherapy 2021, 76, 2983-2987.
Bachelard A, Isernia V, Vallois D, Le Gac S, Chalal L, Landman R, Damond F, Descamps D, Yazdanpanah Y, Peytavin G, Ghosn J
Efficacy and tolerability of combined antiretroviral treatment with bictegravir/emtricitabine/tenofovir alafenamide initiated at the time of primary HIV infection.
The Journal of Antimicrobial Chemotherapy 2021, 76, 2484-2485.
Marcelin AG, Charpentier C, Bellecave P, Abdi B, Chaix ML, Ferre V, Raymond S, Fofana D, Bocket L, Mirand A, Le Guillou-Guillemette H, Montes B, Amiel C, Pallier C, Fafi-Kremer S, De Monte A, Alessandri-Gradt E, Scholtes C, Maillard A, Jeulin H, Bouvier-Alias M, Roussel C, Dos Santos G, Signori-Schmuck A, Dina J, Vallet S, Stefic K, Soulié C, Calvez V, Descamps D, Flandre P, ANRS-MIE AC43 Group
Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey.
The Journal of Antimicrobial Chemotherapy 2021, 76, 2400-2406.
Martin C, Gracias S, Charpentier C, Descamps D, Le Hingrat Q, Plantier JC, Alessandri-Gradt E
HIV-1 non-group M phenotypic susceptibility in vitro to bictegravir and cabotegravir.
The Journal of Antimicrobial Chemotherapy 2021, 76, 2306-2309.
Lê MP, Pencolé L, Peytavin G, Bouchet-Crivat F, Mandelbrot L
Placental transfer of doravirine, a recent HIV-1 NNRTI in the ex vivo human cotyledon perfusion model.
The Journal of Antimicrobial Chemotherapy 2021, 76, 2364-2367.
Bouzid D, Casalino E, Mullaert J, Laurent O, Duval X, Lescure FX, Peiffer Smadja N, Tubiana S, Armand Lefèvre L, Descamps D, Fidouh N, Choquet C, Lucet JC, Visseaux B
Added value of rapid respiratory syndromic testing at point of care versus central laboratory testing: a controlled clinical trial.
The Journal of Antimicrobial Chemotherapy 2021, 76, iii20-iii27.
Bouzid D, Vila J, Hansen G, Manissero D, Pareja J, Rao SN, Visseaux B
Systematic review on the association between respiratory virus real-time PCR cycle threshold values and clinical presentation or outcomes.
The Journal of Antimicrobial Chemotherapy 2021, 76, iii33-iii49.
Deschanvres C, Reynes J, Lamaury I, Rey D, Palich R, Bani-Sadr F, Robineau O, Duvivier C, Hocqueloux L, Cuzin L, Joly V, Raffi F, Cabie A, Allavena C, Dat’AIDS Study Group
Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting.
The Journal of Antimicrobial Chemotherapy 2021, 77, 196-204.
Contejean A, Leporrier J, Canouï E, Fourgeaud J, Mariaggi AA, Alby-Laurent F, Lafont E, Beaudeau L, Rouzaud C, Lecieux F, Greffet A, L'Honneur AS, Tréluyer JM, Lanternier F, Casetta A, Frange P, Leruez-Ville M, Rozenberg F, Lortholary O, Kernéis S
Transmission Routes of Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers of a French University Hospital in Paris, France.
Open Forum Infectious Diseases 2021, 8, ofab054.
Dupuis C, Le Bihan C, Maubon D, Calvet L, Ruckly S, Schwebel C, Bouadma L, Azoulay E, Cornet M, Timsit JF, Empiricus Study Group
Performance of Repeated Measures of (1-3)-β-D-Glucan, Mannan Antigen, and Antimannan Antibodies for the Diagnosis of Invasive Candidiasis in ICU Patients: A Preplanned Ancillary Analysis of the EMPIRICUS Randomized Clinical Trial.
Open Forum Infectious Diseases 2021, 8, ofab080.
Kernéis S, Planas D, Imbeaud S, Staropoli I, Puech J, Robillard N, Rodary J, Bruel T, Vieillard T, Schwartz O, Belec L, Péré H, Veyer D
Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual.
Open Forum Infectious Diseases 2021, 8, ofab369.
Smith GHR, Henry WK, Podzamczer D, Masiá MDM, Bettacchi CJ, Arasteh K, Jaeger H, Khuong-Josses MA, Montes-Ramírez ML, Stellbrink HJ, Yazdanpanah Y, Richmond GJ, Sutton KC, Zhang F, McCoig CC, St Clair MH, Vandermeulen K, Van Solingen-Ristea R, Smith KY, Margolis DA, Spreen WR
Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study.
Open Forum Infectious Diseases 2021, 8, ofab439.
Visseaux B, Bertine M, Le Hingrat Q, Ferré V, Charpentier C, Collin F, Damond F, Matheron S, Hué S, Descamps D
HIV-2 diversity displays two clades within group A with distinct geographical distribution and evolution.
Virus Evolution 2021, 7, veab024.
Dupuis C, Bouadma L, de Montmollin E, Goldgran-Toledano D, Schwebel C, Reignier J, Neuville M, Ursino M, Siami S, Ruckly S, Alberti C, Mourvillier B, Bailly S, Grapin K, Laurent V, Buetti N, Gainnier M, Souweine B, Timsit JF
Association Between Early Invasive Mechanical Ventilation and Day-60 Mortality in Acute Hypoxemic Respiratory Failure Related to Coronavirus Disease-2019 Pneumonia.
Critical Care Explorations 2021, 3, e0329.
de Montmollin E, Schwebel C, Dupuis C, Garrouste-Orgeas M, da Silva D, Azoulay E, Laurent V, Thiéry G, Grinea A, Marcotte G, Oziel J, Gainnier M, Siami S, Reignier J, Sztrymf B, Adrie C, Ruckly S, Sonneville R, Timsit JF
Life Support Limitations in Mechanically Ventilated Stroke Patients.
Critical Care Explorations 2021, 3, e0341.
Flahault C, Trosdorf M, Sonrier M, Vioulac C, Fasse L, Timsit JF, Bailly S, Garrouste-Orgeas M
ICU Survivors Experience of ICU Diaries: An Ancillary Qualitative Analysis of the ICU Diary Study.
Critical Care Explorations 2021, 3, e0384.
Legouy C, Girard-Stein L, Wanono R, de Montmollin E, Vellieux G, Bouadma L, Dupuis C, Abid S, Vinclair C, Ruckly S, Rouvel-Tallec A, d'Ortho MP, Timsit JF, Sonneville R
Association of Standard Electroencephalography Findings With Mortality and Command Following in Mechanically Ventilated Patients Remaining Unresponsive After Sedation Interruption.
Critical Care Medicine 2021, 49, e423-e432.
Lahens A, Mullaert J, Gressens S, Gault N, Flamant M, Deconinck L, Joly V, Yazdanpanah Y, Lescure FX, Vidal-Petiot E
Association between renin-angiotensin-aldosterone system blockers and outcome in coronavirus disease 2019: analysing in-hospital exposure generates a biased seemingly protective effect of treatment.
Journal of Hypertension 2021, 39, 367-375.
Ansquer R, Oriot D, Ghazali DA
Evaluation of Learning Effectiveness After a Simulation-Based Training Pediatric Course for Emergency Physicians.
Pediatric Emergency Care 2021, 37, e1186-e1191.
Oriot D, Trigolet M, Kessler DO, Auerbach MA, Ghazali DA
Stress: A Factor Explaining the Gap Between Simulated and Clinical Procedure Success.
Pediatric Emergency Care 2021, 37, e1192-e1196.
Aubin J, Rivolet O, Taunay AL, Ragot S, Ghazali DA, Oriot D
Benefit of Simulation-Based Training in Medical Adverse Events Disclosure in Pediatrics.
Pediatric Emergency Care 2021
Sibiude J, Le Chenadec J, Mandelbrot L, Dollfus C, Matheron S, Lelong N, Avettand-Fenoel V, Brossard M, Frange P, Reliquet V, Warszawski J, Tubiana R, EPF study group
Risk of birth defects and perinatal outcomes in HIV-infected women exposed to integrase strand inhibitors during pregnancy.
AIDS (London, England) 2021, 35, 219-226.
Hassold N, Baltes V, Martin A, Méchaï F, Bouchaud O, Cordel H
Hemorrhagic cystitis from BK virus in a patient with AIDS.
AIDS (London, England) 2021, 35, 999-1001.
Ronchetti AM, Matheron S, Galicier L, Damond F, Mahjoub N, Chaghil N, Meignin V, Mechaï F, Simon F, Oksenhendler E, Gérard L
Lymphoma in HIV-2-infected patients in combination antiretroviral therapy era.
AIDS (London, England) 2021, 35, 2299-2309.
Chas J, Bauer R, Larabi IA, Peytavin G, Roux P, Cua E, Cotte L, Pasquet A, Capitant C, Meyer L, Raffi F, Spire B, Pialoux G, Molina JM, Alvarez JC
Evaluation of Drug Abuse by Hair Analysis and Self-Reported Use Among MSM Under PrEP: Results From a French Substudy of the ANRS-IPERGAY Trial.
Journal of Acquired Immune Deficiency Syndromes (1999) 2021, 86, 552-561.
Kerneis S, Visseaux B, Armand-Lefevre L, Timsit JF
Molecular diagnostic methods for pneumonia: how can they be applied in practice?.
Current Opinion in Infectious Diseases 2021, 34, 118-125.
Tabah A, Buetti N, Barbier F, Timsit JF
Current opinion in management of septic shock due to Gram-negative bacteria.
Current Opinion in Infectious Diseases 2021, 34, 718-727.
Armand-Lefèvre L, Rondinaud E, Desvillechabrol D, Mullaert J, Clermont O, Petitjean M, Ruppe E, Cokelaer T, Bouchier C, Tenaillon O, Ma L, Nooroya Y, Matheron S, The Voyag-R Study Group , Andremont A, Denamur E, Kennedy SP
Dynamics of extended-spectrum beta-lactamase-producing Enterobacterales colonization in long-term carriers following travel abroad.
Microbial Genomics 2021, 7, 000576.
Abe E, Assoumou L, de Truchis P, Amat K, Gibowski S, Gras G, Bellet J, Saillard J, Katlama C, Costagliola D, Girard PM, Landman R, Alvarez JC
Pharmacological data of a successful 4-days-a-week regimen in HIV antiretroviral therapy (ANRS 162-4D trial).
British Journal of Clinical Pharmacology 2021, 87, 1930-1939.
Gault N, Esposito-Farese M, Revest M, Inamo J, Cabie A, Polard É, Hulot JS, Ghosn J, Chirouze C, Deconinck L, Diehl JL, Poissy J, Epaulard O, Lefèvre B, Piroth L, de Montmollin E, Oziol E, Etienne M, Laouenan C, Rossignol P, Costagliola D, Vidal-Petiot E, French-Covid cohort investigators and study group
Chronic use of Renin-Angiotensin-Aldosterone-System blockers and mortality in COVID-19: a multicenter prospective cohort and literature review.
Fundamental & Clinical Pharmacology 2021
Le Hingrat Q, Bouzid D, Choquet C, Laurent O, Lescure FX, Timsit JF, Houhou-Fidouh N, Casalino E, Lucet JC, Descamps D, Visseaux B
Viral epidemiology and SARS-CoV-2 co-infections with other respiratory viruses during the first COVID-19 wave in Paris, France.
Influenza and Other Respiratory Viruses 2021, 15, 425-428.
Bauvin P, Delacôte C, Lassailly G, Ntandja Wandji LC, Gnemmi V, Dautrecque F, Louvet A, Caiazzo R, Raverdy V, Leteurtre E, Pattou F, Deuffic-Burban S, Mathurin P
A tool to predict progression of non-alcoholic fatty liver disease in severely obese patients.
Liver International: Official Journal of the International Association for the Study of the Liver 2021, 41, 91-100.
Pasquier G, Bounhiol A, Robert Gangneux F, Zahar JR, Gangneux JP, Novara A, Bougnoux ME, Dannaoui E
A review of significance of Aspergillus detection in airways of ICU COVID-19 patients.
Mycoses 2021, 64, 980-988.
Ghelfenstein-Ferreira T, Beaumont AL, Dellière S, Peiffer-Smadja N, Pineros N, Carbonnelle E, Greub G, Abbara S, Luong Nguyen LB, Lescat M
An Educational Game Evening for Medical Residents: A Proof of Concept to Evaluate the Impact on Learning of the Use of Games.
Journal of Microbiology & Biology Education 2021, 22, e00119-21.
Mageau A, Aldebert G, Van Gysel D, Papo T, Timsit JF, Sacre K
SARS-CoV-2 infection among inpatients with systemic lupus erythematosus in France: a nationwide epidemiological study.
Annals of the Rheumatic Diseases 2021
Reignier J, Le Gouge A, Lascarrou JB, Annane D, Argaud L, Hourmant Y, Asfar P, Badie J, Nay MA, Botoc NV, Brisard L, Bui HN, Chatellier D, Chauvelot L, Combes A, Cracco C, Darmon M, Das V, Debarre M, Delbove A, Devaquet J, Voicu S, Aissaoui-Balanant N, Dumont LM, Oziel J, Gontier O, Groyer S, Guidet B, Jaber S, Lambiotte F, Leroy C, Letocart P, Madeux B, Maizel J, Martinet O, Martino F, Mercier E, Mira JP, Nseir S, Picard W, Piton G, Plantefeve G, Quenot JP, Renault A, Guérin L, Richecoeur J, Rigaud JP, Schneider F, Silva D, Sirodot M, Souweine B, Reizine F, Tamion F, Terzi N, Thévenin D, Thiéry G, Thieulot-Rolin N, Timsit JF, Tinturier F, Tirot P, Vanderlinden T, Vinatier I, Vinsonneau C, Maugars D, Giraudeau B
Impact of early low-calorie low-protein versus standard-calorie standard-protein feeding on outcomes of ventilated adults with shock: design and conduct of a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3).
BMJ open 2021, 11, e045041.
Papot E, Kalampalikis N, Doumergue M, Pilorgé F, Quatremère G, Yazdanpanah Y, Préau M, ANRS-GOTA study group
Can we talk about price with patients when choosing antiretroviral therapy? A survey with people living with HIV and prescribers in France.
BMJ open 2021, 11, e046212.
Voiriot G, Fartoukh M, Durand-Zaleski I, Berard L, Rousseau A, Armand-Lefevre L, Verdet C, Argaud L, Klouche K, Megarbane B, Patrier J, Richard JC, Reignier J, Schwebel C, Souweine B, Tandjaoui-Lambiotte Y, Simon T, Timsit JF, MULTI-CAP study group
Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units.
BMJ open 2021, 11, e048187.
Mora M, Rincon G, Bourrelly M, Maradan G, Freire Maresca A, Michard F, Rouveix E, Pannetier J, Leriche D, Alain T, Yazdanpanah Y, Michels D, Spire B
Living conditions, HIV and gender affirmation care pathways of transgender people living with HIV in France: a nationwide, comprehensive, cross-sectional, community-based research protocol (ANRS Trans&HIV).
BMJ open 2021, 11, e052691.
Mahamat-Saleh Y, Fiolet T, Rebeaud ME, Mulot M, Guihur A, El Fatouhi D, Laouali N, Peiffer-Smadja N, Aune D, Severi G
Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies.
BMJ open 2021, 11, e052777.
Isernia V, Phung B, Lepretre AM, Azadi B, Rincon G, Zelie J, Le Gac S, Deprez A, Michard F, Yazdanpanah Y, Ghosn J
Pre-exposure HIV prophylaxis (PrEP) among transgender women: 3 years of follow-up in a university hospital in Paris.
Sexually Transmitted Infections 2021, 97, 465-466.
Ghanem M, Homps-Legrand M, Garnier M, Morer L, Goletto T, Frija-Masson J, Wicky PH, Jaquet P, Bancal C, Hurtado-Nedelec M, de Chaisemartin L, Jaillet M, Mailleux A, Quesnel C, Poté N, Debray MP, de Montmollin E, Neukirch C, Borie R, Taillé C, Crestani B, French COVID Cohort Study Group
Blood fibrocytes are associated with severity and prognosis in COVID-19 pneumonia.
American Journal of Physiology. Lung Cellular and Molecular Physiology 2021, 321, L847-L858.
Buetti N, Mimoz O, Schwebel C, Ruckly S, Castry M, Dupuis C, Souweine B, Lucet JC, Timsit JF
Insertion Site and Infection Risk among Peripheral Arterial Catheters.
American Journal of Respiratory and Critical Care Medicine 2021, 203, 630-633.
Dumas G, Lemiale V, Rathi N, Cortegiani A, Pène F, Bonny V, Salluh J, Albaiceta GM, Soares M, Soubani AO, Canet E, Hanane T, Kouatchet A, Mokart D, Lebiedz P, Türkoğlu M, Coudroy R, Jeon K, Demoule A, Mehta S, Caruso P, Frat JP, Yang KY, Roca O, Laffey J, Timsit JF, Azoulay E, Darmon M
Survival in Immunocompromised Patients Ultimately Requiring Invasive Mechanical Ventilation: A Pooled Individual Patient Data Analysis.
American Journal of Respiratory and Critical Care Medicine 2021, 204, 187-196.
Tandjaoui-Lambiotte Y, Timsit JF, Alloui C, Zahar JR, Vanoli E
Viral Dispersion in the Intensive Care Unit: The Wind Effect.
American Journal of Respiratory and Critical Care Medicine 2021
Besançon L, Peiffer-Smadja N, Segalas C, Jiang H, Masuzzo P, Smout C, Billy E, Deforet M, Leyrat C
Open science saves lives: lessons from the COVID-19 pandemic.
BMC medical research methodology 2021, 21, 117.
von Cube M, Timsit JF, Kammerlander A, Schumacher M
Quantifying and communicating the burden of COVID-19.
BMC medical research methodology 2021, 21, 164.
Marih L, Sawras V, Pavie J, Sodqi M, Malmoussi M, Tassi N, Bensghir R, Nani S, Lahsen AO, Laureillard D, El Filali KM, Champenois K, Weiss L
Missed opportunities for HIV testing in patients newly diagnosed with HIV in Morocco.
BMC infectious diseases 2021, 21, 48.
Rahi M, Le Pluart D, Beaudet A, Ismaël S, Parisey M, Poey N, Tarhini H, Lescure FX, Yazdanpanah Y, Deconinck L
Sociodemographic characteristics and transmission risk factors in patients hospitalized for COVID-19 before and during the lockdown in France.
BMC infectious diseases 2021, 21, 812.
Tchankoni MK, Bitty-Anderson AM, Sadio AJ, Gbeasor-Komlanvi FA, Ferré VM, Zida-Compaore WIC, Dorkenoo AM, Saka B, Dagnra AC, Charpentier C, Ekouevi DK
Prevalence and factors associated with trichomonas vaginalis infection among female sex workers in Togo, 2017.
BMC infectious diseases 2021, 21, 775.
Blanc E, Chaize G, Fievez S, Féger C, Herquelot E, Vainchtock A, Timsit JF, Gaillat J
The impact of comorbidities and their stacking on short- and long-term prognosis of patients over 50 with community-acquired pneumonia.
BMC infectious diseases 2021, 21, 949.
Gheerbrant H, Timsit JF, Terzi N, Ruckly S, Laramas M, Levra MG, Jacquet E, Falque L, Moro-Sibilot D, Toffart AC
Factors associated with survival of patients with solid Cancer alive after intensive care unit discharge between 2005 and 2013.
BMC cancer 2021, 21, 9.
Hellmann R, Feral-Pierssens AL, Michault A, Casalino E, Ricard-Hibon A, Adnet F, Brun-Ney D, Bouzid D, Menu A, Wargon M
The analysis of the geographical distribution of emergency departments' frequent users: a tool to prioritize public health policies?.
BMC public health 2021, 21, 1689.
Le Roux E, Mari Muro M, Mognon K, Saïd M, Caillavet V, Matheron S, Ledoux S, Decq P, Vorspan F, Le Strat Y, Delaugerre C, Le Bras M, Alberti C, Ruszniewski P, Zerr P, Faye A
A governmental program to encourage medical students to deliver primary prevention: experiment and evaluation in a French faculty of medicine.
BMC medical education 2021, 21, 47.
Ridde V, Gautier L, Dagenais C, Chabrol F, Hou R, Bonnet E, David PM, Cloos P, Duhoux A, Lucet JC, Traverson L, de Araujo Oliveira SR, Cazarin G, Peiffer-Smadja N, Touré L, Coulibaly A, Honda A, Noda S, Tamura T, Baba H, Kodoi H, Zinszer K
Learning from public health and hospital resilience to the SARS-CoV-2 pandemic: protocol for a multiple case study (Brazil, Canada, China, France, Japan, and Mali).
Health Research Policy and Systems 2021, 19, 76.
Dupuis C, Sabra A, Patrier J, Chaize G, Saighi A, Féger C, Vainchtock A, Gaillat J, Timsit JF
Burden of pneumococcal pneumonia requiring ICU admission in France: 1-year prognosis, resources use, and costs.
Critical Care (London, England) 2021, 25, 24.
Buetti N, Ruckly S, Lucet JC, Mimoz O, Souweine B, Timsit JF
Factors influencing local signs at catheter insertion site regardless of catheter-related bloodstream infections.
Critical Care (London, England) 2021, 25, 71.
Wicky PH, Niedermann MS, Timsit JF
Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact?.
Critical Care (London, England) 2021, 25, 153.
Timsit JF, Huntington JA, Wunderink RG, Shime N, Kollef MH, Kivistik Ü, Nováček M, Réa-Neto Á, Martin-Loeches I, Yu B, Jensen EH, Butterton JR, Wolf DJ, Rhee EG, Bruno CJ
Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial.
Critical Care (London, England) 2021, 25, 290.
Niederman MS, Baron RM, Bouadma L, Calandra T, Daneman N, DeWaele J, Kollef MH, Lipman J, Nair GB
Initial antimicrobial management of sepsis.
Critical Care (London, England) 2021, 25, 307.
Kollef MH, Shorr AF, Bassetti M, Timsit JF, Micek ST, Michelson AP, Garnacho-Montero J
Timing of antibiotic therapy in the ICU.
Critical Care (London, England) 2021, 25, 360.
Meyer A, Buetti N, Houhou-Fidouh N, Patrier J, Abdel-Nabey M, Jaquet P, Presente S, Girard T, Sayagh F, Ruckly S, Wicky PH, de Montmollin E, Bouadma L, Sonneville R, Descamps D, Timsit JF
HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients.
Critical Care (London, England) 2021, 25, 417.
Badio M, Lhomme E, Kieh M, Beavogui AH, Kennedy SB, Doumbia S, Leigh B, Sow SO, Diallo A, Fusco D, Kirchoff M, Termote M, Vatrinet R, Wentworth D, Esperou H, Lane HC, Pierson J, Watson-Jones D, Roy C, D'Ortenzio E, Greenwood B, Chêne G, Richert L, Neaton JD, Yazdanpanah Y, PREVAC study team
Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.
Trials 2021, 22, 86.
Lemiale V, Dumas G, Demoule A, Pène F, Kouatchet A, Bisbal M, Nseir S, Argaud L, Kontar L, Klouche K, Barbier F, Seguin A, Louis G, Constantin JM, Mayaux J, Wallet F, Peigne V, Girault C, Oziel J, Nyunga M, Terzi N, Bouadma L, Lautrette A, Bige N, Raphalen JH, Papazian L, Bruneel F, Lebert C, Benoit D, Meert AP, Jaber S, Mokart D, Darmon M, Azoulay E, Groupe de Recherche en Reanimation Respiratoire du patient d’Onco-Hématologie (GRRR-OH)
Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failure.
Annals of Intensive Care 2021, 11, 17.
Bonnet N, Martin O, Boubaya M, Levy V, Ebstein N, Karoubi P, Tandjaoui-Lambiotte Y, Van Der Meersch G, Oziel J, Soulie M, Ghalayini M, Winchenne A, Zahar JR, Ahmed P, Gaudry S, Cohen Y
High flow nasal oxygen therapy to avoid invasive mechanical ventilation in SARS-CoV-2 pneumonia: a retrospective study.
Annals of Intensive Care 2021, 11, 37.
Touchard C, Cartailler J, Vellieux G, de Montmollin E, Jaquet P, Wanono R, Reuter J, Para M, Bouadma L, Timsit JF, d'Ortho MP, Kubis N, Rouvel Tallec A, Sonneville R, DINAMO Study Group
Simplified frontal EEG in adults under veno-arterial extracorporeal membrane oxygenation.
Annals of Intensive Care 2021, 11, 76.
Fartoukh M, Voiriot G, Guérin L, Ricard JD, Combes A, Faure M, Benghanem S, de Montmollin E, Tandjaoui-Lambiotte Y, Vieillard-Baron A, Maury E, Diehl JL, Razazi K, Lemiale V, Trouiller P, Planquette B, Savale L, Heming N, Marey J, AP-HP Clinical Data Warehouse, Carrat F, Lapidus N, EPIcuFLU_APHP Group
Seasonal burden of severe influenza virus infection in the critically ill patients, using the Assistance Publique-Hôpitaux de Paris clinical data warehouse: a pilot study.
Annals of Intensive Care 2021, 11, 117.
Yatim N, Boussier J, Chocron R, Hadjadj J, Philippe A, Gendron N, Barnabei L, Charbit B, Szwebel TA, Carlier N, Pène F, Azoulay C, Khider L, Mirault T, Diehl JL, Guerin CL, Rieux-Laucat F, Duffy D, Kernéis S, Smadja DM, Terrier B
Platelet activation in critically ill COVID-19 patients.
Annals of Intensive Care 2021, 11, 113.
Jung B, Le Bihan C, Portales P, Bourgeois N, Vincent T, Lachaud L, Chanques G, Conseil M, Corne P, Massanet P, Timsit JF, Jaber S
Monocyte human leukocyte antigen-DR but not β-D-glucan may help early diagnosing invasive Candida infection in critically ill patients.
Annals of Intensive Care 2021, 11, 129.
Sanchez MA, Vuagnat A, Grimaud O, Leray E, Philippe JM, Lescure FX, Boutonnet M, Coignard H, Hibon AR, Sanchez S, Pottecher J
Impact of ICU transfers on the mortality rate of patients with COVID-19: insights from comprehensive national database in France.
Annals of Intensive Care 2021, 11, 151.
Buetti N, Ruckly S, Lucet JC, Mageau A, Dupuis C, Souweine B, Mimoz O, Timsit JF
Practices and intravascular catheter infection during on- and off-hours in critically ill patients.
Annals of Intensive Care 2021, 11, 153.
Gibelin A, Dumas G, Valade S, de Chambrun MP, Bagate F, Neuville M, Schneider F, Baboi L, Groh M, Raphalen JH, Chiche JD, De Prost N, Luyt CE, Guérin C, Maury E, de Montmollin E, Hertig A, Parrot A, Clere-Jehl R, Fartoukh M
Causes of acute respiratory failure in patients with small-vessel vasculitis admitted to intensive care units: a multicenter retrospective study.
Annals of Intensive Care 2021, 11, 158.
Diab-El Schahawi M, Zingg W, Vos M, Humphreys H, Lopez-Cerero L, Fueszl A, Zahar JR, Presterl E, ESCMID Study Group on Nosocomial Infections “The decontamination research working group”
Ultraviolet disinfection robots to improve hospital cleaning: Real promise or just a gimmick?.
Antimicrobial Resistance and Infection Control 2021, 10, 33.
Andolfo A, Maatoug R, Peiffer-Smadja N, Fayolle C, Blanckaert K
Emergency ward ultrasound: clinical audit on disinfection practices during routine and sterile examinations.
Antimicrobial Resistance and Infection Control 2021, 10, 25.
Deschanvres C, Haudebourg T, Peiffer-Smadja N, Blanckaert K, Boutoille D, Lucet JC, Birgand G
How do the general population behave with facemasks to prevent COVID-19 in the community? A multi-site observational study.
Antimicrobial Resistance and Infection Control 2021, 10, 61.
Epelboin S, Labrosse J, De Mouzon J, Fauque P, Gervoise-Boyer MJ, Levy R, Sermondade N, Hesters L, Bergère M, Devienne C, Jonveaux P, Ghosn J, Pessione F
Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study.
PLoS medicine 2021, 18, e1003857.
Heid-Picard B, Cochand-Priollet B, Rozenberg F, Giang-Phang D, Viard JP, La Torre V, Ghosn J
Ambulatory anal self-sampling in MSM living with HIV, an acceptable and reliable screening method.
PloS One 2021, 16, e0246338.
Farfour E, Dimi S, Chassany O, Fouéré S, Valin N, Timsit J, Ghosn J, Duvivier C, Duracinsky M, Zucman D, DRIVER study group
Trends in asymptomatic STI among HIV-positive MSM and lessons for systematic screening.
PloS One 2021, 16, e0250557.
d'Humières C, Patrier J, Lortat-Jacob B, Tran-Dinh A, Chemali L, Maataoui N, Rondinaud E, Ruppé E, Burdet C, Ruckly S, Montravers P, Timsit JF, Armand-Lefevre L
Two original observations concerning bacterial infections in COVID-19 patients hospitalized in intensive care units during the first wave of the epidemic in France.
PloS One 2021, 16, e0250728.
Papin G, Bailly S, Dupuis C, Ruckly S, Gainnier M, Argaud L, Azoulay E, Adrie C, Souweine B, Goldgran-Toledano D, Marcotte G, Gros A, Reignier J, Mourvillier B, Forel JM, Sonneville R, Dumenil AS, Darmon M, Garrouste-Orgeas M, Schwebel C, Timsit JF, OUTCOMEREA study group
Clinical and biological clusters of sepsis patients using hierarchical clustering.
PloS One 2021, 16, e0252793.
Dupuis C, de Montmollin E, Buetti N, Goldgran-Toledano D, Reignier J, Schwebel C, Domitile J, Neuville M, Ursino M, Siami S, Ruckly S, Alberti C, Mourvillier B, Bailly S, Laurent V, Gainnier M, Souweine B, Timsit JF, OutcomeReaTM research network
Impact of early corticosteroids on 60-day mortality in critically ill patients with COVID-19: A multicenter cohort study of the OUTCOMEREA network.
PloS One 2021, 16, e0255644.
Bitty-Anderson AM, Ferré V, Gbeasor-Komlanvi FA, Tchankoni MK, Sadio A, Salou M, Descamps D, Dagnra CA, Charpentier C, Ekouevi DK, Coffie PA
Prevalence of hepatitis B and C among female sex workers in Togo, West Africa.
PloS One 2021, 16, e0259891.
Delaroche L, Bertine M, Oger P, Descamps D, Damond F, Genauzeau E, Meicler P, Le Hingrat Q, Lamazou F, Gschwind R, Ruppé E, Visseaux B
Evaluation of SARS-CoV-2 in semen, seminal plasma, and spermatozoa pellet of COVID-19 patients in the acute stage of infection.
PloS One 2021, 16, e0260187.
Evrard D, Jurcisin I, Assadi M, Patrier J, Tafani V, Ullmann N, Timsit JF, Montravers P, Barry B, Weiss E, Rozencwajg S
Tracheostomy in COVID-19 acute respiratory distress syndrome patients and follow-up: A parisian bicentric retrospective cohort.
PloS One 2021, 16, e0261024.
Maatoug R, Peiffer-Smadja N, Delval G, Brochu T, Pitrat B, Millet B
Ecological Momentary Assessment Using Smartphones in Patients With Depression: Feasibility Study.
JMIR formative research 2021, 5, e14179.
Denis F, Fontanet A, Le Douarin YM, Le Goff F, Jeanneau S, Lescure FX
A Self-Assessment Web-Based App to Assess Trends of the COVID-19 Pandemic in France: Observational Study.
Journal of Medical Internet Research 2021, 23, e26182.
Denis F, Septans AL, Le Goff F, Jeanneau S, Lescure FX
Analysis of COVID-19 Transmission Sources in France by Self-Assessment Before and After the Partial Lockdown: Observational Study.
Journal of Medical Internet Research 2021, 23, e26932.
Dellière S, Peiffer-Smadja N, João-Lopes M, Cevik M, Pichon M, Bleibtreu A, Schweitzer V, Last K, Ferreira TG, Lemaignen A, Barac A
Aims and challenges of building national trainee networks in clinical microbiology and infectious disease disciplines.
Future Microbiology 2021, 16, 687-695.
Bosetti P, Kiem CT, Yazdanpanah Y, Fontanet A, Lina B, Colizza V, Cauchemez S
Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2021, 26,
Jolivet S, Couturier J, Vuillemin X, Gouot C, Nesa D, Adam M, Brissot E, Mohty M, Bonnin RA, Dortet L, Barbut F
Outbreak of OXA-48-producing Enterobacterales in a haematological ward associated with an uncommon environmental reservoir, France, 2016 to 2019.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2021, 26,
Tran Kiem C, Crépey P, Bosetti P, Levy Bruhl D, Yazdanpanah Y, Salje H, Boëlle PY, Cauchemez S
Lockdown as a last resort option in case of COVID-19 epidemic rebound: a modelling study.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2021, 26,
Castry M, Cousien A, Bellet J, Champenois K, Pialoux G, Yazdanpanah Y, Costagliola D, Grabar S, Deuffic-Burban S, French Hospital Database on HIV (ANRS CO4-FHDH Cohort)
Hepatitis C virus (HCV) incidence among men who have sex with men (MSM) living with HIV: results from the French Hospital Database on HIV (ANRS CO4-FHDH) cohort study, 2014 to 2017.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2021, 26,
Travert B, Dossier A, Jamme M, Cointe A, Delmas Y, Malot S, Wynckel A, Seguin A, Presne C, Hie M, Benhamou Y, Ribes D, Choukroun G, Grangé S, Hertig A, Le Gall EC, Galicier L, Daugas E, Bouadma L, Weill FX, Azoulay E, Fakhouri F, Veyradier A, Bonacorsi S, Hogan J, Frémeaux-Bacchi V, Rondeau E, Mariani-Kurkdjian P, Coppo P, Centre de Référence des Microangiopathies Thrombotiques2
Shiga Toxin-Associated Hemolytic Uremic Syndrome in Adults, France, 2009-2017.
Emerging Infectious Diseases 2021, 27, 1876-1885.
Brousse V, Holvoet L, Pescarmona R, Viel S, Perret M, Visseaux B, Ferre VM, Ithier G, Le Van Kim C, Benkerrou M, Missud F, Koehl B
Low incidence of COVID-19 severe complications in a large cohort of children with sickle cell disease: a protective role for basal interferon-1 activation?.
Haematologica 2021
Lebourgeois S, Chenane HR, Houhou-Fidouh N, Menidjel R, Ferré VM, Collin G, Benmalek N, Coppée R, Larrouy L, Yazdanpanah Y, Timsit JF, Charpentier C, Descamps D, Visseaux B
Earlier In Vitro Viral Production With SARS-CoV-2 Alpha Than With Beta, Gamma, B, or A.27 Variants.
Frontiers in Cellular and Infection Microbiology 2021, 11, 792202.
Bonacorsi S, Visseaux B, Bouzid D, Pareja J, Rao SN, Manissero D, Hansen G, Vila J
Systematic Review on the Correlation of Quantitative PCR Cycle Threshold Values of Gastrointestinal Pathogens With Patient Clinical Presentation and Outcomes.
Frontiers in Medicine 2021, 8, 711809.
Sarda-Mantel L, Kaoutar J, Alfaiate T, Lopes A, Paycha F, Benali K, Mikail N, Soussan M, Lemarignier C, Méchaï F, Nagat SL, Montravers F, Deradji O, Durand E, Goulenok T, Ponscarme D, Yéni P, Laouénan C, Rioux C
[ 18 F]FDG Positron Emission Tomography for Initial Staging and Healing Assessment at the End of Therapy in Lymph Nodes and Bone Tuberculosis.
Frontiers in Medicine 2021, 8, 715115.
Bizot E, Bousquet A, Charpié M, Coquelin F, Lefevre S, Le Lorier J, Patin M, Sée P, Sarfati E, Walle S, Visseaux B, Basmaci R
Rhinovirus: A Narrative Review on Its Genetic Characteristics, Pediatric Clinical Presentations, and Pathogenesis.
Frontiers in Pediatrics 2021, 9, 643219.
Faraut B, Tonetti L, Malmartel A, Grabar S, Ghosn J, Viard JP, Natale V, Léger D
Sleep, Prospective Memory, and Immune Status among People Living with HIV.
International Journal of Environmental Research and Public Health 2021, 18,
Ursino M, Dupuis C, Buetti N, de Montmollin E, Bouadma L, Golgran-Toledano D, Ruckly S, Neuville M, Cohen Y, Mourvillier B, Souweine B, Gainnier M, Laurent V, Terzi N, Shiami S, Reignier J, Alberti C, Timsit JF, On Behalf Of The Outcomerea Study Group n
Multistate Modeling of COVID-19 Patients Using a Large Multicentric Prospective Cohort of Critically Ill Patients.
Journal of Clinical Medicine 2021, 10,
Peyrony O, Gamelon D, Brune R, Chauvin A, Ghazali DA, Yordanov Y, Arsicaud A, Gilleron P, Curac S, Richard MC, Feral-Pierssens AL, Villoing B, Beaune S, Goulet H, Fontaine JP, François A, Pirenne F
Red Blood Cell Transfusion in the Emergency Department: An Observational Cross-Sectional Multicenter Study.
Journal of Clinical Medicine 2021, 10, 2475.
Xu E, Pérez-Torres D, Fragkou PC, Zahar JR, Koulenti D
Nosocomial Pneumonia in the Era of Multidrug-Resistance: Updates in Diagnosis and Management.
Microorganisms 2021
Brossas JY, Griselda B, Bisio M, Guihenneuc J, Gulin JEN, Jauréguiberry S, Lescure FX, Fekkar A, Mazier D, Altcheh J, Paris L
Evaluation of the Chagas Western Blot IgG Assay for the Diagnosis of Chagas Disease.
Pathogens (Basel, Switzerland) 2021, 10, 1455.
Peiffer-Smadja N, Bridier-Nahmias A, Ferré VM, Charpentier C, Garé M, Rioux C, Allemand A, Lavallée P, Ghosn J, Kramer L, Descamps D, Yazdanpanah Y, Visseaux B
Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2.
Viruses 2021, 13, 1642.
Ghazali DA, Choquet C, Bouzid D, Colosi L, Ben Hammouda A, Wargon M, Gay M, Vaittinada Ayar P, Douay B, Revue E, Soulat L, Hellmann R, Casalino E
Analysis of the Feasibility of a Vaccination Campaign against Influenza Epidemic and COVID-19 Pandemic in French Emergency Departments: A National Survey.
Vaccines 2021, 9, 400.
Michiels Y, Houhou-Fidouh N, Collin G, Berger J, Kohli E
Impact of Low-Dose Methotrexate-Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis.
Vaccines 2021, 9, 883.
Michiels Y, Houhou-Fidouh N, Collin G, Berger J, Kohli E
Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient.
Vaccines 2021, 9, 1140.
Prodel M, Finkielsztejn L, Roustand L, Nachbaur G, De Leotoing L, Genreau M, Bonnet F, Ghosn J
Costs and mortality associated with HIV: a machine learning analysis of the French national health insurance database.
Journal of Public Health Research 2021, 11,
Luan L, Fraisse P, Cordel H, Charlois C, Méchaï F, Ibanez G, Hargreaves S, Mechain M, Vignier N
Screening for active and latent TB among migrants in France.
The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union Against Tuberculosis and Lung Disease 2021, 25, 903-910.
Casalino E, Bouzid D, Antoniol S, Pinto A, Choquet C, Pereira L, Pavlovsky T, Ing V, Yazdanpanah Y, Ghosn J, Ghazali DA
Characteristics of human immunodeficiency virus exposure and predictors of time until access to postexposure prophylaxis: a prospective observational study.
Emergencias: Revista De La Sociedad Espanola De Medicina De Emergencias 2021, 33, 35-41.
2020
Vincent JL, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC, Finfer S, Pelosi P, Brazzi L, Aditianingsih D, Timsit JF, Du B, Wittebole X, Máca J, Kannan S, Gorordo-Delsol LA, De Waele JJ, Mehta Y, Bonten MJM, Khanna AK, Kollef M, Human M, Angus DC, EPIC III Investigators
Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017.
JAMA 2020, 323, 1478-1487.
Luyt CE, Forel JM, Hajage D, Jaber S, Cayot-Constantin S, Rimmelé T, Coupez E, Lu Q, Diallo MH, Penot-Ragon C, Clavel M, Schwebel C, Timsit JF, Bedos JP, Hauw-Berlemont C, Bourenne J, Mayaux J, Lefrant JY, Mira JP, Combes A, Wolff M, Chastre J, Papazian L, for the Preemptive Treatment for Herpesviridae Study Group, Réseau Européen de recherche en Ventilation Artificielle Network
Acyclovir for Mechanically Ventilated Patients With Herpes Simplex Virus Oropharyngeal Reactivation: A Randomized Clinical Trial.
JAMA Internal Medicine 2020, 180, 263.
Birgand G, Peiffer-Smadja N, Fournier S, Kerneis S, Lescure FX, Lucet JC
Assessment of Air Contamination by SARS-CoV-2 in Hospital Settings.
JAMA network open 2020, 3, e2033232.
von Cube M, Schumacher M, Putter H, Timsit JF, van de Velde C, Wolkewitz M
The population-attributable fraction for time-dependent exposures using dynamic prediction and landmarking.
Biometrical Journal. Biometrische Zeitschrift 2020, 62, 583-597.
Heyard R, Timsit JF, Held L, COMBACTE-MAGNET consortium
Validation of discrete time-to-event prediction models in the presence of competing risks.
Biometrical Journal. Biometrische Zeitschrift 2020, 62, 643-657.
Lucet JC, Harris AD, Guidet B
Less contact isolation is more in the ICU: not sure.
Intensive Care Medicine 2020, 46, 1735-1738.
Denny KJ, Kumar A, Timsit JF, Laupland KB
Extra-cardiac endovascular infections in the critically ill.
Intensive Care Medicine 2020, 46, 173-181.
Saied WI, Martin-Loeches I, Timsit JF
What is new in non-ventilated ICU-acquired pneumonia?.
Intensive Care Medicine 2020, 46, 488-491.
Tabah A, Bassetti M, Kollef MH, Zahar JR, Paiva JA, Timsit JF, Roberts JA, Schouten J, Giamarellou H, Rello J, De Waele J, Shorr AF, Leone M, Poulakou G, Depuydt P, Garnacho-Montero J
Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP).
Intensive Care Medicine 2020, 46, 245-265.
Barbier F, Mer M, Szychowiak P, Miller RF, Mariotte É, Galicier L, Bouadma L, Tattevin P, Azoulay É
Management of HIV-infected patients in the intensive care unit.
Intensive Care Medicine 2020, 46, 329-342.
Timsit JF, Ruppé E, Barbier F, Tabah A, Bassetti M
Bloodstream infections in critically ill patients: an expert statement.
Intensive Care Medicine 2020, 46, 266-284.
Timsit JF, Lipman J, Bassetti M
Antimicrobial de-escalation is part of appropriate antibiotic usage in ICU.
Intensive Care Medicine 2020, 46, 1039-1042.
Bouadma L, Lescure FX, Lucet JC, Yazdanpanah Y, Timsit JF
Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists.
Intensive Care Medicine 2020, 46, 579-582.
Andremont O, Armand-Lefevre L, Dupuis C, de Montmollin E, Ruckly S, Lucet JC, Smonig R, Magalhaes E, Ruppé E, Mourvillier B, Lebut J, Lermuzeaux M, Sonneville R, Bouadma L, Timsit JF, COMBACTE net consortium
Semi-quantitative cultures of throat and rectal swabs are efficient tests to predict ESBL-Enterobacterales ventilator-associated pneumonia in mechanically ventilated ESBL carriers.
Intensive Care Medicine 2020, 46, 1232-1242.
Abdul-Aziz MH, Alffenaar JWC, Bassetti M, Bracht H, Dimopoulos G, Marriott D, Neely MN, Paiva JA, Pea F, Sjovall F, Timsit JF, Udy AA, Wicha SG, Zeitlinger M, De Waele JJ, Roberts JA, Infection Section of European Society of Intensive Care Medicine (ESICM), Pharmacokinetic/pharmacodynamic and Critically Ill Patient Study Groups of European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Group of International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT), Infections in the ICU and Sepsis Working Group of International Society of Antimicrobial Chemotherapy (ISAC)
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper.
Intensive Care Medicine 2020, 46, 1127-1153.
De Bus L, Depuydt P, Steen J, Dhaese S, De Smet K, Tabah A, Akova M, Cotta MO, De Pascale G, Dimopoulos G, Fujitani S, Garnacho-Montero J, Leone M, Lipman J, Ostermann M, Paiva JA, Schouten J, Sjövall F, Timsit JF, Roberts JA, Zahar JR, Zand F, Zirpe K, De Waele JJ, DIANA study group
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study.
Intensive Care Medicine 2020, 46, 1404-1417.
Wicky PH, Henry-Feugeas MC, Para M, de Montmollin E
Uncharted territories: assessing cerebral vascularization in patients undergoing venoarterial extra-corporeal membrane oxygenation.
Intensive Care Medicine 2020, 46, 2079-2080.
Bassetti M, Kollef MH, Timsit JF
Bacterial and fungal superinfections in critically ill patients with COVID-19.
Intensive Care Medicine 2020, 46, 2071-2074.
Kalil AC, Timsit JF
Less is more: critically ill status is not a carte blanche for unlimited antibiotic use.
Intensive Care Medicine 2020, 46, 2075-2078.
Luyt CE, Bouadma L, Morris AC, Dhanani JA, Kollef M, Lipman J, Martin-Loeches I, Nseir S, Ranzani OT, Roquilly A, Schmidt M, Torres A, Timsit JF
Pulmonary infections complicating ARDS.
Intensive Care Medicine 2020, 46, 2168-2183.
Moulignier A, Viret-Vilayphon AC, Lescure FX, Plaisier E, Salomon L, Lamirel C, Pialoux G, ALCOVE Study Group
Microalbuminuria: a sentinel of neurocognitive impairment in HIV-infected individuals?.
Journal of Neurology 2020, 267, 1368-1376.
Pilmis B, Alby-Laurent F, Fasola ML, Seegers V, Guery R, Guet-Revillet H, Postaire M, Toubiana J, Bille E, Lortholary O, Zahar JR
Pseudomonas aeruginosa bloodstream infections in children: a 9-year retrospective study.
European Journal of Pediatrics 2020, 179, 1247-1254.
Senard O, Lafaurie M, Lesprit P, Nguyen Y, Lescure X, Therby A, Fihman V, Oubaya N, Lepeule R
Efficacy of cefoxitin versus carbapenem in febrile male urinary tract infections caused by extended spectrum beta-lactamase–producing Escherichia coli: a multicenter retrospective cohort study with propensity score analysis.
European Journal of Clinical Microbiology & Infectious Diseases 2020, 39, 121-129.
Farfour E, Visseaux B, Pascreau T, Jolly E, Houhou N, Mazaux L, Asso-Bonnet M, Vasse M
The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis?.
European Journal of Clinical Microbiology & Infectious Diseases 2020, 39, 1997-2000.
Bouadma L, Wiedemann A, Patrier J, Surénaud M, Wicky PH, Foucat E, Diehl JL, Hejblum BP, Sinnah F, de Montmollin E, Lacabaratz C, Thiébaut R, Timsit JF, Lévy Y
Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome.
Journal of Clinical Immunology 2020, 40, 1082-1092.
Sonneville R, Mazighi M, Bresson D, Crassard I, Crozier S, de Montmollin E, Degos V, Faugeras F, Gayat E, Josse L, Lamy C, Magalhaes E, Maldjian A, Ruckly S, Servan J, Vassel P, Vigué B, Timsit JF, Woimant F, SPICE investigators
Outcomes of Acute Stroke Patients Requiring Mechanical Ventilation: Study Protocol for the SPICE Multicenter Prospective Observational Study.
Neurocritical Care 2020, 32, 624-629.
Magalhaes E, Reuter J, Wanono R, Bouadma L, Jaquet P, Tanaka S, Sinnah F, Ruckly S, Dupuis C, de Montmollin E, Para M, Braham W, Pisani A, d'Ortho MP, Rouvel-Tallec A, Timsit JF, Sonneville R, DINAMO study group
Early EEG for Prognostication Under Venoarterial Extracorporeal Membrane Oxygenation.
Neurocritical Care 2020, 33, 688-694.
Bénézit F, Loubet P, Galtier F, Pronier C, Lenzi N, Lesieur Z, Jouneau S, Lagathu G, L'Honneur AS, Foulongne V, Vallejo C, Alain S, Duval X, Houhou N, Costa Y, Vanhems P, Amour S, Carrat F, Lina B, Launay O, Tattevin P, FLUVAC Study Group
Non-influenza respiratory viruses in adult patients admitted with influenza-like illness: a 3-year prospective multicenter study.
Infection 2020, 48, 489-495.
Pichon M, Joly V, Argy N, Houze S, Bretagne S, Alanio A, Wassef M, Verillaud B, Yazdanpanah Y
Aspergillus flavus malignant external otitis in a diabetic patient: case report and literature review.
Infection 2020, 48, 193-203.
Rello J, Belliato M, Dimopoulos MA, Giamarellos-Bourboulis EJ, Jaksic V, Martin-Loeches I, Mporas I, Pelosi P, Poulakou G, Pournaras S, Tamae-Kakazu M, Timsit JF, Waterer G, Tejada S, Dimopoulos G
Update in COVID-19 in the intensive care unit from the 2020 HELLENIC Athens International symposium.
Anaesthesia, Critical Care & Pain Medicine 2020, 39, 723-730.
Louchet M, Sibiude J, Peytavin G, Picone O, Tréluyer JM, Mandelbrot L
Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019.
American journal of obstetrics & gynecology MFM 2020, 2, 100159.
Sallard E, Lescure FX, Yazdanpanah Y, Mentre F, Peiffer-Smadja N
Type 1 interferons as a potential treatment against COVID-19.
Antiviral Research 2020, 178, 104791.
Venisse N, Peytavin G, Bouchet S, Gagnieu MC, Garraffo R, Guilhaumou R, Solas C
Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection.
Antiviral Research 2020, 181, 104866.
Delacôte C, Bauvin P, Louvet A, Dautrecque F, Ntandja Wandji LC, Lassailly G, Voican C, Perlemuter G, Naveau S, Mathurin P, Deuffic-Burban S
A Model to Identify Heavy Drinkers at High Risk for Liver Disease Progression.
Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association 2020, 18, 2315-2323.e6.
Michallet M, Sobh M, Deray G, Gangneux JP, Pigneux A, Larrey D, Ribaud P, Mira JP, Nivoix Y, Yakoub-Agha I, Timsit JF, Alfandari S, Herbrecht R
Antifungal Stewardship in Hematology: Reflection of a Multidisciplinary Group of Experts.
Clinical Lymphoma Myeloma and Leukemia 2020, S2152265020304250.
Loubet P, Tubiana S, Claessens Y, Epelboin L, Ficko C, Le Bel J, Rammaert B, Garin N, Prendki V, Stirnemann J, Leport C, Yazdanpanah Y, Varon E, Duval X, Claessens Y, Duval X, Bouvard E, Carette M, Debray M, Mayaud C, Leport C, Houhou N, Tubiana S, Benjoar M, Blanc F, Brun A, Epelboin L, Ficko C, Khalil A, Lefloch H, Naccache J, Rammaert B, Abry A, Allo J, Andre S, Andreotti C, Baarir N, Bendahou M, Benlafia L, Bernard J, Berthoumieu A, Billemont M, Bokobza J, Brun A, Burggraff E, Canavaggio P, Carette M, Casalino E, Castro S, Choquet C, Clément H, Colosi L, Dabreteau A, Damelincourt S, Dautheville S, Debray M, Delay M, Delerme S, Depierre L, Djamouri F, Dumas F, Fadel M, Feydey A, Freund Y, Garcia L, Goulet H, Hausfater P, Ilic-Habensus E, Josse M, Kansao J, Kieffer Y, Lecomte F, Lemkarane K, Madonna P, Meyniard O, Mzabi L, Pariente D, Pernet J, Perruche F, Piquet J, Ranerison R, Ray P, Renai F, Rouff E, Saget D, Saïdi K, Sauvin G, Trabattoni E, Trimech N, Auger C, Pasquet B, Tamazirt S, Treluyer J, Tubach F, Wang J, Chassany O, Misse C
Community-acquired pneumonia in the emergency department: an algorithm to facilitate diagnosis and guide chest CT scan indication.
Clinical Microbiology and Infection 2020, 26, 382.e1-382.e7.
Peiffer-Smadja N, Rawson TM, Ahmad R, Buchard A, Georgiou P, Lescure FX, Birgand G, Holmes AH
Machine learning for clinical decision support in infectious diseases: a narrative review of current applications.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, 26, 584-595.
de Grooth HJ, Timsit JF, Mermel L, Mimoz O, Buetti N, du Cheyron D, Oudemans-van Straaten HM, Parienti JJ, 3SITES, CLEAN and DRESSING groups
Validity of surrogate endpoints assessing central venous catheter-related infection: evidence from individual- and study-level analyses.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, 26, 563-571.
Tubiana S, Varon E, Biron C, Ploy MC, Mourvillier B, Taha MK, Revest M, Poyart C, Martin-Blondel G, Lecuit M, Cua E, Pasquet B, Preau M, Hoen B, Duval X, COMBAT study group
Community-acquired bacterial meningitis in adults: in-hospital prognosis, long-term disability and determinants of outcome in a multicentre prospective cohort.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, 26, 1192-1200.
Visseaux B, Hué S, Le Hingrat Q, Salmona M, Lebourgeois S, Delaugerre C, Descamps D, Chaix ML, Ghosn J
Phylogenetic investigation of HCV-4d epidemic in Paris MSM HIV population reveals a still active outbreak and a strong link to the Netherlands.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, 26, 785.e1-785.e4.
Peiffer-Smadja N, Dellière S, Rodriguez C, Birgand G, Lescure FX, Fourati S, Ruppé E
Machine learning in the clinical microbiology laboratory: has the time come for routine practice?.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, 26, 1300-1309.
Peiffer-Smadja N, Lucet JC, Bendjelloul G, Bouadma L, Gerard S, Choquet C, Jacques S, Khalil A, Maisani P, Casalino E, Descamps D, Timsit JF, Yazdanpanah Y, Lescure FX
Challenges and issues about organising a hospital to respond to the COVID-19 outbreak: experience from a French reference centre.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020
Fragkou PC, Belhadi D, Peiffer-Smadja N, Moschopoulos CD, Lescure FX, Janocha H, Karofylakis E, Yazdanpanah Y, Mentré F, Skevaki C, Laouénan C, Tsiodras S, ESCMID Study Group for Respiratory Viruses
Review of trials currently testing treatment and prevention of COVID-19.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, 26, 988-998.
Buetti N, Souweine B, Mermel L, Mimoz O, Ruckly S, Loiodice A, Mongardon N, Lucet JC, Parienti JJ, Timsit JF
Concurrent systemic antibiotics at catheter insertion and intravascular catheter-related infection in the ICU: a post hoc analysis using individual data from five large RCTs.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020
Muff S, Hebeisen U, Timsit JF, Mermel L, Harbarth S, Buetti N
Treatment duration of enterococcal intravascular catheter-related infections.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020
Hingrat QL, Visseaux B, Laouenan C, Tubiana S, Bouadma L, Yazdanpanah Y, Duval X, Burdet C, Ichou H, Damond F, Bertine M, Benmalek N, Choquet C, Timsit JF, Ghosn J, Charpentier C, Descamps D, Houhou-Fidouh N, French COVID cohort management committee, CoV-CONTACT study group, members of the French-COVID cohort study group (by alphabetical order), member of the CoV-CONTACT study group. Principal investigator, Steering Committee, CoV-CONTACT Clinical Centers, Coordination and statistical analyses, Virological Lab, Biological Center, Partners, Sponsor, Genetic
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, S1198-743X(20)30721-7.
Saliba R, Zahar JR, El Allaoui F, Carbonnelle E, Lescat M
Impact of freeze/thaw cycles and single freezing at -80 °C on the viability of aerobic bacteria from rectal swabs performed with the ESwabTM system.
Diagnostic Microbiology and Infectious Disease 2020, 96, 114895.
Rondinaud E, Ruppé E, Matheron S, Lucet JC, Armand-Lefevre L, VOYAG-R study group
Screening methods for intestinal carriage of multidrug-resistant Enterobacterales: interest of enrichment broth.
Diagnostic Microbiology and Infectious Disease 2020, 97, 115079.
Ouersighni A, Ghazali DA
Contribution of certified registered nurse anaesthetists to the management of the COVID-19 pandemic health crisis.
Intensive & Critical Care Nursing 2020, 60, 102888.
Mizrahi A, Delerue T, Morel H, Le Monnier A, Carbonnelle E, Pilmis B, Zahar JR, on behalf the Saint-Joseph/Avicenna Study Group
Infections caused by naturally AmpC-producing Enterobacteriaceae: Can we use third-generation cephalosporins? A narrative review.
International Journal of Antimicrobial Agents 2020, 55, 105834.
Benchetrit L, Mathy V, Armand-Lefevre L, Bouadma L, Timsit JF
Successful treatment of septic shock due to NDM-1-producing Klebsiella pneumoniae using ceftazidime/avibactam combined with aztreonam in solid organ transplant recipients: report of two cases.
International Journal of Antimicrobial Agents 2020, 55, 105842.
Deslandes A, Berti V, Tandjaoui-Lambotte Y, Alloui C, Carbonnelle E, Zahar JR, Brichler S, Cohen Y
SARS-CoV-2 was already spreading in France in late December 2019.
International Journal of Antimicrobial Agents 2020, 55, 106006.
André-Garnier E, Hingrat QL, Marcelin AG, Reliquet V, Malet I, Leducq V, Rodallec A, Peytavin G, Ferré V, Charpentier C, Raffi F
Previously unreported emergence of A265V substitution in the integrase gene in association with bictegravir virological failure.
International Journal of Antimicrobial Agents 2020, 106039.
Dubert M, Visseaux B, Isernia V, Bouadma L, Deconinck L, Patrier J, Wicky PH, Le Pluart D, Kramer L, Rioux C, Le Hingrat Q, Houhou-Fidouh N, Yazdanpanah Y, Ghosn J, Lescure FX
Case report study of the first five COVID-19 patients treated with remdesivir in France.
International Journal of Infectious Diseases 2020, 98, 290-293.
Isernia V, Julia Z, Le Gac S, Bachelard A, Landman R, Lariven S, Joly V, Deconinck L, Rioux C, Lescure X, Yazdanpanah Y, Ghosn J
SARS-COV2 infection in 30 HIV-infected patients followed-up in a French University Hospital.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2020, 101, 49-51.
Tsopra R, Courtine M, Sedki K, Eap D, Cabal M, Cohen S, Bouchaud O, Mechaï F, Lamy JB
AntibioGame®: A serious game for teaching medical students about antibiotic use.
International Journal of Medical Informatics 2020, 136, 104074.
Posthuma LM, Downey C, Visscher MJ, Ghazali DA, Joshi M, Ashrafian H, Khan S, Darzi A, Goldstone J, Preckel B
Remote wireless vital signs monitoring on the ward for early detection of deteriorating patients: A case series.
International Journal of Nursing Studies 2020, 104, 103515.
Battesti G, El Khalifa J, Abdelhedi N, Ferre V, Bouscarat F, Picard-Dahan C, Brunet-Possenti F, Collin G, Lavaud J, Le Bozec P, Rousselot M, Tournier A, Lheure C, Couvelard A, Hacein-Bey-Abina S, Abina AM, Charpentier C, Mignot S, Nicaise P, Descamps D, Deschamps L, Descamps V
New insights in COVID-19–associated chilblains: A comparative study with chilblain lupus erythematosus.
Journal of the American Academy of Dermatology 2020, 83, 1219-1222.
Bailly S, Galerneau LM, Ruckly S, Seiller A, Terzi N, Schwebel C, Dupuis C, Tamisier R, Mourvillier B, Pepin JL, Timsit JF
Impact of obstructive sleep apnea on the obesity paradox in critically ill patients.
Journal of Critical Care 2020, 56, 120-124.
Visseaux B, Le Hingrat Q, Collin G, Ferré V, Storto A, Ichou H, Bouzid D, Poey N, de Montmollin E, Descamps D, Houhou-Fidouh N
Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection.
Journal of Clinical Virology 2020, 129, 104520.
Wirden M, Feghoul L, Bertine M, Nere ML, Le Hingrat Q, Abdi B, Boutolleau D, Ferre VM, Jary A, Delaugerre C, Marcelin AG, Descamps D, Legoff J, Visseaux B, Chaix ML
Multicenter comparison of the Cobas 6800 system with the RealStar RT-PCR kit for the detection of SARS-CoV-2.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2020, 130, 104573.
Charpentier C, Ichou H, Damond F, Bouvet E, Chaix ML, Ferré V, Delaugerre C, Mahjoub N, Larrouy L, Le Hingrat Q, Visseaux B, Mackiewicz V, Descamps D, Fidouh-Houhou N
Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott).
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2020, 132, 104618.
Saliba R, Aho-Glélé LS, Karam-Sarkis D, Zahar JR
Evaluation of polymerase chain reaction assays for direct screening of carbapenemase-producing Enterobacteriaceae from rectal swabs: a diagnostic meta-analysis.
Journal of Hospital Infection 2020, 104, 381-389.
Pilmis B, Billard-Pomares T, Martin M, Clarempuy C, Lemezo C, Saint-Marc C, Bourlon N, Seytre D, Carbonnelle E, Zahar JR
Can environmental contamination be explained by particular traits associated with patients?.
The Journal of Hospital Infection 2020, 104, 293-297.
Bouzid D, Lucet JC, Duval X, Houhou-Fidouh N, Casalino E, Visseaux B, ED Influenza Management Study Group
Multiplex PCR implementation as point-of-care testing in a French emergency department.
The Journal of Hospital Infection 2020, 105, 337-338.
Jolivet S, Lolom I, Bailly S, Bouadma L, Lortat-Jacob B, Montravers P, Armand-Lefevre L, Timsit JF, Lucet JC
Impact of colonization pressure on acquisition of extended-spectrum β-lactamase-producing Enterobacterales and meticillin-resistant Staphylococcus aureus in two intensive care units: a 19-year retrospective surveillance.
The Journal of Hospital Infection 2020, 105, 10-16.
Hilliquin D, Lomont A, Zahar JR
Cohorting for preventing the nosocomial spread of Carbapenemase-Producing Enterobacterales, in non-epidemic settings: is it mandatory?.
The Journal of Hospital Infection 2020
Sevin T, Goldstein V, Lolom I, Lenne F, Gaudonnet Y, Baptiste AL, Bendjelloul G, Armand-Lefevre L, Lucet JC
Bathroom contamination by antibiotic-resistant Enterobacterales (ESBLPE and CPE): an experimental study.
The Journal of Hospital Infection 2020, 106, 271-276.
Ong C, Lucet JC, Bourigault C, Birgand G, Aho S, Lepelletier D
Staphylococcus aureus nasal decolonization before cardiac and orthopaedic surgeries: first descriptive survey in France.
The Journal of Hospital Infection 2020, 106, 332-334.
Ibn Saied W, Merceron S, Schwebel C, Le Monnier A, Oziel J, Garrouste-Orgeas M, Marcotte G, Ruckly S, Souweine B, Darmon M, Bouadma L, de Montmollin E, Mourvillier B, Reignier J, Papazian L, Siami S, Azoulay E, Bédos JP, Timsit JF
Ventilator-associated pneumonia due to Stenotrophomonas maltophilia: Risk factors and outcome.
The Journal of Infection 2020, 80, 279-285.
Gousseff M, Penot P, Gallay L, Batisse D, Benech N, Bouiller K, Collarino R, Conrad A, Slama D, Joseph C, Lemaignen A, Lescure FX, Levy B, Mahevas M, Pozzetto B, Vignier N, Wyplosz B, Salmon D, Goehringer F, Botelho-Nevers E, in behalf of the COCOREC study group
Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?.
The Journal of Infection 2020, 81, 816-846.
Cancella de Abreu M, Choquet C, Petit H, Bouzid D, Damond F, Marot S, Ferre VM, Burrel S, Boutolleau D, Houdou-Fidouh N, Marcelin AG, Descamps D, Hausfater P
SARS-CoV-2 IGM and IGG rapid serologic test for the diagnosis of COVID-19 in the emergency department.
The Journal of Infection 2020, 81, 816-846.
Epelboin L, Rapp C, Faucher JF, Méchaï F, Bottieau E, Matheron S, Malvy D, Caumes E
Management and treatment of uncomplicated imported malaria in adults. Update of the French malaria clinical guidelines.
Medecine Et Maladies Infectieuses 2020, 50, 194-212.
Bru JP, Alfandari S, Bleibtreu A, Chavanet P, Gauzit R, Lescure X, Lesprit P, Tattevin P
Carbapenems versus beta-lactam/beta-lactamase inhibitors to treat ESBL-producing Enterobacteriaceae infections.
Medecine Et Maladies Infectieuses 2020, 50, 313-315.
Bleibtreu A, Bertine M, Bertin C, Houhou-Fidouh N, Visseaux B
Focus on Middle East respiratory syndrome coronavirus (MERS-CoV).
Médecine et Maladies Infectieuses 2020, 50, 243-251.
San C, Lê MP, Matheron S, Mourvillier B, Caseris M, Timsit JF, Wolff M, Yazdanpanah Y, Descamps D, Peytavin G
Management of oral antiretroviral administration in patients with swallowing disorders or with an enteral feeding tube.
Medecine Et Maladies Infectieuses 2020, 50, 537-544.
Denis N, Timsit JF, Giaj Levra M, Sakhri L, Duruisseaux M, Schwebel C, Merle P, Pinsolle J, Ferrer L, Moro-Sibilot D, Toffart AC
Impact of systematic advanced care planning in lung cancer patients: A prospective study.
Respiratory Medicine and Research 2020, 77, 11-17.
Leroy J, Houzé S, Dardé ML, Yéra H, Rossi B, Delhaes L, Gabriel F, Loubet P, Deleplancque AS, Senneville E, Ajana F, Sendid B, Malvy D
Severe toxoplasmosis imported from tropical Africa in immunocompetent patients: A case series.
Travel Medicine and Infectious Disease 2020, 35, 101509.
Pizzorno A, Padey B, Julien T, Trouillet-Assant S, Traversier A, Errazuriz-Cerda E, Fouret J, Dubois J, Gaymard A, Lescure FX, Dulière V, Brun P, Constant S, Poissy J, Lina B, Yazdanpanah Y, Terrier O, Rosa-Calatrava M
Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia.
Cell Reports Medicine 2020, 1, 100059.
Gilbert M, Pullano G, Pinotti F, Valdano E, Poletto C, Boëlle PY, D'Ortenzio E, Yazdanpanah Y, Eholie SP, Altmann M, Gutierrez B, Kraemer MUG, Colizza V
Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study.
The Lancet 2020, 395, 871-877.
Jouvin-Marche E, Carrara G, Pulcini C, Andremont A, Danan C, Couderc-Obert C, Lienhardt C, Kieny MP, Yazdanpanah Y
French research strategy to tackle antimicrobial resistance.
The Lancet 2020, 395, 1239-1241.
Norton A, Mphahlele J, Yazdanpanah Y, Piot P, Bayona MT
Strengthening the global effort on COVID-19 research.
The Lancet 2020, S0140673620315981.
Lescure FX, Bouadma L, Nguyen D, Parisey M, Wicky PH, Behillil S, Gaymard A, Bouscambert-Duchamp M, Donati F, Le Hingrat Q, Enouf V, Houhou-Fidouh N, Valette M, Mailles A, Lucet JC, Mentre F, Duval X, Descamps D, Malvy D, Timsit JF, Lina B, van-der-Werf S, Yazdanpanah Y
Clinical and virological data of the first cases of COVID-19 in Europe: a case series.
The Lancet. Infectious Diseases 2020, 20, 697-706.
von Cube M, Timsit JF, Schumacher M, Motschall E, Schumacher M
Quantification and interpretation of attributable mortality in core clinical infectious disease journals.
The Lancet. Infectious Diseases 2020, 20, e299-e306.
Brendish NJ, Poole S, Naidu VV, Mansbridge CT, Norton NJ, Wheeler H, Presland L, Kidd S, Cortes NJ, Borca F, Phan H, Babbage G, Visseaux B, Ewings S, Clark TW
Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study.
The Lancet. Respiratory Medicine 2020, 8, 1192-1200.
Atlani-Duault L, Lina B, Malvy D, Yazdanpanah Y, Chauvin F, Delfraissy JF
COVID-19: France grapples with the pragmatics of isolation.
The Lancet. Public Health 2020, 5, e573-e574.
Ghazali DA, Ouersighni A, Gay M, Audebault V, Pavlovsky T, Casalino E
Feedback to Prepare EMS Teams to Manage Infected Patients with COVID-19: A Case Series.
Prehospital and Disaster Medicine 2020, 35, 451-453.
Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, Feldt T, Green G, Green ML, Lescure FX, Nicastri E, Oda R, Yo K, Quiros-Roldan E, Studemeister A, Redinski J, Ahmed S, Bernett J, Chelliah D, Chen D, Chihara S, Cohen SH, Cunningham J, D'Arminio Monforte A, Ismail S, Kato H, Lapadula G, L'Her E, Maeno T, Majumder S, Massari M, Mora-Rillo M, Mutoh Y, Nguyen D, Verweij E, Zoufaly A, Osinusi AO, DeZure A, Zhao Y, Zhong L, Chokkalingam A, Elboudwarej E, Telep L, Timbs L, Henne I, Sellers S, Cao H, Tan SK, Winterbourne L, Desai P, Mera R, Gaggar A, Myers RP, Brainard DM, Childs R, Flanigan T
Compassionate Use of Remdesivir for Patients with Severe Covid-19.
The New England Journal of Medicine 2020
Triki D, Kermarrec M, Visseaux B, Descamps D, Flatters D, Camproux AC, Regad L
Exploration of the effects of sequence variations between HIV-1 and HIV-2 proteases on their three-dimensional structures.
Journal of Biomolecular Structure & Dynamics 2020, 38, 5014-5026.
Couffignal C, Papot E, Etienne A, Legac S, Laouénan C, Beres D, Blum L, Khuong-Josses MA, Lepretre A, Papazian P, Yazdanpanah Y, Bouvet E
Treatment as prevention (TasP) and perceived sexual changes in behavior among HIV-positive persons: a French survey in infectious diseases departments in Paris.
AIDS care 2020, 32, 811-817.
Puppo C, Spire B, Morel S, Génin M, Béniguel L, Costagliola D, Ghosn J, Mabire X, Molina JM, Rojas Castro D, Préau M
How PrEP users constitute a community in the MSM population through their specific experience and management of stigmatization. The example of the French ANRS-PREVENIR study.
AIDS Care 2020, 32, 32-39.
Deelen JWT, Rottier WC, Giron Ortega JA, Rodriguez-Baño J, Harbarth S, Tacconelli E, Jacobsson G, Zahar JR, van Werkhoven CH, Bonten MJM
An international prospective cohort study to validate two prediction rules for infections caused by 3rd-generation cephalosporin-resistant Enterobacterales.
Clinical Infectious Diseases 2020, ciaa950.
Tzou PL, Descamps D, Rhee SY, Raugi DN, Charpentier C, Taveira N, Smith RA, Soriano V, de Mendoza C, Holmes SP, Gottlieb GS, Shafer RW
Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2.
The Journal of Infectious Diseases 2020, 221, 1962-1972.
Jary A, Leducq V, Desire N, Petit H, Palich R, Joly V, Canestri A, Gothland A, Lambert-Niclot S, Surgers L, Amiel C, Descamps D, Spano JP, Katlama C, Calvez V, Marcelin AG
New Kaposi's sarcoma-associated herpesvirus variant in men who have sex with men associated with severe pathologies.
The Journal of Infectious Diseases 2020, 222, 1320-1328.
Luong Nguyen LB, Freedberg KA, Wanjala S, Maman D, Szumilin E, Mendiharat P, Yazdanpanah Y
Comparative effectiveness of interventions to improve the HIV continuum of care and HIV Pre-Exposure Prophylaxis in Kenya: a model-based analysis.
The Journal of Infectious Diseases 2020
Brice J, Sylla M, Desire N, Sayon S, Telly F, Bocar-Fofana D, Murphy R, Peytavin G, Diallo S, Nastouli E, Calvez V, Marcelin AG, Maiga AI, Lambert-Niclot S
Characterization of drug resistance and the defective HIV reservoir in virally suppressed vertically infected children in Mali.
The Journal of Antimicrobial Chemotherapy 2020, 75, 1272-1279.
Jary A, Marcelin AG, Charpentier C, Wirden M, Lê MP, Peytavin G, Descamps D, Calvez V
M184V/I does not impact the efficacy of abacavir/lamivudine/dolutegravir use as switch therapy in virologically suppressed patients.
The Journal of Antimicrobial Chemotherapy 2020, 75, 1290-1293.
Charpentier C, Peytavin G, Raffi F, Burdet C, Landman R, Lê MP, Katlama C, Collin G, Benalycherif A, Cabie A, Mentré F, Yazdanpanah Y, Descamps D, Joly V
Pharmacovirological analyses of blood and male genital compartment in patients receiving dolutegravir + lamivudine dual therapy as a switch strategy (ANRS 167 LAMIDOL trial).
The Journal of Antimicrobial Chemotherapy 2020, 75, 1611-1617.
Marcelin AG, Charpentier C, Jary A, Perrier M, Margot N, Callebaut C, Calvez V, Descamps D
Frequency of capsid substitutions associated with GS-6207 in vitro resistance in HIV-1 from antiretroviral-naive and -experienced patients.
The Journal of Antimicrobial Chemotherapy 2020, 75, 1588-1590.
Soulie C, Assoumou L, Abdi B, Sayon S, Nguyen T, Valantin MA, Beniguel L, Ferre V, Alloui C, Montes B, Avettand-Fenoel V, Delaugerre C, Descamps D, Martinez E, Reynes J, Peytavin G, Costagliola D, Katlama C, Calvez V, Marcelin AG, ANRS-163 ETRAL study group
Characterization of viral rebounds on dual etravirine/raltegravir maintenance therapy (ANRS-163 ETRAL trial).
The Journal of Antimicrobial Chemotherapy 2020, 75, 1943-1949.
Boyd A, Miailhes P, Chas J, Valantin MA, Yazdanpanah Y, Rosenthal E, Chevaliez S, Piroth L, Rougier H, Peytavin G, Pialoux G, Girard PM, Lacombe K
Grazoprevir/elbasvir for the immediate treatment of recently acquired HCV genotype 1 or 4 infection in MSM.
The Journal of Antimicrobial Chemotherapy 2020, 75, 1961-1968.
Alain S, Feghoul L, Girault S, Lepiller Q, Frobert E, Michonneau D, Berceanu A, Ducastelle-Lepretre S, Tilloy V, Guerin E, Le Goff J, Peytavin G, Hantz S
Letermovir breakthroughs during the French Named Patient Programme: interest of monitoring blood concentration in clinical practice.
The Journal of Antimicrobial Chemotherapy 2020, 75, 2253-2257.
Delory T, Jeanmougin P, Lariven S, Aubert JP, Peiffer-Smadja N, Boëlle PY, Bouvet E, Lescure FX, Le Bel J
A computerized decision support system (CDSS) for antibiotic prescription in primary care-Antibioclic: implementation, adoption and sustainable use in the era of extended antimicrobial resistance.
The Journal of Antimicrobial Chemotherapy 2020, 75, 2353-2362.
Lê MP, Peiffer-Smadja N, Guedj J, Néant N, Mentré F, Ader F, Yazdanpanah Y, Peytavin G
Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.
The Journal of Antimicrobial Chemotherapy 2020, 75, 2376-2380.
Kauv J, Lê MP, Veyrier M, Le Hingrat Q, Visseaux B, Massias L, Chauveheid MP, Descamps D, Ghosn J, Peytavin G
Failure of hydroxychloroquine pre-exposure prophylaxis in COVID-19 infection? A case report.
The Journal of Antimicrobial Chemotherapy 2020, 75, 2706-2707.
Peiffer-Smadja N, Lescure FX, Sallard E, Ravaud P, Vegreville B, Zeitoun JD
Anticovid, a comprehensive open-access real-time platform of registered clinical studies for COVID-19.
Journal of Antimicrobial Chemotherapy 2020, 75, 2708-2710.
Lê MP, Jaquet P, Patrier J, Wicky PH, Le Hingrat Q, Veyrier M, Kauv J, Sonneville R, Visseaux B, Laouénan C, Bouadma L, Descamps D, de Montmollin E, Peytavin G, Timsit JF
Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients.
The Journal of Antimicrobial Chemotherapy 2020, 75, 2657-2660.
Palich R, Wirden M, Peytavin G, Lê MP, Seang S, Abdi B, Schneider L, Tubiana R, Valantin MA, Paccoud O, Soulié C, Calvez V, Katlama C, Marcelin AG
Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrations.
The Journal of Antimicrobial Chemotherapy 2020, 75, 2981-2985.
Katlama C, Assoumou L, Valantin MA, Soulié C, Martinez E, Béniguel L, Bouchaud O, Raffi F, Molina JM, Fellahi S, Peytavin G, Marcelin AG, Kolta S, Capeau J, Gibowski S, Cardon F, Reynes J, Costagliola D
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study-authors' response.
The Journal of Antimicrobial Chemotherapy 2020, 75, 3699-3700.
Visseaux B, Assoumou L, Mahjoub N, Grude M, Trabaud MA, Raymond S, Wirden M, Morand-Joubert L, Roussel C, Montes B, Bocket L, Fafi-Kremer S, Amiel C, De Monte A, Stefic K, Pallier C, Tumiotto C, Maillard A, Vallet S, Ferre V, Bouvier-Alias M, Dina J, Signori-Schmuck A, Carles MJ, Plantier JC, Meyer L, Descamps D, Chaix ML, AC43 ANRS Resistance Group
Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?.
The Journal of Antimicrobial Chemotherapy 2020, 75, 183-193.
Tzou PL, Rhee SY, Descamps D, Clutter DS, Hare B, Mor O, Grude M, Parkin N, Jordan MR, Bertagnolio S, Schapiro JM, Harrigan PR, Geretti AM, Marcelin AG, Shafer RW, WHO HIVResNet Working Groups
Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance.
The Journal of Antimicrobial Chemotherapy 2020, 75, 170-182.
Tebano G, Soulié C, Schneider L, Blanc C, Agher R, Seang S, Valantin MA, Palich R, Tubiana R, Peytavin G, Marcelin AG, Assoumou L, Katlama C
Long-term follow-up of HIV-infected patients on dolutegravir monotherapy.
The Journal of Antimicrobial Chemotherapy 2020, 75, 675-680.
Soulie C, Santoro MM, Storto A, Abdi B, Charpentier C, Armenia D, Jary A, Forbici F, Bertoli A, Gennari W, Andreoni M, Mussini C, Antinori A, Perno CF, Calvez V, Ceccherini-Silberstein F, Descamps D, Marcelin AG
Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy.
The Journal of Antimicrobial Chemotherapy 2020, 75, 1026-1030.
Argy N, Lariven S, Rideau A, Lemoine A, Bourgeois Moine A, Allal L, Choudat L, Ravel C, Michard F, Buffet P, Faye A, Houze S, Yazdanpanah Y
Congenital Leishmaniasis in a Newborn Infant Whose Mother was Coinfected With Leishmaniasis and HIV.
Journal of the Pediatric Infectious Diseases Society 2020, 9, 277-280.
Lescure FX, Fellahi S, Pialoux G, Bastard JP, Eme AL, Esteve E, Lebrette MG, Guiard-Schmid JB, Capeau J, Ronco P, Costagliola D, Plaisier E
Prevalence of tubulopathy and association with renal function loss in HIV-infected patients.
Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 2020, 35, 607-615.
Pichon M, Claire LP, Genet P, Caby F, Yazdanpanah Y, Menn AM
Adult-onset Still's disease in a patient with human immunodeficiency virus infection: pathophysiological link?.
Rheumatology (Oxford, England) 2020, 59, e99-e101.
Bello G, Delatorre E, Lacoste V, Darcissac E, Herrmann-Storck C, Tressières B, Cabras O, Lamaury I, Cabié A, Visseaux B, Chaix ML, Descamps D, Césaire R, Nacher M, Dos Santos G
Increasing prevalence and local transmission of non-B HIV-1 subtypes in the French Antilles and French Guiana between 1995 and 2018.
Virus Evolution 2020, 6, veaa081.
Reuter J, Peoc'h K, Bouadma L, Ruckly S, Chicha-Cattoir V, Faille D, Bourrienne MC, Dupuis C, Magalhaes E, Tanaka S, Vinclair C, de Montmollin E, Mazighi M, Para M, Braham W, Pisani A, Ajzenberg N, Timsit JF, Sonneville R
Neuron-Specific Enolase Levels in Adults Under Venoarterial Extracorporeal Membrane Oxygenation.
Critical Care Explorations 2020, 2, e0239.
Buetti N, Ruckly S, Lucet JC, Perozziello A, Mimoz O, Souweine B, Timsit JF
The Insertion Site Should Be Considered for the Empirical Therapy of Short-Term Central Venous and Arterial Catheter-Related Infections.
Critical Care Medicine 2020, 48, 739-744.
Baudry G, Sonneville R, Waintraub X, Lebreton G, Deguillard C, Mertens E, Bouadma L, Demondion P, Bréchot N, Luyt CE, Extramiana F, Hékimian G, Dupuis C, Para M, Pisani A, Braham W, Gandjbakhch E, Leenhardt A, Timsit JF, Leprince P, Combes A, Schmidt M
Extracorporeal Membrane Oxygenation to Support Life-Threatening Drug-Refractory Electrical Storm.
Critical Care Medicine 2020, 48, e856-e863.
Buetti N, Tabah A, Timsit JF, Zingg W
What is new in catheter use and catheter infection prevention in the ICU.
Current Opinion in Critical Care 2020, 26, 459-465.
Mossoro-Kpinde CD, Gody JC, Mboumba Bouassa RS, Moussa S, Jenabian MA, Péré H, Charpentier C, Matta M, Longo JDD, Grésenguet G, Djoba Siawaya JF, Bélec L
Escalating and sustained immunovirological dissociation among antiretroviral drug-experienced perinatally human immunodeficiency virus-1-infected children and adolescents living in the Central African Republic: A STROBE-compliant study.
Medicine 2020, 99, e19978.
Journeau L, de la Chapelle M, Guimard T, Ferfar Y, Saadoun D, Mahé I, Castier Y, Montravers P, Lescure X, Van Gysel D, Asseray N, Lascarrou JB, Ngohou C, Vandamme YM, Connault J, Cepoy PDd, Brochard J, Goueffic Y, Pistorius MA, Boutoille D, Espitia O
A strobe multicenter descriptive study of 55 infectious aortitis.
Medicine 2020, 99, e22422.
Pencolé L, Lê MP, Bouchet-Crivat F, Duro D, Peytavin G, Mandelbrot L
Placental transfer of the integrase strand inhibitors cabotegravir and bictegravir in the ex-vivo human cotyledon perfusion model.
AIDS (London, England) 2020, 34, 2145-2149.
Patrier J, Timsit JF
Carbapenem use in critically ill patients.
Current Opinion in Infectious Diseases 2020, 33, 86-91.
Barbier F, Timsit JF
Risk stratification for multidrug-resistant bacteria in patients with skin and soft tissue infection.
Current Opinion in Infectious Diseases 2020, 33, 137-145.
Le Fevre L, Timsit JF
Duration of antimicrobial therapy for Gram-negative infections.
Current Opinion in Infectious Diseases 2020, 33, 511-516.
Néant N, Lê MP, Bouazza N, Gattacceca F, Yazdanpanah Y, Dhiver C, Bregigeon S, Mokhtari S, Peytavin G, Tamalet C, Descamps D, Lacarelle B, Solas C
Usefulness of therapeutic drug monitoring of rilpivirine and its relationship with virologic response and resistance in a cohort of naive and pretreated HIV-infected patients.
British Journal of Clinical Pharmacology 2020, 86, 2404-2413.
Hatzakis A, Lazarus JV, Cholongitas E, Baptista-Leite R, Boucher C, Busoi CS, Deuffic-Burban S, Chhatwal J, Esmat G, Hutchinson S, Malliori MM, Maticic M, Mozalevskis A, Negro F, Papandreou GA, Papatheodoridis GV, Peck-Radosavljevic M, Razavi H, Reic T, Schatz E, Tozun N, Younossi Z, Manns MP
Securing sustainable funding for viral hepatitis elimination plans.
Liver International: Official Journal of the International Association for the Study of the Liver 2020, 40, 260-270.
Timsit JF, Leverger G, Milpied N, Gachot B
Treatment of invasive fungal infections in intensive care units with micafungin: The MYRIADE study.
Mycoses 2020, 63, 443-451.
Tiberghien P, de Lamballerie X, Morel P, Gallian P, Lacombe K, Yazdanpanah Y
Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?.
Vox Sanguinis 2020, 115, 488-494.
Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, Péré H, Charbit B, Bondet V, Chenevier-Gobeaux C, Breillat P, Carlier N, Gauzit R, Morbieu C, Pène F, Marin N, Roche N, Szwebel TA, Merkling SH, Treluyer JM, Veyer D, Mouthon L, Blanc C, Tharaux PL, Rozenberg F, Fischer A, Duffy D, Rieux-Laucat F, Kernéis S, Terrier B
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.
Science (New York, N.Y.) 2020, 369, 718-724.
Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, Dorgham K, Philippot Q, Rosain J, Béziat V, Manry J, Shaw E, Haljasmägi L, Peterson P, Lorenzo L, Bizien L, Trouillet-Assant S, Dobbs K, de Jesus AA, Belot A, Kallaste A, Catherinot E, Tandjaoui-Lambiotte Y, Le Pen J, Kerner G, Bigio B, Seeleuthner Y, Yang R, Bolze A, Spaan AN, Delmonte OM, Abers MS, Aiuti A, Casari G, Lampasona V, Piemonti L, Ciceri F, Bilguvar K, Lifton RP, Vasse M, Smadja DM, Migaud M, Hadjadj J, Terrier B, Duffy D, Quintana-Murci L, van de Beek D, Roussel L, Vinh DC, Tangye SG, Haerynck F, Dalmau D, Martinez-Picado J, Brodin P, Nussenzweig MC, Boisson-Dupuis S, Rodríguez-Gallego C, Vogt G, Mogensen TH, Oler AJ, Gu J, Burbelo PD, Cohen JI, Biondi A, Bettini LR, D'Angio M, Bonfanti P, Rossignol P, Mayaux J, Rieux-Laucat F, Husebye ES, Fusco F, Ursini MV, Imberti L, Sottini A, Paghera S, Quiros-Roldan E, Rossi C, Castagnoli R, Montagna D, Licari A, Marseglia GL, Duval X, Ghosn J, HGID Lab, NIAID-USUHS Immune Response to COVID Group, COVID Clinicians, COVID-STORM Clinicians, Imagine COVID Group, French COVID Cohort Study Group, Milieu Intérieur Consortium, CoV-Contact Cohort, Amsterdam UMC Covid-19 Biobank, COVID Human Genetic Effort, Tsang JS, Goldbach-Mansky R, Kisand K, Lionakis MS, Puel A, Zhang SY, Holland SM, Gorochov G, Jouanguy E, Rice CM, Cobat A, Notarangelo LD, Abel L, Su HC, Casanova JL
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.
Science (New York, N.Y.) 2020, 370, eabd4585.
Grzelak L, Temmam S, Planchais C, Demeret C, Tondeur L, Huon C, Guivel-Benhassine F, Staropoli I, Chazal M, Dufloo J, Planas D, Buchrieser J, Rajah MM, Robinot R, Porrot F, Albert M, Chen KY, Crescenzo-Chaigne B, Donati F, Anna F, Souque P, Gransagne M, Bellalou J, Nowakowski M, Backovic M, Bouadma L, Le Fevre L, Le Hingrat Q, Descamps D, Pourbaix A, Laouénan C, Ghosn J, Yazdanpanah Y, Besombes C, Jolly N, Pellerin-Fernandes S, Cheny O, Ungeheuer MN, Mellon G, Morel P, Rolland S, Rey FA, Behillil S, Enouf V, Lemaitre A, Créach MA, Petres S, Escriou N, Charneau P, Fontanet A, Hoen B, Bruel T, Eloit M, Mouquet H, Schwartz O, van der Werf S
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.
Science Translational Medicine 2020, 12,
Zheng Y, Hirt D, Delmas S, Lui G, Benaboud S, Lechedanec J, Tréluyer JM, Chenevier-Gobeaux C, Arezes E, Gelley A, Amri I, Urien S, Bouazza N, Foissac F, Warszawski J, Ghosn J
Effect of Pregnancy on Unbound Raltegravir Concentrations in the ANRS 160 RalFe Trial.
Antimicrobial Agents and Chemotherapy 2020, 64, e00759-20.
Lê MP, Le Hingrat Q, Jaquet P, Wicky PH, Bunel V, Massias L, Visseaux B, Messika J, Descamps D, Mal H, Timsit JF, Peytavin G
Removal of Remdesivir's Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19.
Antimicrobial Agents and Chemotherapy 2020, 64,
Bailly S, Gautier-Veyret E, Lê MP, Bouadma L, Andremont O, Neuville M, Mourvillier B, Sonneville R, Magalhaes E, Lebut J, Radjou A, Smonig R, Wolff M, Massias L, Dupuis C, Timsit JF
Impact of Loading Dose of Caspofungin in Pharmacokinetic-Pharmacodynamic Target Attainment for Severe Candidiasis Infections in Patients in Intensive Care Units: the CASPOLOAD Study.
Antimicrobial Agents and Chemotherapy 2020, 64, e01545-20.
Visseaux B, Le Hingrat Q, Collin G, Bouzid D, Lebourgeois S, Le Pluart D, Deconinck L, Lescure FX, Lucet JC, Bouadma L, Timsit JF, Descamps D, Yazdanpanah Y, Casalino E, Houhou-Fidouh N, McAdam AJ
Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the First Rapid Multiplex PCR Commercial Assay for SARS-CoV-2 Detection.
Journal of Clinical Microbiology 2020, 58, e00630-20, /jcm/58/8/JCM.00630-20.atom.
Le Hingrat Q, Visseaux B, Bertine M, Chauveau L, Schwartz O, Collin F, Damond F, Matheron S, Descamps D, Charpentier C
Genetic Variability of Long Terminal Repeat Region between HIV-2 Groups Impacts Transcriptional Activity.
Journal of Virology 2020, 94,
Mahévas M, Tran VT, Roumier M, Chabrol A, Paule R, Guillaud C, Fois E, Lepeule R, Szwebel TA, Lescure FX, Schlemmer F, Matignon M, Khellaf M, Crickx E, Terrier B, Morbieu C, Legendre P, Dang J, Schoindre Y, Pawlotsky JM, Michel M, Perrodeau E, Carlier N, Roche N, de Lastours V, Ourghanlian C, Kerneis S, Ménager P, Mouthon L, Audureau E, Ravaud P, Godeau B, Gallien S, Costedoat-Chalumeau N
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data.
BMJ 2020, m1844.
Castry M, Cousien A, Supervie V, Velter A, Ghosn J, Paltiel AD, Yazdanpanah Y, Deuffic-Burban S
Impact of test-and-treat and risk reduction strategies on HCV transmission among MSM living with HIV in France: a modelling approach.
Gut 2020
Frija-Masson J, Debray MP, Gilbert M, Lescure FX, Travert F, Borie R, Khalil A, Crestani B, d'Ortho MP, Bancal C
Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post infection.
European Respiratory Journal 2020, 2001754.
Le Hingrat Q, Ghanem M, Cazes A, Visseaux B, Collin G, Descamps D, Charpentier C, Crestani B
No association between human herpesvirus or herpesvirus saimiri and idiopathic pulmonary fibrosis.
ERJ Open Research 2020, 6, 00243-2020.
Lomont A, Boubaya M, Khamis W, Deslandes A, Cordel H, Seytre D, Alloui C, Malaure C, Bonnet N, Carbonnelle E, Cohen Y, Nunes H, Bouchaud O, Zahar JR, Tandjaoui-Lambiotte Y
Environmental contamination related to SARS-CoV-2 in ICU patients.
ERJ open research 2020
Bouchaud O, Matheron S, Loarec A, Dupouy Camet J, Bourée P, Godineau N, Poilane I, Cailhol J, Caumes E
Imported loiasis in France: a retrospective analysis of 167 cases with comparison between sub-Saharan and non sub-Saharan African patients.
BMC infectious diseases 2020, 20, 63.
Ekouevi DK, Larrouy L, Gbeasor-Komlanvi FA, Mackiewicz V, Tchankoni MK, Bitty-Anderson AM, Gnatou GYS, Sadio A, Salou M, Dagnra CA, Descamps D, Coffie PA
Prevalence of hepatitis B among childbearing women and infant born to HBV-positive mothers in Togo.
BMC infectious diseases 2020, 20, 839.
Dubert M, Visseaux B, Birgy A, Mordant P, Metivier AC, Dauriat G, Fidouh N, Yazdanpanah Y, Grall N, Castier Y, Mal H, Thabut G, Lescure FX
Late viral or bacterial respiratory infections in lung transplanted patients: impact on respiratory function.
BMC infectious diseases 2020, 20, 176.
Clément A, Delage R, Chollier M, Josse L, Gaudry S, Zahar JR, Baubet T, Degos B
Prospective study on a fast-track training in psychiatry for medical students: the psychiatric hat game.
BMC medical education 2020, 20, 373.
Norton A, Sigfrid L, Aderoba A, Nasir N, Bannister PG, Collinson S, Lee J, Boily-Larouche G, Golding JP, Depoortere E, Carson G, Kerstiëns B, Yazdanpanah Y
Preparing for a pandemic: highlighting themes for research funding and practice—perspectives from the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R).
BMC Medicine 2020, 18, 273.
Mirouse A, Parrot A, Audigier V, Demoule A, Mayaux J, Géri G, Mariotte E, Bréchot N, de Prost N, Vautier M, Neuville M, Bigé N, de Montmollin E, Cacoub P, Resche-Rigon M, Cadranel J, Saadoun D
Severe diffuse alveolar hemorrhage related to autoimmune disease: a multicenter study.
Critical Care 2020, 24, 231.
Peiffer-Smadja N, Bouadma L, Mathy V, Allouche K, Patrier J, Reboul M, Montravers P, Timsit JF, Armand-Lefevre L
Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia.
Critical Care (London, England) 2020, 24, 366.
Monard C, Pehlivan J, Auger G, Alviset S, Tran Dinh A, Duquaire P, Gastli N, d'Humières C, Maamar A, Boibieux A, Baldeyrou M, Loubinoux J, Dauwalder O, Cattoir V, Armand-Lefèvre L, Kernéis S, ADAPT study group
Multicenter evaluation of a syndromic rapid multiplex PCR test for early adaptation of antimicrobial therapy in adult patients with pneumonia.
Critical Care (London, England) 2020, 24, 434.
Buetti N, Ruckly S, Schwebel C, Mimoz O, Souweine B, Lucet JC, Timsit JF
Chlorhexidine-impregnated sponge versus chlorhexidine gel dressing for short-term intravascular catheters: which one is better?.
Critical Care (London, England) 2020, 24, 458.
Buetti N, Wicky PH, Le Hingrat Q, Ruckly S, Mazzuchelli T, Loiodice A, Trimboli P, Forni Ogna V, de Montmollin E, Bernasconi E, Visseaux B, Timsit JF
SARS-CoV-2 detection in the lower respiratory tract of invasively ventilated ARDS patients.
Critical Care (London, England) 2020, 24, 610.
Buetti N, Ruckly S, Lucet JC, Bouadma L, Garrouste-Orgeas M, Schwebel C, Mimoz O, Souweine B, Timsit JF
Local signs at insertion site and catheter-related bloodstream infections: an observational post hoc analysis using individual data of four RCTs.
Critical Care (London, England) 2020, 24, 694.
Duvignaud A, Lhomme E, Pistone T, Onaisi R, Sitta R, Journot V, Nguyen D, Peiffer-Smadja N, Crémer A, Bouchet S, Darnaud T, Poitrenaud D, Piroth L, Binquet C, Michel JF, Lefèvre B, Lebeaux D, Lebel J, Dupouy J, Roussillon C, Gimbert A, Wittkop L, Thiébaut R, Orne-Gliemann J, Joseph JP, Richert L, Anglaret X, Malvy D, COVERAGE study group
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
Trials 2020, 21, 846.
Vinclair C, De Montmollin E, Sonneville R, Reuter J, Lebut J, Cally R, Mourvillier B, Neuville M, Ruckly S, Timsit JF, Bouadma L
Factors associated with major adverse kidney events in patients who underwent veno-arterial extracorporeal membrane oxygenation.
Annals of Intensive Care 2020, 10, 44.
OUTCOMEREA Study Group, de Montmollin E, Terzi N, Dupuis C, Garrouste-Orgeas M, da Silva D, Darmon M, Laurent V, Thiéry G, Oziel J, Marcotte G, Gainnier M, Siami S, Sztrymf B, Adrie C, Reignier J, Ruckly S, Sonneville R, Timsit JF
One-year survival in acute stroke patients requiring mechanical ventilation: a multicenter cohort study.
Annals of Intensive Care 2020, 10, 53.
Buetti N, Ruckly S, Lucet JC, Bouadma L, Schwebel C, Mimoz O, Timsit JF
Ultrasound guidance and risk for intravascular catheter-related infections among peripheral arterial catheters: a post-hoc analysis of two large randomized-controlled trials.
Annals of Intensive Care 2020, 10, 89.
Timsit JF, Baleine J, Bernard L, Calvino-Gunther S, Darmon M, Dellamonica J, Desruennes E, Leone M, Lepape A, Leroy O, Lucet JC, Merchaoui Z, Mimoz O, Misset B, Parienti JJ, Quenot JP, Roch A, Schmidt M, Slama M, Souweine B, Zahar JR, Zingg W, Bodet-Contentin L, Maxime V
Expert consensus-based clinical practice guidelines management of intravascular catheters in the intensive care unit.
Annals of Intensive Care 2020, 10, 118.
Elabbadi A, Pichon J, Visseaux B, Schnuriger A, Bouadma L, Philippot Q, Patrier J, Labbé V, Ruckly S, Fartoukh M, Timsit JF, Voiriot G
Respiratory virus-associated infections in HIV-infected adults admitted to the intensive care unit for acute respiratory failure: a 6-year bicenter retrospective study (HIV-VIR study).
Annals of Intensive Care 2020, 10, 123.
Dupuis C, Bouadma L, Ruckly S, Perozziello A, Van-Gysel D, Mageau A, Mourvillier B, de Montmollin E, Bailly S, Papin G, Sinnah F, Vinclair C, Abid S, Sonneville R, Timsit JF
Sepsis and septic shock in France: incidences, outcomes and costs of care.
Annals of Intensive Care 2020, 10, 145.
Sonneville R, Smonig R, Dupuis C, Bouadma L, de Montmollin E, Timsit JF
Natural light exposure and delirium in ICU: does the dark side cloud everything?.
Annals of Intensive Care 2020, 10, 25.
Kardaś-Słoma L, Yazdanpanah Y, Perozziello A, Zahar JR, Lescure FX, Cousien A, Lucet JC
Hand hygiene improvement or antibiotic restriction to control the household transmission of extended-spectrum β-lactamase-producing Escherichia coli: a mathematical modelling study.
Antimicrobial Resistance and Infection Control 2020, 9, 139.
Birgand G, Mutters NT, Ahmad R, Tacconelli E, Lucet JC, Holmes A, Percept-R Study Group
Risk perception of the antimicrobial resistance by infection control specialists in Europe: a case-vignette study.
Antimicrobial Resistance and Infection Control 2020, 9, 33.
Vallès X, Stenseth NC, Demeure C, Horby P, Mead PS, Cabanillas O, Ratsitorahina M, Rajerison M, Andrianaivoarimanana V, Ramasindrazana B, Pizarro-Cerda J, Scholz HC, Girod R, Hinnebusch BJ, Vigan-Womas I, Fontanet A, Wagner DM, Telfer S, Yazdanpanah Y, Tortosa P, Carrara G, Deuve J, Belmain SR, D’Ortenzio E, Baril L, Yang R
Human plague: An old scourge that needs new answers.
PLOS Neglected Tropical Diseases 2020, 14, e0008251.
Fauroux B, Hascoët JM, Jarreau PH, Magny JF, Rozé JC, Saliba E, Schwarzinger M, Katz M
Risk factors for bronchiolitis hospitalization in infants: A French nationwide retrospective cohort study over four consecutive seasons (2009-2013).
PLOS ONE 2020, 15, e0229766.
Lamirel C, Valin N, Savatovsky J, Lescure FX, Alonso AS, Girard P, Vincensini JP, Girard PM, Salomon L, Cochereau I, Moulignier A, Lewin AS
Absence of peripapillary retinal nerve-fiber–layer thinning in combined antiretroviral therapy-treated, well-sustained aviremic persons living with HIV.
PLOS ONE 2020, 15, e0229977.
Parčina M, Schneider UV, Visseaux B, Jozić R, Hannet I, Lisby JG, Chan KH
Multicenter evaluation of the QIAstat Respiratory Panel—A new rapid highly multiplexed PCR based assay for diagnosis of acute respiratory tract infections.
PLOS ONE 2020, 15, e0230183.
Faure Bardon V, Peytavin G, Lê MP, Guilleminot T, Elefant E, Stirnemann J, Leruez-Ville M, Ville Y, Spradley FT
Placental transfer of Letermovir & Maribavir in the ex vivo human cotyledon perfusion model. New perspectives for in utero treatment of congenital cytomegalovirus infection.
PLOS ONE 2020, 15, e0232140.
Tchounga BK, Charpentier C, Coffie PA, Dabis F, Descamps D, Eholie SP, Ekouevi DK
Survival among antiretroviral-experienced HIV-2 patients experiencing virologic failure with drug resistance mutations in Cote d'Ivoire West Africa.
PloS One 2020, 15, e0236642.
Bouzid D, Visseaux B, Perozziello A, Lescure X, Duval X, Casalino E, Lucet JC, ED influenza management study group
Factors associated with single-room assignment among patients admitted through the emergency department during influenza epidemics.
PloS One 2020, 15, e0237214.
Fontaine C, Armand-Lefèvre L, Magnan M, Nazimoudine A, Timsit JF, Ruppé E
Relationship between the composition of the intestinal microbiota and the tracheal and intestinal colonization by opportunistic pathogens in intensive care patients.
PloS One 2020, 15, e0237260.
Fournier AL, Parienti JJ, Champenois K, Feret P, Papot E, Yazdanpanah Y, Verdon R
Incidence and risk factors for medical care interruption in people living with HIV in a French provincial city.
PloS One 2020, 15, e0240417.
Bouzid D, Mullaert J, Le Hingrat Q, Laurent O, Duval X, Lescure X, Timsit JF, Descamps D, Montravers P, Choquet C, Lucet JC, Casalino E, Visseaux B, ED influenza study group
Characteristics associated with COVID-19 or other respiratory viruses' infections at a single-center emergency department.
PloS One 2020, 15, e0243261.
Borie R, Savale L, Dossier A, Ghosn J, Taillé C, Visseaux B, Jebreen K, Diallo A, Tesmoingt C, Morer L, Goletto T, Faucher N, Hajouji L, Neukirch C, Phillips M, Stelianides S, Bouadma L, Brosseau S, Ottaviani S, Pluvy J, Le Pluart D, Debray MP, Raynaud-Simon A, Descamps D, Khalil A, Timsit JF, Lescure FX, Descamps V, Papo T, Humbert M, Crestani B, Dieude P, Vicaut E, Zalcman G, Bichat & Kremlin-Bicêtre AP-HP COVID teams
Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study.
PloS One 2020, 15, e0243961.
Mboumba Bouassa RS, Pere H, Mossoro-Kpinde CD, Roques P, Gody JC, Moussa S, Veyer D, Gresenguet G, Charpentier C, Jenabian MA, Djoba Siawaya JF, Belec L
Purifying Selection in Human Immunodeficiency Virus-1 pol Gene in Perinatally Human Immunodeficiency Virus-1-Infected Children Harboring Discordant Immunological Response and Virological Nonresponse to Long-Term Antiretroviral Therapy.
Journal of Clinical Medicine Research 2020, 12, 369-376.
Vandingenen P, Chauvin A, Javaud N, Ghazali DA
Professional practice assessment for minor head injury management in emergency department and clinical impact of a simulation-based training: Interventional study (before/after).
Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery: TJTES 2020, 26, 545-554.
Heilmann E, Gregoriano C, Wirz Y, Luyt CE, Wolff M, Chastre J, Tubach F, Christ-Crain M, Bouadma L, Annane D, Damas P, Kristoffersen KB, Oliveira CF, Stolz D, Tamm M, de Jong E, Reinhart K, Shehabi Y, Verduri A, Nobre V, Nijsten M, deLange DW, van Oers JAH, Beishuizen A, Girbes ARJ, Mueller B, Schuetz P
Association of kidney function with effectiveness of procalcitonin-guided antibiotic treatment: a patient-level meta-analysis from randomized controlled trials.
Clinical Chemistry and Laboratory Medicine 2020, 59, 441-453.
Peiffer-Smadja N, Poda A, Ouedraogo AS, Guiard-Schmid JB, Delory T, Le Bel J, Bouvet E, Lariven S, Jeanmougin P, Ahmad R, Lescure FX
Paving the Way for the Implementation of a Decision Support System for Antibiotic Prescribing in Primary Care in West Africa: Preimplementation and Co-Design Workshop With Physicians.
Journal of Medical Internet Research 2020, 22, e17940.
Denis F, Galmiche S, Dinh A, Fontanet A, Scherpereel A, Benezit F, Lescure FX
Epidemiological Observations on the Association Between Anosmia and COVID-19 Infection: Analysis of Data From a Self-Assessment Web Application.
Journal of Medical Internet Research 2020, 22, e19855.
Yordanov Y, Dechartres A, Lescure X, Apra C, Villie P, Marchand-Arvier J, Debuc E, Dinh A, Jourdain P, AP-HP / Universities / Inserm COVID-19 Research Collaboration
Covidom, a Telesurveillance Solution for Home Monitoring Patients With COVID-19.
Journal of Medical Internet Research 2020, 22, e20748.
Galmiche S, Rahbe E, Fontanet A, Dinh A, Bénézit F, Lescure FX, Denis F
Implementation of a Self-Triage Web Application for Suspected COVID-19 and Its Impact on Emergency Call Centers: Observational Study.
Journal of Medical Internet Research 2020, 22, e22924.
Bernard Stoecklin S, Rolland P, Silue Y, Mailles A, Campese C, Simondon A, Mechain M, Meurice L, Nguyen M, Bassi C, Yamani E, Behillil S, Ismael S, Nguyen D, Malvy D, Lescure FX, Georges S, Lazarus C, Tabaï A, Stempfelet M, Enouf V, Coignard B, Levy-Bruhl D, Investigation team
First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020.
Eurosurveillance 2020, 25,
Okba NMA, Müller MA, Li W, Wang C, GeurtsvanKessel CH, Corman VM, Lamers MM, Sikkema RS, de Bruin E, Chandler FD, Yazdanpanah Y, Le Hingrat Q, Descamps D, Houhou-Fidouh N, Reusken CBEM, Bosch BJ, Drosten C, Koopmans MPG, Haagmans BL
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients.
Emerging Infectious Diseases 2020, 26,
Jaspard M, Butel N, El Helali N, Marigot-Outtandy D, Guillot H, Peytavin G, Veziris N, Bodaghi B, Flandre P, Petitjean G, Caumes E, Pourcher V
Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France.
Emerging Infectious Diseases 2020, 26, 1792-1800.
Iannetta M, Isnard S, Manuzak J, Guillerme JB, Notin M, Bailly K, Andrieu M, Amraoui S, Vimeux L, Figueiredo S, Charmeteau-de Muylder B, Vaton L, Hatton EX, Samri A, Autran B, Thiébaut R, Chaghil N, Glohi D, Charpentier C, Descamps D, Brun-Vézinet F, Matheron S, Cheynier R, Hosmalin A
Conventional Dendritic Cells and Slan+ Monocytes During HIV-2 Infection.
Frontiers in Immunology 2020, 11, 1658.
Méchaï F, Cordel H, Guglielmetti L, Aubry A, Jankovic M, Viveiros M, Santin M, Goletti D, Cambau E
Management of Tuberculosis: Are the Practices Homogeneous in High-Income Countries?.
Frontiers in Public Health 2020, 8, 443.
Peiffer-Smadja N, Allison R, Jones LF, Holmes A, Patel P, Lecky DM, Ahmad R, McNulty CAM
Preventing and Managing Urinary Tract Infections: Enhancing the Role of Community Pharmacists-A Mixed Methods Study.
Antibiotics (Basel, Switzerland) 2020, 9, E583.
Casalino E, Choquet C, Bouzid D, Peyrony O, Curac S, Revue E, Fontaine JP, Plaisance P, Chauvin A, Ghazali DA
Analysis of Emergency Department Visits and Hospital Activity during Influenza Season, COVID-19 Epidemic, and Lockdown Periods in View of Managing a Future Disaster Risk: A Multicenter Observational Study.
International Journal of Environmental Research and Public Health 2020, 17, 8302.
Belaroussi Y, Roblot P, Peiffer-Smadja N, Delaye T, Mathoulin-Pelissier S, Lemeux J, Le Moal G, Caumes E, Roblot F, Bleibtreu A
Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19?.
Journal of Clinical Medicine 2020, 9, E3691.
Pilmis B, Le Monnier A, Zahar JR
Gut Microbiota, Antibiotic Therapy and Antimicrobial Resistance: A Narrative Review.
Microorganisms 2020, 8, 269.
Mihimit A, Adawaye C, Péré H, Costiniuk C, Koyalta D, Mbopi-Keou FX, Bouassa RSM, Talla F, Moussa S, Longo JDD, Tchombou BHZ, Grésenguet G, Charpentier C, Bélec L
HSV-2 Infection as a Potential Cofactor for HIV Disease Progression and Selection of Drug Resistance Mutations in Adults under WHO-Recommended First-Line Antiretroviral Therapy: A Multicentric, Cross-Sectional Study in Cameroon, Central African Republic, Chad, and Gabon.
Tropical Medicine and Infectious Disease 2020, 5, 136.
Dang E, Sayagh F, Lê MP, Neuville M, Sinnah F, Timsit JF, Peytavin G
Plasma pharmacokinetics of bedaquiline administered by nasogastric tube in an intensive care unit.
The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union Against Tuberculosis and Lung Disease 2020, 24, 110-112.
Lévy Y, Lelièvre JD, Assoumou L, Aznar E, Pulido F, Tambussi G, Crespo M, Meybeck A, Molina JM, Delaugerre C, Izopet J, Peytavin G, Cardon F, Diallo A, Lancar R, Béniguel L, Costagliola D
Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection: A Randomized Trial.
Annals of Internal Medicine 2020, 172, 297.
Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017.
JAMA 2020, 323, 1478-1487.
Luyt CE, Forel JM, Hajage D, Jaber S, Cayot-Constantin S, Rimmelé T, Coupez E, Lu Q, Diallo MH, Penot-Ragon C, Clavel M, Schwebel C, Timsit JF, Bedos JP, Hauw-Berlemont C, Bourenne J, Mayaux J, Lefrant JY, Mira JP, Combes A, Wolff M, Chastre J, Papazian L, for the Preemptive Treatment for Herpesviridae Study Group, Réseau Européen de recherche en Ventilation Artificielle Network
Acyclovir for Mechanically Ventilated Patients With Herpes Simplex Virus Oropharyngeal Reactivation: A Randomized Clinical Trial.
JAMA Internal Medicine 2020, 180, 263.
Birgand G, Peiffer-Smadja N, Fournier S, Kerneis S, Lescure FX, Lucet JC
Assessment of Air Contamination by SARS-CoV-2 in Hospital Settings.
JAMA network open 2020, 3, e2033232.
von Cube M, Schumacher M, Putter H, Timsit JF, van de Velde C, Wolkewitz M
The population-attributable fraction for time-dependent exposures using dynamic prediction and landmarking.
Biometrical Journal. Biometrische Zeitschrift 2020, 62, 583-597.
Heyard R, Timsit JF, Held L, COMBACTE-MAGNET consortium
Validation of discrete time-to-event prediction models in the presence of competing risks.
Biometrical Journal. Biometrische Zeitschrift 2020, 62, 643-657.
Lucet JC, Harris AD, Guidet B
Less contact isolation is more in the ICU: not sure.
Intensive Care Medicine 2020, 46, 1735-1738.
Denny KJ, Kumar A, Timsit JF, Laupland KB
Extra-cardiac endovascular infections in the critically ill.
Intensive Care Medicine 2020, 46, 173-181.
Saied WI, Martin-Loeches I, Timsit JF
What is new in non-ventilated ICU-acquired pneumonia?.
Intensive Care Medicine 2020, 46, 488-491.
Tabah A, Bassetti M, Kollef MH, Zahar JR, Paiva JA, Timsit JF, Roberts JA, Schouten J, Giamarellou H, Rello J, De Waele J, Shorr AF, Leone M, Poulakou G, Depuydt P, Garnacho-Montero J
Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP).
Intensive Care Medicine 2020, 46, 245-265.
Barbier F, Mer M, Szychowiak P, Miller RF, Mariotte É, Galicier L, Bouadma L, Tattevin P, Azoulay É
Management of HIV-infected patients in the intensive care unit.
Intensive Care Medicine 2020, 46, 329-342.
Timsit JF, Ruppé E, Barbier F, Tabah A, Bassetti M
Bloodstream infections in critically ill patients: an expert statement.
Intensive Care Medicine 2020, 46, 266-284.
Timsit JF, Lipman J, Bassetti M
Antimicrobial de-escalation is part of appropriate antibiotic usage in ICU.
Intensive Care Medicine 2020, 46, 1039-1042.
Bouadma L, Lescure FX, Lucet JC, Yazdanpanah Y, Timsit JF
Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists.
Intensive Care Medicine 2020, 46, 579-582.
Andremont O, Armand-Lefevre L, Dupuis C, de Montmollin E, Ruckly S, Lucet JC, Smonig R, Magalhaes E, Ruppé E, Mourvillier B, Lebut J, Lermuzeaux M, Sonneville R, Bouadma L, Timsit JF, COMBACTE net consortium
Semi-quantitative cultures of throat and rectal swabs are efficient tests to predict ESBL-Enterobacterales ventilator-associated pneumonia in mechanically ventilated ESBL carriers.
Intensive Care Medicine 2020, 46, 1232-1242.
Abdul-Aziz MH, Alffenaar JWC, Bassetti M, Bracht H, Dimopoulos G, Marriott D, Neely MN, Paiva JA, Pea F, Sjovall F, Timsit JF, Udy AA, Wicha SG, Zeitlinger M, De Waele JJ, Roberts JA, Infection Section of European Society of Intensive Care Medicine (ESICM), Pharmacokinetic/pharmacodynamic and Critically Ill Patient Study Groups of European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Group of International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT), Infections in the ICU and Sepsis Working Group of International Society of Antimicrobial Chemotherapy (ISAC)
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper.
Intensive Care Medicine 2020, 46, 1127-1153.
De Bus L, Depuydt P, Steen J, Dhaese S, De Smet K, Tabah A, Akova M, Cotta MO, De Pascale G, Dimopoulos G, Fujitani S, Garnacho-Montero J, Leone M, Lipman J, Ostermann M, Paiva JA, Schouten J, Sjövall F, Timsit JF, Roberts JA, Zahar JR, Zand F, Zirpe K, De Waele JJ, DIANA study group
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study.
Intensive Care Medicine 2020, 46, 1404-1417.
Wicky PH, Henry-Feugeas MC, Para M, de Montmollin E
Uncharted territories: assessing cerebral vascularization in patients undergoing venoarterial extra-corporeal membrane oxygenation.
Intensive Care Medicine 2020, 46, 2079-2080.
Bassetti M, Kollef MH, Timsit JF
Bacterial and fungal superinfections in critically ill patients with COVID-19.
Intensive Care Medicine 2020, 46, 2071-2074.
Kalil AC, Timsit JF
Less is more: critically ill status is not a carte blanche for unlimited antibiotic use.
Intensive Care Medicine 2020, 46, 2075-2078.
Luyt CE, Bouadma L, Morris AC, Dhanani JA, Kollef M, Lipman J, Martin-Loeches I, Nseir S, Ranzani OT, Roquilly A, Schmidt M, Torres A, Timsit JF
Pulmonary infections complicating ARDS.
Intensive Care Medicine 2020, 46, 2168-2183.
Moulignier A, Viret-Vilayphon AC, Lescure FX, Plaisier E, Salomon L, Lamirel C, Pialoux G, ALCOVE Study Group
Microalbuminuria: a sentinel of neurocognitive impairment in HIV-infected individuals?.
Journal of Neurology 2020, 267, 1368-1376.
Pilmis B, Alby-Laurent F, Fasola ML, Seegers V, Guery R, Guet-Revillet H, Postaire M, Toubiana J, Bille E, Lortholary O, Zahar JR
Pseudomonas aeruginosa bloodstream infections in children: a 9-year retrospective study.
European Journal of Pediatrics 2020, 179, 1247-1254.
Senard O, Lafaurie M, Lesprit P, Nguyen Y, Lescure X, Therby A, Fihman V, Oubaya N, Lepeule R
Efficacy of cefoxitin versus carbapenem in febrile male urinary tract infections caused by extended spectrum beta-lactamase–producing Escherichia coli: a multicenter retrospective cohort study with propensity score analysis.
European Journal of Clinical Microbiology & Infectious Diseases 2020, 39, 121-129.
Farfour E, Visseaux B, Pascreau T, Jolly E, Houhou N, Mazaux L, Asso-Bonnet M, Vasse M
The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis?.
European Journal of Clinical Microbiology & Infectious Diseases 2020, 39, 1997-2000.
Bouadma L, Wiedemann A, Patrier J, Surénaud M, Wicky PH, Foucat E, Diehl JL, Hejblum BP, Sinnah F, de Montmollin E, Lacabaratz C, Thiébaut R, Timsit JF, Lévy Y
Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome.
Journal of Clinical Immunology 2020, 40, 1082-1092.
Sonneville R, Mazighi M, Bresson D, Crassard I, Crozier S, de Montmollin E, Degos V, Faugeras F, Gayat E, Josse L, Lamy C, Magalhaes E, Maldjian A, Ruckly S, Servan J, Vassel P, Vigué B, Timsit JF, Woimant F, SPICE investigators
Outcomes of Acute Stroke Patients Requiring Mechanical Ventilation: Study Protocol for the SPICE Multicenter Prospective Observational Study.
Neurocritical Care 2020, 32, 624-629.
Magalhaes E, Reuter J, Wanono R, Bouadma L, Jaquet P, Tanaka S, Sinnah F, Ruckly S, Dupuis C, de Montmollin E, Para M, Braham W, Pisani A, d'Ortho MP, Rouvel-Tallec A, Timsit JF, Sonneville R, DINAMO study group
Early EEG for Prognostication Under Venoarterial Extracorporeal Membrane Oxygenation.
Neurocritical Care 2020, 33, 688-694.
Bénézit F, Loubet P, Galtier F, Pronier C, Lenzi N, Lesieur Z, Jouneau S, Lagathu G, L'Honneur AS, Foulongne V, Vallejo C, Alain S, Duval X, Houhou N, Costa Y, Vanhems P, Amour S, Carrat F, Lina B, Launay O, Tattevin P, FLUVAC Study Group
Non-influenza respiratory viruses in adult patients admitted with influenza-like illness: a 3-year prospective multicenter study.
Infection 2020, 48, 489-495.
Pichon M, Joly V, Argy N, Houze S, Bretagne S, Alanio A, Wassef M, Verillaud B, Yazdanpanah Y
Aspergillus flavus malignant external otitis in a diabetic patient: case report and literature review.
Infection 2020, 48, 193-203.
Rello J, Belliato M, Dimopoulos MA, Giamarellos-Bourboulis EJ, Jaksic V, Martin-Loeches I, Mporas I, Pelosi P, Poulakou G, Pournaras S, Tamae-Kakazu M, Timsit JF, Waterer G, Tejada S, Dimopoulos G
Update in COVID-19 in the intensive care unit from the 2020 HELLENIC Athens International symposium.
Anaesthesia, Critical Care & Pain Medicine 2020, 39, 723-730.
Louchet M, Sibiude J, Peytavin G, Picone O, Tréluyer JM, Mandelbrot L
Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019.
American journal of obstetrics & gynecology MFM 2020, 2, 100159.
Sallard E, Lescure FX, Yazdanpanah Y, Mentre F, Peiffer-Smadja N
Type 1 interferons as a potential treatment against COVID-19.
Antiviral Research 2020, 178, 104791.
Venisse N, Peytavin G, Bouchet S, Gagnieu MC, Garraffo R, Guilhaumou R, Solas C
Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection.
Antiviral Research 2020, 181, 104866.
Delacôte C, Bauvin P, Louvet A, Dautrecque F, Ntandja Wandji LC, Lassailly G, Voican C, Perlemuter G, Naveau S, Mathurin P, Deuffic-Burban S
A Model to Identify Heavy Drinkers at High Risk for Liver Disease Progression.
Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association 2020, 18, 2315-2323.e6.
Michallet M, Sobh M, Deray G, Gangneux JP, Pigneux A, Larrey D, Ribaud P, Mira JP, Nivoix Y, Yakoub-Agha I, Timsit JF, Alfandari S, Herbrecht R
Antifungal Stewardship in Hematology: Reflection of a Multidisciplinary Group of Experts.
Clinical Lymphoma Myeloma and Leukemia 2020, S2152265020304250.
Loubet P, Tubiana S, Claessens Y, Epelboin L, Ficko C, Le Bel J, Rammaert B, Garin N, Prendki V, Stirnemann J, Leport C, Yazdanpanah Y, Varon E, Duval X, Claessens Y, Duval X, Bouvard E, Carette M, Debray M, Mayaud C, Leport C, Houhou N, Tubiana S, Benjoar M, Blanc F, Brun A, Epelboin L, Ficko C, Khalil A, Lefloch H, Naccache J, Rammaert B, Abry A, Allo J, Andre S, Andreotti C, Baarir N, Bendahou M, Benlafia L, Bernard J, Berthoumieu A, Billemont M, Bokobza J, Brun A, Burggraff E, Canavaggio P, Carette M, Casalino E, Castro S, Choquet C, Clément H, Colosi L, Dabreteau A, Damelincourt S, Dautheville S, Debray M, Delay M, Delerme S, Depierre L, Djamouri F, Dumas F, Fadel M, Feydey A, Freund Y, Garcia L, Goulet H, Hausfater P, Ilic-Habensus E, Josse M, Kansao J, Kieffer Y, Lecomte F, Lemkarane K, Madonna P, Meyniard O, Mzabi L, Pariente D, Pernet J, Perruche F, Piquet J, Ranerison R, Ray P, Renai F, Rouff E, Saget D, Saïdi K, Sauvin G, Trabattoni E, Trimech N, Auger C, Pasquet B, Tamazirt S, Treluyer J, Tubach F, Wang J, Chassany O, Misse C
Community-acquired pneumonia in the emergency department: an algorithm to facilitate diagnosis and guide chest CT scan indication.
Clinical Microbiology and Infection 2020, 26, 382.e1-382.e7.
Peiffer-Smadja N, Rawson TM, Ahmad R, Buchard A, Georgiou P, Lescure FX, Birgand G, Holmes AH
Machine learning for clinical decision support in infectious diseases: a narrative review of current applications.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, 26, 584-595.
de Grooth HJ, Timsit JF, Mermel L, Mimoz O, Buetti N, du Cheyron D, Oudemans-van Straaten HM, Parienti JJ, 3SITES, CLEAN and DRESSING groups
Validity of surrogate endpoints assessing central venous catheter-related infection: evidence from individual- and study-level analyses.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, 26, 563-571.
Tubiana S, Varon E, Biron C, Ploy MC, Mourvillier B, Taha MK, Revest M, Poyart C, Martin-Blondel G, Lecuit M, Cua E, Pasquet B, Preau M, Hoen B, Duval X, COMBAT study group
Community-acquired bacterial meningitis in adults: in-hospital prognosis, long-term disability and determinants of outcome in a multicentre prospective cohort.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, 26, 1192-1200.
Visseaux B, Hué S, Le Hingrat Q, Salmona M, Lebourgeois S, Delaugerre C, Descamps D, Chaix ML, Ghosn J
Phylogenetic investigation of HCV-4d epidemic in Paris MSM HIV population reveals a still active outbreak and a strong link to the Netherlands.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, 26, 785.e1-785.e4.
Peiffer-Smadja N, Dellière S, Rodriguez C, Birgand G, Lescure FX, Fourati S, Ruppé E
Machine learning in the clinical microbiology laboratory: has the time come for routine practice?.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, 26, 1300-1309.
Peiffer-Smadja N, Lucet JC, Bendjelloul G, Bouadma L, Gerard S, Choquet C, Jacques S, Khalil A, Maisani P, Casalino E, Descamps D, Timsit JF, Yazdanpanah Y, Lescure FX
Challenges and issues about organising a hospital to respond to the COVID-19 outbreak: experience from a French reference centre.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020
Fragkou PC, Belhadi D, Peiffer-Smadja N, Moschopoulos CD, Lescure FX, Janocha H, Karofylakis E, Yazdanpanah Y, Mentré F, Skevaki C, Laouénan C, Tsiodras S, ESCMID Study Group for Respiratory Viruses
Review of trials currently testing treatment and prevention of COVID-19.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, 26, 988-998.
Buetti N, Souweine B, Mermel L, Mimoz O, Ruckly S, Loiodice A, Mongardon N, Lucet JC, Parienti JJ, Timsit JF
Concurrent systemic antibiotics at catheter insertion and intravascular catheter-related infection in the ICU: a post hoc analysis using individual data from five large RCTs.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020
Muff S, Hebeisen U, Timsit JF, Mermel L, Harbarth S, Buetti N
Treatment duration of enterococcal intravascular catheter-related infections.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020
Hingrat QL, Visseaux B, Laouenan C, Tubiana S, Bouadma L, Yazdanpanah Y, Duval X, Burdet C, Ichou H, Damond F, Bertine M, Benmalek N, Choquet C, Timsit JF, Ghosn J, Charpentier C, Descamps D, Houhou-Fidouh N, French COVID cohort management committee, CoV-CONTACT study group, members of the French-COVID cohort study group (by alphabetical order), member of the CoV-CONTACT study group. Principal investigator, Steering Committee, CoV-CONTACT Clinical Centers, Coordination and statistical analyses, Virological Lab, Biological Center, Partners, Sponsor, Genetic
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, S1198-743X(20)30721-7.
Saliba R, Zahar JR, El Allaoui F, Carbonnelle E, Lescat M
Impact of freeze/thaw cycles and single freezing at -80 °C on the viability of aerobic bacteria from rectal swabs performed with the ESwabTM system.
Diagnostic Microbiology and Infectious Disease 2020, 96, 114895.
Rondinaud E, Ruppé E, Matheron S, Lucet JC, Armand-Lefevre L, VOYAG-R study group
Screening methods for intestinal carriage of multidrug-resistant Enterobacterales: interest of enrichment broth.
Diagnostic Microbiology and Infectious Disease 2020, 97, 115079.
Ouersighni A, Ghazali DA
Contribution of certified registered nurse anaesthetists to the management of the COVID-19 pandemic health crisis.
Intensive & Critical Care Nursing 2020, 60, 102888.
Mizrahi A, Delerue T, Morel H, Le Monnier A, Carbonnelle E, Pilmis B, Zahar JR, on behalf the Saint-Joseph/Avicenna Study Group
Infections caused by naturally AmpC-producing Enterobacteriaceae: Can we use third-generation cephalosporins? A narrative review.
International Journal of Antimicrobial Agents 2020, 55, 105834.
Benchetrit L, Mathy V, Armand-Lefevre L, Bouadma L, Timsit JF
Successful treatment of septic shock due to NDM-1-producing Klebsiella pneumoniae using ceftazidime/avibactam combined with aztreonam in solid organ transplant recipients: report of two cases.
International Journal of Antimicrobial Agents 2020, 55, 105842.
Deslandes A, Berti V, Tandjaoui-Lambotte Y, Alloui C, Carbonnelle E, Zahar JR, Brichler S, Cohen Y
SARS-CoV-2 was already spreading in France in late December 2019.
International Journal of Antimicrobial Agents 2020, 55, 106006.
André-Garnier E, Hingrat QL, Marcelin AG, Reliquet V, Malet I, Leducq V, Rodallec A, Peytavin G, Ferré V, Charpentier C, Raffi F
Previously unreported emergence of A265V substitution in the integrase gene in association with bictegravir virological failure.
International Journal of Antimicrobial Agents 2020, 106039.
Dubert M, Visseaux B, Isernia V, Bouadma L, Deconinck L, Patrier J, Wicky PH, Le Pluart D, Kramer L, Rioux C, Le Hingrat Q, Houhou-Fidouh N, Yazdanpanah Y, Ghosn J, Lescure FX
Case report study of the first five COVID-19 patients treated with remdesivir in France.
International Journal of Infectious Diseases 2020, 98, 290-293.
Isernia V, Julia Z, Le Gac S, Bachelard A, Landman R, Lariven S, Joly V, Deconinck L, Rioux C, Lescure X, Yazdanpanah Y, Ghosn J
SARS-COV2 infection in 30 HIV-infected patients followed-up in a French University Hospital.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2020, 101, 49-51.
Tsopra R, Courtine M, Sedki K, Eap D, Cabal M, Cohen S, Bouchaud O, Mechaï F, Lamy JB
AntibioGame®: A serious game for teaching medical students about antibiotic use.
International Journal of Medical Informatics 2020, 136, 104074.
Posthuma LM, Downey C, Visscher MJ, Ghazali DA, Joshi M, Ashrafian H, Khan S, Darzi A, Goldstone J, Preckel B
Remote wireless vital signs monitoring on the ward for early detection of deteriorating patients: A case series.
International Journal of Nursing Studies 2020, 104, 103515.
Battesti G, El Khalifa J, Abdelhedi N, Ferre V, Bouscarat F, Picard-Dahan C, Brunet-Possenti F, Collin G, Lavaud J, Le Bozec P, Rousselot M, Tournier A, Lheure C, Couvelard A, Hacein-Bey-Abina S, Abina AM, Charpentier C, Mignot S, Nicaise P, Descamps D, Deschamps L, Descamps V
New insights in COVID-19–associated chilblains: A comparative study with chilblain lupus erythematosus.
Journal of the American Academy of Dermatology 2020, 83, 1219-1222.
Bailly S, Galerneau LM, Ruckly S, Seiller A, Terzi N, Schwebel C, Dupuis C, Tamisier R, Mourvillier B, Pepin JL, Timsit JF
Impact of obstructive sleep apnea on the obesity paradox in critically ill patients.
Journal of Critical Care 2020, 56, 120-124.
Visseaux B, Le Hingrat Q, Collin G, Ferré V, Storto A, Ichou H, Bouzid D, Poey N, de Montmollin E, Descamps D, Houhou-Fidouh N
Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection.
Journal of Clinical Virology 2020, 129, 104520.
Wirden M, Feghoul L, Bertine M, Nere ML, Le Hingrat Q, Abdi B, Boutolleau D, Ferre VM, Jary A, Delaugerre C, Marcelin AG, Descamps D, Legoff J, Visseaux B, Chaix ML
Multicenter comparison of the Cobas 6800 system with the RealStar RT-PCR kit for the detection of SARS-CoV-2.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2020, 130, 104573.
Charpentier C, Ichou H, Damond F, Bouvet E, Chaix ML, Ferré V, Delaugerre C, Mahjoub N, Larrouy L, Le Hingrat Q, Visseaux B, Mackiewicz V, Descamps D, Fidouh-Houhou N
Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott).
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2020, 132, 104618.
Saliba R, Aho-Glélé LS, Karam-Sarkis D, Zahar JR
Evaluation of polymerase chain reaction assays for direct screening of carbapenemase-producing Enterobacteriaceae from rectal swabs: a diagnostic meta-analysis.
Journal of Hospital Infection 2020, 104, 381-389.
Pilmis B, Billard-Pomares T, Martin M, Clarempuy C, Lemezo C, Saint-Marc C, Bourlon N, Seytre D, Carbonnelle E, Zahar JR
Can environmental contamination be explained by particular traits associated with patients?.
The Journal of Hospital Infection 2020, 104, 293-297.
Bouzid D, Lucet JC, Duval X, Houhou-Fidouh N, Casalino E, Visseaux B, ED Influenza Management Study Group
Multiplex PCR implementation as point-of-care testing in a French emergency department.
The Journal of Hospital Infection 2020, 105, 337-338.
Jolivet S, Lolom I, Bailly S, Bouadma L, Lortat-Jacob B, Montravers P, Armand-Lefevre L, Timsit JF, Lucet JC
Impact of colonization pressure on acquisition of extended-spectrum β-lactamase-producing Enterobacterales and meticillin-resistant Staphylococcus aureus in two intensive care units: a 19-year retrospective surveillance.
The Journal of Hospital Infection 2020, 105, 10-16.
Hilliquin D, Lomont A, Zahar JR
Cohorting for preventing the nosocomial spread of Carbapenemase-Producing Enterobacterales, in non-epidemic settings: is it mandatory?.
The Journal of Hospital Infection 2020
Sevin T, Goldstein V, Lolom I, Lenne F, Gaudonnet Y, Baptiste AL, Bendjelloul G, Armand-Lefevre L, Lucet JC
Bathroom contamination by antibiotic-resistant Enterobacterales (ESBLPE and CPE): an experimental study.
The Journal of Hospital Infection 2020, 106, 271-276.
Ong C, Lucet JC, Bourigault C, Birgand G, Aho S, Lepelletier D
Staphylococcus aureus nasal decolonization before cardiac and orthopaedic surgeries: first descriptive survey in France.
The Journal of Hospital Infection 2020, 106, 332-334.
Ibn Saied W, Merceron S, Schwebel C, Le Monnier A, Oziel J, Garrouste-Orgeas M, Marcotte G, Ruckly S, Souweine B, Darmon M, Bouadma L, de Montmollin E, Mourvillier B, Reignier J, Papazian L, Siami S, Azoulay E, Bédos JP, Timsit JF
Ventilator-associated pneumonia due to Stenotrophomonas maltophilia: Risk factors and outcome.
The Journal of Infection 2020, 80, 279-285.
Gousseff M, Penot P, Gallay L, Batisse D, Benech N, Bouiller K, Collarino R, Conrad A, Slama D, Joseph C, Lemaignen A, Lescure FX, Levy B, Mahevas M, Pozzetto B, Vignier N, Wyplosz B, Salmon D, Goehringer F, Botelho-Nevers E, in behalf of the COCOREC study group
Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?.
The Journal of Infection 2020, 81, 816-846.
Cancella de Abreu M, Choquet C, Petit H, Bouzid D, Damond F, Marot S, Ferre VM, Burrel S, Boutolleau D, Houdou-Fidouh N, Marcelin AG, Descamps D, Hausfater P
SARS-CoV-2 IGM and IGG rapid serologic test for the diagnosis of COVID-19 in the emergency department.
The Journal of Infection 2020, 81, 816-846.
Epelboin L, Rapp C, Faucher JF, Méchaï F, Bottieau E, Matheron S, Malvy D, Caumes E
Management and treatment of uncomplicated imported malaria in adults. Update of the French malaria clinical guidelines.
Medecine Et Maladies Infectieuses 2020, 50, 194-212.
Bru JP, Alfandari S, Bleibtreu A, Chavanet P, Gauzit R, Lescure X, Lesprit P, Tattevin P
Carbapenems versus beta-lactam/beta-lactamase inhibitors to treat ESBL-producing Enterobacteriaceae infections.
Medecine Et Maladies Infectieuses 2020, 50, 313-315.
Bleibtreu A, Bertine M, Bertin C, Houhou-Fidouh N, Visseaux B
Focus on Middle East respiratory syndrome coronavirus (MERS-CoV).
Médecine et Maladies Infectieuses 2020, 50, 243-251.
San C, Lê MP, Matheron S, Mourvillier B, Caseris M, Timsit JF, Wolff M, Yazdanpanah Y, Descamps D, Peytavin G
Management of oral antiretroviral administration in patients with swallowing disorders or with an enteral feeding tube.
Medecine Et Maladies Infectieuses 2020, 50, 537-544.
Denis N, Timsit JF, Giaj Levra M, Sakhri L, Duruisseaux M, Schwebel C, Merle P, Pinsolle J, Ferrer L, Moro-Sibilot D, Toffart AC
Impact of systematic advanced care planning in lung cancer patients: A prospective study.
Respiratory Medicine and Research 2020, 77, 11-17.
Leroy J, Houzé S, Dardé ML, Yéra H, Rossi B, Delhaes L, Gabriel F, Loubet P, Deleplancque AS, Senneville E, Ajana F, Sendid B, Malvy D
Severe toxoplasmosis imported from tropical Africa in immunocompetent patients: A case series.
Travel Medicine and Infectious Disease 2020, 35, 101509.
Pizzorno A, Padey B, Julien T, Trouillet-Assant S, Traversier A, Errazuriz-Cerda E, Fouret J, Dubois J, Gaymard A, Lescure FX, Dulière V, Brun P, Constant S, Poissy J, Lina B, Yazdanpanah Y, Terrier O, Rosa-Calatrava M
Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia.
Cell Reports Medicine 2020, 1, 100059.
Gilbert M, Pullano G, Pinotti F, Valdano E, Poletto C, Boëlle PY, D'Ortenzio E, Yazdanpanah Y, Eholie SP, Altmann M, Gutierrez B, Kraemer MUG, Colizza V
Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study.
The Lancet 2020, 395, 871-877.
Jouvin-Marche E, Carrara G, Pulcini C, Andremont A, Danan C, Couderc-Obert C, Lienhardt C, Kieny MP, Yazdanpanah Y
French research strategy to tackle antimicrobial resistance.
The Lancet 2020, 395, 1239-1241.
Norton A, Mphahlele J, Yazdanpanah Y, Piot P, Bayona MT
Strengthening the global effort on COVID-19 research.
The Lancet 2020, S0140673620315981.
Lescure FX, Bouadma L, Nguyen D, Parisey M, Wicky PH, Behillil S, Gaymard A, Bouscambert-Duchamp M, Donati F, Le Hingrat Q, Enouf V, Houhou-Fidouh N, Valette M, Mailles A, Lucet JC, Mentre F, Duval X, Descamps D, Malvy D, Timsit JF, Lina B, van-der-Werf S, Yazdanpanah Y
Clinical and virological data of the first cases of COVID-19 in Europe: a case series.
The Lancet. Infectious Diseases 2020, 20, 697-706.
von Cube M, Timsit JF, Schumacher M, Motschall E, Schumacher M
Quantification and interpretation of attributable mortality in core clinical infectious disease journals.
The Lancet. Infectious Diseases 2020, 20, e299-e306.
Brendish NJ, Poole S, Naidu VV, Mansbridge CT, Norton NJ, Wheeler H, Presland L, Kidd S, Cortes NJ, Borca F, Phan H, Babbage G, Visseaux B, Ewings S, Clark TW
Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study.
The Lancet. Respiratory Medicine 2020, 8, 1192-1200.
Atlani-Duault L, Lina B, Malvy D, Yazdanpanah Y, Chauvin F, Delfraissy JF
COVID-19: France grapples with the pragmatics of isolation.
The Lancet. Public Health 2020, 5, e573-e574.
Ghazali DA, Ouersighni A, Gay M, Audebault V, Pavlovsky T, Casalino E
Feedback to Prepare EMS Teams to Manage Infected Patients with COVID-19: A Case Series.
Prehospital and Disaster Medicine 2020, 35, 451-453.
Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, Feldt T, Green G, Green ML, Lescure FX, Nicastri E, Oda R, Yo K, Quiros-Roldan E, Studemeister A, Redinski J, Ahmed S, Bernett J, Chelliah D, Chen D, Chihara S, Cohen SH, Cunningham J, D'Arminio Monforte A, Ismail S, Kato H, Lapadula G, L'Her E, Maeno T, Majumder S, Massari M, Mora-Rillo M, Mutoh Y, Nguyen D, Verweij E, Zoufaly A, Osinusi AO, DeZure A, Zhao Y, Zhong L, Chokkalingam A, Elboudwarej E, Telep L, Timbs L, Henne I, Sellers S, Cao H, Tan SK, Winterbourne L, Desai P, Mera R, Gaggar A, Myers RP, Brainard DM, Childs R, Flanigan T
Compassionate Use of Remdesivir for Patients with Severe Covid-19.
The New England Journal of Medicine 2020
Triki D, Kermarrec M, Visseaux B, Descamps D, Flatters D, Camproux AC, Regad L
Exploration of the effects of sequence variations between HIV-1 and HIV-2 proteases on their three-dimensional structures.
Journal of Biomolecular Structure & Dynamics 2020, 38, 5014-5026.
Couffignal C, Papot E, Etienne A, Legac S, Laouénan C, Beres D, Blum L, Khuong-Josses MA, Lepretre A, Papazian P, Yazdanpanah Y, Bouvet E
Treatment as prevention (TasP) and perceived sexual changes in behavior among HIV-positive persons: a French survey in infectious diseases departments in Paris.
AIDS care 2020, 32, 811-817.
Puppo C, Spire B, Morel S, Génin M, Béniguel L, Costagliola D, Ghosn J, Mabire X, Molina JM, Rojas Castro D, Préau M
How PrEP users constitute a community in the MSM population through their specific experience and management of stigmatization. The example of the French ANRS-PREVENIR study.
AIDS Care 2020, 32, 32-39.
Deelen JWT, Rottier WC, Giron Ortega JA, Rodriguez-Baño J, Harbarth S, Tacconelli E, Jacobsson G, Zahar JR, van Werkhoven CH, Bonten MJM
An international prospective cohort study to validate two prediction rules for infections caused by 3rd-generation cephalosporin-resistant Enterobacterales.
Clinical Infectious Diseases 2020, ciaa950.
Tzou PL, Descamps D, Rhee SY, Raugi DN, Charpentier C, Taveira N, Smith RA, Soriano V, de Mendoza C, Holmes SP, Gottlieb GS, Shafer RW
Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2.
The Journal of Infectious Diseases 2020, 221, 1962-1972.
Jary A, Leducq V, Desire N, Petit H, Palich R, Joly V, Canestri A, Gothland A, Lambert-Niclot S, Surgers L, Amiel C, Descamps D, Spano JP, Katlama C, Calvez V, Marcelin AG
New Kaposi's sarcoma-associated herpesvirus variant in men who have sex with men associated with severe pathologies.
The Journal of Infectious Diseases 2020, 222, 1320-1328.
Luong Nguyen LB, Freedberg KA, Wanjala S, Maman D, Szumilin E, Mendiharat P, Yazdanpanah Y
Comparative effectiveness of interventions to improve the HIV continuum of care and HIV Pre-Exposure Prophylaxis in Kenya: a model-based analysis.
The Journal of Infectious Diseases 2020
Brice J, Sylla M, Desire N, Sayon S, Telly F, Bocar-Fofana D, Murphy R, Peytavin G, Diallo S, Nastouli E, Calvez V, Marcelin AG, Maiga AI, Lambert-Niclot S
Characterization of drug resistance and the defective HIV reservoir in virally suppressed vertically infected children in Mali.
The Journal of Antimicrobial Chemotherapy 2020, 75, 1272-1279.
Jary A, Marcelin AG, Charpentier C, Wirden M, Lê MP, Peytavin G, Descamps D, Calvez V
M184V/I does not impact the efficacy of abacavir/lamivudine/dolutegravir use as switch therapy in virologically suppressed patients.
The Journal of Antimicrobial Chemotherapy 2020, 75, 1290-1293.
Charpentier C, Peytavin G, Raffi F, Burdet C, Landman R, Lê MP, Katlama C, Collin G, Benalycherif A, Cabie A, Mentré F, Yazdanpanah Y, Descamps D, Joly V
Pharmacovirological analyses of blood and male genital compartment in patients receiving dolutegravir + lamivudine dual therapy as a switch strategy (ANRS 167 LAMIDOL trial).
The Journal of Antimicrobial Chemotherapy 2020, 75, 1611-1617.
Marcelin AG, Charpentier C, Jary A, Perrier M, Margot N, Callebaut C, Calvez V, Descamps D
Frequency of capsid substitutions associated with GS-6207 in vitro resistance in HIV-1 from antiretroviral-naive and -experienced patients.
The Journal of Antimicrobial Chemotherapy 2020, 75, 1588-1590.
Soulie C, Assoumou L, Abdi B, Sayon S, Nguyen T, Valantin MA, Beniguel L, Ferre V, Alloui C, Montes B, Avettand-Fenoel V, Delaugerre C, Descamps D, Martinez E, Reynes J, Peytavin G, Costagliola D, Katlama C, Calvez V, Marcelin AG, ANRS-163 ETRAL study group
Characterization of viral rebounds on dual etravirine/raltegravir maintenance therapy (ANRS-163 ETRAL trial).
The Journal of Antimicrobial Chemotherapy 2020, 75, 1943-1949.
Boyd A, Miailhes P, Chas J, Valantin MA, Yazdanpanah Y, Rosenthal E, Chevaliez S, Piroth L, Rougier H, Peytavin G, Pialoux G, Girard PM, Lacombe K
Grazoprevir/elbasvir for the immediate treatment of recently acquired HCV genotype 1 or 4 infection in MSM.
The Journal of Antimicrobial Chemotherapy 2020, 75, 1961-1968.
Alain S, Feghoul L, Girault S, Lepiller Q, Frobert E, Michonneau D, Berceanu A, Ducastelle-Lepretre S, Tilloy V, Guerin E, Le Goff J, Peytavin G, Hantz S
Letermovir breakthroughs during the French Named Patient Programme: interest of monitoring blood concentration in clinical practice.
The Journal of Antimicrobial Chemotherapy 2020, 75, 2253-2257.
Delory T, Jeanmougin P, Lariven S, Aubert JP, Peiffer-Smadja N, Boëlle PY, Bouvet E, Lescure FX, Le Bel J
A computerized decision support system (CDSS) for antibiotic prescription in primary care-Antibioclic: implementation, adoption and sustainable use in the era of extended antimicrobial resistance.
The Journal of Antimicrobial Chemotherapy 2020, 75, 2353-2362.
Lê MP, Peiffer-Smadja N, Guedj J, Néant N, Mentré F, Ader F, Yazdanpanah Y, Peytavin G
Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.
The Journal of Antimicrobial Chemotherapy 2020, 75, 2376-2380.
Kauv J, Lê MP, Veyrier M, Le Hingrat Q, Visseaux B, Massias L, Chauveheid MP, Descamps D, Ghosn J, Peytavin G
Failure of hydroxychloroquine pre-exposure prophylaxis in COVID-19 infection? A case report.
The Journal of Antimicrobial Chemotherapy 2020, 75, 2706-2707.
Peiffer-Smadja N, Lescure FX, Sallard E, Ravaud P, Vegreville B, Zeitoun JD
Anticovid, a comprehensive open-access real-time platform of registered clinical studies for COVID-19.
Journal of Antimicrobial Chemotherapy 2020, 75, 2708-2710.
Lê MP, Jaquet P, Patrier J, Wicky PH, Le Hingrat Q, Veyrier M, Kauv J, Sonneville R, Visseaux B, Laouénan C, Bouadma L, Descamps D, de Montmollin E, Peytavin G, Timsit JF
Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients.
The Journal of Antimicrobial Chemotherapy 2020, 75, 2657-2660.
Palich R, Wirden M, Peytavin G, Lê MP, Seang S, Abdi B, Schneider L, Tubiana R, Valantin MA, Paccoud O, Soulié C, Calvez V, Katlama C, Marcelin AG
Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrations.
The Journal of Antimicrobial Chemotherapy 2020, 75, 2981-2985.
Katlama C, Assoumou L, Valantin MA, Soulié C, Martinez E, Béniguel L, Bouchaud O, Raffi F, Molina JM, Fellahi S, Peytavin G, Marcelin AG, Kolta S, Capeau J, Gibowski S, Cardon F, Reynes J, Costagliola D
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study-authors' response.
The Journal of Antimicrobial Chemotherapy 2020, 75, 3699-3700.
Visseaux B, Assoumou L, Mahjoub N, Grude M, Trabaud MA, Raymond S, Wirden M, Morand-Joubert L, Roussel C, Montes B, Bocket L, Fafi-Kremer S, Amiel C, De Monte A, Stefic K, Pallier C, Tumiotto C, Maillard A, Vallet S, Ferre V, Bouvier-Alias M, Dina J, Signori-Schmuck A, Carles MJ, Plantier JC, Meyer L, Descamps D, Chaix ML, AC43 ANRS Resistance Group
Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?.
The Journal of Antimicrobial Chemotherapy 2020, 75, 183-193.
Tzou PL, Rhee SY, Descamps D, Clutter DS, Hare B, Mor O, Grude M, Parkin N, Jordan MR, Bertagnolio S, Schapiro JM, Harrigan PR, Geretti AM, Marcelin AG, Shafer RW, WHO HIVResNet Working Groups
Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance.
The Journal of Antimicrobial Chemotherapy 2020, 75, 170-182.
Tebano G, Soulié C, Schneider L, Blanc C, Agher R, Seang S, Valantin MA, Palich R, Tubiana R, Peytavin G, Marcelin AG, Assoumou L, Katlama C
Long-term follow-up of HIV-infected patients on dolutegravir monotherapy.
The Journal of Antimicrobial Chemotherapy 2020, 75, 675-680.
Soulie C, Santoro MM, Storto A, Abdi B, Charpentier C, Armenia D, Jary A, Forbici F, Bertoli A, Gennari W, Andreoni M, Mussini C, Antinori A, Perno CF, Calvez V, Ceccherini-Silberstein F, Descamps D, Marcelin AG
Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy.
The Journal of Antimicrobial Chemotherapy 2020, 75, 1026-1030.
Argy N, Lariven S, Rideau A, Lemoine A, Bourgeois Moine A, Allal L, Choudat L, Ravel C, Michard F, Buffet P, Faye A, Houze S, Yazdanpanah Y
Congenital Leishmaniasis in a Newborn Infant Whose Mother was Coinfected With Leishmaniasis and HIV.
Journal of the Pediatric Infectious Diseases Society 2020, 9, 277-280.
Lescure FX, Fellahi S, Pialoux G, Bastard JP, Eme AL, Esteve E, Lebrette MG, Guiard-Schmid JB, Capeau J, Ronco P, Costagliola D, Plaisier E
Prevalence of tubulopathy and association with renal function loss in HIV-infected patients.
Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 2020, 35, 607-615.
Pichon M, Claire LP, Genet P, Caby F, Yazdanpanah Y, Menn AM
Adult-onset Still's disease in a patient with human immunodeficiency virus infection: pathophysiological link?.
Rheumatology (Oxford, England) 2020, 59, e99-e101.
Bello G, Delatorre E, Lacoste V, Darcissac E, Herrmann-Storck C, Tressières B, Cabras O, Lamaury I, Cabié A, Visseaux B, Chaix ML, Descamps D, Césaire R, Nacher M, Dos Santos G
Increasing prevalence and local transmission of non-B HIV-1 subtypes in the French Antilles and French Guiana between 1995 and 2018.
Virus Evolution 2020, 6, veaa081.
Reuter J, Peoc'h K, Bouadma L, Ruckly S, Chicha-Cattoir V, Faille D, Bourrienne MC, Dupuis C, Magalhaes E, Tanaka S, Vinclair C, de Montmollin E, Mazighi M, Para M, Braham W, Pisani A, Ajzenberg N, Timsit JF, Sonneville R
Neuron-Specific Enolase Levels in Adults Under Venoarterial Extracorporeal Membrane Oxygenation.
Critical Care Explorations 2020, 2, e0239.
Buetti N, Ruckly S, Lucet JC, Perozziello A, Mimoz O, Souweine B, Timsit JF
The Insertion Site Should Be Considered for the Empirical Therapy of Short-Term Central Venous and Arterial Catheter-Related Infections.
Critical Care Medicine 2020, 48, 739-744.
Baudry G, Sonneville R, Waintraub X, Lebreton G, Deguillard C, Mertens E, Bouadma L, Demondion P, Bréchot N, Luyt CE, Extramiana F, Hékimian G, Dupuis C, Para M, Pisani A, Braham W, Gandjbakhch E, Leenhardt A, Timsit JF, Leprince P, Combes A, Schmidt M
Extracorporeal Membrane Oxygenation to Support Life-Threatening Drug-Refractory Electrical Storm.
Critical Care Medicine 2020, 48, e856-e863.
Buetti N, Tabah A, Timsit JF, Zingg W
What is new in catheter use and catheter infection prevention in the ICU.
Current Opinion in Critical Care 2020, 26, 459-465.
Mossoro-Kpinde CD, Gody JC, Mboumba Bouassa RS, Moussa S, Jenabian MA, Péré H, Charpentier C, Matta M, Longo JDD, Grésenguet G, Djoba Siawaya JF, Bélec L
Escalating and sustained immunovirological dissociation among antiretroviral drug-experienced perinatally human immunodeficiency virus-1-infected children and adolescents living in the Central African Republic: A STROBE-compliant study.
Medicine 2020, 99, e19978.
Journeau L, de la Chapelle M, Guimard T, Ferfar Y, Saadoun D, Mahé I, Castier Y, Montravers P, Lescure X, Van Gysel D, Asseray N, Lascarrou JB, Ngohou C, Vandamme YM, Connault J, Cepoy PDd, Brochard J, Goueffic Y, Pistorius MA, Boutoille D, Espitia O
A strobe multicenter descriptive study of 55 infectious aortitis.
Medicine 2020, 99, e22422.
Pencolé L, Lê MP, Bouchet-Crivat F, Duro D, Peytavin G, Mandelbrot L
Placental transfer of the integrase strand inhibitors cabotegravir and bictegravir in the ex-vivo human cotyledon perfusion model.
AIDS (London, England) 2020, 34, 2145-2149.
Patrier J, Timsit JF
Carbapenem use in critically ill patients.
Current Opinion in Infectious Diseases 2020, 33, 86-91.
Barbier F, Timsit JF
Risk stratification for multidrug-resistant bacteria in patients with skin and soft tissue infection.
Current Opinion in Infectious Diseases 2020, 33, 137-145.
Le Fevre L, Timsit JF
Duration of antimicrobial therapy for Gram-negative infections.
Current Opinion in Infectious Diseases 2020, 33, 511-516.
Néant N, Lê MP, Bouazza N, Gattacceca F, Yazdanpanah Y, Dhiver C, Bregigeon S, Mokhtari S, Peytavin G, Tamalet C, Descamps D, Lacarelle B, Solas C
Usefulness of therapeutic drug monitoring of rilpivirine and its relationship with virologic response and resistance in a cohort of naive and pretreated HIV-infected patients.
British Journal of Clinical Pharmacology 2020, 86, 2404-2413.
Hatzakis A, Lazarus JV, Cholongitas E, Baptista-Leite R, Boucher C, Busoi CS, Deuffic-Burban S, Chhatwal J, Esmat G, Hutchinson S, Malliori MM, Maticic M, Mozalevskis A, Negro F, Papandreou GA, Papatheodoridis GV, Peck-Radosavljevic M, Razavi H, Reic T, Schatz E, Tozun N, Younossi Z, Manns MP
Securing sustainable funding for viral hepatitis elimination plans.
Liver International: Official Journal of the International Association for the Study of the Liver 2020, 40, 260-270.
Timsit JF, Leverger G, Milpied N, Gachot B
Treatment of invasive fungal infections in intensive care units with micafungin: The MYRIADE study.
Mycoses 2020, 63, 443-451.
Tiberghien P, de Lamballerie X, Morel P, Gallian P, Lacombe K, Yazdanpanah Y
Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?.
Vox Sanguinis 2020, 115, 488-494.
Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, Péré H, Charbit B, Bondet V, Chenevier-Gobeaux C, Breillat P, Carlier N, Gauzit R, Morbieu C, Pène F, Marin N, Roche N, Szwebel TA, Merkling SH, Treluyer JM, Veyer D, Mouthon L, Blanc C, Tharaux PL, Rozenberg F, Fischer A, Duffy D, Rieux-Laucat F, Kernéis S, Terrier B
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.
Science (New York, N.Y.) 2020, 369, 718-724.
Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, Dorgham K, Philippot Q, Rosain J, Béziat V, Manry J, Shaw E, Haljasmägi L, Peterson P, Lorenzo L, Bizien L, Trouillet-Assant S, Dobbs K, de Jesus AA, Belot A, Kallaste A, Catherinot E, Tandjaoui-Lambiotte Y, Le Pen J, Kerner G, Bigio B, Seeleuthner Y, Yang R, Bolze A, Spaan AN, Delmonte OM, Abers MS, Aiuti A, Casari G, Lampasona V, Piemonti L, Ciceri F, Bilguvar K, Lifton RP, Vasse M, Smadja DM, Migaud M, Hadjadj J, Terrier B, Duffy D, Quintana-Murci L, van de Beek D, Roussel L, Vinh DC, Tangye SG, Haerynck F, Dalmau D, Martinez-Picado J, Brodin P, Nussenzweig MC, Boisson-Dupuis S, Rodríguez-Gallego C, Vogt G, Mogensen TH, Oler AJ, Gu J, Burbelo PD, Cohen JI, Biondi A, Bettini LR, D'Angio M, Bonfanti P, Rossignol P, Mayaux J, Rieux-Laucat F, Husebye ES, Fusco F, Ursini MV, Imberti L, Sottini A, Paghera S, Quiros-Roldan E, Rossi C, Castagnoli R, Montagna D, Licari A, Marseglia GL, Duval X, Ghosn J, HGID Lab, NIAID-USUHS Immune Response to COVID Group, COVID Clinicians, COVID-STORM Clinicians, Imagine COVID Group, French COVID Cohort Study Group, Milieu Intérieur Consortium, CoV-Contact Cohort, Amsterdam UMC Covid-19 Biobank, COVID Human Genetic Effort, Tsang JS, Goldbach-Mansky R, Kisand K, Lionakis MS, Puel A, Zhang SY, Holland SM, Gorochov G, Jouanguy E, Rice CM, Cobat A, Notarangelo LD, Abel L, Su HC, Casanova JL
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.
Science (New York, N.Y.) 2020, 370, eabd4585.
Grzelak L, Temmam S, Planchais C, Demeret C, Tondeur L, Huon C, Guivel-Benhassine F, Staropoli I, Chazal M, Dufloo J, Planas D, Buchrieser J, Rajah MM, Robinot R, Porrot F, Albert M, Chen KY, Crescenzo-Chaigne B, Donati F, Anna F, Souque P, Gransagne M, Bellalou J, Nowakowski M, Backovic M, Bouadma L, Le Fevre L, Le Hingrat Q, Descamps D, Pourbaix A, Laouénan C, Ghosn J, Yazdanpanah Y, Besombes C, Jolly N, Pellerin-Fernandes S, Cheny O, Ungeheuer MN, Mellon G, Morel P, Rolland S, Rey FA, Behillil S, Enouf V, Lemaitre A, Créach MA, Petres S, Escriou N, Charneau P, Fontanet A, Hoen B, Bruel T, Eloit M, Mouquet H, Schwartz O, van der Werf S
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.
Science Translational Medicine 2020, 12,
Zheng Y, Hirt D, Delmas S, Lui G, Benaboud S, Lechedanec J, Tréluyer JM, Chenevier-Gobeaux C, Arezes E, Gelley A, Amri I, Urien S, Bouazza N, Foissac F, Warszawski J, Ghosn J
Effect of Pregnancy on Unbound Raltegravir Concentrations in the ANRS 160 RalFe Trial.
Antimicrobial Agents and Chemotherapy 2020, 64, e00759-20.
Lê MP, Le Hingrat Q, Jaquet P, Wicky PH, Bunel V, Massias L, Visseaux B, Messika J, Descamps D, Mal H, Timsit JF, Peytavin G
Removal of Remdesivir's Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19.
Antimicrobial Agents and Chemotherapy 2020, 64,
Bailly S, Gautier-Veyret E, Lê MP, Bouadma L, Andremont O, Neuville M, Mourvillier B, Sonneville R, Magalhaes E, Lebut J, Radjou A, Smonig R, Wolff M, Massias L, Dupuis C, Timsit JF
Impact of Loading Dose of Caspofungin in Pharmacokinetic-Pharmacodynamic Target Attainment for Severe Candidiasis Infections in Patients in Intensive Care Units: the CASPOLOAD Study.
Antimicrobial Agents and Chemotherapy 2020, 64, e01545-20.
Visseaux B, Le Hingrat Q, Collin G, Bouzid D, Lebourgeois S, Le Pluart D, Deconinck L, Lescure FX, Lucet JC, Bouadma L, Timsit JF, Descamps D, Yazdanpanah Y, Casalino E, Houhou-Fidouh N, McAdam AJ
Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the First Rapid Multiplex PCR Commercial Assay for SARS-CoV-2 Detection.
Journal of Clinical Microbiology 2020, 58, e00630-20, /jcm/58/8/JCM.00630-20.atom.
Le Hingrat Q, Visseaux B, Bertine M, Chauveau L, Schwartz O, Collin F, Damond F, Matheron S, Descamps D, Charpentier C
Genetic Variability of Long Terminal Repeat Region between HIV-2 Groups Impacts Transcriptional Activity.
Journal of Virology 2020, 94,
Mahévas M, Tran VT, Roumier M, Chabrol A, Paule R, Guillaud C, Fois E, Lepeule R, Szwebel TA, Lescure FX, Schlemmer F, Matignon M, Khellaf M, Crickx E, Terrier B, Morbieu C, Legendre P, Dang J, Schoindre Y, Pawlotsky JM, Michel M, Perrodeau E, Carlier N, Roche N, de Lastours V, Ourghanlian C, Kerneis S, Ménager P, Mouthon L, Audureau E, Ravaud P, Godeau B, Gallien S, Costedoat-Chalumeau N
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data.
BMJ 2020, m1844.
Castry M, Cousien A, Supervie V, Velter A, Ghosn J, Paltiel AD, Yazdanpanah Y, Deuffic-Burban S
Impact of test-and-treat and risk reduction strategies on HCV transmission among MSM living with HIV in France: a modelling approach.
Gut 2020
Frija-Masson J, Debray MP, Gilbert M, Lescure FX, Travert F, Borie R, Khalil A, Crestani B, d'Ortho MP, Bancal C
Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post infection.
European Respiratory Journal 2020, 2001754.
Le Hingrat Q, Ghanem M, Cazes A, Visseaux B, Collin G, Descamps D, Charpentier C, Crestani B
No association between human herpesvirus or herpesvirus saimiri and idiopathic pulmonary fibrosis.
ERJ Open Research 2020, 6, 00243-2020.
Lomont A, Boubaya M, Khamis W, Deslandes A, Cordel H, Seytre D, Alloui C, Malaure C, Bonnet N, Carbonnelle E, Cohen Y, Nunes H, Bouchaud O, Zahar JR, Tandjaoui-Lambiotte Y
Environmental contamination related to SARS-CoV-2 in ICU patients.
ERJ open research 2020
Bouchaud O, Matheron S, Loarec A, Dupouy Camet J, Bourée P, Godineau N, Poilane I, Cailhol J, Caumes E
Imported loiasis in France: a retrospective analysis of 167 cases with comparison between sub-Saharan and non sub-Saharan African patients.
BMC infectious diseases 2020, 20, 63.
Ekouevi DK, Larrouy L, Gbeasor-Komlanvi FA, Mackiewicz V, Tchankoni MK, Bitty-Anderson AM, Gnatou GYS, Sadio A, Salou M, Dagnra CA, Descamps D, Coffie PA
Prevalence of hepatitis B among childbearing women and infant born to HBV-positive mothers in Togo.
BMC infectious diseases 2020, 20, 839.
Dubert M, Visseaux B, Birgy A, Mordant P, Metivier AC, Dauriat G, Fidouh N, Yazdanpanah Y, Grall N, Castier Y, Mal H, Thabut G, Lescure FX
Late viral or bacterial respiratory infections in lung transplanted patients: impact on respiratory function.
BMC infectious diseases 2020, 20, 176.
Clément A, Delage R, Chollier M, Josse L, Gaudry S, Zahar JR, Baubet T, Degos B
Prospective study on a fast-track training in psychiatry for medical students: the psychiatric hat game.
BMC medical education 2020, 20, 373.
Norton A, Sigfrid L, Aderoba A, Nasir N, Bannister PG, Collinson S, Lee J, Boily-Larouche G, Golding JP, Depoortere E, Carson G, Kerstiëns B, Yazdanpanah Y
Preparing for a pandemic: highlighting themes for research funding and practice—perspectives from the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R).
BMC Medicine 2020, 18, 273.
Mirouse A, Parrot A, Audigier V, Demoule A, Mayaux J, Géri G, Mariotte E, Bréchot N, de Prost N, Vautier M, Neuville M, Bigé N, de Montmollin E, Cacoub P, Resche-Rigon M, Cadranel J, Saadoun D
Severe diffuse alveolar hemorrhage related to autoimmune disease: a multicenter study.
Critical Care 2020, 24, 231.
Peiffer-Smadja N, Bouadma L, Mathy V, Allouche K, Patrier J, Reboul M, Montravers P, Timsit JF, Armand-Lefevre L
Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia.
Critical Care (London, England) 2020, 24, 366.
Monard C, Pehlivan J, Auger G, Alviset S, Tran Dinh A, Duquaire P, Gastli N, d'Humières C, Maamar A, Boibieux A, Baldeyrou M, Loubinoux J, Dauwalder O, Cattoir V, Armand-Lefèvre L, Kernéis S, ADAPT study group
Multicenter evaluation of a syndromic rapid multiplex PCR test for early adaptation of antimicrobial therapy in adult patients with pneumonia.
Critical Care (London, England) 2020, 24, 434.
Buetti N, Ruckly S, Schwebel C, Mimoz O, Souweine B, Lucet JC, Timsit JF
Chlorhexidine-impregnated sponge versus chlorhexidine gel dressing for short-term intravascular catheters: which one is better?.
Critical Care (London, England) 2020, 24, 458.
Buetti N, Wicky PH, Le Hingrat Q, Ruckly S, Mazzuchelli T, Loiodice A, Trimboli P, Forni Ogna V, de Montmollin E, Bernasconi E, Visseaux B, Timsit JF
SARS-CoV-2 detection in the lower respiratory tract of invasively ventilated ARDS patients.
Critical Care (London, England) 2020, 24, 610.
Buetti N, Ruckly S, Lucet JC, Bouadma L, Garrouste-Orgeas M, Schwebel C, Mimoz O, Souweine B, Timsit JF
Local signs at insertion site and catheter-related bloodstream infections: an observational post hoc analysis using individual data of four RCTs.
Critical Care (London, England) 2020, 24, 694.
Duvignaud A, Lhomme E, Pistone T, Onaisi R, Sitta R, Journot V, Nguyen D, Peiffer-Smadja N, Crémer A, Bouchet S, Darnaud T, Poitrenaud D, Piroth L, Binquet C, Michel JF, Lefèvre B, Lebeaux D, Lebel J, Dupouy J, Roussillon C, Gimbert A, Wittkop L, Thiébaut R, Orne-Gliemann J, Joseph JP, Richert L, Anglaret X, Malvy D, COVERAGE study group
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
Trials 2020, 21, 846.
Vinclair C, De Montmollin E, Sonneville R, Reuter J, Lebut J, Cally R, Mourvillier B, Neuville M, Ruckly S, Timsit JF, Bouadma L
Factors associated with major adverse kidney events in patients who underwent veno-arterial extracorporeal membrane oxygenation.
Annals of Intensive Care 2020, 10, 44.
OUTCOMEREA Study Group, de Montmollin E, Terzi N, Dupuis C, Garrouste-Orgeas M, da Silva D, Darmon M, Laurent V, Thiéry G, Oziel J, Marcotte G, Gainnier M, Siami S, Sztrymf B, Adrie C, Reignier J, Ruckly S, Sonneville R, Timsit JF
One-year survival in acute stroke patients requiring mechanical ventilation: a multicenter cohort study.
Annals of Intensive Care 2020, 10, 53.
Buetti N, Ruckly S, Lucet JC, Bouadma L, Schwebel C, Mimoz O, Timsit JF
Ultrasound guidance and risk for intravascular catheter-related infections among peripheral arterial catheters: a post-hoc analysis of two large randomized-controlled trials.
Annals of Intensive Care 2020, 10, 89.
Timsit JF, Baleine J, Bernard L, Calvino-Gunther S, Darmon M, Dellamonica J, Desruennes E, Leone M, Lepape A, Leroy O, Lucet JC, Merchaoui Z, Mimoz O, Misset B, Parienti JJ, Quenot JP, Roch A, Schmidt M, Slama M, Souweine B, Zahar JR, Zingg W, Bodet-Contentin L, Maxime V
Expert consensus-based clinical practice guidelines management of intravascular catheters in the intensive care unit.
Annals of Intensive Care 2020, 10, 118.
Elabbadi A, Pichon J, Visseaux B, Schnuriger A, Bouadma L, Philippot Q, Patrier J, Labbé V, Ruckly S, Fartoukh M, Timsit JF, Voiriot G
Respiratory virus-associated infections in HIV-infected adults admitted to the intensive care unit for acute respiratory failure: a 6-year bicenter retrospective study (HIV-VIR study).
Annals of Intensive Care 2020, 10, 123.
Dupuis C, Bouadma L, Ruckly S, Perozziello A, Van-Gysel D, Mageau A, Mourvillier B, de Montmollin E, Bailly S, Papin G, Sinnah F, Vinclair C, Abid S, Sonneville R, Timsit JF
Sepsis and septic shock in France: incidences, outcomes and costs of care.
Annals of Intensive Care 2020, 10, 145.
Sonneville R, Smonig R, Dupuis C, Bouadma L, de Montmollin E, Timsit JF
Natural light exposure and delirium in ICU: does the dark side cloud everything?.
Annals of Intensive Care 2020, 10, 25.
Kardaś-Słoma L, Yazdanpanah Y, Perozziello A, Zahar JR, Lescure FX, Cousien A, Lucet JC
Hand hygiene improvement or antibiotic restriction to control the household transmission of extended-spectrum β-lactamase-producing Escherichia coli: a mathematical modelling study.
Antimicrobial Resistance and Infection Control 2020, 9, 139.
Birgand G, Mutters NT, Ahmad R, Tacconelli E, Lucet JC, Holmes A, Percept-R Study Group
Risk perception of the antimicrobial resistance by infection control specialists in Europe: a case-vignette study.
Antimicrobial Resistance and Infection Control 2020, 9, 33.
Vallès X, Stenseth NC, Demeure C, Horby P, Mead PS, Cabanillas O, Ratsitorahina M, Rajerison M, Andrianaivoarimanana V, Ramasindrazana B, Pizarro-Cerda J, Scholz HC, Girod R, Hinnebusch BJ, Vigan-Womas I, Fontanet A, Wagner DM, Telfer S, Yazdanpanah Y, Tortosa P, Carrara G, Deuve J, Belmain SR, D’Ortenzio E, Baril L, Yang R
Human plague: An old scourge that needs new answers.
PLOS Neglected Tropical Diseases 2020, 14, e0008251.
Fauroux B, Hascoët JM, Jarreau PH, Magny JF, Rozé JC, Saliba E, Schwarzinger M, Katz M
Risk factors for bronchiolitis hospitalization in infants: A French nationwide retrospective cohort study over four consecutive seasons (2009-2013).
PLOS ONE 2020, 15, e0229766.
Lamirel C, Valin N, Savatovsky J, Lescure FX, Alonso AS, Girard P, Vincensini JP, Girard PM, Salomon L, Cochereau I, Moulignier A, Lewin AS
Absence of peripapillary retinal nerve-fiber–layer thinning in combined antiretroviral therapy-treated, well-sustained aviremic persons living with HIV.
PLOS ONE 2020, 15, e0229977.
Parčina M, Schneider UV, Visseaux B, Jozić R, Hannet I, Lisby JG, Chan KH
Multicenter evaluation of the QIAstat Respiratory Panel—A new rapid highly multiplexed PCR based assay for diagnosis of acute respiratory tract infections.
PLOS ONE 2020, 15, e0230183.
Faure Bardon V, Peytavin G, Lê MP, Guilleminot T, Elefant E, Stirnemann J, Leruez-Ville M, Ville Y, Spradley FT
Placental transfer of Letermovir & Maribavir in the ex vivo human cotyledon perfusion model. New perspectives for in utero treatment of congenital cytomegalovirus infection.
PLOS ONE 2020, 15, e0232140.
Tchounga BK, Charpentier C, Coffie PA, Dabis F, Descamps D, Eholie SP, Ekouevi DK
Survival among antiretroviral-experienced HIV-2 patients experiencing virologic failure with drug resistance mutations in Cote d'Ivoire West Africa.
PloS One 2020, 15, e0236642.
Bouzid D, Visseaux B, Perozziello A, Lescure X, Duval X, Casalino E, Lucet JC, ED influenza management study group
Factors associated with single-room assignment among patients admitted through the emergency department during influenza epidemics.
PloS One 2020, 15, e0237214.
Fontaine C, Armand-Lefèvre L, Magnan M, Nazimoudine A, Timsit JF, Ruppé E
Relationship between the composition of the intestinal microbiota and the tracheal and intestinal colonization by opportunistic pathogens in intensive care patients.
PloS One 2020, 15, e0237260.
Fournier AL, Parienti JJ, Champenois K, Feret P, Papot E, Yazdanpanah Y, Verdon R
Incidence and risk factors for medical care interruption in people living with HIV in a French provincial city.
PloS One 2020, 15, e0240417.
Bouzid D, Mullaert J, Le Hingrat Q, Laurent O, Duval X, Lescure X, Timsit JF, Descamps D, Montravers P, Choquet C, Lucet JC, Casalino E, Visseaux B, ED influenza study group
Characteristics associated with COVID-19 or other respiratory viruses' infections at a single-center emergency department.
PloS One 2020, 15, e0243261.
Borie R, Savale L, Dossier A, Ghosn J, Taillé C, Visseaux B, Jebreen K, Diallo A, Tesmoingt C, Morer L, Goletto T, Faucher N, Hajouji L, Neukirch C, Phillips M, Stelianides S, Bouadma L, Brosseau S, Ottaviani S, Pluvy J, Le Pluart D, Debray MP, Raynaud-Simon A, Descamps D, Khalil A, Timsit JF, Lescure FX, Descamps V, Papo T, Humbert M, Crestani B, Dieude P, Vicaut E, Zalcman G, Bichat & Kremlin-Bicêtre AP-HP COVID teams
Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study.
PloS One 2020, 15, e0243961.
Mboumba Bouassa RS, Pere H, Mossoro-Kpinde CD, Roques P, Gody JC, Moussa S, Veyer D, Gresenguet G, Charpentier C, Jenabian MA, Djoba Siawaya JF, Belec L
Purifying Selection in Human Immunodeficiency Virus-1 pol Gene in Perinatally Human Immunodeficiency Virus-1-Infected Children Harboring Discordant Immunological Response and Virological Nonresponse to Long-Term Antiretroviral Therapy.
Journal of Clinical Medicine Research 2020, 12, 369-376.
Vandingenen P, Chauvin A, Javaud N, Ghazali DA
Professional practice assessment for minor head injury management in emergency department and clinical impact of a simulation-based training: Interventional study (before/after).
Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery: TJTES 2020, 26, 545-554.
Heilmann E, Gregoriano C, Wirz Y, Luyt CE, Wolff M, Chastre J, Tubach F, Christ-Crain M, Bouadma L, Annane D, Damas P, Kristoffersen KB, Oliveira CF, Stolz D, Tamm M, de Jong E, Reinhart K, Shehabi Y, Verduri A, Nobre V, Nijsten M, deLange DW, van Oers JAH, Beishuizen A, Girbes ARJ, Mueller B, Schuetz P
Association of kidney function with effectiveness of procalcitonin-guided antibiotic treatment: a patient-level meta-analysis from randomized controlled trials.
Clinical Chemistry and Laboratory Medicine 2020, 59, 441-453.
Peiffer-Smadja N, Poda A, Ouedraogo AS, Guiard-Schmid JB, Delory T, Le Bel J, Bouvet E, Lariven S, Jeanmougin P, Ahmad R, Lescure FX
Paving the Way for the Implementation of a Decision Support System for Antibiotic Prescribing in Primary Care in West Africa: Preimplementation and Co-Design Workshop With Physicians.
Journal of Medical Internet Research 2020, 22, e17940.
Denis F, Galmiche S, Dinh A, Fontanet A, Scherpereel A, Benezit F, Lescure FX
Epidemiological Observations on the Association Between Anosmia and COVID-19 Infection: Analysis of Data From a Self-Assessment Web Application.
Journal of Medical Internet Research 2020, 22, e19855.
Yordanov Y, Dechartres A, Lescure X, Apra C, Villie P, Marchand-Arvier J, Debuc E, Dinh A, Jourdain P, AP-HP / Universities / Inserm COVID-19 Research Collaboration
Covidom, a Telesurveillance Solution for Home Monitoring Patients With COVID-19.
Journal of Medical Internet Research 2020, 22, e20748.
Galmiche S, Rahbe E, Fontanet A, Dinh A, Bénézit F, Lescure FX, Denis F
Implementation of a Self-Triage Web Application for Suspected COVID-19 and Its Impact on Emergency Call Centers: Observational Study.
Journal of Medical Internet Research 2020, 22, e22924.
Bernard Stoecklin S, Rolland P, Silue Y, Mailles A, Campese C, Simondon A, Mechain M, Meurice L, Nguyen M, Bassi C, Yamani E, Behillil S, Ismael S, Nguyen D, Malvy D, Lescure FX, Georges S, Lazarus C, Tabaï A, Stempfelet M, Enouf V, Coignard B, Levy-Bruhl D, Investigation team
First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020.
Eurosurveillance 2020, 25,
Okba NMA, Müller MA, Li W, Wang C, GeurtsvanKessel CH, Corman VM, Lamers MM, Sikkema RS, de Bruin E, Chandler FD, Yazdanpanah Y, Le Hingrat Q, Descamps D, Houhou-Fidouh N, Reusken CBEM, Bosch BJ, Drosten C, Koopmans MPG, Haagmans BL
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients.
Emerging Infectious Diseases 2020, 26,
Jaspard M, Butel N, El Helali N, Marigot-Outtandy D, Guillot H, Peytavin G, Veziris N, Bodaghi B, Flandre P, Petitjean G, Caumes E, Pourcher V
Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France.
Emerging Infectious Diseases 2020, 26, 1792-1800.
Iannetta M, Isnard S, Manuzak J, Guillerme JB, Notin M, Bailly K, Andrieu M, Amraoui S, Vimeux L, Figueiredo S, Charmeteau-de Muylder B, Vaton L, Hatton EX, Samri A, Autran B, Thiébaut R, Chaghil N, Glohi D, Charpentier C, Descamps D, Brun-Vézinet F, Matheron S, Cheynier R, Hosmalin A
Conventional Dendritic Cells and Slan+ Monocytes During HIV-2 Infection.
Frontiers in Immunology 2020, 11, 1658.
Méchaï F, Cordel H, Guglielmetti L, Aubry A, Jankovic M, Viveiros M, Santin M, Goletti D, Cambau E
Management of Tuberculosis: Are the Practices Homogeneous in High-Income Countries?.
Frontiers in Public Health 2020, 8, 443.
Peiffer-Smadja N, Allison R, Jones LF, Holmes A, Patel P, Lecky DM, Ahmad R, McNulty CAM
Preventing and Managing Urinary Tract Infections: Enhancing the Role of Community Pharmacists-A Mixed Methods Study.
Antibiotics (Basel, Switzerland) 2020, 9, E583.
Casalino E, Choquet C, Bouzid D, Peyrony O, Curac S, Revue E, Fontaine JP, Plaisance P, Chauvin A, Ghazali DA
Analysis of Emergency Department Visits and Hospital Activity during Influenza Season, COVID-19 Epidemic, and Lockdown Periods in View of Managing a Future Disaster Risk: A Multicenter Observational Study.
International Journal of Environmental Research and Public Health 2020, 17, 8302.
Belaroussi Y, Roblot P, Peiffer-Smadja N, Delaye T, Mathoulin-Pelissier S, Lemeux J, Le Moal G, Caumes E, Roblot F, Bleibtreu A
Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19?.
Journal of Clinical Medicine 2020, 9, E3691.
Pilmis B, Le Monnier A, Zahar JR
Gut Microbiota, Antibiotic Therapy and Antimicrobial Resistance: A Narrative Review.
Microorganisms 2020, 8, 269.
Mihimit A, Adawaye C, Péré H, Costiniuk C, Koyalta D, Mbopi-Keou FX, Bouassa RSM, Talla F, Moussa S, Longo JDD, Tchombou BHZ, Grésenguet G, Charpentier C, Bélec L
HSV-2 Infection as a Potential Cofactor for HIV Disease Progression and Selection of Drug Resistance Mutations in Adults under WHO-Recommended First-Line Antiretroviral Therapy: A Multicentric, Cross-Sectional Study in Cameroon, Central African Republic, Chad, and Gabon.
Tropical Medicine and Infectious Disease 2020, 5, 136.
Dang E, Sayagh F, Lê MP, Neuville M, Sinnah F, Timsit JF, Peytavin G
Plasma pharmacokinetics of bedaquiline administered by nasogastric tube in an intensive care unit.
The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union Against Tuberculosis and Lung Disease 2020, 24, 110-112.
Lévy Y, Lelièvre JD, Assoumou L, Aznar E, Pulido F, Tambussi G, Crespo M, Meybeck A, Molina JM, Delaugerre C, Izopet J, Peytavin G, Cardon F, Diallo A, Lancar R, Béniguel L, Costagliola D
Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection: A Randomized Trial.
Annals of Internal Medicine 2020, 172, 297.
2019
Garrouste-Orgeas M, Bailly S, Timsit JF
Use of an ICU Diary and Patient Posttraumatic Stress Disorder Symptoms—Reply.
JAMA 2019, 322, 2025.
Garrouste-Orgeas M, Flahault C, Vinatier I, Rigaud JP, Thieulot-Rolin N, Mercier E, Rouget A, Grand H, Lesieur O, Tamion F, Hamidfar R, Renault A, Parmentier-Decrucq E, Monseau Y, Argaud L, Bretonnière C, Lautrette A, Badié J, Boulet E, Floccard B, Forceville X, Kipnis E, Soufir L, Valade S, Bige N, Gaffinel A, Hamzaoui O, Simon G, Thirion M, Bouadma L, Large A, Mira JP, Amdjar-Badidi N, Jourdain M, Jost PH, Maxime V, Santoli F, Ruckly S, Vioulac C, Leborgne MA, Bellalou L, Fasse L, Misset B, Bailly S, Timsit JF
Effect of an ICU Diary on Posttraumatic Stress Disorder Symptoms Among Patients Receiving Mechanical Ventilation: A Randomized Clinical Trial.
JAMA 2019, 322, 229-239.
Brunet-Possenti F, Charpentier C, Bouhnik Y, Deschamps L, Descamps D, Moins-Teisserenc H, Descamps V
Occurrence of Extensive Cutaneous Human Papillomavirus Infection After Initiation of Tofacitinib Therapy.
JAMA Dermatology 2019, 155, 629.
Heyard R, Timsit J, Essaied WI, Held L, on behalf of the COMBACTE‐MAGNET consortium
Dynamic clinical prediction models for discrete time‐to‐event data with competing risks—A case study on the OUTCOMEREA database.
Biometrical Journal 2019, 61, 514-534.
Avettand-Fenoel V, Bayan T, Gardiennet E, Boufassa F, Lopez P, Lecuroux C, Noel N, Trémeaux P, Monceaux V, Autran B, Meyer L, Saez-Cirion A, Lambotte O, Rouzioux C, CODEX ANRS Cohort Study Group
Dynamics in HIV-DNA levels over time in HIV controllers.
Journal of the International AIDS Society 2019, 22, e25221.
Lê MP, Valantin M, Assoumou L, Soulie C, Le Mestre S, Weiss L, Yazdanpanah Y, Molina J, Bouchaud O, Raffi F, Reynes J, Calvez V, Marcelin A, Costagliola D, Katlama C, Peytavin G, ANRS‐163 ETRAL study group, Duvivier C, Goujard C, Jeantils V, Salmon D, Simon A, Colin de Verdière N, Morlat P, Poizot‐Martin I, Allavena C, Naqvi A, Bernard L, Chidiac C, Hamdoud K
Lack of a Clinically Significant Pharmacokinetic Interaction between Etravirine and Raltegravir Using an Original Approach Based on Drug Metabolism, Protein Binding, and Penetration in Seminal Fluid: A Pharmacokinetic Substudy of the ANRS ‐163 ETRAL Study.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2019, 39, 514-520.
von Cube M, Schumacher M, Bailly S, Timsit JF, Lepape A, Savey A, Machut A, Wolkewitz M
The population-attributable fraction for time-dependent exposures and competing risks-A discussion on estimands.
Statistics in Medicine 2019, 38, 3880-3895.
Lucet JC, Heard I, Roueli A, Lafourcade A, Mandelbrot L, Estellat C, Dommergues M, PREEV Study Group
Transvaginal ultrasound probes are human papillomavirus-free following low-level disinfection: cross-sectional multicenter survey.
Ultrasound in Obstetrics & Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology 2019, 54, 688-695.
the IPREA-AQVAR Study Group, Kalfon P, Alessandrini M, Boucekine M, Renoult S, Geantot MA, Deparis-Dusautois S, Berric A, Collange O, Floccard B, Mimoz O, Julien A, Robert R, Audibert J, Renault A, Follin A, Thevenin D, Revel N, Venot M, Patrigeon RG, Signouret T, Fromentin M, Sharshar T, Vigne C, Pottecher J, Levrat Q, Sossou A, Garrouste-Orgeas M, Quenot JP, Boulle C, Azoulay E, Baumstarck K, Auquier P
Tailored multicomponent program for discomfort reduction in critically ill patients may decrease post-traumatic stress disorder in general ICU survivors at 1 year.
Intensive Care Medicine 2019, 45, 223-235.
Timsit JF, Bassetti M, Cremer O, Daikos G, de Waele J, Kallil A, Kipnis E, Kollef M, Laupland K, Paiva JA, Rodríguez-Baño J, Ruppé É, Salluh J, Taccone FS, Weiss E, Barbier F
Rationalizing antimicrobial therapy in the ICU: a narrative review.
Intensive Care Medicine 2019, 45, 172-189.
Papin G, Sonneville R, Nataf P, Bouadma L
Emergency craniotomy in semi-lateral position for posterior fossa hemorrhage evacuation under venoarterial extracorporeal membrane oxygenation.
Intensive Care Medicine 2019, 45, 1152-1153.
Schnell D, Montlahuc C, Bruneel F, Resche-Rigon M, Kouatchet A, Zahar JR, Darmon M, Pene F, Lemiale V, Rabbat A, Vincent F, Azoulay E, Mokart D
De-escalation of antimicrobial therapy in critically ill hematology patients: a prospective cohort study.
Intensive Care Medicine 2019, 45, 743-745.
Timsit JF, Citerio G, Lavilloniere M, Perner A, Ruckly S, Bakker J, Bassetti M, Benoit D, Curtis JR, Doig GS, Herridge M, Jaber S, Papazian L, Peters MJ, Singer P, Smith M, Soares M, Torres A, Vieillard-Baron A, Azoulay E
Determinants of downloads and citations for articles published in Intensive Care Medicine.
Intensive Care Medicine 2019, 45, 1058-1060.
Pons S, Timsit JF, Ruckly S, Schwebel C, Papazian L, Azoulay E, Reignier J, Zafrani L
Impact of macrolide therapy in critically ill patients with acute respiratory failure: a desirability of outcome ranking analysis to investigate the OUTCOMEREA database.
Intensive Care Medicine 2019
Timsit JF, Sonneville R, Kalil AC, Bassetti M, Ferrer R, Jaber S, Lanternier F, Luyt CE, Machado F, Mikulska M, Papazian L, Pène F, Poulakou G, Viscoli C, Wolff M, Zafrani L, Van Delden C
Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients.
Intensive Care Medicine 2019, 45, 573-591.
Martin-Loeches I, Antonelli M, Cuenca-Estrella M, Dimopoulos G, Einav S, De Waele JJ, Garnacho-Montero J, Kanj SS, Machado FR, Montravers P, Sakr Y, Sanguinetti M, Timsit JF, Bassetti M
ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients.
Intensive Care Medicine 2019, 45, 789-805.
Timsit JF, Schwebel C, Styfalova L, Cornet M, Poirier P, Forrestier C, Ruckly S, Jacob MC, Souweine B
Impact of bronchial colonization with Candida spp. on the risk of bacterial ventilator-associated pneumonia in the ICU: the FUNGIBACT prospective cohort study.
Intensive Care Medicine 2019, 45, 834-843.
Blot S, Poulakou G, Timsit JF
Catheter-associated bloodstream infection rates: how low can you go?.
Intensive Care Medicine 2019, 45, 896-897.
Jaquet P, de Montmollin E, Dupuis C, Sazio C, Conrad M, Susset V, Demeret S, Tadie JM, Argaud L, Barbier F, Sarton B, Chabane R, Daubin D, Brulé N, Lerolle N, Alves M, Da Silva D, Kalioubi AE, Silva S, Bailly P, Wolff M, Bouadma L, Timsit JF, Sonneville R, ENCEPHALITICA study group
Functional outcomes in adult patients with herpes simplex encephalitis admitted to the ICU: a multicenter cohort study.
Intensive Care Medicine 2019, 45, 1103-1111.
May F, Peytavin G, Fourati S, Pressiat C, Carteaux G, Razazi K, Mekontso Dessap A, de Prost N
Paracetamol absorption test to detect poor enteric absorption of oseltamivir in intensive care unit patients with severe influenza: a pilot study.
Intensive Care Medicine 2019, 45, 1484-1486.
Laurent A, Reignier J, Le Gouge A, Cottereau A, Adda M, Annane D, Audibert J, Barbier F, Bardou P, Bourcier S, Bourenne J, Boyer A, Brenas F, Das V, Desachy A, Devaquet J, Feissel M, Ganster F, Garrouste-Orgeas M, Grillet G, Guisset O, Hamidfar-Roy R, Hyacinthe AC, Jochmans S, Jourdain M, Lautrette A, Lerolle N, Lesieur O, Lion F, Mateu P, Megarbane B, Merceron S, Mercier E, Messika J, Morin-Longuet P, Philippon-Jouve B, Quenot JP, Renault A, Repesse X, Rigaud JP, Robin S, Roquilly A, Seguin A, Thevenin D, Tirot P, Vinatier I, Azoulay E, Robert R, Kentish-Barnes N
“You helped me keep my head above water”—experience of bereavement research after loss of a loved one in the ICU: insights from the ARREVE study.
Intensive Care Medicine 2019, 45, 1252-1261.
Buetti N, Ruckly S, Lucet JC, Mimoz O, Souweine B, Timsit JF
Short-term dialysis catheter versus central venous catheter infections in ICU patients: a post hoc analysis of individual data of 4 multi-centric randomized trials.
Intensive Care Medicine 2019
Blot S, Antonelli M, Arvaniti K, Blot K, Creagh-Brown B, de Lange D, De Waele J, Deschepper M, Dikmen Y, Dimopoulos G, Eckmann C, Francois G, Girardis M, Koulenti D, Labeau S, Lipman J, Lipovestky F, Maseda E, Montravers P, Mikstacki A, Paiva JA, Pereyra C, Rello J, Timsit JF, Vogelaers D, Abdominal Sepsis Study (AbSeS) group on behalf of the Trials Group of the European Society of Intensive Care Medicine
Epidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS", a multinational observational cohort study and ESICM Trials Group Project.
Intensive Care Medicine 2019, 45, 1703-1717.
Delerue T, Cordel H, Delerue T, Figoni J, Dziri S, Billard-Pomares T, Bouchaud O, Carbonnelle E, Zahar JR
Prediction of methicillin-resistant Staphylococcus aureus bloodstream infection: do we need rapid diagnostic tests?.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2019, 38, 1319-1326.
for the EUVAE Study Group, Rello J, Ramírez-Estrada S, Romero A, Arvaniti K, Koulenti D, Nseir S, Oztoprak N, Bouadma L, Vidaur L, Lagunes L, Peña-López Y
Factors associated with ventilator-associated events: an international multicenter prospective cohort study.
European Journal of Clinical Microbiology & Infectious Diseases 2019, 38, 1693-1699.
Mageau A, Timsit JF, Perrozziello A, Ruckly S, Dupuis C, Bouadma L, Papo T, Sacre K
The burden of chronic kidney disease in systemic lupus erythematosus: A nationwide epidemiologic study.
Autoimmunity Reviews 2019, 18, 733-737.
Tacconelli E, Mazzaferri F, de Smet AM, Bragantini D, Eggimann P, Huttner BD, Kuijper EJ, Lucet JC, Mutters NT, Sanguinetti M, Schwaber MJ, Souli M, Torre-Cisneros J, Price JR, Rodríguez-Baño J
ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2019, 25, 807-817.
Ferré V, Ekouevi D, Gbeasor-Komlanvi F, Collin G, Le Hingrat Q, Tchounga B, Salou M, Descamps D, Charpentier C, Dagnra A
Prevalence of human papillomavirus, human immunodeficiency virus and other sexually transmitted infections among female sex workers in Togo: a national cross-sectional survey.
Clinical Microbiology and Infection 2019, 25, 1560.e1-1560.e7.
Schweitzer VA, van Werkhoven CH, Rodríguez Baño J, Bielicki J, Harbarth S, Hulscher M, Huttner B, Islam J, Little P, Pulcini C, Savoldi A, Tacconelli E, Timsit JF, van Smeden M, Wolkewitz M, Bonten MJM, Walker AS, Llewelyn MJ, Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) Working Group on Design of Antimicrobial Stewardship Evaluations
Optimizing design of research to evaluate antibiotic stewardship interventions: consensus recommendations of a multinational working group.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2019
Ghazali DA, Kenway P, Clery R, Choquet C, Casalino E
A multicenter randomized control trial evaluating professional practice assessment of patient pain management after simulation training course: Study protocol.
Contemporary Clinical Trials Communications 2019, 14, 100331.
Casalino E, Kenway P, Bouzid D, Goncalves S, Antoniol S, Radou L, Choquet C, Macaux M, Ghazali DA
Implementation of HIV-exposures triage strategy in emergency departments to improve nurse-triage for HIV-exposures: A pre- and post-intervention period study.
International Emergency Nursing 2019, 47, 100786.
Nguyen T, Akhavan S, Caby F, Bonyhay L, Larrouy L, Gervais A, Lebray P, Poynard T, Calmus Y, Simon A, Valantin MA, Calvez V, Marcelin AG, Todesco E
Net emergence of substitutions at position 28 in NS5A of hepatitis C virus genotype 4 in patients failing direct-acting antivirals detected by next-generation sequencing.
International Journal of Antimicrobial Agents 2019, 53, 80-83.
Pilmis B, Lourtet-Hascoët J, Barraud O, Piau C, Isnard C, Hery-Arnaud G, Amara M, Merens A, Farfour E, Thomas E, Jacquier H, Zahar JR, Bonnet E, Monnier AL, Cattoir V, Corvec S, Boutoille D, de Ponfilly GP, Reissier S, GMC Study Group
Be careful about MICs to amoxicillin for patients with Streptococci-related infective endocarditis.
International Journal of Antimicrobial Agents 2019, 53, 850-854.
Martin-Loeches I, Timsit JF, Leone M, de Waele J, Sartelli M, Kerrigan S, Azevedo LCP, Einav S
Clinical controversies in abdominal sepsis. Insights for critical care settings.
Journal of Critical Care 2019, 53, 53-58.
Saliba R, Neulier C, Seytre D, Fiacre A, Faibis F, Leduc P, Amara M, Jauréguy F, Carbonnelle E, Zahar JR, Marty L
Can real-time polymerase chain reaction allow a faster recovery of hospital activity in cases of an incidental discovery of carbapenemase-producing Enterobacteriaceae and vancomycin-resistant Enterococci carriers?.
Journal of Hospital Infection 2019, 103, 115-120.
Mageau A, Sacré K, Perozziello A, Ruckly S, Dupuis C, Bouadma L, Papo T, Timsit JF
Septic shock among patients with systemic lupus erythematosus: short and long-term outcome. Analysis of a French nationwide database.
The Journal of Infection 2019
de Montmollin E, Ruckly S, Schwebel C, Philippart F, Adrie C, Mariotte E, Marcotte G, Cohen Y, Sztrymf B, da Silva D, Bruneel F, Gainnier M, Garrouste-Orgeas M, Sonneville R, Timsit JF, OUTCOMEREA Study Group
Pneumonia in acute ischemic stroke patients requiring invasive ventilation: Impact on short and long-term outcomes.
The Journal of Infection 2019, 79, 220-227.
Lattuca-Truc M, Timsit JF, Levra MG, Ruckly S, Villa J, Dumas I, Pinsolle J, Ferrer L, Guillem P, Moro-Sibilot D, Toffart AC
Trends in response rate and survival in small-cell lung cancer patients between 1997 and 2017.
Lung Cancer 2019, 131, 122-127.
Pugliese P, Joly V, Valantin M, Cotte L, Huleux T, Allavena C, Reynes J, Poizot-Martin I, Bani-Sadr F, Cuzin L
Which antiretrovirals should be prescribed as first-line treatments? Changes over the past 10 years in France.
Médecine et Maladies Infectieuses 2019, 49, 264-269.
Delaigue S, Signolet I, Consigny PH, de Gentile L, D'Ortenzio E, Gautret P, Sorge F, Strady C, Bouchaud O
New guidelines for the prevention of imported malaria in France.
Medecine Et Maladies Infectieuses 2019
Peiffer-Smadja N, Harent S, Messeca C, Lechapt-Zalcman E, Yazdanpanah Y, Joly V
A case of thoracic actinomycosis presenting as sudden paraplegia.
Revue Neurologique 2019, 175, 89-92.
Méchaï F, Bouchaud O
Tuberculous meningitis: Challenges in diagnosis and management.
Revue Neurologique 2019, 175, 451-457.
Jolivet S, Lucet JC
Surgical field and skin preparation.
Orthopaedics & Traumatology: Surgery & Research 2019, 105, S1-S6.
Pistone T, Ouattara E, Gabillard D, Lele N, Duvignaud A, Cordel H, Malvy D, Bouchaud O, Abgrall S, ANRS VIHVO Study Group
Travel-related health events and their risk factors in HIV-infected sub-Saharan migrants living in France and visiting their native country: The ANRS VIHVO cohort study.
Travel Medicine and Infectious Disease 2019
Le Hingrat Q, Perrier M, Charpentier C, Jacquot A, Houhou-Fidouh N, Descamps D, Visseaux B
Was Zika introduced to Brazil by participants at the 2013 Beach Soccer World Cup held in Tahiti: A phylogeographical analysis.
Travel Medicine and Infectious Disease 2019, 101512.
Billard-Pomares T, Bleibtreu A, Walewski V, Dziri S, Barbat A, Zahar JR, Cruaud P, Carbonnelle E
Proposition of a safe Mycobacterium tuberculosis complex denaturation method that does not compromise the integrity of DNA for whole-genome sequencing.
Tuberculosis 2019, 117, 62-64.
Kollef MH, Nováček M, Kivistik Ü, Réa-Neto Á, Shime N, Martin-Loeches I, Timsit JF, Wunderink RG, Bruno CJ, Huntington JA, Lin G, Yu B, Butterton JR, Rhee EG
Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial.
The Lancet. Infectious Diseases 2019
Lucet JC, Zahar JR
Simplified control measures for ESBL-producing Enterobacteriacae?.
The Lancet. Infectious Diseases 2019, 19, 1036-1037.
Wohl DA, Yazdanpanah Y, Baumgarten A, Clarke A, Thompson MA, Brinson C, Hagins D, Ramgopal MN, Antinori A, Wei X, Acosta R, Collins SE, Brainard D, Martin H
Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial.
The lancet. HIV 2019, 6, e355-e363.
Le Hingrat Q, Charpentier C, Ghosn J, Thiébaut R, Peytavin G, Descamps D, Matheron S
New insights are game-changers in HIV-2 disease management.
The lancet. HIV 2019, 6, e214.
Eholie SP, Moh R, Benalycherif A, Gabillard D, Ello F, Messou E, Zoungrana J, Diallo I, Diallo M, Bado G, Cisse M, Maiga AI, Anzian A, Toni Td, Congo-Ouedraogo M, Toure-Kane C, Seydi M, Minta DK, Sawadogo A, Sangaré L, Drabo J, Karcher S, Le Carrou J, de Monteynard LA, Peytavin G, Gabassi A, Girard PM, Chaix ML, Anglaret X, Landman R, Thilao ANRS 12269 Study Group
Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study.
The lancet. HIV 2019, 6, e750-e759.
Birgand G, Azevedo C, Rukly S, Pissard-Gibollet R, Toupet G, Timsit JF, Lucet JC, the ARIBO Study Group
Motion-capture system to assess intraoperative staff movements and door openings: Impact on surrogates of the infectious risk in surgery.
Infection Control & Hospital Epidemiology 2019, 40, 566-573.
Vieillard V, Combadière B, Tubiana R, Launay O, Pialoux G, Cotte L, Girard PM, Simon A, Dudoit Y, Reynes J, Rockstroh J, Garcia F, Gatell J, Devidas A, Yazdanpanah Y, Weiss L, Fätkenheuer G, Autran B, Joyeux D, Gharakhanian S, Debré P, Katlama C
HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial.
NPJ vaccines 2019, 4, 25.
Assi A, Abu Zaki S, Ghosn J, Kinge N, Naous J, Ghanem A, Abou Abbas D, Bakouny Z, Azzi G, Tomb R
Prevalence of HIV and other sexually transmitted infections and their association with sexual practices and substance use among 2238 MSM in Lebanon.
Scientific Reports 2019, 9, 15142.
Buetti N, Timsit JF
Management and Prevention of Central Venous Catheter-Related Infections in the ICU.
Seminars in Respiratory and Critical Care Medicine 2019, 40, 508-523.
Kernéis S, Lucet JC
Controlling the Diffusion of Multidrug-Resistant Organisms in Intensive Care Units.
Seminars in Respiratory and Critical Care Medicine 2019, 40, 558-568.
Triki D, Fartek S, Visseaux B, Descamps D, Camproux AC, Regad L
Characterizing the structural variability of HIV-2 protease upon the binding of diverse ligands using a structural alphabet approach.
Journal of Biomolecular Structure & Dynamics 2019, 37, 4658-4670.
Leo S, Lazarevic V, Gaïa N, Estellat C, Girard M, Matheron S, Armand-Lefèvre L, Andremont A, Schrenzel J, Ruppé E
The intestinal microbiota predisposes to traveler's diarrhea and to the carriage of multidrug-resistant Enterobacteriaceae after traveling to tropical regions.
Gut Microbes 2019, 10, 631-641.
Parisey M, Louni F, Bouvet E, Landman R, Charpentier C, Lariven S, Joly V, Villemant A, Mackoumbou-Nkouka C, Yazdanpanah Y, Burdet C
HIV Infection in North African Patients.
AIDS research and human retroviruses 2019, 35, 628-633.
Bonnet B, Blum L, Charpentier C, Martres P, Ritvo PG, Autran B, Guihot A
Short Communication: Extremely Severe CD4 Lymphopenia During HIV-1 Primary Infection.
AIDS Research and Human Retroviruses 2019, 35, 930-933.
Cousien A, Abel S, Monthieux A, Andronico A, Calmont I, Cervantes M, Césaire R, Gallian P, de Lamballerie X, Laouénan C, Najioullah F, Pierre-François S, Pircher M, Salje H, Ten Bosch QA, Cabié A, Cauchemez S
Assessing Zika Virus Transmission Within Households During an Outbreak in Martinique, 2015-2016.
American Journal of Epidemiology 2019, 188, 1389-1396.
Ferré VM, Gbeasor-Komlanvi FA, Collin G, Dagnra AC, Le Hingrat Q, Jaquet A, Salou M, Descamps D, Charpentier C, Ekouevi DK
Prevalence of Human Papillomavirus, Human Immunodeficiency Virus, and Other Sexually Transmitted Infections Among Men Who Have Sex With Men in Togo: A National Cross-sectional Survey.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2019, 69, 1019-1026.
Meier MA, Branche A, Neeser OL, Wirz Y, Haubitz S, Bouadma L, Wolff M, Luyt CE, Chastre J, Tubach F, Christ-Crain M, Corti C, Jensen JUS, Deliberato RO, Kristoffersen KB, Damas P, Nobre V, Oliveira CF, Shehabi Y, Stolz D, Tamm M, Mueller B, Schuetz P
Procalcitonin-guided Antibiotic Treatment in Patients With Positive Blood Cultures: A Patient-level Meta-analysis of Randomized Trials.
Clinical Infectious Diseases 2019, 69, 388-396.
Le Hingrat Q, Collin G, Lê M, Peytavin G, Visseaux B, Bertine M, Tubiana R, Karmochkine M, Valin N, Collin F, Lemaignen A, Bernard L, Damond F, Matheron S, Descamps D, Charpentier C, French National Agency for Research on AIDS and Viral Hepatitis (ANRS) CO5 HIV-2 Cohort
A New Mechanism of Resistance of Human Immunodeficiency Virus Type 2 to Integrase Inhibitors: A 5-Amino-Acid Insertion in the Integrase C-Terminal Domain.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2019, 69, 657-667.
Weiss E, Zahar JR, Alder J, Asehnoune K, Bassetti M, Bonten MJM, Chastre J, De Waele J, Dimopoulos G, Eggimann P, Engelhardt M, Ewig S, Kollef M, Lipman J, Luna C, Martin-Loeches I, Pagani L, Palmer LB, Papazian L, Poulakou G, Prokocimer P, Rello J, Rex JH, Shorr AF, Talbot GH, Thamlikitkul V, Torres A, Wunderink RG, Timsit JF
Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials.
Clinical Infectious Diseases 2019, 69, 1912-1918.
Hage-Sleiman M, Tremeaux P, Fillion M, Boufassa F, Melard A, Gardiennet E, Mariaggi AA, Plantier JC, Rouzioux C, Lambotte O, Avettand-Fenoel V, CODEX ANRS Cohort Study Group
False-negative Results of Human Immunodeficiency Virus (HIV) Rapid Testing in HIV Controllers.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2019
Le Roux E, Mellerio H, Jacquin P, Bourmaud A, Guilmin-Crépon S, Faye A, Matheron S, Boulkedid R, Alberti C
Practical generic guidelines for paediatric-to-adult transition for adolescents with chronic disease.
European Journal of Public Health 2019, 29, 442-448.
Ngo-Giang-Huong N, Huynh THK, Dagnra AY, Toni Td, Maiga AI, Kania D, Eymard-Duvernay S, Peeters M, Soulie C, Peytavin G, Rekacewicz C, Chaix ML, Aghokeng AF, ANRS 12333 Study Group, Aghokeng AF, Ayouba A, Brun-Vézinet F, Chaix ML, Calvez V, Dagnra A, Descamps D, Dramane K, Fournier I, Maiga A, de Monteynard LA, Nouhin J, Kane CT, Lien TX, Ngo-Giang-Huong N, Peeters M, Plantier JC, Njouom R, Tuaillon E, Rekacewicz C, d’Aquin TT, Poda A, Zougrana J, Ouedraogo S, Ouedraogo M, Djeuda AD, Kouanfack C, Mandeng N, Mpoudi-Ngole E, Messou E, Jacques DJ, Nguessan JF, Dolo O, Diarra Z, Cisse M, Patassi A, Salou M, Ali-Edjé K, Bowonwatanuwong C, Thongpaen S, Klinbuayaem V, Laomanit L, Luong QA, Tran T
Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries.
Journal of Antimicrobial Chemotherapy 2019, 74, 462-467.
Soulie C, Santoro MM, Charpentier C, Storto A, Paraskevis D, Di Carlo D, Gennari W, Sterrantino G, Zazzi M, Perno CF, Calvez V, Descamps D, Ceccherini-Silberstein F, Marcelin AG
Rare occurrence of doravirine resistance-associated mutations in HIV-1-infected treatment-naive patients.
The Journal of Antimicrobial Chemotherapy 2019, 74, 614-617.
Joly V, Burdet C, Landman R, Vigan M, Charpentier C, Katlama C, Cabié A, Benalycherif A, Peytavin G, Yeni P, Mentre F, Argoud AL, Amri I, Descamps D, Yazdanpanah Y, LAMIDOL Study Group
Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL).
The Journal of Antimicrobial Chemotherapy 2019, 74, 739-745.
Assoumou L, Bocket L, Pallier C, Grude M, Ait-Namane R, Izopet J, Raymond S, Charpentier C, Visseaux B, Wirden M, Trabaud MA, Le Guillou-Guillemette H, Allaoui C, Henquell C, Krivine A, Dos Santos G, Delamare C, Bouvier-Alias M, Montes B, Ferre V, De Monte A, Signori-Schmuck A, Maillard A, Morand-Joubert L, Tumiotto C, Fafi-Kremer S, Amiel C, Barin F, Marque-Juillet S, Courdavault L, Vallet S, Beby-Defaux A, de Rougemont A, Fenaux H, Avettand-Fenoel V, Allardet-Servent A, Plantier JC, Peytavin G, Calvez V, Chaix ML, Descamps D, ANRS AC-43 Resistance Study Group
Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France.
The Journal of Antimicrobial Chemotherapy 2019, 74, 1417-1424.
Marcelin AG, Grude M, Charpentier C, Bellecave P, Le Guen L, Pallier C, Raymond S, Mirand A, Bocket L, Fofana DB, Delaugerre C, Nguyen T, Montès B, Jeulin H, Mourez T, Fafi-Kremer S, Amiel C, Roussel C, Dina J, Trabaud MA, Le Guillou-Guillemette H, Vallet S, Signori-Schmuck A, Maillard A, Ferre V, Descamps D, Calvez V, Flandre P, ANRS AC43 Resistance Group
Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients.
The Journal of Antimicrobial Chemotherapy 2019, 74, 1368-1375.
Perrier M, Castain L, Regad L, Todesco E, Landman R, Visseaux B, Yazdanpanah Y, Rodriguez C, Joly V, Calvez V, Marcelin AG, Descamps D, Charpentier C
HIV-1 protease, Gag and gp41 baseline substitutions associated with virological response to a PI-based regimen.
The Journal of Antimicrobial Chemotherapy 2019, 74, 1679-1692.
Mboumba Bouassa RS, Mossoro-Kpinde CD, Gody JC, Veyer D, Péré H, Matta M, Robin L, Grésenguet G, Charpentier C, Bélec L
High predictive efficacy of integrase strand transfer inhibitors in perinatally HIV-1-infected African children in therapeutic failure of first- and second-line antiretroviral drug regimens recommended by the WHO.
Journal of Antimicrobial Chemotherapy 2019, 74, 2030-2038.
Néant N, Solas C, Bouazza N, Lê MP, Yazdanpanah Y, Dhiver C, Bregigeon S, Mokhtari S, Peytavin G, Tamalet C, Descamps D, Lacarelle B, Gattacceca F
Concentration-response model of rilpivirine in a cohort of HIV-1-infected naive and pre-treated patients.
The Journal of Antimicrobial Chemotherapy 2019, 74, 1992-2002.
Castain L, Perrier M, Charpentier C, Palich R, Desire N, Wirden M, Descamps D, Sayon S, Landman R, Valantin MA, Joly V, Peytavin G, Yazdanpanah Y, Katlama C, Calvez V, Marcelin AG, Todesco E
New mechanisms of resistance in virological failure to protease inhibitors: selection of non-described protease, Gag and Gp41 mutations.
The Journal of Antimicrobial Chemotherapy 2019, 74, 2019-2023.
Perozziello A, Lescure FX, Truel A, Routelous C, Vaillant L, Yazdanpanah Y, Lucet JC, CEFECA study group
Prescribers' experience and opinions on antimicrobial stewardship programmes in hospitals: a French nationwide survey.
The Journal of Antimicrobial Chemotherapy 2019, 74, 2451-2458.
Siguier M, Mera R, Pialoux G, Ohayon M, Cotte L, Valin N, Ghosn J, Cua E, Pintado C, Chas J, Barriere G, Durand F, Molina JM
First year of pre-exposure prophylaxis implementation in France with daily or on-demand tenofovir disoproxil fumarate/emtricitabine.
Journal of Antimicrobial Chemotherapy 2019, 74, 2752-2758.
Katlama C, Assoumou L, Valantin MA, Soulié C, Martinez E, Béniguel L, Bouchaud O, Raffi F, Molina JM, Fellahi S, Peytavin G, Marcelin AG, Kolta S, Capeau J, Gibowski S, Cardon F, Reynes J, Costagliola D, the members of the ANRS 163 ETRAL study, Bernard L, Bottero J, Bouchaud O, Chidiac C, Duvivier C, Goujard C, delMarGutiérrez M, Martinez E, Molina JM, Morlat P, Naqvi A, Podzamczer D, Poizot-Martin I, Raffi F, Reynes J, Salmon-Céron D, Simon A, Valantin MA, Weiss L, Yazdanpanah Y
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study.
Journal of Antimicrobial Chemotherapy 2019, 74, 2742-2751.
Valantin MA, Durand L, Wirden M, Assoumou L, Caby F, Soulié C, Nguyen TTT, Tubiana R, Kirstetter M, Junot H, Marcelin AG, Peytavin G, Tilleul P, Katlama C
Antiretroviral drug reduction in highly experienced HIV-infected patients receiving a multidrug regimen: the ECOVIR study.
Journal of Antimicrobial Chemotherapy 2019, 74, 2716-2722.
Peiffer-Smadja N, Guillotel E, Luque-Paz D, Maataoui N, Lescure FX, Cattoir V
In vitro bactericidal activity of amoxicillin combined with different cephalosporins against endocarditis-associated Enterococcus faecalis clinical isolates.
Journal of Antimicrobial Chemotherapy 2019, 74, 3511-3514.
Rockstroh JK, Yazdanpanah Y
HepCare Europe: a new user-friendly hepatitis C care service model. What have we learned? What are the remaining challenges?.
Journal of Antimicrobial Chemotherapy 2019, 74, v2-v4.
Tsopra R, Sedki K, Courtine M, Falcoff H, De Beco A, Madar R, Mechaï F, Lamy JB
Helping GPs to extrapolate guideline recommendations to patients for whom there are no explicit recommendations, through the visualization of drug properties. The example of AntibioHelp® in bacterial diseases.
Journal of the American Medical Informatics Association: JAMIA 2019, 26, 1010-1019.
McIlroy PA, King RS, Garrouste-Orgeas M, Tabah A, Ramanan M
The Effect of ICU Diaries on Psychological Outcomes and Quality of Life of Survivors of Critical Illness and Their Relatives: A Systematic Review and Meta-Analysis.
Critical Care Medicine 2019, 47, 273-279.
Bertrand PM, Pereira B, Adda M, Timsit JF, Wolff M, Hilbert G, Gruson D, Garrouste-Orgeas M, Argaud L, Constantin JM, Chabanne R, Quenot JP, Bohe J, Guerin C, Papazian L, Jonquet O, Klouche K, Delahaye A, Riu B, Zieleskiewicz L, Darmon M, Azoulay E, Souweine B, Lautrette A
Disagreement Between Clinicians and Score in Decision-Making Capacity of Critically Ill Patients*:.
Critical Care Medicine 2019, 47, 337-344.
Ibn Saied W, Mourvillier B, Cohen Y, Ruckly S, Reignier J, Marcotte G, Siami S, Bouadma L, Darmon M, de Montmollin E, Argaud L, Kallel H, Garrouste-Orgeas M, Soufir L, Schwebel C, Souweine B, Glodgran-Toledano D, Papazian L, Timsit JF
A Comparison of the Mortality Risk Associated With Ventilator-Acquired Bacterial Pneumonia and Nonventilator ICU-Acquired Bacterial Pneumonia*:.
Critical Care Medicine 2019, 47, 345-352.
Bourcier S, Coutrot M, Kimmoun A, Sonneville R, de Montmollin E, Persichini R, Schnell D, Charpentier J, Aubron C, Morawiec E, Bigé N, Nseir S, Terzi N, Razazi K, Azoulay E, Ferré A, Tandjaoui-Lambiotte Y, Ellrodt O, Hraiech S, Delmas C, Barbier F, Lautrette A, Aissaoui N, Repessé X, Pichereau C, Zerbib Y, Lascarrou JB, Carreira S, Reuter D, Frérou A, Peigne V, Fillatre P, Megarbane B, Voiriot G, Combes A, Schmidt M
Thyroid Storm in the ICU: A Retrospective Multicenter Study.
Critical Care Medicine 2019
Leverger G, Timsit JF, Milpied N, Gachot B
Use of Micafungin for the Prevention and Treatment of Invasive Fungal Infections in Everyday Pediatric Care in France: Results of the MYRIADE Study.
The Pediatric Infectious Disease Journal 2019, 38, 716-721.
Bertin C, Abbas R, Andrieu V, Michard F, Rioux C, Descamps V, Yazdanpanah Y, Bouscarat F
Illicit massive silicone injections always induce chronic and definitive silicone blood diffusion with dermatologic complications.
Medicine 2019, 98, e14143.
Palich R, Ghosn J, Chaillon A, Boilet V, Nere ML, Chaix ML, Delobel P, Molina JM, Lucht F, Bouchaud O, Rieux V, Thiebaut R, Levy Y, Delaugerre C, Lelievre JD
Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial:.
AIDS 2019, 33, 279-284.
Lucar O, Sadjo Diallo M, Bayard C, Samri A, Tarantino N, Debré P, Thiébaut R, Brun-Vézinet F, Matheron S, Cheynier R, Vieillard V
B7-H6-mediated downregulation of NKp30 in natural killer cells contributes to HIV-2 immune escape:.
AIDS 2019, 33, 23-32.
Pommier JD, Laouénan C, Michard F, Papot E, Urios P, Boutten A, Peytavin G, Ghander C, Lariven S, Castanedo G, Moho D, Landman R, Phung B, Perez E, Julia Z, Descamps D, Roland-Nicaise P, Le Gac S, Yazdanpanah Y, Guibourdenche J, Yeni P
Metabolic syndrome and endocrine status in HIV-infected transwomen.
AIDS (London, England) 2019, 33, 855-865.
Januel E, Godin O, Moulignier A, Lescure FX, Savatovsky J, Lamirel C, Valin N, Tubiana R, Canestri A, Roux P, Sadik JC, Salomon L, Katlama C, Yazdanpanah Y, Pialoux G, Girard PM, Costagliola D, Assoumou L, Microvascular Brain Retina And Kidney (MicroBREAK) Study Group
Brief Report: Impact of ART Classes on the Increasing Risk of Cerebral Small-Vessel Disease in Middle-Aged, Well-Controlled, cART-Treated, HIV-Infected Individuals.
Journal of Acquired Immune Deficiency Syndromes (1999) 2019, 81, 547-551.
Garnacho-Montero J, Timsit JF
Managing Acinetobacter baumannii infections:.
Current Opinion in Infectious Diseases 2019, 32, 69-76.
Lê MP, Chaix M, Raffi F, Chevret S, Gallien S, Katlama C, Delobel P, Yazdanpanah Y, Saillard J, Molina J, Peytavin G, the ANRS‐165 DARULIGHT study group
Once‐daily darunavir/ritonavir 400/100 mg in triple therapy: efficacy and penetration in seminal compartment in ANRS ‐165 DARULIGHT study.
British Journal of Clinical Pharmacology 2019, 85, 277-280.
Ghazali DA, Choquet C, Casalino E
Simulation-based training for triage of HIV exposures in the emergency department.
Medical Education 2019, 53, 521-522.
Ghazali DA, Kenway P, Casalino E
Simulation-based training for pain assessment in the emergency department.
Medical Education 2019, 53, 1149-1150.
Bassetti M, Scudeller L, Giacobbe DR, Lamoth F, Righi E, Zuccaro V, Grecchi C, Rebuffi C, Akova M, Alastruey-Izquierdo A, Arikan-Akdagli S, Azoulay E, Blot SI, Cornely OA, Lass-Flörl C, Koehler P, Cuenca-Estrella M, de Lange DW, De Rosa FG, De Waele JJ, Dimopoulos G, Garnacho-Montero J, Hoenigl M, Kanj SS, Maertens J, Martin-Loeches I, Muñoz P, Kullberg BJ, Agvald-Ohman C, Poulakou G, Rello J, Sanguinetti M, Taccone FS, Timsit JF, Torres A, Vazquez JA, Calandra T, from the Study Group for Infections in Critically Ill Patients (ESGCIP) and the Fungal Infection Study Group (EFISG) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), European Society of Intensive Care Medicine (ESICM), European Confederation of Medical Mycology (ECMM), Mycoses Study Group Education and Research Consortium (MSGERC)
Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project.
Mycoses 2019, 62, 310-319.
Stefic K, Guinard J, Peytavin G, Saboni L, Sommen C, Sauvage C, Lot F, Laperche S, Velter A, Barin F, Prevagay working group
Screening for Human Immunodeficiency Virus infection using a fourth-generation antigen/antibody assay and dried blood spots: in depth analysis of sensitivity and performance assessment in a cross-sectional study.
Journal of Clinical Microbiology 2019
Baril L, Vallès X, Stenseth NC, Rajerison M, Ratsitorahina M, Pizarro-Cerdá J, Demeure C, Belmain S, Scholz H, Girod R, Hinnebusch J, Vigan-Womas I, Bertherat E, Fontanet A, Yazadanpanah Y, Carrara G, Deuve J, D'ortenzio E, Angulo JOC, Mead P, Horby PW
Can we make human plague history? A call to action.
BMJ Global Health 2019, 4, e001984.
Hentzien M, Dramé M, Delpierre C, Allavena C, Cabié A, Cuzin L, Rey D, Pugliese P, Hédelin G, Bani-Sadr F, Dat’AIDS Study Group
HIV-related excess mortality and age-related comorbidities in patients with HIV aged ≥60: a relative survival analysis in the French Dat'AIDS cohort.
BMJ open 2019, 9, e024841.
Boisson M, Corbi P, Kerforne T, Camilleri L, Debauchez M, Demondion P, Eljezi V, Flecher E, Lepelletier D, Leprince P, Nesseler N, Nizou JY, Roussel JC, Rozec B, Ruckly S, Lucet JC, Timsit JF, Mimoz O
Multicentre, open-label, randomised, controlled clinical trial comparing 2% chlorhexidine-70% isopropanol and 5% povidone iodine-69% ethanol for skin antisepsis in reducing surgical-site infection after cardiac surgery: the CLEAN 2 study protocol.
BMJ open 2019, 9, e026929.
Javaud N, Soria A, Maignan M, Martin L, Descamps V, Fain O, Bouillet L, Berard F, Tazarourte K, Roy PM, Fontaine JP, Bagot M, Khellaf M, Goulet H, Lapostolle F, Casalino E, Doutre MS, Gil-Jardine C, Caux F, Chosidow O, Pateron D, Vicaut E, Adnet F
Glucocorticoids for acute urticaria: study protocol for a double-blind non-inferiority randomised controlled trial.
BMJ open 2019, 9, e027431.
Flowers H, Bérubé D, Ebrahimipour M, Perrier MF, Moloci S, Skoretz S
Swallowing behaviours and feeding environment in relation to communication development from early infancy to 6 years of age: a scoping review protocol.
BMJ Open 2019, 9, e028850.
Le Bel J, Pelaccia T, Ray P, Mayaud C, Brun AL, Hausfater P, Casalino E, Benjoar M, Claessens YE, Duval X, ESCAPED study group
Impact of emergency physician experience on decision-making in patients with suspected community-acquired pneumonia and undergoing systematic thoracic CT scan.
Emergency medicine journal: EMJ 2019, 36, 485-492.
Gobat N, Amuasi J, Yazdanpanah Y, Sigfid L, Davies H, Byrne JP, Carson G, Butler C, Nichol A, Goossens H
Advancing preparedness for clinical research during infectious disease epidemics.
ERJ open research 2019
Lions C, Cabras O, Cotte L, Huleux T, Gagneux-Brugnon A, Makinson A, Cabié A, Bonnet B, Duvivier C, Hocqueloux L, Cua E, Cheret A, Hustache-Mathieu L, Obry-Roguet V, Jacomet C, Poizot-Martin I, DAT’AIDS STUDY GROUP
Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT'AIDS cohort.
BMC infectious diseases 2019, 19, 278.
Vaux S, Chevaliez S, Saboni L, Sauvage C, Sommen C, Barin F, Alexandre A, Jauffret-Roustide M, Lot F, Velter A, ANRS-Prevagay group
Prevalence of hepatitis C infection, screening and associated factors among men who have sex with men attending gay venues: a cross-sectional survey (PREVAGAY), France, 2015.
BMC infectious diseases 2019, 19, 315.
Jary A, Dienta S, Leducq V, Le Hingrat Q, Cisse M, Diarra AB, Fofana DB, Ba A, Baby M, Achenbach CJ, Murphy R, Calvez V, Marcelin AG, Maiga AI
Seroprevalence and risk factors for HIV, HCV, HBV and syphilis among blood donors in Mali.
BMC Infectious Diseases 2019, 19, 1064.
Garrouste-Orgeas M, Flahault C, Poulain E, Evin A, Guirimand F, Fossez-Diaz V, Perruchio S, Verlaine C, Vanbésien A, Kaczmarek W, Birkui de Francqueville L, De Larivière E, Bouquet G, Copel L, Verliac V, Marché V, Mathias C, Gracia D, Mhalla A, Michonneau-Gandon V, Poupardin C, Touzet L, Ranchou G, Guastella V, Richard B, Bienfait F, Sonrier M, Michel D, Ruckly S, Bailly S, Timsit JF
The Fami-life study: protocol of a prospective observational multicenter mixed study of psychological consequences of grieving relatives in French palliative care units on behalf of the family research in palliative care (F.R.I.P.C research network).
BMC Palliative Care 2019, 18, 111.
Schwarzinger M, Luchini S, EPICORL Study Group
Estimating health state utility from activities of daily living in the French National Hospital Discharge Database: a feasibility study with head and neck cancer.
Health and Quality of Life Outcomes 2019, 17, 129.
Prevel R, Boyer A, M’Zali F, Lasheras A, Zahar JR, Rogues AM, Gruson D
Is systematic fecal carriage screening of extended-spectrum beta-lactamase-producing Enterobacteriaceae still useful in intensive care unit: a systematic review.
Critical Care 2019, 23,
Bassetti M, Giacobbe DR, Vena A, Trucchi C, Ansaldi F, Antonelli M, Adamkova V, Alicino C, Almyroudi MP, Atchade E, Azzini AM, Carannante N, Carnelutti A, Corcione S, Cortegiani A, Dimopoulos G, Dubler S, García-Garmendia JL, Girardis M, Cornely OA, Ianniruberto S, Kullberg BJ, Lagrou K, Le Bihan C, Luzzati R, Malbrain MLNG, Merelli M, Marques AJ, Martin-Loeches I, Mesini A, Paiva JA, Peghin M, Raineri SM, Rautemaa-Richardson R, Schouten J, Brugnaro P, Spapen H, Tasioudis P, Timsit JF, Tisa V, Tumbarello M, van den Berg CHSB, Veber B, Venditti M, Voiriot G, Wauters J, Montravers P
Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project.
Critical Care 2019, 23,
Morvan AC, Garrouste-Orgeas M, Ruckly S, Forel JM, Argaud L, Rimmelé T, Bedos JP, Azoulay E, Dupuis C, Mourvillier B, Schwebel C, Timsit JF
Impact of species and antibiotic therapy of enterococcal peritonitis on 30-day mortality in critical care—an analysis of the OUTCOMEREA database.
Critical Care 2019, 23, 307.
Dumas G, Demoule A, Mokart D, Lemiale V, Nseir S, Argaud L, Pène F, Kontar L, Bruneel F, Klouche K, Barbier F, Reignier J, Stoclin A, Louis G, Constantin JM, Wallet F, Kouatchet A, Peigne V, Perez P, Girault C, Jaber S, Cohen Y, Nyunga M, Terzi N, Bouadma L, Lebert C, Lautrette A, Bigé N, Raphalen JH, Papazian L, Benoit D, Darmon M, Chevret S, Azoulay E
Center effect in intubation risk in critically ill immunocompromised patients with acute hypoxemic respiratory failure.
Critical Care 2019, 23, 306.
Bouadma L, Darmon M, Argaud L, Vinclair C, Siami S, Garrouste-Orgeas M, Papazian L, Cohen Y, Marcotte G, Styfalova L, Reignier J, Lautrette A, Schwebel C, Timsit JF
Influence of dyskalemia at admission and early dyskalemia correction on survival and cardiac events of critically ill patients.
Critical Care 2019, 23,
Birgand G, Haudebourg T, Grammatico-Guillon L, Ferrand L, Moret L, Gouin F, Mauduit N, Leux C, Le Manach Y, Lepelletier D, Tavernier E, Lucet JC, Giraudeau B
Improvement in staff behavior during surgical procedures to prevent post-operative complications (ARIBO2): study protocol for a cluster randomised trial.
Trials 2019, 20,
the PREVAC study team, Lhomme E, Modet C, Augier A, Faye S, Dabakuyo-Yonli TS, Levy-Marchal C, D’Ortenzio E, Yazdanpanah Y, Chêne G, Beavogui AH, Richert L
Enrolling study personnel in Ebola vaccine trials: from guidelines to practice in a non-epidemic context.
Trials 2019, 20,
Pons S, Sonneville R, Bouadma L, Styfalova L, Ruckly S, Neuville M, Radjou A, Lebut J, Dilly MP, Mourvillier B, Dorent R, Nataf P, Wolff M, Timsit JF
Infectious complications following heart transplantation in the era of high-priority allocation and extracorporeal membrane oxygenation.
Annals of Intensive Care 2019, 9, 17.
Karpanen TJ, Casey AL, Whitehouse T, Timsit JF, Mimoz O, Palomar M, Elliott TSJ
A clinical evaluation of two central venous catheter stabilization systems.
Annals of Intensive Care 2019, 9, 49.
Balmier A, Dib F, Serret-Larmande A, De Montmollin E, Pouyet V, Sztrymf B, Megarbane B, Thiagarajah A, Dreyfuss D, Ricard JD, Roux D
Initial management of diabetic ketoacidosis and prognosis according to diabetes type: a French multicentre observational retrospective study.
Annals of Intensive Care 2019, 9, 91.
Smonig R, Magalhaes E, Bouadma L, Andremont O, de Montmollin E, Essardy F, Mourvillier B, Lebut J, Dupuis C, Neuville M, Lermuzeaux M, Timsit JF, Sonneville R
Impact of natural light exposure on delirium burden in adult patients receiving invasive mechanical ventilation in the ICU: a prospective study.
Annals of Intensive Care 2019, 9, 120.
Vaillant L, Birgand G, Esposito-Farese M, Astagneau P, Pulcini C, Robert J, Zahar JR, Sales-Wuillemin E, Tubach F, Lucet JC, PerceptR Study group
Awareness among French healthcare workers of the transmission of multidrug resistant organisms: a large cross-sectional survey.
Antimicrobial Resistance and Infection Control 2019, 8, 173.
Kassi FK, Drakulovski P, Bellet V, Roger F, Chabrol A, Krasteva D, Doumbia A, Landman R, Kakou A, Reynes J, Delaporte E, Menan HEI, Bertout S, Govender NP
Cryptococcus genetic diversity and mixed infections in Ivorian HIV patients: A follow up study.
PLOS Neglected Tropical Diseases 2019, 13, e0007812.
Charani E, Smith I, Skodvin B, Perozziello A, Lucet JC, Lescure FX, Birgand G, Poda A, Ahmad R, Singh S, Holmes AH
Investigating the cultural and contextual determinants of antimicrobial stewardship programmes across low-, middle- and high-income countries-A qualitative study.
PloS One 2019, 14, e0209847.
Fournier AL, Yazdanpanah Y, Verdon R, Lariven S, Mackoumbou-Nkouka C, Phung BC, Papot E, Parienti JJ, Landman R, Champenois K
Incidence of and risk factors for medical care interruption in people living with HIV in recent years.
PloS One 2019, 14, e0213526.
Gantner P, Cotte L, Allavena C, Bani-Sadr F, Huleux T, Duvivier C, Valantin MA, Jacomet C, Joly V, Chéret A, Pugliese P, Delobel P, Cabié A, Rey D, for the Dat’AIDS Study Group, Huang JF
Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection.
PLOS ONE 2019, 14, e0215464.
Cossais S, Schwarzinger M, Pol S, Fontaine H, Larrey D, Pageaux GP, Canva V, Mathurin P, Yazdanpanah Y, Deuffic-Burban S, Fischer F
Quality of life in patients with chronic hepatitis C infection: Severe comorbidities and disease perception matter more than liver-disease stage.
PLOS ONE 2019, 14, e0215596.
Gantner P, Sylla B, Morand-Joubert L, Frange P, Lacombe K, Khuong MA, Duvivier C, Launay O, Karmochkine M, Arvieux C, Ménard A, Piroth L, Canestri A, Trias D, Peytavin G, Landman R, Ghosn J, on behalf of the Coferal-IMEA048 Study Group, Güerri-Fernández R
“Real life” use of raltegravir during pregnancy in France: The Coferal-IMEA048 cohort study.
PLOS ONE 2019, 14, e0216010.
Raben D, Sullivan AK, Mocroft A, Kutsyna G, Hadžiosmanović V, Vassilenko A, Chkhartisvili N, Mitsura V, Pedersen C, Anderson J, Begovac J, Bak Dragsted U, Bertisch B, Grzeszczuk A, Minton J, Necsoi VC, Kitchen M, Ajana F, Sokhan A, Comi L, Farazmand P, Pesut D, De Wit S, Gatell JM, Gazzard B, d’Arminio Monforte A, Rockstroh JK, Yazdanpanah Y, Champenois K, Jakobsen ML, Lundgren JD, on behalf of the HIDES Study Group, Sagar M
Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study – 2012 – 2015.
PLOS ONE 2019, 14, e0220108.
Mandelbrot L, Ceccaldi PF, Duro D, Lê M, Pencolé L, Peytavin G, Spradley FT
Placental transfer and tissue accumulation of dolutegravir in the ex vivo human cotyledon perfusion model.
PLOS ONE 2019, 14, e0220323.
Samri A, Charpentier C, Diallo MS, Bertine M, Even S, Morin V, Oudin A, Parizot C, Collin G, Hosmalin A, Cheynier R, Thiébaut R, Matheron S, Collin F, Zoorob R, Brun-Vézinet F, Autran B, ANRS CO5 IMMUNOVIR-2 Study Group
Limited HIV-2 reservoirs in central-memory CD4 T-cells associated to CXCR6 co-receptor expression in attenuated HIV-2 infection.
PLoS pathogens 2019, 15, e1007758.
Visseaux B, Le Hingrat Q, Damond F, Charpentier C, Descamps D
[Physiopathology of HIV-2 infection].
Virologie (Montrouge, France) 2019, 23, 277-291.
Schernberg A, Sagaon-Teyssier L, Schwarzinger M
Clinical and economic burden of head and neck cancer: a nationwide retrospective cohort study from France.
ClinicoEconomics and outcomes research: CEOR 2019, 11, 441-451.
Basilua JM, Sawoo O, Mangin I, Dossou-Yovo F, Boussard A, Chevillard L, Lutete GT, Eto B, Peytavin G, Pochart P
Higher Atazanavir Plasma Exposure in Rats is Associated with Gut Microbiota Changes Induced by Cotrimoxazole.
Current Drug Metabolism 2019, 20, 898-906.
van de Laar MJ, Bosman A, Pharris A, Andersson E, Assoumou L, Ay E, Bannert N, Bartmeyer B, Brady M, Chaix ML, Descamps D, Dauwe K, Fonager J, Hauser A, Lunar M, Mezei M, Neary M, Poljak M, van Sighem A, Verhofstede C, Amato-Gauci AJ, Broberg EK
Piloting a surveillance system for HIV drug resistance in the European Union.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2019, 24,
Wirden M, De Oliveira F, Bouvier-Alias M, Lambert-Niclot S, Chaix ML, Raymond S, Si-Mohammed A, Alloui C, André-Garnier E, Bellecave P, Malve B, Mirand A, Pallier C, Poveda JD, Rabenja T, Schneider V, Signori-Schmuck A, Stefic K, Calvez V, Descamps D, Plantier JC, Marcelin AG, Visseaux B, On Behalf Of The French National Agency For Research On Aids And Viral Hepatitis Anrs Ac Study Group n
New HIV-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in France, 2013 to 2017.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2019, 24,
Liapis E, Bour M, Triponney P, Jové T, Zahar JR, Valot B, Jeannot K, Plésiat P
Identification of Diverse Integron and Plasmid Structures Carrying a Novel Carbapenemase Among Pseudomonas Species.
Frontiers in Microbiology 2019, 10, 404.
Ghazali DA, Richard A, Chaudet A, Choquet C, Guericolas M, Casalino E
Profile and Motivation of Patients Consulting in Emergency Departments While not Requiring Such a Level of Care.
International Journal of Environmental Research and Public Health 2019, 16, 4431.
Garin N, Marti C, Carballo S, Darbellay Farhoumand P, Montet X, Roux X, Scheffler M, Serratrice C, Serratrice J, Claessens YE, Duval X, Loubet P, Stirnemann J, Prendki V
Rational Use of CT-Scan for the Diagnosis of Pneumonia: Comparative Accuracy of Different Strategies.
Journal of Clinical Medicine 2019
Azevedo-Coste C, Pissard-Gibollet R, Toupet G, Fleury É, Lucet JC, Birgand G
Tracking Clinical Staff Behaviors in an Operating Room.
Sensors (Basel, Switzerland) 2019, 19,
Abgrall S, Raho-Moussa M, Seng R, Ghislain M, Matheron S, Pialoux G, Goujard C, Meyer L, ANRS CO9-COPANA study group†
Elevated risk of viral rebound on ART in migrants living in France: role of socioeconomic factors.
Antiviral Therapy 2019, 24, 541-552.
Perrineau S, Lachâtre M, Lê MP, Rioux C, Loubet P, Fréchet-Jachym M, Gonzales MC, Grall N, Bouvet E, Veziris N, Yazdanpanah Y, Peytavin G
Long-term plasma pharmacokinetics of bedaquiline for multidrug- and extensively drug-resistant tuberculosis.
The International Journal of Tuberculosis and Lung Disease 2019, 23, 99-104.
Popping S, Bade D, Boucher C, van der Valk M, El-Sayed M, Sigurour O, Sypsa V, Morgan T, Gamkrelidze A, Mukabatsinda C, Deuffic-Burban S, Ninburg M, Feld J, Hellard M, Ward J
The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals.
Journal of Virus Eradication 2019, 5, 60-66.
Wensing AM, Calvez V, Ceccherini-Silberstein F, Charpentier C, Günthard HF, Paredes R, Shafer RW, Richman DD
2019 update of the drug resistance mutations in HIV-1.
Topics in Antiviral Medicine 2019, 27, 111-121.
Ghazali DA, Fournier E, Breque C, Ragot SP, Oriot D
Immersive simulation training at 6-week intervals for 1 year and multidisciplinary team performance scores: a randomized controlled trial of simulation training for life-threatening pediatric emergencies.
Emergencias: Revista De La Sociedad Espanola De Medicina De Emergencias 2019, 31, 391-398.
Use of an ICU Diary and Patient Posttraumatic Stress Disorder Symptoms—Reply.
JAMA 2019, 322, 2025.
Garrouste-Orgeas M, Flahault C, Vinatier I, Rigaud JP, Thieulot-Rolin N, Mercier E, Rouget A, Grand H, Lesieur O, Tamion F, Hamidfar R, Renault A, Parmentier-Decrucq E, Monseau Y, Argaud L, Bretonnière C, Lautrette A, Badié J, Boulet E, Floccard B, Forceville X, Kipnis E, Soufir L, Valade S, Bige N, Gaffinel A, Hamzaoui O, Simon G, Thirion M, Bouadma L, Large A, Mira JP, Amdjar-Badidi N, Jourdain M, Jost PH, Maxime V, Santoli F, Ruckly S, Vioulac C, Leborgne MA, Bellalou L, Fasse L, Misset B, Bailly S, Timsit JF
Effect of an ICU Diary on Posttraumatic Stress Disorder Symptoms Among Patients Receiving Mechanical Ventilation: A Randomized Clinical Trial.
JAMA 2019, 322, 229-239.
Brunet-Possenti F, Charpentier C, Bouhnik Y, Deschamps L, Descamps D, Moins-Teisserenc H, Descamps V
Occurrence of Extensive Cutaneous Human Papillomavirus Infection After Initiation of Tofacitinib Therapy.
JAMA Dermatology 2019, 155, 629.
Heyard R, Timsit J, Essaied WI, Held L, on behalf of the COMBACTE‐MAGNET consortium
Dynamic clinical prediction models for discrete time‐to‐event data with competing risks—A case study on the OUTCOMEREA database.
Biometrical Journal 2019, 61, 514-534.
Avettand-Fenoel V, Bayan T, Gardiennet E, Boufassa F, Lopez P, Lecuroux C, Noel N, Trémeaux P, Monceaux V, Autran B, Meyer L, Saez-Cirion A, Lambotte O, Rouzioux C, CODEX ANRS Cohort Study Group
Dynamics in HIV-DNA levels over time in HIV controllers.
Journal of the International AIDS Society 2019, 22, e25221.
Lê MP, Valantin M, Assoumou L, Soulie C, Le Mestre S, Weiss L, Yazdanpanah Y, Molina J, Bouchaud O, Raffi F, Reynes J, Calvez V, Marcelin A, Costagliola D, Katlama C, Peytavin G, ANRS‐163 ETRAL study group, Duvivier C, Goujard C, Jeantils V, Salmon D, Simon A, Colin de Verdière N, Morlat P, Poizot‐Martin I, Allavena C, Naqvi A, Bernard L, Chidiac C, Hamdoud K
Lack of a Clinically Significant Pharmacokinetic Interaction between Etravirine and Raltegravir Using an Original Approach Based on Drug Metabolism, Protein Binding, and Penetration in Seminal Fluid: A Pharmacokinetic Substudy of the ANRS ‐163 ETRAL Study.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2019, 39, 514-520.
von Cube M, Schumacher M, Bailly S, Timsit JF, Lepape A, Savey A, Machut A, Wolkewitz M
The population-attributable fraction for time-dependent exposures and competing risks-A discussion on estimands.
Statistics in Medicine 2019, 38, 3880-3895.
Lucet JC, Heard I, Roueli A, Lafourcade A, Mandelbrot L, Estellat C, Dommergues M, PREEV Study Group
Transvaginal ultrasound probes are human papillomavirus-free following low-level disinfection: cross-sectional multicenter survey.
Ultrasound in Obstetrics & Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology 2019, 54, 688-695.
the IPREA-AQVAR Study Group, Kalfon P, Alessandrini M, Boucekine M, Renoult S, Geantot MA, Deparis-Dusautois S, Berric A, Collange O, Floccard B, Mimoz O, Julien A, Robert R, Audibert J, Renault A, Follin A, Thevenin D, Revel N, Venot M, Patrigeon RG, Signouret T, Fromentin M, Sharshar T, Vigne C, Pottecher J, Levrat Q, Sossou A, Garrouste-Orgeas M, Quenot JP, Boulle C, Azoulay E, Baumstarck K, Auquier P
Tailored multicomponent program for discomfort reduction in critically ill patients may decrease post-traumatic stress disorder in general ICU survivors at 1 year.
Intensive Care Medicine 2019, 45, 223-235.
Timsit JF, Bassetti M, Cremer O, Daikos G, de Waele J, Kallil A, Kipnis E, Kollef M, Laupland K, Paiva JA, Rodríguez-Baño J, Ruppé É, Salluh J, Taccone FS, Weiss E, Barbier F
Rationalizing antimicrobial therapy in the ICU: a narrative review.
Intensive Care Medicine 2019, 45, 172-189.
Papin G, Sonneville R, Nataf P, Bouadma L
Emergency craniotomy in semi-lateral position for posterior fossa hemorrhage evacuation under venoarterial extracorporeal membrane oxygenation.
Intensive Care Medicine 2019, 45, 1152-1153.
Schnell D, Montlahuc C, Bruneel F, Resche-Rigon M, Kouatchet A, Zahar JR, Darmon M, Pene F, Lemiale V, Rabbat A, Vincent F, Azoulay E, Mokart D
De-escalation of antimicrobial therapy in critically ill hematology patients: a prospective cohort study.
Intensive Care Medicine 2019, 45, 743-745.
Timsit JF, Citerio G, Lavilloniere M, Perner A, Ruckly S, Bakker J, Bassetti M, Benoit D, Curtis JR, Doig GS, Herridge M, Jaber S, Papazian L, Peters MJ, Singer P, Smith M, Soares M, Torres A, Vieillard-Baron A, Azoulay E
Determinants of downloads and citations for articles published in Intensive Care Medicine.
Intensive Care Medicine 2019, 45, 1058-1060.
Pons S, Timsit JF, Ruckly S, Schwebel C, Papazian L, Azoulay E, Reignier J, Zafrani L
Impact of macrolide therapy in critically ill patients with acute respiratory failure: a desirability of outcome ranking analysis to investigate the OUTCOMEREA database.
Intensive Care Medicine 2019
Timsit JF, Sonneville R, Kalil AC, Bassetti M, Ferrer R, Jaber S, Lanternier F, Luyt CE, Machado F, Mikulska M, Papazian L, Pène F, Poulakou G, Viscoli C, Wolff M, Zafrani L, Van Delden C
Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients.
Intensive Care Medicine 2019, 45, 573-591.
Martin-Loeches I, Antonelli M, Cuenca-Estrella M, Dimopoulos G, Einav S, De Waele JJ, Garnacho-Montero J, Kanj SS, Machado FR, Montravers P, Sakr Y, Sanguinetti M, Timsit JF, Bassetti M
ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients.
Intensive Care Medicine 2019, 45, 789-805.
Timsit JF, Schwebel C, Styfalova L, Cornet M, Poirier P, Forrestier C, Ruckly S, Jacob MC, Souweine B
Impact of bronchial colonization with Candida spp. on the risk of bacterial ventilator-associated pneumonia in the ICU: the FUNGIBACT prospective cohort study.
Intensive Care Medicine 2019, 45, 834-843.
Blot S, Poulakou G, Timsit JF
Catheter-associated bloodstream infection rates: how low can you go?.
Intensive Care Medicine 2019, 45, 896-897.
Jaquet P, de Montmollin E, Dupuis C, Sazio C, Conrad M, Susset V, Demeret S, Tadie JM, Argaud L, Barbier F, Sarton B, Chabane R, Daubin D, Brulé N, Lerolle N, Alves M, Da Silva D, Kalioubi AE, Silva S, Bailly P, Wolff M, Bouadma L, Timsit JF, Sonneville R, ENCEPHALITICA study group
Functional outcomes in adult patients with herpes simplex encephalitis admitted to the ICU: a multicenter cohort study.
Intensive Care Medicine 2019, 45, 1103-1111.
May F, Peytavin G, Fourati S, Pressiat C, Carteaux G, Razazi K, Mekontso Dessap A, de Prost N
Paracetamol absorption test to detect poor enteric absorption of oseltamivir in intensive care unit patients with severe influenza: a pilot study.
Intensive Care Medicine 2019, 45, 1484-1486.
Laurent A, Reignier J, Le Gouge A, Cottereau A, Adda M, Annane D, Audibert J, Barbier F, Bardou P, Bourcier S, Bourenne J, Boyer A, Brenas F, Das V, Desachy A, Devaquet J, Feissel M, Ganster F, Garrouste-Orgeas M, Grillet G, Guisset O, Hamidfar-Roy R, Hyacinthe AC, Jochmans S, Jourdain M, Lautrette A, Lerolle N, Lesieur O, Lion F, Mateu P, Megarbane B, Merceron S, Mercier E, Messika J, Morin-Longuet P, Philippon-Jouve B, Quenot JP, Renault A, Repesse X, Rigaud JP, Robin S, Roquilly A, Seguin A, Thevenin D, Tirot P, Vinatier I, Azoulay E, Robert R, Kentish-Barnes N
“You helped me keep my head above water”—experience of bereavement research after loss of a loved one in the ICU: insights from the ARREVE study.
Intensive Care Medicine 2019, 45, 1252-1261.
Buetti N, Ruckly S, Lucet JC, Mimoz O, Souweine B, Timsit JF
Short-term dialysis catheter versus central venous catheter infections in ICU patients: a post hoc analysis of individual data of 4 multi-centric randomized trials.
Intensive Care Medicine 2019
Blot S, Antonelli M, Arvaniti K, Blot K, Creagh-Brown B, de Lange D, De Waele J, Deschepper M, Dikmen Y, Dimopoulos G, Eckmann C, Francois G, Girardis M, Koulenti D, Labeau S, Lipman J, Lipovestky F, Maseda E, Montravers P, Mikstacki A, Paiva JA, Pereyra C, Rello J, Timsit JF, Vogelaers D, Abdominal Sepsis Study (AbSeS) group on behalf of the Trials Group of the European Society of Intensive Care Medicine
Epidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS", a multinational observational cohort study and ESICM Trials Group Project.
Intensive Care Medicine 2019, 45, 1703-1717.
Delerue T, Cordel H, Delerue T, Figoni J, Dziri S, Billard-Pomares T, Bouchaud O, Carbonnelle E, Zahar JR
Prediction of methicillin-resistant Staphylococcus aureus bloodstream infection: do we need rapid diagnostic tests?.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2019, 38, 1319-1326.
for the EUVAE Study Group, Rello J, Ramírez-Estrada S, Romero A, Arvaniti K, Koulenti D, Nseir S, Oztoprak N, Bouadma L, Vidaur L, Lagunes L, Peña-López Y
Factors associated with ventilator-associated events: an international multicenter prospective cohort study.
European Journal of Clinical Microbiology & Infectious Diseases 2019, 38, 1693-1699.
Mageau A, Timsit JF, Perrozziello A, Ruckly S, Dupuis C, Bouadma L, Papo T, Sacre K
The burden of chronic kidney disease in systemic lupus erythematosus: A nationwide epidemiologic study.
Autoimmunity Reviews 2019, 18, 733-737.
Tacconelli E, Mazzaferri F, de Smet AM, Bragantini D, Eggimann P, Huttner BD, Kuijper EJ, Lucet JC, Mutters NT, Sanguinetti M, Schwaber MJ, Souli M, Torre-Cisneros J, Price JR, Rodríguez-Baño J
ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2019, 25, 807-817.
Ferré V, Ekouevi D, Gbeasor-Komlanvi F, Collin G, Le Hingrat Q, Tchounga B, Salou M, Descamps D, Charpentier C, Dagnra A
Prevalence of human papillomavirus, human immunodeficiency virus and other sexually transmitted infections among female sex workers in Togo: a national cross-sectional survey.
Clinical Microbiology and Infection 2019, 25, 1560.e1-1560.e7.
Schweitzer VA, van Werkhoven CH, Rodríguez Baño J, Bielicki J, Harbarth S, Hulscher M, Huttner B, Islam J, Little P, Pulcini C, Savoldi A, Tacconelli E, Timsit JF, van Smeden M, Wolkewitz M, Bonten MJM, Walker AS, Llewelyn MJ, Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) Working Group on Design of Antimicrobial Stewardship Evaluations
Optimizing design of research to evaluate antibiotic stewardship interventions: consensus recommendations of a multinational working group.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2019
Ghazali DA, Kenway P, Clery R, Choquet C, Casalino E
A multicenter randomized control trial evaluating professional practice assessment of patient pain management after simulation training course: Study protocol.
Contemporary Clinical Trials Communications 2019, 14, 100331.
Casalino E, Kenway P, Bouzid D, Goncalves S, Antoniol S, Radou L, Choquet C, Macaux M, Ghazali DA
Implementation of HIV-exposures triage strategy in emergency departments to improve nurse-triage for HIV-exposures: A pre- and post-intervention period study.
International Emergency Nursing 2019, 47, 100786.
Nguyen T, Akhavan S, Caby F, Bonyhay L, Larrouy L, Gervais A, Lebray P, Poynard T, Calmus Y, Simon A, Valantin MA, Calvez V, Marcelin AG, Todesco E
Net emergence of substitutions at position 28 in NS5A of hepatitis C virus genotype 4 in patients failing direct-acting antivirals detected by next-generation sequencing.
International Journal of Antimicrobial Agents 2019, 53, 80-83.
Pilmis B, Lourtet-Hascoët J, Barraud O, Piau C, Isnard C, Hery-Arnaud G, Amara M, Merens A, Farfour E, Thomas E, Jacquier H, Zahar JR, Bonnet E, Monnier AL, Cattoir V, Corvec S, Boutoille D, de Ponfilly GP, Reissier S, GMC Study Group
Be careful about MICs to amoxicillin for patients with Streptococci-related infective endocarditis.
International Journal of Antimicrobial Agents 2019, 53, 850-854.
Martin-Loeches I, Timsit JF, Leone M, de Waele J, Sartelli M, Kerrigan S, Azevedo LCP, Einav S
Clinical controversies in abdominal sepsis. Insights for critical care settings.
Journal of Critical Care 2019, 53, 53-58.
Saliba R, Neulier C, Seytre D, Fiacre A, Faibis F, Leduc P, Amara M, Jauréguy F, Carbonnelle E, Zahar JR, Marty L
Can real-time polymerase chain reaction allow a faster recovery of hospital activity in cases of an incidental discovery of carbapenemase-producing Enterobacteriaceae and vancomycin-resistant Enterococci carriers?.
Journal of Hospital Infection 2019, 103, 115-120.
Mageau A, Sacré K, Perozziello A, Ruckly S, Dupuis C, Bouadma L, Papo T, Timsit JF
Septic shock among patients with systemic lupus erythematosus: short and long-term outcome. Analysis of a French nationwide database.
The Journal of Infection 2019
de Montmollin E, Ruckly S, Schwebel C, Philippart F, Adrie C, Mariotte E, Marcotte G, Cohen Y, Sztrymf B, da Silva D, Bruneel F, Gainnier M, Garrouste-Orgeas M, Sonneville R, Timsit JF, OUTCOMEREA Study Group
Pneumonia in acute ischemic stroke patients requiring invasive ventilation: Impact on short and long-term outcomes.
The Journal of Infection 2019, 79, 220-227.
Lattuca-Truc M, Timsit JF, Levra MG, Ruckly S, Villa J, Dumas I, Pinsolle J, Ferrer L, Guillem P, Moro-Sibilot D, Toffart AC
Trends in response rate and survival in small-cell lung cancer patients between 1997 and 2017.
Lung Cancer 2019, 131, 122-127.
Pugliese P, Joly V, Valantin M, Cotte L, Huleux T, Allavena C, Reynes J, Poizot-Martin I, Bani-Sadr F, Cuzin L
Which antiretrovirals should be prescribed as first-line treatments? Changes over the past 10 years in France.
Médecine et Maladies Infectieuses 2019, 49, 264-269.
Delaigue S, Signolet I, Consigny PH, de Gentile L, D'Ortenzio E, Gautret P, Sorge F, Strady C, Bouchaud O
New guidelines for the prevention of imported malaria in France.
Medecine Et Maladies Infectieuses 2019
Peiffer-Smadja N, Harent S, Messeca C, Lechapt-Zalcman E, Yazdanpanah Y, Joly V
A case of thoracic actinomycosis presenting as sudden paraplegia.
Revue Neurologique 2019, 175, 89-92.
Méchaï F, Bouchaud O
Tuberculous meningitis: Challenges in diagnosis and management.
Revue Neurologique 2019, 175, 451-457.
Jolivet S, Lucet JC
Surgical field and skin preparation.
Orthopaedics & Traumatology: Surgery & Research 2019, 105, S1-S6.
Pistone T, Ouattara E, Gabillard D, Lele N, Duvignaud A, Cordel H, Malvy D, Bouchaud O, Abgrall S, ANRS VIHVO Study Group
Travel-related health events and their risk factors in HIV-infected sub-Saharan migrants living in France and visiting their native country: The ANRS VIHVO cohort study.
Travel Medicine and Infectious Disease 2019
Le Hingrat Q, Perrier M, Charpentier C, Jacquot A, Houhou-Fidouh N, Descamps D, Visseaux B
Was Zika introduced to Brazil by participants at the 2013 Beach Soccer World Cup held in Tahiti: A phylogeographical analysis.
Travel Medicine and Infectious Disease 2019, 101512.
Billard-Pomares T, Bleibtreu A, Walewski V, Dziri S, Barbat A, Zahar JR, Cruaud P, Carbonnelle E
Proposition of a safe Mycobacterium tuberculosis complex denaturation method that does not compromise the integrity of DNA for whole-genome sequencing.
Tuberculosis 2019, 117, 62-64.
Kollef MH, Nováček M, Kivistik Ü, Réa-Neto Á, Shime N, Martin-Loeches I, Timsit JF, Wunderink RG, Bruno CJ, Huntington JA, Lin G, Yu B, Butterton JR, Rhee EG
Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial.
The Lancet. Infectious Diseases 2019
Lucet JC, Zahar JR
Simplified control measures for ESBL-producing Enterobacteriacae?.
The Lancet. Infectious Diseases 2019, 19, 1036-1037.
Wohl DA, Yazdanpanah Y, Baumgarten A, Clarke A, Thompson MA, Brinson C, Hagins D, Ramgopal MN, Antinori A, Wei X, Acosta R, Collins SE, Brainard D, Martin H
Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial.
The lancet. HIV 2019, 6, e355-e363.
Le Hingrat Q, Charpentier C, Ghosn J, Thiébaut R, Peytavin G, Descamps D, Matheron S
New insights are game-changers in HIV-2 disease management.
The lancet. HIV 2019, 6, e214.
Eholie SP, Moh R, Benalycherif A, Gabillard D, Ello F, Messou E, Zoungrana J, Diallo I, Diallo M, Bado G, Cisse M, Maiga AI, Anzian A, Toni Td, Congo-Ouedraogo M, Toure-Kane C, Seydi M, Minta DK, Sawadogo A, Sangaré L, Drabo J, Karcher S, Le Carrou J, de Monteynard LA, Peytavin G, Gabassi A, Girard PM, Chaix ML, Anglaret X, Landman R, Thilao ANRS 12269 Study Group
Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study.
The lancet. HIV 2019, 6, e750-e759.
Birgand G, Azevedo C, Rukly S, Pissard-Gibollet R, Toupet G, Timsit JF, Lucet JC, the ARIBO Study Group
Motion-capture system to assess intraoperative staff movements and door openings: Impact on surrogates of the infectious risk in surgery.
Infection Control & Hospital Epidemiology 2019, 40, 566-573.
Vieillard V, Combadière B, Tubiana R, Launay O, Pialoux G, Cotte L, Girard PM, Simon A, Dudoit Y, Reynes J, Rockstroh J, Garcia F, Gatell J, Devidas A, Yazdanpanah Y, Weiss L, Fätkenheuer G, Autran B, Joyeux D, Gharakhanian S, Debré P, Katlama C
HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial.
NPJ vaccines 2019, 4, 25.
Assi A, Abu Zaki S, Ghosn J, Kinge N, Naous J, Ghanem A, Abou Abbas D, Bakouny Z, Azzi G, Tomb R
Prevalence of HIV and other sexually transmitted infections and their association with sexual practices and substance use among 2238 MSM in Lebanon.
Scientific Reports 2019, 9, 15142.
Buetti N, Timsit JF
Management and Prevention of Central Venous Catheter-Related Infections in the ICU.
Seminars in Respiratory and Critical Care Medicine 2019, 40, 508-523.
Kernéis S, Lucet JC
Controlling the Diffusion of Multidrug-Resistant Organisms in Intensive Care Units.
Seminars in Respiratory and Critical Care Medicine 2019, 40, 558-568.
Triki D, Fartek S, Visseaux B, Descamps D, Camproux AC, Regad L
Characterizing the structural variability of HIV-2 protease upon the binding of diverse ligands using a structural alphabet approach.
Journal of Biomolecular Structure & Dynamics 2019, 37, 4658-4670.
Leo S, Lazarevic V, Gaïa N, Estellat C, Girard M, Matheron S, Armand-Lefèvre L, Andremont A, Schrenzel J, Ruppé E
The intestinal microbiota predisposes to traveler's diarrhea and to the carriage of multidrug-resistant Enterobacteriaceae after traveling to tropical regions.
Gut Microbes 2019, 10, 631-641.
Parisey M, Louni F, Bouvet E, Landman R, Charpentier C, Lariven S, Joly V, Villemant A, Mackoumbou-Nkouka C, Yazdanpanah Y, Burdet C
HIV Infection in North African Patients.
AIDS research and human retroviruses 2019, 35, 628-633.
Bonnet B, Blum L, Charpentier C, Martres P, Ritvo PG, Autran B, Guihot A
Short Communication: Extremely Severe CD4 Lymphopenia During HIV-1 Primary Infection.
AIDS Research and Human Retroviruses 2019, 35, 930-933.
Cousien A, Abel S, Monthieux A, Andronico A, Calmont I, Cervantes M, Césaire R, Gallian P, de Lamballerie X, Laouénan C, Najioullah F, Pierre-François S, Pircher M, Salje H, Ten Bosch QA, Cabié A, Cauchemez S
Assessing Zika Virus Transmission Within Households During an Outbreak in Martinique, 2015-2016.
American Journal of Epidemiology 2019, 188, 1389-1396.
Ferré VM, Gbeasor-Komlanvi FA, Collin G, Dagnra AC, Le Hingrat Q, Jaquet A, Salou M, Descamps D, Charpentier C, Ekouevi DK
Prevalence of Human Papillomavirus, Human Immunodeficiency Virus, and Other Sexually Transmitted Infections Among Men Who Have Sex With Men in Togo: A National Cross-sectional Survey.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2019, 69, 1019-1026.
Meier MA, Branche A, Neeser OL, Wirz Y, Haubitz S, Bouadma L, Wolff M, Luyt CE, Chastre J, Tubach F, Christ-Crain M, Corti C, Jensen JUS, Deliberato RO, Kristoffersen KB, Damas P, Nobre V, Oliveira CF, Shehabi Y, Stolz D, Tamm M, Mueller B, Schuetz P
Procalcitonin-guided Antibiotic Treatment in Patients With Positive Blood Cultures: A Patient-level Meta-analysis of Randomized Trials.
Clinical Infectious Diseases 2019, 69, 388-396.
Le Hingrat Q, Collin G, Lê M, Peytavin G, Visseaux B, Bertine M, Tubiana R, Karmochkine M, Valin N, Collin F, Lemaignen A, Bernard L, Damond F, Matheron S, Descamps D, Charpentier C, French National Agency for Research on AIDS and Viral Hepatitis (ANRS) CO5 HIV-2 Cohort
A New Mechanism of Resistance of Human Immunodeficiency Virus Type 2 to Integrase Inhibitors: A 5-Amino-Acid Insertion in the Integrase C-Terminal Domain.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2019, 69, 657-667.
Weiss E, Zahar JR, Alder J, Asehnoune K, Bassetti M, Bonten MJM, Chastre J, De Waele J, Dimopoulos G, Eggimann P, Engelhardt M, Ewig S, Kollef M, Lipman J, Luna C, Martin-Loeches I, Pagani L, Palmer LB, Papazian L, Poulakou G, Prokocimer P, Rello J, Rex JH, Shorr AF, Talbot GH, Thamlikitkul V, Torres A, Wunderink RG, Timsit JF
Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials.
Clinical Infectious Diseases 2019, 69, 1912-1918.
Hage-Sleiman M, Tremeaux P, Fillion M, Boufassa F, Melard A, Gardiennet E, Mariaggi AA, Plantier JC, Rouzioux C, Lambotte O, Avettand-Fenoel V, CODEX ANRS Cohort Study Group
False-negative Results of Human Immunodeficiency Virus (HIV) Rapid Testing in HIV Controllers.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2019
Le Roux E, Mellerio H, Jacquin P, Bourmaud A, Guilmin-Crépon S, Faye A, Matheron S, Boulkedid R, Alberti C
Practical generic guidelines for paediatric-to-adult transition for adolescents with chronic disease.
European Journal of Public Health 2019, 29, 442-448.
Ngo-Giang-Huong N, Huynh THK, Dagnra AY, Toni Td, Maiga AI, Kania D, Eymard-Duvernay S, Peeters M, Soulie C, Peytavin G, Rekacewicz C, Chaix ML, Aghokeng AF, ANRS 12333 Study Group, Aghokeng AF, Ayouba A, Brun-Vézinet F, Chaix ML, Calvez V, Dagnra A, Descamps D, Dramane K, Fournier I, Maiga A, de Monteynard LA, Nouhin J, Kane CT, Lien TX, Ngo-Giang-Huong N, Peeters M, Plantier JC, Njouom R, Tuaillon E, Rekacewicz C, d’Aquin TT, Poda A, Zougrana J, Ouedraogo S, Ouedraogo M, Djeuda AD, Kouanfack C, Mandeng N, Mpoudi-Ngole E, Messou E, Jacques DJ, Nguessan JF, Dolo O, Diarra Z, Cisse M, Patassi A, Salou M, Ali-Edjé K, Bowonwatanuwong C, Thongpaen S, Klinbuayaem V, Laomanit L, Luong QA, Tran T
Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries.
Journal of Antimicrobial Chemotherapy 2019, 74, 462-467.
Soulie C, Santoro MM, Charpentier C, Storto A, Paraskevis D, Di Carlo D, Gennari W, Sterrantino G, Zazzi M, Perno CF, Calvez V, Descamps D, Ceccherini-Silberstein F, Marcelin AG
Rare occurrence of doravirine resistance-associated mutations in HIV-1-infected treatment-naive patients.
The Journal of Antimicrobial Chemotherapy 2019, 74, 614-617.
Joly V, Burdet C, Landman R, Vigan M, Charpentier C, Katlama C, Cabié A, Benalycherif A, Peytavin G, Yeni P, Mentre F, Argoud AL, Amri I, Descamps D, Yazdanpanah Y, LAMIDOL Study Group
Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL).
The Journal of Antimicrobial Chemotherapy 2019, 74, 739-745.
Assoumou L, Bocket L, Pallier C, Grude M, Ait-Namane R, Izopet J, Raymond S, Charpentier C, Visseaux B, Wirden M, Trabaud MA, Le Guillou-Guillemette H, Allaoui C, Henquell C, Krivine A, Dos Santos G, Delamare C, Bouvier-Alias M, Montes B, Ferre V, De Monte A, Signori-Schmuck A, Maillard A, Morand-Joubert L, Tumiotto C, Fafi-Kremer S, Amiel C, Barin F, Marque-Juillet S, Courdavault L, Vallet S, Beby-Defaux A, de Rougemont A, Fenaux H, Avettand-Fenoel V, Allardet-Servent A, Plantier JC, Peytavin G, Calvez V, Chaix ML, Descamps D, ANRS AC-43 Resistance Study Group
Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France.
The Journal of Antimicrobial Chemotherapy 2019, 74, 1417-1424.
Marcelin AG, Grude M, Charpentier C, Bellecave P, Le Guen L, Pallier C, Raymond S, Mirand A, Bocket L, Fofana DB, Delaugerre C, Nguyen T, Montès B, Jeulin H, Mourez T, Fafi-Kremer S, Amiel C, Roussel C, Dina J, Trabaud MA, Le Guillou-Guillemette H, Vallet S, Signori-Schmuck A, Maillard A, Ferre V, Descamps D, Calvez V, Flandre P, ANRS AC43 Resistance Group
Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients.
The Journal of Antimicrobial Chemotherapy 2019, 74, 1368-1375.
Perrier M, Castain L, Regad L, Todesco E, Landman R, Visseaux B, Yazdanpanah Y, Rodriguez C, Joly V, Calvez V, Marcelin AG, Descamps D, Charpentier C
HIV-1 protease, Gag and gp41 baseline substitutions associated with virological response to a PI-based regimen.
The Journal of Antimicrobial Chemotherapy 2019, 74, 1679-1692.
Mboumba Bouassa RS, Mossoro-Kpinde CD, Gody JC, Veyer D, Péré H, Matta M, Robin L, Grésenguet G, Charpentier C, Bélec L
High predictive efficacy of integrase strand transfer inhibitors in perinatally HIV-1-infected African children in therapeutic failure of first- and second-line antiretroviral drug regimens recommended by the WHO.
Journal of Antimicrobial Chemotherapy 2019, 74, 2030-2038.
Néant N, Solas C, Bouazza N, Lê MP, Yazdanpanah Y, Dhiver C, Bregigeon S, Mokhtari S, Peytavin G, Tamalet C, Descamps D, Lacarelle B, Gattacceca F
Concentration-response model of rilpivirine in a cohort of HIV-1-infected naive and pre-treated patients.
The Journal of Antimicrobial Chemotherapy 2019, 74, 1992-2002.
Castain L, Perrier M, Charpentier C, Palich R, Desire N, Wirden M, Descamps D, Sayon S, Landman R, Valantin MA, Joly V, Peytavin G, Yazdanpanah Y, Katlama C, Calvez V, Marcelin AG, Todesco E
New mechanisms of resistance in virological failure to protease inhibitors: selection of non-described protease, Gag and Gp41 mutations.
The Journal of Antimicrobial Chemotherapy 2019, 74, 2019-2023.
Perozziello A, Lescure FX, Truel A, Routelous C, Vaillant L, Yazdanpanah Y, Lucet JC, CEFECA study group
Prescribers' experience and opinions on antimicrobial stewardship programmes in hospitals: a French nationwide survey.
The Journal of Antimicrobial Chemotherapy 2019, 74, 2451-2458.
Siguier M, Mera R, Pialoux G, Ohayon M, Cotte L, Valin N, Ghosn J, Cua E, Pintado C, Chas J, Barriere G, Durand F, Molina JM
First year of pre-exposure prophylaxis implementation in France with daily or on-demand tenofovir disoproxil fumarate/emtricitabine.
Journal of Antimicrobial Chemotherapy 2019, 74, 2752-2758.
Katlama C, Assoumou L, Valantin MA, Soulié C, Martinez E, Béniguel L, Bouchaud O, Raffi F, Molina JM, Fellahi S, Peytavin G, Marcelin AG, Kolta S, Capeau J, Gibowski S, Cardon F, Reynes J, Costagliola D, the members of the ANRS 163 ETRAL study, Bernard L, Bottero J, Bouchaud O, Chidiac C, Duvivier C, Goujard C, delMarGutiérrez M, Martinez E, Molina JM, Morlat P, Naqvi A, Podzamczer D, Poizot-Martin I, Raffi F, Reynes J, Salmon-Céron D, Simon A, Valantin MA, Weiss L, Yazdanpanah Y
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study.
Journal of Antimicrobial Chemotherapy 2019, 74, 2742-2751.
Valantin MA, Durand L, Wirden M, Assoumou L, Caby F, Soulié C, Nguyen TTT, Tubiana R, Kirstetter M, Junot H, Marcelin AG, Peytavin G, Tilleul P, Katlama C
Antiretroviral drug reduction in highly experienced HIV-infected patients receiving a multidrug regimen: the ECOVIR study.
Journal of Antimicrobial Chemotherapy 2019, 74, 2716-2722.
Peiffer-Smadja N, Guillotel E, Luque-Paz D, Maataoui N, Lescure FX, Cattoir V
In vitro bactericidal activity of amoxicillin combined with different cephalosporins against endocarditis-associated Enterococcus faecalis clinical isolates.
Journal of Antimicrobial Chemotherapy 2019, 74, 3511-3514.
Rockstroh JK, Yazdanpanah Y
HepCare Europe: a new user-friendly hepatitis C care service model. What have we learned? What are the remaining challenges?.
Journal of Antimicrobial Chemotherapy 2019, 74, v2-v4.
Tsopra R, Sedki K, Courtine M, Falcoff H, De Beco A, Madar R, Mechaï F, Lamy JB
Helping GPs to extrapolate guideline recommendations to patients for whom there are no explicit recommendations, through the visualization of drug properties. The example of AntibioHelp® in bacterial diseases.
Journal of the American Medical Informatics Association: JAMIA 2019, 26, 1010-1019.
McIlroy PA, King RS, Garrouste-Orgeas M, Tabah A, Ramanan M
The Effect of ICU Diaries on Psychological Outcomes and Quality of Life of Survivors of Critical Illness and Their Relatives: A Systematic Review and Meta-Analysis.
Critical Care Medicine 2019, 47, 273-279.
Bertrand PM, Pereira B, Adda M, Timsit JF, Wolff M, Hilbert G, Gruson D, Garrouste-Orgeas M, Argaud L, Constantin JM, Chabanne R, Quenot JP, Bohe J, Guerin C, Papazian L, Jonquet O, Klouche K, Delahaye A, Riu B, Zieleskiewicz L, Darmon M, Azoulay E, Souweine B, Lautrette A
Disagreement Between Clinicians and Score in Decision-Making Capacity of Critically Ill Patients*:.
Critical Care Medicine 2019, 47, 337-344.
Ibn Saied W, Mourvillier B, Cohen Y, Ruckly S, Reignier J, Marcotte G, Siami S, Bouadma L, Darmon M, de Montmollin E, Argaud L, Kallel H, Garrouste-Orgeas M, Soufir L, Schwebel C, Souweine B, Glodgran-Toledano D, Papazian L, Timsit JF
A Comparison of the Mortality Risk Associated With Ventilator-Acquired Bacterial Pneumonia and Nonventilator ICU-Acquired Bacterial Pneumonia*:.
Critical Care Medicine 2019, 47, 345-352.
Bourcier S, Coutrot M, Kimmoun A, Sonneville R, de Montmollin E, Persichini R, Schnell D, Charpentier J, Aubron C, Morawiec E, Bigé N, Nseir S, Terzi N, Razazi K, Azoulay E, Ferré A, Tandjaoui-Lambiotte Y, Ellrodt O, Hraiech S, Delmas C, Barbier F, Lautrette A, Aissaoui N, Repessé X, Pichereau C, Zerbib Y, Lascarrou JB, Carreira S, Reuter D, Frérou A, Peigne V, Fillatre P, Megarbane B, Voiriot G, Combes A, Schmidt M
Thyroid Storm in the ICU: A Retrospective Multicenter Study.
Critical Care Medicine 2019
Leverger G, Timsit JF, Milpied N, Gachot B
Use of Micafungin for the Prevention and Treatment of Invasive Fungal Infections in Everyday Pediatric Care in France: Results of the MYRIADE Study.
The Pediatric Infectious Disease Journal 2019, 38, 716-721.
Bertin C, Abbas R, Andrieu V, Michard F, Rioux C, Descamps V, Yazdanpanah Y, Bouscarat F
Illicit massive silicone injections always induce chronic and definitive silicone blood diffusion with dermatologic complications.
Medicine 2019, 98, e14143.
Palich R, Ghosn J, Chaillon A, Boilet V, Nere ML, Chaix ML, Delobel P, Molina JM, Lucht F, Bouchaud O, Rieux V, Thiebaut R, Levy Y, Delaugerre C, Lelievre JD
Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial:.
AIDS 2019, 33, 279-284.
Lucar O, Sadjo Diallo M, Bayard C, Samri A, Tarantino N, Debré P, Thiébaut R, Brun-Vézinet F, Matheron S, Cheynier R, Vieillard V
B7-H6-mediated downregulation of NKp30 in natural killer cells contributes to HIV-2 immune escape:.
AIDS 2019, 33, 23-32.
Pommier JD, Laouénan C, Michard F, Papot E, Urios P, Boutten A, Peytavin G, Ghander C, Lariven S, Castanedo G, Moho D, Landman R, Phung B, Perez E, Julia Z, Descamps D, Roland-Nicaise P, Le Gac S, Yazdanpanah Y, Guibourdenche J, Yeni P
Metabolic syndrome and endocrine status in HIV-infected transwomen.
AIDS (London, England) 2019, 33, 855-865.
Januel E, Godin O, Moulignier A, Lescure FX, Savatovsky J, Lamirel C, Valin N, Tubiana R, Canestri A, Roux P, Sadik JC, Salomon L, Katlama C, Yazdanpanah Y, Pialoux G, Girard PM, Costagliola D, Assoumou L, Microvascular Brain Retina And Kidney (MicroBREAK) Study Group
Brief Report: Impact of ART Classes on the Increasing Risk of Cerebral Small-Vessel Disease in Middle-Aged, Well-Controlled, cART-Treated, HIV-Infected Individuals.
Journal of Acquired Immune Deficiency Syndromes (1999) 2019, 81, 547-551.
Garnacho-Montero J, Timsit JF
Managing Acinetobacter baumannii infections:.
Current Opinion in Infectious Diseases 2019, 32, 69-76.
Lê MP, Chaix M, Raffi F, Chevret S, Gallien S, Katlama C, Delobel P, Yazdanpanah Y, Saillard J, Molina J, Peytavin G, the ANRS‐165 DARULIGHT study group
Once‐daily darunavir/ritonavir 400/100 mg in triple therapy: efficacy and penetration in seminal compartment in ANRS ‐165 DARULIGHT study.
British Journal of Clinical Pharmacology 2019, 85, 277-280.
Ghazali DA, Choquet C, Casalino E
Simulation-based training for triage of HIV exposures in the emergency department.
Medical Education 2019, 53, 521-522.
Ghazali DA, Kenway P, Casalino E
Simulation-based training for pain assessment in the emergency department.
Medical Education 2019, 53, 1149-1150.
Bassetti M, Scudeller L, Giacobbe DR, Lamoth F, Righi E, Zuccaro V, Grecchi C, Rebuffi C, Akova M, Alastruey-Izquierdo A, Arikan-Akdagli S, Azoulay E, Blot SI, Cornely OA, Lass-Flörl C, Koehler P, Cuenca-Estrella M, de Lange DW, De Rosa FG, De Waele JJ, Dimopoulos G, Garnacho-Montero J, Hoenigl M, Kanj SS, Maertens J, Martin-Loeches I, Muñoz P, Kullberg BJ, Agvald-Ohman C, Poulakou G, Rello J, Sanguinetti M, Taccone FS, Timsit JF, Torres A, Vazquez JA, Calandra T, from the Study Group for Infections in Critically Ill Patients (ESGCIP) and the Fungal Infection Study Group (EFISG) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), European Society of Intensive Care Medicine (ESICM), European Confederation of Medical Mycology (ECMM), Mycoses Study Group Education and Research Consortium (MSGERC)
Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project.
Mycoses 2019, 62, 310-319.
Stefic K, Guinard J, Peytavin G, Saboni L, Sommen C, Sauvage C, Lot F, Laperche S, Velter A, Barin F, Prevagay working group
Screening for Human Immunodeficiency Virus infection using a fourth-generation antigen/antibody assay and dried blood spots: in depth analysis of sensitivity and performance assessment in a cross-sectional study.
Journal of Clinical Microbiology 2019
Baril L, Vallès X, Stenseth NC, Rajerison M, Ratsitorahina M, Pizarro-Cerdá J, Demeure C, Belmain S, Scholz H, Girod R, Hinnebusch J, Vigan-Womas I, Bertherat E, Fontanet A, Yazadanpanah Y, Carrara G, Deuve J, D'ortenzio E, Angulo JOC, Mead P, Horby PW
Can we make human plague history? A call to action.
BMJ Global Health 2019, 4, e001984.
Hentzien M, Dramé M, Delpierre C, Allavena C, Cabié A, Cuzin L, Rey D, Pugliese P, Hédelin G, Bani-Sadr F, Dat’AIDS Study Group
HIV-related excess mortality and age-related comorbidities in patients with HIV aged ≥60: a relative survival analysis in the French Dat'AIDS cohort.
BMJ open 2019, 9, e024841.
Boisson M, Corbi P, Kerforne T, Camilleri L, Debauchez M, Demondion P, Eljezi V, Flecher E, Lepelletier D, Leprince P, Nesseler N, Nizou JY, Roussel JC, Rozec B, Ruckly S, Lucet JC, Timsit JF, Mimoz O
Multicentre, open-label, randomised, controlled clinical trial comparing 2% chlorhexidine-70% isopropanol and 5% povidone iodine-69% ethanol for skin antisepsis in reducing surgical-site infection after cardiac surgery: the CLEAN 2 study protocol.
BMJ open 2019, 9, e026929.
Javaud N, Soria A, Maignan M, Martin L, Descamps V, Fain O, Bouillet L, Berard F, Tazarourte K, Roy PM, Fontaine JP, Bagot M, Khellaf M, Goulet H, Lapostolle F, Casalino E, Doutre MS, Gil-Jardine C, Caux F, Chosidow O, Pateron D, Vicaut E, Adnet F
Glucocorticoids for acute urticaria: study protocol for a double-blind non-inferiority randomised controlled trial.
BMJ open 2019, 9, e027431.
Flowers H, Bérubé D, Ebrahimipour M, Perrier MF, Moloci S, Skoretz S
Swallowing behaviours and feeding environment in relation to communication development from early infancy to 6 years of age: a scoping review protocol.
BMJ Open 2019, 9, e028850.
Le Bel J, Pelaccia T, Ray P, Mayaud C, Brun AL, Hausfater P, Casalino E, Benjoar M, Claessens YE, Duval X, ESCAPED study group
Impact of emergency physician experience on decision-making in patients with suspected community-acquired pneumonia and undergoing systematic thoracic CT scan.
Emergency medicine journal: EMJ 2019, 36, 485-492.
Gobat N, Amuasi J, Yazdanpanah Y, Sigfid L, Davies H, Byrne JP, Carson G, Butler C, Nichol A, Goossens H
Advancing preparedness for clinical research during infectious disease epidemics.
ERJ open research 2019
Lions C, Cabras O, Cotte L, Huleux T, Gagneux-Brugnon A, Makinson A, Cabié A, Bonnet B, Duvivier C, Hocqueloux L, Cua E, Cheret A, Hustache-Mathieu L, Obry-Roguet V, Jacomet C, Poizot-Martin I, DAT’AIDS STUDY GROUP
Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT'AIDS cohort.
BMC infectious diseases 2019, 19, 278.
Vaux S, Chevaliez S, Saboni L, Sauvage C, Sommen C, Barin F, Alexandre A, Jauffret-Roustide M, Lot F, Velter A, ANRS-Prevagay group
Prevalence of hepatitis C infection, screening and associated factors among men who have sex with men attending gay venues: a cross-sectional survey (PREVAGAY), France, 2015.
BMC infectious diseases 2019, 19, 315.
Jary A, Dienta S, Leducq V, Le Hingrat Q, Cisse M, Diarra AB, Fofana DB, Ba A, Baby M, Achenbach CJ, Murphy R, Calvez V, Marcelin AG, Maiga AI
Seroprevalence and risk factors for HIV, HCV, HBV and syphilis among blood donors in Mali.
BMC Infectious Diseases 2019, 19, 1064.
Garrouste-Orgeas M, Flahault C, Poulain E, Evin A, Guirimand F, Fossez-Diaz V, Perruchio S, Verlaine C, Vanbésien A, Kaczmarek W, Birkui de Francqueville L, De Larivière E, Bouquet G, Copel L, Verliac V, Marché V, Mathias C, Gracia D, Mhalla A, Michonneau-Gandon V, Poupardin C, Touzet L, Ranchou G, Guastella V, Richard B, Bienfait F, Sonrier M, Michel D, Ruckly S, Bailly S, Timsit JF
The Fami-life study: protocol of a prospective observational multicenter mixed study of psychological consequences of grieving relatives in French palliative care units on behalf of the family research in palliative care (F.R.I.P.C research network).
BMC Palliative Care 2019, 18, 111.
Schwarzinger M, Luchini S, EPICORL Study Group
Estimating health state utility from activities of daily living in the French National Hospital Discharge Database: a feasibility study with head and neck cancer.
Health and Quality of Life Outcomes 2019, 17, 129.
Prevel R, Boyer A, M’Zali F, Lasheras A, Zahar JR, Rogues AM, Gruson D
Is systematic fecal carriage screening of extended-spectrum beta-lactamase-producing Enterobacteriaceae still useful in intensive care unit: a systematic review.
Critical Care 2019, 23,
Bassetti M, Giacobbe DR, Vena A, Trucchi C, Ansaldi F, Antonelli M, Adamkova V, Alicino C, Almyroudi MP, Atchade E, Azzini AM, Carannante N, Carnelutti A, Corcione S, Cortegiani A, Dimopoulos G, Dubler S, García-Garmendia JL, Girardis M, Cornely OA, Ianniruberto S, Kullberg BJ, Lagrou K, Le Bihan C, Luzzati R, Malbrain MLNG, Merelli M, Marques AJ, Martin-Loeches I, Mesini A, Paiva JA, Peghin M, Raineri SM, Rautemaa-Richardson R, Schouten J, Brugnaro P, Spapen H, Tasioudis P, Timsit JF, Tisa V, Tumbarello M, van den Berg CHSB, Veber B, Venditti M, Voiriot G, Wauters J, Montravers P
Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project.
Critical Care 2019, 23,
Morvan AC, Garrouste-Orgeas M, Ruckly S, Forel JM, Argaud L, Rimmelé T, Bedos JP, Azoulay E, Dupuis C, Mourvillier B, Schwebel C, Timsit JF
Impact of species and antibiotic therapy of enterococcal peritonitis on 30-day mortality in critical care—an analysis of the OUTCOMEREA database.
Critical Care 2019, 23, 307.
Dumas G, Demoule A, Mokart D, Lemiale V, Nseir S, Argaud L, Pène F, Kontar L, Bruneel F, Klouche K, Barbier F, Reignier J, Stoclin A, Louis G, Constantin JM, Wallet F, Kouatchet A, Peigne V, Perez P, Girault C, Jaber S, Cohen Y, Nyunga M, Terzi N, Bouadma L, Lebert C, Lautrette A, Bigé N, Raphalen JH, Papazian L, Benoit D, Darmon M, Chevret S, Azoulay E
Center effect in intubation risk in critically ill immunocompromised patients with acute hypoxemic respiratory failure.
Critical Care 2019, 23, 306.
Bouadma L, Darmon M, Argaud L, Vinclair C, Siami S, Garrouste-Orgeas M, Papazian L, Cohen Y, Marcotte G, Styfalova L, Reignier J, Lautrette A, Schwebel C, Timsit JF
Influence of dyskalemia at admission and early dyskalemia correction on survival and cardiac events of critically ill patients.
Critical Care 2019, 23,
Birgand G, Haudebourg T, Grammatico-Guillon L, Ferrand L, Moret L, Gouin F, Mauduit N, Leux C, Le Manach Y, Lepelletier D, Tavernier E, Lucet JC, Giraudeau B
Improvement in staff behavior during surgical procedures to prevent post-operative complications (ARIBO2): study protocol for a cluster randomised trial.
Trials 2019, 20,
the PREVAC study team, Lhomme E, Modet C, Augier A, Faye S, Dabakuyo-Yonli TS, Levy-Marchal C, D’Ortenzio E, Yazdanpanah Y, Chêne G, Beavogui AH, Richert L
Enrolling study personnel in Ebola vaccine trials: from guidelines to practice in a non-epidemic context.
Trials 2019, 20,
Pons S, Sonneville R, Bouadma L, Styfalova L, Ruckly S, Neuville M, Radjou A, Lebut J, Dilly MP, Mourvillier B, Dorent R, Nataf P, Wolff M, Timsit JF
Infectious complications following heart transplantation in the era of high-priority allocation and extracorporeal membrane oxygenation.
Annals of Intensive Care 2019, 9, 17.
Karpanen TJ, Casey AL, Whitehouse T, Timsit JF, Mimoz O, Palomar M, Elliott TSJ
A clinical evaluation of two central venous catheter stabilization systems.
Annals of Intensive Care 2019, 9, 49.
Balmier A, Dib F, Serret-Larmande A, De Montmollin E, Pouyet V, Sztrymf B, Megarbane B, Thiagarajah A, Dreyfuss D, Ricard JD, Roux D
Initial management of diabetic ketoacidosis and prognosis according to diabetes type: a French multicentre observational retrospective study.
Annals of Intensive Care 2019, 9, 91.
Smonig R, Magalhaes E, Bouadma L, Andremont O, de Montmollin E, Essardy F, Mourvillier B, Lebut J, Dupuis C, Neuville M, Lermuzeaux M, Timsit JF, Sonneville R
Impact of natural light exposure on delirium burden in adult patients receiving invasive mechanical ventilation in the ICU: a prospective study.
Annals of Intensive Care 2019, 9, 120.
Vaillant L, Birgand G, Esposito-Farese M, Astagneau P, Pulcini C, Robert J, Zahar JR, Sales-Wuillemin E, Tubach F, Lucet JC, PerceptR Study group
Awareness among French healthcare workers of the transmission of multidrug resistant organisms: a large cross-sectional survey.
Antimicrobial Resistance and Infection Control 2019, 8, 173.
Kassi FK, Drakulovski P, Bellet V, Roger F, Chabrol A, Krasteva D, Doumbia A, Landman R, Kakou A, Reynes J, Delaporte E, Menan HEI, Bertout S, Govender NP
Cryptococcus genetic diversity and mixed infections in Ivorian HIV patients: A follow up study.
PLOS Neglected Tropical Diseases 2019, 13, e0007812.
Charani E, Smith I, Skodvin B, Perozziello A, Lucet JC, Lescure FX, Birgand G, Poda A, Ahmad R, Singh S, Holmes AH
Investigating the cultural and contextual determinants of antimicrobial stewardship programmes across low-, middle- and high-income countries-A qualitative study.
PloS One 2019, 14, e0209847.
Fournier AL, Yazdanpanah Y, Verdon R, Lariven S, Mackoumbou-Nkouka C, Phung BC, Papot E, Parienti JJ, Landman R, Champenois K
Incidence of and risk factors for medical care interruption in people living with HIV in recent years.
PloS One 2019, 14, e0213526.
Gantner P, Cotte L, Allavena C, Bani-Sadr F, Huleux T, Duvivier C, Valantin MA, Jacomet C, Joly V, Chéret A, Pugliese P, Delobel P, Cabié A, Rey D, for the Dat’AIDS Study Group, Huang JF
Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection.
PLOS ONE 2019, 14, e0215464.
Cossais S, Schwarzinger M, Pol S, Fontaine H, Larrey D, Pageaux GP, Canva V, Mathurin P, Yazdanpanah Y, Deuffic-Burban S, Fischer F
Quality of life in patients with chronic hepatitis C infection: Severe comorbidities and disease perception matter more than liver-disease stage.
PLOS ONE 2019, 14, e0215596.
Gantner P, Sylla B, Morand-Joubert L, Frange P, Lacombe K, Khuong MA, Duvivier C, Launay O, Karmochkine M, Arvieux C, Ménard A, Piroth L, Canestri A, Trias D, Peytavin G, Landman R, Ghosn J, on behalf of the Coferal-IMEA048 Study Group, Güerri-Fernández R
“Real life” use of raltegravir during pregnancy in France: The Coferal-IMEA048 cohort study.
PLOS ONE 2019, 14, e0216010.
Raben D, Sullivan AK, Mocroft A, Kutsyna G, Hadžiosmanović V, Vassilenko A, Chkhartisvili N, Mitsura V, Pedersen C, Anderson J, Begovac J, Bak Dragsted U, Bertisch B, Grzeszczuk A, Minton J, Necsoi VC, Kitchen M, Ajana F, Sokhan A, Comi L, Farazmand P, Pesut D, De Wit S, Gatell JM, Gazzard B, d’Arminio Monforte A, Rockstroh JK, Yazdanpanah Y, Champenois K, Jakobsen ML, Lundgren JD, on behalf of the HIDES Study Group, Sagar M
Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study – 2012 – 2015.
PLOS ONE 2019, 14, e0220108.
Mandelbrot L, Ceccaldi PF, Duro D, Lê M, Pencolé L, Peytavin G, Spradley FT
Placental transfer and tissue accumulation of dolutegravir in the ex vivo human cotyledon perfusion model.
PLOS ONE 2019, 14, e0220323.
Samri A, Charpentier C, Diallo MS, Bertine M, Even S, Morin V, Oudin A, Parizot C, Collin G, Hosmalin A, Cheynier R, Thiébaut R, Matheron S, Collin F, Zoorob R, Brun-Vézinet F, Autran B, ANRS CO5 IMMUNOVIR-2 Study Group
Limited HIV-2 reservoirs in central-memory CD4 T-cells associated to CXCR6 co-receptor expression in attenuated HIV-2 infection.
PLoS pathogens 2019, 15, e1007758.
Visseaux B, Le Hingrat Q, Damond F, Charpentier C, Descamps D
[Physiopathology of HIV-2 infection].
Virologie (Montrouge, France) 2019, 23, 277-291.
Schernberg A, Sagaon-Teyssier L, Schwarzinger M
Clinical and economic burden of head and neck cancer: a nationwide retrospective cohort study from France.
ClinicoEconomics and outcomes research: CEOR 2019, 11, 441-451.
Basilua JM, Sawoo O, Mangin I, Dossou-Yovo F, Boussard A, Chevillard L, Lutete GT, Eto B, Peytavin G, Pochart P
Higher Atazanavir Plasma Exposure in Rats is Associated with Gut Microbiota Changes Induced by Cotrimoxazole.
Current Drug Metabolism 2019, 20, 898-906.
van de Laar MJ, Bosman A, Pharris A, Andersson E, Assoumou L, Ay E, Bannert N, Bartmeyer B, Brady M, Chaix ML, Descamps D, Dauwe K, Fonager J, Hauser A, Lunar M, Mezei M, Neary M, Poljak M, van Sighem A, Verhofstede C, Amato-Gauci AJ, Broberg EK
Piloting a surveillance system for HIV drug resistance in the European Union.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2019, 24,
Wirden M, De Oliveira F, Bouvier-Alias M, Lambert-Niclot S, Chaix ML, Raymond S, Si-Mohammed A, Alloui C, André-Garnier E, Bellecave P, Malve B, Mirand A, Pallier C, Poveda JD, Rabenja T, Schneider V, Signori-Schmuck A, Stefic K, Calvez V, Descamps D, Plantier JC, Marcelin AG, Visseaux B, On Behalf Of The French National Agency For Research On Aids And Viral Hepatitis Anrs Ac Study Group n
New HIV-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in France, 2013 to 2017.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2019, 24,
Liapis E, Bour M, Triponney P, Jové T, Zahar JR, Valot B, Jeannot K, Plésiat P
Identification of Diverse Integron and Plasmid Structures Carrying a Novel Carbapenemase Among Pseudomonas Species.
Frontiers in Microbiology 2019, 10, 404.
Ghazali DA, Richard A, Chaudet A, Choquet C, Guericolas M, Casalino E
Profile and Motivation of Patients Consulting in Emergency Departments While not Requiring Such a Level of Care.
International Journal of Environmental Research and Public Health 2019, 16, 4431.
Garin N, Marti C, Carballo S, Darbellay Farhoumand P, Montet X, Roux X, Scheffler M, Serratrice C, Serratrice J, Claessens YE, Duval X, Loubet P, Stirnemann J, Prendki V
Rational Use of CT-Scan for the Diagnosis of Pneumonia: Comparative Accuracy of Different Strategies.
Journal of Clinical Medicine 2019
Azevedo-Coste C, Pissard-Gibollet R, Toupet G, Fleury É, Lucet JC, Birgand G
Tracking Clinical Staff Behaviors in an Operating Room.
Sensors (Basel, Switzerland) 2019, 19,
Abgrall S, Raho-Moussa M, Seng R, Ghislain M, Matheron S, Pialoux G, Goujard C, Meyer L, ANRS CO9-COPANA study group†
Elevated risk of viral rebound on ART in migrants living in France: role of socioeconomic factors.
Antiviral Therapy 2019, 24, 541-552.
Perrineau S, Lachâtre M, Lê MP, Rioux C, Loubet P, Fréchet-Jachym M, Gonzales MC, Grall N, Bouvet E, Veziris N, Yazdanpanah Y, Peytavin G
Long-term plasma pharmacokinetics of bedaquiline for multidrug- and extensively drug-resistant tuberculosis.
The International Journal of Tuberculosis and Lung Disease 2019, 23, 99-104.
Popping S, Bade D, Boucher C, van der Valk M, El-Sayed M, Sigurour O, Sypsa V, Morgan T, Gamkrelidze A, Mukabatsinda C, Deuffic-Burban S, Ninburg M, Feld J, Hellard M, Ward J
The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals.
Journal of Virus Eradication 2019, 5, 60-66.
Wensing AM, Calvez V, Ceccherini-Silberstein F, Charpentier C, Günthard HF, Paredes R, Shafer RW, Richman DD
2019 update of the drug resistance mutations in HIV-1.
Topics in Antiviral Medicine 2019, 27, 111-121.
Ghazali DA, Fournier E, Breque C, Ragot SP, Oriot D
Immersive simulation training at 6-week intervals for 1 year and multidisciplinary team performance scores: a randomized controlled trial of simulation training for life-threatening pediatric emergencies.
Emergencias: Revista De La Sociedad Espanola De Medicina De Emergencias 2019, 31, 391-398.
2018
Brunet-Possenti F, Deschamps L, Charpentier C
Use of Combination Systemic-Intratumoral HPV Vaccine to Treat Cutaneous Basaloid Squamous Cell Carcinomas.
JAMA dermatology 2018
Bluhmki T, Allignol A, Ruckly S, Timsit JF, Wolkewitz M, Beyersmann J
Estimation of adjusted expected excess length-of-stay associated with ventilation-acquired pneumonia in intensive care: A multistate approach accounting for time-dependent mechanical ventilation.
Biometrical Journal. Biometrische Zeitschrift 2018, 60, 1135-1150.
Costentin CE, Mourad A, Lahmek P, Causse X, Pariente A, Hagège H, Dobrin AS, Becker C, Marks B, Bader R, Condat B, Héluwaert F, Seitz JF, Lesgourgues B, Denis J, Deuffic-Burban S, Rosa I, Decaens T, CHANGH Study Group
Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide study.
Cancer 2018, 124, 1964-1972.
Bailly S, Meyfroidt G, Timsit JF
What's new in ICU in 2050: big data and machine learning.
Intensive Care Medicine 2018, 44, 1524-1527.
De Waele JJ, Akova M, Antonelli M, Canton R, Carlet J, De Backer D, Dimopoulos G, Garnacho-Montero J, Kesecioglu J, Lipman J, Mer M, Paiva JA, Poljak M, Roberts JA, Rodriguez Bano J, Timsit JF, Zahar JR, Bassetti M
Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance.
Intensive Care Medicine 2018, 44, 189-196.
La Combe B, Bleibtreu A, Messika J, Fernandes R, Clermont O, Branger C, Billard-Pomares T, Barnaud G, Magdoud F, Eveillard M, Kouatchet A, Lasocki S, Asfar P, Corvec S, Lakhal K, Armand-Lefevre L, Wolff M, Timsit JF, Bourdon S, Reignier J, Martin S, Fihman V, de Prost N, Bador J, Charles PE, Goret J, Boyer A, Wallet F, Jaillette E, Nseir S, Landraud L, Ruimy R, Danin PE, Dellamonica J, Cremniter J, Frat JP, Jauréguy F, Clec'h C, Decré D, Maury E, Dreyfuss D, Denamur E, Ricard JD
Decreased susceptibility to chlorhexidine affects a quarter of Escherichia coli isolates responsible for pneumonia in ICU patients.
Intensive Care Medicine 2018, 44, 531-533.
von Cube MK, Timsit JF, Sommer H, Darmon M, Schwebel C, Bailly S, Souweine B, Wolkewitz M
Relative risk and population-attributable fraction of ICU death caused by susceptible and resistant Pseudomonas aeruginosa ventilator-associated pneumonia: a competing risks approach to investigate the OUTCOMEREA database.
Intensive Care Medicine 2018, 44, 1177-1179.
Bouadma L, Karpanen T, Elliott T
Chlorhexidine use in adult patients on ICU.
Intensive Care Medicine 2018, 44, 2232-2234.
Barbier F, Bailly S, Schwebel C, Papazian L, Azoulay É, Kallel H, Siami S, Argaud L, Marcotte G, Misset B, Reignier J, Darmon M, Zahar JR, Goldgran-Toledano D, de Montmollin É, Souweine B, Mourvillier B, Timsit JF, OUTCOMEREA Study Group
Infection-related ventilator-associated complications in ICU patients colonised with extended-spectrum β-lactamase-producing Enterobacteriaceae.
Intensive Care Medicine 2018
Timsit JF, Bassetti M
Antipathy against SDD is justified: Yes.
Intensive Care Medicine 2018
Azoulay E, Lemiale V, Mourvillier B, Garrouste-Orgeas M, Schwebel C, Ruckly S, Argaud L, Cohen Y, Souweine B, Papazian L, Reignier J, Marcotte G, Siami S, Kallel H, Darmon M, Timsit JF, OUTCOMEREA Study Group
Management and outcomes of acute respiratory distress syndrome patients with and without comorbid conditions.
Intensive Care Medicine 2018
Timsit JF, Rupp M, Bouza E, Chopra V, Kärpänen T, Laupland K, Lisboa T, Mermel L, Mimoz O, Parienti JJ, Poulakou G, Souweine B, Zingg W
A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill.
Intensive Care Medicine 2018, 44, 742-759.
Kindermans M, Abid S, Alkhoder S, Bouadma L
Pulsatile bleeding after sternal bone marrow puncture.
Intensive Care Medicine 2018, 44, 1758-1759.
Bouadma L, Klompas M
Oral care with chlorhexidine: beware!.
Intensive Care Medicine 2018, 44, 1153-1155.
Puntillo KA, Max A, Timsit JF, Ruckly S, Chanques G, Robleda G, Roche-Campo F, Mancebo J, Divatia JV, Soares M, Ionescu DC, Grintescu IM, Maggiore SM, Rusinova K, Owczuk R, Egerod I, Papathanassoglou EDE, Kyranou M, Joynt GM, Burghi G, Freebairn RC, Ho KM, Kaarlola A, Gerritsen RT, Kesecioglu J, Sulaj MMS, Norrenberg M, Benoit DD, Seha MSG, Hennein A, Pereira FJ, Benbenishty JS, Abroug F, Aquilina A, Monte JRC, An Y, Azoulay E
Pain distress: the negative emotion associated with procedures in ICU patients.
Intensive Care Medicine 2018, 44, 1493-1501.
Timsit JF, Ruppe E, Ferrer R
Focus on sepsis: new concepts and findings in sepsis care.
Intensive Care Medicine 2018, 44, 1997-1999.
Timsit JF, Aboab J, Parienti JJ
Is research from databases reliable? Yes.
Intensive Care Medicine 2018
Néant N, Gattacceca F, Lê MP, Yazdanpanah Y, Dhiver C, Bregigeon S, Mokhtari S, Peytavin G, Tamalet C, Descamps D, Lacarelle B, Solas C
Population pharmacokinetics of Rilpivirine in HIV-1-infected patients treated with the single-tablet regimen rilpivirine/tenofovir/emtricitabine.
European Journal of Clinical Pharmacology 2018, 74, 473-481.
Suzan-Monti M, Celse M, Vilotitch A, Demoulin B, Dray-Spira R, Yéni P, Lert F, Spire B, ANRS VESPA2 study group
Assessement of Awareness of, Concerns and Attitudes Towards HIV-Related Court-Case Sentences in France in a Representative Sample of People Living with HIV (ANRS VESPA2 Survey).
AIDS and behavior 2018, 22, 3264-3272.
Garrouste-Orgeas M, Azoulay E, Ruckly S, Schwebel C, de Montmollin E, Bedos JP, Souweine B, Marcotte G, Adrie C, Goldgran-Toledano D, Dumenil AS, Kallel H, Jamali S, Argaud L, Darmon M, Zahar JR, Timsit JF
Diabetes was the only comorbid condition associated with mortality of invasive pneumococcal infection in ICU patients: a multicenter observational study from the Outcomerea research group.
Infection 2018, 46, 669-677.
Leone M, Bouadma L, Bouhemad B, Brissaud O, Dauger S, Gibot S, Hraiech S, Jung B, Kipnis E, Launey Y, Luyt CE, Margetis D, Michel F, Mokart D, Montravers P, Monsel A, Nseir S, Pugin J, Roquilly A, Velly L, Zahar JR, Bruyère R, Chanques G
Hospital-acquired pneumonia in ICU.
Anaesthesia, Critical Care & Pain Medicine 2018, 37, 83-98.
Loubet P, Burdet C, Vindrios W, Grall N, Wolff M, Yazdanpanah Y, Andremont A, Duval X, Lescure FX
Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review.
Clin Microbiol Infect 2018, 24, 125-132.
Jolivet S, Lescure FX, Armand-Lefevre L, Raffoul R, Dilly MP, Ghodbane W, Nataf P, Lucet JC
Surgical site infection with extended-spectrum β-lactamase-producing Enterobacteriaceae after cardiac surgery: incidence and risk factors.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2018, 24, 283-288.
Lachâtre M, Méchain M, Etienne M, Gautret P, Matheron S, Nahon M, Coignard-Biehler H, Malvy D, Duval X, Tattevin P
No evidence for major adverse events related to suspicion of Ebola in France, 2014-2015.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2018, 24, 310-311.
Ruppe E, Burdet C, Grall N, de Lastours V, Lescure FX, Andremont A, Armand-Lefevre L
Impact of antibiotics on the intestinal microbiota needs to be re-defined to optimize antibiotic usage.
Clin Microbiol Infect 2018, 24, 3-5.
Jolivet S, Vaillant L, Poncin T, Lolom I, Gaudonnet Y, Rondinaud E, Bendjelloul G, Lomont A, Lucet JC, Armand-Lefèvre L
Prevalence of carriage of extended-spectrum β-lactamase-producing enterobacteria and associated factors in a French hospital.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2018, 24, 1311-1314.
Peiffer-Smadja N, Abbara S, Rizk N, Pogliaghi M, Rondinaud E, Tesmoingt C, Massias L, Lucet JC, Alkhoder S, Armand-Lefèvre L, Lescure FX
High-dose daptomycin in patients with infective endocarditis or sternal wound infections.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2018, 24, 1106-1108.
Ruppé E, Martin-Loeches I, Rouzé A, Levast B, Ferry T, Timsit JF
What's new in restoring the gut microbiota in ICU patients? Potential role of faecal microbiota transplantation.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2018, 24, 803-805.
Loubet P, Verger P, Abitbol V, Peyrin-Biroulet L, Launay O
Pneumococcal and influenza vaccine uptake in adults with inflammatory bowel disease in France: Results from a web-based study.
Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2018, 50, 563-567.
Cez A, Brocheriou I, Lescure FX, Adam C, Girard PM, Pialoux G, Moestrup SK, Fellahi S, Bastard JP, Ronco P, Plaisier E
Decreased expression of megalin and cubilin and altered mitochondrial activity in tenofovir nephrotoxicity.
Human Pathology 2018, 73, 89-101.
Zahar JR, Blot S
Dilemmas in infection control in the intensive care unit.
Intensive & Critical Care Nursing 2018, 46, 1-3.
Perozziello A, Routelous C, Charani E, Truel A, Birgand G, Yazdanpanah Y, Lescure FX, Lucet JC, CEFECA Study Group
Experiences and perspectives of implementing antimicrobial stewardship in five French hospitals: a qualitative study.
International Journal of Antimicrobial Agents 2018, 51, 829-835.
Macaux L, Ndoye O, Cordel H, Pomares TB, Seytre D, Bouchaud O, Cohen Y, Zahar JR, Carbonnelle E
Extensively-drug-resistant bacteria carriers among overseas travellers: one-third had not been hospitalized previously.
International Journal of Antimicrobial Agents 2018, 52, 385-389.
Soulie C, Morand-Joubert L, Cottalorda J, Charpentier C, Bellecave P, Le Guen L, Yerly S, Montes B, Fafi-Kremer S, Dina J, Avettand-Fenoel V, Amiel C, Roussel C, Pallier C, Zafilaza K, Sayon S, Signori-Schmuck A, Mirand A, Trabaud MA, Berger S, Calvez V, Marcelin AG, ANRS AC11 resistance group
Performance of genotypic algorithms for predicting tropism for HIV-1 CRF01_AE recombinant.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2018, 99-100, 57-60.
Schwarzinger M, Rehm J, Mallet V
"Who killed JR": Chronic hepatitis C or alcohol use disorders?.
Journal of Hepatology 2018, 68, 1098-1099.
Deuffic-Burban S, Huneau A, Verleene A, Brouard C, Pillonel J, Le Strat Y, Cossais S, Roudot-Thoraval F, Canva V, Mathurin P, Dhumeaux D, Yazdanpanah Y
Assessing the cost-effectiveness of hepatitis C screening strategies in France.
Journal of Hepatology 2018, 69, 785-792.
Hilliquin D, Le Guern R, Thepot Seegers V, Neulier C, Lomont A, Marie V, Legeay C, Merrer J, Lepelletier D, Rogues AM, Grandbastien B, Lucet JC, Zahar JR
Risk factors for acquisition of OXA-48-producing Klebsiella pneumonia among contact patients: a multicentre study.
The Journal of Hospital Infection 2018, 98, 253-259.
Pilmis B, Cattoir V, Lecointe D, Limelette A, Grall I, Mizrahi A, Marcade G, Poilane I, Guillard T, Bourgeois Nicolaos N, Zahar JR, Le Monnier A
Carriage of ESBL-producing Enterobacteriaceae in French hospitals: the PORTABLSE study.
The Journal of Hospital Infection 2018, 98, 247-252.
Legeay C, Thépot-Seegers V, Pailhoriès H, Hilliquin D, Zahar JR
Is cohorting the only solution to control carbapenemase-producing Enterobacteriaceae outbreaks? A single-centre experience.
The Journal of Hospital Infection 2018, 99, 390-395.
Lemaignen A, Armand-Lefevre L, Birgand G, Mabileau G, Lolom I, Ghodbane W, Dilly MP, Nataf P, Lucet JC
Thirteen-year experience with universal Staphylococcus aureus nasal decolonization prior to cardiac surgery: a quasi-experimental study.
The Journal of Hospital Infection 2018, 100, 322-328.
Warszawski J, Thomas C, Dialla O, Garrait V, Dollfus C, Reliquet V, Clech L, Dert C, Mandelbrot L, Audrain M, Blanche S, ANRS EPF Study Group
T-Cell Receptor Excision Circles in HIV-Exposed, Uninfected Newborns Measured During a National Newborn Screening Program for Severe Combined Immunodeficiency.
The Journal of Pediatrics 2018, 202, 311-314.e2.
Le Hingrat Q, Perrier M, Collin G, Drumard S, Storto A, Bertine M, Larrouy L, Matheron S, Damond F, Charpentier C, Descamps D, Visseaux B
Efficiency of HIV-2 cultures from clinical isolates is enhanced after purification by anti-CD44 microbeads.
Journal of Virological Methods 2018, 257, 12-15.
D'Ortenzio E, Lemaître N, Brouat C, Loubet P, Sebbane F, Rajerison M, Baril L, Yazdanpanah Y
Plague: Bridging gaps towards better disease control.
Medecine Et Maladies Infectieuses 2018, 48, 307-317.
Bleibtreu A, Grall N, Laissy JP, Rioux C, Strukov A, Lariven S, Yeni P, Yazdanpanah Y, Joly V
Contribution of brain imaging to the diagnosis of intracranial tuberculoma and other brain lesions in patients presenting with miliary tuberculosis.
Medecine Et Maladies Infectieuses 2018, 48, 533-539.
N'Diaye DS, Launay O, Picone O, Tsatsaris V, Azria E, Rozenberg F, Schwarzinger M, Yazdanpanah Y
Cost-effectiveness of vaccination against cytomegalovirus (CMV) in adolescent girls to prevent infections in pregnant women living in France.
Vaccine 2018, 36, 1285-1296.
Reignier J, Boisramé-Helms J, Brisard L, Lascarrou JB, Ait Hssain A, Anguel N, Argaud L, Asehnoune K, Asfar P, Bellec F, Botoc V, Bretagnol A, Bui HN, Canet E, Da Silva D, Darmon M, Das V, Devaquet J, Djibre M, Ganster F, Garrouste-Orgeas M, Gaudry S, Gontier O, Guérin C, Guidet B, Guitton C, Herbrecht JE, Lacherade JC, Letocart P, Martino F, Maxime V, Mercier E, Mira JP, Nseir S, Piton G, Quenot JP, Richecoeur J, Rigaud JP, Robert R, Rolin N, Schwebel C, Sirodot M, Tinturier F, Thévenin D, Giraudeau B, Le Gouge A, NUTRIREA-2 Trial Investigators, Clinical Research in Intensive Care and Sepsis (CRICS) group
Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2).
Lancet (London, England) 2018, 391, 133-143.
Schwarzinger M, Pollock BG, Hasan OSM, Dufouil C, Rehm J, QalyDays Study Group
Contribution of alcohol use disorders to the burden of dementia in France 2008-13: a nationwide retrospective cohort study.
The Lancet. Public Health 2018, 3, e124-e132.
Triki D, Cano Contreras ME, Flatters D, Visseaux B, Descamps D, Camproux AC, Regad L
Analysis of the HIV-2 protease's adaptation to various ligands: characterization of backbone asymmetry using a structural alphabet.
Scientific Reports 2018, 8, 710.
Triki D, Billot T, Visseaux B, Descamps D, Flatters D, Camproux AC, Regad L
Exploration of the effect of sequence variations located inside the binding pocket of HIV-1 and HIV-2 proteases.
Scientific Reports 2018, 8, 5789.
Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot JP, Siami S, Cariou A, Forceville X, Schwebel C, Martin C, Timsit JF, Misset B, Ali Benali M, Colin G, Souweine B, Asehnoune K, Mercier E, Chimot L, Charpentier C, François B, Boulain T, Petitpas F, Constantin JM, Dhonneur G, Baudin F, Combes A, Bohé J, Loriferne JF, Amathieu R, Cook F, Slama M, Leroy O, Capellier G, Dargent A, Hissem T, Maxime V, Bellissant E, CRICS-TRIGGERSEP Network
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock.
The New England Journal of Medicine 2018, 378, 809-818.
Loubet P, Anselem O, Launay O
Immunization during pregnancy.
Expert Review of Vaccines 2018
Raymond S, Nicot F, Pallier C, Bellecave P, Maillard A, Trabaud MA, Morand-Joubert L, Rodallec A, Amiel C, Mourez T, Bocket L, Beby-Defaux A, Bouvier-Alias M, Lambert-Niclot S, Charpentier C, Malve B, Mirand A, Dina J, Le Guillou-Guillemette H, Marque-Juillet S, Signori-Schmuck A, Barin F, Si-Mohamed A, Avettand Fenoel V, Roussel C, Calvez V, Saune K, Marcelin AG, Rodriguez C, Descamps D, Izopet J, French National Agency for Research on AIDS and Viral Hepatitis (ANRS) AC11 Resistance Study Group
Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018, 66, 1588-1594.
Moulignier A, Savatovsky J, Assoumou L, Lescure FX, Lamirel C, Godin O, Valin N, Tubiana R, Canestri A, Roux P, Sadik JC, Salomon L, Abrivard M, Katlama C, Yazdanpanah Y, Pialoux G, Girard PM, Costagliola D, Microvascular Brain Retina and Kidney (MicroBREAK) Study Group
Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy-Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018, 66, 1762-1769.
Birgand G, Zahar JR, Lucet JC
Insight Into the Complex Epidemiology of Multidrug-Resistant Enterobacteriaceae.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018, 66, 494-496.
Melliez H, Mary-Krause M, Bocket L, Guiguet M, Abgrall S, De Truchis P, Katlama C, Martin-Blondel G, Henn A, Revest M, Robineau O, Khuong-Josses MA, Canestri A, De Castro N, Joly V, Mokhtari S, Risso K, Gasnault J, Costagliola D, French Hospital Database on HIV (ANRS-C4)
Risk of Progressive Multifocal Leukoencephalopathy in the Combination Antiretroviral Therapy Era in the French Hospital Database on Human Immunodeficiency Virus (ANRS-C4).
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018
Peiffer-Smadja N, Hanslik T, Mordant P, Lescure FX
Cultural differences between surgical and medical teams: is it time for comanagement?.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018
Argy N, Le Gal S, Coppée R, Song Z, Vindrios W, Massias L, Kao WC, Hunte C, Yazdanpanah Y, Lucet JC, Houzé S, Clain J, Nevez G
Pneumocystis Cytochrome b Mutants Associated With Atovaquone Prophylaxis Failure as the Cause of Pneumocystis Infection Outbreak Among Heart Transplant Recipients.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018, 67, 913-919.
Luong Nguyen LB, Yazdanpanah Y, Maman D, Wanjala S, Vandenbulcke A, Price J, Parker RA, Hennequin W, Mendiharat P, Freedberg KA
Voluntary Community Human Immunodeficiency Virus Testing, Linkage, and Retention in Care Interventions in Kenya: Modeling the Clinical Impact and Cost-effectiveness.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018, 67, 719-726.
Matheron S, Descamps D, Gallien S, Besseghir A, Sellier P, Blum L, Mortier E, Charpentier C, Tubiana R, Damond F, Peytavin G, Ponscarme D, Collin F, Brun-Vezinet F, Chene G, France REcherche Nord&Sud Sida-Hiv Hépatites (ANRS) 159 HIV-2 Trial Study Group
First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2).
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018, 67, 1161-1167.
de Kraker MEA, Sommer H, de Velde F, Gravestock I, Weiss E, McAleenan A, Nikolakopoulos S, Amit O, Ashton T, Beyersmann J, Held L, Lovering AM, MacGowan AP, Mouton JW, Timsit JF, Wilson D, Wolkewitz M, Bettiol E, Dane A, Harbarth S, COMBACTE-NET Consortium
Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms: A White Paper From COMBACTE's STAT-Net.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018, 67, 1922-1931.
Zahar JR, Blot S, Nordmann P, Martischang R, Timsit JF, Harbarth S, Barbier F
Screening for intestinal carriage of ESBL-producing Enterobacteriaceae in critically ill patients: expected benefits and evidence-based controversies.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018
Mariaggi AA, Péré H, Perrier M, Visseaux B, Collin G, Veyer D, Le Hingrat Q, Ferré VM, Joly V, Couvelard A, Bucau M, Davitian C, Descamps D, Abramowitz L, Charpentier C
Presence of Human Papillomavirus (HPV) Apolipoprotein B Messenger RNA Editing, Catalytic Polypeptide-Like 3 (APOBEC)-Related Minority Variants in HPV-16 Genomes From Anal and Cervical Samples but Not in HPV-52 and HPV-58.
The Journal of Infectious Diseases 2018, 218, 1027-1036.
Perrier M, Visseaux B, Landman R, Joly V, Todesco E, Yazdanpanah Y, Calvez V, Marcelin AG, Descamps D, Charpentier C
No impact of HIV-1 protease minority resistant variants on the virological response to a first-line PI-based regimen containing darunavir or atazanavir.
The Journal of Antimicrobial Chemotherapy 2018, 73, 173-176.
Seang S, Schneider L, Nguyen T, Lê MP, Soulie C, Calin R, Caby F, Valantin MA, Tubiana R, Assoumou L, Marcelin AG, Peytavin G, Katlama C
Darunavir/ritonavir monotherapy at a low dose (600/100 mg/day) in HIV-1-infected individuals with suppressed HIV viraemia.
The Journal of Antimicrobial Chemotherapy 2018, 73, 490-493.
de Truchis P, Assoumou L, Landman R, Mathez D, Le Dû D, Bellet J, Amat K, Katlama C, Gras G, Bouchaud O, Duracinsky M, Abe E, Alvarez JC, Izopet J, Saillard J, Melchior JC, Leibowitch J, Costagliola D, Girard PM, Perronne C, ANRS 162-4D Study Group
Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial.
The Journal of Antimicrobial Chemotherapy 2018, 73, 738-747.
Le Meur L, Tantet C, Lê MP, Desselas E, Bonnal C, Lillo-Le-Louet A, Sonneville R, Massias L, Giraud J, Descamps D, Yazdanpanah Y, Lariven S, Peytavin G
Serious neuropsychiatric adverse effects related to interaction between itraconazole and darunavir/ritonavir in an HIV-infected patient with cerebral histoplasmosis.
The Journal of Antimicrobial Chemotherapy 2018, 73, 1108-1110.
Pressiat C, Hirt D, Treluyer JM, Zheng Y, Morlat P, Naqvi A, Tran L, Viard JP, Avettand-Fenoel V, Rouzioux C, Meyer L, Cheret A, OPTIPRIM Study Group
Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial.
The Journal of Antimicrobial Chemotherapy 2018
Charpentier C, Malet I, Andre-Garnier E, Storto A, Bocket L, Amiel C, Morand-Joubert L, Tumiotto C, Nguyen T, Maillard A, Rodallec A, Leoz M, Montes B, Schneider V, Plantier JC, Dina J, Pallier C, Mirand A, Roussel C, Signori-Schmuck A, Raymond S, Calvez V, Delaugerre C, Marcelin AG, Descamps D
Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen.
The Journal of Antimicrobial Chemotherapy 2018, 73, 1039-1044.
Storto A, Visseaux B, Bertine M, Le Hingrat Q, Collin G, Damond F, Khuong MA, Blum L, Tubiana R, Karmochkine M, Cazanave C, Matheron S, Descamps D, Charpentier C, ANRS HIV-2 CO5 Cohort
Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients.
The Journal of Antimicrobial Chemotherapy 2018
Meynard JL, Moinot L, Landman R, Morand-Joubert L, Besseghir A, Kolta S, Spire B, Todesco E, Bouchaud O, Fagard C, Chene G, Girard PM, ANRS 140 DREAM Study Group
Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM).
The Journal of Antimicrobial Chemotherapy 2018
Charpentier C, Peytavin G, Lê MP, Joly V, Cabras O, Perrier M, Le Gac S, Phung B, Yazdanpanah Y, Descamps D, Landman R
High virological suppression regardless of the genotypic susceptibility score after switching to a dolutegravir-based regimen: week 48 results in an observational cohort.
The Journal of Antimicrobial Chemotherapy 2018, 73, 1665-1671.
Lambert-Niclot S, Grude M, Chaix ML, Charpentier C, Reigadas S, Le Guillou-Guillemette H, Rodallec A, Amiel C, Maillard A, Dufayard J, Mourez T, Mirand A, Guinard J, Montes B, Vallet S, Marcelin AG, Descamps D, Flandre P, Delaugerre C, Morand-Joubert L, ANRS AC-11 Resistance Group
Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study).
The Journal of Antimicrobial Chemotherapy 2018
Molina JM, Gallien S, Chaix ML, El Abbassi EM, Madelaine I, Katlama C, Valin N, Delobel P, Desseaux K, Peytavin G, Saillard J, Raffi F, Chevret S, ANRS 165 Darulight Study Group
Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight).
The Journal of Antimicrobial Chemotherapy 2018
Lê MP, Chaix ML, Chevret S, Bertrand J, Raffi F, Gallien S, El Abbassi EMB, Katlama C, Delobel P, Yazdanpanah Y, Saillard J, Molina JM, Peytavin G, ANRS 165 DARULIGHT Study Group
Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study.
The Journal of Antimicrobial Chemotherapy 2018, 73, 2120-2128.
Nguyen T, Fofana DB, Lê MP, Charpentier C, Peytavin G, Wirden M, Lambert-Niclot S, Desire N, Grude M, Morand-Joubert L, Flandre P, Katlama C, Descamps D, Calvez V, Todesco E, Marcelin AG
Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencing.
The Journal of Antimicrobial Chemotherapy 2018, 73, 2485-2492.
Alessandri-Gradt E, Charpentier C, Leoz M, Mourez T, Descamps D, Plantier JC
Impact of natural polymorphisms of HIV-1 non-group M on genotypic susceptibility to the attachment inhibitor fostemsavir.
The Journal of Antimicrobial Chemotherapy 2018
Fofana DB, d'Almeida M, Lambert-Niclot S, Peytavin G, Girard PM, Lafia B, Zohoun-Guidigbi L, Keke RK, Soulie C, Marcelin AG, Morand-Joubert L
Resistance profile and treatment outcomes in HIV-infected children at virological failure in Benin, West Africa.
The Journal of Antimicrobial Chemotherapy 2018
Dimeglio C, Raymond S, Nicot F, Jeanne N, Carcenac R, Lefebvre C, Izopet J, French National Agency for Research on AIDS and Viral Hepatitis (ANRS) AC11 Resistance Study Group
Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen.
The Journal of Antimicrobial Chemotherapy 2018
Cuzin L, Pugliese P, Katlama C, Bani-Sadr F, Ferry T, Rey D, Lourenco J, Bregigeon S, Allavena C, Reynes J, Cabié A, Dat’AIDS Study Group
Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort.
The Journal of Antimicrobial Chemotherapy 2018
Mabileau G, Scutelniciuc O, Tsereteli M, Konorazov I, Yelizaryeva A, Popovici S, Saifuddin K, Losina E, Manova M, Saldanha V, Malkin JE, Yazdanpanah Y
Intervention Packages to Reduce the Impact of HIV and HCV Infections Among People Who Inject Drugs in Eastern Europe and Central Asia: A Modeling and Cost-effectiveness Study.
Open Forum Infectious Diseases 2018, 5, ofy040.
Cazals N, Le Hingrat Q, Abraham B, Da Silva P, Guindre L, Goffart S, Damond F, Visseaux B, Charpentier C, Ranger-Rogez S, Descamps D
HIV-2 Primary Infection in a French 69-Year-Old Bisexual Man.
Open Forum Infectious Diseases 2018, 5, ofy223.
Chaix ML, Charreau I, Pintado C, Delaugerre C, Mahjoub N, Cotte L, Capitant C, Raffi F, Cua E, Pialoux G, Tremblay C, Meyer L, Molina JM, ANRS IPERGAY Study Group
Effect of On-Demand Oral Pre-exposure Prophylaxis With Tenofovir/Emtricitabine on Herpes Simplex Virus-1/2 Incidence Among Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Trial.
Open Forum Infectious Diseases 2018, 5, ofy295.
Dananché C, Vanhems P, Machut A, Aupée M, Bervas C, L'Hériteau F, Lepape A, Lucet JC, Stoeckel V, Timsit JF, Berger-Carbonne A, Savey A, Bénet T, Healthcare-Associated Infections (HAIs) Surveillance Network of ICUs (Réseau REA-Raisin)
Trends of Incidence and Risk Factors of Ventilator-Associated Pneumonia in Elderly Patients Admitted to French ICUs Between 2007 and 2014.
Critical Care Medicine 2018, 46, 869-877.
Sommer H, Timsit JF, von Cube M, Schumacher M, Darmon M, Schwebel C, Ruckly S, Wolkewitz M, COMBACTE-MAGNET Consortium
The Impact of Early Adequate Treatment on Extubation and Discharge Alive of Patients With Pseudomonas aeruginosa-Related Ventilator-Associated Pneumonia.
Critical Care Medicine 2018, 46, 1643-1648.
Gros A, Dupuis C, Ruckly S, Lautrette A, Garrouste-Orgeas M, Gainnier M, Forel JM, Marcotte G, Azoulay E, Cohen Y, Schwebel C, Argaud L, de Montmollin E, Siami S, Goldgran-Toledano D, Darmon M, Timsit JF, OUTCOMEREA Study Group
Association Between Body Weight Variation and Survival and Other Adverse Events in Critically Ill Patients With Shock: A Multicenter Cohort Study of the OUTCOMEREA Network.
Critical Care Medicine 2018, 46, e981-e987.
de Léotoing L, Yazdanpanah Y, Finkielsztejn L, Chaize G, Vainchtock A, Nachbaur G, Aubin C, Bonnet F
Costs associated with hospitalization in HIV-positive patients in France.
AIDS (London, England) 2018, 32, 2059-2066.
Champenois K, Seng R, Persoz A, Essat A, Gaud C, Laureillard D, Robineau O, Duvivier C, Yazdanpanah Y, Goujard C, Meyer L, ANRS PRIMO cohort study group
Calendar trends in sexual behaviours in a cohort of HIV-infected MSM at the era of treatment as prevention of HIV infection.
AIDS (London, England) 2018, 32, 1871-1879.
Colin De Verdiere N, Durier C, Samri A, Meiffredy V, Launay O, Matheron S, Mercier-Delarue S, Even S, Aboulker JP, Molina JM, Autran B, Simon F, and the ANRS EP46 NOVAA Group
Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients: ANRS EP46 NOVAA.
AIDS (London, England) 2018
Benhammou V, Tubiana R, Matheron S, Sellier P, Mandelbrot L, Chenadec JL, Marel E, Khoshnood B, Warszawski J, ANRS CO1/CO11-EPF French Perinatal Cohort study group
HBV or HCV Coinfection in HIV-1-Infected Pregnant Women in France: Prevalence and Pregnancy Outcomes.
Journal of Acquired Immune Deficiency Syndromes (1999) 2018, 77, 439-450.
Costagliola D, Potard V, Lang S, Abgrall S, Duvivier C, Fischer H, Joly V, Lacombe JM, Valantin MA, Mary-Krause M, Rozenberg S, FHDH ANRS CO4
Impact of antiretroviral drugs on fracture risk in HIV-infected individuals: A case-control study nested within the French Hospital Database on HIV (FHDH-ANRS CO4).
Journal of Acquired Immune Deficiency Syndromes (1999) 2018
Provoost A, Dramé M, Cotte L, Cuzin L, Garraffo R, Rey D, Raffi F, Poizot-Martin I, Pugliese P, Bani-Sadr F, Dat'AIDS study group
Risk of diabetes in HIV-infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort.
Alimentary Pharmacology & Therapeutics 2018
Brunet-Possenti F, Charpentier C, Collin G, Descamps D, Descamps V
Impact of anti-interleukin-17 treatment on cutaneous and genital human papillomavirus infection.
The British Journal of Dermatology 2018, 179, 1179-1180.
Pouga L, Mercedes Santoro M, Charpentier C, Di Carlo D, Romeo I, Artese A, Alcaro S, Antinori A, Wirden M, Perno CF, Ambrosio FA, Calvez V, Descamps D, Marcelin AG, Ceccherini-Silberstein F, Lambert-Niclot S
New Resistance Mutations to Nucleoside Reverse Transcriptase Inhibitors at Codon 184 of HIV-1 Reverse Transcriptase (M184L and M184T).
Chemical Biology & Drug Design 2018
Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord
Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?.
HIV medicine 2018, 19, 42-48.
Cuzin L, Yazdanpanah Y, Huleux T, Cotte L, Pugliese P, Allavena C, Reynes J, Poizot-Martin I, Bani-Sadr F, Delpierre C, Dat'AIDS Study Group
No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France.
HIV medicine 2018, 19, 238-242.
Rosenthal E, Fougerou-Leurent C, Renault A, Carrieri MP, Marcellin F, Garraffo R, Teicher E, Aumaitre H, Lacombe K, Bailly F, Billaud E, Chevaliez S, Dominguez S, Valantin MA, Reynes J, Naqvi A, Cotte L, Metivier S, Leroy V, Dupon M, Allegre T, De Truchis P, Jeantils V, Chas J, Salmon-Ceron D, Morlat P, Neau D, Perré P, Piroth L, Pol S, Bourlière M, Pageaux GP, Alric L, Zucman D, Girard PM, Poizot-Martin I, Yazdanpanah Y, Raffi F, Pabic EL, Tual C, Pailhé A, Amri I, Bellissant E, Molina JM, ANRS HC31 SOFTRIH Study Group
Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study).
HIV medicine 2018, 19, 227-237.
Hentzien M, Cabie A, Pugliese P, Billaud É, Poizot-Martin I, Duvivier C, Valantin MA, Kaladjian A, Dramé M, Bani-Sadr F, Dat'AIDS Study Group
Factors associated with deaths from suicide in a French nationwide HIV-infected cohort.
HIV medicine 2018
Gallien S, Massetti M, Flandre P, Leleu H, Descamps D, Lazaro E
Comparison of 48-week efficacies of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide and nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimens: a systematic review and network meta-analysis.
HIV medicine 2018
Nassereddine H, Charpentier C, Bucau M, Joly V, Bienvenu L, Davitian C, Abramowitz L, Benabderrahmane D, Kotelevets L, Chastre E, Lehy T, Walker F
Interest of cytology combined with Xpert® HPV and Anyplex® II HPV28 Detection human papillomavirus (HPV) typing: differential profiles of anal and cervical HPV lesions in HIV-infected patients on antiretroviral therapy.
HIV medicine 2018
Papatheodoridis GV, Hatzakis A, Cholongitas E, Baptista-Leite R, Baskozos I, Chhatwal J, Colombo M, Cortez-Pinto H, Craxi A, Goldberg D, Gore C, Kautz A, Lazarus JV, Mendão L, Peck-Radosavljevic M, Razavi H, Schatz E, Tözün N, van Damme P, Wedemeyer H, Yazdanpanah Y, Zuure F, Manns MP
Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
Journal of Viral Hepatitis 2018, 25 Suppl 1, 6-17.
Cousien A, Tran VC, Deuffic-Burban S, Jauffret-Roustide M, Mabileau G, Dhersin JS, Yazdanpanah Y
Effectiveness and cost-effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: The case of France.
Journal of Viral Hepatitis 2018, 25, 1197-1207.
Rouzaud C, Rodriguez-Nava V, Catherinot E, Méchaï F, Bergeron E, Farfour E, Scemla A, Poirée S, Delavaud C, Mathieu D, Durupt S, Larosa F, Lengelé JP, Christophe JL, Suarez F, Lortholary O, Lebeaux D
Clinical Assessment of a Nocardia PCR-Based Assay for Diagnosis of Nocardiosis.
Journal of Clinical Microbiology 2018, 56,
Jary A, Leducq V, Palich R, Gothland A, Descamps D, Joly V, Lambert-Niclot S, Amiel C, Canestri A, Mirand A, Gault E, Vabret A, Valantin MA, Katlama C, Calvez V, Dupin N, Spano JP, Marcelin AG
Usefulness of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) DNA Viral Load in Whole Blood for Diagnosis and Monitoring of KSHV-Associated Diseases.
Journal of Clinical Microbiology 2018, 56,
Burdet C, Loubet P, Le Moing V, Vindrios W, Esposito-Farèse M, Linard M, Ferry T, Massias L, Tattevin P, Wolff M, Vandenesch F, Grall N, Quintin C, Mentré F, Duval X, Lescure FX, CloCeBa study group
Efficacy of cloxacillin versus cefazolin for methicillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): study protocol for a randomised, controlled, non-inferiority trial.
BMJ open 2018, 8, e023151.
Kirchgesner J, Beaugerie L, Carrat F, Andersen NN, Jess T, Schwarzinger M, BERENICE study group
Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study.
Gut 2018, 67, 1261-1268.
Januel E, Martin-Blondel G, Lamirel C, Picard H, Pialoux G, Katlama C, Cochereau I, Lescure FX, Moulignier A
Do CCR5 antagonists improve the overall survival of patients with AIDS-related progressive multifocal leucoencephalopathy?.
Journal of Neurology, Neurosurgery, and Psychiatry 2018, 89, 1125-1126.
Bleibtreu A, Jaureguiberry S, Houhou N, Boutolleau D, Guillot H, Vallois D, Lucet JC, Robert J, Mourvillier B, Delemazure J, Jaspard M, Lescure FX, Rioux C, Caumes E, Yazdanapanah Y
Clinical management of respiratory syndrome in patients hospitalized for suspected Middle East respiratory syndrome coronavirus infection in the Paris area from 2013 to 2016.
BMC infectious diseases 2018, 18, 331.
Désiré N, Cerutti L, Le Hingrat Q, Perrier M, Emler S, Calvez V, Descamps D, Marcelin AG, Hué S, Visseaux B
Characterization update of HIV-1 M subtypes diversity and proposal for subtypes A and D sub-subtypes reclassification.
Retrovirology 2018, 15, 80.
Cantier M, Morisot A, Guérot E, Megarbane B, Razazi K, Contou D, Mariotte E, Canet E, De Montmollin E, Dubée V, Boulet E, Gaudry S, Voiriot G, Mayaux J, Pène F, Neuville M, Mourvillier B, Ruckly S, Bouadma L, Wolff M, Timsit JF, Sonneville R, ENCEPHALITICA study group
Functional outcomes in adults with tuberculous meningitis admitted to the ICU: a multicenter cohort study.
Critical Care (London, England) 2018, 22, 210.
Truche AS, Ragey SP, Souweine B, Bailly S, Zafrani L, Bouadma L, Clec'h C, Garrouste-Orgeas M, Lacave G, Schwebel C, Guebre-Egziabher F, Adrie C, Dumenil AS, Zaoui P, Argaud L, Jamali S, Goldran Toledano D, Marcotte G, Timsit JF, Darmon M
ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients.
Annals of Intensive Care 2018, 8, 127.
Birgand G, Castro-Sánchez E, Hansen S, Gastmeier P, Lucet JC, Ferlie E, Holmes A, Ahmad R
Comparison of governance approaches for the control of antimicrobial resistance: Analysis of three European countries.
Antimicrobial Resistance and Infection Control 2018, 7, 28.
Bougnoux ME, Brun S, Zahar JR
Healthcare-associated fungal outbreaks: New and uncommon species, New molecular tools for investigation and prevention.
Antimicrobial Resistance and Infection Control 2018, 7, 45.
Perrier M, Désiré N, Storto A, Todesco E, Rodriguez C, Bertine M, Le Hingrat Q, Visseaux B, Calvez V, Descamps D, Marcelin AG, Charpentier C
Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants.
PloS One 2018, 13, e0198334.
Allavena C, Hanf M, Rey D, Duvivier C, BaniSadr F, Poizot-Martin I, Jacomet C, Pugliese P, Delobel P, Katlama C, Joly V, Chidiac C, Dournon N, Merrien D, May T, Reynes J, Gagneux-Brunon A, Chirouze C, Huleux T, Cabié A, Raffi F, Dat’AIDS study group
Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients.
PloS One 2018, 13, e0203895.
de Monteynard LA, Matheron S, Grabar S, de Truchis P, Gilquin J, Pavie J, Launay O, Meynard JL, Khuong-Josses MA, Rey D, Mahamat A, Dray-Spira R, Simon A, Costagliola D, Abgrall S, FHDH-ANRS CO4
Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in France.
PloS One 2018, 13, e0205385.
Arrive E, Viard JP, Salanave B, Dollfus C, Matheron S, Reliquet V, Arezes E, Nailler L, Vigouroux C, Warszawski J, ANRS CO19 COVERTE and ENNS study groups
Metabolic risk factors in young adults infected with HIV since childhood compared with the general population.
PloS One 2018, 13, e0206745.
Lorme F, Maataoui N, Rondinaud E, Esposito-Farèse M, Clermont O, Ruppe E, Arlet G, Genel N, VOYAG-R study group, Matheron S, Andremont A, Armand-Lefevre L
Acquisition of plasmid-mediated cephalosporinase producing Enterobacteriaceae after a travel to the tropics.
PloS One 2018, 13, e0206909.
Pilmis B, Zahar JR
Ventilator-associated pneumonia related to ESBL-producing gram negative bacilli.
Annals of Translational Medicine 2018, 6, 424.
Gangneux JP, Cornet M, Bailly S, Fradin C, Féger C, Timsit JF, Leroy O, Sendid B, Bougnoux ME
Clinical Impact of Antifungal Susceptibility, Biofilm Formation and Mannoside Expression of Candida Yeasts on the Outcome of Invasive Candidiasis in ICU: An Ancillary Study on the Prospective AmarCAND2 Cohort.
Frontiers in Microbiology 2018, 9, 2907.
Ségéral O, Nerrienet E, Neth S, Spire B, Khol V, Ferradini L, Sarun S, Mom C, Ngin S, Charpentier C, Men P, Mora M, Mean Chhi V, Ly P, Saphonn V
Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study.
Frontiers in Public Health 2018, 6, 63.
Charpentier C, Descamps D
Resistance to HIV Integrase Inhibitors: About R263K and E157Q Mutations.
Viruses 2018, 10,
Todesco E, Mazzola A, Akhavan S, Abravanel F, Poynard T, Roque-Afonso AM, Peytavin G, Marcelin AG, Calmus Y, Lecuyer L, Guillemain R, Conti F
Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective.
Antiviral Therapy 2018
Salmon D, Trimoulet P, Gilbert C, Solas C, Lafourcade E, Chas J, Piroth L, Lacombe K, Katlama C, Peytavin G, Aumaitre H, Alric L, Boué F, Morlat P, Poizot-Martin I, Billaud E, Rosenthal E, Naqvi A, Miailhes P, Bani-Sadr F, Esterle L, Carrieri P, Dabis F, Sogni P, Wittkop L, ANRS CO13 Hepavih study Group
Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients.
World Journal of Hepatology 2018, 10, 856-866.
Use of Combination Systemic-Intratumoral HPV Vaccine to Treat Cutaneous Basaloid Squamous Cell Carcinomas.
JAMA dermatology 2018
Bluhmki T, Allignol A, Ruckly S, Timsit JF, Wolkewitz M, Beyersmann J
Estimation of adjusted expected excess length-of-stay associated with ventilation-acquired pneumonia in intensive care: A multistate approach accounting for time-dependent mechanical ventilation.
Biometrical Journal. Biometrische Zeitschrift 2018, 60, 1135-1150.
Costentin CE, Mourad A, Lahmek P, Causse X, Pariente A, Hagège H, Dobrin AS, Becker C, Marks B, Bader R, Condat B, Héluwaert F, Seitz JF, Lesgourgues B, Denis J, Deuffic-Burban S, Rosa I, Decaens T, CHANGH Study Group
Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide study.
Cancer 2018, 124, 1964-1972.
Bailly S, Meyfroidt G, Timsit JF
What's new in ICU in 2050: big data and machine learning.
Intensive Care Medicine 2018, 44, 1524-1527.
De Waele JJ, Akova M, Antonelli M, Canton R, Carlet J, De Backer D, Dimopoulos G, Garnacho-Montero J, Kesecioglu J, Lipman J, Mer M, Paiva JA, Poljak M, Roberts JA, Rodriguez Bano J, Timsit JF, Zahar JR, Bassetti M
Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance.
Intensive Care Medicine 2018, 44, 189-196.
La Combe B, Bleibtreu A, Messika J, Fernandes R, Clermont O, Branger C, Billard-Pomares T, Barnaud G, Magdoud F, Eveillard M, Kouatchet A, Lasocki S, Asfar P, Corvec S, Lakhal K, Armand-Lefevre L, Wolff M, Timsit JF, Bourdon S, Reignier J, Martin S, Fihman V, de Prost N, Bador J, Charles PE, Goret J, Boyer A, Wallet F, Jaillette E, Nseir S, Landraud L, Ruimy R, Danin PE, Dellamonica J, Cremniter J, Frat JP, Jauréguy F, Clec'h C, Decré D, Maury E, Dreyfuss D, Denamur E, Ricard JD
Decreased susceptibility to chlorhexidine affects a quarter of Escherichia coli isolates responsible for pneumonia in ICU patients.
Intensive Care Medicine 2018, 44, 531-533.
von Cube MK, Timsit JF, Sommer H, Darmon M, Schwebel C, Bailly S, Souweine B, Wolkewitz M
Relative risk and population-attributable fraction of ICU death caused by susceptible and resistant Pseudomonas aeruginosa ventilator-associated pneumonia: a competing risks approach to investigate the OUTCOMEREA database.
Intensive Care Medicine 2018, 44, 1177-1179.
Bouadma L, Karpanen T, Elliott T
Chlorhexidine use in adult patients on ICU.
Intensive Care Medicine 2018, 44, 2232-2234.
Barbier F, Bailly S, Schwebel C, Papazian L, Azoulay É, Kallel H, Siami S, Argaud L, Marcotte G, Misset B, Reignier J, Darmon M, Zahar JR, Goldgran-Toledano D, de Montmollin É, Souweine B, Mourvillier B, Timsit JF, OUTCOMEREA Study Group
Infection-related ventilator-associated complications in ICU patients colonised with extended-spectrum β-lactamase-producing Enterobacteriaceae.
Intensive Care Medicine 2018
Timsit JF, Bassetti M
Antipathy against SDD is justified: Yes.
Intensive Care Medicine 2018
Azoulay E, Lemiale V, Mourvillier B, Garrouste-Orgeas M, Schwebel C, Ruckly S, Argaud L, Cohen Y, Souweine B, Papazian L, Reignier J, Marcotte G, Siami S, Kallel H, Darmon M, Timsit JF, OUTCOMEREA Study Group
Management and outcomes of acute respiratory distress syndrome patients with and without comorbid conditions.
Intensive Care Medicine 2018
Timsit JF, Rupp M, Bouza E, Chopra V, Kärpänen T, Laupland K, Lisboa T, Mermel L, Mimoz O, Parienti JJ, Poulakou G, Souweine B, Zingg W
A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill.
Intensive Care Medicine 2018, 44, 742-759.
Kindermans M, Abid S, Alkhoder S, Bouadma L
Pulsatile bleeding after sternal bone marrow puncture.
Intensive Care Medicine 2018, 44, 1758-1759.
Bouadma L, Klompas M
Oral care with chlorhexidine: beware!.
Intensive Care Medicine 2018, 44, 1153-1155.
Puntillo KA, Max A, Timsit JF, Ruckly S, Chanques G, Robleda G, Roche-Campo F, Mancebo J, Divatia JV, Soares M, Ionescu DC, Grintescu IM, Maggiore SM, Rusinova K, Owczuk R, Egerod I, Papathanassoglou EDE, Kyranou M, Joynt GM, Burghi G, Freebairn RC, Ho KM, Kaarlola A, Gerritsen RT, Kesecioglu J, Sulaj MMS, Norrenberg M, Benoit DD, Seha MSG, Hennein A, Pereira FJ, Benbenishty JS, Abroug F, Aquilina A, Monte JRC, An Y, Azoulay E
Pain distress: the negative emotion associated with procedures in ICU patients.
Intensive Care Medicine 2018, 44, 1493-1501.
Timsit JF, Ruppe E, Ferrer R
Focus on sepsis: new concepts and findings in sepsis care.
Intensive Care Medicine 2018, 44, 1997-1999.
Timsit JF, Aboab J, Parienti JJ
Is research from databases reliable? Yes.
Intensive Care Medicine 2018
Néant N, Gattacceca F, Lê MP, Yazdanpanah Y, Dhiver C, Bregigeon S, Mokhtari S, Peytavin G, Tamalet C, Descamps D, Lacarelle B, Solas C
Population pharmacokinetics of Rilpivirine in HIV-1-infected patients treated with the single-tablet regimen rilpivirine/tenofovir/emtricitabine.
European Journal of Clinical Pharmacology 2018, 74, 473-481.
Suzan-Monti M, Celse M, Vilotitch A, Demoulin B, Dray-Spira R, Yéni P, Lert F, Spire B, ANRS VESPA2 study group
Assessement of Awareness of, Concerns and Attitudes Towards HIV-Related Court-Case Sentences in France in a Representative Sample of People Living with HIV (ANRS VESPA2 Survey).
AIDS and behavior 2018, 22, 3264-3272.
Garrouste-Orgeas M, Azoulay E, Ruckly S, Schwebel C, de Montmollin E, Bedos JP, Souweine B, Marcotte G, Adrie C, Goldgran-Toledano D, Dumenil AS, Kallel H, Jamali S, Argaud L, Darmon M, Zahar JR, Timsit JF
Diabetes was the only comorbid condition associated with mortality of invasive pneumococcal infection in ICU patients: a multicenter observational study from the Outcomerea research group.
Infection 2018, 46, 669-677.
Leone M, Bouadma L, Bouhemad B, Brissaud O, Dauger S, Gibot S, Hraiech S, Jung B, Kipnis E, Launey Y, Luyt CE, Margetis D, Michel F, Mokart D, Montravers P, Monsel A, Nseir S, Pugin J, Roquilly A, Velly L, Zahar JR, Bruyère R, Chanques G
Hospital-acquired pneumonia in ICU.
Anaesthesia, Critical Care & Pain Medicine 2018, 37, 83-98.
Loubet P, Burdet C, Vindrios W, Grall N, Wolff M, Yazdanpanah Y, Andremont A, Duval X, Lescure FX
Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review.
Clin Microbiol Infect 2018, 24, 125-132.
Jolivet S, Lescure FX, Armand-Lefevre L, Raffoul R, Dilly MP, Ghodbane W, Nataf P, Lucet JC
Surgical site infection with extended-spectrum β-lactamase-producing Enterobacteriaceae after cardiac surgery: incidence and risk factors.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2018, 24, 283-288.
Lachâtre M, Méchain M, Etienne M, Gautret P, Matheron S, Nahon M, Coignard-Biehler H, Malvy D, Duval X, Tattevin P
No evidence for major adverse events related to suspicion of Ebola in France, 2014-2015.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2018, 24, 310-311.
Ruppe E, Burdet C, Grall N, de Lastours V, Lescure FX, Andremont A, Armand-Lefevre L
Impact of antibiotics on the intestinal microbiota needs to be re-defined to optimize antibiotic usage.
Clin Microbiol Infect 2018, 24, 3-5.
Jolivet S, Vaillant L, Poncin T, Lolom I, Gaudonnet Y, Rondinaud E, Bendjelloul G, Lomont A, Lucet JC, Armand-Lefèvre L
Prevalence of carriage of extended-spectrum β-lactamase-producing enterobacteria and associated factors in a French hospital.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2018, 24, 1311-1314.
Peiffer-Smadja N, Abbara S, Rizk N, Pogliaghi M, Rondinaud E, Tesmoingt C, Massias L, Lucet JC, Alkhoder S, Armand-Lefèvre L, Lescure FX
High-dose daptomycin in patients with infective endocarditis or sternal wound infections.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2018, 24, 1106-1108.
Ruppé E, Martin-Loeches I, Rouzé A, Levast B, Ferry T, Timsit JF
What's new in restoring the gut microbiota in ICU patients? Potential role of faecal microbiota transplantation.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2018, 24, 803-805.
Loubet P, Verger P, Abitbol V, Peyrin-Biroulet L, Launay O
Pneumococcal and influenza vaccine uptake in adults with inflammatory bowel disease in France: Results from a web-based study.
Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2018, 50, 563-567.
Cez A, Brocheriou I, Lescure FX, Adam C, Girard PM, Pialoux G, Moestrup SK, Fellahi S, Bastard JP, Ronco P, Plaisier E
Decreased expression of megalin and cubilin and altered mitochondrial activity in tenofovir nephrotoxicity.
Human Pathology 2018, 73, 89-101.
Zahar JR, Blot S
Dilemmas in infection control in the intensive care unit.
Intensive & Critical Care Nursing 2018, 46, 1-3.
Perozziello A, Routelous C, Charani E, Truel A, Birgand G, Yazdanpanah Y, Lescure FX, Lucet JC, CEFECA Study Group
Experiences and perspectives of implementing antimicrobial stewardship in five French hospitals: a qualitative study.
International Journal of Antimicrobial Agents 2018, 51, 829-835.
Macaux L, Ndoye O, Cordel H, Pomares TB, Seytre D, Bouchaud O, Cohen Y, Zahar JR, Carbonnelle E
Extensively-drug-resistant bacteria carriers among overseas travellers: one-third had not been hospitalized previously.
International Journal of Antimicrobial Agents 2018, 52, 385-389.
Soulie C, Morand-Joubert L, Cottalorda J, Charpentier C, Bellecave P, Le Guen L, Yerly S, Montes B, Fafi-Kremer S, Dina J, Avettand-Fenoel V, Amiel C, Roussel C, Pallier C, Zafilaza K, Sayon S, Signori-Schmuck A, Mirand A, Trabaud MA, Berger S, Calvez V, Marcelin AG, ANRS AC11 resistance group
Performance of genotypic algorithms for predicting tropism for HIV-1 CRF01_AE recombinant.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2018, 99-100, 57-60.
Schwarzinger M, Rehm J, Mallet V
"Who killed JR": Chronic hepatitis C or alcohol use disorders?.
Journal of Hepatology 2018, 68, 1098-1099.
Deuffic-Burban S, Huneau A, Verleene A, Brouard C, Pillonel J, Le Strat Y, Cossais S, Roudot-Thoraval F, Canva V, Mathurin P, Dhumeaux D, Yazdanpanah Y
Assessing the cost-effectiveness of hepatitis C screening strategies in France.
Journal of Hepatology 2018, 69, 785-792.
Hilliquin D, Le Guern R, Thepot Seegers V, Neulier C, Lomont A, Marie V, Legeay C, Merrer J, Lepelletier D, Rogues AM, Grandbastien B, Lucet JC, Zahar JR
Risk factors for acquisition of OXA-48-producing Klebsiella pneumonia among contact patients: a multicentre study.
The Journal of Hospital Infection 2018, 98, 253-259.
Pilmis B, Cattoir V, Lecointe D, Limelette A, Grall I, Mizrahi A, Marcade G, Poilane I, Guillard T, Bourgeois Nicolaos N, Zahar JR, Le Monnier A
Carriage of ESBL-producing Enterobacteriaceae in French hospitals: the PORTABLSE study.
The Journal of Hospital Infection 2018, 98, 247-252.
Legeay C, Thépot-Seegers V, Pailhoriès H, Hilliquin D, Zahar JR
Is cohorting the only solution to control carbapenemase-producing Enterobacteriaceae outbreaks? A single-centre experience.
The Journal of Hospital Infection 2018, 99, 390-395.
Lemaignen A, Armand-Lefevre L, Birgand G, Mabileau G, Lolom I, Ghodbane W, Dilly MP, Nataf P, Lucet JC
Thirteen-year experience with universal Staphylococcus aureus nasal decolonization prior to cardiac surgery: a quasi-experimental study.
The Journal of Hospital Infection 2018, 100, 322-328.
Warszawski J, Thomas C, Dialla O, Garrait V, Dollfus C, Reliquet V, Clech L, Dert C, Mandelbrot L, Audrain M, Blanche S, ANRS EPF Study Group
T-Cell Receptor Excision Circles in HIV-Exposed, Uninfected Newborns Measured During a National Newborn Screening Program for Severe Combined Immunodeficiency.
The Journal of Pediatrics 2018, 202, 311-314.e2.
Le Hingrat Q, Perrier M, Collin G, Drumard S, Storto A, Bertine M, Larrouy L, Matheron S, Damond F, Charpentier C, Descamps D, Visseaux B
Efficiency of HIV-2 cultures from clinical isolates is enhanced after purification by anti-CD44 microbeads.
Journal of Virological Methods 2018, 257, 12-15.
D'Ortenzio E, Lemaître N, Brouat C, Loubet P, Sebbane F, Rajerison M, Baril L, Yazdanpanah Y
Plague: Bridging gaps towards better disease control.
Medecine Et Maladies Infectieuses 2018, 48, 307-317.
Bleibtreu A, Grall N, Laissy JP, Rioux C, Strukov A, Lariven S, Yeni P, Yazdanpanah Y, Joly V
Contribution of brain imaging to the diagnosis of intracranial tuberculoma and other brain lesions in patients presenting with miliary tuberculosis.
Medecine Et Maladies Infectieuses 2018, 48, 533-539.
N'Diaye DS, Launay O, Picone O, Tsatsaris V, Azria E, Rozenberg F, Schwarzinger M, Yazdanpanah Y
Cost-effectiveness of vaccination against cytomegalovirus (CMV) in adolescent girls to prevent infections in pregnant women living in France.
Vaccine 2018, 36, 1285-1296.
Reignier J, Boisramé-Helms J, Brisard L, Lascarrou JB, Ait Hssain A, Anguel N, Argaud L, Asehnoune K, Asfar P, Bellec F, Botoc V, Bretagnol A, Bui HN, Canet E, Da Silva D, Darmon M, Das V, Devaquet J, Djibre M, Ganster F, Garrouste-Orgeas M, Gaudry S, Gontier O, Guérin C, Guidet B, Guitton C, Herbrecht JE, Lacherade JC, Letocart P, Martino F, Maxime V, Mercier E, Mira JP, Nseir S, Piton G, Quenot JP, Richecoeur J, Rigaud JP, Robert R, Rolin N, Schwebel C, Sirodot M, Tinturier F, Thévenin D, Giraudeau B, Le Gouge A, NUTRIREA-2 Trial Investigators, Clinical Research in Intensive Care and Sepsis (CRICS) group
Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2).
Lancet (London, England) 2018, 391, 133-143.
Schwarzinger M, Pollock BG, Hasan OSM, Dufouil C, Rehm J, QalyDays Study Group
Contribution of alcohol use disorders to the burden of dementia in France 2008-13: a nationwide retrospective cohort study.
The Lancet. Public Health 2018, 3, e124-e132.
Triki D, Cano Contreras ME, Flatters D, Visseaux B, Descamps D, Camproux AC, Regad L
Analysis of the HIV-2 protease's adaptation to various ligands: characterization of backbone asymmetry using a structural alphabet.
Scientific Reports 2018, 8, 710.
Triki D, Billot T, Visseaux B, Descamps D, Flatters D, Camproux AC, Regad L
Exploration of the effect of sequence variations located inside the binding pocket of HIV-1 and HIV-2 proteases.
Scientific Reports 2018, 8, 5789.
Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot JP, Siami S, Cariou A, Forceville X, Schwebel C, Martin C, Timsit JF, Misset B, Ali Benali M, Colin G, Souweine B, Asehnoune K, Mercier E, Chimot L, Charpentier C, François B, Boulain T, Petitpas F, Constantin JM, Dhonneur G, Baudin F, Combes A, Bohé J, Loriferne JF, Amathieu R, Cook F, Slama M, Leroy O, Capellier G, Dargent A, Hissem T, Maxime V, Bellissant E, CRICS-TRIGGERSEP Network
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock.
The New England Journal of Medicine 2018, 378, 809-818.
Loubet P, Anselem O, Launay O
Immunization during pregnancy.
Expert Review of Vaccines 2018
Raymond S, Nicot F, Pallier C, Bellecave P, Maillard A, Trabaud MA, Morand-Joubert L, Rodallec A, Amiel C, Mourez T, Bocket L, Beby-Defaux A, Bouvier-Alias M, Lambert-Niclot S, Charpentier C, Malve B, Mirand A, Dina J, Le Guillou-Guillemette H, Marque-Juillet S, Signori-Schmuck A, Barin F, Si-Mohamed A, Avettand Fenoel V, Roussel C, Calvez V, Saune K, Marcelin AG, Rodriguez C, Descamps D, Izopet J, French National Agency for Research on AIDS and Viral Hepatitis (ANRS) AC11 Resistance Study Group
Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018, 66, 1588-1594.
Moulignier A, Savatovsky J, Assoumou L, Lescure FX, Lamirel C, Godin O, Valin N, Tubiana R, Canestri A, Roux P, Sadik JC, Salomon L, Abrivard M, Katlama C, Yazdanpanah Y, Pialoux G, Girard PM, Costagliola D, Microvascular Brain Retina and Kidney (MicroBREAK) Study Group
Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy-Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018, 66, 1762-1769.
Birgand G, Zahar JR, Lucet JC
Insight Into the Complex Epidemiology of Multidrug-Resistant Enterobacteriaceae.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018, 66, 494-496.
Melliez H, Mary-Krause M, Bocket L, Guiguet M, Abgrall S, De Truchis P, Katlama C, Martin-Blondel G, Henn A, Revest M, Robineau O, Khuong-Josses MA, Canestri A, De Castro N, Joly V, Mokhtari S, Risso K, Gasnault J, Costagliola D, French Hospital Database on HIV (ANRS-C4)
Risk of Progressive Multifocal Leukoencephalopathy in the Combination Antiretroviral Therapy Era in the French Hospital Database on Human Immunodeficiency Virus (ANRS-C4).
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018
Peiffer-Smadja N, Hanslik T, Mordant P, Lescure FX
Cultural differences between surgical and medical teams: is it time for comanagement?.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018
Argy N, Le Gal S, Coppée R, Song Z, Vindrios W, Massias L, Kao WC, Hunte C, Yazdanpanah Y, Lucet JC, Houzé S, Clain J, Nevez G
Pneumocystis Cytochrome b Mutants Associated With Atovaquone Prophylaxis Failure as the Cause of Pneumocystis Infection Outbreak Among Heart Transplant Recipients.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018, 67, 913-919.
Luong Nguyen LB, Yazdanpanah Y, Maman D, Wanjala S, Vandenbulcke A, Price J, Parker RA, Hennequin W, Mendiharat P, Freedberg KA
Voluntary Community Human Immunodeficiency Virus Testing, Linkage, and Retention in Care Interventions in Kenya: Modeling the Clinical Impact and Cost-effectiveness.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018, 67, 719-726.
Matheron S, Descamps D, Gallien S, Besseghir A, Sellier P, Blum L, Mortier E, Charpentier C, Tubiana R, Damond F, Peytavin G, Ponscarme D, Collin F, Brun-Vezinet F, Chene G, France REcherche Nord&Sud Sida-Hiv Hépatites (ANRS) 159 HIV-2 Trial Study Group
First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2).
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018, 67, 1161-1167.
de Kraker MEA, Sommer H, de Velde F, Gravestock I, Weiss E, McAleenan A, Nikolakopoulos S, Amit O, Ashton T, Beyersmann J, Held L, Lovering AM, MacGowan AP, Mouton JW, Timsit JF, Wilson D, Wolkewitz M, Bettiol E, Dane A, Harbarth S, COMBACTE-NET Consortium
Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms: A White Paper From COMBACTE's STAT-Net.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018, 67, 1922-1931.
Zahar JR, Blot S, Nordmann P, Martischang R, Timsit JF, Harbarth S, Barbier F
Screening for intestinal carriage of ESBL-producing Enterobacteriaceae in critically ill patients: expected benefits and evidence-based controversies.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018
Mariaggi AA, Péré H, Perrier M, Visseaux B, Collin G, Veyer D, Le Hingrat Q, Ferré VM, Joly V, Couvelard A, Bucau M, Davitian C, Descamps D, Abramowitz L, Charpentier C
Presence of Human Papillomavirus (HPV) Apolipoprotein B Messenger RNA Editing, Catalytic Polypeptide-Like 3 (APOBEC)-Related Minority Variants in HPV-16 Genomes From Anal and Cervical Samples but Not in HPV-52 and HPV-58.
The Journal of Infectious Diseases 2018, 218, 1027-1036.
Perrier M, Visseaux B, Landman R, Joly V, Todesco E, Yazdanpanah Y, Calvez V, Marcelin AG, Descamps D, Charpentier C
No impact of HIV-1 protease minority resistant variants on the virological response to a first-line PI-based regimen containing darunavir or atazanavir.
The Journal of Antimicrobial Chemotherapy 2018, 73, 173-176.
Seang S, Schneider L, Nguyen T, Lê MP, Soulie C, Calin R, Caby F, Valantin MA, Tubiana R, Assoumou L, Marcelin AG, Peytavin G, Katlama C
Darunavir/ritonavir monotherapy at a low dose (600/100 mg/day) in HIV-1-infected individuals with suppressed HIV viraemia.
The Journal of Antimicrobial Chemotherapy 2018, 73, 490-493.
de Truchis P, Assoumou L, Landman R, Mathez D, Le Dû D, Bellet J, Amat K, Katlama C, Gras G, Bouchaud O, Duracinsky M, Abe E, Alvarez JC, Izopet J, Saillard J, Melchior JC, Leibowitch J, Costagliola D, Girard PM, Perronne C, ANRS 162-4D Study Group
Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial.
The Journal of Antimicrobial Chemotherapy 2018, 73, 738-747.
Le Meur L, Tantet C, Lê MP, Desselas E, Bonnal C, Lillo-Le-Louet A, Sonneville R, Massias L, Giraud J, Descamps D, Yazdanpanah Y, Lariven S, Peytavin G
Serious neuropsychiatric adverse effects related to interaction between itraconazole and darunavir/ritonavir in an HIV-infected patient with cerebral histoplasmosis.
The Journal of Antimicrobial Chemotherapy 2018, 73, 1108-1110.
Pressiat C, Hirt D, Treluyer JM, Zheng Y, Morlat P, Naqvi A, Tran L, Viard JP, Avettand-Fenoel V, Rouzioux C, Meyer L, Cheret A, OPTIPRIM Study Group
Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial.
The Journal of Antimicrobial Chemotherapy 2018
Charpentier C, Malet I, Andre-Garnier E, Storto A, Bocket L, Amiel C, Morand-Joubert L, Tumiotto C, Nguyen T, Maillard A, Rodallec A, Leoz M, Montes B, Schneider V, Plantier JC, Dina J, Pallier C, Mirand A, Roussel C, Signori-Schmuck A, Raymond S, Calvez V, Delaugerre C, Marcelin AG, Descamps D
Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen.
The Journal of Antimicrobial Chemotherapy 2018, 73, 1039-1044.
Storto A, Visseaux B, Bertine M, Le Hingrat Q, Collin G, Damond F, Khuong MA, Blum L, Tubiana R, Karmochkine M, Cazanave C, Matheron S, Descamps D, Charpentier C, ANRS HIV-2 CO5 Cohort
Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients.
The Journal of Antimicrobial Chemotherapy 2018
Meynard JL, Moinot L, Landman R, Morand-Joubert L, Besseghir A, Kolta S, Spire B, Todesco E, Bouchaud O, Fagard C, Chene G, Girard PM, ANRS 140 DREAM Study Group
Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM).
The Journal of Antimicrobial Chemotherapy 2018
Charpentier C, Peytavin G, Lê MP, Joly V, Cabras O, Perrier M, Le Gac S, Phung B, Yazdanpanah Y, Descamps D, Landman R
High virological suppression regardless of the genotypic susceptibility score after switching to a dolutegravir-based regimen: week 48 results in an observational cohort.
The Journal of Antimicrobial Chemotherapy 2018, 73, 1665-1671.
Lambert-Niclot S, Grude M, Chaix ML, Charpentier C, Reigadas S, Le Guillou-Guillemette H, Rodallec A, Amiel C, Maillard A, Dufayard J, Mourez T, Mirand A, Guinard J, Montes B, Vallet S, Marcelin AG, Descamps D, Flandre P, Delaugerre C, Morand-Joubert L, ANRS AC-11 Resistance Group
Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study).
The Journal of Antimicrobial Chemotherapy 2018
Molina JM, Gallien S, Chaix ML, El Abbassi EM, Madelaine I, Katlama C, Valin N, Delobel P, Desseaux K, Peytavin G, Saillard J, Raffi F, Chevret S, ANRS 165 Darulight Study Group
Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight).
The Journal of Antimicrobial Chemotherapy 2018
Lê MP, Chaix ML, Chevret S, Bertrand J, Raffi F, Gallien S, El Abbassi EMB, Katlama C, Delobel P, Yazdanpanah Y, Saillard J, Molina JM, Peytavin G, ANRS 165 DARULIGHT Study Group
Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study.
The Journal of Antimicrobial Chemotherapy 2018, 73, 2120-2128.
Nguyen T, Fofana DB, Lê MP, Charpentier C, Peytavin G, Wirden M, Lambert-Niclot S, Desire N, Grude M, Morand-Joubert L, Flandre P, Katlama C, Descamps D, Calvez V, Todesco E, Marcelin AG
Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencing.
The Journal of Antimicrobial Chemotherapy 2018, 73, 2485-2492.
Alessandri-Gradt E, Charpentier C, Leoz M, Mourez T, Descamps D, Plantier JC
Impact of natural polymorphisms of HIV-1 non-group M on genotypic susceptibility to the attachment inhibitor fostemsavir.
The Journal of Antimicrobial Chemotherapy 2018
Fofana DB, d'Almeida M, Lambert-Niclot S, Peytavin G, Girard PM, Lafia B, Zohoun-Guidigbi L, Keke RK, Soulie C, Marcelin AG, Morand-Joubert L
Resistance profile and treatment outcomes in HIV-infected children at virological failure in Benin, West Africa.
The Journal of Antimicrobial Chemotherapy 2018
Dimeglio C, Raymond S, Nicot F, Jeanne N, Carcenac R, Lefebvre C, Izopet J, French National Agency for Research on AIDS and Viral Hepatitis (ANRS) AC11 Resistance Study Group
Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen.
The Journal of Antimicrobial Chemotherapy 2018
Cuzin L, Pugliese P, Katlama C, Bani-Sadr F, Ferry T, Rey D, Lourenco J, Bregigeon S, Allavena C, Reynes J, Cabié A, Dat’AIDS Study Group
Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort.
The Journal of Antimicrobial Chemotherapy 2018
Mabileau G, Scutelniciuc O, Tsereteli M, Konorazov I, Yelizaryeva A, Popovici S, Saifuddin K, Losina E, Manova M, Saldanha V, Malkin JE, Yazdanpanah Y
Intervention Packages to Reduce the Impact of HIV and HCV Infections Among People Who Inject Drugs in Eastern Europe and Central Asia: A Modeling and Cost-effectiveness Study.
Open Forum Infectious Diseases 2018, 5, ofy040.
Cazals N, Le Hingrat Q, Abraham B, Da Silva P, Guindre L, Goffart S, Damond F, Visseaux B, Charpentier C, Ranger-Rogez S, Descamps D
HIV-2 Primary Infection in a French 69-Year-Old Bisexual Man.
Open Forum Infectious Diseases 2018, 5, ofy223.
Chaix ML, Charreau I, Pintado C, Delaugerre C, Mahjoub N, Cotte L, Capitant C, Raffi F, Cua E, Pialoux G, Tremblay C, Meyer L, Molina JM, ANRS IPERGAY Study Group
Effect of On-Demand Oral Pre-exposure Prophylaxis With Tenofovir/Emtricitabine on Herpes Simplex Virus-1/2 Incidence Among Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Trial.
Open Forum Infectious Diseases 2018, 5, ofy295.
Dananché C, Vanhems P, Machut A, Aupée M, Bervas C, L'Hériteau F, Lepape A, Lucet JC, Stoeckel V, Timsit JF, Berger-Carbonne A, Savey A, Bénet T, Healthcare-Associated Infections (HAIs) Surveillance Network of ICUs (Réseau REA-Raisin)
Trends of Incidence and Risk Factors of Ventilator-Associated Pneumonia in Elderly Patients Admitted to French ICUs Between 2007 and 2014.
Critical Care Medicine 2018, 46, 869-877.
Sommer H, Timsit JF, von Cube M, Schumacher M, Darmon M, Schwebel C, Ruckly S, Wolkewitz M, COMBACTE-MAGNET Consortium
The Impact of Early Adequate Treatment on Extubation and Discharge Alive of Patients With Pseudomonas aeruginosa-Related Ventilator-Associated Pneumonia.
Critical Care Medicine 2018, 46, 1643-1648.
Gros A, Dupuis C, Ruckly S, Lautrette A, Garrouste-Orgeas M, Gainnier M, Forel JM, Marcotte G, Azoulay E, Cohen Y, Schwebel C, Argaud L, de Montmollin E, Siami S, Goldgran-Toledano D, Darmon M, Timsit JF, OUTCOMEREA Study Group
Association Between Body Weight Variation and Survival and Other Adverse Events in Critically Ill Patients With Shock: A Multicenter Cohort Study of the OUTCOMEREA Network.
Critical Care Medicine 2018, 46, e981-e987.
de Léotoing L, Yazdanpanah Y, Finkielsztejn L, Chaize G, Vainchtock A, Nachbaur G, Aubin C, Bonnet F
Costs associated with hospitalization in HIV-positive patients in France.
AIDS (London, England) 2018, 32, 2059-2066.
Champenois K, Seng R, Persoz A, Essat A, Gaud C, Laureillard D, Robineau O, Duvivier C, Yazdanpanah Y, Goujard C, Meyer L, ANRS PRIMO cohort study group
Calendar trends in sexual behaviours in a cohort of HIV-infected MSM at the era of treatment as prevention of HIV infection.
AIDS (London, England) 2018, 32, 1871-1879.
Colin De Verdiere N, Durier C, Samri A, Meiffredy V, Launay O, Matheron S, Mercier-Delarue S, Even S, Aboulker JP, Molina JM, Autran B, Simon F, and the ANRS EP46 NOVAA Group
Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients: ANRS EP46 NOVAA.
AIDS (London, England) 2018
Benhammou V, Tubiana R, Matheron S, Sellier P, Mandelbrot L, Chenadec JL, Marel E, Khoshnood B, Warszawski J, ANRS CO1/CO11-EPF French Perinatal Cohort study group
HBV or HCV Coinfection in HIV-1-Infected Pregnant Women in France: Prevalence and Pregnancy Outcomes.
Journal of Acquired Immune Deficiency Syndromes (1999) 2018, 77, 439-450.
Costagliola D, Potard V, Lang S, Abgrall S, Duvivier C, Fischer H, Joly V, Lacombe JM, Valantin MA, Mary-Krause M, Rozenberg S, FHDH ANRS CO4
Impact of antiretroviral drugs on fracture risk in HIV-infected individuals: A case-control study nested within the French Hospital Database on HIV (FHDH-ANRS CO4).
Journal of Acquired Immune Deficiency Syndromes (1999) 2018
Provoost A, Dramé M, Cotte L, Cuzin L, Garraffo R, Rey D, Raffi F, Poizot-Martin I, Pugliese P, Bani-Sadr F, Dat'AIDS study group
Risk of diabetes in HIV-infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort.
Alimentary Pharmacology & Therapeutics 2018
Brunet-Possenti F, Charpentier C, Collin G, Descamps D, Descamps V
Impact of anti-interleukin-17 treatment on cutaneous and genital human papillomavirus infection.
The British Journal of Dermatology 2018, 179, 1179-1180.
Pouga L, Mercedes Santoro M, Charpentier C, Di Carlo D, Romeo I, Artese A, Alcaro S, Antinori A, Wirden M, Perno CF, Ambrosio FA, Calvez V, Descamps D, Marcelin AG, Ceccherini-Silberstein F, Lambert-Niclot S
New Resistance Mutations to Nucleoside Reverse Transcriptase Inhibitors at Codon 184 of HIV-1 Reverse Transcriptase (M184L and M184T).
Chemical Biology & Drug Design 2018
Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord
Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?.
HIV medicine 2018, 19, 42-48.
Cuzin L, Yazdanpanah Y, Huleux T, Cotte L, Pugliese P, Allavena C, Reynes J, Poizot-Martin I, Bani-Sadr F, Delpierre C, Dat'AIDS Study Group
No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France.
HIV medicine 2018, 19, 238-242.
Rosenthal E, Fougerou-Leurent C, Renault A, Carrieri MP, Marcellin F, Garraffo R, Teicher E, Aumaitre H, Lacombe K, Bailly F, Billaud E, Chevaliez S, Dominguez S, Valantin MA, Reynes J, Naqvi A, Cotte L, Metivier S, Leroy V, Dupon M, Allegre T, De Truchis P, Jeantils V, Chas J, Salmon-Ceron D, Morlat P, Neau D, Perré P, Piroth L, Pol S, Bourlière M, Pageaux GP, Alric L, Zucman D, Girard PM, Poizot-Martin I, Yazdanpanah Y, Raffi F, Pabic EL, Tual C, Pailhé A, Amri I, Bellissant E, Molina JM, ANRS HC31 SOFTRIH Study Group
Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study).
HIV medicine 2018, 19, 227-237.
Hentzien M, Cabie A, Pugliese P, Billaud É, Poizot-Martin I, Duvivier C, Valantin MA, Kaladjian A, Dramé M, Bani-Sadr F, Dat'AIDS Study Group
Factors associated with deaths from suicide in a French nationwide HIV-infected cohort.
HIV medicine 2018
Gallien S, Massetti M, Flandre P, Leleu H, Descamps D, Lazaro E
Comparison of 48-week efficacies of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide and nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimens: a systematic review and network meta-analysis.
HIV medicine 2018
Nassereddine H, Charpentier C, Bucau M, Joly V, Bienvenu L, Davitian C, Abramowitz L, Benabderrahmane D, Kotelevets L, Chastre E, Lehy T, Walker F
Interest of cytology combined with Xpert® HPV and Anyplex® II HPV28 Detection human papillomavirus (HPV) typing: differential profiles of anal and cervical HPV lesions in HIV-infected patients on antiretroviral therapy.
HIV medicine 2018
Papatheodoridis GV, Hatzakis A, Cholongitas E, Baptista-Leite R, Baskozos I, Chhatwal J, Colombo M, Cortez-Pinto H, Craxi A, Goldberg D, Gore C, Kautz A, Lazarus JV, Mendão L, Peck-Radosavljevic M, Razavi H, Schatz E, Tözün N, van Damme P, Wedemeyer H, Yazdanpanah Y, Zuure F, Manns MP
Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
Journal of Viral Hepatitis 2018, 25 Suppl 1, 6-17.
Cousien A, Tran VC, Deuffic-Burban S, Jauffret-Roustide M, Mabileau G, Dhersin JS, Yazdanpanah Y
Effectiveness and cost-effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: The case of France.
Journal of Viral Hepatitis 2018, 25, 1197-1207.
Rouzaud C, Rodriguez-Nava V, Catherinot E, Méchaï F, Bergeron E, Farfour E, Scemla A, Poirée S, Delavaud C, Mathieu D, Durupt S, Larosa F, Lengelé JP, Christophe JL, Suarez F, Lortholary O, Lebeaux D
Clinical Assessment of a Nocardia PCR-Based Assay for Diagnosis of Nocardiosis.
Journal of Clinical Microbiology 2018, 56,
Jary A, Leducq V, Palich R, Gothland A, Descamps D, Joly V, Lambert-Niclot S, Amiel C, Canestri A, Mirand A, Gault E, Vabret A, Valantin MA, Katlama C, Calvez V, Dupin N, Spano JP, Marcelin AG
Usefulness of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) DNA Viral Load in Whole Blood for Diagnosis and Monitoring of KSHV-Associated Diseases.
Journal of Clinical Microbiology 2018, 56,
Burdet C, Loubet P, Le Moing V, Vindrios W, Esposito-Farèse M, Linard M, Ferry T, Massias L, Tattevin P, Wolff M, Vandenesch F, Grall N, Quintin C, Mentré F, Duval X, Lescure FX, CloCeBa study group
Efficacy of cloxacillin versus cefazolin for methicillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): study protocol for a randomised, controlled, non-inferiority trial.
BMJ open 2018, 8, e023151.
Kirchgesner J, Beaugerie L, Carrat F, Andersen NN, Jess T, Schwarzinger M, BERENICE study group
Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study.
Gut 2018, 67, 1261-1268.
Januel E, Martin-Blondel G, Lamirel C, Picard H, Pialoux G, Katlama C, Cochereau I, Lescure FX, Moulignier A
Do CCR5 antagonists improve the overall survival of patients with AIDS-related progressive multifocal leucoencephalopathy?.
Journal of Neurology, Neurosurgery, and Psychiatry 2018, 89, 1125-1126.
Bleibtreu A, Jaureguiberry S, Houhou N, Boutolleau D, Guillot H, Vallois D, Lucet JC, Robert J, Mourvillier B, Delemazure J, Jaspard M, Lescure FX, Rioux C, Caumes E, Yazdanapanah Y
Clinical management of respiratory syndrome in patients hospitalized for suspected Middle East respiratory syndrome coronavirus infection in the Paris area from 2013 to 2016.
BMC infectious diseases 2018, 18, 331.
Désiré N, Cerutti L, Le Hingrat Q, Perrier M, Emler S, Calvez V, Descamps D, Marcelin AG, Hué S, Visseaux B
Characterization update of HIV-1 M subtypes diversity and proposal for subtypes A and D sub-subtypes reclassification.
Retrovirology 2018, 15, 80.
Cantier M, Morisot A, Guérot E, Megarbane B, Razazi K, Contou D, Mariotte E, Canet E, De Montmollin E, Dubée V, Boulet E, Gaudry S, Voiriot G, Mayaux J, Pène F, Neuville M, Mourvillier B, Ruckly S, Bouadma L, Wolff M, Timsit JF, Sonneville R, ENCEPHALITICA study group
Functional outcomes in adults with tuberculous meningitis admitted to the ICU: a multicenter cohort study.
Critical Care (London, England) 2018, 22, 210.
Truche AS, Ragey SP, Souweine B, Bailly S, Zafrani L, Bouadma L, Clec'h C, Garrouste-Orgeas M, Lacave G, Schwebel C, Guebre-Egziabher F, Adrie C, Dumenil AS, Zaoui P, Argaud L, Jamali S, Goldran Toledano D, Marcotte G, Timsit JF, Darmon M
ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients.
Annals of Intensive Care 2018, 8, 127.
Birgand G, Castro-Sánchez E, Hansen S, Gastmeier P, Lucet JC, Ferlie E, Holmes A, Ahmad R
Comparison of governance approaches for the control of antimicrobial resistance: Analysis of three European countries.
Antimicrobial Resistance and Infection Control 2018, 7, 28.
Bougnoux ME, Brun S, Zahar JR
Healthcare-associated fungal outbreaks: New and uncommon species, New molecular tools for investigation and prevention.
Antimicrobial Resistance and Infection Control 2018, 7, 45.
Perrier M, Désiré N, Storto A, Todesco E, Rodriguez C, Bertine M, Le Hingrat Q, Visseaux B, Calvez V, Descamps D, Marcelin AG, Charpentier C
Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants.
PloS One 2018, 13, e0198334.
Allavena C, Hanf M, Rey D, Duvivier C, BaniSadr F, Poizot-Martin I, Jacomet C, Pugliese P, Delobel P, Katlama C, Joly V, Chidiac C, Dournon N, Merrien D, May T, Reynes J, Gagneux-Brunon A, Chirouze C, Huleux T, Cabié A, Raffi F, Dat’AIDS study group
Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients.
PloS One 2018, 13, e0203895.
de Monteynard LA, Matheron S, Grabar S, de Truchis P, Gilquin J, Pavie J, Launay O, Meynard JL, Khuong-Josses MA, Rey D, Mahamat A, Dray-Spira R, Simon A, Costagliola D, Abgrall S, FHDH-ANRS CO4
Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in France.
PloS One 2018, 13, e0205385.
Arrive E, Viard JP, Salanave B, Dollfus C, Matheron S, Reliquet V, Arezes E, Nailler L, Vigouroux C, Warszawski J, ANRS CO19 COVERTE and ENNS study groups
Metabolic risk factors in young adults infected with HIV since childhood compared with the general population.
PloS One 2018, 13, e0206745.
Lorme F, Maataoui N, Rondinaud E, Esposito-Farèse M, Clermont O, Ruppe E, Arlet G, Genel N, VOYAG-R study group, Matheron S, Andremont A, Armand-Lefevre L
Acquisition of plasmid-mediated cephalosporinase producing Enterobacteriaceae after a travel to the tropics.
PloS One 2018, 13, e0206909.
Pilmis B, Zahar JR
Ventilator-associated pneumonia related to ESBL-producing gram negative bacilli.
Annals of Translational Medicine 2018, 6, 424.
Gangneux JP, Cornet M, Bailly S, Fradin C, Féger C, Timsit JF, Leroy O, Sendid B, Bougnoux ME
Clinical Impact of Antifungal Susceptibility, Biofilm Formation and Mannoside Expression of Candida Yeasts on the Outcome of Invasive Candidiasis in ICU: An Ancillary Study on the Prospective AmarCAND2 Cohort.
Frontiers in Microbiology 2018, 9, 2907.
Ségéral O, Nerrienet E, Neth S, Spire B, Khol V, Ferradini L, Sarun S, Mom C, Ngin S, Charpentier C, Men P, Mora M, Mean Chhi V, Ly P, Saphonn V
Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study.
Frontiers in Public Health 2018, 6, 63.
Charpentier C, Descamps D
Resistance to HIV Integrase Inhibitors: About R263K and E157Q Mutations.
Viruses 2018, 10,
Todesco E, Mazzola A, Akhavan S, Abravanel F, Poynard T, Roque-Afonso AM, Peytavin G, Marcelin AG, Calmus Y, Lecuyer L, Guillemain R, Conti F
Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective.
Antiviral Therapy 2018
Salmon D, Trimoulet P, Gilbert C, Solas C, Lafourcade E, Chas J, Piroth L, Lacombe K, Katlama C, Peytavin G, Aumaitre H, Alric L, Boué F, Morlat P, Poizot-Martin I, Billaud E, Rosenthal E, Naqvi A, Miailhes P, Bani-Sadr F, Esterle L, Carrieri P, Dabis F, Sogni P, Wittkop L, ANRS CO13 Hepavih study Group
Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients.
World Journal of Hepatology 2018, 10, 856-866.
2017
Khoo S, Peytavin G, Burger D, Hill A, Brown K, Moecklinghoff C, La Porte C, Hadacek MB
Pharmacokinetics and Safety of Darunavir/Ritonavir in HIV-Infected Pregnant Women.
AIDS reviews 2017, 19, 16-23.
Gantner P, Mélard A, Damond F, Delaugerre C, Dina J, Gueudin M, Maillard A, Sauné K, Rodallec A, Tuaillon E, Plantier JC, Rouzioux C, Avettand-Fenoel V, ANRS-AC11 Quantification Working Group
Interlaboratory quality control of total HIV-1 DNA load measurement for multicenter reservoir studies.
Journal of Medical Virology 2017, 89, 2047-2050.
Sonneville R, Gimenez L, Labreuche J, Smonig R, Magalhaes E, Bouadma L, Timsit JF, Mazighi M
What is the prognosis of acute stroke patients requiring ICU admission?.
Intensive Care Medicine 2017, 43, 271-272.
Capuzzo M, Garrouste-Orgeas M, Martin-Loeches I
What were you able to do in your daily life? Performance status for the critically ill patient.
Intensive Care Medicine 2017, 43, 104-106.
Kentish-Barnes N, Chevret S, Champigneulle B, Thirion M, Souppart V, Gilbert M, Lesieur O, Renault A, Garrouste-Orgeas M, Argaud L, Venot M, Demoule A, Guisset O, Vinatier I, Troché G, Massot J, Jaber S, Bornstain C, Gaday V, Robert R, Rigaud JP, Cinotti R, Adda M, Thomas F, Calvet L, Galon M, Cohen-Solal Z, Cariou A, Azoulay E, Famirea Study Group
Effect of a condolence letter on grief symptoms among relatives of patients who died in the ICU: a randomized clinical trial.
Intensive Care Medicine 2017, 43, 473-484.
Bassetti M, Garnacho-Montero J, Calandra T, Kullberg B, Dimopoulos G, Azoulay E, Chakrabarti A, Kett D, Leon C, Ostrosky-Zeichner L, Sanguinetti M, Timsit JF, Richardson MD, Shorr A, Cornely OA
Intensive care medicine research agenda on invasive fungal infection in critically ill patients.
Intensive Care Medicine 2017, 43, 1225-1238.
Cambau E, Durand-Zaleski I, Bretagne S, Brun-Buisson C, Cordonnier C, Duval X, Herwegh S, Pottecher J, Courcol R, Bastuji-Garin S, EVAMICA study team
Performance and economic evaluation of the molecular detection of pathogens for patients with severe infections: the EVAMICA open-label, cluster-randomised, interventional crossover trial.
Intensive Care Medicine 2017, 43, 1613-1625.
Poulakou G, Matthaiou DK, Bassetti M, Erdem H, Dimopoulos G, Curcio DJ, Carlet J, Lipman J, Timsit JF, Giamarellou H, Arfaras-Melainis A, Rello J, ESGCIP Investigators
"Salvage treatment" for infections by extensively- and pan-drug-resistant pathogens is common and often sub-optimal.
Intensive Care Medicine 2017, 43, 1164-1166.
Timsit JF, de Kraker MEA, Sommer H, Weiss E, Bettiol E, Wolkewitz M, Nikolakopoulos S, Wilson D, Harbarth S, COMBACTE-NET consortium
Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE's STAT-Net.
Intensive Care Medicine 2017, 43, 1002-1012.
Sonneville R, de Montmollin E, Poujade J, Garrouste-Orgeas M, Souweine B, Darmon M, Mariotte E, Argaud L, Barbier F, Goldgran-Toledano D, Marcotte G, Dumenil AS, Jamali S, Lacave G, Ruckly S, Mourvillier B, Timsit JF
Potentially modifiable factors contributing to sepsis-associated encephalopathy.
Intensive Care Medicine 2017, 43, 1075-1084.
Perner A, Gordon AC, Angus DC, Lamontagne F, Machado F, Russell JA, Timsit JF, Marshall JC, Myburgh J, Shankar-Hari M, Singer M
The intensive care medicine research agenda on septic shock.
Intensive Care Medicine 2017, 43, 1294-1305.
Laupland KB, Paiva JA, Timsit JF
Focus on severe infections.
Intensive Care Medicine 2017, 43, 1033-1036.
Yamaga S, Shime N, Sonneville R, de Montmollin E, Timsit JF
Risk factors for sepsis-associated encephalopathy.
Intensive Care Medicine 2017, 43, 1548-1549.
Robert R, Le Gouge A, Kentish-Barnes N, Cottereau A, Giraudeau B, Adda M, Annane D, Audibert J, Barbier F, Bardou P, Bourcier S, Bourenne J, Boyer A, Brenas F, Das V, Desachy A, Devaquet J, Feissel M, Ganster F, Garrouste-Orgeas M, Grillet G, Guisset O, Hamidfar-Roy R, Hyacinthe AC, Jochmans S, Jourdain M, Lautrette A, Lerolle N, Lesieur O, Lion F, Mateu P, Megarbane B, Merceron S, Mercier E, Messika J, Morin-Longuet P, Philippon-Jouve B, Quenot JP, Renault A, Repesse X, Rigaud JP, Robin S, Roquilly A, Seguin A, Thevenin D, Tirot P, Vinatier I, Azoulay E, Reignier J
Terminal weaning or immediate extubation for withdrawing mechanical ventilation in critically ill patients (the ARREVE observational study).
Intensive Care Medicine 2017, 43, 1793-1807.
Lefebvre A, Lucet JC, Bertrand X, Chavanet P, Astruc K, Quantin C, Vanhems P, Aho-Glélé LS
Detection of temporal clusters of health care-associated infections or colonizations with Pseudomonas aeruginosa.
American Journal of Infection Control 2017, 45, 72-74.
Pilmis B, Thepot-Seegers V, Angebault C, Weiss E, Alaabouche I, Bougnoux ME, Zahar JR
Could we predict airborne Aspergillus contamination during construction work?.
American Journal of Infection Control 2017, 45, 39-41.
Montravers P, Perrigault PF, Timsit JF, Mira JP, Lortholary O, Leroy O, Gangneux JP, Guillemot D, Bensoussan C, Bailly S, Azoulay E, Constantin JM, Dupont H, AmarCAND2 Study Group
Antifungal therapy for patients with proven or suspected Candida peritonitis: Amarcand2, a prospective cohort study in French intensive care units.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2017, 23, 117.e1-117.e8.
Argy N, Bertin GI, Milet J, Hubert V, Clain J, Cojean S, Houzé P, Tuikue-Ndam N, Kendjo E, Deloron P, Houzé S, CNRP Study Group
Preferential expression of domain cassettes 4, 8 and 13 of Plasmodium falciparum erythrocyte membrane protein 1 in severe malaria imported in France.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2017, 23, 211.e1-211.e4.
Loubet P, Lenzi N, Valette M, Foulongne V, Krivine A, Houhou N, Lagathu G, Rogez S, Alain S, Duval X, Galtier F, Postil D, Tattevin P, Vanhems P, Carrat F, Lina B, Launay O
Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France.
Clin Microbiol Infect 2017, 23, 253-259.
Bleibtreu A, Arias P, Vallois D, Debit A, Lermuzeaux M, Rioux C, Cabras O, Lucet JC, Choquet C, Timsit JF, Yazdanpanah Y, Lescure FX
Delayed management of Staphyloccocus aureus infective endocarditis in a Middle East respiratory syndrome coronavirus possible case hospitalized in 2015 in Paris, France.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2017, 23, 416-417.
Rhee SY, Varghese V, Holmes SP, Van Zyl GU, Steegen K, Boyd MA, Cooper DA, Nsanzimana S, Saravanan S, Charpentier C, de Oliveira T, Etiebet MAA, Garcia F, Goedhals D, Gomes P, Günthard HF, Hamers RL, Hoffmann CJ, Hunt G, Jiamsakul A, Kaleebu P, Kanki P, Kantor R, Kerschberger B, Marconi VC, D'amour Ndahimana J, Ndembi N, Ngo-Giang-Huong N, Rokx C, Santoro MM, Schapiro JM, Schmidt D, Seu L, Sigaloff KCE, Sirivichayakul S, Skhosana L, Sunpath H, Tang M, Yang C, Carmona S, Gupta RK, Shafer RW
Mutational correlates of virological failure in individuals receiving a WHO-recommended tenofovir-containing first-line regimen: An international collaboration.
EBioMedicine 2017
Guet-Revillet H, Tomini E, Emirian A, Join-Lambert O, Lécuyer H, Zahar JR, Jullien V
Piperacillin/tazobactam as an alternative antibiotic therapy to carbapenems in the treatment of urinary tract infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae: an in silico pharmacokinetic study.
International Journal of Antimicrobial Agents 2017, 49, 62-66.
Zahar JR, Lesprit P, Ruckly S, Eden A, Hikombo H, Bernard L, Harbarth S, Timsit JF, Brun-Buisson C, BacterCom Study Group
Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae.
International Journal of Antimicrobial Agents 2017, 49, 67-73.
Bailly S, Leroy O, Dupont H, Timsit JF
Secondarily documented invasive candidiasis is unpredictable using traditional risk factors in non transplant - non-neutropenic adult ICU patients.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2017, 54, 31-33.
Loubet P, Voiriot G, Houhou-Fidouh N, Neuville M, Bouadma L, Lescure FX, Descamps D, Timsit JF, Yazdanpanah Y, Visseaux B
Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: A single-center retrospective study.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2017, 91, 52-57.
Wirden M, Larrouy L, Mahjoub N, Todesco E, Damond F, Delagreverie H, Akhavan S, Charpentier C, Chaix ML, Descamps D, Calvez V, Marcelin AG
Multicenter comparison of the new Cobas 6800 system with Cobas Ampliprep/Cobas TaqMan and Abbott RealTime for the quantification of HIV, HBV and HCV viral load.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2017, 96, 49-53.
Antoniol S, Fidouh N, Ghazali A, Ichou H, Bouzid D, Kenway P, Choquet C, Visseaux B, Casalino E, Emergency Department study group on respiratory viruses
Diagnostic performances of the Xpert® Flu PCR test and the OSOM® immunochromatographic rapid test for influenza A and B virus among adult patients in the Emergency Department.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2017, 99-100, 5-9.
Deuffic-Burban S, Boursier J, Leroy V, Yazdanpanah Y, Castera L, Mathurin P
Are targeted treatment recommendations in chronic hepatitis C tailored to diagnostic methods of fibrosis?.
Journal of Hepatology 2017, 66, 304-312.
Mallet V, Hamed K, Schwarzinger M
Prognosis of patients with chronic hepatitis B in France (2008-2013): A nationwide, observational and hospital-based study.
Journal of Hepatology 2017, 66, 514-520.
Schwarzinger M, Baillot S, Yazdanpanah Y, Rehm J, Mallet V
Contribution of alcohol use disorders on the burden of chronic hepatitis C in France, 2008-2013: A nationwide retrospective cohort study.
Journal of Hepatology 2017, 67, 454-461.
Loison G, Troughton R, Raymond F, Lepelletier D, Lucet JC, Avril C, Birgand G, ARLIN Working Group
Compliance with clothing regulations and traffic flow in the operating room: a multi-centre study of staff discipline during surgical procedures.
The Journal of Hospital Infection 2017, 96, 281-285.
Adrie C, Garrouste-Orgeas M, Ibn Essaied W, Schwebel C, Darmon M, Mourvillier B, Ruckly S, Dumenil AS, Kallel H, Argaud L, Marcotte G, Barbier F, Laurent V, Goldgran-Toledano D, Clec'h C, Azoulay E, Souweine B, Timsit JF, OUTCOMEREA Study Group*
Attributable mortality of ICU-acquired bloodstream infections: Impact of the source, causative micro-organism, resistance profile and antimicrobial therapy.
The Journal of Infection 2017, 74, 131-141.
Bailly S, Leroy O, Azoulay E, Montravers P, Constantin JM, Dupont H, Guillemot D, Lortholary O, Mira JP, Perrigault PF, Gangneux JP, Timsit JF, AmarCAND2 Study Group
Impact of echinocandin on prognosis of proven invasive candidiasis in ICU: A post-hoc causal inference model using the AmarCAND2 study.
The Journal of Infection 2017, 74, 408-417.
Baldesi O, Bailly S, Ruckly S, Lepape A, L'Heriteau F, Aupee M, Boussat S, Bervas C, Machut A, Berger-Carbonne A, Savey A, Timsit JF, REA-RAISIN network
ICU-acquired candidaemia in France: Epidemiology and temporal trends, 2004-2013 - A study from the REA-RAISIN network.
The Journal of Infection 2017, 75, 59-67.
Welfringer A, Vuong V, Argy N, Chochillon C, Deschamps L, Rollin G, Harent S, Joly V, Vindrios W, Descamps V
A rare fungal infection: Phaehyphomycosis due to Veronaea botryosa and review of literature.
Medical Mycology Case Reports 2017, 15, 21-24.
Lequilliec N, Raymond R, Vanjak D, Baghdadi N, Boulestreau H, Zahar JR, Gangneux JP
Practices of infectious control management during neutropenia: A survey from 149 French hospitals.
Journal De Mycologie Medicale 2017, 27, 227-231.
Hoogewoud F, Frumholtz L, Loubet P, Charlier C, Blanche P, Lebeaux D, Benhaddou N, Sedira N, Coutte L, Vanhaecke C, Launay O, Le Jeunne C, Héron E, Monnet D, Lortholary O, Sahel JA, Dupin N, Brézin A, Errera MH, Salah S, Groh M
Prognostic Factors in Syphilitic Uveitis.
Ophthalmology 2017, 124, 1808-1816.
Pourcher G, Peytavin G, Schneider L, Gallien S, Force G, Pourcher V
Bariatric surgery in HIV patients: experience of an Obesity Reference Center in France.
Surgery for Obesity and Related Diseases: Official Journal of the American Society for Bariatric Surgery 2017, 13, 1990-1996.
Peiffer-Smadja N, Ouedraogo R, D'Ortenzio E, Cissé PN, Zeggani Z, Beavogui AH, Faye SL, Le Marcis F, Yazdanpanah Y, Nguyen VK
Vaccination and blood sampling acceptability during Ramadan fasting month: A cross-sectional study in Conakry, Guinea.
Vaccine 2017, 35, 2569-2574.
Charlier C, Perrodeau É, Leclercq A, Cazenave B, Pilmis B, Henry B, Lopes A, Maury MM, Moura A, Goffinet F, Dieye HB, Thouvenot P, Ungeheuer MN, Tourdjman M, Goulet V, de Valk H, Lortholary O, Ravaud P, Lecuit M, MONALISA study group
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.
The Lancet. Infectious Diseases 2017
Badje A, Moh R, Gabillard D, Guéhi C, Kabran M, Ntakpé JB, Carrou JL, Kouame GM, Ouattara E, Messou E, Anzian A, Minga A, Gnokoro J, Gouesse P, Emieme A, Toni Td, Rabe C, Sidibé B, Nzunetu G, Dohoun L, Yao A, Kamagate S, Amon S, Kouame AB, Koua A, Kouamé E, Daligou M, Hawerlander D, Ackoundzé S, Koule S, Séri J, Ani A, Dembélé F, Koné F, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatunde N, Bleoué G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Karcher S, Rouzioux C, Kouame A, Assi R, Bakayoko A, Domoua SK, Deschamps N, Aka K, N'Dri-Yoman T, Salamon R, Journot V, Ahibo H, Ouassa T, Menan H, Inwoley A, Danel C, Eholié SP, Anglaret X, Temprano ANRS 12136 Study Group
Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial.
The Lancet. Global Health 2017, 5, e1080-e1089.
Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, Tremblay C, Rojas-Castro D, Cua E, Pasquet A, Bernaud C, Pintado C, Delaugerre C, Sagaon-Teyssier L, Mestre SL, Chidiac C, Pialoux G, Ponscarme D, Fonsart J, Thompson D, Wainberg MA, Doré V, Meyer L, ANRS IPERGAY Study Group
Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
The lancet. HIV 2017, 4, e402-e410.
Mamede JI, Damond F, Bernardo Ad, Matheron S, Descamps D, Battini JL, Sitbon M, Courgnaud V
Cyclophilins and nucleoporins are required for infection mediated by capsids from circulating HIV-2 primary isolates.
Scientific Reports 2017, 7, 45214.
Timsit JF, Pilmis B, Zahar JR
How Should We Treat Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae?.
Seminars in Respiratory and Critical Care Medicine 2017, 38, 287-300.
Post FA, Yazdanpanah Y, Schembri G, Lazzarin A, Reynes J, Maggiolo F, Yan M, Abram ME, Tran-Muchowski C, Cheng A, Rhee MS
Efficacy and safety of emtricitabine/tenofovir alafenamide (FTC/TAF) vs. emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) as a backbone for treatment of HIV-1 infection in virologically suppressed adults: subgroup analysis by third agent of a randomized, double-blind, active-controlled phase 3 trial.
HIV clinical trials 2017, 18, 135-140.
Pichon M, Mikail N, Ben Ali K, Rouzet F, Burdet C, Yazdanpanah Y, Joly V, Lepage L, Sarda-Mantel L
18FDG-PET/CT: a useful tool for the management of patients in infectious diseases.
Infect Dis (Lond) 2017, 49, 155-157.
Senard O, Burdet C, Visseaux B, Charpentier C, Le Gac S, Julia Z, Lariven S, Descamps D, Yazdanpanah Y, Yeni P, Joly V
Epidemiological Profile of Newly Diagnosed HIV-Infected Patients in Northern Paris: A Retrospective Study.
AIDS Res Hum Retroviruses 2017, 33, 11-16.
Pourcher V, Desnoyer A, Assoumou L, Lebbe C, Curjol A, Marcelin AG, Cardon F, Gibowski S, Salmon D, Chennebault JM, Poizot-Martin I, Peytavin G, Boué F, Costagliola D
Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial.
AIDS research and human retroviruses 2017, 33, 1–10.
Unal G, Alessandri-Gradt E, Leoz M, Pavie J, Lefevre C, Panjo H, Charpentier C, Descamps D, Barin F, Simon F, Meyer L, Plantier JC
HIV-1 group O infection in France: clinical features and immunovirological response to antiretrovirals.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2017
Duval X, Millot S, Chirouze C, Selton-Suty C, Moby V, Tattevin P, Strady C, Euvrard E, Agrinier N, Thomas D, Hoen B, Alla F, EI-dents Association pour l'Etude et la Prévention de l'Endocardite Infectieuse (AEPEI) Study Group
Oral Streptococcal Endocarditis, Oral Hygiene Habits, and Recent Dental Procedures: A Case-Control Study.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2017, 64, 1678-1685.
Tschudin-Sutter S, Lucet JC, Mutters NT, Tacconelli E, Zahar JR, Harbarth S
Contact precautions for preventing nosocomial transmission of ESBL-producing Escherichia coli - a point/counterpoint review.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2017, 65, 342-347.
Vindrios W, Argy N, Le Gal S, Lescure FX, Massias L, Le MP, Wolff M, Yazdanpanah Y, Nevez G, Houze S, Dorent R, Lucet JC
Outbreak of Pneumocystis jirovecii Infection Among Heart Transplant Recipients: Molecular Investigation and Management of an Interhuman Transmission.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2017, 65, 1120-1126.
Jullien V, Azoulay E, Schwebel C, Le Saux T, Charles PE, Cornet M, Souweine B, Klouche K, Jaber S, Trouillet JL, Bruneel F, Cour M, Cousson J, Meziani F, Gruson D, Paris A, Darmon M, Garrouste-Orgeas M, Navellou JC, Foucrier A, Allaouchiche B, Das V, Gangneux JP, Ruckly S, Wolff M, Timsit JF, ETSG
Population pharmacokinetics of micafungin in ICU patients with sepsis and mechanical ventilation.
The Journal of Antimicrobial Chemotherapy 2017, 72, 181-189.
Calvez V, Hocqueloux L, Meynard JL, Muret P, Castan B, Tardy JC, Peytavin G, Landman R
Less-drug regimen including atazanavir in maintenance treatment of HIV infection: how, who, when, why?.
The Journal of Antimicrobial Chemotherapy 2017, 72, 19-28.
Raffi F, Le Moing V, Assuied A, Habak S, Spire B, Cazanave C, Billaud E, Dellamonica P, Ferry T, Fagard C, Leport C, ANRS CO8 COPILOTE Study Group
Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course.
The Journal of Antimicrobial Chemotherapy 2017, 72, 240-245.
Fonsart J, Saragosti S, Taouk M, Peytavin G, Bushman L, Charreau I, Hance A, Goldwirt L, Morel S, Mammano F, Loze B, Capitant C, Clavel F, Mahjoub N, Meyer L, Anderson PL, Delaugerre C, Molina JM
Single-dose pharmacokinetics and pharmacodynamics of oral tenofovir and emtricitabine in blood, saliva and rectal tissue: a sub-study of the ANRS IPERGAY trial.
The Journal of Antimicrobial Chemotherapy 2017, 72, 478–485.
Briand C, Dollfus C, Faye A, Kantor E, Avettand-Fenoel V, Caseris M, Descamps D, Schneider V, Tabone MD, Vaudre G, Veber F, Blanche S, Frange P
Efficacy and tolerance of dolutegravir-based combined ART in perinatally HIV-1-infected adolescents: a French multicentre retrospective study.
The Journal of Antimicrobial Chemotherapy 2017, 72, 837–843.
Wirden M, Charpentier C, Tubiana R, Le MP, Desire N, Dionou S, Pichon F, Valantin MA, Yasdanpanah Y, Descamps D, Peytavin G, Katlama C, Calvez V, Marcelin AG
HIV-1 diagnosis with unquantifiable viraemia: don't be naive, look for antiretroviral drugs.
The Journal of Antimicrobial Chemotherapy 2017, 72, 630-632.
Madelain V, Le MP, Champenois K, Charpentier C, Landman R, Joly V, Yeni P, Descamps D, Yazdanpanah Y, Peytavin G
Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study.
The Journal of Antimicrobial Chemotherapy 2017, 72, 1137-1146.
Perrier M, Charpentier C, Peytavin G, Lê M, Blondel L, Visseaux B, Joly V, Pinto A, Matheron S, Yazdanpanah Y, Descamps D, Landman R
Switch as maintenance to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate: week 48 results in a clinical cohort.
The Journal of Antimicrobial Chemotherapy 2017, 72, 1745-1751.
Assoumou L, Charpentier C, Recordon-Pinson P, Grudé M, Pallier C, Morand-Joubert L, Fafi-Kremer S, Krivine A, Montes B, Ferré V, Bouvier-Alias M, Plantier JC, Izopet J, Trabaud MA, Yerly S, Dufayard J, Alloui C, Courdavault L, Le Guillou-Guillemette H, Maillard A, Amiel C, Vabret A, Roussel C, Vallet S, Guinard J, Mirand A, Beby-Defaux A, Barin F, Allardet-Servent A, Ait-Namane R, Wirden M, Delaugerre C, Calvez V, Chaix ML, Descamps D, Reigadas S, ANRS AC-11 Resistance Study Group
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study.
The Journal of Antimicrobial Chemotherapy 2017, 72, 1769-1773.
Soulie C, Grudé M, Descamps D, Amiel C, Morand-Joubert L, Raymond S, Pallier C, Bellecave P, Reigadas S, Trabaud MA, Delaugerre C, Montes B, Barin F, Ferré V, Jeulin H, Alloui C, Yerly S, Signori-Schmuck A, Guigon A, Fafi-Kremer S, Haïm-Boukobza S, Mirand A, Maillard A, Vallet S, Roussel C, Assoumou L, Calvez V, Flandre P, Marcelin AG, ANRS AC11 Resistance Study Group
Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma.
The Journal of Antimicrobial Chemotherapy 2017, 72, 2351-2354.
Alessandri-Gradt E, Collin G, Tourneroche A, Bertine M, Leoz M, Charpentier C, Unal G, Descamps D, Plantier JC
HIV-1 non-group M phenotypic susceptibility to integrase strand transfer inhibitors.
The Journal of Antimicrobial Chemotherapy 2017, 72, 2431-2437.
Perrier M, Bertine M, Le Hingrat Q, Joly V, Visseaux B, Collin G, Landman R, Yazdanpanah Y, Descamps D, Charpentier C
Prevalence of gag mutations associated with in vitro resistance to capsid inhibitor GS-CA1 in HIV-1 antiretroviral-naive patients.
The Journal of Antimicrobial Chemotherapy 2017, 72, 2954-2955.
Wittkop L, Arsandaux J, Trevino A, Schim van der Loeff M, Anderson J, van Sighem A, Böni J, Brun-Vezinet F, Soriano V, Boufassa F, Brockmeyer N, Calmy A, Dabis F, Jarrin I, Dorrucci M, Duque V, Fätkenheuer G, Zangerle R, Ferrer E, Porter K, Judd A, Sipsas NV, Lambotte O, Shepherd L, Leport C, Morrison C, Mussini C, Obel N, Ruelle J, Schwarze-Zander C, Sonnerborg A, Teira R, Torti C, Valadas E, Colin C, Friis-Møller N, Costagliola D, Thiebaut R, Chene G, Matheron S, COHERE in EuroCoord and ACHIeV2e Study Group
CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study.
The Journal of Antimicrobial Chemotherapy 2017, 72, 2869-2878.
Charpentier C, Montes B, Perrier M, Meftah N, Reynes J
HIV-1 DNA ultra-deep sequencing analysis at initiation of the dual therapy dolutegravir + lamivudine in the maintenance DOLULAM pilot study.
The Journal of Antimicrobial Chemotherapy 2017, 72, 2831-2836.
Lê MP, Belarbi L, Chaix ML, Dulioust E, Mahjoub N, Salmon D, Viard JP, Duvivier C, Peytavin G, Launay O, Ghosn J
Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretrovirals.
The Journal of Antimicrobial Chemotherapy 2017, 72, 3167-3171.
Supervie V, Assoumou L, Breban R, Lert F, Costagliola D, Pialoux G, Landman R, Girard PM, Slama L, IMEA 040 DATA Study Group
Risk of HIV transmission during combined ART initiation for HIV-infected persons with severe immunosuppression.
The Journal of Antimicrobial Chemotherapy 2017, 72, 3172-3176.
Raffi F, Hanf M, Ferry T, Khatchatourian L, Joly V, Pugliese P, Katlama C, Robineau O, Chirouze C, Jacomet C, Delobel P, Poizot-Martin I, Ravaux I, Duvivier C, Gagneux-Brunon A, Rey D, Reynes J, May T, Bani-Sadr F, Hoen B, Morrier M, Cabie A, Allavena C, Dat’AIDS Study Group
Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimen.
The Journal of Antimicrobial Chemotherapy 2017, 72, 3425-3434.
Squires K, Bekker LG, Katlama C, Yazdanpanah Y, Zhou Y, Rodgers AJ, DiNubile MJ, Sklar PA, Leavitt RY, Teppler H
Influence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients: Pooled Analyses of the STARTMRK and QDMRK Studies.
Open Forum Infectious Diseases 2017, 4, ofw047.
Ragonnet R, Deuffic-Burban S, Boesecke C, Guiguet M, Lacombe K, Guedj J, Rockstroh JK, Yazdanpanah Y
Estimating the Time to Diagnosis and the Chance of Spontaneous Clearance During Acute Hepatitis C in Human Immunodeficiency Virus-Infected Individuals.
Open Forum Infectious Diseases 2017, 4, ofw235.
Kentish-Barnes N, Cohen-Solal Z, Souppart V, Galon M, Champigneulle B, Thirion M, Gilbert M, Lesieur O, Renault A, Garrouste-Orgeas M, Argaud L, Venot M, Demoule A, Guisset O, Vinatier I, Troché G, Massot J, Jaber S, Bornstain C, Gaday V, Robert R, Rigaud JP, Cinotti R, Adda M, Thomas F, Azoulay E
"It Was the Only Thing I Could Hold Onto, But…": Receiving a Letter of Condolence After Loss of a Loved One in the ICU: A Qualitative Study of Bereaved Relatives' Experience.
Critical Care Medicine 2017, 45, 1965-1971.
Dupuis C, Garrouste-Orgeas M, Bailly S, Adrie C, Goldgran-Toledano D, Azoulay E, Ruckly S, Marcotte G, Souweine B, Darmon M, Cohen Y, Schwebel C, Lacave G, Bouadma L, Timsit JF, OUTCOMEREA Study Group
Effect of Transfusion on Mortality and Other Adverse Events Among Critically Ill Septic Patients: An Observational Study Using a Marginal Structural Cox Model.
Critical Care Medicine 2017, 45, 1972-1980.
Crowell CS, Maiga AI, Sylla M, Taiwo B, Kone N, Oron AP, Murphy RL, Marcelin AG, Traore B, Fofana DB, Peytavin G, Chadwick EG
High Rates of Baseline Drug Resistance and Virologic Failure Among ART-naive HIV-infected Children in Mali.
The Pediatric Infectious Disease Journal 2017, 36, e258-e263.
Papot E, Landman R, Louni F, Charpentier C, Peytavin G, Certain A, Fradet C, Castro DR, Preau M, Goujard C, Yeni P, Yazdanpanah Y, ANRS-GOTA Study Group
Budget impact of antiretroviral therapy in a French clinic cohort.
AIDS (London, England) 2017, 31, 1271-1279.
Todesco E, Demeret S, Calin R, Roque-Afonso AM, Thibault V, Mallet V, Akhavan S, Jaspard M, Peytavin G, Poynard T, Katlama C, Pourcher V
Chronic hepatitis E in HIV/HBV coinfected patient: lack of power of sofosbuvir-ribavirin.
AIDS (London, England) 2017, 31, 1346-1348.
Seng R, Ghislain M, Girard PM, Cotte L, Meybeck A, Raffi F, Abgrall S, Yazdanpanah Y, Goujard C, Dray-Spira R, Meyer L
Sub-Saharan African migrants have slower initial CD4+ cell recovery after combined antiretroviral treatment initiation than French natives.
AIDS (London, England) 2017, 31, 1323-1332.
Lebrun D, Hentzien M, Cuzin L, Rey D, Joly V, Cotte L, Allavena C, Dellamonica P, Servettaz A, Bani-Sadr F, and the Dat’AIDS study group
Epidemiology of autoimmune and inflammatory diseases in a French nationwide HIV cohort.
AIDS (London, England) 2017, 31, 2159-2166.
Bardon VF, Mandelbrot L, Duro D, Dussaux C, Le M, Peytavin G
Placental transfer of elvitegravir and cobicistat in an Ex Vivo human cotyledon double perfusion model.
AIDS (London, England) 2017
Dutertre M, Cuzin L, Demonchy E, Puglièse P, Joly V, Valantin MA, Cotte L, Huleux T, Delobel P, Martin-Blondel G, DatʼAIDS Study Group
Initiation of Antiretroviral Therapy Containing Integrase Inhibitors Increases the Risk of IRIS Requiring Hospitalization.
Journal of Acquired Immune Deficiency Syndromes (1999) 2017, 76, e23-e26.
Desvignes C, Becquart C, Launay D, Terriou L, Patenotre P, Deheul S, Peytavin G, Dupin N, Delaporte E, Staumont-Sallé D
Extensive levamisole-induced vasculitis.
Clinical and Experimental Dermatology 2017
Bouteloup V, Sabin C, Mocroft A, Gras L, Pantazis N, Le Moing V, d'Arminio Monforte A, Mary-Krause M, Roca B, Miro JM, Battegay M, Brockmeyer N, Berenguer J, Morlat P, Obel N, De Wit S, Fätkenheuer G, Zangerle R, Ghosn J, Pérez-Hoyos S, Campbell M, Prins M, Chêne G, Meyer L, Dorrucci M, Torti C, Thiébaut R, Standard Reference Distribution of CD4 Response to HAART Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord
Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients.
HIV medicine 2017, 18, 33–44.
Judd A, Lodwick R, Noguera-Julian A, Gibb DM, Butler K, Costagliola D, Sabin C, van Sighem A, Ledergerber B, Torti C, Mocroft A, Podzamczer D, Dorrucci M, De Wit S, Obel N, Dabis F, Cozzi-Lepri A, García F, Brockmeyer NH, Warszawski J, Gonzalez-Tome MI, Mussini C, Touloumi G, Zangerle R, Ghosn J, Castagna A, Fätkenheuer G, Stephan C, Meyer L, Campbell MA, Chene G, Phillips A, Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord
Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe.
HIV medicine 2017, 18, 171–180.
Tron L, Lert F, Spire B, Dray-Spira R, Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)‐Vespa2 Study Group
Levels and determinants of breast and cervical cancer screening uptake in HIV-infected women compared with the general population in France.
HIV medicine 2017, 18, 181-195.
Feuillet P, Lert F, Tron L, Aubriere C, Spire B, Dray-Spira R, Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)-VIH: Enquête sur les personnes atteintes (Vespa2) Study Group
Prevalence of and factors associated with depression among people living with HIV in France.
HIV medicine 2017, 18, 383-394.
Cuzin L, Katlama C, Cotte L, Pugliese P, Cheret A, Bernaud C, Rey D, Poizot-Martin I, Chirouze C, Bani-Sadr F, Cabié A, Dat'AIDS Study Group
Ageing with HIV: do comorbidities and polymedication drive treatment optimization?.
HIV medicine 2017, 18, 395-401.
Gantner P, Cuzin L, Allavena C, Cabie A, Pugliese P, Valantin MA, Bani-Sadr F, Joly V, Ferry T, Poizot-Martin I, Garraffo R, Peytavin G, Fafi-Kremer S, Rey D, Dat'AIDS study group
Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study.
HIV medicine 2017, 18, 704-708.
Todesco E, Charpentier C, Bertine M, Wirden M, Storto A, Desire N, Grude M, Nguyen T, Sayon S, Yazdanpanah Y, Katlama C, Descamps D, Calvez V, Marcelin AG
Disparities in HIV-1 transmitted drug resistance detected by ultradeep sequencing between men who have sex with men and heterosexual populations.
HIV medicine 2017, 18, 696-700.
Bertine M, Gueudin M, Mélard A, Damond F, Descamps D, Matheron S, Collin F, Rouzioux C, Plantier JC, Avettand-Fenoel V
New Highly Sensitive Real-Time PCR Assay for HIV-2 Group A and Group B DNA Quantification.
Journal of Clinical Microbiology 2017, 55, 2850-2857.
Malet I, Subra F, Charpentier C, Collin G, Descamps D, Calvez V, Marcelin AG, Delelis O
Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors.
mBio 2017
Kardaś-Słoma L, Lucet JC, Perozziello A, Pelat C, Birgand G, Ruppé E, Boëlle PY, Andremont A, Yazdanpanah Y
Universal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units: a cost-effectiveness analysis.
BMJ open 2017, 7, e017402.
Sugarman J, Revill P, Zoulim F, Yazdanpanah Y, Janssen HLA, Lim SG, Lewin SR
Ethics and hepatitis B cure research.
Gut 2017, 66, 389-392.
de Montmollin E, Demeret S, Brulé N, Conrad M, Dailler F, Lerolle N, Navellou JC, Schwebel C, Alves M, Cour M, Engrand N, Tonnelier JM, Maury E, Ruckly S, Picard G, Rogemond V, Magalhaes É, Sharshar T, Timsit JF, Honnorat J, Sonneville R, ENCEPHALITICA Study Group ‡
Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Adult Patients Requiring Intensive Care.
American Journal of Respiratory and Critical Care Medicine 2017, 195, 491-499.
Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, Kollef M, Li Bassi G, Luna CM, Martin-Loeches I, Paiva JA, Read RC, Rigau D, Timsit JF, Welte T, Wunderink R
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT).
The European Respiratory Journal 2017, 50,
Veziris N, Bernard C, Guglielmetti L, Le Du D, Marigot-Outtandy D, Jaspard M, Caumes E, Lerat I, Rioux C, Yazdanpanah Y, Tiotiu A, Lemaitre N, Brossier F, Jarlier V, Robert J, Sougakoff W, Aubry A, CNR MyRMA and the Tuberculosis Consilium of the CNR MyRMA, CNR MyRMA and Tuberculosis Consilium of the CNR MyRMA
Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors.
The European Respiratory Journal 2017, 49,
Guglielmetti L, Jaspard M, Le Dû D, Lachâtre M, Marigot-Outtandy D, Bernard C, Veziris N, Robert J, Yazdanpanah Y, Caumes E, Fréchet-Jachym M, French MDR-TB Management Group
Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis.
The European Respiratory Journal 2017, 49,
Cousien A, Leclerc P, Morissette C, Bruneau J, Roy É, Tran VC, Yazdanpanah Y, Cox J
The need for treatment scale-up to impact HCV transmission in people who inject drugs in Montréal, Canada: a modelling study.
BMC infectious diseases 2017, 17, 162.
Douine M, Mosnier E, Le Hingrat Q, Charpentier C, Corlin F, Hureau L, Adenis A, Lazrek Y, Niemetsky F, Aucouturier AL, Demar M, Musset L, Nacher M
Illegal gold miners in French Guiana: a neglected population with poor health.
BMC public health 2017, 18, 23.
Viglino D, Vesin A, Ruckly S, Morelli X, Slama R, Debaty G, Danel V, Maignan M, Timsit JF
Daily volume of cases in emergency call centers: construction and validation of a predictive model.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2017, 25, 86.
Mirouse A, Vignon P, Piron P, Robert R, Papazian L, Géri G, Blanc P, Guitton C, Guérin C, Bigé N, Rabbat A, Lefebvre A, Razazi K, Fartoukh M, Mariotte E, Bouadma L, Ricard JD, Seguin A, Souweine B, Moreau AS, Faguer S, Mari A, Mayaux J, Schneider F, Stoclin A, Perez P, Maizel J, Lafon C, Ganster F, Argaud L, Girault C, Barbier F, Lecuyer L, Lambert J, Canet E
Severe varicella-zoster virus pneumonia: a multicenter cohort study.
Critical Care (London, England) 2017, 21, 137.
Weiss E, Essaied W, Adrie C, Zahar JR, Timsit JF
Treatment of severe hospital-acquired and ventilator-associated pneumonia: a systematic review of inclusion and judgment criteria used in randomized controlled trials.
Critical Care (London, England) 2017, 21, 162.
Terzi N, Darmon M, Reignier J, Ruckly S, Garrouste-Orgeas M, Lautrette A, Azoulay E, Mourvillier B, Argaud L, Papazian L, Gainnier M, Goldgran-Toledano D, Jamali S, Dumenil AS, Schwebel C, Timsit JF, OUTCOMEREA study group
Initial nutritional management during noninvasive ventilation and outcomes: a retrospective cohort study.
Critical Care (London, England) 2017, 21, 293.
Garrouste-Orgeas M, Flahault C, Fasse L, Ruckly S, Amdjar-Badidi N, Argaud L, Badie J, Bazire A, Bige N, Boulet E, Bouadma L, Bretonnière C, Floccard B, Gaffinel A, de Forceville X, Grand H, Halidfar R, Hamzaoui O, Jourdain M, Jost PH, Kipnis E, Large A, Lautrette A, Lesieur O, Maxime V, Mercier E, Mira JP, Monseau Y, Parmentier-Decrucq E, Rigaud JP, Rouget A, Santoli F, Simon G, Tamion F, Thieulot-Rolin N, Thirion M, Valade S, Vinatier I, Vioulac C, Bailly S, Timsit JF
The ICU-Diary study: prospective, multicenter comparative study of the impact of an ICU diary on the wellbeing of patients and families in French ICUs.
Trials 2017, 18, 542.
Dupuis C, Sonneville R, Adrie C, Gros A, Darmon M, Bouadma L, Timsit JF
Impact of transfusion on patients with sepsis admitted in intensive care unit: a systematic review and meta-analysis.
Annals of Intensive Care 2017, 7, 5.
Adrie C, Lugosi M, Sonneville R, Souweine B, Ruckly S, Cartier JC, Garrouste-Orgeas M, Schwebel C, Timsit JF, OUTCOMEREA study group
Persistent lymphopenia is a risk factor for ICU-acquired infections and for death in ICU patients with sustained hypotension at admission.
Annals of Intensive Care 2017, 7, 30.
Neuville M, El-Helali N, Magalhaes E, Radjou A, Smonig R, Soubirou JF, Voiriot G, Le Monnier A, Ruckly S, Bouadma L, Sonneville R, Timsit JF, Mourvillier B
Systematic overdosing of oxa- and cloxacillin in severe infections treated in ICU: risk factors and side effects.
Annals of Intensive Care 2017, 7, 34.
Delerue T, de Pontual L, Carbonnelle E, Zahar JR
The potential role of microbiota for controlling the spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) in neonatal population.
F1000Research 2017, 6, 1217.
Timsit JF, Esaied W, Neuville M, Bouadma L, Mourvllier B
Update on ventilator-associated pneumonia.
F1000Research 2017, 6, 2061.
Visseaux B, Collin G, Ichou H, Charpentier C, Bendhafer S, Dumitrescu M, Allal L, Cojocaru B, Desfrère L, Descamps D, Mandelbrot L, Houhou-Fidouh N
Usefulness of multiplex PCR methods and respiratory viruses' distribution in children below 15 years old according to age, seasons and clinical units in France: A 3 years retrospective study.
PloS One 2017, 12, e0172809.
Azoulay E, Timsit JF, Lautrette A, Legriel S, Max A, Ruckly S, Misset B, Cohen Y, Wolff M
Weekly high-dose liposomal amphotericin B (L-AmB) in critically ill septic patients with multiple Candida colonization: The AmBiDex study.
PloS One 2017, 12, e0177093.
Visseaux B, Burdet C, Voiriot G, Lescure FX, Chougar T, Brugiere O, Crestani B, Casalino E, Charpentier C, Descamps D, Timsit JF, Yazdanpanah Y, Houhou-Fidouh N
Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016.
PLoS One 2017, 12, e0180888.
Casalino E, Antoniol S, Fidouh N, Choquet C, Lucet JC, Duval X, Visseaux B, Pereira L
Influenza virus infections among patients attending emergency department according to main reason to presenting to ED: A 3-year prospective observational study during seasonal epidemic periods.
PloS One 2017, 12, e0182191.
Ibn Saied W, Souweine B, Garrouste-Orgeas M, Ruckly S, Darmon M, Bailly S, Cohen Y, Azoulay E, Schwebel C, Radjou A, Kallel H, Adrie C, Dumenil AS, Argaud L, Marcotte G, Jamali S, Papazian L, Goldgran-Toledano D, Bouadma L, Timsit JF, OUTCOMEREA study group
Respective impact of implementation of prevention strategies, colonization with multiresistant bacteria and antimicrobial use on the risk of early- and late-onset VAP: An analysis of the OUTCOMEREA network.
PloS One 2017, 12, e0187791.
Neuville M, Mourvillier B, Bouadma L, Timsit JF
Bundle of care decreased ventilator-associated events-implications for ventilator-associated pneumonia prevention.
Journal of Thoracic Disease 2017, 9, 430-433.
Ara-Somohano C, Bonadona A, Carpentier F, Pavese P, Vesin A, Hamidfar-Roy R, Minet C, Vanzetto G, Schwebel C, Timsit JF
Evaluation of eight biomarkers to predict short-term mortality in patients with acute severe dyspnea.
Minerva Anestesiologica 2017, 83, 824-835.
Sanna A, Le Strat Y, Roudot-Thoraval F, Deuffic Burban S, Carrieri P, Delarocque-Astagneau E, Larsen C
Severe liver disease related to chronic hepatitis C virus infection in treatment-naive patients: epidemiological characteristics and associated factors at first expert centre visit, France, 2000 to 2007 and 2010 to 2014.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2017, 22,
Sullivan AK, Sperle I, Raben D, Amato-Gauci AJ, Lundgren JD, Yazdanpanah Y, Jakobsen SF, Tavoschi L
HIV testing in Europe: Evaluating the impact, added value, relevance and usability of the European Centre for Disease Prevention and Control (ECDC)'s 2010 HIV testing guidance.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2017, 22,
Guerrier G, Lefèvre P, Chouvin C, D'Ortenzio E
Jarisch-Herxheimer Reaction Among Patients with Leptospirosis: Incidence and Risk Factors.
The American Journal of Tropical Medicine and Hygiene 2017, 96, 791-794.
Haddad E, Lescure FX, Ghodhbane W, Lepage L, D'humieres C, Vindrios W, Yazdanpanah Y, Nataf P, Kirsch M
Left ventricular assist pump pocket infection: conservative treatment strategy for destination therapy candidates.
The International Journal of Artificial Organs 2017, 40, 90-95.
Delory T, Ferrand H, Grall N, Casalino E, Lafarge M, Melot B, Hajage D, Charpentier C, Aubier M, Tubach F, Bouvet E, Gault N, Yazdanpanah Y
Score for pulmonary tuberculosis in patients with clinical presumption of tuberculosis in a low-prevalence area.
Int J Tuberc Lung Dis 2017, 21, 1272-1279.
Sommer H, Timsit JF, Wolkewitz M
Bezlotoxumab and Recurrent Clostridium difficile Infection.
The New England Journal of Medicine 2017, 376, 1594.
Pharmacokinetics and Safety of Darunavir/Ritonavir in HIV-Infected Pregnant Women.
AIDS reviews 2017, 19, 16-23.
Gantner P, Mélard A, Damond F, Delaugerre C, Dina J, Gueudin M, Maillard A, Sauné K, Rodallec A, Tuaillon E, Plantier JC, Rouzioux C, Avettand-Fenoel V, ANRS-AC11 Quantification Working Group
Interlaboratory quality control of total HIV-1 DNA load measurement for multicenter reservoir studies.
Journal of Medical Virology 2017, 89, 2047-2050.
Sonneville R, Gimenez L, Labreuche J, Smonig R, Magalhaes E, Bouadma L, Timsit JF, Mazighi M
What is the prognosis of acute stroke patients requiring ICU admission?.
Intensive Care Medicine 2017, 43, 271-272.
Capuzzo M, Garrouste-Orgeas M, Martin-Loeches I
What were you able to do in your daily life? Performance status for the critically ill patient.
Intensive Care Medicine 2017, 43, 104-106.
Kentish-Barnes N, Chevret S, Champigneulle B, Thirion M, Souppart V, Gilbert M, Lesieur O, Renault A, Garrouste-Orgeas M, Argaud L, Venot M, Demoule A, Guisset O, Vinatier I, Troché G, Massot J, Jaber S, Bornstain C, Gaday V, Robert R, Rigaud JP, Cinotti R, Adda M, Thomas F, Calvet L, Galon M, Cohen-Solal Z, Cariou A, Azoulay E, Famirea Study Group
Effect of a condolence letter on grief symptoms among relatives of patients who died in the ICU: a randomized clinical trial.
Intensive Care Medicine 2017, 43, 473-484.
Bassetti M, Garnacho-Montero J, Calandra T, Kullberg B, Dimopoulos G, Azoulay E, Chakrabarti A, Kett D, Leon C, Ostrosky-Zeichner L, Sanguinetti M, Timsit JF, Richardson MD, Shorr A, Cornely OA
Intensive care medicine research agenda on invasive fungal infection in critically ill patients.
Intensive Care Medicine 2017, 43, 1225-1238.
Cambau E, Durand-Zaleski I, Bretagne S, Brun-Buisson C, Cordonnier C, Duval X, Herwegh S, Pottecher J, Courcol R, Bastuji-Garin S, EVAMICA study team
Performance and economic evaluation of the molecular detection of pathogens for patients with severe infections: the EVAMICA open-label, cluster-randomised, interventional crossover trial.
Intensive Care Medicine 2017, 43, 1613-1625.
Poulakou G, Matthaiou DK, Bassetti M, Erdem H, Dimopoulos G, Curcio DJ, Carlet J, Lipman J, Timsit JF, Giamarellou H, Arfaras-Melainis A, Rello J, ESGCIP Investigators
"Salvage treatment" for infections by extensively- and pan-drug-resistant pathogens is common and often sub-optimal.
Intensive Care Medicine 2017, 43, 1164-1166.
Timsit JF, de Kraker MEA, Sommer H, Weiss E, Bettiol E, Wolkewitz M, Nikolakopoulos S, Wilson D, Harbarth S, COMBACTE-NET consortium
Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE's STAT-Net.
Intensive Care Medicine 2017, 43, 1002-1012.
Sonneville R, de Montmollin E, Poujade J, Garrouste-Orgeas M, Souweine B, Darmon M, Mariotte E, Argaud L, Barbier F, Goldgran-Toledano D, Marcotte G, Dumenil AS, Jamali S, Lacave G, Ruckly S, Mourvillier B, Timsit JF
Potentially modifiable factors contributing to sepsis-associated encephalopathy.
Intensive Care Medicine 2017, 43, 1075-1084.
Perner A, Gordon AC, Angus DC, Lamontagne F, Machado F, Russell JA, Timsit JF, Marshall JC, Myburgh J, Shankar-Hari M, Singer M
The intensive care medicine research agenda on septic shock.
Intensive Care Medicine 2017, 43, 1294-1305.
Laupland KB, Paiva JA, Timsit JF
Focus on severe infections.
Intensive Care Medicine 2017, 43, 1033-1036.
Yamaga S, Shime N, Sonneville R, de Montmollin E, Timsit JF
Risk factors for sepsis-associated encephalopathy.
Intensive Care Medicine 2017, 43, 1548-1549.
Robert R, Le Gouge A, Kentish-Barnes N, Cottereau A, Giraudeau B, Adda M, Annane D, Audibert J, Barbier F, Bardou P, Bourcier S, Bourenne J, Boyer A, Brenas F, Das V, Desachy A, Devaquet J, Feissel M, Ganster F, Garrouste-Orgeas M, Grillet G, Guisset O, Hamidfar-Roy R, Hyacinthe AC, Jochmans S, Jourdain M, Lautrette A, Lerolle N, Lesieur O, Lion F, Mateu P, Megarbane B, Merceron S, Mercier E, Messika J, Morin-Longuet P, Philippon-Jouve B, Quenot JP, Renault A, Repesse X, Rigaud JP, Robin S, Roquilly A, Seguin A, Thevenin D, Tirot P, Vinatier I, Azoulay E, Reignier J
Terminal weaning or immediate extubation for withdrawing mechanical ventilation in critically ill patients (the ARREVE observational study).
Intensive Care Medicine 2017, 43, 1793-1807.
Lefebvre A, Lucet JC, Bertrand X, Chavanet P, Astruc K, Quantin C, Vanhems P, Aho-Glélé LS
Detection of temporal clusters of health care-associated infections or colonizations with Pseudomonas aeruginosa.
American Journal of Infection Control 2017, 45, 72-74.
Pilmis B, Thepot-Seegers V, Angebault C, Weiss E, Alaabouche I, Bougnoux ME, Zahar JR
Could we predict airborne Aspergillus contamination during construction work?.
American Journal of Infection Control 2017, 45, 39-41.
Montravers P, Perrigault PF, Timsit JF, Mira JP, Lortholary O, Leroy O, Gangneux JP, Guillemot D, Bensoussan C, Bailly S, Azoulay E, Constantin JM, Dupont H, AmarCAND2 Study Group
Antifungal therapy for patients with proven or suspected Candida peritonitis: Amarcand2, a prospective cohort study in French intensive care units.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2017, 23, 117.e1-117.e8.
Argy N, Bertin GI, Milet J, Hubert V, Clain J, Cojean S, Houzé P, Tuikue-Ndam N, Kendjo E, Deloron P, Houzé S, CNRP Study Group
Preferential expression of domain cassettes 4, 8 and 13 of Plasmodium falciparum erythrocyte membrane protein 1 in severe malaria imported in France.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2017, 23, 211.e1-211.e4.
Loubet P, Lenzi N, Valette M, Foulongne V, Krivine A, Houhou N, Lagathu G, Rogez S, Alain S, Duval X, Galtier F, Postil D, Tattevin P, Vanhems P, Carrat F, Lina B, Launay O
Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France.
Clin Microbiol Infect 2017, 23, 253-259.
Bleibtreu A, Arias P, Vallois D, Debit A, Lermuzeaux M, Rioux C, Cabras O, Lucet JC, Choquet C, Timsit JF, Yazdanpanah Y, Lescure FX
Delayed management of Staphyloccocus aureus infective endocarditis in a Middle East respiratory syndrome coronavirus possible case hospitalized in 2015 in Paris, France.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2017, 23, 416-417.
Rhee SY, Varghese V, Holmes SP, Van Zyl GU, Steegen K, Boyd MA, Cooper DA, Nsanzimana S, Saravanan S, Charpentier C, de Oliveira T, Etiebet MAA, Garcia F, Goedhals D, Gomes P, Günthard HF, Hamers RL, Hoffmann CJ, Hunt G, Jiamsakul A, Kaleebu P, Kanki P, Kantor R, Kerschberger B, Marconi VC, D'amour Ndahimana J, Ndembi N, Ngo-Giang-Huong N, Rokx C, Santoro MM, Schapiro JM, Schmidt D, Seu L, Sigaloff KCE, Sirivichayakul S, Skhosana L, Sunpath H, Tang M, Yang C, Carmona S, Gupta RK, Shafer RW
Mutational correlates of virological failure in individuals receiving a WHO-recommended tenofovir-containing first-line regimen: An international collaboration.
EBioMedicine 2017
Guet-Revillet H, Tomini E, Emirian A, Join-Lambert O, Lécuyer H, Zahar JR, Jullien V
Piperacillin/tazobactam as an alternative antibiotic therapy to carbapenems in the treatment of urinary tract infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae: an in silico pharmacokinetic study.
International Journal of Antimicrobial Agents 2017, 49, 62-66.
Zahar JR, Lesprit P, Ruckly S, Eden A, Hikombo H, Bernard L, Harbarth S, Timsit JF, Brun-Buisson C, BacterCom Study Group
Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae.
International Journal of Antimicrobial Agents 2017, 49, 67-73.
Bailly S, Leroy O, Dupont H, Timsit JF
Secondarily documented invasive candidiasis is unpredictable using traditional risk factors in non transplant - non-neutropenic adult ICU patients.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2017, 54, 31-33.
Loubet P, Voiriot G, Houhou-Fidouh N, Neuville M, Bouadma L, Lescure FX, Descamps D, Timsit JF, Yazdanpanah Y, Visseaux B
Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: A single-center retrospective study.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2017, 91, 52-57.
Wirden M, Larrouy L, Mahjoub N, Todesco E, Damond F, Delagreverie H, Akhavan S, Charpentier C, Chaix ML, Descamps D, Calvez V, Marcelin AG
Multicenter comparison of the new Cobas 6800 system with Cobas Ampliprep/Cobas TaqMan and Abbott RealTime for the quantification of HIV, HBV and HCV viral load.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2017, 96, 49-53.
Antoniol S, Fidouh N, Ghazali A, Ichou H, Bouzid D, Kenway P, Choquet C, Visseaux B, Casalino E, Emergency Department study group on respiratory viruses
Diagnostic performances of the Xpert® Flu PCR test and the OSOM® immunochromatographic rapid test for influenza A and B virus among adult patients in the Emergency Department.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2017, 99-100, 5-9.
Deuffic-Burban S, Boursier J, Leroy V, Yazdanpanah Y, Castera L, Mathurin P
Are targeted treatment recommendations in chronic hepatitis C tailored to diagnostic methods of fibrosis?.
Journal of Hepatology 2017, 66, 304-312.
Mallet V, Hamed K, Schwarzinger M
Prognosis of patients with chronic hepatitis B in France (2008-2013): A nationwide, observational and hospital-based study.
Journal of Hepatology 2017, 66, 514-520.
Schwarzinger M, Baillot S, Yazdanpanah Y, Rehm J, Mallet V
Contribution of alcohol use disorders on the burden of chronic hepatitis C in France, 2008-2013: A nationwide retrospective cohort study.
Journal of Hepatology 2017, 67, 454-461.
Loison G, Troughton R, Raymond F, Lepelletier D, Lucet JC, Avril C, Birgand G, ARLIN Working Group
Compliance with clothing regulations and traffic flow in the operating room: a multi-centre study of staff discipline during surgical procedures.
The Journal of Hospital Infection 2017, 96, 281-285.
Adrie C, Garrouste-Orgeas M, Ibn Essaied W, Schwebel C, Darmon M, Mourvillier B, Ruckly S, Dumenil AS, Kallel H, Argaud L, Marcotte G, Barbier F, Laurent V, Goldgran-Toledano D, Clec'h C, Azoulay E, Souweine B, Timsit JF, OUTCOMEREA Study Group*
Attributable mortality of ICU-acquired bloodstream infections: Impact of the source, causative micro-organism, resistance profile and antimicrobial therapy.
The Journal of Infection 2017, 74, 131-141.
Bailly S, Leroy O, Azoulay E, Montravers P, Constantin JM, Dupont H, Guillemot D, Lortholary O, Mira JP, Perrigault PF, Gangneux JP, Timsit JF, AmarCAND2 Study Group
Impact of echinocandin on prognosis of proven invasive candidiasis in ICU: A post-hoc causal inference model using the AmarCAND2 study.
The Journal of Infection 2017, 74, 408-417.
Baldesi O, Bailly S, Ruckly S, Lepape A, L'Heriteau F, Aupee M, Boussat S, Bervas C, Machut A, Berger-Carbonne A, Savey A, Timsit JF, REA-RAISIN network
ICU-acquired candidaemia in France: Epidemiology and temporal trends, 2004-2013 - A study from the REA-RAISIN network.
The Journal of Infection 2017, 75, 59-67.
Welfringer A, Vuong V, Argy N, Chochillon C, Deschamps L, Rollin G, Harent S, Joly V, Vindrios W, Descamps V
A rare fungal infection: Phaehyphomycosis due to Veronaea botryosa and review of literature.
Medical Mycology Case Reports 2017, 15, 21-24.
Lequilliec N, Raymond R, Vanjak D, Baghdadi N, Boulestreau H, Zahar JR, Gangneux JP
Practices of infectious control management during neutropenia: A survey from 149 French hospitals.
Journal De Mycologie Medicale 2017, 27, 227-231.
Hoogewoud F, Frumholtz L, Loubet P, Charlier C, Blanche P, Lebeaux D, Benhaddou N, Sedira N, Coutte L, Vanhaecke C, Launay O, Le Jeunne C, Héron E, Monnet D, Lortholary O, Sahel JA, Dupin N, Brézin A, Errera MH, Salah S, Groh M
Prognostic Factors in Syphilitic Uveitis.
Ophthalmology 2017, 124, 1808-1816.
Pourcher G, Peytavin G, Schneider L, Gallien S, Force G, Pourcher V
Bariatric surgery in HIV patients: experience of an Obesity Reference Center in France.
Surgery for Obesity and Related Diseases: Official Journal of the American Society for Bariatric Surgery 2017, 13, 1990-1996.
Peiffer-Smadja N, Ouedraogo R, D'Ortenzio E, Cissé PN, Zeggani Z, Beavogui AH, Faye SL, Le Marcis F, Yazdanpanah Y, Nguyen VK
Vaccination and blood sampling acceptability during Ramadan fasting month: A cross-sectional study in Conakry, Guinea.
Vaccine 2017, 35, 2569-2574.
Charlier C, Perrodeau É, Leclercq A, Cazenave B, Pilmis B, Henry B, Lopes A, Maury MM, Moura A, Goffinet F, Dieye HB, Thouvenot P, Ungeheuer MN, Tourdjman M, Goulet V, de Valk H, Lortholary O, Ravaud P, Lecuit M, MONALISA study group
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.
The Lancet. Infectious Diseases 2017
Badje A, Moh R, Gabillard D, Guéhi C, Kabran M, Ntakpé JB, Carrou JL, Kouame GM, Ouattara E, Messou E, Anzian A, Minga A, Gnokoro J, Gouesse P, Emieme A, Toni Td, Rabe C, Sidibé B, Nzunetu G, Dohoun L, Yao A, Kamagate S, Amon S, Kouame AB, Koua A, Kouamé E, Daligou M, Hawerlander D, Ackoundzé S, Koule S, Séri J, Ani A, Dembélé F, Koné F, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatunde N, Bleoué G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Karcher S, Rouzioux C, Kouame A, Assi R, Bakayoko A, Domoua SK, Deschamps N, Aka K, N'Dri-Yoman T, Salamon R, Journot V, Ahibo H, Ouassa T, Menan H, Inwoley A, Danel C, Eholié SP, Anglaret X, Temprano ANRS 12136 Study Group
Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial.
The Lancet. Global Health 2017, 5, e1080-e1089.
Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, Tremblay C, Rojas-Castro D, Cua E, Pasquet A, Bernaud C, Pintado C, Delaugerre C, Sagaon-Teyssier L, Mestre SL, Chidiac C, Pialoux G, Ponscarme D, Fonsart J, Thompson D, Wainberg MA, Doré V, Meyer L, ANRS IPERGAY Study Group
Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
The lancet. HIV 2017, 4, e402-e410.
Mamede JI, Damond F, Bernardo Ad, Matheron S, Descamps D, Battini JL, Sitbon M, Courgnaud V
Cyclophilins and nucleoporins are required for infection mediated by capsids from circulating HIV-2 primary isolates.
Scientific Reports 2017, 7, 45214.
Timsit JF, Pilmis B, Zahar JR
How Should We Treat Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae?.
Seminars in Respiratory and Critical Care Medicine 2017, 38, 287-300.
Post FA, Yazdanpanah Y, Schembri G, Lazzarin A, Reynes J, Maggiolo F, Yan M, Abram ME, Tran-Muchowski C, Cheng A, Rhee MS
Efficacy and safety of emtricitabine/tenofovir alafenamide (FTC/TAF) vs. emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) as a backbone for treatment of HIV-1 infection in virologically suppressed adults: subgroup analysis by third agent of a randomized, double-blind, active-controlled phase 3 trial.
HIV clinical trials 2017, 18, 135-140.
Pichon M, Mikail N, Ben Ali K, Rouzet F, Burdet C, Yazdanpanah Y, Joly V, Lepage L, Sarda-Mantel L
18FDG-PET/CT: a useful tool for the management of patients in infectious diseases.
Infect Dis (Lond) 2017, 49, 155-157.
Senard O, Burdet C, Visseaux B, Charpentier C, Le Gac S, Julia Z, Lariven S, Descamps D, Yazdanpanah Y, Yeni P, Joly V
Epidemiological Profile of Newly Diagnosed HIV-Infected Patients in Northern Paris: A Retrospective Study.
AIDS Res Hum Retroviruses 2017, 33, 11-16.
Pourcher V, Desnoyer A, Assoumou L, Lebbe C, Curjol A, Marcelin AG, Cardon F, Gibowski S, Salmon D, Chennebault JM, Poizot-Martin I, Peytavin G, Boué F, Costagliola D
Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial.
AIDS research and human retroviruses 2017, 33, 1–10.
Unal G, Alessandri-Gradt E, Leoz M, Pavie J, Lefevre C, Panjo H, Charpentier C, Descamps D, Barin F, Simon F, Meyer L, Plantier JC
HIV-1 group O infection in France: clinical features and immunovirological response to antiretrovirals.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2017
Duval X, Millot S, Chirouze C, Selton-Suty C, Moby V, Tattevin P, Strady C, Euvrard E, Agrinier N, Thomas D, Hoen B, Alla F, EI-dents Association pour l'Etude et la Prévention de l'Endocardite Infectieuse (AEPEI) Study Group
Oral Streptococcal Endocarditis, Oral Hygiene Habits, and Recent Dental Procedures: A Case-Control Study.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2017, 64, 1678-1685.
Tschudin-Sutter S, Lucet JC, Mutters NT, Tacconelli E, Zahar JR, Harbarth S
Contact precautions for preventing nosocomial transmission of ESBL-producing Escherichia coli - a point/counterpoint review.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2017, 65, 342-347.
Vindrios W, Argy N, Le Gal S, Lescure FX, Massias L, Le MP, Wolff M, Yazdanpanah Y, Nevez G, Houze S, Dorent R, Lucet JC
Outbreak of Pneumocystis jirovecii Infection Among Heart Transplant Recipients: Molecular Investigation and Management of an Interhuman Transmission.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2017, 65, 1120-1126.
Jullien V, Azoulay E, Schwebel C, Le Saux T, Charles PE, Cornet M, Souweine B, Klouche K, Jaber S, Trouillet JL, Bruneel F, Cour M, Cousson J, Meziani F, Gruson D, Paris A, Darmon M, Garrouste-Orgeas M, Navellou JC, Foucrier A, Allaouchiche B, Das V, Gangneux JP, Ruckly S, Wolff M, Timsit JF, ETSG
Population pharmacokinetics of micafungin in ICU patients with sepsis and mechanical ventilation.
The Journal of Antimicrobial Chemotherapy 2017, 72, 181-189.
Calvez V, Hocqueloux L, Meynard JL, Muret P, Castan B, Tardy JC, Peytavin G, Landman R
Less-drug regimen including atazanavir in maintenance treatment of HIV infection: how, who, when, why?.
The Journal of Antimicrobial Chemotherapy 2017, 72, 19-28.
Raffi F, Le Moing V, Assuied A, Habak S, Spire B, Cazanave C, Billaud E, Dellamonica P, Ferry T, Fagard C, Leport C, ANRS CO8 COPILOTE Study Group
Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course.
The Journal of Antimicrobial Chemotherapy 2017, 72, 240-245.
Fonsart J, Saragosti S, Taouk M, Peytavin G, Bushman L, Charreau I, Hance A, Goldwirt L, Morel S, Mammano F, Loze B, Capitant C, Clavel F, Mahjoub N, Meyer L, Anderson PL, Delaugerre C, Molina JM
Single-dose pharmacokinetics and pharmacodynamics of oral tenofovir and emtricitabine in blood, saliva and rectal tissue: a sub-study of the ANRS IPERGAY trial.
The Journal of Antimicrobial Chemotherapy 2017, 72, 478–485.
Briand C, Dollfus C, Faye A, Kantor E, Avettand-Fenoel V, Caseris M, Descamps D, Schneider V, Tabone MD, Vaudre G, Veber F, Blanche S, Frange P
Efficacy and tolerance of dolutegravir-based combined ART in perinatally HIV-1-infected adolescents: a French multicentre retrospective study.
The Journal of Antimicrobial Chemotherapy 2017, 72, 837–843.
Wirden M, Charpentier C, Tubiana R, Le MP, Desire N, Dionou S, Pichon F, Valantin MA, Yasdanpanah Y, Descamps D, Peytavin G, Katlama C, Calvez V, Marcelin AG
HIV-1 diagnosis with unquantifiable viraemia: don't be naive, look for antiretroviral drugs.
The Journal of Antimicrobial Chemotherapy 2017, 72, 630-632.
Madelain V, Le MP, Champenois K, Charpentier C, Landman R, Joly V, Yeni P, Descamps D, Yazdanpanah Y, Peytavin G
Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study.
The Journal of Antimicrobial Chemotherapy 2017, 72, 1137-1146.
Perrier M, Charpentier C, Peytavin G, Lê M, Blondel L, Visseaux B, Joly V, Pinto A, Matheron S, Yazdanpanah Y, Descamps D, Landman R
Switch as maintenance to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate: week 48 results in a clinical cohort.
The Journal of Antimicrobial Chemotherapy 2017, 72, 1745-1751.
Assoumou L, Charpentier C, Recordon-Pinson P, Grudé M, Pallier C, Morand-Joubert L, Fafi-Kremer S, Krivine A, Montes B, Ferré V, Bouvier-Alias M, Plantier JC, Izopet J, Trabaud MA, Yerly S, Dufayard J, Alloui C, Courdavault L, Le Guillou-Guillemette H, Maillard A, Amiel C, Vabret A, Roussel C, Vallet S, Guinard J, Mirand A, Beby-Defaux A, Barin F, Allardet-Servent A, Ait-Namane R, Wirden M, Delaugerre C, Calvez V, Chaix ML, Descamps D, Reigadas S, ANRS AC-11 Resistance Study Group
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study.
The Journal of Antimicrobial Chemotherapy 2017, 72, 1769-1773.
Soulie C, Grudé M, Descamps D, Amiel C, Morand-Joubert L, Raymond S, Pallier C, Bellecave P, Reigadas S, Trabaud MA, Delaugerre C, Montes B, Barin F, Ferré V, Jeulin H, Alloui C, Yerly S, Signori-Schmuck A, Guigon A, Fafi-Kremer S, Haïm-Boukobza S, Mirand A, Maillard A, Vallet S, Roussel C, Assoumou L, Calvez V, Flandre P, Marcelin AG, ANRS AC11 Resistance Study Group
Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma.
The Journal of Antimicrobial Chemotherapy 2017, 72, 2351-2354.
Alessandri-Gradt E, Collin G, Tourneroche A, Bertine M, Leoz M, Charpentier C, Unal G, Descamps D, Plantier JC
HIV-1 non-group M phenotypic susceptibility to integrase strand transfer inhibitors.
The Journal of Antimicrobial Chemotherapy 2017, 72, 2431-2437.
Perrier M, Bertine M, Le Hingrat Q, Joly V, Visseaux B, Collin G, Landman R, Yazdanpanah Y, Descamps D, Charpentier C
Prevalence of gag mutations associated with in vitro resistance to capsid inhibitor GS-CA1 in HIV-1 antiretroviral-naive patients.
The Journal of Antimicrobial Chemotherapy 2017, 72, 2954-2955.
Wittkop L, Arsandaux J, Trevino A, Schim van der Loeff M, Anderson J, van Sighem A, Böni J, Brun-Vezinet F, Soriano V, Boufassa F, Brockmeyer N, Calmy A, Dabis F, Jarrin I, Dorrucci M, Duque V, Fätkenheuer G, Zangerle R, Ferrer E, Porter K, Judd A, Sipsas NV, Lambotte O, Shepherd L, Leport C, Morrison C, Mussini C, Obel N, Ruelle J, Schwarze-Zander C, Sonnerborg A, Teira R, Torti C, Valadas E, Colin C, Friis-Møller N, Costagliola D, Thiebaut R, Chene G, Matheron S, COHERE in EuroCoord and ACHIeV2e Study Group
CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study.
The Journal of Antimicrobial Chemotherapy 2017, 72, 2869-2878.
Charpentier C, Montes B, Perrier M, Meftah N, Reynes J
HIV-1 DNA ultra-deep sequencing analysis at initiation of the dual therapy dolutegravir + lamivudine in the maintenance DOLULAM pilot study.
The Journal of Antimicrobial Chemotherapy 2017, 72, 2831-2836.
Lê MP, Belarbi L, Chaix ML, Dulioust E, Mahjoub N, Salmon D, Viard JP, Duvivier C, Peytavin G, Launay O, Ghosn J
Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretrovirals.
The Journal of Antimicrobial Chemotherapy 2017, 72, 3167-3171.
Supervie V, Assoumou L, Breban R, Lert F, Costagliola D, Pialoux G, Landman R, Girard PM, Slama L, IMEA 040 DATA Study Group
Risk of HIV transmission during combined ART initiation for HIV-infected persons with severe immunosuppression.
The Journal of Antimicrobial Chemotherapy 2017, 72, 3172-3176.
Raffi F, Hanf M, Ferry T, Khatchatourian L, Joly V, Pugliese P, Katlama C, Robineau O, Chirouze C, Jacomet C, Delobel P, Poizot-Martin I, Ravaux I, Duvivier C, Gagneux-Brunon A, Rey D, Reynes J, May T, Bani-Sadr F, Hoen B, Morrier M, Cabie A, Allavena C, Dat’AIDS Study Group
Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimen.
The Journal of Antimicrobial Chemotherapy 2017, 72, 3425-3434.
Squires K, Bekker LG, Katlama C, Yazdanpanah Y, Zhou Y, Rodgers AJ, DiNubile MJ, Sklar PA, Leavitt RY, Teppler H
Influence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients: Pooled Analyses of the STARTMRK and QDMRK Studies.
Open Forum Infectious Diseases 2017, 4, ofw047.
Ragonnet R, Deuffic-Burban S, Boesecke C, Guiguet M, Lacombe K, Guedj J, Rockstroh JK, Yazdanpanah Y
Estimating the Time to Diagnosis and the Chance of Spontaneous Clearance During Acute Hepatitis C in Human Immunodeficiency Virus-Infected Individuals.
Open Forum Infectious Diseases 2017, 4, ofw235.
Kentish-Barnes N, Cohen-Solal Z, Souppart V, Galon M, Champigneulle B, Thirion M, Gilbert M, Lesieur O, Renault A, Garrouste-Orgeas M, Argaud L, Venot M, Demoule A, Guisset O, Vinatier I, Troché G, Massot J, Jaber S, Bornstain C, Gaday V, Robert R, Rigaud JP, Cinotti R, Adda M, Thomas F, Azoulay E
"It Was the Only Thing I Could Hold Onto, But…": Receiving a Letter of Condolence After Loss of a Loved One in the ICU: A Qualitative Study of Bereaved Relatives' Experience.
Critical Care Medicine 2017, 45, 1965-1971.
Dupuis C, Garrouste-Orgeas M, Bailly S, Adrie C, Goldgran-Toledano D, Azoulay E, Ruckly S, Marcotte G, Souweine B, Darmon M, Cohen Y, Schwebel C, Lacave G, Bouadma L, Timsit JF, OUTCOMEREA Study Group
Effect of Transfusion on Mortality and Other Adverse Events Among Critically Ill Septic Patients: An Observational Study Using a Marginal Structural Cox Model.
Critical Care Medicine 2017, 45, 1972-1980.
Crowell CS, Maiga AI, Sylla M, Taiwo B, Kone N, Oron AP, Murphy RL, Marcelin AG, Traore B, Fofana DB, Peytavin G, Chadwick EG
High Rates of Baseline Drug Resistance and Virologic Failure Among ART-naive HIV-infected Children in Mali.
The Pediatric Infectious Disease Journal 2017, 36, e258-e263.
Papot E, Landman R, Louni F, Charpentier C, Peytavin G, Certain A, Fradet C, Castro DR, Preau M, Goujard C, Yeni P, Yazdanpanah Y, ANRS-GOTA Study Group
Budget impact of antiretroviral therapy in a French clinic cohort.
AIDS (London, England) 2017, 31, 1271-1279.
Todesco E, Demeret S, Calin R, Roque-Afonso AM, Thibault V, Mallet V, Akhavan S, Jaspard M, Peytavin G, Poynard T, Katlama C, Pourcher V
Chronic hepatitis E in HIV/HBV coinfected patient: lack of power of sofosbuvir-ribavirin.
AIDS (London, England) 2017, 31, 1346-1348.
Seng R, Ghislain M, Girard PM, Cotte L, Meybeck A, Raffi F, Abgrall S, Yazdanpanah Y, Goujard C, Dray-Spira R, Meyer L
Sub-Saharan African migrants have slower initial CD4+ cell recovery after combined antiretroviral treatment initiation than French natives.
AIDS (London, England) 2017, 31, 1323-1332.
Lebrun D, Hentzien M, Cuzin L, Rey D, Joly V, Cotte L, Allavena C, Dellamonica P, Servettaz A, Bani-Sadr F, and the Dat’AIDS study group
Epidemiology of autoimmune and inflammatory diseases in a French nationwide HIV cohort.
AIDS (London, England) 2017, 31, 2159-2166.
Bardon VF, Mandelbrot L, Duro D, Dussaux C, Le M, Peytavin G
Placental transfer of elvitegravir and cobicistat in an Ex Vivo human cotyledon double perfusion model.
AIDS (London, England) 2017
Dutertre M, Cuzin L, Demonchy E, Puglièse P, Joly V, Valantin MA, Cotte L, Huleux T, Delobel P, Martin-Blondel G, DatʼAIDS Study Group
Initiation of Antiretroviral Therapy Containing Integrase Inhibitors Increases the Risk of IRIS Requiring Hospitalization.
Journal of Acquired Immune Deficiency Syndromes (1999) 2017, 76, e23-e26.
Desvignes C, Becquart C, Launay D, Terriou L, Patenotre P, Deheul S, Peytavin G, Dupin N, Delaporte E, Staumont-Sallé D
Extensive levamisole-induced vasculitis.
Clinical and Experimental Dermatology 2017
Bouteloup V, Sabin C, Mocroft A, Gras L, Pantazis N, Le Moing V, d'Arminio Monforte A, Mary-Krause M, Roca B, Miro JM, Battegay M, Brockmeyer N, Berenguer J, Morlat P, Obel N, De Wit S, Fätkenheuer G, Zangerle R, Ghosn J, Pérez-Hoyos S, Campbell M, Prins M, Chêne G, Meyer L, Dorrucci M, Torti C, Thiébaut R, Standard Reference Distribution of CD4 Response to HAART Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord
Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients.
HIV medicine 2017, 18, 33–44.
Judd A, Lodwick R, Noguera-Julian A, Gibb DM, Butler K, Costagliola D, Sabin C, van Sighem A, Ledergerber B, Torti C, Mocroft A, Podzamczer D, Dorrucci M, De Wit S, Obel N, Dabis F, Cozzi-Lepri A, García F, Brockmeyer NH, Warszawski J, Gonzalez-Tome MI, Mussini C, Touloumi G, Zangerle R, Ghosn J, Castagna A, Fätkenheuer G, Stephan C, Meyer L, Campbell MA, Chene G, Phillips A, Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord
Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe.
HIV medicine 2017, 18, 171–180.
Tron L, Lert F, Spire B, Dray-Spira R, Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)‐Vespa2 Study Group
Levels and determinants of breast and cervical cancer screening uptake in HIV-infected women compared with the general population in France.
HIV medicine 2017, 18, 181-195.
Feuillet P, Lert F, Tron L, Aubriere C, Spire B, Dray-Spira R, Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)-VIH: Enquête sur les personnes atteintes (Vespa2) Study Group
Prevalence of and factors associated with depression among people living with HIV in France.
HIV medicine 2017, 18, 383-394.
Cuzin L, Katlama C, Cotte L, Pugliese P, Cheret A, Bernaud C, Rey D, Poizot-Martin I, Chirouze C, Bani-Sadr F, Cabié A, Dat'AIDS Study Group
Ageing with HIV: do comorbidities and polymedication drive treatment optimization?.
HIV medicine 2017, 18, 395-401.
Gantner P, Cuzin L, Allavena C, Cabie A, Pugliese P, Valantin MA, Bani-Sadr F, Joly V, Ferry T, Poizot-Martin I, Garraffo R, Peytavin G, Fafi-Kremer S, Rey D, Dat'AIDS study group
Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study.
HIV medicine 2017, 18, 704-708.
Todesco E, Charpentier C, Bertine M, Wirden M, Storto A, Desire N, Grude M, Nguyen T, Sayon S, Yazdanpanah Y, Katlama C, Descamps D, Calvez V, Marcelin AG
Disparities in HIV-1 transmitted drug resistance detected by ultradeep sequencing between men who have sex with men and heterosexual populations.
HIV medicine 2017, 18, 696-700.
Bertine M, Gueudin M, Mélard A, Damond F, Descamps D, Matheron S, Collin F, Rouzioux C, Plantier JC, Avettand-Fenoel V
New Highly Sensitive Real-Time PCR Assay for HIV-2 Group A and Group B DNA Quantification.
Journal of Clinical Microbiology 2017, 55, 2850-2857.
Malet I, Subra F, Charpentier C, Collin G, Descamps D, Calvez V, Marcelin AG, Delelis O
Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors.
mBio 2017
Kardaś-Słoma L, Lucet JC, Perozziello A, Pelat C, Birgand G, Ruppé E, Boëlle PY, Andremont A, Yazdanpanah Y
Universal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units: a cost-effectiveness analysis.
BMJ open 2017, 7, e017402.
Sugarman J, Revill P, Zoulim F, Yazdanpanah Y, Janssen HLA, Lim SG, Lewin SR
Ethics and hepatitis B cure research.
Gut 2017, 66, 389-392.
de Montmollin E, Demeret S, Brulé N, Conrad M, Dailler F, Lerolle N, Navellou JC, Schwebel C, Alves M, Cour M, Engrand N, Tonnelier JM, Maury E, Ruckly S, Picard G, Rogemond V, Magalhaes É, Sharshar T, Timsit JF, Honnorat J, Sonneville R, ENCEPHALITICA Study Group ‡
Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Adult Patients Requiring Intensive Care.
American Journal of Respiratory and Critical Care Medicine 2017, 195, 491-499.
Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, Kollef M, Li Bassi G, Luna CM, Martin-Loeches I, Paiva JA, Read RC, Rigau D, Timsit JF, Welte T, Wunderink R
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT).
The European Respiratory Journal 2017, 50,
Veziris N, Bernard C, Guglielmetti L, Le Du D, Marigot-Outtandy D, Jaspard M, Caumes E, Lerat I, Rioux C, Yazdanpanah Y, Tiotiu A, Lemaitre N, Brossier F, Jarlier V, Robert J, Sougakoff W, Aubry A, CNR MyRMA and the Tuberculosis Consilium of the CNR MyRMA, CNR MyRMA and Tuberculosis Consilium of the CNR MyRMA
Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors.
The European Respiratory Journal 2017, 49,
Guglielmetti L, Jaspard M, Le Dû D, Lachâtre M, Marigot-Outtandy D, Bernard C, Veziris N, Robert J, Yazdanpanah Y, Caumes E, Fréchet-Jachym M, French MDR-TB Management Group
Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis.
The European Respiratory Journal 2017, 49,
Cousien A, Leclerc P, Morissette C, Bruneau J, Roy É, Tran VC, Yazdanpanah Y, Cox J
The need for treatment scale-up to impact HCV transmission in people who inject drugs in Montréal, Canada: a modelling study.
BMC infectious diseases 2017, 17, 162.
Douine M, Mosnier E, Le Hingrat Q, Charpentier C, Corlin F, Hureau L, Adenis A, Lazrek Y, Niemetsky F, Aucouturier AL, Demar M, Musset L, Nacher M
Illegal gold miners in French Guiana: a neglected population with poor health.
BMC public health 2017, 18, 23.
Viglino D, Vesin A, Ruckly S, Morelli X, Slama R, Debaty G, Danel V, Maignan M, Timsit JF
Daily volume of cases in emergency call centers: construction and validation of a predictive model.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2017, 25, 86.
Mirouse A, Vignon P, Piron P, Robert R, Papazian L, Géri G, Blanc P, Guitton C, Guérin C, Bigé N, Rabbat A, Lefebvre A, Razazi K, Fartoukh M, Mariotte E, Bouadma L, Ricard JD, Seguin A, Souweine B, Moreau AS, Faguer S, Mari A, Mayaux J, Schneider F, Stoclin A, Perez P, Maizel J, Lafon C, Ganster F, Argaud L, Girault C, Barbier F, Lecuyer L, Lambert J, Canet E
Severe varicella-zoster virus pneumonia: a multicenter cohort study.
Critical Care (London, England) 2017, 21, 137.
Weiss E, Essaied W, Adrie C, Zahar JR, Timsit JF
Treatment of severe hospital-acquired and ventilator-associated pneumonia: a systematic review of inclusion and judgment criteria used in randomized controlled trials.
Critical Care (London, England) 2017, 21, 162.
Terzi N, Darmon M, Reignier J, Ruckly S, Garrouste-Orgeas M, Lautrette A, Azoulay E, Mourvillier B, Argaud L, Papazian L, Gainnier M, Goldgran-Toledano D, Jamali S, Dumenil AS, Schwebel C, Timsit JF, OUTCOMEREA study group
Initial nutritional management during noninvasive ventilation and outcomes: a retrospective cohort study.
Critical Care (London, England) 2017, 21, 293.
Garrouste-Orgeas M, Flahault C, Fasse L, Ruckly S, Amdjar-Badidi N, Argaud L, Badie J, Bazire A, Bige N, Boulet E, Bouadma L, Bretonnière C, Floccard B, Gaffinel A, de Forceville X, Grand H, Halidfar R, Hamzaoui O, Jourdain M, Jost PH, Kipnis E, Large A, Lautrette A, Lesieur O, Maxime V, Mercier E, Mira JP, Monseau Y, Parmentier-Decrucq E, Rigaud JP, Rouget A, Santoli F, Simon G, Tamion F, Thieulot-Rolin N, Thirion M, Valade S, Vinatier I, Vioulac C, Bailly S, Timsit JF
The ICU-Diary study: prospective, multicenter comparative study of the impact of an ICU diary on the wellbeing of patients and families in French ICUs.
Trials 2017, 18, 542.
Dupuis C, Sonneville R, Adrie C, Gros A, Darmon M, Bouadma L, Timsit JF
Impact of transfusion on patients with sepsis admitted in intensive care unit: a systematic review and meta-analysis.
Annals of Intensive Care 2017, 7, 5.
Adrie C, Lugosi M, Sonneville R, Souweine B, Ruckly S, Cartier JC, Garrouste-Orgeas M, Schwebel C, Timsit JF, OUTCOMEREA study group
Persistent lymphopenia is a risk factor for ICU-acquired infections and for death in ICU patients with sustained hypotension at admission.
Annals of Intensive Care 2017, 7, 30.
Neuville M, El-Helali N, Magalhaes E, Radjou A, Smonig R, Soubirou JF, Voiriot G, Le Monnier A, Ruckly S, Bouadma L, Sonneville R, Timsit JF, Mourvillier B
Systematic overdosing of oxa- and cloxacillin in severe infections treated in ICU: risk factors and side effects.
Annals of Intensive Care 2017, 7, 34.
Delerue T, de Pontual L, Carbonnelle E, Zahar JR
The potential role of microbiota for controlling the spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) in neonatal population.
F1000Research 2017, 6, 1217.
Timsit JF, Esaied W, Neuville M, Bouadma L, Mourvllier B
Update on ventilator-associated pneumonia.
F1000Research 2017, 6, 2061.
Visseaux B, Collin G, Ichou H, Charpentier C, Bendhafer S, Dumitrescu M, Allal L, Cojocaru B, Desfrère L, Descamps D, Mandelbrot L, Houhou-Fidouh N
Usefulness of multiplex PCR methods and respiratory viruses' distribution in children below 15 years old according to age, seasons and clinical units in France: A 3 years retrospective study.
PloS One 2017, 12, e0172809.
Azoulay E, Timsit JF, Lautrette A, Legriel S, Max A, Ruckly S, Misset B, Cohen Y, Wolff M
Weekly high-dose liposomal amphotericin B (L-AmB) in critically ill septic patients with multiple Candida colonization: The AmBiDex study.
PloS One 2017, 12, e0177093.
Visseaux B, Burdet C, Voiriot G, Lescure FX, Chougar T, Brugiere O, Crestani B, Casalino E, Charpentier C, Descamps D, Timsit JF, Yazdanpanah Y, Houhou-Fidouh N
Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016.
PLoS One 2017, 12, e0180888.
Casalino E, Antoniol S, Fidouh N, Choquet C, Lucet JC, Duval X, Visseaux B, Pereira L
Influenza virus infections among patients attending emergency department according to main reason to presenting to ED: A 3-year prospective observational study during seasonal epidemic periods.
PloS One 2017, 12, e0182191.
Ibn Saied W, Souweine B, Garrouste-Orgeas M, Ruckly S, Darmon M, Bailly S, Cohen Y, Azoulay E, Schwebel C, Radjou A, Kallel H, Adrie C, Dumenil AS, Argaud L, Marcotte G, Jamali S, Papazian L, Goldgran-Toledano D, Bouadma L, Timsit JF, OUTCOMEREA study group
Respective impact of implementation of prevention strategies, colonization with multiresistant bacteria and antimicrobial use on the risk of early- and late-onset VAP: An analysis of the OUTCOMEREA network.
PloS One 2017, 12, e0187791.
Neuville M, Mourvillier B, Bouadma L, Timsit JF
Bundle of care decreased ventilator-associated events-implications for ventilator-associated pneumonia prevention.
Journal of Thoracic Disease 2017, 9, 430-433.
Ara-Somohano C, Bonadona A, Carpentier F, Pavese P, Vesin A, Hamidfar-Roy R, Minet C, Vanzetto G, Schwebel C, Timsit JF
Evaluation of eight biomarkers to predict short-term mortality in patients with acute severe dyspnea.
Minerva Anestesiologica 2017, 83, 824-835.
Sanna A, Le Strat Y, Roudot-Thoraval F, Deuffic Burban S, Carrieri P, Delarocque-Astagneau E, Larsen C
Severe liver disease related to chronic hepatitis C virus infection in treatment-naive patients: epidemiological characteristics and associated factors at first expert centre visit, France, 2000 to 2007 and 2010 to 2014.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2017, 22,
Sullivan AK, Sperle I, Raben D, Amato-Gauci AJ, Lundgren JD, Yazdanpanah Y, Jakobsen SF, Tavoschi L
HIV testing in Europe: Evaluating the impact, added value, relevance and usability of the European Centre for Disease Prevention and Control (ECDC)'s 2010 HIV testing guidance.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2017, 22,
Guerrier G, Lefèvre P, Chouvin C, D'Ortenzio E
Jarisch-Herxheimer Reaction Among Patients with Leptospirosis: Incidence and Risk Factors.
The American Journal of Tropical Medicine and Hygiene 2017, 96, 791-794.
Haddad E, Lescure FX, Ghodhbane W, Lepage L, D'humieres C, Vindrios W, Yazdanpanah Y, Nataf P, Kirsch M
Left ventricular assist pump pocket infection: conservative treatment strategy for destination therapy candidates.
The International Journal of Artificial Organs 2017, 40, 90-95.
Delory T, Ferrand H, Grall N, Casalino E, Lafarge M, Melot B, Hajage D, Charpentier C, Aubier M, Tubach F, Bouvet E, Gault N, Yazdanpanah Y
Score for pulmonary tuberculosis in patients with clinical presumption of tuberculosis in a low-prevalence area.
Int J Tuberc Lung Dis 2017, 21, 1272-1279.
Sommer H, Timsit JF, Wolkewitz M
Bezlotoxumab and Recurrent Clostridium difficile Infection.
The New England Journal of Medicine 2017, 376, 1594.
2016
Timsit JF, Azoulay E, Schwebel C, Charles PE, Cornet M, Souweine B, Klouche K, Jaber S, Trouillet JL, Bruneel F, Argaud L, Cousson J, Meziani F, Gruson D, Paris A, Darmon M, Garrouste-Orgeas M, Navellou JC, Foucrier A, Allaouchiche B, Das V, Gangneux JP, Ruckly S, Maubon D, Jullien V, Wolff M, ETG
Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial.
JAMA 2016, 316, 1555-1564.
Cousien A, Tran VC, Deuffic-Burban S, Jauffret-Roustide M, Dhersin JS, Yazdanpanah Y
Hepatitis C treatment as prevention of viral transmission and liver-related morbidity in persons who inject drugs.
Hepatology (Baltimore, Md.) 2016, 63, 1090-1101.
Delory T, Papot E, Rioux C, Charpentier C, Auge-Courtoi C, Michard F, Peytavin G, Descamps D, Matheron S, Yazdanpanah Y
Foscarnet, zidovudine and dolutegravir combination efficacy and tolerability for late stage HIV salvage therapy: A case-series experience.
Journal of Medical Virology 2016, 88, 1204-1210.
Bailly S, Pirracchio R, Timsit JF
What's new in the quantification of causal effects from longitudinal cohort studies: a brief introduction to marginal structural models for intensivists.
Intensive Care Medicine 2016, 42, 576-579.
Garrouste-Orgeas M, Flaatten H, Moreno R
Understanding medical errors and adverse events in ICU patients.
Intensive Care Medicine 2016, 42, 107-109.
Mekontso Dessap A, Ware LB, Bouadma L
What's new with biomarker-driven clinical strategy in sepsis and circulatory failure?.
Intensive Care Medicine 2016, 42, 418-421.
Poulakou G, Bassetti M, Timsit JF
Critically ill migrants with infection: diagnostic considerations for intensive care physicians in Europe.
Intensive Care Medicine 2016, 42, 245-248.
Sakr Y, Ferrer R, Reinhart K, Beale R, Rhodes A, Moreno R, Timsit JF, Brochard L, Thompson BT, Rezende E, Chiche JD, IC-GLOSSARI Investigators, ESICM Trials Group
The Intensive Care Global Study on Severe Acute Respiratory Infection (IC-GLOSSARI): a multicenter, multinational, 14-day inception cohort study.
Intensive Care Medicine 2016, 42, 817-828.
Mimoz O, Chopra V, Timsit JF
What's new in catheter-related infection: skin cleansing and skin antisepsis.
Intensive Care Medicine 2016, 42, 1784-1786.
Gélisse E, Neuville M, de Montmollin E, Bouadma L, Mourvillier B, Timsit JF, Sonneville R
Extracorporeal membrane oxygenation (ECMO) does not impact on amikacin pharmacokinetics: a case-control study.
Intensive Care Medicine 2016, 42, 946-948.
Bassetti M, Poulakou G, Timsit JF
Focus on antimicrobial use in the era of increasing antimicrobial resistance in ICU.
Intensive Care Medicine 2016, 42, 955-958.
Bruneel F, Tubach F, Mira JP, Houze S, Gibot S, Huisse MG, Megarbane B, Choquet C, Corne P, Peytel E, Villers D, Camus C, Bouchaud O, Caumes E, Girard PM, Simon F, Kalloumeh A, Roy C, Durand R, Le Bras J, Matheron S, Wolff M, PALUREA Study Group
Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study.
Intensive Care Medicine 2016
Truche AS, Darmon M, Bailly S, Clec'h C, Dupuis C, Misset B, Azoulay E, Schwebel C, Bouadma L, Kallel H, Adrie C, Dumenil AS, Argaud L, Marcotte G, Jamali S, Zaoui P, Laurent V, Goldgran-Toledano D, Sonneville R, Souweine B, Timsit JF, OUTCOMEREA Study Group
Continuous renal replacement therapy versus intermittent hemodialysis in intensive care patients: impact on mortality and renal recovery.
Intensive Care Medicine 2016, 42, 1408-1417.
Weiss E, Zahar JR, Garrouste-Orgeas M, Ruckly S, Essaied W, Schwebel C, Timsit JF, OUTCOMEREA Study Group
De-escalation of pivotal beta-lactam in ventilator-associated pneumonia does not impact outcome and marginally affects MDR acquisition.
Intensive Care Medicine 2016, 42, 2098-2100.
Citerio G, Perner A, Timsit JF
The ten wishes and hopes of the deputy editors of Intensive Care Medicine.
Intensive Care Medicine 2016, 42, 1316-1318.
Timsit JF, Paiva JA, Bassetti M
Focus on optimization of early antimicrobial therapy in ICU-acquired infections.
Intensive Care Medicine 2016, 42, 1658-1660.
Jensen JU, Bouadma L
Why biomarkers failed in sepsis.
Intensive Care Medicine 2016, 42, 2049-2051.
Truche AS, Darmon M, Timsit JF, OUTCOMEREA Study Group
Renal replacement therapy modalities in the ICU: the continuity is intermittent-response to comments by Schefold.
Intensive Care Medicine 2016, 42, 1840-1841.
Benoit DD, Doig G, Timsit JF
Focus on adequate antimicrobial treatment and de-escalation in the ICU.
Intensive Care Medicine 2016, 42, 1856-1858.
Günther SC, Schwebel C, Hamidfar-Roy R, Bonadona A, Lugosi M, Ara-Somohano C, Minet C, Potton L, Cartier JC, Vésin A, Chautemps M, Styfalova L, Ruckly S, Timsit JF
Complications of intravascular catheters in ICU: definitions, incidence and severity. A randomized controlled trial comparing usual transparent dressings versus new-generation dressings (the ADVANCED study).
Intensive Care Medicine 2016, 42, 1753-1765.
Timsit JF, Perner A
Sepsis: find me, manage me, and stop me!.
Intensive Care Medicine 2016, 42, 1851-1853.
Castañeda-Sanabria J, Hajage D, Le Jouan M, Perozziello A, Tubach F
Off-label use of the expensive orphan drug eculizumab in France 2009-2013 and the impact of literature: focus on the transplantation field.
European Journal of Clinical Pharmacology 2016, 72, 737-746.
Mahé I, Puget H, Buzzi JC, Lamuraglia M, Chidiac J, Strukov A, Helfer H, Perozziello A
Adherence to treatment guidelines for cancer-associated thrombosis: a French hospital-based cohort study.
Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 2016, 24, 3369-3377.
Bailly S, Garnaud C, Cornet M, Pavese P, Hamidfar-Roy R, Foroni L, Boisset S, Timsit JF, Maubon D
Impact of systemic antifungal therapy on the detection of Candida species in blood cultures in clinical cases of candidemia.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2016, 35, 1023-1032.
Rouzaud D, Alexandra JF, Chauchard M, Delon M, Dossier A, Goulenok T, Perozziello A, Papo T, Sacre K
Frequency of malignancy is high in patients admitted for a first venous thromboembolism episode: an observational study.
Journal of Thrombosis and Thrombolysis 2016, 42, 329-335.
Birgand G, Moore LSP, Bourigault C, Vella V, Lepelletier D, Holmes AH, Lucet JC
Measures to eradicate multidrug-resistant organism outbreaks: how much do they cost?.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2016, 22, 162.e1-9.
Moustarhfir M, Bresson B, Koch P, Perozziello A, Barreau G, Schouman-Claeys E, Henry-Feugeas MC, Ou P, Dallaudière B
MR imaging of Schmorl's nodes: Imaging characteristics and epidemio-clinical relationships.
Diagnostic and Interventional Imaging 2016, 97, 411-417.
Roupie AL, Dossier A, Goulenok T, Perozziello A, Papo T, Sacre K
First venous thromboembolism in admitted patients younger than 50years old.
European Journal of Internal Medicine 2016, 34, e18-e20.
Stora C, Epelboin S, Devouche E, Matheron S, Epelboin L, Yazbeck C, Damond F, Longuet P, Dzineku F, Rajguru M, Delaroche L, Mandelbrot L, Luton D, Patrat C
Women infected with human immunodeficiency virus type 1 have poorer assisted reproduction outcomes: a case-control study.
Fertility and Sterility 2016, 105, 1193-1201.
Picone O, Vauloup-Fellous C, D'Ortenzio E, Huissoud C, Carles G, Benachi A, Faye A, Luton D, Paty MC, Ayoubi JM, Yazdanpanah Y, Mandelbrot L, Matheron S
[Zika virus infection during pregnancy].
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction 2016, 45, 415-423.
Desnoyer A, Pospai D, Lê MP, Gervais A, Heurgué-Berlot A, Laradi A, Harent S, Pinto A, Salmon D, Hillaire S, Fontaine H, Zucman D, Simonpoli AM, Muret P, Larrouy L, Bernard Chabert B, Descamps D, Yazdanpanah Y, Peytavin G
Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C.
Journal of Hepatology 2016, 65, 40-47.
Lefebvre A, Bertrand X, Quantin C, Vanhems P, Lucet JC, Nuemi G, Astruc K, Chavanet P, Aho-Glélé LS
Association between Pseudomonas aeruginosa positive water samples and healthcare-associated cases: nine-year study at one university hospital.
The Journal of Hospital Infection 2016, 96, 238-243.
Bailly S, Maubon D, Fournier P, Pelloux H, Schwebel C, Chapuis C, Foroni L, Cornet M, Timsit JF
Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. - Trends over 10 years.
The Journal of Infection 2016, 72, 103-111.
Perrier M, Désiré N, Deback C, Agut H, Boutolleau D, Burrel S
Complementary assays for monitoring susceptibility of varicella-zoster virus resistance to antivirals.
Journal of Virological Methods 2016, 233, 10–14.
Yazdanpanah Y, Schwarzinger M
Generic antiretroviral drugs and HIV care: An economic review.
Medecine Et Maladies Infectieuses 2016, 46, 67-71.
Lemaire X, Bonnet E, Castan B, Forestier E, Lescure FX, Roblot F, Pulcini C
Management of non-necrotizing cellulitis in France.
Medecine Et Maladies Infectieuses 2016, 46, 355-359.
Visseaux B, Damond F, Matheron S, Descamps D, Charpentier C
Hiv-2 molecular epidemiology.
Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 2016, 46, 233-240.
Collarino R, Vergeylen U, Emeraud C, Latournèrie G, Grall N, Mammeri H, Messika-Zeitoun D, Vallois D, Yazdanpanah Y, Lescure FX, Bleibtreu A
Mitral endocarditis due to Rothia aeria with cerebral haemorrhage and femoral mycotic aneurysms, first French description.
New Microbes and New Infections 2016, 13, 40-42.
Larbi A, Pesquer L, Reboul G, Omoumi P, Perozziello A, Abadie P, Loriaut P, Copin P, Ducouret E, Dallaudière B
MRI in patients with chronic pubalgia: Is precise useful information provided to the surgeon? A case-control study.
Orthopaedics & traumatology, surgery & research: OTSR 2016, 102, 747-754.
Rouzaud D, Alexandra JF, Chauchard M, Delon M, Dossier A, Chauveheid MP, Perozziello A, Papo T, Sacre K
Incidental venous thromboembolism diagnosed in patients admitted with a first venous thromboembolism: Frequency and clinical significance (an observational study).
Thrombosis Research 2016, 144, 116-118.
Delfraissy JF, Yazdanpanah Y, Levy Y
REACTing: the French response to infectious disease crises.
Lancet (London, England) 2016, 387, 2183-2185.
Benmoussa N, Charpentier C, Mariaggi AA, Collin G, Descamps D, Hourseau M, Barry B, Albert S, Picard A, Conan P, Charlier P
HPV 16 in squamous cell carcinoma of 19th century tonsils.
The Lancet. Oncology 2016, 17, e477–e478.
TenoRes Study Group
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study.
The Lancet. Infectious Diseases 2016, 16, 565-575.
Lachâtre M, Rioux C, Dû DL, Fréchet-Jachym M, Veziris N, Bouvet E, Yazdanpanah Y
Bedaquiline plus delamanid for XDR tuberculosis.
The Lancet. Infectious Diseases 2016, 16, 294.
Visseaux B, Mortier E, Houhou-Fidouh N, Brichler S, Collin G, Larrouy L, Charpentier C, Descamps D
Zika virus in the female genital tract.
The Lancet. Infectious Diseases 2016, 16, 1220.
Pépin JL, Timsit JF, Tamisier R, Borel JC, Lévy P, Jaber S
Prevention and care of respiratory failure in obese patients.
The Lancet. Respiratory Medicine 2016, 4, 407-418.
Frange P, Faye A, Avettand-Fenoël V, Bellaton E, Descamps D, Angin M, David A, Caillat-Zucman S, Peytavin G, Dollfus C, Le Chenadec J, Warszawski J, Rouzioux C, Sáez-Cirión A, ANRS EPF-CO10 Pediatric Cohort and the ANRS EP47 VISCONTI study group
HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report.
The lancet. HIV 2016, 3, e49–54.
Pelat C, Kardaś-Słoma L, Birgand G, Ruppé E, Schwarzinger M, Andremont A, Lucet JC, Yazdanpanah Y
Hand Hygiene, Cohorting, or Antibiotic Restriction to Control Outbreaks of Multidrug-Resistant Enterobacteriaceae.
Infection Control and Hospital Epidemiology 2016, 37, 272-280.
Cuzin L, Dellamonica P, Yazdanpanah Y, Bouchez S, Rey D, Hoen B, Cabié A, Dat'AIDS Study Group
Characteristics and consequences of medical care interruptions in HIV-infected patients in France.
Epidemiology and Infection 2016, 144, 2363-2370.
D'Ortenzio E, Matheron S, Yazdanpanah Y, de Lamballerie X, Hubert B, Piorkowski G, Maquart M, Descamps D, Damond F, Leparc-Goffart I
Evidence of Sexual Transmission of Zika Virus.
The New England Journal of Medicine 2016, 374, 2195-2198.
Sagaon-Teyssier L, Suzan-Monti M, Demoulin B, Capitant C, Lorente N, Préau M, Mora M, Rojas Castro D, Chidiac C, Chas J, Meyer L, Molina JM, Spire B, ANRS IPERGAY Study Group
Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial.
AIDS care 2016, 28 Suppl 1, 48–55.
Préau M, Lorente N, Sagaon-Teyssier L, Champenois K, Gall JML, Mabire X, Spire B, Mora M, Yazdanpanah Y, Suzan M, ANRS-DRAG group and ANRS COMTEST-GROUP
Factors associated with satisfaction with community-based non-medicalized counseling and testing using HIV rapid tests among MSM in France.
AIDS care 2016, 28, 1240-1248.
Tabah A, Cotta MO, Garnacho-Montero J, Schouten J, Roberts JA, Lipman J, Tacey M, Timsit JF, Leone M, Zahar JR, De Waele JJ, Working Group for Antimicrobial Use in the ICU
A Systematic Review of the Definitions, Determinants, and Clinical Outcomes of Antimicrobial De-escalation in the Intensive Care Unit.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2016, 62, 1009-1017.
Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DAMC, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Staneková D, Stanojevic M, Van Laethem K, Zazzi M, Zidovec Lepej S, Boucher CAB, Schmit JC, Wensing AMJ, SPREAD Program
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2016, 62, 655–663.
Matheron S, d'Ortenzio E, Leparc-Goffart I, Hubert B, de Lamballerie X, Yazdanpanah Y
Long-Lasting Persistence of Zika Virus in Semen.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2016, 63, 1264.
Pediatric AIDS-Defining Cancer Project Working Group for IeDEA Southern Africa, TApHOD, and COHERE in EuroCoord
Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2016, 63, 1245–1253.
Piroth L, Moinot L, Yeni P, Avettand-Fénoel V, Reynes J, Girard PM, Marchou B, Georget A, Rouzioux C, Autran B, Duvillard L, Chêne G, Fagard C, ANRS 141 TIPI Trial Study Group
Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial).
The Journal of Antimicrobial Chemotherapy 2016, 71, 490–496.
Lortholary O, Roussillon C, Boucherie C, Padoin C, Chaix ML, Breton G, Rami A, Veziris N, Patey O, Caumes E, May T, Molina JM, Robert J, Tod M, Fagard C, Chêne G, ANRS 129 BKVIR Trial Group
Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial.
The Journal of Antimicrobial Chemotherapy 2016, 71, 783–793.
Barbier F, Pommier C, Essaied W, Garrouste-Orgeas M, Schwebel C, Ruckly S, Dumenil AS, Lemiale V, Mourvillier B, Clec'h C, Darmon M, Laurent V, Marcotte G, Lucet JC, Souweine B, Zahar JR, Timsit JF, OUTCOMEREA Study Group
Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?.
The Journal of Antimicrobial Chemotherapy 2016, 71, 1088-1097.
Lambert-Niclot S, George EC, Pozniak A, White E, Schwimmer C, Jessen H, Johnson M, Dunn D, Perno CF, Clotet B, Plettenberg A, Blaxhult A, Palmisano L, Wittkop L, Calvez V, Marcelin AG, Raffi F, NEAT 001/ANRS 143 Study Group
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART.
The Journal of Antimicrobial Chemotherapy 2016, 71, 1056–1062.
De Luca A, Flandre P, Dunn D, Zazzi M, Wensing A, Santoro MM, Günthard HF, Wittkop L, Kordossis T, Garcia F, Castagna A, Cozzi-Lepri A, Churchill D, De Wit S, Brockmeyer NH, Imaz A, Mussini C, Obel N, Perno CF, Roca B, Reiss P, Schülter E, Torti C, van Sighem A, Zangerle R, Descamps D, CHAIN and COHERE in EuroCoord
Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen.
The Journal of Antimicrobial Chemotherapy 2016, 71, 1352–1360.
Slama L, Landman R, Assoumou L, Benalycherif A, Samri A, Joly V, Pialoux G, Valin N, Cabié A, Duvivier C, Lambert-Niclot S, Marcelin AG, Peytavin G, Costagliola D, Girard PM, IMEA 040 DATA Study Group
Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, randomized, multicentre trial (IMEA 040 DATA trial).
The Journal of Antimicrobial Chemotherapy 2016, 71, 2252–2261.
Bocket L, Peytavin G, Alidjinou EK, Ajana F, Choisy P, Lê M, Charpentier C, Descamps D, Yazdanpanah Y, Katlama C, Simon A, Calvez V, Marcelin AG, Soulie C
Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients.
The Journal of Antimicrobial Chemotherapy 2016, 71, 2651-2653.
Katlama C, Soulié C, Caby F, Denis A, Blanc C, Schneider L, Valantin MA, Tubiana R, Kirstetter M, Valdenassi E, Nguyen T, Peytavin G, Calvez V, Marcelin AG
Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia.
The Journal of Antimicrobial Chemotherapy 2016, 71, 2646–2650.
Gantner P, Assoumou L, Leruez-Ville M, David L, Suzan-Monti M, Costagliola D, Rouzioux C, Ghosn J, EVARIST ANRS EP 49 Study Group
HIV-1-RNA in seminal plasma correlates with detection of HIV-1-DNA in semen cells, but not with CMV shedding, among MSM on successful antiretroviral regimens.
The Journal of Antimicrobial Chemotherapy 2016, 71, 3202–3205.
de Truchis P, Lê MP, Daou M, Madougou B, Nouhou Y, Moussa Saley S, Sani A, Adehossi E, Rouveix E, Saidou M, Peytavin G, Delaugerre C
High efficacy of first-line ART in a West African cohort, assessed by dried blood spot virological and pharmacological measurements.
The Journal of Antimicrobial Chemotherapy 2016, 71, 3222-3227.
Diallo YL, Ollivier V, Joly V, Faille D, Catalano G, Jandrot-Perrus M, Rauch A, Yeni P, Ajzenberg N
Abacavir has no prothrombotic effect on platelets in vitro.
The Journal of Antimicrobial Chemotherapy 2016, 71, 3506–3509.
Bassetti M, Peghin M, Timsit JF
The current treatment landscape: candidiasis.
The Journal of Antimicrobial Chemotherapy 2016, 71, ii13-ii22.
Sokal A, D'Ortenzio E, Houhou-Fidouh N, Brichler S, Dorchies J, Cabras O, Leparc-Goffart I, Yazdanpanah Y, Matheron S
Zika virus infection: report of the first imported cases in a Paris travel centre.
Journal of Travel Medicine 2016, 24,
Garrouste-Orgeas M, Max A, Lerin T, Grégoire C, Ruckly S, Kloeckner M, Brochon S, Pichot E, Simons C, El-Mhadri M, Bruel C, Philippart F, Fournier J, Tiercelet K, Timsit JF, Misset B
Impact of Proactive Nurse Participation in ICU Family Conferences: A Mixed-Method Study.
Critical Care Medicine 2016, 44, 1116-1128.
Toubiana J, Timsit S, Ferroni A, Grasseau M, Nassif X, Lortholary O, Zahar JR, Chalumeau M
Community-Onset Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Invasive Infections in Children in a University Hospital in France.
Medicine 2016, 95, e3163.
Sonneville R, Mariotte E, Neuville M, Minaud S, Magalhaes E, Ruckly S, Cantier M, Voiriot G, Radjou A, Smonig R, Soubirou JF, Mourvillier B, Bouadma L, Wolff M, Timsit JF
Early-onset status epilepticus in patients with acute encephalitis.
Medicine 2016, 95, e4092.
Sellier PO, Schnepf N, Amarsy R, Maylin S, Lopes A, Mazeron MC, Flateau C, Morgand M, Ciraru-Vigneron N, Berthe A, Simoneau G, Evans J, Souak S, Matheron S, Benifla JL, Simon F, Bergmann JF
Short article: Hepatitis B virus status in children born to HIV/HBV coinfected women in a French hospital: a cross-sectional study.
European Journal of Gastroenterology & Hepatology 2016, 28, 328–332.
Desgrees-du-Lou A, Pannetier J, Ravalihasy A, Le Guen M, Gosselin A, Panjo H, Bajos N, Lydie N, Lert F, Dray-Spira R, PARCOURS Study Group
Is hardship during migration a determinant of HIV infection? Results from the ANRS PARCOURS study of sub-Saharan African migrants in France.
AIDS 2016, 30, 645–656.
Ananworanich J, Melvin D, Amador JTR, Childs T, Medin G, Boscolo V, Compagnucci A, Kanjanavanit S, Montero S, Gibb DM, PENTA 11 Study Group
Neurocognition and quality of life after reinitiating antiretroviral therapy in children randomized to planned treatment interruption.
AIDS (London, England) 2016, 30, 1075–1081.
Jean K, Puren A, Cutler E, Singh B, Bouscaillou J, Rain-Taljaard R, Taljaard D, Gouws E, Lissouba P, Lewis DA, Peytavin G, Auvert B
Level of viral suppression and the cascade of HIV care in a South African semi-urban setting in 2012.
AIDS (London, England) 2016, 30, 2107-2116.
de Monteynard LA, Matheron S, Gilquin J, Pavie J, de Truchis P, Grabar S, Launay O, Meynard JL, Khuong-Josses MA, Rey D, Simon A, Mahamat A, Dray-Spira R, Costagliola D, Abgrall S, FHDH-ANRS CO4
Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in France.
AIDS (London, England) 2016, 30, 2235–2246.
Bertine M, Visseaux B, Storto A, Collin G, Matheron S, Descamps D, Charpentier C, ANRS CO5 HIV-2 Cohort
HIV-2 Vif Diversity Among Defective and Nondefective Sequences.
Journal of Acquired Immune Deficiency Syndromes (1999) 2016, 72, e9–e11.
De Sousa Mendes M, Hirt D, Vinot C, Valade E, Lui G, Pressiat C, Bouazza N, Foissac F, Blanche S, Lê MP, Peytavin G, Treluyer JM, Urien S, Benaboud S
Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models.
British Journal of Clinical Pharmacology 2016, 81, 646–657.
Desnoyer A, Dupin N, Assoumou L, Carlotti A, Gaudin F, Deback C, Peytavin G, Marcelin AG, Boué F, Balabanian K, Pourcher-Martinez V, ANRS 154 LENAKAP trial group
Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi's sarcoma skin lesions.
The British Journal of Dermatology 2016
Abramowitz L, Benabderrahmane D, Walker F, Yazdapanah Y, Yeni P, Rioux C, Bouscarat F, Lafferre E, Mentre F, Duval X
Determinants of macroscopic anal cancer and precancerous lesions in 1206 HIV-infected screened patients.
Colorectal Dis 2016, 18, 997-1004.
Flandre P, Pugliese P, Allavena C, Katlama C, Cotte L, Cheret A, Cabié A, Rey D, Chirouze C, Bani-Sadr F, Cuzin L, Dat'AIDS Study group
Comparative risk of failure of ABC/3TC or TDF/FTC based first-line regimens in patients with a high viral load.
HIV medicine 2016, 17, 380–384.
Deuffic-Burban S, Obach D, Canva V, Pol S, Roudot-Thoraval F, Dhumeaux D, Mathurin P, Yazdanpanah Y
Cost-effectiveness and budget impact of interferon-free direct-acting antiviral-based regimens for hepatitis C treatment: the French case.
Journal of Viral Hepatitis 2016, 23, 767-779.
Bottero J, Brouard C, Roudot-Thoraval F, Deuffic-Burban S, Hofliger P, Abergel A, Volant J, Dhumeaux D, Yazdanpanah Y, Viral Hepatitis Testing Experts group
2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV.
Liver International: Official Journal of the International Association for the Study of the Liver 2016, 36, 1442-1449.
Vinot C, Tréluyer JM, Giraud C, Gavard L, Peytavin G, Mandelbrot L
Bidirectional Transfer of Raltegravir in an Ex Vivo Human Cotyledon Perfusion Model.
Antimicrobial Agents and Chemotherapy 2016, 60, 3112-3114.
Birgand G, Leroy C, Nerome S, Luong Nguyen LB, Lolom I, Armand-Lefevre L, Ciotti C, Lecorre B, Marcade G, Fihman V, Nicolas-Chanoine MH, Pelat C, Perozziello A, Fantin B, Yazdanpanah Y, Ricard JD, Lucet JC
Costs associated with implementation of a strict policy for controlling spread of highly resistant microorganisms in France.
BMJ open 2016, 6, e009029.
Mourvillier B, Radjou A, Timsit JF
Subclavian site should be preferred for central venous access.
Evidence-Based Nursing 2016, 19, 126.
Pépin JL, Tamisier R, Baguet JP, Lepaulle B, Arbib F, Arnol N, Timsit JF, Lévy P
Fixed-pressure CPAP versus auto-adjusting CPAP: comparison of efficacy on blood pressure in obstructive sleep apnoea, a randomised clinical trial.
Thorax 2016, 71, 726-733.
Carrara J, N'Diaye DS, Azria E, Launay O, Rozenberg F, Yazpandanah Y, Tsatsaris V, Ayoubi JM, Picone O
Management of Cytomegalovirus Seroconversion during Pregnancy in France.
Fetal Diagnosis and Therapy 2016, 39, 4-12.
Guglielmetti L, Le Dû D, Veziris N, Caumes E, Marigot-Outtandy D, Yazdanpanah Y, Robert J, Fréchet-Jachym M, MDR-TB Management Group of the French National Reference Center for Mycobacteria and the Physicians of the French MDR-TB Cohort
Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis?.
The European Respiratory Journal 2016, 48, 582-585.
Sartelli M, Weber DG, Ruppé E, Bassetti M, Wright BJ, Ansaloni L, Catena F, Coccolini F, Abu-Zidan FM, Coimbra R, Moore EE, Moore FA, Maier RV, De Waele JJ, Kirkpatrick AW, Griffiths EA, Eckmann C, Brink AJ, Mazuski JE, May AK, Sawyer RG, Mertz D, Montravers P, Kumar A, Roberts JA, Vincent JL, Watkins RR, Lowman W, Spellberg B, Abbott IJ, Adesunkanmi AK, Al-Dahir S, Al-Hasan MN, Agresta F, Althani AA, Ansari S, Ansumana R, Augustin G, Bala M, Balogh ZJ, Baraket O, Bhangu A, Beltrán MA, Bernhard M, Biffl WL, Boermeester MA, Brecher SM, Cherry-Bukowiec JR, Buyne OR, Cainzos MA, Cairns KA, Camacho-Ortiz A, Chandy SJ, Che Jusoh A, Chichom-Mefire A, Colijn C, Corcione F, Cui Y, Curcio D, Delibegovic S, Demetrashvili Z, De Simone B, Dhingra S, Diaz JJ, Di Carlo I, Dillip A, Di Saverio S, Doyle MP, Dorj G, Dogjani A, Dupont H, Eachempati SR, Enani MA, Egiev VN, Elmangory MM, Ferrada P, Fitchett JR, Fraga GP, Guessennd N, Giamarellou H, Ghnnam W, Gkiokas G, Goldberg SR, Gomes CA, Gomi H, Guzmán-Blanco M, Haque M, Hansen S, Hecker A, Heizmann WR, Herzog T, Hodonou AM, Hong SK, Kafka-Ritsch R, Kaplan LJ, Kapoor G, Karamarkovic A, Kees MG, Kenig J, Kiguba R, Kim PK, Kluger Y, Khokha V, Koike K, Kok KYY, Kong V, Knox MC, Inaba K, Isik A, Iskandar K, Ivatury RR, Labbate M, Labricciosa FM, Laterre PF, Latifi R, Lee JG, Lee YR, Leone M, Leppaniemi A, Li Y, Liang SY, Loho T, Maegele M, Malama S, Marei HE, Martin-Loeches I, Marwah S, Massele A, McFarlane M, Melo RB, Negoi I, Nicolau DP, Nord CE, Ofori-Asenso R, Omari AH, Ordonez CA, Ouadii M, Pereira Júnior GA, Piazza D, Pupelis G, Rawson TM, Rems M, Rizoli S, Rocha C, Sakakhushev B, Sanchez-Garcia M, Sato N, Segovia Lohse HA, Sganga G, Siribumrungwong B, Shelat VG, Soreide K, Soto R, Talving P, Tilsed JV, Timsit JF, Trueba G, Trung NT, Ulrych J, van Goor H, Vereczkei A, Vohra RS, Wani I, Uhl W, Xiao Y, Yuan KC, Zachariah SK, Zahar JR, Zakrison TL, Corcione A, Melotti RM, Viscoli C, Viale P
Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).
World journal of emergency surgery: WJES 2016, 11,
Paiva JA, Pereira JM, Tabah A, Mikstacki A, de Carvalho FB, Koulenti D, Ruckly S, Çakar N, Misset B, Dimopoulos G, Antonelli M, Rello J, Ma X, Tamowicz B, Timsit JF
Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study.
Critical Care (London, England) 2016, 20,
May F, El-Helali N, Timsit JF, Misset B
Absence of obvious link between supra-therapeutic serum levels of β lactams and clinical toxicity in ICU patients with acute renal failure treated with intermittent hemodialysis.
Critical Care (London, England) 2016, 20, 220.
Coupez E, Timsit JF, Ruckly S, Schwebel C, Gruson D, Canet E, Klouche K, Argaud L, Bohe J, Garrouste-Orgeas M, Mariat C, Vincent F, Cayot S, Cointault O, Lepape A, Darmon M, Boyer A, Azoulay E, Bouadma L, Lautrette A, Souweine B
Guidewire exchange vs new site placement for temporary dialysis catheter insertion in ICU patients: is there a greater risk of colonization or dysfunction?.
Critical Care (London, England) 2016, 20, 230.
Voiriot G, Visseaux B, Cohen J, Nguyen LB, Neuville M, Morbieu C, Burdet C, Radjou A, Lescure FX, Smonig R, Armand-Lefevre L, Mourvillier B, Yazdanpanah Y, Soubirou JF, Ruckly S, Houhou-Fidouh N, Timsit JF
Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia.
Crit Care 2016, 20, 375.
Kalfon P, Mimoz O, Loundou A, Geantot MA, Revel N, Villard I, Amour J, Azoulay E, Garrouste-Orgeas M, Martin C, Sharshar T, Baumstarck K, Auquier P
Reduction of self-perceived discomforts in critically ill patients in French intensive care units: study protocol for a cluster-randomized controlled trial.
Trials 2016, 17,
Leroy O, Bailly S, Gangneux JP, Mira JP, Devos P, Dupont H, Montravers P, Perrigault PF, Constantin JM, Guillemot D, Azoulay E, Lortholary O, Bensoussan C, Timsit JF, AmarCAND2 study group
Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study.
Annals of Intensive Care 2016, 6, 2.
Garrouste-Orgeas M, Ruckly S, Grégoire C, Dumesnil AS, Pommier C, Jamali S, Golgran-Toledano D, Schwebel C, Clec'h C, Soufir L, Fartoukh M, Marcotte G, Argaud L, Verdière B, Darmon M, Azoulay E, Timsit JF
Treatment intensity and outcome of nonagenarians selected for admission in ICUs: a multicenter study of the Outcomerea Research Group.
Annals of Intensive Care 2016, 6, 31.
Boumendil A, Woimant M, Quenot JP, Rooryck FX, Makhlouf F, Yordanov Y, Delerme S, Takun K, Ray P, Kouka MC, Poly C, Garrouste-Orgeas M, Thomas C, Simon T, Azerad S, Leblanc G, Pateron D, Guidet B, ICE-CUB 2 study network
Designing and conducting a cluster-randomized trial of ICU admission for the elderly patients: the ICE-CUB 2 study.
Annals of Intensive Care 2016, 6, 74.
Garrouste-Orgeas M, Vinatier I, Tabah A, Misset B, Timsit JF
Reappraisal of visiting policies and procedures of patient's family information in 188 French ICUs: a report of the Outcomerea Research Group.
Annals of Intensive Care 2016, 6, 82.
Schnell D, Azoulay E, Benoit D, Clouzeau B, Demaret P, Ducassou S, Frange P, Lafaurie M, Legrand M, Meert AP, Mokart D, Naudin J, Pene F, Rabbat A, Raffoux E, Ribaud P, Richard JC, Vincent F, Zahar JR, Darmon M
Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF).
Annals of Intensive Care 2016, 6, 90.
Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, Carazo S, Conde MN, Gala JL, Colin G, Savini H, Bore JA, Le Marcis F, Koundouno FR, Petitjean F, Lamah MC, Diederich S, Tounkara A, Poelart G, Berbain E, Dindart JM, Duraffour S, Lefevre A, Leno T, Peyrouset O, Irenge L, Bangoura N, Palich R, Hinzmann J, Kraus A, Barry TS, Berette S, Bongono A, Camara MS, Chanfreau Munoz V, Doumbouya L, Souley Harouna n, Kighoma PM, Koundouno FR, Réné Lolamou n, Loua CM, Massala V, Moumouni K, Provost C, Samake N, Sekou C, Soumah A, Arnould I, Komano MS, Gustin L, Berutto C, Camara D, Camara FS, Colpaert J, Delamou L, Jansson L, Kourouma E, Loua M, Malme K, Manfrin E, Maomou A, Milinouno A, Ombelet S, Sidiboun AY, Verreckt I, Yombouno P, Bocquin A, Carbonnelle C, Carmoi T, Frange P, Mely S, Nguyen VK, Pannetier D, Taburet AM, Treluyer JM, Kolie J, Moh R, Gonzalez MC, Kuisma E, Liedigk B, Ngabo D, Rudolf M, Thom R, Kerber R, Gabriel M, Di Caro A, Wölfel R, Badir J, Bentahir M, Deccache Y, Dumont C, Durant JF, El Bakkouri K, Gasasira Uwamahoro M, Smits B, Toufik N, Van Cauwenberghe S, Ezzedine K, D'Ortenzio E, Dortenzio E, Pizarro L, Etienne A, Guedj J, Fizet A, Barte de Sainte Fare E, Murgue B, Tran-Minh T, Rapp C, Piguet P, Poncin M, Draguez B, Allaford Duverger T, Barbe S, Baret G, Defourny I, Carroll M, Raoul H, Augier A, Eholie SP, Yazdanpanah Y, Levy-Marchal C, Antierrens A, Van Herp M, Günther S, de Lamballerie X, Keïta S, Mentre F, Anglaret X, Malvy D, JIKI Study Group
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
PLoS medicine 2016, 13, e1001967.
Elanga Ndille E, Doucoure S, Poinsignon A, Mouchet F, Cornelie S, D'Ortenzio E, DeHecq JS, Remoue F
Human IgG Antibody Response to Aedes Nterm-34kDa Salivary Peptide, an Epidemiological Tool to Assess Vector Control in Chikungunya and Dengue Transmission Area.
PLoS neglected tropical diseases 2016, 10, e0005109.
Greacen T, Kersaudy-Rahib D, Le Gall JM, Lydié N, Ghosn J, Champenois K
Comparing the Information and Support Needs of Different Population Groups in Preparation for 2015 Government Approval for HIV Self-testing in France.
PloS One 2016, 11, e0152567.
Kirchgesner J, Beaugerie L, Carrat F, Sokol H, Cosnes J, Schwarzinger M, BERENICE Study Group
Impact on Life Expectancy of Withdrawing Thiopurines in Patients with Crohn's Disease in Sustained Clinical Remission: A Lifetime Risk-Benefit Analysis.
PloS One 2016, 11, e0157191.
Bailly S, Destors M, Grillet Y, Richard P, Stach B, Vivodtzev I, Timsit JF, Lévy P, Tamisier R, Pépin JL, scientific council and investigators of the French national sleep apnea registry (OSFP)
Obstructive Sleep Apnea: A Cluster Analysis at Time of Diagnosis.
PloS One 2016, 11, e0157318.
Angin M, Wong G, Papagno L, Versmisse P, David A, Bayard C, Charmeteau-De Muylder B, Besseghir A, Thiébaut R, Boufassa F, Pancino G, Sauce D, Lambotte O, Brun-Vézinet F, Matheron S, Rowland-Jones SL, Cheynier R, Sáez-Cirión A, Appay V, ANRS CO5 IMMUNOVIR-2 Study Group
Preservation of Lymphopoietic Potential and Virus Suppressive Capacity by CD8+ T Cells in HIV-2-Infected Controllers.
Journal of Immunology (Baltimore, Md.: 1950) 2016, 197, 2787–2795.
Loubet P, Palich R, Kojan R, Peyrouset O, Danel C, Nicholas S, Conde M, Porten K, Augier A, Yazdanpanah Y
Development of a Prediction Model for Ebola Virus Disease: A Retrospective Study in Nzérékoré Ebola Treatment Center, Guinea.
The American Journal of Tropical Medicine and Hygiene 2016, 95, 1362-1367.
Suzan-Monti M, Lorente N, Demoulin B, Marcellin F, Préau M, Dray-Spira R, Lert F, Spire B, ANRS-VESPA2 Study Group
Sexual risk behaviour among people living with HIV according to the biomedical risk of transmission: results from the ANRS-VESPA2 survey.
J Int AIDS Soc 2016, 19, 20095.
Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial.
JAMA 2016, 316, 1555-1564.
Cousien A, Tran VC, Deuffic-Burban S, Jauffret-Roustide M, Dhersin JS, Yazdanpanah Y
Hepatitis C treatment as prevention of viral transmission and liver-related morbidity in persons who inject drugs.
Hepatology (Baltimore, Md.) 2016, 63, 1090-1101.
Delory T, Papot E, Rioux C, Charpentier C, Auge-Courtoi C, Michard F, Peytavin G, Descamps D, Matheron S, Yazdanpanah Y
Foscarnet, zidovudine and dolutegravir combination efficacy and tolerability for late stage HIV salvage therapy: A case-series experience.
Journal of Medical Virology 2016, 88, 1204-1210.
Bailly S, Pirracchio R, Timsit JF
What's new in the quantification of causal effects from longitudinal cohort studies: a brief introduction to marginal structural models for intensivists.
Intensive Care Medicine 2016, 42, 576-579.
Garrouste-Orgeas M, Flaatten H, Moreno R
Understanding medical errors and adverse events in ICU patients.
Intensive Care Medicine 2016, 42, 107-109.
Mekontso Dessap A, Ware LB, Bouadma L
What's new with biomarker-driven clinical strategy in sepsis and circulatory failure?.
Intensive Care Medicine 2016, 42, 418-421.
Poulakou G, Bassetti M, Timsit JF
Critically ill migrants with infection: diagnostic considerations for intensive care physicians in Europe.
Intensive Care Medicine 2016, 42, 245-248.
Sakr Y, Ferrer R, Reinhart K, Beale R, Rhodes A, Moreno R, Timsit JF, Brochard L, Thompson BT, Rezende E, Chiche JD, IC-GLOSSARI Investigators, ESICM Trials Group
The Intensive Care Global Study on Severe Acute Respiratory Infection (IC-GLOSSARI): a multicenter, multinational, 14-day inception cohort study.
Intensive Care Medicine 2016, 42, 817-828.
Mimoz O, Chopra V, Timsit JF
What's new in catheter-related infection: skin cleansing and skin antisepsis.
Intensive Care Medicine 2016, 42, 1784-1786.
Gélisse E, Neuville M, de Montmollin E, Bouadma L, Mourvillier B, Timsit JF, Sonneville R
Extracorporeal membrane oxygenation (ECMO) does not impact on amikacin pharmacokinetics: a case-control study.
Intensive Care Medicine 2016, 42, 946-948.
Bassetti M, Poulakou G, Timsit JF
Focus on antimicrobial use in the era of increasing antimicrobial resistance in ICU.
Intensive Care Medicine 2016, 42, 955-958.
Bruneel F, Tubach F, Mira JP, Houze S, Gibot S, Huisse MG, Megarbane B, Choquet C, Corne P, Peytel E, Villers D, Camus C, Bouchaud O, Caumes E, Girard PM, Simon F, Kalloumeh A, Roy C, Durand R, Le Bras J, Matheron S, Wolff M, PALUREA Study Group
Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study.
Intensive Care Medicine 2016
Truche AS, Darmon M, Bailly S, Clec'h C, Dupuis C, Misset B, Azoulay E, Schwebel C, Bouadma L, Kallel H, Adrie C, Dumenil AS, Argaud L, Marcotte G, Jamali S, Zaoui P, Laurent V, Goldgran-Toledano D, Sonneville R, Souweine B, Timsit JF, OUTCOMEREA Study Group
Continuous renal replacement therapy versus intermittent hemodialysis in intensive care patients: impact on mortality and renal recovery.
Intensive Care Medicine 2016, 42, 1408-1417.
Weiss E, Zahar JR, Garrouste-Orgeas M, Ruckly S, Essaied W, Schwebel C, Timsit JF, OUTCOMEREA Study Group
De-escalation of pivotal beta-lactam in ventilator-associated pneumonia does not impact outcome and marginally affects MDR acquisition.
Intensive Care Medicine 2016, 42, 2098-2100.
Citerio G, Perner A, Timsit JF
The ten wishes and hopes of the deputy editors of Intensive Care Medicine.
Intensive Care Medicine 2016, 42, 1316-1318.
Timsit JF, Paiva JA, Bassetti M
Focus on optimization of early antimicrobial therapy in ICU-acquired infections.
Intensive Care Medicine 2016, 42, 1658-1660.
Jensen JU, Bouadma L
Why biomarkers failed in sepsis.
Intensive Care Medicine 2016, 42, 2049-2051.
Truche AS, Darmon M, Timsit JF, OUTCOMEREA Study Group
Renal replacement therapy modalities in the ICU: the continuity is intermittent-response to comments by Schefold.
Intensive Care Medicine 2016, 42, 1840-1841.
Benoit DD, Doig G, Timsit JF
Focus on adequate antimicrobial treatment and de-escalation in the ICU.
Intensive Care Medicine 2016, 42, 1856-1858.
Günther SC, Schwebel C, Hamidfar-Roy R, Bonadona A, Lugosi M, Ara-Somohano C, Minet C, Potton L, Cartier JC, Vésin A, Chautemps M, Styfalova L, Ruckly S, Timsit JF
Complications of intravascular catheters in ICU: definitions, incidence and severity. A randomized controlled trial comparing usual transparent dressings versus new-generation dressings (the ADVANCED study).
Intensive Care Medicine 2016, 42, 1753-1765.
Timsit JF, Perner A
Sepsis: find me, manage me, and stop me!.
Intensive Care Medicine 2016, 42, 1851-1853.
Castañeda-Sanabria J, Hajage D, Le Jouan M, Perozziello A, Tubach F
Off-label use of the expensive orphan drug eculizumab in France 2009-2013 and the impact of literature: focus on the transplantation field.
European Journal of Clinical Pharmacology 2016, 72, 737-746.
Mahé I, Puget H, Buzzi JC, Lamuraglia M, Chidiac J, Strukov A, Helfer H, Perozziello A
Adherence to treatment guidelines for cancer-associated thrombosis: a French hospital-based cohort study.
Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 2016, 24, 3369-3377.
Bailly S, Garnaud C, Cornet M, Pavese P, Hamidfar-Roy R, Foroni L, Boisset S, Timsit JF, Maubon D
Impact of systemic antifungal therapy on the detection of Candida species in blood cultures in clinical cases of candidemia.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2016, 35, 1023-1032.
Rouzaud D, Alexandra JF, Chauchard M, Delon M, Dossier A, Goulenok T, Perozziello A, Papo T, Sacre K
Frequency of malignancy is high in patients admitted for a first venous thromboembolism episode: an observational study.
Journal of Thrombosis and Thrombolysis 2016, 42, 329-335.
Birgand G, Moore LSP, Bourigault C, Vella V, Lepelletier D, Holmes AH, Lucet JC
Measures to eradicate multidrug-resistant organism outbreaks: how much do they cost?.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2016, 22, 162.e1-9.
Moustarhfir M, Bresson B, Koch P, Perozziello A, Barreau G, Schouman-Claeys E, Henry-Feugeas MC, Ou P, Dallaudière B
MR imaging of Schmorl's nodes: Imaging characteristics and epidemio-clinical relationships.
Diagnostic and Interventional Imaging 2016, 97, 411-417.
Roupie AL, Dossier A, Goulenok T, Perozziello A, Papo T, Sacre K
First venous thromboembolism in admitted patients younger than 50years old.
European Journal of Internal Medicine 2016, 34, e18-e20.
Stora C, Epelboin S, Devouche E, Matheron S, Epelboin L, Yazbeck C, Damond F, Longuet P, Dzineku F, Rajguru M, Delaroche L, Mandelbrot L, Luton D, Patrat C
Women infected with human immunodeficiency virus type 1 have poorer assisted reproduction outcomes: a case-control study.
Fertility and Sterility 2016, 105, 1193-1201.
Picone O, Vauloup-Fellous C, D'Ortenzio E, Huissoud C, Carles G, Benachi A, Faye A, Luton D, Paty MC, Ayoubi JM, Yazdanpanah Y, Mandelbrot L, Matheron S
[Zika virus infection during pregnancy].
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction 2016, 45, 415-423.
Desnoyer A, Pospai D, Lê MP, Gervais A, Heurgué-Berlot A, Laradi A, Harent S, Pinto A, Salmon D, Hillaire S, Fontaine H, Zucman D, Simonpoli AM, Muret P, Larrouy L, Bernard Chabert B, Descamps D, Yazdanpanah Y, Peytavin G
Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C.
Journal of Hepatology 2016, 65, 40-47.
Lefebvre A, Bertrand X, Quantin C, Vanhems P, Lucet JC, Nuemi G, Astruc K, Chavanet P, Aho-Glélé LS
Association between Pseudomonas aeruginosa positive water samples and healthcare-associated cases: nine-year study at one university hospital.
The Journal of Hospital Infection 2016, 96, 238-243.
Bailly S, Maubon D, Fournier P, Pelloux H, Schwebel C, Chapuis C, Foroni L, Cornet M, Timsit JF
Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. - Trends over 10 years.
The Journal of Infection 2016, 72, 103-111.
Perrier M, Désiré N, Deback C, Agut H, Boutolleau D, Burrel S
Complementary assays for monitoring susceptibility of varicella-zoster virus resistance to antivirals.
Journal of Virological Methods 2016, 233, 10–14.
Yazdanpanah Y, Schwarzinger M
Generic antiretroviral drugs and HIV care: An economic review.
Medecine Et Maladies Infectieuses 2016, 46, 67-71.
Lemaire X, Bonnet E, Castan B, Forestier E, Lescure FX, Roblot F, Pulcini C
Management of non-necrotizing cellulitis in France.
Medecine Et Maladies Infectieuses 2016, 46, 355-359.
Visseaux B, Damond F, Matheron S, Descamps D, Charpentier C
Hiv-2 molecular epidemiology.
Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 2016, 46, 233-240.
Collarino R, Vergeylen U, Emeraud C, Latournèrie G, Grall N, Mammeri H, Messika-Zeitoun D, Vallois D, Yazdanpanah Y, Lescure FX, Bleibtreu A
Mitral endocarditis due to Rothia aeria with cerebral haemorrhage and femoral mycotic aneurysms, first French description.
New Microbes and New Infections 2016, 13, 40-42.
Larbi A, Pesquer L, Reboul G, Omoumi P, Perozziello A, Abadie P, Loriaut P, Copin P, Ducouret E, Dallaudière B
MRI in patients with chronic pubalgia: Is precise useful information provided to the surgeon? A case-control study.
Orthopaedics & traumatology, surgery & research: OTSR 2016, 102, 747-754.
Rouzaud D, Alexandra JF, Chauchard M, Delon M, Dossier A, Chauveheid MP, Perozziello A, Papo T, Sacre K
Incidental venous thromboembolism diagnosed in patients admitted with a first venous thromboembolism: Frequency and clinical significance (an observational study).
Thrombosis Research 2016, 144, 116-118.
Delfraissy JF, Yazdanpanah Y, Levy Y
REACTing: the French response to infectious disease crises.
Lancet (London, England) 2016, 387, 2183-2185.
Benmoussa N, Charpentier C, Mariaggi AA, Collin G, Descamps D, Hourseau M, Barry B, Albert S, Picard A, Conan P, Charlier P
HPV 16 in squamous cell carcinoma of 19th century tonsils.
The Lancet. Oncology 2016, 17, e477–e478.
TenoRes Study Group
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study.
The Lancet. Infectious Diseases 2016, 16, 565-575.
Lachâtre M, Rioux C, Dû DL, Fréchet-Jachym M, Veziris N, Bouvet E, Yazdanpanah Y
Bedaquiline plus delamanid for XDR tuberculosis.
The Lancet. Infectious Diseases 2016, 16, 294.
Visseaux B, Mortier E, Houhou-Fidouh N, Brichler S, Collin G, Larrouy L, Charpentier C, Descamps D
Zika virus in the female genital tract.
The Lancet. Infectious Diseases 2016, 16, 1220.
Pépin JL, Timsit JF, Tamisier R, Borel JC, Lévy P, Jaber S
Prevention and care of respiratory failure in obese patients.
The Lancet. Respiratory Medicine 2016, 4, 407-418.
Frange P, Faye A, Avettand-Fenoël V, Bellaton E, Descamps D, Angin M, David A, Caillat-Zucman S, Peytavin G, Dollfus C, Le Chenadec J, Warszawski J, Rouzioux C, Sáez-Cirión A, ANRS EPF-CO10 Pediatric Cohort and the ANRS EP47 VISCONTI study group
HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report.
The lancet. HIV 2016, 3, e49–54.
Pelat C, Kardaś-Słoma L, Birgand G, Ruppé E, Schwarzinger M, Andremont A, Lucet JC, Yazdanpanah Y
Hand Hygiene, Cohorting, or Antibiotic Restriction to Control Outbreaks of Multidrug-Resistant Enterobacteriaceae.
Infection Control and Hospital Epidemiology 2016, 37, 272-280.
Cuzin L, Dellamonica P, Yazdanpanah Y, Bouchez S, Rey D, Hoen B, Cabié A, Dat'AIDS Study Group
Characteristics and consequences of medical care interruptions in HIV-infected patients in France.
Epidemiology and Infection 2016, 144, 2363-2370.
D'Ortenzio E, Matheron S, Yazdanpanah Y, de Lamballerie X, Hubert B, Piorkowski G, Maquart M, Descamps D, Damond F, Leparc-Goffart I
Evidence of Sexual Transmission of Zika Virus.
The New England Journal of Medicine 2016, 374, 2195-2198.
Sagaon-Teyssier L, Suzan-Monti M, Demoulin B, Capitant C, Lorente N, Préau M, Mora M, Rojas Castro D, Chidiac C, Chas J, Meyer L, Molina JM, Spire B, ANRS IPERGAY Study Group
Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial.
AIDS care 2016, 28 Suppl 1, 48–55.
Préau M, Lorente N, Sagaon-Teyssier L, Champenois K, Gall JML, Mabire X, Spire B, Mora M, Yazdanpanah Y, Suzan M, ANRS-DRAG group and ANRS COMTEST-GROUP
Factors associated with satisfaction with community-based non-medicalized counseling and testing using HIV rapid tests among MSM in France.
AIDS care 2016, 28, 1240-1248.
Tabah A, Cotta MO, Garnacho-Montero J, Schouten J, Roberts JA, Lipman J, Tacey M, Timsit JF, Leone M, Zahar JR, De Waele JJ, Working Group for Antimicrobial Use in the ICU
A Systematic Review of the Definitions, Determinants, and Clinical Outcomes of Antimicrobial De-escalation in the Intensive Care Unit.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2016, 62, 1009-1017.
Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DAMC, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Staneková D, Stanojevic M, Van Laethem K, Zazzi M, Zidovec Lepej S, Boucher CAB, Schmit JC, Wensing AMJ, SPREAD Program
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2016, 62, 655–663.
Matheron S, d'Ortenzio E, Leparc-Goffart I, Hubert B, de Lamballerie X, Yazdanpanah Y
Long-Lasting Persistence of Zika Virus in Semen.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2016, 63, 1264.
Pediatric AIDS-Defining Cancer Project Working Group for IeDEA Southern Africa, TApHOD, and COHERE in EuroCoord
Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2016, 63, 1245–1253.
Piroth L, Moinot L, Yeni P, Avettand-Fénoel V, Reynes J, Girard PM, Marchou B, Georget A, Rouzioux C, Autran B, Duvillard L, Chêne G, Fagard C, ANRS 141 TIPI Trial Study Group
Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial).
The Journal of Antimicrobial Chemotherapy 2016, 71, 490–496.
Lortholary O, Roussillon C, Boucherie C, Padoin C, Chaix ML, Breton G, Rami A, Veziris N, Patey O, Caumes E, May T, Molina JM, Robert J, Tod M, Fagard C, Chêne G, ANRS 129 BKVIR Trial Group
Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial.
The Journal of Antimicrobial Chemotherapy 2016, 71, 783–793.
Barbier F, Pommier C, Essaied W, Garrouste-Orgeas M, Schwebel C, Ruckly S, Dumenil AS, Lemiale V, Mourvillier B, Clec'h C, Darmon M, Laurent V, Marcotte G, Lucet JC, Souweine B, Zahar JR, Timsit JF, OUTCOMEREA Study Group
Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?.
The Journal of Antimicrobial Chemotherapy 2016, 71, 1088-1097.
Lambert-Niclot S, George EC, Pozniak A, White E, Schwimmer C, Jessen H, Johnson M, Dunn D, Perno CF, Clotet B, Plettenberg A, Blaxhult A, Palmisano L, Wittkop L, Calvez V, Marcelin AG, Raffi F, NEAT 001/ANRS 143 Study Group
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART.
The Journal of Antimicrobial Chemotherapy 2016, 71, 1056–1062.
De Luca A, Flandre P, Dunn D, Zazzi M, Wensing A, Santoro MM, Günthard HF, Wittkop L, Kordossis T, Garcia F, Castagna A, Cozzi-Lepri A, Churchill D, De Wit S, Brockmeyer NH, Imaz A, Mussini C, Obel N, Perno CF, Roca B, Reiss P, Schülter E, Torti C, van Sighem A, Zangerle R, Descamps D, CHAIN and COHERE in EuroCoord
Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen.
The Journal of Antimicrobial Chemotherapy 2016, 71, 1352–1360.
Slama L, Landman R, Assoumou L, Benalycherif A, Samri A, Joly V, Pialoux G, Valin N, Cabié A, Duvivier C, Lambert-Niclot S, Marcelin AG, Peytavin G, Costagliola D, Girard PM, IMEA 040 DATA Study Group
Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, randomized, multicentre trial (IMEA 040 DATA trial).
The Journal of Antimicrobial Chemotherapy 2016, 71, 2252–2261.
Bocket L, Peytavin G, Alidjinou EK, Ajana F, Choisy P, Lê M, Charpentier C, Descamps D, Yazdanpanah Y, Katlama C, Simon A, Calvez V, Marcelin AG, Soulie C
Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients.
The Journal of Antimicrobial Chemotherapy 2016, 71, 2651-2653.
Katlama C, Soulié C, Caby F, Denis A, Blanc C, Schneider L, Valantin MA, Tubiana R, Kirstetter M, Valdenassi E, Nguyen T, Peytavin G, Calvez V, Marcelin AG
Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia.
The Journal of Antimicrobial Chemotherapy 2016, 71, 2646–2650.
Gantner P, Assoumou L, Leruez-Ville M, David L, Suzan-Monti M, Costagliola D, Rouzioux C, Ghosn J, EVARIST ANRS EP 49 Study Group
HIV-1-RNA in seminal plasma correlates with detection of HIV-1-DNA in semen cells, but not with CMV shedding, among MSM on successful antiretroviral regimens.
The Journal of Antimicrobial Chemotherapy 2016, 71, 3202–3205.
de Truchis P, Lê MP, Daou M, Madougou B, Nouhou Y, Moussa Saley S, Sani A, Adehossi E, Rouveix E, Saidou M, Peytavin G, Delaugerre C
High efficacy of first-line ART in a West African cohort, assessed by dried blood spot virological and pharmacological measurements.
The Journal of Antimicrobial Chemotherapy 2016, 71, 3222-3227.
Diallo YL, Ollivier V, Joly V, Faille D, Catalano G, Jandrot-Perrus M, Rauch A, Yeni P, Ajzenberg N
Abacavir has no prothrombotic effect on platelets in vitro.
The Journal of Antimicrobial Chemotherapy 2016, 71, 3506–3509.
Bassetti M, Peghin M, Timsit JF
The current treatment landscape: candidiasis.
The Journal of Antimicrobial Chemotherapy 2016, 71, ii13-ii22.
Sokal A, D'Ortenzio E, Houhou-Fidouh N, Brichler S, Dorchies J, Cabras O, Leparc-Goffart I, Yazdanpanah Y, Matheron S
Zika virus infection: report of the first imported cases in a Paris travel centre.
Journal of Travel Medicine 2016, 24,
Garrouste-Orgeas M, Max A, Lerin T, Grégoire C, Ruckly S, Kloeckner M, Brochon S, Pichot E, Simons C, El-Mhadri M, Bruel C, Philippart F, Fournier J, Tiercelet K, Timsit JF, Misset B
Impact of Proactive Nurse Participation in ICU Family Conferences: A Mixed-Method Study.
Critical Care Medicine 2016, 44, 1116-1128.
Toubiana J, Timsit S, Ferroni A, Grasseau M, Nassif X, Lortholary O, Zahar JR, Chalumeau M
Community-Onset Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Invasive Infections in Children in a University Hospital in France.
Medicine 2016, 95, e3163.
Sonneville R, Mariotte E, Neuville M, Minaud S, Magalhaes E, Ruckly S, Cantier M, Voiriot G, Radjou A, Smonig R, Soubirou JF, Mourvillier B, Bouadma L, Wolff M, Timsit JF
Early-onset status epilepticus in patients with acute encephalitis.
Medicine 2016, 95, e4092.
Sellier PO, Schnepf N, Amarsy R, Maylin S, Lopes A, Mazeron MC, Flateau C, Morgand M, Ciraru-Vigneron N, Berthe A, Simoneau G, Evans J, Souak S, Matheron S, Benifla JL, Simon F, Bergmann JF
Short article: Hepatitis B virus status in children born to HIV/HBV coinfected women in a French hospital: a cross-sectional study.
European Journal of Gastroenterology & Hepatology 2016, 28, 328–332.
Desgrees-du-Lou A, Pannetier J, Ravalihasy A, Le Guen M, Gosselin A, Panjo H, Bajos N, Lydie N, Lert F, Dray-Spira R, PARCOURS Study Group
Is hardship during migration a determinant of HIV infection? Results from the ANRS PARCOURS study of sub-Saharan African migrants in France.
AIDS 2016, 30, 645–656.
Ananworanich J, Melvin D, Amador JTR, Childs T, Medin G, Boscolo V, Compagnucci A, Kanjanavanit S, Montero S, Gibb DM, PENTA 11 Study Group
Neurocognition and quality of life after reinitiating antiretroviral therapy in children randomized to planned treatment interruption.
AIDS (London, England) 2016, 30, 1075–1081.
Jean K, Puren A, Cutler E, Singh B, Bouscaillou J, Rain-Taljaard R, Taljaard D, Gouws E, Lissouba P, Lewis DA, Peytavin G, Auvert B
Level of viral suppression and the cascade of HIV care in a South African semi-urban setting in 2012.
AIDS (London, England) 2016, 30, 2107-2116.
de Monteynard LA, Matheron S, Gilquin J, Pavie J, de Truchis P, Grabar S, Launay O, Meynard JL, Khuong-Josses MA, Rey D, Simon A, Mahamat A, Dray-Spira R, Costagliola D, Abgrall S, FHDH-ANRS CO4
Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in France.
AIDS (London, England) 2016, 30, 2235–2246.
Bertine M, Visseaux B, Storto A, Collin G, Matheron S, Descamps D, Charpentier C, ANRS CO5 HIV-2 Cohort
HIV-2 Vif Diversity Among Defective and Nondefective Sequences.
Journal of Acquired Immune Deficiency Syndromes (1999) 2016, 72, e9–e11.
De Sousa Mendes M, Hirt D, Vinot C, Valade E, Lui G, Pressiat C, Bouazza N, Foissac F, Blanche S, Lê MP, Peytavin G, Treluyer JM, Urien S, Benaboud S
Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models.
British Journal of Clinical Pharmacology 2016, 81, 646–657.
Desnoyer A, Dupin N, Assoumou L, Carlotti A, Gaudin F, Deback C, Peytavin G, Marcelin AG, Boué F, Balabanian K, Pourcher-Martinez V, ANRS 154 LENAKAP trial group
Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi's sarcoma skin lesions.
The British Journal of Dermatology 2016
Abramowitz L, Benabderrahmane D, Walker F, Yazdapanah Y, Yeni P, Rioux C, Bouscarat F, Lafferre E, Mentre F, Duval X
Determinants of macroscopic anal cancer and precancerous lesions in 1206 HIV-infected screened patients.
Colorectal Dis 2016, 18, 997-1004.
Flandre P, Pugliese P, Allavena C, Katlama C, Cotte L, Cheret A, Cabié A, Rey D, Chirouze C, Bani-Sadr F, Cuzin L, Dat'AIDS Study group
Comparative risk of failure of ABC/3TC or TDF/FTC based first-line regimens in patients with a high viral load.
HIV medicine 2016, 17, 380–384.
Deuffic-Burban S, Obach D, Canva V, Pol S, Roudot-Thoraval F, Dhumeaux D, Mathurin P, Yazdanpanah Y
Cost-effectiveness and budget impact of interferon-free direct-acting antiviral-based regimens for hepatitis C treatment: the French case.
Journal of Viral Hepatitis 2016, 23, 767-779.
Bottero J, Brouard C, Roudot-Thoraval F, Deuffic-Burban S, Hofliger P, Abergel A, Volant J, Dhumeaux D, Yazdanpanah Y, Viral Hepatitis Testing Experts group
2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV.
Liver International: Official Journal of the International Association for the Study of the Liver 2016, 36, 1442-1449.
Vinot C, Tréluyer JM, Giraud C, Gavard L, Peytavin G, Mandelbrot L
Bidirectional Transfer of Raltegravir in an Ex Vivo Human Cotyledon Perfusion Model.
Antimicrobial Agents and Chemotherapy 2016, 60, 3112-3114.
Birgand G, Leroy C, Nerome S, Luong Nguyen LB, Lolom I, Armand-Lefevre L, Ciotti C, Lecorre B, Marcade G, Fihman V, Nicolas-Chanoine MH, Pelat C, Perozziello A, Fantin B, Yazdanpanah Y, Ricard JD, Lucet JC
Costs associated with implementation of a strict policy for controlling spread of highly resistant microorganisms in France.
BMJ open 2016, 6, e009029.
Mourvillier B, Radjou A, Timsit JF
Subclavian site should be preferred for central venous access.
Evidence-Based Nursing 2016, 19, 126.
Pépin JL, Tamisier R, Baguet JP, Lepaulle B, Arbib F, Arnol N, Timsit JF, Lévy P
Fixed-pressure CPAP versus auto-adjusting CPAP: comparison of efficacy on blood pressure in obstructive sleep apnoea, a randomised clinical trial.
Thorax 2016, 71, 726-733.
Carrara J, N'Diaye DS, Azria E, Launay O, Rozenberg F, Yazpandanah Y, Tsatsaris V, Ayoubi JM, Picone O
Management of Cytomegalovirus Seroconversion during Pregnancy in France.
Fetal Diagnosis and Therapy 2016, 39, 4-12.
Guglielmetti L, Le Dû D, Veziris N, Caumes E, Marigot-Outtandy D, Yazdanpanah Y, Robert J, Fréchet-Jachym M, MDR-TB Management Group of the French National Reference Center for Mycobacteria and the Physicians of the French MDR-TB Cohort
Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis?.
The European Respiratory Journal 2016, 48, 582-585.
Sartelli M, Weber DG, Ruppé E, Bassetti M, Wright BJ, Ansaloni L, Catena F, Coccolini F, Abu-Zidan FM, Coimbra R, Moore EE, Moore FA, Maier RV, De Waele JJ, Kirkpatrick AW, Griffiths EA, Eckmann C, Brink AJ, Mazuski JE, May AK, Sawyer RG, Mertz D, Montravers P, Kumar A, Roberts JA, Vincent JL, Watkins RR, Lowman W, Spellberg B, Abbott IJ, Adesunkanmi AK, Al-Dahir S, Al-Hasan MN, Agresta F, Althani AA, Ansari S, Ansumana R, Augustin G, Bala M, Balogh ZJ, Baraket O, Bhangu A, Beltrán MA, Bernhard M, Biffl WL, Boermeester MA, Brecher SM, Cherry-Bukowiec JR, Buyne OR, Cainzos MA, Cairns KA, Camacho-Ortiz A, Chandy SJ, Che Jusoh A, Chichom-Mefire A, Colijn C, Corcione F, Cui Y, Curcio D, Delibegovic S, Demetrashvili Z, De Simone B, Dhingra S, Diaz JJ, Di Carlo I, Dillip A, Di Saverio S, Doyle MP, Dorj G, Dogjani A, Dupont H, Eachempati SR, Enani MA, Egiev VN, Elmangory MM, Ferrada P, Fitchett JR, Fraga GP, Guessennd N, Giamarellou H, Ghnnam W, Gkiokas G, Goldberg SR, Gomes CA, Gomi H, Guzmán-Blanco M, Haque M, Hansen S, Hecker A, Heizmann WR, Herzog T, Hodonou AM, Hong SK, Kafka-Ritsch R, Kaplan LJ, Kapoor G, Karamarkovic A, Kees MG, Kenig J, Kiguba R, Kim PK, Kluger Y, Khokha V, Koike K, Kok KYY, Kong V, Knox MC, Inaba K, Isik A, Iskandar K, Ivatury RR, Labbate M, Labricciosa FM, Laterre PF, Latifi R, Lee JG, Lee YR, Leone M, Leppaniemi A, Li Y, Liang SY, Loho T, Maegele M, Malama S, Marei HE, Martin-Loeches I, Marwah S, Massele A, McFarlane M, Melo RB, Negoi I, Nicolau DP, Nord CE, Ofori-Asenso R, Omari AH, Ordonez CA, Ouadii M, Pereira Júnior GA, Piazza D, Pupelis G, Rawson TM, Rems M, Rizoli S, Rocha C, Sakakhushev B, Sanchez-Garcia M, Sato N, Segovia Lohse HA, Sganga G, Siribumrungwong B, Shelat VG, Soreide K, Soto R, Talving P, Tilsed JV, Timsit JF, Trueba G, Trung NT, Ulrych J, van Goor H, Vereczkei A, Vohra RS, Wani I, Uhl W, Xiao Y, Yuan KC, Zachariah SK, Zahar JR, Zakrison TL, Corcione A, Melotti RM, Viscoli C, Viale P
Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).
World journal of emergency surgery: WJES 2016, 11,
Paiva JA, Pereira JM, Tabah A, Mikstacki A, de Carvalho FB, Koulenti D, Ruckly S, Çakar N, Misset B, Dimopoulos G, Antonelli M, Rello J, Ma X, Tamowicz B, Timsit JF
Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study.
Critical Care (London, England) 2016, 20,
May F, El-Helali N, Timsit JF, Misset B
Absence of obvious link between supra-therapeutic serum levels of β lactams and clinical toxicity in ICU patients with acute renal failure treated with intermittent hemodialysis.
Critical Care (London, England) 2016, 20, 220.
Coupez E, Timsit JF, Ruckly S, Schwebel C, Gruson D, Canet E, Klouche K, Argaud L, Bohe J, Garrouste-Orgeas M, Mariat C, Vincent F, Cayot S, Cointault O, Lepape A, Darmon M, Boyer A, Azoulay E, Bouadma L, Lautrette A, Souweine B
Guidewire exchange vs new site placement for temporary dialysis catheter insertion in ICU patients: is there a greater risk of colonization or dysfunction?.
Critical Care (London, England) 2016, 20, 230.
Voiriot G, Visseaux B, Cohen J, Nguyen LB, Neuville M, Morbieu C, Burdet C, Radjou A, Lescure FX, Smonig R, Armand-Lefevre L, Mourvillier B, Yazdanpanah Y, Soubirou JF, Ruckly S, Houhou-Fidouh N, Timsit JF
Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia.
Crit Care 2016, 20, 375.
Kalfon P, Mimoz O, Loundou A, Geantot MA, Revel N, Villard I, Amour J, Azoulay E, Garrouste-Orgeas M, Martin C, Sharshar T, Baumstarck K, Auquier P
Reduction of self-perceived discomforts in critically ill patients in French intensive care units: study protocol for a cluster-randomized controlled trial.
Trials 2016, 17,
Leroy O, Bailly S, Gangneux JP, Mira JP, Devos P, Dupont H, Montravers P, Perrigault PF, Constantin JM, Guillemot D, Azoulay E, Lortholary O, Bensoussan C, Timsit JF, AmarCAND2 study group
Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study.
Annals of Intensive Care 2016, 6, 2.
Garrouste-Orgeas M, Ruckly S, Grégoire C, Dumesnil AS, Pommier C, Jamali S, Golgran-Toledano D, Schwebel C, Clec'h C, Soufir L, Fartoukh M, Marcotte G, Argaud L, Verdière B, Darmon M, Azoulay E, Timsit JF
Treatment intensity and outcome of nonagenarians selected for admission in ICUs: a multicenter study of the Outcomerea Research Group.
Annals of Intensive Care 2016, 6, 31.
Boumendil A, Woimant M, Quenot JP, Rooryck FX, Makhlouf F, Yordanov Y, Delerme S, Takun K, Ray P, Kouka MC, Poly C, Garrouste-Orgeas M, Thomas C, Simon T, Azerad S, Leblanc G, Pateron D, Guidet B, ICE-CUB 2 study network
Designing and conducting a cluster-randomized trial of ICU admission for the elderly patients: the ICE-CUB 2 study.
Annals of Intensive Care 2016, 6, 74.
Garrouste-Orgeas M, Vinatier I, Tabah A, Misset B, Timsit JF
Reappraisal of visiting policies and procedures of patient's family information in 188 French ICUs: a report of the Outcomerea Research Group.
Annals of Intensive Care 2016, 6, 82.
Schnell D, Azoulay E, Benoit D, Clouzeau B, Demaret P, Ducassou S, Frange P, Lafaurie M, Legrand M, Meert AP, Mokart D, Naudin J, Pene F, Rabbat A, Raffoux E, Ribaud P, Richard JC, Vincent F, Zahar JR, Darmon M
Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF).
Annals of Intensive Care 2016, 6, 90.
Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, Carazo S, Conde MN, Gala JL, Colin G, Savini H, Bore JA, Le Marcis F, Koundouno FR, Petitjean F, Lamah MC, Diederich S, Tounkara A, Poelart G, Berbain E, Dindart JM, Duraffour S, Lefevre A, Leno T, Peyrouset O, Irenge L, Bangoura N, Palich R, Hinzmann J, Kraus A, Barry TS, Berette S, Bongono A, Camara MS, Chanfreau Munoz V, Doumbouya L, Souley Harouna n, Kighoma PM, Koundouno FR, Réné Lolamou n, Loua CM, Massala V, Moumouni K, Provost C, Samake N, Sekou C, Soumah A, Arnould I, Komano MS, Gustin L, Berutto C, Camara D, Camara FS, Colpaert J, Delamou L, Jansson L, Kourouma E, Loua M, Malme K, Manfrin E, Maomou A, Milinouno A, Ombelet S, Sidiboun AY, Verreckt I, Yombouno P, Bocquin A, Carbonnelle C, Carmoi T, Frange P, Mely S, Nguyen VK, Pannetier D, Taburet AM, Treluyer JM, Kolie J, Moh R, Gonzalez MC, Kuisma E, Liedigk B, Ngabo D, Rudolf M, Thom R, Kerber R, Gabriel M, Di Caro A, Wölfel R, Badir J, Bentahir M, Deccache Y, Dumont C, Durant JF, El Bakkouri K, Gasasira Uwamahoro M, Smits B, Toufik N, Van Cauwenberghe S, Ezzedine K, D'Ortenzio E, Dortenzio E, Pizarro L, Etienne A, Guedj J, Fizet A, Barte de Sainte Fare E, Murgue B, Tran-Minh T, Rapp C, Piguet P, Poncin M, Draguez B, Allaford Duverger T, Barbe S, Baret G, Defourny I, Carroll M, Raoul H, Augier A, Eholie SP, Yazdanpanah Y, Levy-Marchal C, Antierrens A, Van Herp M, Günther S, de Lamballerie X, Keïta S, Mentre F, Anglaret X, Malvy D, JIKI Study Group
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
PLoS medicine 2016, 13, e1001967.
Elanga Ndille E, Doucoure S, Poinsignon A, Mouchet F, Cornelie S, D'Ortenzio E, DeHecq JS, Remoue F
Human IgG Antibody Response to Aedes Nterm-34kDa Salivary Peptide, an Epidemiological Tool to Assess Vector Control in Chikungunya and Dengue Transmission Area.
PLoS neglected tropical diseases 2016, 10, e0005109.
Greacen T, Kersaudy-Rahib D, Le Gall JM, Lydié N, Ghosn J, Champenois K
Comparing the Information and Support Needs of Different Population Groups in Preparation for 2015 Government Approval for HIV Self-testing in France.
PloS One 2016, 11, e0152567.
Kirchgesner J, Beaugerie L, Carrat F, Sokol H, Cosnes J, Schwarzinger M, BERENICE Study Group
Impact on Life Expectancy of Withdrawing Thiopurines in Patients with Crohn's Disease in Sustained Clinical Remission: A Lifetime Risk-Benefit Analysis.
PloS One 2016, 11, e0157191.
Bailly S, Destors M, Grillet Y, Richard P, Stach B, Vivodtzev I, Timsit JF, Lévy P, Tamisier R, Pépin JL, scientific council and investigators of the French national sleep apnea registry (OSFP)
Obstructive Sleep Apnea: A Cluster Analysis at Time of Diagnosis.
PloS One 2016, 11, e0157318.
Angin M, Wong G, Papagno L, Versmisse P, David A, Bayard C, Charmeteau-De Muylder B, Besseghir A, Thiébaut R, Boufassa F, Pancino G, Sauce D, Lambotte O, Brun-Vézinet F, Matheron S, Rowland-Jones SL, Cheynier R, Sáez-Cirión A, Appay V, ANRS CO5 IMMUNOVIR-2 Study Group
Preservation of Lymphopoietic Potential and Virus Suppressive Capacity by CD8+ T Cells in HIV-2-Infected Controllers.
Journal of Immunology (Baltimore, Md.: 1950) 2016, 197, 2787–2795.
Loubet P, Palich R, Kojan R, Peyrouset O, Danel C, Nicholas S, Conde M, Porten K, Augier A, Yazdanpanah Y
Development of a Prediction Model for Ebola Virus Disease: A Retrospective Study in Nzérékoré Ebola Treatment Center, Guinea.
The American Journal of Tropical Medicine and Hygiene 2016, 95, 1362-1367.
Suzan-Monti M, Lorente N, Demoulin B, Marcellin F, Préau M, Dray-Spira R, Lert F, Spire B, ANRS-VESPA2 Study Group
Sexual risk behaviour among people living with HIV according to the biomedical risk of transmission: results from the ANRS-VESPA2 survey.
J Int AIDS Soc 2016, 19, 20095.
2015
Lemiale V, Mokart D, Resche-Rigon M, Pène F, Mayaux J, Faucher E, Nyunga M, Girault C, Perez P, Guitton C, Ekpe K, Kouatchet A, Théodose I, Benoit D, Canet E, Barbier F, Rabbat A, Bruneel F, Vincent F, Klouche K, Loay K, Mariotte E, Bouadma L, Moreau AS, Seguin A, Meert AP, Reignier J, Papazian L, Mehzari I, Cohen Y, Schenck M, Hamidfar R, Darmon M, Demoule A, Chevret S, Azoulay E, Groupe de Recherche en Réanimation Respiratoire du patient d’Onco-Hématologie (GRRR-OH)
Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory Failure: A Randomized Clinical Trial.
JAMA 2015, 314, 1711-1719.
Obach D, Yazdanpanah Y, Esmat G, Avihingsanon A, Dewedar S, Durier N, Attia A, Anwar WA, Cousien A, Tangkijvanich P, Eholié SP, Doss W, Mostafa A, Fontanet A, Mohamed MK, Deuffic-Burban S
How to optimize hepatitis C virus treatment impact on life years saved in resource-constrained countries.
Hepatology (Baltimore, Md.) 2015, 62, 31-39.
Gautheret-Dejean A, Bocobza J, Brunet S, Damond F, Plantier JC, Barin F
Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infections.
Journal of Medical Virology 2015, 87, 2061–2066.
Laouenan C, Guedj J, Peytavin G, Nguyen TT, Lapalus M, Khelifa-Mouri F, Boyer N, Zoulim F, Serfaty L, Bronowicki JP, Martinot-Peignoux M, Lada O, Asselah T, Dorival C, Hezode C, Carrat F, Nicot F, Marcellin P, Mentre F
A Model-Based Illustrative Exploratory Approach to Optimize the Dosing of Peg-IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy.
CPT Pharmacometrics Syst Pharmacol 2015, 4, e00008.
Clémençon S, Cousien A, Felipe MD, Tran VC
On computer-intensive simulation and estimation methods for rare-event analysis in epidemic models.
Statistics in Medicine 2015, 34, 3696-3713.
Bakker J, Perner A, Timsit JF
Evaluation of 7.5 years of Surviving Sepsis Campaign Guidelines.
Intensive Care Medicine 2015, 41, 151-153.
Yazdanpanah Y, Arribas JR, Malvy D
Treatment of Ebola virus disease.
Intensive Care Medicine 2015, 41, 115-117.
Toffart AC, Dhalluin X, Girard N, Chouaid C, Audigier-Valette C, Duruisseaux M, Mennecier B, Parrot A, Fournel P, Moro-Sibilot D, Timsit JF
Patients with advanced lung cancer harboring oncogenic mutations should be admitted to intensive care units.
Intensive Care Medicine [Letter] 2015, 41, 164-165.
Garrouste-Orgeas M, Perrin M, Soufir L, Vesin A, Blot F, Maxime V, Beuret P, Troché G, Klouche K, Argaud L, Azoulay E, Timsit JF
The Iatroref study: medical errors are associated with symptoms of depression in ICU staff but not burnout or safety culture.
Intensive Care Medicine 2015, 41, 273-284.
Reignier J, Darmon M, Sonneville R, Borel AL, Garrouste-Orgeas M, Ruckly S, Souweine B, Dumenil AS, Haouache H, Adrie C, Argaud L, Soufir L, Marcotte G, Laurent V, Goldgran-Toledano D, Clec'h C, Schwebel C, Azoulay E, Timsit JF
Impact of early nutrition and feeding route on outcomes of mechanically ventilated patients with shock: a post hoc marginal structural model study.
Intensive Care Medicine 2015, 41, 875-886.
Timsit JF, Perner A, Bakker J, Bassetti M, Benoit D, Cecconi M, Curtis JR, Doig GS, Herridge M, Jaber S, Joannidis M, Papazian L, Peters MJ, Singer P, Smith M, Soares M, Torres A, Vieillard-Baron A, Citerio G, Azoulay E
Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics.
Intensive Care Medicine [YEAR IN REVIEW 2014] 2015, 41, 575-588.
Bretonnière C, Leone M, Milési C, Allaouchiche B, Armand-Lefevre L, Baldesi O, Bouadma L, Decré D, Figueiredo S, Gauzit R, Guery B, Joram N, Jung B, Lasocki S, Lepape A, Lesage F, Pajot O, Philippart F, Souweine B, Tattevin P, Timsit JF, Vialet R, Zahar JR, Misset B, Bedos JP
Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).
Intensive Care Medicine 2015, 41, 1181-1196.
Bassetti M, Leon C, Timsit JF
Are prophylactic antifungals in highly colonized patients safe and effective?.
Intensive Care Medicine 2015, 41, 1336-1339.
Lautrette A, Garrouste-Orgeas M, Bertrand PM, Goldgran-Toledano D, Jamali S, Laurent V, Argaud L, Schwebel C, Mourvillier B, Darmon M, Ruckly S, Dumenil AS, Lemiale V, Souweine B, Timsit JF, Outcomerea Study Group
Respective impact of no escalation of treatment, withholding and withdrawal of life-sustaining treatment on ICU patients' prognosis: a multicenter study of the Outcomerea Research Group.
Intensive Care Medicine 2015, 41, 1763-1772.
Schortgen F, Charles-Nelson A, Bouadma L, Bizouard G, Brochard L, Katsahian S
Respective impact of lowering body temperature and heart rate on mortality in septic shock: mediation analysis of a randomized trial.
Intensive Care Medicine 2015, 41, 1800-1808.
Bailly S, Leroy O, Montravers P, Constantin JM, Dupont H, Guillemot D, Lortholary O, Mira JP, Perrigault PF, Gangneux JP, Azoulay E, Timsit JF
Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data.
Intensive Care Medicine 2015, 41, 1931-1940.
Garnacho-Montero J, Dimopoulos G, Poulakou G, Akova M, Cisneros JM, De Waele J, Petrosillo N, Seifert H, Timsit JF, Vila J, Zahar JR, Bassetti M, European Society of Intensive Care Medicine
Task force on management and prevention of Acinetobacter baumannii infections in the ICU.
Intensive Care Medicine 2015, 41, 2057-2075.
Lepelletier D, Lucet JC, Astagneau P, Coignard B, Vaux S, Rabaud C, Grandbastien B, Berthelot P
Control of emerging extensively drug-resistant organisms (eXDRO) in France: a survey among infection preventionists from 286 healthcare facilities.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2015, 34, 1615-1620.
Pichon M, Savatovsky J, Lamirel C, Joly V, Moulignier A
Isolated blepharoptosis may point to HIV-associated Burkitt's lymphoma.
Acta Neurologica Belgica 2015, 115, 833–835.
Brunetta J, Moreno Guillén S, Antinori A, Yeni P, Wade B, Johnson M, Shalit P, Ebrahimi R, Johnson B, Walker I, De-Oertel S
Patient-Reported Outcomes After a Switch to a Single-Tablet Regimen of Rilpivirine, Emtricitabine, and Tenofovir DF in HIV-1-Positive, Virologically Suppressed Individuals: Additional Findings From a Randomized, Open-Label, 48-Week Trial.
The Patient 2015
Birgand G, Toupet G, Rukly S, Antoniotti G, Deschamps MN, Lepelletier D, Pornet C, Stern JB, Vandamme YM, van der Mee-Marquet N, Timsit JF, Lucet JC
Air contamination for predicting wound contamination in clean surgery: A large multicenter study.
American Journal of Infection Control 2015, 43, 516-521.
Parienti JJ, Lucet JC, Lefort A, Armand-Lefèvre L, Wolff M, Caron F, Cattoir V, Yazdanpanah Y
Empirical therapies among adults hospitalized for community-acquired upper urinary tract infections: A decision-tree analysis of mortality, costs, and resistance.
American Journal of Infection Control 2015, 43, e53-e59.
Canlorbe G, Matheron S, Mandelbrot L, Oudet B, Luton D, Azria E
Vasculoplacental complications in pregnant women with HIV infection: a case-control study.
American Journal of Obstetrics and Gynecology 2015, 213, 241.e1-9.
Mabileau G, Schwarzinger M, Flores J, Patrat C, Luton D, Epelboin S, Mandelbrot L, Matheron S, Yazdanpanah Y
HIV-serodiscordant couples desiring a child: 'treatment as prevention,' preexposure prophylaxis, or medically assisted procreation?.
American Journal of Obstetrics and Gynecology 2015, 213, 341.e1-12.
Mallet V, Schwarzinger M, Vallet-Pichard A, Fontaine H, Corouge M, Sogni P, Pol S
Effect of nucleoside and nucleotide analogues on renal function in patients with chronic hepatitis B virus monoinfection.
Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association 2015, 13, 1181-1188.e1.
Lesprit P, de Pontfarcy A, Esposito-Farese M, Ferrand H, Mainardi JL, Lafaurie M, Parize P, Rioux C, Tubach F, Lucet JC
Postprescription review improves in-hospital antibiotic use: a multicenter randomized controlled trial.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 180.e1-7.
Le Dorze M, Gault N, Foucrier A, Ruppé E, Mourvillier B, Woerther PL, Birgand G, Montravers P, Dilly MP, Tubach F, Andremont A, Timsit JF, Wolff M, Armand-Lefèvre L
Performance and impact of a rapid method combining mass spectrometry and direct antimicrobial susceptibility testing on treatment adequacy of patients with ventilator-associated pneumonia.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 468.e1-6.
Weiss E, Zahar JR, Lesprit P, Ruppe E, Leone M, Chastre J, Lucet JC, Paugam-Burtz C, Brun-Buisson C, Timsit JF, De-escalation Study Group
Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 649.e1-10.
Lemaignen A, Birgand G, Ghodhbane W, Alkhoder S, Lolom I, Belorgey S, Lescure FX, Armand-Lefevre L, Raffoul R, Dilly MP, Nataf P, Lucet JC
Sternal wound infection after cardiac surgery: incidence and risk factors according to clinical presentation.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 674.e11-18.
LeGoff J, Roques P, Jenabian MA, Charpentier C, Brochier C, Bouhlal H, Gresenguet G, Frost E, Pepin J, Mayaud P, Belec L, ANRS12-12 Study Group
Variability of human immunodeficiency virus-1 in the female genital reservoir during genital reactivation of herpes simplex virus type 2.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 873.e1-9.
Birgand G, Johansson A, Szilagyi E, Lucet JC
Overcoming the obstacles of implementing infection prevention and control guidelines.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 1067-1071.
Maraux B, Hamelin C, Bajos N, Dray-Spira R, Spire B, Lert F, Vespa2 study group
Women living with HIV still lack highly effective contraception: results from the ANRS VESPA2 study, France, 2011.
Contraception 2015, 92, 160–169.
Shadoud L, Almahmoud I, Jarraud S, Etienne J, Larrat S, Schwebel C, Timsit JF, Schneider D, Maurin M
Hidden Selection of Bacterial Resistance to Fluoroquinolones In Vivo: The Case of Legionella pneumophila and Humans.
EBioMedicine 2015, 2, 1179-1185.
Gauzit R, Pean Y, Alfandari S, Bru JP, Bedos JP, Rabaud C, Robert J, Société de Pathologie Infectieuse de Langue Française (SPILF), Observatoire National de l’Épidémiologie de la Résistance Bactérienne aux Antibiotiques (ONERBA), Surveillance de la Prescription des Antibiotiques (SPA) Group
Carbapenem use in French hospitals: A nationwide survey at the patient level.
International Journal of Antimicrobial Agents 2015, 46, 707-712.
Lefebvre A, Saliou P, Mimoz O, Lucet JC, Le Guyader A, Bruyère F, Roche PH, Astruc K, Tiv M, Lepelletier D, Aho-Glélé LS, French Study Group for the Pre-operative Prevention of Surgical Site Infections
Is surgical site scrubbing before painting of value? Review and meta-analysis of clinical studies.
The Journal of Hospital Infection 2015, 89, 28-37.
Lepelletier D, Berthelot P, Lucet JC, Fournier S, Jarlier V, Grandbastien B, National Working Group
French recommendations for the prevention of 'emerging extensively drug-resistant bacteria' (eXDR) cross-transmission.
The Journal of Hospital Infection 2015, 90, 186-195.
Lefebvre A, Saliou P, Lucet JC, Mimoz O, Keita-Perse O, Grandbastien B, Bruyère F, Boisrenoult P, Lepelletier D, Aho-Glélé LS, French Study Group for the Preoperative Prevention of Surgical Site Infections
Preoperative hair removal and surgical site infections: network meta-analysis of randomized controlled trials.
The Journal of Hospital Infection 2015, 91, 100-108.
Charlier C, Hourrier S, Leruez-Ville M, Zahar JR, Floret D, Salomon LJ, Toubiana J, Lecuit M, Lapillonne A, Lortholary O, Kermorvant-Duchemin E
Polyvalent immunoglobulins in neonates after perinatal exposure to measles: Benefits and long-term tolerance of immunoglobulins.
The Journal of Infection 2015, 71, 131-134.
Bonnal C, Birgand G, Lolom I, Diamantis S, Dumortier C, L'Heriteau F, Armand-Lefevre L, Lucet JC
Staphylococcus aureus healthcare associated bacteraemia: An indicator of catheter related infections.
Medecine Et Maladies Infectieuses 2015, 45, 84-88.
Lefébure A, Papy E, Rioux C, Diamantis S, Armand-Lefèvre L, Longuet P, Lescure FX, Wolff M, Arnaud P, Lucet JC
Audit of carbapenem prescriptions comparing 2 assessment periods.
Medecine Et Maladies Infectieuses 2015, 45, 273-278.
Alfandari S, Robert J, Péan Y, Rabaud C, Bedos JP, Varon E, Lepape A, Bru JP, Gauzit R, French Infectious Diseases Society (French acronym SPILF), the French National Observatory for Epidemiology of Bacterial Resistance to Antibiotics (ONERBA), and the SPA2 group
Antibiotic use and good practice in 314 French hospitals: The 2010 SPA2 prevalence study.
Medecine Et Maladies Infectieuses 2015, 45, 475–480.
Wagner N, Wyler-Lazarevic CA, Yerly S, Samer C, Peytavin G, Posfay-Barbe KM, Calmy A, Ambrosioni J
Dolutegravir-based antiretroviral therapy in a severely overweight child with a multidrug-resistant human immunodeficiency virus infection. A case report and review.
New Microbes and New Infections 2015, 6, 1–4.
Caseris M, Burdet C, Lepeule R, Houhou N, Yeni P, Yazdanpanah Y, Joly V
[An update on measles].
La Revue De Medecine Interne 2015, 36, 339-345.
Ribadeau Dumas F, N’Diaye DS, Paireau J, Gautret P, Bourhy H, Le Pen C, Yazdanpanah Y
Cost-effectiveness of rabies post-exposure prophylaxis in the context of very low rabies risk: A decision-tree model based on the experience of France.
Vaccine 2015, 33, 2367-2378.
Loubet P, Kernéis S, Groh M, Loulergue P, Blanche P, Verger P, Launay O
Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency.
Vaccine 2015, 33, 3703-3708.
Mullaert J, Abgrall S, Lele N, Batteux F, Slama LB, Meritet JF, Lebon P, Bouchaud O, Grabar S, Launay O
Diphtheria, tetanus, poliomyelitis, yellow fever and hepatitis B seroprevalence among HIV1-infected migrants. Results from the ANRS VIHVO vaccine sub-study.
Vaccine 2015, 33, 4938-4944.
Guerrier G, Sjögren L, Guerrier M, Bretonnière S, Letier T, Dancoisne A, Wirtz M, D'Ortenzio E
Scientific journalism in Africa to help fight global health emergencies.
Lancet (London, England) 2015, 386, 851.
Mimoz O, Lucet JC, Kerforne T, Pascal J, Souweine B, Goudet V, Mercat A, Bouadma L, Lasocki S, Alfandari S, Friggeri A, Wallet F, Allou N, Ruckly S, Balayn D, Lepape A, Timsit JF, CLEAN trial investigators
Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial.
Lancet (London, England) 2015, 386, 2069-2077.
Guerrier G, D'Ortenzio E
Teaching anthropology to medical students.
Lancet (London, England) 2015, 385, 603.
Ndawinz JDA, Cissé M, Diallo MSK, Sidibé CT, D'Ortenzio E
Prevention of HIV spread during the Ebola outbreak in Guinea.
Lancet (London, England) 2015, 385, 1393.
Arribas JR, Girard PM, Landman R, Pich J, Mallolas J, Martínez-Rebollar M, Zamora FX, Estrada V, Crespo M, Podzamczer D, Portilla J, Dronda F, Iribarren JA, Domingo P, Pulido F, Montero M, Knobel H, Cabié A, Weiss L, Gatell JM, OLE/RIS-EST13 Study Group
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial.
The Lancet. Infectious Diseases 2015, 15, 785-792.
Rey D, Piroth L, Wendling MJ, Miailhes P, Michel ML, Dufour C, Haour G, Sogni P, Rohel A, Ajana F, Billaud E, Molina JM, Launay O, Carrat F, ANRS HB04 B-BOOST study group
Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial.
The Lancet. Infectious Diseases 2015, 15, 1283–1291.
Yazdanpanah Y, Horby P, van Griensven J, Mentre F, Nguyen VK, Malvy JMD, Dunning J, Sissoko D, Delfraissy JF, Levy Y
Drug assessment in the Ebola virus disease epidemic in west Africa.
The Lancet. Infectious Diseases 2015, 15, 1258.
Horby PW, Endzt H, Muyembe-Tamfum JJ, van Griensven J, Gevao S, Goossens H, Malvy JMD, Haba NY, Yazdanpanah Y, Olliaro P, Semple C, de Jong M, Delamou A, Lang T, Carson G, Kennedy S
Ebola: Europe-Africa research collaborations.
The Lancet. Infectious Diseases 2015, 15, 1258-1259.
Chéret A, Nembot G, Mélard A, Lascoux C, Slama L, Miailhes P, Yeni P, Abel S, Avettand-Fenoel V, Venet A, Chaix ML, Molina JM, Katlama C, Goujard C, Tamalet C, Raffi F, Lafeuillade A, Reynes J, Ravaux I, Hoën B, Delfraissy JF, Meyer L, Rouzioux C, OPTIPRIM ANRS Study Group
Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial.
Lancet Infect Dis 2015, 15, 387–396.
Lodi S, Phillips A, Logan R, Olson A, Costagliola D, Abgrall S, van Sighem A, Reiss P, Miró JM, Ferrer E, Justice A, Gandhi N, Bucher HC, Furrer H, Moreno S, Monge S, Touloumi G, Pantazis N, Sterne J, Young JG, Meyer L, Seng R, Dabis F, Vandehende MA, Pérez-Hoyos S, Jarrín I, Jose S, Sabin C, Hernán MA, HIV-CAUSAL Collaboration
Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.
The lancet. HIV 2015, 2, e335–343.
Birgand G, Saliou P, Lucet JC
Influence of staff behavior on infectious risk in operating rooms: what is the evidence?.
Infection Control and Hospital Epidemiology 2015, 36, 93-106.
Lucet JC, Abiteboul D, Estellat C, Roy C, Chollet-Martin S, Tubach F, Carcelain G, QUANTIPS Study Group
Interferon-γ release assay vs. tuberculin skin test for tuberculosis screening in exposed healthcare workers: a longitudinal multicenter comparative study.
Infection Control and Hospital Epidemiology 2015, 36, 569-574.
Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, Tremblay C, Le Gall JM, Cua E, Pasquet A, Raffi F, Pintado C, Chidiac C, Chas J, Charbonneau P, Delaugerre C, Suzan-Monti M, Loze B, Fonsart J, Peytavin G, Cheret A, Timsit J, Girard G, Lorente N, Préau M, Rooney JF, Wainberg MA, Thompson D, Rozenbaum W, Doré V, Marchand L, Simon MC, Etien N, Aboulker JP, Meyer L, Delfraissy JF, ANRS IPERGAY Study Group
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
The New England Journal of Medicine 2015, 373, 2237–2246.
TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, Ouattara E, Anzian A, Ntakpé JB, Minga A, Kouame GM, Bouhoussou F, Emieme A, Kouamé A, Inwoley A, Toni Td, Ahiboh H, Kabran M, Rabe C, Sidibé B, Nzunetu G, Konan R, Gnokoro J, Gouesse P, Messou E, Dohoun L, Kamagate S, Yao A, Amon S, Kouame AB, Koua A, Kouamé E, Ndri Y, Ba-Gomis O, Daligou M, Ackoundzé S, Hawerlander D, Ani A, Dembélé F, Koné F, Guéhi C, Kanga C, Koule S, Séri J, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatounde N, Bleoué G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Assi R, Bakayoko A, Mahassadi A, Attia A, Oussou A, Mobio M, Bamba D, Koman M, Horo A, Deschamps N, Chenal H, Sassan-Morokro M, Konate S, Aka K, Aoussi E, Journot V, Nchot C, Karcher S, Chaix ML, Rouzioux C, Sow PS, Perronne C, Girard PM, Menan H, Bissagnene E, Kadio A, Ettiegne-Traore V, Moh-Semdé C, Kouame A, Massumbuko JM, Chêne G, Dosso M, Domoua SK, N'Dri-Yoman T, Salamon R, Eholié SP, Anglaret X
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
The New England Journal of Medicine 2015, 373, 808–822.
Soulie C, Peytavin G, Charpentier C, Lambert-Niclot S, Sayon S, Visseaux B, Simon A, Katlama C, Yazdanpanah Y, Descamps D, Calvez V, Marcelin AG
Antiretroviral-Experienced HIV-1-Infected Patients Treated with Maraviroc: Factors Associated with Virological Response.
AIDS research and human retroviruses 2015, 31, 475-478.
Grabar S, Tattevin P, Selinger-Leneman H, de La Blanchardiere A, de Truchis P, Rabaud C, Rey D, Daneluzzi V, Ferret S, Lascaux AS, Hanslik T, Costagliola D, Launay O, French Hospital Database on HIV (FHDH-ANRS CO4 Cohort)
Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 60, 1269–1277.
HIV-CAUSAL Collaboration, Cain LE, Phillips A, Olson A, Sabin C, Jose S, Justice A, Tate J, Logan R, Robins JM, Sterne JAC, van Sighem A, Reiss P, Young J, Fehr J, Touloumi G, Paparizos V, Esteve A, Casabona J, Monge S, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Dabis F, Vandenhende MA, Abgrall S, Costagliola D, Hernán MA
Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 60, 1262–1268.
Delaugerre C, Ghosn J, Lacombe JM, Pialoux G, Cuzin L, Launay O, Menard A, de Truchis P, Costagliola D, FHDH-ANRS CO4
Significant reduction in HIV virologic failure during a 15-year period in a setting with free healthcare access.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 60, 463–472.
Descamps D, Peytavin G, Visseaux B, Tubiana R, Damond F, Campa P, Charpentier C, Khuong-Josses MA, Duvivier C, Karmochkine M, Lukiana T, Matheron S
Dolutegravir in HIV-2 infected patients with resistant virus to first-line integrase inhibitors from the French Named Patient Program.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015
Carrieri MP, Serfaty L, Vilotitch A, Winnock M, Poizot-Martin I, Loko MA, Lions C, Lascoux-Combe C, Roux P, Salmon-Ceron D, Spire B, Dabis F, ANRS CO13 HEPAVIH Study Group
Cannabis use and reduced risk of insulin-resistance in HIV-HCV infected patients: a longitudinal analysis (ANRS HEPAVIH CO-13).
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015
Sibiude J, Le Chenadec J, Bonnet D, Tubiana R, Faye A, Dollfus C, Mandelbrot L, Delmas S, Lelong N, Khoshnood B, Warszawski J, Blanche S, French National Agency for Research on AIDS and Viral Hepatitis French Perinatal Cohort/Protease Inhibitor Monotherapy Evaluation Trial
In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 270-280.
Abgrall S, Rachas A, Tourret J, Isnard-Bagnis C, Billaud E, Tattevin P, Costagliola D, Guiguet M, Durieux P, French Hospital Database on HIV
A multifaceted intervention designed to improve medical management of moderate to advanced chronic kidney disease in HIV-infected patients: a cluster randomized trial.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 375–384.
Ruppé E, Armand-Lefèvre L, Estellat C, Consigny PH, El Mniai A, Boussadia Y, Goujon C, Ralaimazava P, Campa P, Girard PM, Wyplosz B, Vittecoq D, Bouchaud O, Le Loup G, Pialoux G, Perrier M, Wieder I, Moussa N, Esposito-Farèse M, Hoffmann I, Coignard B, Lucet JC, Andremont A, Matheron S
High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 593-600.
Charpentier C, Camacho R, Ruelle J, Eberle J, Gürtler L, Pironti A, Stürmer M, Brun-Vézinet F, Kaiser R, Descamps D, Obermeier M
HIV-2EU-Supporting Standardized HIV-2 Drug-Resistance Interpretation in Europe: An Update.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 1346–1347.
Mandelbrot L, Tubiana R, Le Chenadec J, Dollfus C, Faye A, Pannier E, Matheron S, Khuong MA, Garrait V, Reliquet V, Devidas A, Berrebi A, Allisy C, Elleau C, Arvieux C, Rouzioux C, Warszawski J, Blanche S, ANRS-EPF Study Group
No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 1715-1725.
Fofana DB, Charpentier C, Maïga AI, Lambert-Niclot S, Sayon S, Désiré N, Simon A, Yazdanpanah Y, Katlama C, Descamps D, Calvez V, Marcelin AG, Soulié C
Genetic barrier for attachment inhibitor BMS-626529 resistance in HIV-1 B and non-B subtypes.
The Journal of Antimicrobial Chemotherapy 2015, 70, 130-135.
Lê MP, Landman R, Koulla-Shiro S, Charpentier C, Sow PS, Diallo MB, Ngom Gueye NF, Ngolle M, Le Moing V, Eymard-Duvernay S, Benalycherif A, Delaporte E, Girard PM, Peytavin G, DAYANA Study Group
Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1517–1521.
Fourati S, Charpentier C, Amiel C, Morand-Joubert L, Reigadas S, Trabaud MA, Delaugerre C, Nicot F, Rodallec A, Maillard A, Mirand A, Jeulin H, Montès B, Barin F, Bettinger D, Le Guillou-Guillemette H, Vallet S, Signori-Schmuck A, Descamps D, Calvez V, Flandre P, Marcelin AG, ANRS AC11 Resistance Study Group
Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1507–1512.
Danion F, Belissa E, Peytavin G, Thierry E, Lanternier F, Scemla A, Lortholary O, Delelis O, Avettand-Fenoel V, Duvivier C
Non-virological response to a dolutegravir-containing regimen in a patient harbouring a E157Q-mutated virus in the integrase region.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1921–1923.
Raymond S, Maillard A, Amiel C, Peytavin G, Trabaud MA, Desbois D, Bellecave P, Delaugerre C, Soulie C, Marcelin AG, Descamps D, Izopet J, on behalf the ANRS AC11 Resistance Study Group
Virological failure of patients on maraviroc-based antiretroviral therapy.
The Journal of Antimicrobial Chemotherapy 2015
Loubet P, Charpentier C, Visseaux B, Borbor A, Nuta C, Adu E, Chapplain JM, Baysah M, Tattevin P, Yazdanpanah Y, Descamps D
Prevalence of HIV-1 drug resistance among patients failing first-line ART in Monrovia, Liberia: a cross-sectional study.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1881-1884.
Bastard JP, Fellahi S, Couffignal C, Raffi F, Gras G, Hardel L, Sobel A, Leport C, Fardet L, Capeau J, ANRS CO8 APROCO-COPILOTE Cohort Study Group
Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1816-1824.
Charpentier C, Lee GQ, Rodriguez C, Visseaux B, Storto A, Fagard C, Molina JM, Katlama C, Yazdanpanah Y, Harrigan PR, Descamps D
Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response.
The Journal of Antimicrobial Chemotherapy 2015, 70, 2090-2096.
Frange P, Assoumou L, Descamps D, Chéret A, Goujard C, Tran L, Gousset M, Avettand-Fenoël V, Bocket L, Fafi-Kremer S, Guinard J, Morand-Joubert L, Nicot F, Plantier JC, Rogez S, Wirden M, Rouzioux C, Meyer L, Chaix ML, French ANRS CO 6 PRIMO Cohort, the ANRS 147 OPTIPRIM Clinical Trial and the AC11 Resistance Study Groups, French ANRS CO 6 PRIMO Cohort the ANRS 147 OPTIPRIM Clinical Trial and the AC11 Resistance Study Groups
HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies.
The Journal of Antimicrobial Chemotherapy 2015, 70, 2084–2089.
Raffi F, Yazdanpanah Y, Fagnani F, Laurendeau C, Lafuma A, Gourmelen J
Persistence and adherence to single-tablet regimens in HIV treatment: a cohort study from the French National Healthcare Insurance Database.
The Journal of Antimicrobial Chemotherapy 2015, 70, 2121-2128.
Chéret A, Bacchus-Souffan C, Avettand-Fenoël V, Mélard A, Nembot G, Blanc C, Samri A, Sáez-Cirión A, Hocqueloux L, Lascoux-Combe C, Allavena C, Goujard C, Valantin MA, Leplatois A, Meyer L, Rouzioux C, Autran B, OPTIPRIM ANRS-147 Study Group
Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission.
J. Antimicrob. Chemother. 2015, 70, 2108–2120.
Wirden M, Todesco E, Valantin MA, Lambert-Niclot S, Simon A, Calin R, Tubiana R, Peytavin G, Katlama C, Calvez V, Marcelin AG
Low-level HIV-1 viraemia in patients on HAART: risk factors and management in clinical practice.
The Journal of Antimicrobial Chemotherapy 2015
Lê MP, Soulié C, Assoumou L, Valantin MA, Duvivier C, Chas J, Ponscarme D, Marcelin AG, Calvez V, Katlama C, Peytavin G, ROCnRAL ANRS 157 Study Group
Plasma concentrations of maraviroc and raltegravir after dual therapy in patients with long-term suppressed viraemia: ROCnRAL ANRS 157 study.
The Journal of Antimicrobial Chemotherapy 2015, 70, 2418–2420.
Tabah A, De Waele J, Lipman J, Zahar JR, Cotta MO, Barton G, Timsit JF, Roberts JA, Working Group for Antimicrobial Use in the ICU within the Infection Section of the European Society of Intensive Care Medicine (ESICM)
The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs.
The Journal of Antimicrobial Chemotherapy 2015, 70, 2671-2677.
Ferrand H, Blanc-Gruyelle AL, Amsilli M, Lemaire X, Papot E, Papy E, Bervar J, Senneville E, Bouvet E, Yazdanpanah Y
Use of fluoroquinolones for the treatment of TB: 8 years of experience.
The Journal of Antimicrobial Chemotherapy 2015, 70, 3166-3167.
Lanternier F, Poiree S, Elie C, Garcia-Hermoso D, Bakouboula P, Sitbon K, Herbrecht R, Wolff M, Ribaud P, Lortholary O, French Mycosis Study Group
Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis.
The Journal of Antimicrobial Chemotherapy 2015, 70, 3116–3123.
Soulié C, Assoumou L, Darty M, Rodriguez C, Donati F, Sayon S, Peytavin G, Valantin MA, Caby F, Schneider L, Canestri A, Costagliola D, Katlama C, Calvez V, Marcelin AG, ROCnRAL ANRS-157 Study Group
Virological factors associated with outcome of dual maraviroc/raltegravir therapy (ANRS-157 trial).
The Journal of Antimicrobial Chemotherapy 2015, 70, 3339–3344.
Cazanave C, Reigadas S, Mazubert C, Bellecave P, Hessamfar M, Le Marec F, Lazaro E, Peytavin G, Bruyand M, Fleury H, Dabis F, Neau D
Switch to Rilpivirine/Emtricitabine/Tenofovir Single-Tablet Regimen of Human Immunodeficiency Virus-1 RNA-Suppressed Patients, Agence Nationale de Recherches sur le SIDA et les Hépatites Virales CO3 Aquitaine Cohort, 2012-2014.
Open Forum Infectious Diseases 2015, 2, ofv018.
Belkacem A, Caseris M, Yazdanpanah Y
A Case of Aggregatibacter aphrophilus Multiple Abscess.
Open Forum Infectious Diseases 2015, 2, ofv031.
Bouadma L, Sonneville R, Garrouste-Orgeas M, Darmon M, Souweine B, Voiriot G, Kallel H, Schwebel C, Goldgran-Toledano D, Dumenil AS, Argaud L, Ruckly S, Jamali S, Planquette B, Adrie C, Lucet JC, Azoulay E, Timsit JF, OUTCOMEREA Study Group
Ventilator-Associated Events: Prevalence, Outcome, and Relationship With Ventilator-Associated Pneumonia.
Critical Care Medicine 2015, 43, 1798-1806.
Feeney ER, Chung RT, Yazdanpanah Y
Current guidelines and prioritizing treatment of hepatitis C virus in HIV-infected patients.
Current opinion in HIV and AIDS 2015, 10, 323-329.
Bertine M, Charpentier C, Visseaux B, Storto A, Collin G, Larrouy L, Damond F, Matheron S, Brun-Vézinet F, Descamps D, ANRS CO5 HIV-2 Cohort
High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patients.
AIDS (London, England) 2015, 29, 779–784.
Alessandri-Gradt E, Morgand M, Delaugerre C, Peytavin G, Sellier P, Simon F, Plantier JC
HIV-1 group O resistance pathway with raltegravir is similar to HIV-1 group M.
AIDS (London, England) 2015, 29, 1271–1273.
Péré H, Roques P, Talla F, Meillo H, Charpentier C, Bélec L
Sustained virological failure in Cameroonese patient infected by HIV-1 group N evidenced by sequence-based genotyping assay.
AIDS (London, England) 2015, 29, 1267–1269.
Annequin M, Lert F, Spire B, Dray-Spira R, VESPA2 Study Group
Has the employment status of people living with HIV changed since the early 2000s?.
AIDS 2015, 29, 1537–1547.
Cuzin L, Pugliese P, Sauné K, Allavena C, Ghosn J, Cottalorda J, Rodallec A, Chaix ML, Fafi-Kremer S, Soulié C, Ouka M, Charpentier C, Bocket L, Mirand A, Guiguet M, Dat’AIDS study group
Levels of intracellular HIV-DNA in patients with suppressive antiretroviral therapy.
AIDS (London, England) 2015, 29, 1665–1671.
Loubet P, Mabileau G, Baysah M, Nuta C, Taylor M, Jusu H, Weeks H, Ingels A, Perennec-Olivier M, Chapplain JM, Cartier N, Mendiharat P, Raguin G, Tattevin P, Yazdanpanah Y
Likely effect of the 2014 Ebola epidemic on HIV care in Liberia.
AIDS (London, England) 2015, 29, 2347-2351.
Visseaux B, Charpentier C, Ozanne A, Nizard A, Drumard S, Fagard C, Glohi D, Damond F, Brun-Vézinet F, Matheron S, Descamps D, ANRS CO5 HIV-2 Cohort
Tropism distribution among antiretroviral-naive HIV-2-infected patients.
AIDS (London, England) 2015, 29, 2209–2212.
Zucman D, Sené T, Hillaire S, Kahn JE, Farfour E, Peytavin G
Antihepatitis C virus treatments for HIV-hepatitis C virus coinfected cirrhotic patients: a need to look beyond the sustained viral response.
AIDS (London, England) 2015, 29, 1903–1904.
Boullé C, Kouanfack C, Laborde-Balen G, Boyer S, Aghokeng AF, Carrieri MP, Kazé S, Dontsop M, Mben JM, Koulla-Shiro S, Peytavin G, Spire B, Delaporte E, Laurent C, Stratall ANRS 12110ESTHER Study Group
Gender Differences in Adherence and Response to Antiretroviral Treatment in the Stratall Trial in Rural District Hospitals in Cameroon.
Journal of Acquired Immune Deficiency Syndromes (1999) 2015, 69, 355–364.
Harrison L, Melvin A, Fiscus S, Saidi Y, Nastouli E, Harper L, Compagnucci A, Babiker A, McKinney R, Gibb D, Tudor-Williams G, PENPACT-1 (PENTA 9PACTG 390) Study Team
HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds.
Journal of Acquired Immune Deficiency Syndromes (1999) 2015, 70, 42–53.
Moulignier A, Gueguen A, Lescure FX, Ziegler M, Girard PM, Cardon B, Pialoux G, Molina JM, Brandel JP, Lamirel C
Does HIV Infection Alter Parkinson Disease?.
Journal of Acquired Immune Deficiency Syndromes (1999) 2015, 70, 129-136.
Marcellin F, Demoulin B, Suzan-Monti M, Maradan G, Carrieri MP, Dray-Spira R, Spire B, ANRS-VESPA2 Study Group
Risk Factors for HCV Reinfection or Transmission in HIV-HCV Coinfected MSM (ANRS-VESPA2 French National Survey).
J. Acquir. Immune Defic. Syndr. 2015, 70, e179–182.
Sonneville R, Gault N, de Montmollin E, Klein IF, Mariotte E, Chemam S, Tubach F, Mourvillier B, Timsit JF, Wolff M, Bouadma L
Clinical spectrum and outcomes of patients with encephalitis requiring intensive care.
European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies 2015, 22, 6-16, e1.
Deconinck L, Yazdanpanah Y, Gilson RJ, Melliez H, Viget N, Joly V, Sabin CA
Time to initiation of antiretroviral therapy in HIV-infected patients diagnosed with an opportunistic disease: a cohort study.
HIV medicine 2015, 16, 219-229.
Winston A, Stöhr W, Antinori A, Arenas-Pinto A, Llibre JM, Amieva H, Cabié A, Williams I, Di Perri G, Tellez MJ, Rockstroh J, Babiker A, Pozniak A, Raffi F, Richert L, NEAT 001/Agence Nationale de Recherche sur le SIDA (ANRS) 143 Study Group, NEAT 001/Agence Nationale de Recherche sur le SIDA ANRS 143 Study Group
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy.
HIV medicine 2015
Polivka L, Peytavin G, Franck N, Mouthon L, Dupin N
Testing for levamisole and cocaine in hair samples for the diagnosis of levamisole-related panniculitis.
Journal of the European Academy of Dermatology and Venereology: JEADV 2015, 29, 2487–2489.
Cousien A, Tran VC, Deuffic-Burban S, Jauffret-Roustide M, Dhersin JS, Yazdanpanah Y
Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review.
Journal of Viral Hepatitis 2015, 22, 213-229.
Sellier P, Maylin S, Amarsy R, Mazeron MC, Larrouy L, Haïm-Boukobza S, Lopes A, Moreno MD, Ricbourg A, Simoneau G, Magnier JD, Mercier-Delarue S, Delcey V, Evans J, Cambau E, Barranger E, Simon F, Bergmann JF
Untreated highly viraemic pregnant women from Asia or sub-Saharan Africa often transmit hepatitis B virus despite serovaccination to newborns.
Liver Int. 2015, 35, 409–416.
Mandelbrot L, Duro D, Belissa E, Peytavin G
Placental transfer of rilpivirine in an ex vivo human cotyledon perfusion model.
Antimicrobial Agents and Chemotherapy 2015, 59, 2901-2903.
Pain JB, Lê MP, Caseris M, Amiel C, Lassel L, Charpentier C, Desnoyer A, Farnoux C, Pialoux G, Descamps D, Peytavin G
Pharmacokinetics of dolutegravir in a premature neonate after HIV treatment intensification during pregnancy.
Antimicrobial Agents and Chemotherapy 2015, 59, 3660–3662.
Solis M, Meddeb M, Sueur C, Domingo-Calap P, Soulier E, Chabaud A, Perrin P, Moulin B, Bahram S, Stoll-Keller F, Caillard S, Barth H, Fafi-Kremer S, French BKV Study Group
Sequence Variation in Amplification Target Genes and Standards Influences Interlaboratory Comparison of BK Virus DNA Load Measurement.
Journal of Clinical Microbiology 2015, 53, 3842–3852.
Deuzing IP, Charpentier C, Wright DW, Matheron S, Paton J, Frentz D, van de Vijver DA, Coveney PV, Descamps D, ANRS CO5 HIV-2 Cohort, Boucher CAB, Beerens N
Mutation V111I in HIV-2 reverse transcriptase increases the fitness of the nucleoside analogue-resistant K65R and Q151M viruses.
J. Virol. 2015, 89, 833–843.
Desnos-Ollivier M, Patel S, Raoux-Barbot D, Heitman J, Dromer F, French Cryptococcosis Study Group
Cryptococcosis Serotypes Impact Outcome and Provide Evidence of Cryptococcus neoformans Speciation.
mBio 2015, 6, e00311.
Deuffic-Burban S, Yazdanpanah Y
Fair prices for new direct-acting antiviral agents (DAAs) to make treatment for all affordable.
Gut 2015, 64, 1190-1191.
Zoulim F, Liang TJ, Gerbes AL, Aghemo A, Deuffic-Burban S, Dusheiko G, Fried MW, Pol S, Rockstroh JK, Terrault NA, Wiktor S
Hepatitis C virus treatment in the real world: optimising treatment and access to therapies.
Gut 2015, 64, 1824-1833.
Mansiaux Y, Salez N, Lapidus N, Setbon M, Andreoletti L, Leruez-Ville M, Cauchemez S, Gougeon ML, Vely F, Schwarzinger M, Abel L, Delabre RM, Flahault A, de Lamballerie X, Carrat F
Causal analysis of H1N1pdm09 influenza infection risk in a household cohort.
Journal of Epidemiology and Community Health 2015, 69, 272-277.
Borel JC, Pelletier J, Taleux N, Briault A, Arnol N, Pison C, Tamisier R, Timsit JF, Pepin JL
Parameters recorded by software of non-invasive ventilators predict COPD exacerbation: a proof-of-concept study.
Thorax 2015, 70, 284-285.
El Maaroufi H, Goubard A, Redjoul R, Legrand P, Pautas C, Mikdame M, Doghmi K, Toma A, Maury S, Schwarzinger M, Cordonnier C
Risk factors and scoring system for predicting bacterial resistance to cefepime as used empirically in haematology wards.
BioMed Research International 2015, 2015, 945769.
Souweine B, Lautrette A, Gruson D, Canet E, Klouche K, Argaud L, Bohe J, Garrouste-Orgeas M, Mariat C, Vincent F, Cayot S, Cointault O, Lepape A, Guelon D, Darmon M, Vesin A, Caillot N, Schwebel C, Boyer A, Azoulay E, Bouadma L, Timsit JF
Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial.
American Journal of Respiratory and Critical Care Medicine 2015, 191, 1024-1032.
Bailly S, Bouadma L, Azoulay E, Orgeas MG, Adrie C, Souweine B, Schwebel C, Maubon D, Hamidfar-Roy R, Darmon M, Wolff M, Cornet M, Timsit JF
Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients.
American Journal of Respiratory and Critical Care Medicine 2015, 191, 1139-1146.
van Mourik MSM, Bouadma L, Bonten MJM
An old world's view on a new world's solution.
American Journal of Respiratory and Critical Care Medicine 2015, 191, 243-245.
Pahlavan G, Burdet C, Laouénan C, Guiroy F, Bouscarat F, Tosini W, Yazdanpanah Y, Bouvet E
Predictors of return rate for an HIV-positive result in a French Voluntary Counseling and Testing centre.
International journal of STD & AIDS 2015, 26, 33-36.
Dallaudière B, Larbi A, Lefere M, Perozziello A, Hauger O, Pommerie F, Fraboulet B, Jacob D
Musculoskeletal injuries in a resource-constrained environment: comparing diagnostic accuracy of on-the-spot ultrasonography and conventional radiography for bone fracture screening during the Paris-Dakar rally raid.
Acta Radiologica Open 2015, 4, 2058460115577566.
Toffart AC, Pizarro CA, Schwebel C, Sakhri L, Minet C, Duruisseaux M, Azoulay E, Moro-Sibilot D, Timsit JF
Selection criteria for intensive care unit referral of lung cancer patients: a pilot study.
European Respiratory Journal 2015, 45, 491-500.
Chauveau L, Puigdomenech I, Ayinde D, Roesch F, Porrot F, Bruni D, Visseaux B, Descamps D, Schwartz O
HIV-2 infects resting CD4+ T cells but not monocyte-derived dendritic cells.
Retrovirology 2015, 12, 2.
Orne-Gliemann J, Larmarange J, Boyer S, Iwuji C, McGrath N, Bärnighausen T, Zuma T, Dray-Spira R, Spire B, Rochat T, Lert F, Imrie J, ANRS 12249 TasP Group
Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal.
BMC public health 2015, 15, 209.
Gaillard T, Wurtz N, Houzé S, Sriprawat K, Wangsing C, Hubert V, Lebras J, Nosten F, Briolant S, Pradines B, French National Reference Centre for Imported Malaria Study Group
Absence of association between Plasmodium falciparum small sub-unit ribosomal RNA gene mutations and in vitro decreased susceptibility to doxycycline.
Malar. J. 2015, 14, 348.
Sartelli M, Malangoni MA, Abu-Zidan FM, Griffiths EA, Di Bella S, McFarland LV, Eltringham I, Shelat VG, Velmahos GC, Kelly CP, Khanna S, Abdelsattar ZM, Alrahmani L, Ansaloni L, Augustin G, Bala M, Barbut F, Ben-Ishay O, Bhangu A, Biffl WL, Brecher SM, Camacho-Ortiz A, Caínzos MA, Canterbury LA, Catena F, Chan S, Cherry-Bukowiec JR, Clanton J, Coccolini F, Cocuz ME, Coimbra R, Cook CH, Cui Y, Czepiel J, Das K, Demetrashvili Z, Di Carlo I, Di Saverio S, Dumitru IM, Eckert C, Eckmann C, Eiland EH, Enani MA, Faro M, Ferrada P, Forrester JD, Fraga GP, Frossard JL, Galeiras R, Ghnnam W, Gomes CA, Gorrepati V, Ahmed MH, Herzog T, Humphrey F, Kim JI, Isik A, Ivatury R, Lee YY, Juang P, Furuya-Kanamori L, Karamarkovic A, Kim PK, Kluger Y, Ko WC, LaBarbera FD, Lee JG, Leppaniemi A, Lohsiriwat V, Marwah S, Mazuski JE, Metan G, Moore EE, Moore FA, Nord CE, Ordoñez CA, Júnior GAP, Petrosillo N, Portela F, Puri BK, Ray A, Raza M, Rems M, Sakakushev BE, Sganga G, Spigaglia P, Stewart DB, Tattevin P, Timsit JF, To KB, Tranà C, Uhl W, Urbánek L, van Goor H, Vassallo A, Zahar JR, Caproli E, Viale P
WSES guidelines for management of Clostridium difficile infection in surgical patients.
World journal of emergency surgery: WJES 2015, 10,
Kutz A, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M, Kristoffersen KB, Wei L, Burkhardt O, Welte T, Schroeder S, Nobre V, Tamm M, Bhatnagar N, Bucher HC, Luyt CE, Chastre J, Tubach F, Mueller B, Schuetz P
Prognostic value of procalcitonin in respiratory tract infections across clinical settings.
Critical Care (London, England) 2015, 19,
Allou N, Allyn J, Snauwaert A, Welsch C, Lucet JC, Kortbaoui R, Desmard M, Augustin P, Montravers P
Postoperative pneumonia following cardiac surgery in non-ventilated patients versus mechanically ventilated patients: is there any difference?.
Critical Care (London, England) 2015, 19, 845.
Minet C, Potton L, Bonadona A, Hamidfar-Roy R, Somohano CA, Lugosi M, Cartier JC, Ferretti G, Schwebel C, Timsit JF
Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxis.
Critical Care (London, England) 2015, 19,
El Khoury P, Ghislain M, Villard EF, Le Goff W, Lascoux-Combe C, Yeni P, Meyer L, Vigouroux C, Goujard C, Guerin M
Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART.
Journal of Lipid Research 2015, 56, 692–702.
Timsit JF, Chemam S, Bailly S
Empiric/pre-emptive anti-Candida therapy in non-neutropenic ICU patients.
F1000prime Reports 2015, 7, 21.
Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L, D:A:D study group, Royal Free Hospital Clinic Cohort, INSIGHT study group, SMART study group, ESPRIT study group
Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.
PLoS medicine 2015, 12,
Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, de Wit TFR, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CAB, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, De Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Ng KP, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, Tee KK, Truong HHM, van de Vijver DAMC, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JPA, Vandamme AM, Shafer RW
Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis.
PLoS medicine 2015, 12,
Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, de Wit TFR, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CAB, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, De Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Kee PN, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, Tee KK, Truong HHM, van de Vijver DAMC, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JPA, Vandamme AM, Shafer RW
Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis.
PLoS medicine 2015, 12, e1001845.
de Monteynard LA, Dray-Spira R, de Truchis P, Grabar S, Launay O, Meynard JL, Khuong-Josses MA, Gilquin J, Rey D, Simon A, Pavie J, Mahamat A, Matheron S, Costagliola D, Abgrall S, French Hospital Database on HIV
Later cART Initiation in Migrant Men from Sub-Saharan Africa without Advanced HIV Disease in France.
PloS One 2015, 10, e0118492.
Pereira L, Choquet C, Perozziello A, Wargon M, Juillien G, Colosi L, Hellmann R, Ranaivoson M, Casalino E
Unscheduled-return-visits after an emergency department (ED) attendance and clinical link between both visits in patients aged 75 years and over: a prospective observational study.
PloS One 2015, 10, e0123803.
Chas J, Hema A, Slama L, Kabore NF, Lescure FX, Fontaine C, Pialoux G, Sawadogo A
The Day-Hospital of the University Hospital, Bobo Dioulasso: An Example of Optimized HIV Management in Southern Burkina Faso.
PloS One 2015, 10, e0125588.
Venot M, Weis L, Clec'h C, Darmon M, Allaouchiche B, Goldgran-Tolédano D, Garrouste-Orgeas M, Adrie C, Timsit JF, Azoulay E
Acute Kidney Injury in Severe Sepsis and Septic Shock in Patients with and without Diabetes Mellitus: A Multicenter Study.
PloS One 2015, 10, e0127411.
Rodriguez C, Soulié C, Marcelin AG, Calvez V, Descamps D, Charpentier C, Flandre P, Recordon-Pinson P, Bellecave P, Pawlotsky JM, Masquelier B, ANRS AC11 Study Group
HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to Maraviroc.
PloS One 2015, 10, e0127816.
Ekouévi DK, Avettand-Fènoël V, Tchounga BK, Coffie PA, Sawadogo A, Minta D, Minga A, Eholie SP, Plantier JC, Damond F, Dabis F, Rouzioux C, IeDEA West Africa collaboration
Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration.
PloS One 2015, 10, e0129886.
Maunoury F, Motrunich A, Palka-Santini M, Bernatchez SF, Ruckly S, Timsit JF
Cost-Effectiveness Analysis of a Transparent Antimicrobial Dressing for Managing Central Venous and Arterial Catheters in Intensive Care Units.
PloS One 2015, 10, e0130439.
Béraud G, Kazmercziak S, Beutels P, Levy-Bruhl D, Lenne X, Mielcarek N, Yazdanpanah Y, Boëlle PY, Hens N, Dervaux B
The French Connection: The First Large Population-Based Contact Survey in France Relevant for the Spread of Infectious Diseases.
PloS One 2015, 10, e0133203.
Charpentier C, Lê MP, Joly V, Visseaux B, Lariven S, Phung B, Yéni P, Yazdanpanah Y, Descamps D, Peytavin G, Landman R
Use of PCR Signal and Therapeutic Drug Monitoring in a Switch Cohort Study to Tenofovir/Emtricitabine/Rilpivirine: A W96 Follow-Up.
PloS One 2015, 10, e0134430.
Visseaux B, Charpentier C, Collin G, Bertine M, Peytavin G, Damond F, Matheron S, Lefebvre E, Brun-Vézinet F, Descamps D, ANRS CO5 HIV-2 Cohort
Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates.
PloS One 2015, 10, e0134904.
Philippart F, Bouroche G, Timsit JF, Garrouste-Orgeas M, Azoulay E, Darmon M, Adrie C, Allaouchiche B, Ara-Somohano C, Ruckly S, Dumenil AS, Souweine B, Goldgran-Toledano D, Bouadma L, Misset B, Outcomerea study group
Decreased Risk of Ventilator-Associated Pneumonia in Sepsis Due to Intra-Abdominal Infection.
PloS One 2015, 10, e0137262.
Dubert M, Pourbaix A, Alkhoder S, Mabileau G, Lescure FX, Ghodhbane W, Belorgey S, Rioux C, Armand-Lefèvre L, Wolff M, Raffoul R, Nataf P, Yazdanpanah Y, Lucet JC
Sternal Wound Infection after Cardiac Surgery: Management and Outcome.
PloS One 2015, 10, e0139122.
Lefebvre A, Bertrand X, Vanhems P, Lucet JC, Chavanet P, Astruc K, Thouverez M, Quantin C, Aho-Glélé LS
Detection of Temporal Clusters of Healthcare-Associated Infections or Colonizations with Pseudomonas aeruginosa in Two Hospitals: Comparison of SaTScan and WHONET Software Packages.
PloS One 2015, 10, e0139920.
Raben D, Mocroft A, Rayment M, Mitsura VM, Hadziosmanovic V, Sthoeger ZM, Palfreeman A, Morris S, Kutsyna G, Vassilenko A, Minton J, Necsoi C, Estrada VP, Grzeszczuk A, Johansson VS, Begovac J, Ong ELC, Cabié A, Ajana F, Celesia BM, Maltez F, Kitchen M, Comi L, Dragsted UB, Clumeck N, Gatell J, Gazzard B, d'Arminio Monforte A, Rockstroh J, Yazdanpanah Y, Champenois K, Jakobsen ML, Sullivan A, Lundgren JD, HIDES Audit Study Group
Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study.
PloS One 2015, 10, e0140845.
Fung M, Kim J, Marty FM, Schwarzinger M, Koo S
Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia.
PloS One 2015, 10, e0140930.
Bonnal C, Leleu C, Brugière O, Chochillon C, Porcher R, Boelle PY, Menotti J, Houze S, Lucet JC, Derouin F
Relationship between Fungal Colonisation of the Respiratory Tract in Lung Transplant Recipients and Fungal Contamination of the Hospital Environment.
PloS One 2015, 10, e0144044.
Potard V, Reynes J, Ferry T, Aubin C, Finkielsztejn L, Yazdanpanah Y, Costagliola D, FHDH ANRS CO4
Durability and Effectiveness of Maraviroc-Containing Regimens in HIV-1-Infected Individuals with Virological Failure in Routine Clinical Practice.
PloS One 2015, 10, e0144746.
Leoz M, Feyertag F, Kfutwah A, Mauclère P, Lachenal G, Damond F, De Oliveira F, Lemée V, Simon F, Robertson DL, Plantier JC
The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon.
PLoS pathogens 2015, 11, e1005029.
Schuetz P, Balk R, Briel M, Kutz A, Christ-Crain M, Stolz D, Bouadma L, Wolff M, Kristoffersen KB, Wei L, Burkhardt O, Welte T, Schroeder S, Nobre V, Tamm M, Bhatnagar N, Bucher HC, Luyt CE, Chastre J, Tubach F, Mueller B, Lacey MJ, Ohsfeldt RL, Scheibling CM, Schneider JE
Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective.
Clinical Chemistry and Laboratory Medicine 2015, 53, 583-592.
Marcellin F, Demoulin B, Spire B, Suzan-Monti M, Roux P, Protopopescu C, Sagaon-Teyssier L, Duracinsky M, Dray-Spira R, Carrieri MP, ANRS-VESPA2 Study Group
Spontaneous and post-treatment HCV clearance: relationships with health-related quality of life in HIV infection (ANRS-VESPA2 study).
Expert Rev Gastroenterol Hepatol 2015, 9, 701–713.
Basmaci R, Bonacorsi S, Ilharreborde B, Doit C, Lorrot M, Kahil M, Visseaux B, Houhou N, Bidet P
High respiratory virus oropharyngeal carriage rate during Kingella kingae osteoarticular infections in children.
Future Microbiology 2015, 10, 9-14.
Desgrées-du-Loû A, Pannetier J, Ravalihasy A, Gosselin A, Supervie V, Panjo H, Bajos N, Lert F, Lydié N, Dray-Spira R, Parcours Study Group5
Sub-Saharan African migrants living with HIV acquired after migration, France, ANRS PARCOURS study, 2012 to 2013.
Euro Surveill. 2015, 20,
Late presenters working group in COHERE in EuroCoord, Mocroft A, Lundgren J, Antinori A, Monforte Ad, Brännström J, Bonnet F, Brockmeyer N, Casabona J, Castagna A, Costagliola D, De Wit S, Fätkenheuer G, Furrer H, Jadand C, Johnson A, Lazanas M, Leport C, Moreno S, Mussini C, Obel N, Post F, Reiss P, Sabin C, Skaletz-Rorowski A, Suarez-Loano I, Torti C, Warszawski J, Wittkop L, Zangerle R, Chene G, Raben D, Kirk O
Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2015, 20,
Maignan M, Richard A, Debaty G, Pommier P, Viglino D, Loizzo F, Timsit JF, Hanna J, Carpentier F, Danel V
Intentional Drug Poisoning Care in a Physician-manned Emergency Medical Service.
Prehospital emergency care: official journal of the National Association of EMS Physicians and the National Association of State EMS Directors 2015, 19, 224-231.
Pommier JD, Ben Lasfar N, Van Grunderbeeck N, Burdet C, Laouénan C, Rioux C, Pierre-Audigier C, Meybeck A, Choudat L, Benchikh A, Nguyen S, Bouvet E, Yeni P, Yazdanpanah Y, Joly V
Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients.
Infectious Diseases (London, England) 2015, 47, 725-731.
Jauréguiberry S, Thellier M, Ndour PA, Ader F, Roussel C, Sonneville R, Mayaux J, Matheron S, Angoulvant A, Wyplosz B, Rapp C, Pistone T, Lebrun-Vignes B, Kendjo E, Danis M, Houzé S, Bricaire F, Mazier D, Buffet P, Caumes E, French Artesunate Working Group
Delayed-Onset Hemolytic Anemia in Patients with Travel-Associated Severe Malaria Treated with Artesunate, France, 2011-2013.
Emerging Infectious Diseases 2015, 21, 804–812.
Lê MP, Mandelbrot L, Descamps D, Soulié C, Ichou H, Bourgeois-Moine A, Damond F, Lariven S, Valantin MA, Landman R, Faucher P, Tubiana R, Duro D, Meier F, Legac S, Bourse P, Mortier E, Dommergues M, Calvez V, Matheron S, Peytavin G
Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant women.
Antiviral Therapy 2015, 20, 507-513.
Protopopescu C, Raffi F, Spire B, Hardel L, Michelet C, Cheneau C, Le Moing V, Leport C, Carrieri MP, ANRS CO8 APROCO-COPILOTE Study Group
Twelve-year mortality in HIV-infected patients receiving antiretroviral therapy: the role of social vulnerability. The ANRS CO8 APROCO-COPILOTE cohort.
Antiviral Therapy 2015, 20, 763-772.
Jenabian MA, Talla F, Talla P, Mbopi-Kéou FX, Charpentier C, Kane CT, Bélec L
Pitfalls of antiretroviral drug resistance genotyping of HIV-1 Group M and Group N from Cameroon by sequenced-based assays.
Nigerian Medical Journal: Journal of the Nigeria Medical Association 2015, 56, 420–424.
Dimopoulos G, Koulenti D, Tabah A, Poulakou G, Vesin A, Arvaniti K, Lathyris D, Matthaiou DK, Armaganidis A, Timsit JF
Bloodstream infections in ICU with increased resistance: epidemiology and outcomes.
Minerva Anestesiologica 2015, 81, 405-418.
Loubet P, Lescure FX, Lepage L, Kirsch M, Armand-Lefevre L, Bouadma L, Lariven S, Duval X, Yazdanpanah Y, Joly V
Endocarditis due to gram-negative bacilli at a French teaching hospital over a 6-year period: clinical characteristics and outcome.
Infectious Diseases (London, England) 2015, 47, 889-895.
Freedberg KA, Possas C, Deeks S, Ross AL, Rosettie KL, Di Mascio M, Collins C, Walensky RP, Yazdanpanah Y
The HIV Cure Research Agenda: The Role of Mathematical Modelling and Cost-Effectiveness Analysis.
Journal of Virus Eradication 2015, 1, 245-249.
Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory Failure: A Randomized Clinical Trial.
JAMA 2015, 314, 1711-1719.
Obach D, Yazdanpanah Y, Esmat G, Avihingsanon A, Dewedar S, Durier N, Attia A, Anwar WA, Cousien A, Tangkijvanich P, Eholié SP, Doss W, Mostafa A, Fontanet A, Mohamed MK, Deuffic-Burban S
How to optimize hepatitis C virus treatment impact on life years saved in resource-constrained countries.
Hepatology (Baltimore, Md.) 2015, 62, 31-39.
Gautheret-Dejean A, Bocobza J, Brunet S, Damond F, Plantier JC, Barin F
Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infections.
Journal of Medical Virology 2015, 87, 2061–2066.
Laouenan C, Guedj J, Peytavin G, Nguyen TT, Lapalus M, Khelifa-Mouri F, Boyer N, Zoulim F, Serfaty L, Bronowicki JP, Martinot-Peignoux M, Lada O, Asselah T, Dorival C, Hezode C, Carrat F, Nicot F, Marcellin P, Mentre F
A Model-Based Illustrative Exploratory Approach to Optimize the Dosing of Peg-IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy.
CPT Pharmacometrics Syst Pharmacol 2015, 4, e00008.
Clémençon S, Cousien A, Felipe MD, Tran VC
On computer-intensive simulation and estimation methods for rare-event analysis in epidemic models.
Statistics in Medicine 2015, 34, 3696-3713.
Bakker J, Perner A, Timsit JF
Evaluation of 7.5 years of Surviving Sepsis Campaign Guidelines.
Intensive Care Medicine 2015, 41, 151-153.
Yazdanpanah Y, Arribas JR, Malvy D
Treatment of Ebola virus disease.
Intensive Care Medicine 2015, 41, 115-117.
Toffart AC, Dhalluin X, Girard N, Chouaid C, Audigier-Valette C, Duruisseaux M, Mennecier B, Parrot A, Fournel P, Moro-Sibilot D, Timsit JF
Patients with advanced lung cancer harboring oncogenic mutations should be admitted to intensive care units.
Intensive Care Medicine [Letter] 2015, 41, 164-165.
Garrouste-Orgeas M, Perrin M, Soufir L, Vesin A, Blot F, Maxime V, Beuret P, Troché G, Klouche K, Argaud L, Azoulay E, Timsit JF
The Iatroref study: medical errors are associated with symptoms of depression in ICU staff but not burnout or safety culture.
Intensive Care Medicine 2015, 41, 273-284.
Reignier J, Darmon M, Sonneville R, Borel AL, Garrouste-Orgeas M, Ruckly S, Souweine B, Dumenil AS, Haouache H, Adrie C, Argaud L, Soufir L, Marcotte G, Laurent V, Goldgran-Toledano D, Clec'h C, Schwebel C, Azoulay E, Timsit JF
Impact of early nutrition and feeding route on outcomes of mechanically ventilated patients with shock: a post hoc marginal structural model study.
Intensive Care Medicine 2015, 41, 875-886.
Timsit JF, Perner A, Bakker J, Bassetti M, Benoit D, Cecconi M, Curtis JR, Doig GS, Herridge M, Jaber S, Joannidis M, Papazian L, Peters MJ, Singer P, Smith M, Soares M, Torres A, Vieillard-Baron A, Citerio G, Azoulay E
Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics.
Intensive Care Medicine [YEAR IN REVIEW 2014] 2015, 41, 575-588.
Bretonnière C, Leone M, Milési C, Allaouchiche B, Armand-Lefevre L, Baldesi O, Bouadma L, Decré D, Figueiredo S, Gauzit R, Guery B, Joram N, Jung B, Lasocki S, Lepape A, Lesage F, Pajot O, Philippart F, Souweine B, Tattevin P, Timsit JF, Vialet R, Zahar JR, Misset B, Bedos JP
Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).
Intensive Care Medicine 2015, 41, 1181-1196.
Bassetti M, Leon C, Timsit JF
Are prophylactic antifungals in highly colonized patients safe and effective?.
Intensive Care Medicine 2015, 41, 1336-1339.
Lautrette A, Garrouste-Orgeas M, Bertrand PM, Goldgran-Toledano D, Jamali S, Laurent V, Argaud L, Schwebel C, Mourvillier B, Darmon M, Ruckly S, Dumenil AS, Lemiale V, Souweine B, Timsit JF, Outcomerea Study Group
Respective impact of no escalation of treatment, withholding and withdrawal of life-sustaining treatment on ICU patients' prognosis: a multicenter study of the Outcomerea Research Group.
Intensive Care Medicine 2015, 41, 1763-1772.
Schortgen F, Charles-Nelson A, Bouadma L, Bizouard G, Brochard L, Katsahian S
Respective impact of lowering body temperature and heart rate on mortality in septic shock: mediation analysis of a randomized trial.
Intensive Care Medicine 2015, 41, 1800-1808.
Bailly S, Leroy O, Montravers P, Constantin JM, Dupont H, Guillemot D, Lortholary O, Mira JP, Perrigault PF, Gangneux JP, Azoulay E, Timsit JF
Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data.
Intensive Care Medicine 2015, 41, 1931-1940.
Garnacho-Montero J, Dimopoulos G, Poulakou G, Akova M, Cisneros JM, De Waele J, Petrosillo N, Seifert H, Timsit JF, Vila J, Zahar JR, Bassetti M, European Society of Intensive Care Medicine
Task force on management and prevention of Acinetobacter baumannii infections in the ICU.
Intensive Care Medicine 2015, 41, 2057-2075.
Lepelletier D, Lucet JC, Astagneau P, Coignard B, Vaux S, Rabaud C, Grandbastien B, Berthelot P
Control of emerging extensively drug-resistant organisms (eXDRO) in France: a survey among infection preventionists from 286 healthcare facilities.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2015, 34, 1615-1620.
Pichon M, Savatovsky J, Lamirel C, Joly V, Moulignier A
Isolated blepharoptosis may point to HIV-associated Burkitt's lymphoma.
Acta Neurologica Belgica 2015, 115, 833–835.
Brunetta J, Moreno Guillén S, Antinori A, Yeni P, Wade B, Johnson M, Shalit P, Ebrahimi R, Johnson B, Walker I, De-Oertel S
Patient-Reported Outcomes After a Switch to a Single-Tablet Regimen of Rilpivirine, Emtricitabine, and Tenofovir DF in HIV-1-Positive, Virologically Suppressed Individuals: Additional Findings From a Randomized, Open-Label, 48-Week Trial.
The Patient 2015
Birgand G, Toupet G, Rukly S, Antoniotti G, Deschamps MN, Lepelletier D, Pornet C, Stern JB, Vandamme YM, van der Mee-Marquet N, Timsit JF, Lucet JC
Air contamination for predicting wound contamination in clean surgery: A large multicenter study.
American Journal of Infection Control 2015, 43, 516-521.
Parienti JJ, Lucet JC, Lefort A, Armand-Lefèvre L, Wolff M, Caron F, Cattoir V, Yazdanpanah Y
Empirical therapies among adults hospitalized for community-acquired upper urinary tract infections: A decision-tree analysis of mortality, costs, and resistance.
American Journal of Infection Control 2015, 43, e53-e59.
Canlorbe G, Matheron S, Mandelbrot L, Oudet B, Luton D, Azria E
Vasculoplacental complications in pregnant women with HIV infection: a case-control study.
American Journal of Obstetrics and Gynecology 2015, 213, 241.e1-9.
Mabileau G, Schwarzinger M, Flores J, Patrat C, Luton D, Epelboin S, Mandelbrot L, Matheron S, Yazdanpanah Y
HIV-serodiscordant couples desiring a child: 'treatment as prevention,' preexposure prophylaxis, or medically assisted procreation?.
American Journal of Obstetrics and Gynecology 2015, 213, 341.e1-12.
Mallet V, Schwarzinger M, Vallet-Pichard A, Fontaine H, Corouge M, Sogni P, Pol S
Effect of nucleoside and nucleotide analogues on renal function in patients with chronic hepatitis B virus monoinfection.
Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association 2015, 13, 1181-1188.e1.
Lesprit P, de Pontfarcy A, Esposito-Farese M, Ferrand H, Mainardi JL, Lafaurie M, Parize P, Rioux C, Tubach F, Lucet JC
Postprescription review improves in-hospital antibiotic use: a multicenter randomized controlled trial.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 180.e1-7.
Le Dorze M, Gault N, Foucrier A, Ruppé E, Mourvillier B, Woerther PL, Birgand G, Montravers P, Dilly MP, Tubach F, Andremont A, Timsit JF, Wolff M, Armand-Lefèvre L
Performance and impact of a rapid method combining mass spectrometry and direct antimicrobial susceptibility testing on treatment adequacy of patients with ventilator-associated pneumonia.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 468.e1-6.
Weiss E, Zahar JR, Lesprit P, Ruppe E, Leone M, Chastre J, Lucet JC, Paugam-Burtz C, Brun-Buisson C, Timsit JF, De-escalation Study Group
Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 649.e1-10.
Lemaignen A, Birgand G, Ghodhbane W, Alkhoder S, Lolom I, Belorgey S, Lescure FX, Armand-Lefevre L, Raffoul R, Dilly MP, Nataf P, Lucet JC
Sternal wound infection after cardiac surgery: incidence and risk factors according to clinical presentation.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 674.e11-18.
LeGoff J, Roques P, Jenabian MA, Charpentier C, Brochier C, Bouhlal H, Gresenguet G, Frost E, Pepin J, Mayaud P, Belec L, ANRS12-12 Study Group
Variability of human immunodeficiency virus-1 in the female genital reservoir during genital reactivation of herpes simplex virus type 2.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 873.e1-9.
Birgand G, Johansson A, Szilagyi E, Lucet JC
Overcoming the obstacles of implementing infection prevention and control guidelines.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 1067-1071.
Maraux B, Hamelin C, Bajos N, Dray-Spira R, Spire B, Lert F, Vespa2 study group
Women living with HIV still lack highly effective contraception: results from the ANRS VESPA2 study, France, 2011.
Contraception 2015, 92, 160–169.
Shadoud L, Almahmoud I, Jarraud S, Etienne J, Larrat S, Schwebel C, Timsit JF, Schneider D, Maurin M
Hidden Selection of Bacterial Resistance to Fluoroquinolones In Vivo: The Case of Legionella pneumophila and Humans.
EBioMedicine 2015, 2, 1179-1185.
Gauzit R, Pean Y, Alfandari S, Bru JP, Bedos JP, Rabaud C, Robert J, Société de Pathologie Infectieuse de Langue Française (SPILF), Observatoire National de l’Épidémiologie de la Résistance Bactérienne aux Antibiotiques (ONERBA), Surveillance de la Prescription des Antibiotiques (SPA) Group
Carbapenem use in French hospitals: A nationwide survey at the patient level.
International Journal of Antimicrobial Agents 2015, 46, 707-712.
Lefebvre A, Saliou P, Mimoz O, Lucet JC, Le Guyader A, Bruyère F, Roche PH, Astruc K, Tiv M, Lepelletier D, Aho-Glélé LS, French Study Group for the Pre-operative Prevention of Surgical Site Infections
Is surgical site scrubbing before painting of value? Review and meta-analysis of clinical studies.
The Journal of Hospital Infection 2015, 89, 28-37.
Lepelletier D, Berthelot P, Lucet JC, Fournier S, Jarlier V, Grandbastien B, National Working Group
French recommendations for the prevention of 'emerging extensively drug-resistant bacteria' (eXDR) cross-transmission.
The Journal of Hospital Infection 2015, 90, 186-195.
Lefebvre A, Saliou P, Lucet JC, Mimoz O, Keita-Perse O, Grandbastien B, Bruyère F, Boisrenoult P, Lepelletier D, Aho-Glélé LS, French Study Group for the Preoperative Prevention of Surgical Site Infections
Preoperative hair removal and surgical site infections: network meta-analysis of randomized controlled trials.
The Journal of Hospital Infection 2015, 91, 100-108.
Charlier C, Hourrier S, Leruez-Ville M, Zahar JR, Floret D, Salomon LJ, Toubiana J, Lecuit M, Lapillonne A, Lortholary O, Kermorvant-Duchemin E
Polyvalent immunoglobulins in neonates after perinatal exposure to measles: Benefits and long-term tolerance of immunoglobulins.
The Journal of Infection 2015, 71, 131-134.
Bonnal C, Birgand G, Lolom I, Diamantis S, Dumortier C, L'Heriteau F, Armand-Lefevre L, Lucet JC
Staphylococcus aureus healthcare associated bacteraemia: An indicator of catheter related infections.
Medecine Et Maladies Infectieuses 2015, 45, 84-88.
Lefébure A, Papy E, Rioux C, Diamantis S, Armand-Lefèvre L, Longuet P, Lescure FX, Wolff M, Arnaud P, Lucet JC
Audit of carbapenem prescriptions comparing 2 assessment periods.
Medecine Et Maladies Infectieuses 2015, 45, 273-278.
Alfandari S, Robert J, Péan Y, Rabaud C, Bedos JP, Varon E, Lepape A, Bru JP, Gauzit R, French Infectious Diseases Society (French acronym SPILF), the French National Observatory for Epidemiology of Bacterial Resistance to Antibiotics (ONERBA), and the SPA2 group
Antibiotic use and good practice in 314 French hospitals: The 2010 SPA2 prevalence study.
Medecine Et Maladies Infectieuses 2015, 45, 475–480.
Wagner N, Wyler-Lazarevic CA, Yerly S, Samer C, Peytavin G, Posfay-Barbe KM, Calmy A, Ambrosioni J
Dolutegravir-based antiretroviral therapy in a severely overweight child with a multidrug-resistant human immunodeficiency virus infection. A case report and review.
New Microbes and New Infections 2015, 6, 1–4.
Caseris M, Burdet C, Lepeule R, Houhou N, Yeni P, Yazdanpanah Y, Joly V
[An update on measles].
La Revue De Medecine Interne 2015, 36, 339-345.
Ribadeau Dumas F, N’Diaye DS, Paireau J, Gautret P, Bourhy H, Le Pen C, Yazdanpanah Y
Cost-effectiveness of rabies post-exposure prophylaxis in the context of very low rabies risk: A decision-tree model based on the experience of France.
Vaccine 2015, 33, 2367-2378.
Loubet P, Kernéis S, Groh M, Loulergue P, Blanche P, Verger P, Launay O
Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency.
Vaccine 2015, 33, 3703-3708.
Mullaert J, Abgrall S, Lele N, Batteux F, Slama LB, Meritet JF, Lebon P, Bouchaud O, Grabar S, Launay O
Diphtheria, tetanus, poliomyelitis, yellow fever and hepatitis B seroprevalence among HIV1-infected migrants. Results from the ANRS VIHVO vaccine sub-study.
Vaccine 2015, 33, 4938-4944.
Guerrier G, Sjögren L, Guerrier M, Bretonnière S, Letier T, Dancoisne A, Wirtz M, D'Ortenzio E
Scientific journalism in Africa to help fight global health emergencies.
Lancet (London, England) 2015, 386, 851.
Mimoz O, Lucet JC, Kerforne T, Pascal J, Souweine B, Goudet V, Mercat A, Bouadma L, Lasocki S, Alfandari S, Friggeri A, Wallet F, Allou N, Ruckly S, Balayn D, Lepape A, Timsit JF, CLEAN trial investigators
Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial.
Lancet (London, England) 2015, 386, 2069-2077.
Guerrier G, D'Ortenzio E
Teaching anthropology to medical students.
Lancet (London, England) 2015, 385, 603.
Ndawinz JDA, Cissé M, Diallo MSK, Sidibé CT, D'Ortenzio E
Prevention of HIV spread during the Ebola outbreak in Guinea.
Lancet (London, England) 2015, 385, 1393.
Arribas JR, Girard PM, Landman R, Pich J, Mallolas J, Martínez-Rebollar M, Zamora FX, Estrada V, Crespo M, Podzamczer D, Portilla J, Dronda F, Iribarren JA, Domingo P, Pulido F, Montero M, Knobel H, Cabié A, Weiss L, Gatell JM, OLE/RIS-EST13 Study Group
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial.
The Lancet. Infectious Diseases 2015, 15, 785-792.
Rey D, Piroth L, Wendling MJ, Miailhes P, Michel ML, Dufour C, Haour G, Sogni P, Rohel A, Ajana F, Billaud E, Molina JM, Launay O, Carrat F, ANRS HB04 B-BOOST study group
Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial.
The Lancet. Infectious Diseases 2015, 15, 1283–1291.
Yazdanpanah Y, Horby P, van Griensven J, Mentre F, Nguyen VK, Malvy JMD, Dunning J, Sissoko D, Delfraissy JF, Levy Y
Drug assessment in the Ebola virus disease epidemic in west Africa.
The Lancet. Infectious Diseases 2015, 15, 1258.
Horby PW, Endzt H, Muyembe-Tamfum JJ, van Griensven J, Gevao S, Goossens H, Malvy JMD, Haba NY, Yazdanpanah Y, Olliaro P, Semple C, de Jong M, Delamou A, Lang T, Carson G, Kennedy S
Ebola: Europe-Africa research collaborations.
The Lancet. Infectious Diseases 2015, 15, 1258-1259.
Chéret A, Nembot G, Mélard A, Lascoux C, Slama L, Miailhes P, Yeni P, Abel S, Avettand-Fenoel V, Venet A, Chaix ML, Molina JM, Katlama C, Goujard C, Tamalet C, Raffi F, Lafeuillade A, Reynes J, Ravaux I, Hoën B, Delfraissy JF, Meyer L, Rouzioux C, OPTIPRIM ANRS Study Group
Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial.
Lancet Infect Dis 2015, 15, 387–396.
Lodi S, Phillips A, Logan R, Olson A, Costagliola D, Abgrall S, van Sighem A, Reiss P, Miró JM, Ferrer E, Justice A, Gandhi N, Bucher HC, Furrer H, Moreno S, Monge S, Touloumi G, Pantazis N, Sterne J, Young JG, Meyer L, Seng R, Dabis F, Vandehende MA, Pérez-Hoyos S, Jarrín I, Jose S, Sabin C, Hernán MA, HIV-CAUSAL Collaboration
Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.
The lancet. HIV 2015, 2, e335–343.
Birgand G, Saliou P, Lucet JC
Influence of staff behavior on infectious risk in operating rooms: what is the evidence?.
Infection Control and Hospital Epidemiology 2015, 36, 93-106.
Lucet JC, Abiteboul D, Estellat C, Roy C, Chollet-Martin S, Tubach F, Carcelain G, QUANTIPS Study Group
Interferon-γ release assay vs. tuberculin skin test for tuberculosis screening in exposed healthcare workers: a longitudinal multicenter comparative study.
Infection Control and Hospital Epidemiology 2015, 36, 569-574.
Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, Tremblay C, Le Gall JM, Cua E, Pasquet A, Raffi F, Pintado C, Chidiac C, Chas J, Charbonneau P, Delaugerre C, Suzan-Monti M, Loze B, Fonsart J, Peytavin G, Cheret A, Timsit J, Girard G, Lorente N, Préau M, Rooney JF, Wainberg MA, Thompson D, Rozenbaum W, Doré V, Marchand L, Simon MC, Etien N, Aboulker JP, Meyer L, Delfraissy JF, ANRS IPERGAY Study Group
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
The New England Journal of Medicine 2015, 373, 2237–2246.
TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, Ouattara E, Anzian A, Ntakpé JB, Minga A, Kouame GM, Bouhoussou F, Emieme A, Kouamé A, Inwoley A, Toni Td, Ahiboh H, Kabran M, Rabe C, Sidibé B, Nzunetu G, Konan R, Gnokoro J, Gouesse P, Messou E, Dohoun L, Kamagate S, Yao A, Amon S, Kouame AB, Koua A, Kouamé E, Ndri Y, Ba-Gomis O, Daligou M, Ackoundzé S, Hawerlander D, Ani A, Dembélé F, Koné F, Guéhi C, Kanga C, Koule S, Séri J, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatounde N, Bleoué G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Assi R, Bakayoko A, Mahassadi A, Attia A, Oussou A, Mobio M, Bamba D, Koman M, Horo A, Deschamps N, Chenal H, Sassan-Morokro M, Konate S, Aka K, Aoussi E, Journot V, Nchot C, Karcher S, Chaix ML, Rouzioux C, Sow PS, Perronne C, Girard PM, Menan H, Bissagnene E, Kadio A, Ettiegne-Traore V, Moh-Semdé C, Kouame A, Massumbuko JM, Chêne G, Dosso M, Domoua SK, N'Dri-Yoman T, Salamon R, Eholié SP, Anglaret X
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
The New England Journal of Medicine 2015, 373, 808–822.
Soulie C, Peytavin G, Charpentier C, Lambert-Niclot S, Sayon S, Visseaux B, Simon A, Katlama C, Yazdanpanah Y, Descamps D, Calvez V, Marcelin AG
Antiretroviral-Experienced HIV-1-Infected Patients Treated with Maraviroc: Factors Associated with Virological Response.
AIDS research and human retroviruses 2015, 31, 475-478.
Grabar S, Tattevin P, Selinger-Leneman H, de La Blanchardiere A, de Truchis P, Rabaud C, Rey D, Daneluzzi V, Ferret S, Lascaux AS, Hanslik T, Costagliola D, Launay O, French Hospital Database on HIV (FHDH-ANRS CO4 Cohort)
Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 60, 1269–1277.
HIV-CAUSAL Collaboration, Cain LE, Phillips A, Olson A, Sabin C, Jose S, Justice A, Tate J, Logan R, Robins JM, Sterne JAC, van Sighem A, Reiss P, Young J, Fehr J, Touloumi G, Paparizos V, Esteve A, Casabona J, Monge S, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Dabis F, Vandenhende MA, Abgrall S, Costagliola D, Hernán MA
Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 60, 1262–1268.
Delaugerre C, Ghosn J, Lacombe JM, Pialoux G, Cuzin L, Launay O, Menard A, de Truchis P, Costagliola D, FHDH-ANRS CO4
Significant reduction in HIV virologic failure during a 15-year period in a setting with free healthcare access.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 60, 463–472.
Descamps D, Peytavin G, Visseaux B, Tubiana R, Damond F, Campa P, Charpentier C, Khuong-Josses MA, Duvivier C, Karmochkine M, Lukiana T, Matheron S
Dolutegravir in HIV-2 infected patients with resistant virus to first-line integrase inhibitors from the French Named Patient Program.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015
Carrieri MP, Serfaty L, Vilotitch A, Winnock M, Poizot-Martin I, Loko MA, Lions C, Lascoux-Combe C, Roux P, Salmon-Ceron D, Spire B, Dabis F, ANRS CO13 HEPAVIH Study Group
Cannabis use and reduced risk of insulin-resistance in HIV-HCV infected patients: a longitudinal analysis (ANRS HEPAVIH CO-13).
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015
Sibiude J, Le Chenadec J, Bonnet D, Tubiana R, Faye A, Dollfus C, Mandelbrot L, Delmas S, Lelong N, Khoshnood B, Warszawski J, Blanche S, French National Agency for Research on AIDS and Viral Hepatitis French Perinatal Cohort/Protease Inhibitor Monotherapy Evaluation Trial
In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 270-280.
Abgrall S, Rachas A, Tourret J, Isnard-Bagnis C, Billaud E, Tattevin P, Costagliola D, Guiguet M, Durieux P, French Hospital Database on HIV
A multifaceted intervention designed to improve medical management of moderate to advanced chronic kidney disease in HIV-infected patients: a cluster randomized trial.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 375–384.
Ruppé E, Armand-Lefèvre L, Estellat C, Consigny PH, El Mniai A, Boussadia Y, Goujon C, Ralaimazava P, Campa P, Girard PM, Wyplosz B, Vittecoq D, Bouchaud O, Le Loup G, Pialoux G, Perrier M, Wieder I, Moussa N, Esposito-Farèse M, Hoffmann I, Coignard B, Lucet JC, Andremont A, Matheron S
High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 593-600.
Charpentier C, Camacho R, Ruelle J, Eberle J, Gürtler L, Pironti A, Stürmer M, Brun-Vézinet F, Kaiser R, Descamps D, Obermeier M
HIV-2EU-Supporting Standardized HIV-2 Drug-Resistance Interpretation in Europe: An Update.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 1346–1347.
Mandelbrot L, Tubiana R, Le Chenadec J, Dollfus C, Faye A, Pannier E, Matheron S, Khuong MA, Garrait V, Reliquet V, Devidas A, Berrebi A, Allisy C, Elleau C, Arvieux C, Rouzioux C, Warszawski J, Blanche S, ANRS-EPF Study Group
No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 1715-1725.
Fofana DB, Charpentier C, Maïga AI, Lambert-Niclot S, Sayon S, Désiré N, Simon A, Yazdanpanah Y, Katlama C, Descamps D, Calvez V, Marcelin AG, Soulié C
Genetic barrier for attachment inhibitor BMS-626529 resistance in HIV-1 B and non-B subtypes.
The Journal of Antimicrobial Chemotherapy 2015, 70, 130-135.
Lê MP, Landman R, Koulla-Shiro S, Charpentier C, Sow PS, Diallo MB, Ngom Gueye NF, Ngolle M, Le Moing V, Eymard-Duvernay S, Benalycherif A, Delaporte E, Girard PM, Peytavin G, DAYANA Study Group
Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1517–1521.
Fourati S, Charpentier C, Amiel C, Morand-Joubert L, Reigadas S, Trabaud MA, Delaugerre C, Nicot F, Rodallec A, Maillard A, Mirand A, Jeulin H, Montès B, Barin F, Bettinger D, Le Guillou-Guillemette H, Vallet S, Signori-Schmuck A, Descamps D, Calvez V, Flandre P, Marcelin AG, ANRS AC11 Resistance Study Group
Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1507–1512.
Danion F, Belissa E, Peytavin G, Thierry E, Lanternier F, Scemla A, Lortholary O, Delelis O, Avettand-Fenoel V, Duvivier C
Non-virological response to a dolutegravir-containing regimen in a patient harbouring a E157Q-mutated virus in the integrase region.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1921–1923.
Raymond S, Maillard A, Amiel C, Peytavin G, Trabaud MA, Desbois D, Bellecave P, Delaugerre C, Soulie C, Marcelin AG, Descamps D, Izopet J, on behalf the ANRS AC11 Resistance Study Group
Virological failure of patients on maraviroc-based antiretroviral therapy.
The Journal of Antimicrobial Chemotherapy 2015
Loubet P, Charpentier C, Visseaux B, Borbor A, Nuta C, Adu E, Chapplain JM, Baysah M, Tattevin P, Yazdanpanah Y, Descamps D
Prevalence of HIV-1 drug resistance among patients failing first-line ART in Monrovia, Liberia: a cross-sectional study.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1881-1884.
Bastard JP, Fellahi S, Couffignal C, Raffi F, Gras G, Hardel L, Sobel A, Leport C, Fardet L, Capeau J, ANRS CO8 APROCO-COPILOTE Cohort Study Group
Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1816-1824.
Charpentier C, Lee GQ, Rodriguez C, Visseaux B, Storto A, Fagard C, Molina JM, Katlama C, Yazdanpanah Y, Harrigan PR, Descamps D
Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response.
The Journal of Antimicrobial Chemotherapy 2015, 70, 2090-2096.
Frange P, Assoumou L, Descamps D, Chéret A, Goujard C, Tran L, Gousset M, Avettand-Fenoël V, Bocket L, Fafi-Kremer S, Guinard J, Morand-Joubert L, Nicot F, Plantier JC, Rogez S, Wirden M, Rouzioux C, Meyer L, Chaix ML, French ANRS CO 6 PRIMO Cohort, the ANRS 147 OPTIPRIM Clinical Trial and the AC11 Resistance Study Groups, French ANRS CO 6 PRIMO Cohort the ANRS 147 OPTIPRIM Clinical Trial and the AC11 Resistance Study Groups
HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies.
The Journal of Antimicrobial Chemotherapy 2015, 70, 2084–2089.
Raffi F, Yazdanpanah Y, Fagnani F, Laurendeau C, Lafuma A, Gourmelen J
Persistence and adherence to single-tablet regimens in HIV treatment: a cohort study from the French National Healthcare Insurance Database.
The Journal of Antimicrobial Chemotherapy 2015, 70, 2121-2128.
Chéret A, Bacchus-Souffan C, Avettand-Fenoël V, Mélard A, Nembot G, Blanc C, Samri A, Sáez-Cirión A, Hocqueloux L, Lascoux-Combe C, Allavena C, Goujard C, Valantin MA, Leplatois A, Meyer L, Rouzioux C, Autran B, OPTIPRIM ANRS-147 Study Group
Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission.
J. Antimicrob. Chemother. 2015, 70, 2108–2120.
Wirden M, Todesco E, Valantin MA, Lambert-Niclot S, Simon A, Calin R, Tubiana R, Peytavin G, Katlama C, Calvez V, Marcelin AG
Low-level HIV-1 viraemia in patients on HAART: risk factors and management in clinical practice.
The Journal of Antimicrobial Chemotherapy 2015
Lê MP, Soulié C, Assoumou L, Valantin MA, Duvivier C, Chas J, Ponscarme D, Marcelin AG, Calvez V, Katlama C, Peytavin G, ROCnRAL ANRS 157 Study Group
Plasma concentrations of maraviroc and raltegravir after dual therapy in patients with long-term suppressed viraemia: ROCnRAL ANRS 157 study.
The Journal of Antimicrobial Chemotherapy 2015, 70, 2418–2420.
Tabah A, De Waele J, Lipman J, Zahar JR, Cotta MO, Barton G, Timsit JF, Roberts JA, Working Group for Antimicrobial Use in the ICU within the Infection Section of the European Society of Intensive Care Medicine (ESICM)
The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs.
The Journal of Antimicrobial Chemotherapy 2015, 70, 2671-2677.
Ferrand H, Blanc-Gruyelle AL, Amsilli M, Lemaire X, Papot E, Papy E, Bervar J, Senneville E, Bouvet E, Yazdanpanah Y
Use of fluoroquinolones for the treatment of TB: 8 years of experience.
The Journal of Antimicrobial Chemotherapy 2015, 70, 3166-3167.
Lanternier F, Poiree S, Elie C, Garcia-Hermoso D, Bakouboula P, Sitbon K, Herbrecht R, Wolff M, Ribaud P, Lortholary O, French Mycosis Study Group
Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis.
The Journal of Antimicrobial Chemotherapy 2015, 70, 3116–3123.
Soulié C, Assoumou L, Darty M, Rodriguez C, Donati F, Sayon S, Peytavin G, Valantin MA, Caby F, Schneider L, Canestri A, Costagliola D, Katlama C, Calvez V, Marcelin AG, ROCnRAL ANRS-157 Study Group
Virological factors associated with outcome of dual maraviroc/raltegravir therapy (ANRS-157 trial).
The Journal of Antimicrobial Chemotherapy 2015, 70, 3339–3344.
Cazanave C, Reigadas S, Mazubert C, Bellecave P, Hessamfar M, Le Marec F, Lazaro E, Peytavin G, Bruyand M, Fleury H, Dabis F, Neau D
Switch to Rilpivirine/Emtricitabine/Tenofovir Single-Tablet Regimen of Human Immunodeficiency Virus-1 RNA-Suppressed Patients, Agence Nationale de Recherches sur le SIDA et les Hépatites Virales CO3 Aquitaine Cohort, 2012-2014.
Open Forum Infectious Diseases 2015, 2, ofv018.
Belkacem A, Caseris M, Yazdanpanah Y
A Case of Aggregatibacter aphrophilus Multiple Abscess.
Open Forum Infectious Diseases 2015, 2, ofv031.
Bouadma L, Sonneville R, Garrouste-Orgeas M, Darmon M, Souweine B, Voiriot G, Kallel H, Schwebel C, Goldgran-Toledano D, Dumenil AS, Argaud L, Ruckly S, Jamali S, Planquette B, Adrie C, Lucet JC, Azoulay E, Timsit JF, OUTCOMEREA Study Group
Ventilator-Associated Events: Prevalence, Outcome, and Relationship With Ventilator-Associated Pneumonia.
Critical Care Medicine 2015, 43, 1798-1806.
Feeney ER, Chung RT, Yazdanpanah Y
Current guidelines and prioritizing treatment of hepatitis C virus in HIV-infected patients.
Current opinion in HIV and AIDS 2015, 10, 323-329.
Bertine M, Charpentier C, Visseaux B, Storto A, Collin G, Larrouy L, Damond F, Matheron S, Brun-Vézinet F, Descamps D, ANRS CO5 HIV-2 Cohort
High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patients.
AIDS (London, England) 2015, 29, 779–784.
Alessandri-Gradt E, Morgand M, Delaugerre C, Peytavin G, Sellier P, Simon F, Plantier JC
HIV-1 group O resistance pathway with raltegravir is similar to HIV-1 group M.
AIDS (London, England) 2015, 29, 1271–1273.
Péré H, Roques P, Talla F, Meillo H, Charpentier C, Bélec L
Sustained virological failure in Cameroonese patient infected by HIV-1 group N evidenced by sequence-based genotyping assay.
AIDS (London, England) 2015, 29, 1267–1269.
Annequin M, Lert F, Spire B, Dray-Spira R, VESPA2 Study Group
Has the employment status of people living with HIV changed since the early 2000s?.
AIDS 2015, 29, 1537–1547.
Cuzin L, Pugliese P, Sauné K, Allavena C, Ghosn J, Cottalorda J, Rodallec A, Chaix ML, Fafi-Kremer S, Soulié C, Ouka M, Charpentier C, Bocket L, Mirand A, Guiguet M, Dat’AIDS study group
Levels of intracellular HIV-DNA in patients with suppressive antiretroviral therapy.
AIDS (London, England) 2015, 29, 1665–1671.
Loubet P, Mabileau G, Baysah M, Nuta C, Taylor M, Jusu H, Weeks H, Ingels A, Perennec-Olivier M, Chapplain JM, Cartier N, Mendiharat P, Raguin G, Tattevin P, Yazdanpanah Y
Likely effect of the 2014 Ebola epidemic on HIV care in Liberia.
AIDS (London, England) 2015, 29, 2347-2351.
Visseaux B, Charpentier C, Ozanne A, Nizard A, Drumard S, Fagard C, Glohi D, Damond F, Brun-Vézinet F, Matheron S, Descamps D, ANRS CO5 HIV-2 Cohort
Tropism distribution among antiretroviral-naive HIV-2-infected patients.
AIDS (London, England) 2015, 29, 2209–2212.
Zucman D, Sené T, Hillaire S, Kahn JE, Farfour E, Peytavin G
Antihepatitis C virus treatments for HIV-hepatitis C virus coinfected cirrhotic patients: a need to look beyond the sustained viral response.
AIDS (London, England) 2015, 29, 1903–1904.
Boullé C, Kouanfack C, Laborde-Balen G, Boyer S, Aghokeng AF, Carrieri MP, Kazé S, Dontsop M, Mben JM, Koulla-Shiro S, Peytavin G, Spire B, Delaporte E, Laurent C, Stratall ANRS 12110ESTHER Study Group
Gender Differences in Adherence and Response to Antiretroviral Treatment in the Stratall Trial in Rural District Hospitals in Cameroon.
Journal of Acquired Immune Deficiency Syndromes (1999) 2015, 69, 355–364.
Harrison L, Melvin A, Fiscus S, Saidi Y, Nastouli E, Harper L, Compagnucci A, Babiker A, McKinney R, Gibb D, Tudor-Williams G, PENPACT-1 (PENTA 9PACTG 390) Study Team
HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds.
Journal of Acquired Immune Deficiency Syndromes (1999) 2015, 70, 42–53.
Moulignier A, Gueguen A, Lescure FX, Ziegler M, Girard PM, Cardon B, Pialoux G, Molina JM, Brandel JP, Lamirel C
Does HIV Infection Alter Parkinson Disease?.
Journal of Acquired Immune Deficiency Syndromes (1999) 2015, 70, 129-136.
Marcellin F, Demoulin B, Suzan-Monti M, Maradan G, Carrieri MP, Dray-Spira R, Spire B, ANRS-VESPA2 Study Group
Risk Factors for HCV Reinfection or Transmission in HIV-HCV Coinfected MSM (ANRS-VESPA2 French National Survey).
J. Acquir. Immune Defic. Syndr. 2015, 70, e179–182.
Sonneville R, Gault N, de Montmollin E, Klein IF, Mariotte E, Chemam S, Tubach F, Mourvillier B, Timsit JF, Wolff M, Bouadma L
Clinical spectrum and outcomes of patients with encephalitis requiring intensive care.
European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies 2015, 22, 6-16, e1.
Deconinck L, Yazdanpanah Y, Gilson RJ, Melliez H, Viget N, Joly V, Sabin CA
Time to initiation of antiretroviral therapy in HIV-infected patients diagnosed with an opportunistic disease: a cohort study.
HIV medicine 2015, 16, 219-229.
Winston A, Stöhr W, Antinori A, Arenas-Pinto A, Llibre JM, Amieva H, Cabié A, Williams I, Di Perri G, Tellez MJ, Rockstroh J, Babiker A, Pozniak A, Raffi F, Richert L, NEAT 001/Agence Nationale de Recherche sur le SIDA (ANRS) 143 Study Group, NEAT 001/Agence Nationale de Recherche sur le SIDA ANRS 143 Study Group
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy.
HIV medicine 2015
Polivka L, Peytavin G, Franck N, Mouthon L, Dupin N
Testing for levamisole and cocaine in hair samples for the diagnosis of levamisole-related panniculitis.
Journal of the European Academy of Dermatology and Venereology: JEADV 2015, 29, 2487–2489.
Cousien A, Tran VC, Deuffic-Burban S, Jauffret-Roustide M, Dhersin JS, Yazdanpanah Y
Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review.
Journal of Viral Hepatitis 2015, 22, 213-229.
Sellier P, Maylin S, Amarsy R, Mazeron MC, Larrouy L, Haïm-Boukobza S, Lopes A, Moreno MD, Ricbourg A, Simoneau G, Magnier JD, Mercier-Delarue S, Delcey V, Evans J, Cambau E, Barranger E, Simon F, Bergmann JF
Untreated highly viraemic pregnant women from Asia or sub-Saharan Africa often transmit hepatitis B virus despite serovaccination to newborns.
Liver Int. 2015, 35, 409–416.
Mandelbrot L, Duro D, Belissa E, Peytavin G
Placental transfer of rilpivirine in an ex vivo human cotyledon perfusion model.
Antimicrobial Agents and Chemotherapy 2015, 59, 2901-2903.
Pain JB, Lê MP, Caseris M, Amiel C, Lassel L, Charpentier C, Desnoyer A, Farnoux C, Pialoux G, Descamps D, Peytavin G
Pharmacokinetics of dolutegravir in a premature neonate after HIV treatment intensification during pregnancy.
Antimicrobial Agents and Chemotherapy 2015, 59, 3660–3662.
Solis M, Meddeb M, Sueur C, Domingo-Calap P, Soulier E, Chabaud A, Perrin P, Moulin B, Bahram S, Stoll-Keller F, Caillard S, Barth H, Fafi-Kremer S, French BKV Study Group
Sequence Variation in Amplification Target Genes and Standards Influences Interlaboratory Comparison of BK Virus DNA Load Measurement.
Journal of Clinical Microbiology 2015, 53, 3842–3852.
Deuzing IP, Charpentier C, Wright DW, Matheron S, Paton J, Frentz D, van de Vijver DA, Coveney PV, Descamps D, ANRS CO5 HIV-2 Cohort, Boucher CAB, Beerens N
Mutation V111I in HIV-2 reverse transcriptase increases the fitness of the nucleoside analogue-resistant K65R and Q151M viruses.
J. Virol. 2015, 89, 833–843.
Desnos-Ollivier M, Patel S, Raoux-Barbot D, Heitman J, Dromer F, French Cryptococcosis Study Group
Cryptococcosis Serotypes Impact Outcome and Provide Evidence of Cryptococcus neoformans Speciation.
mBio 2015, 6, e00311.
Deuffic-Burban S, Yazdanpanah Y
Fair prices for new direct-acting antiviral agents (DAAs) to make treatment for all affordable.
Gut 2015, 64, 1190-1191.
Zoulim F, Liang TJ, Gerbes AL, Aghemo A, Deuffic-Burban S, Dusheiko G, Fried MW, Pol S, Rockstroh JK, Terrault NA, Wiktor S
Hepatitis C virus treatment in the real world: optimising treatment and access to therapies.
Gut 2015, 64, 1824-1833.
Mansiaux Y, Salez N, Lapidus N, Setbon M, Andreoletti L, Leruez-Ville M, Cauchemez S, Gougeon ML, Vely F, Schwarzinger M, Abel L, Delabre RM, Flahault A, de Lamballerie X, Carrat F
Causal analysis of H1N1pdm09 influenza infection risk in a household cohort.
Journal of Epidemiology and Community Health 2015, 69, 272-277.
Borel JC, Pelletier J, Taleux N, Briault A, Arnol N, Pison C, Tamisier R, Timsit JF, Pepin JL
Parameters recorded by software of non-invasive ventilators predict COPD exacerbation: a proof-of-concept study.
Thorax 2015, 70, 284-285.
El Maaroufi H, Goubard A, Redjoul R, Legrand P, Pautas C, Mikdame M, Doghmi K, Toma A, Maury S, Schwarzinger M, Cordonnier C
Risk factors and scoring system for predicting bacterial resistance to cefepime as used empirically in haematology wards.
BioMed Research International 2015, 2015, 945769.
Souweine B, Lautrette A, Gruson D, Canet E, Klouche K, Argaud L, Bohe J, Garrouste-Orgeas M, Mariat C, Vincent F, Cayot S, Cointault O, Lepape A, Guelon D, Darmon M, Vesin A, Caillot N, Schwebel C, Boyer A, Azoulay E, Bouadma L, Timsit JF
Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial.
American Journal of Respiratory and Critical Care Medicine 2015, 191, 1024-1032.
Bailly S, Bouadma L, Azoulay E, Orgeas MG, Adrie C, Souweine B, Schwebel C, Maubon D, Hamidfar-Roy R, Darmon M, Wolff M, Cornet M, Timsit JF
Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients.
American Journal of Respiratory and Critical Care Medicine 2015, 191, 1139-1146.
van Mourik MSM, Bouadma L, Bonten MJM
An old world's view on a new world's solution.
American Journal of Respiratory and Critical Care Medicine 2015, 191, 243-245.
Pahlavan G, Burdet C, Laouénan C, Guiroy F, Bouscarat F, Tosini W, Yazdanpanah Y, Bouvet E
Predictors of return rate for an HIV-positive result in a French Voluntary Counseling and Testing centre.
International journal of STD & AIDS 2015, 26, 33-36.
Dallaudière B, Larbi A, Lefere M, Perozziello A, Hauger O, Pommerie F, Fraboulet B, Jacob D
Musculoskeletal injuries in a resource-constrained environment: comparing diagnostic accuracy of on-the-spot ultrasonography and conventional radiography for bone fracture screening during the Paris-Dakar rally raid.
Acta Radiologica Open 2015, 4, 2058460115577566.
Toffart AC, Pizarro CA, Schwebel C, Sakhri L, Minet C, Duruisseaux M, Azoulay E, Moro-Sibilot D, Timsit JF
Selection criteria for intensive care unit referral of lung cancer patients: a pilot study.
European Respiratory Journal 2015, 45, 491-500.
Chauveau L, Puigdomenech I, Ayinde D, Roesch F, Porrot F, Bruni D, Visseaux B, Descamps D, Schwartz O
HIV-2 infects resting CD4+ T cells but not monocyte-derived dendritic cells.
Retrovirology 2015, 12, 2.
Orne-Gliemann J, Larmarange J, Boyer S, Iwuji C, McGrath N, Bärnighausen T, Zuma T, Dray-Spira R, Spire B, Rochat T, Lert F, Imrie J, ANRS 12249 TasP Group
Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal.
BMC public health 2015, 15, 209.
Gaillard T, Wurtz N, Houzé S, Sriprawat K, Wangsing C, Hubert V, Lebras J, Nosten F, Briolant S, Pradines B, French National Reference Centre for Imported Malaria Study Group
Absence of association between Plasmodium falciparum small sub-unit ribosomal RNA gene mutations and in vitro decreased susceptibility to doxycycline.
Malar. J. 2015, 14, 348.
Sartelli M, Malangoni MA, Abu-Zidan FM, Griffiths EA, Di Bella S, McFarland LV, Eltringham I, Shelat VG, Velmahos GC, Kelly CP, Khanna S, Abdelsattar ZM, Alrahmani L, Ansaloni L, Augustin G, Bala M, Barbut F, Ben-Ishay O, Bhangu A, Biffl WL, Brecher SM, Camacho-Ortiz A, Caínzos MA, Canterbury LA, Catena F, Chan S, Cherry-Bukowiec JR, Clanton J, Coccolini F, Cocuz ME, Coimbra R, Cook CH, Cui Y, Czepiel J, Das K, Demetrashvili Z, Di Carlo I, Di Saverio S, Dumitru IM, Eckert C, Eckmann C, Eiland EH, Enani MA, Faro M, Ferrada P, Forrester JD, Fraga GP, Frossard JL, Galeiras R, Ghnnam W, Gomes CA, Gorrepati V, Ahmed MH, Herzog T, Humphrey F, Kim JI, Isik A, Ivatury R, Lee YY, Juang P, Furuya-Kanamori L, Karamarkovic A, Kim PK, Kluger Y, Ko WC, LaBarbera FD, Lee JG, Leppaniemi A, Lohsiriwat V, Marwah S, Mazuski JE, Metan G, Moore EE, Moore FA, Nord CE, Ordoñez CA, Júnior GAP, Petrosillo N, Portela F, Puri BK, Ray A, Raza M, Rems M, Sakakushev BE, Sganga G, Spigaglia P, Stewart DB, Tattevin P, Timsit JF, To KB, Tranà C, Uhl W, Urbánek L, van Goor H, Vassallo A, Zahar JR, Caproli E, Viale P
WSES guidelines for management of Clostridium difficile infection in surgical patients.
World journal of emergency surgery: WJES 2015, 10,
Kutz A, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M, Kristoffersen KB, Wei L, Burkhardt O, Welte T, Schroeder S, Nobre V, Tamm M, Bhatnagar N, Bucher HC, Luyt CE, Chastre J, Tubach F, Mueller B, Schuetz P
Prognostic value of procalcitonin in respiratory tract infections across clinical settings.
Critical Care (London, England) 2015, 19,
Allou N, Allyn J, Snauwaert A, Welsch C, Lucet JC, Kortbaoui R, Desmard M, Augustin P, Montravers P
Postoperative pneumonia following cardiac surgery in non-ventilated patients versus mechanically ventilated patients: is there any difference?.
Critical Care (London, England) 2015, 19, 845.
Minet C, Potton L, Bonadona A, Hamidfar-Roy R, Somohano CA, Lugosi M, Cartier JC, Ferretti G, Schwebel C, Timsit JF
Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxis.
Critical Care (London, England) 2015, 19,
El Khoury P, Ghislain M, Villard EF, Le Goff W, Lascoux-Combe C, Yeni P, Meyer L, Vigouroux C, Goujard C, Guerin M
Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART.
Journal of Lipid Research 2015, 56, 692–702.
Timsit JF, Chemam S, Bailly S
Empiric/pre-emptive anti-Candida therapy in non-neutropenic ICU patients.
F1000prime Reports 2015, 7, 21.
Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L, D:A:D study group, Royal Free Hospital Clinic Cohort, INSIGHT study group, SMART study group, ESPRIT study group
Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.
PLoS medicine 2015, 12,
Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, de Wit TFR, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CAB, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, De Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Ng KP, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, Tee KK, Truong HHM, van de Vijver DAMC, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JPA, Vandamme AM, Shafer RW
Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis.
PLoS medicine 2015, 12,
Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, de Wit TFR, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CAB, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, De Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Kee PN, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, Tee KK, Truong HHM, van de Vijver DAMC, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JPA, Vandamme AM, Shafer RW
Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis.
PLoS medicine 2015, 12, e1001845.
de Monteynard LA, Dray-Spira R, de Truchis P, Grabar S, Launay O, Meynard JL, Khuong-Josses MA, Gilquin J, Rey D, Simon A, Pavie J, Mahamat A, Matheron S, Costagliola D, Abgrall S, French Hospital Database on HIV
Later cART Initiation in Migrant Men from Sub-Saharan Africa without Advanced HIV Disease in France.
PloS One 2015, 10, e0118492.
Pereira L, Choquet C, Perozziello A, Wargon M, Juillien G, Colosi L, Hellmann R, Ranaivoson M, Casalino E
Unscheduled-return-visits after an emergency department (ED) attendance and clinical link between both visits in patients aged 75 years and over: a prospective observational study.
PloS One 2015, 10, e0123803.
Chas J, Hema A, Slama L, Kabore NF, Lescure FX, Fontaine C, Pialoux G, Sawadogo A
The Day-Hospital of the University Hospital, Bobo Dioulasso: An Example of Optimized HIV Management in Southern Burkina Faso.
PloS One 2015, 10, e0125588.
Venot M, Weis L, Clec'h C, Darmon M, Allaouchiche B, Goldgran-Tolédano D, Garrouste-Orgeas M, Adrie C, Timsit JF, Azoulay E
Acute Kidney Injury in Severe Sepsis and Septic Shock in Patients with and without Diabetes Mellitus: A Multicenter Study.
PloS One 2015, 10, e0127411.
Rodriguez C, Soulié C, Marcelin AG, Calvez V, Descamps D, Charpentier C, Flandre P, Recordon-Pinson P, Bellecave P, Pawlotsky JM, Masquelier B, ANRS AC11 Study Group
HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to Maraviroc.
PloS One 2015, 10, e0127816.
Ekouévi DK, Avettand-Fènoël V, Tchounga BK, Coffie PA, Sawadogo A, Minta D, Minga A, Eholie SP, Plantier JC, Damond F, Dabis F, Rouzioux C, IeDEA West Africa collaboration
Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration.
PloS One 2015, 10, e0129886.
Maunoury F, Motrunich A, Palka-Santini M, Bernatchez SF, Ruckly S, Timsit JF
Cost-Effectiveness Analysis of a Transparent Antimicrobial Dressing for Managing Central Venous and Arterial Catheters in Intensive Care Units.
PloS One 2015, 10, e0130439.
Béraud G, Kazmercziak S, Beutels P, Levy-Bruhl D, Lenne X, Mielcarek N, Yazdanpanah Y, Boëlle PY, Hens N, Dervaux B
The French Connection: The First Large Population-Based Contact Survey in France Relevant for the Spread of Infectious Diseases.
PloS One 2015, 10, e0133203.
Charpentier C, Lê MP, Joly V, Visseaux B, Lariven S, Phung B, Yéni P, Yazdanpanah Y, Descamps D, Peytavin G, Landman R
Use of PCR Signal and Therapeutic Drug Monitoring in a Switch Cohort Study to Tenofovir/Emtricitabine/Rilpivirine: A W96 Follow-Up.
PloS One 2015, 10, e0134430.
Visseaux B, Charpentier C, Collin G, Bertine M, Peytavin G, Damond F, Matheron S, Lefebvre E, Brun-Vézinet F, Descamps D, ANRS CO5 HIV-2 Cohort
Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates.
PloS One 2015, 10, e0134904.
Philippart F, Bouroche G, Timsit JF, Garrouste-Orgeas M, Azoulay E, Darmon M, Adrie C, Allaouchiche B, Ara-Somohano C, Ruckly S, Dumenil AS, Souweine B, Goldgran-Toledano D, Bouadma L, Misset B, Outcomerea study group
Decreased Risk of Ventilator-Associated Pneumonia in Sepsis Due to Intra-Abdominal Infection.
PloS One 2015, 10, e0137262.
Dubert M, Pourbaix A, Alkhoder S, Mabileau G, Lescure FX, Ghodhbane W, Belorgey S, Rioux C, Armand-Lefèvre L, Wolff M, Raffoul R, Nataf P, Yazdanpanah Y, Lucet JC
Sternal Wound Infection after Cardiac Surgery: Management and Outcome.
PloS One 2015, 10, e0139122.
Lefebvre A, Bertrand X, Vanhems P, Lucet JC, Chavanet P, Astruc K, Thouverez M, Quantin C, Aho-Glélé LS
Detection of Temporal Clusters of Healthcare-Associated Infections or Colonizations with Pseudomonas aeruginosa in Two Hospitals: Comparison of SaTScan and WHONET Software Packages.
PloS One 2015, 10, e0139920.
Raben D, Mocroft A, Rayment M, Mitsura VM, Hadziosmanovic V, Sthoeger ZM, Palfreeman A, Morris S, Kutsyna G, Vassilenko A, Minton J, Necsoi C, Estrada VP, Grzeszczuk A, Johansson VS, Begovac J, Ong ELC, Cabié A, Ajana F, Celesia BM, Maltez F, Kitchen M, Comi L, Dragsted UB, Clumeck N, Gatell J, Gazzard B, d'Arminio Monforte A, Rockstroh J, Yazdanpanah Y, Champenois K, Jakobsen ML, Sullivan A, Lundgren JD, HIDES Audit Study Group
Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study.
PloS One 2015, 10, e0140845.
Fung M, Kim J, Marty FM, Schwarzinger M, Koo S
Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia.
PloS One 2015, 10, e0140930.
Bonnal C, Leleu C, Brugière O, Chochillon C, Porcher R, Boelle PY, Menotti J, Houze S, Lucet JC, Derouin F
Relationship between Fungal Colonisation of the Respiratory Tract in Lung Transplant Recipients and Fungal Contamination of the Hospital Environment.
PloS One 2015, 10, e0144044.
Potard V, Reynes J, Ferry T, Aubin C, Finkielsztejn L, Yazdanpanah Y, Costagliola D, FHDH ANRS CO4
Durability and Effectiveness of Maraviroc-Containing Regimens in HIV-1-Infected Individuals with Virological Failure in Routine Clinical Practice.
PloS One 2015, 10, e0144746.
Leoz M, Feyertag F, Kfutwah A, Mauclère P, Lachenal G, Damond F, De Oliveira F, Lemée V, Simon F, Robertson DL, Plantier JC
The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon.
PLoS pathogens 2015, 11, e1005029.
Schuetz P, Balk R, Briel M, Kutz A, Christ-Crain M, Stolz D, Bouadma L, Wolff M, Kristoffersen KB, Wei L, Burkhardt O, Welte T, Schroeder S, Nobre V, Tamm M, Bhatnagar N, Bucher HC, Luyt CE, Chastre J, Tubach F, Mueller B, Lacey MJ, Ohsfeldt RL, Scheibling CM, Schneider JE
Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective.
Clinical Chemistry and Laboratory Medicine 2015, 53, 583-592.
Marcellin F, Demoulin B, Spire B, Suzan-Monti M, Roux P, Protopopescu C, Sagaon-Teyssier L, Duracinsky M, Dray-Spira R, Carrieri MP, ANRS-VESPA2 Study Group
Spontaneous and post-treatment HCV clearance: relationships with health-related quality of life in HIV infection (ANRS-VESPA2 study).
Expert Rev Gastroenterol Hepatol 2015, 9, 701–713.
Basmaci R, Bonacorsi S, Ilharreborde B, Doit C, Lorrot M, Kahil M, Visseaux B, Houhou N, Bidet P
High respiratory virus oropharyngeal carriage rate during Kingella kingae osteoarticular infections in children.
Future Microbiology 2015, 10, 9-14.
Desgrées-du-Loû A, Pannetier J, Ravalihasy A, Gosselin A, Supervie V, Panjo H, Bajos N, Lert F, Lydié N, Dray-Spira R, Parcours Study Group5
Sub-Saharan African migrants living with HIV acquired after migration, France, ANRS PARCOURS study, 2012 to 2013.
Euro Surveill. 2015, 20,
Late presenters working group in COHERE in EuroCoord, Mocroft A, Lundgren J, Antinori A, Monforte Ad, Brännström J, Bonnet F, Brockmeyer N, Casabona J, Castagna A, Costagliola D, De Wit S, Fätkenheuer G, Furrer H, Jadand C, Johnson A, Lazanas M, Leport C, Moreno S, Mussini C, Obel N, Post F, Reiss P, Sabin C, Skaletz-Rorowski A, Suarez-Loano I, Torti C, Warszawski J, Wittkop L, Zangerle R, Chene G, Raben D, Kirk O
Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2015, 20,
Maignan M, Richard A, Debaty G, Pommier P, Viglino D, Loizzo F, Timsit JF, Hanna J, Carpentier F, Danel V
Intentional Drug Poisoning Care in a Physician-manned Emergency Medical Service.
Prehospital emergency care: official journal of the National Association of EMS Physicians and the National Association of State EMS Directors 2015, 19, 224-231.
Pommier JD, Ben Lasfar N, Van Grunderbeeck N, Burdet C, Laouénan C, Rioux C, Pierre-Audigier C, Meybeck A, Choudat L, Benchikh A, Nguyen S, Bouvet E, Yeni P, Yazdanpanah Y, Joly V
Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients.
Infectious Diseases (London, England) 2015, 47, 725-731.
Jauréguiberry S, Thellier M, Ndour PA, Ader F, Roussel C, Sonneville R, Mayaux J, Matheron S, Angoulvant A, Wyplosz B, Rapp C, Pistone T, Lebrun-Vignes B, Kendjo E, Danis M, Houzé S, Bricaire F, Mazier D, Buffet P, Caumes E, French Artesunate Working Group
Delayed-Onset Hemolytic Anemia in Patients with Travel-Associated Severe Malaria Treated with Artesunate, France, 2011-2013.
Emerging Infectious Diseases 2015, 21, 804–812.
Lê MP, Mandelbrot L, Descamps D, Soulié C, Ichou H, Bourgeois-Moine A, Damond F, Lariven S, Valantin MA, Landman R, Faucher P, Tubiana R, Duro D, Meier F, Legac S, Bourse P, Mortier E, Dommergues M, Calvez V, Matheron S, Peytavin G
Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant women.
Antiviral Therapy 2015, 20, 507-513.
Protopopescu C, Raffi F, Spire B, Hardel L, Michelet C, Cheneau C, Le Moing V, Leport C, Carrieri MP, ANRS CO8 APROCO-COPILOTE Study Group
Twelve-year mortality in HIV-infected patients receiving antiretroviral therapy: the role of social vulnerability. The ANRS CO8 APROCO-COPILOTE cohort.
Antiviral Therapy 2015, 20, 763-772.
Jenabian MA, Talla F, Talla P, Mbopi-Kéou FX, Charpentier C, Kane CT, Bélec L
Pitfalls of antiretroviral drug resistance genotyping of HIV-1 Group M and Group N from Cameroon by sequenced-based assays.
Nigerian Medical Journal: Journal of the Nigeria Medical Association 2015, 56, 420–424.
Dimopoulos G, Koulenti D, Tabah A, Poulakou G, Vesin A, Arvaniti K, Lathyris D, Matthaiou DK, Armaganidis A, Timsit JF
Bloodstream infections in ICU with increased resistance: epidemiology and outcomes.
Minerva Anestesiologica 2015, 81, 405-418.
Loubet P, Lescure FX, Lepage L, Kirsch M, Armand-Lefevre L, Bouadma L, Lariven S, Duval X, Yazdanpanah Y, Joly V
Endocarditis due to gram-negative bacilli at a French teaching hospital over a 6-year period: clinical characteristics and outcome.
Infectious Diseases (London, England) 2015, 47, 889-895.
Freedberg KA, Possas C, Deeks S, Ross AL, Rosettie KL, Di Mascio M, Collins C, Walensky RP, Yazdanpanah Y
The HIV Cure Research Agenda: The Role of Mathematical Modelling and Cost-Effectiveness Analysis.
Journal of Virus Eradication 2015, 1, 245-249.
2014
van Zanten ARH, Sztark F, Kaisers UX, Zielmann S, Felbinger TW, Sablotzki AR, De Waele JJ, Timsit JF, Honing MLH, Keh D, Vincent JL, Zazzo JF, Fijn HBM, Petit L, Preiser JC, van Horssen PJ, Hofman Z
High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: a randomized clinical trial.
JAMA: the journal of the American Medical Association 2014, 312, 514-524.
Mourad A, Deuffic-Burban S, Ganne-Carrié N, Renaut-Vantroys T, Rosa I, Bouvier AM, Launoy G, Cattan S, Louvet A, Dharancy S, Trinchet JC, Yazdanpanah Y, Mathurin P
Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: A modeling approach.
Hepatology (Baltimore, Md.) 2014, 59, 1471-1481.
Boyd A, Gozlan J, Maylin S, Delaugerre C, Peytavin G, Girard PM, Zoulim F, Lacombe K
Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: virological and clinical implications.
Hepatology (Baltimore, Md.) 2014, 60, 497–507.
Citerio G, Bakker J, Bassetti M, Benoit D, Cecconi M, Curtis JR, Hernandez G, Herridge M, Jaber S, Joannidis M, Papazian L, Peters M, Singer P, Smith M, Soares M, Torres A, Vieillard-Baron A, Timsit JF, Azoulay E
Year in review in Intensive Care Medicine 2013: I. Acute kidney injury, ultrasound, hemodynamics, cardiac arrest, transfusion, neurocritical care, and nutrition.
Intensive Care Medicine 2014, 40, 147-159.
Azoulay E, Citerio G, Bakker J, Bassetti M, Benoit D, Cecconi M, Curtis JR, Hernandez G, Herridge M, Jaber S, Joannidis M, Papazian L, Peters M, Singer P, Smith M, Soares M, Torres A, Vieillard-Baron A, Timsit JF
Year in review in Intensive Care Medicine 2013: II. Sedation, invasive and noninvasive ventilation, airways, ARDS, ECMO, family satisfaction, end-of-life care, organ donation, informed consent, safety, hematological issues in critically ill patients.
Intensive care medicine [YEAR IN REVIEW 2013] 2014, 40, 305-319.
Schnell D, Timsit JF, Darmon M, Vesin A, Goldgran-Toledano D, Dumenil AS, Garrouste-Orgeas M, Adrie C, Bouadma L, Planquette B, Cohen Y, Schwebel C, Soufir L, Jamali S, Souweine B, Azoulay E
Noninvasive mechanical ventilation in acute respiratory failure: trends in use and outcomes.
Intensive Care Medicine 2014, 40, 582-591.
Timsit JF, Citerio G, Bakker J, Bassetti M, Benoit D, Cecconi M, Curtis JR, Hernandez G, Herridge M, Jaber S, Joannidis M, Papazian L, Peters M, Singer P, Smith M, Soares M, Torres A, Vieillard-Baron A, Azoulay E
Year in review in Intensive Care Medicine 2013: III. Sepsis, infections, respiratory diseases, pediatrics.
Intensive care medicine [YEAR IN REVIEW 2013] 2014, 40, 471-483.
Lucet JC, Koulenti D, Zahar JR
Persistence of colonisation with MDRO following discharge from the ICU.
Intensive Care Medicine 2014, 40, 603-605.
Giannini A, Garrouste-Orgeas M, Latour JM
What's new in ICU visiting policies: can we continue to keep the doors closed?.
Intensive Care Medicine 2014, 40, 730-733.
de Montmollin E, Bouadma L, Gault N, Mourvillier B, Mariotte E, Chemam S, Massias L, Papy E, Tubach F, Wolff M, Sonneville R
Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen.
Intensive Care Medicine 2014, 40, 998-1005.
Timsit JF, Harbarth S, Carlet J
De-escalation as a potential way of reducing antibiotic use and antimicrobial resistance in ICU.
Intensive Care Medicine 2014, 40, 1580-1582.
Wolff M, Mourvillier B, Sonneville R, Timsit JF
My paper 10 years later: infective endocarditis in the intensive care unit.
Intensive Care Medicine [MY PAPER 20 YEARS LATER] 2014, 40, 1843-1852.
Debaty G, Maignan M, Savary D, Koch FX, Ruckly S, Durand M, Picard J, Escallier C, Chouquer R, Santre C, Minet C, Guergour D, Hammer L, Bouvaist H, Belle L, Adrie C, Payen JF, Carpentier F, Gueugniaud PY, Danel V, Timsit JF
Impact of intra-arrest therapeutic hypothermia in outcomes of prehospital cardiac arrest: a randomized controlled trial.
Intensive Care Medicine 2014, 40, 1832-1842.
Benenson JF, Kuhn MN, Ryan PJ, Ferranti AJ, Blondin R, Shea M, Charpentier C, Thompson ME, Wrangham RW
Human males appear more prepared than females to resolve conflicts with same-sex peers.
Human Nature (Hawthorne, N.Y.) 2014, 25, 251–268.
Camara S, Zucman D, Vasse M, Goudjo A, Guillard E, Peytavin G
[Lack of bioavailability of generic lopinavir/ritonavir not prequalified by WHO marketed in Africa (Congo Brazzaville).].
Bulletin De La Societe De Pathologie Exotique (1990) 2014
Caby F, Schneider L, Blanc C, Soulié C, Tindel M, Peytavin G, Agher R, Valantin MA, Tubiana R, Wirden M, Calvez V, Marcelin AG, Katlama C
Efficacy of raltegravir switching strategies in HIV-infected patients with suppressed viraemia according to the genotypic sensitivity score.
Infection 2014, 42, 295–301.
Elsen S, Huber P, Bouillot S, Couté Y, Fournier P, Dubois Y, Timsit JF, Maurin M, Attrée I
A type III secretion negative clinical strain of Pseudomonas aeruginosa employs a two-partner secreted exolysin to induce hemorrhagic pneumonia.
Cell Host & Microbe 2014, 15, 164-176.
Rahier J, Magro F, Abreu C, Armuzzi A, Ben-Horin S, Chowers Y, Cottone M, de Ridder L, Doherty G, Ehehalt R, Esteve M, Katsanos K, Lees C, MacMahon E, Moreels T, Reinisch W, Tilg H, Tremblay L, Veereman-Wauters G, Viget N, Yazdanpanah Y, Eliakim R, Colombel J
Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.
Journal of Crohn's and Colitis 2014, 8, 443-468.
Deuffic-Burban S, Mathurin P, Rosa I, Bouvier AM, Cannesson A, Mourad A, Canva V, Louvet A, Deltenre P, Boleslawski E, Truant S, Pruvot FR, Dharancy S
Impact of emerging hepatitis C virus treatments on future needs for liver transplantation in France: a modelling approach.
Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2014, 46, 157-163.
Dallaudière B, Dautry R, Preux PM, Perozziello A, Lincot J, Schouman-Claeys E, Serfaty JM
Comparison of apparent diffusion coefficient in spondylarthritis axial active inflammatory lesions and type 1 Modic changes.
European Journal of Radiology 2014, 83, 366-370.
Mandelbrot L, Berrebi A, Rouzioux C, Partisani M, Faucher P, Tubiana R, Matheron S, Bujan L, Morlat P, commission Prise en charge médicale des personnes vivant avec VIH, chapitre Désir d'enfant et grossesse
[Reproductive options for people living with HIV: 2013 guidelines from the French expert working group].
Gynecologie, Obstetrique & Fertilite 2014, 42, 543-550.
Leporrier J, Etienne M, Chapuzet C, Peytavin G, Bord S, Borsa-Lebas F, Caron F, Plantier JC, Mourez T
Association of dolutegravir and rilpivirine, enhanced by foscarnet induction, in effective salvage antiretroviral therapy.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2014, 60, 428–430.
Mandelbrot L, Berrébi A, Matheron S, Blanche S, Tubiana R, Rouzioux C, Faucher P, Partisani M, Boyer V, Taeron C, Faye A, Bujan L, Dabis F, Warszawski J, Morlat P
[HIV and pregnancy: 2013 guidelines from the French expert working group].
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction 2014, 43, 534-548.
Carrieri MP, Lions C, Sogni P, Winnock M, Roux P, Mora M, Bonnard P, Salmon D, Dabis F, Spire B, ANRS CO13 HEPAVIH Study Group
Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.
Journal of Hepatology 2014, 60, 46–53.
Deuffic-Burban S, Schwarzinger M, Obach D, Mallet V, Pol S, Pageaux GP, Canva V, Deltenre P, Roudot-Thoraval F, Larrey D, Dhumeaux D, Mathurin P, Yazdanpanah Y
Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141).
Journal of Hepatology 2014, 61, 7-14.
Elliott T, Timsit JF
epic3: guidelines for preventing infections associated with the use of intravascular access devices.
The Journal of Hospital Infection 2014, 87, 182.
Krastinova E, Bani-Sadr F, Fromentin D, Goujard C, Hessamfar M, Yazdanpanah Y, Pol S, Cacoub P, Perronne C, Carrat F
Re-treatment of chronic HCV infection in HIV co-infected patients and predictors of sustained viral response.
The Journal of Infection 2014, 68, 462-466.
Lugosi M, Alberti C, Zahar JR, Garrouste M, Lemiale V, Descorps-Desclère A, Ricard JD, Goldgran-Tolédano D, Cohen Y, Schwebel C, Vésin A, Timsit JF, Azoulay E
Aspergillus in the lower respiratory tract of immunocompetent critically ill patients.
The Journal of Infection 2014, 69, 284-292.
Marc F, Esquirol C, Papy E, Longuet P, Armand-Lefevre L, Rioux C, Diamantis S, Dumortier C, Bourgeois-Nicolaos N, Lucet JC, Wolff M, Arnaud P
A retrospective study of daptomycin use in a Paris teaching-hospital.
Médecine et maladies infectieuses 2014, 44, 25-31.
Neulier C, Birgand G, Ruppé E, Armand-Lefèvre L, Lolom I, Yazdanpanah Y, Lucet JC, Andremont A
Enterobacteriaceae bacteremia: Risk factors for ESBLPE.
Médecine et maladies infectieuses 2014, 44, 32-38.
Alioua MA, Labid A, Amoura K, Bertine M, Gacemi-Kirane D, Dekhil M
Emergence of the European ST80 clone of community-associated methicillin-resistant Staphylococcus aureus as a cause of healthcare-associated infections in Eastern Algeria.
Médecine Et Maladies Infectieuses 2014, 44, 180–183.
Lepelletier D, Saliou P, Lefebvre A, Lucet JC, Grandbastien B, Bruyère F, Stahl JP, Keita-Perse O, Berthelot P, Aho S, workgroup SF2H
"Preoperative risk management: strategy for Staphylococcus aureus preoperative decolonization" (2013 update). French society of Hospital Hygiene.
Medecine Et Maladies Infectieuses 2014, 44, 261-267.
Flicoteaux R, Pulcini C, Carrieri P, Schwarzinger M, Leport C, Verger P
Correlates of general practitioners' recommendations to patients regarding vaccination for the 2009-2010 pandemic influenza (A/H1N1) in France: implications for future vaccination campaigns.
Vaccine 2014, 32, 2281-2287.
Clotet B, Feinberg J, van Lunzen J, Khuong-Josses MA, Antinori A, Dumitru I, Pokrovskiy V, Fehr J, Ortiz R, Saag M, Harris J, Brennan C, Fujiwara T, Min S, ING114915 Study Team
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study.
Lancet 2014, 383, 2222–2231.
Raffi F, Babiker AG, Richert L, Molina JM, George EC, Antinori A, Arribas JR, Grarup J, Hudson F, Schwimmer C, Saillard J, Wallet C, Jansson PO, Allavena C, Van Leeuwen R, Delfraissy JF, Vella S, Chêne G, Pozniak A, NEAT001/ANRS143 Study Group
Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial.
Lancet 2014, 384, 1942–1951.
Matheron S, Baize S, Lerat I, Houhou N, Yazdanpanah Y
Ebola: should we consider influenza vaccination?.
Lancet (London, England) 2014, 384, 2023-2024.
Zahar JR, Lucet JC, Timsit JF
Antimicrobial resistance in intensive care units.
The Lancet. Infectious Diseases 2014, 14, 3-5.
Guerrier G, D'Ortenzio E
Africa: Ebola virus control needs local buy-in.
Nature 2014, 513, 315.
Landman R, Sharma J, Sur M, Desimone R
Effect of distracting faces on visual selective attention in the monkey.
Proceedings of the National Academy of Sciences of the United States of America 2014
Rosenthal E, Piroth L, Cua E, Joulié A, Ravaux I, Chauveau M, Lacombe K, Cotte L, Bonnard P, Weiss L, Longuet M, Pradier C, Cacoub P, GERMIVIC Study Group
Preexposure prophylaxis (PrEP) of HIV infection in France: a nationwide cross-sectional study (PREVIC study).
AIDS care 2014, 26, 176–185.
Birgand G, Schwarzinger M, Perozziello A, Lolom I, Pelat C, Armand-Lefevre L, Buzzi JC, Andremont A, Yazdanpanah Y, Lucet JC
Prolonged hospital stay, an adverse effect of strict national policy for controlling the spread of highly resistant microorganisms.
Infection Control and Hospital Epidemiology 2014, 35, 1427-1429.
Loubet P, Charpentier C, Visseaux B, Nuta C, Adu E, Chapplain JM, Baysah M, Walters-Doe S, Tattevin P, Peytavin G, Yazdanpanah Y, Descamps D
Short communication: Prevalence of HIV-1 transmitted drug resistance in Liberia.
AIDS research and human retroviruses 2014, 30, 863-866.
Soares M, Toffart AC, Timsit JF, Burghi G, Irrazábal C, Pattison N, Tobar E, Almeida BFC, Silva UVA, Azevedo LCP, Rabbat A, Lamer C, Parrot A, Souza-Dantas VC, Wallet F, Blot F, Bourdin G, Piras C, Delemazure J, Durand M, Tejera D, Salluh JIF, Azoulay E, Lung Cancer in Critical Care (LUCCA) Study Investigators
Intensive care in patients with lung cancer: a multinational study.
Annals of Oncology: Official Journal of the European Society for Medical Oncology 2014, 25, 1829-1835.
Aghokeng AF, Monleau M, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Toni TD, Touré-Kane C, Truong LXT, Delaporte E, Chaix ML, Peeters M, Ayouba A, ANRS 12186 Study Group
Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 58, 99–109.
Engsig FN, Zangerle R, Katsarou O, Dabis F, Reiss P, Gill J, Porter K, Sabin C, Riordan A, Fätkenheuer G, Gutiérrez F, Raffi F, Kirk O, Mary-Krause M, Stephan C, de Olalla PG, Guest J, Samji H, Castagna A, d'Arminio Monforte A, Skaletz-Rorowski A, Ramos J, Lapadula G, Mussini C, Force L, Meyer L, Lampe F, Boufassa F, Bucher HC, De Wit S, Burkholder GA, Teira R, Justice AC, Sterling TR, M Crane H, Gerstoft J, Grarup J, May M, Chêne G, Ingle SM, Sterne J, Obel N, Antiretroviral Therapy Cohort Collaboration (ART-CC) and the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord
Long-term mortality in HIV-positive individuals virally suppressed for \textgreater3 years with incomplete CD4 recovery.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 58, 1312–1321.
Obach D, Deuffic-Burban S, Esmat G, Anwar WA, Dewedar S, Canva V, Cousien A, Doss W, Mostafa A, Pol S, Buti M, Siebert U, Fontanet A, Mohamed MK, Yazdanpanah Y
Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 58, 1064-1071.
Ghosn J, Leruez-Ville M, Blanche J, Delobelle A, Beaudoux C, Mascard L, Lecuyer H, Canestri A, Landman R, Zucman D, Ponscarme D, Rami A, Viard JP, Spire B, Rouzioux C, Costagliola D, Suzan-Monti M, Evarist–ANRS EP 49 Study Group
HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 58, 1763–1770.
Marcellin F, Roux P, Loko MA, Lions C, Caumont-Prim A, Dabis F, Salmon-Ceron D, Spire B, Carrieri MP, HEPAVIH (ANRS CO13) Study Group
High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: a sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 59, 1190–1192.
Izzedine H, Lescure FX, Bonnet F
HIV medication-based urolithiasis.
Clinical Kidney Journal 2014, 7, 121-126.
Mirabel M, Sonneville R, Hajage D, Novy E, Tubach F, Vignon P, Perez P, Lavoue S, Kouatchet A, Pajot O, Mekontso-Dessap A, Tonnelier JM, Bollaert PE, Frat JP, Navellou JC, Hyvernat H, Hssain AA, Timsit JF, Megarbane B, Wolff M, Trouillet JL, for the ENDOREA Study Group
Long-term outcomes and cardiac surgery in critically ill patients with infective endocarditis.
European Heart Journal 2014, 35, 1195-1204.
Mary-Krause M, Grabar S, Lièvre L, Abgrall S, Billaud E, Boué F, Boyer L, Cabié A, Cotte L, De Truchis P, Duval X, Duvivier C, Enel P, Gasnault J, Gaud C, Gilquin J, Guiguet M, Katlama C, Khuong-Josses MA, Lacombe JM, Lang S, Lascaux AS, Launay O, Mahamat A, Matheron S, Meynard JL, Pavie J, Pilorgé F, Piroth L, Poizot-Martin I, Potard V, Pradier C, Reynes J, Rouveix E, Selinger-Leneman H, Simon A, Tattevin P, Tissot-Dupont H, Viard JP, Viget N, Costagliola D
Cohort Profile: French hospital database on HIV (FHDH-ANRS CO4).
International Journal of Epidemiology 2014, 43, 1425-1436.
Lambert-Niclot S, Charpentier C, Storto A, Fofana D, Soulie C, Fourati S, Wirden M, Morand-Joubert L, Masquelier B, Flandre P, Calvez V, Descamps D, Marcelin AG
Rilpivirine, emtricitabine and tenofovir resistance in HIV-1-infected rilpivirine-naive patients failing antiretroviral therapy.
The Journal of Antimicrobial Chemotherapy 2014, 69, 1086–1089.
Katlama C, Assoumou L, Valantin MA, Soulié C, Duvivier C, Chablais L, Kolta S, Pialoux G, Mercié P, Simon A, Costagliola D, Peytavin G, Marcelin AG, ROCnRAL ANRS 157 Study Group
Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study.
The Journal of Antimicrobial Chemotherapy 2014, 69, 1648–1652.
Charpentier C, Joly V, Ghosn J, Yeni P, Raffi F, Descamps D, Morand-Joubert L
Change in HIV-1 DNA tropism despite virological success in patients receiving an enfuvirtide-based regimen.
The Journal of Antimicrobial Chemotherapy 2014, 69, 2588–2590.
Burdet C, Lepeule R, Duval X, Caseris M, Rioux C, Lucet JC, Yazdanpanah Y
Quinolones versus macrolides in the treatment of legionellosis: a systematic review and meta-analysis.
The Journal of Antimicrobial Chemotherapy 2014, 69, 2354-2360.
Charpentier C, Choquet M, Joly V, Yeni P, Visseaux B, Caseris M, Brun-Vézinet F, Yazdanpanah Y, Peytavin G, Descamps D, Landman R
Virological outcome at week 48 of three recommended first-line regimens using ultrasensitive viral load and plasma drug assay.
The Journal of Antimicrobial Chemotherapy 2014, 69, 2819-2825.
Soulie C, Descamps D, Grudé M, Schneider V, Trabaud MA, Morand-Joubert L, Delaugerre C, Montes B, Barin F, Ferre V, Raymond S, Jeulin H, Alloui C, Yerly S, Pallier C, Reigadas S, Signori-Schmuck A, Guigon A, Fafi-Kremer S, Haïm-Boukobza S, Mirand A, Maillard A, Vallet S, Roussel C, Assoumou L, Calvez V, Flandre P, Marcelin AG, on behalf of the ANRS Resistance AC11 Group
Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma.
The Journal of Antimicrobial Chemotherapy 2014
Chumpitazi BFF, Lebeau B, Faure-Cognet O, Hamidfar-Roy R, Timsit JF, Pavese P, Thiebaut-Bertrand A, Quesada JL, Pelloux H, Pinel C
Characteristic and clinical relevance of Candida mannan test in the diagnosis of probable invasive candidiasis.
Medical Mycology 2014, 52, 462-471.
Allou N, Bronchard R, Guglielminotti J, Dilly MP, Provenchere S, Lucet JC, Laouénan C, Montravers P
Risk factors for postoperative pneumonia after cardiac surgery and development of a preoperative risk score*.
Critical Care Medicine 2014, 42, 1150-1156.
Garrouste-Orgeas M, Ben-Rehouma M, Darmon M, Ruckly S, Clec'h C, Adrie C, Tabah A, Vesin A, Schwebel C, Misset B, Timsit JF
ICU physician-based determinants of life-sustaining therapy during nights and weekends: French multicenter study from the Outcomerea Research Group.
Critical Care Medicine 2014, 42, 2393-2400.
Aupiais C, Faye A, Le Chenadec J, Rouzioux C, Bouallag N, Laurent C, Blanche S, Dollfus C, Warszawski J, ANRS EPF-CO10 French Pediatric Cohort
Interruption of cART in clinical practice is associated with an increase in the long-term risk of subsequent immunosuppression in HIV-1-infected children.
The Pediatric Infectious Disease Journal 2014, 33, 1237–1245.
Zucman D, Camara S, Gravisse J, Dimi S, Vasse M, Goudjo A, Choquet M, Peytavin G
Generic antiretroviral drugs in developing countries: friends or foes?.
AIDS (London, England) 2014, 28, 607–609.
Natural History Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord
Factors associated with short-term changes in HIV viral load and CD4(+) cell count in antiretroviral-naive individuals.
AIDS (London, England) 2014, 28, 1351–1356.
Charpentier C, Eholié S, Anglaret X, Bertine M, Rouzioux C, Avettand-Fenoël V, Messou E, Minga A, Damond F, Plantier JC, Dabis F, Peytavin G, Brun-Vézinet F, Ekouevi DK, IeDEA West Africa Collaboration
Genotypic resistance profiles of HIV-2-treated patients in West Africa.
AIDS (London, England) 2014, 28, 1161–1169.
Yazdanpanah Y, Champenois K
Assessing characteristics of hidden epidemics to design the most efficient HIV testing strategies.
AIDS (London, England) 2014, 28, 1831-1833.
Visseaux B, Charpentier C, Rouard C, Fagard C, Glohi D, Tubiana R, Damond F, Brun-Vézinet F, Matheron S, Descamps D, French HIV-2 ANRS Cohort CO5
HIV-2 X4 tropism is associated with lower CD4+ cell count in treatment-experienced patients.
AIDS (London, England) 2014, 28, 2160–2162.
Nguyen LBL, Harent S, Peytavin G, Visseaux B, Bastard JP, Dubourg O, Lariven S, Patrick Yeni n, Yazdanpanah Y, Lescure FX
Skeletal muscle toxicity associated with emtricitabine/rilpivirine/tenofovir fixed-dose combination: a case report.
AIDS (London, England) 2014, 28, 1995-1997.
Ouattara EN, Ross EL, Yazdanpanah Y, Wong AY, Robine M, Losina E, Moh R, Walensky RP, Danel C, Paltiel AD, Eholié SP, Freedberg KA, Anglaret X
Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'Ivoire.
Journal of Acquired Immune Deficiency Syndromes (1999) 2014, 66, 294-302.
Darmon M, Pichon M, Schwebel C, Ruckly S, Adrie C, Haouache H, Azoulay E, Bouadma L, Clec'h C, Garrouste-Orgeas M, Souweine B, Goldgran-Toledano D, Khallel H, Argaud L, Dumenil AS, Jamali S, Allaouchiche B, Zeni F, Timsit JF
Influence of early dysnatremia correction on survival of critically ill patients.
Shock (Augusta, Ga.) 2014, 41, 394-399.
Barbut F, Surgers L, Eckert C, Visseaux B, Cuingnet M, Mesquita C, Pradier N, Thiriez A, Ait-Ammar N, Aifaoui A, Grandsire E, Lalande V
Does a rapid diagnosis of Clostridium difficile infection impact on quality of patient management?.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, 136–144.
Caseris M, Houhou N, Longuet P, Rioux C, Lepeule R, Choquet C, Yazdanpanah Y, Yeni P, Joly V
French 2010-2011 measles outbreak in adults: report from a Parisian teaching hospital.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, O242-244.
Vironneau P, Kania R, Morizot G, Elie C, Garcia-Hermoso D, Herman P, Lortholary O, Lanternier F, French Mycosis Study Group
Local control of rhino-orbito-cerebral mucormycosis dramatically impacts survival.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, O336–339.
Birgand G, Armand-Lefevre L, Lepainteur M, Lolom I, Neulier C, Reibel F, Yazdanpanah Y, Andremont A, Lucet JC
Introduction of highly resistant bacteria into a hospital via patients repatriated or recently hospitalized in a foreign country.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases [RESEARCH NOTE] 2014, 20, O887-890.
Gagneux-Brunon A, Timsit JF, Lepape A, Berthelot P
Vascular catheter-related infection claims to health insurance company: often preventable.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, O1084-1087.
Almudimeegh A, Rioux C, Ferrand H, Crickx B, Yazdanpanah Y, Descamps V
Drug reaction with eosinophilia and systemic symptoms, or virus reactivation with eosinophilia and systemic symptoms as a manifestation of immune reconstitution inflammatory syndrome in a patient with HIV?.
The British Journal of Dermatology [CASE REPORT] 2014, 171, 895-898.
Borel JC, Pepin JL, Pison C, Vesin A, Gonzalez-Bermejo J, Court-Fortune I, Timsit JF
Long-term adherence with non-invasive ventilation improves prognosis in obese COPD patients.
Respirology (Carlton, Vic.) 2014, 19, 857-865.
Cottrell G, Musset L, Hubert V, Le Bras J, Clain J, Atovaquone-Proguanil Treatment Failure Study Group
Emergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reports.
Antimicrobial Agents and Chemotherapy 2014, 58, 4504–4514.
Laouénan C, Marcellin P, Lapalus M, Khelifa-Mouri F, Boyer N, Zoulim F, Serfaty L, Bronowicki JP, Martinot-Peignoux M, Lada O, Asselah T, Dorival C, Hézode C, Carrat F, Nicot F, Peytavin G, Mentré F, Guedj J
Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patients.
Antimicrobial Agents and Chemotherapy 2014, 58, 5332-5341.
Mandelbrot L, Duro D, Belissa E, Peytavin G
Placental transfer of darunavir in an ex vivo human cotyledon perfusion model.
Antimicrobial Agents and Chemotherapy 2014, 58, 5617-5620.
Avettand-Fenoel V, Damond F, Gueudin M, Matheron S, Mélard A, Collin G, Descamps D, Chaix ML, Rouzioux C, Plantier JC, ANRS-CO5 HIV-2 and the ANRS-AC11 Quantification Working Group
New sensitive one-step real-time duplex PCR method for group A and B HIV-2 RNA load.
Journal of Clinical Microbiology 2014, 52, 3017–3022.
Rouet F, Kania D, Tuaillon E, Maiga A, Nouhin J, Rouzioux C, Descamps D, Plantier JC
Use of reverse transcription-PCR-based assays for quantification of HIV-1 in dried blood spots requires specific HIV-1 RNA isolation for monitoring of antiretroviral treatment efficiency.
Journal of Clinical Microbiology 2014, 52, 2740–2741.
Monleau M, Aghokeng AF, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Touré-Kane C, Truong LXT, Chaix ML, Delaporte E, Ayouba A, Peeters M, ANRS 12235 Study Group
Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia.
Journal of Clinical Microbiology 2014, 52, 578–586.
Moulignier A, Lescure FX, Savatovsky J, Campa P
CD8 transverse myelitis in a patient with HIV-1 infection.
BMJ case reports 2014, 2014,
Birgand G, Azevedo C, Toupet G, Pissard-Gibollet R, Grandbastien B, Fleury E, Lucet JC
Attitudes, risk of infection and behaviours in the operating room (the ARIBO Project): a prospective, cross-sectional study.
BMJ open 2014, 4, e004274.
Pépin JL, Timsit JF, Tamisier R, Lévy P
Is CPAP effective in reducing blood pressure in minimally symptomatic obstructive sleep apnoea?.
Thorax [Editorial] 2014, 69, 1068-1070.
Borel JC, Pison C, Timsit JF, Pepin JL
Domiciliary long-term non-invasive ventilation in COPD: should we select subgroups with a better likelihood to respond to NIV in subsequent randomised controlled trials?.
Thorax 2014, 69, 1143.
Fassa AA, Mazighi M, Himbert D, Deschamps L, Ducrocq G, Cheong AP, Depoix JP, Dilly MP, Alkhoder S, Mourvillier B, Vahanian A
Successful endovascular stroke rescue with retrieval of an embolized calcium fragment after transcatheter aortic valve replacement.
Circulation. Cardiovascular Interventions 2014, 7, 125-126.
Nordell AD, McKenna M, Borges ÁH, Duprez D, Neuhaus J, Neaton JD, INSIGHT SMART ESG, SILCAAT Scientific Committee
Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.
Journal of the American Heart Association 2014
Puntillo KA, Max A, Timsit JF, Vignoud L, Chanques G, Robleda G, Roche-Campo F, Mancebo J, Divatia JV, Soares M, Ionescu DC, Grintescu I, Vasiliu IL, Maggiore SM, Rusinova K, Owczuk R, Egerod I, Papathanassoglou EDE, Kyranou M, Joynt GM, Burghi G, Freebairn RC, Ho KM, Kaarlola A, Gerritsen RT, Kesecioglu J, Sulaj MMS, Norrenberg M, Benoit DD, Seha MSG, Hennein A, Periera FJ, Benbenishty JS, Abroug F, Aquilina A, Monte JRC, An Y, Azoulay E
Determinants of Procedural Pain Intensity in the Intensive Care Unit The Europain (R) Study.
American Journal of Respiratory and Critical Care Medicine 2014, 189, 39-47.
Abgrall S, Fugon L, Lélé N, Carde E, Bentata M, Patey O, Khuong MA, Spire B, Bouchaud O, Carrieri P, AVsg
Risk factors for adherence failure in HIV-infected sub-Saharan migrants living in France and travelling back to their native country.
Int J STD AIDS 2014, 25, 389–390.
Weiss E, Timsit JF
Management of invasive candidiasis in nonneutropenic ICU patients.
Therapeutic Advances in Infectious Disease 2014, 2, 105-115.
Cousien A, Obach D, Deuffic-Burban S, Mostafa A, Esmat G, Canva V, El Kassas M, El-Sayed M, Anwar WA, Fontanet A, Mohamed MK, Yazdanpanah Y
Is expert opinion reliable when estimating transition probabilities? The case of HCV-related cirrhosis in Egypt.
BMC medical research methodology 2014, 14, 39.
Timsit JF, Soubirou JF, Voiriot G, Chemam S, Neuville M, Mourvillier B, Sonneville R, Mariotte E, Bouadma L, Wolff M
Treatment of bloodstream infections in ICUs.
BMC infectious diseases 2014, 14, 489.
Toffart AC, Moro-Sibilot D, Couraud S, Merle P, Perol M, Girard N, Souquet PJ, Mastroianni B, Ferretti GR, Romand P, Chatellain P, Vesin A, Brambilla E, Brambilla C, Timsit JF
Evaluation of RECIST in chemotherapy-treated lung cancer: the Pharmacogenoscan Study.
Bmc Cancer 2014, 14, 989.
N'Diaye DS, Schwarzinger M, Obach D, Poissy J, Matheron S, Casalino E, Yazdanpanah Y
Effectiveness and cost of quick diagnostic tests to determine tetanus immunity in patients with a wound in French emergency departments.
BMC infectious diseases 2014, 14, 603.
Ferraretto X, Estellat C, Damond F, Longuet P, Epelboin S, Demailly P, Yazbeck C, Llabador MA, Pasquet B, Yazdanpanah Y, Matheron S, Patrat C
Timing of intermittent seminal HIV-1 RNA shedding in patients with undetectable plasma viral load under combination antiretroviral therapy.
PloS One 2014, 9, e88922.
N'Diaye DS, Yazdanpanah Y, Krivine A, Andrieu T, Rozenberg F, Picone O, Tsatsaris V, Goffinet F, Launay O
Predictive factors of cytomegalovirus seropositivity among pregnant women in Paris, France.
PloS One 2014, 9, e89857.
Borges AH, O'Connor JL, Phillips AN, Baker JV, Vjecha MJ, Losso MH, Klinker H, Lopardo G, Williams I, Lundgren JD, INSIGHT SMART Study Group, ESPRIT Study Group, SILCAAT Scientific Committee
Factors associated with D-dimer levels in HIV-infected individuals.
PloS One 2014, 9, e90978.
Casalino E, Choquet C, Leleu A, Hellmann R, Wargon M, Juillien G, Yazdanpanah Y, Bouvet E
Trends in Condom Use and Risk Behaviours after Sexual Exposure to HIV: A Seven-Year Observational Study.
PloS One 2014, 9, e104350.
Garrouste-Orgeas M, Périer A, Mouricou P, Grégoire C, Bruel C, Brochon S, Philippart F, Max A, Misset B
Writing in and reading ICU diaries: qualitative study of families' experience in the ICU.
PloS One 2014, 9, e110146.
Tolsma V, Schwebel C, Azoulay E, Darmon M, Souweine B, Vesin A, Goldgran-Toledano D, Lugosi M, Jamali S, Cheval C, Adrie C, Kallel H, Descorps-Declere A, Garrouste-Orgeas M, Bouadma L, Timsit JF
Sepsis severe or septic shock: outcome according to immune status and immunodeficiency profile.
Chest 2014, 146, 1205-1213.
Yin DE, Warshaw MG, Miller WC, Castro H, Fiscus SA, Harper LM, Harrison LJ, Klein NJ, Lewis J, Melvin AJ, Tudor-Williams G, McKinney RE, PENPACT-1 (PENTA 9/PACTG 390) Study Team
Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.
Pediatrics 2014, 134, e1104–1116.
Darmon M, Clec'h C, Adrie C, Argaud L, Allaouchiche B, Azoulay E, Bouadma L, Garrouste-Orgeas M, Haouache H, Schwebel C, Goldgran-Toledano D, Khallel H, Dumenil AS, Jamali S, Souweine B, Zeni F, Cohen Y, Timsit JF
Acute respiratory distress syndrome and risk of AKI among critically ill patients.
Clinical journal of the American Society of Nephrology: CJASN 2014, 9, 1347-1353.
Soubirou JF, Gault N, Alfaiate T, Lolom I, Tubach F, Andremont A, Lucet JC, Wolff M, Barbier F
Ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacilli in an intensive care unit without carbapenemase-producing Enterobacteriaceae or epidemic Acinetobacter baumannii.
Scandinavian Journal of Infectious Diseases 2014, 46, 215-220.
Landman R, Koulla-Shiro S, Sow PS, Ngolle M, Diallo MB, Guèye NFN, Le Moing V, Eymard-Duvernay S, Benalycherif A, Charpentier C, Peytavin G, Delaporte E, Girard PM, DAYANA Study Group
Evaluation of four tenofovir-containing regimens as first-line treatments in Cameroon and Senegal: the ANRS 12115 DAYANA Trial.
Antiviral Therapy 2014, 19, 51–59.
Reliquet V, Chirouze C, Allavena C, Muret P, Peytavin G, André-Garnier E, Bettinger D, Ferré V, Hoen B, Raffi F
Nevirapine-raltegravir combination, an NRTI and PI/r sparing regimen, as maintenance antiretroviral therapy in virologically suppressed HIV-1-infected patients.
Antiviral Therapy 2014, 19, 117–123.
Wohl DA, Orkin C, Doroana M, Pilotto JH, Sungkanuparph S, Yeni P, Vanveggel S, Deckx H, Boven K
Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO).
Antiviral Therapy 2014, 19, 191–200.
Eron JJ, Cooper DA, Steigbigel RT, Clotet B, Yeni P, Strohmaier KM, Rodgers A, Barnard RJ, Nguyen BYT, Teppler H, the BENCHMRK Study Teams
Association between first-year virological response to raltegravir and long-term outcomes in treatment-experienced patients with HIV-1 infection.
Antiviral Therapy 2014
Borel AL, Schwebel C, Planquette B, Vésin A, Garrouste-Orgeas M, Adrie C, Clec'h C, Azoulay E, Souweine B, Allaouchiche B, Goldgran-Toledano D, Jamali S, Darmon M, Timsit JF
Initiation of nutritional support is delayed in critically ill obese patients: a multicenter cohort study.
The American Journal of Clinical Nutrition 2014, 100, 859-866.
Ruppe E, Armand-Lefevre L, Estellat C, El-Mniai A, Boussadia Y, Consigny P, Girard P, Vittecoq D, Bouchaud O, Pialoux G, Esposito-Farese M, Coignard B, Lucet J, Andremont A, Matheron S
Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013.
Euro surveillance: bulletin Européen sur les maladies transmissibles = European communicable disease bulletin 2014, 19,
Poletto C, Pelat C, Levy-Bruhl D, Yazdanpanah Y, Boelle P, Colizza V
Assessment of the Middle East respiratory syndrome coronavirus (MERS-CoV) epidemic in the Middle East and risk of international spread using a novel maximum likelihood analysis approach.
Euro Surveillance: Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2014, 19,
Sellier P, Schnepf N, Amarsy R, Maylin S, Coutellier M, Lopes A, Mazeron MC, Flateau C, Morgand M, Ciraru-Vigneron N, Berthe A, Ricbourg A, Dolores-Moreno AM, Simoneau G, Evans J, Souak S, Matheron S, Mouly S, Benifla JL, Simon F, Bergmann JF
Hepatitis B virus (HBV) status of children born to HIV/HBV co-infected women in a French hospital: a cross-sectional study.
Journal of the International AIDS Society 2014, 17, 19632.
Marcelin AG, Charpentier C, Wirden M, Descamps D, Calvez V
Less frequent follow-up in routine care than in trials does not impact resistance selection in patients failing DRV/r or ATV/r first line treatment.
Journal of the International AIDS Society 2014, 17, 19744.
Yeni P
[HIV infection. Screening, broadcast treatment and prevention of infection are now linked ].
La Revue Du Praticien 2014, 64, 1057–1059.
High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: a randomized clinical trial.
JAMA: the journal of the American Medical Association 2014, 312, 514-524.
Mourad A, Deuffic-Burban S, Ganne-Carrié N, Renaut-Vantroys T, Rosa I, Bouvier AM, Launoy G, Cattan S, Louvet A, Dharancy S, Trinchet JC, Yazdanpanah Y, Mathurin P
Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: A modeling approach.
Hepatology (Baltimore, Md.) 2014, 59, 1471-1481.
Boyd A, Gozlan J, Maylin S, Delaugerre C, Peytavin G, Girard PM, Zoulim F, Lacombe K
Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: virological and clinical implications.
Hepatology (Baltimore, Md.) 2014, 60, 497–507.
Citerio G, Bakker J, Bassetti M, Benoit D, Cecconi M, Curtis JR, Hernandez G, Herridge M, Jaber S, Joannidis M, Papazian L, Peters M, Singer P, Smith M, Soares M, Torres A, Vieillard-Baron A, Timsit JF, Azoulay E
Year in review in Intensive Care Medicine 2013: I. Acute kidney injury, ultrasound, hemodynamics, cardiac arrest, transfusion, neurocritical care, and nutrition.
Intensive Care Medicine 2014, 40, 147-159.
Azoulay E, Citerio G, Bakker J, Bassetti M, Benoit D, Cecconi M, Curtis JR, Hernandez G, Herridge M, Jaber S, Joannidis M, Papazian L, Peters M, Singer P, Smith M, Soares M, Torres A, Vieillard-Baron A, Timsit JF
Year in review in Intensive Care Medicine 2013: II. Sedation, invasive and noninvasive ventilation, airways, ARDS, ECMO, family satisfaction, end-of-life care, organ donation, informed consent, safety, hematological issues in critically ill patients.
Intensive care medicine [YEAR IN REVIEW 2013] 2014, 40, 305-319.
Schnell D, Timsit JF, Darmon M, Vesin A, Goldgran-Toledano D, Dumenil AS, Garrouste-Orgeas M, Adrie C, Bouadma L, Planquette B, Cohen Y, Schwebel C, Soufir L, Jamali S, Souweine B, Azoulay E
Noninvasive mechanical ventilation in acute respiratory failure: trends in use and outcomes.
Intensive Care Medicine 2014, 40, 582-591.
Timsit JF, Citerio G, Bakker J, Bassetti M, Benoit D, Cecconi M, Curtis JR, Hernandez G, Herridge M, Jaber S, Joannidis M, Papazian L, Peters M, Singer P, Smith M, Soares M, Torres A, Vieillard-Baron A, Azoulay E
Year in review in Intensive Care Medicine 2013: III. Sepsis, infections, respiratory diseases, pediatrics.
Intensive care medicine [YEAR IN REVIEW 2013] 2014, 40, 471-483.
Lucet JC, Koulenti D, Zahar JR
Persistence of colonisation with MDRO following discharge from the ICU.
Intensive Care Medicine 2014, 40, 603-605.
Giannini A, Garrouste-Orgeas M, Latour JM
What's new in ICU visiting policies: can we continue to keep the doors closed?.
Intensive Care Medicine 2014, 40, 730-733.
de Montmollin E, Bouadma L, Gault N, Mourvillier B, Mariotte E, Chemam S, Massias L, Papy E, Tubach F, Wolff M, Sonneville R
Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen.
Intensive Care Medicine 2014, 40, 998-1005.
Timsit JF, Harbarth S, Carlet J
De-escalation as a potential way of reducing antibiotic use and antimicrobial resistance in ICU.
Intensive Care Medicine 2014, 40, 1580-1582.
Wolff M, Mourvillier B, Sonneville R, Timsit JF
My paper 10 years later: infective endocarditis in the intensive care unit.
Intensive Care Medicine [MY PAPER 20 YEARS LATER] 2014, 40, 1843-1852.
Debaty G, Maignan M, Savary D, Koch FX, Ruckly S, Durand M, Picard J, Escallier C, Chouquer R, Santre C, Minet C, Guergour D, Hammer L, Bouvaist H, Belle L, Adrie C, Payen JF, Carpentier F, Gueugniaud PY, Danel V, Timsit JF
Impact of intra-arrest therapeutic hypothermia in outcomes of prehospital cardiac arrest: a randomized controlled trial.
Intensive Care Medicine 2014, 40, 1832-1842.
Benenson JF, Kuhn MN, Ryan PJ, Ferranti AJ, Blondin R, Shea M, Charpentier C, Thompson ME, Wrangham RW
Human males appear more prepared than females to resolve conflicts with same-sex peers.
Human Nature (Hawthorne, N.Y.) 2014, 25, 251–268.
Camara S, Zucman D, Vasse M, Goudjo A, Guillard E, Peytavin G
[Lack of bioavailability of generic lopinavir/ritonavir not prequalified by WHO marketed in Africa (Congo Brazzaville).].
Bulletin De La Societe De Pathologie Exotique (1990) 2014
Caby F, Schneider L, Blanc C, Soulié C, Tindel M, Peytavin G, Agher R, Valantin MA, Tubiana R, Wirden M, Calvez V, Marcelin AG, Katlama C
Efficacy of raltegravir switching strategies in HIV-infected patients with suppressed viraemia according to the genotypic sensitivity score.
Infection 2014, 42, 295–301.
Elsen S, Huber P, Bouillot S, Couté Y, Fournier P, Dubois Y, Timsit JF, Maurin M, Attrée I
A type III secretion negative clinical strain of Pseudomonas aeruginosa employs a two-partner secreted exolysin to induce hemorrhagic pneumonia.
Cell Host & Microbe 2014, 15, 164-176.
Rahier J, Magro F, Abreu C, Armuzzi A, Ben-Horin S, Chowers Y, Cottone M, de Ridder L, Doherty G, Ehehalt R, Esteve M, Katsanos K, Lees C, MacMahon E, Moreels T, Reinisch W, Tilg H, Tremblay L, Veereman-Wauters G, Viget N, Yazdanpanah Y, Eliakim R, Colombel J
Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.
Journal of Crohn's and Colitis 2014, 8, 443-468.
Deuffic-Burban S, Mathurin P, Rosa I, Bouvier AM, Cannesson A, Mourad A, Canva V, Louvet A, Deltenre P, Boleslawski E, Truant S, Pruvot FR, Dharancy S
Impact of emerging hepatitis C virus treatments on future needs for liver transplantation in France: a modelling approach.
Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2014, 46, 157-163.
Dallaudière B, Dautry R, Preux PM, Perozziello A, Lincot J, Schouman-Claeys E, Serfaty JM
Comparison of apparent diffusion coefficient in spondylarthritis axial active inflammatory lesions and type 1 Modic changes.
European Journal of Radiology 2014, 83, 366-370.
Mandelbrot L, Berrebi A, Rouzioux C, Partisani M, Faucher P, Tubiana R, Matheron S, Bujan L, Morlat P, commission Prise en charge médicale des personnes vivant avec VIH, chapitre Désir d'enfant et grossesse
[Reproductive options for people living with HIV: 2013 guidelines from the French expert working group].
Gynecologie, Obstetrique & Fertilite 2014, 42, 543-550.
Leporrier J, Etienne M, Chapuzet C, Peytavin G, Bord S, Borsa-Lebas F, Caron F, Plantier JC, Mourez T
Association of dolutegravir and rilpivirine, enhanced by foscarnet induction, in effective salvage antiretroviral therapy.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2014, 60, 428–430.
Mandelbrot L, Berrébi A, Matheron S, Blanche S, Tubiana R, Rouzioux C, Faucher P, Partisani M, Boyer V, Taeron C, Faye A, Bujan L, Dabis F, Warszawski J, Morlat P
[HIV and pregnancy: 2013 guidelines from the French expert working group].
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction 2014, 43, 534-548.
Carrieri MP, Lions C, Sogni P, Winnock M, Roux P, Mora M, Bonnard P, Salmon D, Dabis F, Spire B, ANRS CO13 HEPAVIH Study Group
Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.
Journal of Hepatology 2014, 60, 46–53.
Deuffic-Burban S, Schwarzinger M, Obach D, Mallet V, Pol S, Pageaux GP, Canva V, Deltenre P, Roudot-Thoraval F, Larrey D, Dhumeaux D, Mathurin P, Yazdanpanah Y
Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141).
Journal of Hepatology 2014, 61, 7-14.
Elliott T, Timsit JF
epic3: guidelines for preventing infections associated with the use of intravascular access devices.
The Journal of Hospital Infection 2014, 87, 182.
Krastinova E, Bani-Sadr F, Fromentin D, Goujard C, Hessamfar M, Yazdanpanah Y, Pol S, Cacoub P, Perronne C, Carrat F
Re-treatment of chronic HCV infection in HIV co-infected patients and predictors of sustained viral response.
The Journal of Infection 2014, 68, 462-466.
Lugosi M, Alberti C, Zahar JR, Garrouste M, Lemiale V, Descorps-Desclère A, Ricard JD, Goldgran-Tolédano D, Cohen Y, Schwebel C, Vésin A, Timsit JF, Azoulay E
Aspergillus in the lower respiratory tract of immunocompetent critically ill patients.
The Journal of Infection 2014, 69, 284-292.
Marc F, Esquirol C, Papy E, Longuet P, Armand-Lefevre L, Rioux C, Diamantis S, Dumortier C, Bourgeois-Nicolaos N, Lucet JC, Wolff M, Arnaud P
A retrospective study of daptomycin use in a Paris teaching-hospital.
Médecine et maladies infectieuses 2014, 44, 25-31.
Neulier C, Birgand G, Ruppé E, Armand-Lefèvre L, Lolom I, Yazdanpanah Y, Lucet JC, Andremont A
Enterobacteriaceae bacteremia: Risk factors for ESBLPE.
Médecine et maladies infectieuses 2014, 44, 32-38.
Alioua MA, Labid A, Amoura K, Bertine M, Gacemi-Kirane D, Dekhil M
Emergence of the European ST80 clone of community-associated methicillin-resistant Staphylococcus aureus as a cause of healthcare-associated infections in Eastern Algeria.
Médecine Et Maladies Infectieuses 2014, 44, 180–183.
Lepelletier D, Saliou P, Lefebvre A, Lucet JC, Grandbastien B, Bruyère F, Stahl JP, Keita-Perse O, Berthelot P, Aho S, workgroup SF2H
"Preoperative risk management: strategy for Staphylococcus aureus preoperative decolonization" (2013 update). French society of Hospital Hygiene.
Medecine Et Maladies Infectieuses 2014, 44, 261-267.
Flicoteaux R, Pulcini C, Carrieri P, Schwarzinger M, Leport C, Verger P
Correlates of general practitioners' recommendations to patients regarding vaccination for the 2009-2010 pandemic influenza (A/H1N1) in France: implications for future vaccination campaigns.
Vaccine 2014, 32, 2281-2287.
Clotet B, Feinberg J, van Lunzen J, Khuong-Josses MA, Antinori A, Dumitru I, Pokrovskiy V, Fehr J, Ortiz R, Saag M, Harris J, Brennan C, Fujiwara T, Min S, ING114915 Study Team
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study.
Lancet 2014, 383, 2222–2231.
Raffi F, Babiker AG, Richert L, Molina JM, George EC, Antinori A, Arribas JR, Grarup J, Hudson F, Schwimmer C, Saillard J, Wallet C, Jansson PO, Allavena C, Van Leeuwen R, Delfraissy JF, Vella S, Chêne G, Pozniak A, NEAT001/ANRS143 Study Group
Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial.
Lancet 2014, 384, 1942–1951.
Matheron S, Baize S, Lerat I, Houhou N, Yazdanpanah Y
Ebola: should we consider influenza vaccination?.
Lancet (London, England) 2014, 384, 2023-2024.
Zahar JR, Lucet JC, Timsit JF
Antimicrobial resistance in intensive care units.
The Lancet. Infectious Diseases 2014, 14, 3-5.
Guerrier G, D'Ortenzio E
Africa: Ebola virus control needs local buy-in.
Nature 2014, 513, 315.
Landman R, Sharma J, Sur M, Desimone R
Effect of distracting faces on visual selective attention in the monkey.
Proceedings of the National Academy of Sciences of the United States of America 2014
Rosenthal E, Piroth L, Cua E, Joulié A, Ravaux I, Chauveau M, Lacombe K, Cotte L, Bonnard P, Weiss L, Longuet M, Pradier C, Cacoub P, GERMIVIC Study Group
Preexposure prophylaxis (PrEP) of HIV infection in France: a nationwide cross-sectional study (PREVIC study).
AIDS care 2014, 26, 176–185.
Birgand G, Schwarzinger M, Perozziello A, Lolom I, Pelat C, Armand-Lefevre L, Buzzi JC, Andremont A, Yazdanpanah Y, Lucet JC
Prolonged hospital stay, an adverse effect of strict national policy for controlling the spread of highly resistant microorganisms.
Infection Control and Hospital Epidemiology 2014, 35, 1427-1429.
Loubet P, Charpentier C, Visseaux B, Nuta C, Adu E, Chapplain JM, Baysah M, Walters-Doe S, Tattevin P, Peytavin G, Yazdanpanah Y, Descamps D
Short communication: Prevalence of HIV-1 transmitted drug resistance in Liberia.
AIDS research and human retroviruses 2014, 30, 863-866.
Soares M, Toffart AC, Timsit JF, Burghi G, Irrazábal C, Pattison N, Tobar E, Almeida BFC, Silva UVA, Azevedo LCP, Rabbat A, Lamer C, Parrot A, Souza-Dantas VC, Wallet F, Blot F, Bourdin G, Piras C, Delemazure J, Durand M, Tejera D, Salluh JIF, Azoulay E, Lung Cancer in Critical Care (LUCCA) Study Investigators
Intensive care in patients with lung cancer: a multinational study.
Annals of Oncology: Official Journal of the European Society for Medical Oncology 2014, 25, 1829-1835.
Aghokeng AF, Monleau M, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Toni TD, Touré-Kane C, Truong LXT, Delaporte E, Chaix ML, Peeters M, Ayouba A, ANRS 12186 Study Group
Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 58, 99–109.
Engsig FN, Zangerle R, Katsarou O, Dabis F, Reiss P, Gill J, Porter K, Sabin C, Riordan A, Fätkenheuer G, Gutiérrez F, Raffi F, Kirk O, Mary-Krause M, Stephan C, de Olalla PG, Guest J, Samji H, Castagna A, d'Arminio Monforte A, Skaletz-Rorowski A, Ramos J, Lapadula G, Mussini C, Force L, Meyer L, Lampe F, Boufassa F, Bucher HC, De Wit S, Burkholder GA, Teira R, Justice AC, Sterling TR, M Crane H, Gerstoft J, Grarup J, May M, Chêne G, Ingle SM, Sterne J, Obel N, Antiretroviral Therapy Cohort Collaboration (ART-CC) and the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord
Long-term mortality in HIV-positive individuals virally suppressed for \textgreater3 years with incomplete CD4 recovery.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 58, 1312–1321.
Obach D, Deuffic-Burban S, Esmat G, Anwar WA, Dewedar S, Canva V, Cousien A, Doss W, Mostafa A, Pol S, Buti M, Siebert U, Fontanet A, Mohamed MK, Yazdanpanah Y
Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 58, 1064-1071.
Ghosn J, Leruez-Ville M, Blanche J, Delobelle A, Beaudoux C, Mascard L, Lecuyer H, Canestri A, Landman R, Zucman D, Ponscarme D, Rami A, Viard JP, Spire B, Rouzioux C, Costagliola D, Suzan-Monti M, Evarist–ANRS EP 49 Study Group
HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 58, 1763–1770.
Marcellin F, Roux P, Loko MA, Lions C, Caumont-Prim A, Dabis F, Salmon-Ceron D, Spire B, Carrieri MP, HEPAVIH (ANRS CO13) Study Group
High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: a sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 59, 1190–1192.
Izzedine H, Lescure FX, Bonnet F
HIV medication-based urolithiasis.
Clinical Kidney Journal 2014, 7, 121-126.
Mirabel M, Sonneville R, Hajage D, Novy E, Tubach F, Vignon P, Perez P, Lavoue S, Kouatchet A, Pajot O, Mekontso-Dessap A, Tonnelier JM, Bollaert PE, Frat JP, Navellou JC, Hyvernat H, Hssain AA, Timsit JF, Megarbane B, Wolff M, Trouillet JL, for the ENDOREA Study Group
Long-term outcomes and cardiac surgery in critically ill patients with infective endocarditis.
European Heart Journal 2014, 35, 1195-1204.
Mary-Krause M, Grabar S, Lièvre L, Abgrall S, Billaud E, Boué F, Boyer L, Cabié A, Cotte L, De Truchis P, Duval X, Duvivier C, Enel P, Gasnault J, Gaud C, Gilquin J, Guiguet M, Katlama C, Khuong-Josses MA, Lacombe JM, Lang S, Lascaux AS, Launay O, Mahamat A, Matheron S, Meynard JL, Pavie J, Pilorgé F, Piroth L, Poizot-Martin I, Potard V, Pradier C, Reynes J, Rouveix E, Selinger-Leneman H, Simon A, Tattevin P, Tissot-Dupont H, Viard JP, Viget N, Costagliola D
Cohort Profile: French hospital database on HIV (FHDH-ANRS CO4).
International Journal of Epidemiology 2014, 43, 1425-1436.
Lambert-Niclot S, Charpentier C, Storto A, Fofana D, Soulie C, Fourati S, Wirden M, Morand-Joubert L, Masquelier B, Flandre P, Calvez V, Descamps D, Marcelin AG
Rilpivirine, emtricitabine and tenofovir resistance in HIV-1-infected rilpivirine-naive patients failing antiretroviral therapy.
The Journal of Antimicrobial Chemotherapy 2014, 69, 1086–1089.
Katlama C, Assoumou L, Valantin MA, Soulié C, Duvivier C, Chablais L, Kolta S, Pialoux G, Mercié P, Simon A, Costagliola D, Peytavin G, Marcelin AG, ROCnRAL ANRS 157 Study Group
Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study.
The Journal of Antimicrobial Chemotherapy 2014, 69, 1648–1652.
Charpentier C, Joly V, Ghosn J, Yeni P, Raffi F, Descamps D, Morand-Joubert L
Change in HIV-1 DNA tropism despite virological success in patients receiving an enfuvirtide-based regimen.
The Journal of Antimicrobial Chemotherapy 2014, 69, 2588–2590.
Burdet C, Lepeule R, Duval X, Caseris M, Rioux C, Lucet JC, Yazdanpanah Y
Quinolones versus macrolides in the treatment of legionellosis: a systematic review and meta-analysis.
The Journal of Antimicrobial Chemotherapy 2014, 69, 2354-2360.
Charpentier C, Choquet M, Joly V, Yeni P, Visseaux B, Caseris M, Brun-Vézinet F, Yazdanpanah Y, Peytavin G, Descamps D, Landman R
Virological outcome at week 48 of three recommended first-line regimens using ultrasensitive viral load and plasma drug assay.
The Journal of Antimicrobial Chemotherapy 2014, 69, 2819-2825.
Soulie C, Descamps D, Grudé M, Schneider V, Trabaud MA, Morand-Joubert L, Delaugerre C, Montes B, Barin F, Ferre V, Raymond S, Jeulin H, Alloui C, Yerly S, Pallier C, Reigadas S, Signori-Schmuck A, Guigon A, Fafi-Kremer S, Haïm-Boukobza S, Mirand A, Maillard A, Vallet S, Roussel C, Assoumou L, Calvez V, Flandre P, Marcelin AG, on behalf of the ANRS Resistance AC11 Group
Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma.
The Journal of Antimicrobial Chemotherapy 2014
Chumpitazi BFF, Lebeau B, Faure-Cognet O, Hamidfar-Roy R, Timsit JF, Pavese P, Thiebaut-Bertrand A, Quesada JL, Pelloux H, Pinel C
Characteristic and clinical relevance of Candida mannan test in the diagnosis of probable invasive candidiasis.
Medical Mycology 2014, 52, 462-471.
Allou N, Bronchard R, Guglielminotti J, Dilly MP, Provenchere S, Lucet JC, Laouénan C, Montravers P
Risk factors for postoperative pneumonia after cardiac surgery and development of a preoperative risk score*.
Critical Care Medicine 2014, 42, 1150-1156.
Garrouste-Orgeas M, Ben-Rehouma M, Darmon M, Ruckly S, Clec'h C, Adrie C, Tabah A, Vesin A, Schwebel C, Misset B, Timsit JF
ICU physician-based determinants of life-sustaining therapy during nights and weekends: French multicenter study from the Outcomerea Research Group.
Critical Care Medicine 2014, 42, 2393-2400.
Aupiais C, Faye A, Le Chenadec J, Rouzioux C, Bouallag N, Laurent C, Blanche S, Dollfus C, Warszawski J, ANRS EPF-CO10 French Pediatric Cohort
Interruption of cART in clinical practice is associated with an increase in the long-term risk of subsequent immunosuppression in HIV-1-infected children.
The Pediatric Infectious Disease Journal 2014, 33, 1237–1245.
Zucman D, Camara S, Gravisse J, Dimi S, Vasse M, Goudjo A, Choquet M, Peytavin G
Generic antiretroviral drugs in developing countries: friends or foes?.
AIDS (London, England) 2014, 28, 607–609.
Natural History Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord
Factors associated with short-term changes in HIV viral load and CD4(+) cell count in antiretroviral-naive individuals.
AIDS (London, England) 2014, 28, 1351–1356.
Charpentier C, Eholié S, Anglaret X, Bertine M, Rouzioux C, Avettand-Fenoël V, Messou E, Minga A, Damond F, Plantier JC, Dabis F, Peytavin G, Brun-Vézinet F, Ekouevi DK, IeDEA West Africa Collaboration
Genotypic resistance profiles of HIV-2-treated patients in West Africa.
AIDS (London, England) 2014, 28, 1161–1169.
Yazdanpanah Y, Champenois K
Assessing characteristics of hidden epidemics to design the most efficient HIV testing strategies.
AIDS (London, England) 2014, 28, 1831-1833.
Visseaux B, Charpentier C, Rouard C, Fagard C, Glohi D, Tubiana R, Damond F, Brun-Vézinet F, Matheron S, Descamps D, French HIV-2 ANRS Cohort CO5
HIV-2 X4 tropism is associated with lower CD4+ cell count in treatment-experienced patients.
AIDS (London, England) 2014, 28, 2160–2162.
Nguyen LBL, Harent S, Peytavin G, Visseaux B, Bastard JP, Dubourg O, Lariven S, Patrick Yeni n, Yazdanpanah Y, Lescure FX
Skeletal muscle toxicity associated with emtricitabine/rilpivirine/tenofovir fixed-dose combination: a case report.
AIDS (London, England) 2014, 28, 1995-1997.
Ouattara EN, Ross EL, Yazdanpanah Y, Wong AY, Robine M, Losina E, Moh R, Walensky RP, Danel C, Paltiel AD, Eholié SP, Freedberg KA, Anglaret X
Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'Ivoire.
Journal of Acquired Immune Deficiency Syndromes (1999) 2014, 66, 294-302.
Darmon M, Pichon M, Schwebel C, Ruckly S, Adrie C, Haouache H, Azoulay E, Bouadma L, Clec'h C, Garrouste-Orgeas M, Souweine B, Goldgran-Toledano D, Khallel H, Argaud L, Dumenil AS, Jamali S, Allaouchiche B, Zeni F, Timsit JF
Influence of early dysnatremia correction on survival of critically ill patients.
Shock (Augusta, Ga.) 2014, 41, 394-399.
Barbut F, Surgers L, Eckert C, Visseaux B, Cuingnet M, Mesquita C, Pradier N, Thiriez A, Ait-Ammar N, Aifaoui A, Grandsire E, Lalande V
Does a rapid diagnosis of Clostridium difficile infection impact on quality of patient management?.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, 136–144.
Caseris M, Houhou N, Longuet P, Rioux C, Lepeule R, Choquet C, Yazdanpanah Y, Yeni P, Joly V
French 2010-2011 measles outbreak in adults: report from a Parisian teaching hospital.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, O242-244.
Vironneau P, Kania R, Morizot G, Elie C, Garcia-Hermoso D, Herman P, Lortholary O, Lanternier F, French Mycosis Study Group
Local control of rhino-orbito-cerebral mucormycosis dramatically impacts survival.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, O336–339.
Birgand G, Armand-Lefevre L, Lepainteur M, Lolom I, Neulier C, Reibel F, Yazdanpanah Y, Andremont A, Lucet JC
Introduction of highly resistant bacteria into a hospital via patients repatriated or recently hospitalized in a foreign country.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases [RESEARCH NOTE] 2014, 20, O887-890.
Gagneux-Brunon A, Timsit JF, Lepape A, Berthelot P
Vascular catheter-related infection claims to health insurance company: often preventable.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, O1084-1087.
Almudimeegh A, Rioux C, Ferrand H, Crickx B, Yazdanpanah Y, Descamps V
Drug reaction with eosinophilia and systemic symptoms, or virus reactivation with eosinophilia and systemic symptoms as a manifestation of immune reconstitution inflammatory syndrome in a patient with HIV?.
The British Journal of Dermatology [CASE REPORT] 2014, 171, 895-898.
Borel JC, Pepin JL, Pison C, Vesin A, Gonzalez-Bermejo J, Court-Fortune I, Timsit JF
Long-term adherence with non-invasive ventilation improves prognosis in obese COPD patients.
Respirology (Carlton, Vic.) 2014, 19, 857-865.
Cottrell G, Musset L, Hubert V, Le Bras J, Clain J, Atovaquone-Proguanil Treatment Failure Study Group
Emergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reports.
Antimicrobial Agents and Chemotherapy 2014, 58, 4504–4514.
Laouénan C, Marcellin P, Lapalus M, Khelifa-Mouri F, Boyer N, Zoulim F, Serfaty L, Bronowicki JP, Martinot-Peignoux M, Lada O, Asselah T, Dorival C, Hézode C, Carrat F, Nicot F, Peytavin G, Mentré F, Guedj J
Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patients.
Antimicrobial Agents and Chemotherapy 2014, 58, 5332-5341.
Mandelbrot L, Duro D, Belissa E, Peytavin G
Placental transfer of darunavir in an ex vivo human cotyledon perfusion model.
Antimicrobial Agents and Chemotherapy 2014, 58, 5617-5620.
Avettand-Fenoel V, Damond F, Gueudin M, Matheron S, Mélard A, Collin G, Descamps D, Chaix ML, Rouzioux C, Plantier JC, ANRS-CO5 HIV-2 and the ANRS-AC11 Quantification Working Group
New sensitive one-step real-time duplex PCR method for group A and B HIV-2 RNA load.
Journal of Clinical Microbiology 2014, 52, 3017–3022.
Rouet F, Kania D, Tuaillon E, Maiga A, Nouhin J, Rouzioux C, Descamps D, Plantier JC
Use of reverse transcription-PCR-based assays for quantification of HIV-1 in dried blood spots requires specific HIV-1 RNA isolation for monitoring of antiretroviral treatment efficiency.
Journal of Clinical Microbiology 2014, 52, 2740–2741.
Monleau M, Aghokeng AF, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Touré-Kane C, Truong LXT, Chaix ML, Delaporte E, Ayouba A, Peeters M, ANRS 12235 Study Group
Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia.
Journal of Clinical Microbiology 2014, 52, 578–586.
Moulignier A, Lescure FX, Savatovsky J, Campa P
CD8 transverse myelitis in a patient with HIV-1 infection.
BMJ case reports 2014, 2014,
Birgand G, Azevedo C, Toupet G, Pissard-Gibollet R, Grandbastien B, Fleury E, Lucet JC
Attitudes, risk of infection and behaviours in the operating room (the ARIBO Project): a prospective, cross-sectional study.
BMJ open 2014, 4, e004274.
Pépin JL, Timsit JF, Tamisier R, Lévy P
Is CPAP effective in reducing blood pressure in minimally symptomatic obstructive sleep apnoea?.
Thorax [Editorial] 2014, 69, 1068-1070.
Borel JC, Pison C, Timsit JF, Pepin JL
Domiciliary long-term non-invasive ventilation in COPD: should we select subgroups with a better likelihood to respond to NIV in subsequent randomised controlled trials?.
Thorax 2014, 69, 1143.
Fassa AA, Mazighi M, Himbert D, Deschamps L, Ducrocq G, Cheong AP, Depoix JP, Dilly MP, Alkhoder S, Mourvillier B, Vahanian A
Successful endovascular stroke rescue with retrieval of an embolized calcium fragment after transcatheter aortic valve replacement.
Circulation. Cardiovascular Interventions 2014, 7, 125-126.
Nordell AD, McKenna M, Borges ÁH, Duprez D, Neuhaus J, Neaton JD, INSIGHT SMART ESG, SILCAAT Scientific Committee
Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.
Journal of the American Heart Association 2014
Puntillo KA, Max A, Timsit JF, Vignoud L, Chanques G, Robleda G, Roche-Campo F, Mancebo J, Divatia JV, Soares M, Ionescu DC, Grintescu I, Vasiliu IL, Maggiore SM, Rusinova K, Owczuk R, Egerod I, Papathanassoglou EDE, Kyranou M, Joynt GM, Burghi G, Freebairn RC, Ho KM, Kaarlola A, Gerritsen RT, Kesecioglu J, Sulaj MMS, Norrenberg M, Benoit DD, Seha MSG, Hennein A, Periera FJ, Benbenishty JS, Abroug F, Aquilina A, Monte JRC, An Y, Azoulay E
Determinants of Procedural Pain Intensity in the Intensive Care Unit The Europain (R) Study.
American Journal of Respiratory and Critical Care Medicine 2014, 189, 39-47.
Abgrall S, Fugon L, Lélé N, Carde E, Bentata M, Patey O, Khuong MA, Spire B, Bouchaud O, Carrieri P, AVsg
Risk factors for adherence failure in HIV-infected sub-Saharan migrants living in France and travelling back to their native country.
Int J STD AIDS 2014, 25, 389–390.
Weiss E, Timsit JF
Management of invasive candidiasis in nonneutropenic ICU patients.
Therapeutic Advances in Infectious Disease 2014, 2, 105-115.
Cousien A, Obach D, Deuffic-Burban S, Mostafa A, Esmat G, Canva V, El Kassas M, El-Sayed M, Anwar WA, Fontanet A, Mohamed MK, Yazdanpanah Y
Is expert opinion reliable when estimating transition probabilities? The case of HCV-related cirrhosis in Egypt.
BMC medical research methodology 2014, 14, 39.
Timsit JF, Soubirou JF, Voiriot G, Chemam S, Neuville M, Mourvillier B, Sonneville R, Mariotte E, Bouadma L, Wolff M
Treatment of bloodstream infections in ICUs.
BMC infectious diseases 2014, 14, 489.
Toffart AC, Moro-Sibilot D, Couraud S, Merle P, Perol M, Girard N, Souquet PJ, Mastroianni B, Ferretti GR, Romand P, Chatellain P, Vesin A, Brambilla E, Brambilla C, Timsit JF
Evaluation of RECIST in chemotherapy-treated lung cancer: the Pharmacogenoscan Study.
Bmc Cancer 2014, 14, 989.
N'Diaye DS, Schwarzinger M, Obach D, Poissy J, Matheron S, Casalino E, Yazdanpanah Y
Effectiveness and cost of quick diagnostic tests to determine tetanus immunity in patients with a wound in French emergency departments.
BMC infectious diseases 2014, 14, 603.
Ferraretto X, Estellat C, Damond F, Longuet P, Epelboin S, Demailly P, Yazbeck C, Llabador MA, Pasquet B, Yazdanpanah Y, Matheron S, Patrat C
Timing of intermittent seminal HIV-1 RNA shedding in patients with undetectable plasma viral load under combination antiretroviral therapy.
PloS One 2014, 9, e88922.
N'Diaye DS, Yazdanpanah Y, Krivine A, Andrieu T, Rozenberg F, Picone O, Tsatsaris V, Goffinet F, Launay O
Predictive factors of cytomegalovirus seropositivity among pregnant women in Paris, France.
PloS One 2014, 9, e89857.
Borges AH, O'Connor JL, Phillips AN, Baker JV, Vjecha MJ, Losso MH, Klinker H, Lopardo G, Williams I, Lundgren JD, INSIGHT SMART Study Group, ESPRIT Study Group, SILCAAT Scientific Committee
Factors associated with D-dimer levels in HIV-infected individuals.
PloS One 2014, 9, e90978.
Casalino E, Choquet C, Leleu A, Hellmann R, Wargon M, Juillien G, Yazdanpanah Y, Bouvet E
Trends in Condom Use and Risk Behaviours after Sexual Exposure to HIV: A Seven-Year Observational Study.
PloS One 2014, 9, e104350.
Garrouste-Orgeas M, Périer A, Mouricou P, Grégoire C, Bruel C, Brochon S, Philippart F, Max A, Misset B
Writing in and reading ICU diaries: qualitative study of families' experience in the ICU.
PloS One 2014, 9, e110146.
Tolsma V, Schwebel C, Azoulay E, Darmon M, Souweine B, Vesin A, Goldgran-Toledano D, Lugosi M, Jamali S, Cheval C, Adrie C, Kallel H, Descorps-Declere A, Garrouste-Orgeas M, Bouadma L, Timsit JF
Sepsis severe or septic shock: outcome according to immune status and immunodeficiency profile.
Chest 2014, 146, 1205-1213.
Yin DE, Warshaw MG, Miller WC, Castro H, Fiscus SA, Harper LM, Harrison LJ, Klein NJ, Lewis J, Melvin AJ, Tudor-Williams G, McKinney RE, PENPACT-1 (PENTA 9/PACTG 390) Study Team
Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.
Pediatrics 2014, 134, e1104–1116.
Darmon M, Clec'h C, Adrie C, Argaud L, Allaouchiche B, Azoulay E, Bouadma L, Garrouste-Orgeas M, Haouache H, Schwebel C, Goldgran-Toledano D, Khallel H, Dumenil AS, Jamali S, Souweine B, Zeni F, Cohen Y, Timsit JF
Acute respiratory distress syndrome and risk of AKI among critically ill patients.
Clinical journal of the American Society of Nephrology: CJASN 2014, 9, 1347-1353.
Soubirou JF, Gault N, Alfaiate T, Lolom I, Tubach F, Andremont A, Lucet JC, Wolff M, Barbier F
Ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacilli in an intensive care unit without carbapenemase-producing Enterobacteriaceae or epidemic Acinetobacter baumannii.
Scandinavian Journal of Infectious Diseases 2014, 46, 215-220.
Landman R, Koulla-Shiro S, Sow PS, Ngolle M, Diallo MB, Guèye NFN, Le Moing V, Eymard-Duvernay S, Benalycherif A, Charpentier C, Peytavin G, Delaporte E, Girard PM, DAYANA Study Group
Evaluation of four tenofovir-containing regimens as first-line treatments in Cameroon and Senegal: the ANRS 12115 DAYANA Trial.
Antiviral Therapy 2014, 19, 51–59.
Reliquet V, Chirouze C, Allavena C, Muret P, Peytavin G, André-Garnier E, Bettinger D, Ferré V, Hoen B, Raffi F
Nevirapine-raltegravir combination, an NRTI and PI/r sparing regimen, as maintenance antiretroviral therapy in virologically suppressed HIV-1-infected patients.
Antiviral Therapy 2014, 19, 117–123.
Wohl DA, Orkin C, Doroana M, Pilotto JH, Sungkanuparph S, Yeni P, Vanveggel S, Deckx H, Boven K
Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO).
Antiviral Therapy 2014, 19, 191–200.
Eron JJ, Cooper DA, Steigbigel RT, Clotet B, Yeni P, Strohmaier KM, Rodgers A, Barnard RJ, Nguyen BYT, Teppler H, the BENCHMRK Study Teams
Association between first-year virological response to raltegravir and long-term outcomes in treatment-experienced patients with HIV-1 infection.
Antiviral Therapy 2014
Borel AL, Schwebel C, Planquette B, Vésin A, Garrouste-Orgeas M, Adrie C, Clec'h C, Azoulay E, Souweine B, Allaouchiche B, Goldgran-Toledano D, Jamali S, Darmon M, Timsit JF
Initiation of nutritional support is delayed in critically ill obese patients: a multicenter cohort study.
The American Journal of Clinical Nutrition 2014, 100, 859-866.
Ruppe E, Armand-Lefevre L, Estellat C, El-Mniai A, Boussadia Y, Consigny P, Girard P, Vittecoq D, Bouchaud O, Pialoux G, Esposito-Farese M, Coignard B, Lucet J, Andremont A, Matheron S
Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013.
Euro surveillance: bulletin Européen sur les maladies transmissibles = European communicable disease bulletin 2014, 19,
Poletto C, Pelat C, Levy-Bruhl D, Yazdanpanah Y, Boelle P, Colizza V
Assessment of the Middle East respiratory syndrome coronavirus (MERS-CoV) epidemic in the Middle East and risk of international spread using a novel maximum likelihood analysis approach.
Euro Surveillance: Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2014, 19,
Sellier P, Schnepf N, Amarsy R, Maylin S, Coutellier M, Lopes A, Mazeron MC, Flateau C, Morgand M, Ciraru-Vigneron N, Berthe A, Ricbourg A, Dolores-Moreno AM, Simoneau G, Evans J, Souak S, Matheron S, Mouly S, Benifla JL, Simon F, Bergmann JF
Hepatitis B virus (HBV) status of children born to HIV/HBV co-infected women in a French hospital: a cross-sectional study.
Journal of the International AIDS Society 2014, 17, 19632.
Marcelin AG, Charpentier C, Wirden M, Descamps D, Calvez V
Less frequent follow-up in routine care than in trials does not impact resistance selection in patients failing DRV/r or ATV/r first line treatment.
Journal of the International AIDS Society 2014, 17, 19744.
Yeni P
[HIV infection. Screening, broadcast treatment and prevention of infection are now linked ].
La Revue Du Praticien 2014, 64, 1057–1059.
2013
Mourvillier B, Tubach F, van de Beek D, Garot D, Pichon N, Georges H, Lefevre LM, Bollaert PE, Boulain T, Luis D, Cariou A, Girardie P, Chelha R, Megarbane B, Delahaye A, Chalumeau-Lemoine L, Legriel S, Beuret P, Brivet F, Bruel C, Camou F, Chatellier D, Chillet P, Clair B, Constantin JM, Duguet A, Galliot R, Bayle F, Hyvernat H, Ouchenir K, Plantefeve G, Quenot JP, Richecoeur J, Schwebel C, Sirodot M, Esposito-Farèse M, Le Tulzo Y, Wolff M
Induced hypothermia in severe bacterial meningitis: a randomized clinical trial.
JAMA 2013, 310, 2174-2183.
Steff M, Joly V, Di Lucca J, Feldman J, Burg S, Sarda-Mantel L, Peytavin G, Marinho E, Crickx B, Raymond E, Lariven S, Maubec E
Clinical activity of lenalidomide in visceral human immunodeficiency virus-related Kaposi sarcoma.
JAMA dermatology 2013, 149, 1319-1322.
Demaret J, Walencik A, Jacob MC, Timsit JF, Venet F, Lepape A, Monneret G
Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples.
Cytometry. Part B, Clinical Cytometry 2013, 84, 59-62.
Schuetz P, Müller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bhatnagar N, Bucher HC, Briel M
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Evidence-Based Child Health: A Cochrane Review Journal 2013, 8, 1297-1371.
Ghosn J, Slama L, Chermak A, Houssaini A, Lambert-Niclot S, Schneider L, Fourn E, Duvivier C, Simon A, Courbon E, Murphy R, Flandre P, Peytavin G, Katlama C, RADAR Study Group
Switching to darunavir/ritonavir 800/100 mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1.
Journal of Medical Virology 2013, 85, 8-15.
Antonelli M, Bonten M, Cecconi M, Chastre J, Citerio G, Conti G, Curtis JR, Hedenstierna G, Joannidis M, Macrae D, Maggiore SM, Mancebo J, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2012: I. Neurology and neurointensive care, epidemiology and nephrology, biomarkers and inflammation, nutrition, experimentals.
Intensive Care Medicine 2013, 39, 232-246.
Antonelli M, Bonten M, Cecconi M, Chastre J, Citerio G, Conti G, Curtis JR, Hedenstierna G, Joannidis M, Macrae D, Maggiore SM, Mancebo J, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2012. II: Pneumonia and infection, sepsis, coagulation, hemodynamics, cardiovascular and microcirculation, critical care organization, imaging, ethics and legal issues.
Intensive Care Medicine 2013, 39, 345-364.
Antonelli M, Bonten M, Cecconi M, Chastre J, Citerio G, Conti G, Curtis JR, Hedenstierna G, Joannidis M, Macrae D, Maggiore SM, Mancebo J, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2012: III. Noninvasive ventilation, monitoring and patient-ventilator interactions, acute respiratory distress syndrome, sedation, paediatrics and miscellanea.
Intensive Care Medicine 2013, 39, 543-557.
Potton L, Bonadona A, Minet C, Timsit JF
Pink urine.
Intensive Care Medicine 2013, 39, 389-390.
Vesin A, Azoulay E, Ruckly S, Vignoud L, Rusinovà K, Benoit D, Soares M, Azeivedo-Maia P, Abroug F, Benbenishty J, Timsit JF
Reporting and handling missing values in clinical studies in intensive care units.
Intensive Care Medicine 2013, 39, 1396-1404.
Thiolliere F, Serre-Sapin AF, Reignier J, Benedit M, Constantin JM, Lebert C, Guélon D, Timsit JF, Souweine B
Epidemiology and outcome of thrombocytopenic patients in the intensive care unit: results of a prospective multicenter study.
Intensive Care Medicine 2013, 39, 1460-1468.
Philippart F, Vesin A, Bruel C, Kpodji A, Durand-Gasselin B, Garçon P, Levy-Soussan M, Jagot JL, Calvo-Verjat N, Timsit JF, Misset B, Garrouste-Orgeas M
The ETHICA study (part I): elderly's thoughts about intensive care unit admission for life-sustaining treatments.
Intensive Care Medicine 2013, 39, 1565-1573.
Garrouste-Orgeas M, Tabah A, Vesin A, Philippart F, Kpodji A, Bruel C, Grégoire C, Max A, Timsit JF, Misset B
The ETHICA study (part II): simulation study of determinants and variability of ICU physician decisions in patients aged 80 or over.
Intensive Care Medicine 2013, 39, 1574-1583.
Garrouste-Orgeas M, Valentin A
What's new for patient safety in the ICU?.
Intensive Care Medicine 2013, 39, 1829-1831.
Zahar JR, Garrouste-Orgeas M, Vesin A, Schwebel C, Bonadona A, Philippart F, Ara-Somohano C, Misset B, Timsit JF
Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events.
Intensive Care Medicine 2013, 39, 2153-2160.
Fagedet D, Thony F, Timsit JF, Rodiere M, Monnin-Bares V, Ferretti GR, Vesin A, Moro-Sibilot D
Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy.
Cardiovascular and Interventional Radiology 2013, 36, 140-149.
Harrison L, Ananworanich J, Hamadache D, Compagnucci A, Penazzato M, Bunupuradah T, Mazza A, Ramos JT, Flynn J, Rampon O, Mellado Pena MJ, Floret D, Marczynska M, Puga A, Forcat S, Riault Y, Lallemant M, Castro H, Gibb DM, Giaquinto C, Paediatric European Network for Treatment of AIDS (PENTA) 11 Trial Team
Adherence to antiretroviral therapy and acceptability of planned treatment interruptions in HIV-infected children.
AIDS and behavior 2013, 17, 193-202.
Moulignier A, Savatovsky J, Polivka M, Boutboul D, Depaz R, Lescure FX
CD8 T lymphocytes encephalitis mimicking brain tumor in HIV-1 infection.
Journal of Neurovirology 2013, 19, 606-609.
Prinapori R, Guinaud J, Khalil A, Lecuyer H, Gendrel D, Lortholary O, Nassif X, Viscoli C, Zahar JR
Risk associated with a systematic search of extended-spectrum β-lactamase-producing Enterobacteriaceae.
American Journal of Infection Control 2013, 41, 259-260.
Birgand G, Armand-Lefevre L, Lolom I, Ruppe E, Andremont A, Lucet JC
Duration of colonization by extended-spectrum β-lactamase-producing Enterobacteriaceae after hospital discharge.
American Journal of Infection Control 2013, 41, 443-447.
Rivard-Yazigi L, Zahar JR, Le Guillou S, Chalouhi C, Lecuyer H, Bureau C, Nassif X, Gendrel D, Abadie V
Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae carriage at admission in an infant cohort at a tertiary teaching hospital in France.
American Journal of Infection Control 2013, 41, 844-845.
Dallaudière B, Meyer P, Hummel V, Perozziello A, Peuchant A, Moreau-Durieux MH, Silvestre A, Pelé E, Wakim N, Loriaut P, Boyer P, Schouman-Claeys E, Serfaty JM, Pesquer L
Efficacy of second intra-tendinous platelet-rich-plasma injection in case of incomplete response of the first injection: three-year follow up experience.
Diagnostic and Interventional Imaging 2013, 94, 871-877.
Dallaudière B, Lempicki M, Pesquer L, Louedec L, Preux PM, Meyer P, Hess A, Durieux MHM, Hummel V, Larbi A, Deschamps L, Benayoun Y, Journe C, Perozziello A, Schouman-Claeys E, Michel JB, Serfaty JM
Acceleration of tendon healing using US guided intratendinous injection of bevacizumab: first pre-clinical study on a murine model.
European Journal of Radiology 2013, 82, e823-828.
Marcelin AG, Delaugerre C, Beaudoux C, Descamps D, Morand-Joubert L, Amiel C, Schneider V, Ferre V, Izopet J, Si-Mohamed A, Maillard A, Henquell C, Desbois D, Lazrek M, Signori-Schmuck A, Rogez S, Yerly S, Trabaud MA, Plantier JC, Fourati S, Houssaini A, Masquelier B, Calvez V, Flandre P, ANRS AC11 Resistance Group
A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure.
International Journal of Antimicrobial Agents 2013, 42, 42-47.
Chousterman BG, Bouadma L, Moutereau S, Loric S, Alvarez-Gonzalez A, Mekontso-Dessap A, Laissy JP, Rahmouni A, Katsahian S, Brochard L, Schortgen F
Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results.
Journal of Critical Care 2013, 28, 701-709.
Visseaux B, Larrouy L, Calin R, Katlama C, Poynard T, Ratziu V, Thibault V
Anti-hepatitis C virus antibody detection in oral fluid: influence of human immunodeficiency virus co-infection.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2013, 58, 385-390.
Delarue S, Didier E, Damond F, Ponscarme D, Brengle-Pesce K, Resche-Rigon M, Vray M, Gueudin M, Simon F
Highly sensitive plasma RNA quantification by real-time PCR in HIV-2 group A and group B infection.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2013, 58, 461-467.
Deuffic-Burban S, Yazdanpanah Y
Mathematical modeling: a tool for selecting agents with complementary modes of action?.
Journal of Hepatology 2013, 59, 1346-1348.
Lepelletier D, Lucet JC
Controlling meticillin-susceptible Staphylococcus aureus: not simply meticillin-resistant S. aureus revisited.
The Journal of Hospital Infection 2013, 84, 13-21.
Goulenok T, Ferroni A, Bille E, Lécuyer H, Join-Lambert O, Descamps P, Nassif X, Zahar JR
Risk factors for developing ESBL E. coli: can clinicians predict infection in patients with prior colonization?.
The Journal of Hospital Infection 2013, 84, 294-299.
Denneman L, Vial-Dupuy A, Gault N, Wolff M, van de Beek D, Mourvillier B
Repeated lumbar puncture in adults with pneumococcal meningitis: an observational study.
The Journal of Infection 2013, 67, 350-353.
Chakvetadze C, Bani-Sadr F, Lescure FX, Fontaine C, Le Pendeven C, Bonnard P, Mariot P, Soussan P, Pialoux G
Liver stiffness values in HIV-infected patients with isolated anti-hepatitis B core antibodies.
Medecine Et Maladies Infectieuses 2013, 43, 222-225.
French Society for Hospital Hygiene (SF2H), Lucet JC, Parneix P, Grandbastien B, Berthelot P
Should public reporting be made for performance indicators on healthcare-associated infections?.
Medecine Et Maladies Infectieuses 2013, 43, 108-113.
Stahl JP, Salmon D, Bruneel F, Caumes E, Freymuth F, Bru JP, Morand P, Roblot F, Schmit JL, Strady C, Timsit JF, Rabaud C, Investigators
Adult patients hospitalized for measles in France, in the 21st century.
Medecine Et Maladies Infectieuses 2013, 43, 410-416.
Novy E, Sonneville R, Mazighi M, Klein IF, Mariotte E, Mourvillier B, Bouadma L, Wolff M
Neurological complications of infective endocarditis: new breakthroughs in diagnosis and management.
Medecine Et Maladies Infectieuses 2013, 43, 443-450.
Vaznaisiene D, Beltrand E, Laiskonis AP, Yazdanpanah Y, Migaud H, Senneville E
Major amputation of lower extremity: prognostic value of positive bone biopsy cultures.
Orthopaedics & traumatology, surgery & research: OTSR 2013, 99, 88-93.
Frank T, Gody JC, Nguyen LBL, Berthet N, Le Fleche-Mateos A, Bata P, Rafaï C, Kazanji M, Breurec S
First case of Elizabethkingia anophelis meningitis in the Central African Republic.
Lancet (London, England) 2013, 381, 1876.
Eron JJ, Cooper DA, Steigbigel RT, Clotet B, Gatell JM, Kumar PN, Rockstroh JK, Schechter M, Markowitz M, Yeni P, Loutfy MR, Lazzarin A, Lennox JL, Strohmaier KM, Wan H, Barnard RJO, Nguyen BYT, Teppler H, BENCHMRK Study Teams
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.
The Lancet. Infectious Diseases 2013, 13, 587-596.
Andremont A, Lucet JC
Extensively resistant VIM-2-positive Pseudomonas aeruginosa.
The Lancet. Infectious Diseases 2013, 13, 828-829.
Kebe K, Thiam M, Diagne Gueye NR, Diop H, Dia A, Signate Sy H, Charpentier C, Belec L, Mboup S, Toure Kane C
High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines.
AIDS research and human retroviruses 2013, 29, 242-249.
Jin J, Limburg S, Joshi SK, Landman R, Park M, Zhang Q, Kim HT, Kuo AC
Peripheral nerve repair in rats using composite hydrogel-filled aligned nanofiber conduits with incorporated nerve growth factor.
Tissue Engineering. Part A 2013, 19, 2138-2146.
Chaix ML, Seng R, Frange P, Tran L, Avettand-Fenoël V, Ghosn J, Reynes J, Yazdanpanah Y, Raffi F, Goujard C, Rouzioux C, Meyer L, ANRS PRIMO Cohort Study Group
Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 56, 880-887.
Charpentier C, Camacho R, Ruelle J, Kaiser R, Eberle J, Gürtler L, Pironti A, Stürmer M, Brun-Vézinet F, Descamps D, Obermeier M
HIV-2EU: supporting standardized HIV-2 drug resistance interpretation in Europe.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 56, 1654-1658.
Lescure FX, Moulignier A, Savatovsky J, Amiel C, Carcelain G, Molina JM, Gallien S, Pacanovski J, Pialoux G, Adle-Biassette H, Gray F
CD8 encephalitis in HIV-infected patients receiving cART: a treatable entity.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 57, 101-108.
Briand N, Warszawski J, Mandelbrot L, Dollfus C, Pannier E, Cravello L, Nguyen R, Matheron I, Winer N, Tubiana R, Rouzioux C, Faye A, Blanche S, ANRS-EPF CO1-CO11 Study Group
Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 57, 903-914.
Tubiana R, Mandelbrot L, Le Chenadec J, Delmas S, Rouzioux C, Hirt D, Treluyer JM, Ekoukou D, Bui E, Chaix ML, Blanche S, Warszawski J, ANRS 135 PRIMEVA (Protease Inhibitor Monotherapy Evaluation) Study Group
Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 57, 891-902.
Mocroft A, Furrer HJ, Miro JM, Reiss P, Mussini C, Kirk O, Abgrall S, Ayayi S, Bartmeyer B, Braun D, Castagna A, d'Arminio Monforte A, Gazzard B, Gutierrez F, Hurtado I, Jansen K, Meyer L, Muñoz P, Obel N, Soler-Palacin P, Papadopoulos A, Raffi F, Ramos JT, Rockstroh JK, Salmon D, Torti C, Warszawski J, de Wit S, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Lundgren JD, Opportunistic Infections Working Group on behalf of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCOORD
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 57, 1038-1047.
Birgand G, Radu C, Alkhoder S, Al Attar N, Raffoul R, Dilly MP, Nataf P, Lucet JC
Does a gentamicin-impregnated collagen sponge reduce sternal wound infections in high-risk cardiac surgery patients?.
Interactive Cardiovascular and Thoracic Surgery 2013, 16, 134-141.
Pursuing Later Treatment Option II (PLATO II) Project Team of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE), Costagliola D, Ledergerber B, Torti C, van Sighem A, Podzamczer D, Mocroft A, Dorrucci M, Masquelier B, de Luca A, Jansen K, De Wit S, Obel N, Fätkenheuer G, Touloumi G, Mussini C, Castagna A, Stephan C, García F, Zangerle R, Duval X, Perez-Hoyos S, Meyer L, Ghosn J, Fabre-Colin C, Kjaer J, Chêne G, Grarup J, Phillips A, Lodwick R, Torti C, Dorrucci M, Günthard HF, Michalik C, Chrysos G, Castagna A
Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes.
The Journal of Infectious Diseases 2013, 207, 759-767.
Tang MW, Rhee SY, Bertagnolio S, Ford N, Holmes S, Sigaloff KC, Hamers RL, de Wit TFR, Fleury HJ, Kanki PJ, Ruxrungtham K, Hawkins CA, Wallis CL, Stevens W, van Zyl GU, Manosuthi W, Hosseinipour MC, Ngo-Giang-Huong N, Belec L, Peeters M, Aghokeng A, Bunupuradah T, Burda S, Cane P, Cappelli G, Charpentier C, Dagnra AY, Deshpande AK, El-Katib Z, Eshleman SH, Fokam J, Gody JC, Katzenstein D, Koyalta DD, Kumwenda JJ, Lallemant M, Lynen L, Marconi VC, Margot NA, Moussa S, Ndung'u T, Nyambi PN, Orrell C, Schapiro JM, Schuurman R, Sirivichayakul S, Smith D, Zolfo M, Jordan MR, Shafer RW
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.
The Journal of Infectious Diseases 2013, 207 Suppl 2, S70-77.
Lê MP, Stitou H, Soulie C, Katlama C, Peytavin G
Sialolithiasis in an HIV-1-infected patient treated with atazanavir/ritonavir monotherapy.
The Journal of Antimicrobial Chemotherapy 2013, 68, 727-729.
Charpentier C, Joly V, Larrouy L, Fagard C, Visseaux B, de Verdière NC, Raffi F, Yeni P, Descamps D, ANRS 130 APOLLO Trial Study Group
Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial.
The Journal of Antimicrobial Chemotherapy 2013, 68, 690-696.
Reigadas S, Marcelin AG, Houssaïni A, Yerly S, Descamps D, Plantier JC, Ruffault A, Amiel C, Trabaud MA, Flandre P, Fleury H, Masquelier B, ANRS AC11 Resistance Study Group
HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes.
The Journal of Antimicrobial Chemotherapy 2013, 68, 969-972.
Lê MP, Gervais A, Le Beller C, Long K, Larrouy L, Papy E, Mal H, Descamps D, Peytavin G
Serious neuropsychiatric adverse effects in a hepatitis C virus/hepatitis B virus/HIV-coinfected patient receiving bosentan and telaprevir.
The Journal of Antimicrobial Chemotherapy 2013, 68, 1208-1209.
Lambert-Niclot S, Charpentier C, Storto A, Fofana DB, Soulié C, Fourati S, Visseaux B, Wirden M, Morand-Joubert L, Masquelier B, Flandre P, Calvez V, Descamps D, Marcelin AG
Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses.
The Journal of Antimicrobial Chemotherapy 2013, 68, 1237-1242.
Assoumou L, Descamps D, Yerly S, Dos Santos G, Marcelin AG, Delaugerre C, Morand-Joubert L, Ruffault A, Izopet J, Plantier JC, Pakianather S, Montes B, Chaix ML, Wirden M, Costagliola D, Masquelier B, ANRS AC11 Resistance Group
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study.
The Journal of Antimicrobial Chemotherapy 2013, 68, 1400-1405.
Charpentier C, Lambert-Niclot S, Visseaux B, Morand-Joubert L, Storto A, Larrouy L, Landman R, Calvez V, Marcelin AG, Descamps D
Evolution of the K65R, K103N and M184V/I reverse transcriptase mutations in HIV-1-infected patients experiencing virological failure between 2005 and 2010.
The Journal of Antimicrobial Chemotherapy 2013, 68, 2197-2198.
Fourati S, Visseaux B, Armenia D, Morand-Joubert L, Artese A, Charpentier C, Van Den Eede P, Costa G, Alcaro S, Wirden M, Perno CF, Ceccherini Silberstein F, Descamps D, Calvez V, Marcelin AG
Identification of a rare mutation at reverse transcriptase Lys65 (K65E) in HIV-1-infected patients failing on nucleos(t)ide reverse transcriptase inhibitors.
The Journal of Antimicrobial Chemotherapy 2013, 68, 2199-2204.
Descamps D, Assoumou L, Chaix ML, Chaillon A, Pakianather S, de Rougemont A, Storto A, Dos Santos G, Krivine A, Delaugerre C, Montes B, Izopet J, Charpentier C, Wirden M, Maillard A, Morand-Joubert L, Pallier C, Plantier JC, Guinard J, Tamalet C, Cottalorda J, Marcelin AG, Desbois D, Henquell C, Calvez V, Brun-Vézinet F, Masquelier B, Costagliola D, ANRS AC11 Resistance Study Group
National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.
The Journal of Antimicrobial Chemotherapy 2013, 68, 2626-2631.
Todesco E, Sayon S, Fourati S, Tubiana R, Simon A, Ktorza N, Schneider L, Peytavin G, Malet I, Van den Eede P, Katlama C, Calvez V, Marcelin AG, Wirden M
Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies.
The Journal of Antimicrobial Chemotherapy 2013, 68, 2882-2889.
Antonini TM, Furlan V, Teicher E, Haim-Boukobza S, Sebagh M, Coilly A, Bonhomme-Faivre L, Peytavin G, Roque-Afonso AM, Vittecoq D, Samuel D, Taburet AM, Duclos-Vallée JC
Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graft.
AIDS (London, England) 2013, 27, 2655-2657.
Timsit JF, Laupland KB
Is the burden of severe sepsis and septic shock changing?.
Critical Care Medicine 2013, 41, 1361-1363.
Schwebel C, Clec'h C, Magne S, Minet C, Garrouste-Orgeas M, Bonadona A, Dumenil AS, Jamali S, Kallel H, Goldgran-Toledano D, Marcotte G, Azoulay E, Darmon M, Ruckly S, Souweine B, Timsit JF
Safety of Intrahospital Transport in Ventilated Critically Ill Patients: A Multicenter Cohort Study.
Critical Care Medicine 2013, 41, 1919-1928.
Barbier F, Andremont A, Wolff M, Bouadma L
Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management.
Current Opinion in Pulmonary Medicine 2013, 19, 216-228.
Charpentier C, Bertine M, Visseaux B, Leleu J, Larrouy L, Peytavin G, Mourez T, Collin G, Brun-Vézinet F, Plantier JC, Descamps D
In-vitro phenotypic susceptibility of HIV-1 'non-B' integrase inhibitors naive clinical isolates to dolutegravir and raltegravir.
AIDS (London, England) 2013, 27, 2959-2961.
Zetterberg E, Neuhaus J, Baker JV, Somboonwit C, Llibre JM, Palfreeman A, Chini M, Lundgren JD, INSIGHT SMART Study Group
Platelet count kinetics following interruption of antiretroviral treatment.
AIDS (London, England) 2013, 27, 59-68.
Larrouy L, Vivot A, Charpentier C, Bénard A, Visseaux B, Damond F, Matheron S, Chene G, Brun-Vezinet F, Descamps D, ANRS CO5 HIV-2 Cohort
Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients.
AIDS (London, England) 2013, 27, 69-80.
Visseaux B, Charpentier C, Taieb A, Damond F, Bénard A, Larrouy L, Chêne G, Brun-Vézinet F, Matheron S, Descamps D, ANRS CO5 HIV-2 Cohort
Concordance between HIV-2 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA.
AIDS (London, England) 2013, 27, 292-295.
Bunupuradah T, Duong T, Compagnucci A, McMaster P, Bernardi S, Kanjanavanit S, Rampon O, Faye A, Saïdi Y, Riault Y, De Rossi A, Klein N, Ananworanich J, Gibb D, PENTA 11 Extension Study Group
Outcomes after reinitiating antiretroviral therapy in children randomized to planned treatment interruptions.
AIDS (London, England) 2013, 27, 579-589.
Lacombe JM, Boue F, Grabar S, Viget N, Gazaignes S, Lascaux-Cametz AS, Pacanowski J, Partisani M, Launay O, Matheron S, Rosenthal E, Rouveix E, Tattevin P, de Truchis P, Costagliola D, Goedert JJ
Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy.
AIDS (London, England) 2013, 27, 635-643.
Stellbrink HJ, Reynes J, Lazzarin A, Voronin E, Pulido F, Felizarta F, Almond S, St Clair M, Flack N, Min S, SPRING-1 Team
Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study.
AIDS (London, England) 2013, 27, 1771-1778.
Charpentier C, Visseaux B, Bénard A, Peytavin G, Damond F, Roy C, Taieb A, Chêne G, Matheron S, Brun-Vézinet F, Descamps D, ANRS CO5 HIV-2 Cohort
Transmitted drug resistance in French HIV-2-infected patients.
AIDS 2013, 27, 1671–1674.
Leoz M, Feyertag F, Charpentier C, Delaugerre C, Wirden M, Lemee V, Plantier JC
Characterization of CRF56_cpx, a new circulating B/CRF02/G recombinant form identified in MSM in France.
AIDS (London, England) 2013, 27, 2309-2312.
Cuzin L, Allavena C, Pugliese P, Rey D, Hoen B, Poizot-Martin I, Cabie A, Yazdanpanah Y, DATʼAIDS Study Group
Can the "seek, test, treat, and retain" strategy be effective in France?.
Journal of Acquired Immune Deficiency Syndromes (1999) 2013, 62, e119-121.
Descours B, Lambert-Niclot S, Mory B, Samri A, Charlotte F, Peytavin G, Tubiana R, Papagno L, Bacchus C, Lecardonnel F, Katlama C, Autran B, Marcelin AG, Valantin MA, Carcelain G, DECAMUNE and ORVACS Study Groups
Direct quantification of cell-associated HIV DNA in isolated rectal and blood memory CD4 T cells revealed their similar and low infection levels in long-term treated HIV-infected patients.
Journal of Acquired Immune Deficiency Syndromes (1999) 2013, 62, 255-259.
Rockstroh JK, DeJesus E, Lennox JL, Yazdanpanah Y, Saag MS, Wan H, Rodgers AJ, Walker ML, Miller M, DiNubile MJ, Nguyen BY, Teppler H, Leavitt R, Sklar P, STARTMRK Investigators
Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK.
Journal of acquired immune deficiency syndromes (1999) 2013, 63, 77-85.
Semaille C, Barin F, Bouyssou A, Peytavin G, Guinard J, Le Vu S, Pillonel J, Spire B, Velter A
High viral loads among HIV-positive MSM attending gay venues: implications for HIV transmission.
Journal of Acquired Immune Deficiency Syndromes (1999) 2013, 63, e122-124.
Cotte L, Dellamonica P, Raffi F, Yazdanpanah Y, Molina JM, Boué F, Urata Y, Chan HP, Zhu L, Chang I, Bertz R, Hanna GJ, Grasela DM, Hwang C
Randomized placebo-controlled study of the safety, tolerability, antiviral activity, and pharmacokinetics of 10-day monotherapy with BMS-986001, a novel HIV NRTI, in treatment-experienced HIV-1-infected subjects.
Journal of Acquired Immune Deficiency Syndromes (1999) 2013, 63, 346-354.
de Montmollin E, Tandjaoui-Lambiotte Y, Legrand M, Lambert J, Mokart D, Kouatchet A, Lemiale V, Pène F, Bruneel F, Vincent F, Mayaux J, Chevret S, Azoulay E
Outcomes in critically ill cancer patients with septic shock of pulmonary origin.
Shock (Augusta, Ga.) 2013, 39, 250-254.
Gray F, Lescure FX, Adle-Biassette H, Polivka M, Gallien S, Pialoux G, Moulignier A
Encephalitis with infiltration by CD8+ lymphocytes in HIV patients receiving combination antiretroviral treatment.
Brain Pathology (Zurich, Switzerland) 2013, 23, 525-533.
Murat JB, Lebeau B, Chumpitazi B, Cornet M, Maubon D, Faure O, Quesada JL, Thiebaut-Bertrand A, Timsit JF, Pelloux H
Minimum inhibitory concentrations of amphotericin B against Candida krusei isolates from a French teaching hospital laboratory: a retrospective study over 8 years.
Mycoses 2013, 56, 56-60.
Nguyen HL, Charpentier C, Nguyen N, de Truchis P, Molina JM, Ruxrungtham K, Delaugerre C
Longitudinal analysis of integrase N155H variants in heavily treated patients failing raltegravir-based regimens.
HIV medicine 2013, 14, 85-91.
Baroux N, Rouchon B, Huon B, Germain A, Meunier JM, D'Ortenzio E
High prevalence of rheumatic heart disease in schoolchildren detected by echocardiography screening in New Caledonia.
Journal of Paediatrics and Child Health 2013, 49, 109-114.
Hatzakis A, Van Damme P, Alcorn K, Gore C, Benazzouz M, Berkane S, Buti M, Carballo M, Cortes Martins H, Deuffic-Burban S, Dominguez A, Donoghoe M, Elzouki AN, Ben-Alaya Bouafif N, Esmat G, Esteban R, Fabri M, Fenton K, Goldberg D, Goulis I, Hadjichristodoulou C, Hadjichristodoulou T, Hatzigeorgiou T, Hamouda O, Hasurdjiev S, Hughes S, Kautz A, Malik M, Manolakopoulos S, Matičič M, Papatheodoridis G, Peck R, Peterle A, Potamitis G, Prati D, Roudot-Thoraval F, Reic T, Sharara A, Shennak M, Shiha G, Shouval D, Sočan M, Thomas H, Thursz M, Tosti M, Trépo C, Vince A, Vounou E, Wiessing L, Manns M
The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference.
Journal of Viral Hepatitis 2013, 20 Suppl 2, 1-20.
Bertrand D, Pallet N, Sartorius A, Zahar JR, Soussan RS, Lortholary O, Legendre C, Mamzer MF
Clinical and microbial impact of screening kidney allograft preservative solution for bacterial contamination with high-sensitivity methods.
Transplant International: Official Journal of the European Society for Organ Transplantation 2013, 26, 795-799.
Rousseaux S, Debernardi A, Jacquiau B, Vitte AL, Vesin A, Nagy-Mignotte H, Moro-Sibilot D, Brichon PY, Lantuejoul S, Hainaut P, Laffaire J, de Reyniès A, Beer DG, Timsit JF, Brambilla C, Brambilla E, Khochbin S
Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers.
Science Translational Medicine 2013, 5, 186ra66.
Barau C, Furlan V, Yazdanpanah Y, Fagard C, Molina JM, Taburet AM, Barrail-Tran A
Characterization of binding of raltegravir to plasma proteins.
Antimicrobial Agents and Chemotherapy 2013, 57, 5147-5150.
Kardas-Sloma L, Boëlle PY, Opatowski L, Guillemot D, Temime L
Antibiotic reduction campaigns do not necessarily decrease bacterial resistance: the example of methicillin-resistant Staphylococcus aureus.
Antimicrobial Agents and Chemotherapy 2013, 57, 4410-4416.
Clavel-Osorio C, Cazassus F, Stegmann S, Huc-Anaïs P, Lecam D, Peytavin G
One-month transplacental pharmacokinetics of raltegravir in a premature newborn after short-course treatment of the HIV-1-infected mother.
Antimicrobial Agents and Chemotherapy 2013, 57, 6393-6394.
Joly V, Fagard C, Grondin C, Descamps D, Yazdanpanah Y, Charpentier C, Colin de Verdiere N, Tabuteau S, Raffi F, Cabie A, Chene G, Yeni P, S 130 Apollo Trial Group
Intensification of antiretroviral therapy through addition of enfuvirtide in naive HIV-1-infected patients with severe immunosuppression does not improve immunological response: results of a randomized multicenter trial (ANRS 130 Apollo).
Antimicrobial Agents and Chemotherapy 2013, 57, 758-765.
Vinot C, Gavard L, Tréluyer JM, Manceau S, Courbon E, Scherrmann JM, Declèves X, Duro D, Peytavin G, Mandelbrot L, Giraud C
Placental transfer of maraviroc in an ex vivo human cotyledon perfusion model and influence of ABC transporter expression.
Antimicrobial Agents and Chemotherapy 2013, 57, 1415-1420.
Armand-Lefevre L, Angebault C, Barbier F, Hamelet E, Defrance G, Ruppe E, Bronchard R, Lepeule R, Lucet JC, El Mniai A, Wolff M, Montravers P, Plesiat P, Andremont A
Emergence of Imipenem-Resistant Gram-Negative Bacilli in Intestinal Flora of Intensive Care Patients.
Antimicrobial Agents and Chemotherapy 2013, 57, 1488-1495.
Recordon-Pinson P, Raymond S, Bellecave P, Marcelin AG, Soulie C, Descamps D, Calvez V, Harrigan PR, Fleury H, Izopet J, Masquelier B, S AC11 Resistance Study Group
HIV-1 dynamics and coreceptor usage in Maraviroc-treated patients with ongoing replication.
Antimicrobial Agents and Chemotherapy 2013, 57, 930-935.
Parienti JJ, Barrail-Tran A, Duval X, Nembot G, Descamps D, Vigan M, Vrijens B, Panhard X, Taburet AM, Mentre F, Goujard C
Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial.
Antimicrob Agents Chemother 2013, 57, 2265-71.
Champenois K, Cousien A, Ndiaye B, Soukouna Y, Baclet V, Alcaraz I, Choisy P, Chaud P, Velter A, Gallay A, Yazdanpanah Y
Risk factors for syphilis infection in men who have sex with men: results of a case-control study in Lille, France.
Sexually Transmitted Infections 2013, 89, 128-132.
Lorente N, Champenois K, Blanche J, Préau M, Suzan-Monti M, Mora M, Fugon L, Carrieri MP, Sagaon-Teyssier L, Le Gall JM, Spire B, Yazdanpanah Y
Investigating Recent Testing among MSM: Results from Community-Based HIV Rapid Testing Attendees in France.
Journal of Sexually Transmitted Diseases 2013, 2013, 648791.
Goulenok T, Klein I, Mazighi M, Messika-Zeitoun D, Alexandra JF, Mourvillier B, Laissy JP, Leport C, Iung B, Duval X, IMAGE study group
Infective endocarditis with symptomatic cerebral complications: contribution of cerebral magnetic resonance imaging.
Cerebrovascular Diseases (Basel, Switzerland) 2013, 35, 327-336.
Pham T, Combes A, Rozé H, Chevret S, Mercat A, Roch A, Mourvillier B, Ara-Somohano C, Bastien O, Zogheib E, Clavel M, Constan A, Marie Richard JC, Brun-Buisson C, Brochard L, REVA Research Network
Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: a cohort study and propensity-matched analysis.
American Journal of Respiratory and Critical Care Medicine 2013, 187, 276-285.
Planquette B, Timsit JF, Misset BY, Schwebel C, Azoulay E, Adrie C, Vesin A, Jamali S, Zahar JR, Allaouchiche B, Souweine B, Darmon M, Dumenil AS, Goldgran-Toledano D, Mourvillier BH, Bédos JP, OUTCOMEREA Study Group
Pseudomonas aeruginosa ventilator-associated pneumonia. predictive factors of treatment failure.
American Journal of Respiratory and Critical Care Medicine 2013, 188, 69-76.
Annane D, Timsit JF, Megarbane B, Martin C, Misset B, Mourvillier B, Siami S, Chagnon JL, Constantin JM, Petitpas F, Souweine B, Amathieu R, Forceville X, Charpentier C, Tesnière A, Chastre J, Bohe J, Colin G, Cariou A, Renault A, Brun-Buisson C, Bellissant E, APROCCHSS Trial Investigators
Recombinant human activated protein C for adults with septic shock: a randomized controlled trial.
American Journal of Respiratory and Critical Care Medicine 2013, 187, 1091-1097.
Timsit JF, Bouadma L, Mimoz O, Parienti JJ, Garrouste-Orgeas M, Alfandari S, Plantefeve G, Bronchard R, Troche G, Gauzit R, Antona M, Canet E, Bohe J, Herrault MC, Schwebel C, Ruckly S, Souweine B, Lucet JC
Jugular versus femoral short-term catheterization and risk of infection in intensive care unit patients. Causal analysis of two randomized trials.
American Journal of Respiratory and Critical Care Medicine 2013, 188, 1232-1239.
Domenech de Cellès M, Zahar JR, Abadie V, Guillemot D
Limits of patient isolation measures to control extended-spectrum beta-lactamase-producing Enterobacteriaceae: model-based analysis of clinical data in a pediatric ward.
BMC infectious diseases 2013, 13, 187.
Champenois K, Cousien A, Cuzin L, Le Vu S, Deuffic-Burban S, Lanoy E, Lacombe K, Patey O, Béchu P, Calvez M, Semaille C, Yazdanpanah Y
Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study.
BMC infectious diseases 2013, 13, 200.
Yang ZT, Zahar JR, Méchaï F, Postaire M, Blanot S, Balfagon-Viel S, Nassif X, Lortholary O
Current ciprofloxacin usage in children hospitalized in a referral hospital in Paris.
BMC infectious diseases 2013, 13, 245.
Gasse B, Baroux N, Rouchon B, Meunier JM, Frémicourt ID, D'Ortenzio E
Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study.
BMC public health 2013, 13, 131.
Gharbi M, Flegg JA, Hubert V, Kendjo E, Metcalf JE, Bertaux L, Guérin PJ, Le Bras J, Members of the French National Reference Centre for Imported Malaria Study, Aboubaca A, Agnamey P, Angoulvant A, Barbut P, Basset D, Belkadi G, Bellanger AP, Bemba D, Benoit-Vica F, Berry A, Bigel ML, Bonhomme J, Botterel F, Bouchaud O, Bougnoux ME, Bourée P, Bourgeois N, Branger C, Bret L, Buret B, Casalino E, Chevrier S, Conquere de Monbrison F, Cuisenier B, Danis M, Darde ML, De Gentile L, Delarbre JM, Delaunay P, Delaval A, Desoubeaux G, Develoux M, Dunand J, Durand R, Eloy O, Fauchet N, Faugere B, Faye A, Fenneteau O, Flori P, Fontrouge M, Garabedian C, Gayandrieu F, Godineau N, Houzé P, Houzé S, Hurst JP, Ichou H, Lachaud L, Lebuisson A, Lefevre M, LeGuern AS, Le Moal G, Lusina D, Machouart MC, Malvy D, Matheron S, Maubon D, Mechali D, Megarbane B, Menard G, Millon L, Aiach MM, Minodier P, Morelle C, Nevez G, Parola P, Parzy D, Patey O, Patoz P, Penn P, Perignon A, Picot S, Pilo JE, Poilane I, Pons D, Poupart M, Pradines B, Raffenot D, Rapp C, Receveur MC, Sarfati C, Senghor Y, Simon F, Siriez JY, Taudon N, Thellier M, Thouvenin M, Toubas D
Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011.
Malar. J. 2013, 12, 35.
Cordel H, Cailhol J, Matheron S, Bloch M, Godineau N, Consigny PH, Gros H, Campa P, Bourée P, Fain O, Ralaimazava P, Bouchaud O
Atovaquone-proguanil in the treatment of imported uncomplicated Plasmodium falciparum malaria: a prospective observational study of 553 cases.
Malaria Journal 2013, 12,
Gaillard T, Briolant S, Houzé S, Baragatti M, Wurtz N, Hubert V, Lavina M, Pascual A, Travaillé C, Le Bras J, Pradines B, French National Reference Centre for Imported Malaria Study Group
PftetQ and pfmdt copy numbers as predictive molecular markers of decreased ex vivo doxycycline susceptibility in imported Plasmodium falciparum malaria.
Malar. J. 2013, 12, 414.
Goudet V, Timsit JF, Lucet JC, Lepape A, Balayn D, Seguin S, Mimoz O
Comparison of four skin preparation strategies to prevent catheter-related infection in intensive care unit (CLEAN trial): a study protocol for a randomized controlled trial.
Trials 2013, 14, 114.
Timsit JF, Azoulay E, Cornet M, Gangneux JP, Jullien V, Vésin A, Schir E, Wolff M
EMPIRICUS micafungin versus placebo during nosocomial sepsis in Candida multi-colonized ICU patients with multiple organ failures: study protocol for a randomized controlled trial.
Trials 2013, 14, 399.
Birgand G, Ruimy R, Schwarzinger M, Lolom I, Bendjelloul G, Houhou N, Armand-Lefevre L, Andremont A, Yazdanpanah Y, Lucet JC
Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs.
Antimicrobial Resistance and Infection Control 2013, 2, 30.
Darmon M, Diconne E, Souweine B, Ruckly S, Adrie C, Azoulay E, Clec'h C, Garrouste-Orgeas M, Schwebel C, Goldgran-Toledano D, Khallel H, Dumenil AS, Jamali S, Cheval C, Allaouchiche B, Zeni F, Timsit JF
Prognostic consequences of borderline dysnatremia: pay attention to minimal serum sodium change.
Critical Care (London, England) 2013, 17, R12.
Perier A, Revah-Levy A, Bruel C, Cousin N, Angeli S, Brochon S, Philippart F, Max A, Gregoire C, Misset B, Garrouste-Orgeas M
Phenomenologic analysis of healthcare worker perceptions of intensive care unit diaries.
Critical Care (London, England) 2013, 17, R13.
Toffart AC, Timsit JF
Is prolonged mechanical ventilation of cancer patients futile?.
Critical Care (London, England) 2013, 17, 189.
Adrie C, Schwebel C, Garrouste-Orgeas M, Vignoud L, Planquette B, Azoulay E, Kallel H, Darmon M, Souweine B, Dinh-Xuan AT, Jamali S, Zahar JR, Timsit JF, Article Was Written on behalf of the Outcomerea Study Group
Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: impact on survival and bacterial resistance.
Critical Care (London, England) 2013, 17, R265.
Niven DJ, Laupland KB, Tabah A, Vesin A, Rello J, Koulenti D, Dimopoulos G, de Waele J, Timsit JF, EUROBACT Investigators
Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey.
Critical Care (London, England) 2013, 17, R289.
Abgrall S, Le Bel J, Lele N, Laouénan C, Eychenne N, Mentré F, Peytavin G, Bouchaud O, Vihvo Study Group
Lack of effect of doxycycline on trough concentrations of protease inhibitors or non-nucleoside reverse transcriptase inhibitors in HIV-infected patients.
HIV clinical trials 2013, 14, 313-318.
Auvert B, Taljaard D, Rech D, Lissouba P, Singh B, Bouscaillou J, Peytavin G, Mahiane SG, Sitta R, Puren A, Lewis D
Association of the ANRS-12126 male circumcision project with HIV levels among men in a South African township: evaluation of effectiveness using cross-sectional surveys.
PLoS medicine 2013, 10, e1001509.
Mocroft A, Lundgren JD, Sabin ML, Monforte Ad, Brockmeyer N, Casabona J, Castagna A, Costagliola D, Dabis F, De Wit S, Fätkenheuer G, Furrer H, Johnson AM, Lazanas MK, Leport C, Moreno S, Obel N, Post FA, Reekie J, Reiss P, Sabin C, Skaletz-Rorowski A, Suarez-Lozano I, Torti C, Warszawski J, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Kirk O, Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord
Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE).
PLoS medicine 2013, 10, e1001510.
Goarant C, Bourhy P, D'Ortenzio E, Dartevelle S, Mauron C, Soupé-Gilbert ME, Bruyère-Ostells L, Gourinat AC, Picardeau M, Nato F, Chanteau S
Sensitivity and Specificity of a New Vertical Flow Rapid Diagnostic Test for the Serodiagnosis of Human Leptospirosis.
PLoS neglected tropical diseases 2013, 7, e2289.
Cordel H, Prendki V, Madec Y, Houze S, Paris L, Bourée P, Caumes E, Matheron S, Bouchaud O, ALA Study Group
Imported amoebic liver abscess in France.
PLoS neglected tropical diseases 2013
Guerrier G, Hie P, Gourinat AC, Huguon E, Polfrit Y, Goarant C, D'Ortenzio E, Missotte I
Association between age and severity to leptospirosis in children.
PLoS neglected tropical diseases 2013, 7, e2436.
Charpentier C, Fagard C, Colin C, Katlama C, Molina JM, Jacomet C, Visseaux B, Taburet AM, Brun-Vézinet F, Chêne G, Yazdanpanah Y, Descamps D, ANRS139 TRIO Trial study group
Role of baseline HIV-1 DNA level in highly-experienced patients receiving raltegravir, etravirine and darunavir/ritonavir regimen (ANRS139 TRIO trial).
PloS One 2013, 8, e53621.
Charpentier C, Lambert-Niclot S, Alteri C, Storto A, Flandre P, Svicher V, Perno CF, Brun-Vézinet F, Calvez V, Marcelin AG, Ceccherini-Silberstein F, Descamps D
Description of the L76V resistance protease mutation in HIV-1 B and "non-B" subtypes.
PloS One 2013
Bjerk SM, Baker JV, Emery S, Neuhaus J, Angus B, Gordin FM, Pett SL, Stephan C, Kunisaki KM, INSIGHT SMART Study Group
Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study.
PloS One 2013
Charpentier C, Champenois K, Gervais A, Landman R, Joly V, Le Gac S, Larrouy L, Damond F, Brun-Vézinet F, Descamps D, Yazdanpanah Y
Predictive value of liver enzymes and inflammatory biomarkers for the severity of liver fibrosis stage in HIV/HCV co-infected patients.
PloS One 2013, 8, e59205.
Guerrier G, D'Ortenzio E
The Jarisch-Herxheimer reaction in leptospirosis: a systematic review.
PloS One 2013, 8, e59266.
Lécuroux C, Girault I, Chéret A, Versmisse P, Nembot G, Meyer L, Rouzioux C, Pancino G, Venet A, Sáez-Cirión A, ANRS 147 OPTIPRIM clinical trial
CD8 T-cells from most HIV-infected patients lack ex vivo HIV-suppressive capacity during acute and early infection.
PloS One 2013
Lapidus N, de Lamballerie X, Salez N, Setbon M, Delabre RM, Ferrari P, Moyen N, Gougeon ML, Vely F, Leruez-Ville M, Andreoletti L, Cauchemez S, Boëlle PY, Vivier E, Abel L, Schwarzinger M, Legeas M, Le Cann P, Flahault A, Carrat F
Factors associated with post-seasonal serological titer and risk factors for infection with the pandemic A/H1N1 virus in the French general population.
PloS One 2013, 8, e60127.
Bacchus C, Cheret A, Avettand-Fenoël V, Nembot G, Mélard A, Blanc C, Lascoux-Combe C, Slama L, Allegre T, Allavena C, Yazdanpanah Y, Duvivier C, Katlama C, Goujard C, Seksik BCP, Leplatois A, Molina JM, Meyer L, Autran B, Rouzioux C, OPTIPRIM ANRS 147 study group
A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infection.
PloS One 2013, 8, e64219.
Schwarzinger M, Sagaon-Teyssier L, Cabaret O, Bretagne S, Cordonnier C, PREVERT Investigators
Performance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: a multi-state model.
PloS One 2013, 8, e65776.
Birgand G, Lepelletier D, Baron G, Barrett S, Breier AC, Buke C, Markovic-Denic L, Gastmeier P, Kluytmans J, Lyytikainen O, Sheridan E, Szilagyi E, Tacconelli E, Troillet N, Ravaud P, Lucet JC
Agreement among healthcare professionals in ten European countries in diagnosing case-vignettes of surgical-site infections.
PloS One 2013, 8, e68618.
Frange P, Meyer L, Jung M, Goujard C, Zucman D, Abel S, Hochedez P, Gousset M, Gascuel O, Rouzioux C, Chaix ML, ANRS PRIMO Cohort Study Group
Sexually-transmitted/founder HIV-1 cannot be directly predicted from plasma or PBMC-derived viral quasispecies in the transmitting partner.
PloS One 2013
Krastinova E, Seng R, Yeni P, Viard JP, Vittecoq D, Lascoux-Combe C, Fourn E, Pahlavan G, Delfraissy JF, Meyer L, ANRS PRIMO and COPANA Cohorts
Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts.
PLoS ONE 2013, 8, e71473.
Legeai C, Vigouroux C, Souberbielle JC, Bouchaud O, Boufassa F, Bastard JP, Carlier R, Capeau J, Goujard C, Meyer L, Viard JP, ANRS-COPANA Cohort Study Group
Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study.
PLoS ONE 2013, 8, e74868.
Houzé S, Boutron I, Marmorat A, Dalichampt M, Choquet C, Poilane I, Godineau N, Le Guern AS, Thellier M, Broutier H, Fenneteau O, Millet P, Dulucq S, Hubert V, Houzé P, Tubach F, Le Bras J, Matheron S
Performance of rapid diagnostic tests for imported malaria in clinical practice: results of a national multicenter study.
PloS One 2013
Klein N, Sefe D, Mosconi I, Zanchetta M, Castro H, Jacobsen M, Jones H, Bernardi S, Pillay D, Giaquinto C, Walker AS, Gibb DM, De Rossi A, Paediatric European Network for Treatment of AIDS 11 Trial Team
The immunological and virological consequences of planned treatment interruptions in children with HIV infection.
PloS One 2013
Yazdanpanah Y, Perelman J, DiLorenzo MA, Alves J, Barros H, Mateus C, Pereira J, Mansinho K, Robine M, Park JE, Ross EL, Losina E, Walensky RP, Noubary F, Freedberg KA, Paltiel AD
Routine HIV screening in Portugal: clinical impact and cost-effectiveness.
PloS One 2013, 8, e84173.
Chougrani I, Luton D, Matheron S, Mandelbrot L, Azria E
Safety of protease inhibitors in HIV-infected pregnant women.
HIV/AIDS (Auckland, N.Z.) 2013, 5, 253-262.
Zaidan M, Lescure FX, Brochériou I, Dettwiler S, Guiard-Schmid JB, Pacanowski J, Rondeau E, Pialoux G, Girard PM, Ronco P, Plaisier E
Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: a clinico-pathological study.
Clinical journal of the American Society of Nephrology: CJASN 2013, 8, 930-938.
Dervaux B, Baseilhac E, Fagon JY, participants of round table N°6 of Giens Workshops XXVIII (th), Ameye V, Angot P, Audry A, Becquemont L, Borel T, Cazeneuve B, Courtois J, Detournay B, Favre P, Granger M, Josseran A, Lassale C, Louvet O, Pinson J, de Pouvourville G, Rochaix L, Rumeau-Pichon C, de Saab R, Schwarzinger M, Sun A
Medico-economic evaluation of health products in the context of the Social Security Financing Act for 2012.
Therapie 2013, 68, 253-263.
Zucman D, De Truchis P, Peytavin G, Descamps D, Duvivier C, Tegna L, Weiss L, Delassus JL, Benalycherif A, Landman R
Efficacy, safety, and pharmacokinetics of once-daily boosted darunavir in pretreated HIV-infected patients.
Scandinavian Journal of Infectious Diseases 2013, 45, 407-410.
Schnell D, Lécuyer H, Geeraerts T, Dumenil AS, Bille E, Mercier FJ, Benhamou D, Zahar JR
Preliminary evaluation of a new clinical algorithm to interpret blood cultures growing coagulase-negative staphylococci.
Scandinavian Journal of Infectious Diseases 2013, 45, 562-566.
Nguyen LBL, Epelboin L, Gabarre J, Lecso M, Guillot S, Bricaire F, Caumes E, Guiso N
Recurrent Bordetella holmesii bacteremia and nasal carriage in a patient receiving rituximab.
Emerging Infectious Diseases 2013, 19, 1703-1705.
Zahar JR, Timsit JF
Clostridium difficile outcomes difficult to generalize. Authors' response.
Critical Care (London, England) 2013, 17, 415.
Induced hypothermia in severe bacterial meningitis: a randomized clinical trial.
JAMA 2013, 310, 2174-2183.
Steff M, Joly V, Di Lucca J, Feldman J, Burg S, Sarda-Mantel L, Peytavin G, Marinho E, Crickx B, Raymond E, Lariven S, Maubec E
Clinical activity of lenalidomide in visceral human immunodeficiency virus-related Kaposi sarcoma.
JAMA dermatology 2013, 149, 1319-1322.
Demaret J, Walencik A, Jacob MC, Timsit JF, Venet F, Lepape A, Monneret G
Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples.
Cytometry. Part B, Clinical Cytometry 2013, 84, 59-62.
Schuetz P, Müller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bhatnagar N, Bucher HC, Briel M
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Evidence-Based Child Health: A Cochrane Review Journal 2013, 8, 1297-1371.
Ghosn J, Slama L, Chermak A, Houssaini A, Lambert-Niclot S, Schneider L, Fourn E, Duvivier C, Simon A, Courbon E, Murphy R, Flandre P, Peytavin G, Katlama C, RADAR Study Group
Switching to darunavir/ritonavir 800/100 mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1.
Journal of Medical Virology 2013, 85, 8-15.
Antonelli M, Bonten M, Cecconi M, Chastre J, Citerio G, Conti G, Curtis JR, Hedenstierna G, Joannidis M, Macrae D, Maggiore SM, Mancebo J, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2012: I. Neurology and neurointensive care, epidemiology and nephrology, biomarkers and inflammation, nutrition, experimentals.
Intensive Care Medicine 2013, 39, 232-246.
Antonelli M, Bonten M, Cecconi M, Chastre J, Citerio G, Conti G, Curtis JR, Hedenstierna G, Joannidis M, Macrae D, Maggiore SM, Mancebo J, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2012. II: Pneumonia and infection, sepsis, coagulation, hemodynamics, cardiovascular and microcirculation, critical care organization, imaging, ethics and legal issues.
Intensive Care Medicine 2013, 39, 345-364.
Antonelli M, Bonten M, Cecconi M, Chastre J, Citerio G, Conti G, Curtis JR, Hedenstierna G, Joannidis M, Macrae D, Maggiore SM, Mancebo J, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2012: III. Noninvasive ventilation, monitoring and patient-ventilator interactions, acute respiratory distress syndrome, sedation, paediatrics and miscellanea.
Intensive Care Medicine 2013, 39, 543-557.
Potton L, Bonadona A, Minet C, Timsit JF
Pink urine.
Intensive Care Medicine 2013, 39, 389-390.
Vesin A, Azoulay E, Ruckly S, Vignoud L, Rusinovà K, Benoit D, Soares M, Azeivedo-Maia P, Abroug F, Benbenishty J, Timsit JF
Reporting and handling missing values in clinical studies in intensive care units.
Intensive Care Medicine 2013, 39, 1396-1404.
Thiolliere F, Serre-Sapin AF, Reignier J, Benedit M, Constantin JM, Lebert C, Guélon D, Timsit JF, Souweine B
Epidemiology and outcome of thrombocytopenic patients in the intensive care unit: results of a prospective multicenter study.
Intensive Care Medicine 2013, 39, 1460-1468.
Philippart F, Vesin A, Bruel C, Kpodji A, Durand-Gasselin B, Garçon P, Levy-Soussan M, Jagot JL, Calvo-Verjat N, Timsit JF, Misset B, Garrouste-Orgeas M
The ETHICA study (part I): elderly's thoughts about intensive care unit admission for life-sustaining treatments.
Intensive Care Medicine 2013, 39, 1565-1573.
Garrouste-Orgeas M, Tabah A, Vesin A, Philippart F, Kpodji A, Bruel C, Grégoire C, Max A, Timsit JF, Misset B
The ETHICA study (part II): simulation study of determinants and variability of ICU physician decisions in patients aged 80 or over.
Intensive Care Medicine 2013, 39, 1574-1583.
Garrouste-Orgeas M, Valentin A
What's new for patient safety in the ICU?.
Intensive Care Medicine 2013, 39, 1829-1831.
Zahar JR, Garrouste-Orgeas M, Vesin A, Schwebel C, Bonadona A, Philippart F, Ara-Somohano C, Misset B, Timsit JF
Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events.
Intensive Care Medicine 2013, 39, 2153-2160.
Fagedet D, Thony F, Timsit JF, Rodiere M, Monnin-Bares V, Ferretti GR, Vesin A, Moro-Sibilot D
Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy.
Cardiovascular and Interventional Radiology 2013, 36, 140-149.
Harrison L, Ananworanich J, Hamadache D, Compagnucci A, Penazzato M, Bunupuradah T, Mazza A, Ramos JT, Flynn J, Rampon O, Mellado Pena MJ, Floret D, Marczynska M, Puga A, Forcat S, Riault Y, Lallemant M, Castro H, Gibb DM, Giaquinto C, Paediatric European Network for Treatment of AIDS (PENTA) 11 Trial Team
Adherence to antiretroviral therapy and acceptability of planned treatment interruptions in HIV-infected children.
AIDS and behavior 2013, 17, 193-202.
Moulignier A, Savatovsky J, Polivka M, Boutboul D, Depaz R, Lescure FX
CD8 T lymphocytes encephalitis mimicking brain tumor in HIV-1 infection.
Journal of Neurovirology 2013, 19, 606-609.
Prinapori R, Guinaud J, Khalil A, Lecuyer H, Gendrel D, Lortholary O, Nassif X, Viscoli C, Zahar JR
Risk associated with a systematic search of extended-spectrum β-lactamase-producing Enterobacteriaceae.
American Journal of Infection Control 2013, 41, 259-260.
Birgand G, Armand-Lefevre L, Lolom I, Ruppe E, Andremont A, Lucet JC
Duration of colonization by extended-spectrum β-lactamase-producing Enterobacteriaceae after hospital discharge.
American Journal of Infection Control 2013, 41, 443-447.
Rivard-Yazigi L, Zahar JR, Le Guillou S, Chalouhi C, Lecuyer H, Bureau C, Nassif X, Gendrel D, Abadie V
Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae carriage at admission in an infant cohort at a tertiary teaching hospital in France.
American Journal of Infection Control 2013, 41, 844-845.
Dallaudière B, Meyer P, Hummel V, Perozziello A, Peuchant A, Moreau-Durieux MH, Silvestre A, Pelé E, Wakim N, Loriaut P, Boyer P, Schouman-Claeys E, Serfaty JM, Pesquer L
Efficacy of second intra-tendinous platelet-rich-plasma injection in case of incomplete response of the first injection: three-year follow up experience.
Diagnostic and Interventional Imaging 2013, 94, 871-877.
Dallaudière B, Lempicki M, Pesquer L, Louedec L, Preux PM, Meyer P, Hess A, Durieux MHM, Hummel V, Larbi A, Deschamps L, Benayoun Y, Journe C, Perozziello A, Schouman-Claeys E, Michel JB, Serfaty JM
Acceleration of tendon healing using US guided intratendinous injection of bevacizumab: first pre-clinical study on a murine model.
European Journal of Radiology 2013, 82, e823-828.
Marcelin AG, Delaugerre C, Beaudoux C, Descamps D, Morand-Joubert L, Amiel C, Schneider V, Ferre V, Izopet J, Si-Mohamed A, Maillard A, Henquell C, Desbois D, Lazrek M, Signori-Schmuck A, Rogez S, Yerly S, Trabaud MA, Plantier JC, Fourati S, Houssaini A, Masquelier B, Calvez V, Flandre P, ANRS AC11 Resistance Group
A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure.
International Journal of Antimicrobial Agents 2013, 42, 42-47.
Chousterman BG, Bouadma L, Moutereau S, Loric S, Alvarez-Gonzalez A, Mekontso-Dessap A, Laissy JP, Rahmouni A, Katsahian S, Brochard L, Schortgen F
Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results.
Journal of Critical Care 2013, 28, 701-709.
Visseaux B, Larrouy L, Calin R, Katlama C, Poynard T, Ratziu V, Thibault V
Anti-hepatitis C virus antibody detection in oral fluid: influence of human immunodeficiency virus co-infection.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2013, 58, 385-390.
Delarue S, Didier E, Damond F, Ponscarme D, Brengle-Pesce K, Resche-Rigon M, Vray M, Gueudin M, Simon F
Highly sensitive plasma RNA quantification by real-time PCR in HIV-2 group A and group B infection.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2013, 58, 461-467.
Deuffic-Burban S, Yazdanpanah Y
Mathematical modeling: a tool for selecting agents with complementary modes of action?.
Journal of Hepatology 2013, 59, 1346-1348.
Lepelletier D, Lucet JC
Controlling meticillin-susceptible Staphylococcus aureus: not simply meticillin-resistant S. aureus revisited.
The Journal of Hospital Infection 2013, 84, 13-21.
Goulenok T, Ferroni A, Bille E, Lécuyer H, Join-Lambert O, Descamps P, Nassif X, Zahar JR
Risk factors for developing ESBL E. coli: can clinicians predict infection in patients with prior colonization?.
The Journal of Hospital Infection 2013, 84, 294-299.
Denneman L, Vial-Dupuy A, Gault N, Wolff M, van de Beek D, Mourvillier B
Repeated lumbar puncture in adults with pneumococcal meningitis: an observational study.
The Journal of Infection 2013, 67, 350-353.
Chakvetadze C, Bani-Sadr F, Lescure FX, Fontaine C, Le Pendeven C, Bonnard P, Mariot P, Soussan P, Pialoux G
Liver stiffness values in HIV-infected patients with isolated anti-hepatitis B core antibodies.
Medecine Et Maladies Infectieuses 2013, 43, 222-225.
French Society for Hospital Hygiene (SF2H), Lucet JC, Parneix P, Grandbastien B, Berthelot P
Should public reporting be made for performance indicators on healthcare-associated infections?.
Medecine Et Maladies Infectieuses 2013, 43, 108-113.
Stahl JP, Salmon D, Bruneel F, Caumes E, Freymuth F, Bru JP, Morand P, Roblot F, Schmit JL, Strady C, Timsit JF, Rabaud C, Investigators
Adult patients hospitalized for measles in France, in the 21st century.
Medecine Et Maladies Infectieuses 2013, 43, 410-416.
Novy E, Sonneville R, Mazighi M, Klein IF, Mariotte E, Mourvillier B, Bouadma L, Wolff M
Neurological complications of infective endocarditis: new breakthroughs in diagnosis and management.
Medecine Et Maladies Infectieuses 2013, 43, 443-450.
Vaznaisiene D, Beltrand E, Laiskonis AP, Yazdanpanah Y, Migaud H, Senneville E
Major amputation of lower extremity: prognostic value of positive bone biopsy cultures.
Orthopaedics & traumatology, surgery & research: OTSR 2013, 99, 88-93.
Frank T, Gody JC, Nguyen LBL, Berthet N, Le Fleche-Mateos A, Bata P, Rafaï C, Kazanji M, Breurec S
First case of Elizabethkingia anophelis meningitis in the Central African Republic.
Lancet (London, England) 2013, 381, 1876.
Eron JJ, Cooper DA, Steigbigel RT, Clotet B, Gatell JM, Kumar PN, Rockstroh JK, Schechter M, Markowitz M, Yeni P, Loutfy MR, Lazzarin A, Lennox JL, Strohmaier KM, Wan H, Barnard RJO, Nguyen BYT, Teppler H, BENCHMRK Study Teams
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.
The Lancet. Infectious Diseases 2013, 13, 587-596.
Andremont A, Lucet JC
Extensively resistant VIM-2-positive Pseudomonas aeruginosa.
The Lancet. Infectious Diseases 2013, 13, 828-829.
Kebe K, Thiam M, Diagne Gueye NR, Diop H, Dia A, Signate Sy H, Charpentier C, Belec L, Mboup S, Toure Kane C
High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines.
AIDS research and human retroviruses 2013, 29, 242-249.
Jin J, Limburg S, Joshi SK, Landman R, Park M, Zhang Q, Kim HT, Kuo AC
Peripheral nerve repair in rats using composite hydrogel-filled aligned nanofiber conduits with incorporated nerve growth factor.
Tissue Engineering. Part A 2013, 19, 2138-2146.
Chaix ML, Seng R, Frange P, Tran L, Avettand-Fenoël V, Ghosn J, Reynes J, Yazdanpanah Y, Raffi F, Goujard C, Rouzioux C, Meyer L, ANRS PRIMO Cohort Study Group
Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 56, 880-887.
Charpentier C, Camacho R, Ruelle J, Kaiser R, Eberle J, Gürtler L, Pironti A, Stürmer M, Brun-Vézinet F, Descamps D, Obermeier M
HIV-2EU: supporting standardized HIV-2 drug resistance interpretation in Europe.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 56, 1654-1658.
Lescure FX, Moulignier A, Savatovsky J, Amiel C, Carcelain G, Molina JM, Gallien S, Pacanovski J, Pialoux G, Adle-Biassette H, Gray F
CD8 encephalitis in HIV-infected patients receiving cART: a treatable entity.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 57, 101-108.
Briand N, Warszawski J, Mandelbrot L, Dollfus C, Pannier E, Cravello L, Nguyen R, Matheron I, Winer N, Tubiana R, Rouzioux C, Faye A, Blanche S, ANRS-EPF CO1-CO11 Study Group
Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 57, 903-914.
Tubiana R, Mandelbrot L, Le Chenadec J, Delmas S, Rouzioux C, Hirt D, Treluyer JM, Ekoukou D, Bui E, Chaix ML, Blanche S, Warszawski J, ANRS 135 PRIMEVA (Protease Inhibitor Monotherapy Evaluation) Study Group
Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 57, 891-902.
Mocroft A, Furrer HJ, Miro JM, Reiss P, Mussini C, Kirk O, Abgrall S, Ayayi S, Bartmeyer B, Braun D, Castagna A, d'Arminio Monforte A, Gazzard B, Gutierrez F, Hurtado I, Jansen K, Meyer L, Muñoz P, Obel N, Soler-Palacin P, Papadopoulos A, Raffi F, Ramos JT, Rockstroh JK, Salmon D, Torti C, Warszawski J, de Wit S, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Lundgren JD, Opportunistic Infections Working Group on behalf of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCOORD
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 57, 1038-1047.
Birgand G, Radu C, Alkhoder S, Al Attar N, Raffoul R, Dilly MP, Nataf P, Lucet JC
Does a gentamicin-impregnated collagen sponge reduce sternal wound infections in high-risk cardiac surgery patients?.
Interactive Cardiovascular and Thoracic Surgery 2013, 16, 134-141.
Pursuing Later Treatment Option II (PLATO II) Project Team of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE), Costagliola D, Ledergerber B, Torti C, van Sighem A, Podzamczer D, Mocroft A, Dorrucci M, Masquelier B, de Luca A, Jansen K, De Wit S, Obel N, Fätkenheuer G, Touloumi G, Mussini C, Castagna A, Stephan C, García F, Zangerle R, Duval X, Perez-Hoyos S, Meyer L, Ghosn J, Fabre-Colin C, Kjaer J, Chêne G, Grarup J, Phillips A, Lodwick R, Torti C, Dorrucci M, Günthard HF, Michalik C, Chrysos G, Castagna A
Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes.
The Journal of Infectious Diseases 2013, 207, 759-767.
Tang MW, Rhee SY, Bertagnolio S, Ford N, Holmes S, Sigaloff KC, Hamers RL, de Wit TFR, Fleury HJ, Kanki PJ, Ruxrungtham K, Hawkins CA, Wallis CL, Stevens W, van Zyl GU, Manosuthi W, Hosseinipour MC, Ngo-Giang-Huong N, Belec L, Peeters M, Aghokeng A, Bunupuradah T, Burda S, Cane P, Cappelli G, Charpentier C, Dagnra AY, Deshpande AK, El-Katib Z, Eshleman SH, Fokam J, Gody JC, Katzenstein D, Koyalta DD, Kumwenda JJ, Lallemant M, Lynen L, Marconi VC, Margot NA, Moussa S, Ndung'u T, Nyambi PN, Orrell C, Schapiro JM, Schuurman R, Sirivichayakul S, Smith D, Zolfo M, Jordan MR, Shafer RW
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.
The Journal of Infectious Diseases 2013, 207 Suppl 2, S70-77.
Lê MP, Stitou H, Soulie C, Katlama C, Peytavin G
Sialolithiasis in an HIV-1-infected patient treated with atazanavir/ritonavir monotherapy.
The Journal of Antimicrobial Chemotherapy 2013, 68, 727-729.
Charpentier C, Joly V, Larrouy L, Fagard C, Visseaux B, de Verdière NC, Raffi F, Yeni P, Descamps D, ANRS 130 APOLLO Trial Study Group
Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial.
The Journal of Antimicrobial Chemotherapy 2013, 68, 690-696.
Reigadas S, Marcelin AG, Houssaïni A, Yerly S, Descamps D, Plantier JC, Ruffault A, Amiel C, Trabaud MA, Flandre P, Fleury H, Masquelier B, ANRS AC11 Resistance Study Group
HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes.
The Journal of Antimicrobial Chemotherapy 2013, 68, 969-972.
Lê MP, Gervais A, Le Beller C, Long K, Larrouy L, Papy E, Mal H, Descamps D, Peytavin G
Serious neuropsychiatric adverse effects in a hepatitis C virus/hepatitis B virus/HIV-coinfected patient receiving bosentan and telaprevir.
The Journal of Antimicrobial Chemotherapy 2013, 68, 1208-1209.
Lambert-Niclot S, Charpentier C, Storto A, Fofana DB, Soulié C, Fourati S, Visseaux B, Wirden M, Morand-Joubert L, Masquelier B, Flandre P, Calvez V, Descamps D, Marcelin AG
Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses.
The Journal of Antimicrobial Chemotherapy 2013, 68, 1237-1242.
Assoumou L, Descamps D, Yerly S, Dos Santos G, Marcelin AG, Delaugerre C, Morand-Joubert L, Ruffault A, Izopet J, Plantier JC, Pakianather S, Montes B, Chaix ML, Wirden M, Costagliola D, Masquelier B, ANRS AC11 Resistance Group
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study.
The Journal of Antimicrobial Chemotherapy 2013, 68, 1400-1405.
Charpentier C, Lambert-Niclot S, Visseaux B, Morand-Joubert L, Storto A, Larrouy L, Landman R, Calvez V, Marcelin AG, Descamps D
Evolution of the K65R, K103N and M184V/I reverse transcriptase mutations in HIV-1-infected patients experiencing virological failure between 2005 and 2010.
The Journal of Antimicrobial Chemotherapy 2013, 68, 2197-2198.
Fourati S, Visseaux B, Armenia D, Morand-Joubert L, Artese A, Charpentier C, Van Den Eede P, Costa G, Alcaro S, Wirden M, Perno CF, Ceccherini Silberstein F, Descamps D, Calvez V, Marcelin AG
Identification of a rare mutation at reverse transcriptase Lys65 (K65E) in HIV-1-infected patients failing on nucleos(t)ide reverse transcriptase inhibitors.
The Journal of Antimicrobial Chemotherapy 2013, 68, 2199-2204.
Descamps D, Assoumou L, Chaix ML, Chaillon A, Pakianather S, de Rougemont A, Storto A, Dos Santos G, Krivine A, Delaugerre C, Montes B, Izopet J, Charpentier C, Wirden M, Maillard A, Morand-Joubert L, Pallier C, Plantier JC, Guinard J, Tamalet C, Cottalorda J, Marcelin AG, Desbois D, Henquell C, Calvez V, Brun-Vézinet F, Masquelier B, Costagliola D, ANRS AC11 Resistance Study Group
National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.
The Journal of Antimicrobial Chemotherapy 2013, 68, 2626-2631.
Todesco E, Sayon S, Fourati S, Tubiana R, Simon A, Ktorza N, Schneider L, Peytavin G, Malet I, Van den Eede P, Katlama C, Calvez V, Marcelin AG, Wirden M
Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies.
The Journal of Antimicrobial Chemotherapy 2013, 68, 2882-2889.
Antonini TM, Furlan V, Teicher E, Haim-Boukobza S, Sebagh M, Coilly A, Bonhomme-Faivre L, Peytavin G, Roque-Afonso AM, Vittecoq D, Samuel D, Taburet AM, Duclos-Vallée JC
Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graft.
AIDS (London, England) 2013, 27, 2655-2657.
Timsit JF, Laupland KB
Is the burden of severe sepsis and septic shock changing?.
Critical Care Medicine 2013, 41, 1361-1363.
Schwebel C, Clec'h C, Magne S, Minet C, Garrouste-Orgeas M, Bonadona A, Dumenil AS, Jamali S, Kallel H, Goldgran-Toledano D, Marcotte G, Azoulay E, Darmon M, Ruckly S, Souweine B, Timsit JF
Safety of Intrahospital Transport in Ventilated Critically Ill Patients: A Multicenter Cohort Study.
Critical Care Medicine 2013, 41, 1919-1928.
Barbier F, Andremont A, Wolff M, Bouadma L
Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management.
Current Opinion in Pulmonary Medicine 2013, 19, 216-228.
Charpentier C, Bertine M, Visseaux B, Leleu J, Larrouy L, Peytavin G, Mourez T, Collin G, Brun-Vézinet F, Plantier JC, Descamps D
In-vitro phenotypic susceptibility of HIV-1 'non-B' integrase inhibitors naive clinical isolates to dolutegravir and raltegravir.
AIDS (London, England) 2013, 27, 2959-2961.
Zetterberg E, Neuhaus J, Baker JV, Somboonwit C, Llibre JM, Palfreeman A, Chini M, Lundgren JD, INSIGHT SMART Study Group
Platelet count kinetics following interruption of antiretroviral treatment.
AIDS (London, England) 2013, 27, 59-68.
Larrouy L, Vivot A, Charpentier C, Bénard A, Visseaux B, Damond F, Matheron S, Chene G, Brun-Vezinet F, Descamps D, ANRS CO5 HIV-2 Cohort
Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients.
AIDS (London, England) 2013, 27, 69-80.
Visseaux B, Charpentier C, Taieb A, Damond F, Bénard A, Larrouy L, Chêne G, Brun-Vézinet F, Matheron S, Descamps D, ANRS CO5 HIV-2 Cohort
Concordance between HIV-2 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA.
AIDS (London, England) 2013, 27, 292-295.
Bunupuradah T, Duong T, Compagnucci A, McMaster P, Bernardi S, Kanjanavanit S, Rampon O, Faye A, Saïdi Y, Riault Y, De Rossi A, Klein N, Ananworanich J, Gibb D, PENTA 11 Extension Study Group
Outcomes after reinitiating antiretroviral therapy in children randomized to planned treatment interruptions.
AIDS (London, England) 2013, 27, 579-589.
Lacombe JM, Boue F, Grabar S, Viget N, Gazaignes S, Lascaux-Cametz AS, Pacanowski J, Partisani M, Launay O, Matheron S, Rosenthal E, Rouveix E, Tattevin P, de Truchis P, Costagliola D, Goedert JJ
Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy.
AIDS (London, England) 2013, 27, 635-643.
Stellbrink HJ, Reynes J, Lazzarin A, Voronin E, Pulido F, Felizarta F, Almond S, St Clair M, Flack N, Min S, SPRING-1 Team
Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study.
AIDS (London, England) 2013, 27, 1771-1778.
Charpentier C, Visseaux B, Bénard A, Peytavin G, Damond F, Roy C, Taieb A, Chêne G, Matheron S, Brun-Vézinet F, Descamps D, ANRS CO5 HIV-2 Cohort
Transmitted drug resistance in French HIV-2-infected patients.
AIDS 2013, 27, 1671–1674.
Leoz M, Feyertag F, Charpentier C, Delaugerre C, Wirden M, Lemee V, Plantier JC
Characterization of CRF56_cpx, a new circulating B/CRF02/G recombinant form identified in MSM in France.
AIDS (London, England) 2013, 27, 2309-2312.
Cuzin L, Allavena C, Pugliese P, Rey D, Hoen B, Poizot-Martin I, Cabie A, Yazdanpanah Y, DATʼAIDS Study Group
Can the "seek, test, treat, and retain" strategy be effective in France?.
Journal of Acquired Immune Deficiency Syndromes (1999) 2013, 62, e119-121.
Descours B, Lambert-Niclot S, Mory B, Samri A, Charlotte F, Peytavin G, Tubiana R, Papagno L, Bacchus C, Lecardonnel F, Katlama C, Autran B, Marcelin AG, Valantin MA, Carcelain G, DECAMUNE and ORVACS Study Groups
Direct quantification of cell-associated HIV DNA in isolated rectal and blood memory CD4 T cells revealed their similar and low infection levels in long-term treated HIV-infected patients.
Journal of Acquired Immune Deficiency Syndromes (1999) 2013, 62, 255-259.
Rockstroh JK, DeJesus E, Lennox JL, Yazdanpanah Y, Saag MS, Wan H, Rodgers AJ, Walker ML, Miller M, DiNubile MJ, Nguyen BY, Teppler H, Leavitt R, Sklar P, STARTMRK Investigators
Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK.
Journal of acquired immune deficiency syndromes (1999) 2013, 63, 77-85.
Semaille C, Barin F, Bouyssou A, Peytavin G, Guinard J, Le Vu S, Pillonel J, Spire B, Velter A
High viral loads among HIV-positive MSM attending gay venues: implications for HIV transmission.
Journal of Acquired Immune Deficiency Syndromes (1999) 2013, 63, e122-124.
Cotte L, Dellamonica P, Raffi F, Yazdanpanah Y, Molina JM, Boué F, Urata Y, Chan HP, Zhu L, Chang I, Bertz R, Hanna GJ, Grasela DM, Hwang C
Randomized placebo-controlled study of the safety, tolerability, antiviral activity, and pharmacokinetics of 10-day monotherapy with BMS-986001, a novel HIV NRTI, in treatment-experienced HIV-1-infected subjects.
Journal of Acquired Immune Deficiency Syndromes (1999) 2013, 63, 346-354.
de Montmollin E, Tandjaoui-Lambiotte Y, Legrand M, Lambert J, Mokart D, Kouatchet A, Lemiale V, Pène F, Bruneel F, Vincent F, Mayaux J, Chevret S, Azoulay E
Outcomes in critically ill cancer patients with septic shock of pulmonary origin.
Shock (Augusta, Ga.) 2013, 39, 250-254.
Gray F, Lescure FX, Adle-Biassette H, Polivka M, Gallien S, Pialoux G, Moulignier A
Encephalitis with infiltration by CD8+ lymphocytes in HIV patients receiving combination antiretroviral treatment.
Brain Pathology (Zurich, Switzerland) 2013, 23, 525-533.
Murat JB, Lebeau B, Chumpitazi B, Cornet M, Maubon D, Faure O, Quesada JL, Thiebaut-Bertrand A, Timsit JF, Pelloux H
Minimum inhibitory concentrations of amphotericin B against Candida krusei isolates from a French teaching hospital laboratory: a retrospective study over 8 years.
Mycoses 2013, 56, 56-60.
Nguyen HL, Charpentier C, Nguyen N, de Truchis P, Molina JM, Ruxrungtham K, Delaugerre C
Longitudinal analysis of integrase N155H variants in heavily treated patients failing raltegravir-based regimens.
HIV medicine 2013, 14, 85-91.
Baroux N, Rouchon B, Huon B, Germain A, Meunier JM, D'Ortenzio E
High prevalence of rheumatic heart disease in schoolchildren detected by echocardiography screening in New Caledonia.
Journal of Paediatrics and Child Health 2013, 49, 109-114.
Hatzakis A, Van Damme P, Alcorn K, Gore C, Benazzouz M, Berkane S, Buti M, Carballo M, Cortes Martins H, Deuffic-Burban S, Dominguez A, Donoghoe M, Elzouki AN, Ben-Alaya Bouafif N, Esmat G, Esteban R, Fabri M, Fenton K, Goldberg D, Goulis I, Hadjichristodoulou C, Hadjichristodoulou T, Hatzigeorgiou T, Hamouda O, Hasurdjiev S, Hughes S, Kautz A, Malik M, Manolakopoulos S, Matičič M, Papatheodoridis G, Peck R, Peterle A, Potamitis G, Prati D, Roudot-Thoraval F, Reic T, Sharara A, Shennak M, Shiha G, Shouval D, Sočan M, Thomas H, Thursz M, Tosti M, Trépo C, Vince A, Vounou E, Wiessing L, Manns M
The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference.
Journal of Viral Hepatitis 2013, 20 Suppl 2, 1-20.
Bertrand D, Pallet N, Sartorius A, Zahar JR, Soussan RS, Lortholary O, Legendre C, Mamzer MF
Clinical and microbial impact of screening kidney allograft preservative solution for bacterial contamination with high-sensitivity methods.
Transplant International: Official Journal of the European Society for Organ Transplantation 2013, 26, 795-799.
Rousseaux S, Debernardi A, Jacquiau B, Vitte AL, Vesin A, Nagy-Mignotte H, Moro-Sibilot D, Brichon PY, Lantuejoul S, Hainaut P, Laffaire J, de Reyniès A, Beer DG, Timsit JF, Brambilla C, Brambilla E, Khochbin S
Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers.
Science Translational Medicine 2013, 5, 186ra66.
Barau C, Furlan V, Yazdanpanah Y, Fagard C, Molina JM, Taburet AM, Barrail-Tran A
Characterization of binding of raltegravir to plasma proteins.
Antimicrobial Agents and Chemotherapy 2013, 57, 5147-5150.
Kardas-Sloma L, Boëlle PY, Opatowski L, Guillemot D, Temime L
Antibiotic reduction campaigns do not necessarily decrease bacterial resistance: the example of methicillin-resistant Staphylococcus aureus.
Antimicrobial Agents and Chemotherapy 2013, 57, 4410-4416.
Clavel-Osorio C, Cazassus F, Stegmann S, Huc-Anaïs P, Lecam D, Peytavin G
One-month transplacental pharmacokinetics of raltegravir in a premature newborn after short-course treatment of the HIV-1-infected mother.
Antimicrobial Agents and Chemotherapy 2013, 57, 6393-6394.
Joly V, Fagard C, Grondin C, Descamps D, Yazdanpanah Y, Charpentier C, Colin de Verdiere N, Tabuteau S, Raffi F, Cabie A, Chene G, Yeni P, S 130 Apollo Trial Group
Intensification of antiretroviral therapy through addition of enfuvirtide in naive HIV-1-infected patients with severe immunosuppression does not improve immunological response: results of a randomized multicenter trial (ANRS 130 Apollo).
Antimicrobial Agents and Chemotherapy 2013, 57, 758-765.
Vinot C, Gavard L, Tréluyer JM, Manceau S, Courbon E, Scherrmann JM, Declèves X, Duro D, Peytavin G, Mandelbrot L, Giraud C
Placental transfer of maraviroc in an ex vivo human cotyledon perfusion model and influence of ABC transporter expression.
Antimicrobial Agents and Chemotherapy 2013, 57, 1415-1420.
Armand-Lefevre L, Angebault C, Barbier F, Hamelet E, Defrance G, Ruppe E, Bronchard R, Lepeule R, Lucet JC, El Mniai A, Wolff M, Montravers P, Plesiat P, Andremont A
Emergence of Imipenem-Resistant Gram-Negative Bacilli in Intestinal Flora of Intensive Care Patients.
Antimicrobial Agents and Chemotherapy 2013, 57, 1488-1495.
Recordon-Pinson P, Raymond S, Bellecave P, Marcelin AG, Soulie C, Descamps D, Calvez V, Harrigan PR, Fleury H, Izopet J, Masquelier B, S AC11 Resistance Study Group
HIV-1 dynamics and coreceptor usage in Maraviroc-treated patients with ongoing replication.
Antimicrobial Agents and Chemotherapy 2013, 57, 930-935.
Parienti JJ, Barrail-Tran A, Duval X, Nembot G, Descamps D, Vigan M, Vrijens B, Panhard X, Taburet AM, Mentre F, Goujard C
Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial.
Antimicrob Agents Chemother 2013, 57, 2265-71.
Champenois K, Cousien A, Ndiaye B, Soukouna Y, Baclet V, Alcaraz I, Choisy P, Chaud P, Velter A, Gallay A, Yazdanpanah Y
Risk factors for syphilis infection in men who have sex with men: results of a case-control study in Lille, France.
Sexually Transmitted Infections 2013, 89, 128-132.
Lorente N, Champenois K, Blanche J, Préau M, Suzan-Monti M, Mora M, Fugon L, Carrieri MP, Sagaon-Teyssier L, Le Gall JM, Spire B, Yazdanpanah Y
Investigating Recent Testing among MSM: Results from Community-Based HIV Rapid Testing Attendees in France.
Journal of Sexually Transmitted Diseases 2013, 2013, 648791.
Goulenok T, Klein I, Mazighi M, Messika-Zeitoun D, Alexandra JF, Mourvillier B, Laissy JP, Leport C, Iung B, Duval X, IMAGE study group
Infective endocarditis with symptomatic cerebral complications: contribution of cerebral magnetic resonance imaging.
Cerebrovascular Diseases (Basel, Switzerland) 2013, 35, 327-336.
Pham T, Combes A, Rozé H, Chevret S, Mercat A, Roch A, Mourvillier B, Ara-Somohano C, Bastien O, Zogheib E, Clavel M, Constan A, Marie Richard JC, Brun-Buisson C, Brochard L, REVA Research Network
Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: a cohort study and propensity-matched analysis.
American Journal of Respiratory and Critical Care Medicine 2013, 187, 276-285.
Planquette B, Timsit JF, Misset BY, Schwebel C, Azoulay E, Adrie C, Vesin A, Jamali S, Zahar JR, Allaouchiche B, Souweine B, Darmon M, Dumenil AS, Goldgran-Toledano D, Mourvillier BH, Bédos JP, OUTCOMEREA Study Group
Pseudomonas aeruginosa ventilator-associated pneumonia. predictive factors of treatment failure.
American Journal of Respiratory and Critical Care Medicine 2013, 188, 69-76.
Annane D, Timsit JF, Megarbane B, Martin C, Misset B, Mourvillier B, Siami S, Chagnon JL, Constantin JM, Petitpas F, Souweine B, Amathieu R, Forceville X, Charpentier C, Tesnière A, Chastre J, Bohe J, Colin G, Cariou A, Renault A, Brun-Buisson C, Bellissant E, APROCCHSS Trial Investigators
Recombinant human activated protein C for adults with septic shock: a randomized controlled trial.
American Journal of Respiratory and Critical Care Medicine 2013, 187, 1091-1097.
Timsit JF, Bouadma L, Mimoz O, Parienti JJ, Garrouste-Orgeas M, Alfandari S, Plantefeve G, Bronchard R, Troche G, Gauzit R, Antona M, Canet E, Bohe J, Herrault MC, Schwebel C, Ruckly S, Souweine B, Lucet JC
Jugular versus femoral short-term catheterization and risk of infection in intensive care unit patients. Causal analysis of two randomized trials.
American Journal of Respiratory and Critical Care Medicine 2013, 188, 1232-1239.
Domenech de Cellès M, Zahar JR, Abadie V, Guillemot D
Limits of patient isolation measures to control extended-spectrum beta-lactamase-producing Enterobacteriaceae: model-based analysis of clinical data in a pediatric ward.
BMC infectious diseases 2013, 13, 187.
Champenois K, Cousien A, Cuzin L, Le Vu S, Deuffic-Burban S, Lanoy E, Lacombe K, Patey O, Béchu P, Calvez M, Semaille C, Yazdanpanah Y
Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study.
BMC infectious diseases 2013, 13, 200.
Yang ZT, Zahar JR, Méchaï F, Postaire M, Blanot S, Balfagon-Viel S, Nassif X, Lortholary O
Current ciprofloxacin usage in children hospitalized in a referral hospital in Paris.
BMC infectious diseases 2013, 13, 245.
Gasse B, Baroux N, Rouchon B, Meunier JM, Frémicourt ID, D'Ortenzio E
Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study.
BMC public health 2013, 13, 131.
Gharbi M, Flegg JA, Hubert V, Kendjo E, Metcalf JE, Bertaux L, Guérin PJ, Le Bras J, Members of the French National Reference Centre for Imported Malaria Study, Aboubaca A, Agnamey P, Angoulvant A, Barbut P, Basset D, Belkadi G, Bellanger AP, Bemba D, Benoit-Vica F, Berry A, Bigel ML, Bonhomme J, Botterel F, Bouchaud O, Bougnoux ME, Bourée P, Bourgeois N, Branger C, Bret L, Buret B, Casalino E, Chevrier S, Conquere de Monbrison F, Cuisenier B, Danis M, Darde ML, De Gentile L, Delarbre JM, Delaunay P, Delaval A, Desoubeaux G, Develoux M, Dunand J, Durand R, Eloy O, Fauchet N, Faugere B, Faye A, Fenneteau O, Flori P, Fontrouge M, Garabedian C, Gayandrieu F, Godineau N, Houzé P, Houzé S, Hurst JP, Ichou H, Lachaud L, Lebuisson A, Lefevre M, LeGuern AS, Le Moal G, Lusina D, Machouart MC, Malvy D, Matheron S, Maubon D, Mechali D, Megarbane B, Menard G, Millon L, Aiach MM, Minodier P, Morelle C, Nevez G, Parola P, Parzy D, Patey O, Patoz P, Penn P, Perignon A, Picot S, Pilo JE, Poilane I, Pons D, Poupart M, Pradines B, Raffenot D, Rapp C, Receveur MC, Sarfati C, Senghor Y, Simon F, Siriez JY, Taudon N, Thellier M, Thouvenin M, Toubas D
Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011.
Malar. J. 2013, 12, 35.
Cordel H, Cailhol J, Matheron S, Bloch M, Godineau N, Consigny PH, Gros H, Campa P, Bourée P, Fain O, Ralaimazava P, Bouchaud O
Atovaquone-proguanil in the treatment of imported uncomplicated Plasmodium falciparum malaria: a prospective observational study of 553 cases.
Malaria Journal 2013, 12,
Gaillard T, Briolant S, Houzé S, Baragatti M, Wurtz N, Hubert V, Lavina M, Pascual A, Travaillé C, Le Bras J, Pradines B, French National Reference Centre for Imported Malaria Study Group
PftetQ and pfmdt copy numbers as predictive molecular markers of decreased ex vivo doxycycline susceptibility in imported Plasmodium falciparum malaria.
Malar. J. 2013, 12, 414.
Goudet V, Timsit JF, Lucet JC, Lepape A, Balayn D, Seguin S, Mimoz O
Comparison of four skin preparation strategies to prevent catheter-related infection in intensive care unit (CLEAN trial): a study protocol for a randomized controlled trial.
Trials 2013, 14, 114.
Timsit JF, Azoulay E, Cornet M, Gangneux JP, Jullien V, Vésin A, Schir E, Wolff M
EMPIRICUS micafungin versus placebo during nosocomial sepsis in Candida multi-colonized ICU patients with multiple organ failures: study protocol for a randomized controlled trial.
Trials 2013, 14, 399.
Birgand G, Ruimy R, Schwarzinger M, Lolom I, Bendjelloul G, Houhou N, Armand-Lefevre L, Andremont A, Yazdanpanah Y, Lucet JC
Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs.
Antimicrobial Resistance and Infection Control 2013, 2, 30.
Darmon M, Diconne E, Souweine B, Ruckly S, Adrie C, Azoulay E, Clec'h C, Garrouste-Orgeas M, Schwebel C, Goldgran-Toledano D, Khallel H, Dumenil AS, Jamali S, Cheval C, Allaouchiche B, Zeni F, Timsit JF
Prognostic consequences of borderline dysnatremia: pay attention to minimal serum sodium change.
Critical Care (London, England) 2013, 17, R12.
Perier A, Revah-Levy A, Bruel C, Cousin N, Angeli S, Brochon S, Philippart F, Max A, Gregoire C, Misset B, Garrouste-Orgeas M
Phenomenologic analysis of healthcare worker perceptions of intensive care unit diaries.
Critical Care (London, England) 2013, 17, R13.
Toffart AC, Timsit JF
Is prolonged mechanical ventilation of cancer patients futile?.
Critical Care (London, England) 2013, 17, 189.
Adrie C, Schwebel C, Garrouste-Orgeas M, Vignoud L, Planquette B, Azoulay E, Kallel H, Darmon M, Souweine B, Dinh-Xuan AT, Jamali S, Zahar JR, Timsit JF, Article Was Written on behalf of the Outcomerea Study Group
Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: impact on survival and bacterial resistance.
Critical Care (London, England) 2013, 17, R265.
Niven DJ, Laupland KB, Tabah A, Vesin A, Rello J, Koulenti D, Dimopoulos G, de Waele J, Timsit JF, EUROBACT Investigators
Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey.
Critical Care (London, England) 2013, 17, R289.
Abgrall S, Le Bel J, Lele N, Laouénan C, Eychenne N, Mentré F, Peytavin G, Bouchaud O, Vihvo Study Group
Lack of effect of doxycycline on trough concentrations of protease inhibitors or non-nucleoside reverse transcriptase inhibitors in HIV-infected patients.
HIV clinical trials 2013, 14, 313-318.
Auvert B, Taljaard D, Rech D, Lissouba P, Singh B, Bouscaillou J, Peytavin G, Mahiane SG, Sitta R, Puren A, Lewis D
Association of the ANRS-12126 male circumcision project with HIV levels among men in a South African township: evaluation of effectiveness using cross-sectional surveys.
PLoS medicine 2013, 10, e1001509.
Mocroft A, Lundgren JD, Sabin ML, Monforte Ad, Brockmeyer N, Casabona J, Castagna A, Costagliola D, Dabis F, De Wit S, Fätkenheuer G, Furrer H, Johnson AM, Lazanas MK, Leport C, Moreno S, Obel N, Post FA, Reekie J, Reiss P, Sabin C, Skaletz-Rorowski A, Suarez-Lozano I, Torti C, Warszawski J, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Kirk O, Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord
Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE).
PLoS medicine 2013, 10, e1001510.
Goarant C, Bourhy P, D'Ortenzio E, Dartevelle S, Mauron C, Soupé-Gilbert ME, Bruyère-Ostells L, Gourinat AC, Picardeau M, Nato F, Chanteau S
Sensitivity and Specificity of a New Vertical Flow Rapid Diagnostic Test for the Serodiagnosis of Human Leptospirosis.
PLoS neglected tropical diseases 2013, 7, e2289.
Cordel H, Prendki V, Madec Y, Houze S, Paris L, Bourée P, Caumes E, Matheron S, Bouchaud O, ALA Study Group
Imported amoebic liver abscess in France.
PLoS neglected tropical diseases 2013
Guerrier G, Hie P, Gourinat AC, Huguon E, Polfrit Y, Goarant C, D'Ortenzio E, Missotte I
Association between age and severity to leptospirosis in children.
PLoS neglected tropical diseases 2013, 7, e2436.
Charpentier C, Fagard C, Colin C, Katlama C, Molina JM, Jacomet C, Visseaux B, Taburet AM, Brun-Vézinet F, Chêne G, Yazdanpanah Y, Descamps D, ANRS139 TRIO Trial study group
Role of baseline HIV-1 DNA level in highly-experienced patients receiving raltegravir, etravirine and darunavir/ritonavir regimen (ANRS139 TRIO trial).
PloS One 2013, 8, e53621.
Charpentier C, Lambert-Niclot S, Alteri C, Storto A, Flandre P, Svicher V, Perno CF, Brun-Vézinet F, Calvez V, Marcelin AG, Ceccherini-Silberstein F, Descamps D
Description of the L76V resistance protease mutation in HIV-1 B and "non-B" subtypes.
PloS One 2013
Bjerk SM, Baker JV, Emery S, Neuhaus J, Angus B, Gordin FM, Pett SL, Stephan C, Kunisaki KM, INSIGHT SMART Study Group
Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study.
PloS One 2013
Charpentier C, Champenois K, Gervais A, Landman R, Joly V, Le Gac S, Larrouy L, Damond F, Brun-Vézinet F, Descamps D, Yazdanpanah Y
Predictive value of liver enzymes and inflammatory biomarkers for the severity of liver fibrosis stage in HIV/HCV co-infected patients.
PloS One 2013, 8, e59205.
Guerrier G, D'Ortenzio E
The Jarisch-Herxheimer reaction in leptospirosis: a systematic review.
PloS One 2013, 8, e59266.
Lécuroux C, Girault I, Chéret A, Versmisse P, Nembot G, Meyer L, Rouzioux C, Pancino G, Venet A, Sáez-Cirión A, ANRS 147 OPTIPRIM clinical trial
CD8 T-cells from most HIV-infected patients lack ex vivo HIV-suppressive capacity during acute and early infection.
PloS One 2013
Lapidus N, de Lamballerie X, Salez N, Setbon M, Delabre RM, Ferrari P, Moyen N, Gougeon ML, Vely F, Leruez-Ville M, Andreoletti L, Cauchemez S, Boëlle PY, Vivier E, Abel L, Schwarzinger M, Legeas M, Le Cann P, Flahault A, Carrat F
Factors associated with post-seasonal serological titer and risk factors for infection with the pandemic A/H1N1 virus in the French general population.
PloS One 2013, 8, e60127.
Bacchus C, Cheret A, Avettand-Fenoël V, Nembot G, Mélard A, Blanc C, Lascoux-Combe C, Slama L, Allegre T, Allavena C, Yazdanpanah Y, Duvivier C, Katlama C, Goujard C, Seksik BCP, Leplatois A, Molina JM, Meyer L, Autran B, Rouzioux C, OPTIPRIM ANRS 147 study group
A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infection.
PloS One 2013, 8, e64219.
Schwarzinger M, Sagaon-Teyssier L, Cabaret O, Bretagne S, Cordonnier C, PREVERT Investigators
Performance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: a multi-state model.
PloS One 2013, 8, e65776.
Birgand G, Lepelletier D, Baron G, Barrett S, Breier AC, Buke C, Markovic-Denic L, Gastmeier P, Kluytmans J, Lyytikainen O, Sheridan E, Szilagyi E, Tacconelli E, Troillet N, Ravaud P, Lucet JC
Agreement among healthcare professionals in ten European countries in diagnosing case-vignettes of surgical-site infections.
PloS One 2013, 8, e68618.
Frange P, Meyer L, Jung M, Goujard C, Zucman D, Abel S, Hochedez P, Gousset M, Gascuel O, Rouzioux C, Chaix ML, ANRS PRIMO Cohort Study Group
Sexually-transmitted/founder HIV-1 cannot be directly predicted from plasma or PBMC-derived viral quasispecies in the transmitting partner.
PloS One 2013
Krastinova E, Seng R, Yeni P, Viard JP, Vittecoq D, Lascoux-Combe C, Fourn E, Pahlavan G, Delfraissy JF, Meyer L, ANRS PRIMO and COPANA Cohorts
Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts.
PLoS ONE 2013, 8, e71473.
Legeai C, Vigouroux C, Souberbielle JC, Bouchaud O, Boufassa F, Bastard JP, Carlier R, Capeau J, Goujard C, Meyer L, Viard JP, ANRS-COPANA Cohort Study Group
Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study.
PLoS ONE 2013, 8, e74868.
Houzé S, Boutron I, Marmorat A, Dalichampt M, Choquet C, Poilane I, Godineau N, Le Guern AS, Thellier M, Broutier H, Fenneteau O, Millet P, Dulucq S, Hubert V, Houzé P, Tubach F, Le Bras J, Matheron S
Performance of rapid diagnostic tests for imported malaria in clinical practice: results of a national multicenter study.
PloS One 2013
Klein N, Sefe D, Mosconi I, Zanchetta M, Castro H, Jacobsen M, Jones H, Bernardi S, Pillay D, Giaquinto C, Walker AS, Gibb DM, De Rossi A, Paediatric European Network for Treatment of AIDS 11 Trial Team
The immunological and virological consequences of planned treatment interruptions in children with HIV infection.
PloS One 2013
Yazdanpanah Y, Perelman J, DiLorenzo MA, Alves J, Barros H, Mateus C, Pereira J, Mansinho K, Robine M, Park JE, Ross EL, Losina E, Walensky RP, Noubary F, Freedberg KA, Paltiel AD
Routine HIV screening in Portugal: clinical impact and cost-effectiveness.
PloS One 2013, 8, e84173.
Chougrani I, Luton D, Matheron S, Mandelbrot L, Azria E
Safety of protease inhibitors in HIV-infected pregnant women.
HIV/AIDS (Auckland, N.Z.) 2013, 5, 253-262.
Zaidan M, Lescure FX, Brochériou I, Dettwiler S, Guiard-Schmid JB, Pacanowski J, Rondeau E, Pialoux G, Girard PM, Ronco P, Plaisier E
Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: a clinico-pathological study.
Clinical journal of the American Society of Nephrology: CJASN 2013, 8, 930-938.
Dervaux B, Baseilhac E, Fagon JY, participants of round table N°6 of Giens Workshops XXVIII (th), Ameye V, Angot P, Audry A, Becquemont L, Borel T, Cazeneuve B, Courtois J, Detournay B, Favre P, Granger M, Josseran A, Lassale C, Louvet O, Pinson J, de Pouvourville G, Rochaix L, Rumeau-Pichon C, de Saab R, Schwarzinger M, Sun A
Medico-economic evaluation of health products in the context of the Social Security Financing Act for 2012.
Therapie 2013, 68, 253-263.
Zucman D, De Truchis P, Peytavin G, Descamps D, Duvivier C, Tegna L, Weiss L, Delassus JL, Benalycherif A, Landman R
Efficacy, safety, and pharmacokinetics of once-daily boosted darunavir in pretreated HIV-infected patients.
Scandinavian Journal of Infectious Diseases 2013, 45, 407-410.
Schnell D, Lécuyer H, Geeraerts T, Dumenil AS, Bille E, Mercier FJ, Benhamou D, Zahar JR
Preliminary evaluation of a new clinical algorithm to interpret blood cultures growing coagulase-negative staphylococci.
Scandinavian Journal of Infectious Diseases 2013, 45, 562-566.
Nguyen LBL, Epelboin L, Gabarre J, Lecso M, Guillot S, Bricaire F, Caumes E, Guiso N
Recurrent Bordetella holmesii bacteremia and nasal carriage in a patient receiving rituximab.
Emerging Infectious Diseases 2013, 19, 1703-1705.
Zahar JR, Timsit JF
Clostridium difficile outcomes difficult to generalize. Authors' response.
Critical Care (London, England) 2013, 17, 415.
2012
Yazdanpanah Y, Walensky RP, Rozenbaum W, Yeni P, Paltiel AD
What is a modest public health impact?.
Archives of Internal Medicine 2012, 172, 521-522; author reply 522-523.
Coeurjolly JF, Nguile-Makao M, Timsit JF, Liquet B
Attributable risk estimation for adjusted disability multistate models: application to nosocomial infections.
Biometrical Journal. Biometrische Zeitschrift 2012, 54, 600-616.
Soulié C, Charpentier C, Flandre P, Nino C, Carcelain G, Simon A, Katlama C, Landman R, Brun-Vézinet F, Descamps D, Calvez V, Marcelin AG
Natural evolution of CD4+ cell count in patients with CD4 >350 or >500 cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropism.
Journal of Medical Virology 2012, 84, 1853-1856.
Antonelli M, Bonten M, Chastre J, Citerio G, Conti G, Curtis JR, De Backer D, Hedenstierna G, Joannidis M, Macrae D, Mancebo J, Maggiore SM, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2011: I. Nephrology, epidemiology, nutrition and therapeutics, neurology, ethical and legal issues, experimentals.
Intensive Care Medicine 2012, 38, 192-209.
Rhodes A, Moreno RP, Azoulay E, Capuzzo M, Chiche JD, Eddleston J, Endacott R, Ferdinande P, Flaatten H, Guidet B, Kuhlen R, León-Gil C, Martin Delgado MC, Metnitz PG, Soares M, Sprung CL, Timsit JF, Valentin A, Task Force on Safety and Quality of European Society of Intensive Care Medicine (ESICM)
Prospectively defined indicators to improve the safety and quality of care for critically ill patients: a report from the Task Force on Safety and Quality of the European Society of Intensive Care Medicine (ESICM).
Intensive Care Medicine 2012, 38, 598-605.
Antonelli M, Bonten M, Chastre J, Citerio G, Conti G, Curtis JR, De Backer D, Hedenstierna G, Joannidis M, Macrae D, Mancebo J, Maggiore SM, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2011. II. Cardiovascular, infections, pneumonia and sepsis, critical care organization and outcome, education, ultrasonography, metabolism and coagulation.
Intensive Care Medicine 2012, 38, 345-358.
Antonelli M, Bonten M, Chastre J, Citerio G, Conti G, Curtis JR, De Backer D, Hedenstierna G, Joannidis M, Macrae D, Mancebo J, Maggiore SM, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2011: III. ARDS and ECMO, weaning, mechanical ventilation, noninvasive ventilation, pediatrics and miscellanea.
Intensive Care Medicine 2012, 38, 542-556.
Azoulay E, Garrouste M, Goldgran-Toledano D, Adrie C, Max A, Vesin A, Francais A, Zahar JR, Cohen Y, Allaouchiche B, Schlemmer B, Timsit JF
Increased nonbeneficial care in patients spending their birthday in the ICU.
Intensive Care Medicine 2012, 38, 1169-1176.
Timsit JF, L'Hériteau F, Lepape A, Francais A, Ruckly S, Venier AG, Jarno P, Boussat S, Coignard B, Savey A
A multicentre analysis of catheter-related infection based on a hierarchical model.
Intensive Care Medicine 2012, 38, 1662-1672.
Tabah A, Koulenti D, Laupland K, Misset B, Valles J, Bruzzi de Carvalho F, Paiva JA, Cakar N, Ma X, Eggimann P, Antonelli M, Bonten MJM, Csomos A, Krueger WA, Mikstacki A, Lipman J, Depuydt P, Vesin A, Garrouste-Orgeas M, Zahar JR, Blot S, Carlet J, Brun-Buisson C, Martin C, Rello J, Dimopoulos G, Timsit JF
Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study.
Intensive Care Medicine 2012, 38, 1930-1945.
Charpentier C, Piketty C, Laureillard D, Tisserand P, Si-Mohamed A, Weiss L, Bélec L
Dynamics of HIV-1 DNA level in highly antiretroviral-experienced patients receiving raltegravir-based therapy.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2012, 31, 129-133.
Ruppe E, Pitsch A, Tubach F, de Lastours V, Chau F, Pasquet B, Lucet JC, Andremont A, Fantin B
Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards.
European Journal of Clinical Microbiology & Infectious Diseases 2012, 31, 319-325.
Diamantis S, Rioux C, Bonnal C, Farfour É, Papy E, Andremont A, Yeni P, Bouvet É, Lucet JC
Suitability of initial antibiotic therapy for the treatment of bloodstream infections and the potential role of antibiotic management teams in improving it.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2012, 31, 1667-1671.
de Montmollin E, Corcos O, Noussair L, Leflon-Guibout V, Belmatoug N, Joly F, Lefort A
Retroperitoneal abscesses due to Nocardia farcinica: report of two cases in patients with malnutrition.
Infection 2012, 40, 93-96.
Guillet M, Zahar JR, Timsit MO, Grandin L, Carbonnelle E, Join-Lambert O, Quesne G, Nassif X, Mejean A, Carbonne A
Horizontal transmission of Streptococcus pneumoniae in the surgical ward: a rare source of nosocomial wound infection.
American Journal of Infection Control 2012, 40, 71-72.
Guet-Revillet H, Le Monnier A, Breton N, Descamps P, Lecuyer H, Alaabouche I, Bureau C, Nassif X, Zahar JR
Environmental contamination with extended-spectrum β-lactamases: is there any difference between Escherichia coli and Klebsiella spp?.
American Journal of Infection Control 2012, 40, 845-848.
Carlet J, Rambaud C, Pulcini C, l'Alliance contre développement des bactéries multirésistantes (ACdeBMR)
[Alliance against MDRO: safeguarding antibiotics].
Ann Fr Anesth Reanim 2012, 31, 704–708.
Fourati S, Malet I, Guenzel CA, Soulie C, Maidou-Peindara P, Morand-Joubert L, Wirden M, Sayon S, Peytavin G, Simon A, Katlama C, Benichou S, Calvez V, Marcelin AG
E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutations.
Antiviral Research 2012, 93, 167-174.
Bourcier V, Winnock M, Ait Ahmed M, Sogni P, Pambrun E, Poizot-Martin I, Chaffaut C, Chevret S, Trinchet JC, Salmon D, ANRS CO13 Hepavih study group, ANRS CO12 Cirvir study group
Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir).
Clinics and Research in Hepatology and Gastroenterology 2012, 36, 214-221.
Ouanes I, Schwebel C, Français A, Bruel C, Philippart F, Vesin A, Soufir L, Adrie C, Garrouste-Orgeas M, Timsit JF, Misset B, Outcomerea Study Group
A model to predict short-term death or readmission after intensive care unit discharge.
Journal of Critical Care 2012, 27, 422.e1-9.
Deuffic-Burban S, Castel H, Wiegand J, Manns MP, Wedemeyer H, Mathurin P, Yazdanpanah Y
Immediate vs. delayed treatment in patients with acute hepatitis C based on IL28B polymorphism: a model-based analysis.
Journal of Hepatology 2012, 57, 260-266.
Zahar JR, Masse V, Watier L, Lanternier F, Degand N, Postaire M, Descamps P, Nassif X, Lortholary O
Is hand-rub consumption correlated with hand hygiene and rate of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE)-acquired infections?.
The Journal of Hospital Infection 2012, 80, 348-350.
Gibert P, Brudieu E, Timsit JF, Foroni L, Thiébaut-Bertrand A, Allenet B, Pelloux H, Brenier Pinchart MP
Invasive aspergillosis: drug-dispensing systems as a source of filamentous fungal contamination in high-risk units?.
The Journal of Hospital Infection 2012, 82, 293-296.
Fihman V, Le Monnier A, Corvec S, Jaureguy F, Tankovic J, Jacquier H, Carbonnelle E, Bille E, Illiaquer M, Cattoir V, Zahar JR
Stenotrophomonas maltophilia--the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study.
The Journal of Infection 2012, 64, 391-398.
Nagy-Mignotte H, Guillem P, Vignoud L, Coudurier M, Vesin A, Bonneterre V, Toffart AC, Sakhri L, Brambilla C, Brambilla E, Timsit JF, Moro-Sibilot D, Multidisciplinary Thoracic Oncology Group
Outcomes in recurrent small-cell lung cancer after one to four chemotherapy lines: a retrospective study of 300 patients.
Lung Cancer (Amsterdam, Netherlands) 2012, 78, 112-120.
Renault P, Balleydier E, D'Ortenzio E, Bâville M, Filleul L
Epidemiology of Chikungunya infection on Reunion Island, Mayotte, and neighboring countries.
Medecine Et Maladies Infectieuses 2012, 42, 93-101.
Ciotti C, Pellissier G, Rabaud C, Lucet JC, Abiteboul D, Bouvet E, GERES
Effectiveness of respirator masks for healthcare workers, in France.
Medecine Et Maladies Infectieuses 2012, 42, 264-269.
Gros C, Yazdanpanah Y, Vachet A, Roussel-Delvallez M, Senneville E, Lemaire X
Skin and soft tissue infections due to Panton-Valentine leukocidin producing Staphylococcus aureus.
Medecine Et Maladies Infectieuses 2012, 42, 488-494.
Minet C, Vivodtzev I, Tamisier R, Arbib F, Wuyam B, Timsit JF, Monneret D, Borel JC, Baguet JP, Lévy P, Pépin JL
Reduced six-minute walking distance, high fat-free-mass index and hypercapnia are associated with endothelial dysfunction in COPD.
Respiratory Physiology & Neurobiology 2012, 183, 128-134.
Boissier F, Khalil A, Chalumeau-Lemoine L, Lescure FX, Parrot A
Rash diagnosis of blood expectoration.
Lancet (London, England) 2012, 379, 1170.
DeJesus E, Rockstroh JK, Henry K, Molina JM, Gathe J, Ramanathan S, Wei X, Yale K, Szwarcberg J, White K, Cheng AK, Kearney BP, GS-236-0103 Study Team
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial.
Lancet 2012, 379, 2429-2438.
Pursuing Later Treatment Option II (PLATO II) project team, Observational HIV Epidemiological Research Europe (COHERE) Group, Costagliola D, Lodwick R, Ledergerber B, Torti C, van Sighem A, Podzamczer D, Mocroft A, Dorrucci M, Masquelier B, de Luca A, Jansen K, De Wit S, Obel N, Fätkenheuer G, Touoloumi G, Mussini C, Castagna A, Stephan C, García F, Zangerle R, Duval X, Pérez-Hoyos S, Meyer L, Ghosn J, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Phillips A
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study.
The Lancet. Infectious Diseases 2012, 12, 119-127.
Savic RM, Barrail-Tran A, Duval X, Nembot G, Panhard X, Descamps D, Verstuyft C, Vrijens B, Taburet AM, Goujard C, Mentré F, ANRS 134–COPHAR 3 Study Group
Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patients.
Clinical Pharmacology and Therapeutics 2012, 92, 575-583.
Deuffic-Burban S, Deltenre P, Buti M, Stroffolini T, Parkes J, Mühlberger N, Siebert U, Moreno C, Hatzakis A, Rosenberg W, Zeuzem S, Mathurin P
Predicted effects of treatment for HCV infection vary among European countries.
Gastroenterology 2012, 143, 974-985.e14.
Préau M, Protopopescu C, Raffi F, Rey D, Chêne G, Marcellin F, Perronne C, Ragnaud JM, Leport C, Spire B, Anrs Co8 Aproco-Copilote Study Group
Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerability.
AIDS care 2012, 24, 434-443.
Wilkin A, Pozniak AL, Morales-Ramirez J, Lupo SH, Santoscoy M, Grinsztejn B, Ruxrungtham K, Rimsky LT, Vanveggel S, Boven K, TMC278-C204 Study Group
Long-term efficacy, safety, and tolerability of rilpivirine (RPV, TMC278) in HIV type 1-infected antiretroviral-naive patients: week 192 results from a phase IIb randomized trial.
AIDS research and human retroviruses 2012, 28, 437-446.
Péré H, Charpentier C, Mbelesso P, Dandy M, Matta M, Moussa S, De Dieu Longo J, Grésenguet G, Abraham B, Bélec L
Virological response and resistance profiles after 24 months of first-line antiretroviral treatment in adults living in Bangui, Central African Republic.
AIDS research and human retroviruses 2012, 28, 315-323.
Rozenberg S, Lanoy E, Bentata M, Viard JP, Valantin MA, Missy P, Darasteanu I, Roux C, Kolta S, Costagliola D, ANRS 120 Fosivir Study Group
Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120).
AIDS research and human retroviruses 2012, 28, 972-980.
Monleau M, Aghokeng AF, Nkano BA, Chaix ML, Peeters M, AC11/AC12 ANRS Working Group
Drug resistance mutations of HIV type 1 non-B viruses to integrase inhibitors in treatment-naive patients from sub-saharan countries and discordant interpretations.
AIDS research and human retroviruses 2012, 28, 1157-1160.
Jacquier H, Le Monnier A, Carbonnelle E, Corvec S, Illiaquer M, Bille E, Zahar JR, Jauréguy F, Fihman V, Tankovic J, Cattoir V, Gmc Study Group
In vitro antimicrobial activity of "last-resort" antibiotics against unusual nonfermenting Gram-negative bacilli clinical isolates.
Microbial Drug Resistance (Larchmont, N.Y.) 2012, 18, 396-401.
Dupont-Rouzeyrol M, Caro V, Guillaumot L, Vazeille M, D'Ortenzio E, Thiberge JM, Baroux N, Gourinat AC, Grandadam M, Failloux AB
Chikungunya virus and the mosquito vector Aedes aegypti in New Caledonia (South Pacific Region).
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.) 2012, 12, 1036-1041.
Laupland KB, Zahar JR, Adrie C, Minet C, Vésin A, Goldgran-Toledano D, Azoulay E, Garrouste-Orgeas M, Cohen Y, Schwebel C, Jamali S, Darmon M, Dumenil AS, Kallel H, Souweine B, Timsit JF
Severe hypothermia increases the risk for intensive care unit-acquired infection.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54, 1064-1070.
Mermond S, Zurawski V, D'Ortenzio E, Driscoll AJ, DeLuca AN, Deloria-Knoll M, Moïsi JC, Murdoch DR, Missotte I, Besson-Leaud L, Chevalier C, Debarnot V, Feray F, Noireterre S, Duparc B, Fresnais F, O'Connor O, Dupont-Rouzeyrol M, Levine OS
Lower respiratory infections among hospitalized children in New Caledonia: a pilot study for the Pneumonia Etiology Research for Child Health project.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54 Suppl 2, S180-189.
Rammaert B, Lanternier F, Zahar JR, Dannaoui E, Bougnoux ME, Lecuit M, Lortholary O
Healthcare-associated mucormycosis.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54 Suppl 1, S44-54.
Lanternier F, Dannaoui E, Morizot G, Elie C, Garcia-Hermoso D, Huerre M, Bitar D, Dromer F, Lortholary O, French Mycosis Study Group
A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54 Suppl 1, S35-43.
Deuffic-Burban S, Yazdanpanah Y
It is time to change the paradigm for hepatitis C virus testing.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54, 1272-1274.
HIV-CAUSAL Collaboration
Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54, 1364-1372.
Wolff M, Mourvillier B
Linezolid for the treatment of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 55, 160-161.
Schuetz P, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M, Luyt CE, Chastre J, Tubach F, Kristoffersen KB, Wei L, Burkhardt O, Welte T, Schroeder S, Nobre V, Tamm M, Bhatnagar N, Bucher HC, Mueller B
Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 55, 651-662.
Thiébaut R, Charpentier C, Damond F, Taieb A, Antoine R, Capeau J, Chêne G, Collin G, Matheron S, Descamps D, Brun-Vézinet F, French ANRS HIV-2 CO5 Cohort
Association of soluble CD14 and inflammatory biomarkers with HIV-2 disease progression.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 55, 1417-1425.
Iung B, Klein I, Mourvillier B, Olivot JM, Détaint D, Longuet P, Ruimy R, Fourchy D, Laurichesse JJ, Laissy JP, Escoubet B, Duval X, Study Group
Respective effects of early cerebral and abdominal magnetic resonance imaging on clinical decisions in infective endocarditis.
European Heart Journal Cardiovascular Imaging 2012, 13, 703-710.
Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord, Lewden C, Bouteloup V, De Wit S, Sabin C, Mocroft A, Wasmuth JC, van Sighem A, Kirk O, Obel N, Panos G, Ghosn J, Dabis F, Mary-Krause M, Leport C, Perez-Hoyos S, Sobrino-Vegas P, Stephan C, Castagna A, Antinori A, d'Arminio Monforte A, Torti C, Mussini C, Isern V, Calmy A, Teira R, Egger M, Grarup J, Chêne G
All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.
International Journal of Epidemiology 2012, 41, 433-445.
May MT, Hogg RS, Justice AC, Shepherd BE, Costagliola D, Ledergerber B, Thiébaut R, Gill MJ, Kirk O, van Sighem A, Saag MS, Navarro G, Sobrino-Vegas P, Lampe F, Ingle S, Guest JL, Crane HM, D'Arminio Monforte A, Vehreschild JJ, Sterne JAC, Antiretroviral Therapy Cohort Collaboration (ART-CC)
Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics.
International Journal of Epidemiology 2012, 41, 1807-1820.
Visseaux B, Hurtado-Nedelec M, Charpentier C, Collin G, Storto A, Matheron S, Larrouy L, Damond F, Brun-Vézinet F, Descamps D, ANRS CO 05 HIV-2 Cohort
Molecular determinants of HIV-2 R5-X4 tropism in the V3 loop: development of a new genotypic tool.
The Journal of Infectious Diseases 2012, 205, 111-120.
Courbon E, Laylavoix F, Soulié C, Le Beller C, Calvez V, Katlama C, Peytavin G
Unexpected atazanavir-associated biliary lithiasis in an HIV-infected patient.
The Journal of Antimicrobial Chemotherapy 2012, 67, 250-251.
Dominguez S, Ghosn J, Cassard B, Melica G, Poizot-Martin I, Solas C, Lascaux AS, Bouvier-Alias M, Katlama C, Lévy Y, Peytavin G
Erythrocyte and plasma ribavirin concentrations in the assessment of early and sustained virological responses to pegylated interferon-alpha 2a and ribavirin in patients coinfected with hepatitis C virus and HIV.
The Journal of Antimicrobial Chemotherapy 2012, 67, 1449-1452.
Marcelin AG, Charpentier C, Wirden M, Landman R, Valantin MA, Simon A, Katlama C, Yeni P, Descamps D, Aubron-Olivier C, Calvez V
Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens.
The Journal of Antimicrobial Chemotherapy 2012, 67, 1475-1478.
Lambert-Niclot S, Flandre P, Valantin MA, Peytavin G, Sayon S, Morand-Joubert L, Delaugerre C, Algarte-Genin M, Katlama C, Calvez V, Marcelin AG
Resistant minority species are rarely observed in patients on darunavir/ritonavir monotherapy.
The Journal of Antimicrobial Chemotherapy 2012, 67, 1470-1474.
Charpentier C, Larrouy L, Visseaux B, Landman R, Levittas M, Storto A, Damond F, Yazdanpanah Y, Yeni P, Brun-Vézinet F, Descamps D
Prevalence of subtype-related polymorphisms associated with in vitro resistance to attachment inhibitor BMS-626529 in HIV-1 'non-B'-infected patients.
The Journal of Antimicrobial Chemotherapy 2012, 67, 1459-1461.
Nelson M, Amaya G, Clumeck N, Arns da Cunha C, Jayaweera D, Junod P, Li T, Tebas P, Stevens M, Buelens A, Vanveggel S, Boven K, ECHO and THRIVE Study Groups
Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials.
The Journal of Antimicrobial Chemotherapy 2012, 67, 2020-2028.
Charpentier C, Landman R, Laouénan C, Joly V, Hamet G, Damond F, Brun-Vézinet F, Mentré F, Descamps D, Yeni P
Persistent low-level HIV-1 RNA between 20 and 50 copies/mL in antiretroviral-treated patients: associated factors and virological outcome.
The Journal of Antimicrobial Chemotherapy 2012, 67, 2231-2235.
Lambert-Niclot S, Masquelier B, Cohen Codar I, Soulie C, Delaugerre C, Morand-Joubert L, Charpentier C, Ferre V, Plantier JC, Montes B, Carret S, Perrot V, Peytavin G, Costagliola D, Calvez V, Marcelin AG, EOLE Study Group
Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice.
The Journal of Antimicrobial Chemotherapy 2012, 67, 2487-2493.
Lê MP, Solas C, Garraffo R, Gagnieu MC, Muret P, Yeni P, Dhiver C, Katlama C, Poizot-Martin I, Durant J, Peytavin G
Pharmacokinetic interaction between maraviroc and etravirine in HIV-infected patients receiving regimens containing both drugs and no ritonavir-boosted protease inhibitor.
The Journal of Antimicrobial Chemotherapy 2012, 67, 2779-2781.
Lescure FX, Flateau C, Pacanowski J, Brocheriou I, Rondeau E, Girard PM, Ronco P, Pialoux G, Plaisier E
HIV-associated kidney glomerular diseases: changes with time and HAART.
Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 2012, 27, 2349-2355.
Froissart A, Buffet M, Veyradier A, Poullin P, Provôt F, Malot S, Schwarzinger M, Galicier L, Vanhille P, Vernant JP, Bordessoule D, Guidet B, Azoulay E, Mariotte E, Rondeau E, Mira JP, Wynckel A, Clabault K, Choukroun G, Presne C, Pourrat J, Hamidou M, Coppo P, French Thrombotic Microangiopathies Reference Center
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.
Critical Care Medicine 2012, 40, 104-111.
Schwebel C, Lucet JC, Vesin A, Arrault X, Calvino-Gunther S, Bouadma L, Timsit JF
Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study.
Critical Care Medicine 2012, 40, 11-17.
Laupland KB, Zahar JR, Adrie C, Schwebel C, Goldgran-Toledano D, Azoulay E, Garrouste-Orgeas M, Cohen Y, Jamali S, Souweine B, Darmon M, Timsit JF
Determinants of temperature abnormalities and influence on outcome of critical illness.
Critical Care Medicine 2012, 40, 145-151.
Garrouste-Orgeas M, Soufir L, Tabah A, Schwebel C, Vesin A, Adrie C, Thuong M, Timsit JF, Outcomerea Study Group
A multifaceted program for improving quality of care in intensive care units: IATROREF study.
Critical Care Medicine 2012, 40, 468-476.
Azoulay E, Dupont H, Tabah A, Lortholary O, Stahl JP, Francais A, Martin C, Guidet B, Timsit JF
Systemic antifungal therapy in critically ill patients without invasive fungal infection*.
Critical Care Medicine 2012, 40, 813-822.
Parienti JJ, du Cheyron D, Timsit JF, Traoré O, Kalfon P, Mimoz O, Mermel LA
Meta-analysis of subclavian insertion and nontunneled central venous catheter-associated infection risk reduction in critically ill adults.
Critical Care Medicine 2012, 40, 1627-1634.
Timsit JF, Bouadma L, Ruckly S, Schwebel C, Garrouste-Orgeas M, Bronchard R, Calvino-Gunther S, Laupland K, Adrie C, Thuong M, Herault MC, Pease S, Arrault X, Lucet JC
Dressing disruption is a major risk factor for catheter-related infections.
Crit Care Med 2012, 40, 1707-14.
Garrouste-Orgeas M, Coquet I, Périer A, Timsit JF, Pochard F, Lancrin F, Philippart F, Vesin A, Bruel C, Blel Y, Angeli S, Cousin N, Carlet J, Misset B
Impact of an intensive care unit diary on psychological distress in patients and relatives*.
Critical Care Medicine 2012, 40, 2033-2040.
Piednoir P, Quesnel C, Nardelli L, Leçon V, Bouadma L, Lasocki S, Philip I, Mailleux A, Soler P, Crestani B, Dehoux M
Alveolar fluid in acute respiratory distress syndrome promotes fibroblast migration: role of platelet-derived growth factor pathway*.
Critical Care Medicine 2012, 40, 2041-2049.
Minet C, Lugosi M, Savoye PY, Menez C, Ruckly S, Bonadona A, Schwebel C, Hamidfar-Roy R, Dumanoir P, Ara-Somohano C, Ferretti GR, Timsit JF
Pulmonary embolism in mechanically ventilated patients requiring computed tomography: Prevalence, risk factors, and outcome.
Critical Care Medicine 2012, 40, 3202-3208.
Timsit JF, Laupland KB
Update on bloodstream infections in ICUs.
Current Opinion in Critical Care 2012, 18, 479-486.
Sloan CE, Champenois K, Choisy P, Losina E, Walensky RP, Schackman BR, Ajana F, Melliez H, Paltiel AD, Freedberg KA, Yazdanpanah Y, Cost-Effectiveness of Preventing AIDS Complications (CEPAC) investigators
Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults.
AIDS (London, England) 2012, 26, 45-56.
Dray-Spira R, Legeai C, Le Den M, Boué F, Lascoux-Combe C, Simon A, May T, Goujard C, Meyer L, ANRS-COPANA Cohort Study Group
Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use.
AIDS 2012, 26, 207–215.
Capeau J, Bouteloup V, Katlama C, Bastard JP, Guiyedi V, Salmon-Ceron D, Protopopescu C, Leport C, Raffi F, Chêne G, ANRS CO8 APROCO-COPILOTE Cohort Study Group
Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment.
AIDS (London, England) 2012, 26, 303-314.
Lévy Y, Thiébaut R, Gougeon ML, Molina JM, Weiss L, Girard PM, Venet A, Morlat P, Poirier B, Lascaux AS, Boucherie C, Sereni D, Rouzioux C, Viard JP, Lane C, Delfraissy JF, Sereti I, Chêne G, ILIADE Study Group
Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV.
AIDS (London, England) 2012, 26, 711-720.
HIV-CAUSAL Collaboration
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study.
AIDS (London, England) 2012, 26, 1691-1705.
Pasquet A, Ajana F, Melliez H, Giurca C, Poissy J, Yazdanpanah Y
Central nervous system HIV replication and HIV-related pachymeningitis in a patient on protease inhibitor monotherapy despite an undetectable plasma viral load.
AIDS (London, England) 2012, 26, 1726-1728.
Solas C, Pambrun E, Winnock M, Salmon D, Poizot-Martin I, Dominguez S, Bani-Sadr F, Izopet J, Garraffo R, Peytavin G, ANRS CO-13 HEPAVIH Study Group
Ribavirin and abacavir drug interaction in HIV-HCV coinfected patients: fact or fiction?.
AIDS (London, England) 2012, 26, 2193-2199.
Pursuing Later Treatment Options II (PLATO II) project team, Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Group, Nakagawa F, Lodwick R, Costagliola D, van Sighem A, Torti C, Podzamczer D, Mocroft A, Ledergerber B, Dorrucci M, Cozzi-Lepri A, Jansen K, Masquelier B, García F, De Wit S, Stephan C, Obel N, Fätkenhaeuer G, Castagna A, Sambatakou H, Mussini C, Ghosn J, Zangerle R, Duval X, Meyer L, Perez-Hoyos S, Fabre Colin C, Kjaer J, Chene G, Grarup J, Phillips A
Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe.
Journal of Acquired Immune Deficiency Syndromes (1999) 2012, 59, 294-299.
Fagard C, Colin C, Charpentier C, Rami A, Jacomet C, Yeni P, Vittecoq D, Katlama C, Molina JM, Descamps D, Chêne G, Yazdanpanah Y, ANRS 139 TRIO Trial Group
Long-term efficacy and safety of raltegravir, etravirine, and darunavir/ritonavir in treatment-experienced patients: week 96 results from the ANRS 139 TRIO trial.
Journal of Acquired Immune Deficiency Syndromes (1999) 2012, 59, 489-493.
Henard S, Jeanmaire E, Nguyen Y, Yazdanpanah Y, Cheret A, Hoen B, Rey D, Borel A, Chavanet P, May T, Rabaud C, ICONE Group
Is total community viral load a robust predictive marker of the efficacy of the TasP strategy?.
Journal of Acquired Immune Deficiency Syndromes (1999) 2012, 61, 400-402.
Cuzin L, Trabelsi S, Delobel P, Barbuat C, Reynes J, Allavena C, Peytavin G, Ghosn J, Lascoux-Combe C, Psomas C, Corbeau P, Flandre P, ANRS 145 MARIMUNO Study group
Maraviroc intensification of stable antiviral therapy in HIV-1-infected patients with poor immune restoration: MARIMUNO-ANRS 145 study.
Journal of Acquired Immune Deficiency Syndromes (1999) 2012, 61, 557-564.
Bouadma L, Wolff M, Lucet JC
Ventilator-associated pneumonia and its prevention.
Current Opinion in Infectious Diseases 2012, 25, 395-404.
Zhao W, Cella M, Della Pasqua O, Burger D, Jacqz-Aigrain E, Pediatric European Network for Treatment of AIDS (PENTA) 15 study group
Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV-infected infants and toddlers.
British Journal of Clinical Pharmacology 2012, 73, 641-650.
Senneville E, Gaworowska D, Topolinski H, Devemy F, Nguyen S, Singer B, Beltrand E, Legout L, Caillaux M, Descamps D, Canonne JP, Yazdanpanah Y
Outcome of patients with diabetes with negative percutaneous bone biopsy performed for suspicion of osteomyelitis of the foot.
Diabet Med 2012, 29, 56-61.
Pichenot M, Deuffic-Burban S, Cuzin L, Yazdanpanah Y
Efficacy of new antiretroviral drugs in treatment-experienced HIV-infected patients: a systematic review and meta-analysis of recent randomized controlled trials.
HIV Med 2012, 13, 148-55.
Legout L, Sarraz-Bournet B, D'Elia PV, Devos P, Pasquet A, Caillaux M, Wallet F, Yazdanpanah Y, Senneville E, Haulon S, Leroy O
Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective observational cohort study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2012, 18, 352-358.
Lada O, Gervais A, Branger M, Peytavin G, Roquebert B, Collin G, Fraqueiro G, Moucari R, Hamet G, Martinot-Peignoux M, Matheron S, Marcellin P
Long-term outcome of primary non-responders to tenofovir therapy in HIV/HBV-co-infected patients: impact of HBV genotype G.
Liver International: Official Journal of the International Association for the Study of the Liver 2012, 32, 93-101.
Fournier S, Lepainteur M, Kassis-Chikhani N, Huang M, Brun-Buisson C, Jarlier V, AP-HP Outbreaks Control Group
Link between carbapenemase-producing Enterobacteria carriage and cross-border exchanges: eight-year surveillance in a large French multihospitals institution.
Journal of Travel Medicine 2012, 19, 320-323.
Grégoire C, Brumpt C, Loirat D, Lau N, Bruel C, Philippart F, Couzigou C, Garrouste-Orgeas M, Misset B
A case of daptomycin-induced immune thrombocytopenia.
Antimicrobial Agents and Chemotherapy 2012, 56, 6430-6431.
Visseaux B, Charpentier C, Hurtado-Nedelec M, Storto A, Antoine R, Peytavin G, Damond F, Matheron S, Brun-Vézinet F, Descamps D, French ANRS HIV-2 Cohort (ANRS CO 05 VIH-2)
In vitro phenotypic susceptibility of HIV-2 clinical isolates to CCR5 inhibitors.
Antimicrobial Agents and Chemotherapy 2012, 56, 137-139.
Clavel C, Peytavin G, Tubiana R, Soulié C, Courbon E, Crenn-Hebert C, Ichou H, Blanc C, Schneider L, Katlama C, Marcelin AG, Mandelbrot L
Etravirine concentrations in the cervicovaginal compartment in HIV-1-infected women receiving etravirine-containing antiretroviral therapy: DIVA 02 study.
Antimicrobial Agents and Chemotherapy 2012, 56, 4018-4020.
Lazareth H, Peytavin G, Polivka L, Dupin N
The hairy-print for levamisole-induced vasculitis.
BMJ case reports 2012, 2012,
Champenois K, Le Gall JM, Jacquemin C, Jean S, Martin C, Rios L, Benoit O, Vermoesen S, Lert F, Spire B, Yazdanpanah Y
ANRS-COM'TEST: description of a community-based HIV testing intervention in non-medical settings for men who have sex with men.
BMJ open 2012, 2, e000693.
Deuffic-Burban S, Mathurin P, Pol S, Larsen C, Roudot-Thoraval F, Desenclos JC, Dhumeaux D, Yazdanpanah Y
Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysis.
Gut 2012, 61, 290-296.
Fallot G, Halgand B, Garnier E, Branger M, Gervais A, Roque-Afonso AM, Thiers V, Billaud E, Matheron S, Samuel D, Féray C
Recombination of hepatitis B virus DNA in patients with HIV.
Gut 2012, 61, 1197-1208.
Schortgen F, Clabault K, Katsahian S, Devaquet J, Mercat A, Deye N, Dellamonica J, Bouadma L, Cook F, Beji O, Brun-Buisson C, Lemaire F, Brochard L
Fever control using external cooling in septic shock: a randomized controlled trial.
American Journal of Respiratory and Critical Care Medicine 2012, 185, 1088-1095.
Foucrier A, Woerther PL, Le Dorze M, Ruimy R, Laissy JP, Castier Y, Mourvillier B
Pulmonary sequestration syndrome diagnosed from a Nocardia infection.
American Journal of Respiratory and Critical Care Medicine 2012, 186, 288.
Timsit JF, Mimoz O, Mourvillier B, Souweine B, Garrouste-Orgeas M, Alfandari S, Plantefeve G, Bronchard R, Troche G, Gauzit R, Antona M, Canet E, Bohe J, Lepape A, Vesin A, Arrault X, Schwebel C, Adrie C, Zahar JR, Ruckly S, Tournegros C, Lucet JC
Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults.
American Journal of Respiratory and Critical Care Medicine 2012, 186, 1272-1278.
Shi JG, Chen X, Emm T, Scherle PA, McGee RF, Lo Y, Landman RR, McKeever EG, Punwani NG, Williams WV, Yeleswaram S
The effect of CYP3A4 inhibition or induction on the pharmacokinetics and pharmacodynamics of orally administered ruxolitinib (INCB018424 phosphate) in healthy volunteers.
Journal of Clinical Pharmacology 2012, 52, 809-818.
Scoccianti C, Vesin A, Martel G, Olivier M, Brambilla E, Timsit JF, Tavecchio L, Brambilla C, Field JK, Hainaut P, European Early Lung Cancer Consortium
Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: the EUELC cohort.
The European Respiratory Journal 2012, 40, 177-184.
Liquet B, Timsit JF, Rondeau V
Investigating hospital heterogeneity with a multi-state frailty model: application to nosocomial pneumonia disease in intensive care units.
BMC medical research methodology 2012, 12, 79.
Poissy J, Champenois K, Dewilde A, Melliez H, Georges H, Senneville E, Yazdanpanah Y
Impact of Herpes simplex virus load and red blood cells in cerebrospinal fluid upon herpes simplex meningo-encephalitis outcome.
BMC infectious diseases 2012, 12, 356.
Lapidus N, de Lamballerie X, Salez N, Setbon M, Ferrari P, Delabre RM, Gougeon ML, Vely F, Leruez-Ville M, Andreoletti L, Cauchemez S, Boëlle PY, Vivier E, Abel L, Schwarzinger M, Legeas M, Le Cann P, Flahault A, Carrat F
Integrative study of pandemic A/H1N1 influenza infections: design and methods of the CoPanFlu-France cohort.
BMC public health 2012, 12, 417.
Salmon-Ceron D, Cohen J, Winnock M, Roux P, Sadr FB, Rosenthal E, Martin IP, Loko MA, Mora M, Sogni P, Spire B, Dabis F, Carrieri MP, HEPAVIH group
Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France).
BMC health services research 2012, 12,
Meybeck A, Lecomte L, Valette M, Van Grunderbeeck N, Boussekey N, Chiche A, Georges H, Yazdanpanah Y, Leroy O
Should highly active antiretroviral therapy be prescribed in critically ill HIV-infected patients during the ICU stay? A retrospective cohort study.
AIDS research and therapy 2012, 9, 27.
Garrouste-Orgeas M, Philippart F, Bruel C, Max A, Lau N, Misset B
Overview of medical errors and adverse events.
Annals of Intensive Care 2012, 2, 2.
Mrozek N, Lautrette A, Timsit JF, Souweine B
How to deal with dialysis catheters in the ICU setting.
Annals of Intensive Care 2012, 2, 48.
Lucet JC
Methicillin-resistant Staphylococcus aureus carriage at ICU admission: to screen (rapidly) or not to screen?.
Critical Care (London, England) 2012, 16, 120.
Richard JCM, Pham T, Brun-Buisson C, Reignier J, Mercat A, Beduneau G, Régnier B, Mourvillier B, Guitton C, Castanier M, Combes A, Le Tulzo Y, Brochard L, REVA study group
Interest of a simple on-line screening registry for measuring ICU burden related to an influenza pandemic.
Critical Care (London, England) 2012, 16, R118.
Zahar JR, Schwebel C, Adrie C, Garrouste-Orgeas M, Français A, Vesin A, Nguile-Makao M, Tabah A, Laupland K, Le-Monnier A, Timsit JF, OUTCOMEREA study group
Outcome of ICU patients with Clostridium difficile infection.
Critical Care (London, England) 2012, 16, R215.
Clec'h C, Darmon M, Lautrette A, Chemouni F, Azoulay E, Schwebel C, Dumenil AS, Garrouste-Orgeas M, Goldgran-Toledano D, Cohen Y, Timsit JF
Efficacy of renal replacement therapy in critically ill patients: a propensity analysis.
Critical Care (London, England) 2012, 16, R236.
Pajares MJ, Agorreta J, Larrayoz M, Vesin A, Ezponda T, Zudaire I, Torre W, Lozano MD, Brambilla E, Brambilla C, Wistuba II, Behrens C, Timsit JF, Pio R, Field JK, Montuenga LM
Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung.
Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2012, 30, 1129-1136.
Sonneville R, Schmidt M, Messika J, Ait Hssain A, da Silva D, Klein IF, Bouadma L, Wolff M, Mourvillier B
Neurologic outcomes and adjunctive steroids in HIV patients with severe cerebral toxoplasmosis.
Neurology 2012, 79, 1762-1766.
Colombie V, Pugliese-Wehrlen S, Deuffic-Burban S, Cuzin L, Pugliese P, Katlama C, Poizot-Martin I, Raffi F, Cabie A, Dellamonica P, Yazdanpanah Y, Dat'Aids
Mean cost of a first combination antiretroviral therapy in HIV-infected patients in France, and determinants of expensive drugs prescription.
International journal of STD & AIDS 2012, 23, 865-869.
Schneider L, Ktorza N, Fourati S, Assoumou L, Courbon E, Caby F, Blanc C, Tindel M, Agher R, Marcelin AG, Calvez V, Peytavin G, Katlama C
Switch from etravirine twice daily to once daily in non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant HIV-infected patients with suppressed viremia: the Monetra study.
HIV clinical trials 2012, 13, 284-288.
Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord, Young J, Psichogiou M, Meyer L, Ayayi S, Grabar S, Raffi F, Reiss P, Gazzard B, Sharland M, Gutierrez F, Obel N, Kirk O, Miro JM, Furrer H, Castagna A, De Wit S, Muñoz J, Kjaer J, Grarup J, Chêne G, Bucher H
CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE.
PLoS medicine 2012, 9, e1001194.
Groh M, Faussart A, Villena I, Ajzenberg D, Carme B, Demar M, Joly V, Houze S, Simon S, Aubert D, Charlois-Ou C, Yeni P
Acute lung, heart, liver, and pancreatic involvements with hyponatremia and retinochoroiditis in a 33-year-old French Guianan patient.
PLoS neglected tropical diseases 2012
Boumendil A, Angus DC, Guitonneau AL, Menn AM, Ginsburg C, Takun K, Davido A, Masmoudi R, Doumenc B, Pateron D, Garrouste-Orgeas M, Somme D, Simon T, Aegerter P, Guidet B, ICE-CUB study group
Variability of intensive care admission decisions for the very elderly.
PloS One 2012, 7, e34387.
Lepelletier D, Ravaud P, Baron G, Lucet JC
Agreement among health care professionals in diagnosing case Vignette-based surgical site infections.
PloS One 2012, 7, e35131.
Lucet JC, Laouenan C, Chelius G, Veziris N, Lepelletier D, Friggeri A, Abiteboul D, Bouvet E, Mentre F, Fleury E
Electronic sensors for assessing interactions between healthcare workers and patients under airborne precautions.
PloS One 2012, 7, e37893.
Bouadma L, Barbier F, Biard L, Esposito-Farèse M, Le Corre B, Macrez A, Salomon L, Bonnal C, Zanker C, Najem C, Mourvillier B, Lucet JC, Régnier B, Wolff M, Tubach F, INFLUENCE-A Study Group
Personal decision-making criteria related to seasonal and pandemic A(H1N1) influenza-vaccination acceptance among French healthcare workers.
PloS One 2012, 7, e38646.
Le Vu S, Velter A, Meyer L, Peytavin G, Guinard J, Pillonel J, Barin F, Semaille C
Biomarker-based HIV incidence in a community sample of men who have sex with men in Paris, France.
PloS One 2012
Verger P, Flicoteaux R, Schwarzinger M, Sagaon-Teyssier L, Peretti-Watel P, Launay O, Sebbah R, Moatti JP
Pandemic influenza (A/H1N1) vaccine uptake among French private general practitioners: a cross sectional study in 2010.
PloS One 2012, 7, e41837.
Pellissier G, Yazdanpanah Y, Adehossi E, Tosini W, Madougou B, Ibrahima K, Lolom I, Legac S, Rouveix E, Champenois K, Rabaud C, Bouvet E
Is universal HBV vaccination of healthcare workers a relevant strategy in developing endemic countries? The case of a university hospital in Niger.
PloS One 2012, 7, e44442.
Legriel S, Schraub O, Azoulay E, Hantson P, Magalhaes E, Coquet I, Bretonniere C, Gilhodes O, Anguel N, Megarbane B, Benayoun L, Schnell D, Plantefeve G, Charpentier J, Argaud L, Mourvillier B, Galbois A, Chalumeau-Lemoine L, Rivoal M, Durand F, Geffroy A, Simon M, Stoclin A, Pallot JL, Arbelot C, Nyunga M, Lesieur O, Troché G, Bruneel F, Cordoliani YS, Bedos JP, Pico F, Critically III Posterior Reversible Encephalopathy Syndrome Study Group (CYPRESS)
Determinants of recovery from severe posterior reversible encephalopathy syndrome.
PloS One 2012, 7, e44534.
Casalino E, Bernot B, Bouchaud O, Alloui C, Choquet C, Bouvet E, Damond F, Firmin S, Delobelle A, Nkoumazok BE, Der Sahakian G, Viard JP, Zbar OZD, Aslangul E, Krivine A, Zundel J, Ghosn J, Nordmann P, Claessens YE, Tahi T, Riou B, Gautheret-Dejean A, Katlama C, Hausfater P, Brun-Vézinet F, Costagliola D
Twelve months of routine HIV screening in 6 emergency departments in the Paris area: results from the ANRS URDEP study.
PLoS ONE 2012, 7, e46437.
Hocqueloux L, Choisy P, Le Moal G, Borsa-Lebas F, Plainchamp D, Legac E, Prazuck T, de la Tribonnière X, Yazdanpanah Y, Parienti JJ
Pharmacologic boosting of atazanavir in maintenance HIV-1 therapy: the COREYA propensity-score adjusted study.
PloS One 2012, 7, e49289.
Roux D, Huy C, Lolom I, Andremont A, Arlet G, Armand-Lefevre L, Lucet JC
Diversity of extended-spectrum β-lactamase-producing Enterobacteriaceae on hospital admission.
Scandinavian Journal of Infectious Diseases 2012, 44, 231-236.
Lupo J, Bernard S, Wintenberger C, Baccard M, Vabret A, Antona D, Timsit JF, Morand P
Fatal measles without rash in immunocompetent adult, France.
Emerging Infectious Diseases 2012, 18, 521-523.
Cojean S, Houzé S, Haouchine D, Huteau F, Lariven S, Hubert V, Michard F, Bories C, Pratlong F, Le Bras J, Loiseau PM, Matheron S
Leishmania resistance to miltefosine associated with genetic marker.
Emerging Infectious Diseases 2012, 18, 704-706.
Marcelin AG, Descamps D, Tamalet C, Cottalorda J, Izopet J, Delaugerre C, Morand-Joubert L, Trabaud MA, Bettinger D, Rogez S, Ruffault A, Henquell C, Signori-Schmuck A, Bouvier-Alias M, Vallet S, Masquelier B, Flandre P, Calvez V, ANRS AC11 Resistance Study group
Emerging mutations and associated factors in patients displaying treatment failure on an etravirine-containing regimen.
Antiviral Therapy 2012, 17, 119-123.
Boufassa F, Goujard C, Viard JP, Carlier R, Lefebvre B, Yeni P, Bouchaud O, Capeau J, Meyer L, Vigouroux C, ANRS COPANA Cohort Study Group
Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort.
Antivir. Ther. (Lond.) 2012, 17, 91–100.
Lada O, Gervais A, Branger M, Peytavin G, Roquebert B, Collin G, Fraqueiro G, Moucari R, Leclerc L, Martinot-Peignoux M, Matheron S, Marcellin P
Quasispecies analysis and in vitro susceptibility of HBV strains isolated from HIV-HBV-coinfected patients with delayed response to tenofovir.
Antiviral Therapy 2012, 17, 61-70.
Protopopescu C, Raffi F, Brunet-François C, Salmon D, Verdon R, Reboud P, Carrieri MP, Leport C, Spire B, Michel L, APROCO-COPILOTE (ANRS CO8) Study Group
Incidence, medical and socio-behavioural predictors of psychiatric events in an 11-year follow-up of HIV-infected patients on antiretroviral therapy.
Antiviral Therapy 2012, 17, 1079-1083.
Calin R, Paris L, Simon A, Peytavin G, Wirden M, Schneider L, Valantin MA, Tubiana R, Agher R, Katlama C
Dual raltegravir/etravirine combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy.
Antiviral Therapy 2012, 17, 1601-1604.
Breton G, Bourgarit A, Pavy S, Bonnet D, Martinez V, Duval X, Longuet P, Abgrall S, Simon A, Leport C, Paradox-TB Study Group
Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients.
The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union Against Tuberculosis and Lung Disease 2012, 16, 1365-1370.
Fournier S, Brossier F, Fortineau N, Gillaizeau F, Akpabie A, Aubry A, Barbut F, Chedhomme FX, Kassis-Chikhani N, Lucet JC, Robert J, Seytre D, Simon I, Vanjak D, Zahar JR, Brun-Buisson C, Jarlier V
Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2012, 17,
What is a modest public health impact?.
Archives of Internal Medicine 2012, 172, 521-522; author reply 522-523.
Coeurjolly JF, Nguile-Makao M, Timsit JF, Liquet B
Attributable risk estimation for adjusted disability multistate models: application to nosocomial infections.
Biometrical Journal. Biometrische Zeitschrift 2012, 54, 600-616.
Soulié C, Charpentier C, Flandre P, Nino C, Carcelain G, Simon A, Katlama C, Landman R, Brun-Vézinet F, Descamps D, Calvez V, Marcelin AG
Natural evolution of CD4+ cell count in patients with CD4 >350 or >500 cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropism.
Journal of Medical Virology 2012, 84, 1853-1856.
Antonelli M, Bonten M, Chastre J, Citerio G, Conti G, Curtis JR, De Backer D, Hedenstierna G, Joannidis M, Macrae D, Mancebo J, Maggiore SM, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2011: I. Nephrology, epidemiology, nutrition and therapeutics, neurology, ethical and legal issues, experimentals.
Intensive Care Medicine 2012, 38, 192-209.
Rhodes A, Moreno RP, Azoulay E, Capuzzo M, Chiche JD, Eddleston J, Endacott R, Ferdinande P, Flaatten H, Guidet B, Kuhlen R, León-Gil C, Martin Delgado MC, Metnitz PG, Soares M, Sprung CL, Timsit JF, Valentin A, Task Force on Safety and Quality of European Society of Intensive Care Medicine (ESICM)
Prospectively defined indicators to improve the safety and quality of care for critically ill patients: a report from the Task Force on Safety and Quality of the European Society of Intensive Care Medicine (ESICM).
Intensive Care Medicine 2012, 38, 598-605.
Antonelli M, Bonten M, Chastre J, Citerio G, Conti G, Curtis JR, De Backer D, Hedenstierna G, Joannidis M, Macrae D, Mancebo J, Maggiore SM, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2011. II. Cardiovascular, infections, pneumonia and sepsis, critical care organization and outcome, education, ultrasonography, metabolism and coagulation.
Intensive Care Medicine 2012, 38, 345-358.
Antonelli M, Bonten M, Chastre J, Citerio G, Conti G, Curtis JR, De Backer D, Hedenstierna G, Joannidis M, Macrae D, Mancebo J, Maggiore SM, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2011: III. ARDS and ECMO, weaning, mechanical ventilation, noninvasive ventilation, pediatrics and miscellanea.
Intensive Care Medicine 2012, 38, 542-556.
Azoulay E, Garrouste M, Goldgran-Toledano D, Adrie C, Max A, Vesin A, Francais A, Zahar JR, Cohen Y, Allaouchiche B, Schlemmer B, Timsit JF
Increased nonbeneficial care in patients spending their birthday in the ICU.
Intensive Care Medicine 2012, 38, 1169-1176.
Timsit JF, L'Hériteau F, Lepape A, Francais A, Ruckly S, Venier AG, Jarno P, Boussat S, Coignard B, Savey A
A multicentre analysis of catheter-related infection based on a hierarchical model.
Intensive Care Medicine 2012, 38, 1662-1672.
Tabah A, Koulenti D, Laupland K, Misset B, Valles J, Bruzzi de Carvalho F, Paiva JA, Cakar N, Ma X, Eggimann P, Antonelli M, Bonten MJM, Csomos A, Krueger WA, Mikstacki A, Lipman J, Depuydt P, Vesin A, Garrouste-Orgeas M, Zahar JR, Blot S, Carlet J, Brun-Buisson C, Martin C, Rello J, Dimopoulos G, Timsit JF
Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study.
Intensive Care Medicine 2012, 38, 1930-1945.
Charpentier C, Piketty C, Laureillard D, Tisserand P, Si-Mohamed A, Weiss L, Bélec L
Dynamics of HIV-1 DNA level in highly antiretroviral-experienced patients receiving raltegravir-based therapy.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2012, 31, 129-133.
Ruppe E, Pitsch A, Tubach F, de Lastours V, Chau F, Pasquet B, Lucet JC, Andremont A, Fantin B
Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards.
European Journal of Clinical Microbiology & Infectious Diseases 2012, 31, 319-325.
Diamantis S, Rioux C, Bonnal C, Farfour É, Papy E, Andremont A, Yeni P, Bouvet É, Lucet JC
Suitability of initial antibiotic therapy for the treatment of bloodstream infections and the potential role of antibiotic management teams in improving it.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2012, 31, 1667-1671.
de Montmollin E, Corcos O, Noussair L, Leflon-Guibout V, Belmatoug N, Joly F, Lefort A
Retroperitoneal abscesses due to Nocardia farcinica: report of two cases in patients with malnutrition.
Infection 2012, 40, 93-96.
Guillet M, Zahar JR, Timsit MO, Grandin L, Carbonnelle E, Join-Lambert O, Quesne G, Nassif X, Mejean A, Carbonne A
Horizontal transmission of Streptococcus pneumoniae in the surgical ward: a rare source of nosocomial wound infection.
American Journal of Infection Control 2012, 40, 71-72.
Guet-Revillet H, Le Monnier A, Breton N, Descamps P, Lecuyer H, Alaabouche I, Bureau C, Nassif X, Zahar JR
Environmental contamination with extended-spectrum β-lactamases: is there any difference between Escherichia coli and Klebsiella spp?.
American Journal of Infection Control 2012, 40, 845-848.
Carlet J, Rambaud C, Pulcini C, l'Alliance contre développement des bactéries multirésistantes (ACdeBMR)
[Alliance against MDRO: safeguarding antibiotics].
Ann Fr Anesth Reanim 2012, 31, 704–708.
Fourati S, Malet I, Guenzel CA, Soulie C, Maidou-Peindara P, Morand-Joubert L, Wirden M, Sayon S, Peytavin G, Simon A, Katlama C, Benichou S, Calvez V, Marcelin AG
E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutations.
Antiviral Research 2012, 93, 167-174.
Bourcier V, Winnock M, Ait Ahmed M, Sogni P, Pambrun E, Poizot-Martin I, Chaffaut C, Chevret S, Trinchet JC, Salmon D, ANRS CO13 Hepavih study group, ANRS CO12 Cirvir study group
Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir).
Clinics and Research in Hepatology and Gastroenterology 2012, 36, 214-221.
Ouanes I, Schwebel C, Français A, Bruel C, Philippart F, Vesin A, Soufir L, Adrie C, Garrouste-Orgeas M, Timsit JF, Misset B, Outcomerea Study Group
A model to predict short-term death or readmission after intensive care unit discharge.
Journal of Critical Care 2012, 27, 422.e1-9.
Deuffic-Burban S, Castel H, Wiegand J, Manns MP, Wedemeyer H, Mathurin P, Yazdanpanah Y
Immediate vs. delayed treatment in patients with acute hepatitis C based on IL28B polymorphism: a model-based analysis.
Journal of Hepatology 2012, 57, 260-266.
Zahar JR, Masse V, Watier L, Lanternier F, Degand N, Postaire M, Descamps P, Nassif X, Lortholary O
Is hand-rub consumption correlated with hand hygiene and rate of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE)-acquired infections?.
The Journal of Hospital Infection 2012, 80, 348-350.
Gibert P, Brudieu E, Timsit JF, Foroni L, Thiébaut-Bertrand A, Allenet B, Pelloux H, Brenier Pinchart MP
Invasive aspergillosis: drug-dispensing systems as a source of filamentous fungal contamination in high-risk units?.
The Journal of Hospital Infection 2012, 82, 293-296.
Fihman V, Le Monnier A, Corvec S, Jaureguy F, Tankovic J, Jacquier H, Carbonnelle E, Bille E, Illiaquer M, Cattoir V, Zahar JR
Stenotrophomonas maltophilia--the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study.
The Journal of Infection 2012, 64, 391-398.
Nagy-Mignotte H, Guillem P, Vignoud L, Coudurier M, Vesin A, Bonneterre V, Toffart AC, Sakhri L, Brambilla C, Brambilla E, Timsit JF, Moro-Sibilot D, Multidisciplinary Thoracic Oncology Group
Outcomes in recurrent small-cell lung cancer after one to four chemotherapy lines: a retrospective study of 300 patients.
Lung Cancer (Amsterdam, Netherlands) 2012, 78, 112-120.
Renault P, Balleydier E, D'Ortenzio E, Bâville M, Filleul L
Epidemiology of Chikungunya infection on Reunion Island, Mayotte, and neighboring countries.
Medecine Et Maladies Infectieuses 2012, 42, 93-101.
Ciotti C, Pellissier G, Rabaud C, Lucet JC, Abiteboul D, Bouvet E, GERES
Effectiveness of respirator masks for healthcare workers, in France.
Medecine Et Maladies Infectieuses 2012, 42, 264-269.
Gros C, Yazdanpanah Y, Vachet A, Roussel-Delvallez M, Senneville E, Lemaire X
Skin and soft tissue infections due to Panton-Valentine leukocidin producing Staphylococcus aureus.
Medecine Et Maladies Infectieuses 2012, 42, 488-494.
Minet C, Vivodtzev I, Tamisier R, Arbib F, Wuyam B, Timsit JF, Monneret D, Borel JC, Baguet JP, Lévy P, Pépin JL
Reduced six-minute walking distance, high fat-free-mass index and hypercapnia are associated with endothelial dysfunction in COPD.
Respiratory Physiology & Neurobiology 2012, 183, 128-134.
Boissier F, Khalil A, Chalumeau-Lemoine L, Lescure FX, Parrot A
Rash diagnosis of blood expectoration.
Lancet (London, England) 2012, 379, 1170.
DeJesus E, Rockstroh JK, Henry K, Molina JM, Gathe J, Ramanathan S, Wei X, Yale K, Szwarcberg J, White K, Cheng AK, Kearney BP, GS-236-0103 Study Team
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial.
Lancet 2012, 379, 2429-2438.
Pursuing Later Treatment Option II (PLATO II) project team, Observational HIV Epidemiological Research Europe (COHERE) Group, Costagliola D, Lodwick R, Ledergerber B, Torti C, van Sighem A, Podzamczer D, Mocroft A, Dorrucci M, Masquelier B, de Luca A, Jansen K, De Wit S, Obel N, Fätkenheuer G, Touoloumi G, Mussini C, Castagna A, Stephan C, García F, Zangerle R, Duval X, Pérez-Hoyos S, Meyer L, Ghosn J, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Phillips A
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study.
The Lancet. Infectious Diseases 2012, 12, 119-127.
Savic RM, Barrail-Tran A, Duval X, Nembot G, Panhard X, Descamps D, Verstuyft C, Vrijens B, Taburet AM, Goujard C, Mentré F, ANRS 134–COPHAR 3 Study Group
Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patients.
Clinical Pharmacology and Therapeutics 2012, 92, 575-583.
Deuffic-Burban S, Deltenre P, Buti M, Stroffolini T, Parkes J, Mühlberger N, Siebert U, Moreno C, Hatzakis A, Rosenberg W, Zeuzem S, Mathurin P
Predicted effects of treatment for HCV infection vary among European countries.
Gastroenterology 2012, 143, 974-985.e14.
Préau M, Protopopescu C, Raffi F, Rey D, Chêne G, Marcellin F, Perronne C, Ragnaud JM, Leport C, Spire B, Anrs Co8 Aproco-Copilote Study Group
Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerability.
AIDS care 2012, 24, 434-443.
Wilkin A, Pozniak AL, Morales-Ramirez J, Lupo SH, Santoscoy M, Grinsztejn B, Ruxrungtham K, Rimsky LT, Vanveggel S, Boven K, TMC278-C204 Study Group
Long-term efficacy, safety, and tolerability of rilpivirine (RPV, TMC278) in HIV type 1-infected antiretroviral-naive patients: week 192 results from a phase IIb randomized trial.
AIDS research and human retroviruses 2012, 28, 437-446.
Péré H, Charpentier C, Mbelesso P, Dandy M, Matta M, Moussa S, De Dieu Longo J, Grésenguet G, Abraham B, Bélec L
Virological response and resistance profiles after 24 months of first-line antiretroviral treatment in adults living in Bangui, Central African Republic.
AIDS research and human retroviruses 2012, 28, 315-323.
Rozenberg S, Lanoy E, Bentata M, Viard JP, Valantin MA, Missy P, Darasteanu I, Roux C, Kolta S, Costagliola D, ANRS 120 Fosivir Study Group
Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120).
AIDS research and human retroviruses 2012, 28, 972-980.
Monleau M, Aghokeng AF, Nkano BA, Chaix ML, Peeters M, AC11/AC12 ANRS Working Group
Drug resistance mutations of HIV type 1 non-B viruses to integrase inhibitors in treatment-naive patients from sub-saharan countries and discordant interpretations.
AIDS research and human retroviruses 2012, 28, 1157-1160.
Jacquier H, Le Monnier A, Carbonnelle E, Corvec S, Illiaquer M, Bille E, Zahar JR, Jauréguy F, Fihman V, Tankovic J, Cattoir V, Gmc Study Group
In vitro antimicrobial activity of "last-resort" antibiotics against unusual nonfermenting Gram-negative bacilli clinical isolates.
Microbial Drug Resistance (Larchmont, N.Y.) 2012, 18, 396-401.
Dupont-Rouzeyrol M, Caro V, Guillaumot L, Vazeille M, D'Ortenzio E, Thiberge JM, Baroux N, Gourinat AC, Grandadam M, Failloux AB
Chikungunya virus and the mosquito vector Aedes aegypti in New Caledonia (South Pacific Region).
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.) 2012, 12, 1036-1041.
Laupland KB, Zahar JR, Adrie C, Minet C, Vésin A, Goldgran-Toledano D, Azoulay E, Garrouste-Orgeas M, Cohen Y, Schwebel C, Jamali S, Darmon M, Dumenil AS, Kallel H, Souweine B, Timsit JF
Severe hypothermia increases the risk for intensive care unit-acquired infection.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54, 1064-1070.
Mermond S, Zurawski V, D'Ortenzio E, Driscoll AJ, DeLuca AN, Deloria-Knoll M, Moïsi JC, Murdoch DR, Missotte I, Besson-Leaud L, Chevalier C, Debarnot V, Feray F, Noireterre S, Duparc B, Fresnais F, O'Connor O, Dupont-Rouzeyrol M, Levine OS
Lower respiratory infections among hospitalized children in New Caledonia: a pilot study for the Pneumonia Etiology Research for Child Health project.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54 Suppl 2, S180-189.
Rammaert B, Lanternier F, Zahar JR, Dannaoui E, Bougnoux ME, Lecuit M, Lortholary O
Healthcare-associated mucormycosis.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54 Suppl 1, S44-54.
Lanternier F, Dannaoui E, Morizot G, Elie C, Garcia-Hermoso D, Huerre M, Bitar D, Dromer F, Lortholary O, French Mycosis Study Group
A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54 Suppl 1, S35-43.
Deuffic-Burban S, Yazdanpanah Y
It is time to change the paradigm for hepatitis C virus testing.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54, 1272-1274.
HIV-CAUSAL Collaboration
Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54, 1364-1372.
Wolff M, Mourvillier B
Linezolid for the treatment of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 55, 160-161.
Schuetz P, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M, Luyt CE, Chastre J, Tubach F, Kristoffersen KB, Wei L, Burkhardt O, Welte T, Schroeder S, Nobre V, Tamm M, Bhatnagar N, Bucher HC, Mueller B
Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 55, 651-662.
Thiébaut R, Charpentier C, Damond F, Taieb A, Antoine R, Capeau J, Chêne G, Collin G, Matheron S, Descamps D, Brun-Vézinet F, French ANRS HIV-2 CO5 Cohort
Association of soluble CD14 and inflammatory biomarkers with HIV-2 disease progression.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 55, 1417-1425.
Iung B, Klein I, Mourvillier B, Olivot JM, Détaint D, Longuet P, Ruimy R, Fourchy D, Laurichesse JJ, Laissy JP, Escoubet B, Duval X, Study Group
Respective effects of early cerebral and abdominal magnetic resonance imaging on clinical decisions in infective endocarditis.
European Heart Journal Cardiovascular Imaging 2012, 13, 703-710.
Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord, Lewden C, Bouteloup V, De Wit S, Sabin C, Mocroft A, Wasmuth JC, van Sighem A, Kirk O, Obel N, Panos G, Ghosn J, Dabis F, Mary-Krause M, Leport C, Perez-Hoyos S, Sobrino-Vegas P, Stephan C, Castagna A, Antinori A, d'Arminio Monforte A, Torti C, Mussini C, Isern V, Calmy A, Teira R, Egger M, Grarup J, Chêne G
All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.
International Journal of Epidemiology 2012, 41, 433-445.
May MT, Hogg RS, Justice AC, Shepherd BE, Costagliola D, Ledergerber B, Thiébaut R, Gill MJ, Kirk O, van Sighem A, Saag MS, Navarro G, Sobrino-Vegas P, Lampe F, Ingle S, Guest JL, Crane HM, D'Arminio Monforte A, Vehreschild JJ, Sterne JAC, Antiretroviral Therapy Cohort Collaboration (ART-CC)
Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics.
International Journal of Epidemiology 2012, 41, 1807-1820.
Visseaux B, Hurtado-Nedelec M, Charpentier C, Collin G, Storto A, Matheron S, Larrouy L, Damond F, Brun-Vézinet F, Descamps D, ANRS CO 05 HIV-2 Cohort
Molecular determinants of HIV-2 R5-X4 tropism in the V3 loop: development of a new genotypic tool.
The Journal of Infectious Diseases 2012, 205, 111-120.
Courbon E, Laylavoix F, Soulié C, Le Beller C, Calvez V, Katlama C, Peytavin G
Unexpected atazanavir-associated biliary lithiasis in an HIV-infected patient.
The Journal of Antimicrobial Chemotherapy 2012, 67, 250-251.
Dominguez S, Ghosn J, Cassard B, Melica G, Poizot-Martin I, Solas C, Lascaux AS, Bouvier-Alias M, Katlama C, Lévy Y, Peytavin G
Erythrocyte and plasma ribavirin concentrations in the assessment of early and sustained virological responses to pegylated interferon-alpha 2a and ribavirin in patients coinfected with hepatitis C virus and HIV.
The Journal of Antimicrobial Chemotherapy 2012, 67, 1449-1452.
Marcelin AG, Charpentier C, Wirden M, Landman R, Valantin MA, Simon A, Katlama C, Yeni P, Descamps D, Aubron-Olivier C, Calvez V
Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens.
The Journal of Antimicrobial Chemotherapy 2012, 67, 1475-1478.
Lambert-Niclot S, Flandre P, Valantin MA, Peytavin G, Sayon S, Morand-Joubert L, Delaugerre C, Algarte-Genin M, Katlama C, Calvez V, Marcelin AG
Resistant minority species are rarely observed in patients on darunavir/ritonavir monotherapy.
The Journal of Antimicrobial Chemotherapy 2012, 67, 1470-1474.
Charpentier C, Larrouy L, Visseaux B, Landman R, Levittas M, Storto A, Damond F, Yazdanpanah Y, Yeni P, Brun-Vézinet F, Descamps D
Prevalence of subtype-related polymorphisms associated with in vitro resistance to attachment inhibitor BMS-626529 in HIV-1 'non-B'-infected patients.
The Journal of Antimicrobial Chemotherapy 2012, 67, 1459-1461.
Nelson M, Amaya G, Clumeck N, Arns da Cunha C, Jayaweera D, Junod P, Li T, Tebas P, Stevens M, Buelens A, Vanveggel S, Boven K, ECHO and THRIVE Study Groups
Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials.
The Journal of Antimicrobial Chemotherapy 2012, 67, 2020-2028.
Charpentier C, Landman R, Laouénan C, Joly V, Hamet G, Damond F, Brun-Vézinet F, Mentré F, Descamps D, Yeni P
Persistent low-level HIV-1 RNA between 20 and 50 copies/mL in antiretroviral-treated patients: associated factors and virological outcome.
The Journal of Antimicrobial Chemotherapy 2012, 67, 2231-2235.
Lambert-Niclot S, Masquelier B, Cohen Codar I, Soulie C, Delaugerre C, Morand-Joubert L, Charpentier C, Ferre V, Plantier JC, Montes B, Carret S, Perrot V, Peytavin G, Costagliola D, Calvez V, Marcelin AG, EOLE Study Group
Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice.
The Journal of Antimicrobial Chemotherapy 2012, 67, 2487-2493.
Lê MP, Solas C, Garraffo R, Gagnieu MC, Muret P, Yeni P, Dhiver C, Katlama C, Poizot-Martin I, Durant J, Peytavin G
Pharmacokinetic interaction between maraviroc and etravirine in HIV-infected patients receiving regimens containing both drugs and no ritonavir-boosted protease inhibitor.
The Journal of Antimicrobial Chemotherapy 2012, 67, 2779-2781.
Lescure FX, Flateau C, Pacanowski J, Brocheriou I, Rondeau E, Girard PM, Ronco P, Pialoux G, Plaisier E
HIV-associated kidney glomerular diseases: changes with time and HAART.
Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 2012, 27, 2349-2355.
Froissart A, Buffet M, Veyradier A, Poullin P, Provôt F, Malot S, Schwarzinger M, Galicier L, Vanhille P, Vernant JP, Bordessoule D, Guidet B, Azoulay E, Mariotte E, Rondeau E, Mira JP, Wynckel A, Clabault K, Choukroun G, Presne C, Pourrat J, Hamidou M, Coppo P, French Thrombotic Microangiopathies Reference Center
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.
Critical Care Medicine 2012, 40, 104-111.
Schwebel C, Lucet JC, Vesin A, Arrault X, Calvino-Gunther S, Bouadma L, Timsit JF
Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study.
Critical Care Medicine 2012, 40, 11-17.
Laupland KB, Zahar JR, Adrie C, Schwebel C, Goldgran-Toledano D, Azoulay E, Garrouste-Orgeas M, Cohen Y, Jamali S, Souweine B, Darmon M, Timsit JF
Determinants of temperature abnormalities and influence on outcome of critical illness.
Critical Care Medicine 2012, 40, 145-151.
Garrouste-Orgeas M, Soufir L, Tabah A, Schwebel C, Vesin A, Adrie C, Thuong M, Timsit JF, Outcomerea Study Group
A multifaceted program for improving quality of care in intensive care units: IATROREF study.
Critical Care Medicine 2012, 40, 468-476.
Azoulay E, Dupont H, Tabah A, Lortholary O, Stahl JP, Francais A, Martin C, Guidet B, Timsit JF
Systemic antifungal therapy in critically ill patients without invasive fungal infection*.
Critical Care Medicine 2012, 40, 813-822.
Parienti JJ, du Cheyron D, Timsit JF, Traoré O, Kalfon P, Mimoz O, Mermel LA
Meta-analysis of subclavian insertion and nontunneled central venous catheter-associated infection risk reduction in critically ill adults.
Critical Care Medicine 2012, 40, 1627-1634.
Timsit JF, Bouadma L, Ruckly S, Schwebel C, Garrouste-Orgeas M, Bronchard R, Calvino-Gunther S, Laupland K, Adrie C, Thuong M, Herault MC, Pease S, Arrault X, Lucet JC
Dressing disruption is a major risk factor for catheter-related infections.
Crit Care Med 2012, 40, 1707-14.
Garrouste-Orgeas M, Coquet I, Périer A, Timsit JF, Pochard F, Lancrin F, Philippart F, Vesin A, Bruel C, Blel Y, Angeli S, Cousin N, Carlet J, Misset B
Impact of an intensive care unit diary on psychological distress in patients and relatives*.
Critical Care Medicine 2012, 40, 2033-2040.
Piednoir P, Quesnel C, Nardelli L, Leçon V, Bouadma L, Lasocki S, Philip I, Mailleux A, Soler P, Crestani B, Dehoux M
Alveolar fluid in acute respiratory distress syndrome promotes fibroblast migration: role of platelet-derived growth factor pathway*.
Critical Care Medicine 2012, 40, 2041-2049.
Minet C, Lugosi M, Savoye PY, Menez C, Ruckly S, Bonadona A, Schwebel C, Hamidfar-Roy R, Dumanoir P, Ara-Somohano C, Ferretti GR, Timsit JF
Pulmonary embolism in mechanically ventilated patients requiring computed tomography: Prevalence, risk factors, and outcome.
Critical Care Medicine 2012, 40, 3202-3208.
Timsit JF, Laupland KB
Update on bloodstream infections in ICUs.
Current Opinion in Critical Care 2012, 18, 479-486.
Sloan CE, Champenois K, Choisy P, Losina E, Walensky RP, Schackman BR, Ajana F, Melliez H, Paltiel AD, Freedberg KA, Yazdanpanah Y, Cost-Effectiveness of Preventing AIDS Complications (CEPAC) investigators
Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults.
AIDS (London, England) 2012, 26, 45-56.
Dray-Spira R, Legeai C, Le Den M, Boué F, Lascoux-Combe C, Simon A, May T, Goujard C, Meyer L, ANRS-COPANA Cohort Study Group
Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use.
AIDS 2012, 26, 207–215.
Capeau J, Bouteloup V, Katlama C, Bastard JP, Guiyedi V, Salmon-Ceron D, Protopopescu C, Leport C, Raffi F, Chêne G, ANRS CO8 APROCO-COPILOTE Cohort Study Group
Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment.
AIDS (London, England) 2012, 26, 303-314.
Lévy Y, Thiébaut R, Gougeon ML, Molina JM, Weiss L, Girard PM, Venet A, Morlat P, Poirier B, Lascaux AS, Boucherie C, Sereni D, Rouzioux C, Viard JP, Lane C, Delfraissy JF, Sereti I, Chêne G, ILIADE Study Group
Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV.
AIDS (London, England) 2012, 26, 711-720.
HIV-CAUSAL Collaboration
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study.
AIDS (London, England) 2012, 26, 1691-1705.
Pasquet A, Ajana F, Melliez H, Giurca C, Poissy J, Yazdanpanah Y
Central nervous system HIV replication and HIV-related pachymeningitis in a patient on protease inhibitor monotherapy despite an undetectable plasma viral load.
AIDS (London, England) 2012, 26, 1726-1728.
Solas C, Pambrun E, Winnock M, Salmon D, Poizot-Martin I, Dominguez S, Bani-Sadr F, Izopet J, Garraffo R, Peytavin G, ANRS CO-13 HEPAVIH Study Group
Ribavirin and abacavir drug interaction in HIV-HCV coinfected patients: fact or fiction?.
AIDS (London, England) 2012, 26, 2193-2199.
Pursuing Later Treatment Options II (PLATO II) project team, Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Group, Nakagawa F, Lodwick R, Costagliola D, van Sighem A, Torti C, Podzamczer D, Mocroft A, Ledergerber B, Dorrucci M, Cozzi-Lepri A, Jansen K, Masquelier B, García F, De Wit S, Stephan C, Obel N, Fätkenhaeuer G, Castagna A, Sambatakou H, Mussini C, Ghosn J, Zangerle R, Duval X, Meyer L, Perez-Hoyos S, Fabre Colin C, Kjaer J, Chene G, Grarup J, Phillips A
Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe.
Journal of Acquired Immune Deficiency Syndromes (1999) 2012, 59, 294-299.
Fagard C, Colin C, Charpentier C, Rami A, Jacomet C, Yeni P, Vittecoq D, Katlama C, Molina JM, Descamps D, Chêne G, Yazdanpanah Y, ANRS 139 TRIO Trial Group
Long-term efficacy and safety of raltegravir, etravirine, and darunavir/ritonavir in treatment-experienced patients: week 96 results from the ANRS 139 TRIO trial.
Journal of Acquired Immune Deficiency Syndromes (1999) 2012, 59, 489-493.
Henard S, Jeanmaire E, Nguyen Y, Yazdanpanah Y, Cheret A, Hoen B, Rey D, Borel A, Chavanet P, May T, Rabaud C, ICONE Group
Is total community viral load a robust predictive marker of the efficacy of the TasP strategy?.
Journal of Acquired Immune Deficiency Syndromes (1999) 2012, 61, 400-402.
Cuzin L, Trabelsi S, Delobel P, Barbuat C, Reynes J, Allavena C, Peytavin G, Ghosn J, Lascoux-Combe C, Psomas C, Corbeau P, Flandre P, ANRS 145 MARIMUNO Study group
Maraviroc intensification of stable antiviral therapy in HIV-1-infected patients with poor immune restoration: MARIMUNO-ANRS 145 study.
Journal of Acquired Immune Deficiency Syndromes (1999) 2012, 61, 557-564.
Bouadma L, Wolff M, Lucet JC
Ventilator-associated pneumonia and its prevention.
Current Opinion in Infectious Diseases 2012, 25, 395-404.
Zhao W, Cella M, Della Pasqua O, Burger D, Jacqz-Aigrain E, Pediatric European Network for Treatment of AIDS (PENTA) 15 study group
Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV-infected infants and toddlers.
British Journal of Clinical Pharmacology 2012, 73, 641-650.
Senneville E, Gaworowska D, Topolinski H, Devemy F, Nguyen S, Singer B, Beltrand E, Legout L, Caillaux M, Descamps D, Canonne JP, Yazdanpanah Y
Outcome of patients with diabetes with negative percutaneous bone biopsy performed for suspicion of osteomyelitis of the foot.
Diabet Med 2012, 29, 56-61.
Pichenot M, Deuffic-Burban S, Cuzin L, Yazdanpanah Y
Efficacy of new antiretroviral drugs in treatment-experienced HIV-infected patients: a systematic review and meta-analysis of recent randomized controlled trials.
HIV Med 2012, 13, 148-55.
Legout L, Sarraz-Bournet B, D'Elia PV, Devos P, Pasquet A, Caillaux M, Wallet F, Yazdanpanah Y, Senneville E, Haulon S, Leroy O
Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective observational cohort study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2012, 18, 352-358.
Lada O, Gervais A, Branger M, Peytavin G, Roquebert B, Collin G, Fraqueiro G, Moucari R, Hamet G, Martinot-Peignoux M, Matheron S, Marcellin P
Long-term outcome of primary non-responders to tenofovir therapy in HIV/HBV-co-infected patients: impact of HBV genotype G.
Liver International: Official Journal of the International Association for the Study of the Liver 2012, 32, 93-101.
Fournier S, Lepainteur M, Kassis-Chikhani N, Huang M, Brun-Buisson C, Jarlier V, AP-HP Outbreaks Control Group
Link between carbapenemase-producing Enterobacteria carriage and cross-border exchanges: eight-year surveillance in a large French multihospitals institution.
Journal of Travel Medicine 2012, 19, 320-323.
Grégoire C, Brumpt C, Loirat D, Lau N, Bruel C, Philippart F, Couzigou C, Garrouste-Orgeas M, Misset B
A case of daptomycin-induced immune thrombocytopenia.
Antimicrobial Agents and Chemotherapy 2012, 56, 6430-6431.
Visseaux B, Charpentier C, Hurtado-Nedelec M, Storto A, Antoine R, Peytavin G, Damond F, Matheron S, Brun-Vézinet F, Descamps D, French ANRS HIV-2 Cohort (ANRS CO 05 VIH-2)
In vitro phenotypic susceptibility of HIV-2 clinical isolates to CCR5 inhibitors.
Antimicrobial Agents and Chemotherapy 2012, 56, 137-139.
Clavel C, Peytavin G, Tubiana R, Soulié C, Courbon E, Crenn-Hebert C, Ichou H, Blanc C, Schneider L, Katlama C, Marcelin AG, Mandelbrot L
Etravirine concentrations in the cervicovaginal compartment in HIV-1-infected women receiving etravirine-containing antiretroviral therapy: DIVA 02 study.
Antimicrobial Agents and Chemotherapy 2012, 56, 4018-4020.
Lazareth H, Peytavin G, Polivka L, Dupin N
The hairy-print for levamisole-induced vasculitis.
BMJ case reports 2012, 2012,
Champenois K, Le Gall JM, Jacquemin C, Jean S, Martin C, Rios L, Benoit O, Vermoesen S, Lert F, Spire B, Yazdanpanah Y
ANRS-COM'TEST: description of a community-based HIV testing intervention in non-medical settings for men who have sex with men.
BMJ open 2012, 2, e000693.
Deuffic-Burban S, Mathurin P, Pol S, Larsen C, Roudot-Thoraval F, Desenclos JC, Dhumeaux D, Yazdanpanah Y
Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysis.
Gut 2012, 61, 290-296.
Fallot G, Halgand B, Garnier E, Branger M, Gervais A, Roque-Afonso AM, Thiers V, Billaud E, Matheron S, Samuel D, Féray C
Recombination of hepatitis B virus DNA in patients with HIV.
Gut 2012, 61, 1197-1208.
Schortgen F, Clabault K, Katsahian S, Devaquet J, Mercat A, Deye N, Dellamonica J, Bouadma L, Cook F, Beji O, Brun-Buisson C, Lemaire F, Brochard L
Fever control using external cooling in septic shock: a randomized controlled trial.
American Journal of Respiratory and Critical Care Medicine 2012, 185, 1088-1095.
Foucrier A, Woerther PL, Le Dorze M, Ruimy R, Laissy JP, Castier Y, Mourvillier B
Pulmonary sequestration syndrome diagnosed from a Nocardia infection.
American Journal of Respiratory and Critical Care Medicine 2012, 186, 288.
Timsit JF, Mimoz O, Mourvillier B, Souweine B, Garrouste-Orgeas M, Alfandari S, Plantefeve G, Bronchard R, Troche G, Gauzit R, Antona M, Canet E, Bohe J, Lepape A, Vesin A, Arrault X, Schwebel C, Adrie C, Zahar JR, Ruckly S, Tournegros C, Lucet JC
Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults.
American Journal of Respiratory and Critical Care Medicine 2012, 186, 1272-1278.
Shi JG, Chen X, Emm T, Scherle PA, McGee RF, Lo Y, Landman RR, McKeever EG, Punwani NG, Williams WV, Yeleswaram S
The effect of CYP3A4 inhibition or induction on the pharmacokinetics and pharmacodynamics of orally administered ruxolitinib (INCB018424 phosphate) in healthy volunteers.
Journal of Clinical Pharmacology 2012, 52, 809-818.
Scoccianti C, Vesin A, Martel G, Olivier M, Brambilla E, Timsit JF, Tavecchio L, Brambilla C, Field JK, Hainaut P, European Early Lung Cancer Consortium
Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: the EUELC cohort.
The European Respiratory Journal 2012, 40, 177-184.
Liquet B, Timsit JF, Rondeau V
Investigating hospital heterogeneity with a multi-state frailty model: application to nosocomial pneumonia disease in intensive care units.
BMC medical research methodology 2012, 12, 79.
Poissy J, Champenois K, Dewilde A, Melliez H, Georges H, Senneville E, Yazdanpanah Y
Impact of Herpes simplex virus load and red blood cells in cerebrospinal fluid upon herpes simplex meningo-encephalitis outcome.
BMC infectious diseases 2012, 12, 356.
Lapidus N, de Lamballerie X, Salez N, Setbon M, Ferrari P, Delabre RM, Gougeon ML, Vely F, Leruez-Ville M, Andreoletti L, Cauchemez S, Boëlle PY, Vivier E, Abel L, Schwarzinger M, Legeas M, Le Cann P, Flahault A, Carrat F
Integrative study of pandemic A/H1N1 influenza infections: design and methods of the CoPanFlu-France cohort.
BMC public health 2012, 12, 417.
Salmon-Ceron D, Cohen J, Winnock M, Roux P, Sadr FB, Rosenthal E, Martin IP, Loko MA, Mora M, Sogni P, Spire B, Dabis F, Carrieri MP, HEPAVIH group
Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France).
BMC health services research 2012, 12,
Meybeck A, Lecomte L, Valette M, Van Grunderbeeck N, Boussekey N, Chiche A, Georges H, Yazdanpanah Y, Leroy O
Should highly active antiretroviral therapy be prescribed in critically ill HIV-infected patients during the ICU stay? A retrospective cohort study.
AIDS research and therapy 2012, 9, 27.
Garrouste-Orgeas M, Philippart F, Bruel C, Max A, Lau N, Misset B
Overview of medical errors and adverse events.
Annals of Intensive Care 2012, 2, 2.
Mrozek N, Lautrette A, Timsit JF, Souweine B
How to deal with dialysis catheters in the ICU setting.
Annals of Intensive Care 2012, 2, 48.
Lucet JC
Methicillin-resistant Staphylococcus aureus carriage at ICU admission: to screen (rapidly) or not to screen?.
Critical Care (London, England) 2012, 16, 120.
Richard JCM, Pham T, Brun-Buisson C, Reignier J, Mercat A, Beduneau G, Régnier B, Mourvillier B, Guitton C, Castanier M, Combes A, Le Tulzo Y, Brochard L, REVA study group
Interest of a simple on-line screening registry for measuring ICU burden related to an influenza pandemic.
Critical Care (London, England) 2012, 16, R118.
Zahar JR, Schwebel C, Adrie C, Garrouste-Orgeas M, Français A, Vesin A, Nguile-Makao M, Tabah A, Laupland K, Le-Monnier A, Timsit JF, OUTCOMEREA study group
Outcome of ICU patients with Clostridium difficile infection.
Critical Care (London, England) 2012, 16, R215.
Clec'h C, Darmon M, Lautrette A, Chemouni F, Azoulay E, Schwebel C, Dumenil AS, Garrouste-Orgeas M, Goldgran-Toledano D, Cohen Y, Timsit JF
Efficacy of renal replacement therapy in critically ill patients: a propensity analysis.
Critical Care (London, England) 2012, 16, R236.
Pajares MJ, Agorreta J, Larrayoz M, Vesin A, Ezponda T, Zudaire I, Torre W, Lozano MD, Brambilla E, Brambilla C, Wistuba II, Behrens C, Timsit JF, Pio R, Field JK, Montuenga LM
Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung.
Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2012, 30, 1129-1136.
Sonneville R, Schmidt M, Messika J, Ait Hssain A, da Silva D, Klein IF, Bouadma L, Wolff M, Mourvillier B
Neurologic outcomes and adjunctive steroids in HIV patients with severe cerebral toxoplasmosis.
Neurology 2012, 79, 1762-1766.
Colombie V, Pugliese-Wehrlen S, Deuffic-Burban S, Cuzin L, Pugliese P, Katlama C, Poizot-Martin I, Raffi F, Cabie A, Dellamonica P, Yazdanpanah Y, Dat'Aids
Mean cost of a first combination antiretroviral therapy in HIV-infected patients in France, and determinants of expensive drugs prescription.
International journal of STD & AIDS 2012, 23, 865-869.
Schneider L, Ktorza N, Fourati S, Assoumou L, Courbon E, Caby F, Blanc C, Tindel M, Agher R, Marcelin AG, Calvez V, Peytavin G, Katlama C
Switch from etravirine twice daily to once daily in non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant HIV-infected patients with suppressed viremia: the Monetra study.
HIV clinical trials 2012, 13, 284-288.
Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord, Young J, Psichogiou M, Meyer L, Ayayi S, Grabar S, Raffi F, Reiss P, Gazzard B, Sharland M, Gutierrez F, Obel N, Kirk O, Miro JM, Furrer H, Castagna A, De Wit S, Muñoz J, Kjaer J, Grarup J, Chêne G, Bucher H
CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE.
PLoS medicine 2012, 9, e1001194.
Groh M, Faussart A, Villena I, Ajzenberg D, Carme B, Demar M, Joly V, Houze S, Simon S, Aubert D, Charlois-Ou C, Yeni P
Acute lung, heart, liver, and pancreatic involvements with hyponatremia and retinochoroiditis in a 33-year-old French Guianan patient.
PLoS neglected tropical diseases 2012
Boumendil A, Angus DC, Guitonneau AL, Menn AM, Ginsburg C, Takun K, Davido A, Masmoudi R, Doumenc B, Pateron D, Garrouste-Orgeas M, Somme D, Simon T, Aegerter P, Guidet B, ICE-CUB study group
Variability of intensive care admission decisions for the very elderly.
PloS One 2012, 7, e34387.
Lepelletier D, Ravaud P, Baron G, Lucet JC
Agreement among health care professionals in diagnosing case Vignette-based surgical site infections.
PloS One 2012, 7, e35131.
Lucet JC, Laouenan C, Chelius G, Veziris N, Lepelletier D, Friggeri A, Abiteboul D, Bouvet E, Mentre F, Fleury E
Electronic sensors for assessing interactions between healthcare workers and patients under airborne precautions.
PloS One 2012, 7, e37893.
Bouadma L, Barbier F, Biard L, Esposito-Farèse M, Le Corre B, Macrez A, Salomon L, Bonnal C, Zanker C, Najem C, Mourvillier B, Lucet JC, Régnier B, Wolff M, Tubach F, INFLUENCE-A Study Group
Personal decision-making criteria related to seasonal and pandemic A(H1N1) influenza-vaccination acceptance among French healthcare workers.
PloS One 2012, 7, e38646.
Le Vu S, Velter A, Meyer L, Peytavin G, Guinard J, Pillonel J, Barin F, Semaille C
Biomarker-based HIV incidence in a community sample of men who have sex with men in Paris, France.
PloS One 2012
Verger P, Flicoteaux R, Schwarzinger M, Sagaon-Teyssier L, Peretti-Watel P, Launay O, Sebbah R, Moatti JP
Pandemic influenza (A/H1N1) vaccine uptake among French private general practitioners: a cross sectional study in 2010.
PloS One 2012, 7, e41837.
Pellissier G, Yazdanpanah Y, Adehossi E, Tosini W, Madougou B, Ibrahima K, Lolom I, Legac S, Rouveix E, Champenois K, Rabaud C, Bouvet E
Is universal HBV vaccination of healthcare workers a relevant strategy in developing endemic countries? The case of a university hospital in Niger.
PloS One 2012, 7, e44442.
Legriel S, Schraub O, Azoulay E, Hantson P, Magalhaes E, Coquet I, Bretonniere C, Gilhodes O, Anguel N, Megarbane B, Benayoun L, Schnell D, Plantefeve G, Charpentier J, Argaud L, Mourvillier B, Galbois A, Chalumeau-Lemoine L, Rivoal M, Durand F, Geffroy A, Simon M, Stoclin A, Pallot JL, Arbelot C, Nyunga M, Lesieur O, Troché G, Bruneel F, Cordoliani YS, Bedos JP, Pico F, Critically III Posterior Reversible Encephalopathy Syndrome Study Group (CYPRESS)
Determinants of recovery from severe posterior reversible encephalopathy syndrome.
PloS One 2012, 7, e44534.
Casalino E, Bernot B, Bouchaud O, Alloui C, Choquet C, Bouvet E, Damond F, Firmin S, Delobelle A, Nkoumazok BE, Der Sahakian G, Viard JP, Zbar OZD, Aslangul E, Krivine A, Zundel J, Ghosn J, Nordmann P, Claessens YE, Tahi T, Riou B, Gautheret-Dejean A, Katlama C, Hausfater P, Brun-Vézinet F, Costagliola D
Twelve months of routine HIV screening in 6 emergency departments in the Paris area: results from the ANRS URDEP study.
PLoS ONE 2012, 7, e46437.
Hocqueloux L, Choisy P, Le Moal G, Borsa-Lebas F, Plainchamp D, Legac E, Prazuck T, de la Tribonnière X, Yazdanpanah Y, Parienti JJ
Pharmacologic boosting of atazanavir in maintenance HIV-1 therapy: the COREYA propensity-score adjusted study.
PloS One 2012, 7, e49289.
Roux D, Huy C, Lolom I, Andremont A, Arlet G, Armand-Lefevre L, Lucet JC
Diversity of extended-spectrum β-lactamase-producing Enterobacteriaceae on hospital admission.
Scandinavian Journal of Infectious Diseases 2012, 44, 231-236.
Lupo J, Bernard S, Wintenberger C, Baccard M, Vabret A, Antona D, Timsit JF, Morand P
Fatal measles without rash in immunocompetent adult, France.
Emerging Infectious Diseases 2012, 18, 521-523.
Cojean S, Houzé S, Haouchine D, Huteau F, Lariven S, Hubert V, Michard F, Bories C, Pratlong F, Le Bras J, Loiseau PM, Matheron S
Leishmania resistance to miltefosine associated with genetic marker.
Emerging Infectious Diseases 2012, 18, 704-706.
Marcelin AG, Descamps D, Tamalet C, Cottalorda J, Izopet J, Delaugerre C, Morand-Joubert L, Trabaud MA, Bettinger D, Rogez S, Ruffault A, Henquell C, Signori-Schmuck A, Bouvier-Alias M, Vallet S, Masquelier B, Flandre P, Calvez V, ANRS AC11 Resistance Study group
Emerging mutations and associated factors in patients displaying treatment failure on an etravirine-containing regimen.
Antiviral Therapy 2012, 17, 119-123.
Boufassa F, Goujard C, Viard JP, Carlier R, Lefebvre B, Yeni P, Bouchaud O, Capeau J, Meyer L, Vigouroux C, ANRS COPANA Cohort Study Group
Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort.
Antivir. Ther. (Lond.) 2012, 17, 91–100.
Lada O, Gervais A, Branger M, Peytavin G, Roquebert B, Collin G, Fraqueiro G, Moucari R, Leclerc L, Martinot-Peignoux M, Matheron S, Marcellin P
Quasispecies analysis and in vitro susceptibility of HBV strains isolated from HIV-HBV-coinfected patients with delayed response to tenofovir.
Antiviral Therapy 2012, 17, 61-70.
Protopopescu C, Raffi F, Brunet-François C, Salmon D, Verdon R, Reboud P, Carrieri MP, Leport C, Spire B, Michel L, APROCO-COPILOTE (ANRS CO8) Study Group
Incidence, medical and socio-behavioural predictors of psychiatric events in an 11-year follow-up of HIV-infected patients on antiretroviral therapy.
Antiviral Therapy 2012, 17, 1079-1083.
Calin R, Paris L, Simon A, Peytavin G, Wirden M, Schneider L, Valantin MA, Tubiana R, Agher R, Katlama C
Dual raltegravir/etravirine combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy.
Antiviral Therapy 2012, 17, 1601-1604.
Breton G, Bourgarit A, Pavy S, Bonnet D, Martinez V, Duval X, Longuet P, Abgrall S, Simon A, Leport C, Paradox-TB Study Group
Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients.
The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union Against Tuberculosis and Lung Disease 2012, 16, 1365-1370.
Fournier S, Brossier F, Fortineau N, Gillaizeau F, Akpabie A, Aubry A, Barbut F, Chedhomme FX, Kassis-Chikhani N, Lucet JC, Robert J, Seytre D, Simon I, Vanjak D, Zahar JR, Brun-Buisson C, Jarlier V
Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2012, 17,
